PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cleland, JFG; Clark, RA				Cleland, John F. G.; Clark, Robyn A.			Telehealth: delivering high-quality care for heart failure	LANCET			English	Editorial Material							MANAGEMENT; MORTALITY		[Cleland, John F. G.] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland; [Cleland, John F. G.] Univ Glasgow, Clin Trials Unit, Glasgow G12 8QQ, Lanark, Scotland; [Cleland, John F. G.] Imperial Coll, Natl Heart & Lung Inst, Clin Cardiol, London, England; [Clark, Robyn A.] Flinders Univ S Australia, Acute Care & Cardiovasc Res, Adelaide, SA, Australia	University of Glasgow; University of Glasgow; Imperial College London; Flinders University South Australia	Cleland, JFG (corresponding author), Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland.; Cleland, JFG (corresponding author), Univ Glasgow, Clin Trials Unit, Glasgow G12 8QQ, Lanark, Scotland.; Cleland, JFG (corresponding author), Imperial Coll, Natl Heart & Lung Inst, Clin Cardiol, London, England.	john.cleland@glasgow.ac.uk	Clark, Robyn A/D-1604-2009; Cleland, John G./AAZ-4185-2020	Clark, Robyn A/0000-0002-5063-2618; Cleland, John G./0000-0002-1471-7016				Atherton JJ, 2018, HEART LUNG CIRC, V27, P1123, DOI 10.1016/j.hlc.2018.06.1042; Cleland JGF, 2006, J AM COLL CARDIOL, V47, P1603, DOI 10.1016/j.jacc.2005.11.069; Cleland JGF, 2005, J AM COLL CARDIOL, V45, P1654, DOI 10.1016/j.jacc.2005.01.050; Cleland JGF, 2011, EUR HEART J, V32, P2225, DOI 10.1093/eurheartj/ehr120; Cleland JGF, 2010, JAMA-J AM MED ASSOC, V304, P1383, DOI 10.1001/jama.2010.1387; Cleland JGF, 2009, EUR J HEART FAIL, V11, P227, DOI [10.1093/eurjhf/hfp071, 10.1093/eurjhf/hfp027]; Inglis SC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub3; Koehler F, 2018, LANCET, V392, P1047, DOI 10.1016/S0140-6736(18)31880-4; Koehler F, 2010, EUR J HEART FAIL, V12, P1354, DOI 10.1093/eurjhf/hfq199; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Steventon A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3874	11	6	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2018	392	10152					990	991		10.1016/S0140-6736(18)31995-0	http://dx.doi.org/10.1016/S0140-6736(18)31995-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GU2KP	30153986	Green Accepted			2022-12-28	WOS:000445098800006
J	Roglic, G; Norris, SL				Roglic, Gojka; Norris, Susan L.			Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings: Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the Control of Blood Glucose Levels in Nonpregnant Adults With Diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Article							METAANALYSIS	Description: The World Health Organization developed these guidelines to provide guidance on selection of medicines for treatment intensification in type 2 diabetes and on use of insulin (human or analogue) in type 1 and 2 diabetes. The target audience includes clinicians, policymakers, national diabetes program managers, and medicine procurement officers. The target population is adults with type 1 or 2 diabetes in low-resource settings in low- or high-income countries. The guidelines also apply to disadvantaged populations in high-income countries. Methods: The recommendations were formulated by a 12-member guideline development group and are based on high-quality systematic reviews identified via a search of several bibliographic databases from 1 January 2007 to 1 March 2017. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) system was used to assess the quality of the evidence and the strength of the recommendations. The guideline was peer-reviewed by 6 external reviewers. Recommendation 1: Give a sulfonylurea to patients with type 2 diabetes who do not achieve glycemic control with metformin alone or who have contraindications to metformin (strong recommendation, moderate-quality evidence). Recommendation 2: Introduce human insulin treatment to patients with type 2 diabetes who do not achieve glycemic control with metformin and/or a sulfonylurea (strong recommendation, very-low-quality evidence). Recommendation 3: If insulin is unsuitable, a dipeptidyl peptidase-4 (DPP-4) inhibitor, a sodium-glucose cotransporter-2 (SGLT-2) inhibitor, or a thiazolidinedione (TZD) may be added (weak recommendation, very-low-quality evidence). Recommendation 4: Use human insulin to manage blood glucose in adults with type 1 diabetes and in adults with type 2 diabetes for whom insulin is indicated (strong recommendation, low-quality evidence). Recommendation 5: Consider long-acting insulin analogues to manage blood glucose in adults with type 1 or type 2 diabetes who have frequent severe hypoglycemia with human insulin (weak recommendation, moderate-quality evidence for severe hypoglycemia).	[Roglic, Gojka; Norris, Susan L.] WHO, 20 Ave Appia, CH-1211 Geneva, Switzerland	World Health Organization	Roglic, G (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva, Switzerland.	roglicg@who.int		Roglic, Gojka/0000-0003-0872-0689	World Health Organization	World Health Organization(World Health Organization)	Financial support for the development of this synopsis came from the World Health Organization budget.	Canadian Agency for Drugs and Technologies in Health, 2017, NEW DRUGS TYP 2 DIAB; Fullerton B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012161; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3; Palmer SC, 2016, JAMA-J AM MED ASSOC, V316, P313, DOI 10.1001/jama.2016.9400; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Tricco AC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5459; WHO, 2018, GUID 2 3 LIN MED TYP; WHO, 2016, GLOB REP PSOR; World Health Organization, 2014, WHO HDB GUID DEV, V2nd; World Health Organization, 2013, IMPL TOOLS PACK ESS	11	32	33	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2018	169	6					394	+		10.7326/M18-1149	http://dx.doi.org/10.7326/M18-1149			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT7CZ	30178023				2022-12-28	WOS:000444679800016
J	Insogna, KL				Insogna, Karl L.			Primary Hyperparathyroidism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; MILD PRIMARY HYPERPARATHYROIDISM; 4TH INTERNATIONAL WORKSHOP; NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM; PARATHYROID SURGERY; SURGICAL-MANAGEMENT; VERTEBRAL FRACTURES; CALCIUM INTAKE; RISK-FACTORS; NEPHROLITHIASIS	A 57-year-old woman has a fasting serum calcium level of 10.8 mg per deciliter (2.70 mmol per liter; reference range, 9.0 to 10.2 mg per deciliter [2.24 to 2.56 mmol per liter]) detected on routine laboratory testing. On repeat testing a week later, the level is 10.5 mg per deciliter (2.62 mmol per liter). The serum phosphorus level is 2.4 mg per deciliter (0.75 mmol per liter), the estimated glomerular filtration rate (eGFR) more than 60 ml per minute, the total serum protein level 7.0 g per liter, and the albumin level 4.0 g per liter. The parathyroid hormone (PTH) level is 95 pg per milliliter (reference range, 20 to 65). The patient's last menstrual period occurred at 54 years of age. She has no history of fracture or renal stones and no family history of hypercalcemia. Her mother fractured her hip slipping on ice at 70 years of age. How should this patient's condition be evaluated and treated?	[Insogna, Karl L.] Yale Sch Med, Yale Bone Ctr, New Haven, CT USA	Yale University	Insogna, KL (corresponding author), Yale Sch Med, Sect Endocrinol, POB 208020, New Haven, CT 06520 USA.	karl.insogna@yale.edu						Bilezikian JP, 2014, J CLIN ENDOCR METAB, V99, P3561, DOI 10.1210/jc.2014-1413; Bollerslev J, 2007, J CLIN ENDOCR METAB, V92, P1687, DOI 10.1210/jc.2006-1836; Bollerslev J, 2009, J CLIN ENDOCR METAB, V94, P2255, DOI 10.1210/jc.2008-2742; BROADUS AE, 1980, NEW ENGL J MED, V302, P421, DOI 10.1056/NEJM198002213020801; Cheung K, 2012, ANN SURG ONCOL, V19, P577, DOI 10.1245/s10434-011-1870-5; Clifton-Bligh PB, 2015, BONE, V74, P121, DOI 10.1016/j.bone.2014.12.067; Corbetta S, 2005, J ENDOCRINOL INVEST, V28, P122, DOI 10.1007/BF03345354; Costa AG, 2013, J CLIN DENSITOM, V16, P22, DOI 10.1016/j.jocd.2012.11.004; Dempster DW, 2015, PARATHYROIDS: BASIC AND CLINICAL CONCEPTS, 3RD EDITION, P429, DOI 10.1016/B978-0-12-397166-1.00029-1; Elkoushy MA, 2014, UROLOGY, V84, P22, DOI 10.1016/j.urology.2014.01.016; INSOGNA KL, 1985, NEW ENGL J MED, V313, P1126, DOI 10.1056/NEJM198510313131805; Jorde R, 2002, EUR J NUTR, V41, P258, DOI 10.1007/s00394-002-0383-1; KHOSLA S, 2002, J BONE MINER RES S2, V17; Koumakis E, 2014, OSTEOPOROSIS INT, V25, P1963, DOI 10.1007/s00198-014-2689-2; Lowe H, 2007, J CLIN ENDOCR METAB, V92, P3001, DOI 10.1210/jc.2006-2802; Lundstam K, 2015, J CLIN ENDOCR METAB, V100, P1359, DOI 10.1210/jc.2014-3441; Marcocci C, 2014, J CLIN ENDOCR METAB, V99, P3607, DOI 10.1210/jc.2014-1417; Misiorowski W, 2012, ADV MED SCI-POLAND, V57, P308, DOI 10.2478/v10039-012-0062-2; Mollerup CL, 2002, BMJ-BRIT MED J, V325, P807, DOI 10.1136/bmj.325.7368.807; Nael K, 2015, AM J NEURORADIOL, V36, P2147, DOI 10.3174/ajnr.A4425; Nemeth EF, 1999, TRENDS ENDOCRIN MET, V10, P66, DOI 10.1016/S1043-2760(98)00119-2; Ospina NMS, 2016, WORLD J SURG, V40, P2359, DOI 10.1007/s00268-016-3514-1; Pak CYC, 2003, AM J MED, V115, P26, DOI 10.1016/S0002-9343(03)00201-8; Peacock M, 2009, J CLIN ENDOCR METAB, V94, P4860, DOI 10.1210/jc.2009-1472; Pepe J, 2017, EUR J ENDOCRINOL, V177, pR297, DOI 10.1530/EJE-17-0485; Persson A, 2011, CLIN ENDOCRINOL, V74, P174, DOI 10.1111/j.1365-2265.2010.03909.x; Pradeep PV, 2008, WORLD J SURG, V32, P829, DOI 10.1007/s00268-007-9384-9; Rao DS, 2004, J CLIN ENDOCR METAB, V89, P5415, DOI 10.1210/jc.2004-0028; Reilly RF, 2010, CLIN J AM SOC NEPHRO, V5, P1893, DOI 10.2215/CJN.04670510; Rejnmark L, 2011, J CLIN ENDOCR METAB, V96, P2377, DOI 10.1210/jc.2011-0569; Richards ML, 2011, ARCH SURG-CHICAGO, V146, P280, DOI 10.1001/archsurg.2011.5; Rolighed L, 2014, J CLIN ENDOCR METAB, V99, P1072, DOI 10.1210/jc.2013-3978; Rowlands C, 2013, ANN ROY COLL SURG, V95, P523, DOI 10.1308/003588413X13629960048712; Rubin MR, 2008, J CLIN ENDOCR METAB, V93, P3462, DOI 10.1210/jc.2007-1215; Sankaran S, 2010, J CLIN ENDOCR METAB, V95, P1653, DOI 10.1210/jc.2009-2384; Shinall MC, 2013, ENDOCR PRACT, V19, P697, DOI 10.4158/EP12284.RA; Silverberg SJ, 2014, J CLIN ENDOCR METAB, V99, P3580, DOI 10.1210/jc.2014-1415; SILVERBERG SJ, 1989, J BONE MINER RES, V4, P283, DOI 10.1002/jbmr.5650040302; Silverberg SJ, 1996, J CLIN ENDOCR METAB, V81, P4007, DOI 10.1210/jc.81.11.4007; Sorensen MD, 2012, J UROLOGY, V187, P516, DOI 10.1016/j.juro.2011.10.027; Starup-Linde J, 2012, EUR J ENDOCRINOL, V166, P1093, DOI 10.1530/EJE-12-0032; Stephen AE, 2017, JAMA SURG, V152, P878, DOI 10.1001/jamasurg.2017.1721; Tsvetov G, 2017, J CLIN ENDOCR METAB, V102, P1270, DOI 10.1210/jc.2016-2481; Udelsman R, 2002, ANN SURG, V235, P665, DOI 10.1097/00000658-200205000-00008; Udelsman R, 2014, J CLIN ENDOCR METAB, V99, P3595, DOI 10.1210/jc.2014-2000; Vestergaard P, 2004, J INTERN MED, V255, P108, DOI 10.1046/j.0954-6820.2003.01237.x; Vestergaard P, 2003, WORLD J SURG, V27, P343, DOI 10.1007/s00268-002-6589-9; Vignali E, 2009, J CLIN ENDOCR METAB, V94, P2306, DOI 10.1210/jc.2008-2006; Walker MD, 2012, EUR J ENDOCRINOL, V167, P277, DOI 10.1530/EJE-12-0124; Wasserman JD, 2017, CLIN CANCER RES, V23, pE123, DOI 10.1158/1078-0432.CCR-17-0548; Wilhelm SM, 2016, JAMA SURG, V151, P959, DOI 10.1001/jamasurg.2016.2310; Yeh MW, 2016, ANN INTERN MED, V164, P715, DOI 10.7326/M15-1232; Yeh MW, 2013, J CLIN ENDOCR METAB, V98, P1122, DOI 10.1210/jc.2012-4022; Yu N, 2010, CLIN ENDOCRINOL, V73, P30, DOI 10.1111/j.1365-2265.2009.03766.x; Zhao L, 2013, J CLIN ENDOCR METAB, V98, P721, DOI 10.1210/jc.2012-2914	55	66	67	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					1050	1059		10.1056/NEJMcp1714213	http://dx.doi.org/10.1056/NEJMcp1714213			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4UV	30207907				2022-12-28	WOS:000444501600009
J	Weinberg-Shukron, A; Rachmiel, M; Renbaum, P; Gulsuner, S; Walsh, T; Lobel, O; Dreifuss, A; Ben-Moshe, A; Zeligson, S; Segel, R; Shore, T; Kalifa, R; Goldberg, M; King, MC; Gerlitz, O; Levy-Lahad, E; Zangen, D				Weinberg-Shukron, Ariella; Rachmiel, Mariana; Renbaum, Paul; Gulsuner, Suleyman; Walsh, Tom; Lobel, Orit; Dreifuss, Amatzia; Ben-Moshe, Avital; Zeligson, Sharon; Segel, Reeval; Shore, Tikva; Kalifa, Rachel; Goldberg, Michal; King, Mary-Claire; Gerlitz, Offer; Levy-Lahad, Ephrat; Zangen, David			Essential Role of BRCA2 in Ovarian Development and Function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIALLELIC FANCD1/BRCA2 MUTATIONS; FANCONI-ANEMIA; DNA-REPAIR; CANCER; INSIGHTS; CHILDREN; RECOMBINATION; DROSOPHILA; COMPLEX	The causes of ovarian dysgenesis remain incompletely understood. Two sisters with XX ovarian dysgenesis carried compound heterozygous truncating mutations in the BRCA2 gene that led to reduced BRCA2 protein levels and an impaired response to DNA damage, which resulted in chromosomal breakage and the failure of RAD51 to be recruited to double-stranded DNA breaks. The sisters also had microcephaly, and one sister was in long-term remission from leukemia, which had been diagnosed when she was 5 years old. Drosophila mutants that were null for an orthologue of BRCA2 were sterile, and gonadal dysgenesis was present in both sexes. These results revealed a new role for BRCA2 and highlight the importance to ovarian development of genes that are critical for recombination during meiosis. (Funded by the Israel Science Foundation and others.)	[Weinberg-Shukron, Ariella; Renbaum, Paul; Lobel, Orit; Zeligson, Sharon; Segel, Reeval; Levy-Lahad, Ephrat] Shaare Zedek Med Ctr, Med Genet Inst, IL-91031 Jerusalem, Israel; [Weinberg-Shukron, Ariella; Levy-Lahad, Ephrat; Zangen, David] Hebrew Univ Jerusalem, Fac Med, Hadassah Med Sch, Jerusalem, Israel; [Dreifuss, Amatzia; Shore, Tikva; Kalifa, Rachel; Gerlitz, Offer] Hebrew Univ Jerusalem, IMRIC, Dept Dev Biol & Canc Res, Fac Med, IL-9112102 Jerusalem, Israel; [Ben-Moshe, Avital; Goldberg, Michal] Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, Jerusalem, Israel; [Zangen, David] Hadassah Hebrew Univ, Div Pediatr Endocrinol, Med Ctr, IL-91240 Jerusalem, Israel; [Rachmiel, Mariana] Assaf Harofeh Med Ctr, Pediat Endocrinol Clin, Zerifin, Israel; [Rachmiel, Mariana] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Gulsuner, Suleyman; Walsh, Tom; King, Mary-Claire] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Gulsuner, Suleyman; Walsh, Tom; King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Levy-Lahad, E (corresponding author), Shaare Zedek Med Ctr, Med Genet Inst, IL-91031 Jerusalem, Israel.; Gerlitz, O (corresponding author), Hebrew Univ Jerusalem, IMRIC, Dept Dev Biol & Canc Res, Fac Med, IL-9112102 Jerusalem, Israel.; Zangen, D (corresponding author), Hadassah Hebrew Univ, Med Ctr, Div Pediat Endocrinol & Diabet, IL-91240 Jerusalem, Israel.	offerg@ekmd.huji.ac.il; lahad@szmc.org.il; zangend@hadassah.org.il	Gulsuner, Suleyman/AAF-2098-2020; Segel, Reeval/AAT-1498-2020	Gulsuner, Suleyman/0000-0002-3897-1238; Shore, Tikva/0000-0002-7140-0226; Goldberg, Michal/0000-0001-9397-2383; King, Mary-Claire/0000-0001-9426-1743; Gerlitz, Offer/0000-0002-1574-2088	Breast Cancer Research Foundation; National Institutes of Health [R35CA197458]; Israel Science Foundation [1788/15, 1353/12]; Israel Science Foundation; NATIONAL CANCER INSTITUTE [R35CA197458] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Israel Science Foundation(Israel Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the Israel Science Foundation and others.; Supported by a grant (1788/15) from the Legacy Heritage Biomedical Program of the Israel Science Foundation (to Drs. Gerlitz and Zangen), by grants from the Breast Cancer Research Foundation (to Drs. King and Levy-Lahad), by a grant (R35CA197458) from the National Institutes of Health (to Dr. King), by a grant (1353/12) from the Israel Science Foundation (to Dr. Goldberg), and by a donation from the Hassenfeld family to Shaare Zedek Medical Center.	ALTER BP, 1991, BRIT J HAEMATOL, V77, P410, DOI 10.1111/j.1365-2141.1991.tb08593.x; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Brough R, 2008, DNA REPAIR, V7, P10, DOI 10.1016/j.dnarep.2007.07.013; Ceccaldi R, 2016, NAT REV MOL CELL BIO, V17, P337, DOI 10.1038/nrm.2016.48; Dodgshun AJ, 2016, CANCER GENET-NY, V209, P53, DOI 10.1016/j.cancergen.2015.11.005; Eggers S, 2014, NAT REV ENDOCRINOL, V10, P673, DOI 10.1038/nrendo.2014.163; Elkan PN, 2014, NEW ENGL J MED, V370, P921, DOI 10.1056/NEJMoa1307362; Feben C, 2017, FAM CANCER, V16, P441, DOI 10.1007/s10689-017-9968-y; Fu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144285; Gazy I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134120; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Inaki K, 2012, TRENDS GENET, V28, P550, DOI 10.1016/j.tig.2012.07.002; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Mehta PA, 2018, GENEREVIEWS; Meyer S, 2014, J MED GENET, V51, P71, DOI 10.1136/jmedgenet-2013-101642; Myers K, 2012, PEDIATR BLOOD CANCER, V58, P462, DOI 10.1002/pbc.23168; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Petryk A, 2015, J CLIN ENDOCR METAB, V100, P803, DOI 10.1210/jc.2014-4357; Rodriguez-Mari A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001357; Rossetti R, 2017, CLIN GENET, V91, P183, DOI 10.1111/cge.12921; Sekelsky JJ, 2000, J CELL BIOL, V150, pF31, DOI 10.1083/jcb.150.2.F31; Sklavos MM, 2014, J CLIN ENDOCR METAB, V99, P1608, DOI 10.1210/jc.2013-3559; Smirin-Yosef P, 2017, J CLIN ENDOCR METAB, V102, P681, DOI 10.1210/jc.2016-2714; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Svojgr K, 2016, EUR J MED GENET, V59, P152, DOI 10.1016/j.ejmg.2015.11.013; Tenenbaum-Rakover Y, 2015, J MED GENET, V52, P391, DOI 10.1136/jmedgenet-2014-102921; Wagner JE, 2004, BLOOD, V103, P3226, DOI 10.1182/blood-2003-09-3138	29	53	54	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					1042	1049		10.1056/NEJMoa1800024	http://dx.doi.org/10.1056/NEJMoa1800024			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4UV	30207912	Green Accepted, Bronze			2022-12-28	WOS:000444501600008
J	Newman, M				Newman, Melanie			Global hunger grows amid conflict and climate change	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Food and Agriculture Organization International Fund for Agricultural Development Unicef World Food Programme World Health Organization, 2018, STAT FOOD SEC NUTR W	1	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2018	362								k3893	10.1136/bmj.k3893	http://dx.doi.org/10.1136/bmj.k3893			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JJ	30209049				2022-12-28	WOS:000445016500013
J	Kuehn, B				Kuehn, Bridget			Gaps in HIV Testing for Black Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2018	320	10					966	966		10.1001/jama.2018.12833	http://dx.doi.org/10.1001/jama.2018.12833			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT2QE	30208462				2022-12-28	WOS:000444341400033
J	Festa-Bianchet, M				Festa-Bianchet, Marco			Learning to migrate	SCIENCE			English	Editorial Material									[Festa-Bianchet, Marco] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Festa-Bianchet, Marco] Australian Natl Univ, Res Sch Biol, Div Evolut & Ecol, Canberra, ACT 2601, Australia	University of Sherbrooke; Australian National University	Festa-Bianchet, M (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.; Festa-Bianchet, M (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut & Ecol, Canberra, ACT 2601, Australia.	m.festa@usherbrooke.ca						FRYXELL JM, 1988, AM NAT, V131, P781, DOI 10.1086/284822; Jesmer BR, 2018, SCIENCE, V361, P1023, DOI 10.1126/science.aat0985; Merkle JA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0456; Middleton AD, 2013, ECOLOGY, V94, P1245, DOI 10.1890/11-2298.1; Poirier MA, 2018, BIOL CONSERV, V218, P1, DOI 10.1016/j.biocon.2017.11.031; Singer FJ, 2000, RESTOR ECOL, V8, P6, DOI 10.1046/j.1526-100x.2000.80061.x	6	5	5	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					972	973		10.1126/science.aau6835	http://dx.doi.org/10.1126/science.aau6835			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS7OT	30190389				2022-12-28	WOS:000443892700025
J	Spilker, JS; Aravena, M; Bethermin, M; Chapman, SC; Chen, CC; Cunningham, DJM; De Breuck, C; Dong, C; Gonzalez, AH; Hayward, CC; Hezaveh, YD; Litke, KC; Ma, J; Malkan, M; Marrone, DP; Miller, TB; Morningstar, WR; Narayanan, D; Phadke, KA; Sreevani, J; Stark, AA; Vieira, JD; Weiss, A				Spilker, J. S.; Aravena, M.; Bethermin, M.; Chapman, S. C.; Chen, C-C; Cunningham, D. J. M.; De Breuck, C.; Dong, C.; Gonzalez, A. H.; Hayward, C. C.; Hezaveh, Y. D.; Litke, K. C.; Ma, J.; Malkan, M.; Marrone, D. P.; Miller, T. B.; Morningstar, W. R.; Narayanan, D.; Phadke, K. A.; Sreevani, J.; Stark, A. A.; Vieira, J. D.; Weiss, A.			Fast molecular outflow from a dusty star-forming galaxy in the early Universe	SCIENCE			English	Article							SUPERMASSIVE BLACK-HOLES; STELLAR FEEDBACK; GALACTIC WINDS; GAS; COEVOLUTION; MERGERS; FLOWS	Galaxies grow inefficiently, with only a small percentage of the available gas converted into stars each free-fall time. Feedback processes, such as outflowing winds driven by radiation pressure, supernovae, or supermassive black hole accretion, can act to halt star formation if they heat or expel the gas supply. We report a molecular outflow launched from a dust-rich star-forming galaxy at redshift 5.3, 1 billion years after the Big Bang. The outflow reaches velocities up to 800 kilometers per second relative to the galaxy, is resolved into multiple clumps, and carries mass at a rate within a factor of 2 of the star formation rate. Our results show that molecular outflows can remove a large fraction of the gas available for star formation from galaxies at high redshift.	[Spilker, J. S.] Univ Texas Austin, Dept Astron, 2515 Speedway Stop C1400, Austin, TX 78712 USA; [Spilker, J. S.; Litke, K. C.; Marrone, D. P.] Univ Arizona, Steward Observ, 933 North Cherry Ave, Tucson, AZ 85721 USA; [Aravena, M.] Univ Diego Portales, Fac Ingn, Nucleo Astron, Av Ejercito 441, Santiago, Chile; [Bethermin, M.] Aix Marseille Univ, CNRS, Lab Astrophys Marseille, Marseille, France; [Chapman, S. C.; Cunningham, D. J. M.; Miller, T. B.] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada; [Chen, C-C; De Breuck, C.] European Southern Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany; [Cunningham, D. J. M.] St Marys Univ, Dept Astron & Phys, Halifax, NS, Canada; [Dong, C.; Gonzalez, A. H.; Narayanan, D.] Univ Florida, Bryant Space Sci Ctr, Dept Astron, Gainesville, FL 32611 USA; [Hayward, C. C.] Flatiron Inst, Ctr Computat Astrophys, 162 Fifth Ave, New York, NY 10010 USA; [Hayward, C. C.; Stark, A. A.] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Hezaveh, Y. D.; Morningstar, W. R.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Ma, J.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Malkan, M.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Miller, T. B.] Yale Univ, Dept Astron, 52 Hillhouse Ave, New Haven, CT 06511 USA; [Phadke, K. A.; Sreevani, J.; Vieira, J. D.] Univ Illinois, Dept Astron, 1002 West Green St, Urbana, IL 61801 USA; [Weiss, A.] Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany	University of Texas System; University of Texas Austin; University of Arizona; University Diego Portales; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Dalhousie University; European Southern Observatory; Saint Marys University - Canada; State University System of Florida; University of Florida; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Stanford University; University of California System; University of California Irvine; University of California System; University of California Los Angeles; Yale University; University of Illinois System; University of Illinois Urbana-Champaign; Max Planck Society	Spilker, JS (corresponding author), Univ Texas Austin, Dept Astron, 2515 Speedway Stop C1400, Austin, TX 78712 USA.; Spilker, JS (corresponding author), Univ Arizona, Steward Observ, 933 North Cherry Ave, Tucson, AZ 85721 USA.	spilkerj@gmail.com	Dong, Chenxing/E-7909-2016; CHEN, Chian-Chou (TC) 陳建州/ABB-2819-2020	Dong, Chenxing/0000-0002-5823-0349; CHEN, Chian-Chou (TC) 陳建州/0000-0002-3805-0789; Jarugula, Sreevani/0000-0002-5386-7076; Spilker, Justin/0000-0003-3256-5615; Hayward, Christopher/0000-0003-4073-3236; Stark, Antony/0000-0002-2718-9996; Cunningham, Daniel/0000-0001-7184-2967; Phadke, Kedar/0000-0001-7946-557X; De Breuck, Carlos/0000-0002-6637-3315; Aravena, Manuel/0000-0002-6290-3198; Weiss, Axel/0000-0003-4678-3939	NSF [PLR-1248097, AST-1312950]; Kavli Foundation; Gordon and Betty Moore Foundation [GBMF 947]; Australian government; McDonald Observatory at the University of Texas at Austin; Flatiron Institute; Simons Foundation;  [PHY-1125897];  [AST-1715213];  [AST-1716127]; Office of Polar Programs (OPP) [1248097] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Kavli Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Australian government(Australian GovernmentCGIAR); McDonald Observatory at the University of Texas at Austin; Flatiron Institute; Simons Foundation; ; ; ; Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	ALMA is a partnership of ESO (representing its member states), the NSF (USA), and NINS (Japan), together with the NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO, and NAOJ. The South Pole Telescope is supported by the NSF through grant PLR-1248097, with partial support through PHY-1125897, the Kavli Foundation, and Gordon and Betty Moore Foundation grant GBMF 947. The Australia Telescope Compact Array is part of the Australia Telescope National Facility, which is funded by the Australian government for operation as a National Facility managed by CSIRO. J.S.S. thanks the McDonald Observatory at the University of Texas at Austin for support through a Smith fellowship. J.S.S., K.C.L., D.P.M., J.S., and J.D.V. acknowledge support from the NSF under grant AST-1312950; K.C.L. and D.P.M. also acknowledge support under AST-1715213, and J.S. and J.D.V. also acknowledge support under AST-1716127. C.C.H. acknowledges support from the Flatiron Institute, which is supported by the Simons Foundation. Y.D.H. is a Hubble fellow.	Alatalo K, 2015, ASTROPHYS J LETT, V801, DOI 10.1088/2041-8205/801/1/L17; Aravena M, 2016, MON NOT R ASTRON SOC, V457, P4406, DOI 10.1093/mnras/stw275; Behroozi PS, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/57; Blain AW, 2004, ASTROPHYS J, V611, P725, DOI 10.1086/422353; Ceverino D, 2016, MON NOT R ASTRON SOC, V457, P2605, DOI 10.1093/mnras/stw064; Dekel A, 2006, MON NOT R ASTRON SOC, V368, P2, DOI 10.1111/j.1365-2966.2006.10145.x; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Glazebrook K, 2017, NATURE, V544, P71, DOI 10.1038/nature21680; Gonzalez-Alfonso E, 2017, ASTROPHYS J, V836, DOI 10.3847/1538-4357/836/1/11; Hayward CC, 2017, MON NOT R ASTRON SOC, V465, P1682, DOI 10.1093/mnras/stw2888; Hezaveh YD, 2016, ASTROPHYS J, V823, DOI 10.3847/0004-637X/823/1/37; Hopkins PF, 2008, ASTROPHYS J SUPPL S, V175, P356, DOI 10.1086/524362; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Mocanu LM, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/61; Murray N, 2005, ASTROPHYS J, V618, P569, DOI 10.1086/426067; Narayanan D, 2015, NATURE, V525, P496, DOI 10.1038/nature15383; Spilker JS, 2016, ASTROPHYS J, V826, DOI 10.3847/0004-637X/826/2/112; Spoon HWW, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/127; Straatman CMS, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L14; Strandet ML, 2016, ASTROPHYS J, V822, DOI 10.3847/0004-637X/822/2/80; Sturm E, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/1/L16; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; Veilleux S, 2005, ANNU REV ASTRON ASTR, V43, P769, DOI 10.1146/annurev.astro.43.072103.150610; Veilleux S, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/27; Vieira JD, 2013, NATURE, V495, P344, DOI 10.1038/nature12001	29	44	44	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					1016	+		10.1126/science.aap8900	http://dx.doi.org/10.1126/science.aap8900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190403	Green Published, Green Submitted			2022-12-28	WOS:000443892700046
J	Thomson, M; Mitra, T				Thomson, Murray; Mitra, Tirthankar			A radical approach to soot formation	SCIENCE			English	Editorial Material									[Thomson, Murray; Mitra, Tirthankar] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada	University of Toronto	Thomson, M (corresponding author), Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada.	murray.thomson@utoronto.ca	Mitra, Tirthankar/HHR-9181-2022	Mitra, Tirthankar/0000-0003-3024-1641				Eaves NA, 2015, P COMBUST INST, V35, P1787, DOI 10.1016/j.proci.2014.05.036; Frenklach M., 1991, S INT COMBUST, V23, P1559; Johansson KO, 2018, SCIENCE, V361, P997, DOI 10.1126/science.aat3417; Kutsovsky Y, 2003, ENCY POLYM SCI TECHN, DOI [DOI 10.1002/0471440264.PST477, 10.1002/0471440264.pst477]; Tielens AGGM, 2008, ANNU REV ASTRON ASTR, V46, P289, DOI 10.1146/annurev.astro.46.060407.145211; Totton TS, 2012, PHYS CHEM CHEM PHYS, V14, P4081, DOI 10.1039/c2cp23008a	6	54	54	13	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					978	979		10.1126/science.aau5941	http://dx.doi.org/10.1126/science.aau5941			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS7OT	30190393				2022-12-28	WOS:000443892700029
J	Yu, HY; Cleveland, DW				Yu, Haiyang; Cleveland, Don W.			Tuning Apoptosis and Neuroinflammation: TBK1 Restrains RIPK1	CELL			English	Editorial Material							ALS; GENES	Partial loss of TANK-binding kinase 1 (TBK1) causes amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Xu et al. identify the role of TBK1 in suppressing neuroinflammation and apoptosis by its inhibition of the receptor-interacting serine/threonine-protein kinase 1 (RIPK1) and elucidate how aging and genetic susceptibility together cause neuroinflammation.	[Yu, Haiyang; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.; Cleveland, DW (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Yu, Haiyang/AAK-3112-2020; Cleveland, Don/AAN-9783-2021	Yu, Haiyang/0000-0003-3460-6716; Cleveland, Don/0000-0002-1934-3682	NIA NIH HHS [F32 AG059358] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [F32AG059358] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmad L, 2016, TRENDS MOL MED, V22, P511, DOI 10.1016/j.molmed.2016.04.006; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Cuchet-Lourenco D, 2018, SCIENCE, V361, P810, DOI 10.1126/science.aar2641; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Xu D, 2018, AGING CELL, V174, p[TBK1 Suppresses RIPK1, 1477]	10	7	10	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1339	1341		10.1016/j.cell.2018.08.035	http://dx.doi.org/10.1016/j.cell.2018.08.035			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193106	Bronze			2022-12-28	WOS:000443841000004
J	Armentrout, PB				Armentrout, P. B.			18 electrons and counting	SCIENCE			English	Editorial Material									[Armentrout, P. B.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Armentrout, PB (corresponding author), Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.	armentrout@chem.utah.edu						Andrews L., 1999, ENCY SPECTROSCOPY SP, P1479; Bistoni G, 2016, CHEM SCI, V7, P1174, DOI 10.1039/c5sc02971f; CHATT J, 1953, J CHEM SOC, P2939, DOI 10.1039/jr9530002939; Cotton F. A., 1988, ADV INORGANIC CHEM; DEWAR JS, 1951, B SOC CHIM FR, V18, pC71; Mond L., 1890, J CHEM SOC, V57, P749, DOI DOI 10.1039/CT8905700749; Wu X, 2018, SCIENCE, V361, P912, DOI 10.1126/science.aau0839	7	6	6	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					849	850		10.1126/science.aau6622	http://dx.doi.org/10.1126/science.aau6622			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS3UB	30166476				2022-12-28	WOS:000443547000018
J	Tadaki, K; Iono, D; Yun, MS; Aretxaga, I; Hatsukade, B; Hughes, DH; Ikarashi, S; Izumi, T; Kawabe, R; Kohno, K; Lee, M; Matsuda, Y; Nakanishi, K; Saito, T; Tamura, Y; Ueda, J; Umehata, H; Wilson, GW; Michiyama, T; Ando, M; Kamieneski, P				Tadaki, K.; Iono, D.; Yun, M. S.; Aretxaga, I.; Hatsukade, B.; Hughes, D. H.; Ikarashi, S.; Izumi, T.; Kawabe, R.; Kohno, K.; Lee, M.; Matsuda, Y.; Nakanishi, K.; Saito, T.; Tamura, Y.; Ueda, J.; Umehata, H.; Wilson, G. W.; Michiyama, T.; Ando, M.; Kamieneski, P.			The gravitationally unstable gas disk of a starburst galaxy 12 billion years ago	NATURE			English	Article							MOLECULAR GAS; STAR-FORMATION; ATOMIC CARBON; FIELD; POPULATION; TELESCOPE; STABILITY; EMISSION; DUST; CO	Galaxies in the early Universe that are bright at submillimetre wavelengths (submillimetre-bright galaxies) are forming stars at a rate roughly 1,000 times higher than the Milky Way. A large fraction of the new stars form in the central kiloparsec of the galaxy(1-3), a region that is comparable in size to the massive, quiescent galaxies found at the peak of cosmic star-formation history' and the cores of present-day giant elliptical galaxies. The physical and kinematic properties inside these compact starburst cores are poorly understood because probing them at relevant spatial scales requires extremely high angular resolution. Here we report observations with a linear resolution of 550 parsecs of gas and dust in an unlensed, submillimetre-bright galaxy at a redshift of z = 4.3, when the Universe was less than two billion years old. We resolve the spatial and kinematic structure of the molecular gas inside the heavily dust-obscured core and show that the underlying gas disk is clumpy and rotationally supported (that is, its rotation velocity is larger than the velocity dispersion). Our analysis of the molecular gas mass per unit area suggests that the starburst disk is gravitationally unstable, which implies that the self-gravity of the gas is stronger than the differential rotation of the disk and the internal pressure due to stellar-radiation feedback. As a result of the gravitational instability in the disk, the molecular gas would be consumed by star formation on a timescale of 100 million years, which is comparable to gas depletion times in merging starburst galaxies(5).	[Tadaki, K.; Iono, D.; Izumi, T.; Kawabe, R.; Lee, M.; Matsuda, Y.; Nakanishi, K.; Ueda, J.; Michiyama, T.; Ando, M.] Natl Astron Observ Japan, Tokyo, Japan; [Iono, D.; Kawabe, R.; Matsuda, Y.; Nakanishi, K.; Michiyama, T.; Ando, M.] SOKENDAI Grad Univ Adv Studies, Tokyo, Japan; [Yun, M. S.; Wilson, G. W.; Kamieneski, P.] Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA; [Aretxaga, I.; Hughes, D. H.] INAOE, Puebla, Mexico; [Hatsukade, B.; Kohno, K.; Umehata, H.] Univ Tokyo, Grad Sch Sci, Inst Astron, Tokyo, Japan; [Ikarashi, S.] Univ Groningen, Kapteyn Astron Inst, Groningen, Netherlands; [Kawabe, R.] Univ Tokyo, Dept Astron, Tokyo, Japan; [Kohno, K.] Univ Tokyo, Res Ctr Early Universe, Tokyo, Japan; [Lee, M.; Tamura, Y.] Nagoya Univ, Div Particle & Astrophys Sci, Nagoya, Aichi, Japan; [Saito, T.] Max Planck Inst Astron, Heidelberg, Germany; [Umehata, H.] RIKEN, Cluster Pioneering Res, Saitama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Graduate University for Advanced Studies - Japan; University of Massachusetts System; University of Massachusetts Amherst; Instituto Nacional de Astrofisica, Optica y Electronica; University of Tokyo; University of Groningen; University of Tokyo; University of Tokyo; Nagoya University; Max Planck Society; RIKEN	Tadaki, K (corresponding author), Natl Astron Observ Japan, Tokyo, Japan.	tadaki.ken@nao.ac.jp	Tamura, Yoichi/W-1382-2019; Umehata, Hideki/GZB-1722-2022	Tamura, Yoichi/0000-0003-4807-8117; Michiyama, Tomonari/0000-0003-2475-7983; Kamieneski, Patrick/0000-0001-9394-6732; Tadaki, Ken-ichi/0000-0001-9728-8909; Nakanishi, Kouichiro/0000-0002-6939-0372; Hatsukade, Bunyo/0000-0001-6469-8725	JSPS KAKENHI [JP17J04449]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Baba for discussions about a gravitational instability in SMGs. This work was supported by JSPS KAKENHI JP17J04449. We thank the ALMA staff and in particular the EA-ARC staff for their support. This research has made use of data from ALMA and HerMES project (http://hermes.sussex.ac.uk/). ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada), MOST and ASIAA (Taiwan), and KASI (South Korea), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. HerMES is a Herschel Key Programme utilizing Guaranteed Time from the SPIRE instrument team, ESAC scientists and a mission scientist. Data analysis was in part carried out on the common-use data analysis computer system at the Astronomy Data Center (ADC) of the National Astronomical Observatory of Japan.	Barger AJ, 1998, NATURE, V394, P248, DOI 10.1038/28338; Binney J., 2008, GALACTIC DYNAMICS, P494; Bolatto AD, 2008, ASTROPHYS J, V686, P948, DOI 10.1086/591513; Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Bothwell MS, 2017, MON NOT R ASTRON SOC, V466, P2825, DOI 10.1093/mnras/stw3270; Bothwell MS, 2013, MON NOT R ASTRON SOC, V429, P3047, DOI 10.1093/mnras/sts562; Bouche N, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/3/92; Bournaud F, 2015, ASTRON ASTROPHYS, V575, DOI 10.1051/0004-6361/201425078; Bournaud F, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/57; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Cacciato M, 2012, MON NOT R ASTRON SOC, V421, P818, DOI 10.1111/j.1365-2966.2011.20359.x; Cappellari M, 2016, ANNU REV ASTRON ASTR, V54, P597, DOI 10.1146/annurev-astro-082214-122432; Carilli CL, 2013, ANNU REV ASTRON ASTR, V51, P105, DOI 10.1146/annurev-astro-082812-140953; Chabrier G, 2003, ASTROPHYS J, V586, pL133, DOI 10.1086/374879; Chapman SC, 2005, ASTROPHYS J, V622, P772, DOI 10.1086/428082; da Cunha E, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/1/110; da Cunha E, 2008, MON NOT R ASTRON SOC, V388, P1595, DOI 10.1111/j.1365-2966.2008.13535.x; Danielson ALR, 2011, MON NOT R ASTRON SOC, V410, P1687, DOI 10.1111/j.1365-2966.2010.17549.x; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; Genzel R, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/75; Genzel R, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/101; Hodge JA, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/11; Hughes DH, 1998, NATURE, V394, P241, DOI 10.1038/28328; Ikarashi S, 2015, ASTROPHYS J, V810, DOI 10.1088/0004-637X/810/2/133; Iono D, 2016, ASTROPHYS J LETT, V829, DOI 10.3847/2041-8205/829/1/L10; Ivison RJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/137; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Laigle C, 2016, ASTROPHYS J SUPPL S, V224, DOI 10.3847/0067-0049/224/2/24; Mandelker N, 2014, MON NOT R ASTRON SOC, V443, P3675, DOI 10.1093/mnras/stu1340; McMullin JP, 2007, ASTR SOC P, V376, P127; Naab T, 2014, MON NOT R ASTRON SOC, V444, P3357, DOI 10.1093/mnras/stt1919; Narayanan D, 2009, MON NOT R ASTRON SOC, V400, P1919, DOI 10.1111/j.1365-2966.2009.15581.x; Oliver SJ, 2012, MON NOT R ASTRON SOC, V424, P1614, DOI 10.1111/j.1365-2966.2012.20912.x; Papadopoulos PP, 2004, MON NOT R ASTRON SOC, V351, P147, DOI 10.1111/j.1365-2966.2004.07762.x; Romeo AB, 2011, MON NOT R ASTRON SOC, V416, P1191, DOI 10.1111/j.1365-2966.2011.19120.x; Roseboom IG, 2012, MON NOT R ASTRON SOC, V419, P2758, DOI 10.1111/j.1365-2966.2011.19827.x; Scott KS, 2008, MON NOT R ASTRON SOC, V385, P2225, DOI 10.1111/J.1365-2966.2008.12989.x; Sharda P, 2018, MON NOT R ASTRON SOC, V477, P4380, DOI 10.1093/mnras/sty886; Simpson JM, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/81; Smolcic V, 2017, ASTRON ASTROPHYS, V602, DOI 10.1051/0004-6361/201628704; Smolcic V, 2011, ASTROPHYS J LETT, V731, DOI 10.1088/2041-8205/731/2/L27; Swinbank AM, 2015, ASTROPHYS J LETT, V806, DOI 10.1088/2041-8205/806/1/L17; Swinbank AM, 2010, NATURE, V464, P733, DOI 10.1038/nature08880; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; Tacconi LJ, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/74; Tadaki K, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/2/135; Thompson TA, 2005, ASTROPHYS J, V630, P167, DOI 10.1086/431923; Toft S, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/68; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; Ueda J, 2014, ASTROPHYS J SUPPL S, V214, DOI 10.1088/0067-0049/214/1/1; van Dokkum PG, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/1/23; Veale M, 2017, MON NOT R ASTRON SOC, V464, P356, DOI 10.1093/mnras/stw2330; WANG BQ, 1994, ASTROPHYS J, V427, P759, DOI 10.1086/174182; Weiss A, 2005, ASTRON ASTROPHYS, V429, pL25, DOI 10.1051/0004-6361:200400085; Weiss A, 2003, ASTRON ASTROPHYS, V409, pL41, DOI 10.1051/0004-6361:20031337; WHITE GJ, 1994, ASTRON ASTROPHYS, V284, pL23; Wilson CD, 2008, ASTROPHYS J SUPPL S, V178, P189, DOI 10.1086/590910; Yun MS, 2015, MON NOT R ASTRON SOC, V454, P3485, DOI 10.1093/mnras/stv1963	59	46	46	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					613	+		10.1038/s41586-018-0443-1	http://dx.doi.org/10.1038/s41586-018-0443-1			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS0SZ	30158605	Green Submitted, Green Published			2022-12-28	WOS:000443218600043
J	Dick, RA; Zadrozny, KK; Xu, CY; Schur, FKM; Lyddon, TD; Ricana, CL; Wagner, JM; Perilla, JR; Ganser-Pornillos, BK; Johnson, MC; Pornillos, O; Vogt, VM				Dick, Robert A.; Zadrozny, Kaneil K.; Xu, Chaoyi; Schur, Florian K. M.; Lyddon, Terri D.; Ricana, Clifton L.; Wagner, Jonathan M.; Perilla, Juan R.; Ganser-Pornillos, Barbie K.; Johnson, Marc C.; Pornillos, Owen; Vogt, Volker M.			Inositol phosphates are assembly co-factors for HIV-1 (vol 560, pg 509, 2018)	NATURE			English	Correction																		Dick RA, 2018, NATURE, V560, P509, DOI 10.1038/s41586-018-0396-4	1	1	1	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2018	563	7731					E22	E22		10.1038/s41586-018-0505-4	http://dx.doi.org/10.1038/s41586-018-0505-4			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA2EY	30158708	Bronze			2022-12-28	WOS:000450048400010
J	Qi, B; Han, M				Qi, Bin; Han, Min			Microbial Siderophore Enterobactin Promotes Mitochondrial Iron Uptake and Development of the Host via Interaction with ATP Synthase	CELL			English	Article							ESCHERICHIA-COLI; BACTERIA; METABOLISM; ABSORPTION; RECEPTOR	Elucidating the benefits of individual microbiota-derived molecules in host animals is important for understanding the symbiosis between humans and their microbiota. The bacteria-secreted enterobactin (Ent) is an iron scavenging siderophore with presumed negative effects on hosts. However, the high prevalence of Ent-producing commensal bacteria in the human gut raises the intriguing question regarding a potential host mechanism to beneficially use Ent. We discovered an unexpected and striking role of Ent in supporting growth and the labile iron pool in C. elegans. We show that Ent promotes mitochondrial iron uptake and does so, surprisingly, by binding to the ATP synthase alpha subunit, which acts inside of mitochondria and independently of ATP synthase. We also demonstrated the conservation of this mechanism in mammalian cells. This study reveals a distinct paradigm for the "iron tug of war" between commensal bacteria and their hosts and an important mechanism for mitochondrial iron uptake and homeostasis.	[Qi, Bin; Han, Min] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Qi, Bin; Han, Min] Univ Colorado, Dept MCDB, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Han, M (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.; Han, M (corresponding author), Univ Colorado, Dept MCDB, Boulder, CO 80309 USA.	mhan@colorado.edu			NIH [P40 OD010440]; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Phoom Chairatana and Elizabeth Nolan at MIT for generously sharing Biotin-Ent; Joel Kralj for reagents; Michael Stowell, Marina Kniazeva, Jingshi Shen, Ken Krauter, Matam Vijay-Kumar, Alexander Bogdan, Romana Gerner, and Aileen Sewell for advice and discussion; Aileen Sewell for editing; Thomas Lee of Mass Spectrometry Facility at CU-Boulder for mass spectrometry; and our lab members for assistance and discussions. Some strains were provided by Caenorhabditis Genetics Center (supported by NIH P40 OD010440). This work was supported by the Howard Hughes Medical Institute.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849; Berg M, 2016, ISME J, V10, P1998, DOI 10.1038/ismej.2015.253; Blanton LV, 2016, SCIENCE, V352, DOI 10.1126/science.aad9359; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Ellermann M, 2017, FREE RADICAL BIO MED, V105, P68, DOI 10.1016/j.freeradbiomed.2016.10.489; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Froissard M, 2007, TRAFFIC, V8, P1601, DOI 10.1111/j.1600-0854.2007.00627.x; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Grillo AS, 2017, SCIENCE, V356, P608, DOI 10.1126/science.aah3862; Gusarov I, 2013, CELL, V152, P818, DOI 10.1016/j.cell.2012.12.043; Han B, 2017, CELL, V169, P1249, DOI 10.1016/j.cell.2017.05.036; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; James SA, 2015, CHEM SCI, V6, P2952, DOI 10.1039/c5sc00233h; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Junge W, 2015, ANNU REV BIOCHEM, V84, P631, DOI 10.1146/annurev-biochem-060614-034124; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kirienko NV, 2015, P NATL ACAD SCI USA, V112, P1821, DOI 10.1073/pnas.1424954112; Klang IM, 2014, AGING-US, V6, P975, DOI 10.18632/aging.100689; Kortman GAM, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01481; Kundu P, 2017, CELL, V171, P1481, DOI 10.1016/j.cell.2017.11.024; Kwon O, 1996, J BACTERIOL, V178, P3252, DOI 10.1128/jb.178.11.3252-3259.1996; LIU J, 1993, P NATL ACAD SCI USA, V90, P10653, DOI 10.1073/pnas.90.22.10653; Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889; Meisel JD, 2014, CELL, V159, P267, DOI 10.1016/j.cell.2014.09.011; Moore BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057142; Moretti D, 2015, BLOOD, V126, P1981, DOI 10.1182/blood-2015-05-642223; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Portal-Celhay C, 2012, INFECT IMMUN, V80, P1288, DOI 10.1128/IAI.05522-11; Postler TS, 2017, CELL METAB, V26, P110, DOI 10.1016/j.cmet.2017.05.008; Qi B, 2017, ELIFE, V6, DOI 10.7554/eLife.26243; Rauen U, 2007, CHEMBIOCHEM, V8, P341, DOI 10.1002/cbic.200600311; Romney SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002394; Saha P, 2017, J IMMUNOL, V198, P4293, DOI 10.4049/jimmunol.1700261; Samuel BS, 2016, P NATL ACAD SCI USA, V113, pE3941, DOI 10.1073/pnas.1607183113; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Scott TA, 2017, CELL, V169, P442, DOI 10.1016/j.cell.2017.03.040; Searle LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117906; Smith GA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009532.pub2; Stiernagle Theresa, 2006, WormBook, P1; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tsang WY, 2003, DEV DYNAM, V226, P719, DOI 10.1002/dvdy.10272; Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352; Wilson BR, 2016, TRENDS MOL MED, V22, P1077, DOI 10.1016/j.molmed.2016.10.005; World Health Organisation, 2002, IR DEF AN ASS PREV C; Xiao X, 2017, ANNU REV NUTR, V37, P103, DOI 10.1146/annurev-nutr-071816-064559; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014; Zheng TF, 2012, J AM CHEM SOC, V134, P18388, DOI 10.1021/ja3077268	54	68	70	3	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 4	2018	175	2					571	+		10.1016/j.cell.2018.07.032	http://dx.doi.org/10.1016/j.cell.2018.07.032			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GV7PQ	30146159	Bronze			2022-12-28	WOS:000446321300025
J	Sullivan, WJ; Mullen, PJ; Schmid, EW; Flores, A; Momcilovic, M; Sharpley, MS; Jelinek, D; Whiteley, AE; Maxwell, MB; Wilde, BR; Banerjee, U; Coller, HA; Shackelford, DB; Braas, D; Ayer, DE; Vallim, TQD; Lowry, WE; Christofk, HR				Sullivan, William J.; Mullen, Peter J.; Schmid, Ernst W.; Flores, Aimee; Momcilovic, Milica; Sharpley, Mark S.; Jelinek, David; Whiteley, Andrew E.; Maxwell, Matthew B.; Wilde, Blake R.; Banerjee, Utpal; Coller, Hilary A.; Shackelford, David B.; Braas, Daniel; Ayer, Donald E.; Vallim, Thomas Q. de Aguiar; Lowry, William E.; Christofk, Heather R.			Extracellular Matrix Remodeling Regulates Glucose Metabolism through TXNIP Destabilization	CELL			English	Article							THIOREDOXIN-INTERACTING PROTEIN; CELL-GROWTH; HYALURONAN; CANCER; PHOSPHORYLATION; DIFFERENTIATION; HETEROGENEITY; LOCALIZATION; DEGRADATION; ANTIOXIDANT	The metabolic state of a cell is influenced by cellextrinsic factors, including nutrient availability and growth factor signaling. Here, we present extracellular matrix (ECM) remodeling as another fundamental node of cell-extrinsic metabolic regulation. Unbiased analysis of glycolytic drivers identified the hyaluronan-mediated motility receptor as being among the most highly correlated with glycolysis in cancer. Confirming a mechanistic link between the ECM component hyaluronan and metabolism, treatment of cells and xenografts with hyaluronidase triggers a robust increase in glycolysis. This is largely achieved through rapid receptor tyrosine kinasemediated induction of the mRNA decay factor ZFP36, which targets TXNIP transcripts for degradation. Because TXNIP promotes internalization of the glucose transporter GLUT1, its acute decline enriches GLUT1 at the plasmamembrane. Functionally, induction of glycolysis by hyaluronidase is required for concomitant acceleration of cell migration. This interconnection between ECM remodeling and metabolism is exhibited in dynamic tissue states, including tumorigenesis and embryogenesis.	[Sullivan, William J.; Mullen, Peter J.; Schmid, Ernst W.; Whiteley, Andrew E.; Maxwell, Matthew B.; Banerjee, Utpal; Coller, Hilary A.; Vallim, Thomas Q. de Aguiar; Christofk, Heather R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Sullivan, William J.; Braas, Daniel; Christofk, Heather R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Flores, Aimee; Sharpley, Mark S.; Jelinek, David; Banerjee, Utpal; Coller, Hilary A.; Lowry, William E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Flores, Aimee; Banerjee, Utpal; Lowry, William E.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Momcilovic, Milica; Shackelford, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Wilde, Blake R.; Ayer, Donald E.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Banerjee, Utpal; Coller, Hilary A.; Lowry, William E.; Christofk, Heather R.] Univ Calif Los Angeles, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Braas, Daniel] Univ Calif Los Angeles, Metabol Ctr, Los Angeles, CA 90095 USA; [Vallim, Thomas Q. de Aguiar] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Coller, Hilary A.; Shackelford, David B.; Lowry, William E.; Christofk, Heather R.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Christofk, HR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.; Christofk, HR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Christofk, HR (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.; Christofk, HR (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.	hchristofk@mednet.ucla.edu		Wilde, Blake/0000-0002-8372-3954; Whiteley, Andrew/0000-0002-0165-8395; Flores, Aimee/0000-0002-3112-8934	UCLA Tumor Cell Biology Training Program (USHHS Ruth L. Kirschstein Institutional National Research Service Award) [T32 CA009056]; American Cancer Society [RSG-16-111-01-MPC, RO1 CA215185]; UCLA Jonsson Comprehensive Cancer Center; Eli and Edythe Broad Center for Regenerative Medicine Ablon Scholars Program;  [R01 AR070245]; NATIONAL CANCER INSTITUTE [T32CA009056, R01CA215185, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112119] Funding Source: NIH RePORTER	UCLA Tumor Cell Biology Training Program (USHHS Ruth L. Kirschstein Institutional National Research Service Award); American Cancer Society(American Cancer Society); UCLA Jonsson Comprehensive Cancer Center; Eli and Edythe Broad Center for Regenerative Medicine Ablon Scholars Program; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Yonggang Zhou for technical assistance with generating RNA-seq data from murine embryos and William Tu for designing shMYC sequences. W.J.S. was supported by the UCLA Tumor Cell Biology Training Program (USHHS Ruth L. Kirschstein Institutional National Research Service Award T32 CA009056). W.E.L. and H.R.C. were supported by R01 AR070245. H.R.C. was also supported by RO1 CA215185, a research scholar grant (RSG-16-111-01-MPC) from the American Cancer Society, and the UCLA Jonsson Comprehensive Cancer Center and Eli and Edythe Broad Center for Regenerative Medicine Ablon Scholars Program.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cohen M, 2003, BIOPHYS J, V85, P1996, DOI 10.1016/S0006-3495(03)74627-X; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Elgort Marc G, 2010, Genes Cancer, V1, P893, DOI 10.1177/1947601910389604; Gardner DK, 2000, SEMIN REPROD MED, V18, P205, DOI 10.1055/s-2000-12559; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Gu W, 2016, CELL STEM CELL, V19, P476, DOI 10.1016/j.stem.2016.08.008; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Hong CS, 2016, CELL REP, V14, P1590, DOI 10.1016/j.celrep.2016.01.057; Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kidder GM, 2002, REPRODUCTION, V123, P613, DOI 10.1530/rep.0.1230613; KUPPUSAMY UR, 1990, BIOCHEM PHARMACOL, V40, P397, DOI 10.1016/0006-2952(90)90709-T; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lee S, 2013, NORTHEAST ASIAN PERSPECTIVES ON INTERNATIONAL LAW: CONTEMPORARY ISSUES AND CHALLENGES, P1; LIM RW, 1989, MOL CELL BIOL, V9, P1790, DOI 10.1128/MCB.9.4.1790; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Nagaraj R, 2017, CELL, V168, P210, DOI 10.1016/j.cell.2016.12.026; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Purcell SH, 2009, TRENDS ENDOCRIN MET, V20, P483, DOI 10.1016/j.tem.2009.06.006; RAGHOW R, 1994, FASEB J, V8, P823, DOI 10.1096/fasebj.8.11.8070631; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shen LL, 2015, P NATL ACAD SCI USA, V112, P5425, DOI 10.1073/pnas.1501555112; Slomiany MG, 2009, CANCER RES, V69, P1293, DOI 10.1158/0008-5472.CAN-08-2491; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamada M, 2012, CANCER RES, V72, P1438, DOI 10.1158/0008-5472.CAN-11-3024; Tarling EJ, 2017, J CLIN INVEST, V127, P3741, DOI 10.1172/JCI94029; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Waldhart AN, 2017, CELL REP, V19, P2005, DOI 10.1016/j.celrep.2017.05.041; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; ZHANG LR, 1995, CANCER RES, V55, P428; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321	49	110	114	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	2018	175	1					117	+	132.e1	10.1016/j.cell.2018.08.017	http://dx.doi.org/10.1016/j.cell.2018.08.017			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GU2SI	30197082	Bronze, Green Accepted			2022-12-28	WOS:000445120000018
J	Bhatt, DL				Bhatt, Deepak L.			Aspirin-still the GLOBAL LEADER in antiplatelet therapy	LANCET			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; PLACEBO-CONTROLLED TRIAL; DRUG-ELUTING STENTS; ARTERY-DISEASE; DOUBLE-BLIND; IMPLANTATION; RIVAROXABAN; DURATION; DAPT		[Bhatt, Deepak L.] Harvard Med Sch, Heart & Vasc Ctr, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bhatt, DL (corresponding author), Harvard Med Sch, Heart & Vasc Ctr, Brigham & Womens Hosp, Boston, MA 02115 USA.	dlbhattmd@post.harvard.edu						Anand SS, 2018, LANCET, V391, P219, DOI 10.1016/S0140-6736(17)32409-1; Bavry AA, 2008, LANCET, V371, P2134, DOI 10.1016/S0140-6736(08)60922-8; Bhatt DL, 2012, LANCET, V380, P1453, DOI 10.1016/S0140-6736(12)61021-6; Connolly SJ, 2018, LANCET, V391, P205, DOI 10.1016/S0140-6736(17)32458-3; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; Curzen N, 2013, LANCET, V382, P633, DOI 10.1016/S0140-6736(13)61453-1; Eisen A, 2015, NAT REV CARDIOL, V12, P445, DOI 10.1038/nrcardio.2015.87; Fox KAA, 2019, EUR HEART J, V40, P1466, DOI 10.1093/eurheartj/ehy347; Hahn JY, 2018, LANCET, V391, P1274, DOI 10.1016/S0140-6736(18)30493-8; Motovska Z, 2018, LANCET, V391, P1240, DOI 10.1016/S0140-6736(18)30612-3; Palmerini T, 2017, EUR HEART J, V38, P1034, DOI 10.1093/eurheartj/ehw627; Palmerini T, 2015, LANCET, V385, P2371, DOI 10.1016/S0140-6736(15)60263-X; Sibbing D, 2017, LANCET, V390, P1747, DOI 10.1016/S0140-6736(17)32155-4; Vranckx P, 2018, LANCET, V392, P940, DOI 10.1016/S0140-6736(18)31858-0	14	8	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2018	392	10151					896	897		10.1016/S0140-6736(18)31884-1	http://dx.doi.org/10.1016/S0140-6736(18)31884-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT4LN	30166072				2022-12-28	WOS:000444475700006
J	Wagner, Z; Heft-Neal, S; Bhutta, ZA; Black, RE; Burke, M; Bendavid, E				Wagner, Zachary; Heft-Neal, Sam; Bhutta, Zulfiqar A.; Black, Robert E.; Burke, Marshall; Bendavid, Eran			Armed conflict and child mortality in Africa: a geospatial analysis	LANCET			English	Article							GLOBAL BURDEN; CIVIL-WAR; HEALTH; UNDER-5; DISEASE	Background A substantial portion of child deaths in Africa take place in countries with recent history of armed conflict and political instability. However, the extent to which armed conflict is an important cause of child mortality, especially in Africa, remains unknown. Methods We matched child survival with proximity to armed conflict using information in the Uppsala Conflict Data Program Georeferenced Events Dataset on the location and intensity of armed conflict from 1995 to 2015 together with the location, timing, and survival of infants younger than 1 year (primary outcome) in 35 African countries. We measured the increase in mortality risk for infants exposed to armed conflicts within 50 km in the year of birth and, to study conflicts' extended health risks, up to 250 km away and 10 years before birth. We also examined the effects of conflicts of varying intensity and chronicity (conflicts lasting several years), and effect heterogeneity by residence and sex of the child. We then estimated the number and portion of deaths of infants younger than 1 year related to conflict. Findings We identified 15 441 armed conflict events that led to 968 444 combat-related deaths and matched these data with 1.99 million births and 133 361 infant deaths (infant mortality of 67 deaths per 1000 births) between 1995 and 2015. A child born within 50 km of an armed conflict had a risk of dying before reaching age 1 year of 5.2 per 1000 births higher than being born in the same region during periods without conflict (95% CI 3 7-6.7; a 7.7% increase above baseline). This increased risk of dying ranged from a 3.0% increase for armed conflicts with one to four deaths to a 26.7% increase for armed conflicts with more than 1000 deaths. We find evidence of increased mortality risk from an armed conflict up to 100 km away, and for 8 years after conflicts, with cumulative increase in infant mortality two to four times higher than the contemporaneous increase. In the entire continent, the number of infant deaths related to conflict from 1995 to 2015 was between 3.2 and 3.6 times the number of direct deaths from armed conflicts. Interpretation Armed conflict substantially and persistently increases infant mortality in Africa, with effect sizes on a scale with malnutrition and several times greater than existing estimates of the mortality burden of conflict. The toll of conflict on children, who are presumably not combatants, underscores the indirect toll of conflict on civilian populations, and the importance of developing interventions to address child health in areas of conflict.	[Wagner, Zachary; Bendavid, Eran] Stanford Univ, Dept Med, Ctr Populat Hlth Sci, Div Primary Care & Populat Hlth, Stanford, CA 94305 USA; [Heft-Neal, Sam; Burke, Marshall] Stanford Univ, Ctr Food Secur & Environm, Stanford, CA 94305 USA; [Burke, Marshall] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Primary Care & Outcomes Res, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Black, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bendavid, E (corresponding author), Stanford Univ, Dept Med, Ctr Populat Hlth Sci, Div Primary Care & Populat Hlth, Stanford, CA 94305 USA.	ebd@stanford.edu	Heft-Neal, Sam/I-6838-2019; Bhutta, Zulfiqar/L-7822-2015	Burke, Marshall/0000-0003-4288-5858; Heft-Neal, Sam/0000-0002-9129-2365; Bhutta, Zulfiqar/0000-0003-0637-599X	Doris Duke Charitable Foundation; Centre for Global Child Health at the Hospital for Sick Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD010724] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Centre for Global Child Health at the Hospital for Sick Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The Doris Duke Charitable Foundation, and the Centre for Global Child Health at the Hospital for Sick Children.	Akresh R, 2012, J DEV ECON, V99, P330, DOI 10.1016/j.jdeveco.2012.04.001; Akresh Richard, 2008, IZA DISCUSSION PAPER, V47; Alegana VA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0073; Aliaga A., 2006, OPTIMAL SAMPLE SIZES; Allansson M, 2017, J PEACE RES, V54, P574, DOI 10.1177/0022343317718773; [Anonymous], 2017, UCDP GED CODEBOOK VE; Bond D, 2003, J PEACE RES, V40, P733, DOI 10.1177/00223433030406009; Bundervoet T, 2009, J HUM RESOUR, V44, P536; Burgert C. R., 2013, DHS SPATIAL ANAL REP; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; Gleditsch NP, 2002, J PEACE RES, V39, P615, DOI 10.1177/0022343302039005007; Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0; Guha-Sapir D, 2018, LANCET GLOB HEALTH, V6, pE103, DOI [10.1016/s2214-109x(17)30469-2, 10.1016/S2214-109X(17)30469-2]; Gupta Sanjeev, 2004, EUR J POLIT ECON, V20, P403, DOI 10.1016/j.ejpoleco.2003.12.001; IHME, 2017, AFR UND 5 NEON MORT; Jean N, 2016, SCIENCE, V353, P790, DOI 10.1126/science.aaf7894; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Kreutz J, 2010, J PEACE RES, V47, P243, DOI 10.1177/0022343309353108; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; McGuirk E, 2017, 23056 NBER; Minoiu C, 2014, J DEV ECON, V108, P237, DOI 10.1016/j.jdeveco.2014.03.003; Perez-Heydrich C., 2013, GUIDELINES USE DHS G; Raleigh C, 2010, J PEACE RES, V47, P651, DOI 10.1177/0022343310378914; Sundberg R, 2010, UCDP GEOREFERENCED E; Sundberg R, 2013, J PEACE RES, V50, P523, DOI 10.1177/0022343313484347; Sundberg R, 2012, J PEACE RES, V49, P351, DOI 10.1177/0022343311431598; Tatem AJ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-2; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Wise PH, 2017, DAEDALUS-US, V146, P139, DOI 10.1162/DAED_a_00428; World Health Organization Expert Committee on Physical Status, 1995, TECHNICAL REPORT SER, V854; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	34	76	76	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2018	392	10150					857	865		10.1016/S0140-6736(18)31437-5	http://dx.doi.org/10.1016/S0140-6736(18)31437-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT0KV	30173907	Green Accepted			2022-12-28	WOS:000444130000031
J	Kitamura, N; Kitahara, M; Shoji, M; Miyoshi, Y; Hasegawa, H; Nakamura, S; Katoh, Y; Saito, Y; Yokota, S; Gershman, DJ; Vinas, AF; Giles, BL; Moore, TE; Paterson, WR; Pollock, CJ; Russell, CT; Strangeway, RJ; Fuselier, SA; Burch, JL				Kitamura, N.; Kitahara, M.; Shoji, M.; Miyoshi, Y.; Hasegawa, H.; Nakamura, S.; Katoh, Y.; Saito, Y.; Yokota, S.; Gershman, D. J.; Vinas, A. F.; Giles, B. L.; Moore, T. E.; Paterson, W. R.; Pollock, C. J.; Russell, C. T.; Strangeway, R. J.; Fuselier, S. A.; Burch, J. L.			Direct measurements of two-way wave-particle energy transfer in a collisionless space plasma	SCIENCE			English	Article							ION-CYCLOTRON WAVES; ALLEN RADIATION BELTS; MAGNETOSPHERIC MULTISCALE; INTERACTION ANALYZER; OMEGA-HE; ACCELERATION; ELECTRONS; RESONANCE; GEOS-1; HEART	Particle acceleration by plasma waves and spontaneous wave generation are fundamental energy and momentum exchange processes in collisionless plasmas. Such wave-particle interactions occur ubiquitously in space. We present ultrafast measurements in Earth's magnetosphere by the Magnetospheric Multiscale spacecraft that enabled quantitative evaluation of energy transfer in interactions associated with electromagnetic ion cyclotron waves. The observed ion distributions are not symmetric around the magnetic field direction but are in phase with the plasma wave fields. The wave-ion phase relations demonstrate that a cyclotron resonance transferred energy from hot protons to waves, which in turn nonresonantly accelerated cold He+ to energies up to similar to 2 kilo-electron volts. These observations provide direct quantitative evidence for collisionless energy transfer in plasmas between distinct particle populations via wave-particle interactions.	[Kitamura, N.; Hasegawa, H.; Saito, Y.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa, Japan; [Kitamura, N.] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo, Japan; [Kitahara, M.; Katoh, Y.] Tohoku Univ, Grad Sch Sci, Dept Geophys, Sendai, Miyagi, Japan; [Shoji, M.; Miyoshi, Y.] Nagoya Univ, Inst Space Earth Environm Res ISEE, Nagoya, Aichi, Japan; [Nakamura, S.] Kyoto Univ, RISH, Uji, Kyoto, Japan; [Yokota, S.] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Toyonaka, Osaka, Japan; [Gershman, D. J.; Vinas, A. F.; Giles, B. L.; Moore, T. E.; Paterson, W. R.] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Vinas, A. F.] Amer Univ, Dept Phys, Washington, DC 20016 USA; [Pollock, C. J.] Denali Sci, Fairbanks, AK USA; [Russell, C. T.; Strangeway, R. J.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90024 USA; [Fuselier, S. A.; Burch, J. L.] Southwest Res Inst, San Antonio, TX USA; [Fuselier, S. A.] Univ Texas San Antonio, San Antonio, TX USA	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Tokyo; Tohoku University; Nagoya University; Kyoto University; Osaka University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; American University; University of California System; University of California Los Angeles; Southwest Research Institute; University of Texas System; University of Texas at San Antonio (UTSA)	Kitamura, N (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa, Japan.; Kitamura, N (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo, Japan.	kitamura@eps.s.u-tokyo.ac.jp	Nakamura, Satoko/ABC-8245-2021; MMS, Science Team NASA/J-5393-2013; Nakamura, Satoko/T-5506-2019; Kitamura, Naritoshi/AAR-7023-2020; Hasegawa, Hiroshi/A-1192-2007; Russell, Christopher T/E-7745-2012; Miyoshi, Yoshizumi/B-5834-2015; Shoji, Masafumi/S-8304-2019; Giles, Barbara L/J-7393-2017; Katoh, Yuto/B-8007-2015; Miyoshi, Yoshizumi/T-5748-2019	Kitamura, Naritoshi/0000-0002-2397-273X; Hasegawa, Hiroshi/0000-0002-1172-021X; Russell, Christopher T/0000-0003-1639-8298; Miyoshi, Yoshizumi/0000-0001-7998-1240; Giles, Barbara L/0000-0001-8054-825X; Katoh, Yuto/0000-0002-4318-0633; Miyoshi, Yoshizumi/0000-0001-7998-1240; Nakamura, Satoko/0000-0003-4367-696X; Kitahara, Masahiro/0000-0003-1077-4870; Shoji, Masafumi/0000-0001-6573-525X; yokota, shoichiro/0000-0001-8851-9146; Saito, Yoshifumi/0000-0002-1354-3544	NASA MMS Mission; NASA [NNG04EB99C]; Japan Society for the Promotion of Science (JSPS) [17H06140, 15H05747, 15H05815, 17K14402, 16H06286, 15H03730]; NASA MMS Mission Guest Investigators program; CNES; CNRS; University of New Hampshire; NASA; SwRI	NASA MMS Mission; NASA(National Aeronautics & Space Administration (NASA)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NASA MMS Mission Guest Investigators program; CNES(Centre National D'etudes Spatiales); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of New Hampshire; NASA(National Aeronautics & Space Administration (NASA)); SwRI	This research was supported by the NASA MMS Mission in association with NASA contract NNG04EB99C, and by Grants-in-Aid for Scientific Research (17H06140 to N.K. and Y.S.; 15H05747 to M.K., Y.M., and Y.K.; 15H05815 to M.S., Y.M., and Y.K.; 17K14402 to M.S.; 16H06286 to Y.M.; and 15H03730 to Y.K.) of the Japan Society for the Promotion of Science (JSPS). D.J.G. is supported by the NASA MMS Mission Guest Investigators program. IRAP contributions to Fast Plasma Investigation on MMS were supported by CNES and CNRS. Support for R.J.S.'s effort was provided under subcontract with the University of New Hampshire, in turn under contract from SwRI and NASA.	Allen RC, 2016, J GEOPHYS RES-SPACE, V121, P6458, DOI 10.1002/2016JA022541; BERCHEM J, 1985, J GEOPHYS RES-SPACE, V90, P945, DOI 10.1029/JA090iA11p10945; Burch JL, 2016, SPACE SCI REV, V199, P5, DOI 10.1007/s11214-015-0164-9; CHANG T, 1986, GEOPHYS RES LETT, V13, P636, DOI 10.1029/GL013i007p00636; Fukuhara H, 2009, EARTH PLANETS SPACE, V61, P765, DOI 10.1186/BF03353183; GOUGH MP, 1990, J GEOPHYS RES-SPACE, V95, P12287, DOI 10.1029/JA095iA08p12287; Horne RB, 2005, NATURE, V437, P227, DOI 10.1038/nature03939; Jordanova VK, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011644; Katoh Y, 2013, ANN GEOPHYS-GERMANY, V31, P503, DOI 10.5194/angeo-31-503-2013; MAUK BH, 1981, GEOPHYS RES LETT, V8, P103, DOI 10.1029/GL008i001p00103; Meredith NP, 2001, J GEOPHYS RES-SPACE, V106, P13165, DOI 10.1029/2000JA900156; Miyoshi Y, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2001JA007542; Mouikis CG, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013899; Mourenas D, 2016, GEOPHYS RES LETT, V43, P4155, DOI 10.1002/2016GL068921; Omura Y, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015300; Pollock C, 2016, SPACE SCI REV, V199, P331, DOI 10.1007/s11214-016-0245-4; Reeves GD, 2013, SCIENCE, V341, P991, DOI 10.1126/science.1237743; ROUX A, 1982, J GEOPHYS RES-SPACE, V87, P8174, DOI 10.1029/JA087iA10p08174; Shoji M, 2017, GEOPHYS RES LETT, V44, P8730, DOI 10.1002/2017GL074254; Shprits YY, 2017, GEOPHYS RES LETT, V44, P1204, DOI 10.1002/2016GL072258; Thorne RM, 2013, NATURE, V504, P411, DOI 10.1038/nature12889; YOUNG DT, 1981, J GEOPHYS RES-SPACE, V86, P6755, DOI 10.1029/JA086iA08p06755; Zhang JC, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014784; Zhang JC, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016690	24	28	28	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					1000	1003		10.1126/science.aap8730	http://dx.doi.org/10.1126/science.aap8730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190400				2022-12-28	WOS:000443892700042
J	Rusimova, KR; Purkiss, RM; Howes, R; Lee, F; Crampin, S; Sloan, PA				Rusimova, K. R.; Purkiss, R. M.; Howes, R.; Lee, F.; Crampin, S.; Sloan, P. A.			Regulating the femtosecond excited-state lifetime of a single molecule	SCIENCE			English	Article							ELECTRONIC CONTROL; BOND FORMATION; DYNAMICS; SURFACES; DISSOCIATION; MANIPULATION; DESORPTION; PROBE	The key to controlling reactions of molecules induced with the current of a scanning tunneling microscope (STM) tip is the ultrashort intermediate excited ionic state. The initial condition of the excited state is set by the energy and position of the injected current; thereafter, its dynamics determines the reaction outcome. We show that a STM can directly and controllably influence the excited-state dynamics. For the STM-induced desorption of toluene molecules from the Si(111)-7x7 surface, as the tip approaches the molecule, the probability of manipulation drops by two orders of magnitude. A two-channel quenching of the excited state is proposed, consisting of an invariant surface channel and a tip height-dependent channel. We conclude that picometer tip proximity regulates the lifetime of the excited state from 10 femtoseconds to less than 0.1 femtoseconds.	[Rusimova, K. R.; Purkiss, R. M.; Howes, R.; Lee, F.; Crampin, S.; Sloan, P. A.] Univ Bath, Dept Phys, Bath BA2 7AY, Avon, England; [Crampin, S.; Sloan, P. A.] Univ Bath, Ctr Nanosci & Nanotechnol, Bath BA2 7AY, Avon, England	University of Bath; University of Bath	Sloan, PA (corresponding author), Univ Bath, Dept Phys, Bath BA2 7AY, Avon, England.; Sloan, PA (corresponding author), Univ Bath, Ctr Nanosci & Nanotechnol, Bath BA2 7AY, Avon, England.	p.sloan@bath.ac.uk	Sloan, Peter/N-8818-2019	Sloan, Peter/0000-0002-0810-8468; Lee, Frank/0000-0001-8010-9919; Rusimova, Kristina/0000-0002-3679-9948; Howes, Ruairidh/0000-0003-3623-7053	EPSRC [EP/K00137X/1]; University of Bath studentship; EPSRC CDT CMP grant [EP/L015544/1]	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Bath studentship; EPSRC CDT CMP grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by EPSRC grant EP/K00137X/1 (P.A.S.), a University of Bath studentship (K.R.R.), and EPSRC CDT CMP grant EP/L015544/1 (R.M.P.).	Alavi S, 2000, PHYS REV LETT, V85, P5372, DOI 10.1103/PhysRevLett.85.5372; Bartels L, 1998, PHYS REV LETT, V80, P2004, DOI 10.1103/PhysRevLett.80.2004; Feenstra RM, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.125316; FEENSTRA RM, 1994, PHYS REV B, V50, P4561, DOI 10.1103/PhysRevB.50.4561; Garcia R, 2014, NAT NANOTECHNOL, V9, P577, DOI [10.1038/NNANO.2014.157, 10.1038/nnano.2014.157]; Jelinek P, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/8/084001; Jiang Y, 2013, NAT CHEM, V5, P36, DOI [10.1038/nchem.1488, 10.1038/NCHEM.1488]; Lastapis M, 2005, SCIENCE, V308, P1000, DOI 10.1126/science.1108048; Liljeroth P, 2007, SCIENCE, V317, P1203, DOI 10.1126/science.1144366; Lock D, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/5/054003; Lu XK, 2006, NANO LETT, V6, P809, DOI 10.1021/nl0601379; Mayne AJ, 2006, CHEM REV, V106, P4355, DOI 10.1021/cr050177h; Myslivecek J, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.161302; Naydenov B, 2006, NANO LETT, V6, P1752, DOI 10.1021/nl061294a; PALMER RE, 1992, REV MOD PHYS, V64, P383, DOI 10.1103/RevModPhys.64.383; Pascual JI, 2003, NATURE, V423, P525, DOI 10.1038/nature01649; Paul W, 2017, NAT PHYS, V13, P403, DOI [10.1038/nphys3965, 10.1038/NPHYS3965]; Repp J, 2006, SCIENCE, V312, P1196, DOI 10.1126/science.1126073; Rusimova KR, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/28/5/054002; Ryan PM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096801; Saalfrank P, 2000, FARADAY DISCUSS, V117, P65, DOI 10.1039/b002734k; Saalfrank P, 2006, CHEM REV, V106, P4116, DOI 10.1021/cr0501691; Simic-Milosevic V, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.116102; Sloan PA, 2005, NATURE, V434, P367, DOI 10.1038/nature03385; Stipe BC, 1997, PHYS REV LETT, V78, P4410, DOI 10.1103/PhysRevLett.78.4410; Stipe BC, 1997, PHYS REV LETT, V79, P4397, DOI 10.1103/PhysRevLett.79.4397	26	22	22	5	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					1012	+		10.1126/science.aat9688	http://dx.doi.org/10.1126/science.aat9688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190402	Green Submitted			2022-12-28	WOS:000443892700045
J	Bakhoum, SF; Cantley, LC				Bakhoum, Samuel F.; Cantley, Lewis C.			The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment	CELL			English	Review							MEROTELIC KINETOCHORE ORIENTATION; CELL LUNG-CANCER; BREAST-CANCER; PANCREATIC-CANCER; DNA SENSOR; ANEUPLOIDY PATTERNS; GENOMIC INSTABILITY; EXONUCLEASE TREX1; TUMOR; EVOLUTION	Chromosomal instability (CIN) is a hallmark of human cancer, and it is associated with poor prognosis, metastasis, and therapeutic resistance. CIN results from errors in chromosome segregation during mitosis, leading to structural and numerical chromosomal abnormalities. In addition to generating genomic heterogeneity that acts as a substrate for natural selection, CIN promotes inflammatory signaling by introducing double-stranded DNA into the cytosol, engaging the cGAS-STING anti-viral pathway. These multipronged effects distinguish CIN as a central driver of tumor evolution and as a genomic source for the crosstalk between the tumor and its microenvironment, in the course of immune editing and evasion.	[Bakhoum, Samuel F.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Bakhoum, Samuel F.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Cantley, Lewis C.] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Bakhoum, SF (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.; Bakhoum, SF (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA.	samuel.bakhoum@gmail.com			Department of Defense Breast Cancer Research Breakthrough Award [W81XWH-16-1-0315, BC151244]; Elsa U. Pardee Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists; MSKCC core grant [P30-CA008748]; NIH [R35-CA197588, U54-CA210184]; Breast Cancer Research Foundation; Gray Foundation Basser Initiative; NATIONAL CANCER INSTITUTE [U54CA210184, R35CA197588, P30CA008748] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Breakthrough Award; Elsa U. Pardee Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); MSKCC core grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Gray Foundation Basser Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Ashley Laughney and Nadeem Riaz (MSKCC) for constructive feedback and Wenjing Wu and Terry Helms (MSKCC) for assistance with illustrations. Samuel Bakhoum is supported by the Department of Defense Breast Cancer Research Breakthrough Award W81XWH-16-1-0315 (Project: BC151244), the Elsa U. Pardee Foundation, the Burroughs Wellcome Fund Career Award for Medical Scientists, and the MSKCC core grant P30-CA008748. Lewis Cantley is supported by NIH grant R35-CA197588, U54-CA210184, Breast Cancer Research Foundation, and the Gray Foundation Basser Initiative.	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6166; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Bakhoum SF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6990; Bakhoum SF, 2014, CANCER DISCOV, V4, P1281, DOI 10.1158/2159-8290.CD-14-0403; Bakhoum SF, 2011, CLIN CANCER RES, V17, P7704, DOI 10.1158/1078-0432.CCR-11-2049; Bakker B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0971-7; Bielski CM, 2018, NAT GENET, V50, P1189, DOI 10.1038/s41588-018-0165-1; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Boveri T, 1914, NAT MED; Burkard ME, 2017, CANCER DISCOV, V7, P134, DOI 10.1158/2159-8290.CD-16-1415; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cerboni S, 2017, J EXP MED, V214, P1769, DOI 10.1084/jem.20161674; Chandra D, 2014, CANCER IMMUNOL RES, V2, P901, DOI 10.1158/2326-6066.CIR-13-0123; Chen GB, 2012, NATURE, V482, P246, DOI 10.1038/nature10795; Chen YF, 2017, J EXP MED, V214, P991, DOI 10.1084/jem.20161387; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Comaills V, 2016, CELL REP, V17, P2632, DOI 10.1016/j.celrep.2016.11.022; Coquel F, 2018, NATURE, V557, P57, DOI 10.1038/s41586-018-0050-1; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Ding L, 2015, BBA-MOL BASIS DIS, V1852, P2494, DOI 10.1016/j.bbadis.2015.08.011; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Galluzzi L, 2018, CELL, V173, DOI 10.1016/j.cell.2018.03.015; Gaston J, 2016, ONCOTARGET, V7, P77205, DOI 10.18632/oncotarget.12858; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Goh JY, 2017, NAT MED, V23, P1319, DOI 10.1038/nm.4405; Graham NA, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167159; Gulen MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00573-w; Gutenberg A, 2010, CANCER GENET CYTOGEN, V198, P47, DOI 10.1016/j.cancergencyto.2009.12.006; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; HEYMAN M, 1993, INT J CANCER, V54, P748, DOI 10.1002/ijc.2910540507; Ho SSW, 2016, IMMUNITY, V44, P1177, DOI 10.1016/j.immuni.2016.04.010; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jamal-Hanjani M, 2015, ANN ONCOL, V26, P1340, DOI 10.1093/annonc/mdv178; Karagiannis GS, 2017, SCI TRANSL MED, V9; KATO H, 1968, J NATL CANCER I, V40, P165; Kis-Toth K, 2011, J IMMUNOL, V187, P1222, DOI 10.4049/jimmunol.1100469; Konno H, 2018, ONCOGENE, V37, P2037, DOI 10.1038/s41388-017-0120-0; Lam AR, 2014, CANCER RES, V74, P2193, DOI 10.1158/0008-5472.CAN-13-1703; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Laughney AM, 2015, CELL REP, V12, P809, DOI 10.1016/j.celrep.2015.06.065; Lee HS, 2016, CANCER RES, V76, P902, DOI 10.1158/0008-5472.CAN-15-1617; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li Q, 2016, FEBS J, V283, P2836, DOI 10.1111/febs.13767; Liang H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01566-5; Linsley PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109760; Litvin O, 2015, MOL CELL, V57, P784, DOI 10.1016/j.molcel.2014.12.030; Loh PR, 2018, NATURE, V559, P350, DOI 10.1038/s41586-018-0321-x; Ly P, 2017, NAT CELL BIOL, V19, P68, DOI 10.1038/ncb3450; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; Mueller S, 2018, NATURE, V554, P62, DOI 10.1038/nature25459; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; Pailler E, 2015, ANN ONCOL, V26, P1408, DOI 10.1093/annonc/mdv165; Paulsson K, 2007, PATHOL BIOL, V55, P37, DOI 10.1016/j.patbio.2006.04.007; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Potapova TA, 2013, CANCER METAST REV, V32, P377, DOI 10.1007/s10555-013-9436-6; Rowald K, 2016, CELL REP, V15, P2679, DOI 10.1016/j.celrep.2016.05.048; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Sack LM, 2018, CELL, V173, P499, DOI 10.1016/j.cell.2018.02.037; Santaguida S, 2017, DEV CELL, V41, P638, DOI 10.1016/j.devcel.2017.05.022; Schoonen PM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15981; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Sheltzer JM, 2017, CANCER CELL, V31, P240, DOI 10.1016/j.ccell.2016.12.004; Shen J, 2018, BIORXIV, DOI [10.1101/318980, DOI 10.1101/318980]; Song SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep39858; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Suarez-Carmona M, 2017, MOL ONCOL, V11, P805, DOI 10.1002/1878-0261.12095; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8; Takashima K, 2016, BIOCHEM BIOPH RES CO, V478, P1764, DOI 10.1016/j.bbrc.2016.09.021; Tang CHA, 2016, CANCER RES, V76, P2137, DOI 10.1158/0008-5472.CAN-15-1885; TAVASSOLI M, 1993, GENE CHROMOSOME CANC, V8, P195, DOI 10.1002/gcc.2870080310; Taylor AM, 2018, CANCER CELL, V33, P676, DOI 10.1016/j.ccell.2018.03.007; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Turajlic S, 2018, CELL, V173, P581, DOI 10.1016/j.cell.2018.03.057; Turner KM, 2017, NATURE, V543, P122, DOI 10.1038/nature21356; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Vogel CFA, 2013, IMMUNOL CELL BIOL, V91, P568, DOI 10.1038/icb.2013.43; Warth A, 2009, EXP MOL MED, V41, P349, DOI 10.3858/emm.2009.41.5.039; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Zaki BI, 2014, CANCER-AM CANCER SOC, V120, P1733, DOI 10.1002/cncr.28656; Zhang AW, 2018, CELL, V173, P1755, DOI 10.1016/j.cell.2018.03.073; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493; Zierhut  C., 2017, BIORXIV, DOI [10.1101/168070, DOI 10.1101/168070]	110	209	211	8	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1347	1360		10.1016/j.cell.2018.08.027	http://dx.doi.org/10.1016/j.cell.2018.08.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193109	Bronze, Green Accepted			2022-12-28	WOS:000443841000007
J	Miller, WC; Hoffman, IF; Hanscom, BS; Ha, TV; Dumchev, K; Djoerban, Z; Rose, SM; Latkin, CA; Metzger, DS; Lancaster, KE; Go, VF; Dvoriak, S; Mollan, KR; Reifeis, SA; Piwowar-Manning, EM; Richardson, P; Hudgens, MG; Hamilton, EL; Sugarman, J; Eshleman, SH; Susami, H; Chu, VA; Djauzi, S; Kiriazova, T; Bui, DD; Strathdee, SA; Burns, DN				Miller, William C.; Hoffman, Irving F.; Hanscom, Brett S.; Ha, Tran, V; Dumchev, Kostyantyn; Djoerban, Zubairi; Rose, Scott M.; Latkin, Carl A.; Metzger, David S.; Lancaster, Kathryn E.; Go, Vivian F.; Dvoriak, Sergii; Mollan, Katie R.; Reifeis, Sarah A.; Piwowar-Manning, Estelle M.; Richardson, Paul; Hudgens, Michael G.; Hamilton, Erica L.; Sugarman, Jeremy; Eshleman, Susan H.; Susami, Hepa; Viet Anh Chu; Djauzi, Samsuridjal; Kiriazova, Tetiana; Bui, Duong D.; Strathdee, Steffanie A.; Burns, David N.			A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study	LANCET			English	Article							ANTIRETROVIRAL THERAPY; CONTROLLED-TRIAL; UNITED-STATES; CENTRAL-ASIA; HEPATITIS-C; RISK-FACTOR; EPIDEMIOLOGY; METAANALYSIS; ENROLLMENT; MORTALITY	Background People who inject drugs (PWID) have a high incidence of HIV, little access to antiretroviral therapy (ART) and medication-assisted treatment (MAT), and high mortality. We aimed to assess the feasibility of a future controlled trial based on the incidence of HIV, enrolment, retention, and uptake of the intervention, and the efficacy of an integrated and flexible intervention on ART use, viral suppression, and MAT use. Methods This randomised, controlled vanguard study was run in Kyiv, Ukraine (one community site), Thai Nguyen, Vietnam (two district health centre sites), and Jakarta, Indonesia (one hospital site). PWID who were HIV infected (index participants) and non-infected injection partners were recruited as PWID network units and were eligible for screening if they were aged 18-45 years (updated to 18-60 years 8 months into study), and active injection drug users. Further eligibility criteria for index participants included a viral load of 1000 copies per mL or higher, willingness and ability to recruit at least one injection partner who would be willing to participate. Index participants were randomly assigned via a computer generated sequence accessed through a secure web portal (3:1) to standard of care or intervention, stratified by site. Masking of assignment was not possible due to the nature of intervention. The intervention comprised systems navigation, psychosocial counselling, and ART at any CD4 count. Local ART and MAT services were used. Participants were followed up for 12-24 months. The primary objective was to assess the feasibility of a future randomised controlled trial. To achieve this aim we looked at the following endpoints: HIV incidence among injection partners in the standard of care group, and enrolment and retention of HIV-infected PWID and their injection partners and the uptake of the integrated intervention. The study was also designed to assess the feasibility, barriers, and uptake of the integrated intervention. Endpoints were assessed in a modified intention-to-treat popualtion after exclusion of ineligible participants. This trial is registered on ClinicalTrials.gov , NCT02935296, and is active but not recruiting new participants. Findings Between Feb 5, 2015, and June 3, 2016, 3343 potential index participants were screened, of whom 502 (15%) were eligible and enrolled. 1171 injection partners were referred, and 806 (69%) were eligible and enrolled. Index participants were randomly assigned to intervention (126 [25%]) and standard of care (376 [75%]) groups. At week 52, most living index participants (389 [86%] of 451) and partners (567 [80%] of 710) were retained, and self-reported ART use was higher among index participants in the intervention group than those in the standard of care group (probability ratio [PR] 1.7, 95% CI 1. 4-1. 9). Viral suppression was also higher in the intervention group than in the standard of care group (PR 1.7, 95% CI 1.3-2.2). Index participants in the intervention group reported more MAT use at 52 weeks than those in the standard of care group (PR 1.7, 95% CI 1.3-2.2). Seven incident HIV infections occurred, and all in injection partners in the standard of care group (intervention incidence 0.0 per 100 person-years, 95% CI 0. 0-1. 7; standard of care incidence 1.0 per 100 person-years, 95% CI 0.4-2.1; incidence rate difference -1.0 per 100 person-years, 95% CI -2.1 to 1.1). No severe adverse events due to the intervention were recorded. Interpretation This vanguard study provides evidence that a flexible, scalable intervention increases ART and MAT use and reduces mortality among PWID. The low incidence of HIV in both groups impedes a future randomised, controlled trial, but given the strength of the effect of the intervention, its implementation among HIV-infected PWID should be considered. Copyright (C) 2018 Elsevier Ltd. All rights reserved.	[Miller, William C.; Lancaster, Kathryn E.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43220 USA; [Hoffman, Irving F.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Sch Med, Div Infect Dis, Chapel Hill, NC USA; [Mollan, Katie R.; Reifeis, Sarah A.; Hudgens, Michael G.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Ctr AIDS Res, Chapel Hill, NC USA; [Ha, Tran, V; Go, Vivian F.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA; [Hudgens, Michael G.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [Hanscom, Brett S.] Fred Hutchinson Canc Res Ctr, SCHARP, 1124 Columbia St, Seattle, WA 98104 USA; [Ha, Tran, V; Viet Anh Chu] UNC Vietnam, Hanoi, Vietnam; [Dumchev, Kostyantyn; Kiriazova, Tetiana] Ukrainian Inst Publ Hlth Policy, Kiev, Ukraine; [Djoerban, Zubairi; Susami, Hepa; Djauzi, Samsuridjal] Univ Indonesia, Cipto Mangunkusumo Hosp, Fac Med, Jakarta, Indonesia; [Rose, Scott M.; Hamilton, Erica L.] FHI 360, Sci Facilitat Dept, Durham, NC USA; [Latkin, Carl A.] Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MA USA; [Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MA USA; [Sugarman, Jeremy] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MA USA; [Piwowar-Manning, Estelle M.; Richardson, Paul; Eshleman, Susan H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MA USA; [Piwowar-Manning, Estelle M.; Richardson, Paul; Eshleman, Susan H.] Johns Hopkins Univ, Dept Pathol, Baltimore, MA USA; [Metzger, David S.] Univ Penn, Sch Med, Dept Psychiat, HIV Prevent Res Div, Philadelphia, PA 19104 USA; [Dvoriak, Sergii] Acad Lab Social Relat & Tourism, Kiev, Ukraine; [Bui, Duong D.] Vietnam Adm HIV AIDS Control, Hanoi, Vietnam; [Strathdee, Steffanie A.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Burns, David N.] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA	University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Fred Hutchinson Cancer Center; Ukrainian Institute on Public Health Policy; University of Indonesia; FHI 360; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Pennsylvania; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Miller, WC (corresponding author), Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43220 USA.	miller.8332@osu.edu	Miller, William C/H-4800-2014; Dumchev, Kostya/AAU-2820-2020; Strathdee, Steffanie A/B-9042-2009	Miller, William C/0000-0002-1934-7827; Dumchev, Kostya/0000-0003-2862-4977; Hamilton, Erica L./0000-0003-1174-9263; Sugarman, Jeremy/0000-0001-7022-8332; Lancaster, Kathryn/0000-0003-2389-6973	US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068617, UM1AI068619, UM1AI068613, P30AI050410] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	US National Institutes of Health.	Berleva G, 2012, ANAL REPORT ESTIMATI; Beyrer C, 2013, CURR OPIN HIV AIDS, V8, P306, DOI 10.1097/COH.0b013e328361f53a; Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Boltaev AA, 2013, DRUG ALCOHOL DEPEN, V132, pS41, DOI 10.1016/j.drugalcdep.2013.07.033; Degenhardt L, 2016, LANCET INFECT DIS, V16, P1385, DOI 10.1016/S1473-3099(16)30325-5; DeHovitz J, 2014, CURR HIV-AIDS REP, V11, P168, DOI 10.1007/s11904-014-0202-3; Go VF, 2017, JAIDS-J ACQ IMM DEF, V74, P166, DOI 10.1097/QAI.0000000000001245; Hayashi K, 2018, J INFECT DIS, V217, P64, DOI 10.1093/infdis/jix459; Heimer R, 2017, ADDICTION, V112, P1421, DOI 10.1111/add.13798; Hoots BE, 2017, JAIDS-J ACQ IMM DEF, V75, pS392, DOI 10.1097/qai.0000000000001416; Indonesian National AIDS Commission, 2014, GLOB AIDS REP PROGR; Jolley E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001465; Joseph B, 2016, AIDS, V30, P925, DOI 10.1097/QAD.0000000000000989; Kiriazova TK, 2013, HIV MED, V14, P38, DOI 10.1111/hiv.12059; Kral AH, 2018, AIDS BEHAV, V22, P146, DOI 10.1007/s10461-017-1903-6; Larney S, 2017, LANCET GLOB HEALTH, V5, pE1208, DOI [10.1016/S2214-109X(17)30373-X, 10.1016/s2214-109x(17)30373-x]; Lazarus L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166942; Lesko CR, 2016, AIDS, V30, P2227, DOI 10.1097/QAD.0000000000001183; Low AJ, 2016, CLIN INFECT DIS, V63, P1094, DOI 10.1093/cid/ciw416; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Safren SA, 2012, J CONSULT CLIN PSYCH, V80, P404, DOI 10.1037/a0028208; Strathdee SA, 2012, CURR OPIN HIV AIDS, V7, P320, DOI 10.1097/COH.0b013e32835369ad; Sypsa V, 2017, J INFECT DIS, V215, P1496, DOI 10.1093/infdis/jix100; Underwood J. Michael, 2012, Morbidity and Mortality Weekly Report, V61, P1; Vu MQ, 2011, ADDICTION, V106, P583, DOI 10.1111/j.1360-0443.2010.03175.x; World Health Organisation (WHO), 2009, WHO UNODC UNAIDS TEC; Zelaya CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161718; Zhou BQ, 2011, BIOMETRICS, V67, P661, DOI 10.1111/j.1541-0420.2010.01493.x	30	53	53	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2018	392	10149					747	759		10.1016/S0140-6736(18)31487-9	http://dx.doi.org/10.1016/S0140-6736(18)31487-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS0VL	30191830	Green Accepted			2022-12-28	WOS:000443226900026
J	Cernansky, R				Cernansky, Rachel			HOW TO REBUILD A FOREST	NATURE			English	News Item																			0	18	19	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					542	544		10.1038/d41586-018-06031-x	http://dx.doi.org/10.1038/d41586-018-06031-x			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS0SZ	30158623				2022-12-28	WOS:000443218600020
J	Wang, FM; Matsuoka, M				Wang, Fanmiao; Matsuoka, Makoto			A new green revolution on the horizon	NATURE			English	Editorial Material							GENES		[Wang, Fanmiao; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	Nagoya University	Matsuoka, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	makoto@nuagr1.agr.nagoya-u.ac.jp						Che RH, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.195, 10.1038/nplants.2015.195]; Duan PG, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.203, 10.1038/nplants.2015.203]; Gooding MJ, 2012, J AGR SCI-CAMBRIDGE, V150, P3, DOI 10.1017/S0021859611000414; Hu J, 2015, MOL PLANT, V8, P1455, DOI 10.1016/j.molp.2015.07.002; Li S, 2018, NATURE, V560, P595, DOI 10.1038/s41586-018-0415-5; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sun PY, 2016, J INTEGR PLANT BIOL, V58, P836, DOI 10.1111/jipb.12473	8	2	4	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					563	+		10.1038/d41586-018-05928-x	http://dx.doi.org/10.1038/d41586-018-05928-x			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS0SZ	30143754				2022-12-28	WOS:000443218600035
J	Oliver, D				Oliver, David			David Oliver: What's behind the reported rise in sepsis deaths?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2017, BBC NEWS; Association of Clinical Documentation Improvement Specialists, 2017, AR WE NOW SEPS; Bloch-Budzier S, 2018, BBC NEWS; Busby M, 2018, GUARDIAN; Evans T, 2018, CLIN MED, V18, P146, DOI 10.7861/clinmedicine.18-2-146; NHS England, NAT EARL WARN SCOR N; Powell N, 2018, CLIN MED, V18, P276, DOI 10.7861/clinmedicine.18-4-276	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2018	362								k3573	10.1136/bmj.k3573	http://dx.doi.org/10.1136/bmj.k3573			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5YZ	30154204	Bronze			2022-12-28	WOS:000443756600003
J	Rushton, J; Bruce, M; Bellet, C; Torgerson, P; Shaw, A; Marsh, T; Pigott, D; Stone, M; Pinto, J; Mesenhowski, S; Wood, P				Rushton, Jonathan; Bruce, Mieghan; Bellet, Camille; Torgerson, Paul; Shaw, Alexandra; Marsh, Tom; Pigott, David; Stone, Matthew; Pinto, Julio; Mesenhowski, Shannon; Wood, Paul			Initiation of Global Burden of Animal Diseases Programme	LANCET			English	Editorial Material							ENDEMIC LIVESTOCK DISEASES; GREAT-BRITAIN; COSTS		[Rushton, Jonathan; Bellet, Camille] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L3 5RF, Merseyside, England; [Bruce, Mieghan] Murdoch Univ, Murdoch, WA, Australia; [Torgerson, Paul] Univ Zurich, Vetsuisse Fac, Zurich, Switzerland; [Shaw, Alexandra] APM Consultants, Andover, England; [Marsh, Tom] Washington State Univ, Pullman, WA 99164 USA; [Pigott, David] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Stone, Matthew] World Org Anim Hlth, Paris, France; [Pinto, Julio] Food & Agr Org United Nations, Rome, Italy; [Mesenhowski, Shannon] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Liverpool; Murdoch University; University of Zurich; Washington State University; University of Washington; University of Washington Seattle; Food & Agriculture Organization of the United Nations (FAO); Bill & Melinda Gates Foundation	Rushton, J (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L3 5RF, Merseyside, England.	j.rushton@liverpool.ac.uk	Torgerson, Paul R/M-4447-2013; Bruce, Mieghan/K-2472-2019	Torgerson, Paul R/0000-0003-4277-9983; Bruce, Mieghan/0000-0003-3176-2094	Bill & Melinda Gates Foundation; BBSRC [BB/R021279/1] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MS has received grants for animal health-related projects supported by the Bill & Melinda Gates Foundation. SM is employed by the Bill & Melinda Gates Foundation. We declare no other competing interests.	Bennett R, 2005, J AGR ECON, V56, P135, DOI 10.1111/j.1477-9552.2005.tb00126.x; Bennett R, 2003, J AGR ECON, V54, P55, DOI 10.1111/j.1477-9552.2003.tb00048.x; Food and Agriculture Organization, 2009, STAT FOOD AGR LIV BA, DOI 10.1017/S2078633610001128; GBD 2015 DALYs and HALE Collaborators, GLOB REG NAT DIS ADJ; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Pradere J-P, 2014, REV SCI TECH, V33, P710; Rushton J, 2009, ECONOMICS OF ANIMAL HEALTH AND PRODUCTION, P1; Rushton J, 2017, ANIMAL HLTH DEV ITS; Rushton J, 2016, 84 GEN WORLD ASS OIE, V84; Vallat B., 2009, ONE WORLD ONE HLTH; World Health Organization, 1992, INT STAT CLASS DIS R	11	35	35	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2018	392	10147					538	540		10.1016/S0140-6736(18)31472-7	http://dx.doi.org/10.1016/S0140-6736(18)31472-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ8MN	30152376				2022-12-28	WOS:000442009500007
J	McCoy, MS; Kanter, GP				McCoy, Matthew S.; Kanter, Genevieve P.			Campaign Contributions From Political Action Committees to Members of Congressional Committees Responding to the Opioid Crisis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[McCoy, Matthew S.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,14th Floor, Philadelphia, PA 19104 USA; [Kanter, Genevieve P.] Univ Penn, Perelman Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	McCoy, MS (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,14th Floor, Philadelphia, PA 19104 USA.	mmcco@pennmedicine.upenn.edu		Kanter, Genevieve/0000-0002-3044-7829				Haffajee RL, 2017, NEW ENGL J MED, V377, P2301, DOI 10.1056/NEJMp1710756; Homeland Security Digital Library, FUEL EP REP 2 EXP FI; Lozada LI, 2015, REUTERS; Wyden  Ron, 2017, COMMUNICATION	4	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2018	320	14					1489	1491		10.1001/jama.2018.11338	http://dx.doi.org/10.1001/jama.2018.11338			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW3IX	30193339	Bronze, Green Published			2022-12-28	WOS:000446792500021
J	De Schepper, S; Verheijden, S; Aguilera-Lizarraga, J; Viola, MF; Boesmans, W; Stakenborg, N; Voytyuk, I; Smidt, I; Boeckx, B; de Casterle, ID; Baekelandt, V; Dominguez, EG; Mack, M; Depoortere, I; De Strooper, B; Sprangers, B; Himmelreich, U; Soenen, S; Guilliams, M; Vanden Berghe, P; Jones, E; Lambrechts, D; Boeckxstaens, G				De Schepper, Sebastiaan; Verheijden, Simon; Aguilera-Lizarraga, Javier; Viola, Maria Francesca; Boesmans, Werend; Stakenborg, Nathalie; Voytyuk, Iryna; Smidt, Inga; Boeckx, Bram; de Casterle, Isabelle Dierckx; Baekelandt, Veerle; Dominguez, Erika Gonzalez; Mack, Matthias; Depoortere, Inge; De Strooper, Bart; Sprangers, Ben; Himmelreich, Uwe; Soenen, Stefaan; Guilliams, Martin; Vanden Berghe, Pieter; Jones, Elizabeth; Lambrechts, Diether; Boeckxstaens, Guy			Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis	CELL			English	Article							EXPRESSION PROFILES; ADULT MICROGLIA; TISSUE; CELL; MONOCYTES; RESPONSES; IDENTITY; REVEALS; ORIGINS	Macrophages are highly heterogeneous tissue-resident immune cells that perform a variety of tissue- supportive functions. The current paradigm dictates that intestinal macrophages are continuously replaced by incoming monocytes that acquire a pro-inflammatory or tissue-protective signature. Here, we identify a self-maintaining population of macrophages that arise from both embryonic precursors and adult bone marrow-derived monocytes and persists throughout adulthood. Gene expression and imaging studies of self-maintaining macrophages revealed distinct transcriptional profiles that reflect their unique localization (i.e., closely positioned to blood vessels, submucosal and myenteric plexus, Paneth cells, and Peyer's patches). Depletion of self-maintaining macrophages resulted in morphological abnormalities in the submucosal vasculature and loss of enteric neurons, leading to vascular leakage, impaired secretion, and reduced intestinal motility. These results provide critical insights in intestinal macrophage heterogeneity and demonstrate the strategic role of self-maintaining macrophages in gut homeostasis and intestinal physiology.	[De Schepper, Sebastiaan; Verheijden, Simon; Aguilera-Lizarraga, Javier; Viola, Maria Francesca; Stakenborg, Nathalie; Dominguez, Erika Gonzalez; Boeckxstaens, Guy] Univ Leuven, Dept Chron Dis Metab & Ageing, Translat Res Ctr Gastrointestinal Disorders, Lab Intestinal Neuroimmune Interact, Leuven, Belgium; [Boesmans, Werend; Vanden Berghe, Pieter] Univ Leuven, Dept Chron Dis Metab & Ageing, Translat Res Ctr Gastrointestinal Disorders, Lab Enter Neurosci, Leuven, Belgium; [Voytyuk, Iryna; Smidt, Inga; De Strooper, Bart] VIB KU Leuven Ctr Brain & Dis Res, Leuven, Belgium; [Boeckx, Bram; Lambrechts, Diether] VIB Ctr Canc Biol, Leuven, Belgium; [Boeckx, Bram; Lambrechts, Diether] Univ Leuven, Dept Human Genet, Lab Translat Genet, Leuven, Belgium; [de Casterle, Isabelle Dierckx; Sprangers, Ben] Univ Leuven, Dept Microbiol & Immunol, Lab Expt Transplantat, Leuven, Belgium; [Baekelandt, Veerle] Univ Leuven, Dept Neurosci, Res Grp Neurobiol & Gene Therapy, Leuven, Belgium; [Mack, Matthias] Univ Hosp Regensburg, Dept Internal Med Nephrol, Regensburg, Germany; [Depoortere, Inge] Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Dept Chron Dis Metab & Ageing, Gut Peptide Res Lab, Leuven, Belgium; [De Strooper, Bart] UCL, UK Dementia Res Inst, London, England; [Himmelreich, Uwe; Soenen, Stefaan] Univ Leuven, Dept Imaging & Pathol, Biomed MRI Unit, Leuven, Belgium; [Guilliams, Martin] VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium; [Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Jones, Elizabeth] Univ Leuven, Ctr Mol & Vasc Biol, Dept Cardiovasc Sci, Leuven, Belgium; [Verheijden, Simon] UCB Pharma, Chemin Foriest, B-1420 Braine Lalleud, Belgium	KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; University of Regensburg; KU Leuven; University of London; University College London; KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; KU Leuven; UCB Pharma SA	Boeckxstaens, G (corresponding author), Univ Leuven, Dept Chron Dis Metab & Ageing, Translat Res Ctr Gastrointestinal Disorders, Lab Intestinal Neuroimmune Interact, Leuven, Belgium.	guy.boeckxstaens@kuleuven.be	Soenen, Stefaan J/D-7370-2014; Aguilera-Lizarraga, Javier/AAF-9307-2021; Boeckxstaens, Guy/AAP-2502-2020; Jones, Elizabeth AV/I-2180-2018; Guilliams, Martin/N-7803-2013; de+Strooper, Bart/Z-1638-2019; Baekelandt, Veerle/ABB-9736-2020; Soenen, Stefaan/GLR-3797-2022; Lambrechts, Diether/AAJ-3167-2020; Depoortere, Inge/I-5019-2013	Soenen, Stefaan J/0000-0003-2390-3133; Aguilera-Lizarraga, Javier/0000-0002-8135-9933; Jones, Elizabeth AV/0000-0002-2006-7064; Guilliams, Martin/0000-0003-3525-7570; Baekelandt, Veerle/0000-0001-8966-2921; Lambrechts, Diether/0000-0002-3429-302X; Depoortere, Inge/0000-0002-0289-2175; De Strooper, Bart/0000-0001-5455-5819; Viola, Maria/0000-0003-0660-9506; Boeckxstaens, Guy/0000-0001-8267-5797; Voytyuk, Iryna/0000-0003-3484-3658; Himmelreich, Uwe/0000-0002-2060-8895; Boesmans, Werend/0000-0002-2426-0451; Vanden Berghe, Pieter/0000-0002-0009-2094	European Research Council (ERC) Advanced Grant (ERC-2013-Adg) [340101]; Research Foundation Flanders [12J8117N]; KU Leuven [C12/16/019]; ERA-NET;  [AKUL 15/37]; MRC [UKDRI-1004] Funding Source: UKRI	European Research Council (ERC) Advanced Grant (ERC-2013-Adg)(European Research Council (ERC)); Research Foundation Flanders(FWO); KU Leuven(KU Leuven); ERA-NET; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Naomi Fabre and Iris Appeltans for the excellent technical assistance during experiments. We also thank Christele Nkama and Pier Andree Penttila from FACS Core (KU Leuven) for cell sorting, Evelien Labeeuw and other members of our laboratory for assistance with our experiments, and Theo Thijs for assistance during muscle strip experiments and analysis. Thanks also to Stijn Roden for the assistance during irradiation experiments and Paolo Carai for intravenous injections. We thank Ari Waisman and Daniel Saban for helpful experimental discussions. We also thank the Cell Imaging Core (Pieter Vanden Berghe and Werend Boesmans, KU Leuven) for confocal imaging (Zeiss LSM880 microscope was supported by AKUL 15/37) and acknowledge the ImmGen Consortium. We thank Annelies Nonneman from the Lab of Neurobiology (KU Leuven) for providing R26-YFP<SUP>LSL</SUP> mice. G.B. is supported by the European Research Council (ERC) Advanced Grant (ERC-2013-Adg: 340101 Cholstim). S.V. was supported by a fellowship of the Research Foundation Flanders (12J8117N). E.J. is supported by KU Leuven C1 funding (C12/16/019) and ERA-NET funding.	Asano K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8802; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Becker L, 2018, GUT, V67, P827, DOI 10.1136/gutjnl-2016-312940; Bhogal HS, 2004, DEV COMP IMMUNOL, V28, P843, DOI 10.1016/j.dci.2003.12.006; Boesmans W, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00183; Boisset JC, 2018, NAT METHODS, V15, P547, DOI 10.1038/s41592-018-0009-z; Bonnardel J, 2015, CELL REP, V11, P770, DOI 10.1016/j.celrep.2015.03.067; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Haimon Z, 2018, NAT IMMUNOL, V19, P636, DOI 10.1038/s41590-018-0110-6; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Krishnasamy K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00953-2; Kurotaki D, 2015, MICROBIOL IMMUNOL, V59, P55, DOI 10.1111/1348-0421.12228; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Preziosi Giuseppe, 2009, Expert Rev Gastroenterol Hepatol, V3, P417, DOI 10.1586/egh.09.31; Prinz M, 2014, ACTA NEUROPATHOL, V128, P319, DOI 10.1007/s00401-014-1267-1; Reboldi A, 2016, IMMUNOL REV, V271, P230, DOI 10.1111/imr.12400; Sellin JH, 2008, NAT CLIN PRACT GASTR, V5, P162, DOI 10.1038/ncpgasthep1054; Shaw TN, 2018, J EXP MED, V215, P1507, DOI 10.1084/jem.20180019; SHELDON RJ, 1990, J PHARMACOL EXP THER, V252, P636; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stakenborg N, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13075; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	42	223	224	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 4	2018	175	2					400	+		10.1016/j.cell.2018.07.048	http://dx.doi.org/10.1016/j.cell.2018.07.048			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GV7PQ	30173915	Bronze, Green Submitted			2022-12-28	WOS:000446321300013
J	[Anonymous]				[Anonymous]			Global mortality from firearms, 1990-2016 (vol 320, pg 792, 2018)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Correction																		Naghavi M, 2018, JAMA-J AM MED ASSOC, V320, P792, DOI 10.1001/jama.2018.10060	1	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2018	320	12					1288	1288		10.1001/jama.2018.13590	http://dx.doi.org/10.1001/jama.2018.13590			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU8GX	30167671	Green Published, Bronze			2022-12-28	WOS:000445577000030
J	Pottegard, A; Kristensen, KB; Ernst, MT; Johansen, NB; Quartarolo, P; Hallas, J				Pottegard, Anton; Kristensen, Kasper Bruun; Ernst, Martin Thomsen; Johansen, Nanna Borup; Quartarolo, Pierre; Hallas, Jesper			Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NITROSO COMPOUNDS; MECHANISMS; EXPOSURES; REGISTRY; QUALITY; RATS	OBJECTIVES To perform an expedited assessment of cancer risk associated with exposure to N-nitrosodimethylamine (NDMA) through contaminated valsartan products. DESIGN Nationwide cohort study. SETTING Danish health registries on individual level prescription drug use, cancer occurrence, and hospital diagnoses. PARTICIPANTS 5150 Danish patients with no history of cancer, aged 40 years or older, and using valsartan at 1 January 2012 or initiating use between 1 January 2012 and 30 June 2017. Participants were followed from one year after cohort entry (lag time period) until experiencing a cancer outcome, death, migration, or end of study period (30 June 2018). Each participant's exposure to NDMA (ever exposure and predefined categories of cumulative valsartan exposure) was mapped out as a time varying variable while also applying a one year lag. MAIN OUTCOME MEASURES Association between NDMA exposure and a primary composite endpoint comprising all cancers except non-melanoma skin cancer, estimated using Cox regression. In supplementary analyses, the risk of individual cancers was determined. RESULTS The final cohort comprised 5150 people followed for a median of 4.6 years. In total, 3625 cohort participants contributed 7344 person years classified as unexposed to NDMA, and 3450 participants contributed 11920 person years classified as ever exposed to NDMA. With 104 cancer outcomes among NDMA unexposed participants and 198 among exposed participants, the adjusted hazard ratio for overall cancer was 1.09 (95% confidence interval 0.85 to 1.41), with no evidence of a dose-response relation (P=0.70). For single cancer outcomes, increases in risk were observed for colorectal cancer (hazard ratio 1.46, 95% confidence interval 0.79 to 2.73) and for uterine cancer (1.81, 0.55 to 5.90), although with wide confidence intervals that included the null. CONCLUSIONS The results do not imply a markedly increased short term overall risk of cancer in users of valsartan contaminated with NDMA. However, uncertainty persists about single cancer outcomes, and studies with longer follow-up are needed to assess long term cancer risk.	[Pottegard, Anton; Kristensen, Kasper Bruun; Ernst, Martin Thomsen; Hallas, Jesper] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol & Pharm, JB Winslowsvej 19,2, DK-5000 Odense C, Denmark; [Johansen, Nanna Borup] Danish Med Agcy, Med Evaluat & Biostat, Copenhagen, Denmark; [Quartarolo, Pierre] Danish Med Agcy, Pharmacovigitance & Med Devices, Copenhagen, Denmark	University of Southern Denmark	Pottegard, A (corresponding author), Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol & Pharm, JB Winslowsvej 19,2, DK-5000 Odense C, Denmark.	apottegaard@health.sdu.dk		Pottegard, Anton/0000-0001-9314-5679; Ernst, Martin/0000-0001-9003-3823; Kristensen, Kasper Bruun/0000-0001-6373-1386				Abdel-Tawab M, 2018, PZ PHARM ZTG, V30; Agency for Toxic Substances and Disease Registry U. S. Public Health Service, 1989, TOX PROF N NITR; BARTSCH H, 1988, CANCER RES, V48, P4711; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; European Medicines Agency, 2018, EMA REV MED CONT VAL; Friis S, 2015, CANCER EPIDEMIOL, V39, pS107, DOI 10.1016/j.canep.2015.08.003; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Heisterberg J, 2016, PHARMACOEPIDEM DR S, V25, P344, DOI 10.1002/pds.3969; Hellfritzsch M, 2016, PHARMACOEPIDEM DR S, V25, P336, DOI 10.1002/pds.3942; International Agency for Research on Cancer, 1987, IARC MON EV CARC S7, V1-42; Knekt P, 1999, INT J CANCER, V80, P852, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;852::AID-IJC9&gt;3.0.CO;2-S; LIJINSKY W, 1984, CANCER LETT, V22, P83, DOI 10.1016/0304-3835(84)90047-8; Loh YH, 2011, AM J CLIN NUTR, V93, P1053, DOI 10.3945/ajcn.111.012377; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; PETO R, 1991, CANCER RES, V51, P6415; Peto R., 1984, IARC SCI PUBL, V57, P627; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Pottegard A, 2018, BASIC CLIN PHARMACOL, V122, P451, DOI 10.1111/bcpt.12946; Pottegard A, 2017, INT J EPIDEMIOL, V46, P798, DOI 10.1093/ije/dyw213; Pottegard A, 2014, EUR J CLIN PHARMACOL, V70, P757, DOI 10.1007/s00228-014-1677-y; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Storm HH, 1997, DAN MED BULL, V44, P535; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; TRICKER AR, 1991, MUTAT RES, V259, P277, DOI 10.1016/0165-1218(91)90123-4; Weberpals J, 2017, EUR J EPIDEMIOL, V32, P1019, DOI 10.1007/s10654-017-0304-5; WHO Collaborating Centre for Drug Statistics Methodology, 2016, GUID ATC CLASS DDD A; Zhu Y, 2014, BRIT J NUTR, V111, P1109, DOI 10.1017/S0007114513003462	29	43	43	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2018	362								k3851	10.1136/bmj.k3851	http://dx.doi.org/10.1136/bmj.k3851			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JJ	30209057	Green Published, hybrid			2022-12-28	WOS:000445016500009
J	Wise, J				Wise, Jacqui			CQC: Trusts must do more to protect mental health patients from sexual abuse	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Care Quality Commission, 2018, SEX SAF MENT HLTH WA	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2018	362								k3865	10.1136/bmj.k3865	http://dx.doi.org/10.1136/bmj.k3865			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GU1JF	30201629				2022-12-28	WOS:000445015700004
J	Roehr, B				Roehr, Bob			US hospitals launch non-profit generic drug producer to counter rising prices	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2018	362								k3840	10.1136/bmj.k3840	http://dx.doi.org/10.1136/bmj.k3840			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WY	30194067				2022-12-28	WOS:000444507900003
J	Stone, R				Stone, Richard			INTERNATIONAL RELATIONS Renewed sanctions strangle science in Iran	SCIENCE			English	News Item									[Stone, Richard] Tangled Bank Studios, Chevy Chase, MD 20815 USA		Stone, R (corresponding author), Tangled Bank Studios, Chevy Chase, MD 20815 USA.								0	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					961	961		10.1126/science.361.6406.961	http://dx.doi.org/10.1126/science.361.6406.961			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190386				2022-12-28	WOS:000443892700014
J	Lee, SH; Singh, I; Tisdale, S; Abdel-Wahab, O; Leslie, CS; Mayr, C				Lee, Shih-Han; Singh, Irtisha; Tisdale, Sarah; Abdel-Wahab, Omar; Leslie, Christina S.; Mayr, Christine			Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia	NATURE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; T-CELL DIFFERENTIATION; NF-KAPPA-B; CANCER GENOME; C-MYC; MUTATIONS; ACTIVATION; PATHWAY; PROLIFERATION; LOCALIZATION	DNA mutations are known cancer drivers. Here we investigated whether mRNA events that are upregulated in cancer can functionally mimic the outcome of genetic alterations. RNA sequencing or 3'-end sequencing techniques were applied to normal and malignant B cells from 59 patients with chronic lymphocytic leukaemia (CLL)(1-3). We discovered widespread upregulation of truncated mRNAs and proteins in primary CLL cells that were not generated by genetic alterations but instead occurred by intronic polyadenylation. Truncated mRNAs caused by intronic polyadenylation were recurrent (n = 330) and predominantly affected genes with tumour-suppressive functions. The truncated proteins generated by intronic polyadenylation often lack the tumour-suppressive functions of the corresponding full-length proteins (such as DICER and FOXN3), and several even acted in an oncogenic manner (such as CARD11, MGA and CHST11). In CLL, the inactivation of tumour-suppressor genes by aberrant mRNA processing is substantially more prevalent than the functional loss of such genes through genetic events. We further identified new candidate tumour-suppressor genes that are inactivated by intronic polyadenylation in leukaemia and by truncating DNA mutations in solid tumours(4,5). These genes are understudied in cancer, as their overall mutation rates are lower than those of well-known tumour-suppressor genes. Our findings show the need to go beyond genomic analyses in cancer diagnostics, as mRNA events that are silent at the DNA level are widespread contributors to cancer pathogenesis through the inactivation of tumour-suppressor genes.	[Lee, Shih-Han; Tisdale, Sarah; Mayr, Christine] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Singh, Irtisha; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Singh, Irtisha] Weill Cornell Grad Coll, TriI Program Computat Biol & Med, New York, NY USA; [Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center	Mayr, C (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	mayrc@mskcc.org	Singh, Irtisha/W-6182-2019	Singh, Irtisha/0000-0002-9460-3587	NCI [U01-CA164190]; Starr Cancer Foundation; Damon Runyon-Rachleff Cancer Foundation; Island Outreach Foundation [DRR-24-13]; NIH [DP1-GM123454]; Pershing Square Sohn Cancer Research Alliance; MSK Core Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [U01CA164190, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM123454] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Starr Cancer Foundation; Damon Runyon-Rachleff Cancer Foundation; Island Outreach Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); MSK Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the NCI grant U01-CA164190 (to C.M. and C.S.L.), a Starr Cancer Foundation grant (to C.M. and C.S.L.), the Innovator Award of the Damon Runyon-Rachleff Cancer Foundation and the Island Outreach Foundation (DRR-24-13; to C.M.), the NIH Director's Pioneer Award (DP1-GM123454, to C.M.), the Pershing Square Sohn Cancer Research Alliance (to C.M.) and the MSK Core Grant (P30 CA008748). We are grateful to V.K. Modi for access to lymphatic tissue, to D.A. Landau for providing CLL RNA-seq data and sample identities to validate our findings, and to C. Wu and D. Neuberg for clinical outcome analyses. We thank J. Mendell and V. Narry Kim for providing the V5-DICER construct and the DICER knockout cells, J. Chaudhuri for critical reading of the manuscript, and the members of the Mayr laboratory for discussions.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; De Paoli L, 2013, LEUKEMIA LYMPHOMA, V54, P1087, DOI 10.3109/10428194.2012.723706; Dvinge H, 2016, NAT REV CANCER, V16, P413, DOI 10.1038/nrc.2016.51; Gruber AJ, 2016, GENOME RES, V26, P1145, DOI 10.1101/gr.202432.115; Hoek KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118528; Huot G, 2014, MOL BIOL CELL, V25, P554, DOI 10.1091/mbc.E13-02-0110; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Jezkova J, 2014, ONCOTARGET, V5, P3813, DOI 10.18632/oncotarget.1999; Karanth S, 2016, CELL REP, V15, P2745, DOI 10.1016/j.celrep.2016.05.056; Kessenbrock K, 2013, CELL STEM CELL, V13, P300, DOI 10.1016/j.stem.2013.06.005; Kim YK, 2016, P NATL ACAD SCI USA, V113, pE1881, DOI 10.1073/pnas.1602532113; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Mansouri L, 2016, SEMIN CANCER BIOL, V39, P40, DOI 10.1016/j.semcancer.2016.07.005; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Milland J, 2002, J BIOL CHEM, V277, P10374, DOI 10.1074/jbc.M111799200; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; Ni TK, 2016, ELIFE, V5, DOI 10.7554/eLife.14730; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rakheja D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5802; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Schmidt HH, 2004, ONCOGENE, V23, P6991, DOI 10.1038/sj.onc.1207934; Singh I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04112-z; Stilgenbauer S, 2002, LEUKEMIA, V16, P993, DOI 10.1038/sj.leu.2402537; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Vorlova S, 2011, MOL CELL, V43, P927, DOI 10.1016/j.molcel.2011.08.009; Wang LL, 2014, BLOOD, V124, P1089, DOI 10.1182/blood-2014-01-552067; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	46	104	107	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					127	+		10.1038/s41586-018-0465-8	http://dx.doi.org/10.1038/s41586-018-0465-8			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30150773	Green Accepted			2022-12-28	WOS:000443755200045
J	Marshall, CH; Nahas-Vigon, J; Manesh, R; Gelber, AC				Marshall, Catherine Handy; Nahas-Vigon, Jordan; Manesh, Reza; Gelber, Allan C.			Just Beneath the Surface	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							B-CELL LYMPHOMA; RANDOM SKIN BIOPSY; INTRAVASCULAR LYMPHOMA; DIAGNOSIS; MANAGEMENT; FEVER		[Marshall, Catherine Handy; Nahas-Vigon, Jordan; Manesh, Reza; Gelber, Allan C.] Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Osler Med Serv, Baltimore, MD USA; [Marshall, Catherine Handy; Nahas-Vigon, Jordan; Manesh, Reza; Gelber, Allan C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Marshall, Catherine Handy] Johns Hopkins Univ, Sch Med, Dept Oncol, 1650 Orleans St,Suite 186, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Marshall, CH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, 1650 Orleans St,Suite 186, Baltimore, MD 21287 USA.	handy@jhmi.edu		Gelber, Allan/0000-0001-8463-311X				Asada N, 2007, MAYO CLIN PROC, V82, P1525, DOI 10.4065/82.12.1525; Brunet V, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005985; Ferreri AJM, 2004, BRIT J HAEMATOL, V127, P173, DOI 10.1111/j.1365-2141.2004.05177.x; Le EN, 2008, J AM ACAD DERMATOL, V59, P148, DOI 10.1016/j.jaad.2008.03.010; Matsue K, 2008, EUR J HAEMATOL, V80, P236, DOI 10.1111/j.1600-0609.2007.01008.x; Matsue K, 2011, ANN HEMATOL, V90, P417, DOI 10.1007/s00277-010-1101-3; Murase T, 2007, BLOOD, V109, P478, DOI 10.1182/blood-2006-01-021253; Pongpudpunth M, 2015, AM J DERMATOPATH, V37, P686, DOI 10.1097/DAD.0000000000000321; Ponzoni M, 2007, J CLIN ONCOL, V25, P3168, DOI 10.1200/JCO.2006.08.2313; Rajyaguru DJ, 2017, LEUKEMIA LYMPHOMA, V58, P2080, DOI 10.1080/10428194.2017.1287363; Shimada K, 2008, J CLIN ONCOL, V26, P3189, DOI 10.1200/JCO.2007.15.4278; Shimada K, 2009, LANCET ONCOL, V10, P895, DOI 10.1016/S1470-2045(09)70140-8; Sitthinamsuwan P, 2017, J CUTAN PATHOL, V44, P729, DOI 10.1111/cup.12984; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Thwaites GE, 2017, NEW ENGL J MED, V376, P548, DOI 10.1056/NEJMra1508435	15	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2018	379	10					968	973		10.1056/NEJMcps1802664	http://dx.doi.org/10.1056/NEJMcps1802664			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS5XM	30184453				2022-12-28	WOS:000443748200014
J	Cass, KS				Cass, Keith S.			Twitter helped me decide that I'm not for resuscitation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material														Taubert, Mark/0000-0003-0454-5609					0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2018	362								k2784	10.1136/bmj.k2784	http://dx.doi.org/10.1136/bmj.k2784			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WB	30185527	Bronze			2022-12-28	WOS:000444505300001
J	Kozlowski, S; Birger, N; Brereton, S; McKean, SJ; Wernecke, M; Christl, L; Kelman, JA				Kozlowski, Steven; Birger, Noy; Brereton, Stephaeno; McKean, Stephen J.; Wernecke, Michael; Christl, Leah; Kelman, Jeffrey A.			Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kozlowski, Steven; Christl, Leah] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Birger, Noy; Brereton, Stephaeno; McKean, Stephen J.; Wernecke, Michael] Acumen LLC, Burlingame, CA USA; [Kelman, Jeffrey A.] Ctr Medicare & Medicaid Serv, Washington, DC USA	US Food & Drug Administration (FDA); Centers for Medicare & Medicaid Services	Kozlowski, S (corresponding author), US FDA, Off Biotechnol Prod, Off Pharmaceut Qual, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave,White Oak Bldg 71, Silver Spring, MD 20993 USA.	steven.kozlowski@fda.hhs.gov						[Anonymous], FDANEWS; Grabowski H, 2014, NAT REV DRUG DISCOV, V13, P99, DOI 10.1038/nrd4210; IMS Institute for Healthcare Informatics, 2016, DEL POT BIOS MED ROL; Megerlin F, 2013, HEALTH AFFAIR, V32, P1803, DOI 10.1377/hlthaff.2009.0196; Royzman I., US VALUE BEING HIGHL; US Food and Drug Administration, CTR DRUG EV RES LIST	6	19	19	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2018	320	9					929	931		10.1001/jama.2018.9014	http://dx.doi.org/10.1001/jama.2018.9014			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS4OQ	30193265	Green Published, Bronze			2022-12-28	WOS:000443627300018
J	Best, RB; Zheng, WW; Borgia, A; Buholzer, K; Borgia, MB; Hofmann, H; Soranno, A; Nettels, D; Gast, K; Grishaev, A; Schuler, B				Best, Robert B.; Zheng, Wenwei; Borgia, Alessandro; Buholzer, Karin; Borgia, Madeleine B.; Hofmann, Hagen; Soranno, Andrea; Nettels, Daniel; Gast, Klaus; Grishaev, Alexander; Schuler, Benjamin			Comment on "Innovative scattering analysis shows that hydrophobic disordered proteins are expanded in water"	SCIENCE			English	Editorial Material							MOLECULE FRET SPECTROSCOPY; DENATURANT	Riback et al. (Reports, 13 October 2017, p. 238) used small-angle x-ray scattering (SAXS) experiments to infer a degree of compaction for unfolded proteins in water versus chemical denaturant that is highly consistent with the results from Forster resonance energy transfer (FRET) experiments. There is thus no "contradiction" between the two methods, nor evidence to support their claim that commonly used FRET fluorophores cause protein compaction.	[Best, Robert B.] NIDDK, Lab Chem Phys, Bethesda, MD 20892 USA; [Zheng, Wenwei] Arizona State Univ, Coll Integrat Sci & Arts, Mesa, AZ 85212 USA; [Borgia, Alessandro; Buholzer, Karin; Borgia, Madeleine B.; Nettels, Daniel; Schuler, Benjamin] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Hofmann, Hagen] Weizmann Inst Sci, Dept Struct Biol, IL-76100 Rehovot, Israel; [Soranno, Andrea] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Gast, Klaus] Univ Potsdam, Phys Biochem, D-14476 Potsdam, Germany; [Grishaev, Alexander] NIST, Rockville, MD 20850 USA; [Grishaev, Alexander] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Schuler, Benjamin] Univ Zurich, Dept Phys, CH-8057 Zurich, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Arizona State University; University of Zurich; Weizmann Institute of Science; Washington University (WUSTL); University of Potsdam; National Institute of Standards & Technology (NIST) - USA; University of Zurich	Best, RB (corresponding author), NIDDK, Lab Chem Phys, Bethesda, MD 20892 USA.; Schuler, B (corresponding author), Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland.; Schuler, B (corresponding author), Univ Zurich, Dept Phys, CH-8057 Zurich, Switzerland.	robert.best2@nih.gov; schuler@bioc.uzh.ch	Schuler, Benjamin/E-7342-2011; Borgia, Alessandro/AAF-9203-2019; Zheng, Wenwei/M-5031-2015	Schuler, Benjamin/0000-0002-5970-4251; Borgia, Alessandro/0000-0002-4701-8967; Hofmann, Hagen/0000-0003-1669-3158; Grishaev, Alexander/0000-0002-9347-2327; Zheng, Wenwei/0000-0002-9603-009X; Buholzer, Karin/0000-0003-2324-5492	NIDDK Intramural Research Program of NIH; Arizona State University; Swiss National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056114] Funding Source: NIH RePORTER	NIDDK Intramural Research Program of NIH; Arizona State University; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the NIDDK Intramural Research Program of NIH (R.B.B.) and Arizona State University (W.Z.). Work at the University of Zurich was supported by funding from the Swiss National Science Foundation.	Borgia A, 2016, J AM CHEM SOC, V138, P11714, DOI 10.1021/jacs.6b05917; CALMETTES P, 1993, J PHYS IV, V3, P253, DOI 10.1051/jp4:1993849; Fuertes G, 2017, P NATL ACAD SCI USA, V114, pE6342, DOI 10.1073/pnas.1704692114; Hofmann H, 2012, P NATL ACAD SCI USA, V109, P16155, DOI 10.1073/pnas.1207719109; Hummer G, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4937786; Jacob J, 2004, J MOL BIOL, V338, P369, DOI 10.1016/j.jmb.2004.02.065; Jacob J, 2007, J MOL BIOL, V367, P609, DOI 10.1016/j.jmb.2007.01.012; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Merchant KA, 2007, P NATL ACAD SCI USA, V104, P1528, DOI 10.1073/pnas.0607097104; O'Brien EP, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3082151; Riback JA, 2017, SCIENCE, V358, P238, DOI 10.1126/science.aan5774; Song JH, 2015, J PHYS CHEM B, V119, P15191, DOI 10.1021/acs.jpcb.5b09133; Watkins HM, 2015, P NATL ACAD SCI USA, V112, P6631, DOI 10.1073/pnas.1418673112; Yoo TY, 2012, J MOL BIOL, V418, P226, DOI 10.1016/j.jmb.2012.01.016; Zheng WW, 2016, J AM CHEM SOC, V138, P11702, DOI 10.1021/jacs.6b05443	15	28	29	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405							eaar7101	10.1126/science.aar7101	http://dx.doi.org/10.1126/science.aar7101			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS3UB	30166459	Green Accepted			2022-12-28	WOS:000443547000001
J	Cheben, P; Halir, R; Schmid, JH; Atwater, HA; Smith, DR				Cheben, Pavel; Halir, Robert; Schmid, Jens H.; Atwater, Harry A.; Smith, David R.			Subwavelength integrated photonics	NATURE			English	Review							SILICON-ON-INSULATOR; SURFACE GRATING COUPLER; WAVE-GUIDES; POLARIZATION SPLITTER; OPTICAL-PROPERTIES; PHASE MODULATION; MODE CONVERSION; INDEX; DESIGN; PLANAR	In the late nineteenth century, Heinrich Hertz demonstrated that the electromagnetic properties of materials are intimately related to their structure at the subwavelength scale by using wire grids with centimetre spacing to manipulate metre-long radio waves. More recently, the availability of nanometre-scale fabrication techniques has inspired scientists to investigate subwavelength-structured metamaterials with engineered optical properties at much shorter wavelengths, in the infrared and visible regions of the spectrum. Here we review how optical metamaterials are expected to enhance the performance of the next generation of integrated photonic devices, and explore some of the challenges encountered in the transition from concept demonstration to viable technology.	[Cheben, Pavel; Schmid, Jens H.] Natl Res Council Canada, Ottawa, ON, Canada; [Halir, Robert] Univ Malaga, Dept Ingn Comunicac, ETSI Telecomunicac, Malaga, Spain; [Halir, Robert] Bionand Ctr Nanomed & Biotechnol, Malaga, Spain; [Atwater, Harry A.] CALTECH, Pasadena, CA 91125 USA; [Smith, David R.] Duke Univ, Durham, NC USA	National Research Council Canada; Universidad de Malaga; California Institute of Technology; Duke University	Cheben, P (corresponding author), Natl Res Council Canada, Ottawa, ON, Canada.	pavel.cheben@nrc.ca	Halir, Robert/K-8832-2014; Dominguez, Thalia/AAW-7633-2020; Atwater, Harry A/H-2823-2014	Halir, Robert/0000-0002-5560-3189; Dominguez, Thalia/0000-0002-3664-1403; Atwater, Harry A/0000-0001-9435-0201	Ministerio de Economia y Competitividad, Programa Estatal de Investigacion, Desarrollo e Innovacion Orientada a los Retos de la Sociedad (cofinanciado FEDER) [TEC2016-80718-R]; Air Force Office of Scientific Research [FA9550-16-1-0019]	Ministerio de Economia y Competitividad, Programa Estatal de Investigacion, Desarrollo e Innovacion Orientada a los Retos de la Sociedad (cofinanciado FEDER); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	We are grateful to S. Janz, D.-X. Xu, A. Ortega-Monux, I. Molina-Fernandez, J. G. Wanguemert-Perez, J. Lapointe, J. Ctyroky, C. Alonso-Ramos, D. Benedikovic, G. Mashanovich, A. V. Velasco, W. Ye, M. L. Calvo, L. Vivien, Y. Grinberg, D. Melati and M. Dado for discussions. R.H. acknowledges financial support from Ministerio de Economia y Competitividad, Programa Estatal de Investigacion, Desarrollo e Innovacion Orientada a los Retos de la Sociedad (cofinanciado FEDER) Proyecto TEC2016-80718-R. H.A.A. acknowledges financial support from the Air Force Office of Scientific Research under grant number FA9550-16-1-0019.	Almeida VR, 2003, OPT LETT, V28, P1302, DOI 10.1364/OL.28.001302; Barwicz T., 2017, P OPT FIB COMM C TH2; Barwicz T, 2016, 2016 OPTICAL FIBER COMMUNICATIONS CONFERENCE AND EXHIBITION (OFC); Barwicz T, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2593637; Benedikovic D, 2017, OPT LETT, V42, P3439, DOI 10.1364/OL.42.003439; Benedikovic D, 2017, OPT EXPRESS, V25, P19468, DOI 10.1364/OE.25.019468; Benedikovic D, 2015, OPT EXPRESS, V23, P22628, DOI 10.1364/OE.23.022628; Berini P, 2014, LASER PHOTONICS REV, V8, P197, DOI 10.1002/lpor.201300019; Bloembergen N, 1970, APPL PHYS LETT, V17, P483, DOI 10.1063/1.1653278; Bock PJ, 2010, OPT EXPRESS, V18, P20251, DOI 10.1364/OE.18.020251; Bock PJ, 2010, OPT EXPRESS, V18, P16146, DOI 10.1364/OE.18.016146; Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258; Chang-Hasnain CJ, 2012, ADV OPT PHOTONICS, V4, P379, DOI 10.1364/AOP.4.000379; Cheben P, 2006, OPT EXPRESS, V14, P4695, DOI 10.1364/OE.14.004695; Cheben P, 2015, OPT EXPRESS, V23, P22553, DOI 10.1364/OE.23.022553; Cheben P, 2010, OPT LETT, V35, P2526, DOI 10.1364/OL.35.002526; Chen HT, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/7/076401; Cheng ZZ, 2014, OPT LETT, V39, P2206, DOI 10.1364/OL.39.002206; Ctyroky J, 2018, OPT EXPRESS, V26, P179, DOI 10.1364/OE.26.000179; Dabidian N, 2016, NANO LETT, V16, P3607, DOI 10.1021/acs.nanolett.6b00732; Sarmiento-Merenguel JD, 2016, OPT LETT, V41, P3443, DOI 10.1364/OL.41.003443; Fedotov VA, 2007, NANO LETT, V7, P1996, DOI 10.1021/nl0707961; Gavela AF, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030285; Flueckiger J, 2016, OPT EXPRESS, V24, P15672, DOI 10.1364/OE.24.015672; Frandsen LH, 2014, OPT EXPRESS, V22, P8525, DOI 10.1364/OE.22.008525; Gabrielli LH, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/2/024010; Gao G, 2017, OPT EXPRESS, V25, P2918, DOI 10.1364/OE.25.002918; Genevet P, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/2/024401; Glesk I, 2011, OPT EXPRESS, V19, P14031, DOI 10.1364/OE.19.014031; Halir R, 2012, OPT EXPRESS, V20, P13470, DOI 10.1364/OE.20.013470; Halir R, 2016, LASER PHOTONICS REV, V10, P1039, DOI 10.1002/lpor.201600213; Halir R, 2015, LASER PHOTONICS REV, V9, P25, DOI 10.1002/lpor.201400083; He Y., 2017, P OPT FIB COMM C TH1; Huang YW, 2016, NANO LETT, V16, P5319, DOI 10.1021/acs.nanolett.6b00555; Hunt J, 2012, OPT EXPRESS, V20, P1706, DOI 10.1364/OE.20.001706; Jahani S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04276-8; Jahani S, 2016, NAT NANOTECHNOL, V11, P23, DOI [10.1038/nnano.2015.304, 10.1038/NNANO.2015.304]; Jahani S, 2014, OPTICA, V1, P96, DOI 10.1364/OPTICA.1.000096; Jensen JS, 2011, LASER PHOTONICS REV, V5, P308, DOI 10.1002/lpor.201000014; Jeong SH, 2013, OPT EXPRESS, V21, P30163, DOI 10.1364/OE.21.030163; Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1; Kang J, 2017, OPT LETT, V42, P2094, DOI 10.1364/OL.42.002094; Kashyap R, 2010, FIBER BRAGG GRATINGS, 2ND EDITION, P1; Kildishev AV, 2013, SCIENCE, V339, DOI 10.1126/science.1232009; Kuznetsov AI, 2016, SCIENCE, V354, DOI 10.1126/science.aag2472; Lalanne P, 1999, J OPT SOC AM A, V16, P1143, DOI 10.1364/JOSAA.16.001143; Lalanne P, 2017, LASER PHOTONICS REV, V11, DOI 10.1002/lpor.201600295; Levy U, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.243901; Li ZY, 2017, NAT NANOTECHNOL, V12, P675, DOI [10.1038/nnano.2017.50, 10.1038/NNANO.2017.50]; Lu LLZ, 2016, OPT LETT, V41, P5051, DOI 10.1364/OL.41.005051; Ma K, 2017, OPT EXPRESS, V25, P30876, DOI 10.1364/OE.25.030876; Mait J. N., 2001, SELECTED PAPERS SUBW; Mauser KW, 2017, NAT NANOTECHNOL, V12, P770, DOI [10.1038/nnano.2017.87, 10.1038/NNANO.2017.87]; McGrath D., 2017, EETIMES; Mekis A, 2011, IEEE J SEL TOP QUANT, V17, P597, DOI 10.1109/JSTQE.2010.2086049; Melati D, 2014, ADV OPT PHOTONICS, V6, P156, DOI 10.1364/AOP.6.000156; Naghdi B, 2016, OPT EXPRESS, V24, P23429, DOI 10.1364/OE.24.023429; Notaros J., 2016, P OPT FIB COMM C EXH, P1; Ortega-Monux A, 2017, OPT EXPRESS, V25, P12222, DOI 10.1364/OE.25.012222; Park J, 2017, NANO LETT, V17, P407, DOI 10.1021/acs.nanolett.6b04378; Penades JS, 2018, OPT LETT, V43, P795, DOI 10.1364/OL.43.000795; Penades JS, 2016, OPT EXPRESS, V24, P22908, DOI 10.1364/OE.24.022908; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Peng B, 2017, 2017 OPTICAL FIBER COMMUNICATIONS CONFERENCE AND EXHIBITION (OFC); Perez-Galacho D, 2017, OPT LETT, V42, P1468, DOI 10.1364/OL.42.001468; Piggott AY, 2015, NAT PHOTONICS, V9, P374, DOI [10.1038/nphoton.2015.69, 10.1038/NPHOTON.2015.69]; Podmore H, 2017, OPT LETT, V42, P1440, DOI 10.1364/OL.42.001440; Poulton CV, 2017, OPT LETT, V42, P4091, DOI 10.1364/OL.42.004091; RYTOV SM, 1956, SOV PHYS JETP-USSR, V2, P466; Sanchez-Postigo A, 2016, OPT LETT, V41, P3013, DOI 10.1364/OL.41.003013; Schmid JH, 2007, OPT LETT, V32, P1794, DOI 10.1364/OL.32.001794; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Shen B, 2015, NAT PHOTONICS, V9, P378, DOI [10.1038/NPHOTON.2015.80, 10.1038/nphoton.2015.80]; Sherrott MC, 2017, NANO LETT, V17, P3027, DOI 10.1021/acs.nanolett.7b00359; Smith DR, 2006, J OPT SOC AM B, V23, P391, DOI 10.1364/JOSAB.23.000391; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; Staude I, 2017, NAT PHOTONICS, V11, P274, DOI [10.1038/nphoton.2017.39, 10.1038/NPHOTON.2017.39]; Sun J, 2013, NATURE, V493, P195, DOI 10.1038/nature11727; Urbas AM, 2016, J OPTICS-UK, V18, DOI 10.1088/2040-8978/18/9/093005; Valentine J, 2009, NAT MATER, V8, P568, DOI [10.1038/nmat2461, 10.1038/NMAT2461]; VANDERZIEL JP, 1975, APPL PHYS LETT, V26, P60, DOI 10.1063/1.88055; Vivien L, 2013, SER OPT OPTOELECTRON, pVII; Walser RM, 2001, PROC SPIE, V4467, P1, DOI 10.1117/12.432921; Wang JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30235; Wang X, 2012, OPT EXPRESS, V20, P15547, DOI 10.1364/OE.20.015547; Wang YJ, 2016, IEEE PHOTONICS J, V8, DOI 10.1109/JPHOT.2015.2509862; Wang Y, 2015, OPT LETT, V40, P4647, DOI 10.1364/OL.40.004647; Wangueemert-Perez JG, 2014, OPT LETT, V39, P4442, DOI 10.1364/OL.39.004442; Watanabe T, 2017, J LIGHTWAVE TECHNOL, V35, P4663, DOI 10.1109/JLT.2017.2755673; Wu H, 2017, IEEE PHOTONIC TECH L, V29, P474, DOI 10.1109/LPT.2017.2657539; Xiong YL, 2014, OPT LETT, V39, P6931, DOI 10.1364/OL.39.006931; Xu LH, 2018, IEEE PHOTONIC TECH L, V30, P403, DOI 10.1109/LPT.2018.2794466; Xu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27949; Yan H, 2016, OPT EXPRESS, V24, P29725, DOI 10.1364/OE.24.029724; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025; Yu ZJ, 2017, OPT LETT, V42, P3093, DOI 10.1364/OL.42.003093; Zentgraf T, 2010, ADV MATER, V22, P2561, DOI 10.1002/adma.200904139; Zheludev NI, 2016, NAT NANOTECHNOL, V11, P16, DOI [10.1038/nnano.2015.302, 10.1038/NNANO.2015.302]; Zheludev NI, 2015, SCIENCE, V348, P973, DOI 10.1126/science.aac4360; Zhou W, 2017, OPT LETT, V42, P1245, DOI 10.1364/OL.42.001245; Zhu AY, 2017, NANOPHOTONICS-BERLIN, V6, P452, DOI 10.1515/nanoph-2016-0032	103	420	424	51	597	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					565	572		10.1038/s41586-018-0421-7	http://dx.doi.org/10.1038/s41586-018-0421-7			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS0SZ	30158604				2022-12-28	WOS:000443218600036
J	Dyer, C				Dyer, Clare			GP is struck off after being jailed for human trafficking	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2018	362								k3665	10.1136/bmj.k3665	http://dx.doi.org/10.1136/bmj.k3665			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5YZ	30154080				2022-12-28	WOS:000443756600008
J	McCall, B				McCall, Becky			Scientific evidence against HIV criminalisation	LANCET			English	Editorial Material								An expert consensus statement draws attention to the thousands of HIV-related prosecutions and convictions worldwide. Becky McCall reports.											0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2018	392	10147					543	544		10.1016/S0140-6736(18)31732-X	http://dx.doi.org/10.1016/S0140-6736(18)31732-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ8MN	30152379				2022-12-28	WOS:000442009500010
J	Munn, Z; Qaseem, A				Munn, Zachary; Qaseem, Amir		Amer Coll Phys; Joanna Briggs Inst	Disappearance of the National Guideline Clearinghouse: A Huge Loss for Evidence-Based Health Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Munn, Zachary] Joanna Briggs Inst, Adelaide, SA, Australia; [Munn, Zachary] Univ Adelaide, Adelaide, SA, Australia; [Qaseem, Amir] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Munn, Zachary] Univ Adelaide, Fac Hlth & Med Sci, Joanna Briggs Inst, Adelaide, SA 5005, Australia	University of Adelaide; American College of Physicians; University of Adelaide	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	Munn, Zachary/AAV-9760-2021	Munn, Zachary/0000-0002-7091-5842				Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077; Duda S, 2017, J CAN ACAD CHILD ADO, V26, P86; Haynes Brian, 2007, Evid Based Nurs, V10, P6, DOI 10.1136/ebn.10.1.6; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Steinberg E, 2011, CLIN PRACTICE GUIDEL	6	11	12	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2018	169	9					648	+		10.7326/M18-2216	http://dx.doi.org/10.7326/M18-2216			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ4UP	30167676				2022-12-28	WOS:000449399700010
J	Berwick, D; Snair, M; Nishtar, S				Berwick, Donald; Snair, Megan; Nishtar, Sania			Crossing the Global Health Care Quality Chasm A Key Component of Universal Health Coverage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Berwick, Donald] Editorial Affairs, IHI, 53 State St,19th Floor, Boston, MA 02109 USA; [Snair, Megan] Cleveland Clin, Ctr Populat Hlth Res, Cleveland, OH 44106 USA; [Nishtar, Sania] Heartfile, Islamabad, Pakistan	Institute for Healthcare Improvement; Cleveland Clinic Foundation	Berwick, D (corresponding author), Editorial Affairs, IHI, 53 State St,19th Floor, Boston, MA 02109 USA.	donberwick@gmail.com						[Anonymous], 2018, ICTS LDCS SDGS ACHIE; Berwick DM, 2018, LANCET, V392, P194, DOI 10.1016/S0140-6736(18)31430-2; Gee J., 2015, FINANCIAL COST FRAUD; Irimu G, 2018, ARCH DIS CHILD, V103, P1013, DOI 10.1136/archdischild-2017-314348; Lew L., 2018, TENC MED EC SHAP FUT; National Academies of Sciences Engineering and Medicine, 2018, COMMITTEE IMPROVING, DOI [10.17226/25152, 10.17226/23446, DOI 10.17226/23446]; Slawomirski L., 2017, EC PATIENT SAFETY; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978	8	11	11	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2018	320	13					1317	1318		10.1001/jama.2018.13696	http://dx.doi.org/10.1001/jama.2018.13696			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV5LJ	30177995				2022-12-28	WOS:000446143400008
J	Burton, R; Sheron, N				Burton, Robyn; Sheron, Nick			No level of alcohol consumption improves health	LANCET			English	Editorial Material							REDUCED MORTALITY; METAANALYSIS; DRINKING; RISK		[Burton, Robyn] Kings Coll London, Inst Psychiat Psychol & Neurosci, Addict Dept, London, England; [Sheron, Nick] Univ Southampton, Fac Med, Div Infect Inflammat & Immun, Clin Hepatol, Southampton, Hants, England	University of London; King's College London; University of Southampton	Burton, R (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Addict Dept, London, England.	robyn.burton@kcl.ac.uk		Sheron, Nick/0000-0001-5232-8292	British Liver Trust; Alcohol Education Research Council; Gilead	British Liver Trust; Alcohol Education Research Council; Gilead(Gilead Sciences)	RB is employed full-time at Public Health England (PHE), is a visiting researcher at King's College London, and declares no other competing interests. NS is employed part-time at PHE. NS has received research grants from the British Liver Trust, Alcohol Education Research Council, and various other funding bodies. NS has undertaken paid consultancy work and received travelling expenses from Gilead (who develop drugs for the treatment of inflammatory bowel disease, liver disease, and viral hepatitis), and has been paid for medicolegal work in the area of hepatitis C and alcohol-related liver disease. NS is a clinical adviser to PHE, a scientific adviser to the European Public Health Alliance, and Royal College of Physicians representative on European Union (EU) Alcohol Policies, EU Alcohol Forum, Alcohol Health Alliance UK, UK Department of Health, Home Office, Department of Transport, National Institute for Health and Care Excellence (NICE), Southampton City Council, British Liver Trust, European Association for the Study of the Liver, British Association for the Study of the Liver, and British Society of Gastroenterology. One of the GBD authors (F Greaves) is affiliated with PHE but had no involvement in or knowledge of the Comment.	[Anonymous], BMJ; Britton A, 2017, ADDICTION, V112, P218, DOI 10.1111/add.13585; Burton R, 2017, LANCET, V389, P1558, DOI 10.1016/S0140-6736(16)32420-5; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Ferris JA, 2011, MED J AUSTRALIA, V195, pS22; Fillmore KM, 2006, ADDICT RES THEORY, V14, P101, DOI 10.1080/16066350500497983; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/S0140-6736(18)31310-2, 10.1016/s0140-6736(18)31310-2, 10.1136/bmj.l94]; Kickbusch I, 2016, LANCET GLOB HEALTH, V4, pE895, DOI 10.1016/S2214-109X(16)30217-0; Laslett AM, 2011, ADDICTION, V106, P1603, DOI 10.1111/j.1360-0443.2011.03445.x; Naimi TS, 2017, ADDICTION, V112, P207, DOI 10.1111/add.13451; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Stockwell T, 2016, J STUD ALCOHOL DRUGS, V77, P185, DOI 10.15288/jsad.2016.77.185; UK Department of Health, 2016, UK CHIEF MED OFF LOW	14	106	109	2	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2018	392	10152					987	988		10.1016/S0140-6736(18)31571-X	http://dx.doi.org/10.1016/S0140-6736(18)31571-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GU2KP	30146328	hybrid, Green Accepted			2022-12-28	WOS:000445098800004
J	Meyer, K; Kirchner, M; Uyar, B; Cheng, JY; Russo, G; Hernandez-Miranda, LR; Szymborska, A; Zauber, H; Rudolph, IM; Willnow, TE; Akalin, A; Haucke, V; Gerhardt, H; Birchmeier, C; Kuhn, R; Krauss, M; Diecke, S; Pascual, JM; Selbach, M				Meyer, Katrina; Kirchner, Marieluise; Uyar, Bora; Cheng, Jing-Yuan; Russo, Giulia; Hernandez-Miranda, Luis R.; Szymborska, Anna; Zauber, Henrik; Rudolph, Ina-Maria; Willnow, Thomas E.; Akalin, Altuna; Haucke, Volker; Gerhardt, Holger; Birchmeier, Carmen; Kuehn, Ralf; Krauss, Michael; Diecke, Sebastian; Pascual, Juan M.; Selbach, Matthias			Mutations in Disordered Regions Can Cause Disease by Creating Dileucine Motifs	CELL			English	Article							PURIFICATION MASS-SPECTROMETRY; LINEAR MOTIFS; GLUCOSE-TRANSPORT; PROTEINS; PROTEOMICS; SEQUENCE; QUANTIFICATION; EXTRACTION; GENETICS; VARIANTS	Many disease-causing missense mutations affect intrinsically disordered regions (IDRs) of proteins, but the molecular mechanism of their pathogenicity is enigmatic. Here, we employ a peptide-based proteomic screen to investigate the impact of mutations in IDRs on protein-protein interactions. We find that mutations in disordered cytosolic regions of three transmembrane proteins (GLUT1, ITPR1, and CACNA1H) lead to an increased clathrin binding. All three mutations create dileucine motifs known to mediate clathrin-dependent trafficking. Follow-up experiments on GLUT1 (SLC2A1), the glucose transporter causative of GLUT1 deficiency syndrome, revealed that the mutated protein mislocalizes to intracellular compartments. Mutant GLUT1 interacts with adaptor proteins (APs) in vitro, and knocking down AP-2 reverts the cellular mislocalization and restores glucose transport. A systematic analysis of other known disease-causing variants revealed a significant and specific overrepresentation of gained dileucine motifs in structurally disordered cytosolic domains of transmembrane proteins. Thus, several mutations in disordered regions appear to cause "dileucineopathies.''	[Meyer, Katrina; Kirchner, Marieluise; Cheng, Jing-Yuan; Zauber, Henrik; Selbach, Matthias] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Proteome Dynam, Robert Rossle Str 10, D-13125 Berlin, Germany; [Uyar, Bora; Akalin, Altuna] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Bioinformat Platform, Robert Rossle Str 10, D-13125 Berlin, Germany; [Russo, Giulia; Haucke, Volker; Krauss, Michael] Leibniz Forsch Inst Mol Pharmakol, Mol Pharmacol & Cell Biol, Robert Rossle Str 10, D-13125 Berlin, Germany; [Hernandez-Miranda, Luis R.; Birchmeier, Carmen] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Dev Biol Signal Transduct, Robert Rossle Str 10, D-13125 Berlin, Germany; [Szymborska, Anna; Gerhardt, Holger] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Integrat Vasc Biol Lab, Robert Rossle Str 10, D-13125 Berlin, Germany; [Rudolph, Ina-Maria; Willnow, Thomas E.] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Mol Cardiovasc Res, Robert Rossle Str 10, D-13125 Berlin, Germany; [Szymborska, Anna; Gerhardt, Holger; Diecke, Sebastian] DZHK German Ctr Cardiovasc Res, Partner Site, D-13347 Berlin, Germany; [Gerhardt, Holger; Kuehn, Ralf; Diecke, Sebastian] BIH, D-10178 Berlin, Germany; [Kuehn, Ralf] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Core Facil Transgen, Robert Rossle Str 10, D-13125 Berlin, Germany; [Diecke, Sebastian] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Core Facil Pluripotent Stem Cells, Robert Rossle Str 10, D-13125 Berlin, Germany; [Pascual, Juan M.] UT Southwestern Med Ctr, Dept Neurol & Neurotherapeut, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Selbach, Matthias] Charite Univ Med Berlin, D-10117 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; German Centre for Cardiovascular Research; Berlin Institute of Health; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Selbach, M (corresponding author), Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Proteome Dynam, Robert Rossle Str 10, D-13125 Berlin, Germany.; Selbach, M (corresponding author), Charite Univ Med Berlin, D-10117 Berlin, Germany.	matthias.selbach@mdc-berlin.de	Hernandez-Miranda, Luis Rodrigo/ABE-1269-2021; Kühn, Ralf/U-1278-2017; Hernandez-Miranda, Luis R./ABE-1283-2021; AKALIN, ALTUNA/A-4424-2012	Kühn, Ralf/0000-0003-1694-9803; Cheng, Jingyuan/0000-0001-8942-0607; Uyar, Bora/0000-0002-3170-4890; Krauss, Michael/0000-0003-1010-9723; Willnow, Thomas/0000-0001-9515-7921; Pascual, Juan/0000-0002-0843-8221; Kirchner, Marieluise/0000-0002-7049-534X; Meyer, Katrina/0000-0002-8244-6887; AKALIN, ALTUNA/0000-0002-0468-0117; Birchmeier, Carmen/0000-0002-2041-8872; Hernandez-Miranda, Luis R./0000-0002-0498-708X; Gerhardt, Holger/0000-0002-3030-0384	German Research Foundation (DFG) [SFB958/A11]; German Federal Ministry of Education and Research (BMBF), RNA Bioinformatics Center of the German Network for Bioinformatics Infrastructure (de.NBI) [031 A538C RBC]; NIH [NS077015, NS094257]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF), RNA Bioinformatics Center of the German Network for Bioinformatics Infrastructure (de.NBI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are indebted to the patient and her family for providing fibroblasts. We also thank members of the Gunnar Dittmar and Achim Leutz labs (MDC) and Ulf Reimer (JPT) for helpful discussions in setting up the screen. We thank Philip Kim (University of Toronto) for useful suggestions on peptide selection and Russ Hodge (MDC) for valuable comments on the manuscript. Markus Landthaler (MDC) kindly provided stable cell lines, and the Advanced Light Microscopy Technology Platform (MDC) helped with microscopy. We also like to thank Martha Hergeselle and Sven Buchert (both MDC) for excellent technical assistance during cloning, cell culture and mouse experiments as well as Jane Reznick (MDC) for help in setting up the glucose uptake assay. G.R. was funded by the German Research Foundation (DFG, SFB958/A11 to M. Krauss). B.U. acknowledges funding by the German Federal Ministry of Education and Research (BMBF) as part of the RNA Bioinformatics Center of the German Network for Bioinformatics Infrastructure (de.NBI) (031 A538C RBC). J.M.P. is supported by NIH (NS077015 and NS094257).	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Briatte F., 2016, GGNETWORK GEOMETRIES; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Deng H, 2014, NAT REV NEUROL, V10, P337, DOI 10.1038/nrneurol.2014.78; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Diril MK, 2009, FEBS J, V276, P4153, DOI 10.1111/j.1742-4658.2009.07089.x; Dittmar G., 2017, BIORXIV, DOI [10.1101/238709, DOI 10.1101/238709]; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Famiglietti ML, 2014, HUM MUTAT, V35, P927, DOI 10.1002/humu.22594; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gibson TJ, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0121-y; Gingras AC, 2012, FEBS LETT, V586, P2723, DOI 10.1016/j.febslet.2012.03.065; Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633; Hernandez-Miranda LR, 2011, J NEUROSCI, V31, P6174, DOI 10.1523/JNEUROSCI.5464-10.2011; Hosp F, 2015, CELL REP, V11, P1134, DOI 10.1016/j.celrep.2015.04.030; Ishigaki S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00529; Ittner LM, 2007, NAT PROTOC, V2, P1206, DOI 10.1038/nprot.2007.145; Kadaveru K, 2008, FRONT BIOSCI, V13, P6455, DOI 10.2741/3166; Keilhauer EC, 2015, MOL CELL PROTEOMICS, V14, P120, DOI 10.1074/mcp.M114.041012; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; Kreykenbohm V, 2002, EUR J CELL BIOL, V81, P273, DOI 10.1078/0171-9335-00247; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Leen WG, 2010, BRAIN, V133, P655, DOI 10.1093/brain/awp336; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meyer K, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00237; Narayan S, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0311-2; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Okada H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037035; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Park SY, 2014, BIOSCIENCE REP, V34, P381, DOI 10.1042/BSR20140069; Pascual JM, 2008, J BIOL CHEM, V283, P16732, DOI 10.1074/jbc.M801403200; Qiu HY, 2014, J CLIN INVEST, V124, P981, DOI 10.1172/JCI72723; Radivojac P, 2008, BIOINFORMATICS, V24, pI241, DOI 10.1093/bioinformatics/btn267; Rahnenfuhrer J, 2016, TOPGO ENRICHMENT ANA; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rogelj B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00603; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Ryan CJ, 2013, NAT REV GENET, V14, P865, DOI 10.1038/nrg3574; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi Jun, 2008, V456, P307, DOI 10.1007/978-1-59745-245-8_23; Silvis MR, 2003, J BIOL CHEM, V278, P11554, DOI 10.1074/jbc.M212843200; Slaughter L, 2009, EPILEPSY RES, V84, P254, DOI 10.1016/j.eplepsyres.2009.01.004; Smits AH, 2016, TRENDS BIOTECHNOL, V34, P825, DOI 10.1016/j.tibtech.2016.02.014; Staudt C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010047; Subramanian S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-306; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Toprak UH, 2014, MOL CELL PROTEOMICS, V13, P2056, DOI 10.1074/mcp.O113.036475; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uyar B, 2014, MOL BIOSYST, V10, P2626, DOI 10.1039/c4mb00290c; Vacic V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002709; Van Roey K, 2014, CHEM REV, V114, P6733, DOI 10.1021/cr400585q; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; Vogt G, 2005, NAT GENET, V37, P692, DOI 10.1038/ng1581; Wang PI, 2010, J PROTEOMICS, V73, P2277, DOI 10.1016/j.jprot.2010.07.005; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wefers B, 2017, METHODS, V121, P55, DOI 10.1016/j.ymeth.2017.02.008; Wilkinson L, 2011, BIOMETRICS, V67, P678, DOI [DOI 10.1111/J.1541-0420.2011.01616.X, 10.1111/j.1541-0420.2011.01616.x]; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zauber H, 2018, NAT METHODS, V15, P156, DOI 10.1038/nmeth.4607; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	82	60	60	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	2018	175	1					239	+		10.1016/j.cell.2018.08.019	http://dx.doi.org/10.1016/j.cell.2018.08.019			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GU2SI	30197081	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000445120000027
J	Perraki, A; DeFalco, TA; Derbyshire, P; Avila, J; Sere, D; Sklenar, J; Qi, XY; Stransfeld, L; Schwessinger, B; Kadota, Y; Macho, AP; Jiang, SS; Couto, D; Torii, KU; Menke, FLH; Zipfel, C				Perraki, Artemis; DeFalco, Thomas A.; Derbyshire, Paul; Avila, Julian; Sere, David; Sklenar, Jan; Qi, Xingyun; Stransfeld, Lena; Schwessinger, Benjamin; Kadota, Yasuhiro; Macho, Alberto P.; Jiang, Shushu; Couto, Daniel; Torii, Keiko U.; Menke, Frank L. H.; Zipfel, Cyril			Phosphocode-dependent functional dichotomy of a common co-receptor in plant signalling	NATURE			English	Article							RECEPTOR-LIKE KINASES; ARABIDOPSIS-THALIANA; PATTERN-RECOGNITION; PROTEIN-KINASE; STRUCTURAL BASIS; INNATE IMMUNITY; IN-VITRO; BAK1; ACTIVATION; COMPLEX	Multicellular organisms use cell-surface receptor kinases to sense and process extracellular signals. Many plant receptor kinases are activated by the formation of ligand-induced complexes with shape-complementary co-receptors(1). The best-characterized co-receptor is BRASSINOSTEROID INSENSITIVE 1-ASSOCIATED KINASE 1 (BAK1), which associates with numerous leucine-rich repeat receptor kinases (LRR-RKs) to control immunity, growth and development(2). Here we report key regulatory events that control the function of BAK1 and, more generally, LRR-RKs. Through a combination of phosphoproteomics and targeted mutagenesis, we identified conserved phosphosites that are required for the immune function of BAK1 in Arabidopsis thaliana. Notably, these phosphosites are not required for BAK1-dependent brassinosteroid-regulated growth. In addition to revealing a critical role for the phosphorylation of the BAK1 C-terminal tail, we identified a conserved tyrosine phosphosite that may be required for the function of the majority of Arabidopsis LRR-RKs, and which separates them into two distinct functional classes based on the presence or absence of this tyrosine. Our results suggest a phosphocode-based dichotomy of BAK1 function in plant signalling, and provide insights into receptor kinase activation that have broad implications for our understanding of how plants respond to their changing environment.	[Perraki, Artemis; DeFalco, Thomas A.; Derbyshire, Paul; Sere, David; Sklenar, Jan; Stransfeld, Lena; Schwessinger, Benjamin; Kadota, Yasuhiro; Macho, Alberto P.; Jiang, Shushu; Couto, Daniel; Menke, Frank L. H.; Zipfel, Cyril] Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England; [DeFalco, Thomas A.; Stransfeld, Lena; Zipfel, Cyril] Univ Zurich, Inst Plant & Microbial Biol, Zurich, Switzerland; [DeFalco, Thomas A.; Stransfeld, Lena; Zipfel, Cyril] Univ Zurich, Zurich Basel Plant Sci Ctr, Zurich, Switzerland; [Avila, Julian; Qi, Xingyun; Torii, Keiko U.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Avila, Julian; Qi, Xingyun; Torii, Keiko U.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Perraki, Artemis] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Avila, Julian] Broad Inst, Metabol Platform, Cambridge, MA USA; [Sere, David] UMR CNRS INRA SupAgro UM2, Inst Biol Integrat Plantes Claude Grignon, Lab Biochim & Physiol Mol Plantes, Montpellier, France; [Schwessinger, Benjamin] Australian Natl Univ, Res Sch Biol, Acton, ACT, Australia; [Kadota, Yasuhiro] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Macho, Alberto P.] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Mol Plant Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China; [Jiang, Shushu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Couto, Daniel] Univ Geneva, Dept Bot & Plant Biol, Geneva, Switzerland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Zurich; University of Zurich; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Cambridge; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; INRAE; Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Australian National University; RIKEN; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Geneva	Zipfel, C (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.; Zipfel, C (corresponding author), Univ Zurich, Inst Plant & Microbial Biol, Zurich, Switzerland.; Zipfel, C (corresponding author), Univ Zurich, Zurich Basel Plant Sci Ctr, Zurich, Switzerland.	cyril.zipfel@botinst.uzh.ch	Qi, Xingyun/AAW-7767-2020; Schwessinger, Benjamin/R-5869-2018; TORII, KEIKO U./A-6041-2013; ZIPFEL, CYRIL B/D-7103-2011; Macho, Alberto/L-1393-2014; Kadota, Yasuhiro/AGJ-3017-2022; Kadota, Yasuhiro/AAC-4545-2019; ZIPFEL, CYRIL/ABD-5076-2021; Menke, Frank/F-2739-2014	Schwessinger, Benjamin/0000-0002-7194-2922; TORII, KEIKO U./0000-0002-6168-427X; ZIPFEL, CYRIL B/0000-0003-4935-8583; Kadota, Yasuhiro/0000-0002-4782-1418; Kadota, Yasuhiro/0000-0002-4782-1418; ZIPFEL, CYRIL/0000-0003-4935-8583; DeFalco, Thomas/0000-0003-2897-1485; Menke, Frank/0000-0003-2490-4824; Couto, Daniel/0000-0003-0223-1497; Perraki, Artemis/0000-0002-4144-8069; Macho, Alberto P/0000-0001-9935-8026; Avila, Julian/0000-0001-9388-3946	Gatsby Charitable Foundation; European Research Council (grant 'PHOSPHinnATE'); Gordon and Betty Moore Foundation [GBMF3035]; Howard Hughes Medical Institute; European Molecular Biology Organization (EMBO-LTFs) [100-2017, 225-2015]; RIKEN Special Postdoctoral Research Fellowship; JSPS Excellent Young Researcher Overseas Visit Program; Uehara Memorial Foundation; JIC/TSL PhD Rotation Program; BBSRC [BBS/E/J/000PR9795, BBS/E/J/000PR9796] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000PR9796, BBS/E/J/000PR9795] Funding Source: researchfish	Gatsby Charitable Foundation; European Research Council (grant 'PHOSPHinnATE'); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Molecular Biology Organization (EMBO-LTFs); RIKEN Special Postdoctoral Research Fellowship; JSPS Excellent Young Researcher Overseas Visit Program; Uehara Memorial Foundation(Uehara Memorial Foundation); JIC/TSL PhD Rotation Program; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K. Morehouse, M. Smoker, J. Taylor and the John Innes Centre Horticultural Services for technical help; V. Ntoukakis, M. Stegmann and J. Dang for technical advice; S. Huber, K. Bender and R. Zielinski for providing materials; Y. Belkhadir and S. Huber for reading the manuscript; and all members of the Zipfel laboratory for discussion. This work was supported by the Gatsby Charitable Foundation and the European Research Council (grant 'PHOSPHinnATE') (C.Z.); the Gordon and Betty Moore Foundation (grant GBMF3035) and the Howard Hughes Medical Institute (K.U.T.); the European Molecular Biology Organization (EMBO-LTFs 100-2017 to T.A.D. and 225-2015 to S.J.); the RIKEN Special Postdoctoral Research Fellowship, the JSPS Excellent Young Researcher Overseas Visit Program, and the Uehara Memorial Foundation (Y.K.); and the JIC/TSL PhD Rotation Program (B.S.).	aan den Toorn M, 2015, MOL PLANT, V8, P762, DOI 10.1016/j.molp.2015.03.015; Bender KW, 2017, J BIOL CHEM, V292, P3988, DOI 10.1074/jbc.M116.763243; Bender KW, 2015, BIOCHEM J, V467, P399, DOI 10.1042/BJ20141403; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hohmann U, 2017, ANNU REV PLANT BIOL, V68, P109, DOI 10.1146/annurev-arplant-042916-040957; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Horst RJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005374; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Ladwig F, 2015, PLANT CELL, V27, P1718, DOI 10.1105/tpc.15.00306; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; Lehti-Shiu MD, 2012, PHILOS T R SOC B, V367, P2619, DOI 10.1098/rstb.2012.0003; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Ma XY, 2016, TRENDS PLANT SCI, V21, P1017, DOI 10.1016/j.tplants.2016.08.014; Macho AP, 2015, TRENDS PLANT SCI, V20, P269, DOI 10.1016/j.tplants.2015.02.005; Macho AP, 2014, SCIENCE, V343, P1509, DOI 10.1126/science.1248849; Meng XZ, 2016, CELL REP, V14, P1330, DOI 10.1016/j.celrep.2016.01.023; Meng XZ, 2015, CURR BIOL, V25, P2361, DOI 10.1016/j.cub.2015.07.068; Mitra SK, 2015, PLANT J, V82, P1042, DOI 10.1111/tpj.12863; Monaghan J, 2014, CELL HOST MICROBE, V16, P605, DOI 10.1016/j.chom.2014.10.007; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Ntoukakis V, 2011, PLANT CELL, V23, P3871, DOI 10.1105/tpc.111.090779; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Singh V, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01273; Stuhrwohldt N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021054; Sun YD, 2013, CELL RES, V23, P1326, DOI 10.1038/cr.2013.131; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Suzuki M, 2016, PLANT CELL PHYSIOL, V57, P2312, DOI 10.1093/pcp/pcw150; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang YL, 2014, J PROTEOMICS, V108, P484, DOI 10.1016/j.jprot.2014.06.009; Wu D, 2018, J INTEGR PLANT BIOL, V60, P270, DOI 10.1111/jipb.12623; Wu X, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00262; Yan LM, 2012, CELL RES, V22, P1304, DOI 10.1038/cr.2012.74; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu X, 2017, ANNU REV PHYTOPATHOL, V55, P109, DOI 10.1146/annurev-phyto-080516-035649; Yun HS, 2009, MOL CELLS, V27, P183, DOI 10.1007/s10059-009-0023-1; Zhang GL, 2011, J PROTEOME RES, V10, P305, DOI 10.1021/pr1006203	47	71	72	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2018	561	7722					248	+		10.1038/s41586-018-0471-x	http://dx.doi.org/10.1038/s41586-018-0471-x			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT3XQ	30177827	Green Accepted			2022-12-28	WOS:000444437900045
J	Glaser, A; Mian, Z				Glaser, Alexander; Mian, Zia			Denuclearizing North Korea: A verified, phased approach The process must reflect existing levels of trust at each stage	SCIENCE			English	Editorial Material									[Glaser, Alexander; Mian, Zia] Princeton Univ, Program Sci & Global Secur, Princeton, NJ 08544 USA	Princeton University	Glaser, A (corresponding author), Princeton Univ, Program Sci & Global Secur, Princeton, NJ 08544 USA.	alx@princeton.edu						Albright D, 2018, ANNU REV EARTH PL SC, V46, P99, DOI 10.1146/annurev-earth-063016-015704; [Anonymous], 1992, JOINT DECLARATION DE; [Anonymous], 2018, COMMUNICATION   0612; [Anonymous], 2018, NEW YORK TIMES; Hecker S. S., 2018, TECHNICALLY INFORMED; Kemp RS, 2016, ANNU REV EARTH PL SC, V44, P17, DOI 10.1146/annurev-earth-060115-012526; Lewis Jeffrey, 2015, RECENT IMAGERY SUGGE; Mazarr M. J., 2018, KOREAN PENINSULA 3 D; Philippe S., 2017, P 58 INMM ANN M 16 2; Podvig P., 2017, DEFERRED VERIFICATIO; Schoeppner M, 2018, SCI GLOB SECUR, V26, P3, DOI 10.1080/08929882.2018.1446540; Wood TW, 2014, SCI GLOB SECUR, V22, P4, DOI 10.1080/08929882.2014.874217	12	4	4	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					981	983		10.1126/science.aau4817	http://dx.doi.org/10.1126/science.aau4817			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS7OT	30190395	Green Submitted			2022-12-28	WOS:000443892700031
J	Keren, L; Bosse, M; Marquez, D; Angoshtari, R; Jain, S; Varma, S; Yang, SR; Kurian, A; Van Valen, D; West, R; Bendall, SC; Angelo, M				Keren, Leeat; Bosse, Marc; Marquez, Diana; Angoshtari, Roshan; Jain, Samir; Varma, Sushama; Yang, Soo-Ryum; Kurian, Allison; Van Valen, David; West, Robert; Bendall, Sean C.; Angelo, Michael			A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging	CELL			English	Article							MOLECULAR PATHWAYS; INFILTRATING LYMPHOCYTES; PD-1 BLOCKADE; CELLS; IPILIMUMAB; EXPRESSION; RESISTANCE; NIVOLUMAB; CYTOMETRY; RESPONSES	The immune system is critical in modulating cancer progression, but knowledge of immune composition, phenotype, and interactions with tumor is limited. We used multiplexed ion beam imaging by time-of-flight (MIBI-TOF) to simultaneously quantify in situ expression of 36 proteins covering identity, function, and immune regulation at sub-cellular resolution in 41 triple-negative breast cancer patients. Multi-step processing, including deep-learning-based segmentation, revealed variability in the composition of tumor-immune populations across individuals, reconciled by overall immune infiltration and enriched co-occurrence of immune subpopulations and checkpoint expression. Spatial enrichment analysis showed immune mixed and compartmentalized tumors, coinciding with expression of PD1, PD-L1, and IDO in a cell-type- and location-specific manner. Ordered immune structures along the tumor-immune border were associated with compartmentalization and linked to survival. These data demonstrate organization in the tumor-immune microenvironment that is structured in cellular composition, spatial arrangement, and regulatory-protein expression and provide a framework to apply multiplexed imaging to immune oncology.	[Keren, Leeat; Bosse, Marc; Marquez, Diana; Angoshtari, Roshan; Jain, Samir; Varma, Sushama; Yang, Soo-Ryum; Kurian, Allison; West, Robert; Bendall, Sean C.; Angelo, Michael] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Van Valen, David] CALTECH, Dept Biol, Pasadena, CA 91125 USA; [Van Valen, David] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	Stanford University; California Institute of Technology; California Institute of Technology	Bendall, SC; Angelo, M (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	bendall@stanford.edu; mangelo0@stanford.edu	Bendall, Sean/AGG-0126-2022; Bosse, Marc/AAM-8593-2021; Kurian, Allison/A-4560-2019	Bendall, Sean/0000-0003-1341-2453; West, Robert/0000-0002-8330-8283; Marquez, Diana/0000-0001-5343-8696; Kurian, Allison/0000-0002-6175-9470	Damon Runyon Cancer Research Foundation [DRG-2292-17, DRG-2017-09]; EMBO Long-Term fellowship [ALTF 1128-2016]; NIH F32 Postdoctoral Fellowship; Burroughs Wellcome PDEP award; Allen Discovery Center at Stanford University; Crowdflower A.I. for everyone award; NIH [5R01CA18390402, 1DP2OD022550-01, 1-R00-GM104148-01, 5U19AI116484-02, U19 AI104209, 1-DP5-OD019822, 1R01AG056287-01, 1R01AG057915-01, 1U24CA224309-01]; Bill and Melinda Gates Foundation; Translational Research Award from the Stanford Cancer Institute; NSF [ECCS-1542152]; NATIONAL CANCER INSTITUTE [U24CA224309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI104209, U19AI116484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP2EB024246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM104148, K99GM104148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG056287, R01AG057915] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD019822] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; EMBO Long-Term fellowship(European Molecular Biology Organization (EMBO)); NIH F32 Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome PDEP award; Allen Discovery Center at Stanford University; Crowdflower A.I. for everyone award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Translational Research Award from the Stanford Cancer Institute; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Tom Carver, Dana Pe'er, Tyler Risom, David Glass, Erin McCaffrey, and Felix Hartmann for discussions and comments. L.K. is supported by the Damon Runyon Cancer Research Foundation (DRG-2292-17) and EMBO Long-Term fellowship (ALTF 1128-2016). D.V.V. is supported by an NIH F32 Postdoctoral Fellowship, a Burroughs Wellcome PDEP award, The Allen Discovery Center at Stanford University, and a Crowdflower A.I. for everyone award. R.W. is supported by NIH 5R01CA18390402. S.C.B. is supported by a gift from Christy and Bill Neidig, the Damon Runyon Cancer Research Foundation (DRG-2017-09), NIH 1DP2OD022550-01, 1-R00-GM104148-01, 5U19AI116484-02, and U19 AI104209. M.A. is supported by NIH 1-DP5-OD019822. S.C.B. and M.A. are supported by NIH 1R01AG056287-01, 1R01AG057915-01, and 1U24CA224309-01, the Bill and Melinda Gates Foundation, and a Translational Research Award from the Stanford Cancer Institute. The Stanford Nano Shared Facility is supported by NSF ECCS-1542152.	Andre F, 2013, CLIN CANCER RES, V19, P28, DOI 10.1158/1078-0432.CCR-11-2701; Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Bagaitkar J, 2014, BLOOD, V124, P1701, DOI 10.1182/blood-2014-07-589341; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Burugu S, 2017, ANN ONCOL, V28, P2977, DOI 10.1093/annonc/mdx557; CARREL S, 1985, EUR J IMMUNOL, V15, P118, DOI 10.1002/eji.1830150204; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Coskun AF, 2016, NAT METHODS, V13, P657, DOI [10.1038/nmeth.3895, 10.1038/NMETH.3895]; de Matos LL, 2010, BIOMARK INSIGHTS, V5, P9; Denkert C, 2017, LANCET, V389, P2430, DOI 10.1016/S0140-6736(16)32454-0; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Di Minin G, 2014, MOL CELL, V56, P617, DOI 10.1016/j.molcel.2014.10.013; Disis Mary L, 2015, Am Soc Clin Oncol Educ Book, pe25, DOI 10.14694/EdBook_AM.2015.35.e25; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Fortis SP, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0240-7; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Huang W, 2013, HUM PATHOL, V44, P29, DOI 10.1016/j.humpath.2012.05.009; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwa MJ, 2018, CANCER-AM CANCER SOC, V124, P2086, DOI 10.1002/cncr.31272; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Munn DH, 2011, CURR MED CHEM, V18, P2240, DOI 0929-8673/11 $58.00+.00; Muro K, 2016, LANCET ONCOL, V17, P717, DOI 10.1016/S1470-2045(16)00175-3; Nirschl CJ, 2013, CLIN CANCER RES, V19, P4917, DOI 10.1158/1078-0432.CCR-12-1972; Oelkrug C, 2014, CLIN EXP IMMUNOL, V178, P1, DOI 10.1111/cei.12382; Ott PA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0218-5; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seiwert TY, 2016, LANCET ONCOL, V17, P956, DOI 10.1016/S1470-2045(16)30066-3; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Troncone G, 2017, TRANSL LUNG CANCER R, V6, pS74, DOI 10.21037/tlcr.2017.10.05; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Vareki SM, 2017, CRIT REV ONCOL HEMAT, V116, P116, DOI 10.1016/j.critrevonc.2017.06.001; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Yeong J, 2017, BREAST CANCER RES TR, V163, P21, DOI 10.1007/s10549-017-4161-4; Yu LY, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14010068; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	52	387	397	11	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1373	+		10.1016/j.cell.2018.08.039	http://dx.doi.org/10.1016/j.cell.2018.08.039			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193111	Green Accepted, Bronze			2022-12-28	WOS:000443841000009
J	Maeder, CI; Kim, JI; Liang, X; Kaganovsky, K; Shen, A; Li, Q; Li, ZY; Wang, S; Xu, XZS; Li, JB; Xiang, YK; Ding, JB; Shen, K				Maeder, Celine I.; Kim, Jae-Ick; Liang, Xing; Kaganovsky, Konstantin; Shen, Ao; Li, Qin; Li, Zhaoyu; Wang, Sui; Xu, X. Z. Shawn; Li, Jin Billy; Xiang, Yang Kevin; Ding, Jun B.; Shen, Kang			The THO Complex Coordinates Transcripts for Synapse Development and Dopamine Neuron Survival	CELL			English	Article							MESSENGER-RNA-EXPORT; CAENORHABDITIS-ELEGANS; NUCLEOCYTOPLASMIC TRANSPORT; NERVOUS-SYSTEM; NUCLEAR EXPORT; IN-VIVO; CREB; PROTEIN; PLASTICITY; MOUSE	Synaptic vesicle and active zone proteins are required for synaptogenesis. The molecular mechanisms for coordinated synthesis of these proteins are not understood. Using forward genetic screens, we identified the conserved THO nuclear export complex (THOC) as an important regulator of presynapse development in C. elegans dopaminergic neurons. In THOC mutants, synaptic messenger RNAs are retained in the nucleus, resulting in dramatic decrease of synaptic protein expression, near complete loss of synapses, and compromised dopamine function. CRE binding protein (CREB) interacts with THOC to mark synaptic transcripts for efficient nuclear export. Deletion of Thoc5, a THOC subunit, in mouse dopaminergic neurons causes severe defects in synapse maintenance and subsequent neuronal death in the substantia nigra compacta. These cellular defects lead to abrogated dopamine release, ataxia, and animal death. Together, our results argue that nuclear export mechanisms can select specific mRNAs and be a rate-limiting step for neuronal differentiation and survival.	[Maeder, Celine I.; Liang, Xing; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Kim, Jae-Ick; Kaganovsky, Konstantin; Ding, Jun B.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Kim, Jae-Ick; Kaganovsky, Konstantin; Ding, Jun B.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Shen, Ao; Xiang, Yang Kevin] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Li, Qin; Li, Jin Billy] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Li, Zhaoyu; Xu, X. Z. Shawn] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Li, Zhaoyu; Xu, X. Z. Shawn] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wang, Sui] Stanford Univ, Dept Opthalmol, Sch Med, Stanford, CA 94305 USA; [Kim, Jae-Ick] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan 44919, South Korea	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of California System; University of California Davis; Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; Ulsan National Institute of Science & Technology (UNIST)	Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.; Ding, JB (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.; Ding, JB (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	dingjun@stanford.edu; kangshen@stanford.edu	Li, Qin/AAP-9448-2020; Kim, Jae-Ick/AAY-6005-2020; Ding, Jun/B-2513-2009; Kim, Jae-Ick/R-4007-2017; Liang, Xing/AAT-4144-2021	Li, Qin/0000-0002-8948-2717; Ding, Jun/0000-0003-0690-1312; Kim, Jae-Ick/0000-0001-9705-0394; Liang, Xing/0000-0002-8298-1214; Wang, Sui/0000-0003-1563-9117; SHEN, AO/0000-0002-1559-3895; Li, Zhaoyu/0000-0002-5222-6832; Kaganovsky, Konstantin/0000-0002-1577-109X	Howard Hughes Medical Institute; NIH [NS048392, NS103037, NS091144, HL127764, GM126917]; American Diabetes Association [1-16-INI-16]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM126917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091144, R37NS048392, R01NS103037] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Michael L. Nonet for sharing antibodies. We thank the international Caenorhabditis Genetics Center for strains. We also thank C. Yee and the Stanford FACS facility for help with FACS sorting, C. Gao and K. Vega for technical assistance, and members of the Shen lab for valuable comments and discussion. This work is supported by Howard Hughes Medical Institute and NIH (NS048392 to K.S.), NIH (NS103037 and NS091144 to J.B.D.), GG Technologies gift fund (to J.B.D.), NIH (HL127764 to Y.K.X.), NIH (GM126917 to X.Z.S.X.), and American Diabetes Association (#1-16-INI-16 to S.W.).	Aguado F, 2009, J NEUROSCI, V29, P328, DOI 10.1523/JNEUROSCI.5252-08.2009; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chavez S, 2001, MOL CELL BIOL, V21, P7054, DOI 10.1128/MCB.21.20.7054-7064.2001; De Cesare D, 1999, TRENDS BIOCHEM SCI, V24, P281, DOI 10.1016/S0968-0004(99)01414-0; Tran DDH, 2014, NUCLEIC ACIDS RES, V42, P12249, DOI 10.1093/nar/gku911; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; Frank RAW, 2017, CURR OPIN NEUROBIOL, V45, P139, DOI 10.1016/j.conb.2017.05.019; Guria A, 2011, RNA, V17, P1048, DOI 10.1261/rna.2607011; Hardaway JA, 2015, J NEUROSCI, V35, P9409, DOI 10.1523/JNEUROSCI.0800-15.2015; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Hobert O, 2016, CURR TOP DEV BIOL, V116, P455, DOI 10.1016/bs.ctdb.2015.12.007; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Katahira J, 2013, NUCLEIC ACIDS RES, V41, P7060, DOI 10.1093/nar/gkt414; Katahira J, 2009, EMBO J, V28, P556, DOI 10.1038/emboj.2009.5; Kumar R, 2015, AM J HUM GENET, V97, P302, DOI 10.1016/j.ajhg.2015.05.021; Laek M, 2015, CELL TISSUE RES, V359, P255, DOI 10.1007/s00441-014-1943-4; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lill CM, 2011, AMYOTROPH LATERAL SC, V12, P238, DOI 10.3109/17482968.2011.584629; Luna R, 2012, BBA-GENE REGUL MECH, V1819, P514, DOI 10.1016/j.bbagrm.2011.11.012; Mancini A, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-1; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Okuno H, 2011, NEUROSCI RES, V69, P175, DOI 10.1016/j.neures.2010.12.007; Pena A, 2012, EMBO J, V31, P1605, DOI 10.1038/emboj.2012.10; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Pitzonka L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097628; Pokala N, 2014, P NATL ACAD SCI USA, V111, P2770, DOI 10.1073/pnas.1400615111; Raj B, 2015, NEURON, V87, P14, DOI 10.1016/j.neuron.2015.05.004; Rangaraju V, 2017, EMBO REP, V18, P693, DOI 10.15252/embr.201744045; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Rodriguez-Tornos FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053848; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Saran S, 2016, ONCOGENE, V35, P3872, DOI 10.1038/onc.2015.433; Saran S, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-51; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schwartz ML, 2016, GENETICS, V202, P1277, DOI 10.1534/genetics.115.184275; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tran DDH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.409; Tran DDH, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-3; Tsoi H, 2011, HUM MOL GENET, V20, P3787, DOI 10.1093/hmg/ddr297; Van Vactor D, 2017, CURR OPIN NEUROBIOL, V43, P119, DOI 10.1016/j.conb.2017.03.003; Wang L, 2013, CELL STEM CELL, V13, P676, DOI 10.1016/j.stem.2013.10.008; Wang XL, 2006, MOL CELL BIOL, V26, P4362, DOI 10.1128/MCB.02163-05; Wang XL, 2009, MOL CELL BIOL, V29, P2794, DOI 10.1128/MCB.01633-08; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; ZIGMOND MJ, 1984, ARCH NEUROL-CHICAGO, V41, P856, DOI 10.1001/archneur.1984.04050190062015	51	17	17	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1436	+		10.1016/j.cell.2018.07.046	http://dx.doi.org/10.1016/j.cell.2018.07.046			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30146163	Bronze, Green Accepted			2022-12-28	WOS:000443841000013
J	Partridge, L; Deelen, J; Slagboom, PE				Partridge, Linda; Deelen, Joris; Slagboom, P. Eline			Facing up to the global challenges of ageing	NATURE			English	Review							GENOME-WIDE ASSOCIATION; ADVERSE DRUG-REACTIONS; LIFE-SPAN; CALORIE RESTRICTION; CELLULAR SENESCENCE; HUMAN LONGEVITY; CARDIOVASCULAR-DISEASE; DIETARY RESTRICTION; POPULATION HEALTH; GUT MICROBIOTA	Longer human lives have led to a global burden of late-life disease. However, some older people experience little ill health, a trait that should be extended to the general population. Interventions into lifestyle, including increased exercise and reduction in food intake and obesity, can help to maintain healthspan. Altered gut microbiota, removal of senescent cells, blood factors obtained from young individuals and drugs can all improve late-life health in animals. Application to humans will require better biomarkers of disease risk and responses to interventions, closer alignment of work in animals and humans, and increased use of electronic health records, biobank resources and cohort studies.	[Partridge, Linda; Deelen, Joris; Slagboom, P. Eline] Max Planck Inst Biol Ageing, Cologne, Germany; [Partridge, Linda] UCL, Inst Hlth Ageing, London, England; [Partridge, Linda] UCL, Dept Genet Evolut & Environm, London, England; [Deelen, Joris; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Mol Epidemiol, Leiden, Netherlands	Max Planck Society; University of London; University College London; University of London; University College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Partridge, L; Deelen, J (corresponding author), Max Planck Inst Biol Ageing, Cologne, Germany.; Deelen, J (corresponding author), UCL, Inst Hlth Ageing, London, England.; Partridge, L (corresponding author), UCL, Dept Genet Evolut & Environm, London, England.; Deelen, J (corresponding author), Leiden Univ, Med Ctr, Dept Biomed Data Sci, Mol Epidemiol, Leiden, Netherlands.	linda.partridge@age.mpg.de; p.slagboom@lumc.nl	Deelen, Joris/H-3201-2019	Deelen, Joris/0000-0003-4483-3701; Partridge, Linda/0000-0001-9615-0094	European Research Council (ERC) under the European Union [741989]; Wellcome Trust; Alexander von Humboldt Foundation	European Research Council (ERC) under the European Union(European Research Council (ERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank N. van den Berg for help with the preparation of Fig. 1 and N. Chaturvedi and B. J. Zwaan for their critical reading of the manuscript. L.P. acknowledges support from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (no. 741989) and a Wellcome Trust Strategic Award. J.D. acknowledges support from the Alexander von Humboldt Foundation. We apologize to the authors of many relevant studies for not citing their work owing to space limitations.	Acosta-Rodriguez VA, 2017, CELL METAB, V26, P267, DOI 10.1016/j.cmet.2017.06.007; Ahmadi SF, 2015, J AM MED DIR ASSOC, V16, P933, DOI 10.1016/j.jamda.2015.07.014; Ainsworth HF, 2017, GENET EPIDEMIOL, V41, P577, DOI 10.1002/gepi.22061; Andersen S.L., J GERONTOL A, V67A, P395; Anderson R, 2018, EXP GERONTOL, V109, P5, DOI 10.1016/j.exger.2017.10.015; Apelo SIA, 2016, J GERONTOL A-BIOL, V71, P876, DOI 10.1093/gerona/glw064; Ash AS, 2015, J GERONTOL A-BIOL, V70, P971, DOI 10.1093/gerona/glv015; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Beijers RJHCG, 2018, CURR OPIN CLIN NUTR, V21, P138, DOI 10.1097/MCO.0000000000000444; Bektas A, 2018, EXP GERONTOL, V105, P10, DOI 10.1016/j.exger.2017.12.015; Belsky DW, 2015, P NATL ACAD SCI USA, V112, pE4104, DOI 10.1073/pnas.1506264112; Bergman A, 2007, PLOS COMPUT BIOL, V3, P1648, DOI 10.1371/journal.pcbi.0030170; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Bitto A, 2016, ELIFE, V5, DOI 10.7554/eLife.16351; Blenis J, 2017, CELL, V171, P10, DOI 10.1016/j.cell.2017.08.019; Broer L, 2015, J GERONTOL A-BIOL, V70, P110, DOI 10.1093/gerona/glu166; Budovsky A, 2013, TRENDS GENET, V29, P559, DOI 10.1016/j.tig.2013.08.003; Burger O, 2012, P NATL ACAD SCI USA, V109, P18210, DOI 10.1073/pnas.1215627109; Bushardt RL, 2008, CLIN INTERV AGING, V3, P383, DOI 10.2147/CIA.S2468; Camernik K, 2018, STEM CELL REV REP, V14, P346, DOI 10.1007/s12015-018-9800-6; Casey JA, 2016, ANNU REV PUBL HEALTH, V37, P61, DOI 10.1146/annurev-publhealth-032315-021353; Castellano JM, 2017, NATURE, V544, P488, DOI 10.1038/nature22067; Chahal HS, 2007, J PATHOL, V211, P173, DOI 10.1002/path.2110; Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Christensen K, 2013, LANCET, V382, P1507, DOI 10.1016/S0140-6736(13)60777-1; Clark RI, 2018, CELL MOL LIFE SCI, V75, P93, DOI 10.1007/s00018-017-2671-1; Cole JH, 2018, MOL PSYCHIATR, V23, P1385, DOI 10.1038/mp.2017.62; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557; Cooper R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2219; Crimmins E, 2010, DEMOGRAPHY, V47, pS41, DOI 10.1353/dem.2010.0005; Crimmins EM, 2015, GERONTOLOGIST, V55, P901, DOI 10.1093/geront/gnv130; Crimmins EM, 2009, J GERONTOL A-BIOL, V64, P286, DOI 10.1093/gerona/gln010; de Haan G, 2018, BLOOD, V131, P479, DOI 10.1182/blood-2017-06-746412; Declerck K, 2018, MECH AGEING DEV, V174, P18, DOI 10.1016/j.mad.2018.01.002; Deelen J, 2016, EXP GERONTOL, V82, P166, DOI 10.1016/j.exger.2016.06.013; Deelen J, 2014, HUM MOL GENET, V23, P4420, DOI 10.1093/hmg/ddu139; Deelen J, 2013, AGE, V35, P235, DOI 10.1007/s11357-011-9340-3; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; Druley TE, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0253-y; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; Erikson GA, 2016, CELL, V165, P1002, DOI 10.1016/j.cell.2016.03.022; Espeland MA, 2017, J GERONTOL A-BIOL, V72, P355, DOI 10.1093/gerona/glw220; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Finan C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1166; Flachsbart F, 2016, AGING CELL, V15, P585, DOI 10.1111/acel.12471; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Fogel RW, 1997, DEMOGRAPHY, V34, P49, DOI 10.2307/2061659; Fontana L, 2017, AGEING RES REV, V39, P1, DOI 10.1016/j.arr.2017.08.002; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Frake RA, 2015, J CLIN INVEST, V125, P65, DOI 10.1172/JCI73944; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Goodell MA, 2015, SCIENCE, V350, P1199, DOI 10.1126/science.aab3388; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Gu Qiuping, 2010, NCHS Data Brief, P1; Guthrie B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0322-7; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Harvey JA, 2015, J AGING PHYS ACTIV, V23, P471, DOI 10.1123/japa.2014-0164; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Hertel J, 2016, J PROTEOME RES, V15, P400, DOI 10.1021/acs.jproteome.5b00561; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Hu JL, 2018, J CELL BIOL, V217, P39, DOI 10.1083/jcb.201709054; Ingram DK, 2017, AGEING RES REV, V39, P15, DOI 10.1016/j.arr.2017.05.008; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324; Johnson SC, 2016, ONCOTARGET, V7, P44876, DOI 10.18632/oncotarget.10381; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006; JOSHI PK, 2017, NAT COMMUN, V8; Jylhava J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046; Kapahi P, 2017, AGEING RES REV, V39, P3, DOI 10.1016/j.arr.2016.12.005; Kaplanis J, 2018, SCIENCE, V360, P171, DOI 10.1126/science.aam9309; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9; Kootte RS, 2017, CELL METAB, V26, P611, DOI 10.1016/j.cmet.2017.09.008; Kundu P, 2017, CELL, V171, P1481, DOI 10.1016/j.cell.2017.11.024; Laird E, 2018, J GERONTOL A-BIOL, V73, P519, DOI 10.1093/gerona/glx168; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lara J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0470-9; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mannick JB, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009892; Manoogian ENC, 2017, AGEING RES REV, V39, P59, DOI 10.1016/j.arr.2016.12.006; Marcum ZA, 2012, J AM GERIATR SOC, V60, P34, DOI 10.1111/j.1532-5415.2011.03772.x; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Mattson MP, 2017, AGEING RES REV, V39, P46, DOI 10.1016/j.arr.2016.10.005; McGuigan FE, 2017, BEST PRACT RES CL RH, V31, P145, DOI 10.1016/j.berh.2017.11.002; McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092; Meiners S, 2015, EUR RESPIR J, V45, P807, DOI 10.1183/09031936.00186914; Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001; Mitchell SJ, 2015, ANNU REV ANIM BIOSCI, V3, P283, DOI 10.1146/annurev-animal-022114-110829; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Morris BJ, 2015, GERONTOLOGY, V61, P515, DOI 10.1159/000375235; Most J, 2017, AGEING RES REV, V39, P36, DOI 10.1016/j.arr.2016.08.005; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Nair NP, 2016, CLIN INTERV AGING, V11, P497, DOI 10.2147/CIA.S99097; Nathan DM, 2015, LANCET DIABETES ENDO, V3, P866, DOI 10.1016/S2213-8587(15)00291-0; Newman AB, 2011, AGING-US, V3, P63, DOI 10.18632/aging.100242; Newman JC, 2016, J GERONTOL A-BIOL, V71, P1424, DOI 10.1093/gerona/glw149; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024; Nygaard M, 2014, EXP GERONTOL, V57, P41, DOI 10.1016/j.exger.2014.04.018; O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Pan H, 2017, J BIOL CHEM, V292, P6452, DOI 10.1074/jbc.R116.771915; Passtoors WM, 2013, AGING CELL, V12, P24, DOI 10.1111/acel.12015; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570; Pilling LC, 2017, AGING-US, V9, P2504, DOI 10.18632/aging.101334; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Pomatto LCD, 2017, J PHYSIOL-LONDON, V595, P7275, DOI 10.1113/JP275072; Poulain M., 2013, VIENNA YB POPUL RES, V11, P87, DOI [10.1553/populationyearbook2013s87, DOI 10.1553/POPULATIONYEARBOOK2013S87]; Racette SB, 2006, J GERONTOL A-BIOL, V61, P943, DOI 10.1093/gerona/61.9.943; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044; Schrauwen-Hinderling VB, 2018, J APPL PHYSIOL, V124, P160, DOI 10.1152/japplphysiol.00906.2017; Sebastiani P, 2017, J GERONTOL A-BIOL, V72, P1453, DOI 10.1093/gerona/glx027; Sebastiani P, 2016, J GERONTOL A-BIOL, V71, P340, DOI 10.1093/gerona/glv020; Sharples AP, 2015, AGING CELL, V14, P511, DOI 10.1111/acel.12342; Slack Cathy, 2017, Nutr Healthy Aging, V4, P195, DOI 10.3233/NHA-160021; Slagboom PE, 2018, BBA-MOL BASIS DIS, V1864, P2742, DOI 10.1016/j.bbadis.2017.09.017; Slieker R.C., 2016, GENOME BIOL, V17; Smith P, 2017, ELIFE, V6, DOI 10.7554/eLife.27014; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Stenholm S, 2017, INT J OBESITY, V41, P769, DOI 10.1038/ijo.2017.29; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Stott DJ, 2017, NEW ENGL J MED, V376, P2534, DOI 10.1056/NEJMoa1603825; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496; Sturmlechner I, 2017, NAT REV NEPHROL, V13, P77, DOI 10.1038/nrneph.2016.183; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Swerdlow DI, 2016, INT J EPIDEMIOL, V45, P1600, DOI 10.1093/ije/dyw088; Tazearslan C, 2011, AGING CELL, V10, P551, DOI 10.1111/j.1474-9726.2011.00697.x; Terry DF, 2004, J AM GERIATR SOC, V52, P2074, DOI 10.1111/j.1532-5415.2004.52561.x; Tiku V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16083; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Toledo E, 2015, JAMA INTERN MED, V175, P1752, DOI 10.1001/jamainternmed.2015.4838; van den Akker EB, 2016, BLOOD, V127, P1512, DOI 10.1182/blood-2015-12-685925; van den Berg N, 2017, AGEING RES REV, V38, P28, DOI 10.1016/j.arr.2017.06.005; van Dongen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11115; van Willigenburg H, 2018, PHARMACOL RES, V130, P322, DOI 10.1016/j.phrs.2018.02.015; Varela E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11739; Vaughan KL, 2018, J GERONTOL A-BIOL, V73, P48, DOI 10.1093/gerona/glx088; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Vijg J., 2007, AGING GENOME DUAL RO; Wahl D, 2016, AGEING RES REV, V31, P80, DOI 10.1016/j.arr.2016.06.006; Waite L. J., 2004, AGING HLTH PUBLIC PO; Walter S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.026; Wei M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8700; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Witham M. D., 2018, AGE AGEING; World Health Organization, 2018, WORLD REP AG HLTH; World Health Organization, 2018, DIS BURD MORT EST DI; World Health Organization Rotary International Centers for Disease Control and Prevention and UNICEF, 2013, GLOBAL ACTION PLAN P; Xie K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00178-3; Yanai H, 2018, AGEING RES REV, V41, P18, DOI 10.1016/j.arr.2017.10.004; Zeng YD, 2016, SCI REP-UK, V6, DOI 10.1038/srep29250; Zeng Y, 2017, LANCET, V389, P1619, DOI 10.1016/S0140-6736(17)30548-2	180	352	362	14	46	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					45	56		10.1038/s41586-018-0457-8	http://dx.doi.org/10.1038/s41586-018-0457-8			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS5YU	30185958	Green Submitted			2022-12-28	WOS:000443755200030
J	Hampton, T				Hampton, Tracy			Research Reveals Mechanism That May Drive Alcohol Use Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2018	320	9					862	863		10.1001/jama.2017.12864	http://dx.doi.org/10.1001/jama.2017.12864			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS4OQ	30193255				2022-12-28	WOS:000443627300003
J	Liu, JW; Ma, DL				Liu, Jia-Wei; Ma, Dong-Lai			An ominous sign from Sister Mary Joseph	LANCET			English	Editorial Material									[Ma, Dong-Lai] Chinese Acad Med Sci, Dept Dermatol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Liu, Jia-Wei; Ma, Dong-Lai] Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ma, DL (corresponding author), Chinese Acad Med Sci, Dept Dermatol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.; Ma, DL (corresponding author), Peking Union Med Coll, Beijing 100730, Peoples R China.	mdonglai@sohu.com							0	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2018	392	10149					776	776		10.1016/S0140-6736(18)31864-6	http://dx.doi.org/10.1016/S0140-6736(18)31864-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS0VL	30191831				2022-12-28	WOS:000443226900028
J	Farzadfard, F; Lu, TK				Farzadfard, Fahim; Lu, Timothy K.			Emerging applications for DNA writers and molecular recorders	SCIENCE			English	Review							LIVING CELLS; GENOMIC DNA; LINEAGE; INFORMATION; CIRCUITS; CLEAVAGE; LOGIC; BASE	Natural life is encoded by evolvable, DNA-based memory. Recent advances in dynamic genome-engineering technologies, which we collectively refer to as in vivo DNA writing, have opened new avenues for investigating and engineering biology. This Review surveys these technological advances, outlines their prospects and emerging applications, and discusses the features and current limitations of these technologies for building various genetic circuits for processing and recording information in living cells.	[Farzadfard, Fahim] MIT, Dept Elect Engn & Comp Sci, Elect Res Lab, Synthet Biol Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Farzadfard, F (corresponding author), MIT, Dept Elect Engn & Comp Sci, Elect Res Lab, Synthet Biol Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ffard@mit.edu; timlu@mit.edu		/0000-0003-1389-8203	National Institutes of Health [P50 GM098792]; Office of Naval Research [N00014-13-1-0424]; NSF [MCB-1350625, 1522074]; Defense Advanced Research Projects Agency; Schmidt Science Fellows Program; Rhodes Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM098792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Schmidt Science Fellows Program; Rhodes Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (P50 GM098792), the Office of Naval Research (N00014-13-1-0424), the NSF (MCB-1350625), the Defense Advanced Research Projects Agency, and NSF Expeditions in Computing program award 1522074. F.F. thanks the Schmidt Science Fellows Program, in partnership with the Rhodes Trust, for support.	Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Chen Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02473-5; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Farzadfard F., 2018, 263657 BIORXIV; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Kalhor R, 2017, NAT METHODS, V14, P195, DOI [10.1038/nmeth.4108, 10.1038/NMETH.4108]; Kawashima T, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00037; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kording KP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002291; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Meyer A. J., 2018, 285866 BIORXIV; Perli SD, 2016, SCIENCE, V353, DOI 10.1126/science.aag0511; Roquet N, 2016, SCIENCE, V353, P363, DOI 10.1126/science.aad8559; Schmidt ST, 2017, ACS SYNTH BIOL, V6, P936, DOI 10.1021/acssynbio.6b00309; Sheth RU, 2017, SCIENCE, V358, P1457, DOI 10.1126/science.aao0958; Shipman SL, 2017, NATURE, V547, P345, DOI 10.1038/nature23017; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tang WX, 2018, SCIENCE, V360, DOI 10.1126/science.aap8992; Weinberg BH, 2017, NAT BIOTECHNOL, V35, P453, DOI 10.1038/nbt.3805; Zador AM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001411	28	51	55	8	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					870	875		10.1126/science.aat9249	http://dx.doi.org/10.1126/science.aat9249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166483	Green Accepted			2022-12-28	WOS:000443547000027
J							Drug Therapeutics Bulletin	Managing scarlet fever	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ENGLAND; EPIDEMIOLOGY; DISEASE		[Drug Therapeutics Bulletin] Drug & Therapeut Bulletin Editorial Off, London WC1H 9JR, England		Drug & Therapeut Bulletin Editorial Off, London WC1H 9JR, England.							Andrey DO, 2016, EXPERT REV ANTI-INFE, V14, P687, DOI 10.1080/14787210.2016.1195684; Ben Zakour NL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15877; Centers for Disease Control and Prevention, 2017, SCARL FEV GROUP A ST; Centers for Disease Control and Prevention, 2016, SCARL FEV; Chalker V, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3603-z; Department of Health, 2010, HLTH PROT LEG ENGL G; DermNet New Zealand, 2015, SCARL FEV; Direct Wales NHS, 2016, SCARL FEV; Guy R, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.12.20749; Health Service Executive, 2013, INCR INV GROUP A STR; Lamagni T, 2018, LANCET INFECT DIS, V18, P180, DOI 10.1016/S1473-3099(17)30693-X; Lamagni TL, 2008, J CLIN MICROBIOL, V46, P2359, DOI 10.1128/JCM.00422-08; Mearkle R, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.19.30532; National Institute for Health and Care Excellence, 2015, CLIN KNOWL SUMM SCAR; Public Health England, 2017, GUID PUBL HLTH MAN S; Public Health England, 2017, GROUP STREPT INF 4 U; Public Health England, 2014, SCARL FEV FREQ ASK Q; Public Health England, 2016, 4 PUBL HLTH ENGL; Public Health England, 2015, 5 PUBL HLTH ENGL; Public Health Wales, 2017, SCARL FEV; Steer AC, 2012, DRUGS, V72, P1213, DOI 10.2165/11634180-000000000-00000; Turner CE, 2016, EMERG INFECT DIS, V22, P1075, DOI 10.3201/eid2206.151726; Wessels MR, 2016, STREPTOCOCCUS PYOGEN; Worrall GJ, 2007, CAN FAM PHYSICIAN, V53, P1961	24	3	3	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2018	362								k3005	10.1136/bmj.k3005	http://dx.doi.org/10.1136/bmj.k3005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5ZI	30166279				2022-12-28	WOS:000443758100002
J	Dyer, C				Dyer, Clare			Leading heart surgeon is allowed back to work after judge overturns hospital's ban	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2018	362								k3697	10.1136/bmj.k3697	http://dx.doi.org/10.1136/bmj.k3697			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU9VE	30158113				2022-12-28	WOS:000445701700012
J	Rubin, R				Rubin, Rita			Medicaid and Improper Payments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					748	748		10.1001/jama.2018.12070	http://dx.doi.org/10.1001/jama.2018.12070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167682				2022-12-28	WOS:000442958800006
J	Jennewein, MF; Butler, AL; Alter, G				Jennewein, Madeleine F.; Butler, Audrey L.; Alter, Galit			Neonate-omics: Charting the Unknown Immune Response in Early Life	CELL			English	Editorial Material								The study of neonatal immunology has been hampered by lack of access to infant samples. Novel sample sparing methods and systems-wide approaches have uniquely expanded this field, demonstrating that newborn immunity varies widely but converges over the first 3 months of life. During this important time window, environmental and genetic factors impact the infant immune system and can influence lifelong immunity.	[Jennewein, Madeleine F.; Butler, Audrey L.; Alter, Galit] MGH MIT & Harvard, Ragon Inst, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Alter, G (corresponding author), MGH MIT & Harvard, Ragon Inst, Cambridge, MA 02139 USA.	galter@partners.org						Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Dauby N, 2012, LANCET INFECT DIS, V12, P330, DOI 10.1016/S1473-3099(11)70341-3; Davis MM, 2017, NAT IMMUNOL, V18, P725, DOI 10.1038/ni.3768; de Bree LCJ, 2018, SEMIN IMMUNOL, V39, P35, DOI 10.1016/j.smim.2018.06.002; Edwards KM, 2015, VACCINE, V33, P6469, DOI 10.1016/j.vaccine.2015.07.085; Hagan T, 2015, VACCINE, V33, P5294, DOI 10.1016/j.vaccine.2015.03.072; Laforest-Lapointe I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00788; MacGillivray DM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00434; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Whittaker E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00532	11	8	8	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2018	174	5					1051	1053		10.1016/j.cell.2018.08.001	http://dx.doi.org/10.1016/j.cell.2018.08.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GR3WU	30142343	Bronze			2022-12-28	WOS:000442529100004
J	Mazer, CD; Whitlock, RP; Fergusson, DA; Belley-Cote, E; Connolly, K; Khanykin, B; Gregory, AJ; de Medicis, E; Carrier, FM; McGuinness, S; Young, PJ; Byrne, K; Villar, JC; Royse, A; Grocott, HP; Seeberger, MD; Mehta, C; Lellouche, F; Hare, GMT; Painter, TW; Fremes, S; Syed, S; Bagshaw, SM; Hwang, NC; Royse, C; Hall, J; Dai, D; Mistry, N; Thorpe, K; Verma, S; Juni, P; Shehata, N				Mazer, C. D.; Whitlock, R. P.; Fergusson, D. A.; Belley-Cote, E.; Connolly, K.; Khanykin, B.; Gregory, A. J.; de Medicis, E.; Carrier, F. M.; McGuinness, S.; Young, P. J.; Byrne, K.; Villar, J. C.; Royse, A.; Grocott, H. P.; Seeberger, M. D.; Mehta, C.; Lellouche, F.; Hare, G. M. T.; Painter, T. W.; Fremes, S.; Syed, S.; Bagshaw, S. M.; Hwang, N-C; Royse, C.; Hall, J.; Dai, D.; Mistry, N.; Thorpe, K.; Verma, S.; Juni, P.; Shehata, N.		TRICS Investigators; Perioperative Anesthesia Clinical	Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-CELL TRANSFUSION; LONG-TERM SURVIVAL; RANDOMIZED CONTROLLED-TRIAL; ARTERY-BYPASS SURGERY; PREOPERATIVE ANEMIA; RISK-FACTORS; CARDIOPULMONARY BYPASS; MULTICENTER COHORT; READMISSIONS; MORTALITY	BACKGROUND We reported previously that, in patients undergoing cardiac surgery who were at moderate-to-high risk for death, a restrictive transfusion strategy was noninferior to a liberal strategy with respect to the composite outcome of death from any cause, myocardial infarction, stroke, or new-onset renal failure with dialysis by hospital discharge or 28 days after surgery, whichever came first. We now report the clinical outcomes at 6 months after surgery. METHODS We randomly assigned 5243 adults undergoing cardiac surgery to a restrictive red-cell transfusion strategy (transfusion if the hemoglobin concentration was <7.5 g per deciliter intraoperatively or postoperatively) or a liberal red-cell transfusion strategy (transfusion if the hemoglobin concentration was <9.5 g per deciliter intraoperatively or postoperatively when the patient was in the intensive care unit (ICU] or was <8.5 g per deciliter when the patient was in the non-ICU ward). The primary composite outcome was death from any cause, myocardial infarction, stroke, or new-onset renal failure with dialysis occurring within 6 months after the initial surgery. An expanded secondary composite outcome included all the components of the primary outcome as well as emergency department visit, hospital readmission, or coronary revascularization occurring within 6 months after the index surgery. The secondary outcomes included the individual components of the two composite outcomes. RESULTS At 6 months after surgery, the primary composite outcome had occurred in 402 of 2317 patients (17.4%) in the restrictive-threshold group and in 402 of 2347 patients (17.1%) in the liberal-threshold group (absolute risk difference before rounding, 0.22 percentage points; 95% confidence interval (CI), -1.95 to 2.39; odds ratio, 1.02; 95% CI, 0.87 to 1.18; P-=0.006 for noninferiority). Mortality was 6.2 0 10 in the restrictive-threshold group and 6.4% in the liberal-threshold group (odds ratio, 0.95; 95% CI, 0.75 to 1.21). There were no significant between-group differences in the secondary outcomes. CONCLUSIONS In patients undergoing cardiac surgery who were at moderate-to-high risk for death, a restrictive strategy for red-cell transfusion was noninferior to a liberal strategy with respect to the composite outcome of death from any cause, myocardial infarction, stroke, or new-onset renal failure with dialysis at 6 months after surgery.	[Mazer, C. D.; Hare, G. M. T.; Mistry, N.] Univ Toronto, St Michaels Hosp, Dept Anesthesia, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Verma, S.] Univ Toronto, St Michaels Hosp, Dept Surg, Div Cardiac Surg, Toronto, ON, Canada; [Mazer, C. D.; Hare, G. M. T.; Thorpe, K.; Verma, S.; Juni, P.] Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Hall, J.; Dai, D.; Thorpe, K.; Verma, S.; Juni, P.] Univ Toronto, Appl Hlth Res Ctr, Toronto, ON, Canada; [Fremes, S.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Shehata, N.] Univ Toronto, Div Hematol, Mt Sinai Hosp, Toronto, ON, Canada; [Juni, P.; Shehata, N.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Mazer, C. D.; Hare, G. M. T.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Shehata, N.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Thorpe, K.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Thorpe, K.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Shehata, N.] Canadian Blood Serv, Toronto, ON, Canada; [Whitlock, R. P.; Belley-Cote, E.] Populat Hlth Res Inst, Hamilton, ON, Canada; [Whitlock, R. P.; Belley-Cote, E.; Connolly, K.; Syed, S.] Hamilton Hlth Sci Ctr, Hamilton, ON, Canada; [Whitlock, R. P.; Belley-Cote, E.; Connolly, K.; Syed, S.] McMaster Univ, Hamilton, ON, Canada; [Fergusson, D. A.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Gregory, A. J.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Gregory, A. J.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [Bagshaw, S. M.] Univ Alberta, Fac Med & Dent, Dept Crit Care Med, Edmonton, AB, Canada; [de Medicis, E.] CHUS, Sherbrooke, PQ, Canada; [Lellouche, F.] Laval Univ, Inst Univ Cardiol & Pneumol Quebec, Dept Anesthesiol & Crit Care Med, Laval, PQ, Canada; [Carrier, F. M.] Ctr Hosp Univ Montreal, Dept Anesthesia, Div Crit Care, Montreal, PQ, Canada; [Carrier, F. M.] Ctr Hosp Univ Montreal, Dept Med, Div Crit Care, Montreal, PQ, Canada; [Grocott, H. P.] Univ Manitoba, Dept Anesthesia Perioperat & Pain Med, St Boniface Hosp, Winnipeg, MB, Canada; [Khanykin, B.] Copenhagen Univ Hosp, Rigshosp, Dept Cardiothorac Anesthesia, Copenhagen, Denmark; [McGuinness, S.; Young, P. J.] Med Res Inst New Zealand, Wellington, New Zealand; [Byrne, K.] Waikato Hosp, Hamilton, New Zealand; [Villar, J. C.] Fdn Cardioinfantil Inst Cardiol, Bucaramanga, Colombia; [Villar, J. C.] Univ Autonoma Bucaramanga, Bucaramanga, Colombia; [Royse, A.; Royse, C.] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia; [Royse, C.] Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, Melbourne, Vic, Australia; [Painter, T. W.] Univ Adelaide, Royal Adelaide Hosp, Dept Anaesthesia, Adelaide, SA, Australia; [Painter, T. W.] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA, Australia; [Seeberger, M. D.] Univ Basel, Dept Anesthesia Surg Intens Care Prehosp Emergenc, Univ Hosp Basel, Basel, Switzerland; [Seeberger, M. D.] Klin Hirslanden Zurich, Zurich, Switzerland; [Mehta, C.] SAL Hosp, Heart Care Associates, Ahmadabad, Gujarat, India; [Hwang, N-C] Singapore Gen Hosp, Dept Cardiothorac Anaesthesia, Natl Heart Ctr, Singapore, Singapore; [Hwang, N-C] Singapore Gen Hosp, Dept Anaesthesiol, Singapore, Singapore	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Canadian Blood Services; Population Health Research Institute; McMaster University; McMaster University; University of Ottawa; Ottawa Hospital Research Institute; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Alberta; University of Sherbrooke; Laval University; Universite de Montreal; Universite de Montreal; University of Manitoba; Children's Hospital Research Institute of Manitoba; Rigshospitalet; University of Copenhagen; Medical Research Institute Of New Zealand; Waikato Hospital; University of Melbourne; Royal Melbourne Hospital; Royal Adelaide Hospital; University of Adelaide; University of Adelaide; University of Basel; National Heart Centre Singapore; Singapore General Hospital; Singapore General Hospital	Mazer, CD (corresponding author), Univ Toronto, St Michaels Hosp, Dept Anesthesia, 30 Bond St, Toronto, ON M5B 1W8, Canada.	mazerd@smh.ca	Royse, Alistair/A-6046-2008; Sander, Michael/H-5434-2012; Hare, Greg/AAM-5599-2021; Kashani, Hessam H./S-7968-2017; Shehata, Nadine/AAG-1124-2019; Chassé, Michaël/Y-7820-2019; Juni, Peter/Q-8700-2016; Seeberger, Manfred D/J-2847-2019; Painter, Thomas/K-6311-2017; Syed, Summer/AAJ-4134-2020; Painter, Thomas/K-3899-2019; Villar Centeno, Juan Carlos/AAX-5401-2021; Lellouche, Francois/AAB-9014-2019; Carrier, François Martin/AAE-4623-2021	Royse, Alistair/0000-0002-4449-663X; Sander, Michael/0000-0003-1677-3609; Kashani, Hessam H./0000-0003-2581-1769; Juni, Peter/0000-0002-5985-0670; Painter, Thomas/0000-0003-2216-2046; Painter, Thomas/0000-0003-2216-2046; Carrier, François Martin/0000-0003-0310-0616; Hwang, Nian Chih/0000-0002-1220-345X; Martinez-Zapata/0000-0002-5836-1138; Chasse, Michael/0000-0001-7075-1924; Thorpe, Kevin/0000-0002-7586-3893; McGuinness, Shay/0000-0003-0620-4787; Mazer, Cyril David/0000-0003-2566-4308; Shehata, Nadine/0000-0002-9267-6256; Hu, Raymond/0000-0002-0169-0600; Villar, Juan Carlos/0000-0002-7047-7299; Bannon, Paul/0000-0002-3117-7250; Karangelis, Dimos/0000-0001-7633-9949; Young, Paul/0000-0002-3428-3083	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Canadian Institutes of Health Research and others; TRICS III ClinicalTrials.gov number, NCT02042898.)	Ad N, 2015, J THORAC CARDIOV SUR, V150, P1322, DOI 10.1016/j.jtcvs.2015.07.076; Beggs V L, 1996, Best Pract Benchmarking Healthc, V1, P180; Bhaskar B, 2012, ANN THORAC SURG, V94, P460, DOI 10.1016/j.athoracsur.2012.04.005; Brown CH, 2014, ANESTH ANALG, V118, P1168, DOI 10.1213/ANE.0000000000000033; Carson JL, 2018, AM HEART J, V200, P96, DOI 10.1016/j.ahj.2018.04.007; Chen QH, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2062-5; Engoren MC, 2002, ANN THORAC SURG, V74, P1180, DOI 10.1016/S0003-4975(02)03766-9; Ferraris VA, 2001, J THORAC CARDIOV SUR, V122, P278, DOI 10.1067/mtc.2001.114776; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hare GMT, 2013, CAN J ANESTH, V60, P168, DOI 10.1007/s12630-012-9861-y; Iribarne A, 2014, ANN THORAC SURG, V98, P1274, DOI 10.1016/j.athoracsur.2014.06.059; Karkouti K, 2008, CIRCULATION, V117, P478, DOI 10.1161/CIRCULATIONAHA.107.718353; Karkouti K, 2015, CAN J ANESTH, V62, P377, DOI 10.1007/s12630-014-0302-y; Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037; Kulier A, 2007, CIRCULATION, V116, P471, DOI 10.1161/CIRCULATIONAHA.106.653501; Lee WC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180165; Loor G, 2012, J THORAC CARDIOV SUR, V144, P654, DOI 10.1016/j.jtcvs.2012.03.058; Maniar HS, 2014, J THORAC CARDIOV SUR, V147, P1013, DOI 10.1016/j.jtcvs.2013.10.066; Mazer CD, 2017, NEW ENGL J MED, V377, P2133, DOI 10.1056/NEJMoa1711818; Mistry N, 2018, AM J PHYSIOL-REG I, V314, pR611, DOI 10.1152/ajpregu.00182.2017; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Patel NN, 2018, CAN J ANESTH, V65, P868, DOI 10.1007/s12630-018-1150-y; Ranucci M, 2013, ANN THORAC SURG, V96, P478, DOI 10.1016/j.athoracsur.2013.03.015; Remy KE, 2018, TRANSFUSION, V58, P804, DOI 10.1111/trf.14488; Shehata N, 2018, EUR HEART J; Shehata N, 2018, J CARDIOTHOR VASC AN, V32, P121, DOI 10.1053/j.jvca.2017.10.036; Shehata N, 2013, TRANSFUSION, V53, P1688, DOI 10.1111/trf.12007; Swaminathan M, 2003, ANN THORAC SURG, V76, P784, DOI 10.1016/S0003-4975(03)00558-7; Tsui AKY, 2011, P NATL ACAD SCI USA, V108, P17544, DOI 10.1073/pnas.1114026108; Valero-Elizondo J, 2015, SURGERY, V158, P1372, DOI 10.1016/j.surg.2015.04.030; Vetter TR, 2014, ANESTH ANALG, V118, P1301, DOI 10.1213/ANE.0000000000000131; Westenbrink BD, 2017, AM HEART J, V185, P140, DOI 10.1016/j.ahj.2016.12.008; Zitser-Gurevich Y, 1999, MED CARE, V37, P625, DOI 10.1097/00005650-199907000-00002	34	125	129	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2018	379	13					1224	1233		10.1056/NEJMoa1808561	http://dx.doi.org/10.1056/NEJMoa1808561			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV1KS	30146969	Green Published, Bronze			2022-12-28	WOS:000445835100007
J	Kim, YS; Kato, HE; Yamashita, K; Ito, S; Inoue, K; Ramakrishnan, C; Fenno, LE; Evans, KE; Paggi, JM; Dror, RO; Kandori, H; Kobilka, BK; Deisseroth, K				Kim, Yoon Seok; Kato, Hideaki E.; Yamashita, Keitaro; Ito, Shota; Inoue, Keiichi; Ramakrishnan, Charu; Fenno, Lief E.; Evans, Kathryn E.; Paggi, Joseph M.; Dror, Ron O.; Kandori, Hideki; Kobilka, Brian K.; Deisseroth, Karl			Crystal structure of the natural anion-conducting channelrhodopsin GtACR1	NATURE			English	Article							LIGHT; BACTERIORHODOPSIN; INHIBITION; EXCITATION; FEATURES; FAMILY; STATE; TOOL	The naturally occurring channelrhodopsin variant anion channelrhodopsin-1 (ACR1), discovered in the cryptophyte algae Guillardia theta, exhibits large light-gated anion conductance and high anion selectivity when expressed in heterologous settings, properties that support its use as an optogenetic tool to inhibit neuronal firing with light. However, molecular insight into ACR1 is lacking owing to the absence of structural information underlying light-gated anion conductance. Here we present the crystal structure of G. theta ACR1 at 2.9 angstrom resolution. The structure reveals unusual architectural features that span the extracellular domain, retinal-binding pocket, Schiff-base region, and anion-conduction pathway. Together with electrophysiological and spectroscopic analyses, these findings reveal the fundamental molecular basis of naturally occurring light-gated anion conductance, and provide a framework for designing the next generation of optogenetic tools.	[Kim, Yoon Seok; Ramakrishnan, Charu; Fenno, Lief E.; Evans, Kathryn E.; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Dept Bioengn, Stanford, CA 94305 USA; [Kim, Yoon Seok; Ramakrishnan, Charu; Fenno, Lief E.; Evans, Kathryn E.; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kato, Hideaki E.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Kato, Hideaki E.; Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Yamashita, Keitaro] RIKEN, SPring Ctr 8, Sayo, Hyogo, Japan; [Ito, Shota; Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi, Japan; [Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi, Japan; [Paggi, Joseph M.; Dror, Ron O.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Paggi, Joseph M.; Dror, Ron O.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Japan Science & Technology Agency (JST); RIKEN; Nagoya Institute of Technology; Nagoya Institute of Technology; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Dept Bioengn, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.; Kato, HE (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Kato, HE (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan.	hekato@stanford.edu; deissero@stanford.edu	Kato, Hideaki/AAQ-4323-2020; Inoue, Keiichi/AEO-3337-2022; Fenno, Lief/AAF-9638-2019; Fenno, Lief/AAK-2924-2020	Kato, Hideaki/0000-0002-1941-5535; Inoue, Keiichi/0000-0002-6898-4347; Dror, Ron/0000-0002-6418-2793; Yamashita, Keitaro/0000-0002-5442-7582; Evans, Kathryn/0000-0003-4352-005X; Kobilka, Brian/0000-0001-5958-3990	Stanford Bio-X; Kwanjeong Foundation; JST PRESTO [JPMJPR1782, JPMJPR15P2]; US Department of Energy, Scientific Discovery through Advanced Computing (SciDAC) program (R.O.D.), MEXT [17H03007, 25104009/15H02391]; J.S.T. CREST [JPMJCR1753]; Mathers Charitable Foundation; NIMH [R01MH075957]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH075957, R01MH075957] Funding Source: NIH RePORTER	Stanford Bio-X; Kwanjeong Foundation; JST PRESTO(Japan Science & Technology Agency (JST)); US Department of Energy, Scientific Discovery through Advanced Computing (SciDAC) program (R.O.D.), MEXT; J.S.T. CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Mathers Charitable Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Lee, M. Lo, K. Geiselhart and M. Lima for technical support; K. K. Kumar, N. R. Latorraca, M. Inoue and K. Katayama for critical comments; and the APS beamline staff at 23ID-B and 23ID-D for assistance in data collection. We acknowledge support by the Stanford Bio-X and the Kwanjeong Foundation (Y.S.K.), JST PRESTO (JPMJPR1782 to H.E.K., JPMJPR15P2 to K.I.), the US Department of Energy, Scientific Discovery through Advanced Computing (SciDAC) program (R.O.D.), MEXT (17H03007 to K. I., 25104009/15H02391 for H.K.), J.S.T. CREST (JPMJCR1753, H.K.) and Mathers Charitable Foundation (B.K.K.). K. D. was supported by a grant for channelrhodopsin crystal structure determination from the NIMH (R01MH075957 to K. D.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Berndt A, 2015, SCIENCE, V349, P590, DOI 10.1126/science.aac7889; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Betancourt FMH, 2000, BBA-BIOENERGETICS, V1460, P106, DOI 10.1016/S0005-2728(00)00133-X; Bruun S, 2015, BIOCHEMISTRY-US, V54, P5389, DOI 10.1021/acs.biochem.5b00597; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deisseroth K, 2017, SCIENCE, V357, DOI 10.1126/science.aan5544; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; DiMaio F, 2013, ACTA CRYSTALLOGR D, V69, P2202, DOI 10.1107/S0907444913023305; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Facciotti MT, 2004, FEBS LETT, V564, P301, DOI 10.1016/S0014-5793(04)00208-X; GOVINDJEE R, 1995, BIOCHEMISTRY-US, V34, P4828, DOI 10.1021/bi00014a040; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Govorunova EG, 2017, SCI REP-UK, V7, DOI 10.1038/srep43358; Govorunova EG, 2016, PHOTOCHEM PHOTOBIOL, V92, P257, DOI 10.1111/php.12558; GREENHALGH DA, 1993, J BIOL CHEM, V268, P20305; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hontani Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07363-w; Iyer SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep30570; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kandori H, 2008, BIOCHEMISTRY-US, V42, P2300; Kato HE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8177; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Krause N, 2013, FEBS LETT, V587, P3309, DOI 10.1016/j.febslet.2013.08.043; Li H, 2016, J BIOL CHEM, V291, P25319, DOI 10.1074/jbc.C116.760041; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Maeda A, 2003, BIOCHEMISTRY-US, V42, P2535, DOI 10.1021/bi020532n; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Mohammad F, 2017, NAT METHODS, V14, P271, DOI [10.1038/NMETH.4148, 10.1038/nmeth.4148]; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pescitelli G, 2014, J PHYS CHEM B, V118, P11873, DOI 10.1021/jp505917p; Rajasethupathy P, 2015, NATURE, V526, P653, DOI 10.1038/nature15389; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sattig T, 2013, ANGEW CHEM INT EDIT, V52, P9705, DOI 10.1002/anie.201301698; Sineshchekov OA, 2016, P NATL ACAD SCI USA, V113, pE1993, DOI 10.1073/pnas.1525269113; Sineshchekov OA, 2015, P NATL ACAD SCI USA, V112, P14236, DOI 10.1073/pnas.1513602112; Volkov O, 2017, SCIENCE, V358, DOI 10.1126/science.aan8862; Wiegert JS, 2017, NEURON, V95, P504, DOI 10.1016/j.neuron.2017.06.050; Wietek J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14330-y; Wietek J, 2016, J BIOL CHEM, V291, P4121, DOI 10.1074/jbc.M115.699637; Wietek J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14807; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Yamashita K, 2018, ACTA CRYSTALLOGR D, V74, P441, DOI 10.1107/S2059798318004576; Yi A, 2017, BIOCHEMISTRY-US, V56, P2197, DOI 10.1021/acs.biochem.7b00002; Yi A, 2016, BIOCHEMISTRY-US, V55, P2371, DOI 10.1021/acs.biochem.6b00104; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004; Zhao Z, 2017, NEURON, V95, P138, DOI 10.1016/j.neuron.2017.05.031	62	48	48	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2018	561	7723					343	+		10.1038/s41586-018-0511-6	http://dx.doi.org/10.1038/s41586-018-0511-6			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU1HZ	30158696	Green Published, Green Accepted			2022-12-28	WOS:000445011500044
J	Okiro, EA; Ayieko, P				Okiro, Emelda A.; Ayieko, Philip			Childhood mortality during conflicts in Africa	LANCET			English	Editorial Material									[Okiro, Emelda A.] Kenya Govt Med Res Ctr, Populat Publ Hlth Unit, Wellcome Trust Res Programme, Nairobi 00100, Kenya; [Ayieko, Philip] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine	Okiro, EA (corresponding author), Kenya Govt Med Res Ctr, Populat Publ Hlth Unit, Wellcome Trust Res Programme, Nairobi 00100, Kenya.	eokiro@kemri-wellcome.org		Okiro, Emelda/0000-0001-9543-8360	Medical Research Council [MR/K012126/1] Funding Source: Medline; Wellcome Trust [201866/Z/16/Z, 203077] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Allansson M, 2017, J PEACE RES, V54, P574, DOI 10.1177/0022343317718773; Gleditsch NP, 2002, J PEACE RES, V39, P615, DOI 10.1177/0022343302039005007; Guha-Sapir D, 2005, EPIDEMIOL REV, V27, P67, DOI 10.1093/epirev/mxi010; Guha-Sapir D., 2011, WORLD DEV REPORT 201; International Committee of the Red Cross, 2008, IS TERM ARMED CONFLI; Roberts Leslie F, 2010, Confl Health, V4, P10, DOI 10.1186/1752-1505-4-10; Shann F, 2014, NEW ENGL J MED, V370, P783, DOI 10.1056/NEJMc1315507; Wagner Z, 2018, LANCET, V392, P857, DOI 10.1016/S0140-6736(18)31437-5; William PD, 2017, PRISM, V6, P4; Wise PH, 2017, DAEDALUS-US, V146, P139, DOI 10.1162/DAED_a_00428	10	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2018	392	10150					804	805		10.1016/S0140-6736(18)31373-4	http://dx.doi.org/10.1016/S0140-6736(18)31373-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT0KV	30173905	Green Accepted			2022-12-28	WOS:000444130000009
J	Zwart, SP				Zwart, Simon Portegies			Computational astrophysics for the future	SCIENCE			English	Editorial Material									[Zwart, Simon Portegies] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Zwart, SP (corresponding author), Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands.	spz@strw.leidenuniv.nl						Allen A, 2018, ASTROPHYS J SUPPL S, V236, DOI 10.3847/1538-4365/aab764; Allen A, 2013, ASTR SOC P, V475, P387; [Anonymous], 2013, ASTRON ASTROPHYS, V558, pA33; Bauer F., 1969, NATO SOFTW ENG C 196; Bedorf J, 2014, INT CONF HIGH PERFOR, P54, DOI 10.1109/SC.2014.10; Brooks F.P., 1995, MYTHICAL MAN MONTH; CHIDAMBER SR, 1994, IEEE T SOFTWARE ENG, V20, P476, DOI 10.1109/32.295895; Collberg C, 2016, COMMUN ACM, V59, P62, DOI 10.1145/2812803; Lehman M. M., 1997, P 4 INT S SOFTW METR; Portegies Zwart S., 2018, ASTROPHYSICAL RECIPE, DOI 10.1088/978-0-7503-1320-9; Spinellis D, 2015, 12TH WORKING CONFERENCE ON MINING SOFTWARE REPOSITORIES (MSR 2015), P462, DOI 10.1109/MSR.2015.64	12	10	10	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					979	980		10.1126/science.aau3206	http://dx.doi.org/10.1126/science.aau3206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS7OT	30190394	Green Submitted			2022-12-28	WOS:000443892700030
J	Aly, M				Aly, Mariam			The key to a happy lab life is in the manual	NATURE			English	Editorial Material									[Aly, Mariam] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Columbia University	Aly, M (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	ma3631@columbia.edu		tester22, sciencv/0000-0002-2791-7842; Aly, Mariam/0000-0003-4033-6134; Holland, Sherri/0000-0003-2860-0668					0	2	2	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					7	7		10.1038/d41586-018-06167-w	http://dx.doi.org/10.1038/d41586-018-06167-w			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS5YU	30185962	Bronze			2022-12-28	WOS:000443755200008
J	Chandrasoma, J; Harrison, TK; Ching, H; Vokach-Brodsky, L; Chu, LF				Chandrasoma, Janak; Harrison, T. Kyle; Ching, Howard; Vokach-Brodsky, Lindsey; Chu, Larry F.			Peripheral Nerve Blocks for Hand Procedures	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REGIONAL ANESTHESIA; COMPLICATIONS; EXTREMITY		[Chandrasoma, Janak; Harrison, T. Kyle; Ching, Howard; Vokach-Brodsky, Lindsey; Chu, Larry F.] Stanford Univ, Anesthesia Informat & Media Lab, Stanford, CA 94305 USA	Stanford University	Chandrasoma, J (corresponding author), Stanford Univ, Anesthesia Informat & Media Lab, Stanford, CA 94305 USA.		Chu, Larry/B-5324-2008	Chu, Larry/0000-0003-0814-6402				Auroy Y, 2002, ANESTHESIOLOGY, V97, P1274, DOI 10.1097/00000542-200211000-00034; Brown Anthony R, 2002, Best Pract Res Clin Anaesthesiol, V16, P227, DOI 10.1053/bean.2002.0235; Brutus Jp, 2003, Can J Plast Surg, V11, P33; Hadzic A, 2012, HADZICS PERIPHERAL N, P199; Hu P, 2007, J CLIN ANESTH, V19, P67, DOI 10.1016/j.jclinane.2006.02.016; Hunt TR III, 2018, OPERATIVE TECHNIQUES, P815; Neal JM, 2008, REGION ANESTH PAIN M, V33, P404, DOI 10.1016/j.rapm.2008.07.527; Neal JM, 2009, REGION ANESTH PAIN M, V34, P134, DOI 10.1097/AAP.0b013e31819624eb; Salam GA, 2004, AM FAM PHYSICIAN, V69, P896; Thompson WL, 2002, MIL MED, V167, P478, DOI 10.1093/milmed/167.6.478	10	3	3	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2018	379	10							e15	10.1056/NEJMvcm1400191	http://dx.doi.org/10.1056/NEJMvcm1400191			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS5XM	30184448				2022-12-28	WOS:000443748200011
J	Geisler, S				Geisler, Sarah			Body Art Gets Smart	CELL			English	Editorial Material																		Bandodkar AJ, 2015, ANAL CHEM, V87, P394, DOI 10.1021/ac504300n; Liu XY, 2018, ADV MATER, V30, DOI 10.1002/adma.201704821; Tastanova A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap8562; Vega K, 2017, PROCEEDINGS OF THE 2017 ACM INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS (ISWC 17), P138, DOI 10.1145/3123021.3123039	4	2	2	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1329	1331		10.1016/j.cell.2018.08.051	http://dx.doi.org/10.1016/j.cell.2018.08.051			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193103	Bronze			2022-12-28	WOS:000443841000001
J	Hawkes, N				Hawkes, Nigel			Cochrane editors hit back at criticisms of HPV vaccine review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Jorgensen L, 2018, BMJ EVID-BASED MED, V23, P165, DOI 10.1136/bmjebm-2018-111012; Tovey D, 2018, RESPONSE BMJ EVIDENC	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2018	362								k3834	10.1136/bmj.k3834	http://dx.doi.org/10.1136/bmj.k3834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WS	30190376				2022-12-28	WOS:000444507200013
J	Zhang, GM; Wang, Z; Du, Z; Zhang, H				Zhang, Gangming; Wang, Zheng; Du, Zhuo; Zhang, Hong			mTOR Regulates Phase Separation of PGL Granules to Modulate Their Autophagic Degradation	CELL			English	Article							EUKARYOTIC STRESS GRANULES; C. ELEGANS; LIQUID DROPLETS; DISEASE; RECOGNITION; COMPONENTS; GERMLINE	The assembly of phase-separated structures is thought to play an important role in development and disease, but little is known about the regulation and function of phase separation under physiological conditions. We showed that during C. elegans embryogenesis, PGL granules assemble via liquidliquid phase separation (LLPS), and their size and biophysical properties determine their susceptibility to autophagic degradation. The receptor SEPA-1 promotes LLPS of PGL-1/-3, while the scaffold protein EPG-2 controls the size of PGL-1/-3 compartments and converts them into less dynamic gel-like structures. Under heat-stress conditions, mTORC1-mediated phosphorylation of PGL-1/-3 is elevated and PGL-1/-3 undergo accelerated phase separation, forming PGL granules that are resistant to autophagic degradation. Significantly, accumulation of PGL granules is an adaptive response to maintain embryonic viability during heat stress. We revealed that mTORC1-mediated LLPS of PGL-1/-3 acts as a switch-like stress sensor, coupling phase separation to autophagic degradation and adaptation to stress during development.	[Zhang, Gangming; Wang, Zheng; Zhang, Hong] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Du, Zhuo] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Zhang, Hong] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, H (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Zhang, H (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.	hongzhang@ibp.ac.cn	Du, Zhuo/AAD-2263-2019	Du, Zhuo/0000-0002-6322-4656	Strategic Priority Research Program, CAS [XDB19000000]; NSFC [31561143001, 31630048, 31790403, 31421002]; National Chinese Ministry of Science and Technology [2017YFA0503401]; Key Research Program of Frontier Sciences, CAS	Strategic Priority Research Program, CAS; NSFC(National Natural Science Foundation of China (NSFC)); National Chinese Ministry of Science and Technology; Key Research Program of Frontier Sciences, CAS	We thank Dr. Isabel Hanson for editing work, Ms. Shuoguo Li from the Center for Biological Imaging (CBI), IBP, for analyzing 3D deconvolution images, and Mr. Jifeng Wang from the Laboratory of Proteomics, IBP, for MS analysis. We thank Professors Yunyu Shi, Huaqing Cai, and Xiaochen Wang for helpful discussions. This work was supported by the following grants to H.Z.: the Strategic Priority Research Program, CAS (XDB19000000), NSFC (31561143001, 31630048, 31790403, and 31421002), the National Chinese Ministry of Science and Technology (2017YFA0503401), and the Key Research Program of Frontier Sciences, CAS.	Aguzzi A, 2016, TRENDS CELL BIOL, V26, P547, DOI 10.1016/j.tcb.2016.03.004; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Bergeron-Sandoval LP, 2016, CELL, V165, P1067, DOI 10.1016/j.cell.2016.05.026; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Gallo CM, 2010, SCIENCE, V330, P1685, DOI 10.1126/science.1193697; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Li SH, 2013, MOL CELL, V52, P421, DOI 10.1016/j.molcel.2013.09.014; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Saha S, 2016, CELL, V166, P1572, DOI 10.1016/j.cell.2016.08.006; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shah Kavita, 2003, Methods Mol Biol, V233, P253; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Smith J, 2016, ELIFE, V5, DOI 10.7554/eLife.21337; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Strome Susan, 2005, WormBook, P1, DOI 10.1895/wormbook.1.9.1; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Wu F, 2015, MOL CELL, V60, P914, DOI 10.1016/j.molcel.2015.11.019; Yang PG, 2014, CELL RES, V24, P80, DOI 10.1038/cr.2013.154; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	31	109	115	17	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1492	+		10.1016/j.cell.2018.08.006	http://dx.doi.org/10.1016/j.cell.2018.08.006			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30173914	Bronze			2022-12-28	WOS:000443841000017
J	Zmora, N; Zilberman-Schapira, G; Suez, J; Mor, U; Dori-Bachash, M; Bashiardes, S; Kotler, E; Zur, M; Regev-Lehavi, D; Brik, RB; Federici, S; Cohen, Y; Linevsky, R; Rothschild, D; Moor, AE; Ben-Moshe, S; Harmelin, A; Itzkovitz, S; Maharshak, N; Shibolet, O; Shapiro, H; Pevsner-Fischer, M; Sharon, I; Halpern, Z; Segal, E; Elinav, E				Zmora, Niv; Zilberman-Schapira, Gili; Suez, Jotham; Mor, Uria; Dori-Bachash, Mally; Bashiardes, Stavros; Kotler, Eran; Zur, Maya; Regev-Lehavi, Dana; Brik, Rotem Ben-Zeev; Federici, Sara; Cohen, Yotam; Linevsky, Raquel; Rothschild, Daphna; Moor, Andreas E.; Ben-Moshe, Shani; Harmelin, Alon; Itzkovitz, Shalev; Maharshak, Nitsan; Shibolet, Oren; Shapiro, Hagit; Pevsner-Fischer, Meirav; Sharon, Itai; Halpern, Zamir; Segal, Eran; Elinav, Eran			Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features	CELL			English	Article							LACTOBACILLUS-PLANTARUM 299V; LACTIC-ACID BACTERIA; DOUBLE-BLIND; INTESTINAL MICROBIOTA; FECAL MICROBIOTA; FERMENTED MILK; BODY-WEIGHT; QUANTIFICATION; METAANALYSIS; SYMPTOMS	Empiric probiotics are commonly consumed by healthy individuals as means of life quality improvement and disease prevention. However, evidence of probiotic gut mucosal colonization efficacy remains sparse and controversial. We metagenomically characterized the murine and human mucosal-associated gastrointestinal microbiome and found it to only partially correlate with stool microbiome. A sequential invasive multi-omics measurement at baseline and during consumption of an 11-strain probiotic combination or placebo demonstrated that probiotics remain viable upon gastrointestinal passage. In colonized, but not germ-free mice, probiotics encountered a marked mucosal colonization resistance. In contrast, humans featured person-, region- and strain-specific mucosal colonization patterns, hallmarked by predictive baseline host and microbiome features, but indistinguishable by probiotics presence in stool. Consequently, probiotics induced a transient, individualized impact on mucosal community structure and gut transcriptome. Collectively, empiric probiotics supplementation may be limited in universally and persistently impacting the gut mucosa, meriting development of new personalized probiotic approaches.	[Zmora, Niv; Zilberman-Schapira, Gili; Suez, Jotham; Mor, Uria; Dori-Bachash, Mally; Bashiardes, Stavros; Zur, Maya; Regev-Lehavi, Dana; Brik, Rotem Ben-Zeev; Federici, Sara; Cohen, Yotam; Linevsky, Raquel; Shapiro, Hagit; Pevsner-Fischer, Meirav; Elinav, Eran] Weizmann Inst Sci, Immunol Dept, IL-7610001 Rehovot, Israel; [Zmora, Niv] Tel Aviv Sourasky Med Ctr, Internal Med Dept, IL-6423906 Tel Aviv, Israel; [Kotler, Eran; Rothschild, Daphna; Moor, Andreas E.; Ben-Moshe, Shani; Itzkovitz, Shalev; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel; [Kotler, Eran; Rothschild, Daphna; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-7610001 Rehovot, Israel; [Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, IL-7610001 Rehovot, Israel; [Maharshak, Nitsan; Shibolet, Oren; Halpern, Zamir] Tel Aviv Sourasky Med Ctr, Dept Gastroenterol & Liver Dis, IL-6423906 Tel Aviv, Israel; [Maharshak, Nitsan; Shibolet, Oren; Halpern, Zamir] Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, IL-6423906 Tel Aviv, Israel; [Maharshak, Nitsan; Shibolet, Oren; Halpern, Zamir] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Sharon, Itai] Migal Galilee Res Inst, IL-11016 Kiryat Shmona, Israel; [Sharon, Itai] Tel Hai Coll, IL-1220800 Upper Galilee, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Hai Academy College	Elinav, E (corresponding author), Weizmann Inst Sci, Immunol Dept, IL-7610001 Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-7610001 Rehovot, Israel.; Halpern, Z (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Gastroenterol & Liver Dis, IL-6423906 Tel Aviv, Israel.; Halpern, Z (corresponding author), Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, IL-6423906 Tel Aviv, Israel.; Halpern, Z (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel.	zamir@tlvmc.gov.il; eran.segal@weizmann.ac.il; eran.elinav@weizmann.ac.il	Shapiro, Hagit/F-8648-2015; Federici, Sara/ABD-4056-2021; Maharshak, Nitsan/AAK-5288-2020; Suez, Jotham/AAZ-5433-2020; Sharon, Itai/M-4472-2019; Elinav, Eran/ABE-8881-2020; Segal, Eran/AAF-4855-2019	Suez, Jotham/0000-0003-3836-972X; Sharon, Itai/0000-0003-0705-2316; Elinav, Eran/0000-0002-5775-2110; Moor, Andreas/0000-0001-8715-8449; Mor, Uria/0000-0002-2918-6406	Gilead Sciences International Research Scholars Program in Liver Disease; Strauss Institute research fellowship; Crown Human Genome Center; Else Kroener Fresenius Foundation; European Research Council; Israel Science Foundation; Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; French National Center for Scientific Research (CNRS); V. R. Schwartz Research Fellow Chair; Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development; Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation; European Foundation	Gilead Sciences International Research Scholars Program in Liver Disease; Strauss Institute research fellowship; Crown Human Genome Center; Else Kroener Fresenius Foundation; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); V. R. Schwartz Research Fellow Chair; Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation(Helmholtz Association); European Foundation(European Science Foundation (ESF))	We thank the members of the Elinav and Segal laboratories for discussions and apologize to authors whose work was not included due to space constraints. We thank Max Horn and Axel De Baat of the Elinav lab, Refael Kohen of the Weizmann Institute of Science bioinformatics unit, Nadin Jbara from the Elinav lab, and Pierre Bost of the Amit lab, Weizmann Institute of Science, for helpful computational advice, and Carmit Bar Natan for dedicated germ-free animal husbandry. N.Z. is supported by the Gilead Sciences International Research Scholars Program in Liver Disease. J.S. is the recipient of the Strauss Institute research fellowship. E.S. is supported by the Crown Human Genome Center; the Else Kroener Fresenius Foundation; Donald L. Schwarz, Sherman Oaks, CA; Jack N. Halpern, NY, NY; Leesa Steinberg, Canada; and grants funded by the European Research Council and the Israel Science Foundation. E.E. is supported by: Y. and R. Ungar; the Abisch Frenkel Foundation for the Promotion of Life Sciences; the Gurwin Family Fund for Scientific Research; the Leona M. and Harry B. Helmsley Charitable Trust; the Crown Endowment Fund for Immunological Research; the Else Kroener Fresenius Foundation; the estate of J. Gitlitz; the estate of L. Hershkovich; the Benoziyo Endowment Fund for the Advancement of Science; the Adelis Foundation; J. L. and V. Schwartz; A. and G. Markovitz; A. and C. Adelson; the French National Center for Scientific Research (CNRS); D. L. Schwarz; The V. R. Schwartz Research Fellow Chair; L. Steinberg; J. N. Halpern; A. Edelheit, and by grants funded by the European Research Council; a Marie Curie Integration grant; the German-Israeli Foundation for Scientific Research and Development; the Israel Science Foundation; the Minerva Foundation; the Rising Tide Foundation; the Helmholtz Foundation; and the European Foundation for the Study of Diabetes. E.E. is a senior fellow, Canadian Institute for Advanced Research (CIFAR) and an international scholar, Bill & Melinda Gates Foundation and the Howard Hughes Medical Institute (HHMI).	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Bafeta A, 2018, ANN INTERN MED, V169, P240, DOI 10.7326/M18-0343; BERNET MF, 1994, GUT, V35, P483, DOI 10.1136/gut.35.4.483; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charbonneau D, 2013, GUT MICROBES, V4, P201, DOI 10.4161/gmic.24196; Clarke Tainya C, 2015, Natl Health Stat Report, P1; Crovesy L, 2017, INT J OBESITY, V41, P1607, DOI 10.1038/ijo.2017.161; Degnan FH, 2012, GUT MICROBES, V3, P485, DOI 10.4161/gmic.22158; Del Piano M, 2010, J CLIN GASTROENTEROL, V44, pS42, DOI 10.1097/MCG.0b013e3181ed0e71; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Drago L, 2016, EUR J GASTROEN HEPAT, V28, P532, DOI 10.1097/MEG.0000000000000581; Draper K, 2017, BENEF MICROBES, V8, P507, DOI 10.3920/BM2016.0146; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eloe-Fadrosh EA, 2015, MBIO, V6, DOI 10.1128/mBio.00231-15; Ferrario C, 2014, J NUTR, V144, P1787, DOI 10.3945/jn.114.197723; Fukushima Y, 1998, INT J FOOD MICROBIOL, V42, P39, DOI 10.1016/S0168-1605(98)00056-7; FULLER R, 1991, GUT, V32, P439, DOI 10.1136/gut.32.4.439; Furet JP, 2004, INT J FOOD MICROBIOL, V97, P197, DOI 10.1016/j.ijfoodmicro.2004.04.020; GOLDIN BR, 1992, DIGEST DIS SCI, V37, P121, DOI 10.1007/BF01308354; Goossens D, 2003, ALIMENT PHARM THER, V18, P495, DOI 10.1046/j.1365-2036.2003.01708.x; Goossens DAM, 2006, ALIMENT PHARM THER, V23, P255, DOI 10.1111/j.1365-2036.2006.02749.x; Guyonnet D, 2009, BRIT J NUTR, V102, P1654, DOI 10.1017/S0007114509990882; Haarman M, 2005, APPL ENVIRON MICROB, V71, P2318, DOI 10.1128/AEM.71.5.2318-2324.2005; Hanifi A, 2015, BENEF MICROBES, V6, P19, DOI 10.3920/BM2014.0031; Hecht G, 2014, LAB ANIM-UK, V48, P292, DOI 10.1177/0023677214544728; Hegarty JW, 2017, PROBIOTICS ANTIMICRO, V9, P459, DOI 10.1007/s12602-017-9326-2; Herbel SR, 2013, J APPL MICROBIOL, V115, P1402, DOI 10.1111/jam.12341; Honeycutt TCB, 2007, PEDIATR CRIT CARE ME, V8, P452, DOI 10.1097/01.PCC.0000282176.41134.E6; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaushik JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008099; Kristensen NB, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0300-5; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Laursen MF, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1090-7; Lee YK, 2000, APPL ENVIRON MICROB, V66, P3692, DOI 10.1128/AEM.66.9.3692-3697.2000; Li XH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176185; Maldonado-Gomez MX, 2016, CELL HOST MICROBE, V20, P515, DOI 10.1016/j.chom.2016.09.001; Manor O, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0231-4; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; McKean J, 2017, J ALTERN COMPLEM MED, V23, P249, DOI 10.1089/acm.2016.0023; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; O'Brien CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062815; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rijkers GT, 2011, BRIT J NUTR, V106, P1291, DOI 10.1017/S000711451100287X; Rochet V, 2006, BRIT J NUTR, V95, P421, DOI 10.1079/BJN20051625; Rondanelli M, 2017, GUT MICROBES, V8, P521, DOI 10.1080/19490976.2017.1345414; Ruggirello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114280; Saldanha LG, 2008, CLIN INFECT DIS, V46, pS119, DOI 10.1086/523328; Schwendimann L, 2015, J MICROBIOL METH, V115, P94, DOI 10.1016/j.mimet.2015.05.022; Senok AC, 2005, CLIN MICROBIOL INFEC, V11, P958, DOI 10.1111/j.1469-0691.2005.01228.x; Sharon I, 2015, GENOME RES, V25, P534, DOI 10.1101/gr.183012.114; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Sierra S, 2010, ANAEROBE, V16, P195, DOI 10.1016/j.anaerobe.2010.02.001; Suez J, 2018, CELL, V174, P1406, DOI 10.1016/j.cell.2018.08.047; Sun J, 2016, BRIT J NUTR, V115, P1167, DOI 10.1017/S0007114516000076; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Tuomola E, 2001, AM J CLIN NUTR, V73, p393S, DOI 10.1093/ajcn/73.2.393s; Turroni F, 2013, P NATL ACAD SCI USA, V110, P11151, DOI 10.1073/pnas.1303897110; Van Tassell ML, 2011, NUTRIENTS, V3, P613, DOI 10.3390/nu3050613; Vogel G, 2008, SCIENCE, V319, P557, DOI 10.1126/science.319.5863.557a; Wang CX, 2015, ANN NUTR METAB, V67, P257, DOI 10.1159/000441066; Yang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep27427; Yuan FQ, 2017, CURR MED RES OPIN, V33, P1191, DOI 10.1080/03007995.2017.1292230; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zhang QQ, 2016, INT J FOOD SCI NUTR, V67, P571, DOI 10.1080/09637486.2016.1181156; Zmora N, 2016, CELL HOST MICROBE, V19, P12, DOI 10.1016/j.chom.2015.12.016	75	620	641	48	381	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1388	+		10.1016/j.cell.2018.08.041	http://dx.doi.org/10.1016/j.cell.2018.08.041			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193112	Bronze			2022-12-28	WOS:000443841000010
J	Finkelstein, A; Ji, YA; Mahoney, N; Skinner, J				Finkelstein, Amy; Ji, Yunan; Mahoney, Neale; Skinner, Jonathan			Mandatory Medicare Bundled Payment Program for Lower Extremity Joint Replacement and Discharge to Institutional Postacute Care Interim Analysis of the First Year of a 5-Year Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-INSURANCE EXPERIMENT; ADMINISTRATIVE DATA; OREGON EXPERIMENT; COST SAVINGS; SURGERY; PARTICIPATION; ARTHROPLASTY; OUTCOMES; QUALITY; MODELS	IMPORTANCE Bundled payments are an increasingly common alternative payment model for Medicare, yet there is limited evidence regarding their effectiveness. OBJECTIVE To report interim outomes from the first year of implementation of a bundled payment model for lower extremity joint replacement (LEJR). DESIGN, SETTING, AND PARTICIPANTS As part of a 5-year, mandatory-participation randomized trial by the Centers for Medicare & Medicaid Services, eligible metropolitan statistical areas (MSAs) were randomized to the Comprehensive Care for Joint Replacement (CJR) bundled payment model for LEJR episodes or to a control group. In the first performance year, hospitals received bonus payments if Medicare spending for LEJR episodes was below the target price and hospitals met quality standards. This interim analysis reports first-year data on LEJR episodes starting April 1, 2016, with data collection through December 31, 2016. EXPOSURE Randomization of MSAs into the CJR bundled payment model group (75 assigned; 67 included) or to the control group without the CJR model (121 assigned; 121 included). Instrumental variable analysis was used to evaluate the relationship between inclusion of MSAs in the CJR model and outcomes. MAIN OUTCOMES AND MEASURES The primary outcome was share of LEJR admissions discharged to institutional postacute care. Secondary outcomes included the number of days in institutional postacute care, discharges to other locations, Medicare spending during the episode (overall and for institutional postacute care), net Medicare spending during the episode, LEJR patient volume and patient case mix, and quality-of-care measures. RESULTS Among the 196 MSAs and 1633 hospitals, 131 285 eligible LEJR procedures were performed during the study period (mean volume, 110 LEJR episodes per hospital) among 130 343 patients (mean age, 72.5 [SD, 0.91] years; 65% women; 90% white). The mean percentage of LEJR admissions discharged to institutional postacute care was 33.7%(SD, 11.2%) in the control group and was 2.9 percentage points lower (95% CI, -4.95 to -0.90 percentage points) in the CJR group. Mean Medicare spending for institutional postacute care per LEJR episode was $3871 (SD, $1394) in the control group and was $307 lower (95% CI, -$587 to -$27) in the CJR group. Mean overall Medicare spending per LEJR episode was $22 872 (SD, $3619) in the control group and was $453 lower (95% CI, -$909to$3) in the CJR group, a statistically nonsignificant difference. None of the other secondary outcomes differed significantly between groups. CONCLUSIONS AND RELEVANCE In this interim analysis of the first year of the CJR bundled payment model for LEJR among Medicare beneficiaries, MSAs covered by CJR, compared with those that were not, had a significantly lower percentage of discharges to institutional postacute care but no significant difference in total Medicare spending per LEJR episode. Further evaluation is needed as the program is more fully implemented.	[Finkelstein, Amy] MIT, Dept Econ, 77 Massachusetts Ave,Bldg E52,Room 442, Cambridge, MA 02139 USA; [Finkelstein, Amy] MIT, J PAL North Amer, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Finkelstein, Amy; Mahoney, Neale; Skinner, Jonathan] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Ji, Yunan] Harvard Univ, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Mahoney, Neale] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA; [Skinner, Jonathan] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Bureau of Economic Research; Harvard University; University of Chicago; Dartmouth College	Finkelstein, A (corresponding author), MIT, Dept Econ, 77 Massachusetts Ave,Bldg E52,Room 442, Cambridge, MA 02139 USA.	afink@mit.edu			J-PAL North America; National Institute on Aging [P01AG019783-15]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	J-PAL North America; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J-PAL North America and the National Institute on Aging (grant P01AG019783-15) provided research support.	Baicker K, 2014, AM ECON REV, V104, P322, DOI 10.1257/aer.104.5.322; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Centers for Medicare and Medicaid Services and US, 2016, FED REGISTER, V81, P56761; Centers for Medicare and Medicaid Services (CMS) HHS, 2015, Fed Regist, V80, P49325; Centers for Medicare & Medicaid Services, 2014, NAT SUMM INP CHARG D; Centers for Medicare & Medicaid Services, HOSP COMP DAT; Centers for Medicare & Medicaid Services, 2018, OV CJR MEAS COMP QUA; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colla C., 2016, NATL BUREAU EC RES W, P22826; Cromwell J, 1997, HEALTH CARE FINANC R, V19, P41; Cutler D, 2010, HEALTH AFFAIR, V29, P1131, DOI 10.1377/hlthaff.2010.0416; Cutler DM, 2012, NEW ENGL J MED, V366, P1075, DOI 10.1056/NEJMp1113361; Doran JP, 2015, J ARTHROPLASTY, V30, P353, DOI 10.1016/j.arth.2015.01.035; Dummit LA, 2016, JAMA-J AM MED ASSOC, V316, P1267, DOI 10.1001/jama.2016.12717; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Federal Register, 2015, FED REGISTER, V80, P73273; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Finkelstein AN, 2016, NEW ENGL J MED, V375, P1505, DOI 10.1056/NEJMp1609533; Fisher ES, 2016, JAMA-J AM MED ASSOC, V316, P1262, DOI 10.1001/jama.2016.12525; Froemke CC, 2015, J ARTHROPLASTY, V30, P1676, DOI 10.1016/j.arth.2015.04.028; Furman Jason, 2017, WALL STREET J; Gronniger T, 2017, HLTH AFFAIRS BLOG; Heckman JJ, 2006, REV ECON STAT, V88, P389, DOI 10.1162/rest.88.3.389; IMBENS GW, 1994, ECONOMETRICA, V62, P467, DOI 10.2307/2951620; Lewin Group, 2018, CMS COMPR CAR JOINT; McWilliams JM, 2017, JAMA INTERN MED, V177, P518, DOI 10.1001/jamainternmed.2016.9115; Mechanic RE, 2015, NEW ENGL J MED, V373, P1291, DOI 10.1056/NEJMp1509155; Meyer H, 2017, MODERN HEALTHCARE; Miller DC, 2011, HEALTH AFFAIR, V30, P2107, DOI 10.1377/hlthaff.2011.0783; Navathe AS, 2018, JAMA-J AM MED ASSOC, V319, P930, DOI 10.1001/jama.2018.0678; Navathe AS, 2017, JAMA INTERN MED, V177, P214, DOI 10.1001/jamainternmed.2016.8263; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Shatto JD, 2016, CTR MED MED INNOVATI; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183; US Department of Health and Human Services, 2014, 2014 CMS STAT	35	110	109	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2018	320	9					892	900		10.1001/jama.2018.12346	http://dx.doi.org/10.1001/jama.2018.12346			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS4OQ	30193277	Green Published, Bronze			2022-12-28	WOS:000443627300013
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: A summary of four and a half years of columns in one column	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2018	362								k3745	10.1136/bmj.k3745	http://dx.doi.org/10.1136/bmj.k3745			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4VO	30181339	Bronze			2022-12-28	WOS:000444503800008
J	Voelker, R				Voelker, Rebecca			When Is Milk Really Milk?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2018	320	9					864	864		10.1001/jama.2018.12148	http://dx.doi.org/10.1001/jama.2018.12148			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS4OQ	30193260				2022-12-28	WOS:000443627300030
J	Voelker, R				Voelker, Rebecca			Magnetic Tracer System Identifies Sentinel Lymph Nodes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2018	320	9					864	864		10.1001/jama.2018.12152	http://dx.doi.org/10.1001/jama.2018.12152			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS4OQ	30193261				2022-12-28	WOS:000443627300031
J	Humphrey, V; Zscheischler, J; Ciais, P; Gudmundsson, L; Sitch, S; Seneviratne, SI				Humphrey, Vincent; Zscheischler, Jakob; Ciais, Philippe; Gudmundsson, Lukas; Sitch, Stephen; Seneviratne, Sonia I.			Sensitivity of atmospheric CO2 growth rate to observed changes in terrestrial water storage	NATURE			English	Article							CARBON-DIOXIDE; INTERANNUAL VARIABILITY; SEMIARID ECOSYSTEMS; GRACE; DROUGHT; TRENDS; PRECIPITATION; SATELLITE; CYCLE; PRODUCTS	Land ecosystems absorb on average 30 per cent of anthropogenic carbon dioxide (CO2) emissions, thereby slowing the increase of CO2 concentration in the atmosphere(1). Year-to-year variations in the atmospheric CO2 growth rate are mostly due to fluctuating carbon uptake by land ecosystems(1). The sensitivity of these fluctuations to changes in tropical temperature has been well documented(2-6), but identifying the role of global water availability has proved to be elusive. So far, the only usable proxies for water availability have been time-lagged precipitation anomalies and drought indices(3-5), owing to a lack of direct observations. Here, we use recent observations of terrestrial water storage changes derived from satellite gravimetry(7) to investigate terrestrial water effects on carbon cycle variability at global to regional scales. We show that the CO2 growth rate is strongly sensitive to observed changes in terrestrial water storage, drier years being associated with faster atmospheric CO2 growth. We demonstrate that this global relationship is independent of known temperature effects and is underestimated in current carbon cycle models. Our results indicate that interannual fluctuations in terrestrial water storage strongly affect the terrestrial carbon sink and highlight the importance of the interactions between the water and carbon cycles.	[Humphrey, Vincent; Zscheischler, Jakob; Gudmundsson, Lukas; Seneviratne, Sonia I.] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland; [Ciais, Philippe] UVSQ, CNRS, CEA, Lab Sci Climat & Environm, Gif Sur Yvette, France; [Sitch, Stephen] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Exeter	Humphrey, V; Seneviratne, SI (corresponding author), Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland.	vincent.humphrey@env.ethz.ch; sonia.seneviratne@ethz.ch	Gudmundsson, Lukas/I-9535-2014; Zscheischler, Jakob/ABE-7324-2021; Seneviratne, Sonia I./G-8761-2011; Humphrey, Vincent/AAD-4990-2019; Ciais, Philippe/A-6840-2011; Sitch, Stephen A/F-8034-2015	Gudmundsson, Lukas/0000-0003-3539-8621; Zscheischler, Jakob/0000-0001-6045-1629; Seneviratne, Sonia I./0000-0001-9528-2917; Humphrey, Vincent/0000-0002-2541-6382; Ciais, Philippe/0000-0001-8560-4943; Sitch, Stephen A/0000-0003-1821-8561	European Research Council DROUGHT-HEAT project [617518]; European Research Council [ERC-2013-SyG-610028 IMBALANCE-P]; NERC [NE/J010154/1] Funding Source: UKRI; Natural Environment Research Council [NE/J010154/1] Funding Source: researchfish	European Research Council DROUGHT-HEAT project; European Research Council(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	All datasets supporting the results of this paper are openly accessible from the references listed in Supplementary Table 1. This research was funded by the European Research Council DROUGHT-HEAT project (contract 617518). P.C. was supported by the European Research Council Synergy grant ERC-2013-SyG-610028 IMBALANCE-P. We thank M. Jung and U. Weber for providing the water availability index used in FluxCom and R. Wartenburger for technical support. We gratefully thank the following data providers and model developers for their continuous efforts and for sharing their data: the NASA Jet Propulsion Laboratory, the NOAA Earth System Research Laboratory, the Global Carbon Project, the WaterGAP Global Hydrology Model (WGHM), the Global Land Data Assimilation System (GLDAS), Multi-Source Weighted-Ensemble Precipitation (MSWEP), the Global Precipitation Climatology Project (GPCP), the University of East Anglia Climatic Research Unit (CRU), Berkeley Earth, and all contributors as well as data providers to the FluxCom initiative and the TRENDY experiment version 3, which included the models CABLE, CLM, ISAM, JSBACH, JULES, LPJ, LJP-GUESS, LPX-Bern, ORCHIDEE, VEGAS and VISIT.	Abelen S, 2013, REMOTE SENS ENVIRON, V136, P89, DOI 10.1016/j.rse.2013.04.012; Adhikari S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501693; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Ahlstrom A, 2015, SCIENCE, V348, P895, DOI 10.1126/science.aaa1668; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Beck HE, 2017, HYDROL EARTH SYST SC, V21, P589, DOI 10.5194/hess-21-589-2017; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Cazenave A, 2014, NAT CLIM CHANGE, V4, P358, DOI [10.1038/nclimate2159, 10.1038/NCLIMATE2159]; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cox PM, 2013, NATURE, V494, P341, DOI 10.1038/nature11882; Doll P, 2014, WATER RESOUR RES, V50, P5698, DOI 10.1002/2014WR015595; Fan Y, 2017, P NATL ACAD SCI USA, V114, P10572, DOI 10.1073/pnas.1712381114; Fang YY, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6e8e; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Friedlingstein P, 2014, J CLIMATE, V27, P511, DOI 10.1175/JCLI-D-12-00579.1; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Huffman GJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040000; Humphrey V, 2017, GEOPHYS RES LETT, V44, P2300, DOI 10.1002/2017GL072564; Humphrey V, 2016, SURV GEOPHYS, V37, P357, DOI 10.1007/s10712-016-9367-1; Jung M, 2017, NATURE, V541, P516, DOI 10.1038/nature20780; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; Le Quere C, 2018, EARTH SYST SCI DATA, V10, P405, DOI 10.5194/essd-10-405-2018; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; MASARIE KA, 1995, J GEOPHYS RES-ATMOS, V100, P11593, DOI 10.1029/95JD00859; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Mudelsee M, 2014, ATMOS OCEAN SCI LIB, V51, P1, DOI 10.1007/978-3-319-04450-7; Ni SN, 2018, SURV GEOPHYS, V39, P1, DOI 10.1007/s10712-017-9421-7; Orlowsky B, 2013, HYDROL EARTH SYST SC, V17, P1765, DOI 10.5194/hess-17-1765-2013; Peters GP, 2017, NAT CLIM CHANGE, V7, P848, DOI 10.1038/s41558-017-0013-9; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Poulter B, 2014, NATURE, V509, P600, DOI 10.1038/nature13376; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Rohde R., 2013, GEOINFOR GEOSTAT OVE, V1, P1, DOI [10.4172/gigs.1000101, DOI 10.4172/2327-4581.1000101]; Scanlon BR, 2018, P NATL ACAD SCI USA, V115, pE1080, DOI 10.1073/pnas.1704665115; Scanlon BR, 2016, WATER RESOUR RES, V52, P9412, DOI 10.1002/2016WR019494; Sitch S, 2015, BIOGEOSCIENCES, V12, P653, DOI 10.5194/bg-12-653-2015; Swann ALS, 2016, P NATL ACAD SCI USA, V113, P10019, DOI 10.1073/pnas.1604581113; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Tramontana G, 2016, BIOGEOSCIENCES, V13, P4291, DOI 10.5194/bg-13-4291-2016; Trenberth KE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030524; Wahr J, 1998, J GEOPHYS RES-SOL EA, V103, P30205, DOI 10.1029/98JB02844; Wahr J, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019779; Wang J, 2016, BIOGEOSCIENCES, V13, P2339, DOI 10.5194/bg-13-2339-2016; Wang WL, 2013, P NATL ACAD SCI USA, V110, P13061, DOI 10.1073/pnas.1219683110; Wang XH, 2014, NATURE, V506, P212, DOI 10.1038/nature12915; Watkins MM, 2015, J GEOPHYS RES-SOL EA, V120, P2648, DOI 10.1002/2014JB011547; Wiese DN, 2016, WATER RESOUR RES, V52, P7490, DOI 10.1002/2016WR019344; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wouters B, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/11/116801	49	197	200	69	329	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					628	+		10.1038/s41586-018-0424-4	http://dx.doi.org/10.1038/s41586-018-0424-4			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS0SZ	30158603				2022-12-28	WOS:000443218600046
J	Rimmer, A				Rimmer, Abi			Scottish consultants being "singled out" for low pay award, says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2018, REV BODY DOCTORS DEN; Rimmer A, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3236	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2018	362								k3746	10.1136/bmj.k3746	http://dx.doi.org/10.1136/bmj.k3746			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5ZI	30166282				2022-12-28	WOS:000443758100018
J	Reeves, D; Pye, S; Ashcroft, DM; Clegg, A; Kontopantelis, E; Blakeman, T; van Marwijk, H				Reeves, David; Pye, Stephen; Ashcroft, Darren M.; Clegg, Andrew; Kontopantelis, Evangelos; Blakeman, Tom; van Marwijk, Harm			The challenge of ageing populations and patient frailty: can primary care adapt?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ELDERLY-PEOPLE; OLDER PERSONS; MANAGEMENT; ADULTS; INDEX		[Reeves, David; Pye, Stephen; Kontopantelis, Evangelos; Blakeman, Tom; van Marwijk, Harm] Univ Manchester, NIHR Sch Primary Care Res, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Reeves, David; Pye, Stephen; Kontopantelis, Evangelos; Blakeman, Tom] Univ Manchester, Div Populat Hlth Hlth Serv Res & Primary Care, Manchester, Lancs, England; [Ashcroft, Darren M.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester, Lancs, England; [Clegg, Andrew] Univ Leeds, Acad Unit Elderly Care & Rehabil, Leeds, W Yorkshire, England; [van Marwijk, Harm] Brighton & Sussex Med Sch, Div Primary Care & Publ Hlth, Brighton, E Sussex, England	University of Manchester; University of Manchester; University of Manchester; University of Leeds; University of Brighton; University of Sussex	Reeves, D (corresponding author), Univ Manchester, NIHR Sch Primary Care Res, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.; Reeves, D (corresponding author), Univ Manchester, Div Populat Hlth Hlth Serv Res & Primary Care, Manchester, Lancs, England.	david.reeves@manchester.ac.uk	Van Marwijk, Harm/K-6306-2013; Kontopantelis, Evangelos/H-2966-2019; Ashcroft, Darren/G-3244-2015	Van Marwijk, Harm/0000-0001-6206-485X; Kontopantelis, Evangelos/0000-0001-6450-5815; Ashcroft, Darren/0000-0002-2958-915X; Clegg, Andrew/0000-0001-5972-1097				Age UK, 2015, PERS INT CAR PROGR; Age UK, 2015, FRAILT LANG PERC; Apostolo Joao, 2017, JBI Database System Rev Implement Rep, V15, P1154, DOI 10.11124/JBISRIR-2016-003018; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Bleijenberg N, 2017, J AM MED DIR ASSOC, V18, P1029, DOI 10.1016/j.jamda.2017.06.023; Cassell A, 2018, BRIT J GEN PRACT, V68, pE245, DOI 10.3399/bjgp18X695465; Cesari M, 2016, EUR J INTERN MED, V31, P11, DOI 10.1016/j.ejim.2016.03.005; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Goldstein J, 2014, CAN J EMERG MED, V16, P370, DOI 10.2310/8000.2013.130937; HAMILTON W, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J4478; Hoogendijk EO, 2016, AGE AGEING, V45, P587, DOI 10.1093/ageing/afw081; Jonkers CCM, 2010, INT J INTEGR CARE S, V10, pe8110, DOI DOI 10.5334/IJIC.609; Lacas A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-4; Lansbury LN, 2017, BRIT J GEN PRACT, V67, pE751, DOI 10.3399/bjgp17X693089; Mackintosh W, 2017, BRIT J GEN PRACT, V67, P216, DOI 10.3399/bjgp17X690641; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; Miettinen M, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0660-8; Muscedere J, 2016, CAN J AGING, V35, P281, DOI 10.1017/S0714980816000301; Nagpaul Chaand, 2017, IMP MESS ALL GPS ENG; National Institute for Health and Care Excellence, 2016, MULT CLIN ASS MAN RE; National Institute for Health and Clinical Excellence, 2015, OLD PEOPL IND MENT W; National Institute for Health and Clinical Excellence, 2016, QS120 NAT I HLTH CLI; National Institute for Health and Clinical Excellence, 2016, MULT CLIN ASS MAN; National Institute for Health and Clinical Excellence, 2017, QS86 NAT I HLTH CLIN; NHS England, 2017, TOOLK GEN PRACT SUPP; NHS England, 2017, UPD GUID SUPP ROUT F; Reeves D, 2016, CHARACTERISING PRIMA; Romero-Ortuno R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006645; Shaw S, 2017, FRAILTY NURSING PRIM; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Strain WD, 2018, DIABETIC MED, V35, P838, DOI 10.1111/dme.13644; Sutorius FL, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0487-y; World Health Organization, 2018, WORLD REP AG HLTH; Yarnall AJ, 2017, AGE AGEING, V46, P882, DOI 10.1093/ageing/afx150	36	57	57	3	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2018	362								k3349	10.1136/bmj.k3349	http://dx.doi.org/10.1136/bmj.k3349			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5YZ	30154082	Green Accepted, Green Submitted			2022-12-28	WOS:000443756600001
J	Slomski, A				Slomski, Anita			Behavior Therapy May Help Prevent Teen Suicide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					749	749		10.1001/jama.2018.12044	http://dx.doi.org/10.1001/jama.2018.12044			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167697				2022-12-28	WOS:000442958800010
J	Iacobucci, G				Iacobucci, Gareth			Stop smoking services: BMJ analysis shows how councils are stubbing them out	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		British Lung Foundation, 2018, LESS HELP QUIT; Cancer Research UK, 2018, FEEL HEAT DECL STOP; Ealing Council Health and Wellbeing Board, 2018, M DET; Mayor S, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2953; Royal College of Physicians, 2018, HID PLAIN SIGHT TREA; Wise J, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3571	6	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2018	362								k3649	10.1136/bmj.k3649	http://dx.doi.org/10.1136/bmj.k3649			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8SY	30143515				2022-12-28	WOS:000443000000003
J	Oparil, S; Fu, RH				Oparil, Suzanne; Fu, Richard H.			Revisiting ASCOT 16 years later	LANCET			English	Editorial Material							LIPID-LOWERING TREATMENT; CARDIAC OUTCOMES TRIAL; HEART-ATTACK TRIAL; RANDOMIZED CONTROLLED-TRIAL; HYPERTENSIVE PATIENTS; BLOOD-PRESSURE; SYSTOLIC HYPERTENSION; ALLHAT-LLT; USUAL CARE; THERAPY		[Oparil, Suzanne] Univ Alabama Birmingham, Vasc Biol & Hypertens Program, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Fu, Richard H.] Univ S Alabama, Mobile, AL USA	University of Alabama System; University of Alabama Birmingham; University of South Alabama	Oparil, S (corresponding author), Univ Alabama Birmingham, Vasc Biol & Hypertens Program, Div Cardiovasc Dis, Birmingham, AL 35294 USA.	soparil@uabmc.edu						Cushman WC, 2012, J CLIN HYPERTENS, V14, P20, DOI 10.1111/j.1751-7176.2011.00568.x; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; FORD CE, 1988, JAMA-J AM MED ASSOC, V259, P2113; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Gupta A, 2018, LANCET, V392, P1127, DOI 10.1016/S0140-6736(18)31776-8; Kostis JB, 2005, AM J CARDIOL, V95, P29, DOI 10.1016/j.amjcard.2004.08.059; Kostis WJ, 2010, HYPERTENSION, V56, P1060, DOI 10.1161/HYPERTENSIONAHA.110.160291; Margolis KL, 2013, J CLIN HYPERTENS, V15, P542, DOI 10.1111/jch.12139; Nelson MR, 2015, J HYPERTENS, V33, P2331, DOI 10.1097/HJH.0000000000000709; Sever PS, 2001, J HYPERTENS, V19, P1139, DOI 10.1097/00004872-200106000-00020; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Staessen JA, 2004, J HYPERTENS, V22, P847, DOI 10.1097/00004872-200404000-00029	13	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2018	392	10153					1092	1094		10.1016/S0140-6736(18)31943-3	http://dx.doi.org/10.1016/S0140-6736(18)31943-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV3BV	30158071				2022-12-28	WOS:000445968800007
J	Vranckx, P; Valgimigli, M; Juni, P; Hamm, C; Steg, PG; Heg, D; van Es, GA; McFadden, EP; Onuma, Y; van Meijeren, C; Chichareon, P; Benit, E; Mollmann, H; Janssens, L; Ferrario, M; Moschovitis, A; Zurakowski, A; Dominici, M; Van Geuns, RJ; Huber, K; Slagboom, T; Serruys, PW; Windecker, S				Vranckx, Pascal; Valgimigli, Marco; Juni, Peter; Hamm, Christian; Steg, Philippe Gabriel; Heg, Dik; van Es, Gerrit Anne; McFadden, Eugene P.; Onuma, Yoshinobu; van Meijeren, Cokky; Chichareon, Ply; Benit, Edouard; Mollmann, Helge; Janssens, Luc; Ferrario, Maurizio; Moschovitis, Aris; Zurakowski, Aleksander; Dominici, Marcello; Van Geuns, Robert Jan; Huber, Kurt; Slagboom, Ton; Serruys, Patrick W.; Windecker, Stephan		GLOBAL LEADERS Investigators	Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial	LANCET			English	Article							DUAL-ANTIPLATELET THERAPY; BIODEGRADABLE POLYMER; DURABLE POLYMER; CORONARY INTERVENTION; MYOCARDIAL-INFARCTION; CLINICAL-TRIALS; METAANALYSIS; DEFINITIONS; VALIDATION; DURATION	Background We hypothesised that ticagrelor, in combination with aspirin for 1 month, followed by ticagrelor alone, improves outcomes after percutaneous coronary intervention compared with standard antiplatelet regimens. Methods GLOBAL LEADERS was a randomised, open-label superiority trial at 130 sites in 18 countries. Patients undergoing percutaneous coronary intervention with a biolimus A9-eluting stent for stable coronary artery disease or acute coronary syndromes were randomly assigned (1:1) to 75-100 mg aspirin daily plus 90 mg ticagrelor twice daily for 1 month, followed by 23 months of ticagrelor monotherapy, or standard dual antiplatelet therapy with 75-100 mg aspirin daily plus either 75 mg clopidogrel daily (for patients with stable coronary artery disease) or 90 mg ticagrelor twice daily (for patients with acute coronary syndromes) for 12 months, followed by aspirin monotherapy for 12 months. Randomisation was concealed, stratified by centre and clinical presentation (stable coronary artery disease vs acute coronary syndrome), and blocked, with randomly varied block sizes of two and four. The primary endpoint at 2 years was a composite of all-cause mortality or non-fatal centrally adjudicated new Q-wave myocardial infarction as assessed by a core lab in a blinded manner. The key secondary safety endpoint was site-reported bleeding assessed according to the Bleeding Academic Research Consortium criteria (grade 3 or 5). Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01813435, and is closed to new participants, with followup completed. Findings Between July 1, 2013, and Nov 9, 2015, 15 968 participants were randomly assigned, 7980 to the experimental group and 7988 to the control group. At 2 years, 304 (3.81%) participants in the experimental group had died or had a non-fatal centrally adjudicated new Q-wave myocardial infarction, compared with 349 (4.37%) participants in the control group (rate ratio 0.87 [95% CI 0. 75-1. 01]; p=0.073]). There was no evidence for a difference in treatment effects for the primary endpoint across prespecified subgroups of acute coronary syndromes and stable coronary artery disease (p=0.93). Grade 3 or 5 bleeding occurred in 163 participants in the experimental group and 169 in the control group (2.04% vs 2.12%; rate ratio 0.97 [95% CI 0. 78-1. 20]; p=0.77). Interpretation Ticagrelor in combination with aspirin for 1 month followed by ticagrelor alone for 23 months was not superior to 12 months of standard dual antiplatelet therapy followed by 12 months of aspirin alone in the prevention of all-cause mortality or new Q-wave myocardial infarction 2 years after percutaneous coronary intervention. Copright (C) 2018 Elsevier Ltd. All rights reserved.	[Vranckx, Pascal; Benit, Edouard] Hasselt Univ, Fac Med & Life Sci, Jessa Ziekenhuis, Hasselt, Belgium; [Valgimigli, Marco; Moschovitis, Aris; Windecker, Stephan] Univ Bern, Bern Univ Hosp, Inselspital, Dept Cardiol, Bern, Switzerland; [Juni, Peter] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON, Canada; [Juni, Peter] Univ Toronto, Dept Med, Toronto, ON, Canada; [Juni, Peter] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Hamm, Christian; Mollmann, Helge] Kerckhoff Heart & Thorax Ctr, Bad Nauheim, Germany; [Steg, Philippe Gabriel] Univ Paris Diderot, Hop Bichat, AP HP, INSERM,U 1148,French Alliance Cardiovasc Trials, Paris, France; [Steg, Philippe Gabriel] Imperial Coll London, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England; [Heg, Dik] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [van Es, Gerrit Anne] European Cardiovasc Res Inst, Rotterdam, Netherlands; [McFadden, Eugene P.] Cork Univ Hosp, Cork, Ireland; [Onuma, Yoshinobu; Van Geuns, Robert Jan; Serruys, Patrick W.] Erasmus MC, Rotterdam, Netherlands; [Onuma, Yoshinobu; van Meijeren, Cokky] Cardialysis, Rotterdam, Netherlands; [Chichareon, Ply; Serruys, Patrick W.] Acad Med Ctr Amsterdam, Amsterdam, Netherlands; [Janssens, Luc] Imeldaziekenhuis, Bonheiden, Belgium; [Ferrario, Maurizio] Fdn IRCCS Policlin San Matteo, UOC Cardiol, Pavia, Italy; [Zurakowski, Aleksander] Amer Heart Poland, Ctr Cardiovasc Res & Dev, Katowice, Poland; [Dominici, Marcello] Azienda Osped S Maria, Terni, Italy; [Huber, Kurt] Wilhelminenhospital, Dept Med Cardiol & Intens Care Med 3, Vienna, Austria; [Huber, Kurt] Sigmund Freud Univ, Med Fac, Vienna, Austria; [Slagboom, Ton] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands	Hasselt University; University of Bern; University Hospital of Bern; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Kerckhoff Clinic; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Royal Brompton Hospital; University of Bern; University College Cork; Erasmus University Rotterdam; Erasmus MC; Cardialysis; University of Amsterdam; Academic Medical Center Amsterdam; Imeldaziekenhuis; IRCCS Fondazione San Matteo; Wilhelminenspital; Onze Lieve Vrouwe Gasthuis Hospital	Serruys, PW (corresponding author), Erasmus MC, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.; Windecker, S (corresponding author), Bern Univ Hosp, Inselspital, Dept Cardiol, CH-3010 Bern, Switzerland.	patrick.w.j.c.serruys@gmail.com; stephan.windecker@insel.ch	Juni, Peter/Q-8700-2016; van Geuns, Robert/AAR-6386-2021; STEG, Philippe Gabriel/Z-1567-2019; Seidler, Tim/ABH-8333-2020; Onuma, Yoshinobu/AHB-6273-2022; Manavifar, Negar/X-9569-2019; van Geuns, Robert-Jan M/N-7976-2017; Valgimigli, Marco/AAE-9103-2019; Koszegi, Zsolt/L-1856-2013; amyn slyman/C-8913-2016	Juni, Peter/0000-0002-5985-0670; Seidler, Tim/0000-0002-6158-5087; Onuma, Yoshinobu/0000-0001-7702-0649; Manavifar, Negar/0000-0001-7643-7944; van Geuns, Robert-Jan M/0000-0003-2943-5932; Valgimigli, Marco/0000-0002-4353-7110; Sabate Tenas, Manel/0000-0002-2316-3705; Heg, Dik/0000-0002-8766-7945; , IIS Galicia Sur/0000-0003-3812-7413; Soliman, Osama/0000-0003-0758-3539; CARRIE, didier/0000-0003-2479-8144; Koszegi, Zsolt/0000-0002-2817-6900; TEIGER, emmanuel/0000-0001-7515-4344; Buszman, Pawel/0000-0002-2511-4077; GARGIULO, Giuseppe/0000-0003-4395-6742; Spitzer, Ernest/0000-0003-2371-5431; amyn slyman/0000-0002-8480-1248; Asano, Taku/0000-0001-5733-3381; Petrov, Ivo/0000-0002-9989-0730; Garg, Scot/0000-0002-8911-0278; Cotton, James/0000-0001-6548-2723; Curzen, Nick/0000-0001-9651-7829	European Clinical Research Institute; Biosensors International; AstraZeneca; Medicines Company; Canada Research Chairs Programme	European Clinical Research Institute; Biosensors International; AstraZeneca(AstraZeneca); Medicines Company; Canada Research Chairs Programme(Canada Research Chairs)	GLOBAL LEADERS was sponsored by the European Clinical Research Institute, which received funding from Biosensors International, AstraZeneca, and the Medicines Company. PJ is a Tier 1 Canada Research Chair in Clinical Epidemiology of Chronic Diseases. This research was completed, in part, with funding from the Canada Research Chairs Programme.	Baber U, 2016, AM HEART J, V182, P125, DOI 10.1016/j.ahj.2016.09.006; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Capodanno D, 2018, NAT REV CARDIOL, V15, P480, DOI 10.1038/s41569-018-0049-1; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; El-Hayek G, 2017, JACC-CARDIOVASC INTE, V10, P462, DOI 10.1016/j.jcin.2016.12.002; Gargiulo G, 2016, CIRCULATION, V134, P1881, DOI 10.1161/CIRCULATIONAHA.116.023952; Hiatt WR, 2017, NEW ENGL J MED, V376, P32, DOI 10.1056/NEJMoa1611688; Hicks KA, 2018, J AM COLL CARDIOL, V71, P1021, DOI 10.1016/j.jacc.2017.12.048; Johnston SC, 2016, NEW ENGL J MED, V375, P35, DOI 10.1056/NEJMoa1603060; Klauss V, 2011, JACC-CARDIOVASC INTE, V4, P887, DOI 10.1016/j.jcin.2011.03.017; Mahaffey KW, 2011, CIRCULATION, V124, P544, DOI 10.1161/CIRCULATIONAHA.111.047498; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530; Navarese EP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1618; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Prineas R., 1982, MINNESOTA CODE MANUA; Prineas RJ., 2009, MINNESOTA CODE MANUA; Qureshi WT, 2018, J AM COLL CARDIOL, V71, P1, DOI 10.1016/j.jacc.2017.10.071; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stone GW, 2001, CIRCULATION, V104, P642, DOI 10.1161/hc3101.093902; Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Vranckx P, 2016, EUROINTERVENTION, V12, P1239, DOI 10.4244/EIJY15M11_07; Vranckx P, 2014, EUR HEART J, V35, P2524, DOI 10.1093/eurheartj/ehu161; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Zhang ZM, 2016, CIRCULATION, V133, P2141, DOI 10.1161/CIRCULATIONAHA.115.021177	28	423	432	2	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2018	392	10151					940	949		10.1016/S0140-6736(18)31858-0	http://dx.doi.org/10.1016/S0140-6736(18)31858-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4LN	30166073	Green Submitted			2022-12-28	WOS:000444475700026
J	Adnan, N; Conlan-Trant, R; McCormick, C; Boland, F; Murphy, DJ				Adnan, Nita; Conlan-Trant, Rebecca; McCormick, Ciara; Boland, Fiona; Murphy, Deirdre J.			Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							3RD STAGE; MANAGEMENT; INFUSION; BOLUS	OBJECTIVE To determine whether intravenous oxytocin is more effective than intramuscular oxytocin at preventing postpartum haemorrhage at vaginal delivery. DESIGN Double blind placebo controlled randomised trial. SETTING University affiliated maternity unit in the Republic of Ireland. PARTICIPANTS 1075 women aged 18 years or older, at term with a singleton pregnancy who were aiming for a vaginal delivery with an actively managed third stage of labour. INTERVENTIONS Women were allocated to an intravenous bolus of oxytocin (10 IU in 1 mL given slowly over one minute) and placebo intramuscular injection (1 mL 0.9% saline) or an intramuscular bolus of oxytocin (10 IU in 1 mL) and placebo intravenous injection (1 mL 0.9% saline given slowly over one minute) at vaginal delivery. Allocation was by a secure web based randomisation service with masking of participants and clinicians to the trial intervention. MAIN OUTCOME MEASURES The primary outcome was postpartum haemorrhage (PPH, measured blood loss >= 500 mL). Secondary outcomes were severe PPH (measured blood loss >= 1000 mL), need for blood transfusion, admission to a high dependency unit, and side effects to oxytocin. RESULTS Between 4 January 2016 and 13 December 2017, 1075 women were randomised and 1035 (96.3%) included in the primary and secondary analyses (517 in the intravenous oxytocin group and 518 in the intramuscular oxytocin group). The incidence of PPH was not significantly lower in the intravenous group (18.8%, 97/517) compared with intramuscular group (23.2%, 120/518): adjusted odds ratio 0.75 (95% confidence interval 0.55 to 1.03). The incidence of severe PPH, however, was significantly lower in the intravenous group (4.6%, 24/517) compared with intramuscular group (8.1%, 42/518): 0.54 (0.32 to 0.91) as was the need for blood transfusion (1.5% v 4.4%, 0.31, 0.13 to 0.70) and admission to a high dependency unit (1.7% v3.7%, 0.44, 0.20 to 0.98). The number needed to treat to prevent one case of severe PPH was 29 (95% confidence interval 16 to 201) and to prevent one case of blood transfusion was 35 (20 to 121). The incidence of side effects to oxytocin was not increased in the intravenous group compared with intramuscular group (4.1% v 5.2%, 0.75, 0.42 to 1.35). CONCLUSION Intravenous oxytocin for the third stage of labour results in less frequent severe PPH, blood transfusion, and admission to a high dependency unit than intramuscular oxytocin, and without excess side effects.	[Adnan, Nita; Conlan-Trant, Rebecca; McCormick, Ciara; Murphy, Deirdre J.] Univ Dublin, Trinity Coll, Acad Dept Obstet & Gynaecol, Dublin 8, Ireland; [Adnan, Nita; Conlan-Trant, Rebecca; McCormick, Ciara; Murphy, Deirdre J.] Coombe Women & Infants Univ Hosp, Dublin 8, Ireland; [Boland, Fiona] Royal Coll Surgeons Ireland, Dept Gen Practice, HRB Ctr Primary Care Res, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Health Research Board - Ireland; Royal College of Surgeons - Ireland	Murphy, DJ (corresponding author), Univ Dublin, Trinity Coll, Acad Dept Obstet & Gynaecol, Dublin 8, Ireland.; Murphy, DJ (corresponding author), Coombe Women & Infants Univ Hosp, Dublin 8, Ireland.	deirdre.j.murphy@tcd.ie		McCormick, Ciara/0000-0002-2142-1678; Boland, Fiona/0000-0003-3228-0046	Trinity College, University of Dublin; Coombe Women and Infants University Hospital	Trinity College, University of Dublin; Coombe Women and Infants University Hospital	This study was funded by Trinity College, University of Dublin and Coombe Women and Infants University Hospital. Coombe Women and Infants University Hospital sponsored the study.	Adnan N, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2269-9; Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; [Anonymous], 2009, GREEN TOP GUID; [Anonymous], ANN REP 2014; [Anonymous], 2015, 14 CLAMP UMB CORD PL, V14; Begley CM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007412.pub2; Begley CM, COCHRANE DATABASE SY; Choy CMY, 2002, BJOG-INT J OBSTET GY, V109, P173, DOI 10.1016/S1470-0328(02)01204-1; Dagdeviren H, 2016, ARCH GYNECOL OBSTET, V294, P911, DOI 10.1007/s00404-016-4060-7; Davies GAL, 2005, OBSTET GYNECOL, V105, P294, DOI 10.1097/01.AOG.0000148264.20909.bb; Dept. of Reproductive Health and Research. World Health Organization dept. of reproductive health and research World Health Organization, 2012, WHO REC PREV TREATM; Farrar D, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-23; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Lewis G, WHY MOTHERS 1997 199; Lutomski JE, 2012, BJOG-INT J OBSTET GY, V119, P306, DOI 10.1111/j.1471-0528.2011.03198.x; McLeod G, 2010, INT J OBSTET ANESTH, V19, P155, DOI 10.1016/j.ijoa.2009.08.005; National Institute for Health and Clinical Excellence, 2007, NORM LAB 3 STAG INTR; Oladapo OT, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009332.pub2; Orhan EO, 2014, INT J GYNECOL OBSTET, V127, P175, DOI 10.1016/j.ijgo.2014.05.022; Rall TW, 1990, PHARMACOL BASIS THER, P933; Rath WH, 2011, ACTA OBSTET GYN SCAN, V90, P421, DOI 10.1111/j.1600-0412.2011.01107.x; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Sheehan SR, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4661; Soriano D, 1996, BRIT J OBSTET GYNAEC, V103, P1068, DOI 10.1111/j.1471-0528.1996.tb09584.x; The Central Statistics Office, VIT STAT ANN REP 201; Thomas JS, 2007, BRIT J ANAESTH, V98, P116, DOI 10.1093/bja/ael302; Westhoff G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001808.pub2	30	28	30	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2018	362								k3546	10.1136/bmj.k3546	http://dx.doi.org/10.1136/bmj.k3546			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4VO	30181338	Green Published, hybrid			2022-12-28	WOS:000444503800004
J	Rimmer, A				Rimmer, Abi			Five minutes with ... Colville Laird	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2018	362								k3755	10.1136/bmj.k3755	http://dx.doi.org/10.1136/bmj.k3755			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4VO	30181141				2022-12-28	WOS:000444503800010
J	Anderson, ND; de Borja, R; Young, MD; Fuligni, F; Rosic, A; Roberts, ND; Hajjar, S; Layeghifard, M; Novokmet, A; Kowalski, PE; Anaka, M; Davidson, S; Zarrei, M; Said, BI; Schreiner, LC; Marchand, R; Sitter, J; Gokgoz, N; Brunga, L; Graham, GT; Fullam, A; Pillay, N; Toretsky, JA; Yoshida, A; Shibata, T; Metzler, M; Somers, GR; Scherer, SW; Flanagan, AM; Campbell, PJ; Schiffman, JD; Shago, M; Alexandrov, LB; Wunder, JS; Andrulis, IL; Malkin, D; Behjati, S; Shlien, A				Anderson, Nathaniel D.; de Borja, Richard; Young, Matthew D.; Fuligni, Fabio; Rosic, Andrej; Roberts, Nicola D.; Hajjar, Simon; Layeghifard, Mehdi; Novokmet, Ana; Kowalski, Paul E.; Anaka, Matthew; Davidson, Scott; Zarrei, Mehdi; Said, Badr Id; Schreiner, L. Christine; Marchand, Remi; Sitter, Joseph; Gokgoz, Nalan; Brunga, Ledia; Graham, Garrett T.; Fullam, Anthony; Pillay, Nischalan; Toretsky, Jeffrey A.; Yoshida, Akihiko; Shibata, Tatsuhiro; Metzler, Markus; Somers, Gino R.; Scherer, Stephen W.; Flanagan, Adrienne M.; Campbell, Peter J.; Schiffman, Joshua D.; Shago, Mary; Alexandrov, Ludmil B.; Wunder, Jay S.; Andrulis, Irene L.; Malkin, David; Behjati, Sam; Shlien, Adam			Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors	SCIENCE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MUTATIONAL PROCESSES; GENOMIC LANDSCAPE; EWING SARCOMA; CANCER; SIGNATURES; METASTASIS; COMPLEXITY; EVOLUTION; IMPACT	Sarcomas are cancers of the bone and soft tissue often defined by gene fusions. Ewing sarcoma involves fusions between EWSR1, a gene encoding an RNA binding protein, and E26 transformation-specific (ETS) transcription factors. We explored how and when EWSR1-ETS fusions arise by studying the whole genomes of Ewing sarcomas. In 52 of 124 (42%) of tumors, the fusion gene arises by a sudden burst of complex, loop-like rearrangements, a process called chromoplexy, rather than by simple reciprocal translocations. These loops always contained the disease-defining fusion at the center, but they disrupted multiple additional genes. The loops occurred preferentially in early replicating and transcriptionally active genomic regions. Similar loops forming canonical fusions were found in three other sarcoma types. Chromoplexy-generated fusions appear to be associated with an aggressive form of Ewing sarcoma. These loops arise early, giving rise to both primary and relapse Ewing sarcoma tumors, which can continue to evolve in parallel.	[Anderson, Nathaniel D.; de Borja, Richard; Fuligni, Fabio; Rosic, Andrej; Hajjar, Simon; Layeghifard, Mehdi; Novokmet, Ana; Kowalski, Paul E.; Anaka, Matthew; Said, Badr Id; Schreiner, L. Christine; Marchand, Remi; Sitter, Joseph; Brunga, Ledia; Scherer, Stephen W.; Malkin, David; Shlien, Adam] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada; [Anderson, Nathaniel D.; Somers, Gino R.; Shago, Mary; Shlien, Adam] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Young, Matthew D.; Roberts, Nicola D.; Fullam, Anthony; Campbell, Peter J.; Behjati, Sam] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, Cambs, England; [Davidson, Scott; Shago, Mary; Shlien, Adam] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON, Canada; [Zarrei, Mehdi; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON, Canada; [Gokgoz, Nalan; Andrulis, Irene L.] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Graham, Garrett T.; Toretsky, Jeffrey A.] Georgetown Univ, Dept Oncol & Pediat, Washington, DC USA; [Pillay, Nischalan] UCL, Inst Canc, Huntley St, London, England; [Pillay, Nischalan; Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp NHS Trust, Histopathol, Stanmore, Middx, England; [Yoshida, Akihiko; Flanagan, Adrienne M.] Natl Canc Ctr, Dept Pathol, Tokyo, Japan; [Yoshida, Akihiko; Flanagan, Adrienne M.] Natl Canc Ctr, Clin Labs, Tokyo, Japan; [Shibata, Tatsuhiro] Natl Canc Ctr, Div Canc Genom, Tokyo, Japan; [Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med,Minato Ku, Tokyo, Japan; [Metzler, Markus] Univ Hosp Erlangen, Dept Pediat & Adolescent Med, Erlangen, Germany; [Somers, Gino R.] Univ Toronto, Hosp Sick Children, Dept Pathol, Toronto, ON, Canada; [Scherer, Stephen W.; Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England; [Schiffman, Joshua D.] Univ Utah, Dept Pediat, Huntsman Canc Inst, Salt Lake City, UT USA; [Schiffman, Joshua D.] Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT USA; [Alexandrov, Ludmil B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Alexandrov, Ludmil B.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Alexandrov, Ludmil B.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Wunder, Jay S.] Mt Sinai Hosp, Univ Musculoskeletal Oncol Unit, Toronto, ON, Canada; [Wunder, Jay S.] Univ Toronto, Dept Surg, Div Orthopaed Surg, Toronto, ON, Canada; [Malkin, David] Hosp Sick Children, Div Hematol Oncol, Toronto, ON, Canada; [Malkin, David] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Behjati, Sam] Univ Cambridge, Dept Paediat, Cambridge, England	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Wellcome Trust Sanger Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Georgetown University; University of London; University College London; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo; University of Erlangen Nuremberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Cambridge; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Cambridge	Malkin, D; Shlien, A (corresponding author), Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada.; Shlien, A (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Behjati, S (corresponding author), Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, Cambs, England.; Shlien, A (corresponding author), Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON, Canada.; Malkin, D (corresponding author), Hosp Sick Children, Div Hematol Oncol, Toronto, ON, Canada.; Malkin, D (corresponding author), Univ Toronto, Dept Pediat, Toronto, ON, Canada.; Behjati, S (corresponding author), Univ Cambridge, Dept Paediat, Cambridge, England.	david.malkin@sickkids.ca; sb31@sanger.ac.uk; adam.shlien@sickkids.ca	Alexandrov, Ludmil/AAS-1454-2021; Shibata, Tatsuhiro/AAO-1278-2021; Scherer, Stephen W./B-3785-2013; Shibata, Tatsuhiro/ABA-8234-2020; Malkin, David/AAW-8715-2021; Metzler, Markus/AAS-2066-2021; Young, Matthew/ABF-1000-2021	Alexandrov, Ludmil/0000-0003-3596-4515; Scherer, Stephen W./0000-0002-8326-1999; Metzler, Markus/0000-0002-4523-1676; Graham, Garrett/0000-0002-1097-0962; Flanagan, Adrienne/0000-0002-2832-1303; de Borja, Richard/0000-0002-8181-6348; Pillay, Nischalan/0000-0003-0579-4105; Roberts, Nicola/0000-0002-0469-1043; Anderson, Nathaniel/0000-0003-4523-6327; Young, Matthew/0000-0003-0937-5290; Fullam, Anthony/0000-0002-0884-8124; Behjati, Sam/0000-0002-6600-7665; Rosic, Andrej/0000-0001-7806-6964; Layeghifard, Mehdi/0000-0002-6224-3628	Ewings Cancer Foundation of Canada; Childhood Cancer Canada Foundation; SickKids Foundation through the Garron Family Cancer Centre; NSERC Canada; SickKids Restracomp Award; Wellcome; St. Baldrick's Foundation; C17	Ewings Cancer Foundation of Canada; Childhood Cancer Canada Foundation; SickKids Foundation through the Garron Family Cancer Centre; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); SickKids Restracomp Award; Wellcome; St. Baldrick's Foundation; C17	This research project was conducted with support from C<SUP>17</SUP> and partially funded by Ewings Cancer Foundation of Canada and Childhood Cancer Canada Foundation. A.S. and D.M. received financial support from the SickKids Foundation through the Garron Family Cancer Centre. N.D.A is personally supported by an NSERC Canada Graduate Scholarship (Master's) and a SickKids Restracomp Award. S.B. receives personal Fellowships from Wellcome and the St. Baldrick's Foundation.	Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Brasme JF, 2014, J CLIN ONCOL, V32, P1935, DOI 10.1200/JCO.2013.53.8058; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cooper CS, 2015, NAT GENET, V47, P367, DOI 10.1038/ng.3221; Craig DW, 2016, SCI REP-UK, V6, DOI 10.1038/srep24607; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; Gray JW, 2003, CANCER CELL, V4, P4, DOI 10.1016/S1535-6108(03)00167-3; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hattinger CM, 2002, BRIT J CANCER, V86, P1763, DOI 10.1038/sj.bjc.6600332; Jahromi MS, 2012, CANCER GENET-NY, V205, P391, DOI 10.1016/j.cancergen.2012.05.012; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Kovar H, 2014, EXPERT OPIN THER TAR, V18, P1315, DOI 10.1517/14728222.2014.947963; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Malhotra A, 2013, GENOME RES, V23, P762, DOI 10.1101/gr.143677.112; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Merlevede J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10767; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Neilsen Paul M., 2011, Sarcoma, V2011, P746939, DOI 10.1155/2011/746939; Nord KH, 2014, NAT GENET, V46, P474, DOI 10.1038/ng.2927; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Pilati C, 2017, J PATHOL, V242, P10, DOI 10.1002/path.4880; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roberts P, 2008, GENE CHROMOSOME CANC, V47, P207, DOI 10.1002/gcc.20523; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sankar S, 2011, CANCER GENET-NY, V204, P351, DOI 10.1016/j.cancergen.2011.07.008; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Sima J, 2014, CURR OPIN GENET DEV, V25, P93, DOI 10.1016/j.gde.2013.11.022; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Xi RB, 2011, P NATL ACAD SCI USA, V108, pE1128, DOI 10.1073/pnas.1110574108; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; ZOUBEK A, 1994, BRIT J CANCER, V70, P908, DOI 10.1038/bjc.1994.419	43	74	75	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405							eaam8419	10.1126/science.aam8419	http://dx.doi.org/10.1126/science.aam8419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166462	Green Accepted, Green Submitted			2022-12-28	WOS:000443547000030
J	Bugaj, LJ; Sabnis, AJ; Mitchell, A; Garbarino, JE; Toettcher, JE; Bivona, TG; Lim, WA				Bugaj, L. J.; Sabnis, A. J.; Mitchell, A.; Garbarino, J. E.; Toettcher, J. E.; Bivona, T. G.; Lim, W. A.			Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway	SCIENCE			English	Article							WILD-TYPE; FEEDBACK PHOSPHORYLATION; MAPK PATHWAY; BRAF; SPECIFICITY; INHIBITORS; ACTIVATION; MECHANISMS; TRANSMISSION; INFORMATION	The Ras-Erk (extracellular signal-regulated kinase) pathway encodes information in its dynamics; the duration and frequency of Erk activity can specify distinct cell fates. To enable dynamic encoding, temporal informationmust be accurately transmitted from the plasma membrane to the nucleus. We used optogenetic profiling to show that both oncogenic B-Raf mutations and B-Raf inhibitors can cause corruption of this transmission, so that short pulses of input Ras activity are distorted into abnormally long Erk outputs. These changes can reshape downstream transcription and cell fates, resulting in improper decisions to proliferate. These findings illustrate how altered dynamic signal transmission properties, and not just constitutively increased signaling, can contribute to cell proliferation and perhaps cancer, and how optogenetic profiling can dissect mechanisms of signaling dysfunction in disease.	[Bugaj, L. J.; Mitchell, A.; Toettcher, J. E.; Bivona, T. G.; Lim, W. A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Sabnis, A. J.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Sabnis, A. J.; Bivona, T. G.; Lim, W. A.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Garbarino, J. E.; Lim, W. A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Bivona, T. G.] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94158 USA; [Lim, W. A.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Bugaj, L. J.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Mitchell, A.] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01655 USA; [Toettcher, J. E.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; University of Massachusetts System; University of Massachusetts Worcester; Princeton University	Toettcher, JE; Bivona, TG; Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Bivona, TG; Lim, WA (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.; Lim, WA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.; Bivona, TG (corresponding author), Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94158 USA.; Lim, WA (corresponding author), Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA.; Toettcher, JE (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	toettcher@princeton.edu; trever.bivona@ucsf.edu; wendell.lim@ucsf.edu	Mitchell, Amir/AAS-1148-2020	Mitchell, Amir/0000-0001-9376-3987; Sabnis, Amit/0000-0002-2061-5139; Toettcher, Jared/0000-0002-1546-4030	Arnold O. Beckman Postdoctoral Fellowship; European Molecular Biology Organization [ALTF 419-2010]; UCSF Program for Breakthrough Biomedical Research Postdoctoral Research Award; NIH [DP2EB024247, DP2 CA174497, R01CA169338, R01CA204302, R01CA211052, P50GM081879, R01GM55040]; St. Baldrick's Foundation; Damon Runyon-Sohn Foundation fellowship [6P-13]; Howard Hughes Medical Institute; Pew and Stewart Foundations; NATIONAL CANCER INSTITUTE [R01CA211052, R01CA204302, DP2CA174497, R01CA169338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP2EB024247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040, P50GM081879] Funding Source: NIH RePORTER	Arnold O. Beckman Postdoctoral Fellowship; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); UCSF Program for Breakthrough Biomedical Research Postdoctoral Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Foundation; Damon Runyon-Sohn Foundation fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pew and Stewart Foundations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Arnold O. Beckman Postdoctoral Fellowship (L.J.B.); the European Molecular Biology Organization ALTF 419-2010 (A.M.); the UCSF Program for Breakthrough Biomedical Research Postdoctoral Research Award (A.M.); NIH DP2EB024247 (J.E.T.); St. Baldrick's Foundation and a Damon Runyon-Sohn Foundation fellowship 6P-13 (A.S.); NIH DP2 CA174497, R01CA169338, R01CA204302, and R01CA211052 (T.G.B); the Pew and Stewart Foundations (T.G.B.); the Howard Hughes Medical Institute (W.A.L); and NIH P50GM081879 and R01GM55040 (W.A.L.).	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Behar M, 2007, P NATL ACAD SCI USA, V104, P16146, DOI 10.1073/pnas.0703894104; Behar M, 2013, CELL, V155, P448, DOI 10.1016/j.cell.2013.09.018; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; Bugaj LJ, 2017, J CELL BIOL, V216, P25, DOI 10.1083/jcb.201612094; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen SH, 2016, SCIENCE, V351, P1204, DOI 10.1126/science.aac5610; Cho KJ, 2012, CURR BIOL, V22, P945, DOI 10.1016/j.cub.2012.03.067; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hiratsuka T, 2015, ELIFE, V4, DOI 10.7554/eLife.05178; Kellogg RA, 2015, CELL, V160, P381, DOI 10.1016/j.cell.2015.01.013; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Larkin J, 2014, LANCET ONCOL, V15, P436, DOI 10.1016/S1470-2045(14)70051-8; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rauch N, 2016, CURR OPIN STRUC BIOL, V41, P151, DOI 10.1016/j.sbi.2016.07.019; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Selimkhanov J, 2014, SCIENCE, V346, P1370, DOI 10.1126/science.1254933; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Sparta B, 2015, J BIOL CHEM, V290, P24784, DOI 10.1074/jbc.M115.662247; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; Uhlitz F, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177554; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982; Zhang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092917	47	83	83	6	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405							eaao3048	10.1126/science.aao3048	http://dx.doi.org/10.1126/science.aao3048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166458	Green Accepted			2022-12-28	WOS:000443547000031
J	Cheng, YF				Cheng, Yifan			Single-particle cryo-EM-How did it get here and where will it go	SCIENCE			English	Review							BEAM-INDUCED MOTION; CRYOELECTRON MICROSCOPY; ELECTRON-MICROSCOPY; TRP CHANNELS; ION-CHANNEL; 3-DIMENSIONAL RECONSTRUCTION; STRUCTURAL BIOLOGY; RIBOSOMAL-SUBUNIT; PROTEIN CRYSTALS; CRYSTALLOGRAPHY	Cryo-electron microscopy, or simply cryo-EM, refers mainly to three very different yet closely related techniques: electron crystallography, single-particle cryo-EM, and electron cryotomography. In the past few years, single-particle cryo-EM in particular has triggered a revolution in structural biology and has become a newly dominant discipline. This Review examines the fascinating story of its start and evolution over the past 40-plus years, delves into how and why the recent technological advances have been so groundbreaking, and briefly considers where the technique may be headed in the future.	[Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Cheng, YF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Cheng, Yifan/0000-0001-9535-0369	NIH [R01GM082893, R01GM098672, R01HL134183, P50GM082250, P01GM111126, S10OD020054, S10OD021741]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL134183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098672, P50GM082250, P01GM111126, R01GM082893] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020054, S10OD021741] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This is a brief story of single-particle cryo-EM but not a comprehensive historical review. I apologize to many colleagues whose important works are not cited here. I thank many of my colleagues and all past and present members of my laboratory for sharing their thoughts about single-particle cryo-EM with me, and L. Wang for editing. The cryo- EM work in my laboratory is funded by various NIH grants: R01GM082893, R01GM098672, R01HL134183, P50GM082250 (Nevan Krogan), P01GM111126 (Robert Stroud), and S10OD020054 and S10OD021741. I am a Howard Hughes Medical Institute investigator.	ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chen QF, 2017, NATURE, V550, DOI 10.1038/nature24035; Cheng Y, 2015, CELL, V161, P438, DOI 10.1016/j.cell.2015.03.050; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dandey VP, 2018, J STRUCT BIOL, V202, P161, DOI 10.1016/j.jsb.2018.01.002; Danev R, 2014, P NATL ACAD SCI USA, V111, P15635, DOI 10.1073/pnas.1418377111; DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0; DUBOCHET J, 1982, ULTRAMICROSCOPY, V10, P55, DOI 10.1016/0304-3991(82)90187-5; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Fernandez-Leiro R, 2016, NATURE, V537, P339, DOI 10.1038/nature19948; Feynman R.P., 1999, FEYNMAN COMPUTATION, P63; Fica SM, 2017, NAT STRUCT MOL BIOL, V24, P791, DOI 10.1038/nsmb.3463; FRANK J, 1978, ULTRAMICROSCOPY, V3, P283, DOI 10.1016/S0304-3991(78)80038-2; FRANK J, 1975, ULTRAMICROSCOPY, V1, P159, DOI 10.1016/S0304-3991(75)80020-9; Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1; Galej WP, 2014, CURR OPIN STRUC BIOL, V25, P57, DOI 10.1016/j.sbi.2013.12.002; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Jin P, 2017, NATURE, V547, P118, DOI 10.1038/nature22981; Jones N, 2014, NATURE, V505, P602, DOI 10.1038/505602a; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kaledhonkar S, 2018, METHODS MOL BIOL, V1764, P59, DOI 10.1007/978-1-4939-7759-8_4; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Khoshouei M, 2017, J MOL BIOL, V429, P2611, DOI 10.1016/j.jmb.2017.07.004; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Li MH, 2011, ADV EXP MED BIOL, V704, P1, DOI 10.1007/978-94-007-0265-3_1; Li XM, 2013, J STRUCT BIOL, V184, P251, DOI 10.1016/j.jsb.2013.08.005; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Ludtke SJ, 2003, J STRUCT BIOL, V144, P73, DOI 10.1016/j.jsb.2003.10.012; McMullan G, 2016, METHOD ENZYMOL, V579, P1, DOI 10.1016/bs.mie.2016.05.056; Mooney P, 2007, METHOD CELL BIOL, V79, P661, DOI 10.1016/S0091-679X(06)79027-6; Moran MM, 2018, ANNU REV PHARMACOL, V58, P309, DOI 10.1146/annurev-pharmtox-010617-052832; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Ohi MD, 2007, P NATL ACAD SCI USA, V104, P3195, DOI 10.1073/pnas.0611591104; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; RADERMACHER M, 1987, EMBO J, V6, P1107, DOI 10.1002/j.1460-2075.1987.tb04865.x; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Samei E, 1998, MED PHYS, V25, P102, DOI 10.1118/1.598165; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Shen PS, 2016, CELL, V167, P763, DOI 10.1016/j.cell.2016.09.048; Shi YG, 2017, NAT REV MOL CELL BIO, V18, P655, DOI 10.1038/nrm.2017.86; Shi YG, 2014, CELL, V159, P995, DOI 10.1016/j.cell.2014.10.051; Sigworth FJ, 1998, J STRUCT BIOL, V122, P328, DOI 10.1006/jsbi.1998.4014; SRIVASTAVA S, 1995, J MOL BIOL, V245, P461, DOI 10.1006/jmbi.1994.0037; Stark H, 1996, ULTRAMICROSCOPY, V63, P75, DOI 10.1016/0304-3991(96)00045-9; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036; Taylor KA, 2008, J STRUCT BIOL, V163, P214, DOI 10.1016/j.jsb.2008.06.004; UNWIN PNT, 1975, J MOL BIOL, V94, P425, DOI 10.1016/0022-2836(75)90212-0; Vinayagam D, 2018, ELIFE, V7, DOI 10.7554/eLife.36615; WADE RH, 1992, ULTRAMICROSCOPY, V46, P145, DOI 10.1016/0304-3991(92)90011-8; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041	66	173	177	34	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					876	+		10.1126/science.aat4346	http://dx.doi.org/10.1126/science.aat4346			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166484	Green Accepted			2022-12-28	WOS:000443547000028
J	Fuertes, G; Banterle, N; Ruff, KM; Chowdhury, A; Pappu, RV; Svergun, DI; Lemke, EA				Fuertes, Gustavo; Banterle, Niccolo; Ruff, Kiersten M.; Chowdhury, Aritra; Pappu, Rohit V.; Svergun, Dmitri I.; Lemke, Edward A.			Comment on "Innovative scattering analysis shows that hydrophobic disordered proteins are expanded in water"	SCIENCE			English	Editorial Material							FRET MEASUREMENTS; DIMENSIONS	Editors at Science requested our input on the above discussion (comment by Best et al. and response by Riback et al.) because both sets of authors use our data from Fuertes et al. (2017) to support their arguments. The topic of discussion pertains to the discrepant inferences drawn from SAXS versus FRET measurements regarding the dimensions of intrinsically disordered proteins (IDPs) in aqueous solvents. Using SAXS measurements on labeled and unlabeled proteins, we ruled out the labels used for FRET measurements as the cause of discrepant inferences between the two methods. Instead, we propose that FRET and SAXS provide complementary readouts because of a decoupling of size and shape fluctuations that is intrinsic to finite-sized, heteropolymeric IDPs. Accounting for this decoupling resolves the discrepant inferences between the two methods, thus making a case for the utility of both methods.	[Fuertes, Gustavo; Banterle, Niccolo; Chowdhury, Aritra; Lemke, Edward A.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Fuertes, Gustavo; Svergun, Dmitri I.] European Mol Biol Lab, D-22607 Hamburg, Germany; [Fuertes, Gustavo] Inst Biotechnol CAS, Vestec 25250, Czech Republic; [Ruff, Kiersten M.; Pappu, Rohit V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Ruff, Kiersten M.; Pappu, Rohit V.] Washington Univ, Ctr Biol Syst Engn, St Louis, MO 63130 USA; [Lemke, Edward A.] Johannes Gutenberg Univ Mainz, Bioctr, Dept Biol, D-55128 Mainz, Germany; [Lemke, Edward A.] Johannes Gutenberg Univ Mainz, Bioctr, Dept Chem, D-55128 Mainz, Germany; [Lemke, Edward A.] Johannes Gutenberg Univ Mainz, Bioctr, Dept Pharm & Geosci, D-55128 Mainz, Germany; [Lemke, Edward A.] Inst Mol Biol, D-55128 Mainz, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Washington University (WUSTL); Washington University (WUSTL); Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Institute of Molecular Biology (IMB)	Lemke, EA (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.; Svergun, DI (corresponding author), European Mol Biol Lab, D-22607 Hamburg, Germany.; Pappu, RV (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.; Pappu, RV (corresponding author), Washington Univ, Ctr Biol Syst Engn, St Louis, MO 63130 USA.; Lemke, EA (corresponding author), Johannes Gutenberg Univ Mainz, Bioctr, Dept Biol, D-55128 Mainz, Germany.; Lemke, EA (corresponding author), Johannes Gutenberg Univ Mainz, Bioctr, Dept Chem, D-55128 Mainz, Germany.; Lemke, EA (corresponding author), Johannes Gutenberg Univ Mainz, Bioctr, Dept Pharm & Geosci, D-55128 Mainz, Germany.; Lemke, EA (corresponding author), Inst Mol Biol, D-55128 Mainz, Germany.	pappu@wustl.edu; svergun@embl-hamburg.de; edlemke@uni-mainz.de	Vives, Gustavo Fuertes/S-8618-2016; Lemke, Edward/J-3337-2015	Vives, Gustavo Fuertes/0000-0002-8564-8644; Chowdhury, Aritra/0000-0002-0579-292X; Banterle, Niccolo/0000-0002-1607-0324; Svergun, Dmitri/0000-0003-0830-5696; Lemke, Edward/0000-0002-0634-0503; Pappu, Rohit/0000-0003-2568-1378	Gutenberg Research College [SFB1129]; CellNetworks; European Research Council [SMPFv2.0]; European Union (H2020 grant iNEXT) [653706]; Joachim Herz Foundation; NIH [5R01NS056114]; project "Structural dynamics of biomolecular systems" from European Regional Development Fund (ELIBIO) [CZ.02.1.01/0.0/0.0/15_003/0000447]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056114] Funding Source: NIH RePORTER	Gutenberg Research College; CellNetworks; European Research Council(European Research Council (ERC)European Commission); European Union (H2020 grant iNEXT); Joachim Herz Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); project "Structural dynamics of biomolecular systems" from European Regional Development Fund (ELIBIO); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by funding from the Gutenberg Research College, SFB1129, CellNetworks, and the European Research Council (SMPFv2.0) (E.A.L.); the European Union (H2020 grant iNEXT # 653706) and the Joachim Herz Foundation (D.I.S.); NIH grant (5R01NS056114 (R.V.P.); and the project "Structural dynamics of biomolecular systems" (CZ.02.1.01/0.0/0.0/15_003/0000447) from European Regional Development Fund (ELIBIO) (G.F.).	Best RB, 2018, SCIENCE, V361, DOI 10.1126/science.aar7101; Borgia A, 2016, J AM CHEM SOC, V138, P11714, DOI 10.1021/jacs.6b05917; Fuertes G, 2017, P NATL ACAD SCI USA, V114, pE6342, DOI 10.1073/pnas.1704692114; O'Brien EP, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3082151; Riback JA, 2018, SCIENCE, V361, DOI 10.1126/science.aar7949; Riback JA, 2017, SCIENCE, V358, P238, DOI 10.1126/science.aan5774; Song JH, 2017, BIOPHYS J, V113, P1012, DOI 10.1016/j.bpj.2017.07.023; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Watkins HM, 2015, P NATL ACAD SCI USA, V112, P6631, DOI 10.1073/pnas.1418673112	9	19	19	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405							aau8230	10.1126/science.aau8230	http://dx.doi.org/10.1126/science.aau8230			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS3UB	30166461	Green Accepted			2022-12-28	WOS:000443547000004
J	Benger, JR; Kirby, K; Black, S; Brett, SJ; Clout, M; Lazaroo, MJ; Nolan, JP; Reeves, BC; Robinson, M; Scott, LJ; Smartt, H; South, A; Stokes, EA; Taylor, J; Thomas, M; Voss, S; Wordsworth, S; Rogers, CA				Benger, Jonathan R.; Kirby, Kim; Black, Sarah; Brett, Stephen J.; Clout, Madeleine; Lazaroo, Michelle J.; Nolan, Jerry P.; Reeves, Barnaby C.; Robinson, Maria; Scott, Lauren J.; Smartt, Helena; South, Adrian; Stokes, Elizabeth A.; Taylor, Jodi; Thomas, Matthew; Voss, Sarah; Wordsworth, Sarah; Rogers, Chris A.			Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest on Functional Outcome The AIRWAYS-2 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOPULMONARY-RESUSCITATION; I-GEL; ENDOTRACHEAL INTUBATION; MASK VENTILATION; MANAGEMENT; SURVIVAL; EPIDEMIOLOGY; METAANALYSIS; ASSOCIATION; PERFORMANCE	IMPORTANCE The optimal approach to airway management during out-of-hospital cardiac arrest is unknown. OBJECTIVE To determine whether a supraglottic airway device (SGA) is superior to tracheal intubation (TI) as the initial advanced airway management strategy in adults with nontraumatic out-of-hospital cardiac arrest. DESIGN, SETTING, AND PARTICIPANTS Multicenter, cluster randomized clinical trial of paramedics from 4 ambulance services in England responding to emergencies for approximately 21 million people. Patients aged 18 years or older who had a nontraumatic out-of-hospital cardiac arrest and were treated by a participating paramedic were enrolled automatically under a waiver of consent between June 2015 and August 2017; follow-up ended in February 2018. INTERVENTIONS Paramedics were randomized 1: 1 to use TI (764 paramedics) or SGA (759 paramedics) as their initial advanced airway management strategy. MAIN OUTCOMES AND MEASURES The primary outcome was modified Rankin Scale score at hospital discharge or 30 days after out-of-hospital cardiac arrest, whichever occurred sooner. Modified Rankin Scale score was divided into 2 ranges: 0-3 (good outcome) or 4-6 (poor outcome; 6 = death). Secondary outcomes included ventilation success, regurgitation, and aspiration. RESULTS A total of 9296 patients (4886 in the SGA group and 4410 in the TI group) were enrolled (median age, 73 years; 3373 were women [36.3%]), and the modified Rankin Scale score was known for 9289 patients. In the SGA group, 311 of 4882 patients (6.4%) had a good outcome (modified Rankin Scale score range, 0-3) vs 300 of 4407 patients (6.8%) in the TI group (adjusted risk difference [RD], -0.6%[95% CI, -1.6% to 0.4%]). Initial ventilation was successful in 4255 of 4868 patients (87.4%) in the SGA group compared with 3473 of 4397 patients (79.0%) in the TI group (adjusted RD, 8.3%[95% CI, 6.3% to 10.2%]). However, patients randomized to receive TI were less likely to receive advanced airway management (3419 of 4404 patients [77.6%] vs 4161 of 4883 patients [85.2%] in the SGA group). Two of the secondary outcomes (regurgitation and aspiration) were not significantly different between groups (regurgitation: 1268 of 4865 patients [26.1%] in the SGA group vs 1072 of 4372 patients [24.5%] in the TI group; adjusted RD, 1.4%[95% CI, -0.6% to 3.4%]; aspiration: 729 of 4824 patients [15.1%] vs 647 of 4337 patients [14.9%], respectively; adjusted RD, 0.1%[95% CI, -1.5% to 1.8%]). CONCLUSIONS AND RELEVANCE Among patients with out-of-hospital cardiac arrest, randomization to a strategy of advanced airway management with a supraglottic airway device compared with tracheal intubation did not result in a favorable functional outcome at 30 days.	[Benger, Jonathan R.; Kirby, Kim; Voss, Sarah] Univ West England, Glenside Campus, Bristol, Avon, England; [Kirby, Kim; Black, Sarah; Robinson, Maria; South, Adrian] South Westren Ambulance Serv NHS Fdn Trust, Exeter, Devon, England; [Brett, Stephen J.] Imperial Coll Healthcare NHS Trust, Dept Surg & Canc, London, England; [Clout, Madeleine; Lazaroo, Michelle J.; Reeves, Barnaby C.; Scott, Lauren J.; Smartt, Helena; Taylor, Jodi; Rogers, Chris A.] Univ Bristol, Bristol Med Sch, Bristol Trials Ctr, Clin Trials & Evaluat Unit, Bristol, Avon, England; [Nolan, Jerry P.; Taylor, Jodi] Univ Bristol, Bristol Med Sch, Bristol, Avon, England; [Nolan, Jerry P.] Royal United Hosp, Dept Anaesthesia, Bath, Avon, England; [Scott, Lauren J.] CLAHRC West, Bristol, Avon, England; [Stokes, Elizabeth A.; Wordsworth, Sarah] Univ Oxford, Nuffield Dept Populat Hlth, Hlth Econ Res Ctr, Oxford, England; [Thomas, Matthew] Univ Hosp Bristol NHS Fdn Trust, Intens Care Unit, Bristol, Avon, England	University of West England; Imperial College London; University of Bristol; University of Bristol; University of Oxford; University of Bristol	Benger, JR (corresponding author), Univ West England, Fac Hlth & Appl Sci, Glenside Campus, Bristol BS16 1DD, Avon, England.	jonathan.benger@uwe.ac.uk	Clout, Madeleine/L-5122-2018; Clout, Madeleine/Z-4646-2019; Nolan, Jerry P./ABF-2561-2020	Clout, Madeleine/0000-0001-7645-1199; Clout, Madeleine/0000-0001-7645-1199; Nolan, Jerry/0000-0003-3141-3812; Black, Sarah/0000-0001-6678-7502; Reeves, Barnaby/0000-0002-5101-9487; Wordsworth, Sarah/0000-0002-2361-3040	National Institute for Health Research (NIHR) Health Technology Assessment Programme [12/167/102]; NIHR Comprehensive Research Networks	National Institute for Health Research (NIHR) Health Technology Assessment Programme(National Institute for Health Research (NIHR)); NIHR Comprehensive Research Networks	The trial was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (project No. 12/167/102), and supported by the NIHR Comprehensive Research Networks. The study was not funded by any commercial organization or equipment manufacturer. This study was designed and performed in collaboration with the Clinical Trials and Evaluation Unit, a UK Clinical Research Collaboration-registered clinical trials unit which, as part of the Bristol Trials Centre, is in receipt of NIHR clinical trials unit support funding.	Andersen LW, 2018, RESUSCITATION, V125, P79, DOI 10.1016/j.resuscitation.2018.02.006; Benger J, 2016, BRIT J ANAESTH, V116, P262, DOI 10.1093/bja/aev477; Carlson JN, 2014, ANN EMERG MED, V64, P163, DOI 10.1016/j.annemergmed.2013.12.003; Christenson J, 2009, CIRCULATION, V120, P1241, DOI 10.1161/CIRCULATIONAHA.109.852202; Cook T, 2011, BJA EDUC, V11, P56, DOI 10.1093/bjaceaccp/mkq058; Do Shin S, 2012, RESUSCITATION, V83, P313, DOI 10.1016/j.resuscitation.2011.10.028; Duckett J, 2014, EMERG MED J, V31, P505, DOI 10.1136/emermed-2012-202126; Dyson K, 2017, ANN EMERG MED, V70, P382, DOI 10.1016/j.annemergmed.2017.02.002; Fouche PF, 2014, PREHOSP EMERG CARE, V18, P244, DOI 10.3109/10903127.2013.831509; Gwinnutt CL, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1772; Haske D, 2013, RESUSCITATION, V84, P1229, DOI 10.1016/j.resuscitation.2013.04.025; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Hawkes C, 2017, RESUSCITATION, V110, P133, DOI 10.1016/j.resuscitation.2016.10.030; Higgs A, 2018, BRIT J ANAESTH, V120, P323, DOI 10.1016/j.bja.2017.10.021; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; Jabre P, 2018, JAMA-J AM MED ASSOC, V319, P779, DOI 10.1001/jama.2018.0156; Jentzer JC, 2016, ANN EMERG MED, V68, P678, DOI 10.1016/j.annemergmed.2016.05.022; Joint Royal Colleges Ambulance Liaison Committee, 2016, CLIN PRACT GUID 2016; Kramer-Johansen J, 2006, RESUSCITATION, V68, P61, DOI 10.1016/j.resuscitation.2005.05.020; Kurola J, 2004, RESUSCITATION, V61, P149, DOI 10.1016/j.resuscitation.2004.01.014; Kyriacou DN, 2016, JAMA-J AM MED ASSOC, V316, P1818, DOI 10.1001/jama.2016.16435; Monsieurs KG, 2015, RESUSCITATION, V95, P1, DOI 10.1016/j.resuscitation.2015.07.038; Nichol G, 2016, RESUSCITATION, V107, P115, DOI 10.1016/j.resuscitation.2016.08.004; Perkins GD, 2015, RESUSCITATION, V96, P328, DOI 10.1016/j.resuscitation.2014.11.002; Rittenberger JC, 2011, RESUSCITATION, V82, P1036, DOI 10.1016/j.resuscitation.2011.03.034; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Soar J, 2013, CURR OPIN CRIT CARE, V19, P181, DOI 10.1097/MCC.0b013e328360ac5e; Swanson SA, 2015, AM J EPIDEMIOL, V181, P191, DOI 10.1093/aje/kwu284; Taylor J, 2016, RESUSCITATION, V109, P25, DOI 10.1016/j.resuscitation.2016.09.016; Wang HE, 2012, RESUSCITATION, V83, P1061, DOI 10.1016/j.resuscitation.2012.05.018; Wang HE, 2009, ANN EMERG MED, V54, P645, DOI 10.1016/j.annemergmed.2009.05.024; Whitehead L, 2015, RESUSCITATION, V88, P150, DOI 10.1016/j.resuscitation.2014.11.013	32	186	192	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					779	791		10.1001/jama.2018.11597	http://dx.doi.org/10.1001/jama.2018.11597			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167701	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000442958800023
J	Wright, JS; Wall, HK; Ritchey, MD				Wright, Janet S.; Wall, Hilary K.; Ritchey, Matthew D.			Million Hearts 2022 Small Steps Are Needed for Cardiovascular Disease Prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wright, Janet S.; Wall, Hilary K.; Ritchey, Matthew D.] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Wright, JS (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Hwy NE,MS F-73, Atlanta, GA 30341 USA.	janet.wright@cms.hhs.gov		Wall, Hilary/0000-0001-6088-0706	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		[Anonymous], CLIN QUAL MEAS ALIG; Centers for Disease Control and Prevention, TOOLS PROTOCOLS; Centers for Disease Control and Prevention, HYPERTENSION CONT CH; Centers for Disease Control and Prevention, MILL HEARTS MEAN; Health Resources and Services Administration, 2017 NAT HEALTH CENT; Ritchey MD, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006021; Ritchey MD, MMWR MORB MORTAL WKL; Vaughan AS, 2017, ANN EPIDEMIOL, V27, P796, DOI 10.1016/j.annepidem.2017.10.012; Wall HK, MMWR MORB MORTAL WKL; Yang QH, 2017, MMWR-MORBID MORTAL W, V66, P933, DOI 10.15585/mmwr.mm6635e1	10	34	34	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2018	320	18					1857	1858		10.1001/jama.2018.13326	http://dx.doi.org/10.1001/jama.2018.13326			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA1BH	30193304	Green Accepted			2022-12-28	WOS:000449945900007
J	Treadway, N				Treadway, Nicole			A Student Reflection on Doctoring With Confidence: Mind the Gap	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GENDER; PHYSICIANS		[Treadway, Nicole] Emory Univ, Sch Med, 1648 Pierce Dr NE, Atlanta, GA 30307 USA	Emory University	Treadway, N (corresponding author), Emory Univ, Sch Med, 1648 Pierce Dr NE, Atlanta, GA 30307 USA.	nicole.treadway@emory.edu						Armstrong K, 2018, ANN INTERN MED, V168, P818, DOI 10.7326/M18-0445; Baumhakel M, 2009, EUR J HEART FAIL, V11, P299, DOI 10.1093/eurjhf/hfn041; Blanch DC, 2008, PATIENT EDUC COUNS, V72, P374, DOI 10.1016/j.pec.2008.05.021; Butkus R, 2018, ANN INTERN MED, V168, P721, DOI 10.7326/M17-3438; Ehrlinger J, 2003, J PERS SOC PSYCHOL, V84, P5, DOI 10.1037/0022-3514.84.1.5; ESTES R, 1988, J PSYCHOL, V122, P577, DOI 10.1080/00223980.1988.9915532; Massachusetts Medical Society, 2017, EV PROF WOM LEAD FOR; Roter DL, 2002, JAMA-J AM MED ASSOC, V288, P756, DOI 10.1001/jama.288.6.756; Sarsons H., 2015, CONFIDENCE MEN GENDE; Tsugawa Y, 2017, JAMA INTERN MED, V177, P206, DOI 10.1001/jamainternmed.2016.7875	10	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2018	169	8					564	+		10.7326/M18-0865	http://dx.doi.org/10.7326/M18-0865			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GW9SP	30208402				2022-12-28	WOS:000447340800019
J	Lowe, WL; Scholtens, DM; Lowe, LP; Kuang, A; Nodzenski, M; Talbot, O; Catalano, PM; Linder, B; Brickman, WJ; Clayton, P; Deerochanawong, C; Hamilton, J; Josefson, JL; Lashley, M; Lawrence, JM; Lebenthal, Y; Ma, R; Maresh, M; McCance, D; Tam, WH; Sacks, DA; Dyer, AR; Metzger, BE				Lowe, William L., Jr.; Scholtens, Denise M.; Lowe, Lynn P.; Kuang, Alan; Nodzenski, Michael; Talbot, Octavious; Catalano, Patrick M.; Linder, Barbara; Brickman, Wendy J.; Clayton, Peter; Deerochanawong, Chaicharn; Hamilton, Jill; Josefson, Jami L.; Lashley, Michele; Lawrence, Jean M.; Lebenthal, Yael; Ma, Ronald; Maresh, Michael; McCance, David; Tam, Wing Hung; Sacks, David A.; Dyer, Alan R.; Metzger, Boyd E.		Hapo Follow-Up Study Cooperative R	Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; PREGNANCY; MELLITUS; HYPERGLYCEMIA; OBESITY; WOMEN; RISK; CLASSIFICATION; PREDICTORS; CRITERIA	IMPORTANCE The sequelae of gestational diabetes (GD) by contemporary criteria that diagnose approximately twice as many women as previously used criteria are unclear. OBJECTIVE To examine associations of GD with maternal glucose metabolism and childhood adiposity 10 to 14 years' postpartum. DESIGN, SETTING, AND PARTICIPANTS The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study established associations of glucose levels during pregnancy with perinatal outcomes and the follow-up study evaluated the long-term outcomes (4697 mothers and 4832 children; study visits occurred between February 13, 2013, and December 13, 2016). EXPOSURES Gestational diabetes was defined post hoc using criteria from the International Association of Diabetes and Pregnancy Study Groups consisting of 1 or more of the following 75-g oral glucose tolerance test results (fasting plasma glucose >= 92mg/dL; 1-hour plasma glucose level >= 180mg/dL; 2-hour plasma glucose level >= 153mg/dL). MAIN OUTCOMES AND MEASURES Primary maternal outcome: a disorder of glucose metabolism (composite of type 2 diabetes or prediabetes). Primary outcome for children: being overweight or obese; secondary outcomes: obesity, body fat percentage, waist circumference, and sum of skinfolds (>85th percentile for latter 3 outcomes). RESULTS The analytic cohort included 4697 mothers (mean [SD] age, 41.7 [5.7] years) and 4832 children (mean [SD] age, 11.4 [1.2] years; 51.0% male). The median duration of follow-up was 11.4 years. The criteria for GD were met by 14.3%(672/4697) of mothers overall and by 14.1%(683/4832) of mothers of participating children. Among mothers with GD, 52.2% (346/663) developed a disorder of glucose metabolism vs 20.1%(791/3946) of mothers without GD (odds ratio [OR], 3.44 [95% CI, 2.85 to 4.14]; risk difference [RD], 25.7%[95% CI, 21.7% to 29.7%]). Among children of mothers with GD, 39.5%(269/681) were overweight or obese and 19.1%(130/681) were obese vs 28.6%(1172/4094) and 9.9% (405/4094), respectively, for children of mothers without GD. Adjusted for maternal body mass index during pregnancy, the OR was 1.21 (95% CI, 1.00 to 1.46) for children who were overweight or obese and the RD was 3.7%(95% CI, -0.16% to 7.5%); the OR was 1.58 (95% CI, 1.24 to 2.01) for children who were obese and the RD was 5.0%(95% CI, 2.0% to 8.0%); the OR was 1.35 (95% CI, 1.08 to 1.68) for body fat percentage and the RD was 4.2%(95% CI, 0.9% to 7.4%); the OR was 1.34 (95% CI, 1.08 to 1.67) for waist circumference and the RD was 4.1%(95% CI, 0.8% to 7.3%); and the OR was 1.57 (95% CI, 1.27 to 1.95) for sum of skinfolds and the RD was 6.5%(95% CI, 3.1% to 9.9%). CONCLUSIONS AND RELEVANCE Among women with GD identified by contemporary criteria compared with those without it, GD was significantly associated with a higher maternal risk for a disorder of glucose metabolism during long-term follow-up after pregnancy. Among children of mothers with GD vs those without it, the difference in childhood overweight or obesity defined by body mass index cutoffs was not statistically significant; however, additional measures of childhood adiposity may be relevant in interpreting the study findings.	[Lowe, William L., Jr.; Scholtens, Denise M.; Lowe, Lynn P.; Kuang, Alan; Nodzenski, Michael; Talbot, Octavious; Brickman, Wendy J.; Josefson, Jami L.; Dyer, Alan R.; Metzger, Boyd E.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Catalano, Patrick M.] Case Western Reserve Univ, MetroHlth Med Ctr, Cleveland, OH 44106 USA; [Linder, Barbara] NIDDK, NIH, Bethesda, MD 20892 USA; [Brickman, Wendy J.; Josefson, Jami L.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Clayton, Peter] Univ Manchester, Manchester Univ Hosp NHS Fdn Trust, Royal Manchester Childrens Hosp,Sch Med Sci, Manchester Acad Hlth Sci Ctr,Fac Biol Med & Hlth, Manchester, Lancs, England; [Deerochanawong, Chaicharn] Rajavithi Hosp, Bangkok, Thailand; [Hamilton, Jill] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Lashley, Michele] Univ West Indies, Queen Elizabeth Hosp, Sch Clin Med & Res, Cave Hill, Barbados; [Lawrence, Jean M.; Sacks, David A.] Kaiser Permanente So Calif, Pasadena, CA 91101 USA; [Lebenthal, Yael] Tel Aviv Univ, Jesse Z & Sara Lea Shafer Inst Endocrinol & Diabe, Natl Ctr Childhood Diabet, Schneider Childrens Med Ctr Israel, Tel Aviv, Israel; [Lebenthal, Yael] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Ma, Ronald; Tam, Wing Hung] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Maresh, Michael] Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [McCance, David] Royal Victoria Hosp, Belfast, Antrim, North Ireland	Northwestern University; Feinberg School of Medicine; Case Western Reserve University; MetroHealth System; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Ann & Robert H. Lurie Children's Hospital of Chicago; Royal Manchester Children's Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Rajavithi Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University West Indies Mona Jamaica; University West Indies Cave Hill Campus; Kaiser Permanente; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Chinese University of Hong Kong; Prince of Wales Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust	Metzger, BE (corresponding author), Northwestern Univ, Feinberg Sch Med, Endocrinol, 300 Super,Ste12-703, Chicago, IL 60611 USA.	bem@northwestern.edu	Lebenthal, Yael/AAZ-5216-2020; Ma, Ronald/C-2788-2009; Lebenthal, Yael/AAW-7891-2020; Tam, Hung/AAE-3628-2020; Catalano, Patrick/GVR-9069-2022	Ma, Ronald/0000-0002-1227-803X; Lebenthal, Yael/0000-0001-5963-0574; Tam, Hung/0000-0003-1189-740X; Clayton, Peter/0000-0003-1225-4537; Deerochanawong, Chaicharn/0000-0001-9666-7050; Lawrence, Jean/0000-0002-2480-8480; Josefson, Jami/0000-0003-0339-0166	National Institute of Diabetes and Digestive and Kidney Diseases [1U01DK094830]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD-34242, R01-HD-34243]; Feinberg School of Medicine by the Northwestern University Clinical and Translational Science Institute; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR001422]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK094830] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Feinberg School of Medicine by the Northwestern University Clinical and Translational Science Institute; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The HAPO Follow-up Study was funded by grant 1U01DK094830 from the National Institute of Diabetes and Digestive and Kidney Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The HAPO Study was funded by grants R01-HD-34242 and R01-HD-34243 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The HAPO Follow-up Study data were collected and managed using REDCap electronic data capture tools hosted at Northwestern University Feinberg School of Medicine. REDCap is supported at Feinberg School of Medicine by the Northwestern University Clinical and Translational Science Institute. The research reported in this article was supported, in part, by grant UL1TR001422 from the National Center for Advancing Translational Sciences, National Institutes of Health.	Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; [Anonymous], 2021, LANG ENV STAT COMP; Bao W, 2015, DIABETOLOGIA, V58, P1212, DOI 10.1007/s00125-015-3537-4; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Carr DB, 2008, DIABETES CARE, V31, P1037, DOI 10.2337/dc07-1957; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P914, DOI 10.1016/0002-9378(91)90438-W; Caughey AB, 2017, OBSTET GYNECOL, V130, pE17, DOI 10.1097/AOG.0000000000002159; Cheung YB, 2007, AM J EPIDEMIOL, V166, P1337, DOI 10.1093/aje/kwm223; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; COUSTAN DR, 1993, AM J OBSTET GYNECOL, V168, P1139, DOI 10.1016/0002-9378(93)90358-P; Dabelea D, 2011, DIABETES, V60, P1849, DOI 10.2337/db11-0400; Donovan LE, 2015, DIABETIC MED, V32, P295, DOI 10.1111/dme.12625; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Hosmer DW, 2013, WILEY SER PROBAB ST, P269; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Kim SY, 2012, CURR OPIN OBSTET GYN, V24, P376, DOI 10.1097/GCO.0b013e328359f0f4; Kim SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/541308; Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738; Lawlor DA, 2010, DIABETOLOGIA, V53, P89, DOI 10.1007/s00125-009-1560-z; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Lobner K, 2006, DIABETES, V55, P792, DOI 10.2337/diabetes.55.03.06.db05-0746; McCabe CF, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0890-3; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Philipps LH, 2011, DIABETOLOGIA, V54, P1957, DOI 10.1007/s00125-011-2180-y; Regnell SE, 2017, DIABETOLOGIA, V60, P1370, DOI 10.1007/s00125-017-4308-1; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Sacks DA, 2012, DIABETES CARE, V35, P526, DOI 10.2337/dc11-1641; Scholtens DM, 2016, DIABETES, V65, P2039, DOI 10.2337/db15-1748; Tam WH, 2008, PEDIATRICS, V122, P1229, DOI 10.1542/peds.2008-0158; van Buuren S, 2011, J STAT SOFTW, V45, P1; White IR, 2010, COMPUT STAT DATA AN, V54, P2267, DOI 10.1016/j.csda.2010.04.005; Zhao P, 2016, DIABETOLOGIA, V59, P2339, DOI 10.1007/s00125-016-4062-9	40	237	249	3	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2018	320	10					1005	1016		10.1001/jama.2018.11628	http://dx.doi.org/10.1001/jama.2018.11628			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT2QE	30208453	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000444341400014
J	Hamad, Y; Warren, DK				Hamad, Yasir; Warren, David K.			Black Hairy Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hamad, Yasir; Warren, David K.] Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Hamad, Y (corresponding author), Washington Univ, St Louis, MO 63130 USA.	yhamad@wustl.edu		Warren, David/0000-0001-8679-8241					0	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2018	379	10					E16	E16		10.1056/NEJMicm1800351	http://dx.doi.org/10.1056/NEJMicm1800351			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS5XM	30184449				2022-12-28	WOS:000443748200013
J	Allen, CE; Merad, M; McClain, KL				Allen, Carl E.; Merad, Miriam; McClain, Kenneth L.			Langerhans-Cell Histiocytosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ERDHEIM-CHESTER DISEASE; PERIPHERAL LYMPHOID ORGANS; STEADY-STATE CONDITIONS; DENDRITIC CELLS; MUTATIONS; THERAPY; VEMURAFENIB; EXPRESSION; DISORDERS; NEOPLASMS		[Allen, Carl E.; McClain, Kenneth L.] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Allen, Carl E.; McClain, Kenneth L.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Merad, Miriam] Icahn Sch Med, Dept Oncol Sci, New York, NY USA; [Merad, Miriam] Icahn Sch Med, Precis Immunol Inst, New York, NY USA; [Merad, Miriam] Icahn Sch Med, Tisch Canc Inst, New York, NY USA	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Allen, CE (corresponding author), Feigin Ctr, Suite 730-06,1102 Bates St, Houston, TX 77030 USA.	ceallen@txch.org			NATIONAL CANCER INSTITUTE [R01CA154947, R01CA190400] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA190400, R01 CA154947, P50 CA126752] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allen CE, 2015, BLOOD, V126, P26, DOI 10.1182/blood-2014-12-569301; Allen CE, 2010, J IMMUNOL, V184, P4557, DOI 10.4049/jimmunol.0902336; Allen CE, 2010, PEDIATR BLOOD CANCER, V54, P416, DOI 10.1002/pbc.22326; Angeli Veronique, 2006, Lymphatic Research and Biology, V4, P217, DOI 10.1089/lrb.2006.4406; Arceci RJ, 1998, HEMATOL ONCOL CLIN N, V12, P339, DOI 10.1016/S0889-8588(05)70514-1; Arico M, 2003, EUR J CANCER, V39, P2341, DOI 10.1016/S0959-8049(03)00672-5; Aubart FC, 2017, BLOOD, V130, P1377, DOI 10.1182/blood-2017-03-771873; Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Bank MI, 2003, APMIS, V111, P300, DOI 10.1034/j.1600-0463.2003.1110202.x; Bernard F, 2005, EUR J CANCER, V41, P2682, DOI 10.1016/j.ejca.2005.02.007; Berres ML, 2015, BRIT J HAEMATOL, V169, P3, DOI 10.1111/bjh.13247; Berres ML, 2014, J EXP MED, V211, P669, DOI 10.1084/jem.20130977; Bhatia A, 2018, HAEMATOLOGICA, V103, pE177, DOI 10.3324/haematol.2017.185298; Braier J, 2014, J PEDIAT HEMATOL ONC, V36, P280; Brown NA, 2014, BLOOD, V124, P1655, DOI 10.1182/blood-2014-05-577361; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Cantu MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043257; Chakraborty R, 2016, BLOOD, V128, P2533, DOI 10.1182/blood-2016-08-733790; Chakraborty R, 2014, BLOOD, V124, P3007, DOI 10.1182/blood-2014-05-577825; Chikwava K, 2004, PEDIATR DEVEL PATHOL, V7, P607, DOI 10.1007/s10024-004-3027-z; Christian HA, 1920, MED CLIN N AM, V3, P849; da Costa CET, 2009, GENE CHROMOSOME CANC, V48, P239, DOI 10.1002/gcc.20634; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Diamond EL, 2018, JAMA ONCOL, V4, P384, DOI 10.1001/jamaoncol.2017.5029; Diamond EL, 2016, CANCER DISCOV, V6, P154, DOI [10.1158/2159-8290.CD-15-0913, 10.1158/2159-8290.CD-NB2016-001]; Donadieu J, 2015, BLOOD, V126, P1415, DOI 10.1182/blood-2015-03-635151; EGELER RM, 1993, CANCER, V71, P865, DOI 10.1002/1097-0142(19930201)71:3<865::AID-CNCR2820710334>3.0.CO;2-0; Emile JF, 2016, BLOOD, V127, P2672, DOI [10.1182/blood-2016-01690636, 10.1182/blood-2016-01-690636]; FARBER SIDNEY, 1941, AMER JOUR PATHOL, V17, P625; Favara BE, 1997, MED PEDIATR ONCOL, V29, P157, DOI 10.1002/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C; Gadner H, 2001, J PEDIATR-US, V138, P728, DOI 10.1067/mpd.2001.111331; Gadner H, 2008, BLOOD, V111, P2556, DOI 10.1182/blood-2007-08-106211; Gadner H, 2013, BLOOD, V121, P5006, DOI 10.1182/blood-2012-09-455774; Gatalica Z, 2015, ONCOTARGET, V6, P19819, DOI 10.18632/oncotarget.4378; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Girschikofsky M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-72; Grois N, 2005, BRAIN, V128, P829, DOI 10.1093/brain/awh403; Grois NG, 1998, HEMATOL ONCOL CLIN N, V12, P287, DOI 10.1016/S0889-8588(05)70511-6; Guyot-Goubin A, 2008, PEDIATR BLOOD CANCER, V51, P71, DOI 10.1002/pbc.21498; Hand. A., 1893, ARCH PEDIAT, V10, P673; Haroche J, 2015, J CLIN ONCOL, V33, P411, DOI 10.1200/JCO.2014.57.1950; Haroche J, 2013, BLOOD, V121, P1495, DOI 10.1182/blood-2012-07-446286; Haupt R, 2004, PEDIATR BLOOD CANCER, V42, P438, DOI 10.1002/pbc.20021; Heritier S, 2017, BRIT J HAEMATOL, V178, P457, DOI 10.1111/bjh.14695; Heritier S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0690-z; Heritier S, 2016, J CLIN ONCOL, V34, P3023, DOI 10.1200/JCO.2015.65.9508; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hogstad B, 2018, J EXP MED, V215, P319, DOI 10.1084/jem.20161881; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Hyman DM, 2015, CANCER DISCOV, V5, P64, DOI 10.1158/2159-8290.CD-14-0742; Imashuku S, 2015, HEMATOL ONCOL CLIN N, V29, P875, DOI 10.1016/j.hoc.2015.06.006; Laman JD, 2003, TRENDS IMMUNOL, V24, P190, DOI 10.1016/S1471-4906(03)00063-2; Langerhans P, 1868, VIRCHOWS ARCH PATHOL, V44, P325, DOI [DOI 10.1007/BF01959006, 10.1007/BF01959006]; Lee LH, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89473; Letterer E., 1924, FRANKFURT Z PATHOL, V30, P377; LICHTENSTEIN L, 1953, AMA ARCH PATHOL, V56, P84; Mass E, 2017, NATURE, V549, P389, DOI 10.1038/nature23672; McClain KL, 2007, PEDIATR BLOOD CANCER, V48, P44, DOI 10.1002/pbc.20578; McClain KL, 2018, CANCER-AM CANCER SOC, V124, P2607, DOI 10.1002/cncr.31348; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Michaloglou C, 2008, ONCOGENE, V27, P877, DOI 10.1038/sj.onc.1210704; Minkov M, 2000, KLIN PADIATR, V212, P139, DOI 10.1055/s-2000-9667; Morimoto A, 2016, INT J HEMATOL, V104, P99, DOI 10.1007/s12185-016-1993-3; Mourah S, 2016, EUR RESPIR J, V47, P1785, DOI 10.1183/13993003.01677-2015; Nelson DS, 2015, GENE CHROMOSOME CANC, V54, P361, DOI 10.1002/gcc.22247; NEZELOF C, 1973, BIOMEDICINE, V18, P365; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Peckham-Gregory EC, 2017, BLOOD, V130, P2229, DOI 10.1182/blood-2017-08-800565; Peckham-Gregory EC, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26321; Peters TL, 2011, MOL THER, V19, P1433, DOI 10.1038/mt.2011.106; Picarsic J, 2015, HEMATOL ONCOL CLIN N, V29, P799, DOI 10.1016/j.hoc.2015.06.001; Pileri SA, 2002, HISTOPATHOLOGY, V41, P1, DOI 10.1046/j.1365-2559.2002.01418.x; Poulikakos PI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001948; Ribeiro KB, 2015, PEDIATR BLOOD CANCER, V62, P982, DOI 10.1002/pbc.25404; Rodig SJ, 2008, AM J HEMATOL, V83, P116, DOI 10.1002/ajh.21044; Rollins BJ, 2015, HEMATOL ONCOL CLIN N, V29, P839, DOI 10.1016/j.hoc.2015.06.004; Sahm F, 2012, BLOOD, V120, pE28, DOI 10.1182/blood-2012-06-429597; Satoh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033891; Schueller A, 1915, FORTSCHR ROENTGENSTR, V23, P12; Senechal B, 2007, PLOS MED, V4, P1374, DOI 10.1371/journal.pmed.0040253; Simko SJ, 2015, BRIT J HAEMATOL, V169, P299, DOI 10.1111/bjh.13208; Simko SJ, 2014, J PEDIATR-US, V165, P990, DOI 10.1016/j.jpeds.2014.07.063; Simko SJ, 2014, PEDIATR BLOOD CANCER, V61, P479, DOI 10.1002/pbc.24772; Siwe SA., 1933, Z KINDERHEILKD, V55, P212; Stalemark H, 2008, PEDIATR BLOOD CANCER, V51, P76, DOI 10.1002/pbc.21504; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; van de Ven R, 2011, BLOOD, V118, P2502, DOI 10.1182/blood-2011-03-344838; Venkatramani R, 2012, PEDIATR BLOOD CANCER, V59, P1324, DOI 10.1002/pbc.24136; Veys PA, 2015, BRIT J HAEMATOL, V169, P711, DOI 10.1111/bjh.13347; Weitzman S, 2009, PEDIATR BLOOD CANCER, V53, P1271, DOI 10.1002/pbc.22229; WILLMAN CL, 1994, NEW ENGL J MED, V331, P154, DOI 10.1056/NEJM199407213310303; Yeh EA, 2018, PEDIAT BLOOD CANC, V65, P1; YU RC, 1994, LANCET, V343, P767, DOI 10.1016/S0140-6736(94)91842-2	97	189	210	9	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2018	379	9					856	868		10.1056/NEJMra1607548	http://dx.doi.org/10.1056/NEJMra1607548			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR9EA	30157397	Green Accepted			2022-12-28	WOS:000443047800009
J	[Anonymous]				[Anonymous]			Seven days in medicine: 22-28 August 2018	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, 2018, TRANS WAT VAP ABL LO	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2018	362								k3651	10.1136/bmj.k3651	http://dx.doi.org/10.1136/bmj.k3651			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5ZI	30166317				2022-12-28	WOS:000443758100006
J	Naghavi, M; Marczak, LB; Kutz, M; Shackelford, KA; Arora, M; Miller-Petrie, M; Aichour, MTE; Akseer, N; Al-Raddadi, RM; Alam, K; Alghnam, SA; Antonio, CAT; Aremu, O; Arora, A; Asadi-Lari, M; Assadi, R; Atey, TM; Avila-Burgos, L; Awasthi, A; Quintanilla, BPA; Barker-Collo, SL; Barnighausen, TW; Bazargan-Hejazi, S; Behzadifar, M; Behzadifar, M; Bennett, JR; Bhalla, A; Bhutta, ZA; Bilal, AI; Borges, G; Borschmann, R; Brazinova, A; Rincon, JCC; Carvalho, F; Castaneda-Orjuela, CA; Dandona, L; Dandona, R; Dargan, PI; De Leo, D; Dharmaratne, SD; Ding, EL; Do, HP; Doku, DT; Doyle, KE; Driscoll, T; Edessa, D; El-Khatib, Z; Endries, AY; Esteghamati, A; Faro, A; Farzadfar, F; Feigin, VL; Fischer, F; Foreman, KJ; Franklin, RC; Fullman, N; Futran, ND; Gebrehiwot, TT; Gutierrez, RA; Hafezi-Nejad, N; Bidgoli, HH; Hailu, GB; Haro, JM; Hassen, HY; Hawley, C; Hendrie, D; Hijar, M; Hu, GQ; Ilesanmi, OS; Jakovljevic, M; James, SL; Jayaraman, S; Jonas, JB; Kahsay, A; Kasaeian, A; Keiyoro, PN; Khader, Y; Khalil, IA; Khang, YH; Khubchandani, J; Kiadaliri, AA; Kieling, C; Kim, YJ; Kosen, S; Krohn, KJ; Kumar, GA; Lami, FH; Lansingh, VC; Larson, HJ; Linn, S; Lunevicius, R; Abd El Razek, HM; Abd El Razek, MM; Malekzadeh, R; Malta, DC; Mason-Jones, AJ; Matzopoulos, R; Memiah, PTN; Mendoza, W; Meretoja, TJ; Mezgebe, HB; Miller, TR; Mohammed, S; Moradi-Lakeh, M; Mori, R; Nand, D; Nguyen, CT; Nguyen, QL; Ningrum, DNA; Ogbo, FA; Olagunju, AT; Patton, GC; Phillips, MR; Polinder, S; Pourmalek, F; Qorbani, M; Rahimi-Movaghar, A; Rahimi-Movaghar, V; Rahman, M; Rai, RK; Ranabhat, CL; Rawaf, DL; Rawaf, S; Rowhani-Rahbar, A; Safdarian, M; Safiri, S; Sagar, R; Salama, JS; Sanabria, J; Milicevic, MMS; Sarmiento-Suarez, R; Sartorius, B; Satpathy, M; Schwebel, DC; Seedat, S; Sepanlou, SG; Shaikh, MA; Sharew, NT; Shiue, I; Singh, JA; Sisay, M; Skirbekk, V; Soares, AM; Stein, DJ; Stokes, MA; Sufiyan, MB; Swaroop, M; Sykes, BL; Tabares-Seisdedos, R; Tadese, F; Tran, BX; Tran, TT; Ukwaja, KN; Vasankari, TJ; Vlassov, V; Werdecker, A; Ye, PP; Yip, P; Yonemoto, N; Younis, MZ; Zaidi, Z; Zaki, ME; Hay, SI; Lim, SS; Lopez, AD; Mokdad, AH; Vos, T; Murray, CJL				Naghavi, Mohsen; Marczak, Laurie B.; Kutz, Michael; Shackelford, Katya Anne; Arora, Megha; Miller-Petrie, Molly; Aichour, Miloud Taki Eddine; Akseer, Nadia; Al-Raddadi, Rajaa M.; Alam, Khurshid; Alghnam, Suliman A.; Antonio, Carl Abelardo T.; Aremu, Olatunde; Arora, Amit; Asadi-Lari, Mohsen; Assadi, Reza; Atey, Tesfay Mehari; Avila-Burgos, Leticia; Awasthi, Ashish; Quintanilla, Beatriz Paulina Ayala; Barker-Collo, Suzanne Lyn; Barnighausen, Till Winfried; Bazargan-Hejazi, Shahrzad; Behzadifar, Masoud; Behzadifar, Meysam; Bennett, James R.; Bhalla, Ashish; Bhutta, Zulfiqar A.; Bilal, Arebu Issa; Borges, Guilherme; Borschmann, Rohan; Brazinova, Alexandra; Rincon, Julio Cesar Campuzano; Carvalho, Felix; Castaneda-Orjuela, Carlos A.; Dandona, Lalit; Dandona, Rakhi; Dargan, Paul I.; De Leo, Diego; Dharmaratne, Samath Dhamminda; Ding, Eric L.; Huyen Phuc Do; Doku, David Teye; Doyle, Kerrie E.; Driscoll, TimRobert; Edessa, Dumessa; El-Khatib, Ziad; Endries, Aman Yesuf; Esteghamati, Alireza; Faro, Andre; Farzadfar, Farshad; Feigin, Valery L.; Fischer, Florian; Foreman, Kyle J.; Franklin, Richard Charles; Fullman, Nancy; Futran, Neal D.; Gebrehiwot, Tsegaye Tewelde; Gutierrez, Reyna Alma; Hafezi-Nejad, Nima; Bidgoli, Hassan Haghparast; Hailu, Gessessew Bugssa; Haro, Josep Maria; Hassen, Hamid Yimam; Hawley, Caitlin; Hendrie, Delia; Hijar, Martha; Hu, Guoqing; Ilesanmi, Olayinka Stephen; Jakovljevic, Mihajlo; James, Spencer L.; Jayaraman, Sudha; Jonas, Jost B.; Kahsay, Amaha; Kasaeian, Amir; Keiyoro, Peter Njenga; Khader, Yousef; Khalil, Ibrahim A.; Khang, Young-Ho; Khubchandani, Jagdish; Kiadaliri, Aliasghar Ahmad; Kieling, Christian; Kim, Yun Jin; Kosen, Soewarta; Krohn, Kristopher J.; Kumar, G. Anil; Lami, Faris Hasan; Lansingh, Van C.; Larson, Heidi Jane; Linn, Shai; Lunevicius, Raimundas; Abd El Razek, Hassan Magdy; Abd El Razek, Muhammed Magdy; Malekzadeh, Reza; Malta, Deborah Carvalho; Mason-Jones, Amanda J.; Matzopoulos, Richard; Memiah, Peter T. N.; Mendoza, Walter; Meretoja, Tuomo J.; Mezgebe, Haftay Berhane; Miller, Ted R.; Mohammed, Shafiu; Moradi-Lakeh, Maziar; Mori, Rintaro; Nand, Devina; Cuong Tat Nguyen; Quyen Le Nguyen; Ningrum, Dina Nur Anggraini; Ogbo, Felix Akpojene; Olagunju, Andrew T.; Patton, George C.; Phillips, Michael R.; Polinder, Suzanne; Pourmalek, Farshad; Qorbani, Mostafa; Rahimi-Movaghar, Afarin; Rahimi-Movaghar, Vafa; Rahman, Mahfuzar; Rai, Rajesh Kumar; Ranabhat, Chhabi Lal; Rawaf, David Laith; Rawaf, Salman; Rowhani-Rahbar, Ali; Safdarian, Mahdi; Safiri, Saeid; Sagar, Rajesh; Salama, Joseph S.; Sanabria, Juan; Milicevic, Milena M. Santric; Sarmiento-Suarez, Rodrigo; Sartorius, Benn; Satpathy, Maheswar; Schwebel, David C.; Seedat, Soraya; Sepanlou, Sadaf G.; Shaikh, Masood Ali; Sharew, Nigussie Tadesse; Shiue, Ivy; Singh, Jasvinder A.; Sisay, Mekonnen; Skirbekk, Vegard; Soares Filho, Adauto Martins; Stein, Dan J.; Stokes, Mark Andrew; Sufiyan, Mu'awiyyah Babale; Swaroop, Mamta; Sykes, Bryan L.; Tabares-Seisdedos, Rafael; Tadese, Fentaw; Bach Xuan Tran; Tung Thanh Tran; Ukwaja, Kingsley Nnanna; Vasankari, Tommi Juhani; Vlassov, Vasily; Werdecker, Andrea; Ye, Pengpeng; Yip, Paul; Yonemoto, Naohiro; Younis, Mustafa Z.; Zaidi, Zoubida; Zaki, Maysaa El Sayed; Hay, Simon I.; Lim, Stephen S.; Lopez, Alan D.; Mokdad, Ali H.; Vos, Theo; Murray, Christopher J. L.		Global Burden Dis 2016 Injury Col	Global Mortality From Firearms, 1990-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOMICIDE RATES; SUICIDE; GUN; VIOLENCE; RISK; LAWS	IMPORTANCE Understanding global variation in firearm mortality rates could guide prevention policies and interventions. OBJECTIVE To estimate mortality due to firearm injury deaths from 1990 to 2016 in 195 countries and territories. DESIGN, SETTING, AND PARTICIPANTS This study used deidentified aggregated data including 13 812 location-years of vital registration data to generate estimates of levels and rates of death by age-sex-year-location. The proportion of suicides in which a firearm was the lethal means was combined with an estimate of per capita gun ownership in a revised proxy measure used to evaluate the relationship between availability or access to firearms and firearm injury deaths. EXPOSURES Firearm ownership and access. MAIN OUTCOMES AND MEASURES Cause-specific deaths by age, sex, location, and year. RESULTS Worldwide, it was estimated that 251 000 (95% uncertainty interval [UI], 195 000-276 000) people died from firearm injuries in 2016, with 6 countries (Brazil, United States, Mexico, Colombia, Venezuela, and Guatemala) accounting for 50.5%(95% UI, 42.2%-54.8%) of those deaths. In 1990, there were an estimated 209 000 (95% UI, 172 000 to 235 000) deaths from firearm injuries. Globally, the majority of firearm injury deaths in 2016 were homicides (64.0%[95% UI, 54.2%-68.0%]; absolute value, 161 000 deaths [95% UI, 107 000-182 000]); additionally, 27% were firearm suicide deaths (67 500 [95% UI, 55 400-84 100]) and 9% were unintentional firearm deaths (23 000 [95% UI, 18 200-24 800]). From 1990 to 2016, there was no significant decrease in the estimated global age-standardized firearm homicide rate (-0.2%[95% UI, -0.8% to 0.2%]). Firearm suicide rates decreased globally at an annualized rate of 1.6%(95% UI, 1.1-2.0), but in 124 of 195 countries and territories included in this study, these levels were either constant or significant increases were estimated. There was an annualized decrease of 0.9% (95% UI, 0.5%-1.3%) in the global rate of age-standardized firearm deaths from 1990 to 2016. Aggregate firearm injury deaths in 2016 were highest among persons aged 20 to 24 years (for men, an estimated 34 700 deaths [95% UI, 24 900-39 700] and for women, an estimated 3580 deaths [95% UI, 2810-4210]). Estimates of the number of firearms by country were associated with higher rates of firearm suicide (P<.001; R-2 = 0.21) and homicide (P<.001; R-2 = 0.35). CONCLUSIONS AND RELEVANCE This study estimated between 195 000 and 276 000 firearm injury deaths globally in 2016, the majority of which were firearm homicides. Despite an overall decrease in rates of firearm injury death since 1990, there was variation among countries and across demographic subgroups.	[Naghavi, Mohsen; Marczak, Laurie B.; Kutz, Michael; Shackelford, Katya Anne; Arora, Megha; Miller-Petrie, Molly; Dandona, Lalit; Dandona, Rakhi; Dharmaratne, Samath Dhamminda; Feigin, Valery L.; Foreman, Kyle J.; Fullman, Nancy; Hawley, Caitlin; James, Spencer L.; Khalil, Ibrahim A.; Krohn, Kristopher J.; Larson, Heidi Jane; Salama, Joseph S.; Hay, Simon I.; Lim, Stephen S.; Lopez, Alan D.; Mokdad, Ali H.; Vos, Theo; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Aichour, Miloud Taki Eddine] Higher Natl Sch Vet Med, Algiers, Algeria; [Akseer, Nadia; Bhutta, Zulfiqar A.] Univ Toronto, Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada; [Al-Raddadi, Rajaa M.] King Abdulaziz Univ, Dept Family & Community Med, Jeddah, Saudi Arabia; [Alam, Khurshid] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia; [Alghnam, Suliman A.] King Abdullah Int Med Res Ctr, Dept Populat Hlth, Riyadh, Saudi Arabia; [Antonio, Carl Abelardo T.] Univ Philippines Manila, Dept Hlth Policy & Adm, Manila, Philippines; [Aremu, Olatunde] Birmingham City Univ, Dept Publ & Community Hlth, Birmingham, England; [Arora, Amit] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia; [Arora, Amit] Sydney Local Hlth Dist, Oral Hlth Serv, Sydney, NSW, Australia; [Asadi-Lari, Mohsen] Iran Univ Med Sci, Dept Epidemiol & Biostat, Tehran, Iran; [Asadi-Lari, Mohsen] Iranian Minist Hlth & Med Educ, Int Relat Dept, Tehran, Iran; [Assadi, Reza] Mashhad Univ Med Sci, Educ Dev Ctr, Mashhad, Iran; [Atey, Tesfay Mehari] Mekelle Univ, Dept Pharm, Mekelle, Ethiopia; [Avila-Burgos, Leticia] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Awasthi, Ashish] Indian Inst Publ Hlth, Gandhinagar, India; [Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil; Rawaf, David Laith] Publ Hlth Fdn India, Gurugram, India; [Quintanilla, Beatriz Paulina Ayala] La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia; [Quintanilla, Beatriz Paulina Ayala] Peruvian Natl Inst Hlth, Gen Off Res & Technol Transfer, Lima, Peru; [Barker-Collo, Suzanne Lyn] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Barnighausen, Till Winfried; Mohammed, Shafiu] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Barnighausen, Till Winfried] Harvard Univ, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Bazargan-Hejazi, Shahrzad] Charles R Drew Univ Med & Sci, Dept Psychiat, 1621 E 120th St, Los Angeles, CA 90059 USA; [Bazargan-Hejazi, Shahrzad] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Behzadifar, Masoud; Behzadifar, Meysam] Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Khorranmabad, Iran; [Behzadifar, Masoud; Behzadifar, Meysam] Lorestan Univ Med Sci, Fac Hlth & Nutr, Khorranmabad, Iran; [Bhalla, Ashish] Post Grad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bilal, Arebu Issa] Addis Ababa Univ, Sch Pharm, Addis Ababa, Ethiopia; [Borges, Guilherme] Natl Inst Psychiat Ramon Fuente, Dept Epidemiol, Mexico City, DF, Mexico; [Borschmann, Rohan] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Borschmann, Rohan] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Brazinova, Alexandra] Comenius Univ, Inst Epidemiol, Bratislava, Slovakia; [Rincon, Julio Cesar Campuzano] Natl Inst Hlth, Cuernavaca, Morelos, Mexico; [Rincon, Julio Cesar Campuzano] Univ Valle Cuernavaca, Escuela Med, Cuernavaca, Morelos, Mexico; [Carvalho, Felix] Univ Porto, Ucibio Requimte Fac Pharm, Porto, Portugal; [Castaneda-Orjuela, Carlos A.] Inst Nacl Salud, Colombian Natl Hlth Observ, Bogota, Colombia; [Castaneda-Orjuela, Carlos A.] Univ Nacl Colombia, Epidemiol & Publ Hlth Evaluat Grp, Bogota, Colombia; [Dargan, Paul I.] Guys & St Thomas NHS Fdn Trust, Dept Clin Toxicol, London, England; [Dargan, Paul I.] Kings Coll London, Dept Fac Life Sci & Med, London, England; [De Leo, Diego] Griffith Univ, Australian Inst Suicide Res & Prevent, Mt Gravatt, Qld, Australia; [Dharmaratne, Samath Dhamminda] Univ Peradeniya, Dept Community Med, Peradeniya, Sri Lanka; [Ding, Eric L.] Harvard Univ, Harvard Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Huyen Phuc Do; Cuong Tat Nguyen; Quyen Le Nguyen; Tung Thanh Tran] Duy Tan Univ, Inst Global Hlth Innovat, Hanoi, Vietnam; [Doku, David Teye] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana; [Doku, David Teye] Univ Tampere, Fac Social Sci, Tampere, Finland; [Doyle, Kerrie E.] Royal Melbourne Inst Technol Univ RMIT, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia; [Driscoll, TimRobert] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Edessa, Dumessa] Haramaya Univ, Sch Pharm, Harar, Ethiopia; [El-Khatib, Ziad] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Endries, Aman Yesuf] St Pauls Hosp, Millennium Med Coll, Dept Publ Hlth, Addis Ababa, Ethiopia; [Esteghamati, Alireza] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran; [Faro, Andre] Univ Fed Sergipe, Dept Psychol, Sao Cristovao, Brazil; [Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran; [Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Fischer, Florian] Univ Bielefeld, Dept Publ Hlth Med, Bielefeld, Germany; [Franklin, Richard Charles] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Douglas, Qld, Australia; [Futran, Neal D.] Univ Washington, Sch Med, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA; [Gebrehiwot, Tsegaye Tewelde] Jimma Univ, Dept Epidemiol & Biostat, Jimma, Ethiopia; [Gutierrez, Reyna Alma] Natl Inst Psychiat Ramon de la Fuente, Epidemiol & Psychosocial Invest, Mexico City, DF, Mexico; [Hafezi-Nejad, Nima] Univ Tehran Med Sci, Sch Med, Tehran, Iran; [Hafezi-Nejad, Nima] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Bidgoli, Hassan Haghparast] UCL, Inst Global Hlth, London, England; [Hailu, Gessessew Bugssa] Mekelle Univ, Sch Med, Biomed Sci Div, Mekelle, Ethiopia; [Haro, Josep Maria] Parc Sanitari Sant Joan Deu CIBERSAM, Res Unit, Sant Boi De Llobregat, Spain; [Haro, Josep Maria] Univ Barcelona, Dept Med, Barcelona, Spain; [Hassen, Hamid Yimam] Mizan Tepi Univ, Dept Publ Hlth, Mizan Teferi, Ethiopia; [Hassen, Hamid Yimam] Univ Hosp Antwerp, Unit Epidemiol & Social Med, Antwerp, Belgium; [Hendrie, Delia; Miller, Ted R.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Hijar, Martha] Fdn Entornos AC, Res Coordinat, Cuernavaca, Morelos, Mexico; [Hijar, Martha] Natl Inst Publ Hlth, CISS, Cuernavaca, Morelos, Mexico; [Hu, Guoqing] Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Ilesanmi, Olayinka Stephen] Univ Liberia, Dept Publ Hlth & Community Med, Monrovia, Liberia; [Jakovljevic, Mihajlo] Univ Kragujevac, Fac Med Sci, Kragujevac, Serbia; [Jayaraman, Sudha] Virginia Commonwealth Univ, Dept Surg, Richmond, VA USA; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Jonas, Jost B.] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Kahsay, Amaha] Mekelle Univ, Dept Nutr & Dietet, Mekelle, Ethiopia; [Kasaeian, Amir] Univ Tehran Med Sci, Hemat Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Malignancies Res Ctr, Tehran, Iran; [Keiyoro, Peter Njenga] Univ Nairobi, Sch Continuing & Distance Educ, Nairobi, Kenya; [Khader, Yousef] Jordan Univ Sci & Technol, Publ Hlth & Community Med, Alramtha, Jordan; [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea; [Khang, Young-Ho] Seoul Natl Univ, SNU Med Res Ctr, Inst Hlth Policy & Management, Seoul, South Korea; [Khubchandani, Jagdish] Ball State Univ, Dept Nutr & Hlth Sci, Muncie, IN 47306 USA; [Kiadaliri, Aliasghar Ahmad] Lund Univ, Clin Epidemiol Unit, Lund, Sweden; [Kieling, Christian] Univ Fed Rio Grande do Sul, Dept Psychiat, Porto Alegre, RS, Brazil; [Kieling, Christian] Hosp Clin Porto Alegre, Child & Adolescent Psychiat Div, Porto Alegre, RS, Brazil; [Kim, Yun Jin] Xiamen Univ Malaysia, Sch Med, Sepang, Malaysia; [Lami, Faris Hasan] Acad Med Sci, Dept Community & Family Med, Baghdad, Iraq; [Lansingh, Van C.] Helpmesee, New York, NY USA; [Lansingh, Van C.] Mexican Inst Ophthalmol, Dept Int Relat, Queretaro, Mexico; [Larson, Heidi Jane] London Sch Hyg & Trop Med London, Dept Infect Dis Epidemiol, London, England; [Linn, Shai] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Lunevicius, Raimundas] Aintree Univ Hosp Natl Hlth Serv Fdn Trust NHS, Gen Surg Dept, Liverpool, Merseyside, England; [Lunevicius, Raimundas] Univ Liverpool, Sch Med, Liverpool, Merseyside, England; [Abd El Razek, Hassan Magdy] Damietta Univ, Dept Cardiol, Dumyat, Egypt; [Abd El Razek, Muhammed Magdy] Aswan Fac Med, Ophthalmol Dept, Aswan, Egypt; [Malekzadeh, Reza; Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Malekzadeh, Reza; Sepanlou, Sadaf G.] Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Iran; [Malta, Deborah Carvalho] Univ Fed Minas Gerais, Dept Materno Infantil & Saude Publ, Belo Horizonte, MG, Brazil; [Mason-Jones, Amanda J.] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Matzopoulos, Richard] South African Med Res Council, Burden Dis Res Unit, Cape Town, South Africa; [Matzopoulos, Richard] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Memiah, Peter T. N.] Univ West Florida, Dept Publ Hlth, Pensacola, FL 32514 USA; [Mendoza, Walter] United Nations Populat Fund UNFPA, Peru Country Off, Lima, Peru; [Meretoja, Tuomo J.] Helsinki Univ Hosp, Breast Surg Unit, Comprehens Canc Ctr, Helsinki, Finland; [Meretoja, Tuomo J.] Univ Helsinki, Dept Surg, Helsinki, Finland; [Mezgebe, Haftay Berhane] Acad Med Sci, Sch Pharm, Baghdad, Iraq; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Mohammed, Shafiu] Ahmadu Bello Univ, Hlth Syst & Policy Res Unit, Zaria, Nigeria; [Moradi-Lakeh, Maziar] Iran Univ Med Sci, Prevent Med & Publ Hlth Res Ctr, Tehran, Iran; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Nand, Devina] Minist Hlth, Hlth Informat Unit, Suva, Fiji; [Nand, Devina] Accamargo Canc Ctr, Sao Paulo, Brazil; [Ningrum, Dina Nur Anggraini] Semarang State Univ, Publ Hlth Dept, Kota Semarang, Indonesia; [Ningrum, Dina Nur Anggraini] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Ogbo, Felix Akpojene] Western Sydney Univ, Penrith, NSW, Australia; [Olagunju, Andrew T.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Olagunju, Andrew T.] Univ Lagos, Dept Psychiat, Lagos, Nigeria; [Patton, George C.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Patton, George C.] Murdoch Childrens Res Inst, Dept Paediat, Melbourne, Vic, Australia; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Shanghai, Peoples R China; [Polinder, Suzanne] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Pourmalek, Farshad] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Qorbani, Mostafa] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran; [Rahimi-Movaghar, Afarin] Univ Tehran Med Sci, INCAS, Tehran, Iran; [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Rahman, Mahfuzar] BRAC, Res & Evaluat Div, Dhaka, Bangladesh; [Rai, Rajesh Kumar] Soc Hlth & Demog Surveillance, Suri, India; [Rai, Rajesh Kumar] Univ Gottingen, Dept Econ, Gottingen, Germany; [Ranabhat, Chhabi Lal] Yonsei Univ, Inst Poverty Alleviat & Int Dev, Seoul, South Korea; [Rawaf, David Laith] Imperial Coll London, WHO Collaborating Ctr Publ Hlth Educ & Training, London, England; [Rawaf, David Laith] Univ Coll London Hosp, London, England; [Rawaf, Salman] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Rawaf, Salman] Publ Hlth England, London, England; [Rowhani-Rahbar, Ali] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Safdarian, Mahdi] Iran Univ Med Sci, Sina Trauma & Surg Ctr, Tehran, Iran; [Safiri, Saeid] Maragheh Univ Med Sci, Sch Nursing & Midwifery, Dept Publ Hlth, Managerial Epidemiol Res Ctr, Maragheh, Iran; [Sagar, Rajesh] AIIMS, Dept Psychiat, New Delhi, India; [Sanabria, Juan] Marshall Univ, Dept Surg, Huntington, WV USA; [Sanabria, Juan] Case Western Reserve Univ, Dept Nutr & Prevent Med, Cleveland, OH 44106 USA; [Milicevic, Milena M. Santric] Univ Belgrade, Ctr Sch Publ Hlth & Hlth Management, Inst Social Med, Fac Med, Belgrade, Serbia; [Sarmiento-Suarez, Rodrigo] Univ Ciencias Aplicadas & Ambient, Fac Med, Dept Hlth & Soc, Bogota, Colombia; [Sartorius, Benn] Univ Kwazulu Natal, Dept Publ Hlth Med, Durban, South Africa; [Satpathy, Maheswar] Utkal Univ, UGC Ctr Adv Study Psychol, Bhubaneswar, India; [Schwebel, David C.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Seedat, Soraya] Stellenbosch Univ, Dept Psychiat, Cape Town, South Africa; [Sharew, Nigussie Tadesse] Debre Berhan Univ, Coll Hlth Sci, Debre Berhan, Ethiopia; [Shiue, Ivy] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biometrie & Informat, Haale, Germany; [Singh, Jasvinder A.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Singh, Jasvinder A.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Sisay, Mekonnen] Haramaya Univ, Sch Pharm, Harar, Ethiopia; [Skirbekk, Vegard] Norwegian Inst Publ Hlth, Oslo, Norway; [Soares Filho, Adauto Martins] Fed Minist Hlth, Dept Dis & Noncommunicable Dis & Hlth Promot, Brasilia, DF, Brazil; [Stein, Dan J.] South African Med Res Council, Cape Town, South Africa; [Stein, Dan J.] Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Stokes, Mark Andrew] Deakin Univ, Sch Psychol, Burwood, Vic, Australia; [Sufiyan, Mu'awiyyah Babale] Ahmadu Bello Univ, Dept Community Med, Zaria, Nigeria; [Swaroop, Mamta] Northwestern Univ, Dept Surg, Chicago, IL 60611 USA; [Sykes, Bryan L.] Univ Calif Irvine, Dept Criminol Law & Soc, Irvine, CA USA; [Tabares-Seisdedos, Rafael] Univ Valencia, Dept Med, Valencia, Spain; [Tadese, Fentaw] Wollo Univ, Dept Publ Hlth, Dessie, Ethiopia; [Bach Xuan Tran; Tung Thanh Tran] Hanoi Med Univ, Dept Hlth Econ, Hanoi, Vietnam; [Ukwaja, Kingsley Nnanna] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Nigeria; [Vasankari, Tommi Juhani] UKK Inst Hlth Promot Res, Tampere, Finland; [Vlassov, Vasily] Natl Res Univ, Higher Sch Econ, Dept Hlth Care Management & Econ, Moscow, Russia; [Werdecker, Andrea] Fed Inst Populat Res, Demog Change & Ageing, Wiesbaden, Germany; [Ye, Pengpeng] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Div Injury Prevent & Mental Hlth Improvement, Xicheng Dist, Peoples R China; [Yip, Paul] Univ Hong Kong, Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Yonemoto, Naohiro] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan; [Younis, Mustafa Z.] Jackson State Univ, Healthcare Management Hlth Econ & Finance Global, Jackson, MO USA; [Younis, Mustafa Z.] Tsinghua Univ, Res Ctr Publ Hlth, Beijing, Peoples R China; [Zaidi, Zoubida] Univ Hosp Setif, Dept Epidemiol, Setif, Algeria; [Zaidi, Zoubida] ACS Med Coll & Hosp, Fac Med Sci, Algiers, Algeria; [Zaki, Maysaa El Sayed] Mansoura Univ, Fac Med, Mansoura, Egypt; [Lopez, Alan D.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); King Abdulaziz University; University of Western Australia; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); University of the Philippines System; University of the Philippines Manila; Birmingham City University; Western Sydney University; Iran University of Medical Sciences; Ministry of Health & Medical Education (MOHME); Mashhad University Medical Science; Mekelle University; Instituto Nacional de Salud Publica; Public Health Foundation of India; La Trobe University; Instituto Nacional de Salud - Peru; University of Auckland; Ruprecht Karls University Heidelberg; Harvard University; Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; Lorestan University of Medical Sciences; Lorestan University of Medical Sciences; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Aga Khan University; Addis Ababa University; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Murdoch Children's Research Institute; University of Melbourne; Comenius University Bratislava; Universidade do Porto; Instituto Nacional de Salud (Colombia); Universidad Nacional de Colombia; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Griffith University; University of Peradeniya; Harvard University; Harvard T.H. Chan School of Public Health; Duy Tan University; University of Cape Coast; Tampere University; Royal Melbourne Institute of Technology (RMIT); University of Sydney; Haramaya University; Karolinska Institutet; Tehran University of Medical Sciences; Universidade Federal de Sergipe; Tehran University of Medical Sciences; Auckland University of Technology; University of Bielefeld; James Cook University; University of Washington; University of Washington Seattle; Jimma University; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Tehran University of Medical Sciences; Johns Hopkins University; University of London; University College London; Mekelle University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; University of Antwerp; Curtin University; Instituto Nacional de Salud Publica; Central South University; University of Kragujevac; Virginia Commonwealth University; Ruprecht Karls University Heidelberg; Capital Medical University; Mekelle University; Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of Nairobi; Jordan University of Science & Technology; Seoul National University (SNU); Seoul National University (SNU); Ball State University; Lund University; Universidade Federal do Rio Grande do Sul; Xiamen University Malaysia Campus; University of Haifa; University of Liverpool; Egyptian Knowledge Bank (EKB); Damietta University; Tehran University of Medical Sciences; Shiraz University of Medical Science; Universidade Federal de Minas Gerais; University of York - UK; South African Medical Research Council; University of Cape Town; State University System of Florida; University of West Florida; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Pacific Institute for Research & Evaluation (PIRE); Ahmadu Bello University; Iran University of Medical Sciences; National Center for Child Health & Development - Japan; A.C.Camargo Cancer Center; Universitas Negeri Semarang; Taipei Medical University; Western Sydney University; University of Adelaide; University of Lagos; University of Melbourne; Murdoch Children's Research Institute; Shanghai Jiao Tong University; Erasmus University Rotterdam; Erasmus MC; University of British Columbia; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Bangladesh Rural Advancement Committee BRAC; University of Gottingen; Yonsei University; Imperial College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London; Public Health England; University of Washington; University of Washington Seattle; Iran University of Medical Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; Marshall University; Case Western Reserve University; University of Belgrade; University of Kwazulu Natal; Utkal University; University of Alabama System; University of Alabama Birmingham; Stellenbosch University; Martin Luther University Halle Wittenberg; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Haramaya University; Norwegian Institute of Public Health (NIPH); South African Medical Research Council; University of Cape Town; Deakin University; Ahmadu Bello University; Northwestern University; University of California System; University of California Irvine; University of Valencia; Hanoi Medical University; UKK Institute; HSE University (National Research University Higher School of Economics); Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Hong Kong; Kyoto University; Tsinghua University; Egyptian Knowledge Bank (EKB); Mansoura University; University of Melbourne	Naghavi, M (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Global Hlth Dept, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA.	nagham@uw.edu	Behzadifar, Masoud/H-1433-2016; Brazinova, Alexandra/C-4265-2016; Edessa, Dumessa/K-3885-2019; Singh, Jasvinder/R-6172-2019; Qorbani, Mostafa/M-8171-2017; Phillips, Michael Robert/AAE-7585-2021; Ribeiro, Ana Cristina/HHN-7466-2022; Pourmalek, Farshad/A-8188-2010; Sharew, Nigussie Tadesse/AAD-5597-2022; Naohiro, Yonemoto/Y-3761-2019; Milicevic, Milena Santric/H-6423-2018; Stein, Dan/A-1752-2008; Patton, George C/B-5246-2013; Carvalho, Félix/D-4914-2013; Lami, Faris/AAW-7666-2021; Hay, Simon Iain/F-8967-2015; Hassen, Hamid Y./K-6445-2019; Malta, Deborah Carvalho/L-2491-2019; Zaki, Maysaa El Sayed/H-3049-2019; Aremu, Olatunde/AAD-1995-2019; Kasaeian, Amir/C-8290-2017; Ningrum, Dina Nur Anggraini/ABA-1698-2020; Bidgoli, Hassan Haghparast/C-1601-2018; Matzopoulos, Richard/AAL-9965-2021; Lopez, Alan D/F-1487-2010; Boothapati, Anil Kumar/HHS-1813-2022; Behzadifar, Meysam/K-2781-2016; Sisay, Mekonnen/AAD-3257-2020; Bärnighausen, Till/Y-2388-2019; Tabares-Seisdedos, Rafael/H-6432-2013; Feigin, Valery/AAF-2313-2019; T., Olagunju Andrew/B-4746-2017; Sufiyan, Muawiyyah Babale/GWN-2609-2022; Satpathy, Maheswar/J-3135-2017; Awasthi, Ashish/Y-5915-2019; Mansour-Ghanaei, Fariborz/ABC-0170-2022; Stokes, Mark A/P-8937-2017; Jakovljevic, Mihajlo/B-3002-2014; Haro, Josep Maria/D-1423-2011; Phuc, Huyen/I-5061-2019; Lopez, Alan/AAA-2734-2022; assadi, reza/AAI-1124-2021; Filho, Adauto Martins Soares/M-2176-2016; Mohammed, Shafiu/P-2016-2014; KUMAR, ANIL/ACD-8340-2022; assadi, reza/AAT-6629-2020; Edessa, Dumessa/K-2892-2019; Ayala Quintanilla, Beatriz Paulina/C-8325-2016; Lunevicius, Raimundas/B-2528-2018; Mokdad, Ali H./AAD-1232-2022; Zaki, Maysaa El Sayed/C-1522-2013; Ukwaja, Kingsley N./A-7794-2013; Kim, Yun Jin/AAE-8281-2019; Endries, Aman Yesuf/AAN-6871-2021; Schwebel, David/GXH-9944-2022; Ilesanmi, Olayinka/AAF-8628-2021; Ding, Eric L./K-1118-2019; Khader, Yousef/AAE-9620-2019; Jayaraman, Sudha/AAH-3059-2019; Rahimi-Movaghar, Vafa/L-6339-2019; Khubchandani, Jagdish/D-1831-2014; Kieling, Christian/U-3905-2019; Antonio, Carl Abelardo/AAP-4280-2020; Mason-Jones, Amanda/ABF-1565-2020; Franklin, Richard Charles/H-1731-2012; Sagar, Rajesh/L-7775-2016; Rahimi-Movaghar, Afarin/E-9505-2011; Safiri, Saeid/A-1678-2017; Al-Raddadi, Rajaa/F-8337-2010; Milicevic, Milena/AAV-3679-2021; Faro, Andre/J-1696-2014; Moradi-Lakeh, Maziar/ABC-9793-2021; Hassen, Hamid Y./A-1105-2019; El-Khatib, Ziad/B-5161-2017; Rahimi-Movaghar, Vafa/T-7816-2017; Bhutta, Zulfiqar/L-7822-2015; Sepanlou, Sadaf/H-9343-2016; Castaneda-Orjuela, Carlos/N-2601-2017; Larson, Heidi J./N-1018-2017	Behzadifar, Masoud/0000-0002-0271-4360; Brazinova, Alexandra/0000-0003-0625-256X; Edessa, Dumessa/0000-0001-6558-5829; Singh, Jasvinder/0000-0003-3485-0006; Phillips, Michael Robert/0000-0002-5973-2439; Ribeiro, Ana Cristina/0000-0002-0493-8376; Pourmalek, Farshad/0000-0002-2134-0771; Sharew, Nigussie Tadesse/0000-0002-6443-6992; Milicevic, Milena Santric/0000-0002-0684-359X; Stein, Dan/0000-0001-7218-7810; Patton, George C/0000-0001-5039-8326; Carvalho, Félix/0000-0003-3858-3494; Lami, Faris/0000-0002-3673-3818; Hay, Simon Iain/0000-0002-0611-7272; Hassen, Hamid Y./0000-0001-6485-4193; Malta, Deborah Carvalho/0000-0002-8214-5734; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Aremu, Olatunde/0000-0002-5832-2403; Kasaeian, Amir/0000-0003-2018-9368; Ningrum, Dina Nur Anggraini/0000-0002-8557-2862; Bidgoli, Hassan Haghparast/0000-0001-6365-2944; Matzopoulos, Richard/0000-0001-9063-6210; Lopez, Alan D/0000-0001-5818-6512; Sisay, Mekonnen/0000-0001-6611-1174; T., Olagunju Andrew/0000-0003-1736-9886; Sufiyan, Muawiyyah Babale/0000-0003-3630-6995; Satpathy, Maheswar/0000-0003-3521-4781; Awasthi, Ashish/0000-0002-9308-9782; Mansour-Ghanaei, Fariborz/0000-0001-6747-0232; Stokes, Mark A/0000-0001-6488-4544; Jakovljevic, Mihajlo/0000-0002-9160-6846; Haro, Josep Maria/0000-0002-3984-277X; Phuc, Huyen/0000-0003-0461-7529; Filho, Adauto Martins Soares/0000-0002-0917-7473; Mohammed, Shafiu/0000-0001-5715-966X; Ayala Quintanilla, Beatriz Paulina/0000-0002-2630-4569; Lunevicius, Raimundas/0000-0003-3295-0142; Mokdad, Ali H./0000-0002-4994-3339; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Ukwaja, Kingsley N./0000-0002-1974-8735; Kim, Yun Jin/0000-0001-8853-6587; Ilesanmi, Olayinka/0000-0003-0827-6442; Ding, Eric L./0000-0002-5881-8097; Khader, Yousef/0000-0002-7830-6857; Jayaraman, Sudha/0000-0003-1094-5836; Khubchandani, Jagdish/0000-0002-9058-4278; Kieling, Christian/0000-0001-7691-4149; Antonio, Carl Abelardo/0000-0001-7476-0553; Mason-Jones, Amanda/0000-0002-4292-3183; Franklin, Richard Charles/0000-0003-1864-4552; Rahimi-Movaghar, Afarin/0000-0002-5761-1668; Safiri, Saeid/0000-0001-7986-9072; Al-Raddadi, Rajaa/0000-0002-8921-9628; Faro, Andre/0000-0002-7348-6297; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Hassen, Hamid Y./0000-0001-6485-4193; Sarmiento Suarez, Rodrigo/0000-0002-7301-277X; Farzadfar, Farshad/0000-0001-8288-4046; Rai, Rajesh Kumar/0000-0002-5249-9937; Rowhani-Rahbar, Ali/0000-0002-2705-4485; Seedat, Soraya/0000-0002-5118-786X; El-Khatib, Ziad/0000-0003-0756-7280; , bennsartorius/0000-0001-6761-2325; Rahimi-Movaghar, Vafa/0000-0001-7347-8767; Feigin, Valery L./0000-0002-6372-1740; Bhutta, Zulfiqar/0000-0003-0637-599X; Mori, Rintaro/0000-0001-7656-6156; International, ArvinMed/0000-0002-1322-878X; Shiue, Ivy/0000-0003-1788-3009; Dargan, Paul/0000-0002-3433-9622; Meretoja, Tuomo/0000-0002-2691-0710; /0000-0002-4565-5364; Alghnam, Suliman/0000-0001-5817-0481; Sepanlou, Sadaf/0000-0002-3669-5129; Rawaf, Salman/0000-0001-7191-2355; Borges, Guilherme/0000-0002-3269-0507; ZAIDI, ZOUBIDA/0000-0003-3378-4799; Tabares-Seisdedos, Rafael/0000-0002-1089-2204; Dandona, Rakhi/0000-0003-0926-788X; Kiadaliri, Ali/0000-0002-4254-9099; Kahsay, Amaha/0000-0002-6242-8040; Borschmann, Rohan/0000-0002-0365-7775; Miller, Ted/0000-0002-0958-2639; Ye, Pengpeng/0000-0002-2924-1436; Castaneda-Orjuela, Carlos/0000-0002-8735-6223; Marczak, Laurie/0000-0001-5979-4261; SAGAR, RAJESH/0000-0003-4563-7841; Hendrie, Delia/0000-0001-5022-5281; Larson, Heidi J./0000-0002-8477-7583; Alam, Khurshid/0000-0002-7402-7519; Magdy Abd El Razek, Hassan/0000-0002-8857-0408; Esteghamati, Alireza/0000-0001-5114-3982	Bill & Melinda Gates Foundation [OPP1152504]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill & Melinda Gates Foundation (OPP1152504).	Alpers P., 2013, GLOBAL IMPACT GUN VI; Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; Banks G, 2017, AGGRESS VIOLENT BEH, V34, P113, DOI 10.1016/j.avb.2017.02.002; Butchart A, 2002, B WORLD HEALTH ORGAN, V80, P797; Castillo J.C., 2013, ILLEGAL DRUG MARKETS; Chapman S, 2016, JAMA-J AM MED ASSOC, V316, P291, DOI 10.1001/jama.2016.8752; Dube A, 2013, AM POLIT SCI REV, V107, P397, DOI 10.1017/S0003055413000178; Eskin M, 2016, SCAND J PSYCHOL, V57, P554, DOI 10.1111/sjop.12318; Foley RJ, 2016, US TODAY; Fowler KA, 2015, PREV MED, V79, P5, DOI 10.1016/j.ypmed.2015.06.002; Garenne M, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.32795; Global Health Data Exchange, GLOB BURD DIS STUD 2; Grossman DC, 2005, JAMA-J AM MED ASSOC, V293, P707, DOI 10.1001/jama.293.6.707; Hemenway D, 2017, INJURY PREV, DOI [10.1136/injuryprev-2017-042607, DOI 10.1136/INJURYPREV-2017-042607]; Institute for Health Metrics and Evaluation, DAT VIS TOOL; Karp A, 2007, SMALL ARMS SURVEY 20; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; KILLIAS M, 1993, CAN MED ASSOC J, V148, P1721; Lai DWL, 2017, J IMMIGR MINOR HEALT, V19, P755, DOI 10.1007/s10903-016-0490-3; Lankford A, 2016, VIOLENCE VICTIMS, V31, P187, DOI 10.1891/0886-6708.VV-D-15-00093; Lee LK, 2017, JAMA INTERN MED, V177, P106, DOI 10.1001/jamainternmed.2016.7051; Levine PB, 2017, SCIENCE, V358, P1324, DOI 10.1126/science.aan8179; Malta Deborah Carvalho, 2017, Rev. bras. epidemiol., V20, P142, DOI 10.1590/1980-5497201700050012; Matzopoulos R, 2016, SAMJ, S. Afr. med. j., V106, P589, DOI [10.7196/samj.2016.v106i6.10379, 10.7196/SAMJ.2016.v106i6.10379]; Matzopoulos RG, 2014, AM J PUBLIC HEALTH, V104, P455, DOI 10.2105/AJPH.2013.310650; Meszaros J, 2017, J MENT HEALTH, V26, P359, DOI 10.1080/09638237.2017.1340608; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Persio S. L., 2017, NEWSWEEK; Rivera M, 2016, J PEACE RES, V53, P84, DOI 10.1177/0022343315598823; Santaella-Tenorio J, 2016, EPIDEMIOL REV, V38, P140, DOI 10.1093/epirev/mxv012; Schroeder M., 2013, SMALL ARMS SURVEY 20, P282, DOI [https://doi.org/10.1017/CBO9781107323612.021, DOI 10.1017/CBO9781107323612.021]; Shenassa ED, 2003, J EPIDEMIOL COMMUN H, V57, P120, DOI 10.1136/jech.57.2.120; Siegel MB, 2016, VIOLENCE GEND, V3, P20, DOI 10.1089/vio.2015.0047; Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9; Tracy M, 2016, EPIDEMIOL REV, V38, P70, DOI 10.1093/epirev/mxv009; US Department of State, MAJ ILL DRUG PROD DR; Villaveces A, 2000, JAMA-J AM MED ASSOC, V283, P1205, DOI 10.1001/jama.283.9.1205; World Health Organization, 2007, VERB AUT STAND ASC A; World Pop, NAT POP EST	39	117	121	1	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					792	814		10.1001/jama.2018.10060	http://dx.doi.org/10.1001/jama.2018.10060			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GR8HM	30167700	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000442958800024
J	Vagnarelli, P; Alessi, DR				Vagnarelli, Paola; Alessi, Dario R.			PP1 Phosphatase Complexes: Undruggable No Longer	CELL			English	Editorial Material								The identification of inhibitors targeting regulatory subunits of serine/threonine PP1 phosphatases reported by Krzyzosiak et al. is a significant step in expanding the pharmacological regulation of phosphorylation beyond kinases. The selective inhibitor of the R15B phosphatase regulatory subunit, termed Raphin1, protects cells from stress and delays neurodegeneration in a mouse model of Huntington's disease.	[Vagnarelli, Paola] Brunel Univ London, Res Inst Environm Hlth & Soc, Coll Hlth & Life Sci, Uxbridge UB8 3PH, Middx, England; [Alessi, Dario R.] Univ Dundee, Sch Life Sci, Prot Phosphorylat & Ubiquitylat Unit, MRC, Dundee DD1 5EH, Scotland	Brunel University; University of Dundee	Vagnarelli, P (corresponding author), Brunel Univ London, Res Inst Environm Hlth & Soc, Coll Hlth & Life Sci, Uxbridge UB8 3PH, Middx, England.; Alessi, DR (corresponding author), Univ Dundee, Sch Life Sci, Prot Phosphorylat & Ubiquitylat Unit, MRC, Dundee DD1 5EH, Scotland.	paola.vagnarelli@brunel.ac.uk; d.r.alessi@dundee.ac.uk	Vagnarelli, Paola/AAI-1996-2020	Vagnarelli, Paola/0000-0002-0000-2271; Alessi, Dario/0000-0002-2140-9185	Wellcome Trust; Brunel Idea Award; Wellcome Trust Investigator Award in Science; Medical Research Council [MC_UU_12016/2]; Michael J. Fox Foundation [6986]; BBSRC [BB/K017632/1] Funding Source: UKRI; MRC [MC_UU_12016/2, MC_UU_00018/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Brunel Idea Award; Wellcome Trust Investigator Award in Science; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Michael J. Fox Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work in the Vagnarelli lab is supported by the Wellcome Trust and Brunel Idea Award. P.V. is recipient of a Wellcome Trust Investigator Award in Science. The Alessi lab is supported by the Medical Research Council (MC_UU_12016/2) and the Michael J. Fox Foundation (6986).	Cohen PTW, 2002, J CELL SCI, V115, P241; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Ferguson FM, 2018, NAT REV DRUG DISCOV, V17, P353, DOI 10.1038/nrd.2018.21; Ferreira M, 2019, BBA-MOL CELL RES, V1866, P16, DOI 10.1016/j.bbamcr.2018.07.019; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; He RJ, 2014, ACTA PHARMACOL SIN, V35, P1227, DOI 10.1038/aps.2014.80; Krzyzosiak A, 2018, CELL, V174, P1216, DOI 10.1016/j.cell.2018.06.030; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396	9	8	8	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2018	174	5					1049	1051		10.1016/j.cell.2018.08.007	http://dx.doi.org/10.1016/j.cell.2018.08.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GR3WU	30142342	Bronze, Green Published			2022-12-28	WOS:000442529100003
J	Green, A				Green, Andrew			HPV vaccine to be offered to boys in England	LANCET			English	Editorial Material																			0	7	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2018	392	10145					374	374		10.1016/S0140-6736(18)31728-8	http://dx.doi.org/10.1016/S0140-6736(18)31728-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GP1SM	30152370				2022-12-28	WOS:000440597100008
J	Nakatsuka, N; Yang, KA; Abendroth, JM; Cheung, KM; Xu, XB; Yang, HY; Zhao, CZ; Zhu, BW; Rim, YS; Yang, Y; Weiss, PS; Stojanovic, MN; Andrews, AM				Nakatsuka, Nako; Yang, Kyung-Ae; Abendroth, John M.; Cheung, Kevin M.; Xu, Xiaobin; Yang, Hongyan; Zhao, Chuanzhen; Zhu, Bowen; Rim, You Seung; Yang, Yang; Weiss, Paul S.; Stojanovic, Milan N.; Andrews, Anne M.			Aptamer-field-effect transistors overcome Debye length limitations for small-molecule sensing	SCIENCE			English	Article							LIFT-OFF LITHOGRAPHY; CIRCULAR-DICHROISM; G-QUADRUPLEX; BIOSENSORS; SEROTONIN; RECOGNITION; RECEPTORS; DNA	Detection of analytes by means of field-effect transistors bearing ligand-specific receptors is fundamentally limited by the shielding created by the electrical double layer (the "Debye length" limitation). We detected small molecules under physiological high-ionic strength conditions by modifying printed ultrathin metal-oxide field-effect transistor arrays with deoxyribonucleotide aptamers selected to bind their targets adaptively. Target-induced conformational changes of negatively charged aptamer phosphodiester backbones in close proximity to semiconductor channels gated conductance in physiological buffers, resulting in highly sensitive detection. Sensing of charged and electroneutral targets (serotonin, dopamine, glucose, and sphingosine-1-phosphate) was enabled by specifically isolated aptameric stem-loop receptors.	[Nakatsuka, Nako; Abendroth, John M.; Cheung, Kevin M.; Xu, Xiaobin; Zhao, Chuanzhen; Zhu, Bowen; Rim, You Seung; Yang, Yang; Weiss, Paul S.; Andrews, Anne M.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Nakatsuka, Nako; Abendroth, John M.; Cheung, Kevin M.; Xu, Xiaobin; Zhao, Chuanzhen; Weiss, Paul S.; Andrews, Anne M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Yang, Kyung-Ae; Stojanovic, Milan N.] Columbia Univ, Dept Med, Ctr Innovat Diagnost & Therapeut Approaches, New York, NY 10032 USA; [Yang, Hongyan; Andrews, Anne M.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Yang, Hongyan; Andrews, Anne M.] Univ Calif Los Angeles, Hatos Ctr Neuropharmacol, Los Angeles, CA 90095 USA; [Zhu, Bowen; Rim, You Seung; Yang, Yang; Weiss, Paul S.] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Stojanovic, Milan N.] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA; [Stojanovic, Milan N.] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Rim, You Seung] Sejong Univ, Sch Intelligent Mechatron Engn, Seoul 05006, South Korea	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University; Columbia University; Sejong University	Weiss, PS; Andrews, AM (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.; Weiss, PS; Andrews, AM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Stojanovic, MN (corresponding author), Columbia Univ, Dept Med, Ctr Innovat Diagnost & Therapeut Approaches, New York, NY 10032 USA.; Andrews, AM (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.; Andrews, AM (corresponding author), Univ Calif Los Angeles, Hatos Ctr Neuropharmacol, Los Angeles, CA 90095 USA.; Weiss, PS (corresponding author), Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA.; Stojanovic, MN (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA.; Stojanovic, MN (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10032 USA.	psw@cnsi.ucla.edu; mns18@cumc.columbia.edu; aandrews@mednet.ucla.edu	Xu, Xiaobin/Y-3862-2019; Zhao, Chuanzhen/B-6430-2017; Xu, Xiaobin/AAN-1273-2020; Andrews, Anne/AAA-8459-2021; Weiss, Paul/P-8016-2019; Weiss, Paul S/A-2575-2011; Zhu, Bowen/C-2422-2019	Zhao, Chuanzhen/0000-0003-0162-1231; Xu, Xiaobin/0000-0002-3479-0130; Andrews, Anne/0000-0002-1961-4833; Weiss, Paul/0000-0001-5527-6248; Weiss, Paul S/0000-0001-5527-6248; Abendroth, John/0000-0002-2369-4311; Zhu, Bowen/0000-0001-7534-9723; Cheung, Kevin/0000-0003-1586-0364	NIH [DA045550, CA199849, GM104960]; NSF [CCF1518715, 1509794, CMMI-1636136]; CalBrain; NantWorks; Hewlett Packard; Merkin Family Foundation; China Scholarship Council; NATIONAL CANCER INSTITUTE [R21CA199849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA045550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); CalBrain; NantWorks; Hewlett Packard; Merkin Family Foundation; China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by NIH (DA045550, CA199849, GM104960), NSF (CCF1518715, 1509794, CMMI-1636136), CalBrain, NantWorks, Hewlett Packard, the Merkin Family Foundation, and the China Scholarship Council.	Alivisatos AP, 2013, ACS NANO, V7, P1850, DOI 10.1021/nn4012847; Altieri SC, 2015, NEUROPSYCHOPHARMACOL, V40, P1456, DOI 10.1038/npp.2014.331; Angoa-Perez M, 2014, ACS CHEM NEUROSCI, V5, P908, DOI 10.1021/cn500096g; Armstrong RE, 2014, BIOCONJUGATE CHEM, V25, P1769, DOI 10.1021/bc500286r; Casal P, 2012, PHILOS T R SOC A, V370, P2474, DOI 10.1098/rsta.2011.0503; Chen XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032511; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Gao N, 2016, P NATL ACAD SCI USA, V113, P14633, DOI 10.1073/pnas.1625010114; Ke CF, 2012, NAT CHEM, V4, P718, DOI [10.1038/nchem.1409, 10.1038/NCHEM.1409]; Kim J, 2015, ACS NANO, V9, P4572, DOI 10.1021/acsnano.5b01211; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Landry MP, 2017, NAT NANOTECHNOL, V12, P368, DOI [10.1038/NNANO.2016.284, 10.1038/nnano.2016.284]; Liao WS, 2012, SCIENCE, V337, P1517, DOI 10.1126/science.1221774; Liu W, 2011, J PHYS CHEM B, V115, P13051, DOI 10.1021/jp2074489; Masango SS, 2016, NANO LETT, V16, P4251, DOI 10.1021/acs.nanolett.6b01276; Nagai Y, 2013, LANGMUIR, V29, P9951, DOI 10.1021/la400975b; Nagatoishi S, 2007, BIOCHEM BIOPH RES CO, V352, P812, DOI 10.1016/j.bbrc.2006.11.088; Nakatsuka N., 2018, CHEM REV; Nakatsuka N, 2017, ACS CHEM NEUROSCI, V8, P218, DOI 10.1021/acschemneuro.7b00056; Nutiu R, 2005, ANGEW CHEM INT EDIT, V44, P1061, DOI 10.1002/anie.200461848; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Purschke WG, 2014, BIOCHEM J, V462, P153, DOI 10.1042/BJ20131422; Ricci F, 2016, ACCOUNTS CHEM RES, V49, P1884, DOI 10.1021/acs.accounts.6b00276; Rodeberg NT, 2017, ACS CHEM NEUROSCI, V8, P221, DOI 10.1021/acschemneuro.6b00393; Shoorideh K, 2014, P NATL ACAD SCI USA, V111, P5111, DOI 10.1073/pnas.1315485111; Vacic A, 2011, J AM CHEM SOC, V133, P13886, DOI 10.1021/ja205684a; Walsh R, 2009, BIOCHEM BIOPH RES CO, V388, P732, DOI 10.1016/j.bbrc.2009.08.084; WEISS PS, 1989, J CHEM PHYS, V90, P5146, DOI 10.1063/1.456557; Yang HY, 2013, ACS CHEM NEUROSCI, V4, P790, DOI 10.1021/cn400072f; Yang KA, 2014, NAT CHEM, V6, P1003, DOI [10.1038/NCHEM.2058, 10.1038/nchem.2058]	30	309	313	60	443	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					319	+		10.1126/science.aao6750	http://dx.doi.org/10.1126/science.aao6750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30190311	Green Accepted			2022-12-28	WOS:000447680100043
J	Mena, EL; Kjolby, RAS; Saxton, RA; Werner, A; Lew, BG; Boyle, JM; Harland, R; Rape, M				Mena, Elijah L.; Kjolby, Rachel A. S.; Saxton, Robert A.; Werner, Achim; Lew, Brandon G.; Boyle, John M.; Harland, Richard; Rape, Michael			Dimerization quality control ensures neuronal development and survival	SCIENCE			English	Article							UBIQUITIN-DEPENDENT REGULATION; TRANSCRIPTION FACTORS; HUMAN INTERACTOME; POZ DOMAIN; LIGASE; COMPLEXES; MECHANISM; DISEASE; ADAPTER; MUTATIONS	Aberrant complex formation by recurrent interaction modules, such as BTB domains, leucine zippers, or coiled coils, can disrupt signal transduction, yet whether cells detect and eliminate complexes of irregular composition is unknown. By searching for regulators of the BTB family, we discovered a quality control pathway that ensures functional dimerization [dimerization quality control (DQC)]. Key to this network is the E3 ligase SCFFBXL17, which selectively binds and ubiquitylates BTB dimers of aberrant composition to trigger their clearance by proteasomal degradation. Underscoring the physiological importance of DQC, SCFFBXL17 is required for the differentiation, function, and survival of neural crest and neuronal cells. We conclude that metazoan organisms actively monitor BTB dimerization, and we predict that distinct E3 ligases similarly control complex formation by other recurrent domains.	[Mena, Elijah L.; Kjolby, Rachel A. S.; Saxton, Robert A.; Lew, Brandon G.; Boyle, John M.; Harland, Richard; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Werner, Achim] NIDCR, NIH, Bethesda, MD 20892 USA; [Rape, Michael] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Saxton, Robert A.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Howard Hughes Medical Institute; University of California System; University of California Berkeley; Stanford University	Rape, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Rape, M (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	mrape@berkeley.edu		Saxton, Robert/0000-0002-9376-3984; Boyle, John Michael/0000-0001-6173-6765; Saxton, Robert/0000-0001-9777-8270; Mena, Elijah/0000-0001-9980-9018; Lew, Brandon/0000-0003-4923-7570; Harland, Richard M./0000-0001-8247-4880; Rape, Michael/0000-0003-4849-6343	NSF predoctoral fellowship; NIH [GM42341]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042341] Funding Source: NIH RePORTER	NSF predoctoral fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	E.M. was supported by an NSF predoctoral fellowship. R.H. was funded by NIH GM42341. M.R. is an Investigator of the Howard Hughes Medical Institute.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Aharoni S, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0343-x; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Cai HC, 2016, P NATL ACAD SCI USA, V113, P14751, DOI 10.1073/pnas.1612520114; Ci WM, 2008, CURR OPIN HEMATOL, V15, P381, DOI 10.1097/MOH.0b013e328302c7df; Cleasby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098896; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Goeke S, 2003, NAT NEUROSCI, V6, P917, DOI 10.1038/nn1105; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Igarashi K, 2017, NAT REV IMMUNOL, V17, P437, DOI 10.1038/nri.2017.26; Ji AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060445; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kun-Rodrigues C, 2015, HUM MOL GENET, V24, P6711, DOI 10.1093/hmg/ddv376; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; McGourty CA, 2016, CELL, V167, P525, DOI 10.1016/j.cell.2016.09.026; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Raducu M, 2016, EMBO J, V35, P1400, DOI 10.15252/embj.201593374; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Werner A, 2018, ELIFE, V7, DOI 10.7554/eLife.35407; Werner A, 2015, NATURE, V525, P523, DOI 10.1038/nature14978; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yanagitani K, 2017, SCIENCE, V357, P472, DOI 10.1126/science.aan0178; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	40	36	37	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2018	362	6411			SI		198	+	eaap8236	10.1126/science.aap8236	http://dx.doi.org/10.1126/science.aap8236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW9RX	30190310				2022-12-28	WOS:000447337200047
J	Chowkwanyun, M; Bayer, R; Galea, S				Chowkwanyun, Merlin; Bayer, Ronald; Galea, Sandro			"Precision" Public Health - Between Novelty and Hype	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chowkwanyun, Merlin; Bayer, Ronald] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA USA	Columbia University; Boston University	Chowkwanyun, M (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA.		Galea, Sandro/GLR-6066-2022					Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL; Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a; Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32	5	66	66	3	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2018	379	15					1398	1400		10.1056/NEJMp1806634	http://dx.doi.org/10.1056/NEJMp1806634			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GW4VQ	30184442				2022-12-28	WOS:000446923400003
J	Glen, JB				Glen, John Baird (Iain)			The Discovery and Development of Propofol Anesthesia The 2018 Lasker-DeBakey Clinical Medical Research Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AGENTS; MODEL		[Glen, John Baird (Iain)] 35A Bexton Rd, Knutsford WA16 0DZ, Cheshire, England		Glen, JB (corresponding author), 35A Bexton Rd, Knutsford WA16 0DZ, Cheshire, England.	iglen2@compuserve.com						COETZEE JF, 1995, ANESTHESIOLOGY, V82, P1328, DOI 10.1097/00000542-199506000-00003; GLEN JB, 1979, BRIT J ANAESTH, V51, P819, DOI 10.1093/bja/51.9.819; GLEN JB, 1984, BRIT J ANAESTH, V56, P617, DOI 10.1093/bja/56.6.617; Glen JB, 1998, ANAESTHESIA, V53, P13, DOI 10.1111/j.1365-2044.1998.53s115.x; GLEN JB, 1980, BRIT J ANAESTH, V52, P731, DOI 10.1093/bja/52.8.731; JAMES R, 1980, J MED CHEM, V23, P1350, DOI 10.1021/jm00186a013; Marinho S, 2018, BRIT J ANAESTH, V121, P146, DOI 10.1016/j.bja.2018.04.016; STOKES DN, 1990, ANAESTHESIA, V45, P1062, DOI 10.1111/j.1365-2044.1990.tb14890.x	8	10	11	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2018	320	12					1235	1236		10.1001/jama.2018.12756	http://dx.doi.org/10.1001/jama.2018.12756			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU8GX	30208399				2022-12-28	WOS:000445577000009
J	Iacobucci, G				Iacobucci, Gareth			NHS staff get online service to voice concerns about working conditions	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rimmer A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1074	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2018	362								k3864	10.1136/bmj.k3864	http://dx.doi.org/10.1136/bmj.k3864			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JC	30201696				2022-12-28	WOS:000445015400014
J	Modi, N; Clarke, J; McKee, M				Modi, Neena; Clarke, Jonathan; McKee, Martin			Health systems should be publicly funded and publicly provided	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SECTOR TREATMENT CENTERS; CARE; SERVICES; ECONOMICS; IMPACT; HOSPITALS; REFORMS; COST		[Modi, Neena] Imperial Coll London, Chelsea & Westminster Campus,369 Fulham Rd, London SW10 9NG, England; [Clarke, Jonathan] Imperial Coll London, Ctr Hlth Policy, London, England; [McKee, Martin] London Sch Hyg & Trop Med, London, England	Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Modi, N (corresponding author), Imperial Coll London, Chelsea & Westminster Campus,369 Fulham Rd, London SW10 9NG, England.	n.modi@imperial.ac.uk	Clarke, Jonathan/S-8958-2019	Clarke, Jonathan/0000-0003-1495-7746				ARROW KJ, 1963, AM ECON REV, V53, P941; Boffey D., 2015, GUARDIAN; Brindle D., 2018, GUARDIAN; Campbell D, 2018, GUARDIAN; Care Quality Commission, 2018, STAT CAR IND AC HOSP; Centre for Health and the Public Interest, NO SAF LIAB REF PRIV; Centre for Health and the Public Interest, HEALTHC FRAUD NEW NH; Chapman A, 2014, HEALTH HUM RIGHTS, V16, P122; Chard J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6404; Clamp JA, 2008, ANN ROY COLL SURG, V90, P492, DOI 10.1308/003588408X301073; Costa ND, 2017, CIENC SAUDE COLETIVA, V22, P1065, DOI 10.1590/1413-81232017224.28192016; Cusano D., 2018, RCGP CHAIR KINGS FUN; Dalton I., 2018, Q PERFORMANCE NHS PR; Davies S, 2010, POLICY POLIT, V38, P445, DOI 10.1332/030557310X488493; Foundation A, 2018, CHOOS WIS PROM CONV; Gulland A., 2017, BMJ-BRIT MED J, V356, pj258; Gulland A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k654; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Herrera CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093456; Hope C., 2015, DAILY TELEGRAPH; Illich I., 1976, LIMITS TO MED; Krachler N, 2015, SOC SCI MED, V124, P215, DOI 10.1016/j.socscimed.2014.11.045; Kruse FM, 2018, INT J HEALTH PLAN M, V33, pE434, DOI 10.1002/hpm.2502; Matthews-King A., INDEPENDENT; McCartney M., 2013, THE PATIENT PARADOX; McCartney M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3959; McKee M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4898; McKelvey A, 2009, BJOG-INT J OBSTET GY, V116, P1520, DOI 10.1111/j.1471-0528.2009.02294.x; O'Dowd A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4479; Plimmer G., 2018, FINANCIAL TIMES; Pollock AM, 2009, J ROY SOC MED, V102, P278, DOI 10.1258/jrsm.2009.090092; Pozzobon D, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017689; Preker AS, 2000, B WORLD HEALTH ORGAN, V78, P779; Public Health England, 2017, HLTH MATT OB FOOD EN; Reynolds L, 2012, CLIN MED, V12, P128, DOI 10.7861/clinmedicine.12-2-128; Rotarou ES, 2017, HEALTH POLICY, V121, P495, DOI 10.1016/j.healthpol.2017.03.005; Royal College of Paediatrics and Child Health, 2018, NAT NEON AUD PROGR N; The Portland Hospital, 2018, LOOK PREM ILL BAB; Thrall JH, 2007, RADIOLOGY, V244, P325, DOI 10.1148/radiol.2442070676; Toffolutti V, 2017, HEALTH AFFAIR, V36, P355, DOI 10.1377/hlthaff.2016.1217; Toffolutti V, 2017, SOC SCI MED, V174, P64, DOI 10.1016/j.socscimed.2016.12.015; Torjesen I, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1256; Turner S, 2011, SOC SCI MED, V73, P522, DOI 10.1016/j.socscimed.2011.06.014; Vanhegan I, 2015, ANN ROY COLL SURG, V97, P519, DOI 10.1308/rcsann.2015.0029; Wiist WH, 2010, BOTTOM LINE PUBLIC H; WILLIAMSON OE, 1979, J LAW ECON, V22, P233, DOI 10.1086/466942	46	9	10	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2018	362								k3580	10.1136/bmj.k3580	http://dx.doi.org/10.1136/bmj.k3580			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GU1JC	30201731	Green Published			2022-12-28	WOS:000445015400003
J	Enserink, M				Enserink, Martin			SCIENTIFIC PUBLISHING European funders seek to end reign of paywalled journals	SCIENCE			English	News Item																			0	8	8	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					957	958		10.1126/science.361.6406.957	http://dx.doi.org/10.1126/science.361.6406.957			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190383				2022-12-28	WOS:000443892700011
J	Kommer, CG				Kommer, Curtis G.			Good Documentation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kommer, Curtis G.] Accord Hospice, 2155 W State Rte 89A,Ste 212, Sedona, AZ 86336 USA		Kommer, CG (corresponding author), Accord Hospice, 2155 W State Rte 89A,Ste 212, Sedona, AZ 86336 USA.	ckommer1955@yahoo.com							0	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2018	320	9					875	876		10.1001/jama.2018.11781	http://dx.doi.org/10.1001/jama.2018.11781			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS4OQ	30193280				2022-12-28	WOS:000443627300010
J	Mi, MY; Matthay, MA; Morris, AH				Mi, Michael Y.; Matthay, Michael A.; Morris, Alan H.			Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mi, Michael Y.] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiol, Boston, MA 02215 USA; [Matthay, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Matthay, Michael A.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA USA; [Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Morris, Alan H.] Univ Utah, Pulm Crit Care Div, Salt Lake City, UT USA	Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah	Mi, MY (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiol, Boston, MA 02215 USA.		Mi, Michael/GZG-4113-2022	Mi, Michael/0000-0001-8031-8948				Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Cavalcanti AB, 2017, JAMA-J AM MED ASSOC, V318, P1335, DOI 10.1001/jama.2017.14171; Combes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Fan E, 2014, AM J RESP CRIT CARE, V189, P1293, DOI 10.1164/rccm.201404-0711ED; Han F, 2015, AM J MED SCI, V349, P199, DOI 10.1097/MAJ.0000000000000379; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Meadow W, 2011, CRIT CARE MED, V39, P474, DOI 10.1097/CCM.0b013e318205df9b; Miller RR, 2010, CHEST, V137, P752, DOI 10.1378/chest.09-2517; Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835; Sahetya SK, 2017, JAMA-J AM MED ASSOC, V318, P1327, DOI 10.1001/jama.2017.13695; Wennberg JE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1513	12	11	12	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2018	379	9					884	887		10.1056/NEJMclde1804601	http://dx.doi.org/10.1056/NEJMclde1804601			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GR9EA	30157406				2022-12-28	WOS:000443047800015
J	Polka, JK; Kiley, R; Konforti, B; Stern, B; Vale, RD				Polka, Jessica K.; Kiley, Robert; Konforti, Boyana; Stern, Bodo; Vale, Ronald D.			Publish peer reviews	NATURE			English	Editorial Material									[Polka, Jessica K.; Vale, Ronald D.] ASAPbio, San Francisco, CA 94143 USA; [Kiley, Robert] Wellcome Trust Res Labs, Open Res, London, England; [Stern, Bodo] Howard Hughes Med Inst, Chevy Chase, MD USA; [Vale, Ronald D.] Univ Calif San Francisco, Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Polka, JK (corresponding author), ASAPbio, San Francisco, CA 94143 USA.	jessica.polka@asapbio.org; ron.vale@ucsf.edu		Polka, Jessica/0000-0001-6610-9293				[Anonymous], 2016, Nat Commun, V7, P13626, DOI 10.1038/ncomms13626; Publishing Research Consortium, 2016, PRC PEER REV SURV 20; Pulverer B, 2010, EMBO J, V29, P3891, DOI 10.1038/emboj.2010.307; Ross-Hellauer T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189311; Ross-Hellauer Tony, 2017, F1000Res, V6, P588, DOI 10.12688/f1000research.11369.2; Tregenza T, 2002, TRENDS ECOL EVOL, V17, P349, DOI 10.1016/S0169-5347(02)02545-4; van Rooyen S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5729	7	30	30	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					545	547		10.1038/d41586-018-06032-w	http://dx.doi.org/10.1038/d41586-018-06032-w			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS0SZ	30158621				2022-12-28	WOS:000443218600021
J	Rubin, R				Rubin, Rita			Partnership to Develop Over-the-Counter Flu Tests	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					748	748		10.1001/jama.2018.11316	http://dx.doi.org/10.1001/jama.2018.11316			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167680				2022-12-28	WOS:000442958800004
J	Fraser, B				Fraser, Barbara			Measles outbreak in the Americas	LANCET			English	Editorial Material																			0	8	11	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2018	392	10145					373	373		10.1016/S0140-6736(18)31727-6	http://dx.doi.org/10.1016/S0140-6736(18)31727-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GP1SM	30152369				2022-12-28	WOS:000440597100007
J	Choo, EK; van Dis, J; Kass, D				Choo, Esther K.; van Dis, Jane; Kass, Dara			Time's Up for Medicine? Only Time Will Tell	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEX-DIFFERENCES		[Choo, Esther K.] Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Portland, OR 97201 USA; [van Dis, Jane] OB Hospitalist Grp, Burbank, CA USA; [Kass, Dara] Columbia Univ, Med Ctr, Dept Emergency Med, New York, NY USA	Oregon Health & Science University; Columbia University	Choo, EK (corresponding author), Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Portland, OR 97201 USA.			Choo, Esther/0000-0001-8847-5745				[Anonymous], 2018, LANCET, V391, P2576, DOI 10.1016/S0140-6736(18)31428-4; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Jena AB, 2015, JAMA-J AM MED ASSOC, V314, P1149, DOI 10.1001/jama.2015.10680; National Academies of Sciences, 2018, ENG MED SEX HAR WOM; Wehner MR, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6311	5	34	35	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2018	379	17					1592	1593		10.1056/NEJMp1809351	http://dx.doi.org/10.1056/NEJMp1809351			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY1GI	30207825				2022-12-28	WOS:000448273500002
J	Koehler, F; Koehler, K; Deckwart, O; Prescher, S; Wegscheider, K; Kirwan, BA; Winkler, S; Vettorazzi, E; Bruch, L; Oeff, M; Zugck, C; Doerr, G; Naegele, H; Stork, S; Butter, C; Sechtem, U; Angermann, C; Gola, G; Prondzinsky, R; Edelmann, F; Spethmann, S; Schellong, SM; Schulze, PC; Bauersachs, J; Wellge, B; Schoebel, C; Tajsic, M; Dreger, H; Anker, SD; Stangl, K				Koehler, Friedrich; Koehler, Kerstin; Deckwart, Oliver; Prescher, Sandra; Wegscheider, Karl; Kirwan, Bridget-Anne; Winkler, Sebastian; Vettorazzi, Eik; Bruch, Leonhard; Oeff, Michael; Zugck, Christian; Doerr, Gesine; Naegele, Herbert; Stoerk, Stefan; Butter, Christian; Sechtem, Udo; Angermann, Christiane; Gola, Guntram; Prondzinsky, Roland; Edelmann, Frank; Spethmann, Sebastian; Schellong, Sebastian M.; Schulze, P. Christian; Bauersachs, Johann; Wellge, Brunhilde; Schoebel, Christoph; Tajsic, Milos; Dreger, Henryk; Anker, Stefan D.; Stangl, Karl			Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial	LANCET			English	Article							ALERTS; CARE	Background Remote patient management in patients with heart failure might help to detect early signs and symptoms of cardiac decompensation, thus enabling a prompt initiation of the appropriate treatment and care before a full manifestation of a heart failure decompensation. We aimed to investigate the efficacy of our remote patient management intervention on mortality and morbidity in a well defined heart failure population. Methods The Telemedical Interventional Management in Heart Failure II (TIM-HF2) trial was a prospective, randomised, controlled, parallel-group, unmasked (with randomisation concealment), multicentre trial with pragmatic elements introduced for data collection. The trial was done in Germany, and patients were recruited from hospitals and cardiology practices. Eligible patients had heart failure, were in New York Heart Association class II or III, had been admitted to hospital for heart failure within 12 months before randomisation, and had a left ventricular ejection fraction (LVEF) of 45% or lower (or if higher than 45%, oral diuretics were being prescribed). Patients with major depression were excluded. Patients were randomly assigned (1:1) using a secure web-based system to either remote patient management plus usual care or to usual care only and were followed up for a maximum of 393 days. The primary outcome was percentage of days lost due to unplanned cardiovascular hospital admissions or all-cause death, analysed in the full analysis set. Key secondary outcomes were all-cause and cardiovascular mortality. This study is registered with ClinicalTrials.gov, number NCT01878630, and has now been completed. Findings Between Aug 13,2013, and May 12,2017,1571 patients were randomly assigned to remote patient management (n=796) or usual care (n=775). Of these 1571 patients, 765 in the remote patient management group and 773 in the usual care group started their assigned care, and were included in the full analysis set. The percentage of days lost due to unplanned cardiovascular hospital admissions and all-cause death was 4.88% (95% CI 4.55-5.23) in the remote patient management group and 6.64% (6.19-7.13) in the usual care group (ratio 0.80, 95% CI 0.65-1.00; p=0.0460). Patients assigned to remote patient management lost a mean of 17.8 days (95% CI 16.6-19.1) per year compared with 24.2 days (22.6-26.0) per year for patients assigned to usual care. The all-cause death rate was 7.86 (95% CI 6.14-10.10) per 100 person-years of follow-up in the remote patient management group compared with 11.34 (9.21-13.95) per 100 person-years of follow-up in the usual care group (hazard ratio [HR] 0.70, 95% CI 0-50-0.96; p=0.0280). Cardiovascular mortality was not significantly different between the two groups (HR 0-671,95% CI 0.45-1.01; p=0.0560). Interpretation The TIM-HF2 trial suggests that a structured remote patient management intervention, when used in a well defined heart failure population, could reduce the percentage of days lost due to unplanned cardiovascular hospital admissions and all-cause mortality.	[Koehler, Friedrich; Koehler, Kerstin; Deckwart, Oliver; Prescher, Sandra; Wellge, Brunhilde] Charite Univ Med Berlin, Ctr Cardiovasc Telemed, Campus Mitte, Berlin, Germany; [Schoebel, Christoph; Tajsic, Milos; Dreger, Henryk; Stangl, Karl] Charite Univ Med Berlin, Dept Cardiol & Angiol, Campus Mitte, Berlin, Germany; [Edelmann, Frank] Charite Univ Med Berlin, Dept Cardiol, Campus Virchow Klinikum, Berlin, Germany; [Anker, Stefan D.] Charite Univ Med Berlin, Div Cardiol & Metab, Dept Cardiol, Campus Virchow Klinikum, Berlin, Germany; [Wegscheider, Karl; Vettorazzi, Eik] Med Ctr Hamburg Eppendorf UKE, Inst Med Biometry & Epidemiol, Hamburg, Germany; [Kirwan, Bridget-Anne] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London, England; [Winkler, Sebastian; Bruch, Leonhard] Unfallkrankenhaus Berlin, Clin Internal Med & Cardiol, Berlin, Germany; [Oeff, Michael] Municipal Hosp, Telemed Ctr, Dept Cardiol, Brandenburg Havel, Germany; [Oeff, Michael] Brandenburg Med Sch, Brandenburg Havel, Germany; [Zugck, Christian] Cardiol Practice Im Steiner Thor, Straubing, Germany; [Doerr, Gesine] St Josefs Krankenhaus Potsdam, Clin Internal Med, Potsdam, Germany; [Naegele, Herbert] Albertinen Cardiovasc Ctr, Dept Heart Insufficiency & Device Therapy, Hamburg, Germany; [Stoerk, Stefan; Angermann, Christiane] Univ & Univ Hosp Wurzburg, Comprehens Heart Failure Ctr CHFC Wurzburg, Wurzburg, Germany; [Butter, Christian] Immanuel Hosp Bernau, Dept Cardiol, Brandenburg Heart Ctr, Bernau, Germany; [Butter, Christian] Med Sch Brandenburg Theodor Fontane, Bernau, Germany; [Sechtem, Udo] Robert Bosch Krankenhaus, Dept Cardiol, Stuttgart, Germany; [Gola, Guntram] Cardiol Practice, Berlin, Germany; [Prondzinsky, Roland] Carl von Basedow Klinikum Merseburg, Dept Internal Med 1, Merseburg, Germany; [Edelmann, Frank] BIH, Berlin, Germany; [Spethmann, Sebastian] Fed Armed Forces Hosp Berlin, Dept Internal Med, Div Cardiol, Berlin, Germany; [Schellong, Sebastian M.] Municipal Hosp Dresden, Med Dept 2, Dresden, Germany; [Schulze, P. Christian] Friedrich Schiller Univ Jena, Div Cardiol Angiol Pneumol & Intens Med Care, Dept Internal Med 1, Univ Hosp Jena, Jena, Germany; [Bauersachs, Johann] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Anker, Stefan D.] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Edelmann, Frank; Anker, Stefan D.; Stangl, Karl] German Ctr Cardiovasc Res DZHK, Partner Site Berlin, Berlin, Germany; [Anker, Stefan D.] Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; London School of Hygiene & Tropical Medicine; University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Berlin Institute of Health; Technische Universitat Dresden; Municipal Hospital Dresden; Friedrich Schiller University of Jena; Hannover Medical School; German Centre for Cardiovascular Research; University of Gottingen	Koehler, F (corresponding author), Charite Univ Med Berlin, Ctr Cardiovasc Telemed, Dept Cardiol & Angiol, Campus Mitte, D-10117 Berlin, Germany.	friedrich.koehler@charite.de	Schulze, Christian/AGJ-7744-2022; Deckwart, Oliver/Y-4218-2019; Stork, Stefan/AAR-4182-2020; Vettorazzi, Eik/B-8130-2019; Dreger, Henryk/A-9733-2009	Schulze, Christian/0000-0001-9442-7141; Deckwart, Oliver/0000-0002-8333-0931; Stork, Stefan/0000-0002-1771-7249; Vettorazzi, Eik/0000-0002-3737-6402; Dreger, Henryk/0000-0003-1909-4329; Spethmann, Sebastian/0000-0003-0987-8007; Prescher, Sandra/0000-0002-1962-701X; Koehler, Friedrich/0000-0003-0441-4123; Edelmann, Frank/0000-0003-4401-5936; Kohler, Kerstin/0000-0001-9503-2432; Winkler, Sebastian/0000-0002-0926-311X	German Federal Ministry of Education and Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	German Federal Ministry of Education and Research.	Abraham WT, 2011, LANCET, V377, P658, DOI 10.1016/S0140-6736(11)60101-3; Anker SD, 2011, LANCET, V378, P731, DOI 10.1016/S0140-6736(11)61229-4; Bohm M, 2016, EUR HEART J, V37, P3154, DOI 10.1093/eurheartj/ehw099; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Chioncel O, 2017, EUR J HEART FAIL, V19, P1574, DOI 10.1002/ejhf.813; Cleland JGF, 2005, J AM COLL CARDIOL, V45, P1654, DOI 10.1016/j.jacc.2005.01.050; Cowie MR, 2016, EUR HEART J, V37, P63, DOI 10.1093/eurheartj/ehv416; Cowie MR, 2014, ESC HEART FAIL, V1, P110, DOI 10.1002/ehf2.12021; Dierckx R, 2017, EUR J HEART FAIL, V19, P304, DOI 10.1002/ejhf.759; Garthwaite PH, 1996, BIOMETRICS, V52, P1387, DOI 10.2307/2532852; Hindricks G, 2014, LANCET, V384, P583, DOI 10.1016/S0140-6736(14)61176-4; Inglis SC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub3; Koehler F, EUR J HEART FAIL; Koehler F, 2012, INT J CARDIOL, V161, P143, DOI 10.1016/j.ijcard.2011.09.007; Koehler F, 2011, CIRCULATION, V123, P1873, DOI 10.1161/CIRCULATIONAHA.111.018473; Morgan JM, 2017, EUR HEART J, V38, P2352, DOI 10.1093/eurheartj/ehx227; Ong MK, 2016, JAMA INTERN MED, V176, P310, DOI 10.1001/jamainternmed.2015.7712; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; van Riet EES, 2016, EUR J HEART FAIL, V18, P242, DOI 10.1002/ejhf.483; van Veldhuisen DJ, 2011, CIRCULATION, V124, P1719, DOI 10.1161/CIRCULATIONAHA.111.043042	21	268	273	3	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2018	392	10152					1047	1057		10.1016/S0140-6736(18)31880-4	http://dx.doi.org/10.1016/S0140-6736(18)31880-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU2KP	30153985				2022-12-28	WOS:000445098800027
J	Bohnert, ASB; Guy, GP; Losby, JL				Bohnert, Amy S. B.; Guy, Gery P., Jr.; Losby, Jan L.			Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline	ANNALS OF INTERNAL MEDICINE			English	Article							INTERRUPTED TIME-SERIES; CLINICAL GUIDELINES; MEDICAL-PRACTICE; OVERDOSE DEATHS; CHRONIC PAIN; IMPACT; DRUG; PATTERNS; PHYSICIANS; EPIDEMIC	Background: In response to adverse outcomes from prescription opioids, the Centers for Disease Control and Prevention (CDC) released the Guideline for Prescribing Opioids for Chronic Pain in March 2016. Objective: To test the hypothesis that the CDC guideline release corresponded to declines in specific opioid prescribing practices. Design: Interrupted time series analysis of monthly prescribing measures from the IQVIA transactional data warehouse and Real-World Data Longitudinal Prescriptions population-level estimates based on retail pharmacy data. Population size was determined by U.S. Census monthly estimates. Setting: United States, 2012 to 2017. Patients: Persons prescribed opioid analgesics. Measurements: Outcomes included opioid dosage, days supplied, overlapping benzodiazepine prescriptions, and the overall rate of prescribing. Results: The rate of high-dosage prescriptions (>= 90 morphine equivalent milligrams per day) was 683 per 100 000 persons in January 2012 and declined by 3.56 (95% CI, -3.79 to -3.32) per month before March 2016 and by 8.00 (CI, -8.69 to -7.31) afterward. Likewise, the percentage of patients with overlapping opioid and benzodiazepine prescriptions was 21.04% in January 2012 and declined by 0.02% (CI, -0.04% to -0.01%) per month before the CDC guideline release and by 0.08% (CI, -0.08% to -0.07%) per month afterward. The overall opioid prescribing rate was 6577 per 100 000 persons in January 2012 and declined by 23.48 (CI, -26.18 to -20.78) each month before the guideline release and by 56.74 (CI, -65.96 to -47.53) per month afterward. Limitation: No control population; inability to determine the appropriateness of opioid prescribing. Conclusion: Several opioid prescribing practices were decreasing before the CDC guideline, but the time of its release was associated with a greater decline. Guidelines may be effective in changing prescribing practices.	[Bohnert, Amy S. B.] Univ Michigan, North Campus Res Complex,2800 Plymouth Rd,Bldg 16, Ann Arbor, MI 48109 USA; [Bohnert, Amy S. B.] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Guy, Gery P., Jr.; Losby, Jan L.] Ctr Dis Control & Prevent, 4770 Buford Highway NE,MS F-62, Atlanta, GA 30041 USA	University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA	Guy, GP (corresponding author), Ctr Dis Control & Prevent, Div Unintent Injury Prevent, 4770 Buford Highway NE,MS F-62, Atlanta, GA 30041 USA.	gguy@cdc.gov			CDC	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the CDC via employment of Drs. Guy and Losby, an intergovernmental personnel agreement with Dr. Bohnert, and costs associated with data acquisition.	[Anonymous], 2010, VA DOD CLIN PRACT GU; AUDET AM, 1990, ANN INTERN MED, V113, P709, DOI 10.7326/0003-4819-113-9-709; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Brands B, 2004, DRUG ALCOHOL DEPEN, V73, P199, DOI 10.1016/j.drugalcdep.2003.10.012; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; Centers for Disease Control and Prevention, OV PREV; Centers for Disease Control and Prevention, GUID RES; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Corcoran P, 2015, INT J EPIDEMIOL, V44, P969, DOI 10.1093/ije/dyv058; Cram P, 2003, ARCH INTERN MED, V163, P1601, DOI 10.1001/archinte.163.13.1601; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Evans DGR, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0442-6; French DD, 2005, PHARMACOEPIDEM DR S, V14, P17, DOI 10.1002/pds.967; Gellad WF, 2017, JAMA INTERN MED, V177, P611, DOI 10.1001/jamainternmed.2017.0147; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Haegerich TM, 2014, DRUG ALCOHOL DEPEN, V145, P34, DOI 10.1016/j.drugalcdep.2014.10.001; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Han B, 2015, JAMA-J AM MED ASSOC, V314, P1468, DOI 10.1001/jama.2015.11859; Hedegaard H., 2017, DRUG OVERDOSE DEATHS; Lin LWA, 2017, PAIN, V158, P833, DOI 10.1097/j.pain.0000000000000837; Linden A, 2017, STATA J, V17, P73, DOI 10.1177/1536867X1701700105; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; Miller M, 2014, JAMA INTERN MED, V174, P899, DOI 10.1001/jamainternmed.2014.1053; National Center for Injury Prevention and Control, 2018, DAT RES OR MMES; Nuckols TK, 2014, ANN INTERN MED, V160, P38, DOI 10.7326/0003-4819-160-1-201401070-00732; Park TW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2698; Paulozzi LJ, 2011, J CLIN PSYCHIAT, V72, P589, DOI 10.4088/JCP.10com06560; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Soumerai SB, 2017, J GEN INTERN MED, V32, P204, DOI 10.1007/s11606-016-3841-9; U. S. Census Bureau Population Division, 2017, MONTH POP EST US; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	37	216	215	2	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2018	169	6					367	+		10.7326/M18-1243	http://dx.doi.org/10.7326/M18-1243			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT7CZ	30167651	Green Accepted			2022-12-28	WOS:000444679800013
J	Scaturro, P; Stukalov, A; Haas, DA; Cortese, M; Draganova, K; Plaszczyca, A; Bartenschlager, R; Gotz, M; Pichlmair, A				Scaturro, Pietro; Stukalov, Alexey; Haas, Darya A.; Cortese, Mirko; Draganova, Kalina; Plaszczyca, Anna; Bartenschlager, Ralf; Goetz, Magdalena; Pichlmair, Andreas			An orthogonal proteomic survey uncovers novel Zika virus host factors	NATURE			English	Article							PROTEIN; PHOSPHOPROTEOMICS; DIFFERENTIATION; ENRICHMENT; PLATFORM; GENOME; KINASE; CELLS	Zika virus (ZIKV) has recently emerged as a global health concern owing to its widespread diffusion and its association with severe neurological symptoms and microcephaly in newborns(1). However, the molecular mechanisms that are responsible for the pathogenicity of ZIKV remain largely unknown. Here we use human neural progenitor cells and the neuronal cell line SK-N-BE2 in an integrated proteomics approach to characterize the cellular responses to viral infection at the proteome and phosphoproteome level, and use affinity proteomics to identify cellular targets of ZIKV proteins. Using this approach, we identify 386 ZIKV-interacting proteins, ZIKV-specific and pan-flaviviral activities as well as host factors with known functions in neuronal development, retinal defects and infertility. Moreover, our analysis identified 1,216 phosphorylation sites that are specifically up-or downregulated after ZIKV infection, indicating profound modulation of fundamental signalling pathways such as AKT, MAPK-ERK and ATM-ATR and thereby providing mechanistic insights into the proliferation arrest elicited by ZIKV infection. Functionally, our integrative study identifies ZIKV host-dependency factors and provides a comprehensive framework for a system-level understanding of ZIKV-induced perturbations at the levels of proteins and cellular pathways.	[Scaturro, Pietro; Stukalov, Alexey; Haas, Darya A.; Pichlmair, Andreas] Max Planck Inst Biochem, Innate Immun Lab, Martinsried, Germany; [Scaturro, Pietro; Stukalov, Alexey; Pichlmair, Andreas] Tech Univ Munich, Inst Virol, Sch Med, Munich, Germany; [Cortese, Mirko; Plaszczyca, Anna; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany; [Draganova, Kalina; Goetz, Magdalena] Helmholtz Ctr Munich, Inst Stem Cell Res, Neuherberg, Germany; [Draganova, Kalina; Goetz, Magdalena] Ludwig Maximilians Univ Munchen, Biomed Ctr, Physiol Genom, Munich, Germany; [Bartenschlager, Ralf] German Ctr Infect Res DZIF, Heidelberg Partner Site, Heidelberg, Germany; [Goetz, Magdalena] Ludwig Maximilians Univ Munchen, Biomed Ctr, Synergy, Excellence Cluster Syst Neurol, Munich, Germany; [Pichlmair, Andreas] German Ctr Infect Res DZIF, Munich Partner Site, Munich, Germany	Max Planck Society; Technical University of Munich; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; German Center for Infection Research; University of Munich; German Center for Infection Research	Scaturro, P; Pichlmair, A (corresponding author), Max Planck Inst Biochem, Innate Immun Lab, Martinsried, Germany.; Scaturro, P; Pichlmair, A (corresponding author), Tech Univ Munich, Inst Virol, Sch Med, Munich, Germany.; Pichlmair, A (corresponding author), German Ctr Infect Res DZIF, Munich Partner Site, Munich, Germany.	pietro.scaturro@tum.de; andreas.pichlmair@tum.de	Cortese, Mirko/T-4742-2019; Stukalov, Alexey/AAS-3208-2021	Cortese, Mirko/0000-0003-1786-4211; Stukalov, Alexey/0000-0002-4981-8124; Draganova, Kalina/0000-0002-0287-0937; Scaturro, Pietro/0000-0001-9098-3087; Haas, Darya/0000-0001-5543-4875	ERC starting grant [StG 311339]; Max-Planck free-floater program; German Research Foundation [PI1084/2, PI1084/3, PI1084/4, TRR 237, TRR179]; Federal Ministry for Education and Research (ERA-Net grant ERASe); Deutsche Forschungsgemeinschaft [BA1505/8-1]; Horizon 2020: Marie Sklodowska-Curie ETN "ANTIVIRALS" [642434]; DFG [SFB871]; advanced ERC grant ChroNeuroRepair	ERC starting grant(European Research Council (ERC)); Max-Planck free-floater program; German Research Foundation(German Research Foundation (DFG)); Federal Ministry for Education and Research (ERA-Net grant ERASe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Horizon 2020: Marie Sklodowska-Curie ETN "ANTIVIRALS"; DFG(German Research Foundation (DFG)); advanced ERC grant ChroNeuroRepair	We thank D. Mauceri, F. Sacco and L. Chatel-Chaix for discussions and R. Hornberger, I. Paron, K. Mayr and G. Sowa for technical assistance. The work in the authors' laboratory was funded by an ERC starting grant (StG 311339, iVIP), the Max-Planck free-floater program, the German Research Foundation (PI1084/2, PI1084/3, PI1084/4, TRR 237 and TRR179) and the Federal Ministry for Education and Research (ERA-Net grant ERASe) all to A.Pi. R.B. was supported by the Deutsche Forschungsgemeinschaft (BA1505/8-1). A. Pl. was supported by the Horizon 2020: Marie Sklodowska-Curie ETN "ANTIVIRALS" (grant agreement 642434 to R.B.). M.G. was supported by the DFG (SFB871) and the advanced ERC grant ChroNeuroRepair.	Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004; Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957; Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008; Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243; El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266; Gebhardt A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9192; Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111; Havlicek S, 2014, HUM MOL GENET, V23, P2527, DOI 10.1093/hmg/ddt644; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327; Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05; Li HM, 2008, MOL BIOL CELL, V19, P4804, DOI 10.1091/mbc.E08-03-0294; Li H, 2009, STEM CELLS, V27, P1244, DOI 10.1002/stem.55; Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170; Ochrietor JD, 2004, DEV NEUROSCI-BASEL, V26, P380, DOI 10.1159/000082280; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Paul D, 2015, J GEN VIROL, V96, P1696, DOI 10.1099/vir.0.000111; Politis PK, 2007, P NATL ACAD SCI USA, V104, P17861, DOI 10.1073/pnas.0610973104; Radke J, 2015, BBA-MOL BASIS DIS, V1852, P2262, DOI 10.1016/j.bbadis.2015.05.007; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028; Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752; Slomnicki LP, 2016, MOL CELL PROTEOMICS, V15, P2055, DOI 10.1074/mcp.M115.051920; Soderholm S, 2016, MOL CELL PROTEOMICS, V15, P3203, DOI 10.1074/mcp.M116.057984; Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Tarlungeanu DC, 2016, CELL, V167, P1481, DOI 10.1016/j.cell.2016.11.013; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wojcechowskyj JA, 2013, CELL HOST MICROBE, V13, P613, DOI 10.1016/j.chom.2013.04.011; Yamashita N, 2012, J NEUROSCI, V32, P1360, DOI 10.1523/JNEUROSCI.5563-11.2012	38	96	98	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2018	561	7722					253	+		10.1038/s41586-018-0484-5	http://dx.doi.org/10.1038/s41586-018-0484-5			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT3XQ	30177828	Green Submitted			2022-12-28	WOS:000444437900046
J	D'Silva, J				D'Silva, Jeetha			Glad to be gay in India	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2018	362								k3885	10.1136/bmj.k3885	http://dx.doi.org/10.1136/bmj.k3885			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JF	30206145				2022-12-28	WOS:000445015700008
J	Herberg, S; Gert, KR; Schleiffer, A; Pauli, A				Herberg, Sarah; Gert, Krista R.; Schleiffer, Alexander; Pauli, Andrea			The Ly6/uPAR protein Bouncer is necessary and sufficient for species-specific fertilization	SCIENCE			English	Article							GAMETE RECOGNITION PROTEINS; EGG VITELLINE ENVELOPE; MAMMALIAN FERTILIZATION; ZONA-PELLUCIDA; CD9-DEFICIENT MICE; SPERM ADHESION; RECEPTOR; SEA; SUPERFAMILY; MECHANISM	Fertilization is fundamental for sexual reproduction, yet its molecular mechanisms are poorly understood. We found that an oocyte-expressed Ly6/uPAR protein, which we call Bouncer, is a crucial fertilization factor in zebrafish. Membrane-bound Bouncer mediates sperm-egg binding and is thus essential for sperm entry into the egg. Remarkably, Bouncer not only is required for sperm-egg interaction but is also sufficient to allow cross-species fertilization between zebrafish and medaka, two fish species that diverged more than 200 million years ago. Our study thus identifies Bouncer as a key determinant of species-specific fertilization in fish. Bouncer's closest homolog in tetrapods, SPACA4, is restricted to the male germline in internally fertilizing vertebrates, which suggests that our findings in fish have relevance to human biology.	[Herberg, Sarah; Gert, Krista R.; Schleiffer, Alexander; Pauli, Andrea] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Schleiffer, Alexander] Vienna Bioctr VBC, Inst Mol Biotechnol, Austrian Acad Sci IMBA, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Pauli, A (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria.	andrea.pauli@imp.ac.at		Gert, Krista/0000-0002-5673-5335; Schleiffer, Alexander/0000-0001-6251-2747; Pauli, Andrea/0000-0001-9646-2303	Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim; Austrian Academy of Sciences; HFSP Career Development Award [CDA00066/2015]; FWF START program	Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Academy of Sciences; HFSP Career Development Award; FWF START program	Supported by the Research Institute of Molecular Pathology (IMP), Boehringer Ingelheim, and the Austrian Academy of Sciences; a DOC Fellowship from the Austrian Academy of Sciences (S.H.); and HFSP Career Development Award CDA00066/2015 and the FWF START program (A.P.).	Avella MA, 2014, J CELL BIOL, V205, P801, DOI 10.1083/jcb.201404025; Bianchi E, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0101; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Chew GL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11663; Chew GL, 2013, DEVELOPMENT, V140, P2828, DOI 10.1242/dev.098343; Firman RC, 2017, TRENDS ECOL EVOL, V32, P368, DOI 10.1016/j.tree.2017.02.010; Haberle V, 2014, NATURE, V507, P381, DOI 10.1038/nature12974; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; Kamei N, 2003, GENE DEV, V17, P2502, DOI 10.1101/gad.1133003; Kato K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12198; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Levitan DR, 2018, AM NAT, V191, P88, DOI 10.1086/694780; Levitan DR, 2006, SCIENCE, V312, P267, DOI 10.1126/science.1122183; LEWIS CA, 1982, DEV BIOL, V92, P227, DOI 10.1016/0012-1606(82)90167-1; Li B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04520-z; Loughner CL, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0074-2; Lyon JD, 1999, DEV BIOL, V214, P151, DOI 10.1006/dbio.1999.9411; Marin R, 2017, GENOME RES, V27, P1974, DOI 10.1101/gr.223727.117; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Pasquier J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2709-z; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Raj I, 2017, CELL, V169, P1315, DOI 10.1016/j.cell.2017.05.033; Satouh Y, 2012, J CELL SCI, V125, P4985, DOI 10.1242/jcs.100867; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Shetty J, 2003, J BIOL CHEM, V278, P30506, DOI 10.1074/jbc.M301713200; Stapper AP, 2015, MOL BIOL EVOL, V32, P859, DOI 10.1093/molbev/msv010; Swanson WJ, 1997, P NATL ACAD SCI USA, V94, P6724, DOI 10.1073/pnas.94.13.6724; Tardif S, 2010, J BIOL CHEM, V285, P24863, DOI 10.1074/jbc.M110.123125; VACQUIER VD, 1977, P NATL ACAD SCI USA, V74, P2456, DOI 10.1073/pnas.74.6.2456; Wang ZC, 2017, COMP BIOCHEM PHYS D, V22, P50, DOI 10.1016/j.cbd.2017.02.002; Wassarman P. M., 2016, BESPOKE COAT EGGS GE; Wassarman PM, 2008, INT J DEV BIOL, V52, P665, DOI 10.1387/ijdb.072524pw	33	39	41	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					1029	+		10.1126/science.aat7113	http://dx.doi.org/10.1126/science.aat7113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190407	Green Accepted, Green Submitted			2022-12-28	WOS:000443892700050
J	Spires-Jones, TL; Ritchie, CW				Spires-Jones, Tara L.; Ritchie, Craig W.			A brain boost to fight Alzheimer's disease	SCIENCE			English	Editorial Material							HIPPOCAMPAL NEUROGENESIS; BETA		[Spires-Jones, Tara L.] Univ Edinburgh, Ctr Discovery Brain Sci, UK Dementia Res Inst, Edinburgh, Midlothian, Scotland; [Ritchie, Craig W.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Spires-Jones, TL (corresponding author), Univ Edinburgh, Ctr Discovery Brain Sci, UK Dementia Res Inst, Edinburgh, Midlothian, Scotland.	tara.spires-jones@ed.ac.uk	Spires-Jones, Tara/AAR-7697-2020	Spires-Jones, Tara/0000-0003-2530-0598	MRC [UKDRI-4004] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Chen MK, 2018, JAMA NEUROL, V75, P1215, DOI 10.1001/jamaneurol.2018.1836; Choi SH, 2018, SCIENCE, V361, P991, DOI 10.1126/science.aan8821; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Forbes D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub4; Gomez-Nicola D, 2014, BRAIN, V137, P2312, DOI 10.1093/brain/awu155; Hamer M, 2018, J EPIDEMIOL COMMUN H, V72, P477, DOI 10.1136/jech-2017-210228; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Young J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005381.pub4	14	6	7	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					975	976		10.1126/science.aau8060	http://dx.doi.org/10.1126/science.aau8060			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS7OT	30190391				2022-12-28	WOS:000443892700027
J	Murphy, DC				Murphy, Declan C.			Rise in long term consultant vacancies in Scotland is "deeply troubling," says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Murphy, Declan C/0000-0001-9295-7712				Rimmer A, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3746; Scotland IDS, 2018, NHS SCOTL WORKF INF	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2018	362								k3828	10.1136/bmj.k3828	http://dx.doi.org/10.1136/bmj.k3828			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WS	30190340				2022-12-28	WOS:000444507200010
J	Watkins, K; Sridhar, D				Watkins, Kevin; Sridhar, Devi			Pneumonia: a global cause without champions	LANCET			English	Editorial Material									[Watkins, Kevin] Save Children UK, London EC1M 4AR, England; [Sridhar, Devi] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Global Hlth Governance Programme, Edinburgh EH8 9LD, Midlothian, Scotland	Save the Children; University of Edinburgh	Watkins, K (corresponding author), Save Children UK, London EC1M 4AR, England.	k.watkins@savethechildren.org.uk			 [GHR 16/136/109]		KW is CEO of Save the Children UK. DS served on the Board of Save the Children (2014-16) and is a co-investigator on the NIHR Global Health Research Unit on Respiratory Health at the University of Edinburgh, funding number GHR 16/136/109. We declare no other competing interests.	Bradley BD, 2015, HEALTH TECHNOL-GER, V4, P319, DOI 10.1007/s12553-015-0094-2; Campbell H, 2015, LANCET GLOB HEALTH, V3, pE65, DOI 10.1016/S2214-109X(14)70308-0; Ginsburg AS, 2016, LANCET GLOB HEALTH, V4, pE893, DOI 10.1016/S2214-109X(16)30296-0; Just Actions, 2018, EV BREATH COUNTS PUB; Kevin W., 2017, FIGHTING BREATH CALL; Mulholland K., 2016, PNEUMONIA CHILDREN E; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Sridhar D, 2010, J LAW MED ETHICS, V38, P459, DOI 10.1111/j.1748-720X.2010.00505.x; UN Inter-agency group for Child Mortality Estimation, 2017, UN INT GROUP CHIL MO; UNICEF, 2016, ONE IS TOO MANY END; WHO, 2018, DRAFT 13 GEN PROGR W	11	21	23	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2018	392	10149					718	719		10.1016/S0140-6736(18)31666-0	http://dx.doi.org/10.1016/S0140-6736(18)31666-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS0VL	30191817				2022-12-28	WOS:000443226900007
J	Cotter, KA; Rubin, MA				Cotter, Kellie A.; Rubin, Mark A.			Sequence of events in prostate cancer	NATURE			English	Editorial Material							ANDROGEN-RECEPTOR GENE; SUPER-ENHANCERS		[Cotter, Kellie A.; Rubin, Mark A.] Univ Bern, Dept BioMed Res, CH-3008 Bern, Switzerland; [Cotter, Kellie A.; Rubin, Mark A.] Inselspital Bern, Bern, Switzerland; [Rubin, Mark A.] Weill Cornell Med, New York, NY 10065 USA	University of Bern; Cornell University	Rubin, MA (corresponding author), Univ Bern, Dept BioMed Res, CH-3008 Bern, Switzerland.; Rubin, MA (corresponding author), Inselspital Bern, Bern, Switzerland.; Rubin, MA (corresponding author), Weill Cornell Med, New York, NY 10065 USA.	mark.rubin@dbmr.unibe.ch		Cotter, Kellie/0000-0002-2574-815X; Rubin, Mark/0000-0002-8321-9950				Aggarwal R, 2016, EUR UROL FOCUS, V2, P469, DOI 10.1016/j.euf.2016.10.011; Armenia J, 2018, NAT GENET, V50, P645, DOI 10.1038/s41588-018-0078-z; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Glodzik D, 2017, NAT GENET, V49, P341, DOI 10.1038/ng.3771; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Holmes MG, 2017, J VASC INTERV RADIOL, V28, P1073, DOI 10.1016/j.jvir.2017.04.019; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Quigley DA, 2018, CELL, V174, P758, DOI 10.1016/j.cell.2018.06.039; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Takeda DY, 2018, CELL, V174, P422, DOI 10.1016/j.cell.2018.05.037; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Viswanathan SR, 2018, CELL, V174, P433, DOI 10.1016/j.cell.2018.05.036; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470	17	4	4	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					557	+		10.1038/d41586-018-06029-5	http://dx.doi.org/10.1038/d41586-018-06029-5			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS0SZ	30143757	Bronze			2022-12-28	WOS:000443218600031
J	DeVries, PMR; Viegas, F; Wattenberg, M; Meade, BJ				DeVries, Phoebe M. R.; Viegas, Fernanda; Wattenberg, Martin; Meade, Brendan J.			Deep learning of aftershock patterns following large earthquakes	NATURE			English	Article							STRONG-MOTION DATA; WAVE-FORM INVERSION; SOURCE RUPTURE PROCESS; STRONG GROUND MOTION; 1992 LANDERS EARTHQUAKE; TOKACHI-OKI EARTHQUAKE; LOMA-PRIETA EARTHQUAKE; TELESEISMIC BODY-WAVE; 1979 IMPERIAL-VALLEY; HYOGO-KEN NANBU	Aftershocks are a response to changes in stress generated by large earthquakes and represent the most common observations of the triggering of earthquakes. The maximum magnitude of aftershocks and their temporal decay are well described by empirical laws (such as Bath's law(1) and Omori's law(2)), but explaining and forecasting the spatial distribution of aftershocks is more difficult. Coulomb failure stress change(3) is perhaps the most widely used criterion to explain the spatial distributions of aftershocks(4-8), but its applicability has been disputed(9-11). Here we use a deep-learning approach to identify a static-stress-based criterion that forecasts aftershock locations without prior assumptions about fault orientation. We show that a neural network trained on more than 131,000 mainshock-aftershock pairs can predict the locations of aftershocks in an independent test dataset of more than 30,000 mainshock-aftershock pairs more accurately (area under curve of 0.849) than can classic Coulomb failure stress change (area under curve of 0.583). We find that the learned aftershock pattern is physically interpretable: the maximum change in shear stress, the von Mises yield criterion (a scaled version of the second invariant of the deviatoric stress-change tensor) and the sum of the absolute values of the independent components of the stress-change tensor each explain more than 98 per cent of the variance in the neural-network prediction. This machine-learning-driven insight provides improved forecasts of aftershock locations and identifies physical quantities that may control earthquake triggering during the most active part of the seismic cycle.	[DeVries, Phoebe M. R.; Meade, Brendan J.] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA; [DeVries, Phoebe M. R.] Univ Connecticut, Ctr Integrat Geosci, Storrs, CT 06269 USA; [DeVries, Phoebe M. R.] Univ Connecticut, Dept Phys, Storrs, CT 06269 USA; [Viegas, Fernanda; Wattenberg, Martin] Google, Cambridge, MA USA	Harvard University; University of Connecticut; University of Connecticut; Google Incorporated	DeVries, PMR (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.; DeVries, PMR (corresponding author), Univ Connecticut, Ctr Integrat Geosci, Storrs, CT 06269 USA.; DeVries, PMR (corresponding author), Univ Connecticut, Dept Phys, Storrs, CT 06269 USA.	phoebe.devries@uconn.edu		Wattenberg, Martin/0000-0003-0904-4862	Harvard University; Google	Harvard University; Google(Google Incorporated)	This work was supported by Harvard University and Google. The computations in this paper were run on the Odyssey cluster supported by the FAS Division of Science, Research Computing Group at Harvard University.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Ammon CJ, 2005, SCIENCE, V308, P1133, DOI 10.1126/science.1112260; [Anonymous], 2012, ARXIV PREPRINT ARXIV; [Anonymous], 1998, J SEISMOLOGICAL SOC; ARCHULETA RJ, 1984, J GEOPHYS RES, V89, P4559, DOI 10.1029/JB089iB06p04559; Asano K, 2005, B SEISMOL SOC AM, V95, P1701, DOI 10.1785/0120040154; Atzori S, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009178; BATH M, 1965, TECTONOPHYSICS, V2, P483, DOI 10.1016/0040-1951(65)90003-X; Bejar-Pizarro M, 2010, GEOPHYS J INT, V183, P390, DOI 10.1111/j.1365-246X.2010.04748.x; Birgoren G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019194; Bouchon M, 2002, B SEISMOL SOC AM, V92, P256, DOI 10.1785/0120000845; Cakir Z, 2003, GEOPHYS J INT, V155, P93, DOI 10.1046/j.1365-246X.2003.02001.x; Calais E, 2010, NAT GEOSCI, V3, P794, DOI [10.1038/ngeo992, 10.1038/NGEO992]; Chi WC, 2001, B SEISMOL SOC AM, V91, P1144; Cho I, 2000, B SEISMOL SOC AM, V90, P450, DOI 10.1785/0119990078; Cirella A, 2012, GEOPHYS J INT, V190, P607, DOI 10.1111/j.1365-246X.2012.05505.x; COHEE BP, 1994, B SEISMOL SOC AM, V84, P692; Copley A., SOURCE MODELS LARGE; Copley A, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008137; COTTON F, 1995, J GEOPHYS RES-SOL EA, V100, P3961, DOI 10.1029/94JB02121; Courboulex F, 1997, B SEISMOL SOC AM, V87, P999; Custodio S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024417; DAS S, 1981, B SEISMOL SOC AM, V71, P1669; Delouis B, 2002, B SEISMOL SOC AM, V92, P278, DOI 10.1785/0120000806; Delouis B., EQUAKE RC FINITE SOU; Dreger DS, 2005, SEISMOL RES LETT, V76, P40, DOI 10.1785/gssrl.76.1.40; Emolo A, 2005, B SEISMOL SOC AM, V95, P981, DOI 10.1785/0120030193; Felzer KR, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003277; Fielding EJ, 2013, GEOPHYS J INT, V194, P1138, DOI 10.1093/gji/ggt155; Fujii Y, 2011, EARTH PLANETS SPACE, V63, P815, DOI 10.5047/eps.2011.06.010; FUKUYAMA E, 1986, B SEISMOL SOC AM, V76, P1623; Gualandi A., EQUAKE RC FINITE SOU; Hardebeck JL, 1998, J GEOPHYS RES-SOL EA, V103, P24427, DOI 10.1029/98JB00573; HARTZELL S, 1990, J GEOPHYS RES-SOLID, V95, P12475, DOI 10.1029/JB095iB08p12475; HARTZELL S, 1991, B SEISMOL SOC AM, V81, P305; Hartzell S, 1996, J GEOPHYS RES-SOL EA, V101, P20091, DOI 10.1029/96JB01883; HARTZELL S, 1994, B SEISMOL SOC AM, V84, P1703; HARTZELL S, 1989, J GEOPHYS RES-SOLID, V94, P7515, DOI 10.1029/JB094iB06p07515; HARTZELL S, 1993, J GEOPHYS RES-SOL EA, V98, P22123, DOI 10.1029/93JB02453; HARTZELL SH, 1986, B SEISMOL SOC AM, V76, P649; HARTZELL SH, 1983, B SEISMOL SOC AM, V73, P1553; Hayes G., EQUAKE RC FINITE SOU; Hayes GP, 2010, NAT GEOSCI, V3, P800, DOI [10.1038/ngeo977, 10.1038/NGEO977]; HEATON TH, 1982, B SEISMOL SOC AM, V72, P2037; Hernandez B, 2004, ANN GEOPHYS-ITALY, V47, P1355; Hernandez B, 1999, J GEOPHYS RES-SOL EA, V104, P13083, DOI 10.1029/1999JB900078; Hernandez B, 2001, GEOPHYS RES LETT, V28, P363, DOI 10.1029/2000GL011975; Horikawa H, 1996, J PHYS EARTH, V44, P455, DOI 10.4294/jpe1952.44.455; Horikawa H, 2001, B SEISMOL SOC AM, V91, P112, DOI 10.1785/0119990131; Hough SE, 1995, B SEISMOL SOC AM, V85, P1576; Hudnut KW, 1996, B SEISMOL SOC AM, V86, pS19; Ide S, 1996, B SEISMOL SOC AM, V86, P547; Ide S, 2001, TECTONOPHYSICS, V334, P35, DOI 10.1016/S0040-1951(01)00027-0; Iwata T., 2000, 2000 FALL M SEISM SO; Jacques E, 1996, GEOPHYS RES LETT, V23, P2481, DOI 10.1029/96GL02261; Ji C, 2002, B SEISMOL SOC AM, V92, P1208, DOI 10.1785/0120000917; Ji C., EQUAKE RC FINITE SOU; Ji C., SOURCE MODELS LARGE; Ji C., KURIL ISLAND EARTHQU; Jonsson S, 2002, B SEISMOL SOC AM, V92, P1377, DOI 10.1785/0120000922; Kagan YY, 1998, J GEOPHYS RES-SOL EA, V103, P24453, DOI 10.1029/98JB00699; Kakehi Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB002980; KING GCP, 1994, B SEISMOL SOC AM, V84, P935; Koketsu K, 2004, EARTH PLANETS SPACE, V56, P329, DOI 10.1186/BF03353060; Koketsu K, 1998, EARTH PLANETS SPACE, V50, P803, DOI 10.1186/BF03352173; LARSEN S, 1992, J GEOPHYS RES-SOL EA, V97, P4885, DOI 10.1029/92JB00128; Lay T, 2013, EARTH PLANET SC LETT, V375, P57, DOI 10.1016/j.epsl.2013.05.005; Lay T, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006280; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; LIU HL, 1983, B SEISMOL SOC AM, V73, P201; Ma KF, 2000, GEOPHYS RES LETT, V27, P3417, DOI 10.1029/2000GL011393; Ma KF, 2001, B SEISMOL SOC AM, V91, P1069; Mallman EP, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004076; Meade BJ, 2017, GEOPHYS RES LETT, V44, P11409, DOI 10.1002/2017GL075875; MENDOZA C, 1988, B SEISMOL SOC AM, V78, P1092; MENDOZA C, 1994, B SEISMOL SOC AM, V84, P269; MENDOZA C, 1995, GEOPHYS J INT, V121, P675, DOI 10.1111/j.1365-246X.1995.tb06430.x; MENDOZA C, 1993, J GEOPHYS RES-SOL EA, V98, P8197, DOI 10.1029/93JB00021; MENDOZA C, 1989, B SEISMOL SOC AM, V79, P655; Mendoza C, 1999, B SEISMOL SOC AM, V89, P1338; Mendoza C, 1996, J GEOPHYS RES-SOL EA, V101, P791, DOI 10.1029/95JB02805; Miyakoshi K., 2000, P 12 WORLD C EARTHQ; Nagai R., 2001, J SEISMOLOGICAL SOC, V54, P267; Nakahara H, 2002, B SEISMOL SOC AM, V92, P1708, DOI 10.1785/0120010161; Nakayama W, 1997, B SEISMOL SOC AM, V87, P918; Nostro C, 1997, B SEISMOL SOC AM, V87, P234; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; OLSON AH, 1982, B SEISMOL SOC AM, V72, P1969; Ozgun Konca A., SOURCE MODELS LARGE; Parsons T, 1999, J GEOPHYS RES-SOL EA, V104, P20183, DOI 10.1029/1999JB900056; Poiata N, 2012, B SEISMOL SOC AM, V102, P1477, DOI 10.1785/0120110198; REASENBERG PA, 1992, SCIENCE, V255, P1687, DOI 10.1126/science.255.5052.1687; Reilinger RE, 2000, SCIENCE, V289, P1519, DOI 10.1126/science.289.5484.1519; Rhie J, 2007, B SEISMOL SOC AM, V97, pS115, DOI 10.1785/0120050620; Salichon J, 2004, B SEISMOL SOC AM, V94, P2015, DOI 10.1785/0120030038; Salichon J, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000913; Satake K, 2013, B SEISMOL SOC AM, V103, P1473, DOI 10.1785/0120120122; Sekiguchi H, 2000, B SEISMOL SOC AM, V90, P117, DOI 10.1785/0119990027; Sekiguchi H, 2002, GEOPHYS J INT, V150, P377, DOI 10.1046/j.1365-246X.2002.01669.x; Sekiguchi H., 2001, 2001 JAP EARTH PLAN; Semmane F, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021268; Shao G., PRELIMINARY RESULT A; Shao G., PRELIMINARY RESULT J; Shao G., PRELIMINARY RESULT O; Shao G., PAKISTAN EARTHQUAKE; Shen ZK, 1996, B SEISMOL SOC AM, V86, pS37; Silva W., EQUAKE RC FINITE SOU; Sladen A., SOURCE MODELS LARGE; STEIDL JH, 1991, B SEISMOL SOC AM, V81, P1573; Sudhaus H, 2011, GEOPHYS J INT, V185, P676, DOI 10.1111/j.1365-246X.2011.04973.x; Takeo M., 1990, Bulletin of the Earthquake Research Institute, University of Tokyo, V65, P541; TAKEO M, 1987, TECTONOPHYSICS, V144, P271, DOI 10.1016/0040-1951(87)90022-9; TAKEO M, 1988, B SEISMOL SOC AM, V78, P1074; Tanioka Y, 2004, EARTH PLANETS SPACE, V56, P373, DOI 10.1186/BF03353067; The Theano Development Team, 2016, THEANO PYTHON FRAMEW; Toda S, 1998, J GEOPHYS RES-SOL EA, V103, P24543, DOI 10.1029/98JB00765; Utsu T., 1961, GEOPHYS MAG, V30, P521, DOI DOI 10.1007/BF01592930; WALD DJ, 1992, J GEOPHYS RES-SOL EA, V97, P11033, DOI 10.1029/92JB00565; WALD DJ, 1990, B SEISMOL SOC AM, V80, P1079; Wald DJ, 1996, J PHYS EARTH, V44, P489, DOI 10.4294/jpe1952.44.489; WALD DJ, 1994, B SEISMOL SOC AM, V84, P668; WALD DJ, 1991, B SEISMOL SOC AM, V81, P1540; Wald DJ, 1996, B SEISMOL SOC AM, V86, pS49; Wei S., SOURCE MODELS LARGE; Wei SJ, 2013, GEOPHYS RES LETT, V40, P847, DOI 10.1002/grl.50259; Wei SJ, 2011, NAT GEOSCI, V4, P615, DOI 10.1038/ngeo1213; Wu CJ, 2001, B SEISMOL SOC AM, V91, P1128, DOI 10.1785/0120000713; Yagi Y, 1999, GEOPHYS RES LETT, V26, P3161, DOI 10.1029/1999GL005340; Yagi Y, 2000, GEOPHYS RES LETT, V27, P1969, DOI 10.1029/1999GL011208; Yagi Y, 2004, B SEISMOL SOC AM, V94, P1795, DOI 10.1785/012003095; Yagi Y, 2004, EARTH PLANETS SPACE, V56, P311, DOI 10.1186/BF03353057; Yagi Y., EQUAKE RC FINITE SOU; Yagi Y, 2012, EARTH PLANETS SPACE, V64, pE13, DOI 10.5047/eps.2012.05.006; Yagi Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048701; Yamanaka Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002683; Yamanaka Y, 2003, EARTH PLANETS SPACE, V55, pE21, DOI 10.1186/BF03352479; Yen YT, 2008, TERR ATMOS OCEAN SCI, V19, P567, DOI 10.3319/TAO.2008.19.6.567(PT); Yoshida S, 1996, J PHYS EARTH, V44, P437, DOI 10.4294/jpe1952.44.437; Yue H, 2013, J GEOPHYS RES-SOL EA, V118, P5453, DOI 10.1002/jgrb.50379; Yue H, 2013, B SEISMOL SOC AM, V103, P1242, DOI 10.1785/0120120119; Zeng Y., EQUAKE RC FINITE SOU; Zeng Y., 2000, 200001 PEER; Zeng YH, 2001, B SEISMOL SOC AM, V91, P1088, DOI 10.1785/0120000743; Zhang WB, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019827	144	131	137	17	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					632	+		10.1038/s41586-018-0438-y	http://dx.doi.org/10.1038/s41586-018-0438-y			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS0SZ	30158606				2022-12-28	WOS:000443218600047
J	Fox, RJ; Coffey, CS; Conwit, R; Cudkowicz, ME; Gleason, T; Goodman, A; Klawiter, EC; Matsuda, K; McGovern, M; Naismith, RT; Ashokkumar, A; Barnes, J; Ecklund, D; Klingner, E; Koepp, M; Long, JD; Natarajan, S; Thornell, B; Yankey, J; Bermel, RA; Debbins, JP; Huang, X; Jagodnik, P; Lowe, MJ; Nakamura, K; Narayanan, S; Sakaie, KE; Thoomukuntla, B; Zhou, X; Krieger, S; Alvarez, E; Apperson, M; Bashir, K; Cohen, BA; Coyle, PK; Delgado, S; Dewitt, LD; Flores, A; Giesser, BS; Goldman, MD; Jubelt, B; Lava, N; Lynch, SG; Moses, H; Ontaneda, D; Perumal, JS; Racke, M; Repovic, P; Riley, CS; Severson, C; Shinnar, S; Suski, V; Weinstock-Guttman, B; Yadav, V; Zabeti, A				Fox, R. J.; Coffey, C. S.; Conwit, R.; Cudkowicz, M. E.; Gleason, T.; Goodman, A.; Klawiter, E. C.; Matsuda, K.; McGovern, M.; Naismith, R. T.; Ashokkumar, A.; Barnes, J.; Ecklund, D.; Klingner, E.; Koepp, M.; Long, J. D.; Natarajan, S.; Thornell, B.; Yankey, J.; Bermel, R. A.; Debbins, J. P.; Huang, X.; Jagodnik, P.; Lowe, M. J.; Nakamura, K.; Narayanan, S.; Sakaie, K. E.; Thoomukuntla, B.; Zhou, X.; Krieger, S.; Alvarez, E.; Apperson, M.; Bashir, K.; Cohen, B. A.; Coyle, P. K.; Delgado, S.; Dewitt, L. D.; Flores, A.; Giesser, B. S.; Goldman, M. D.; Jubelt, B.; Lava, N.; Lynch, S. G.; Moses, H.; Ontaneda, D.; Perumal, J. S.; Racke, M.; Repovic, P.; Riley, C. S.; Severson, C.; Shinnar, S.; Suski, V.; Weinstock-Guttman, B.; Yadav, V.; Zabeti, A.		NN102 SPRINT-MS Trial Invest	Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRAIN ATROPHY; MULTICENTER; DISABILITY; DISEASE; PLACEBO; LESIONS	BACKGROUND There are limited treatments for progressive multiple sclerosis. Ibudilast inhibits several cyclic nucleotide phosphodiesterases, macrophage migration inhibitory factor, and toll-like receptor 4 and can cross the blood-brain barrier, with potential salutary effects in progressive multiple sclerosis. METHODS We enrolled patients with primary or secondary progressive multiple sclerosis in a phase 2 randomized trial of oral ibudilast (<= 100 mg daily) or placebo for 96 weeks. The primary efficacy end point was the rate of brain atrophy, as measured by the brain parenchymal fraction (brain size relative to the volume of the outer surface contour of the brain). Major secondary end points included the change in the pyramidal tracts on diffusion tensor imaging, the magnetization transfer ratio in normal-appearing brain tissue, the thickness of the retinal nerve-fiber layer, and cortical atrophy, all measures of tissue damage in multiple sclerosis. RESULTS Of 255 patients who underwent randomization, 129 were assigned to ibudilast and 126 to placebo. A total of 53% of the patients in the ibudilast group and 52% of those in the placebo group had primary progressive disease; the others had secondary progressive disease. The rate of change in the brain parenchymal fraction was -0.0010 per year with ibudilast and -0.0019 per year with placebo (difference, 0.0009; 95% confidence interval, 0.00004 to 0.0017; P = 0.04), which represents approximately 2.5 ml less brain-tissue loss with ibudilast over a period of 96 weeks. Adverse events with ibudilast included gastrointestinal symptoms, headache, and depression. CONCLUSIONS In a phase 2 trial involving patients with progressive multiple sclerosis, ibudilast was associated with slower progression of brain atrophy than placebo but was associated with higher rates of gastrointestinal side effects, headache, and depression.	[Fox, R. J.; Natarajan, S.; Bermel, R. A.; Ontaneda, D.] Cleveland Clin, Mellen Ctr Multiple Sclerosis, Neurol Inst, Cleveland, OH 44106 USA; [Huang, X.; Lowe, M. J.; Sakaie, K. E.; Zhou, X.] Cleveland Clin, Imaging Inst, Cleveland, OH 44106 USA; [Jagodnik, P.; Nakamura, K.; Thoomukuntla, B.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Racke, M.] Ohio State Univ, Columbus, OH 43210 USA; [Zabeti, A.] Univ Cincinnati, Cincinnati, OH USA; [Coffey, C. S.; Barnes, J.; Ecklund, D.; Klingner, E.; Long, J. D.; Yankey, J.] Univ Iowa, Data Coordinating Ctr, Network Excellence Neurosci Clin Trials NeuroNEXT, Iowa City, IA USA; [Conwit, R.] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Cudkowicz, M. E.; McGovern, M.; Ashokkumar, A.; Thornell, B.] Massachusetts Gen Hosp, NeuroNEXT, Clin Coordinating Ctr, Neurol Clin Res Inst,Harvard Partners, Boston, MA USA; [Klawiter, E. C.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Coffey, C. S.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Gleason, T.] Patient Advocate, Seattle, WA USA; [Repovic, P.] Swedish Med Ctr, Seattle, WA USA; [Goodman, A.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Krieger, S.] Mt Sinai Med Ctr, Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, New York, NY 10029 USA; [Perumal, J. S.] Weill Cornell Med Coll, New York, NY USA; [Riley, C. S.] Columbia Univ, Med Ctr, New York, NY USA; [Shinnar, S.] Albert Einstein Coll Med, Montefiore Med Ctr, New York, NY USA; [Coyle, P. K.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Jubelt, B.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Weinstock-Guttman, B.] SUNY Buffalo, Buffalo, NY USA; [Matsuda, K.] MediciNova, La Jolla, CA USA; [Apperson, M.] Univ Calif Davis, Sacramento, CA 95817 USA; [Giesser, B. S.] Univ Calif Los Angeles, Los Angeles, CA USA; [Naismith, R. T.] Washington Univ, Sch Med, St Louis, MO USA; [Debbins, J. P.] Barrow Neurol Inst, St Josephs Hosp & Med Ctr, Phoenix, AZ 85013 USA; [Natarajan, S.] NeuroRx Res, Montreal, PQ, Canada; [Zhou, X.] Purdue Univ, Sch Hlth Sci, Coll Hlth & Human Sci, W Lafayette, IN 47907 USA; [Alvarez, E.] Univ Colorado Denver, Aurora, CO USA; [Bashir, K.] Univ Alabama Birmingham, Birmingham, AL USA; [Cohen, B. A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Delgado, S.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Dewitt, L. D.] Univ Utah, Salt Lake City, UT USA; [Flores, A.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Goldman, M. D.] Univ Virginia, Charlottesville, VA USA; [Lava, N.] Emory Univ, Atlanta, GA 30322 USA; [Lynch, S. G.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Moses, H.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Suski, V.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Yadav, V.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Swedish Medical Center; University of Rochester; Icahn School of Medicine at Mount Sinai; Cornell University; Columbia University; Montefiore Medical Center; Yeshiva University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California Davis; University of California System; University of California Los Angeles; Washington University (WUSTL); Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alabama System; University of Alabama Birmingham; Northwestern University; Feinberg School of Medicine; University of Miami; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Virginia; Emory University; University of Kansas; University of Kansas Medical Center; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University	Fox, RJ (corresponding author), Cleveland Clin, Mellen Ctr Multiple Sclerosis, 9500 Euclid Ave,JJ36, Cleveland, OH 44195 USA.	foxr@ccf.org	Goldman, Myla D/D-1955-2017; CUDKOWICZ, MERIT/GWM-6585-2022; Goldman, Myla/AAG-8737-2020; Repovic, Pavle/AAV-1594-2020; Yadav, Vijayshree/Y-9772-2019	CUDKOWICZ, MERIT/0000-0002-7075-1681; Goldman, Myla/0000-0002-5675-945X; Bermel, Robert/0000-0003-2334-6883; Ontaneda, Daniel/0000-0002-2838-9148; Yadav, Vijayshree/0000-0001-8476-403X; Arnold, Douglas/0000-0003-4266-0106; Long, Jeffrey/0000-0001-7181-9652; GOODMAN, ANDREW/0000-0001-7642-4502; Nakamura, Kunio/0000-0002-7833-8138	National Institute of Neurological Disorders and Stroke (NINDS) [U01NS082329]; National Multiple Sclerosis Society [RG 4778-A-6]; Medici-Nova; National Institutes of Health (NIH); NINDS (Central Coordinating Center) [U01NS077179]; NINDS (Data Coordinating Center) [U01NS077352]; National Center for Advancing Translational Sciences of the NIH [UL1 TR000439, UL1 TR 000040, UL1 TR002556, UL1TR0002369, UL1 TR001425-03, KL2 TR001080, UL1 TR000448, UL1 TR000457]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040, UL1TR002345, UL1TR001425, UL1TR000457, UL1TR000439, KL2TR001080, UL1TR002556, UL1TR002369, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U10NS077265, U01NS077352, U24NS107128, U01NS082329, U24NS107182, U01NS077179, U24NS107165, U10NS077260] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Medici-Nova; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS (Central Coordinating Center); NINDS (Data Coordinating Center); National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the National Institute of Neurological Disorders and Stroke (NINDS) (U01NS082329) and the National Multiple Sclerosis Society (RG 4778-A-6) and by Medici-Nova through a contract with the National Institutes of Health (NIH). The NeuroNEXT Network is supported by the NINDS (Central Coordinating Center, U01NS077179; Data Coordinating Center, U01NS077352; and individual grants to each trial site). Research reported in this article was also supported by grants from the National Center for Advancing Translational Sciences of the NIH to Case Western Reserve University (UL1 TR000439), Columbia University Medical Center (UL1 TR 000040), Montefiore Medical Center (UL1 TR002556), Oregon Health and Science University (UL1TR0002369), University of Cincinnati (UL1 TR001425-03), University of Colorado Denver (KL2 TR001080), Washington University in St. Louis (UL1 TR000448), and Weill Cornell Medical Center (UL1 TR000457).	Andersson A, 2008, J LEUKOCYTE BIOL, V84, P1248, DOI 10.1189/jlb.1207844; [Anonymous], 2018, OCREVUS EPAR PRODUCT; Barkhof F, 2010, NEUROLOGY, V74, P1033, DOI 10.1212/WNL.0b013e3181d7d651; Brown RA, 2013, NEUROIMAGE, V66, P103, DOI 10.1016/j.neuroimage.2012.10.059; Chataway J, 2014, LANCET, V383, P2213, DOI 10.1016/S0140-6736(13)62242-4; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Duning T, 2005, NEUROLOGY, V64, P548, DOI 10.1212/01.WNL.0000150542.16969.CC; Fisher E, 1997, SPIE MED IMAG, V3034, P599; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Fox RJ, 2011, AM J NEURORADIOL, V32, P85, DOI 10.3174/ajnr.A2238; Fox RJ, 2016, CONTEMP CLIN TRIALS, V50, P166, DOI 10.1016/j.cct.2016.08.009; Hagman S, 2011, J NEUROIMMUNOL, V234, P141, DOI 10.1016/j.jneuroim.2011.02.009; International Council for Harmonisa-tion of Technical Requirements for Phar-maceuticals for Human Use, 2016, INT AD DEND ICH E6 R; Johnson K. W., 2014, Clinical Investigation, V4, P269; Kappos L, 2018, LANCET, V391, P1263, DOI 10.1016/S0140-6736(18)30475-6; Khaleeli Z, 2008, ANN NEUROL, V63, P790, DOI 10.1002/ana.21375; Kurtzke JF, 2015, MULT SCLER RELAT DIS, V4, P95, DOI 10.1016/j.msard.2015.02.003; Moccia M, 2017, MULT SCLER J, V23, P1614, DOI 10.1177/1352458517729456; Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468; Nakamura K, 2011, NEUROIMAGE, V54, P278, DOI 10.1016/j.neuroimage.2010.07.052; Neitzer A, 2012, HEMODIAL INT, V16, P207, DOI 10.1111/j.1542-4758.2012.00663.x; Ontaneda D, 2012, MULT SCLER J, V18, P1074, DOI 10.1177/1352458512451512; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Richert ND, 2001, MULT SCLER, V7, P49, DOI 10.1191/135245801669116174; Ruiz-Perez D, 2016, ANESTH ANALG, V122, P1370, DOI 10.1213/ANE.0000000000001171; Su Y, 2017, ONCOTARGET, V8, P2719, DOI 10.18632/oncotarget.13739; Swanton JK, 2007, LANCET NEUROL, V6, P677, DOI 10.1016/S1474-4422(07)70176-X; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Verbeke G, 2000, LINEAR MIXED MODELS; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	31	143	148	3	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2018	379	9					846	855		10.1056/NEJMoa1803583	http://dx.doi.org/10.1056/NEJMoa1803583			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR9EA	30157388	Green Accepted, Bronze			2022-12-28	WOS:000443047800008
J	Shah, RD; Howlett, D				Shah, Rupali D.; Howlett, David			Sudden onset abdominal pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTESTINALIS		[Shah, Rupali D.; Howlett, David] KSS Deanery, London, England; East Sussex Healthcare NHS Trust, Hastings, St Leonards On, England; Brighton & Sussex Med Sch, Brighton, E Sussex, England	University of Brighton; University of Sussex	Shah, RD (corresponding author), KSS Deanery, London, England.	rupali_shah34@yahoo.co.uk						Gore R, TXB GASTROINTESTINAL, V62, P1102; JAMART J, 1979, ACTA HEPATO-GASTRO, V26, P419; KNECHTLE SJ, 1990, ANN SURG, V212, P160, DOI 10.1097/00000658-199008000-00008; KOSS LG, 1952, AMA ARCH PATHOL, V53, P523; Wayne E, 2010, J GASTROINTEST SURG, V14, P437, DOI 10.1007/s11605-009-1143-9	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2018	362								k2945	10.1136/bmj.k2945	http://dx.doi.org/10.1136/bmj.k2945			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5ZI	30166286				2022-12-28	WOS:000443758100001
J	Rubin, R				Rubin, Rita			Expanding Veterans' Access to Cancer Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					748	748		10.1001/jama.2018.12069	http://dx.doi.org/10.1001/jama.2018.12069			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167681				2022-12-28	WOS:000442958800005
J	Rimmer, A				Rimmer, Abi			Full time GPs fall by over 500 in three months	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS Digital, 2018, GEN PERS MED SERV; Rimmer A, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2175	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2018	362								k3652	10.1136/bmj.k3652	http://dx.doi.org/10.1136/bmj.k3652			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8SY	30143480				2022-12-28	WOS:000443000000004
J	Di Liberto, G; Pantelyushin, S; Kreutzfeldt, M; Page, N; Musardo, S; Coras, R; Steinbach, K; Vincenti, I; Klimek, B; Lingner, T; Salinas, G; Lin-Marq, N; Staszewski, O; Jordao, MJC; Wagner, I; Egervari, K; Mack, M; Bellone, C; Blumcke, I; Prinz, M; Pinschewer, DD; Merkler, D				Di Liberto, Giovanni; Pantelyushin, Stanislav; Kreutzfeldt, Mario; Page, Nicolas; Musardo, Stefano; Coras, Roland; Steinbach, Karin; Vincenti, Ilene; Klimek, Bogna; Lingner, Thomas; Salinas, Gabriela; Lin-Marq, Nathalie; Staszewski, Ori; Jordao, Marta Joana Costa; Wagner, Ingrid; Egervari, Kristof; Mack, Matthias; Bellone, Camilla; Bluemcke, Ingmar; Prinz, Marco; Pinschewer, Daniel D.; Merkler, Doron			Neurons under T Cell Attack Coordinate Phagocyte-Mediated Synaptic Stripping	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; MICROGLIA; MICE; CNS; ENCEPHALITIS; COMPLEMENT; ACTIVATION; INTERVENTION; MACROPHAGES	Inflammatory disorders of the CNS are frequently accompanied by synaptic loss, is thought to involve phagocytic microglia and complement components. However, the mechanisms accounting for aberrant synaptic connectivity in the context of CD8(+) T cell-driven neuronal damage are poorly understood. Here, we profiled the neuronal translatome in a murine model of encephalitis caused by CD8(+) T cells targeting antigenic neurons. Neuronal STAT1 signaling and downstream CCL2 expression were essential for apposition of phagocytes, ensuing synaptic loss and neurological disease. Analogous observations were made in the brains of Rasmussen's encephalitis patients. In this devastating CD8(+) T cell-driven autoimmune disease, neuronal STAT1 phosphorylation and CCL2 expression co-clustered with infiltrating CD8(+) T cells as well as phagocytes. Taken together, our findings uncover an active role of neurons in coordinating phagocyte-mediated synaptic loss and highlight neuronal STAT1 and CCL2 as critical steps in this process that are amenable to pharmacological interventions.	[Di Liberto, Giovanni; Pantelyushin, Stanislav; Kreutzfeldt, Mario; Page, Nicolas; Steinbach, Karin; Vincenti, Ilene; Klimek, Bogna; Wagner, Ingrid; Egervari, Kristof; Merkler, Doron] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Musardo, Stefano; Bellone, Camilla] Univ Geneva, Dept Basic Neurosci, CH-1205 Geneva, Switzerland; [Coras, Roland; Bluemcke, Ingmar] Univ Hosp Erlangen, Dept Neuropathol, D-91054 Erlangen, Germany; [Lingner, Thomas; Salinas, Gabriela] Univ Med Ctr Gottingen, Inst Dev Biochem, Microarray & Deep Sequencing Core Facil, Gottingen, Germany; [Lin-Marq, Nathalie; Egervari, Kristof; Merkler, Doron] Geneva Univ Hosp, Div Clin Pathol, CH-1211 Geneva, Switzerland; [Staszewski, Ori; Jordao, Marta Joana Costa; Prinz, Marco] Univ Freiburg, Med Fac, Inst Neuropathol, Freiburg, Germany; [Mack, Matthias] Regensburg Ctr Intervent Immunol, Dept Internal Med Nephrol 2, Regensburg, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Pinschewer, Daniel D.] Univ Basel, Dept Biomed Haus Peterspl, Div Expt Virol, Basel, Switzerland; [Pantelyushin, Stanislav] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland	University of Geneva; University of Geneva; University of Erlangen Nuremberg; University of Gottingen; University of Geneva; University of Freiburg; University of Freiburg; University of Basel; University of Zurich	Merkler, D (corresponding author), Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland.; Merkler, D (corresponding author), Geneva Univ Hosp, Div Clin Pathol, CH-1211 Geneva, Switzerland.	doron.merkler@unige.ch	Merkler, Doron/N-9157-2016; Pantelyushin, Stanislav/AAH-8637-2021	Merkler, Doron/0000-0002-0247-2007; Staszewski, Ori/0000-0002-0579-6701; Pinschewer, Daniel/0000-0002-1594-3189; Musardo, Stefano/0000-0003-0392-0905; Di Liberto, Giovanni/0000-0001-6788-0215; Kreutzfeldt, Mario/0000-0003-0335-2733; Pantelyushin, Stanislav/0000-0002-3490-3860; Vincenti, Ilena/0000-0003-1061-6071; bellone, camilla/0000-0002-6774-6275	Gebert-Ruf Foundation [GRS-049/13]; Klaus-Tschira Foundation; Swiss National Science Foundation; Swiss MS Society; Helmut Horten Foundation; BMBF; Sobek-Stiftung; DFG [SFB 992, SFB1160, SFB/TRR167]; DFG (Reinhart-Koselleck grant); Ministry of Science, Research and the Arts, Baden-Wuerttemberg (Sonderlinie "Neuroinflammation'')	Gebert-Ruf Foundation; Klaus-Tschira Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss MS Society; Helmut Horten Foundation; BMBF(Federal Ministry of Education & Research (BMBF)); Sobek-Stiftung; DFG(German Research Foundation (DFG)); DFG (Reinhart-Koselleck grant)(German Research Foundation (DFG)); Ministry of Science, Research and the Arts, Baden-Wuerttemberg (Sonderlinie "Neuroinflammation'')	This work was supported by the Gebert-Ruf Foundation (GRS-049/13 to D.M.). D.M. and D.D.P. are supported by the Klaus-Tschira Foundation and Swiss National Science Foundation. D.M. and N.P. are supported by the Swiss MS Society. D.M. is supported by the Helmut Horten Foundation. M.P. is supported by the BMBF-funded Competence Network of Multiple Sclerosis (KKNMS), the Sobek-Stiftung, the DFG (SFB 992, SFB1160, SFB/TRR167, and Reinhart-Koselleck grant), and the Ministry of Science, Research and the Arts, Baden-Wuerttemberg (Sonderlinie "Neuroinflammation''). We acknowledge Philippe Henchoz for EM. We thank Angela Andersen (Life Science Editors) for her support in manuscript editing.	Albert M, 2017, BRAIN PATHOL, V27, P737, DOI 10.1111/bpa.12450; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bernard-Valnet R, 2016, P NATL ACAD SCI USA, V113, P10956, DOI 10.1073/pnas.1603325113; Bialas AR, 2017, NATURE, V546, P539, DOI 10.1038/nature22821; Bien CG, 2012, BRAIN, V135, P1622, DOI 10.1093/brain/aws082; Binder GK, 2001, SCIENCE, V293, P303, DOI 10.1126/science.1059742; Brook I, 2013, CLIN MICROBIOL REV, V26, P526, DOI 10.1128/CMR.00086-12; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Chevalier G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002393; Dalmau J, 2018, NEW ENGL J MED, V378, P840, DOI 10.1056/NEJMra1708712; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Dewachter I, 2002, J NEUROSCI, V22, P3445; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Gendusa R, 2014, J HISTOCHEM CYTOCHEM, V62, P519, DOI 10.1369/0022155414536732; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Kallert SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15327; Khaibullin T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00531; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kim KW, 2011, BLOOD, V118, pE156, DOI 10.1182/blood-2011-04-348946; Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kreutzfeldt M, 2013, J EXP MED, V210, P2087, DOI 10.1084/jem.20122143; Liblau RS, 2013, TRENDS NEUROSCI, V36, P315, DOI 10.1016/j.tins.2013.01.008; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Marzo A, 2016, CURR BIOL, V26, P2551, DOI 10.1016/j.cub.2016.07.024; Medana I, 2001, AM J PATHOL, V159, P809, DOI 10.1016/S0002-9440(10)61755-5; Merkler D, 2006, J CLIN INVEST, V116, P1254, DOI 10.1172/JCI27372; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pardo CA, 2004, EPILEPSIA, V45, P516, DOI 10.1111/j.0013-9580.2004.33103.x; Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703; R Development Core Team, 2017, R LANG ENV STAT COMP; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schneider-Hohendorf T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11153; Schrier RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116526; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Varadkar S, 2014, LANCET NEUROL, V13, P195, DOI 10.1016/S1474-4422(13)70260-6; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wallner B, 2012, TRANSGENIC RES, V21, P217, DOI 10.1007/s11248-011-9519-5; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	54	75	75	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 4	2018	175	2					458	+		10.1016/j.cell.2018.07.049	http://dx.doi.org/10.1016/j.cell.2018.07.049			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GV7PQ	30173917	Bronze			2022-12-28	WOS:000446321300017
J	Kouyos, RD; Rusert, P; Kadelka, C; Huber, M; Marzel, A; Ebner, H; Schanz, M; Liechti, T; Friedrich, N; Braun, DL; Scherrer, AU; Weber, J; Uhr, T; Baumann, NS; Leemann, C; Kuster, H; Chave, JP; Cavassini, M; Bernasconi, E; Hoffmann, M; Calmy, A; Battegay, M; Rauch, A; Yerly, S; Aubert, V; Klimkait, T; Boni, J; Metzner, KJ; Gunthard, HF; Trkola, A				Kouyos, Roger D.; Rusert, Peter; Kadelka, Claus; Huber, Michael; Marzel, Alex; Ebner, Hanna; Schanz, Merle; Liechti, Thomas; Friedrich, Nikolas; Braun, Dominique L.; Scherrer, Alexandra U.; Weber, Jacqueline; Uhr, Therese; Baumann, Nicolas S.; Leemann, Christine; Kuster, Herbert; Chave, Jean-Philippe; Cavassini, Matthias; Bernasconi, Enos; Hoffmann, Matthias; Calmy, Alexandra; Battegay, Manuel; Rauch, Andri; Yerly, Sabine; Aubert, Vincent; Klimkait, Thomas; Boni, Jurg; Metzner, Karin J.; Gunthard, Huldrych F.; Trkola, Alexandra		Swiss HIV Cohort Study	Tracing HIV-1 strains that imprint broadly neutralizing antibody responses	NATURE			English	Article							TRANSMISSION; HERITABILITY; AMPLIFICATION; PROGRESSION; GENERATION; EVOLUTION; VARIANTS	Understanding the determinants of broadly neutralizing antibody (bNAb) evolution is crucial for the development of bNAb-based HIV vaccines(1). Despite emerging information on cofactors that promote bNAb evolution in natural HIV-1 infections, in which the induction of bNAbs is genuinely rare(2), information on the impact of the infecting virus strain on determining the breadth and specificity of the antibody responses to HIV-1 is lacking. Here we analyse the influence of viral antigens in shaping antibody responses in humans. We call the ability of a virus strain to induce similar antibody responses across different hosts its antibody-imprinting capacity, which from an evolutionary biology perspective corresponds to the viral heritability of the antibody responses. Analysis of 53 measured parameters of HIV-1-binding and neutralizing antibody responses in a cohort of 303 HIV-1 transmission pairs (individuals who harboured highly related HIV-1 strains and were putative direct transmission partners or members of an HIV-1 transmission chain) revealed that the effect of the infecting virus on the outcome of the bNAb response is moderate in magnitude but highly significant. We introduce the concept of bNAb-imprinting viruses and provide evidence for the existence of such viruses in a systematic screening of our cohort. The bNAb-imprinting capacity can be substantial, as indicated by a transmission pair with highly similar HIV-1 antibody responses and strong bNAb activity. Identification of viruses that have bNAb-imprinting capacities and their characterization may thus provide the potential to develop lead immunogens.	[Kouyos, Roger D.; Rusert, Peter; Kadelka, Claus; Huber, Michael; Marzel, Alex; Ebner, Hanna; Schanz, Merle; Liechti, Thomas; Friedrich, Nikolas; Braun, Dominique L.; Scherrer, Alexandra U.; Weber, Jacqueline; Uhr, Therese; Baumann, Nicolas S.; Leemann, Christine; Kuster, Herbert; Boni, Jurg; Metzner, Karin J.; Gunthard, Huldrych F.; Trkola, Alexandra] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Kouyos, Roger D.; Kadelka, Claus; Marzel, Alex; Braun, Dominique L.; Scherrer, Alexandra U.; Leemann, Christine; Kuster, Herbert; Metzner, Karin J.; Gunthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis, Zurich, Switzerland; [Kouyos, Roger D.; Kadelka, Claus; Marzel, Alex; Braun, Dominique L.; Scherrer, Alexandra U.; Leemann, Christine; Kuster, Herbert; Metzner, Karin J.; Gunthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Hosp Epidemiol, Zurich, Switzerland; [Chave, Jean-Philippe] Clin La Source, Lausanne, Switzerland; [Cavassini, Matthias] Univ Lausanne, Univ Hosp Lausanne, Div Infect Dis, Lausanne, Switzerland; [Bernasconi, Enos] Reg Hosp Lugano, Div Infect Dis, Lugano, Switzerland; [Hoffmann, Matthias] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland; [Calmy, Alexandra] Univ Geneva, Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Battegay, Manuel] Univ Basel, Univ Hosp Basel, Div Infect Dis, Basel, Switzerland; [Rauch, Andri] Univ Bern, Univ Hosp Bern, Dept Infect Dis, Bern, Switzerland; [Yerly, Sabine] Univ Geneva, Univ Hosp Geneva, Div Infect Dis, Lab Virol, Geneva, Switzerland; [Aubert, Vincent] Univ Lausanne, Univ Hosp Lausanne, Div Immunol & Allergy, Lausanne, Switzerland; [Klimkait, Thomas] Univ Basel, Dept Biomed Peterspl, Div Infect Diagnost, Basel, Switzerland; [Liechti, Thomas] NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital St. Gallen; University of Geneva; University of Basel; University of Bern; University Hospital of Bern; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kouyos, RD; Gunthard, HF; Trkola, A (corresponding author), Univ Zurich, Inst Med Virol, Zurich, Switzerland.; Kouyos, RD; Gunthard, HF (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis, Zurich, Switzerland.	roger.kouyos@usz.ch; huldrych.guenthard@usz.ch; trkola.alexandra@virology.uzh.ch	Rauch, Andri/E-9948-2017; Metzner, Karin J/G-5319-2011; gunthard, huldrych f/F-1724-2011; Boeni, Juerg/B-8386-2015; Huber, Michael/B-8509-2015; Kouyos, Roger/G-6226-2014; Kouyos, Roger/ABB-2291-2021; Trkola, Alexandra/K-2115-2012; Kadelka, C/ABL-5824-2022; Fellay, Jacques/A-6681-2009	Rauch, Andri/0000-0001-5297-6062; Metzner, Karin J/0000-0003-4862-1503; gunthard, huldrych f/0000-0002-1142-6723; Huber, Michael/0000-0002-0384-0000; Kouyos, Roger/0000-0002-9220-8348; Kouyos, Roger/0000-0002-9220-8348; Trkola, Alexandra/0000-0003-1013-876X; TARR, Philip/0000-0002-1488-5407; Hirsch, Hans H./0000-0003-0883-0423; Klimkait, Thomas/0000-0003-4945-6511; Marzel, Alex/0000-0002-4795-6224; Friedrich, Nikolas/0000-0003-0694-657X; Braun, Dominique Laurent/0000-0003-4036-1030; Liechti, Thomas/0000-0001-8738-6679; Fellay, Jacques/0000-0002-8240-939X; Kadelka, Claus/0000-0002-5712-8529	Swiss National Science Foundation (SNF) [314730_152663, 314730_172790, 324730B_179571, PZ00P3-142411, BSSGIO_155851]; Clinical Priority Research Program of the University of Zurich; Yvonne-Jacob Foundation; Swiss Vaccine Research Institute; SystemsX.ch grant AntibodyX; SNF [33CS30_148522]; small nested SHCS project [744]; SHCS research foundation	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Clinical Priority Research Program of the University of Zurich; Yvonne-Jacob Foundation; Swiss Vaccine Research Institute; SystemsX.ch grant AntibodyX; SNF; small nested SHCS project; SHCS research foundation	Financial support for this study has been provided by the Swiss National Science Foundation (SNF; 314730_152663 and 314730_172790 to A.T.; 324730B_179571 to H.F.G.; PZ00P3-142411 and BSSGIO_155851 to R.D.K.), the Clinical Priority Research Program of the University of Zurich (Viral infectious diseases: Zurich Primary HIV Infection Study to H.F.G. and A. T.), the Yvonne-Jacob Foundation (to H.F.G.), the Swiss Vaccine Research Institute (to A.T., H.F.G. and R.D.K.) and the SystemsX.ch grant AntibodyX (to A.T.). This study has been cofinanced within the framework of the Swiss HIV Cohort Study, supported by the SNF (33CS30_148522 to H.F.G.), by the small nested SHCS project 744 (to A.T.) and by the SHCS research foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The SHCS data are collected by the five Swiss University Hospitals, two Cantonal Hospitals, 15 affiliated hospitals and 36 private physicians (listed in http://www.shcs.ch/180-health-care-providers). We thank the patients participating in the ZPHI and the SHCS and their physicians and study nurses for patient care and D. Perraudin and M. Minichiello for administrative assistance.	Alizon S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-49; Bachmann N, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0356-3; Bertels F, 2018, MOL BIOL EVOL, V35, P27, DOI 10.1093/molbev/msx246; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Blanquart F, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001855; Brenner B, 2013, AIDS, V27, P1045, DOI 10.1097/QAD.0b013e32835cffd9; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Di Giallonardo F, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku537; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gall A, 2012, J CLIN MICROBIOL, V50, P3838, DOI 10.1128/JCM.01516-12; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Hassan AS, 2017, AIDS, V31, P1211, DOI 10.1097/QAD.0000000000001470; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Kadelka C, 2018, J EXP MED, V215, P1589, DOI 10.1084/jem.20180246; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Liechti T, 2018, J IMMUNOL METHODS, V454, P48, DOI 10.1016/j.jim.2017.12.003; Mabuka J, 2013, AIDS, V27, P1535, DOI 10.1097/QAD.0b013e32835faba5; Marzel A, 2016, CLIN INFECT DIS, V62, P115, DOI 10.1093/cid/civ732; McLaren PJ, 2015, P NATL ACAD SCI USA, V112, P14658, DOI 10.1073/pnas.1514867112; Mitov V, 2018, MOL BIOL EVOL, V35, P756, DOI 10.1093/molbev/msx328; Oberle CS, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0299-0; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rieder P, 2011, CLIN INFECT DIS, V53, P1271, DOI 10.1093/cid/cir725; Rusert P, 2016, NAT MED, V22, P1260, DOI 10.1038/nm.4187; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Simonich CA, 2016, CELL, V166, P77, DOI 10.1016/j.cell.2016.05.055; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Subbaraman H, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0433-2; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Venner CM, 2016, EBIOMEDICINE, V13, P305, DOI 10.1016/j.ebiom.2016.10.014; von Wyl V, 2011, J INFECT DIS, V204, P1095, DOI 10.1093/infdis/jir491; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	39	31	31	0	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 20	2018	561	7723					406	+		10.1038/s41586-018-0517-0	http://dx.doi.org/10.1038/s41586-018-0517-0			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU1HZ	30202088	Bronze			2022-12-28	WOS:000445011500057
J	Duncavage, EJ; Jacoby, MA; Chang, GS; Miller, CA; Edwin, N; Shao, J; Elliott, K; Robinson, J; Abel, H; Fulton, RS; Fronick, CC; O'Laughlin, M; Heath, SE; Brendel, K; Saba, R; Wartman, LD; Christopher, MJ; Pusic, I; Welch, JS; Uy, GL; Link, DC; DiPersio, JF; Westervelt, P; Ley, TJ; Trinkaus, K; Graubert, TA; Walter, MJ				Duncavage, E. J.; Jacoby, M. A.; Chang, G. S.; Miller, C. A.; Edwin, N.; Shao, J.; Elliott, K.; Robinson, J.; Abel, H.; Fulton, R. S.; Fronick, C. C.; O'Laughlin, M.; Heath, S. E.; Brendel, K.; Saba, R.; Wartman, L. D.; Christopher, M. J.; Pusic, I.; Welch, J. S.; Uy, G. L.; Link, D. C.; DiPersio, J. F.; Westervelt, P.; Ley, T. J.; Trinkaus, K.; Graubert, T. A.; Walter, M. J.			Mutation Clearance after Transplantation for Myelodysplastic Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; ACUTE MYELOID-LEUKEMIA; PROGNOSTIC SCORING SYSTEM; STEM-CELL TRANSPLANTATION; BM CYTOMORPHOLOGY; SOMATIC MUTATIONS; ALLO-SCT; RELAPSE; MDS; AZACITIDINE	BACKGROUND Allogeneic hematopoietic stem-cell transplantation is the only curative treatment for patients with myelodysplastic syndrome (MDS). The molecular predictors of disease progression after transplantation are unclear. METHODS We sequenced bone marrow and skin samples from 90 adults with MDS who underwent allogeneic hematopoietic stem-cell transplantation after a myeloablative or reduced-intensity conditioning regimen. We detected mutations before transplantation using enhanced exome sequencing, and we evaluated mutation clearance by using error-corrected sequencing to genotype mutations in bone marrow samples obtained 30 days after transplantation. In this exploratory study, we evaluated the association of a mutation detected after transplantation with disease progression and survival. RESULTS Sequencing identified at least one validated somatic mutation before transplantation in 86 of 90 patients (96%); 32 of these patients (37%) had at least one mutation with a maximum variant allele frequency of at least 0.5% (equivalent to 1 heterozygous mutant cell in 100 cells) 30 days after transplantation. Patients with disease progression had mutations with a higher maximum variant allele frequency at 30 days than those who did not (median maximum variant allele frequency, 0.9% vs. 0%; P<0.001). The presence of at least one mutation with a variant allele frequency of at least 0.5% at day 30 was associated with a higher risk of progression (53.1% vs. 13.0%; conditioning regimen-adjusted hazard ratio, 3.86; 95% confidence interval [CI], 1.96 to 7.62; P<0.001) and a lower 1-year rate of progression-free survival than the absence of such a mutation (31.3% vs. 59.3%; conditioning regimen-adjusted hazard ratio for progression or death, 2.22; 95% CI, 1.32 to 3.73; P=0.005). The rate of progression-free survival was lower among patients who had received a reduced-intensity conditioning regimen and had at least one persistent mutation with a variant allele frequency of at least 0.5% at day 30 than among patients with other combinations of conditioning regimen and mutation status (P.0.001). Multivariate analysis confirmed that patients who had a mutation with a variant allele frequency of at least 0.5% detected at day 30 had a higher risk of progression (hazard ratio, 4.48; 95% CI, 2.21 to 9.08; P<0.001) and a lower 1-year rate of progression-free survival than those who did not (hazard ratio for progression or death, 2.39; 95% CI, 1.40 to 4.09; P=0.002). CONCLUSIONS The risk of disease progression was higher among patients with MDS in whom persistent disease-associated mutations were detected in the bone marrow 30 days after transplantation than among those in whom these mutations were not detected.	[Duncavage, E. J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Jacoby, M. A.; Miller, C. A.; Edwin, N.; Shao, J.; Elliott, K.; Robinson, J.; Heath, S. E.; Brendel, K.; Wartman, L. D.; Christopher, M. J.; Pusic, I.; Welch, J. S.; Uy, G. L.; Link, D. C.; DiPersio, J. F.; Westervelt, P.; Ley, T. J.; Walter, M. J.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Chang, G. S.; Miller, C. A.; Fulton, R. S.; Fronick, C. C.; O'Laughlin, M.] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO USA; [Saba, R.] Washington Univ, Dept Med, Div Hosp Med, Sch Med, St Louis, MO USA; [Trinkaus, K.] Washington Univ, Sch Med, Siteman Biostat Shared Resource, Siteman Canc Ctr, St Louis, MO USA; [Graubert, T. A.] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Harvard University; Massachusetts General Hospital	Walter, MJ (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave,Campus Box 8007, St Louis, MO 63110 USA.	mjwalter@wustl.edu	Uy, Geoffrey/AAD-9815-2021; Walter, Matthew J/S-7758-2018; Miller, Christopher A./A-1060-2009	Miller, Christopher A./0000-0003-4266-6700; Uy, Geoffrey/0000-0002-7809-0996	Leukemia and Lymphoma Society; Edward P. Evans Foundation; National Cancer Institute (NCI) [R33CA217700]; Specialized Program of Research Excellence in AML of the NCI [P50CA171963]; Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR002345, TL1TR002344]; American Society of Hematology Scholar Award; Gabrielle's Angel Foundation; Lottie Caroline Hardy Trust; Genomics of AML Program Project of the NCI [P01 CA101937]; Specialized Program of Research Excellence in AML [P50CA171963]; NCI Cancer Center grant [P30CA091842]; NATIONAL CANCER INSTITUTE [R35CA197561, P50CA171963, P30CA091842, R33CA217700, P01CA101937, K08CA222630, K08CA166229, R35CA210084] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, TL1TR002344] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Edward P. Evans Foundation; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Specialized Program of Research Excellence in AML of the NCI; Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences of the National Institutes of Health; American Society of Hematology Scholar Award; Gabrielle's Angel Foundation; Lottie Caroline Hardy Trust; Genomics of AML Program Project of the NCI; Specialized Program of Research Excellence in AML; NCI Cancer Center grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by the Leukemia and Lymphoma Society and others.; Supported by a Leukemia and Lymphoma Society Quest for Cures and Scholar Award (to Dr. Walter); grants from the Edward P. Evans Foundation (to Drs. Walter and Duncavage), the National Cancer Institute (NCI) (R33CA217700, to Drs. Walter and Duncavage), the Specialized Program of Research Excellence in AML of the NCI (P50CA171963 Career Enhancement Program, to Dr. Duncavage), and the Washington University Institute of Clinical and Translational Sciences (UL1TR002345) from the National Center for Advancing Translational Sciences of the National Institutes of Health (TL1TR002344, to Dr. Duncavage); an American Society of Hematology Scholar Award (to Dr. Jacoby); and grants from Gabrielle's Angel Foundation (to Dr. Walter) and the Lottie Caroline Hardy Trust (to Dr. Walter). Support for procurement of human samples was provided by the Genomics of AML Program Project of the NCI (P01 CA101937, to Dr. Ley) and the Specialized Program of Research Excellence in AML (P50CA171963, to Dr. Link). Core services were provided by the Alvin J. Siteman Cancer Center Tissue Procurement Core and Biostatistics Shared Resource Core supported by an NCI Cancer Center grant (P30CA091842).	Bejar R, 2014, J CLIN ONCOL, V32, P2691, DOI 10.1200/JCO.2013.52.3381; Bornhauser M, 2009, HAEMATOL-HEMATOL J, V94, P1613, DOI 10.3324/haematol.2009.007765; Christopeit M, 2013, BONE MARROW TRANSPL, V48, P465, DOI 10.1038/bmt.2012.161; Christopeit M, 2012, BONE MARROW TRANSPL, V47, P1538, DOI 10.1038/bmt.2012.70; de Witte T, 2017, BLOOD, V129, P1753, DOI 10.1182/blood-2016-06-724500; Della Porta MG, 2016, J CLIN ONCOL, V34, P3627, DOI 10.1200/JCO.2016.67.3616; Diez-Campelo M, 2009, AM J HEMATOL, V84, P149, DOI 10.1002/ajh.21340; Festuccia M, 2016, BIOL BLOOD MARROW TR, V22, P1227, DOI 10.1016/j.bbmt.2016.03.029; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Heuser M, 2017, ANN HEMATOL, V96, P1361, DOI 10.1007/s00277-017-3027-5; Israyelyan A, 2015, BONE MARROW TRANSPL, V50, P26, DOI 10.1038/bmt.2014.209; Ivey A, 2016, NEW ENGL J MED, V374, P422, DOI [10.1056/NEJMoa1507471, 10.1056/NEJMc1603847]; Jacoby MA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98962; Jongen-Lavrencic M, 2018, NEW ENGL J MED, V378, P1189, DOI 10.1056/NEJMoa1716863; Klco JM, 2015, JAMA-J AM MED ASSOC, V314, P811, DOI 10.1001/jama.2015.9643; Koenecke C, 2015, HAEMATOLOGICA, V100, P400, DOI 10.3324/haematol.2014.116715; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lindsley RC, 2017, NEW ENGL J MED, V376, P536, DOI 10.1056/NEJMoa1611604; Mo XD, 2016, ANN HEMATOL, V95, P1233, DOI 10.1007/s00277-016-2706-y; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Platzbecker U, 2012, LEUKEMIA, V26, P381, DOI 10.1038/leu.2011.234; Rosenow F, 2013, BONE MARROW TRANSPL, V48, P1070, DOI 10.1038/bmt.2013.2; Schroeder T, 2013, LEUKEMIA, V27, P1229, DOI 10.1038/leu.2013.7; Scott BL, 2017, J CLIN ONCOL, V35, P1154, DOI 10.1200/JCO.2016.70.7091; Tobiasson M, 2011, BONE MARROW TRANSPL, V46, P719, DOI 10.1038/bmt.2010.179; Uy GL, 2017, LEUKEMIA, V31, P872, DOI 10.1038/leu.2016.282; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Woo J, 2017, HAEMATOLOGICA, V102, pE216, DOI 10.3324/haematol.2016.162909; Yoshizato T, 2017, BLOOD, V129, P2347, DOI 10.1182/blood-2016-12-754796	31	65	65	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					1028	1041		10.1056/NEJMoa1804714	http://dx.doi.org/10.1056/NEJMoa1804714			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4UV	30207916	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000444501600007
J	Murphy, DC				Murphy, Declan C.			Going paper free: five minutes with Martin Kelsall	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Murphy, Declan C/0000-0001-9295-7712					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2018	362								k3846	10.1136/bmj.k3846	http://dx.doi.org/10.1136/bmj.k3846			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JJ	30209048				2022-12-28	WOS:000445016500007
J	Ilic, D; Djulbegovic, M; Jung, JH; Hwang, EC; Zhou, Q; Cleves, A; Agoritsas, T; Dahm, P				Ilic, Dragan; Djulbegovic, Mia; Jung, Jae Hung; Hwang, Eu Chang; Zhou, Qi; Cleves, Anne; Agoritsas, Thomas; Dahm, Philipp			Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FOLLOW-UP; MORTALITY; QUALITY; GRADE; BENEFITS; BIOPSY; TRIAL; MEN	OBJECTIVE To investigate the efficacy and safety of prostate-specific antigen (PSA) testing to screen for prostate cancer. DESIGN Systematic review and meta-analysis. DATA SOURCES Electronic search of Cochrane Central Register of Controlled Trials, Web of Science, Embase, Scopus, OpenGrey, LILACS, and Medline, and search of scientific meeting abstracts and trial registers to April 2018. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Randomised controlled trials comparing PSA screening with usual care in men without a diagnosis of prostate cancer. DATA EXTRACTION At least two reviewers screened studies, extracted data, and assessed the quality of eligible studies. A parallel guideline committee (BMJ Rapid Recommendation) provided input on the design and interpretation of the systematic review, including selection of outcomes important to patients. We used a random effects model to obtain pooled incidence rate ratios (IRR) and, when feasible, conducted subgroup analyses (defined a priori) based on age, frequency of screening, family history, ethnicity, and socioeconomic level, as well as a sensitivity analysis based on the risk of bias. The quality of the evidence was assessed with the GRADE approach. RESULTS Five randomised controlled trials, enrolling 721 718 men, were included. Studies varied with respect to screening frequency and intervals, PSA thresholds for biopsy, and risk of bias. When considering the whole body of evidence, screening probably has no effect on all-cause mortality (IRR 0.99, 95% CI 0.98 to 1.01; moderate certainty) and may have no effect on prostate-specific mortality (IRR 0.96, 0.85 to 1.08; low certainty). Sensitivity analysis of studies at lower risk of bias (n=1) also demonstrates that screening seems to have no effect on all-cause mortality (IRR 1.0, 0.98 to 1.02; moderate certainty) but may have a small effect on prostate-specific mortality (IRR 0.79, 0.69 to 0.91; moderate certainty). This corresponds to one less death from prostate cancer per 1000 men screened over 10 years. Direct comparative data on biopsy and treatment related complications from the included trials were limited. Using modelling, we estimated that for every 1000 men screened, approximately 1, 3, and 25 more men would be hospitalised for sepsis, require pads for urinary incontinence, and report erectile dysfunction, respectively. CONCLUSIONS At best, screening for prostate cancer leads to a small reduction in disease-specific mortality over 10 years but has does not affect overall mortality. Clinicians and patients considering PSA based screening need to weigh these benefits against the potential short and long term harms of screening, including complications from biopsies and subsequent treatment, as well as the risk of overdiagnosis and overtreatment.	[Ilic, Dragan] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Djulbegovic, Mia] Yale Univ, Sch Med, Natl Clinicians Scholars Program, New Haven, CT USA; [Djulbegovic, Mia] Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; [Jung, Jae Hung] Yonsei Univ, Wonju Coll Med, Dept Urol, Wonju, South Korea; [Hwang, Eu Chang] Chonnam Natl Univ, Med Sch, Dept Urol, Gwangju, South Korea; [Hwang, Eu Chang; Dahm, Philipp] Univ Minnesota, Minneapolis VAMC, Urol Sect, Minneapolis, MN 55455 USA; [Hwang, Eu Chang; Dahm, Philipp] Univ Minnesota, Dept Urol, Minneapolis, MN 55455 USA; [Zhou, Qi; Agoritsas, Thomas] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Cleves, Anne] Cardiff Univ, Velindre Canc Ctr, Lib Serv, Velindre NHS Trust, Cardiff, S Glam, Wales; [Agoritsas, Thomas] Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr, Div Gen Internal Med, Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr, Div Epidemiol, Geneva, Switzerland	Monash University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yonsei University; Chonnam National University; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; McMaster University; Cardiff University; Velindre Cancer Centre; University of Geneva; University of Geneva	Dahm, P (corresponding author), Univ Minnesota, Minneapolis VAMC, Urol Sect, Minneapolis, MN 55455 USA.; Dahm, P (corresponding author), Univ Minnesota, Dept Urol, Minneapolis, MN 55455 USA.	pdahm@umn.edu	Zhou, Qi/GSM-9583-2022; Agoritsas, Thomas/F-4321-2014; Hwang, Eu Chang/K-3680-2019; Dahm, Philipp/I-1614-2019	Agoritsas, Thomas/0000-0002-6182-9969; Dahm, Philipp/0000-0003-2819-2553; Cleves, Anne/0000-0002-9899-7894				Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Booth N, 2014, EUR UROL, V65, P39, DOI 10.1016/j.eururo.2012.11.041; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Dahm P, SCREENING PROSTATE C; Dahm P, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4200; Djulbegovic M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4543; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Fenton JJ, 2018, AHRQ PUBLICATION; Fenton JJ, 2018, JAMA-J AM MED ASSOC, V319, P1914, DOI 10.1001/jama.2018.3712; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Godtman RA, 2015, EUR UROL, V68, P354, DOI 10.1016/j.eururo.2014.12.006; Gulati R, 2013, ANN INTERN MED, V158, P145, DOI 10.7326/0003-4819-158-3-201302050-00003; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Han PKJ, 2013, ANN FAM MED, V11, P306, DOI 10.1370/afm.1539; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hultcrantz M, 2017, J CLIN EPIDEMIOL, V87, P4, DOI 10.1016/j.jclinepi.2017.05.006; Ilic Dragan, 2013, Cochrane Database Syst Rev, pCD004720, DOI 10.1002/14651858.CD004720.pub3; International Agency for Research on Cancer, GLOBOCAN 2012 CANC I; Kasivisvanathan V, 2018, NEW ENGL J MED, V378, P1767, DOI 10.1056/NEJMoa1801993; Kilpelainen TP, 2016, AM J EPIDEMIOL, V184, P720, DOI 10.1093/aje/kww084; Kilpelainen TP, 2011, EUR J CANCER, V47, P2698, DOI 10.1016/j.ejca.2011.06.055; Labrie F, 2004, PROSTATE, V59, P311, DOI 10.1002/pros.20017; Lin K, 2008, ANN INTERN MED, V149, P192, DOI 10.7326/0003-4819-149-3-200808050-00009; Lundgren PO, 2018, J UROLOGY, V200, P82, DOI 10.1016/j.juro.2018.01.080; Martin RM, 2018, JAMA-J AM MED ASSOC, V319, P883, DOI 10.1001/jama.2018.0154; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Misra-Hebert AD, 2017, BJU INT, V120, P257, DOI 10.1111/bju.13793; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Rahal AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153417; Rosario DJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7894; Sandblom G, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1539; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Siemieniuk RA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5191; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tikkinen KAO, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3581; Vernooij RWM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-025470; Vickers AJ, 2017, ANN INTERN MED, V167, P509, DOI 10.7326/M17-2012; Wilt TJ, 2017, NEW ENGL J MED, V377, P132, DOI 10.1056/NEJMoa1615869	42	217	222	8	59	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2018	362								k3519	10.1136/bmj.k3519	http://dx.doi.org/10.1136/bmj.k3519			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WB	30185521	hybrid, Green Published			2022-12-28	WOS:000444505300005
J	Shepherd, A				Shepherd, Alison			After a near decade's wait, patient appeals for a heart donor	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2018	362								k3782	10.1136/bmj.k3782	http://dx.doi.org/10.1136/bmj.k3782			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WB	30185487				2022-12-28	WOS:000444505300013
J	Berg, J				Berg, Jeremy			Revolutionary technologies	SCIENCE			English	News Item												jberg@aaas.org	Berg, Jeremy/GRY-6706-2022	Berg, Jeremy/0000-0002-2444-8139; Berg, Jeremy/0000-0003-3022-0963					0	1	1	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405								10.1126/science.aav1775	http://dx.doi.org/10.1126/science.aav1775			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166463				2022-12-28	WOS:000443547000005
J	Nie, M; Zou, JY; Xu, X; Liang, C; Fang, CM; Li, B				Nie, Ming; Zou, Junyu; Xu, Xiao; Liang, Chao; Fang, Changming; Li, Bo			Comment on "Unexpected reversal of C-3 versus C-4 grass response to elevated CO2 during a 20-year field experiment"	SCIENCE			English	Editorial Material							SEMIARID GRASSLAND; GROWTH	Reich et al. (Reports, 20 April 2018, p. 317) reported that elevated carbon dioxide (eCO(2)) switched its effect from promoting C-3 grasses to favoring C-4 grasses in a long-term experiment. We argue that the authors did not appropriately elucidate the interannual climate variation as a potential mechanism for the reversal of C-4-C-3 biomass in response to eCO(2).	[Nie, Ming; Zou, Junyu; Xu, Xiao; Fang, Changming; Li, Bo] Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, 2005 Songhu Rd, Shanghai 200438, Peoples R China; [Liang, Chao] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Liaoning, Peoples R China	Fudan University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Nie, M (corresponding author), Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, 2005 Songhu Rd, Shanghai 200438, Peoples R China.	mnie@fudan.edu.cn	Xu, Xiao/HHM-9482-2022; Zou, Junyu/AFU-9916-2022; Nie, Ming/F-1880-2010	Xu, Xiao/0000-0001-6844-3914; Zou, Junyu/0000-0002-9365-1835; Nie, Ming/0000-0003-0702-8009	National Key Research and Development Program of China [2017YFC1200100]; National Science Foundation of China [41630528, 31670491]; Young Thousand Talents Program Scholar; Direct For Biological Sciences [1242531] Funding Source: National Science Foundation	National Key Research and Development Program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Thousand Talents Program Scholar; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Prof. Reich for discussing with us. The work was supported by the National Key Research and Development Program of China (2017YFC1200100), National Science Foundation of China (41630528 and 31670491), and Young Thousand Talents Program Scholar.	Ghannoum O, 2000, PLANT CELL ENVIRON, V23, P931, DOI 10.1046/j.1365-3040.2000.00609.x; Ghannoum O, 2009, ANN BOT-LONDON, V103, P635, DOI 10.1093/aob/mcn093; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Mueller KE, 2016, ECOL LETT, V19, P956, DOI 10.1111/ele.12634; Poorter H, 2003, NEW PHYTOL, V157, P175, DOI 10.1046/j.1469-8137.2003.00680.x; Reich PB, 2018, SCIENCE, V360, P317, DOI 10.1126/science.aas9313	6	2	2	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405							aau3016	10.1126/science.aau3016	http://dx.doi.org/10.1126/science.aau3016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS3UB	30166457				2022-12-28	WOS:000443547000003
J	McCartney, M				McCartney, Margaret			Margaret McCartney: We must fight the gravitational pull between money and power	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Shaw SE, 2014, SOCIOL HEALTH ILL, V36, P447, DOI 10.1111/1467-9566.12071; Snyder T., 2017, ON TYRANNY	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2018	362								k3473	10.1136/bmj.k3473	http://dx.doi.org/10.1136/bmj.k3473			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5YZ	30154140	Bronze			2022-12-28	WOS:000443756600002
J	Bathgate, G; Karra, E; Khoo, B				Bathgate, Gabriella; Karra, Efthimia; Khoo, Bernard			New diagnosis of hyperthyroidism in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THYROID ASSOCIATION GUIDELINES; GRAVES ORBITOPATHY; MANAGEMENT; METAANALYSIS; DISEASE		[Bathgate, Gabriella; Karra, Efthimia; Khoo, Bernard] Royal Free London NHS Trust, London, England	University of London; University College London; Royal Free London NHS Foundation Trust	Bathgate, G (corresponding author), Royal Free London NHS Trust, London, England.	g.j.bathgate@doctors.org.uk	Khoo, Bernard/B-1247-2009	Khoo, Bernard/0000-0002-4223-9736				Association of Clinical Biochemistry British Thyroid Association and British Thyroid Foundation, 2006, UK GUID US THYR FUNC; Bartalena L, 2016, EUR THYROID J, V5, P9, DOI 10.1159/000443828; Madariaga AG, 2014, J CLIN ENDOCR METAB, V99, P923, DOI 10.1210/jc.2013-2409; Marcocci C, 2011, NEW ENGL J MED, V364, P1920, DOI 10.1056/NEJMoa1012985; Perros P, 2015, CLIN MED, V15, P173, DOI 10.7861/clinmedicine.15-2-173; Perros P, 2014, CLIN ENDOCRINOL, V81, P1, DOI 10.1111/cen.12515; Ross DS, 2016, THYROID, V26, P1343, DOI 10.1089/thy.2016.0229; Tozzoli R, 2012, AUTOIMMUN REV, V12, P107, DOI 10.1016/j.autrev.2012.07.003; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030; Vicente N, 2017, DRUGS R&D, V17, P91, DOI 10.1007/s40268-017-0172-1	10	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2018	362								k2880	10.1136/bmj.k2880	http://dx.doi.org/10.1136/bmj.k2880			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8SY	30143512	Green Submitted			2022-12-28	WOS:000443000000001
J	Yuan, X				Yuan, Xun			China's vaccine production scare	LANCET			English	Editorial Material																			0	14	15	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2018	392	10145					371	371		10.1016/S0140-6736(18)31725-2	http://dx.doi.org/10.1016/S0140-6736(18)31725-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GP1SM	30152367				2022-12-28	WOS:000440597100005
J	Barnett, R				Barnett, Richard			Hypertension	LANCET			English	Editorial Material												richard@richardbarnettwriter.com							0	5	5	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2365	2365		10.1016/S0140-6736(17)31570-2	http://dx.doi.org/10.1016/S0140-6736(17)31570-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX6ED	30199660				2022-12-28	WOS:000403334400015
J	Cao, JY; Cusanovich, DA; Ramani, V; Aghamirzaie, D; Pliner, HA; Hill, AJ; Daza, RM; McFaline-Figueroa, JL; Packer, JS; Christiansen, L; Steemers, FJ; Adey, AC; Trapnell, C; Shendure, J				Cao, Junyue; Cusanovich, Darren A.; Ramani, Vijay; Aghamirzaie, Delasa; Pliner, Hannah A.; Hill, Andrew J.; Daza, Riza M.; McFaline-Figueroa, Jose L.; Packer, Jonathan S.; Christiansen, Lena; Steemers, Frank J.; Adey, Andrew C.; Trapnell, Cole; Shendure, Jay			Joint profiling of chromatin accessibility and gene expression in thousands of single cells	SCIENCE			English	Article							DNA METHYLATION; SEQ; HETEROGENEITY; BINDING; GENOME	Although we can increasingly measure transcription, chromatin, methylation, and other aspects of molecular biology at single-cell resolution, most assays survey only one aspect of cellular biology. Here we describe sci-CAR, a combinatorial indexing-based coassay that jointly profiles chromatin accessibility and mRNA (CAR) in each of thousands of single cells. As a proof of concept, we apply sci-CAR to 4825 cells, including a time series of dexamethasone treatment, as well as to 11,296 cells from the adult mouse kidney. With the resulting data, we compare the pseudotemporal dynamics of chromatin accessibility and gene expression, reconstruct the chromatin accessibility profiles of cell types defined by RNA profiles. and link cis-regulatory sites to their target genes on the basis of the covariance of chromatin accessibility and transcription across large numbers of single cells.	[Cao, Junyue; Cusanovich, Darren A.; Ramani, Vijay; Aghamirzaie, Delasa; Pliner, Hannah A.; Hill, Andrew J.; Daza, Riza M.; McFaline-Figueroa, Jose L.; Packer, Jonathan S.; Trapnell, Cole; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Cao, Junyue] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Christiansen, Lena; Steemers, Frank J.] Illumina Inc, San Diego, CA USA; [Adey, Andrew C.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Adey, Andrew C.] Knight Cardiovasc Inst, Portland, OR USA; [Trapnell, Cole; Shendure, Jay] Allen Discovery Ctr Cell Lineage Tracing, Seattle, WA 98195 USA; [Trapnell, Cole; Shendure, Jay] Brotman Baty Inst Precis Med, Seattle, WA 98195 USA; [Shendure, Jay] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Cusanovich, Darren A.] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ USA; [Cusanovich, Darren A.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Illumina; Oregon Health & Science University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Arizona; University of Arizona	Trapnell, C; Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Trapnell, C; Shendure, J (corresponding author), Allen Discovery Ctr Cell Lineage Tracing, Seattle, WA 98195 USA.; Trapnell, C; Shendure, J (corresponding author), Brotman Baty Inst Precis Med, Seattle, WA 98195 USA.; Shendure, J (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	coletrap@uw.edu; shendure@uw.edu	Daza, Riza M./HCH-4047-2022; Horwitz, Marshall/AAE-8376-2021; Shendure, Jay/AAU-3684-2021; Pliner, Hannah Andersen/F-3608-2015	McFaline-Figueroa, Jose L./0000-0003-4387-1511; Daza, Riza/0000-0003-1635-8675; Cao, Junyue/0000-0003-4097-489X; Packer, Jonathan/0000-0003-4025-0007; Pliner, Hannah Andersen/0000-0003-1484-6501; Cusanovich, Darren/0000-0001-6889-0095	Paul G. Allen Frontiers Foundation (Allen Discovery Center grant); NIH [DP1HG007811, R01HG006283, DP2 HD088158, R35GM124704]; W. M. Keck Foundation; Dale. F. Frey Award for Breakthrough Scientists; Alfred P. Sloan Foundation Research Fellowship; Brotman Baty Institute for Precision Medicine; National Heart, Lung, and Blood Institute [T32HL007828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD088158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006281, DP1HG007811, R01HG006283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124704] Funding Source: NIH RePORTER	Paul G. Allen Frontiers Foundation (Allen Discovery Center grant); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); Dale. F. Frey Award for Breakthrough Scientists; Alfred P. Sloan Foundation Research Fellowship(Alfred P. Sloan Foundation); Brotman Baty Institute for Precision Medicine; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Paul G. Allen Frontiers Foundation (Allen Discovery Center grant to J.S. and C.T.), grants from the NIH (DP1HG007811 and R01HG006283 to J.S.; DP2 HD088158 to C.T.; R35GM124704 to A.C.A.), the W. M. Keck Foundation (to C.T. and J.S.), the Dale. F. Frey Award for Breakthrough Scientists (to C.T.), the Alfred P. Sloan Foundation Research Fellowship (to C.T.), and the Brotman Baty Institute for Precision Medicine. D.A.C. was supported in part by T32HL007828 from the National Heart, Lung, and Blood Institute. J.S. is an investigator of the Howard Hughes Medical Institute.	Amini S, 2014, NAT GENET, V46, P1343, DOI 10.1038/ng.3119; Angermueller C, 2016, NAT METHODS, V13, P229, DOI 10.1038/nmeth.3728; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Chen LH, 2017, P NATL ACAD SCI USA, V114, pE9989, DOI 10.1073/pnas.1710964114; Chinenov Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-656; Clark SJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03149-4; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Guo F, 2017, CELL RES, V27, P967, DOI 10.1038/cr.2017.82; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Hou Y, 2016, CELL RES, V26, P304, DOI 10.1038/cr.2016.23; Hu YJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0950-z; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Mulqueen RM, 2018, NAT BIOTECHNOL, V36, P428, DOI 10.1038/nbt.4112; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Pott S, 2017, ELIFE, V6, DOI 10.7554/eLife.23203; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Ramani V, 2017, NAT METHODS, V14, P263, DOI [10.1038/NMETH.4155, 10.1038/nmeth.4155]; Reddy TE, 2012, MOL CELL BIOL, V32, P3756, DOI 10.1128/MCB.00062-12; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Vitak SA, 2017, NAT METHODS, V14, P302, DOI [10.1038/NMETH.4154, 10.1038/nmeth.4154]; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; Yin Y, 2018, BIORXIV338053, DOI [10.1101/338053, DOI 10.1101/338053]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	26	332	340	15	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2018	361	6409			SI		1380	1385		10.1126/science.aau0730	http://dx.doi.org/10.1126/science.aau0730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5LA	30166440	Green Accepted			2022-12-28	WOS:000446142200049
J	Mittal, S; Goldschmidt, EA; Hafezi, M				Mittal, Sunil; Goldschmidt, Elizabeth A.; Hafezi, Mohammad			A topological source of quantum light	NATURE			English	Article							WAVE-GUIDES; GENERATION; INSULATOR; RESONATORS; PHOTONICS; STATES	Quantum light is characterized by distinctive statistical distributions that are possible only because of quantum mechanical effects. For example, single photons and correlated photon pairs exhibit photon number distributions with variance lower than classically allowed limits. This enables high-fidelity transmission of quantum information and sensing with lower noise than possible with classical light sources(1,2). Most quantum light sources rely on spontaneous parametric processes such as down-conversion and four-wave mixing(2). These processes are mediated by vacuum fluctuations of the electromagnetic field. Therefore, by manipulating the electromagnetic mode structure, for example with dispersion-engineered nanophotonic systems, the spectrum of generated photons can be controlled(3-7). However, disorder, which is ubiquitous in nanophotonic fabrication, causes device-to-device spectral variations(8-11). Here we realize topologically robust electromagnetic modes and use their vacuum fluctuations to create a quantum light source in which the spectrum of generated photons is much less affected by fabrication-induced disorder. Specifically, we use the topological edge states realized in a two-dimensional array of ring resonators to generate correlated photon pairs by spontaneous four-wave mixing and show that they outperform their topologically trivial one-dimensional counterparts in terms of spectral robustness. We demonstrate the non-classical nature of the generated light and the realization of a robust source of heralded single photons by measuring the conditional antibunching of photons, that is, the reduced likelihood of photons arriving together compared to thermal or laser light. Such topological effects, which are unique to bosonic systems, could pave the way for the development of robust quantum photonic devices.	[Mittal, Sunil; Goldschmidt, Elizabeth A.; Hafezi, Mohammad] Univ Maryland, NIST, Joint Quantum Inst, College Pk, MD 20742 USA; [Mittal, Sunil; Hafezi, Mohammad] Univ Maryland, Dept Elect & Comp Engn, IREAP, College Pk, MD 20742 USA; [Goldschmidt, Elizabeth A.] US Army Res Lab, Adelphi, MD USA; [Hafezi, Mohammad] Univ Maryland, Dept Phys, College Pk, MD 20742 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); University System of Maryland; University of Maryland College Park	Mittal, S (corresponding author), Univ Maryland, NIST, Joint Quantum Inst, College Pk, MD 20742 USA.; Mittal, S (corresponding author), Univ Maryland, Dept Elect & Comp Engn, IREAP, College Pk, MD 20742 USA.	mittals@umd.edu	Hafezi, Mohammad/A-1197-2008; Goldschmidt, Elizabeth/N-3777-2018	Hafezi, Mohammad/0000-0003-1679-4880; Goldschmidt, Elizabeth/0000-0002-6553-9731	AFOSR-MURI [FA955014-1-0267]; YIP-ONR; Sloan Foundation; Physics Frontier Center at the Joint Quantum Institute	AFOSR-MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); YIP-ONR; Sloan Foundation(Alfred P. Sloan Foundation); Physics Frontier Center at the Joint Quantum Institute	This research was supported by AFOSR-MURI FA955014-1-0267, YIP-ONR, Sloan Foundation and the Physics Frontier Center at the Joint Quantum Institute. We thank V. V. Orre for help with the experimental set-up, A. Karasahin for help with the SEM, T. Huber and D. Englund for discussions and Q. Quraishi for providing the nanowire detectors.	Bahari B, 2017, SCIENCE, V358, P636, DOI 10.1126/science.aao4551; Bauters JF, 2011, OPT EXPRESS, V19, P3163, DOI 10.1364/OE.19.003163; Chen J, 2011, OPT EXPRESS, V19, P1470, DOI 10.1364/OE.19.001470; Chen WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6782; Cheng XJ, 2016, NAT MATER, V15, P542, DOI [10.1038/NMAT4573, 10.1038/nmat4573]; Clemmen S, 2009, OPT EXPRESS, V17, P16558, DOI 10.1364/OE.17.016558; Davanco M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4711253; Eisaman MD, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3610677; Fortsch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2838; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hafezi M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.210405; Hafezi M, 2011, NAT PHYS, V7, P907, DOI [10.1038/NPHYS2063, 10.1038/nphys2063]; Kraus YE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106402; Kumar R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6489; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI [10.1038/nphoton.2014.248, 10.1038/NPHOTON.2014.248]; Mittal S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.087403; Mittal S, 2016, NAT PHOTONICS, V10, P180, DOI [10.1038/nphoton.2016.10, 10.1038/NPHOTON.2016.10]; Mookherjea S, 2008, NAT PHOTONICS, V2, P90, DOI 10.1038/nphoton.2007.278; Morichetti F, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1294; Moss DJ, 2013, NAT PHOTONICS, V7, P597, DOI [10.1038/NPHOTON.2013.183, 10.1038/nphoton.2013.183]; Ong JR, 2013, OPT EXPRESS, V21, P5171, DOI 10.1364/OE.21.005171; Peano V, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041026; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Sapienza L, 2010, SCIENCE, V327, P1352, DOI 10.1126/science.1185080; Sharping JE, 2006, OPT EXPRESS, V14, P12388, DOI 10.1364/OE.14.012388; Shi T, 2017, P NATL ACAD SCI USA, V114, pE8967, DOI 10.1073/pnas.1708944114; Spring JB, 2017, OPTICA, V4, P90, DOI 10.1364/OPTICA.4.000090; St-Jean P, 2017, NAT PHOTONICS, V11, P651, DOI 10.1038/s41566-017-0006-2; Topolancik J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.253901; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; Yariv A, 1999, OPT LETT, V24, P711, DOI 10.1364/OL.24.000711	32	132	135	13	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2018	561	7724					502	+		10.1038/s41586-018-0478-3	http://dx.doi.org/10.1038/s41586-018-0478-3			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU8WA	30202090	Green Submitted			2022-12-28	WOS:000445622500049
J	Anderson, MA; O'Shea, TM; Burda, JE; Ao, Y; Barlatey, SL; Bernstein, AM; Kim, JH; James, ND; Rogers, A; Kato, B; Wollenberg, AL; Kawaguchi, R; Coppola, G; Wang, C; Deming, TJ; He, ZG; Courtine, G; Sofroniew, MV				Anderson, Mark A.; O'Shea, Timothy M.; Burda, Joshua E.; Ao, Yan; Barlatey, Sabry L.; Bernstein, Alexander M.; Kim, Jae H.; James, Nicholas D.; Rogers, Alexandra; Kato, Brian; Wollenberg, Alexander L.; Kawaguchi, Riki; Coppola, Giovanni; Wang, Chen; Deming, Timothy J.; He, Zhigang; Courtine, Gregoire; Sofroniew, Michael V.			Required growth facilitators propel axon regeneration across complete spinal cord injury	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; SYNAPSE FORMATION; REACTIVE ASTROCYTES; NEURITE OUTGROWTH; LOCAL-DELIVERY; SCAR FORMATION; GLIAL SCAR; CELLS; RECOVERY; CONDUCTION	Transected axons fail to regrow across anatomically complete spinal cord injuries (SCI) in adults. Diverse molecules can partially facilitate or attenuate axon growth during development or after injury(1-3), but efficient reversal of this regrowth failure remains elusive(4). Here we show that three factors that are essential for axon growth during development but are attenuated or lacking in adults- (i) neuron intrinsic growth capacity(2,5-9), (ii) growth-supportive substrate(10,11) and (iii) chemoattraction(12)(,13)-are all individually required and, in combination, are sufficient to stimulate robust axon regrowth across anatomically complete SCI lesions in adult rodents. We reactivated the growth capacity of mature descending propriospinal neurons with osteopontin, insulin-like growth factor 1 and ciliary-derived neurotrophic factor before SCI14,15; induced growth-supportive substrates with fibroblast growth factor 2 and epidermal growth factor; and chemoattracted propriospinal axons with glial-derived neurotrophic factor(16,17) delivered via spatially and temporally controlled release from biomaterial depots(18,19), placed sequentially after SCI. We show in both mice and rats that providing these three mechanisms in combination, but not individually, stimulated robust propriospinal axon regrowth through astrocyte scar borders and across lesion cores of non-neural tissue that was over 100-fold greater than controls. Stimulated, supported and chemoattracted propriospinal axons regrew a full spinal segment beyond lesion centres, passed well into spared neural tissue, formed terminal-like contacts exhibiting synaptic markers and conveyed a significant return of electrophysiological conduction capacity across lesions. Thus, overcoming the failure of axon regrowth across anatomically complete SCI lesions after maturity required the combined sequential reinstatement of several developmentally essential mechanisms that facilitate axon growth. These findings identify a mechanism-based biological repair strategy for complete SCI lesions that could be suitable to use with rehabilitation models designed to augment the functional recovery of remodelling circuits.	[Anderson, Mark A.; O'Shea, Timothy M.; Burda, Joshua E.; Ao, Yan; Bernstein, Alexander M.; Kim, Jae H.; Rogers, Alexandra; Kato, Brian; Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Anderson, Mark A.; Barlatey, Sabry L.; James, Nicholas D.; Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland; [Anderson, Mark A.; Barlatey, Sabry L.; James, Nicholas D.; Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland; [Wollenberg, Alexander L.; Deming, Timothy J.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Wollenberg, Alexander L.; Deming, Timothy J.] Univ Calif Los Angeles, Dept Chem, Los Angeles, CA 90024 USA; [Wollenberg, Alexander L.; Deming, Timothy J.] Univ Calif Los Angeles, Dept Biochem, Los Angeles, CA USA; [Kawaguchi, Riki; Coppola, Giovanni] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; [Kawaguchi, Riki; Coppola, Giovanni] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Wang, Chen; He, Zhigang] Harvard Med Sch, Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Neurol, Boston, MA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Boston Children's Hospital; Harvard Medical School	Sofroniew, MV (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.; Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet, Lausanne, Switzerland.; Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland.	gregoire.courtine@epfl.ch; sofroniew@mednet.ucla.edu	Kawaguchi, Riki/AAV-6090-2020; Sofroniew, Michael/ABE-8857-2020	Kim, Jae/0000-0002-1027-8845; Rogers Beasley, Alexandra/0000-0002-4675-6968; Deming, Timothy/0000-0002-0594-5025; courtine, gregoire/0000-0002-5744-4142	US National Institutes of Health [NS084030, F32NS096858, NS096294, NS062691]; Dr. Miriam and Sheldon G. Adelson Medical Foundation; International Foundation for Research in Paraplegia [146]; ALARME Foundation [531066]; Association Song Taaba; Craig H. Neilsen Foundation [381357]; Consolidator Grant from the European Research Council [ERC-2015-CoG HOW2WALKAGAIN 682999]; Paralyzed Veterans Foundation of America [3080]; Swiss National Science Foundation [323530-164220]; Microscopy Core Resource of UCLA Broad Stem Cell Research Center; Microscopy Core Resource of the Wyss Center for Bio and Neuroengineering; Wings for Life; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691, K99NS105915, R01NS096294, R01NS084030, F32NS096858] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Foundation; International Foundation for Research in Paraplegia; ALARME Foundation; Association Song Taaba; Craig H. Neilsen Foundation; Consolidator Grant from the European Research Council; Paralyzed Veterans Foundation of America; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Microscopy Core Resource of UCLA Broad Stem Cell Research Center; Microscopy Core Resource of the Wyss Center for Bio and Neuroengineering; Wings for Life; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health (NS084030 to M.V.S., F32NS096858 to J.E.B., NS096294 to Z.H., and NS062691 to G.Cop.); Dr. Miriam and Sheldon G. Adelson Medical Foundation (M.V.S., Z.H., T.J.D. and G. Cop.); International Foundation for Research in Paraplegia (146 to M.A.A. and G.Cou.); ALARME Foundation (531066 to M.A.A. and G. Cou.); Association Song Taaba (M.A.A.); Craig H. Neilsen Foundation (381357 to T.M.O. and M.V.S); Consolidator Grant from the European Research Council [ERC-2015-CoG HOW2WALKAGAIN 682999] (G. Cou.); Paralyzed Veterans Foundation of America (3080 to J.E.B. and M.V.S.); Swiss National Science Foundation (323530-164220 to S.L.B and G. Cou.); Microscopy Core Resource of UCLA Broad Stem Cell Research Center; Microscopy Core Resource of the Wyss Center for Bio and Neuroengineering; and Wings for Life (M.V.S., J.E.B. and Z.H.).	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Asboth L, 2018, NAT NEUROSCI, V21, P576, DOI 10.1038/s41593-018-0093-5; AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Deng LX, 2013, J NEUROSCI, V33, P5655, DOI 10.1523/JNEUROSCI.2973-12.2013; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Geoffroy CG, 2016, CELL REP, V15, P238, DOI 10.1016/j.celrep.2016.03.028; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; Harrison M, 2013, NEUROIMAGE, V68, P22, DOI 10.1016/j.neuroimage.2012.11.048; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Jacobi A, 2015, EMBO J, V34, P1231, DOI 10.15252/embj.201490578; James ND, 2011, J NEUROSCI, V31, P18543, DOI 10.1523/JNEUROSCI.4306-11.2011; Kashpur O, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-656; LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Plantman S, 2008, MOL CELL NEUROSCI, V39, P50, DOI 10.1016/j.mcn.2008.05.015; Puttagunta R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4527; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Siebert JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-69; Sofroniew MV, 2018, NATURE, V557, P343, DOI 10.1038/s41586-018-0068-4; Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Tedeschi A, 2016, NEURON, V92, P419, DOI 10.1016/j.neuron.2016.09.026; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Watson C, 2008, THE SPINAL CORD; White RE, 2008, EXP NEUROL, V214, P10, DOI 10.1016/j.expneurol.2008.06.012; Yang CY, 2009, BIOMATERIALS, V30, P2881, DOI 10.1016/j.biomaterials.2009.01.056; Zhang S, 2014, BIOMATERIALS, V35, P1989, DOI 10.1016/j.biomaterials.2013.11.005; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	47	207	215	18	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2018	561	7723					396	+		10.1038/s41586-018-0467-6	http://dx.doi.org/10.1038/s41586-018-0467-6			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU1HZ	30158698	Green Submitted, Green Accepted			2022-12-28	WOS:000445011500055
J	Kurita, M; Araoka, T; Hishida, T; O'Keefe, DD; Takahashi, Y; Sakamoto, A; Sakurai, M; Suzuki, K; Wu, J; Yamamoto, M; Hernandez-Benitez, R; Ocampo, A; Reddy, P; Shokhirev, MN; Magistretti, P; Delicado, EN; Eto, H; Harii, K; Belmonte, JCI				Kurita, Masakazu; Araoka, Toshikazu; Hishida, Tomoaki; O'Keefe, David D.; Takahashi, Yuta; Sakamoto, Akihisa; Sakurai, Masahiro; Suzuki, Keiichiro; Wu, Jun; Yamamoto, Mako; Hernandez-Benitez, Reyna; Ocampo, Alejandro; Reddy, Pradeep; Shokhirev, Maxim Nikolaievich; Magistretti, Pierre; Delicado, Estrella Nunez; Eto, Hitomi; Harii, Kiyonori; Belmonte, Juan Carlos Izpisua			In vivo reprogramming of wound-resident cells generates skin epithelial tissue	NATURE			English	Article							FIBROBLAST-GROWTH-FACTOR; STEM-CELLS; GENE-THERAPY; ADENOASSOCIATED VIRUSES; KERATINOCYTES; REGENERATION; EXPRESSION; REPAIR; DIFFERENTIATION; INDUCTION	Large cutaneous ulcers are, in severe cases, life threatening(1,2). As the global population ages, non-healing ulcers are becoming increasingly common(1,2). Treatment currently requires the transplantation of pre-existing epithelial components, such as skin grafts, or therapy using cultured cells(2). Here we develop alternative supplies of epidermal coverage for the treatment of these kinds of wounds. We generated expandable epithelial tissues using in vivo reprogramming of wound-resident mesenchymal cells. Transduction of four transcription factors that specify the skin-cell lineage enabled efficient and rapid de novo epithelialization from the surface of cutaneous ulcers in mice. Our findings may provide a new therapeutic avenue for treating skin wounds and could be extended to other disease situations in which tissue homeostasis and repair are impaired.	[Kurita, Masakazu; Araoka, Toshikazu; Hishida, Tomoaki; O'Keefe, David D.; Takahashi, Yuta; Sakamoto, Akihisa; Sakurai, Masahiro; Suzuki, Keiichiro; Wu, Jun; Yamamoto, Mako; Hernandez-Benitez, Reyna; Ocampo, Alejandro; Reddy, Pradeep; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Kurita, Masakazu; Eto, Hitomi; Harii, Kiyonori] Kyorin Univ, Dept Plast Surg, Sch Med, Tokyo, Japan; [Araoka, Toshikazu; Sakamoto, Akihisa; Sakurai, Masahiro; Delicado, Estrella Nunez] Univ Catolica San Antonio Murcia UCAM, Campus Jeronimos, Guadalupe, Spain; [Shokhirev, Maxim Nikolaievich] Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Magistretti, Pierre] KAUST, Thuwal, Saudi Arabia	Salk Institute; Kyorin University; Universidad Catolica de Murcia; Salk Institute; King Abdullah University of Science & Technology	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Wu, Jun/AAF-1830-2019; Núñez-Delicado, Estrella/AAR-9438-2021; Reddy, Pradeep/G-1770-2014	Wu, Jun/0000-0001-9863-1668; Núñez-Delicado, Estrella/0000-0002-0554-2365; Reddy, Pradeep/0000-0002-9173-3845; Sakurai, Masahiro/0000-0002-6376-0299; Ocampo, Alejandro/0000-0002-3731-3647; Hernandez-Benitez, Reyna/0000-0003-2546-8956; Magistretti, Pierre Julius/0000-0002-6678-320X; KURITA, Masakazu/0000-0001-7626-9565	MEXT KAKENHI [JP26293381, JP23689073, JP21689046]; Kyorin University research promotion award; JSPS Overseas Research Fellowships; Uehara Memorial Foundation Research Fellowship for Research Abroad; NIH-NCI [CCSG: P30 014195]; Leona M. and Harry B. Helmsley Charitable Trust; G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation; Evergreen Foundation; Fundacion Dr. Pedro Guillen; Universidad Catolica San Antonio de Murcia (UCAM)	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyorin University research promotion award; JSPS Overseas Research Fellowships; Uehara Memorial Foundation Research Fellowship for Research Abroad; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leona M. and Harry B. Helmsley Charitable Trust; G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation; Evergreen Foundation; Fundacion Dr. Pedro Guillen; Universidad Catolica San Antonio de Murcia (UCAM)	This work was supported by MEXT KAKENHI Grant numbers JP26293381(Grant-in-Aid for Scientific Research (B) to M.K.), JP23689073 (Grant-in-Aid for Young Scientists (A) to M.K.), JP21689046 (Grant-in-Aid for Young Scientists (A) to M.K.), Kyorin University research promotion award to M.K. (2013), JSPS Overseas Research Fellowships (2015-17) to M.K., and the Uehara Memorial Foundation Research Fellowship for Research Abroad (2017-18) to M.K. M.K. thanks H. Green for support materials. T.H. thanks F. Sugiyama for support materials. M.N.S. is supported by NIH-NCI CCSG: P30 014195 and The Leona M. and Harry B. Helmsley Charitable Trust. Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust, The Moxie Foundation, The Evergreen Foundation, Fundacion Dr. Pedro Guillen and Universidad Catolica San Antonio de Murcia (UCAM).	Akita S, 2008, WOUND REPAIR REGEN, V16, P635, DOI 10.1111/j.1524-475X.2008.00414.x; BOUKAMP P, 1990, DIFFERENTIATION, V44, P150, DOI 10.1111/j.1432-0436.1990.tb00548.x; Chandler RJ, 2017, HUM GENE THER, V28, P314, DOI 10.1089/hum.2017.009; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Dassule HR, 2000, DEVELOPMENT, V127, P4775; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Gonzales KAU, 2017, DEV CELL, V43, P387, DOI 10.1016/j.devcel.2017.10.001; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harajly M, 2016, MOL CELL BIOL, V36, P438, DOI 10.1128/MCB.00747-15; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hirsch T, 2017, NATURE, V551, P327, DOI 10.1038/nature24487; Jeune VL, 2013, HUM GENE THER METHOD, V24, P59, DOI 10.1089/hgtb.2012.243; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kurashige C, 2014, FASEB J, V28, P1237, DOI 10.1096/fj.13-238998; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Melino G, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1033; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Okazaki M, 2003, PLAST RECONSTR SURG, V111, P286, DOI 10.1097/01.PRS.0000034942.09960.2E; Provost JJ, 2012, CELL ONCOL, V35, P95, DOI 10.1007/s13402-011-0068-y; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROBSON MC, 1992, ANN SURG, V216, P401, DOI 10.1097/00000658-199210000-00002; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Schmitz Annika, 2015, J Invest Dermatol, V135, P1, DOI 10.1038/jid.2014.495; Shimizukawa R, 2005, GENESIS, V42, P47, DOI 10.1002/gene.20122; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Srivastava D, 2016, CELL, V166, P1386, DOI 10.1016/j.cell.2016.08.055; Sun BK, 2014, SCIENCE, V346, P941, DOI 10.1126/science.1253836; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VANMUIJEN GNP, 1987, EXP CELL RES, V171, P331, DOI 10.1016/0014-4827(87)90166-2	33	63	68	7	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2018	561	7722					243	+		10.1038/s41586-018-0477-4	http://dx.doi.org/10.1038/s41586-018-0477-4			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT3XQ	30185909	Green Accepted			2022-12-28	WOS:000444437900044
J	Wise, J				Wise, Jacqui			Half of all European clinical trials break rules on reporting results within a year	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Goldacre B, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3218	1	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2018	362								k3863	10.1136/bmj.k3863	http://dx.doi.org/10.1136/bmj.k3863			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JN	30209059				2022-12-28	WOS:000445016900005
J	Marks, L; Spec, A				Marks, Laura; Spec, Andrej			Glandular Tularemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Marks, Laura] Barnes Jewish Hosp, St Louis, MO 63110 USA; [Spec, Andrej] Washington Univ, St Louis, MO USA	Barnes-Jewish Hospital; Washington University (WUSTL); Washington University (WUSTL)	Marks, L (corresponding author), Barnes Jewish Hosp, St Louis, MO 63110 USA.	marks@wustl.edu		Spec, Andrej/0000-0001-7612-4710; Marks, Laura/0000-0002-5317-443X					0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2018	379	10					967	967		10.1056/NEJMicm1801531	http://dx.doi.org/10.1056/NEJMicm1801531			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS5XM	30184456				2022-12-28	WOS:000443748200012
J	Mucida, D; Esterhazy, D				Mucida, Daniel; Esterhazy, Daria			SnapShot: Gut Immune Niches	CELL			English	Editorial Material									[Mucida, Daniel] Rockefeller Univ, New York, NY 10065 USA; [Esterhazy, Daria] Univ Chicago, Chicago, IL 60637 USA	Rockefeller University; University of Chicago	Mucida, D (corresponding author), Rockefeller Univ, New York, NY 10065 USA.							Agace WW, 2017, IMMUNITY, V46, P532, DOI 10.1016/j.immuni.2017.04.004; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Spencer SP, 2012, CURR OPIN IMMUNOL, V24, P379, DOI 10.1016/j.coi.2012.07.006; Veldhoen M, 2015, NAT MED, V21, P709, DOI 10.1038/nm.3894	4	5	5	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1600	+	1600.e1	10.1016/j.cell.2018.08.043	http://dx.doi.org/10.1016/j.cell.2018.08.043			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193116	Bronze			2022-12-28	WOS:000443841000026
J	Curry, SJ; Krist, AH; Owens, DK; Barry, MJ; Caughey, AB; Davidson, KW; Doubeni, CA; Epling, JW; Kemper, AR; Kubik, M; Kurth, AE; Landefeld, CS; Mangione, CM; Phipps, MG; Silverstein, M; Simon, MA; Tseng, CW; Wong, JB				Curry, Susan J.; Krist, Alex H.; Owens, Douglas K.; Barry, Michael J.; Caughey, Aaron B.; Davidson, Karina W.; Doubeni, Chyke A.; Epling, John W., Jr.; Kemper, Alex R.; Kubik, Martha; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phipps, Maureen G.; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen; Wong, John B.		US Preventive Serv Task Force	Screening for Syphilis Infection in Pregnant Women US Preventive Services Task Force Reaffirmation Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CONGENITAL-SYPHILIS; OUTCOMES; IMMUNOASSAYS; ADOLESCENTS; MANAGEMENT; ADULTS; CHINA	IMPORTANCE Untreated syphilis infection in pregnant women can be transmitted to the fetus (congenital syphilis) at any time during pregnancy or at birth. Congenital syphilis is associated with stillbirth, neonatal death, and significant morbidity in infants (eg, bone deformities and neurologic impairment). After a steady decline from 2008 to 2012, cases of congenital syphilis markedly increased from 2012 to 2106, from 8.4 to 15.7 cases per 100 000 live births (an increase of 87%). At the same time, national rates of syphilis increased among women of reproductive age. OBJECTIVE To update the US Preventive Services Task Force (USPSTF) 2009 recommendation on screening for syphilis infection in pregnant women. EVIDENCE REVIEW The USPSTF commissioned a reaffirmation evidence update to identify new and substantial evidence sufficient enough to change its prior recommendation. Given the established benefits and practice of screening for syphilis in pregnant women, the USPSTF targeted its evidence review on the direct benefits of screening on the prevention of congenital syphilis morbidity and mortality and the harms of screening for and treatment of syphilis infection in pregnant women. FINDINGS Using a reaffirmation process, the USPSTF found that accurate screening algorithms are available to identify syphilis infection. Effective treatment with antibiotics can prevent congenital syphilis and significantly decrease adverse pregnancy outcomes, with small associated harms, providing an overall substantial health benefit. Therefore, the USPSTF reaffirms its previous conclusion that there is convincing evidence that screening for syphilis infection in pregnant women provides substantial benefit. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends early screening for syphilis infection in all pregnant women. (A recommendation)	[Curry, Susan J.] Univ Iowa, 111 Jessup Hall, Iowa City, IA 52242 USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA 19104 USA; [Epling, John W., Jr.] Virginia Tech, Caril Sch Med, Roanoke, VA USA; [Kemper, Alex R.] Nationwide Childrens Hosp, Columbus, OH USA; [Kubik, Martha] Temple Univ, Philadelphia, PA 19122 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Medford, MA 02155 USA	University of Iowa; Virginia Commonwealth University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Harvard University; Harvard Medical School; Oregon Health & Science University; Columbia University; University of Pennsylvania; Virginia Polytechnic Institute & State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; Brown University; Boston University; Northwestern University; University of Hawaii System; Pacific Health Research & Education Institute; Tufts University	Curry, SJ (corresponding author), Univ Iowa, 111 Jessup Hall, Iowa City, IA 52242 USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022; Epling, John W/J-1097-2019; Davidson, Karina/AAG-2388-2019	Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Kemper, Alex/0000-0001-5491-3997; Wong, John/0000-0003-4203-9010	US Congress - Agency for Healthcare Research and Quality (AHRQ); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002649] Funding Source: NIH RePORTER	US Congress - Agency for Healthcare Research and Quality (AHRQ); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	American Academy of Family Physicians (AAFP), 2018, CLIN PREV SERV REC S; American Academy of Pediatrics American College of Obstetricians and Gynecologists, 2017, GUID PER CAR, V8th; Bacterial Vaginosis, 2015, SEX TRANSM DIS TREAT; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P2525, DOI 10.1001/jama.2016.16776; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2321, DOI 10.1001/jama.2016.5824; Boonchaoy Amphiwan, 2016, Journal of the Medical Association of Thailand, V99, P119; Bowen V, 2015, MMWR-MORBID MORTAL W, V64, P1241, DOI 10.15585/mmwr.mm6444a3; Calonge N, 2009, ANN INTERN MED, V150, P705; Cantor AG, 2016, JAMA-J AM MED ASSOC, V315, P2328, DOI 10.1001/jama.2016.4114; Centers for Disease Control and Prevention, 2017, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, SEX TRANSM DIS STDS; Cooper JM, 2018, SEMIN PERINATOL, V42, P176, DOI 10.1053/j.semperi.2018.02.005; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Henrich TJ, 2011, SEX TRANSM DIS, V38, P1126, DOI 10.1097/OLQ.0b013e31822e60e1; Kingston M, 2016, INT J STD AIDS, V27, P421, DOI 10.1177/0956462415624059; LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981; LeFevre ML, 2014, ANN INTERN MED, V161, P58, DOI 10.7326/M14-1018; Lin JS, 2018, JAMA-J AM MED ASSOC, V320, P918, DOI 10.1001/jama.2018.7769; Lin JS, 2018, AHRQ PUBLICATION; Liu LL, 2014, CLIN INFECT DIS, V59, P384, DOI 10.1093/cid/ciu325; Mmeje O, 2015, CLIN INFECT DIS, V61, P1049, DOI 10.1093/cid/civ445; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Qin JB, 2014, EUR J CLIN MICROBIOL, V33, P2183, DOI 10.1007/s10096-014-2186-8; Qin JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102203; US Preventive Services Task Force (USPSTF), 2018, PROC MAN; Wang KD, 2016, INFECT DIS-NOR, V48, P26, DOI 10.3109/23744235.2015.1044465; Warren HP, 2018, MATERN CHILD HLTH J, V22, P1227, DOI 10.1007/s10995-018-2592-0; Wellinghausen N, 2011, CLIN CHEM LAB MED, V49, P1375, DOI 10.1515/CCLM.2011.643; Wolff T, 2009, ANN INTERN MED, V150, P710, DOI 10.7326/0003-4819-150-10-200905190-00009	29	40	43	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2018	320	9					911	917		10.1001/jama.2018.11785	http://dx.doi.org/10.1001/jama.2018.11785			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS4OQ	30193283	Bronze			2022-12-28	WOS:000443627300015
J	Navathe, AS; Liao, JM; Dykstra, SE; Wang, EK; Lyon, ZM; Shah, Y; Martinez, J; Small, DS; Werner, RM; Dinh, C; Ma, XS; Emanuel, EJ				Navathe, Amol S.; Liao, Joshua M.; Dykstra, Sarah E.; Wang, Erkuan; Lyon, Zoe M.; Shah, Yash; Martinez, Joseph; Small, Dylan S.; Werner, Rachel M.; Dinh, Claire; Ma, Xinshuo; Emanuel, Ezekiel J.			Association of Hospital Participation in a Medicare Bundled Payment Program With Volume and Case Mix of Lower Extremity Joint Replacement Episodes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARTHROPLASTY; COST; CARE; KNEE	IMPORTANCE Medicare's Bundled Payments for Care Improvement (BPCI) initiative for lower extremity joint replacement (LEJR) surgery has been associated with a reduction in episode spending and stable-to-improved quality. However, BPCI may create unintended effects by prompting participating hospitals to increase the overall volume of episodes paid for by Medicare, which could potentially eliminate program-related savings or prompt them to shift case mix to lower-risk patients. OBJECTIVE To evaluate whether hospital BPCI participation for LEJR was associated with changes in overall volume and case mix. DESIGN, SETTING, AND PARTICIPANTS Observational study using Medicare claims data and a difference-in-differences method to compare 131 markets (hospital referral regions) with at least 1 BPCI participant hospital (n = 322) and 175 markets with no participating hospitals (n = 1340), accounting for 580 043 Medicare beneficiaries treated before (January 2011-September 2013) and 462 161 after (October 2013-December 2015) establishing the BPCI initiative. Hospital-level case-mix changes were assessed by comparing 265 participating hospitals with a 1: 1 propensity-matched set of nonparticipating hospitals from non-BPCI markets. EXPOSURES Hospital BPCI participation. MAIN OUTCOMES AND MEASURES Changes in market-level LEJR volume in the before vs after BPCI periods and changes in hospital-level case mix based on demographic, socioeconomic, clinical, and utilization factors. RESULTS Among the 1 717 243 Medicare beneficiaries who underwent LEJR (mean age, 75 years; 64% women; and 95% nonblack race/ethnicity), BPCI participation was not significantly associated with a change in overall market-level volume. The mean quarterly market volume in non-BPCI markets increased 3.8% from 3.8 episodes per 1000 beneficiaries before BPCI to 3.9 episodes per 1000 beneficiaries after BPCI was launched. For BPCI markets, the mean quarterly market volume increased 4.4% from 3.6 episodes per 1000 beneficiaries before BPCI to 3.8 episodes per 1000 beneficiaries after BPCI was launched. The adjusted difference-in-differences estimate between the market types was 0.32%(95% CI, -0.06% to 0.69%; P = .10). Among 20 demographic, socioeconomic, clinical, and utilization factors, BPCI participation was associated with differential changes in hospital-level case mix for only 1 factor, prior skilled nursing facility use (adjusted difference-in-differences estimate, -0.53%; 95% CI, -0.96% to -0.10%; P = .01) in BPCI vs non-BPCI markets. CONCLUSIONS AND RELEVANCE In this observational study of Medicare beneficiaries who underwent LEJR, hospital participation in Bundled Payments for Care Improvementwas not associated with changes in market-level lower extremity joint replacement volume and largely was not associated with changes in hospital case mix. These findings may provide reassurance regarding 2 potential unintended effects associated with bundled payments for LEJR.	[Navathe, Amol S.; Werner, Rachel M.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA; [Navathe, Amol S.; Wang, Erkuan; Lyon, Zoe M.; Shah, Yash; Martinez, Joseph; Dinh, Claire; Ma, Xinshuo; Emanuel, Ezekiel J.] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Navathe, Amol S.; Liao, Joshua M.; Werner, Rachel M.; Emanuel, Ezekiel J.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Liao, Joshua M.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Dykstra, Sarah E.; Martinez, Joseph; Small, Dylan S.] Univ Penn, Wharton Sch Business, Philadelphia, PA 19104 USA; [Werner, Rachel M.] Univ Penn, Perelman Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Washington; University of Washington Seattle; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Navathe, AS (corresponding author), 1108 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	amol@wharton.upenn.edu		Dinh, Claire T./0000-0001-7597-1125; Werner, Rachel/0000-0003-3435-4221; Navathe, Amol/0000-0001-7182-4988	The Commonwealth Fund	The Commonwealth Fund	This research was supported by The Commonwealth Fund.	Alexander D, DOCTORS RESPOND INCE; [Anonymous], 2018, MEAS METH; Barrack RL, 2014, CLIN ORTHOP RELAT R, V472, P86, DOI 10.1007/s11999-013-3002-y; Berenson RA, 2016, ACA IMPL MON TRACK; Centers for Medicare and Medicaid Services, 2017, SHAR SAV PROGR ACC C; Centers for Medicare and Medicaid Services, PROV SERV CURR FIL 2; Centers for Medicare & Medicaid Services, 2017, COMPR CAR JOINT REPL; Centers for Medicare & Medicaid Services, 2018, BPCI ADV; Centers for Medicare & Medicaid Services, HOSP COMP; CMS.gov, 2017, BUNDL PAYM CAR IMPR; Dummit LA, 2016, JAMA-J AM MED ASSOC, V316, P1267, DOI 10.1001/jama.2016.12717; Escalante A, 2000, ARTHRITIS RHEUM-US, V43, P390, DOI 10.1002/1529-0131(200002)43:2<390::AID-ANR20>3.0.CO;2-R; Fisher ES, 2016, JAMA-J AM MED ASSOC, V316, P1262, DOI 10.1001/jama.2016.12525; Ibrahim SA, 2016, JAMA-J AM MED ASSOC, V316, P1258, DOI 10.1001/jama.2016.12330; Initiative USPM, 2017, KEN ANN ENT MON REP; Joynt KE, 2017, HEALTHCARE-J DEL SCI, V5, P62, DOI 10.1016/j.hjdsi.2016.11.002; Kim DH, 2014, PHARMACOEPIDEM DR S, V23, P891, DOI 10.1002/pds.3674; Liao JM, 2018, JAMA SURG, V153, P199, DOI 10.1001/jamasurg.2017.4903; Liao JM, 2017, HEALTHCARE-J DEL SCI, V5, P136, DOI 10.1016/j.hjdsi.2016.04.008; MACKINNON JG, 1985, J ECONOMETRICS, V29, P305, DOI 10.1016/0304-4076(85)90158-7; Maddox KEJ, 2018, JAMA-J AM MED ASSOC, V319, P191, DOI 10.1001/jama.2017.14771; McWilliams JM, 2016, NEW ENGL J MED, V374, P2357, DOI 10.1056/NEJMsa1600142; Mechanic RE, 2015, NEW ENGL J MED, V373, P1291, DOI 10.1056/NEJMp1509155; Mechanic RE, 2011, NEW ENGL J MED, V365, P777, DOI 10.1056/NEJMp1105963; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369; Navathe AS, 2018, ANN SURG, V267, P35, DOI 10.1097/SLA.0000000000002283; Navathe AS, 2017, JAMA INTERN MED, V177, P214, DOI 10.1001/jamainternmed.2016.8263; Rhoades S., 1993, FEDERAL RES B, V79, P188; Ryan AM, 2017, JAMA INTERN MED, V177, P862, DOI 10.1001/jamainternmed.2017.0518; Singh JA, 2014, ANN RHEUM DIS, V73, P2107, DOI 10.1136/annrheumdis-2013-203494; The Lewin Group, 2016, CMS BUNDL PAYM CAR I; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5	32	43	43	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2018	320	9					901	910		10.1001/jama.2018.12345	http://dx.doi.org/10.1001/jama.2018.12345			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS4OQ	30193276	Bronze, Green Published			2022-12-28	WOS:000443627300014
J	von Birgelen, C; Zocca, P				von Birgelen, Clemens; Zocca, Paolo			Late clinical outcome of stent trials: a matter of life or death?	LANCET			English	Editorial Material							EVEROLIMUS-ELUTING STENTS; FINAL 5-YEAR REPORT; CORONARY STENTS; II TRIAL; IMPLANTATION; SAFETY; SORT		[von Birgelen, Clemens; Zocca, Paolo] Med Spectrum Twente, Thorax Ctr Twente, Dept Cardiol, NL-7500 KA Enschede, Netherlands; [von Birgelen, Clemens] Univ Twente, Tech Med Ctr, Dept Hlth Technol & Serv Res, Fac Behav Management & Social Sci, Enschede, Netherlands	Medical Spectrum Twente; University of Twente	von Birgelen, C (corresponding author), Med Spectrum Twente, Thorax Ctr Twente, Dept Cardiol, NL-7500 KA Enschede, Netherlands.; von Birgelen, C (corresponding author), Univ Twente, Tech Med Ctr, Dept Hlth Technol & Serv Res, Fac Behav Management & Social Sci, Enschede, Netherlands.	c.vonbirgelen@mst.nl			Abbott Vascular; Biotronik; Boston Scientific; Medtronic	Abbott Vascular(Abbott Laboratories); Biotronik; Boston Scientific(Boston Scientific); Medtronic(Medtronic)	CvB's research department of Thorax Centrum Twente reports institutional research grants from Abbott Vascular, Biotronik, Boston Scientific, and Medtronic.	Byrne RA, 2017, LANCET, V390, P781, DOI 10.1016/S0140-6736(17)31927-X; Iqbal J, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002230; Jakobsen L, 2017, EUROINTERVENTION, V13, P1337, DOI 10.4244/EIJ-D-17-00434; Jensen LO, 2016, J AM COLL CARDIOL, V67, P751, DOI 10.1016/j.jacc.2015.11.051; Kok MM, 2018, EUROINTERVENTION, V14, P915, DOI 10.4244/EIJ-D-18-00336; Maeng M, 2014, LANCET, V383, P2047, DOI 10.1016/S0140-6736(14)60405-0; Pilgrim T, 2018, LANCET, V392, P737, DOI 10.1016/S0140-6736(18)31715-X; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Smits PC, 2015, JACC-CARDIOVASC INTE, V8, P1157, DOI 10.1016/j.jcin.2015.03.028; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Vlachojannis GJ, 2017, JACC-CARDIOVASC INTE, V10, P1215, DOI 10.1016/j.jcin.2017.02.029; von Birgelen C, 2017, JAMA CARDIOL, V2, P268, DOI 10.1001/jamacardio.2016.5190; Zocca P, 2018, JACC-CARDIOVASC INTE, V11, P462, DOI 10.1016/j.jcin.2017.11.031	13	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2018	392	10149					713	714		10.1016/S0140-6736(18)31860-9	http://dx.doi.org/10.1016/S0140-6736(18)31860-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS0VL	30170847				2022-12-28	WOS:000443226900004
J	Holford, M; Daly, M; King, GF; Norton, RS				Holford, Mande; Daly, Marymegan; King, Glenn F.; Norton, Raymond S.			Venoms to the rescue	SCIENCE			English	Editorial Material							THERAPEUTICS; RESISTANCE; EVOLUTION; TOXINS		[Holford, Mande] Hunter Coll, New York, NY 10065 USA; [Holford, Mande] CUNY, Grad Ctr, New York, NY 10016 USA; [Daly, Marymegan] Ohio State Univ, Columbus, OH 43210 USA; [King, Glenn F.] Univ Queensland, Brisbane, Qld, Australia; [Norton, Raymond S.] Monash Univ, Melbourne, Vic, Australia	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; University System of Ohio; Ohio State University; University of Queensland; Monash University	Holford, M (corresponding author), Hunter Coll, New York, NY 10065 USA.; Holford, M (corresponding author), CUNY, Grad Ctr, New York, NY 10016 USA.	mholford@hunter.cuny.edu	Daly, Marymegan/F-9178-2011	Norton, Raymond/0000-0001-8893-0584; King, Glenn/0000-0002-2308-2200	U.S. National Science Foundation; Camille Dreyfus Teacher-Scholar Award; Australian National Health and Medical Research Council	U.S. National Science Foundation(National Science Foundation (NSF)); Camille Dreyfus Teacher-Scholar Award; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	M.H. acknowledges support from the U.S. National Science Foundation and the Camille Dreyfus Teacher-Scholar Award. M.D. acknowledges support from the U.S. National Science Foundation. G.F.K. and R.S.N. are supported by a Principal Research Fellowship from the Australian National Health and Medical Research Council.	Arbuckle K, 2017, TOXICON, V140, P118, DOI 10.1016/j.toxicon.2017.10.026; Chandy KG, 2017, CURR OPIN CHEM BIOL, V38, P97, DOI 10.1016/j.cbpa.2017.02.015; Dutertre S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4521; Holding ML, 2016, INTEGR COMP BIOL, V56, P1032, DOI 10.1093/icb/icw082; Jouiaei M, 2015, MOL BIOL EVOL, V32, P1598, DOI 10.1093/molbev/msv050; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Leffler AE, 2017, P NATL ACAD SCI USA, V114, pE8100, DOI 10.1073/pnas.1703952114; Mamelak AN, 2006, J CLIN ONCOL, V24, P3644, DOI 10.1200/JCO.2005.05.4569; Menting JG, 2016, NAT STRUCT MOL BIOL, V23, P916, DOI 10.1038/nsmb.3292; Undheim EAB, 2015, P NATL ACAD SCI USA, V112, P4026, DOI 10.1073/pnas.1424068112; Verdes A, 2016, TOXINS, V8, DOI 10.3390/toxins8040117; von Reumont BM, 2014, TOXINS, V6, P3488, DOI 10.3390/toxins6123488; von Reumont BM, 2017, TOXINS, V9, DOI 10.3390/toxins9080234; Walker AA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03091-5	15	49	49	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					842	844		10.1126/science.aau7761	http://dx.doi.org/10.1126/science.aau7761			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS3UB	30166472				2022-12-28	WOS:000443547000013
J	Kranzler, HR; Soyka, M				Kranzler, Henry R.; Soyka, Michael			Diagnosis and Pharmacotherapy of Alcohol Use Disorder A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PHARMACOLOGICAL-TREATMENT; DEPENDENT PATIENTS; EXTENDED-RELEASE; NALTREXONE; EFFICACY; TOPIRAMATE; GABAPENTIN; QUESTIONS; NALMEFENE; VETERANS	IMPORTANCE Alcohol consumption is associated with 88 000 US deaths annually. Although routine screening for heavy alcohol use can identify patients with alcohol use disorder (AUD) and has been recommended, only 1 in 6 US adults report ever having been asked by a health professional about their drinking behavior. Alcohol use disorder, a problematic pattern of alcohol use accompanied by clinically significant impairment or distress, is present in up to 14% of US adults during a 1-year period, although only about 8% of affected individuals are treated in an alcohol treatment facility. OBSERVATIONS Four medications are approved by the US Food and Drug Administration to treat AUD: disulfiram, naltrexone (oral and long-acting injectable formulations), and acamprosate. However, patients with AUD most commonly receive counseling. Medications are prescribed to less than 9% of patients who are likely to benefit from them, given evidence that they exert clinically meaningful effects and their inclusion in clinical practice guidelines as first-line treatments for moderate to severe AUD. Naltrexone, which can be given once daily, reduces the likelihood of a return to any drinking by 5% and binge-drinking risk by 10%. Randomized clinical trials also show that some medications approved for other indications, including seizure disorder (eg, topiramate), are efficacious in treating AUD. Currently, there is not sufficient evidence to support the use of pharmacogenetics to personalize AUD treatments. CONCLUSIONS AND RELEVANCE Alcohol consumption is associated with a high rate of morbidity and mortality, and heavy alcohol use is the major risk factor for AUD. Simple, valid screeningmethods can be used to identify patients with heavy alcohol use, who can then be evaluated for the presence of an AUD. Patients receiving a diagnosis of the disorder should be given brief counseling and prescribed a first-line medication (eg, naltrexone) or referred for a more intensive psychosocial intervention.	[Kranzler, Henry R.] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Kranzler, Henry R.] Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA; [Soyka, Michael] Ludwig Maximilians Univ Munchen, Dept Psychiat, Munich, Germany; [Soyka, Michael] Medicalpk Chiemseeblick, Bernau Felden, Germany	University of Pennsylvania; Pennsylvania Medicine; University of Munich	Kranzler, HR (corresponding author), Univ Penn, Ctr Studies Addict, 3535 Market St,Ste 500, Philadelphia, PA 19104 USA.	kranzler@pennmedicine.upenn.edu	kranzler, henry/AAS-1113-2020	kranzler, henry/0000-0002-1018-0450	National Institute on Alcohol Abuse and Alcoholism [R01 AA023192, R01 AA021164]; Mental Illness Research, Education and Clinical Center of the Veterans Integrated Service Network 4, US Department of Veterans Affairs; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021164, R01AA023192] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Mental Illness Research, Education and Clinical Center of the Veterans Integrated Service Network 4, US Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Dr Kranzler's work was supported by National Institute on Alcohol Abuse and Alcoholism grants R01 AA023192 and R01 AA021164 and the Mental Illness Research, Education and Clinical Center of the Veterans Integrated Service Network 4, US Department of Veterans Affairs.	Al-Kubaisy W, 2012, PROCD SOC BEHV, V38, P59, DOI 10.1016/j.sbspro.2012.03.324; Ambrogne JA, 2002, J SUBST ABUSE TREAT, V22, P45, DOI 10.1016/S0740-5472(01)00210-0; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Blodgett JC, 2014, ALCOHOL CLIN EXP RES, V38, P1481, DOI 10.1111/acer.12411; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; BROWN SA, 1995, AM J PSYCHIAT, V152, P45; Busch AC, 2017, ALCOHOL CLIN EXP RES, V41, P1352, DOI 10.1111/acer.13410; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Center for Behavioral Health Statistics and Quality, RES 2016 NAT SURV DR; Centers for Disease Control and Prevention, ALC PUBL HLTH ALC RE; Centers for Disease Control and Prevention, EXC DRINK DRAIN US E; Chick J, 1999, DRUG SAFETY, V20, P427, DOI 10.2165/00002018-199920050-00003; Del Re AC, 2013, ADDICT SCI CLIN PRAC, V8, DOI 10.1186/1940-0640-8-12; Department of Veterans Affairs Department of Defense, VA DOD CLIN PRACT GU; Donoghue K, 2015, ADDICTION, V110, P920, DOI 10.1111/add.12875; Dube SR, 2002, ADDICT BEHAV, V27, P713, DOI 10.1016/S0306-4603(01)00204-0; Falk DE, 2018, ALCOHOL CLIN EXP RES, V42, p67A; Falk D, 2010, ALCOHOL CLIN EXP RES, V34, P2022, DOI 10.1111/j.1530-0277.2010.01290.x; Fitzgerald N, 2016, ADDICTION, V111, P1477, DOI 10.1111/add.13438; FULLER RK, 1986, JAMA-J AM MED ASSOC, V256, P1449, DOI 10.1001/jama.256.11.1449; Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1617, DOI 10.1001/jama.293.13.1617; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Guerzoni S, 2018, PHARMACOL RES, V133, P65, DOI 10.1016/j.phrs.2018.04.024; Harris AHS, 2012, PSYCHIAT SERV, V63, P679, DOI 10.1176/appi.ps.201000553; Hauser P, 2017, ADDICTION, V112, P1173, DOI 10.1111/add.13787; Hillemacher T, 2015, EXPERT OPIN INV DRUG, V24, P17, DOI 10.1517/13543784.2014.954037; Johnson BA, 2007, JAMA-J AM MED ASSOC, V298, P1641, DOI 10.1001/jama.298.14.1641; Jonas DE, 2014, JAMA-J AM MED ASSOC, V311, P1889, DOI 10.1001/jama.2014.3628; Jones JD, 2015, ALCOHOL CLIN EXP RES, V39, P391, DOI 10.1111/acer.12643; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Knapp CM, 2015, J CLIN PSYCHOPHARM, V35, P34, DOI 10.1097/JCP.0000000000000246; Kranzler HR, 2014, AM J PSYCHIAT, V171, P445, DOI 10.1176/appi.ajp.2013.13081014; Kranzler HR, 2003, J CLIN PSYCHOPHARM, V23, P294, DOI 10.1097/00004714-200306000-00010; Kranzler HR, 2014, CLIN MANUAL ADDICTIO; Kriston L, 2008, ANN INTERN MED, V149, P879, DOI 10.7326/0003-4819-149-12-200812160-00007; Leung JG, 2015, ANN PHARMACOTHER, V49, P897, DOI 10.1177/1060028015585849; Maisel NC, 2013, ADDICTION, V108, P275, DOI 10.1111/j.1360-0443.2012.04054.x; Mark TL, 2009, DRUG ALCOHOL DEPEN, V99, P345, DOI 10.1016/j.drugalcdep.2008.07.018; Mason BJ, 2014, JAMA INTERN MED, V174, P70, DOI 10.1001/jamainternmed.2013.11950; McKnight-Eily LR, 2014, MMWR-MORBID MORTAL W, V63, P16; Moyer VA, 2013, ANN INTERN MED, V159, P210, DOI 10.7326/0003-4819-159-3-201308060-00652; Noronha A, 2014, NEUROBIOLOGY ALCOHOL; O'Malley SS, 2007, J CLIN PSYCHOPHARM, V27, P507, DOI 10.1097/jcp.0b013e31814ce50d; Odlaug BL, 2016, ALCOHOL ALCOHOLISM, V51, P201, DOI 10.1093/alcalc/agv088; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Palpacuer C, 2018, ADDICTION, V113, P220, DOI 10.1111/add.13974; Palpacuer C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001924; Petry NM, 2014, CLIN MANUAL ADDICTIO, P387; Pettinati HM, 2010, AM J PSYCHIAT, V167, P668, DOI 10.1176/appi.ajp.2009.08060852; Pierce M, 2018, EUR NEUROPSYCHOPHARM, V28, P795, DOI 10.1016/j.euroneuro.2018.03.017; Rehm J, 2014, ALCOHOL CLIN EXP RES, V38, P1068, DOI 10.1111/acer.12331; Reus VI, 2018, AM J PSYCHIAT, V175, P86, DOI 10.1176/appi.ajp.2017.1750101; Reynaud Michel, 2017, Alcohol Alcohol, V52, P439, DOI 10.1093/alcalc/agx030; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001867.pub3; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004332.pub2; Skinner MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087366; Smith RV, 2016, ADDICTION, V111, P1160, DOI 10.1111/add.13324; Substance Abuse and Mental Health Services Administration (SAMHSA), REC SERV SUBST US ME; US Department of Health and Human Services and USDA, 2015, DIET GUID AM 2015 20; US Department of Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research (CDER), 2015, ALC DEV DRUGS TREATM; van den Brink W, 2015, EXPERT OPIN DRUG SAF, V14, P495, DOI 10.1517/14740338.2015.1011619; Verhulst B, 2015, PSYCHOL MED, V45, P1061, DOI 10.1017/S0033291714002165; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; Weisner C, 2003, ADDICTION, V98, P901, DOI 10.1046/j.1360-0443.2003.00438.x; Wiffen Philip J, 2017, Cochrane Database Syst Rev, V6, pCD007938, DOI 10.1002/14651858.CD007938.pub4; Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X	67	220	223	6	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					815	824		10.1001/jama.2018.11406	http://dx.doi.org/10.1001/jama.2018.11406			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GR8HM	30167705	Green Accepted			2022-12-28	WOS:000442958800025
J	Slomski, A				Slomski, Anita			Automated Device Improves Glucose Control in Hospitalized Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					749	749		10.1001/jama.2018.12042	http://dx.doi.org/10.1001/jama.2018.12042			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167696				2022-12-28	WOS:000442958800009
J	Jain, S; Goyal, A; Kumar, V				Jain, Shreyans; Goyal, Alpesh; Kumar, Vinod			Lipaemia retinalis in familial chylomicronaemia syndrome	LANCET			English	Editorial Material									[Jain, Shreyans; Kumar, Vinod] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India; [Goyal, Alpesh] All India Inst Med Sci, Dept Endocrinol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi	Jain, S (corresponding author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India.	shreyansjainmamc@yahoo.com	Goyal, Alpesh/AAF-7732-2019	Goyal, Alpesh/0000-0003-0922-5022					0	0	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2018	392	10148					E7	E7						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GR4MP	30152345				2022-12-28	WOS:000442585300001
J	Liao, JM; Stack, CB; Goodman, S				Liao, Joshua M.; Stack, Catharine B.; Goodman, Steven			Annals Understanding Clinical Research: Interpreting Results With Large P Values	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Liao, Joshua M.] Univ Washington, 1959 NE Pacific St,BB 1240, Seattle, WA 98195 USA; [Stack, Catharine B.] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Goodman, Steven] Stanford Univ, Sch Med, 259 Campus Dr,T265 Redwood Bldg HRP, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; American College of Physicians; Stanford University	Stack, CB (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	cstack@acponline.org		Goodman, Steven/0000-0002-3872-5723				Alderson P, 2004, BMJ-BRIT MED J, V328, P476, DOI 10.1136/bmj.328.7438.476; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Callahan CM, 2017, ANN INTERN MED, V166, P164, DOI 10.7326/M16-0830; GOODMAN SN, 1994, ANN INTERN MED, V121, P200, DOI 10.7326/0003-4819-121-3-199408010-00008; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108	6	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2018	169	7					485	+		10.7326/M18-2003	http://dx.doi.org/10.7326/M18-2003			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV4BN	30208404				2022-12-28	WOS:000446042400008
J	Gaziano, JM; Brotons, C; Coppolecchia, R; Critelli, C; Darius, H; Gorelick, PB; Howard, G; Pearson, TA; Rothwell, PM; Ruilope, LM; Tendera, M; Tognoni, G				Gaziano, J. Michael; Brotons, Curios; Coppolecchia, Rosa; Critelli, Claudio; Darius, Harald; Gorelick, Philip B.; Howard, George; Pearson, Thomas A.; Rothwell, Peter M.; Miguel Ruilope, Luis; Tendera, Michal; Tognoni, Gianni		ARRIVE Executive Comm	Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							LOW-DOSE ASPIRIN; PRIMARY PREVENTION	Background The use of aspirin in the primary prevention of cardiovascular events remains controversial. We aimed to assess the efficacy and safety of aspirin versus placebo in patients with a moderate estimated risk of a first cardiovascular event. Methods ARRIVE is a randomised, double-blind, placebo-controlled, multicentre study done in seven countries. Eligible patients were aged 55 years (men) or 60 years (women) and older and had an average cardiovascular risk, deemed to be moderate on the basis of the number of specific risk factors. We excluded patients at high risk of gastrointestinal bleeding or other bleeding, or diabetes. Patients were randomly assigned (1:1) with a computer-generated randomisation code to receive enteric-coated aspirin tablets (100 mg) or placebo tablets, once daily. Patients, investigators, and others involved in treatment or data analysis were masked to treatment allocation. The primary efficacy endpoint was a composite outcome of time to first occurrence of cardiovascular death, myocardial infarction, unstable angina, stroke, or transient ischaemic attack. Safety endpoints were haemorrhagic events and incidence of other adverse events, and were analysed in the intention-to-treat population. This study is registered with Clinical Trials. gov, number NCT00501059. Findings Between July 5, 2007, and Nov 15, 2016, 12546 patients were enrolled and randomly assigned to receive aspirin (n=6270) or placebo (n=6276) at 501 study sites. Median follow-up was 60 months. In the intention-to-treat analysis, the primary endpoint occurred in 269 (4.29%) patients in the aspirin group versus 281 (4-48%) patients in the placebo group (hazard ratio [HR] 0.96; 95% CI 0.81-1.13; p=0.6038). Gastrointestinal bleeding events (mostly mild) occurred in 61 (0.97%) patients in the aspirin group versus 29 (0.46%) in the placebo group (HR 2.11; 95% CI 1.36-3.28; 1:0-0007). The overall incidence rate of serious adverse events was similar in both treatment groups (n=1266 [20.19%] in the aspirin group vs n=1311 [20.89%] in the placebo group. The overall incidence of adverse events was similar in both treatment groups (n=5142 [82.01%] vs n=5129 [81.72%] in the placebo group). The overall incidence of treatment-related adverse events was low (n=1050 [16.75%] vs n=850 [13.54%] in the placebo group; p<0.0001). There were 321 documented deaths in the intention-to-treat population (n=160 [2.55%] vs n=161 [2.57%] of 6276 patients in the placebo group). Interpretation The event rate was much lower than expected, which is probably reflective of contemporary risk management strategies, making the study more representative of a low-risk population. The role of aspirin in primary prevention among patients at moderate risk could therefore not be addressed. Nonetheless, the findings with respect to aspirin's effects are consistent with those observed in the previously published low-risk primary prevention studies.	[Brotons, Curios] EAP Sardenya Biomed Res Inst St Pau IIB St Pau, Sardenya Primary Hlth Care Ctr, Barcelona, Spain; [Coppolecchia, Rosa] Bayer HealthCare LLC, Whippany, NJ USA; [Critelli, Claudio] Soc Italian Med Gen, Florence, Italy; [Darius, Harald] Vivantes Neukoelln Med Ctr, Dept Cardiol Angiol Nephrol & Intens Care Med, Berlin, Germany; [Gaziano, J. Michael] Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02120 USA; [Gaziano, J. Michael] Harvard Med Sch, Boston, MA USA; [Gaziano, J. Michael] VA Boston Healthcare Syst, Boston, MA USA; [Gorelick, Philip B.] Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI USA; [Gorelick, Philip B.] Mercy Hlth Hauenstein Neurosci, Vasc Neurol Program, Grand Rapids, MI USA; [Howard, George] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Pearson, Thomas A.] Univ Florida, Hlth Sci Ctr, Dept Epidemiol & Med, Gainesville, FL USA; [Rothwell, Peter M.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Miguel Ruilope, Luis] Univ Complutense Madrid, Head Hypertens Unit, 12 Octubre Hosp, Internal Med, Madrid, Spain; [Tendera, Michal] Med Univ Silesia, Sch Med Katowice, Dept Cardiol & Struct Heart Dis, Katowice, Poland; [Tognoni, Gianni] IRCCS Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, IRCSS, Milan, Italy	Bayer AG; Bayer Healthcare Pharmaceuticals; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Michigan State University; Michigan State University College of Human Medicine; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida; University of Oxford; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Medical University Silesia; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Gaziano, JM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02120 USA.	jmgaziano@partners.org	Rothwell, Peter/ABE-5913-2020; Tendera, Michal/AAA-1875-2022; CRICELLI, Claudio/E-7607-2010	Rothwell, Peter/0000-0001-9739-9211; Howard, George/0000-0002-3068-5720; CRICELLI, Claudio/0000-0002-9607-5802; Tendera, Michal/0000-0002-0812-6113; Brotons, Carlos/0000-0001-9388-6581	Bayer	Bayer(Bayer AG)	Bayer.	Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Berkowitz SD, 1997, CIRCULATION, V95, P2508, DOI 10.1161/01.CIR.95.11.2508; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; European Association of Preventive Cardiology, HEARTSC QUICK CALC; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Guirguis-Blake JM, 2016, ANN INTERN MED, V164, P804, DOI 10.7326/M15-2113; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Ikeda Y, 2014, JAMA-J AM MED ASSOC, V312, P2510, DOI 10.1001/jama.2014.15690; *INT TASK FORC PRE, 2003, POCK GUID PREV COR H; Meade TW, 1998, LANCET, V351, P233; National Cholesterol Education Program, 2001, DET EV TREATM HIGH C; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Raju N, 2016, AM J MED, V129, pE35, DOI 10.1016/j.amjmed.2015.10.046; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Van't Hof JR, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006328	21	412	438	3	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2018	392	10152					1036	1046		10.1016/S0140-6736(18)31924-X	http://dx.doi.org/10.1016/S0140-6736(18)31924-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU2KP	30158069	Green Accepted, Green Submitted			2022-12-28	WOS:000445098800026
J	Brick, K; Thibault-Sennett, S; Smagulova, F; Lam, KWG; Pu, YM; Pratto, F; Camerini-Otero, RD; Petukhova, GV				Brick, Kevin; Thibault-Sennett, Sarah; Smagulova, Fatima; Lam, Kwan-Wood G.; Pu, Yongmei; Pratto, Florencia; Camerini-Otero, R. Daniel; Petukhova, Galina V.			Extensive sex differences at the initiation of genetic recombination	NATURE			English; English	Article							STRAND BREAK FORMATION; MEIOTIC RECOMBINATION; DNA METHYLATION; GERM-CELLS; MOUSE MEIOSIS; HOT-SPOTS; MICE; CHROMATIN; SPERMATOGENESIS; ESTABLISHMENT	Meiotic recombination differs between males and females; however, when and how these differences are established is unknown. Here we identify extensive sex differences at the initiation of recombination by mapping hotspots of meiotic DNA double-strand breaks in male and female mice. Contrary to past findings in humans, few hotspots are used uniquely in either sex. Instead, grossly different recombination landscapes result from up to fifteen-fold differences in hotspot usage between males and females. Indeed, most recombination occurs at sex-biased hotspots. Sex-biased hotspots seem to be partly determined by chromosome structure, and DNA methylation, which is absent in females at the onset of meiosis, has a substantial role. Sex differences are also evident later in meiosis as the rate at which meiotic breaks are repaired as crossovers differs between males and females in distal regions. The suppression of distal crossovers may help to minimize age-related aneuploidy that arises owing to cohesion loss during dictyate arrest in females.	[Brick, Kevin; Lam, Kwan-Wood G.; Pratto, Florencia; Camerini-Otero, R. Daniel] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA; [Thibault-Sennett, Sarah; Smagulova, Fatima; Pu, Yongmei; Petukhova, Galina V.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA; [Smagulova, Fatima] INSERM, IRSET, U1085, Rennes, France	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Uniformed Services University of the Health Sciences - USA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Camerini-Otero, RD (corresponding author), NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA.; Petukhova, GV (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA.	rdcamerini@mail.nih.gov; galina.petukhova@usuhs.edu	Brick, Kevin/N-1156-2019; Smagulova, Fatima/K-5459-2015	Brick, Kevin/0000-0002-9596-6400; Lam, Kwan Wood Gabriel/0000-0003-2527-9186; Smagulova, Fatima/0000-0001-6883-1968; Pratto, Florencia/0000-0002-9678-8044	NIGMS [R01GM084104]; March of Dimes Foundation [1-FY13-506]; NIDDK Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084104] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); March of Dimes Foundation(March of Dimes); NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Hsieh for critical feedback and the NIDDK genomics core and NHLBI flow cytometry core for assistance. This work used the computational resources of the NIH HPC Biowulf cluster (http://hpc.nih.gov). This research was supported by NIGMS grant R01GM084104 (G.V.P.), March of Dimes Foundation grant 1-FY13-506 (G.V.P.) and by the NIDDK Intramural Research Program (R.D.C.-O.).	Baker CL, 2014, GENOME RES, V24, P724, DOI 10.1101/gr.170167.113; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Bherer C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14994; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brick K, 2018, METHOD ENZYMOL, V601, P391, DOI 10.1016/bs.mie.2017.11.037; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Cole F, 2014, NAT GENET, V46, P1072, DOI 10.1038/ng.3068; Collings CK, 2013, NUCLEIC ACIDS RES, V41, P2918, DOI 10.1093/nar/gks893; Davies B, 2016, NATURE, V530, P171, DOI 10.1038/nature16931; de Boer E, 2006, P NATL ACAD SCI USA, V103, P9607, DOI 10.1073/pnas.0600418103; de Boer E, 2015, GENE DEV, V29, P1721, DOI 10.1101/gad.265561.115; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; dos Santos CO, 2015, CELL REP, V11, P1102, DOI 10.1016/j.celrep.2015.04.015; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gruhn JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085075; Halldorsson BV, 2016, NAT GENET, V48, P1377, DOI 10.1038/ng.3669; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Hunt P, 2010, CURR BIOL, V20, pR699, DOI 10.1016/j.cub.2010.08.011; Jain D, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006964; Kafer GR, 2016, CELL REP, V14, P1283, DOI 10.1016/j.celrep.2016.01.035; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khil PP, 2012, GENOME RES, V22, P957, DOI 10.1101/gr.130583.111; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lange J, 2016, CELL, V167, P695, DOI 10.1016/j.cell.2016.09.035; Lenormand T, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0001; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-199; Lin IH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170779; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu EY, 2014, GENETICS, V197, P91, DOI 10.1534/genetics.114.161653; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Oey H, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0047-z; Perry J, 2001, GENOME RES, V11, P1826, DOI 10.1101/gr.203001; Persikov AV, 2009, BIOINFORMATICS, V25, P22, DOI 10.1093/bioinformatics/btn580; PETERS H, 1970, PHILOS T R SOC B, V259, P91, DOI 10.1098/rstb.1970.0048; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Pratto F, 2014, SCIENCE, V346, P826, DOI 10.1126/science.1256442; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Smagulova F, 2016, GENE DEV, V30, P266, DOI 10.1101/gad.270009.115; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; Teng MX, 2017, GENOME RES, V27, P1930, DOI 10.1101/gr.220673.117; Tortereau F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-586; Vlachogiannis G, 2015, CELL REP, V10, P944, DOI 10.1016/j.celrep.2015.01.021; Walker M, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0024-6; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Yamada S, 2017, CELL CYCLE, V16, P1870, DOI 10.1080/15384101.2017.1361065; Zamudio N, 2015, GENE DEV, V29, P1256, DOI 10.1101/gad.257840.114; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	41	42	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2018	561	7723					338	+		10.1038/s41586-018-0492-5	http://dx.doi.org/10.1038/s41586-018-0492-5			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU1HZ	30185906	Green Accepted, Green Submitted			2022-12-28	WOS:000445011500043
J	Cai, Y; Hossain, MJ; Heriche, JK; Politi, AZ; Walther, N; Koch, B; Wachsmuth, M; Nijmeijer, B; Kueblbeck, M; Martinic-Kavur, M; Ladurner, R; Alexander, S; Peters, JM; Ellenberg, J				Cai, Yin; Hossain, M. Julius; Heriche, Jean-Karim; Politi, Antonio Z.; Walther, Nike; Koch, Birgit; Wachsmuth, Malte; Nijmeijer, Bianca; Kueblbeck, Moritz; Martinic-Kavur, Marina; Ladurner, Rene; Alexander, Stephanie; Peters, Jan-Michael; Ellenberg, Jan			Experimental and computational framework for a dynamic protein atlas of human cell division	NATURE			English	Article							AURORA-B; GENOME; PHOSPHORYLATION; INTEGRATION; ANAPHASE; REVEALS; GENES	Essential biological functions, such as mitosis, require tight coordination of hundreds of proteins in space and time. Localization, the timing of interactions and changes in cellular structure are all crucial to ensure the correct assembly, function and regulation of protein complexes(1-4). Imaging of live cells can reveal protein distributions and dynamics but experimental and theoretical challenges have prevented the collection of quantitative data, which are necessary for the formulation of a model of mitosis that comprehensively integrates information and enables the analysis of the dynamic interactions between the molecular parts of the mitotic machinery within changing cellular boundaries. Here we generate a canonical model of the morphological changes during the mitotic progression of human cells on the basis of four-dimensional image data. We use this model to integrate dynamic three-dimensional concentration data of many fluorescently knocked-in mitotic proteins, imaged by fluorescence correlation spectroscopy-calibrated microscopy(5). The approach taken here to generate a dynamic protein atlas of human cell division is generic; it can be applied to systematically map and mine dynamic protein localization networks that drive cell division in different cell types, and can be conceptually transferred to other cellular functions.	[Cai, Yin; Hossain, M. Julius; Heriche, Jean-Karim; Politi, Antonio Z.; Walther, Nike; Koch, Birgit; Wachsmuth, Malte; Nijmeijer, Bianca; Kueblbeck, Moritz; Alexander, Stephanie; Ellenberg, Jan] EMBL, Heidelberg, Germany; [Martinic-Kavur, Marina; Ladurner, Rene; Peters, Jan-Michael] Res Inst Mol Pathol IMP, Vienna, Austria; [Cai, Yin] Roche Diagnost, Waiblingen, Germany; [Politi, Antonio Z.] Max Planck Inst Biophys Chem, Gottingen, Germany; [Koch, Birgit] Max Planck Inst Med Res, Heidelberg, Germany; [Wachsmuth, Malte] Luxendo GmbH, Heidelberg, Germany; [Martinic-Kavur, Marina] Genos, Glycosci Res Lab, Zagreb, Croatia; [Ladurner, Rene] Stanford Sch Med, Stanford, CA USA	European Molecular Biology Laboratory (EMBL); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society; Max Planck Society; Stanford University	Ellenberg, J (corresponding author), EMBL, Heidelberg, Germany.	jan.ellenberg@embl.de	Hossain, M. Julius/P-2932-2019; Alexander, Stephanie/B-7150-2012; Ellenberg, Jan/I-4688-2014	Hossain, M. Julius/0000-0003-3303-5755; Nijmeijer-Winter, Bianca/0000-0002-9429-8439; Ladurner, Rene/0000-0001-9261-7304; Heriche, Jean-Karim/0000-0001-6867-9425; Alexander, Stephanie/0000-0002-8308-3977; Ellenberg, Jan/0000-0001-5909-701X; Walther, Nike/0000-0002-7591-5251; Koch, Birgit/0000-0003-4683-3115; Politi, Antonio/0000-0003-4788-0933	EMBL mechanical and electronic workshop; EMBL advanced light microscopy facility; EMBL flow cytometry core facility; IMP BioOptics Facility; EU-FP7-MitoSys [241548]; EU-FP7-SystemsMicroscopy NoE [258068]; EU-H2020-iNEXT [653706]; 4D Nucleome/4DN National Institutes of Health common fund [5 U01 EB021223-04 / 8 U01 DA047728-04]; European Molecular Biology Laboratory; EMBL International PhD Programme (EIPP); Boehringer Ingelheim; Austrian Science Fund [SFB F34, Z196-B20]; Austrian Research Promotion Agency [FFG-834223, FFG-852936]; European Research Council (ERC) under the European Union Horizon 2020 research and innovation programme [693949]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA047728] Funding Source: NIH RePORTER	EMBL mechanical and electronic workshop; EMBL advanced light microscopy facility; EMBL flow cytometry core facility; IMP BioOptics Facility; EU-FP7-MitoSys; EU-FP7-SystemsMicroscopy NoE; EU-H2020-iNEXT; 4D Nucleome/4DN National Institutes of Health common fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Laboratory; EMBL International PhD Programme (EIPP); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Research Promotion Agency; European Research Council (ERC) under the European Union Horizon 2020 research and innovation programme(European Research Council (ERC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. Hyman and I. Poser for donating multiple mouse BAC protein-GFP cell lines and T. Hirota for giving us the eGFP-CENPA cell line. The automatic imaging would not have been possible without R. Hofler and D. W. Gerlich, who developed the Micronaut software. We thank all members of the Ellenberg and Peters laboratories for support, especially M. Isokane, M. J. Roberti, J. Mergenthaler, S. Otsuka, W. Tang and D. Cisneros for generating cell lines, reagents and constructs. We thank A. Callegari for supporting the U2OS data generation. We also thank W. Huber, B. Fischer, B. Klaus and L. P. Coelho for discussions, the EMBL mechanical and electronic workshop, the EMBL advanced light microscopy facility, the EMBL flow cytometry core facility and the IMP BioOptics Facility for their support. This study has benefited from the collaboration with Carl ZEISS Jena, especially with T. Ohrt. The work was supported by grants from EU-FP7-MitoSys (Grant Agreement 241548) to J.E. and J. M. P., EU-FP7-SystemsMicroscopy NoE (Grant Agreement 258068), EU-H2020-iNEXT (Grant Agreement 653706) and the 4D Nucleome/4DN National Institutes of Health common fund (5 U01 EB021223-04 / 8 U01 DA047728-04) all to J.E., as well as by the European Molecular Biology Laboratory (Y.C., M.J.H., J.-K.H., A.Z.P., N.W., B.K., M. W., B.N., M.K., S. A. and J.E.). Y.C. and N.W. were also supported by the EMBL International PhD Programme (EIPP). Research in the laboratory of J. M. P. was further supported by Boehringer Ingelheim, the Austrian Science Fund (FWF special research program SFB F34 'Chromosome Dynamics' and Wittgenstein award Z196-B20), the Austrian Research Promotion Agency (Headquarter grants FFG-834223 and FFG-852936) and the European Research Council (ERC) under the European Union Horizon 2020 research and innovation programme (Grant Agreement 693949).	Aitchison J, 2003, STAT ANAL COMPOSITIO; Alberts B., 2008, MOL BIOL CEL, V5th ed.; Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340; BARTON GJ, 1987, J MOL BIOL, V198, P327, DOI 10.1016/0022-2836(87)90316-0; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Bodor DL, 2014, ELIFE, V3, DOI 10.7554/eLife.02137; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cichocki A., 2009, NONNEGATIVE MATRIX T; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davidson IF, 2016, EMBO J, V35, P2671, DOI 10.15252/embj.201695402; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Gascoigne KE, 2013, J CELL BIOL, V201, P23, DOI 10.1083/jcb.201301006; Ghongane P, 2014, J CELL SCI, V127, P3415, DOI 10.1242/jcs.149922; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Heikkila M, 2006, IEEE T PATTERN ANAL, V28, P657, DOI 10.1109/TPAMI.2006.68; Heriche JK, 2014, MOL BIOL CELL, V25, P2522, DOI 10.1091/mbc.E13-04-0221; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holt G. A. T., 2007, P 19 ANN C ADV SCH C, V300, P1; Holzmann J, 2011, J PROTEOME RES, V10, P780, DOI 10.1021/pr100927x; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Isokane M, 2016, J CELL BIOL, V212, P647, DOI 10.1083/jcb.201408089; Jolliffe IT., 2002, PRINCIPAL COMPONENT, DOI DOI 10.1007/B98835; KEYS RG, 1981, IEEE T ACOUST SPEECH, V29, P1153, DOI 10.1109/TASSP.1981.1163711; Koch B, 2018, NAT PROTOC, V13, P1465, DOI 10.1038/nprot.2018.042; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lazebnik S, 2005, IEEE T PATTERN ANAL, V27, P1265, DOI 10.1109/TPAMI.2005.151; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; LI CH, 1993, PATTERN RECOGN, V26, P617, DOI 10.1016/0031-3203(93)90115-D; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Mahen R, 2014, MOL BIOL CELL, V25, P3610, DOI 10.1091/mbc.E14-06-1091; Maliga Z, 2013, NAT CELL BIOL, V15, P325, DOI 10.1038/ncb2689; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Otsuka S, 2018, NAT STRUCT MOL BIOL, V25, P21, DOI 10.1038/s41594-017-0001-9; Otsuka S, 2016, ELIFE, V5, DOI 10.7554/eLife.19071; Politi AZ, 2018, NAT PROTOC, V13, P1445, DOI 10.1038/nprot.2018.040; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rodriguez-Bravo V, 2014, CELL, V156, P1017, DOI 10.1016/j.cell.2014.01.010; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tran TN, 2013, CHEMOMETR INTELL LAB, V120, P92, DOI 10.1016/j.chemolab.2012.11.006; Tucker L.R., 1951, METHOD SYNTHESIS FAC; Wachsmuth M, 2015, NAT BIOTECHNOL, V33, P384, DOI 10.1038/nbt.3146; Walther N, 2018, J CELL BIOL, V217, P2309, DOI 10.1083/jcb.201801048; Williams E, 2017, NAT METHODS, V14, P775, DOI [10.1038/NMETH.4326, 10.1038/nmeth.4326]; Zuin J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004153	52	55	55	1	47	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 20	2018	561	7723					411	+		10.1038/s41586-018-0518-z	http://dx.doi.org/10.1038/s41586-018-0518-z			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU1HZ	30202089	Green Accepted, Green Submitted			2022-12-28	WOS:000445011500058
J	Humphrey, LL; Kansagara, D; Qaseem, A				Humphrey, Linda L.; Kansagara, Devan; Qaseem, Amir		Amer Coll Phys	World Health Organization Guidelines on Medicines for Diabetes Treatment Intensification: Commentary From the American College of Physicians High Value Care Committee	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR OUTCOMES; TYPE-2; EMPAGLIFLOZIN; LIRAGLUTIDE; MORTALITY		[Humphrey, Linda L.; Kansagara, Devan] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Kansagara, Devan] Vet Affairs Med Ctr, Portland, OR USA; [Qaseem, Amir] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); American College of Physicians	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			ACP	ACP	Financial support for the development of this commentary comes exclusively from the ACP operating budget.	Bain S, 2017, DIABETES OBES METAB, V19, P329, DOI 10.1111/dom.12821; Mann JFE, 2017, NEW ENGL J MED, V377, P839, DOI 10.1056/NEJMoa1616011; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Qaseem A, 2017, ANN INTERN MED, V166, P279, DOI 10.7326/M16-1860; Roglic G, 2018, ANN INTERN MED, V169, P394, DOI 10.7326/M18-1149; Storgaard H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166125; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; WHO, 2018, GUID 2 3 LIN MED TYP; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	10	5	6	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2018	169	6					398	+		10.7326/M18-1148	http://dx.doi.org/10.7326/M18-1148			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT7CZ	30178054				2022-12-28	WOS:000444679800017
J	Antonarakis, ES				Antonarakis, Emmanuel S.			Cyclin-Dependent Kinase 12, Immunity, and Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CDK12		[Antonarakis, Emmanuel S.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Antonarakis, ES (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.			Antonarakis, Emmanuel S./0000-0003-0031-9655; Antonarakis, Emmanuel Stylianos/0000-0003-3531-3851				Bajrami I, 2014, CANCER RES, V74, P287, DOI 10.1158/0008-5472.CAN-13-2541; Boudadi Karim, 2018, Oncotarget, V9, P28561, DOI 10.18632/oncotarget.25564; De Bono JS, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.5007; Wu YM, 2018, CELL, V173, P1770, DOI 10.1016/j.cell.2018.04.034; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	5	38	39	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					1087	1089		10.1056/NEJMcibr1808772	http://dx.doi.org/10.1056/NEJMcibr1808772			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT4UV	30207914				2022-12-28	WOS:000444501600016
J	Hawkes, N				Hawkes, Nigel			Sixty seconds on . . . neonatal herpes	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Batra D, 2014, ARCH DIS CHILD, V99, P916, DOI 10.1136/archdischild-2013-305335	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2018	362								k3852	10.1136/bmj.k3852	http://dx.doi.org/10.1136/bmj.k3852			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JJ	30209054				2022-12-28	WOS:000445016500010
J	Harris, PNA; Tambyah, PA; Lye, DC; Mo, Y; Lee, TH; Yilmaz, M; Alenazi, TH; Arabi, Y; Falcone, M; Bassetti, M; Righi, E; Rogers, BA; Kanj, S; Bhally, H; Iredell, J; Mendelson, M; Boyles, TH; Looke, D; Miyakis, S; Walls, G; Al Khamis, M; Zikri, A; Crowe, A; Ingram, P; Daneman, N; Griffin, P; Athan, E; Lorenc, P; Baker, P; Roberts, L; Beatson, SA; Peleg, AY; Harris-Brown, T; Paterson, DL				Harris, Patrick N. A.; Tambyah, Paul A.; Lye, David C.; Mo, Yin; Lee, Tau H.; Yilmaz, Mesut; Alenazi, Tamer H.; Arabi, Yaseen; Falcone, Marco; Bassetti, Matteo; Righi, Elda; Rogers, Benjamin A.; Kanj, Souha; Bhally, Hasan; Iredell, Jon; Mendelson, Marc; Boyles, Tom H.; Looke, David; Miyakis, Spiros; Walls, Genevieve; Al Khamis, Mohammed; Zikri, Ahmed; Crowe, Amy; Ingram, Paul; Daneman, Nick; Griffin, Paul; Athan, Eugene; Lorenc, Penelope; Baker, Peter; Roberts, Leah; Beatson, Scott A.; Peleg, Anton Y.; Harris-Brown, Tiffany; Paterson, David L.		Merino Trial Investigators; Australasian Soc Infect Dis Clinic	Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; SPECTRUM BETA-LACTAMASES; EXTENDED-SPECTRUM; UNITED-STATES; BACTEREMIA; EXTENSION; CEFEPIME; THERAPY	IMPORTANCE Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella pneumoniae. Significant infections caused by these strains are usually treated with carbapenems, potentially selecting for carbapenem resistance. Piperacillin-tazobactam may be an effective "carbapenem-sparing" option to treat extended-spectrum beta-lactamase producers. OBJECTIVES To determine whether definitive therapy with piperacillin-tazobactam is noninferior to meropenem (a carbapenem) in patients with bloodstream infection caused by ceftriaxone-nonsusceptible E coli or K pneumoniae. DESIGN, SETTING, AND PARTICIPANTS Noninferiority, parallel group, randomized clinical trial included hospitalized patients enrolled from 26 sites in 9 countries from February 2014 to July 2017. Adult patients were eligible if they had at least 1 positive blood culture with E coli or Klebsiella spp testing nonsusceptible to ceftriaxone but susceptible to piperacillin-tazobactam. Of 1646 patients screened, 391 were included in the study. INTERVENTIONS Patients were randomly assigned 1: 1 to intravenous piperacillin-tazobactam, 4.5 g, every 6 hours (n = 188 participants) or meropenem, 1 g, every 8 hours (n = 191 participants) for a minimum of 4 days, up to a maximum of 14 days, with the total duration determined by the treating clinician. MAIN OUTCOMES AND MEASURES The primary outcome was all-cause mortality at 30 days after randomization. A noninferiority margin of 5% was used. RESULTS Among 379 patients (mean age, 66.5 years; 47.8% women) who were randomized appropriately, received at least 1 dose of study drug, and were included in the primary analysis population, 378 (99.7%) completed the trial and were assessed for the primary outcome. A total of 23 of 187 patients (12.3%) randomized to piperacillin-tazobactam met the primary outcome of mortality at 30 days compared with 7 of 191 (3.7%) randomized to meropenem (risk difference, 8.6%[1-sided 97.5% CI, -infinity to 14.5%]; P = .90 for noninferiority). Effects were consistent in an analysis of the per-protocol population. Nonfatal serious adverse events occurred in 5 of 188 patients (2.7%) in the piperacillin-tazobactam group and 3 of 191 (1.6%) in the meropenem group. CONCLUSIONS AND RELEVANCE Among patients with E coli or K pneumoniae bloodstream infection and ceftriaxone resistance, definitive treatment with piperacillin-tazobactam compared with meropenem did not result in a noninferior 30-day mortality. These findings do not support use of piperacillin-tazobactam in this setting.	[Harris, Patrick N. A.; Lorenc, Penelope; Harris-Brown, Tiffany] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Harris, Patrick N. A.] Royal Brisbane & Womens Hosp, Pathol Queensland, Dept Microbiol, Brisbane, Qld, Australia; [Harris, Patrick N. A.; Looke, David] Princess Alexandra Hosp, Infect Management Serv, Brisbane, Qld, Australia; [Tambyah, Paul A.; Mo, Yin] Natl Univ Singapore Hosp, Dept Infect Dis, Singapore, Singapore; [Lye, David C.; Lee, Tau H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Lye, David C.; Lee, Tau H.] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Dept Infect Dis, Singapore, Singapore; [Lye, David C.; Lee, Tau H.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Yilmaz, Mesut] Istanbul Medipol Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey; [Alenazi, Tamer H.; Arabi, Yaseen] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Alenazi, Tamer H.; Arabi, Yaseen] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Falcone, Marco] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Bassetti, Matteo; Righi, Elda] Univ Udine, Dept Med, Infect Dis Clin, Udine, Italy; [Bassetti, Matteo; Righi, Elda] Santa Maria Misericordia Hosp, Udine, Italy; [Rogers, Benjamin A.] Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, Australia; [Rogers, Benjamin A.] Monash Hlth, Monash Infect Dis, Melbourne, Vic, Australia; [Kanj, Souha] Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Infect Dis, Beirut, Lebanon; [Bhally, Hasan] North Shore Hosp, Dept Med & Infect Dis, Auckland, New Zealand; [Iredell, Jon] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Iredell, Jon] Westmead Hosp, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia; [Mendelson, Marc; Boyles, Tom H.] Univ Cape Town, Groote Schuur Hosp, Dept Med, Div Infect Dis & HIV Med, Cape Town, South Africa; [Looke, David; Griffin, Paul] Univ Queensland, Brisbane, Qld, Australia; [Miyakis, Spiros] Univ Wollongong, Sch Med, Wollongong, NSW, Australia; [Miyakis, Spiros] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Miyakis, Spiros] Wollongong Hosp, Dept Infect Dis, Wollongong, NSW, Australia; [Walls, Genevieve] Middlemore Hosp, Dept Infect Dis, Auckland, New Zealand; [Al Khamis, Mohammed; Zikri, Ahmed] King Fahad Specialist Hosp, Dammam, Saudi Arabia; [Crowe, Amy] St Vincents Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Crowe, Amy] St Vincents Hosp, Dept Microbiol, Melbourne, Vic, Australia; [Ingram, Paul] Univ Western Australia, Sch Pathol & Lab Med, Crawley, Australia; [Ingram, Paul] Fiona Stanley Hosp, Dept Infect Dis, Murdoch, WA, Australia; [Ingram, Paul] PathWest Lab Med, Dept Microbiol, Perth, WA, Australia; [Daneman, Nick] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Griffin, Paul] Mater Hosp, Dept Med & Infect Dis, Brisbane, Qld, Australia; [Griffin, Paul] Mater Med Res Inst, Brisbane, Qld, Australia; [Griffin, Paul] QIMR Berghofer, Brisbane, Qld, Australia; [Athan, Eugene] Barwon Hlth, Dept Infect Dis, Geelong, Vic, Australia; [Athan, Eugene] Deakin Univ, Geelong, Vic, Australia; [Baker, Peter] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Roberts, Leah; Beatson, Scott A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogen, Brisbane, Qld, Australia; [Peleg, Anton Y.] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Peleg, Anton Y.] Monash Univ, Dept Microbiol, Clayton, Vic, Australia; [Peleg, Anton Y.] Monash Univ, Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Peleg, Anton Y.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Paterson, David L.] Royal Brisbane & Womens Hosp, Dept Infect Dis, Brisbane, Qld, Australia	University of Queensland; Royal Brisbane & Women's Hospital; National University of Singapore; National University of Singapore; Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Istanbul Medipol University; King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Sapienza University Rome; University of Udine; Hospital Santa Maria della Misericordia; Monash University; American University of Beirut; University of Sydney; University of Sydney; University of Cape Town; University of Queensland; University of Wollongong; University of Wollongong; Wollongong Hospital; St Vincent's Hospital Melbourne; St Vincent's Hospital Melbourne; University of Western Australia; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Mater Research; QIMR Berghofer Medical Research Institute; Deakin University; University of Queensland; University of Queensland; Monash University; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Royal Brisbane & Women's Hospital	Paterson, DL (corresponding author), Univ Queensland, Fac Med, Ctr Clin Res, Bldg 71-918 Royal Brisbane & Womens Hosp Campus, Herston, Qld 4029, Australia.	d.paterson1@uq.edu.au	YILMAZ, Mesut/V-3088-2019; Merelli, Maria/AAC-7748-2022; Wasserman, Sean/AAR-1752-2021; Arabi, Yaseen/ABF-3316-2020; Tayyar, Ralph/GRR-3590-2022; Bassetti, Matteo/L-3081-2019; Beatson, Scott/B-6985-2013; Lye, David/ABF-4402-2021; Alli, Ahmad/GPT-5028-2022; Righi, Elda/Y-3558-2019; Harris, Patrick/P-3813-2014; Runnegar, Naomi/ABF-6386-2021; Runnegar, Naomi J/N-2911-2016; Rogers, Benjamin/J-3309-2012; Griffin, Paul/L-4696-2014	Merelli, Maria/0000-0003-3907-5264; Wasserman, Sean/0000-0002-3508-6719; Arabi, Yaseen/0000-0001-5735-6241; Tayyar, Ralph/0000-0002-5354-0209; Beatson, Scott/0000-0002-1806-3283; Alli, Ahmad/0000-0003-4879-7090; Righi, Elda/0000-0001-8718-1200; Harris, Patrick/0000-0002-2895-0345; Runnegar, Naomi/0000-0003-1196-4131; Runnegar, Naomi J/0000-0003-1196-4131; Miyakis, Spiros/0000-0003-4268-1599; McNamara, John/0000-0002-7818-0422; Mo, Yin/0000-0002-0216-9550; YILMAZ, Mesut/0000-0001-8022-7325; Rogers, Benjamin/0000-0001-6515-2118; Lye, David/0000-0003-0324-0205; Griffin, Paul/0000-0002-1656-421X; Kanj, Souha/0000-0001-6413-3396; Mert, Ali/0000-0001-8945-2385; Bassetti, Matteo/0000-0002-0145-9740; Paterson, David/0000-0003-2079-4437; Harris-Brown, Tiffany/0000-0002-1229-7863; Roberts, Leah Wendy/0000-0002-1024-0564; Tabaja, Hussam/0000-0002-5650-4852; Mendelson, Marc/0000-0001-6668-3893; Young, Barnaby/0000-0003-1010-2230; Henderson, Andrew/0000-0002-2149-0745; Zikri, Ahmed/0000-0002-0820-5081	University of Queensland; Australian Society for Antimicrobials (ASA); International Society for Chemotherapy (ISC); National University Hospital Singapore Clinician Researcher Grant [NUHSRO/2014/121/CRG/07]; Australian Infectious Disease Centre; Australian Genome Research Facility; Royal College of Pathologists of Australasia (RCPA) Foundation; Study, Education, and Research Committee (SERC) of Pathology Queensland; National Health and Medical Research Council (NHMRC) Career Development Fellowship; Australian Postgraduate Award from the University of Queensland; NHMRC Career Development and Practitioner Fellowship; NHMRC Practitioner Fellowship	University of Queensland(University of Queensland); Australian Society for Antimicrobials (ASA); International Society for Chemotherapy (ISC); National University Hospital Singapore Clinician Researcher Grant; Australian Infectious Disease Centre; Australian Genome Research Facility; Royal College of Pathologists of Australasia (RCPA) Foundation; Study, Education, and Research Committee (SERC) of Pathology Queensland; National Health and Medical Research Council (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award from the University of Queensland; NHMRC Career Development and Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The study was sponsored by the University of Queensland. This study was funded by grants from the Australian Society for Antimicrobials (ASA), International Society for Chemotherapy (ISC), National University Hospital Singapore Clinician Researcher Grant NUHSRO/2014/121/CRG/07. Whole-genome sequencing was funded by grants from the Australian Infectious Disease Centre and Australian Genome Research Facility; the Royal College of Pathologists of Australasia (RCPA) Foundation; and the Study, Education, and Research Committee (SERC) of Pathology Queensland. Dr Beatson was supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship during the course of the trial. Dr Harris was supported by an Australian Postgraduate Award from the University of Queensland. Dr Peleg was supported by a NHMRC Career Development and Practitioner Fellowship during the course of the trial. Dr Paterson was supported by a NHMRC Practitioner Fellowship during the course of the trial.	Ambrose PG, 2003, ANTIMICROB AGENTS CH, V47, P1643, DOI 10.1128/AAC.47.5.1643-1646.2003; [Anonymous], 2017, R LANG ENV STAT COMP; Bethel CR, 2008, ANTIMICROB AGENTS CH, V52, P3135, DOI 10.1128/AAC.01677-07; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Chang HJ, 2011, J MICROBIOL IMMUNOL, V44, P125, DOI 10.1016/j.jmii.2010.06.001; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chow JW, 1999, INT J ANTIMICROB AG, V11, P7, DOI 10.1016/S0924-8579(98)00060-0; Chow SC., 2007, SAMPLE SIZE CALCULAT, V2nd; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI; Doi Y, 2013, CLIN INFECT DIS, V56, P641, DOI 10.1093/cid/cis942; GART JJ, 1990, BIOMETRICS, V46, P637, DOI 10.2307/2532084; Groothuis-Oudshoorn K, 2011, J STAT SOFTWARE; Gutierrez-Gutierrez B, 2016, ANTIMICROB AGENTS CH, V60, P4159, DOI 10.1128/AAC.00365-16; Harris PNA, 2018, J ANTIMICROB CHEMOTH, V73, P634, DOI 10.1093/jac/dkx466; Harris PNA, 2015, LANCET INFECT DIS, V15, P475, DOI 10.1016/S1473-3099(14)70950-8; Harris PNA, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0541-9; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Johnson JR, 2012, ANTIMICROB AGENTS CH, V56, P2364, DOI 10.1128/AAC.05824-11; Kaye KS, 2018, JAMA-J AM MED ASSOC, V319, P788, DOI 10.1001/jama.2018.0438; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lin JC, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-21; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; McLaughlin M, 2013, ANTIMICROB AGENTS CH, V57, P5131, DOI 10.1128/AAC.00607-13; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Ng TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153696; Nguyen HM, 2014, J ANTIMICROB CHEMOTH, V69, P871, DOI 10.1093/jac/dkt450; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rodriguez-Bano J, 2012, CLIN INFECT DIS, V54, P167, DOI 10.1093/cid/cir790; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Sugumar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091800; Tamma PD, 2017, CLIN INFECT DIS, V64, P972, DOI 10.1093/cid/cix034; Tamma PD, 2015, CLIN INFECT DIS, V60, P1319, DOI 10.1093/cid/civ003; The European Committee on Antimicrobial Susceptibility Testing, 2017, BREAKP TABL INT MICS; The European Committee on Antimicrobial Susceptibility Testing, 2017, EUCAST GUIDELINES DE; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301	39	377	384	5	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2018	320	10					984	994		10.1001/jama.2018.12163	http://dx.doi.org/10.1001/jama.2018.12163			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT2QE	30208454	Green Published, Bronze			2022-12-28	WOS:000444341400012
J	Mason, DJ				Mason, Diana J.			Forced Separation of Children From Parents: Another Consideration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Mason, Diana J.] George Washington Univ, Sch Nursing, Washington, DC 20052 USA; [Mason, Diana J.] George Washington Univ, Sch Nursing, Ctr Hlth Policy & Media Engagement, Washington, DC 20052 USA	George Washington University; George Washington University	Mason, DJ (corresponding author), George Washington Univ, Sch Nursing, Washington, DC 20052 USA.; Mason, DJ (corresponding author), George Washington Univ, Sch Nursing, Ctr Hlth Policy & Media Engagement, Washington, DC 20052 USA.	djmasonrn@gmail.com							0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2018	320	10					963	964		10.1001/jama.2018.12154	http://dx.doi.org/10.1001/jama.2018.12154			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT2QE	30208442	Bronze			2022-12-28	WOS:000444341400002
J	Mayor, S				Mayor, Susan			New NHS app will let patients book GP appointments on mobiles	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2018	362								k3844	10.1136/bmj.k3844	http://dx.doi.org/10.1136/bmj.k3844			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WY	30194065				2022-12-28	WOS:000444507900004
J	Moore, KM; Yadav, RK; Kulowski, L; Cao, H; Bloxham, J; Connerney, JEP; Kotsiaros, S; Jorgensen, JL; Merayo, JMG; Stevenson, DJ; Bolton, SJ; Levin, SM				Moore, Kimberly M.; Yadav, Rakesh K.; Kulowski, Laura; Cao, Hao; Bloxham, Jeremy; Connerney, John E. P.; Kotsiaros, Stavros; Jorgensen, John L.; Merayo, Jose M. G.; Stevenson, David J.; Bolton, Scott J.; Levin, Steven M.			A complex dynamo inferred from the hemispheric dichotomy of Jupiter's magnetic field	NATURE			English	Article							ROTATING SPHERICAL-SHELLS; GIANT PLANETS; ELECTRICAL-CONDUCTIVITY; CONVECTION; MODELS; SATURN	The Juno spacecraft, which is in a polar orbit around Jupiter, is providing direct measurements of the planet's magnetic field close to its surface(1). A recent analysis of observations of Jupiter's magnetic field from eight (of the first nine) Juno orbits has provided a spherical-harmonic reference model (JRM09)(2) of Jupiter's magnetic field outside the planet. This model is of particular interest for understanding processes in Jupiter's magnetosphere, but to study the field within the planet and thus the dynamo mechanism that is responsible for generating Jupiter's main magnetic field, alternative models are preferred. Here we report maps of the magnetic field at a range of depths within Jupiter. We find that Jupiter's magnetic field is different from all other known planetary magnetic fields. Within Jupiter, most of the flux emerges from the dynamo region in a narrow band in the northern hemisphere, some of which returns through an intense, isolated flux patch near the equator. Elsewhere, the field is much weaker. The non-dipolar part of the field is confined almost entirely to the northern hemisphere, so there the field is strongly non-dipolar and in the southern hemisphere it is predominantly dipolar. We suggest that Jupiter's dynamo, unlike Earth's, does not operate in a thick, homogeneous shell, and we propose that this unexpected field morphology arises from radial variations, possibly including layering, in density or electrical conductivity, or both.	[Moore, Kimberly M.; Yadav, Rakesh K.; Kulowski, Laura; Cao, Hao; Bloxham, Jeremy] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA; [Connerney, John E. P.; Kotsiaros, Stavros] NASA, GSFC, Greenbelt, MD USA; [Connerney, John E. P.] Space Res Corp, Annapolis, MD USA; [Kotsiaros, Stavros] Univ Maryland, College Pk, MD 20742 USA; [Jorgensen, John L.; Merayo, Jose M. G.] Tech Univ Denmark, Natl Space Inst, Lyngby, Denmark; [Stevenson, David J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Bolton, Scott J.] Southwest Res Inst, San Antonio, TX USA; [Levin, Steven M.] CALTECH, Jet Prop Lab, Pasadena, CA USA	Harvard University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; Technical University of Denmark; California Institute of Technology; Southwest Research Institute; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Bloxham, J (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	jeremy_bloxham@harvard.edu	Yadav, Rakesh Kumar/J-6671-2019; Cao, Hao/AAV-7560-2020; Bolton, Scott/M-4392-2019	Yadav, Rakesh Kumar/0000-0002-9569-2438; Cao, Hao/0000-0002-6917-8363; Merayo, Jose M.G./0000-0002-7820-8931; bolton, scott/0000-0002-9115-0789; Kotsiaros, Stavros/0000-0003-2636-5545; Jorgensen, John Leif/0000-0002-0343-239X; Levin, Steven/0000-0003-2242-5459	Juno project; US Department of Defense (DoD) through the National Defense Science and Engineering Graduate Fellowship (NDSEG) programme; US National Science Foundation Graduate Fellowship	Juno project; US Department of Defense (DoD) through the National Defense Science and Engineering Graduate Fellowship (NDSEG) programme; US National Science Foundation Graduate Fellowship(National Science Foundation (NSF))	All authors acknowledge support from the Juno project. K.M.M. is supported by the US Department of Defense (DoD) through the National Defense Science and Engineering Graduate Fellowship (NDSEG) programme and L.K. through a US National Science Foundation Graduate Fellowship.	Bolton SJ, 2017, SPACE SCI REV, V213, P5, DOI 10.1007/s11214-017-0429-6; Cao H, 2017, ICARUS, V296, P59, DOI 10.1016/j.icarus.2017.05.015; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Connerney JEP, 2017, SPACE SCI REV, V213, P39, DOI 10.1007/s11214-017-0334-z; Dietrich W, 2018, ICARUS, V305, P15, DOI 10.1016/j.icarus.2018.01.003; Duarte LDV, 2018, ICARUS, V299, P206, DOI 10.1016/j.icarus.2017.07.016; French M, 2012, ASTROPHYS J SUPPL S, V202, DOI 10.1088/0067-0049/202/1/5; Gastine T, 2014, GEOPHYS RES LETT, V41, P5410, DOI 10.1002/2014GL060814; Glatzmaier GA, 2018, P NATL ACAD SCI USA, V115, P6896, DOI 10.1073/pnas.1709125115; Gonzalez-Cataldo F, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/79; Grote E, 2000, PHYS REV E, V62, P4457, DOI 10.1103/PhysRevE.62.4457; Helled R, 2017, ASTROPHYS J LETT, V840, DOI 10.3847/2041-8213/aa6d08; Jones CA, 2014, ICARUS, V241, P148, DOI 10.1016/j.icarus.2014.06.020; Jones CA, 2011, ANNU REV FLUID MECH, V43, P583, DOI 10.1146/annurev-fluid-122109-160727; Liu J, 2008, ICARUS, V196, P653, DOI 10.1016/j.icarus.2007.11.036; Moore KM, 2017, GEOPHYS RES LETT, V44, P4687, DOI 10.1002/2017GL073133; Nellis WJ, 1996, SCIENCE, V273, P936, DOI 10.1126/science.273.5277.936; Ridley VA, 2016, J GEOPHYS RES-PLANET, V121, P309, DOI 10.1002/2015JE004951; SALPETER EE, 1973, ASTROPHYS J, V181, pL83, DOI 10.1086/181190; SHURE L, 1982, PHYS EARTH PLANET IN, V28, P215, DOI 10.1016/0031-9201(82)90003-6; Stanley S, 2008, PHYS EARTH PLANET IN, V168, P179, DOI 10.1016/j.pepi.2008.06.016; Stanley S, 2006, ICARUS, V184, P556, DOI 10.1016/j.icarus.2006.05.005; STEVENSON DJ, 1985, ICARUS, V62, P4, DOI 10.1016/0019-1035(85)90168-X; Vazan A, 2018, ASTRON ASTROPHYS, V610, DOI 10.1051/0004-6361/201732522; Wahl SM, 2017, GEOPHYS RES LETT, V44, P4649, DOI 10.1002/2017GL073160; Wilson HF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.111101	30	44	47	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					76	78		10.1038/s41586-018-0468-5	http://dx.doi.org/10.1038/s41586-018-0468-5			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30185957				2022-12-28	WOS:000443755200034
J	Pierson, TC; Diamond, MS				Pierson, Theodore C.; Diamond, Michael S.			The emergence of Zika virus and its new clinical syndromes	NATURE			English	Review							GUILLAIN-BARRE-SYNDROME; ANTIBODY-DEPENDENT ENHANCEMENT; NEUTRALIZING HUMAN-ANTIBODIES; DENGUE VIRUS; BIRTH-DEFECTS; SEXUAL TRANSMISSION; CROSS-REACTIVITY; STRUCTURAL BASIS; DNA VACCINE; MOUSE MODEL	Zika virus (ZIKV) is a mosquito-transmitted flavivirus that has emerged as a global health threat because of its potential to generate explosive epidemics and ability to cause congenital disease in the context of infection during pregnancy. Whereas much is known about the biology of related flaviviruses, the unique features of ZIKV pathogenesis, including infection of the fetus, persistence in immune-privileged sites and sexual transmission, have presented new challenges. The rapid development of cell culture and animal models has facilitated a new appreciation of ZIKV biology. This knowledge has created opportunities for the development of countermeasures, including multiple ZIKV vaccine candidates, which are advancing through clinical trials. Here we describe the recent advances that have led to a new understanding of the causes and consequences of the ZIKV epidemic.	[Pierson, Theodore C.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63130 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pierson, TC (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63130 USA.	piersontc@mail.nih.gov; diamond@wusm.wustl.edu	Diamond, Michael/AAH-1733-2019; Otero-Ojeda, Gloria Adelina/B-4024-2016	Diamond, Michael/0000-0002-8791-3165; Otero-Ojeda, Gloria Adelina/0000-0003-0548-1387	NIH [R01 AI073755, R01 AI104972, U19 AI083019, R01 HD091218]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD091218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104972, R01AI073755, ZIAAI001209, U19AI083019] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants (R01 AI073755, R01 AI104972, U19 AI083019 and R01 HD091218) and by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. We thank E. Tyler (NIH) for assistance with figure preparation of virion models. This publication is the responsibility of the authors and does not necessarily represent the official view of the NIH.	Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0; Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163; Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168; Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]; Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007; Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365; Bayer A, 2018, PLACENTA, V61, P33, DOI 10.1016/j.placenta.2017.11.004; Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558; Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180; Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243; Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w; Cimini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06536-x; Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001; Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2; Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115; Dirlikov E, 2018, EMERG INFECT DIS, V24, P114, DOI 10.3201/eid2401.171331; Dirlikov E, 2017, JAMA-J AM MED ASSOC, V318, P1498, DOI 10.1001/jama.2017.11483; Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048; dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849; Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7; George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1; Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003; Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]; Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472; Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]; Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012; Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9; Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z; Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]; Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289; Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877; Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1; Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627; Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031; Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022; Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365; Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878; Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016; Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004; Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631; Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X; Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2; Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019; Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975; McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487; Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]; Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045; Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402; Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0; Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597; Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17; da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956; Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394; Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2; Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]; Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010; Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378; Oehler E, 2013, EUROSURVEILLANCE, V19, P20720, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184; Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039; Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564; Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090; Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352; Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6; Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015; Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113; Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009; Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000; Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114; Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692; Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2; Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074; Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8; Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322; Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1; Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869; Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087; Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613; Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16; Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994; Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120; Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258; Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1; Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36; Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363; Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2; Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]; Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004; Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042; Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020; Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093	147	196	198	5	75	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					573	581		10.1038/s41586-018-0446-y	http://dx.doi.org/10.1038/s41586-018-0446-y			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS0SZ	30158602				2022-12-28	WOS:000443218600037
J	Davies, R				Davies, Rachael			John Strang: global leader in tackling addiction	LANCET			English	Biographical-Item																		[Anonymous], PUBLICATION LIST	1	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2018	392	10147					546	546		10.1016/S0140-6736(18)31703-3	http://dx.doi.org/10.1016/S0140-6736(18)31703-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ8MN	30152381				2022-12-28	WOS:000442009500012
J	Pichichero, ME				Pichichero, Michael E.			Helping children with hearing loss from otitis media with effusion	LANCET			English	Editorial Material									[Pichichero, Michael E.] Rochester Gen Hosp, Res Inst, Rochester, NY 14621 USA	Rochester General Hospital	Pichichero, ME (corresponding author), Rochester Gen Hosp, Res Inst, Rochester, NY 14621 USA.	michael.pichichero@rochesterregional.org	Pichichero, Michael E/AID-7886-2022					Francis NA, 2018, LANCET, V392, P557, DOI 10.1016/S0140-6736(18)31490-9; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Kaur R, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0181; National Institute for Health and Care Excellence (NICE), 2008, SURG MAN OT MED EFF; Osgood R, 2015, LARYNGOSCOPE, V125, P2204, DOI 10.1002/lary.25102; Simpson SA, 2011, COCHRANE DB SYST REV, V5	6	8	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2018	392	10147					533	534		10.1016/S0140-6736(18)31862-2	http://dx.doi.org/10.1016/S0140-6736(18)31862-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ8MN	30152374	hybrid			2022-12-28	WOS:000442009500004
J	McCall, C				McCall, Chris			Opt-out digital health records cause debate in Australia	LANCET			English	Editorial Material																			0	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2018	392	10145					372	372		10.1016/S0140-6736(18)31726-4	http://dx.doi.org/10.1016/S0140-6736(18)31726-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GP1SM	30152368				2022-12-28	WOS:000440597100006
J	Grischkan, JA; George, BP; Dorsey, ER; Asch, DA				Grischkan, Justin A.; George, Benjamin P.; Dorsey, E. Ray; Asch, David A.			Medical Education and the Public Service Loan Forgiveness Program: Unnecessary Uncertainties	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Grischkan, Justin A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Grischkan, Justin A.; George, Benjamin P.; Dorsey, E. Ray] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [George, Benjamin P.] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA; [Asch, David A.] Univ Penn, Philadelphia, PA 19104 USA; [Asch, David A.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA	Harvard University; Massachusetts General Hospital; University of Rochester; Yale University; University of Pennsylvania	Asch, DA (corresponding author), Perelman Ctr Adv Med, Ctr Hlth Care Innovat, 14-171,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	asch@wharton.upenn.edu		Asch, David/0000-0002-7970-286X				Asch DA, 2013, NEW ENGL J MED, V369, P1973, DOI 10.1056/NEJMp1310778; Association of American Medical Colleges, 2017, MED STUD ED DEBT COS; Association of American Medical Colleges, GRAD QUEST; Grischkan J, 2017, JAMA INTERN MED, V177, P1532, DOI 10.1001/jamainternmed.2017.4023; Jolly P., DIVERSITY US MED STU; Lieber Ron, 2017, NY TIMES; McCaskill C, 2017, COMMUNICATION; Simpkin AL, 2016, NEW ENGL J MED, V375, P1713, DOI 10.1056/NEJMp1606402	8	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2018	169	8					566	+		10.7326/M18-1511	http://dx.doi.org/10.7326/M18-1511			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW9SP	30167662				2022-12-28	WOS:000447340800020
J	Chitnis, T; Arnold, DL; Banwell, B; Bruck, W; Ghezzi, A; Giovannoni, G; Greenberg, B; Krupp, L; Rostasy, K; Tardieu, M; Waubant, E; Wolinsky, JS; Bar-Or, A; Stites, T; Chen, Y; Putzki, N; Merschhemke, M; Gartner, J				Chitnis, Tanuja; Arnold, Douglas L.; Banwell, Brenda; Brueck, Wolfgang; Ghezzi, Angelo; Giovannoni, Gavin; Greenberg, Benjamin; Krupp, Lauren; Rostasy, Kevin; Tardieu, Marc; Waubant, Emmanuelle; Wolinsky, Jerry S.; Bar-Or, Amit; Stites, Tracy; Chen, Yu; Putzki, Norman; Merschhemke, Martin; Gaertner, Jutta			Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-FEATURES; ORAL FINGOLIMOD; ONSET; MANAGEMENT; MS; POPULATION; CHILDHOOD; RECOVERY	BACKGROUND Treatment of patients younger than 18 years of age with multiple sclerosis has not been adequately examined in randomized trials. We compared fingolimod with interferon beta-la in this population. METHODS In this phase 3 trial, we randomly assigned patients 10 to 17 years of age with relapsing multiple sclerosis in a 1:1 ratio to receive oral fingolimod at a dose of 0.5 mg per day (0.25 mg per day for patients with a body weight of <= 40 kg) or intramuscular interferon beta-1a at a dose of 30 mu g per week for up to 2 years. The primary end point was the annualized relapse rate. RESULTS Of a total of 215 patients, 107 were assigned to fingolimod and 108 to interferon beta-1a. The mean age of the patients was 15.3 years. Among all patients, there was a mean of 2.4 relapses during the preceding 2 years. The adjusted annualized relapse rate was 0.12 with fingolimod and 0.67 with interferon beta-1a (absolute difference, 0.55 relapses; relative difference, 82%; P<0.001). The key secondary end point of the annualized rate of new or newly enlarged lesions on T-2-weighted magnetic resonance imaging (MRI) was 4.39 with fingolimod and 9.27 with interferon beta-1a (absolute difference, 4.88 lesions; relative difference, 53%; P<0.001). Adverse events, excluding relapses of multiple sclerosis, occurred in 88.8% of patients who received fingolimod and 95.3% of those who received interferon beta-1a. Serious adverse events occurred in 18 patients (16.8%) in the fingolimod group and included seizures (in 4 patients), infection (in 4 patients), and leukopenia (in 2 patients). Serious adverse events occurred in 7 patients (6.5%) in the interferon beta-1a group and included infection (in 2 patients) and supraventricular tachycardia (in 1 patient). CONCLUSIONS Among pediatric patients with relapsing multiple sclerosis, fingolimod was associated with a lower rate of relapse and less accumulation of lesions on NU over a 2-year period than interferon beta-1a but was associated with a higher rate of serious adverse events. Longer studies are required to determine the durability and safety of fingolimod in pediatric multiple sclerosis.	[Chitnis, Tanuja] Massachusetts Gen Hosp, Partners Pediat Multiple Sclerosis Ctr, Boston, MA 02114 USA; [Arnold, Douglas L.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Arnold, Douglas L.] NeuroRx Res, Montreal, PQ, Canada; [Banwell, Brenda] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Bar-Or, Amit] Univ Penn, Ctr Neuroinflammat & Expt Neurotherapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bar-Or, Amit] Univ Penn, Dept Neurol, Sch Med, Philadelphia, PA 19104 USA; [Brueck, Wolfgang] Univ Med Ctr Gottingen, Dept Neuropathol, Gottingen, Germany; [Gaertner, Jutta] Univ Med Ctr Gottingen, Dept Pediat & Adolescent Med, German Ctr Multiple Sclerosis Childhood & Adole, Gottingen, Germany; [Rostasy, Kevin] Witten Herdecke Univ, Div Pediat Neurol, Childrens Hosp Datteln, Datteln, Germany; [Ghezzi, Angelo] Gallarate Hosp, Gallarate, Italy; [Giovannoni, Gavin] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Greenberg, Benjamin] Univ Texas Southwestern Med Ctr Dallas, Childrens Hlth, Dallas, TX 75390 USA; [Wolinsky, Jerry S.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA; [Krupp, Lauren] NYU Langone, Pediat Multiple Sclerosis Ctr, New York, NY USA; [Tardieu, Marc] Hop Univ Paris Sud, AP HP, Paris, France; [Waubant, Emmanuelle] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Stites, Tracy; Chen, Yu; Putzki, Norman] Novartis Pharmaceut, E Hanover, NH USA; [Merschhemke, Martin] Novartis Pharmaceut, Basel, Switzerland	Harvard University; Massachusetts General Hospital; McGill University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Gottingen; University of Gottingen; University of London; Queen Mary University London; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston; NYU Langone Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; University of California System; University of California San Francisco; Novartis; Novartis	Chitnis, T (corresponding author), Massachusetts Gen Hosp, ACC708,55 Fruit St, Boston, MA 02114 USA.	tchitnis@rics.bwh.harvard.edu	Stasiolek, Mariusz Pawel/S-9546-2016; Ozakbas, Serkan/V-6427-2019; Greenberg, Benjamin/AAT-1027-2020; Craiu, Dana/ABE-4886-2020; ghezzi, angelo/AAJ-9606-2020; Montalban, Xavier/J-5938-2016; Nehrych, Tetyana I/L-7555-2016; Bar-Or, Amit/AIC-1416-2022; Yalcinkaya, Cengiz/B-6288-2012	Stasiolek, Mariusz Pawel/0000-0002-2582-1708; Greenberg, Benjamin/0000-0002-2091-8201; Montalban, Xavier/0000-0002-0098-9918; Nehrych, Tetyana I/0000-0003-0170-511X; Jancic, Jasna/0000-0002-2935-0798; krupp, lauren/0000-0001-7003-807X; Arnold, Douglas/0000-0003-4266-0106; Pozzilli, Carlo/0000-0002-6360-4798; Yilmaz, Unsal/0000-0002-7256-8557; Yalcinkaya, Cengiz/0000-0002-3443-8524; Shetty, Jayakara/0000-0002-3114-4002; Meca-Lallana, Virginia/0000-0001-9418-4127; Deiva, Kumaran/0000-0002-8409-2365	Novartis Pharma	Novartis Pharma	Funded by Novartis Pharma; PARADIGMS ClinicalTrials.gov number, NCT01892722.; Supported by Novartis Pharma.	[Anonymous], 2017, PRESCR INF GIL FING; Benson LA, 2014, MULT SCLER RELAT DIS, V3, P186, DOI 10.1016/j.msard.2013.06.004; Boiko A, 2002, NEUROLOGY, V59, P1006, DOI 10.1212/WNL.59.7.1006; Brenton JN, 2016, NEUROTHERAPEUTICS, V13, P84, DOI 10.1007/s13311-015-0396-0; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Chitnis T, 2012, MULT SCLER J, V18, P116, DOI 10.1177/1352458511430704; Chitnis T, 2009, MULT SCLER, V15, P627, DOI 10.1177/1352458508101933; Chitnis T, 2016, NEUROLOGY, V87, pS103, DOI 10.1212/WNL.0000000000002884; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Fay AJ, 2012, MULT SCLER J, V18, P1008, DOI 10.1177/1352458511431725; Gartner J, 2018, MULT SCLER J EXP TRA, V4; Ghezzi A, 1997, MULT SCLER, V3, P43, DOI 10.1177/135245859700300105; Ghezzi A, 2016, NEUROLOGY, V87, pS97, DOI 10.1212/WNL.0000000000002823; Ghezzi A, 2010, MULT SCLER J, V16, P1258, DOI 10.1177/1352458510375568; Gorman MP, 2009, ARCH NEUROL-CHICAGO, V66, P54, DOI 10.1001/archneurol.2008.505; Harding KE, 2013, J NEUROL NEUROSUR PS, V84, P141, DOI 10.1136/jnnp-2012-303996; Jancic J, 2016, NEUROL THER, V5, P131, DOI 10.1007/s40120-016-0052-6; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547; Malik MT, 2014, NEUROLOGY, V82, P2173, DOI 10.1212/WNL.0000000000000524; Renoux C, 2007, NEW ENGL J MED, V356, P2603, DOI 10.1056/NEJMoa067597; Simone IL, 2002, NEUROLOGY, V59, P1922, DOI 10.1212/01.WNL.0000036907.37650.8E; Tenembaum SN, 2013, J CHILD NEUROL, V28, P849, DOI 10.1177/0883073813488828; Waldman A, 2016, NEUROLOGY, V87, pS74, DOI 10.1212/WNL.0000000000003028; World Medical Association, 2013, DECL HELS ETH PRINC	25	145	147	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					1017	1027		10.1056/NEJMoa1800149	http://dx.doi.org/10.1056/NEJMoa1800149			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4UV	30207920	Bronze			2022-12-28	WOS:000444501600006
J	Alexander, S; Fisher, BT; Gaur, AH; Dvorak, CC; Luna, DV; Dang, H; Chen, L; Green, M; Nieder, ML; Fisher, B; Bailey, LC; Wiernikowski, J; Sung, L				Alexander, Sarah; Fisher, Brian T.; Gaur, Aditya H.; Dvorak, Christopher C.; Luna, Doojduen Villa; Dang, Ha; Chen, Lu; Green, Michael; Nieder, Michael L.; Fisher, Beth; Bailey, L. Charles; Wiernikowski, John; Sung, Lillian		Children's Oncology Grp	Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYELOID-LEUKEMIA; CLOSTRIDIUM-DIFFICILE INFECTION; ACUTE LYMPHOBLASTIC-LEUKEMIA; ANTIMICROBIAL RESISTANCE; BACTERIAL-INFECTION; ONCOLOGY; CANCER; FLUOROQUINOLONES; CIPROFLOXACIN; THERAPY	IMPORTANCE Bacteremia causes considerable morbidity among children with acute leukemia and those undergoing hematopoietic stem cell transplantation (HSCT). There are limited data on the effect of antibiotic prophylaxis in children. OBJECTIVE To determine the efficacy and risks of levofloxacin prophylaxis in children receiving intensive chemotherapy for acute leukemia or undergoing HSCT. DESIGN, SETTING, AND PARTICIPANTS In this multicenter, open-label, randomized trial, patients (6 months-21 years) receiving intensive chemotherapy were enrolled (September 2011-April 2016) in 2 separate groups-acute leukemia, consisting of acute myeloid leukemia or relapsed acute lymphoblastic leukemia, and HSCT recipients-at 76 centers in the United States and Canada, with follow-up completed September 2017. INTERVENTIONS Patients with acute leukemia were randomized to receive levofloxacin prophylaxis for 2 consecutive cycles of chemotherapy (n = 100) or no prophylaxis (n = 100). Those undergoing HSCT were randomized to receive levofloxacin prophylaxis during 1 HSCT procedure (n = 210) or no prophylaxis (n = 214). MAIN OUTCOMES AND MEASURES The primary outcome was the occurrence of bacteremia during 2 chemotherapy cycles (acute leukemia) or 1 transplant procedure (HSCT). Secondary outcomes included fever and neutropenia, severe infection, invasive fungal disease, Clostridium difficile-associated diarrhea, and musculoskeletal toxic effects. RESULTS A total of 624 patients, 200 with acute leukemia (median [interquartile range {IQR}] age, 11 years [6-15 years]; 46% female) and 424 undergoing HSCT (median [IQR] age, 7 years [3-14]; 38% female), were enrolled. Among 195 patients with acute leukemia, the likelihood of bacteremia was significantly lower in the levofloxacin prophylaxis group than in the control group (21.9% vs 43.4%; risk difference, 21.6%; 95% CI, 8.8%-34.4%, P = .001), whereas among 418 patients undergoing HSCT, the risk of bacteremia was not significantly lower in the levofloxacin prophylaxis group (11.0% vs 17.3%; risk difference, 6.3%; 95% CI, 0.3%-13.0%; P = .06). Fever and neutropenia were less common in the levofloxacin group (71.2% vs 82.1%; risk difference, 10.8%; 95% CI, 4.2%-17.5%; P = .002). There were no significant differences in severe infection (3.6% vs 5.9%; risk difference, 2.3%; 95% CI, -1.1% to 5.6%; P = .20), invasive fungal disease (2.9% vs 2.0%; risk difference, -1.0%; 95% CI, -3.4% to 1.5%, P = .41), C difficile-associated diarrhea (2.3% vs 5.2%; risk difference, 2.9%; 95% CI, -0.1% to 5.9%; P = .07), or musculoskeletal toxic effects at 2 months (11.4% vs 16.3%; risk difference, 4.8%; 95% CI, -1.6% to 11.2%; P = .15) or at 12 months (10.1% vs 14.4%; risk difference, 4.3%; 95% CI, -3.4% to 12.0%; P = .28) between the levofloxacin and control groups. CONCLUSIONS AND RELEVANCE Among children with acute leukemia receiving intensive chemotherapy, receipt of levofloxacin prophylaxis compared with no prophylaxis resulted in a significant reduction in bacteremia. However, there was no significant reduction in bacteremia for levofloxacin prophylaxis among children undergoing HSCT.	[Alexander, Sarah; Sung, Lillian] Hosp Sick Children, Toronto, ON, Canada; [Fisher, Brian T.; Bailey, L. Charles] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Gaur, Aditya H.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Dvorak, Christopher C.] Univ Calif San Francisco, Benioff Childrens Hosp, San Francisco, CA 94143 USA; [Luna, Doojduen Villa] Childrens Oncol Grp, Monrovia, CA USA; [Dang, Ha] Univ Southern Calif, Los Angeles, CA USA; [Chen, Lu] City Hope Natl Med Ctr, Duarte, CA USA; [Green, Michael] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 19104 USA; [Nieder, Michael L.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Fisher, Beth] Childrens Healthcare Atlanta, Atlanta, GA USA; [Wiernikowski, John] McMaster Childrens Hosp, Hamilton, ON, Canada; [Sung, Lillian] Hosp Sick Children, Child Hlth Evaluat Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; St Jude Children's Research Hospital; University of California System; University of California San Francisco; Children's Oncology Group (COG); University of Southern California; City of Hope; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; H Lee Moffitt Cancer Center & Research Institute; Children's Healthcare of Atlanta (CHOA); McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Alexander, S (corresponding author), Hosp Sick Children, Div Haematol Oncol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sarah.alexander@sickkids.ca	Dvorak, Christopher C/AAX-1630-2020; Gaur, Aditya H/N-8057-2018; Dang, Ha/N-4375-2019	Dvorak, Christopher C/0000-0002-6146-3952; Gaur, Aditya H/0000-0002-6639-5231; Dang, Ha/0000-0002-0711-3783; Fisher, Brian/0000-0002-8224-4281	Community Clinical Oncology Program [U10CA095861]; National Cancer Institute Community Oncology Research Program Research Base Grant [U10CA095861]; Biomarker; Quality of Life Studies Program [HHSN261200800001E]; National Cancer Institute; Imaging; NATIONAL CANCER INSTITUTE [U10CA180899, U10CA095861, U10CA180886, UG1CA189955] Funding Source: NIH RePORTER	Community Clinical Oncology Program; National Cancer Institute Community Oncology Research Program Research Base Grant; Biomarker; Quality of Life Studies Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Imaging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants U10CA095861 from the Community Clinical Oncology Program, U10CA095861 from National Cancer Institute Community Oncology Research Program Research Base Grant (awarded to the Children's Oncology Group), and funding from the Biomarker, Imaging, and HHSN261200800001E from the Quality of Life Studies Program, which is supported by the National Cancer Institute.	Alexander S, 2012, PEDIATR BLOOD CANCER, V59, P16, DOI 10.1002/pbc.23416; Ammann RA, 2015, EUR J PEDIATR, V174, P675, DOI 10.1007/s00431-015-2525-5; Bow EJ, 2011, CURR OPIN INFECT DIS, V24, P545, DOI 10.1097/QCO.0b013e32834cf054; Bradley JS, 2014, PEDIATRICS, V134, pE146, DOI 10.1542/peds.2013-3636; Bucaneve G, 2005, NEW ENGL J MED, V353, P977, DOI 10.1056/NEJMoa044097; Clinical and Laboratory Standards Institute, 2013, PERFORMANCE STANDARD; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; FDA Drug Safety Communication, 2016, FDA UPD WARN OR INJ; Gafter-Gvili A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004386.pub3; Inaba H, 2014, CANCER-AM CANCER SOC, V120, P1985, DOI 10.1002/cncr.28688; Kurt B, 2008, CANCER-AM CANCER SOC, V113, P376, DOI 10.1002/cncr.23563; Leather HL, 2015, BACTERIAL INFECT THO; Lehrnbecher T, 2014, EXPERT REV HEMATOL, V7, P819, DOI 10.1586/17474086.2014.965140; Lehrnbecher T, 2012, J CLIN ONCOL, V30, P4427, DOI 10.1200/JCO.2012.42.7161; National Cancer Institute, CREP CANC THER EV PR; National Healthcare Safety Network, 2017, CENTR LIN ASS BLOODS; Noel GJ, 2007, PEDIATR INFECT DIS J, V26, P879, DOI 10.1097/INF.0b013e3180cbd382; Proschan MA, 2006, STAT BIOL HEALTH, P1; Sammons JS, 2013, JAMA PEDIATR, V167, P567, DOI 10.1001/jamapediatrics.2013.441; Schaad UB, 2007, PEDIATR INFECT DIS J, V26, P865, DOI 10.1097/INF.0b013e3180cc20e4; See I, 2016, CLIN INFECT DIS, V62, P1203, DOI 10.1093/cid/ciw113; Sulis ML, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26952; Sung LL, 2012, J PEDIAT HEMATOL ONC, V34, pE30, DOI 10.1097/MPH.0b013e31822817a6; Vardakas KZ, 2016, INT J ANTIMICROB AG, V48, P1, DOI 10.1016/j.ijantimicag.2016.03.008; Wolf J, 2017, CLIN INFECT DIS, V65, P1790, DOI 10.1093/cid/cix644; Yeh TC, 2014, CANCER-AM CANCER SOC, V120, P1255, DOI 10.1002/cncr.28524; Yousef AA, 2004, PEDIATR BLOOD CANCER, V43, P637, DOI 10.1002/pbc.20065	28	89	97	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2018	320	10					995	1004		10.1001/jama.2018.12512	http://dx.doi.org/10.1001/jama.2018.12512			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT2QE	30208456	Bronze, Green Published			2022-12-28	WOS:000444341400013
J	Grinberg, C				Grinberg, Charlotte			Pumped	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Grinberg, Charlotte] Mt Auburn Hosp, Dept Internal Med, 330 Mt Auburn St, Cambridge, MA 02138 USA	Harvard University; Mount Auburn Hospital	Grinberg, C (corresponding author), Mt Auburn Hosp, Dept Internal Med, 330 Mt Auburn St, Cambridge, MA 02138 USA.	cgrinberg@mah.harvard.edu							0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2018	320	10					977	978		10.1001/jama.2018.12212	http://dx.doi.org/10.1001/jama.2018.12212			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT2QE	30208459				2022-12-28	WOS:000444341400009
J	Reiter, JG; Makohon-Moore, AP; Gerold, JM; Heyde, A; Attiyeh, MA; Kohutek, ZA; Tokheim, CJ; Brown, A; DeBlasio, RM; Niyazov, J; Zucker, A; Karchin, R; Kinzler, KW; Iacobuzio-Donahue, CA; Vogelstein, B; Nowak, MA				Reiter, Johannes G.; Makohon-Moore, Alvin P.; Gerold, Jeffrey M.; Heyde, Alexander; Attiyeh, Marc A.; Kohutek, Zachary A.; Tokheim, Collin J.; Brown, Alexia; DeBlasio, Rayne M.; Niyazov, Juliana; Zucker, Amanda; Karchin, Rachel; Kinzler, Kenneth W.; Iacobuzio-Donahue, Christine A.; Vogelstein, Bert; Nowak, Martin A.			Minimal functional driver gene heterogeneity among untreated metastases	SCIENCE			English	Article							CLONAL EVOLUTION; MODEL; ACCUMULATION; PROGRESSION; MUTATIONS	Metastases are responsible for the majority of cancer-related deaths. Although genomic heterogeneity within primary tumors is associated with relapse, heterogeneity among treatment-naive metastases has not been comprehensively assessed. We analyzed sequencing data for 76 untreated metastases from 20 patients and inferred cancer phylogenies for breast, colorectal, endometrial, gastric, lung, melanoma, pancreatic, and prostate cancers. We found that within individual patients, a large majority of driver gene mutations are common to all metastases. Further analysis revealed that the driver gene mutations that were not shared by all metastases are unlikely to have functional consequences. A mathematical model of tumor evolution and metastasis formation provides an explanation for the observed driver gene homogeneity. Thus, single biopsies capture most of the functionally important mutations in metastases and therefore provide essential information for therapeutic decision-making.	[Reiter, Johannes G.] Stanford Univ, Caney Ctr Canc Early Detect, Sch Med, Dept Radiol, Palo Alto, CA 94305 USA; [Reiter, Johannes G.; Gerold, Jeffrey M.; Heyde, Alexander; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Makohon-Moore, Alvin P.; Attiyeh, Marc A.; Brown, Alexia; DeBlasio, Rayne M.; Niyazov, Juliana; Zucker, Amanda; Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, David M Rubenstein Ctr Pancreat Canc Res, New York, NY 10065 USA; [Kohutek, Zachary A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Tokheim, Collin J.; Karchin, Rachel] Johns Hopkins Univ, Inst Computat Med, Dept Biomed Engn, Baltimore, MD 21218 USA; [Karchin, Rachel] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Ludwig Ctr, Baltimore, MD 21287 USA; [Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21287 USA; [Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21205 USA; [Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA	Stanford University; Harvard University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Johns Hopkins University; Harvard University; Harvard University	Reiter, JG (corresponding author), Stanford Univ, Caney Ctr Canc Early Detect, Sch Med, Dept Radiol, Palo Alto, CA 94305 USA.; Reiter, JG; Nowak, MA (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.; Nowak, MA (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Nowak, MA (corresponding author), Harvard Univ, Dept Math, Cambridge, MA 02138 USA.	johannes.reiter@stanford.edu; martin_nowak@harvard.edu	Makohon-Moore, Alvin/ABH-1764-2020; Iacobuzio-Donahue, Christine/ABF-1295-2020; Karchin, Rachel/AFO-2592-2022; Reiter, Johannes G./Y-4083-2019	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Reiter, Johannes G./0000-0002-0170-7353; Karchin, Rachel/0000-0002-5069-1239; Attiyeh, Marc/0000-0002-9949-1449; Brown, Alexia/0000-0003-1243-2575; Tokheim, Collin/0000-0003-1395-5378; Heyde, Alexander/0000-0003-0324-7095; Makohon-Moore, Alvin/0000-0002-4781-3565; DeBlasio, Rayne/0000-0003-3614-2804; Zucker, Amanda/0000-0002-9283-7072	National Institutes of Health [K99CA229991, CA179991, F31CA180682, T32 CA160001-06, F31CA200266, U24CA204817, CA43460]; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Center for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Erwin Schrodinger fellowship [FWF J-3996]; Landry Cancer Biology fellowship; Office of Naval Research [N00014-16-1-2914]; NATIONAL CANCER INSTITUTE [T32CA160001, F31CA200266, R01CA179991, F31CA180682, U24CA204817, R37CA043460, K99CA229991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Center for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Erwin Schrodinger fellowship; Landry Cancer Biology fellowship; Office of Naval Research(Office of Naval Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grants K99CA229991 (J.G.R.), CA179991 (C.A.I.-D.), F31CA180682 (A.P.M.-M.), T32 CA160001-06 (A.P.M.-M.), F31CA200266 (C.J.T.), U24CA204817 (R.K.), CA43460 (B.V.), as well as by the Lustgarten Foundation for Pancreatic Cancer Research, The Sol Goldman Center for Pancreatic Cancer Research, The Virginia and D. K. Ludwig Fund for Cancer Research, an Erwin Schrodinger fellowship (J.G.R.; Austrian Science Fund FWF J-3996), a Landry Cancer Biology fellowship (J.M.G.), and the Office of Naval Research grant N00014-16-1-2914.	Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Bozic I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004731; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Brown D, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms15759, 10.1038/ncomms14944]; Durrett R, 2015, MATH BIOSCI INST LEC, V1-1, P1, DOI 10.1007/978-3-319-16065-8; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Furukawa H, 2001, PANCREAS, V22, P366, DOI 10.1097/00006676-200105000-00005; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gibson WJ, 2016, NAT GENET, V48, P848, DOI 10.1038/ng.3602; Good BH, 2017, NATURE, V551, P45, DOI 10.1038/nature24287; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; Hong MKH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7605; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Kim TM, 2015, CLIN CANCER RES, V21, P4461, DOI 10.1158/1078-0432.CCR-14-2413; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pectasides E, 2018, CANCER DISCOV, V8, P37, DOI 10.1158/2159-8290.CD-17-0395; Reiter JG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14114; Sanborn JZ, 2015, P NATL ACAD SCI USA, V112, P10995, DOI 10.1073/pnas.1508074112; Shihab HA, 2013, BIOINFORMATICS, V29, P1504, DOI 10.1093/bioinformatics/btt182; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Tokheim C., 2018, BIORXIV, DOI [10.1101/313296, DOI 10.1101/313296]; Turajlic S, 2016, SCIENCE, V352, P169, DOI 10.1126/science.aaf2784; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Williams MJ, 2018, NAT GENET, V50, P895, DOI 10.1038/s41588-018-0128-6	29	154	157	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					1033	1037		10.1126/science.aat7171	http://dx.doi.org/10.1126/science.aat7171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190408	Green Accepted			2022-12-28	WOS:000443892700051
J	Hayden, FG; Sugaya, N; Hirotsu, N; Lee, N; de Jong, MD; Hurt, AC; Ishida, T; Sekino, H; Yamada, K; Portsmouth, S; Kawaguchi, K; Shishido, T; Arai, M; Tsuchiya, K; Uehara, T; Watanabe, A				Hayden, Frederick G.; Sugaya, Norio; Hirotsu, Nobuo; Lee, Nelson; de Jong, Menno D.; Hurt, Aeron C.; Ishida, Tadashi; Sekino, Hisakuni; Yamada, Kota; Portsmouth, Simon; Kawaguchi, Keiko; Shishido, Takao; Arai, Masatsugu; Tsuchiya, Kenji; Uehara, Takeki; Watanabe, Akira		Baloxavir Marboxil Investigators	Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVENOUS PERAMIVIR; HOSPITALIZED-PATIENTS; ANTIVIRAL RESISTANCE; ORAL OSELTAMIVIR; VIRUS; POLYMERASE; DURATION; EFFICACY; SAFETY; INFECTION	BACKGROUND Baloxavir marboxil is a selective inhibitor of influenza cap-dependent endonuclease. It has shown therapeutic activity in preclinical models of influenza A and B virus infections, including strains resistant to current antiviral agents. METHODS We conducted two randomized, double-blind, controlled trials involving otherwise healthy outpatients with acute uncomplicated influenza. After a dose-ranging (10 to 40 mg) placebo-controlled trial, we undertook a placebo-and oseltamivir-controlled trial of single, weight-based doses of baloxavir (40 or 80 mg) in patients 12 to 64 years of age during the 2016-2017 season. The dose of oseltamivir was 75 mg twice daily for 5 days. The primary efficacy end point was the time to alleviation of influenza symptoms in the intention-to-treat infected population. RESULTS In the phase 2 trial, the median time to alleviation of influenza symptoms was 23.4 to 28.2 hours shorter in the baloxavir groups than in the placebo group (P<0.05). In the phase 3 trial, the intention-to-treat infected population included 1064 patients; 84.8 to 88.1% of patients in each group had influenza A(H3N2) infection. The median time to alleviation of symptoms was 53.7 hours (95% confidence interval [CI], 49.5 to 58.5) with baloxavir, as compared with 80.2 hours (95% CI, 72.6 to 87.1) with placebo (P<0.001). The time to alleviation of symptoms was similar with baloxavir and oseltamivir. Baloxavir was associated with greater reductions in viral load 1 day after initiation of the regimen than placebo or oseltamivir. Adverse events were reported in 20.7% of baloxavir recipients, 24.6% of placebo recipients, and 24.8% of oseltamivir recipients. The emergence of polymerase acidic protein variants with I38T/M/F substitutions conferring reduced susceptibility to baloxavir occurred in 2.2% and 9.7% of baloxavir recipients in the phase 2 trial and phase 3 trial, respectively. CONCLUSIONS Single-dose baloxavir was without evident safety concerns, was superior to placebo in alleviating influenza symptoms, and was superior to both oseltamivir and placebo in reducing the viral load 1 day after initiation of the trial regimen in patients with uncomplicated influenza. Evidence for the development of decreased susceptibility to baloxavir after treatment was also observed.	[Hayden, Frederick G.] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA; [Sugaya, Norio] Keiyu Hosp, Dept Pediat, Yokohama, Kanagawa, Japan; [Hirotsu, Nobuo] Hirotsu Clin, Kawasaki, Kanagawa, Japan; [Ishida, Tadashi] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan; [Sekino, Hisakuni] Sekino Hosp, Tokyo, Japan; [Yamada, Kota] Tsuchiura Beryl Clin, Tsuchiura, Ibaraki, Japan; [Kawaguchi, Keiko; Shishido, Takao; Arai, Masatsugu; Tsuchiya, Kenji; Uehara, Takeki] Shionogi, Osaka, Japan; [Watanabe, Akira] Tohoku Univ, Res Div Dev Antiinfect Agents, Inst Dev Aging & Canc, Sendai, Miyagi, Japan; [Lee, Nelson] Univ Alberta, Dept Med, Div Infect Dis, Edmonton, AB, Canada; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [Hurt, Aeron C.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Portsmouth, Simon] Shionogi, Florham Pk, NJ USA	University of Virginia; Kurashiki Central Hospital; Tohoku University; University of Alberta; University of Amsterdam; Academic Medical Center Amsterdam; University of Melbourne; Shionogi & Company Limited	Hayden, FG (corresponding author), Univ Virginia Hlth Syst, Div Infect Dis & Int Hlth, POB 801342, Charlottesville, VA 22908 USA.	fgh@virginia.edu	Lee, Nelson/B-6418-2008	Lee, Nelson/0000-0002-0783-6607	Shionogi	Shionogi	Funded by Shionogi; JapicCTI number, 153090, and CAPSTONE-1 ClinicalTrials.gov number, NCT02954354.	Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; Choi SM, 2011, BLOOD, V117, P5050, DOI 10.1182/blood-2010-11-319186; Clark MP, 2014, J MED CHEM, V57, P6668, DOI 10.1021/jm5007275; de Jong MD, 2014, CLIN INFECT DIS, V59, pE172, DOI 10.1093/cid/ciu632; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Epstein C, 2017, 5 ISIRV AVG C PREV T; Fielding JE, 2014, INFLUENZA OTHER RESP, V8, P142, DOI 10.1111/irv.12216; Finberg R, 2017, 5 ISIRV AVG C PREV T; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Kawasaki A, 2016, IDWEEK NEW ORL OCT 2; Kitano M, 2017, IDWEEK SAN DIEG CA O; Kohno S, 2010, ANTIMICROB AGENTS CH, V54, P4568, DOI 10.1128/AAC.00474-10; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850; Marty FM, 2017, LANCET RESP MED, V5, P135, DOI 10.1016/S2213-2600(16)30435-0; Memoli MJ, 2014, CLIN INFECT DIS, V58, P214, DOI 10.1093/cid/cit725; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Noshi T, 2017, ASM MICR NEW ORL JUN; O'Neil B, 2017, LAT BREAK 6 ESWI C R; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Reddy KP, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw023; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Sedyaningsih ER, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3039; Shi FY, 2013, CURR MED CHEM, V20, P3923; Shishido T, 2017, 5 ISIRV AVG C PREV T; Stevaert A, 2016, MED RES REV, V36, P1127, DOI 10.1002/med.21401; Stevaert A, 2013, J VIROL, V87, P10524, DOI 10.1128/JVI.00832-13; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Uehara T, 2016, OPT 9 CONTR INFL CHI; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	33	439	462	5	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2018	379	10					913	923		10.1056/NEJMoa1716197	http://dx.doi.org/10.1056/NEJMoa1716197			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5XM	30184455	Bronze			2022-12-28	WOS:000443748200006
J	Said, A; Vlachaki, E; Abukar, J; Tsitsikas, DA				Said, Ammaarah; Vlachaki, Efthymia; Abukar, Jibril; Tsitsikas, Dimitris A.			A man with fever and haemoglobinuria after blood transfusion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SICKLE-CELL-DISEASE; HYPERHEMOLYSIS SYNDROME		[Said, Ammaarah; Abukar, Jibril; Tsitsikas, Dimitris A.] Homerton Univ Hosp NHS Fdn Trust, Haemoglobinopathy Serv, London, England; [Vlachaki, Efthymia] Hippokrateion Hosp, Dept Internal Med 2, Adults Thalassemia Unit, Thessaloniki, Greece		Said, A (corresponding author), Homerton Univ Hosp NHS Fdn Trust, Haemoglobinopathy Serv, London, England.	ammaarah.said@nhs.net	Tsitsikas, Dimitris A./AGL-2303-2022; TSITSIKAS, DIMITRIS/GNW-3079-2022	Tsitsikas, Dimitris A./0000-0003-3468-049X; 				Knowles S, SERIOUS HAZARDS TRAN; Marti-Carvajal AJ, 2010, COCHRANE DB SYST REV, V6; Petz LD, 1997, TRANSFUSION, V37, P382, DOI 10.1046/j.1537-2995.1997.37497265338.x; Royal Children's Hospital Melbourne, ADV EFF TRANSF; Win N, 2008, TRANSFUSION, V48, P1231, DOI 10.1111/j.1537-2995.2008.01693.x; Win N, 2009, EXPERT REV HEMATOL, V2, P111, DOI 10.1586/EHM.09.2	6	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2018	362								k3138	10.1136/bmj.k3138	http://dx.doi.org/10.1136/bmj.k3138			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WS	30190313				2022-12-28	WOS:000444507200001
J	Tikkinen, KAO; Dahm, P; Lytvyn, L; Heen, AF; Vernooij, RWM; Siemieniuk, RAC; Wheeler, R; Vaughan, B; Fobuzi, AC; Blanker, MH; Junod, N; Sommer, J; Stirnemann, J; Yoshimura, M; Auer, R; MacDonald, H; Guyatt, G; Vandvik, PO; Agoritsas, T				Tikkinen, Kari A. O.; Dahm, Philipp; Lytvyn, Lyubov; Heen, Anja F.; Vernooij, Robin W. M.; Siemieniuk, Reed A. C.; Wheeler, Russell; Vaughan, Bill; Fobuzi, Awah Cletus; Blanker, Marco H.; Junod, Noelle; Sommer, Johanna; Stirnemann, Jerome; Yoshimura, Manabu; Auer, Reto; MacDonald, Helen; Guyatt, Gordon; Vandvik, Per Olav; Agoritsas, Thomas			Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISCRETE-CHOICE EXPERIMENT; FOLLOW-UP; MENS PREFERENCES; FAMILY-HISTORY; MORTALITY; TRIAL; RECOMMENDATIONS; ERSPC; LIFE; QUALITY		[Tikkinen, Kari A. O.] Univ Helsinki, Dept Urol, Helsinki 00029, Finland; [Tikkinen, Kari A. O.] Helsinki Univ Hosp, Helsinki 00029, Finland; [Tikkinen, Kari A. O.] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; [Dahm, Philipp] Univ Minnesota, Minneapolis VAMC, Urol Sect, Minneapolis, MN USA; [Dahm, Philipp] Univ Minnesota, Dept Urol, Minneapolis, MN USA; [Lytvyn, Lyubov; Siemieniuk, Reed A. C.; Guyatt, Gordon; Agoritsas, Thomas] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Heen, Anja F.; Vandvik, Per Olav] Innlandet Hosp Trust Div, Dept Med, Gjovik, Norway; [Vernooij, Robin W. M.] Netherlands Comprehens Canc Org IKNL, Dept Res, Utrecht, Netherlands; [Wheeler, Russell] Cochrane Consumers, London, England; [Vaughan, Bill] Citizens United Evidence Based Med, Richmond, VA USA; [Fobuzi, Awah Cletus] Cameroon Consumer Serv Org CamCoSO, Bamenda, Cameroon; [Fobuzi, Awah Cletus] Coalit Civil Soc Org Cameroon, Bamenda, Cameroon; [Blanker, Marco H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice & Elderly Med, Groningen, Netherlands; [Junod, Noelle] Geneva Univ Hosp, Inst Primary Care, Geneva, Switzerland; [Sommer, Johanna] Univ Geneva, Unit Primary Care Med, Fac Med, Geneva, Switzerland; [Stirnemann, Jerome; Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Yoshimura, Manabu] Univ Miyazaki, Sch Med, Miyazaki, Japan; [Auer, Reto] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Auer, Reto] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [MacDonald, Helen] BMJ, London, England; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; McMaster University; Innlandet Hospital Trust; University of Groningen; University of Geneva; University of Geneva; University of Geneva; University of Miyazaki; University of Bern; University of Lausanne; University of Geneva	Tikkinen, KAO (corresponding author), Univ Helsinki, Dept Urol, Helsinki 00029, Finland.; Tikkinen, KAO (corresponding author), Helsinki Univ Hosp, Helsinki 00029, Finland.; Tikkinen, KAO (corresponding author), Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland.	kari.tikkinen@gmail.com	Vernooij, Robin/N-3652-2018; Dahm, Philipp/I-1614-2019; Sommer, Johanna/ABF-7237-2020; Blanker, Marco/AAV-7028-2020; Agoritsas, Thomas/F-4321-2014; Tikkinen, Kari/L-3632-2018; Blanker, Marco/B-4453-2012	Vernooij, Robin/0000-0001-5734-4566; Dahm, Philipp/0000-0003-2819-2553; Agoritsas, Thomas/0000-0002-6182-9969; Tikkinen, Kari/0000-0002-1389-8214; Auer, Reto/0000-0003-4222-4849; Blanker, Marco/0000-0002-1086-8730				Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Bell N, 2014, CAN MED ASSOC J, V186, P1225, DOI 10.1503/cmaj.140703; Booth N, 2014, EUR UROL, V65, P39, DOI 10.1016/j.eururo.2012.11.041; Bratt O, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw110; Carroll PR, 2014, J NATL COMPR CANC NE, V12, P1211, DOI 10.6004/jnccn.2014.0120; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Dahm P, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4200; de Bekker-Grob EW, 2013, BRIT J CANCER, V108, P533, DOI 10.1038/bjc.2013.5; de Carvalho TM, 2018, CANCER-AM CANCER SOC, V124, P507, DOI 10.1002/cncr.31141; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Drazer MW, 2015, J CLIN ONCOL, V33, P2416, DOI 10.1200/JCO.2015.61.6532; Drazer MW, 2014, CANCER-AM CANCER SOC, V120, P1491, DOI 10.1002/cncr.28600; Fall K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000197; Fang F, 2010, JNCI-J NATL CANCER I, V102, P307, DOI 10.1093/jnci/djp537; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Howard K, 2015, HEALTH EXPECT, V18, P3123, DOI 10.1111/hex.12301; Ilic D, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3519; Ilic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub3; Jemal A, 2015, JAMA-J AM MED ASSOC, V314, P2054, DOI 10.1001/jama.2015.14905; Kasivisvanathan V, 2018, NEW ENGL J MED, V378, P1767, DOI 10.1056/NEJMoa1801993; Kilpelainen TP, 2016, AM J EPIDEMIOL, V184, P720, DOI 10.1093/aje/kww084; Kilpelainen TP, 2011, EUR J CANCER, V47, P2698, DOI 10.1016/j.ejca.2011.06.055; Loeb S, 2010, CURR OPIN UROL, V20, P185, DOI 10.1097/MOU.0b013e3283384047; Martin RM, 2018, JAMA-J AM MED ASSOC, V319, P883, DOI 10.1001/jama.2018.0154; Miller EA, 2018, PROSTATE, V78, P830, DOI 10.1002/pros.23540; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Misra-Hebert AD, 2017, BJU INT, V120, P257, DOI 10.1111/bju.13793; Mottet N., EAU ANN C BARC 2019, V2019 Edition; Nordstrom T, 2016, SCAND J UROL, V50, P104, DOI 10.3109/21681805.2015.1113200; Jakupsstovu JOI, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1202; Pinsky PF, 2017, CANCER-AM CANCER SOC, V123, P592, DOI 10.1002/cncr.30474; Randazzo M, 2016, BJU INT, V117, P576, DOI 10.1111/bju.13310; Rosario DJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7894; Saarimaki L, 2015, INT J CANCER, V136, P2172, DOI 10.1002/ijc.29243; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Siemieniuk RA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5191; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; US Preventive Services Task Force, 2018, JAMA, V319, P1901, DOI 10.1001/jama.2018.3710; Van der Meer S, 2013, BJU INT, V112, P26, DOI 10.1111/bju.12029; Vernooij RWM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-025470; Young GJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017729	44	62	63	4	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2018	362								k3581	10.1136/bmj.k3581	http://dx.doi.org/10.1136/bmj.k3581			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WB	30185545	Green Published, hybrid			2022-12-28	WOS:000444505300006
J	Rimmer, A				Rimmer, Abi			Sixty seconds on ... the 100 Word Project	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2018	362								k3766	10.1136/bmj.k3766	http://dx.doi.org/10.1136/bmj.k3766			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4VO	30181116				2022-12-28	WOS:000444503800011
J	Nolan, C; Overpeck, JT; Allen, JRM; Anderson, PM; Betancourt, JL; Binney, HA; Brewer, S; Bush, MB; Chase, BM; Cheddadi, R; Djamali, M; Dodson, J; Edwards, ME; Gosling, WD; Haberle, S; Hotchkiss, SC; Huntley, B; Ivory, SJ; Kershaw, AP; Kim, SH; Latorre, C; Leydet, M; Lezine, AM; Liu, KB; Liu, Y; Lozhkin, AV; McGlone, MS; Marchant, RA; Momohara, A; Moreno, PI; Muller, S; Otto-Bliesner, BL; Shen, CM; Stevenson, J; Takahara, H; Tarasov, PE; Tipton, J; Vincens, A; Weng, CY; Xu, QH; Zheng, Z; Jackson, ST				Nolan, Connor; Overpeck, Jonathan T.; Allen, Judy R. M.; Anderson, Patricia M.; Betancourt, Julio L.; Binney, Heather A.; Brewer, Simon; Bush, Mark B.; Chase, Brian M.; Cheddadi, Rachid; Djamali, Morteza; Dodson, John; Edwards, Mary E.; Gosling, William D.; Haberle, Simon; Hotchkiss, Sara C.; Huntley, Brian; Ivory, Sarah J.; Kershaw, A. Peter; Kim, Soo-Hyun; Latorre, Claudio; Leydet, Michelle; Lezine, Anne-Marie; Liu, Kam-Biu; Liu, Yao; Lozhkin, A. V.; McGlone, Matt S.; Marchant, Robert A.; Momohara, Arata; Moreno, Patricio I.; Mueller, Stefanie; Otto-Bliesner, Bette L.; Shen, Caiming; Stevenson, Janelle; Takahara, Hikaru; Tarasov, Pavel E.; Tipton, John; Vincens, Annie; Weng, Chengyu; Xu, Qinghai; Zheng, Zhuo; Jackson, Stephen T.			Past and future global transformation of terrestrial ecosystems under climate change	SCIENCE			English	Article							FOREST; BIODIVERSITY; CONSEQUENCES; DISTURBANCE; RESPONSES; DROUGHT; RECORD	Impacts of global climate change on terrestrial ecosystems are imperfectly constrained by ecosystem models and direct observations. Pervasive ecosystem transformations occurred in response to warming and associated climatic changes during the last glacial-to-interglacial transition, which was comparable in magnitude to warming projected for the next century under high-emission scenarios. We reviewed 594 published paleoecological records to examine compositional and structural changes in terrestrial vegetation since the last glacial period and to project the magnitudes of ecosystem transformations under alternative future emission scenarios. Our results indicate that terrestrial ecosystems are highly sensitive to temperature change and suggest that, without major reductions in greenhouse gas emissions to the atmosphere, terrestrial ecosystems worldwide are at risk of major transformation, with accompanying disruption of ecosystem services and impacts on biodiversity.	[Nolan, Connor; Overpeck, Jonathan T.; Jackson, Stephen T.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Overpeck, Jonathan T.] Univ Michigan, Sch Environm & Sustainabil, Ann Arbor, MI 48109 USA; [Allen, Judy R. M.; Huntley, Brian] Univ Durham, Dept Biosci, Durham DH1 3LE, England; [Anderson, Patricia M.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Betancourt, Julio L.] US Geol Survey, Natl Res Program, Reston, VA 20192 USA; [Binney, Heather A.; Edwards, Mary E.] Univ Southampton, Geog & Environm, Southampton SO17 1BJ, Hants, England; [Brewer, Simon] Univ Utah, Dept Geog, Salt Lake City, UT 84112 USA; [Bush, Mark B.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Chase, Brian M.; Cheddadi, Rachid] Univ Montpellier, CNRS, UMR 5554, Inst Sci Evolut Montpellier, Bat 22,CC061,Pl Eugene Bataillon, F-34095 Montpellier, France; [Djamali, Morteza; Leydet, Michelle] Aix Marseille Univ, Avignon Univ, CNRS, IRD,Inst Mediterraneen Biodiversite & Ecol, F-13545 Aix En Provence, France; [Dodson, John] Univ New South Wales, Palaeontol Geobiol & Earth Arch Res Ctr PANGEA, Sydney, NSW 2052, Australia; [Dodson, John] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 71002, Shaanxi, Peoples R China; [Edwards, Mary E.] Univ Alaska Fairbanks, Coll Nat Sci & Math, Fairbanks, AK 99775 USA; [Gosling, William D.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1090 GE Amsterdam, Netherlands; [Gosling, William D.] Open Univ, Sch Environm Earth & Ecosyst Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England; [Haberle, Simon] Australian Natl Univ, Dept Archaeol & Nat Hist, Canberra, ACT, Australia; [Hotchkiss, Sara C.; Kim, Soo-Hyun] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Ivory, Sarah J.] Penn State Univ, Dept Geosci, State Coll, PA 16802 USA; [Kershaw, A. Peter] Monash Univ, Sch Earth Atmosphere & Environm, Melbourne, Vic 3800, Australia; [Latorre, Claudio] Pontificia Univ Catolica Chile, Dept Ecol, IEB, Santiago, Chile; [Lezine, Anne-Marie] Sorbonne Univ, CNRS, IRD, MNHN,LOCEAN,IPSL Lab, 4 Pl Jussieu, F-75005 Paris, France; [Liu, Kam-Biu] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Liu, Yao] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA; [Lozhkin, A. V.] Russian Acad Sci, North East Interdisciplinary Sci Res Inst, Far East Branch, Magadan 685000, Russia; [McGlone, Matt S.] Landcare Res, Lincoln 7640, New Zealand; [Marchant, Robert A.] Univ York, Dept Environm, York Inst Trop Ecosyst, York YO10 5NG, N Yorkshire, England; [Momohara, Arata] Chiba Univ, Grad Sch Hort, Matsudo, Chiba 2718510, Japan; [Moreno, Patricio I.] Univ Chile, Dept Ciencias Ecol, IEB, Santiago, Chile; [Moreno, Patricio I.] Univ Chile, CR2, Santiago, Chile; [Mueller, Stefanie; Tarasov, Pavel E.] Free Univ Berlin, Inst Geol Sci, D-12249 Berlin, Germany; [Otto-Bliesner, Bette L.] Natl Ctr Atmospher Res, Climate & Global Dynam Lab, POB 3000, Boulder, CO 80307 USA; [Shen, Caiming] Yunnan Normal Univ, Key Lab Plateau Lake Ecol & Global Change, Kunming 650092, Yunnan, Peoples R China; [Stevenson, Janelle] Australian Natl Univ, Sch Culture Hist & Language, Canberra, ACT, Australia; [Takahara, Hikaru] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan; [Tipton, John] Univ Arkansas, Dept Math Sci, Fayetteville, AR 72701 USA; [Vincens, Annie] CEREGE, F-13545 Aix En Provence, France; [Weng, Chengyu] Tongji Univ, Sch Ocean & Earth Sci, Shanghai, Peoples R China; [Xu, Qinghai] Hebei Normal Univ, Inst Nihewan Archaeol, Shijiazhuang 050024, Hebei, Peoples R China; [Xu, Qinghai] Hebei Normal Univ, Coll Resource & Environm Sci, Shijiazhuang 050024, Hebei, Peoples R China; [Zheng, Zhuo] Sun Yat Sen Univ, Sch Earth Sci & Engn, Guangdong Prov Key Lab Geodynam & Geohazards, Guangzhou 510275, Guangdong, Peoples R China; [Jackson, Stephen T.] US Geol Survey, Southwest Climate Adaptat Sci Ctr, Tucson, AZ 85721 USA	University of Arizona; University of Michigan System; University of Michigan; Durham University; University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey; University of Southampton; Utah System of Higher Education; University of Utah; Florida Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of New South Wales Sydney; Chinese Academy of Sciences; University of Alaska System; University of Alaska Fairbanks; University of Amsterdam; Open University - UK; Australian National University; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Monash University; Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Louisiana State University System; Louisiana State University; Northern Arizona University; Russian Academy of Sciences; Landcare Research - New Zealand; University of York - UK; Chiba University; Universidad de Chile; Universidad de Chile; Free University of Berlin; National Center Atmospheric Research (NCAR) - USA; Yunnan Normal University; Australian National University; Kyoto Prefectural University; University of Arkansas System; University of Arkansas Fayetteville; UDICE-French Research Universities; Aix-Marseille Universite; Tongji University; Hebei Normal University; Hebei Normal University; Sun Yat Sen University; United States Department of the Interior; United States Geological Survey	Jackson, ST (corresponding author), Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA.; Jackson, ST (corresponding author), US Geol Survey, Southwest Climate Adaptat Sci Ctr, Tucson, AZ 85721 USA.	stjackson@usgs.gov	Tipton, John/AAV-4148-2020; Moreno, Patricio I/D-2317-2012; Lu, houyuan/AAD-3100-2019; Cheddadi, Rachid/GXM-6391-2022; Takahara, Hikaru/AAZ-6642-2020; Liu, Kam-Biu/B-4966-2012; Latorre, Claudio/P-3917-2019; Shen, Caiming/F-5687-2012; Gosling, William/D-2459-2009; Tarasov, Pavel/ABG-3993-2020; Gosling, William/AAB-2761-2020; Otto-Bliesner, Bette/AAY-7691-2020; Haberle, Simon/U-4118-2019; Leydet, Michelle/HGD-0578-2022; Latorre, Claudio/E-6805-2012; Chase, Brian/A-1202-2010	Tipton, John/0000-0002-6135-8191; Moreno, Patricio I/0000-0002-1333-6238; Lu, houyuan/0000-0001-5721-6679; Liu, Kam-Biu/0000-0002-0038-2198; Latorre, Claudio/0000-0003-4708-7599; Shen, Caiming/0000-0002-8126-8775; Gosling, William/0000-0001-9903-8401; Tarasov, Pavel/0000-0002-7219-5009; Gosling, William/0000-0001-9903-8401; Latorre, Claudio/0000-0003-4708-7599; Haberle, Simon/0000-0001-5802-6535; Chase, Brian/0000-0001-6987-1291; Stevenson, Janelle/0000-0001-9640-7275; Ivory, Sarah/0000-0003-4709-4406; Leydet, Michelle/0000-0003-1123-3427; Kershaw, Peter/0000-0002-9478-0567; Brewer, Simon/0000-0002-6810-1911; Liu, Yao/0000-0003-2783-3291; Jackson, Stephen/0000-0002-1487-4652; LEZINE, Anne-Marie/0000-0002-3555-5124; Bush, Mark/0000-0001-6894-8613	NSF [DEB-1241851, AGS-1243125, EAR-1304083]; Department of the Interior's Southwest Climate Adaptation Science Center; Russian Academy of Sciences, FEB [15-1-2-067]; Russian Foundation for Fundamental Research [15-05-06420]	NSF(National Science Foundation (NSF)); Department of the Interior's Southwest Climate Adaptation Science Center; Russian Academy of Sciences, FEB; Russian Foundation for Fundamental Research(Russian Foundation for Basic Research (RFBR))	This research was supported by the NSF (DEB-1241851, AGS-1243125, and EAR-1304083) and by the Department of the Interior's Southwest Climate Adaptation Science Center. Research in northeast Siberia was funded by the Russian Academy of Sciences, FEB (15-1-2-067), and the Russian Foundation for Fundamental Research (15-05-06420).	Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Allen CD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00203.1; Allen JRM, 2000, QUATERN INT, V73-4, P91, DOI 10.1016/S1040-6182(00)00067-7; Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Annan JD, 2013, CLIM PAST, V9, P367, DOI 10.5194/cp-9-367-2013; [Anonymous], 2007, TERRESTRIAL ECOSYSTE, DOI [10.1007/978-3-540-32730-1, DOI 10.1007/978-3-540-32730-1_15]; Asner GP, 2016, P NATL ACAD SCI USA, V113, pE249, DOI 10.1073/pnas.1523397113; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bush MB, 2004, PALAEOGEOGR PALAEOCL, V214, P359, DOI 10.1016/j.palaeo.2004.07.031; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chapin F.S.I.I.I., 2002, PRINCIPLES TERRESTRI; Clark PU, 2016, NAT CLIM CHANGE, V6, P360, DOI 10.1038/NCLIMATE2923; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Colinvaux PA, 1996, SCIENCE, V274, P85, DOI 10.1126/science.274.5284.85; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Correa-Metrio A, 2012, QUATERNARY SCI REV, V38, P63, DOI 10.1016/j.quascirev.2012.01.025; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Guiot J, 2016, SCIENCE, V354, P465, DOI 10.1126/science.aah5015; Guiterman C. H., 2017, ECOSYSTEMS; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; He F., 2011, THESIS; Hobbs R. J., 2013, NOVEL ECOSYSTEMS DO; Jackson S. T., P NATL ACAD SCI U S2, V106, P19685; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; Johnstone JF, 2016, FRONT ECOL ENVIRON, V14, P369, DOI 10.1002/fee.1311; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Liu ZY, 2014, P NATL ACAD SCI USA, V111, pE3501, DOI 10.1073/pnas.1407229111; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; Meehl GA, 2012, J CLIMATE, V25, P3661, DOI 10.1175/JCLI-D-11-00240.1; Midgley GF, 2015, NAT CLIM CHANGE, V5, P823, DOI [10.1038/NCLIMATE2753, 10.1038/nclimate2753]; Millar CI, 2015, SCIENCE, V349, P823, DOI 10.1126/science.aaa9933; Millennium, 2005, EC HUM WELL BEING SY; OVERPECK JT, 1990, NATURE, V343, P51, DOI 10.1038/343051a0; Parmesan C, 2015, ANN BOT-LONDON, V116, P849, DOI 10.1093/aob/mcv169; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271; Shakun JD, 2010, QUATERNARY SCI REV, V29, P1801, DOI 10.1016/j.quascirev.2010.03.016; United Nations Framework Convention on Climate Change (UNFCCC), 2014, UN FRAM CONV CLIM CH; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Williams JW, 2002, GEOLOGY, V30, P971, DOI 10.1130/0091-7613(2002)030<0971:RAWVRT>2.0.CO;2; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986	42	195	201	82	399	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					920	923		10.1126/science.aan5360	http://dx.doi.org/10.1126/science.aan5360			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166491	Green Accepted, Green Submitted			2022-12-28	WOS:000443547000039
J	Moss, S				Moss, Sherry			Research is set up for bullies to thrive	NATURE			English	Editorial Material									[Moss, Sherry] Wake Forest Univ, Bowman Gray Sch Med, Org Studies, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest Baptist Medical Center	Moss, S (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Org Studies, Winston Salem, NC 27109 USA.	mosss@wfu.edu						[Anonymous], 2007, ACAD MANAGE J; Kouchaki M, 2015, J APPL PSYCHOL, V100, P360, DOI 10.1037/a0037796; Neuman, 2010, ADM THEORY PRAXIS, V32, P48, DOI DOI 10.2753/ATP1084-1806320103	3	13	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					529	529		10.1038/d41586-018-06040-w	http://dx.doi.org/10.1038/d41586-018-06040-w			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS0SZ	30154542	Bronze			2022-12-28	WOS:000443218600014
J	Slavitt, A				Slavitt, Andy			Work Requirements for Health Coverage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Slavitt, Andy] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services	Slavitt, A (corresponding author), Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA.	andy.slavitt@gmail.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					746	747		10.1001/jama.2018.11492	http://dx.doi.org/10.1001/jama.2018.11492			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167684	Bronze			2022-12-28	WOS:000442958800003
J	La Placa, M; Chessa, MA				La Placa, Michelangelo; Chessa, Marco Adriano			Erythema multiforme major with swollen lips and crusted erosions	LANCET			English	Editorial Material									[La Placa, Michelangelo; Chessa, Marco Adriano] Univ Bologna, Dept Expt Diagnost & Specialty Med, Div Dermatol, I-40138 Bologna, Italy	University of Bologna	La Placa, M (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Div Dermatol, I-40138 Bologna, Italy.	michelangelo.laplaca@unibo.it	La Placa, Michelangelo/U-7723-2018; Chessa, Marco Adriano/AAN-3310-2020	La Placa, Michelangelo/0000-0002-6894-3350; Chessa, Marco Adriano/0000-0002-0149-8870					0	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2018	392	10147					592	592		10.1016/S0140-6736(18)31770-7	http://dx.doi.org/10.1016/S0140-6736(18)31770-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ8MN	30152391				2022-12-28	WOS:000442009500024
J	Kruk, ME; Gage, AD; Joseph, NT; Danaei, G; Garcia-Saiso, S; Salomon, JA				Kruk, Margaret E.; Gage, Anna D.; Joseph, Naima T.; Danaei, Goodarz; Garcia-Saiso, Sebastian; Salomon, Joshua A.			Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries	LANCET			English	Article							FOLLOW-UP; CARE; OUTCOMES; BURDEN; INEQUALITIES; CHILDHOOD; PROGRESS; NATIONS; ACCESS; INDEX	Background Universal health coverage has been proposed as a strategy to improve health in low-income and middle income countries (LMIC5). However, this is contingent on the provision of good-quality health care. We estimate the excess mortality for conditions targeted in the Sustainable Development Goals (SDG) that are amenable to health care and the portion of this excess mortality due to poor-quality care in 137 LMICs, in which excess mortality refers to deaths that could have been averted in settings with strong health systems. Methods Using data from the 2016 Global Burden of Disease study, we calculated mortality amenable to personal health care for 61 SDG conditions by comparing case fatality between each LMIC with corresponding numbers from 23 high-income reference countries with strong health systems. We used data on health-care utilisation from population surveys to separately estimate the portion of amenable mortality attributable to non-utilisation of health care versus that attributable to receipt of poor-quality care. Findings 15.6 million excess deaths from 61 conditions occurred in LMICs in 2016. After excluding deaths that could be prevented through public health measures, 8.6 million excess deaths were amenable to health care of which 5.0 million were estimated to be due to receipt of poor-quality care and 3.6 million were due to non-utilisation of health care. Poor quality of health care was a major driver of excess mortality across conditions, from cardiovascular disease and injuries to neonatal and communicable disorders. Interpretation Universal health coverage for SDG conditions could avert 8.6 million deaths per year but only if expansion of service coverage is accompanied by investments into high-quality health systems. Funding Bill & Melinda Gates Foundation. Copyright (C) 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Kruk, Margaret E.; Gage, Anna D.; Danaei, Goodarz] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Joseph, Naima T.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; [Garcia-Saiso, Sebastian] Minist Hlth, Mexico City, DF, Mexico; [Salomon, Joshua A.] Stanford Univ, Sch Med, Ctr Hlth Policy, Stanford, CA 94305 USA; [Salomon, Joshua A.] Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Harvard University; Harvard T.H. Chan School of Public Health; Emory University; Stanford University; Stanford University	Kruk, ME (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	mkruk@hsph.harvard.edu	Salomon, Joshua/S-1929-2019; Gage, Anna/ABC-1778-2020	Salomon, Joshua/0000-0003-3929-5515; Gage, Anna/0000-0002-4422-0545; Joseph, Naima/0000-0001-6021-1609; Garcia-Saiso, Sebastian/0000-0003-4455-3080	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Bill & Melinda Gates Foundation.	Abajobir AA, 2016, MEASURING PROGR PROJ; Alkire BC, 2018, HEALTH AFFAIR, V37, P988, DOI 10.1377/hlthaff.2017.1233; Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Biccard BM, 2018, LANCET, V391, P1589, DOI [10.1016/S0140-6736(18)30001-1, 10.1016/s0140-6736(18)30001-1]; Boerma T, 2018, LANCET, V391, P1538, DOI 10.1016/S0140-6736(18)30104-1; Cazabon D, 2017, INT J INFECT DIS, V56, P111, DOI 10.1016/j.ijid.2016.10.016; Chang CY, 2016, EMERG MED J, V33, P794, DOI 10.1136/emermed-2016-205709; Chaturvedi S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-174; Dare AJ, 2015, LANCET GLOB HEALTH, V3, pE646, DOI 10.1016/S2214-109X(15)00079-0; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Egbujie BA, 2018, SAMJ S AFR MED J, V108, P311, DOI [10.7196/SAMJ.2017.v108i4.12583, 10.7196/samj.2018.v108i4.12583]; ESCOBAR ML, 2011, IMPACT HLTH INSURANC; Evans DB, 2013, B WORLD HEALTH ORGAN, V91, P546, DOI 10.2471/BLT.13.125450; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Hogan DR, 2018, LANCET GLOB HEALTH, V6, pE152, DOI 10.1016/S2214-109X(17)30472-2; Holland WW, 1988, EUROPEAN COMMUNITY A; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Kruk ME, 2017, B WORLD HEALTH ORGAN, V95, P408, DOI [10.2471/BLT.16.175869, 10.2471/blt.16.175869]; Kruk ME, 2016, LANCET GLOB HEALTH, V4, pE845, DOI [10.1016/s2214-109x(16)30180-2, 10.1016/S2214-109X(16)30180-2]; Kruk ME, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-27; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Mohanan M, 2015, JAMA PEDIATR, V169, P349, DOI 10.1001/jamapediatrics.2014.3445; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Ng M, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24939; Nolte E, 2003, BRIT MED J, V327, P1129, DOI 10.1136/bmj.327.7424.1129; Nolte E, 2002, SOC SCI MED, V55, P1905, DOI 10.1016/S0277-9536(01)00320-3; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Nolte E, 2012, HEALTH AFFAIR, V31, P2114, DOI 10.1377/hlthaff.2011.0851; Nolte E, 2011, HEALTH POLICY, V103, P47, DOI 10.1016/j.healthpol.2011.08.002; Powell-Jackson T, 2015, J HEALTH ECON, V43, P154, DOI 10.1016/j.jhealeco.2015.07.001; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Simonato L, 1998, J EPIDEMIOL COMMUN H, V52, P624, DOI 10.1136/jech.52.10.624; Siril HN, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0145-z; Sommers BD, 2017, NEW ENGL J MED, V377, P586, DOI 10.1056/NEJMsb1706645; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; United Nations, 2015, SUST DEV GOALS; Vapattanawong P, 2007, LANCET, V369, P850, DOI 10.1016/S0140-6736(07)60413-9; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; World Bank, 2022, WORLD BANK DEV IND; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]; Zurcher K, 2017, TROP MED INT HEALTH, V22, P375, DOI 10.1111/tmi.12843; 2010, WORLD HLTH REP, P1	44	186	194	6	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2018	392	10160					2203	2212		10.1016/S0140-6736(18)31668-4	http://dx.doi.org/10.1016/S0140-6736(18)31668-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HA5ZQ	30195398	hybrid, Green Published			2022-12-28	WOS:000450358900032
J	Schwartz, J				Schwartz, Joel			"Transparency" as Mask? The EPA's Proposed Rule on Scientific Data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MORTALITY		[Schwartz, Joel] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Schwartz, Joel] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Schwartz, J (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.; Schwartz, J (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.							Curtis Andrew J, 2006, Int J Health Geogr, V5, P44, DOI 10.1186/1476-072X-5-44; National Research Council, 2002, ACC RES DAT 21 CENT; Pinault L, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0111-6; Sweeney L., 2017, TECHNOLOGY SCI, P1329; Vodonos A, 2018, ENVIRON RES, V166, P677, DOI 10.1016/j.envres.2018.06.021	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2018	379	16					1496	1497		10.1056/NEJMp1807751	http://dx.doi.org/10.1056/NEJMp1807751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX4EI	30156992				2022-12-28	WOS:000447679900004
J	Sun, JH; Zhou, LD; Emerson, DJ; Phyo, SA; Titus, KR; Gong, WF; Gilgenast, TG; Beagan, JA; Davidson, BL; Tassone, F; Phillips-Cremins, JE				Sun, James H.; Zhou, Linda; Emerson, Daniel J.; Phyo, Sai A.; Titus, Katelyn R.; Gong, Wanfeng; Gilgenast, Thomas G.; Beagan, Jonathan A.; Davidson, Beverly L.; Tassone, Flora; Phillips-Cremins, Jennifer E.			Disease-Associated Short Tandem Repeats Co-localize with Chromatin Domain Boundaries	CELL			English	Article							FRAGILE-X-SYNDROME; TRINUCLEOTIDE REPEATS; HUNTINGTONS-DISEASE; LINEAGE COMMITMENT; MYOTONIC-DYSTROPHY; DNA METHYLATION; HUMAN GENOME; CTG REPEAT; GENE; CTCF	More than 25 inherited human disorders are caused by the unstable expansion of repetitive DNA sequences termed short tandem repeats (STRs). A fundamental unresolved question is why some STRs are susceptible to pathologic expansion, whereas thousands of repeat tracts across the human genome are relatively stable. Here, we discover that nearly all disease-associated STRs (daSTRs) are located at boundaries demarcating 3D chromatin domains. We identify a subset of boundaries with markedly higher CpG island density compared to the rest of the genome. daSTRs specifically localize to ultra-high-density CpG island boundaries, suggesting they might be hotspots for epigenetic misregulation or topological disruption linked to STR expansion. Fragile X syndrome patients exhibit severe boundary disruption in a manner that correlates with local loss of CTCF occupancy and the degree of FMR1 silencing. Our data uncover higher-order chromatin architecture as a new dimension in understanding repeat expansion disorders.	[Sun, James H.; Zhou, Linda; Emerson, Daniel J.; Phyo, Sai A.; Titus, Katelyn R.; Gong, Wanfeng; Gilgenast, Thomas G.; Beagan, Jonathan A.; Phillips-Cremins, Jennifer E.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Zhou, Linda] Univ Penn, Perelman Sch Med, Genom & Computat Biol Program, Philadelphia, PA 19104 USA; [Sun, James H.; Zhou, Linda; Phyo, Sai A.; Beagan, Jonathan A.; Phillips-Cremins, Jennifer E.] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA; [Davidson, Beverly L.] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Davidson, Beverly L.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Tassone, Flora] Univ Calif Davis, Biochem & Mol Med, Sacramento, CA 95616 USA; [Tassone, Flora] Univ Calif Davis, MIND Inst, Sacramento, CA 95616 USA; [Phillips-Cremins, Jennifer E.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of California System; University of California Davis; University of California System; University of California Davis; University of Pennsylvania	Phillips-Cremins, JE (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Phillips-Cremins, JE (corresponding author), Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA.; Phillips-Cremins, JE (corresponding author), Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.	jcremins@seas.upenn.edu		Titus, Katelyn/0000-0002-8594-729X; Phillips-Cremins, Jennifer/0000-0002-4702-0450; Davidson, Beverly/0000-0002-3715-6290; Sun, James/0000-0002-9254-4245	New York Stem Cell Foundation; Alfred P. Sloan Foundation; NIH Director's New Innovator Award [1DP2MH11024701]; 4D Nucleome Common Fund [1U01HL12999801]; NIH [R01 GM113929]; NSF-NIGMS [1562665]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954, U01HL129998] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP2MH110247] Funding Source: NIH RePORTER	New York Stem Cell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 4D Nucleome Common Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	J.E.P.-C. is a New York Stem Cell Foundation (NYSCF) Robertson Investigator and an Alfred P. Sloan Foundation Fellow. This research was funded by The New York Stem Cell Foundation (J.E.P.-C.), the Alfred P. Sloan Foundation (J.E.P.-C.), the NIH Director's New Innovator Award (1DP2MH11024701 to J.E.P.-C.), a 4D Nucleome Common Fund grant (1U01HL12999801 to J.E.P.-C.), the NIH (R01 GM113929 to F.T.), and a joint NSF-NIGMS grant to support research at the interface of the biological and mathematical sciences (1562665 to J.E.P.-C.).	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beagan JA, 2017, GENOME RES, V27, P1139, DOI 10.1101/gr.215160.116; Beagan JA, 2016, CELL STEM CELL, V18, P611, DOI 10.1016/j.stem.2016.04.004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brock GJR, 1999, HUM MOL GENET, V8, P1061, DOI 10.1093/hmg/8.6.1061; Burman RW, 1999, AM J HUM GENET, V65, P1375, DOI 10.1086/302628; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Du ZH, 2017, NATURE, V547, P232, DOI 10.1038/nature23263; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Gymrek M, 2016, NAT GENET, V48, P22, DOI 10.1038/ng.3461; Gymrek M, 2013, METHODS MOL BIOL, V1038, P113, DOI 10.1007/978-1-62703-514-9_7; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Iyer RR, 2015, ANNU REV BIOCHEM, V84, P199, DOI 10.1146/annurev-biochem-060614-034010; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; Libby RT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000257; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Norton H. K., 2016, BIORXIV, DOI [10.1101/089011, DOI 10.1101/089011]; Norton HK, 2018, NAT METHODS, V15, P119, DOI 10.1038/nmeth.4560; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Park CY, 2015, CELL REP, V13, P234, DOI 10.1016/j.celrep.2015.08.084; Pearson CE, 2003, TRENDS MOL MED, V9, P490, DOI 10.1016/j.molmed.2003.09.006; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Sopher BL, 2011, NEURON, V70, P1071, DOI 10.1016/j.neuron.2011.05.027; Steinbach P, 1998, AM J HUM GENET, V62, P278, DOI 10.1086/301711; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wohrle D, 1998, J MED GENET, V35, P103, DOI 10.1136/jmg.35.2.103; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; Wohrle D, 2001, AM J HUM GENET, V69, P504, DOI 10.1086/322739; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; WONG LJC, 1995, AM J HUM GENET, V56, P114; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; ZHANG L, 1994, NAT GENET, V7, P531, DOI 10.1038/ng0894-531; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	63	93	94	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	2018	175	1					224	+		10.1016/j.cell.2018.08.005	http://dx.doi.org/10.1016/j.cell.2018.08.005			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GU2SI	30173918	Green Accepted, Bronze			2022-12-28	WOS:000445120000026
J	Blankenberg, S; Neumann, JT; Westermann, D				Blankenberg, Stefan; Neumann, Johannes Tobias; Westermann, Dirk			Diagnosing myocardial infarction: a highly sensitive issue	LANCET			English	Editorial Material							CARDIAC TROPONIN-I; VALIDATION; OUTCOMES		[Blankenberg, Stefan; Neumann, Johannes Tobias; Westermann, Dirk] Univ Heart Ctr Hamburg, D-20249 Hamburg, Germany; [Blankenberg, Stefan; Neumann, Johannes Tobias; Westermann, Dirk] German Ctr Cardiovasc Res DZHK, Dept Gen & Intervent Cardiol, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research	Blankenberg, S (corresponding author), Univ Heart Ctr Hamburg, D-20249 Hamburg, Germany.; Blankenberg, S (corresponding author), German Ctr Cardiovasc Res DZHK, Dept Gen & Intervent Cardiol, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany.	s.blankenberg@uke.de	Westermann, Dirk/D-1344-2011; Neumann, Johannes/AAW-6131-2020	Neumann, Johannes/0000-0002-9478-2757; Blankenberg, Stefan/0000-0001-6488-2362; Westermann, Dirk/0000-0002-7542-1956				Blankenberg S, 2016, EUR HEART J, V37, P2428, DOI 10.1093/eurheartj/ehw172; Chapman AR, 2017, JAMA-J AM MED ASSOC, V318, P1913, DOI 10.1001/jama.2017.17488; Cullen L, 2013, J AM COLL CARDIOL, V62, P1242, DOI 10.1016/j.jacc.2013.02.078; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Neumann JT, 2016, JAMA CARDIOL, V1, P397, DOI 10.1001/jamacardio.2016.0695; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Sandoval Y, 2017, CLIN CHEM, V63, P1594, DOI 10.1373/clinchem.2017.272930; Shah ASV, 2018, LANCET, V392, P919, DOI 10.1016/S0140-6736(18)31923-8; Twerenbold R, 2018, J AM COLL CARDIOL, V72, P620, DOI 10.1016/j.jacc.2018.05.040; Westermann D, 2017, NAT REV CARDIOL, V14, P472, DOI 10.1038/nrcardio.2017.48	10	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2018	392	10151					893	894		10.1016/S0140-6736(18)31996-2	http://dx.doi.org/10.1016/S0140-6736(18)31996-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT4LN	30170849	hybrid			2022-12-28	WOS:000444475700004
J	Shah, ASV; Anand, A; Strachan, FE; Ferry, AV; Lee, KK; Chapman, AR; Sandeman, D; Stables, CL; Adamson, PD; Andrews, JPM; Anwar, MS; Hung, J; Moss, AJ; O'Brien, R; Berry, C; Findlay, I; Walker, S; Cruickshank, A; Reid, A; Gray, A; Collinson, PO; Apple, FS; McAllister, DA; Maguire, D; Fox, KAA; Newby, DE; Tuck, C; Harkess, R; Parker, RA; Keerie, C; Weir, CJ; Mills, NL				Shah, Anoop S. V.; Anand, Atul; Strachan, Fiona E.; Ferry, Amy V.; Lee, Kuan Ken; Chapman, Andrew R.; Sandeman, Dennis; Stables, Catherine L.; Adamson, Philip D.; Andrews, Jack P. M.; Anwar, Mohamed S.; Hung, John; Moss, Alistair J.; O'Brien, Rachel; Berry, Colin; Findlay, Iain; Walker, Simon; Cruickshank, Anne; Reid, Alan; Gray, Alasdair; Collinson, Paul O.; Apple, Fred S.; McAllister, David A.; Maguire, Donogh; Fox, Keith A. A.; Newby, David E.; Tuck, Christopher; Harkess, Ronald; Parker, Richard A.; Keerie, Catriona; Weir, Christopher J.; Mills, Nicholas L.		High-STEACS Investigators	High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIAC TROPONIN; EARLY-DIAGNOSIS; RULE-OUT; I ASSAY; OUTCOMES; IMPLEMENTATION; RISK	Background High-sensitivity cardiac troponin assays permit use of lower thresholds for the diagnosis of myocardial infarction, but whether this improves clinical outcomes is unknown. We aimed to determine whether the introduction of a high-sensitivity cardiac troponin I (hs-cTnI) assay with a sex-specific 99th centile diagnostic threshold would reduce subsequent myocardial infarction or cardiovascular death in patients with suspected acute coronary syndrome. Methods In this stepped-wedge, cluster-randomised controlled trial across ten secondary or tertiary care hospitals in Scotland, we evaluated the implementation of an hs-cTnI assay in consecutive patients who had been admitted to the hospitals' emergency departments with suspected acute coronary syndrome. Patients were eligible for inclusion if they presented with suspected acute coronary syndrome and had paired cardiac troponin measurements from the standard care and trial assays. During a validation phase of 6-12 months, results from the hs-cTnI assay were concealed from the attending clinician, and a contemporary cardiac troponin I (cTnI) assay was used to guide care. Hospitals were randomly allocated to early (n=5 hospitals) or late (n=5 hospitals) implementation, in which the high sensitivity assay and sex-specific 99th centile diagnostic threshold was introduced immediately after the 6-month validation phase or was deferred for a further 6 months. Patients reclassified by the high-sensitivity assay were defined as those with an increased hs-cTnI concentration in whom cTnI concentrations were below the diagnostic threshold on the contemporary assay. The primary outcome was subsequent myocardial infarction or death from cardiovascular causes at 1 year after initial presentation. Outcomes were compared in patients reclassified by the high-sensitivity assay before and after its implementation by use of an adjusted generalised linear mixed model. This trial is registered with ClinicalTrials.gov, number NCT0185 2123. Findings Between June 10, 2013, and March 3, 2016, we enrolled 48 282 consecutive patients (61 [SD 17] years, 47% women) of whom 10 360 (21%) patients had cTnI concentrations greater than those of the 99th centile of the normal range of values, who were identified by the contemporary assay or the high-sensitivity assay. The high sensitivity assay reclassified 1771 (17%) of 10 360 patients with myocardial injury or infarction who were not identified by the contemporary assay. In those reclassified, subsequent myocardial infarction or cardiovascular death within 1 year occurred in 105 (15%) of 720 patients in the validation phase and 131 (12%) of1051 patients in the implementation phase (adjusted odds ratio for implementation vs validation phase 1.10, 95% CI 0.75 to 1.61; p=0.620). Interpretation Use of a high-sensitivity assay prompted reclassification of 1771 (17%) of 10 360 patients with myocardial injury or infarction, but was not associated with a lower subsequent incidence of myocardial infarction or cardiovascular death at 1 year. Our findings question whether the diagnostic threshold for myocardial infarction should be based on the 99th centile derived from a normal reference population. Funding The British Heart Foundation. Copyright (C) 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Shah, Anoop S. V.; Anand, Atul; Strachan, Fiona E.; Ferry, Amy V.; Lee, Kuan Ken; Chapman, Andrew R.; Stables, Catherine L.; Adamson, Philip D.; Andrews, Jack P. M.; Anwar, Mohamed S.; Hung, John; Moss, Alistair J.; Fox, Keith A. A.; Newby, David E.; Mills, Nicholas L.] Univ Edinburgh, British Heart Fdn, Ctr Cardiovasc Sci, Edinburgh EH16 4SA, Midlothian, Scotland; [Shah, Anoop S. V.; Mills, Nicholas L.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Tuck, Christopher; Harkess, Ronald; Parker, Richard A.; Keerie, Catriona; Weir, Christopher J.] Univ Edinburgh, Edinburgh Clin Trials Unit, Edinburgh, Midlothian, Scotland; [Sandeman, Dennis] Victoria Hosp, Dept Cardiol, Kirkcaldy, England; [O'Brien, Rachel; Gray, Alasdair] Royal Infirm Edinburgh NHS Trust, Emergency Med Res Grp Edinburgh, Edinburgh, Midlothian, Scotland; [Walker, Simon] Royal Infirm Edinburgh NHS Trust, Dept Clin Biochem, Edinburgh, Midlothian, Scotland; [Berry, Colin] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [McAllister, David A.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Findlay, Iain] Royal Alexandra Hosp, Dept Cardiol, Paisley, Renfrew, Scotland; [Cruickshank, Anne; Reid, Alan] Queen Elizabeth Univ Hosp, Dept Biochem, Glasgow, Lanark, Scotland; [Collinson, Paul O.] St Georges Univ Hosp NHS Trust, Dept Clin Blood Sci, London, England; [Collinson, Paul O.] St Georges Univ Hosp NHS Trust, Dept Cardiol, London, England; [Collinson, Paul O.] St Georges Univ, London, England; [Apple, Fred S.] Hennepin Cty Med Ctr, Dept Lab Med & Pathol, Minneapolis, MN 55415 USA; [Apple, Fred S.] Univ Minnesota, Minneapolis, MN USA; [Maguire, Donogh] Glasgow Royal Infirm, Emergency Med Dept, Glasgow, Lanark, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Glasgow; University of Glasgow; Queen Elizabeth University Hospital (QEUH); St Georges University London; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Glasgow	Mills, NL (corresponding author), Univ Edinburgh, British Heart Fdn, Ctr Cardiovasc Sci, Edinburgh EH16 4SA, Midlothian, Scotland.	nick.mills@ed.ac.uk	Adamson, Philip/AAC-3699-2019; Anand, Atul/ABC-1393-2020; Newby, David Ernest/AAB-1364-2019; Fox, keith A A/I-3742-2013	Adamson, Philip/0000-0002-6177-956X; Anand, Atul/0000-0002-6428-4554; Stables, Catherine/0000-0002-5173-3090; Vallejos, Catalina/0000-0003-3638-1960; Mills, Nicholas/0000-0003-0533-7991; Tsanas, Athanasios/0000-0002-0994-8100; Tuck, Christopher/0000-0003-4994-6342; Shah, Anoop/0000-0002-2825-3419; Fox, Keith/0000-0002-0140-2752; Chapman, Andrew/0000-0003-1926-5925; Moss, Alastair/0000-0003-4123-2070; Weir, Christopher/0000-0002-6494-4903; Keerie, Catriona/0000-0001-5459-6178	British Heart Foundation [SP/12/10/29922]; British Heart Foundation Centre for Research Excellence [RE/13/3/30183]; NHS Lothian through the Edinburgh Clinical Trials Unit; Butler Senior Clinical Research Fellowship, from the British Heart Foundation [FS/16/14/32023]	British Heart Foundation(British Heart Foundation); British Heart Foundation Centre for Research Excellence; NHS Lothian through the Edinburgh Clinical Trials Unit; Butler Senior Clinical Research Fellowship, from the British Heart Foundation	This trial was funded by the British Heart Foundation (SP/12/10/29922) with support from the British Heart Foundation Centre for Research Excellence (RE/13/3/30183). CJW was supported by NHS Lothian through the Edinburgh Clinical Trials Unit. Abbott Laboratories provided cardiac troponin assay reagents, calibrators, and controls without charge. NLM is supported by the Butler Senior Clinical Research Fellowship (FS/16/14/32023), from the British Heart Foundation. We would like to thank researchers from the Emergency Medicine Research Group of Edinburgh for their support during the conduct of this trial.	Anand A, 2018, BIORXIV, DOI [10.1101/371138, DOI 10.1101/371138]; [Anonymous], 2013, SCOTT INT GUID NETW; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Bagai A, 2017, AM HEART J, V190, P135, DOI 10.1016/j.ahj.2017.04.016; Body R, 2011, J AM COLL CARDIOL, V58, P1333, DOI 10.1016/j.jacc.2011.06.026; Boeddinghaus J, 2016, CLIN CHEM, V62, P494, DOI 10.1373/clinchem.2015.249508; Chapman AR, 2018, CIRCULATION, V137, P1236, DOI 10.1161/CIRCULATIONAHA.117.031806; Chapman AR, 2017, JAMA-J AM MED ASSOC, V318, P1913, DOI 10.1001/jama.2017.17488; Chapman AR, 2017, CIRCULATION, V135, P1586, DOI 10.1161/CIRCULATIONAHA.116.025021; Christ M, 2010, AM J MED, V123, P1134, DOI 10.1016/j.amjmed.2010.07.015; Eggers KM, 2016, EUR HEART J, V37, P2417, DOI 10.1093/eurheartj/ehw029; Ford I, 2016, NEW ENGL J MED, V375, P454, DOI 10.1056/NEJMra1510059; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Holzmann M, 2018, J AM COLL CARDIOL, V71, P238, DOI [10.1016/S0735-1097(18)30779-4, 10.1016/j.jacc.2018.03.515]; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Kimenai DM, 2018, CLIN CHEM, V64, P1034, DOI 10.1373/clinchem.2018.286781; Miller-Hodges E, 2018, CIRCULATION, V137, P425, DOI 10.1161/CIRCULATIONAHA.117.030320; Mills NL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1533; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; Nejatian A, 2017, J AM COLL CARDIOL, V69, P2622, DOI 10.1016/j.jacc.2017.03.586; Neumann JT, 2017, CLIN CHEM, V63, P394, DOI 10.1373/clinchem.2016.262659; Neumann JT, 2016, JAMA CARDIOL, V1, P397, DOI 10.1001/jamacardio.2016.0695; Newby D, 2015, LANCET, V385, P2383, DOI 10.1016/S0140-6736(15)60291-4; NHS National Services Scotland Information Services Division National Statistics, 2018, SCOTT HEART DIS STAT; Pickering JW, 2017, ANN INTERN MED, V166, P715, DOI 10.7326/M16-2562; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Reichlin T, 2012, ARCH INTERN MED, V172, P1211, DOI 10.1001/archinternmed.2012.3698; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Gimenez MR, 2015, AM J MED, V128, P861, DOI 10.1016/j.amjmed.2015.01.046; Sandoval Y, 2017, AM J MED, V130, P1431, DOI 10.1016/j.amjmed.2017.05.049; Shah ASV, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4788; Shah ASV, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0839-9; Shah ASV, 2015, LANCET, V386, P2481, DOI 10.1016/S0140-6736(15)00391-8; Shah ASV, 2015, AM J MED, V128, P493, DOI 10.1016/j.amjmed.2014.10.056; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h626, 10.1136/bmj.g7873]; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Twerenbold R, 2016, EUR HEART J, V37, P3324, DOI 10.1093/eurheartj/ehw232; Twerenbold R, 2015, CIRCULATION, V131, P2041, DOI 10.1161/CIRCULATIONAHA.114.014245	39	183	188	3	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2018	392	10151					919	928		10.1016/S0140-6736(18)31923-8	http://dx.doi.org/10.1016/S0140-6736(18)31923-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4LN	30170853	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000444475700024
J	Sun, TY				Sun, Thomas Yang			To Be Guided by Instinct	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sun, Thomas Yang] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Sun, TY (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.		Sun, Thomas/AAG-4824-2020	Sun, Thomas Yang/0000-0001-7436-0138					0	0	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					1004	1005		10.1056/NEJMp1805651	http://dx.doi.org/10.1056/NEJMp1805651			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT4UV	30207908				2022-12-28	WOS:000444501600004
J	Dyer, C				Dyer, Clare			Anaesthetist suspended after GMC appeal to High Court	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2018	362								k3854	10.1136/bmj.k3854	http://dx.doi.org/10.1136/bmj.k3854			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JC	30201659				2022-12-28	WOS:000445015400012
J	Lehmann, R				Lehmann, Ruth			Matchmaking molecule for egg and sperm	SCIENCE			English	Editorial Material							MAMMALIAN FERTILIZATION; RECEPTOR; JUNO; SUPERFAMILY; IZUMO1		[Lehmann, Ruth] NYU, Sch Med, Dept Cell Biol, Howard Hughes Med Inst,Skirball Inst Biomol Med, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University	Lehmann, R (corresponding author), NYU, Sch Med, Dept Cell Biol, Howard Hughes Med Inst,Skirball Inst Biomol Med, New York, NY 10016 USA.	ruth.lehmann@med.nyu.edu		Lehmann, Ruth/0000-0002-8454-5651				Aydin H, 2016, NATURE, V534, P562, DOI 10.1038/nature18595; Bianchi E, 2016, ANNU REV GENET, V50, P93, DOI 10.1146/annurev-genet-121415-121834; Bianchi E, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0101; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Chalbi M, 2014, DEVELOPMENT, V141, P3732, DOI 10.1242/dev.111534; Herberg S, 2018, SCIENCE, V361, P1029, DOI 10.1126/science.aat7113; Hertwig O., 1875, MORPHOL JB, V1, P347, DOI [10.2307/1411521, DOI 10.2307/1411521]; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Ohto U, 2016, NATURE, V534, P566, DOI 10.1038/nature18596; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Shetty J, 2003, J BIOL CHEM, V278, P30506, DOI 10.1074/jbc.M301713200; Wassarman PM, 2018, CURR TOP DEV BIOL, V130, P331, DOI 10.1016/bs.ctdb.2018.01.003	12	1	1	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					974	975		10.1126/science.aau8356	http://dx.doi.org/10.1126/science.aau8356			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS7OT	30190390				2022-12-28	WOS:000443892700026
J	Ramos, R; Comas-Cufi, M; Marti-Lluch, R; Ballo, E; Ponjoan, A; Alves-Cabratosa, L; Blanch, J; Marrugat, J; Elosua, R; Grau, M; Elosua-Bayes, M; Garcia-Ortiz, L; Garcia-Gil, M				Ramos, Rafel; Comas-Cufi, Marc; Marti-Lluch, Ruth; Ballo, Elisabeth; Ponjoan, Anna; Alves-Cabratosa, Lia; Blanch, Jordi; Marrugat, Jaume; Elosua, Roberto; Grau, Maria; Elosua-Bayes, Marc; Garcia-Ortiz, Luis; Garcia-Gil, Maria			Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; MYOCARDIAL-INFARCTION; PRIMARY-CARE; ELDERLY-PATIENTS; RISK; THERAPY; PRAVASTATIN; POPULATION; BENEFITS	OBJECTIVE To assess whether statin treatment is associated with a reduction in atherosclerotic cardiovascular disease (CVD) and mortality in old and very old adults with and without diabetes. DESIGN Retrospective cohort study. SETTING Database of the Catalan primary care system (SIDIAP), Spain, 2006-15. PARTICIPANTS 46 864 people aged 75 years or more without clinically recognised atherosclerotic CVD. Participants were stratified by presence of type 2 diabetes mellitus and as statin non-users or new users. MAIN OUTCOME MEASURES Incidences of atherosclerotic CVD and all cause mortality compared using Cox proportional hazards modelling, adjusted by the propensity score of statin treatment. The relation of age with the effect of statins was assessed using both a categorical approach, stratifying the analysis by old (75-84 years) and very old (>= 85 years) age groups, and a continuous analysis, using an additive Cox proportional hazard model. RESULTS The cohort included 46 864 participants (mean age 77 years; 63% women; median follow-up 5.6 years). In participants without diabetes, the hazard ratios for statin use in 75-84 year olds were 0.94 (95% confidence interval 0.86 to 1.04) for atherosclerotic CVD and 0.98 (0.91 to 1.05) for all cause mortality, and in those aged 85 and older were 0.93 (0.82 to 1.06) and 0.97 (0.90 to 1.05), respectively. In participants with diabetes, the hazard ratio of statin use in 75-84 year olds was 0.76 (0.65 to 0.89) for atherosclerotic CVD and 0.84 (0.75 to 0.94) for all cause mortality, and in those aged 85 and older were 0.82 (0.53 to 1.26) and 1.05 (0.86 to 1.28), respectively. Similarly, effect analysis of age in a continuous scale, using splines, corroborated the lack of beneficial statins effect for atherosclerotic CVD and all cause mortality in participants without diabetes older than 74 years. In participants with diabetes, statins showed a protective effect against atherosclerotic CVD and all cause mortality; this effect was substantially reduced beyond the age of 85 years and disappeared in nonagenarians. CONCLUSIONS In participants older than 74 years without type 2 diabetes, statin treatment was not associated with a reduction in atherosclerotic CVD or in all cause mortality, even when the incidence of atherosclerotic CVD was statistically significantly higher than the risk thresholds proposed for statin use. In the presence of diabetes, statin use was statistically significantly associated with reductions in the incidence of atherosclerotic CVD and in all cause mortality. This effect decreased after age 85 years and disappeared in nonagenarians.	[Ramos, Rafel; Comas-Cufi, Marc; Marti-Lluch, Ruth; Ballo, Elisabeth; Ponjoan, Anna; Alves-Cabratosa, Lia; Blanch, Jordi; Elosua-Bayes, Marc] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Catalonia, Spain; [Ramos, Rafel; Comas-Cufi, Marc; Marti-Lluch, Ruth; Ballo, Elisabeth; Ponjoan, Anna; Alves-Cabratosa, Lia; Blanch, Jordi; Elosua-Bayes, Marc; Garcia-Gil, Maria] Catalan Inst Hlth, ISV Res Grp, Primary Care Serv, Res Unit Primary Care, Girona, Catalonia, Spain; [Ramos, Rafel; Marti-Lluch, Ruth; Ballo, Elisabeth; Ponjoan, Anna; Garcia-Gil, Maria] Inst Invest Biomed Girona IdIBGi, Catalonia, Spain; [Ramos, Rafel; Ballo, Elisabeth; Garcia-Gil, Maria] Univ Girona, Sch Med, Dept Med Sci, Girona, Spain; [Marrugat, Jaume; Elosua, Roberto; Grau, Maria] Registre Gironi COR Grp REGICOR, Barcelona, Spain; [Marrugat, Jaume; Elosua, Roberto; Grau, Maria] Municipal Inst Med Res IMIM, Epidemiol & Genet Res Grp EGEC, Cardiovasc, Barcelona, Spain; [Marrugat, Jaume; Elosua, Roberto; Grau, Maria] CIBER Cardiovasc Dis, Barcelona, Spain; [Garcia-Ortiz, Luis] Univ Salamanca, Castilla & Leon Hlth Serv SACYL, Inst Biomed Res Salamanca, Alamedilla Hlth Ctr,Primary Care Res Unit, Salamanca, Spain; [Garcia-Ortiz, Luis] Univ Salamanca, Dept Biomed & Diagnost Sci, Salamanca, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; University of Salamanca; University of Salamanca	Ramos, R (corresponding author), Carrer Maluquer Salvador 11, Girona 17002, Spain.	rramos.girona.ics@gencat.cat	Ponjoan, Anna/ABA-3221-2020; Grau, Maria/AAX-4625-2021; Ramos, Rafel/D-9627-2016; Blanch, Jordi/U-1407-2019; Alves, Lia/U-1469-2019; Ramos, Rafel/P-2083-2019; Grau, Maria/H-5572-2011; Martí, Ruth/H-8198-2014; Comas-Cufí, Marc/V-5842-2019; Garcia-Gil, Maria/E-5093-2016	Grau, Maria/0000-0003-2807-8136; Ramos, Rafel/0000-0001-7970-5537; Blanch, Jordi/0000-0001-8211-3292; Alves, Lia/0000-0002-5006-952X; Ramos, Rafel/0000-0001-7970-5537; Grau, Maria/0000-0003-2807-8136; Martí, Ruth/0000-0002-7320-9521; Comas-Cufí, Marc/0000-0001-9759-0622; Elosua-Bayes, Marc/0000-0001-5315-815X; Garcia-Gil, Maria/0000-0001-8146-5288; Ballo, Elisabet/0000-0002-5216-0765; Marrugat, Jaume/0000-0003-3320-554X; ELOSUA, ROBERTO/0000-0001-8235-0095	Ministerio de Salud [EC11-267]; Spain's Ministry of Science and Innovation through the Carlos III Health Institute; European Union ERDF funds [RedIAPP RD16/0007/0004, RD12/0042/0061, RD12/0042/0013, CP12/03287]; Departament de Salut, Generalitat de Catalunya, Agency for Management of University and Research Grants [2014 SGR 240, 2017 SGR 1146]	Ministerio de Salud; Spain's Ministry of Science and Innovation through the Carlos III Health Institute; European Union ERDF funds(European Commission); Departament de Salut, Generalitat de Catalunya, Agency for Management of University and Research Grants	This project was supported by clinical research grants from the Ministerio de Salud (EC11-267); Spain's Ministry of Science and Innovation through the Carlos III Health Institute, co-financed with European Union ERDF funds (Network for Prevention and Health Promotion in primary Care (RedIAPP RD16/0007/0004); the Red de Investigacion Cardiovascular (RD12/0042/0061, RD12/0042/0013) and Miguel Servet Contract CP12/03287); and by the Departament de Salut, Generalitat de Catalunya, Agency for Management of University and Research Grants (2014 SGR 240; 2017 SGR 1146). The sponsors had no role in the design and conduct of the study; the collection, management, analysis, or interpretation of the data; or the preparation, review, or approval of the manuscript.	Afilalo J, 2008, J AM COLL CARDIOL, V51, P37, DOI 10.1016/j.jacc.2007.06.063; Ageing WP, 2001, 1950 2050 NEW YORK; [Anonymous], 2016, LIF EXP BIRTH 65 75; [Anonymous], 2018, ID CAT; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Bolibar B, 2012, MED CLIN-BARCELONA, V138, P617, DOI 10.1016/j.medcli.2012.01.020; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Cooney MT, 2016, EUR J PREV CARDIOL, V23, P1093, DOI 10.1177/2047487315588390; Cruz M, 2013, JAMA-J AM MED ASSOC, V309, P874, DOI 10.1001/jama.2013.1184; Dominguez-Berjon MF, 2008, GAC SANIT, V22, P179, DOI 10.1157/13123961; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Ford I, 2016, CIRCULATION, V133, P1073, DOI 10.1161/CIRCULATIONAHA.115.019014; Garcia-Gil M Del Mar, 2011, Inform Prim Care, V19, P135; Garcia-Gil M, 2016, J CLIN LIPIDOL, V10, P134, DOI 10.1016/j.jacl.2015.10.007; Glynn RJ, 2010, ANN INTERN MED, V152, P488, DOI 10.7326/0003-4819-152-8-201004200-00005; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Gotto AM, 2003, CLIN CARDIOL, V26, P3, DOI 10.1002/clc.4960261503; Han BH, 2017, JAMA INTERN MED, V177, P955, DOI 10.1001/jamainternmed.2017.1442; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Howard BV, 2006, DIABETES CARE, V29, P391, DOI 10.2337/diacare.29.02.06.dc05-1299; Hunt D, 2001, ANN INTERN MED, V134, P931, DOI 10.7326/0003-4819-134-10-200105150-00007; Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; Konrat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033559; Lewis SJ, 1998, ANN INTERN MED, V129, P681, DOI 10.7326/0003-4819-129-9-199811010-00002; Marrugat J, 2004, EUR J EPIDEMIOL, V19, P231, DOI 10.1023/B:EJEP.0000020446.57845.b0; McGrath LJ, 2015, AM J EPIDEMIOL, V182, P17, DOI 10.1093/aje/kwu485; McKinney JS, 2012, STROKE, V43, P2149, DOI 10.1161/STROKEAHA.112.655894; Miettinen TA, 1997, CIRCULATION, V96, P4211; National Institute for Health and Care Excellence, 2014, CG181 NICE; NIH. ClinicalTrials. gov, 2014, CLIN TRIAL STATIN TH; O'Keeffe AG, 2016, CLIN EPIDEMIOL, V8, P123, DOI 10.2147/CLEP.S104258; Olafsdottir E, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000132; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramos R, 2016, J AM COLL CARDIOL, V67, P630, DOI 10.1016/j.jacc.2015.11.052; Ramos R, 2012, REV ESP CARDIOL, V65, P29, DOI [10.1016/j.rec.2011.07.016, 10.1016/j.recesp.2011.07.017]; Rana JS, 2016, J GEN INTERN MED, V31, P387, DOI 10.1007/s11606-015-3556-3; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Savarese G, 2013, J AM COLL CARDIOL, V62, P2090, DOI 10.1016/j.jacc.2013.07.069; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Statistics WH, 2015, GEN; Strandberg TE, 2014, JAMA-J AM MED ASSOC, V312, P1136, DOI 10.1001/jama.2014.10924; Teng M, 2015, DRUG AGING, V32, P649, DOI 10.1007/s40266-015-0290-9; Thai M, 2016, EUR J CLIN PHARMACOL, V72, P513, DOI 10.1007/s00228-016-2011-7; Ueda P, 2017, BRIT J GEN PRACT, V67, pE598, DOI 10.3399/bjgp17X692141; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wannamethee SG, 2011, ARCH INTERN MED, V171, P404, DOI 10.1001/archinternmed.2011.2; Weng TC, 2010, J CLIN PHARM THER, V35, P139, DOI 10.1111/j.1365-2710.2009.01085.x; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307	54	101	105	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2018	362								k3359	10.1136/bmj.k3359	http://dx.doi.org/10.1136/bmj.k3359			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WB	30185425	hybrid, Green Published			2022-12-28	WOS:000444505300002
J	Lin, JS; Eder, ML; Bean, SI				Lin, Jennifer S.; Eder, Michelle L.; Bean, Sarah I.			Screening for Syphilis Infection in Pregnant Women Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							REAFFIRMATION RECOMMENDATION STATEMENT; CONGENITAL-SYPHILIS; UNITED-STATES; OUTCOMES; IMMUNOASSAYS; LABORATORIES; DIAGNOSIS; CHINA	IMPORTANCE The incidence of syphilis and congenital syphilis in the United States has increased after reaching historic lows in the early 2000s. OBJECTIVE To systematically review literature on the effectiveness and harms of screening for syphilis in pregnancy and the harms of penicillin treatment in pregnancy to inform the US Preventive Services Task Force. DATA SOURCES MEDLINE, PubMed, and the Cochrane Central Register of Controlled Trials for relevant English-language literature, published from January 1, 2008, to June 2, 2017. Ongoing surveillance was conducted through November 22, 2017. STUDY SELECTION Studies conducted in countries categorized as "high" or "very high" on the Human Development Index that explicitly addressed 1 of 3 a priori-defined key questions. DATA EXTRACTION AND SYNTHESIS Independent critical appraisal and data abstraction by 2 reviewers. Data from included studies were narratively synthesized without pooling data. MAIN OUTCOMES AND MEASURES Incidence of congenital syphilis; any harms of screening or penicillin treatment in pregnancy. RESULTS Seven studies in 8 publications were included. One observational study evaluated the implementation of syphilis screening in pregnancy in 2 441 237 women in China. From 2002 to 2012, screening for syphilis in all pregnant women increased from 89.8% to 97.2%, and the incidence of congenital syphilis decreased from 109.3 to 9.4 cases per 100 000 live births. Five studies (n = 21795) evaluated the false-positive findings of treponemal tests and 1 study (n = 318) evaluated the false-negative findings of nontreponemal tests. These studies found that false-positives with treponemal-specific enzyme or chemiluminescent immunoassays were common (46.5%-88.2%), therefore warranting reflexive (automatic confirmatory) testing for all positive test findings. One study (n = 318) found no false-negatives with treponemal tests, and 1 study (n = 139) demonstrated the prozone phenomenon (false-negative response from high antibody titer) with rapid plasma reagin screening using undiluted samples (2.9%). No studies were identified for harms of penicillin in pregnancy. CONCLUSIONS AND RELEVANCE Screening for syphilis infection in pregnant women is associated with reduced incidence of congenital syphilis, and available evidence supports the need for reflexive testing for positive test results.	[Lin, Jennifer S.; Eder, Michelle L.; Bean, Sarah I.] Kaiser Permanente, Kaiser Permanente Res Affiliates Evidence Based P, Ctr Hlth Res, Portland, OR USA	Kaiser Permanente	Lin, JS (corresponding author), Kaiser Permanente Northwest, Kaiser Permanente Res Affiliates Evidence Based P, Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.	jennifer.s.lin@kpchr.org			Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA290201200015I, 5]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA290201200015I, Task Order 5, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Boonchaoy Amphiwan, 2016, Journal of the Medical Association of Thailand, V99, P119; Bowen V, 2015, MMWR-MORBID MORTAL W, V64, P1241, DOI 10.15585/mmwr.mm6444a3; Calonge N, 2009, ANN INTERN MED, V150, P705; Centers for Disease Control and Prevention, 2017, SEX TRANSM DIS SURV; Galvao TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056463; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Hawkes SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056713; Henrich TJ, 2011, SEX TRANSM DIS, V38, P1126, DOI 10.1097/OLQ.0b013e31822e60e1; Liu LL, 2014, CLIN INFECT DIS, V59, P384, DOI 10.1093/cid/ciu325; Mmeje O, 2015, CLIN INFECT DIS, V61, P1049, DOI 10.1093/cid/civ445; Morshed MG, 2015, CLIN VACCINE IMMUNOL, V22, P137, DOI 10.1128/CVI.00681-14; Patnode CD, 2018, AM J PREV MED, V54, pS19, DOI 10.1016/j.amepre.2017.07.024; Qin JB, 2014, EUR J CLIN MICROBIOL, V33, P2183, DOI 10.1007/s10096-014-2186-8; Qin JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102203; Radolf J. D., 2011, Morbidity and Mortality Weekly Report, V60, P133; US Preventive Services Task Force, 2015, US PREV SERV TASK FO; Wang KD, 2016, INFECT DIS-NOR, V48, P26, DOI 10.3109/23744235.2015.1044465; Warren HP, 2018, MATERN CHILD HLTH J, V22, P1227, DOI 10.1007/s10995-018-2592-0; Wellinghausen N, 2011, CLIN CHEM LAB MED, V49, P1375, DOI 10.1515/CCLM.2011.643; Wolff T, 2009, ANN INTERN MED, V150, P710, DOI 10.7326/0003-4819-150-10-200905190-00009; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	21	14	16	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2018	320	9					918	925		10.1001/jama.2018.7769	http://dx.doi.org/10.1001/jama.2018.7769			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS4OQ	30193282	Bronze			2022-12-28	WOS:000443627300016
J	Xu, GF; Liu, BY; Sun, YB; Du, Y; Snetselaar, LG; Hu, FB; Bao, W				Xu, Guifeng; Liu, Buyun; Sun, Yangbo; Du, Yang; Snetselaar, Linda G.; Hu, Frank B.; Bao, Wei			Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-STATES; CARDIOVASCULAR-DISEASE; INCIDENCE TRENDS; RISK; MORTALITY; CHILDREN; LIFE; COMPLICATIONS; EPIDEMIOLOGY; ADOLESCENTS	OBJECTIVE To estimate the prevalence of diagnosed total diabetes, type 1 diabetes, and type 2 diabetes in the US general population and the proportions of each among US adults with a diagnosis of diabetes. DESIGN Nationwide, population based, cross sectional survey. SETTING National Health Interview Survey, 2016 and 2017. PARTICIPANTS Adults aged 20 years or older (n=58 186), as a nationally representative sample of the civilian, non-institutionalized US population. MAIN OUTCOME MEASURES Prevalence of diagnosed diabetes, type 1 diabetes, and type 2 diabetes in the US general population, and the proportions of each subtype in participants with a diagnosis of diabetes. RESULTS Among the 58 186 included adults, 6317 had received a diagnosis of diabetes. The weighted prevalence of diagnosed diabetes, type 1 diabetes, and type 2 diabetes among US adults was 9.7% (95% confidence interval 9.4% to 10.0%), 0.5% (0.5% to 0.6%), and 8.5% (8.2% to 8.8%), respectively. Type 1 diabetes was more prevalent among adults with lower education level, and type 2 diabetes was more prevalent among older adults, men, and those with lower educational level, lower family income level, and higher body mass index (BMI). Among adults with a diagnosis of diabetes, the weighted percentage of type 1 and type 2 diabetes was 5.6% (4.9% to 6.4%) and 91.2% (90.4% to 92.1%), respectively. The percentage of type 1 diabetes was higher among younger adults (age 20-44 years), non-Hispanic white people, those with higher education level, and those with lower BMI, whereas the percentage of type 2 diabetes was higher among older adults (age >= 65 years), non-Hispanic Asians, those with lower education level, and those with higher BMI. CONCLUSION This study provided benchmark estimates on the national prevalence of diagnosed type 1 diabetes (0.5%) and type 2 diabetes (8.5%) among US adults. Among US adults with diagnosed diabetes, type 1 and type 2 diabetes accounted for 5.6% and 91.2%, respectively.	[Xu, Guifeng; Liu, Buyun; Sun, Yangbo; Du, Yang; Snetselaar, Linda G.; Bao, Wei] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA; [Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Med Sch, Boston, MA USA; [Bao, Wei] Univ Iowa, Obes Res & Educ Initiat, Iowa City, IA 52242 USA; [Bao, Wei] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA	University of Iowa; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Iowa; University of Iowa	Bao, W (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA.; Bao, W (corresponding author), Univ Iowa, Obes Res & Educ Initiat, Iowa City, IA 52242 USA.; Bao, W (corresponding author), Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA.	wei-bao@uiowa.edu	Bao, Wei/AAG-2431-2019	Bao, Wei/0000-0002-7301-5786; Sun, Yangbo/0000-0003-0377-4450	National Institutes of Health [R21 HD091458]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD091458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partly supported by a research grant from the National Institutes of Health (R21 HD091458).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Blackwell Debra L, 2014, Vital Health Stat 10, P1; Bommer C, 2017, LANCET DIABETES ENDO, V5, P423, DOI 10.1016/S2213-8587(17)30097-9; Bruno G, 2005, DIABETES CARE, V28, P2613, DOI 10.2337/diacare.28.11.2613; Centers for Disease Control and Prevention, LONG TERM TRENDS DIA; Centers for Disease Control and Prevention, 2017, EST DIAB ITS BURD US; Chatterjee S, 2017, LANCET, V389, P2239, DOI 10.1016/S0140-6736(17)30058-2; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Dall TM, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0110-4; Diaz-Valencia PA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1591-y; Farsani SF, 2013, DIABETOLOGIA, V56, P1471, DOI 10.1007/s00125-013-2915-z; Flannick J, 2016, NAT REV ENDOCRINOL, V12, P394, DOI 10.1038/nrendo.2016.50; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Harding JL, 2015, DIABETES CARE, V38, P264, DOI 10.2337/dc14-1996; Harron KL, 2011, DIABETES CARE, V34, P652, DOI 10.2337/dc10-1512; Holman N, 2015, DIABETIC MED, V32, P1119, DOI 10.1111/dme.12791; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Imperatore G, 2012, DIABETES CARE, V35, P2515, DOI 10.2337/dc12-0669; Katsarou Anastasia, 2017, Nat Rev Dis Primers, V3, P17016, DOI 10.1038/nrdp.2017.16; KEHOE R, 1994, AM J EPIDEMIOL, V139, P813, DOI 10.1093/oxfordjournals.aje.a117078; Mayer-Davis EJ, 2017, NEW ENGL J MED, V377, P301, DOI 10.1056/NEJMc1706291; McNeely MJ, 2004, DIABETES CARE, V27, P66, DOI 10.2337/diacare.27.1.66; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Menke A, 2013, EPIDEMIOLOGY, V24, P773, DOI 10.1097/EDE.0b013e31829ef01a; Baena-Diez JM, 2016, DIABETES CARE, V39, P1987, DOI 10.2337/dc16-0614; Miller RG, 2012, DIABETES, V61, P2987, DOI 10.2337/db11-1625; Nathan DM, 2015, JAMA-J AM MED ASSOC, V314, P1052, DOI 10.1001/jama.2015.9536; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Nishimura R, 2001, DIABETES CARE, V24, P823, DOI 10.2337/diacare.24.5.823; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Parsons Van L, 2014, Vital Health Stat 2, P1; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Rewers M, 2016, LANCET, V387, P2340, DOI 10.1016/S0140-6736(16)30507-4; Rogers MAM, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0958-6; Schneider ALC, 2012, AM J EPIDEMIOL, V176, P738, DOI 10.1093/aje/kws156; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Sharma M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010210; Thomas NJ, 2018, LANCET DIABETES ENDO, V6, P122, DOI 10.1016/S2213-8587(17)30362-5; Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596; WENG J, 2018, BMJ-BRIT MED J, V360, P74024, DOI DOI 10.1136/BMJ.J5295	43	208	214	21	68	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2018	362								k1497	10.1136/bmj.k1497	http://dx.doi.org/10.1136/bmj.k1497			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4VO	30181166	Green Published, hybrid			2022-12-28	WOS:000444503800001
J	Li, Q; Xue, C; Liu, JP; Wu, JF; Yang, SQ; Shao, CG; Quan, LD; Tan, WH; Tu, LC; Liu, Q; Xu, H; Liu, LX; Wang, QL; Hu, ZK; Zhou, ZB; Luo, PS; Wu, SC; Milyukov, V; Luo, J				Li, Qing; Xue, Chao; Liu, Jian-Ping; Wu, Jun-Fei; Yang, Shan-Qing; Shao, Cheng-Gang; Quan, Li-Di; Tan, Wen-Hai; Tu, Liang-Cheng; Liu, Qi; Xu, Hao; Liu, Lin-Xia; Wang, Qing-Lan; Hu, Zhong-Kun; Zhou, Ze-Bing; Luo, Peng-Shun; Wu, Shu-Chao; Milyukov, Vadim; Luo, Jun			Measurements of the gravitational constant using two independent methods	NATURE			English	Article							MEASURE BIG G; TORSION PENDULUM; FUNDAMENTAL CONSTANTS; REDETERMINATION; BALANCE	The Newtonian gravitational constant, G, is one of the most fundamental constants of nature, but we still do not have an accurate value for it. Despite two centuries of experimental effort, the value of G remains the least precisely known of the fundamental constants. A discrepancy of up to 0.05 per cent in recent determinations of G suggests that there may be undiscovered systematic errors in the various existing methods. One way to resolve this issue is to measure G using a number of methods that are unlikely to involve the same systematic effects. Here we report two independent determinations of G using torsion pendulum experiments with the time-of-swing method and the angular-acceleration-feedback method. We obtain G values of 6.674184 x 10(-11) and 6.674484 x 10(-11) cubic metres per kilogram per second squared, with relative standard uncertainties of 11.64 and 11.61 parts per million, respectively. These values have the smallest uncertainties reported until now, and both agree with the latest recommended value within two standard deviations.	[Li, Qing; Liu, Jian-Ping; Wu, Jun-Fei; Yang, Shan-Qing; Shao, Cheng-Gang; Tan, Wen-Hai; Tu, Liang-Cheng; Xu, Hao; Hu, Zhong-Kun; Zhou, Ze-Bing; Luo, Peng-Shun; Wu, Shu-Chao; Luo, Jun] Huazhong Univ Sci & Technol, Sch Phys, Hubei Key Lab Gravitat & Quantum Phys, MOE Key Lab Fundamental Phys Quant Measurements, Wuhan, Hubei, Peoples R China; [Xue, Chao; Tu, Liang-Cheng; Liu, Qi; Luo, Jun] Sun Yat Sen Univ, TianQin Res Ctr Gravitat Phys, Zhuhai, Peoples R China; [Xue, Chao; Liu, Qi; Luo, Jun] Sun Yat Sen Univ, Sch Phys & Astron, Zhuhai, Peoples R China; [Quan, Li-Di] Huzhou Univ, Coll Engn, Huzhou, Peoples R China; [Liu, Lin-Xia] Henan Inst Technol, Teaching Res & Assessment Ctr, Xinxiang, Peoples R China; [Wang, Qing-Lan] Hubei Univ Automot Technol, Sch Sci, Shiyan, Peoples R China; [Milyukov, Vadim] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Moscow, Russia	Huazhong University of Science & Technology; Sun Yat Sen University; Sun Yat Sen University; Huzhou University; Henan Institute of Technology; Hubei University of Automotive Technology; Lomonosov Moscow State University	Yang, SQ; Shao, CG; Luo, J (corresponding author), Huazhong Univ Sci & Technol, Sch Phys, Hubei Key Lab Gravitat & Quantum Phys, MOE Key Lab Fundamental Phys Quant Measurements, Wuhan, Hubei, Peoples R China.; Luo, J (corresponding author), Sun Yat Sen Univ, TianQin Res Ctr Gravitat Phys, Zhuhai, Peoples R China.; Luo, J (corresponding author), Sun Yat Sen Univ, Sch Phys & Astron, Zhuhai, Peoples R China.	ysq2011@hust.edu.cn; cgshao@hust.edu.cn; junluo@hust.edu.cn	Luo, Pengshun/AAZ-9563-2021; zhou, ze-bing/N-7108-2013; Luo, Pengshun/G-8009-2011; TU, Liangcheng/AAD-1616-2019	Luo, Pengshun/0000-0002-5818-2906; TU, Liangcheng/0000-0003-1014-9784	National Natural Science Foundation of China [91536223, 11722542, 11325523, 11605295]; National Basic Research Program of China [2010CB832801]; National Precise Gravity Measurement Facility	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Precise Gravity Measurement Facility	We are grateful to R. Newman, T. Quinn, C. Speake, J. E. Faller, J. H. Gundlach, H. J. Paik, Z. H. Lu, J. Luo and S. H. Fan for discussions and suggestions. We thank Q. T. Fan, Y. T. Zhang, B. P. Wang, X. D. Fan, M. Ke, L. Zhao, Y. Tu, J. Q. Guo, D. C. Chen, W. M. Wang, X. L. Wang, X. J. Luo, X. H. Fu, J. Tang and Y. B. Cheng for their early works on G measurement. We thank the National Institute of Metrology (NIM) of China for the calibration of some measuring instruments, source masses and the length gauges. This work is partly supported by the National Natural Science Foundation of China under grants number 91536223, 11722542, 11325523 and 11605295, the National Basic Research Program of China under grant number 2010CB832801 and the National Precise Gravity Measurement Facility.	Armstrong TR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.201101; Bagley CH, 1997, PHYS REV LETT, V78, P3047, DOI 10.1103/PhysRevLett.78.3047; Cavendish H., 1798, PHILOS T ROYAL SOC L, V88, P469, DOI [DOI 10.1098/RSTL.1798.0022, 10.1098/RSTL.1798]; Fan XD, 2008, PHYS LETT A, V372, P547, DOI 10.1016/j.physleta.2007.08.020; Gibney E, 2014, NATURE, V514, P150, DOI 10.1038/514150a; GILLIES GT, 1987, METROLOGIA, V24, P1, DOI 10.1088/0026-1394/24/S/001; Gundlach JH, 2000, PHYS REV LETT, V85, P2869, DOI 10.1103/PhysRevLett.85.2869; Guo JQ, 2004, CHINESE PHYS LETT, V21, P612, DOI 10.1088/0256-307X/21/4/006; Heyl PR, 1942, J RES NAT BUR STAND, V29, P1, DOI 10.6028/jres.029.001; Heyl PR, 1930, BUR STAND J RES, V5, P1243; Hu ZK, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.127505; Hu ZK, 2001, CHINESE PHYS LETT, V18, P7, DOI 10.1088/0256-307X/18/1/303; Karagioz OV, 1996, MEAS TECH+, V39, P979, DOI 10.1007/BF02377461; Kleinevo&beta; U., 2002, THESIS; KURODA K, 1995, PHYS REV LETT, V75, P2796, DOI 10.1103/PhysRevLett.75.2796; Li Q, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4944475; Li Q, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0141; Li Q, 2010, CHINESE PHYS LETT, V27, DOI 10.1088/0256-307X/27/7/070401; Liu LX, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/9/090402; Liu LX, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/1/010403; Liu LX, 2008, CHINESE PHYS LETT, V25, P4203, DOI 10.1088/0256-307X/25/12/005; Luo J, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.042001; Luo J, 2000, REV SCI INSTRUM, V71, P1524, DOI 10.1063/1.1150489; Luo J, 2001, CHINESE PHYS LETT, V18, P1012, DOI 10.1088/0256-307X/18/8/305; Luo J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.240801; LUTHER GG, 1982, PHYS REV LETT, V48, P121, DOI 10.1103/PhysRevLett.48.121; Mohr PJ, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.035009; Newman RD, 1999, MEAS SCI TECHNOL, V10, P445, DOI 10.1088/0957-0233/10/6/306; Newman R, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0025; Numata K, 2007, PHYS LETT A, V370, P91, DOI 10.1016/j.physleta.2007.05.048; Parks HV, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.110801; Quan LD, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4861189; Quinn T, 2000, NATURE, V408, P919, DOI 10.1038/35050187; Quinn T, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0032; Quinn T, 2014, NATURE, V505, P455, DOI 10.1038/505455a; Quinn T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.101102; Quinn TJ, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.111101; ROSE RD, 1969, PHYS REV LETT, V23, P655, DOI 10.1103/PhysRevLett.23.655; Rosi G, 2014, NATURE, V510, P518, DOI 10.1038/nature13433; Rothleitner C, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.4994619; Schlamminger S, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.082001; Schlamminger S, 2014, NATURE, V510, P478, DOI 10.1038/nature13507; Tian YL, 2004, REV SCI INSTRUM, V75, P1971, DOI 10.1063/1.1753095; Tu LC, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.022001; Xue C, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0031; Yang SQ, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.122005; Zener C.M., 1948, ELASTICITY ANELASTIC	47	60	61	16	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					582	+		10.1038/s41586-018-0431-5	http://dx.doi.org/10.1038/s41586-018-0431-5			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS0SZ	30158607				2022-12-28	WOS:000443218600038
J	Herrtwich, L; Nanda, I; Evangelou, K; Nikolova, T; Horn, V; Sagar; Erny, D; Stefanowski, J; Rogell, L; Klein, C; Gharun, K; Follo, M; Seidl, M; Kremer, B; Munke, N; Senges, J; Fliegauf, M; Aschman, T; Pfeifer, D; Sarrazin, S; Sieweke, MH; Wagner, D; Dierks, C; Haaf, T; Ness, T; Zaiss, MM; Voll, RE; Deshmukh, SD; Prinz, M; Goldmann, T; Holscher, C; Hauser, AE; Lopez-Contreras, AJ; Grun, D; Gorgoulis, V; Diefenbach, A; Henneke, P; Triantafyllopoulou, A				Herrtwich, Laura; Nanda, Indrajit; Evangelou, Konstantinos; Nikolova, Teodora; Horn, Veronika; Sagar; Erny, Daniel; Stefanowski, Jonathan; Rogell, Leif; Klein, Claudius; Gharun, Kourosh; Follo, Marie; Seidl, Maximilian; Kremer, Bernhard; Munke, Nikolas; Senges, Julia; Fliegauf, Manfred; Aschman, Tom; Pfeifer, Dietmar; Sarrazin, Sandrine; Sieweke, Michael H.; Wagner, Dirk; Dierks, Christine; Haaf, Thomas; Ness, Thomas; Zaiss, Mario M.; Voll, Reinhard E.; Deshmukh, Sachin D.; Prinz, Marco; Goldmann, Torsten; Holscher, Christoph; Hauser, Anja E.; Lopez-Contreras, Andres J.; Grun, Dominic; Gorgoulis, Vassilis; Diefenbach, Andreas; Henneke, Philipp; Triantafyllopoulou, Antigoni			DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas (vol 167, pg 1264, 2016)	CELL			English	Correction												diefenbach@uni-mainz.de; antigoni.triantafyllopoulou@uniklinik-freiburg.de	Hölscher, Christoph/O-1732-2018; Sieweke, Michael/AAR-7515-2020; Gorgoulis, Vassilis/AAD-3630-2019; Erny, Daniel/AAU-7015-2020; Evangelou, Konstantinos/AAG-5092-2020; Zaiss, Mario M./ABE-7125-2021; Seidl, Maxmilian/ABF-3322-2021	Hölscher, Christoph/0000-0002-7520-9146; Sieweke, Michael/0000-0002-3228-9537; Gorgoulis, Vassilis/0000-0001-9001-4112; Erny, Daniel/0000-0001-6000-8838; Evangelou, Konstantinos/0000-0002-2462-5748; Zaiss, Mario M./0000-0003-3844-1664; Seidl, Maxmilian/0000-0002-5559-4980; Aschman, Tom/0000-0002-2101-6146; , Dr. Sagar/0000-0002-8657-4704				Herrtwich L, 2016, CELL, V167, P1264, DOI 10.1016/j.cell.2016.09.054	1	7	7	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2018	174	5					1325	1326		10.1016/j.cell.2018.08.015	http://dx.doi.org/10.1016/j.cell.2018.08.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GR3WU	30142346	Bronze			2022-12-28	WOS:000442529100025
J	Vivier, E; Artis, D; Colonna, M; Diefenbach, A; Di Santo, JP; Eberl, G; Koyasu, S; Locksley, RM; McKenzie, ANJ; Mebius, RE; Powrie, F; Spits, H				Vivier, Eric; Artis, David; Colonna, Marco; Diefenbach, Andreas; Di Santo, James P.; Eberl, Gerard; Koyasu, Shigeo; Locksley, Richard M.; McKenzie, Andrew N. J.; Mebius, Reina E.; Powrie, Fiona; Spits, Hergen			Innate Lymphoid Cells: 10 Years On	CELL			English	Review							ROR-GAMMA-T; TRANSCRIPTION FACTOR GATA3; NK CELLS; TYPE-2 IMMUNITY; TUFT CELLS; INTERLEUKIN-22; PROTECTION; EXPRESSION; PLASTICITY; PROMOTES	Innate lymphoid cells (ILCs) are lymphocytes that do not express the type of diversified antigen receptors expressed on T cells and B cells. ILCs are largely tissue-resident cells and are deeply integrated into the fabric of tissues. The discovery and investigation of ILCs over the past decade has changed our perception of immune regulation and how the immune system contributes to the maintenance of tissue homeostasis. We now know that cytokine-producing ILCs contribute to multiple immune pathways by, for example, sustaining appropriate immune responses to commensals and pathogens at mucosal barriers, potentiating adaptive immunity, and regulating tissue inflammation. Critically, the biology of ILCs also extends beyond classical immunology to metabolic homeostasis, tissue remodeling, and dialog with the nervous system. The last 10 years have also contributed to our greater understanding of the transcriptional networks that regulate lymphocyte commitment and delineation. This, in conjunction with the recent advances in our understanding of the influence of local tissue microenvironments on the plasticity and function of ILCs, has led to a re-evaluation of their existing categorization. In this review, we distill the advances in ILC biology over the past decade to refine the nomenclature of ILCs and highlight the importance of ILCs in tissue homeostasis, morphogenesis, metabolism, repair, and regeneration.	[Vivier, Eric] Innate Pharma, Innate Pharma Res Labs, Marseille, France; [Vivier, Eric] Aix Marseille Univ, CNRS, INSERM, Hop la Timone,APHM,CIML,Immunol,Marseille Immunop, Marseille, France; [Artis, David] Cornell Univ, Weill Cornell Med, Joan & Sanford I Weill Dept Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA; [Artis, David] Cornell Univ, Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10021 USA; [Colonna, Marco] Washington Univ, Sch Med St Louis, Dept Pathol & Immunol, St Louis, MO USA; [Diefenbach, Andreas] Charite Univ Med Berlin, Dept Microbiol & Infect Immunol, Lab Innate Immun, Berlin, Germany; [Diefenbach, Andreas] Berlin Inst Hlth, Berlin, Germany; [Diefenbach, Andreas] Deutsch Rheuma Forschungszentrum, Mucosal & Dev Immunol, Berlin, Germany; [Di Santo, James P.] Inst Pasteur, Innate Immun Unit, Paris, France; [Di Santo, James P.] Inserm U1223, Paris, France; [Eberl, Gerard] Inst Pasteur, Microenvironm & Immun Unit, Paris, France; [Eberl, Gerard] INSERM U1224, Paris, France; [Koyasu, Shigeo] RIKEN, Ctr Integrat Med Sci, Lab Immune Cell Syst, Yokohama, Kanagawa, Japan; [Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Locksley, Richard M.] Univ Calif San Francisco, HHMI, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [McKenzie, Andrew N. J.] MRC, Lab Mol Biol, Cambridge, England; [Mebius, Reina E.] Vrije Univ Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Powrie, Fiona] Univ Oxford, Kennedy Inst Rheumatol, NDORMS, Oxford, England; [Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Cornell University; Cornell University; Saint Louis University; Washington University (WUSTL); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Deutsches Rheuma-Forschungszentrum (DRFZ); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); RIKEN; Keio University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; MRC Laboratory Molecular Biology; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam	Vivier, E (corresponding author), Innate Pharma, Innate Pharma Res Labs, Marseille, France.; Vivier, E (corresponding author), Aix Marseille Univ, CNRS, INSERM, Hop la Timone,APHM,CIML,Immunol,Marseille Immunop, Marseille, France.	vivier@ciml.univ-mrs.fr	Diefenbach, Andreas/T-2589-2018; Eberl, Gerard/A-1160-2013; Vivier, Eric/F-8939-2010; Koyasu, Shigeo/J-5583-2015; Spits, Hergen/N-2581-2019; Di Santo, James P/M-4298-2014; wang, edwin/G-5372-2010	Diefenbach, Andreas/0000-0002-9176-9530; Vivier, Eric/0000-0001-7022-8287; Koyasu, Shigeo/0000-0001-9585-3038; Spits, Hergen/0000-0003-3269-8338; Di Santo, James P/0000-0002-7146-1862; Mebius, Reina/0000-0003-0451-7464; Artis, David/0000-0002-1753-4100	NIH; Crohn's and Colitis Foundation; Burroughs Wellcome Fund; Cure for IBD; Jill Roberts Institute; US NIH [UO1 AI095542, RO1 DE025884, RO1 DK103039]; European Research Council (ERC) [311377 - NUTRIMMUNE]; Deutsche Forschungsgemeinschaft (DFG); Einstein Foundation Berlin; Berlin Institute of Health; ANR; FRM; CCFA; Rainin Foundation; Institut Pasteur; HHMI; SABRE Center at UCSF; MRC [U105178805]; Wellcome Trust [100963/Z/13/Z]; Inserm; Agence Nationale de la Recherche; Ligue Nationale contre le Cancer; European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Program [695467 - ILC_REACTIVITY, 694502-TILC]; advanced ERC grant [341038-AsthmaVir]; Equipe Labellisee "La Ligue''; MSDAvenir; Innate Pharma; Marseille Immunopole; CNRS; Aix-Marseille University;  [16H02631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095542, R01AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103039] Funding Source: NIH RePORTER; MRC [MC_U105178805] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cure for IBD; Jill Roberts Institute; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC)(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Einstein Foundation Berlin; Berlin Institute of Health; ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); CCFA; Rainin Foundation; Institut Pasteur(European Commission); HHMI(Howard Hughes Medical Institute); SABRE Center at UCSF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Program(European Research Council (ERC)); advanced ERC grant; Equipe Labellisee "La Ligue''; MSDAvenir; Innate Pharma; Marseille Immunopole; CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research in the Artis lab is supported by the NIH, the Crohn's and Colitis Foundation, the Burroughs Wellcome Fund, the Cure for IBD, and the Jill Roberts Institute. M.C. is supported by the US NIH (UO1 AI095542, RO1 DE025884, and RO1 DK103039). The Diefenbach laboratory is supported by the European Research Council (ERC) (311377 - NUTRIMMUNE), the Priority Program 1937 "Innate Lymphoid Cells'' of the Deutsche Forschungsgemeinschaft (DFG), the Einstein Foundation Berlin, and the Berlin Institute of Health. The Eberl lab is supported by grants from ANR, FRM, CCFA, Rainin Foundation and the Institut Pasteur. Research in the Koyasu laboratory is supported by a Grant-in-Aid for Scientific Research (A) (16H02631). Research in the Locksley laboratory is supported by the HHMI, the NIH, and the SABRE Center at UCSF. Research in the McKenzie laboratory is supported by funding from the MRC (U105178805) and the Wellcome Trust (100963/Z/13/Z). The Di Santo laboratory receives grants from the Institut Pasteur, Inserm, the Agence Nationale de la Recherche, the Ligue Nationale contre le Cancer, and the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Program (695467 - ILC_REACTIVITY). The Spits lab is supported by an advanced ERC grant (341038-AsthmaVir). Research in the Vivier laboratory is supported by funding from the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Program (694502-TILC), the Agence Nationale de la Recherche; Equipe Labellisee "La Ligue,'' Ligue Nationale contre le Cancer, MSDAvenir, and Innate Pharma and institutional grants to the CIML (INSERM, CNRS, and Aix-Marseille University) and Marseille Immunopole.	Abt MC, 2015, CELL HOST MICROBE, V18, P27, DOI 10.1016/j.chom.2015.06.011; Aparicio-Domingo P, 2015, J EXP MED, V212, P1783, DOI 10.1084/jem.20150318; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Boulenouar S, 2017, IMMUNITY, V46, P273, DOI 10.1016/j.immuni.2017.01.008; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chea S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2223; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Dalli J, 2017, IMMUNITY, V46, P92, DOI 10.1016/j.immuni.2016.12.009; Dalmas E, 2017, IMMUNITY, V47, P928, DOI 10.1016/j.immuni.2017.10.015; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Ebbo M, 2017, NAT REV IMMUNOL, V17, P665, DOI 10.1038/nri.2017.86; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Freud AG, 2016, CELL REP, V16, P379, DOI 10.1016/j.celrep.2016.05.095; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hernandez P, 2018, EUR J IMMUNOL, V48, P15, DOI 10.1002/eji.201747183; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Kabata H, 2016, ANN AM THORAC SOC, V13, pS95, DOI 10.1513/AnnalsATS.201508-557MG; Kim MH, 2015, IMMUNITY, V43, P107, DOI 10.1016/j.immuni.2015.06.009; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Lee BC, 2016, CELL METAB, V23, P685, DOI 10.1016/j.cmet.2016.03.002; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Pearson C, 2016, ELIFE, V5, DOI 10.7554/eLife.10066; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Quatrini L, 2017, J EXP MED, V214, P3531, DOI 10.1084/jem.20171048; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Renoux VM, 2015, IMMUNITY, V43, P394, DOI 10.1016/j.immuni.2015.07.011; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Seehus CR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02023-z; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shikhagaie MM, 2017, CELL REP, V18, P1761, DOI 10.1016/j.celrep.2017.01.063; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sui PF, 2018, SCIENCE, V360, P1086, DOI 10.1126/science.aan8546; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Veiga-Fernandes H, 2018, SCIENCE, V359, P1465, DOI 10.1126/science.aap9598; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Viant C, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2176; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang S, 2017, CELL, V171, P201, DOI 10.1016/j.cell.2017.07.027; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Wilhelm C, 2016, J EXP MED, V213, P1409, DOI 10.1084/jem.20151448; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023	111	936	957	28	182	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2018	174	5					1054	1066		10.1016/j.cell.2018.07.017	http://dx.doi.org/10.1016/j.cell.2018.07.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GR3WU	30142344	Bronze			2022-12-28	WOS:000442529100005
J	Barnett, R				Barnett, Richard			Cerebral palsy	LANCET			English	Editorial Material												richard@richardbarnettwriter.com						ACCARDO P, 1989, J HIST MED ALL SCI, V44, P56, DOI 10.1093/jhmas/44.1.56; [Anonymous], 2016, LANCET, V387, P211; [Anonymous], 2018, LANCET, V391, P195; Davies C., 2002, CHANGING SOC PERSONA; Kavcic A, 2005, EUR J NEUROL, V12, P582, DOI 10.1111/j.1468-1331.2005.01013.x; Watson N, 2005, SOC HIST MED, V18, P459, DOI 10.1093/shm/hki047	6	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2018	392	10147					545	545		10.1016/S0140-6736(18)31702-1	http://dx.doi.org/10.1016/S0140-6736(18)31702-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ8MN	30152380				2022-12-28	WOS:000442009500011
J	Mahabadi, AA; Rassaf, T				Mahabadi, Amir A.; Rassaf, Tienush			Imaging of coronary inflammation for cardiovascular risk prediction	LANCET			English	Editorial Material							EPICARDIAL ADIPOSE-TISSUE; ARTERY-DISEASE; CHEST-PAIN; ANGIOGRAPHY; ASSOCIATION; EVENTS; TRIAL; WOMEN		[Mahabadi, Amir A.; Rassaf, Tienush] Univ Hosp Essen, West German Heart & Vasc Ctr Essen, Dept Cardiol & Vasc Med, D-45147 Essen, Germany	University of Duisburg Essen	Mahabadi, AA (corresponding author), Univ Hosp Essen, West German Heart & Vasc Ctr Essen, Dept Cardiol & Vasc Med, D-45147 Essen, Germany.	amir-abbas.mahabadi@uk-essen.de	Mahabadi, Amir/ABE-6057-2020					Alexopoulos N, 2013, J AM COLL CARDIOL, V61, P1956, DOI 10.1016/j.jacc.2012.12.051; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Ferencik M, 2018, JAMA CARDIOL, V3, P144, DOI 10.1001/jamacardio.2017.4973; Hoffmann U, 2012, NEW ENGL J MED, V367, P299, DOI 10.1056/NEJMoa1201161; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Mahabadi AA, 2014, JACC-CARDIOVASC IMAG, V7, P909, DOI 10.1016/j.jcmg.2014.07.002; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Mahabadi AA, 2010, ATHEROSCLEROSIS, V211, P195, DOI 10.1016/j.atherosclerosis.2010.02.013; Nielsen LH, 2017, EUR HEART J, V38, P413, DOI 10.1093/eurheartj/ehw548; Oikonomou EK, 2018, LANCET, V392, P929, DOI 10.1016/S0140-6736(18)31114-0; Packer M, 2018, J AM COLL CARDIOL, V71, P2360, DOI 10.1016/j.jacc.2018.03.509; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646	12	10	11	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2018	392	10151					894	896		10.1016/S0140-6736(18)31716-1	http://dx.doi.org/10.1016/S0140-6736(18)31716-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT4LN	30170850	hybrid			2022-12-28	WOS:000444475700005
J	[Anonymous]				[Anonymous]			Mumps Outbreak Preparedness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2018	320	10					966	966		10.1001/jama.2018.12455	http://dx.doi.org/10.1001/jama.2018.12455			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT2QE	30208461				2022-12-28	WOS:000444341400004
J	Ma, XL; Kumar, P; Mittal, N; Khlyustova, A; Daoutidis, P; Mkhoyan, KA; Tsapatsis, M				Ma, Xiaoli; Kumar, Prashant; Mittal, Nitish; Khlyustova, Alexandra; Daoutidis, Prodromos; Mkhoyan, K. Andre; Tsapatsis, Michael			Zeolitic imidazolate framework membranes made by ligand-induced permselectivation	SCIENCE			English	Article							ZIF-8 MEMBRANES; PROPYLENE/PROPANE SEPARATION; STABILITY; PERFORMANCES; PROPANE; FILMS; GAS; CVD	Zeolitic imidazolate framework (ZIF) membranes are emerging as a promising energy-efficient separation technology. However, their reliable and scalable manufacturing remains a challenge. We demonstrate the fabrication of ZIF nanocomposite membranes by means of an all-vapor-phase processing method based on atomic layer deposition (ALD) of ZnO in a porous support followed by ligand-vapor treatment. After ALD, the obtained nanocomposite exhibits low flux and is not selective, whereas after ligand-vapor (2-methylimidazole) treatment, it is partially transformed to ZIF and shows stable performance with high mixture separation factor for propylene over propane (an energy-intensive high-volume separation) and high propylene flux. Membrane synthesis through ligand-induced permselectivation of a nonselective and impermeable deposit is shown to be simple and highly reproducible and holds promise for scalability.	[Ma, Xiaoli; Kumar, Prashant; Mittal, Nitish; Khlyustova, Alexandra; Daoutidis, Prodromos; Mkhoyan, K. Andre; Tsapatsis, Michael] Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Ma, XL; Tsapatsis, M (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	maxx0183@umn.edu; tsapatsis@umn.edu	Kumar, Prashant/AAR-9397-2020; Mittal, Nitish/H-7246-2019; Ma, Xiaoli/AAI-9579-2020; Tsapatsis, Michael/AAA-2527-2019; Khlyustova, Alexandra/AAD-3670-2022	Kumar, Prashant/0000-0003-4622-0917; Ma, Xiaoli/0000-0002-0429-8663; Khlyustova, Alexandra/0000-0002-4313-5066; Mittal, Nitish/0000-0003-4117-3293; Mkhoyan, Andre/0000-0003-3568-5452	Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001015]; National Science Foundation through the Materials Research Science and Engineering Center; National Nanotechnology Coordinated Infrastructure programs	Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation through the Materials Research Science and Engineering Center(National Science Foundation (NSF)); National Nanotechnology Coordinated Infrastructure programs	This work was supported by the Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Basic Energy Sciences under award DE-SC0001015. Parts of this work were carried out in the Characterization Facility, University of Minnesota and the Minnesota Nano Center, which receive partial support from the National Science Foundation through the Materials Research Science and Engineering Center and National Nanotechnology Coordinated Infrastructure programs, respectively. SEM measurements were partially performed on a Hitachi 8230 provided by NSF MRI DMR-1229263.	Adhikari P, 2016, J PHYS CHEM C, V120, P15362, DOI 10.1021/acs.jpcc.6b06337; Brown AJ, 2014, SCIENCE, V345, P72, DOI 10.1126/science.1251181; Bux H, 2009, J AM CHEM SOC, V131, P16000, DOI 10.1021/ja907359t; CHANG CH, 1994, J MEMBRANE SCI, V91, P27, DOI 10.1016/0376-7388(94)00041-7; Drobek M, 2015, J MEMBRANE SCI, V475, P39, DOI 10.1016/j.memsci.2014.10.011; ELDRIDGE RB, 1993, IND ENG CHEM RES, V32, P2208, DOI 10.1021/ie00022a002; Eum K, 2016, ADV FUNCT MATER, V26, P5011, DOI 10.1002/adfm.201601550; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Galizia M, 2017, MACROMOLECULES, V50, P7809, DOI 10.1021/acs.macromol.7b01718; Hara N, 2015, J JPN PETROL INST, V58, P237, DOI 10.1627/jpi.58.237; Hara N, 2014, J MEMBRANE SCI, V450, P215, DOI 10.1016/j.memsci.2013.09.012; Hess SC, 2016, CHEM MATER, V28, P7638, DOI 10.1021/acs.chemmater.6b02499; Jang E, 2017, J MEMBRANE SCI, V540, P430, DOI 10.1016/j.memsci.2017.06.072; Jeon MY, 2017, NATURE, V543, P690, DOI 10.1038/nature21421; Koros WJ, 2012, AICHE J, V58, P2624, DOI 10.1002/aic.13888; Kwon HT, 2016, CHEM COMMUN, V52, P11669, DOI 10.1039/c6cc05433a; Kwon HT, 2015, J AM CHEM SOC, V137, P12304, DOI 10.1021/jacs.5b06730; Lee MJ, 2018, ANGEW CHEM INT EDIT, V57, P156, DOI 10.1002/anie.201708924; Li KH, 2009, J AM CHEM SOC, V131, P10368, DOI 10.1021/ja9039983; Li WB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00544-1; LIN YS, 1991, CHEM ENG SCI, V46, P3067, DOI 10.1016/0009-2509(91)85010-U; Liu DF, 2014, J MEMBRANE SCI, V451, P85, DOI 10.1016/j.memsci.2013.09.029; Pan YC, 2015, J MEMBRANE SCI, V493, P88, DOI 10.1016/j.memsci.2015.06.019; Pan YC, 2012, J MEMBRANE SCI, V390, P93, DOI 10.1016/j.memsci.2011.11.024; Park KS, 2006, P NATL ACAD SCI USA, V103, P10186, DOI 10.1073/pnas.0602439103; Sholl DS, 2016, NATURE, V532, P435, DOI 10.1038/532435a; Stassen I, 2016, NAT MATER, V15, P304, DOI [10.1038/NMAT4509, 10.1038/nmat4509]; Tanaka S, 2017, J MEMBRANE SCI, V544, P306, DOI 10.1016/j.memsci.2017.09.037; Tao HZ, 2017, ADV MATER, V29, DOI 10.1002/adma.201601705; TSAPATSIS M, 1992, AICHE J, V38, P847, DOI 10.1002/aic.690380606; Pham TCT, 2013, ANGEW CHEM INT EDIT, V52, P8693, DOI 10.1002/anie.201301766	31	202	210	65	632	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					1008	1011		10.1126/science.aat4123	http://dx.doi.org/10.1126/science.aat4123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190401				2022-12-28	WOS:000443892700044
J	Murphy, DC				Murphy, Declan C.			Complaints about primary care services increased by 4.5% last year	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Murphy, Declan C/0000-0001-9295-7712				NHS Digital, 2018, DAT WRITT COMPL NHS	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2018	362								k3839	10.1136/bmj.k3839	http://dx.doi.org/10.1136/bmj.k3839			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WY	30194248				2022-12-28	WOS:000444507900002
J	Pilgrim, T; Piccolo, R; Heg, D; Roffi, M; Tuller, D; Muller, O; Moarof, I; Siontis, GCM; Cook, S; Weilenmann, D; Kaiser, C; Cuculi, F; Hunziker, L; Eberli, FR; Juni, P; Windecker, S				Pilgrim, Thomas; Piccolo, Raffaele; Heg, Dik; Roffi, Marco; Tuller, David; Muller, Olivier; Moarof, Igal; Siontis, George C. M.; Cook, Stephane; Weilenmann, Daniel; Kaiser, Christoph; Cuculi, Florim; Hunziker, Lukas; Eberli, Franz R.; Juni, Peter; Windecker, Stephan			Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial	LANCET			English	Article							NON-INFERIORITY TRIAL; TERM CLINICAL-OUTCOMES; FOLLOW-UP; II TRIAL; LEADERS; IMPLANTATION; DEFINITIONS; MULTICENTER; SECONDARY; SAFETY	Background Drug-eluting stents combining an ultrathin cobalt-chromium stent platform with a biodegradable polymer eluting sirolimus have been shown to be non-inferior or superior to thin-strut, durable-polymer, everolimus-eluting stents in terms of 1 year safety and efficacy outcomes. Methods In the randomised, single-blind, multicentre, non-inferiority BIOSCIENCE trial, we compared biodegradable-polymer sirolimus-eluting stents with durable-polymer everolimus-eluting stents in patients with chronic stable coronary artery disease or acute coronary syndromes. Here, we assess the final 5-year clinical outcomes of BIOSCIENCE with regards to the primary clinical outcome of target lesion failure, which was a composite of cardiac death, target vessel myocardial infarction, and clinically indicated target lesion revascularisation. The primary analysis was done by intention to treat. The BIOSCIENCE trial is registered with ClinicalTrials.gov, number NCT01443104. Findings 2008 (95%) of 2119 patients recruited between March 1,2012, and May 31,2013, completed 5 years of followup. Target lesion failure occurred in 198 patients (cumulative incidence 20.2%) treated with biodegradable-polymer sirolimus-eluting stents and in 189 patients (18.8%) treated with durable-polymer everolimus-eluting stents (rate ratio [RR] 1.07, 95% CI 0.88-1.31; p=0.487). All-cause mortality was significantly higher in patients treated with biodegradable-polymer sirolimus-eluting stents than in those treated with durable-polymer everolimus-eluting stents (14.1% vs 10.3%; RR 1.36, 95% CI 1.06-1.75; p=0.017), driven by a difference in non-cardiovascular deaths. We observed no difference between groups in cumulative incidence of definite stent thrombosis at 5 years (1.6% in both groups; 1.02,0.51-2.05; p=0.950). Interpretation 5-year risk of target lesion failure among all-comer patients undergoing percutaneous coronary intervention is similar after implantation of ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents or thin-strut, durable-polymer, everolimus-eluting stents. Higher incidences of all-cause and non-cardiovascular mortality in patients treated with biodegradable-polymer stents eluting sirolimus than in those treated with durable-polymer stents eluting everolimus warrant careful observation in ongoing clinical trials. Copyright (C) 2018 Elsevier Ltd. All rights reserved.	[Pilgrim, Thomas; Siontis, George C. M.; Hunziker, Lukas; Windecker, Stephan] Univ Bern, Inselspital, Dept Cardiol, CH-3010 Bern, Switzerland; [Heg, Dik] Univ Bern, Inselspital, Inst Social & Prevent Med, Bern, Switzerland; [Heg, Dik] Univ Bern, Inselspital, Clin Trials Unit, Bern, Switzerland; [Piccolo, Raffaele] Univ Naples Federico II, Dept Adv Biomed Sci, Div Cardiol, Naples, Italy; [Roffi, Marco] Geneva Univ Hosp, Dept Cardiol, Geneva, Switzerland; [Tuller, David; Eberli, Franz R.] Triemli Municipal Hosp, Dept Cardiol, Zurich, Switzerland; [Muller, Olivier] Lausanne Univ Hosp, Dept Cardiol, Lausanne, Switzerland; [Moarof, Igal] Kantonsspital Aarau, Dept Cardiol, Aarau, Switzerland; [Cook, Stephane] Univ & Hosp Fribourg, Dept Cardiol, Fribourg, Switzerland; [Weilenmann, Daniel] Kantonsspital St Gallen, Dept Cardiol, St Gallen, Switzerland; [Kaiser, Christoph] Univ Hosp Basel, Dept Cardiol, Basel, Switzerland; [Cuculi, Florim] Luzerner Kantonsspital, Dept Cardiol, Luzern, Switzerland; [Juni, Peter] Univ Toronto, Appl Hlth Res Ctr, St Michaels Hosp, Dept Med,Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Juni, Peter] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Naples Federico II; University of Geneva; Triemli Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Basel; Lucerne Cantonal Hospital; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Pilgrim, T (corresponding author), Univ Bern, Inselspital, Dept Cardiol, CH-3010 Bern, Switzerland.	thomas.pilgrim@insel.ch	Juni, Peter/Q-8700-2016; Pilgrim, Thomas/AAS-9120-2021; Kaiser, Christoph/AAA-9284-2022; Piccolo, Raffaele/AAA-7871-2019	Juni, Peter/0000-0002-5985-0670; Pilgrim, Thomas/0000-0001-8721-4068; Piccolo, Raffaele/0000-0002-3124-9912; Heg, Dik/0000-0002-8766-7945	Clinical Trials Unit of the University of Bern; Biotronik	Clinical Trials Unit of the University of Bern; Biotronik	Clinical Trials Unit of the University of Bern and Biotronik.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Bangalore S, 2018, CIRCULATION, V138, P2216, DOI 10.1161/CIRCULATIONAHA.118.034456; Barlis P, 2010, EUR HEART J, V31, P165, DOI 10.1093/eurheartj/ehp480; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Hamon M, 2013, EUROINTERVENTION, V8, P1006, DOI 10.4244/EIJV8I9A155; Han YL, 2014, JACC-CARDIOVASC INTE, V7, P1352, DOI 10.1016/j.jcin.2014.09.001; Iglesias JF, 2018, EUROINTERVENTION, V14, P692, DOI 10.4244/EIJ-D-17-00734; Iqbal J, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002230; Jakobsen L, 2017, EUROINTERVENTION, V13, P1337, DOI 10.4244/EIJ-D-17-00434; Jensen LO, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003610; Jensen LO, 2016, J AM COLL CARDIOL, V67, P751, DOI 10.1016/j.jacc.2015.11.051; Kandzari DE, 2017, LANCET, V390, P1843, DOI 10.1016/S0140-6736(17)32249-3; Kereiakes DJ, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002372; Kufner S, 2016, JACC-CARDIOVASC INTE, V9, P784, DOI 10.1016/j.jcin.2016.01.009; Kufner S, 2016, EUROINTERVENTION, V11, P1372, DOI 10.4244/EIJY14M11_02; Lefevre T, 2018, JACC-CARDIOVASC INTE, V11, P995, DOI 10.1016/j.jcin.2018.04.014; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Maeng M, 2014, LANCET, V383, P2047, DOI 10.1016/S0140-6736(14)60405-0; Piccolo R, 2016, JACC-CARDIOVASC INTE, V9, P981, DOI 10.1016/j.jcin.2016.02.044; Pilgrim T, 2016, EUROINTERVENTION, V12, pE1343, DOI 10.4244/EIJY15M12_09; Pilgrim T, 2014, LANCET, V384, P2111, DOI 10.1016/S0140-6736(14)61038-2; Pilgrim T, 2014, AM HEART J, V168, P256, DOI 10.1016/j.ahj.2014.06.004; Prineas R, 1982, CIRCULATION; Saito S, 2014, EUR HEART J, V35, P2021, DOI 10.1093/eurheartj/ehu210; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Smits PC, 2015, JACC-CARDIOVASC INTE, V8, P1157, DOI 10.1016/j.jcin.2015.03.028; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Teeuwen K, 2017, JACC-CARDIOVASC INTE, V10, P133, DOI 10.1016/j.jcin.2016.10.017; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; von Birgelen C, 2017, JAMA CARDIOL, V2, P268, DOI 10.1001/jamacardio.2016.5190; von Birgelen C, 2016, LANCET, V388, P2607, DOI 10.1016/S0140-6736(16)31920-1; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Wijns W, 2018, EUROINTERVENTION, V14, P343, DOI 10.4244/EIJ-D-18-00358; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Windecker S, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001441; Xaplanteris P, 2018, NEW ENGL J MED, V379, P250, DOI 10.1056/NEJMoa1803538; Zbinden R, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003255; Zocca P, 2018, JACC-CARDIOVASC INTE, V11, P462, DOI 10.1016/j.jcin.2017.11.031	38	79	81	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2018	392	10149					737	746		10.1016/S0140-6736(18)31715-X	http://dx.doi.org/10.1016/S0140-6736(18)31715-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS0VL	30170848				2022-12-28	WOS:000443226900025
J	Murphy, D				Murphy, Declan			Doctors call for tighter UK rules on tissue importation after controversial Real Bodies exhibition	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Murphy, Declan C/0000-0001-9295-7712				Carey A, 2018, CALLS CLOSE REAL BOD; Dai SP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h239; Griffiths J, 2016, CNN              JUN; Kajinek M., 2017, EPOCH TIMES; Mao F, 2018, BBC NEWS; Shepherd A, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3329	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2018	362								k3668	10.1136/bmj.k3668	http://dx.doi.org/10.1136/bmj.k3668			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5YZ	30154122				2022-12-28	WOS:000443756600009
J	Obadia, JF; Messika-Zeitoun, D; Leurent, G; Iung, B; Bonnet, G; Piriou, N; Lefevre, T; Piot, C; Rouleau, F; Carrie, D; Nejjari, M; Ohlmann, P; Leclercq, F; Saint Etienne, C; Teiger, E; Leroux, L; Karam, N; Michel, N; Gilard, M; Donal, E; Trochu, JN; Cormier, B; Armoiry, X; Boutitie, F; Maucort-Boulch, D; Barnel, C; Samson, G; Guerin, P; Vahanian, A; Mewton, N				Obadia, J. -F.; Messika-Zeitoun, D.; Leurent, G.; Iung, B.; Bonnet, G.; Piriou, N.; Lefevre, T.; Piot, C.; Rouleau, F.; Carrie, D.; Nejjari, M.; Ohlmann, P.; Leclercq, F.; Saint Etienne, C.; Teiger, E.; Leroux, L.; Karam, N.; Michel, N.; Gilard, M.; Donal, E.; Trochu, J. -N.; Cormier, B.; Armoiry, X.; Boutitie, F.; Maucort-Boulch, D.; Barnel, C.; Samson, G.; Guerin, P.; Vahanian, A.; Mewton, N.		MITRA-FR Investigators	Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FAILURE ASSOCIATION HFA; VALVULAR HEART-DISEASE; VALVE REPAIR; EUROPEAN-SOCIETY; TASK-FORCE; GUIDELINES; MANAGEMENT; IMPACT; ESC; DIAGNOSIS	BACKGROUND In patients who have chronic heart failure with reduced left ventricular ejection fraction, severe secondary mitral-valve regurgitation is associated with a poor prognosis. Whether percutaneous mitral-valve repair improves clinical outcomes in this patient population is unknown. METHODS We randomly assigned patients who had severe secondary mitral regurgitation (defined as an effective regurgitant orifice area of > 20 mm(2) or a regurgitant volume of > 30 ml per beat), a left ventricular ejection fraction between 15 and 40%, and symptomatic heart failure, in a 1:1 ratio, to undergo percutaneous mitral-valve repair in addition to receiving medical therapy (intervention group; 152 patients) or to receive medical therapy alone (control group; 152 patients). The primary efficacy outcome was a composite of death from any cause or unplanned hospitalization for heart failure at 12 months. RESULTS At 12 months, the rate of the primary outcome was 54.6% (83 of 152 patients) in the intervention group and 51.3% (78 of 152 patients) in the control group (odds ratio, 1.16; 95% confidence interval [CI], 0.73 to 1.84; P = 0.53). The rate of death from any cause was 24.3% (37 of 152 patients) in the intervention group and 22.4% (34 of 152 patients) in the control group (hazard ratio, 1.11; 95% CI, 0.69 to 1.77). The rate of unplanned hospitalization for heart failure was 48.7% (74 of 152 patients) in the intervention group and 47.4% (72 of 152 patients) in the control group (hazard ratio, 1.13; 95% CI, 0.81 to 1.56). CONCLUSIONS Among patients with severe secondary mitral regurgitation, the rate of death or unplanned hospitalization for heart failure at 1 year did not differ significantly between patients who underwent percutaneous mitral-valve repair in addition to receiving medical therapy and those who received medical therapy alone.	[Obadia, J. -F.] Hop Cardiovasc & Pneumol Louis Pradel, Chirurg Cardiovasc & Transplantat Cardiaque, 28 Ave Doyen Lepine, F-69677 Bron, France; [Armoiry, X.] Hosp Civils Lyon, Pharm Dept, Lyon, France; [Armoiry, X.] Hosp Civils Lyon, Lab Mateis, Lyon, France; [Barnel, C.; Samson, G.; Mewton, N.] Hosp Civils Lyon, Hop Cardiovasc Louis Pradel, Clin Invest Ctr, Lyon, France; [Barnel, C.; Samson, G.; Mewton, N.] Hosp Civils Lyon, Heart Failure Dept, INSERM 1407, Lyon, France; [Barnel, C.; Samson, G.; Mewton, N.] Claude Bernard Univ, Lyon, France; [Messika-Zeitoun, D.; Iung, B.; Vahanian, A.] Hop Bichat Claude Bernard, AP HP, Paris, France; [Karam, N.] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Leurent, G.; Donal, E.] CHU Rennes, Hop Pontchaillou, Rennes, France; [Bonnet, G.] Hop La Timone, AP HM, Marseille, France; [Michel, N.] Hop St Joseph, Marseille, France; [Piriou, N.; Trochu, J. -N.; Guerin, P.] CHU Nantes, Hop Guillaume & Rene Laennec, Nantes, France; [Lefevre, T.; Cormier, B.] Inst Jacques Cartier, Massy, France; [Piot, C.] Clin Millenaire, Montpellier, France; [Leclercq, F.] CHU Montpellier, Hop Arnaud de Villeneuve, Montpellier, France; [Rouleau, F.] CHU Angers, Angers, France; [Carrie, D.] CHU Toulouse, Hop Rangueil, Toulouse, France; [Nejjari, M.] Ctr Cardiol Nord, St Denis, France; [Ohlmann, P.] Hop Univ Strasbourg, Nouvel Hop Civil, Strasbourg, France; [Saint Etienne, C.] CHRU Tours, Hop Trousseau, Tours, France; [Teiger, E.] Hop Henri Mondor, AP HP, Creteil, France; [Leroux, L.] CHU Bordeaux, Hop Haut Leveque, Pessac, France; [Gilard, M.] CHRU Brest, Hop La Cavale Blanche, Brest, France; [Boutitie, F.; Maucort-Boulch, D.] Hosp Civils Lyon, CNRS, Pole Sante Publ, Serv Biostat Bioinformat, Villeurbanne, France; [Boutitie, F.; Maucort-Boulch, D.] Equipe Biostat Sante, Lab Biomet & Biol Evolut, Villeurbanne, France; [Messika-Zeitoun, D.] Univ Ottawa Heart Inst, Div Cardiol, Ottawa, ON, Canada	CHU Lyon; CHU Lyon; CHU Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; CHU Lyon; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Nantes Universite; CHU de Nantes; Jacques Cartier Private Hospital; Universite de Montpellier; CHU de Montpellier; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Toulouse; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU Bordeaux; CHU Brest; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CHU Lyon; VetAgro Sup; University of Ottawa; University of Ottawa Heart Institute	Obadia, JF (corresponding author), Hop Cardiovasc & Pneumol Louis Pradel, Chirurg Cardiovasc & Transplantat Cardiaque, 28 Ave Doyen Lepine, F-69677 Bron, France.	jean-francois.obadia@chu-lyon.fr	Carmen, Team3/Y-7384-2019; Piriou, Nicolas/D-9154-2015; Juillière, Yves/AAG-1038-2020; Karam, Nicole/AAP-9686-2021; Moceri, Pamela/D-3053-2014; Leurent, Guillaume/AAQ-4697-2021; donal, erwan/ABC-9736-2020; Nicolas, Piriou/CAH-2512-2022; Iung, Bernard/AAQ-9004-2020; Coisne, Augustin/R-6567-2018	Carmen, Team3/0000-0002-3614-0924; Piriou, Nicolas/0000-0002-6677-6552; Juillière, Yves/0000-0002-6101-7530; Moceri, Pamela/0000-0002-0741-1609; Nicolas, Piriou/0000-0002-6677-6552; Iung, Bernard/0000-0002-9127-348X; DIDIER, Romain/0000-0001-6214-7612; Coisne, Augustin/0000-0002-1662-7874; Baruteau, Alban-Elouen/0000-0003-2548-7858; Sportouch, Catherine/0000-0001-5079-5874; Lab, Carmen/0000-0002-5935-3236; Pathak, Atul/0000-0001-6151-0096; Gilard, Martine/0000-0002-2794-7953; Karam, Nicole/0000-0002-3861-6914; Piot, Christophe/0000-0001-7497-0294; CARRIE, didier/0000-0003-2479-8144; patrick, nataf/0000-0002-8412-6182; Le Ven, Florent/0000-0003-0555-1816; LAVIE-BADIE, Yoan/0000-0002-8310-4512; TEIGER, emmanuel/0000-0001-7515-4344	French Ministry of Health and Research National Program; Abbott Vascular	French Ministry of Health and Research National Program; Abbott Vascular(Abbott Laboratories)	Supported by the French Ministry of Health and Research National Program and Abbott Vascular.	Armoiry X, 2013, ARCH CARDIOVASC DIS, V106, P287, DOI 10.1016/j.acvd.2013.03.059; Baldus S, 2012, EUR J HEART FAIL, V14, P1050, DOI 10.1093/eurjhf/hfs079; Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391; Buzzatti N, 2016, J THORAC CARDIOV SUR, V151, P88, DOI 10.1016/j.jtcvs.2015.09.099; Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355; Geis NA, 2018, EUR J HEART FAIL, V20, P598, DOI 10.1002/ejhf.910; Glower DD, 2014, J AM COLL CARDIOL, V64, P172, DOI 10.1016/j.jacc.2013.12.062; Goel SS, 2014, J AM COLL CARDIOL, V63, P185, DOI 10.1016/j.jacc.2013.08.723; Goliasch G, 2018, EUR HEART J, V39, P39, DOI 10.1093/eurheartj/ehx402; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Maisano F, 2013, J AM COLL CARDIOL, V62, P1052, DOI 10.1016/j.jacc.2013.02.094; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Mendirichaga R, 2017, AM J CARDIOL, V120, P708, DOI 10.1016/j.amjcard.2017.05.041; Nickenig G, 2014, J AM COLL CARDIOL, V64, P875, DOI 10.1016/j.jacc.2014.06.1166; Nishimura RA, 2017, CIRCULATION, V135, pE1159, DOI 10.1161/CIR.0000000000000503; Obadia JF, 2015, EUROINTERVENTION, V10, P1354, DOI 10.4244/EIJV10I11A232; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rossi A, 2011, HEART, V97, P1675, DOI 10.1136/hrt.2011.225789; Stone GW, 2015, J AM COLL CARDIOL, V66, P308, DOI 10.1016/j.jacc.2015.05.049; Trichon BH, 2003, AM J CARDIOL, V91, P538, DOI 10.1016/S0002-9149(02)03301-5; Vahanian A, 2012, EUR J CARDIO-THORAC, V42, pS1, DOI 10.1093/ejcts/ezs455; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wu AH, 2005, J AM COLL CARDIOL, V45, P381, DOI 10.1016/j.jacc.2004.09.073	25	1019	1033	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2018	379	24					2297	2306		10.1056/NEJMoa1805374	http://dx.doi.org/10.1056/NEJMoa1805374			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD9HM	30145927	Bronze			2022-12-28	WOS:000452872600005
J	Hopkins, BD; Pauli, C; Du, X; Wang, DG; Li, X; Wu, D; Amadiume, SC; Goncalves, MD; Hodakoski, C; Lundquist, MR; Bareja, R; Ma, Y; Harris, EM; Sboner, A; Beltran, H; Rubin, MA; Mukherjee, S; Cantley, LC				Hopkins, Benjamin D.; Pauli, Chantal; Du, Xing; Wang, Diana G.; Li, Xiang; Wu, David; Amadiume, Solomon C.; Goncalves, Marcus D.; Hodakoski, Cindy; Lundquist, Mark R.; Bareja, Rohan; Ma, Yan; Harris, Emily M.; Sboner, Andrea; Beltran, Himisha; Rubin, Mark A.; Mukherjee, Siddhartha; Cantley, Lewis C.			Suppression of insulin feedback enhances the efficacy of PI3K inhibitors (vol 560, pg 499, 2018)	NATURE			English	Correction													Goncalves, Marcus/L-6073-2019; Bareja, Rohan/AAP-7336-2020	Goncalves, Marcus/0000-0002-0784-9248; 				Hopkins BD, 2018, NATURE, V560, P499, DOI 10.1038/s41586-018-0343-4	1	4	4	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2018	563	7731					E24	E24		10.1038/s41586-018-0506-3	http://dx.doi.org/10.1038/s41586-018-0506-3			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA2EY	30158705	Bronze			2022-12-28	WOS:000450048400012
J	Meltzer-Brody, S; Colquhoun, H; Riesenberg, R; Epperson, CN; Deligiannidis, KM; Rubinow, DR; Li, HH; Sankoh, AJ; Clemson, C; Schacterle, A; Jonas, J; Kanes, S				Meltzer-Brody, Samantha; Colquhoun, Helen; Riesenberg, Robert; Epperson, C. Neill; Deligiannidis, Kristina M.; Rubinow, David R.; Li, Haihong; Sankoh, Abdul J.; Clemson, Christine; Schacterle, Amy; Jonas, Jeffrey; Kanes, Stephen			Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials	LANCET			English	Article							PERINATAL MENTAL-HEALTH; RATING-SCALE; POSTNATAL DEPRESSION; MATERNAL DEPRESSION; MAJOR DEPRESSION; SELF-REPORT; ALL-CAUSE; PREGNANCY; WOMEN; DISORDERS	Background Post-partum depression is associated with substantial morbidity, and improved pharmacological treatment options are urgently needed. We assessed brexanolone injection (formerly SAGE-547 injection), a positive allosteric modulator of gamma-aminobutyric-acid type A (GABA(A)) receptors, for the treatment of moderate to severe post-partum depression. Methods We did two double-blind, randomised, placebo-controlled, phase 3 trials, at 30 clinical research centres and specialised psychiatric units in the USA. Eligible women were aged 18-45 years, 6 months post part-um or less at screening, with post-partum depression and a qualifying 17-item Hamilton Rating Scale for Depression (HAM-D) score (>= 26 for study 1; 20-25 for study 2). Women with renal failure requiring dialysis, anaemia, known allergy to allopregnanolone or to progesterone, or medical history of schizophrenia, bipolar disorder, or schizoaffective disorder were excluded. Patients were randomly assigned (1:1:1) to receive a single intravenous injection of either brexanolone 90 mu g/kg per h (BRX90), brexanolone 60 mu g/kg per h (BRX60), or matching placebo for 60 h in study 1, or (1:1) BRX90 or matching placebo for 60 h in study 2. Patients, the study team, site staff, and the principal investigator were masked to treatment allocation. The primary efficacy endpoint was the change from baseline in the 17-item HAM-D total score at 60 h, assessed in all patients who started infusion of study drug or placebo, had a valid HAM-D baseline assessment, and had at least one post-baseline HAM-D assessment. The safety population included all randomised patients who started infusion of study drug or placebo. Patients were followed up until day 30. The trials have been completed and are registered with ClinicalTrials.gov, numbers NCT02942004 (study 1) and NCT02942017 (study 2). Findings Participants were enrolled between Aug 1, 2016, and Oct 19, 2017, in study 1, and between July 25, 2016, and Oct 11, 2017, in study 2. We screened 375 women simultaneously across both studies, of whom 138 were randomly assigned to receive either BRX90 (n=45), BRX60 (n=47), or placebo (n=46) in study 1, and 108 were randomly assigned to receive BRX90 (n=54) or placebo (n=54) in study 2. In study 1, at 60 h, the least-squares (LS) mean reduction in HAM-D total score from baseline was 19.5 points (SE 1.2) in the BRX60 group and 17.7 points (1.2) in the BRX90 group compared with 14.0 points (1.1) in the placebo group (difference -5.5 [95% CI -8.8 to -2.2], p=0.0013 for the BRX60 group; -3.7 [95% CI -6.9 to -0.5], p=0.0252 for the BRX90 group). In study 2, at 60 h, the LS mean reduction in HAM-D total score from baseline was 14.6 points (SE 0.8) in the BRX90 group compared with 12.1 points (SE 0.8) for the placebo group (difference -2.5 [95% CI -4.5 to -0.5], p=0.0160). In study 1, 19 patients in the BRX60 group and 22 patients in the BRX90 group had adverse events compared with 22 patients in the placebo group. In study 2, 25 patients in the BRX90 group had adverse events compared with 24 patients in the placebo group. The most common treatment-emergent adverse events in the brexanolone groups were headache (n=7 BRX60 group and n=6 BRX90 group vs n=7 placebo group for study 1; n=9 BRX90 group vs n=6 placebo group for study 2), dizziness (n=6 BRX60 group and n=6 BRX90 group vs n=1 placebo group for study 1; n=5 BRX90 group vs n=4 placebo group for study 2), and somnolence (n=7 BRX60 group and n=2 BRX90 group vs n=3 placebo group for study 1; n=4 BRX90 group vs n=2 placebo group for study 2). In study 1, one patient in the BRX60 group had two serious adverse events (suicidal ideation and intentional overdose attempt during follow-up). In study 2, one patient in the BRX90 group had two serious adverse events (altered state of consciousness and syncope), which were considered to be treatment related. Interpretation Administration of brexanolone injection for post-partum depression resulted in significant and clinically meaningful reductions in HAM-D total score at 60 h compared with placebo, with rapid onset of action and durable treatment response during the study period. Our results suggest that brexanolone injection is a novel therapeutic drug for postpartum depression that has the potential to improve treatment options for women with this disorder.	[Meltzer-Brody, Samantha; Rubinow, David R.] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27514 USA; [Colquhoun, Helen; Li, Haihong; Sankoh, Abdul J.; Clemson, Christine; Schacterle, Amy; Jonas, Jeffrey; Kanes, Stephen] Sage Therapeut, Cambridge, MA USA; [Riesenberg, Robert] Atlanta Ctr Med Res, Atlanta, GA USA; [Epperson, C. Neill] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Deligiannidis, Kristina M.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Deligiannidis, Kristina M.] Zucker Hillside Hosp, Dept Psychiat, Glen Oaks, NY USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Pennsylvania; Pennsylvania Medicine; Northwell Health; Northwell Health	Meltzer-Brody, S (corresponding author), Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27514 USA.	samantha_meltzer-brody@med.unc.edu	Kanes, Steve/AAX-6132-2021; Deligiannidis, Kristina M./C-3654-2014; Epperson, Cynthia Neill/ABE-9424-2021; Kanes, Stephen/AAX-5531-2021; Meltzer-Brody, Samantha/Q-5026-2018	Deligiannidis, Kristina M./0000-0001-7439-2236; Meltzer-Brody, Samantha/0000-0002-8509-408X	Sage Therapeutics, Inc.	Sage Therapeutics, Inc.	Sage Therapeutics, Inc.	Accortt EE, 2015, MATERN CHILD HLTH J, V19, P1306, DOI 10.1007/s10995-014-1637-2; Alexander JL, 2007, J MANAGE CARE PHARM, V13, pS3; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Bauer A, 2014, COSTS PERINATAL MENT; BECH P, 1981, ACTA PSYCHIAT SCAND, V63, P290, DOI 10.1111/j.1600-0447.1981.tb00676.x; Byatt N, 2013, GEN HOSP PSYCHIAT, V35, P598, DOI 10.1016/j.genhosppsych.2013.07.011; Chesney E, 2014, WORLD PSYCHIATRY, V13, P153, DOI 10.1002/wps.20128; Cox EQ, 2016, J CLIN PSYCHIAT, V77, P1189, DOI 10.4088/JCP.15r10174; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Di Florio A, 2017, PSYCHOL MED, V47, P787, DOI 10.1017/S0033291716002087; Earls MF, 2010, PEDIATRICS, V126, P1032, DOI 10.1542/peds.2010-2348; Fellmeth G, 2017, BJOG-INT J OBSTET GY, V124, P742, DOI 10.1111/1471-0528.14184; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; First M.B., 2014, STRUCTURED CLIN INTE; Flynn HA, 2004, GEN HOSP PSYCHIAT, V26, P316, DOI 10.1016/j.genhosppsych.2004.03.009; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; GIBBONS RD, 1993, J PSYCHIATR RES, V27, P259, DOI 10.1016/0022-3956(93)90037-3; Goodman SH, 2008, INFANT MENT HEALTH J, V29, P492, DOI 10.1002/imhj.20188; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hantsoo L, 2014, PSYCHOPHARMACOLOGY, V231, P939, DOI 10.1007/s00213-013-3316-1; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Johannsen BMW, 2016, AM J PSYCHIAT, V173, P635, DOI 10.1176/appi.ajp.2015.14121510; Kanes S, 2017, LANCET, V390, P480, DOI 10.1016/S0140-6736(17)31264-3; Kanes SJ, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2576; Kauppi A, 2008, ARCH WOMEN MENT HLTH, V11, P201, DOI 10.1007/s00737-008-0013-x; Khan A, 2002, INT CLIN PSYCHOPHARM, V17, P281, DOI 10.1097/00004850-200211000-00003; Khan A, 2017, WORLD PSYCHIATRY, V16, P181, DOI 10.1002/wps.20421; Kim DR, 2014, EXPERT OPIN PHARMACO, V15, P1223, DOI 10.1517/14656566.2014.911842; Ko JY, 2017, MMWR-MORBID MORTAL W, V66, P153, DOI 10.15585/mmwr.mm6606a1; Luisi S, 2000, J CLIN ENDOCR METAB, V85, P2429, DOI 10.1210/jc.85.7.2429; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; MAIER W, 1985, PHARMACOPSYCHIATRY, V18, P114, DOI 10.1055/s-2007-1017335; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Melon LC, 2018, PSYCHONEUROENDOCRINO, V90, P182, DOI 10.1016/j.psyneuen.2017.12.003; Meltzer-Brody S, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.22; Meltzer-Brody S, 2014, OBSTET GYNECOL, V124, P653, DOI 10.1097/AOG.0000000000000498; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Mody I, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00004; Molyneaux E, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004363.pub3; Molyneaux E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002018.pub2; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murray L., 2010, WILEY BLACKWELL HDB, V2, P192, DOI [10.1002/9781444327588.ch8, DOI 10.1002/9781444327588.CH8]; Muzik M, 2017, J AFFECT DISORDERS, V207, P242, DOI 10.1016/j.jad.2016.08.035; Netsi E, 2018, JAMA PSYCHIAT, V75, P247, DOI 10.1001/jamapsychiatry.2017.4363; NICE, 2014, ANT POSTN MENT HLTH; O'Connor E, 2016, JAMA-J AM MED ASSOC, V315, P388, DOI 10.1001/jama.2015.18948; Osborne LM, 2017, PSYCHONEUROENDOCRINO, V79, P116, DOI 10.1016/j.psyneuen.2017.02.012; Pancheri P, 2002, J AFFECT DISORDERS, V68, P41, DOI 10.1016/S0165-0327(00)00328-1; Parsons CE, 2012, BRIT MED BULL, V101, P57, DOI 10.1093/bmb/ldr047; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Pearson RM, 2013, JAMA PSYCHIAT, V70, P1312, DOI 10.1001/jamapsychiatry.2013.2163; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Putnam K, 2015, LANCET PSYCHIAT, V2, P59, DOI 10.1016/S2215-0366(14)00055-8; Serati M, 2016, J AFFECT DISORDERS, V193, P391, DOI 10.1016/j.jad.2016.01.027; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Szegda K, 2014, J MATERN-FETAL NEO M, V27, P960, DOI 10.3109/14767058.2013.845157; Undurraga J, 2012, NEUROPSYCHOPHARMACOL, V37, P851, DOI 10.1038/npp.2011.306; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Wisner KL, 2006, J CLIN PSYCHOPHARM, V26, P353, DOI 10.1097/01.jcp.0000227706.56870.dd	63	224	232	11	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2018	392	10152					1058	1070		10.1016/S0140-6736(18)31551-4	http://dx.doi.org/10.1016/S0140-6736(18)31551-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GU2KP	30177236				2022-12-28	WOS:000445098800028
J	Nishimasu, H; Shi, X; Ishiguro, S; Gao, LY; Hirano, S; Okazaki, S; Noda, T; Abudayyeh, OO; Gootenberg, JS; Mori, H; Oura, S; Holmes, B; Tanaka, M; Seki, M; Hirano, H; Aburatani, H; Ishitani, R; Ikawa, M; Yachie, N; Zhang, F; Nureki, O				Nishimasu, Hiroshi; Shi, Xi; Ishiguro, Soh; Gao, Linyi; Hirano, Seiichi; Okazaki, Sae; Noda, Taichi; Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Mori, Hideto; Oura, Seiya; Holmes, Benjamin; Tanaka, Mamoru; Seki, Motoaki; Hirano, Hisato; Aburatani, Hiroyuki; Ishitani, Ryuichiro; Ikawa, Masahito; Yachie, Nozomu; Zhang, Feng; Nureki, Osamu			Engineered CRISPR-Cas9 nuclease with expanded targeting space	SCIENCE			English	Article							ALTERED PAM SPECIFICITIES; RNA-GUIDED ENDONUCLEASE; STRUCTURAL BASIS; DNA CLEAVAGE; CAS9; VARIANTS; RECOGNITION; CPF1	The RNA-guided endonuclease Cas9 cleaves its target DNA and is a powerful genomeediting tool. However, the widely used Streptococcus pyogenes Cas9 enzyme (SpCas9) requires an NGG protospacer adjacent motif (PAM) for target recognition, thereby restricting the targetable genomic loci. Here, we report a rationally engineered SpCas9 variant (SpCas9-NG) that can recognize relaxed NG PAMs. The crystal structure revealed that the loss of the base-specific interaction with the third nucleobase is compensated by newly introduced non-base-specific interactions, thereby enabling the NG PAM recognition. We showed that SpCas9-NG induces indels at endogenous target sites bearing NG PAMs in human cells. Furthermore, we found that the fusion of SpCas9-NG and the activation-induced cytidine deaminase (AID) mediates the C-to-T conversion at target sites with NG PAMs in human cells.	[Nishimasu, Hiroshi; Hirano, Seiichi; Okazaki, Sae; Hirano, Hisato; Ishitani, Ryuichiro; Yachie, Nozomu; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Shi, Xi; Gao, Linyi; Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Holmes, Benjamin; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Shi, Xi; Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Holmes, Benjamin; Zhang, Feng] McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Ishiguro, Soh; Mori, Hideto; Tanaka, Mamoru; Seki, Motoaki; Aburatani, Hiroyuki; Yachie, Nozomu] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan; [Ishiguro, Soh; Mori, Hideto; Yachie, Nozomu] Keio Univ, Inst Adv Biosci, 14-1 Baba Cho, Tsuruoka, Yamagata 9970035, Japan; [Ishiguro, Soh; Mori, Hideto; Yachie, Nozomu] Keio Univ, Grad Sch Media & Governance, 5322 Endo, Fujisawa, Kanagawa 2520882, Japan; [Gao, Linyi; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Noda, Taichi; Oura, Seiya; Ikawa, Masahito] Osaka Univ, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Oura, Seiya; Ikawa, Masahito] Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan; [Ikawa, Masahito] Univ Tokyo, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan	University of Tokyo; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Tokyo; Keio University; Keio University; Massachusetts Institute of Technology (MIT); Osaka University; Massachusetts Institute of Technology (MIT); Osaka University; University of Tokyo	Nishimasu, H; Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nisimasu@bs.s.u-tokyo.ac.jp; nureki@bs.s.u-tokyo.ac.jp	NODA, Taichi/K-1785-2018; ikawa, masahito/A-5315-2009; Gootenberg, Jonathan/AAY-8174-2021; NUREKI, OSAMU/G-4960-2014; Abudayyeh, Omar/ABF-1746-2020; Macrae, Rhiannon/AAX-1536-2020	NODA, Taichi/0000-0003-0260-7861; ikawa, masahito/0000-0001-9859-6217; Gootenberg, Jonathan/0000-0003-2757-2175; Abudayyeh, Omar/0000-0002-7979-3220; Gao, Alex/0000-0002-3579-0327; Ishiguro, Soh/0000-0002-2826-2470; Oura, Seiya/0000-0002-7606-732X; Mori, Hideto/0000-0003-4849-0056	JST [JPMJPR13L8, 10814]; JSPS [26291010, 15H01463, 16J06287, 17H01394, 18H02428]; AMED [JP18gm5010001, 17g6110007h0002, 16am0301002h0003]; Takeda Science Foundation; NICHD [P01HD087157, R01HD088412]; Bill & Melinda Gates Foundation [OPP1160866]; NEDO (Genome Editing Program); NIMH [5DP1-MH100706, 1R01-MH110049]; NIDDK [5R01DK097768-03]; New York Stem Cell foundation; Simons foundation; Paul G. Allen Family foundation; Vallee foundation; CSTI, SIP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD088412, P01HD087157] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP1HL141201] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG006193, R01HG009761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706, R01MH110049] Funding Source: NIH RePORTER	JST(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); AMED; Takeda Science Foundation(Takeda Science Foundation (TSF)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NEDO (Genome Editing Program); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); New York Stem Cell foundation; Simons foundation; Paul G. Allen Family foundation; Vallee foundation; CSTI, SIP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by JST (JPMJPR13L8) and JSPS (26291010 and 15H01463) (H.N.); JSPS (16J06287) (S.I.); JSPS (17H01394), AMED (JP18gm5010001), Takeda Science Foundation, NICHD (P01HD087157 and R01HD088412), and the Bill & Melinda Gates Foundation (OPP1160866) (M.I.); NEDO (Genome Editing Program), AMED (17g6110007h0002), JST (10814) and JSPS (18H02428) (N.Y.); NIMH (5DP1-MH100706 and 1R01-MH110049), NIDDK (5R01DK097768-03), and the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee foundations (F.Z.); AMED (16am0301002h0003) and CSTI, SIP (O.N.). F.Z. is a New York Stem Cell Foundation Robertson Investigator.	Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Hirano S, 2016, MOL CELL, V61, P886, DOI 10.1016/j.molcel.2016.02.018; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	16	475	526	25	290	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2018	361	6408			SI		1259	1262		10.1126/science.aas9129	http://dx.doi.org/10.1126/science.aas9129			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU3CQ	30166441	Green Accepted, Green Submitted			2022-12-28	WOS:000445152500043
J	Jelcic, I; Al Nimer, F; Wang, J; Lentsch, V; Planas, R; Jelcic, I; Madjovski, A; Ruhrmann, S; Faigle, W; Frauenknecht, K; Pinilla, C; Santos, R; Hammer, C; Ortiz, Y; Opitz, L; Gronlund, H; Rogler, G; Boyman, O; Reynolds, R; Lutterotti, A; Khademi, M; Olsson, T; Piehl, F; Sospedra, M; Martin, R				Jelcic, Ivan; Al Nimer, Faiez; Wang, Jian; Lentsch, Verena; Planas, Raquel; Jelcic, Ilijas; Madjovski, Aleksandar; Ruhrmann, Sabrina; Faigle, Wolfgang; Frauenknecht, Katrin; Pinilla, Clemencia; Santos, Radleigh; Hammer, Christian; Ortiz, Yaneth; Opitz, Lennart; Gronlund, Hans; Rogler, Gerhard; Boyman, Onur; Reynolds, Richard; Lutterotti, Andreas; Khademi, Mohsen; Olsson, Tomas; Piehl, Fredrik; Sospedra, Mireia; Martin, Roland			Memory B Cells Activate Brain-Homing, Autoreactive CD4(+) T Cells in Multiple Sclerosis	CELL			English	Article							GENE-EXPRESSION; SELF-ANTIGENS; ANTIBODIES; LESIONS; TCR; AUTOIMMUNITY; REPERTOIRES; HOMEOSTASIS; MECHANISMS; INDUCTION	Multiple sclerosis is an autoimmune disease that is caused by the interplay of genetic, particularly the HLA-DR15 haplotype, and environmental risk factors. How these etiologic factors contribute to generating an autoreactive CD4(+) T cell repertoire is not clear. Here, we demonstrate that self-reactivity, defined as "autoproliferation'' of peripheral Th1 cells, is elevated in patients carrying the HLA-DR15 haplotype. Autoproliferation is mediated by memory B cells in a HLA-DR-dependent manner. Depletion of B cells in vitro and therapeutically in vivo by anti-CD20 effectively reduces T cell autoproliferation. T cell receptor deep sequencing showed that in vitro autoproliferating T cells are enriched for brain-homing T cells. Using an unbiased epitope discovery approach, we identified RASGRP2 as target autoantigen that is expressed in the brain and B cells. These findings will be instrumental to address important questions regarding pathogenic B-T cell interactions in multiple sclerosis and possibly also to develop novel therapies.	[Jelcic, Ivan; Al Nimer, Faiez; Wang, Jian; Lentsch, Verena; Planas, Raquel; Jelcic, Ilijas; Madjovski, Aleksandar; Faigle, Wolfgang; Ortiz, Yaneth; Lutterotti, Andreas; Sospedra, Mireia; Martin, Roland] Univ Zurich, Univ Hosp Zurich, Neurol Clin, Neuroimmunol & MS Res Sect NIMS, CH-8091 Zurich, Switzerland; [Al Nimer, Faiez; Ruhrmann, Sabrina; Khademi, Mohsen; Olsson, Tomas; Piehl, Fredrik] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, S-17176 Stockholm, Sweden; [Frauenknecht, Katrin] Univ Zurich, Univ Hosp Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Pinilla, Clemencia] TPIMS, San Diego, CA USA; [Santos, Radleigh] TPIMS, Port St Lucie, FL USA; [Hammer, Christian] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Hammer, Christian] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Opitz, Lennart] Swiss Fed Inst Technol, Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Opitz, Lennart] Univ Zurich, CH-8057 Zurich, Switzerland; [Gronlund, Hans] Karolinska Inst, Dept Clin Neurosci, Therapeut Immune Design Unit, S-17176 Stockholm, Sweden; [Rogler, Gerhard] Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Boyman, Onur] Univ Zurich, Univ Hosp Zurich, Dept Immunol, CH-8091 Zurich, Switzerland; [Reynolds, Richard] Imperial Coll London, Dept Med, Div Brain Sci, London, England	University of Zurich; University Zurich Hospital; Karolinska Institutet; University of Zurich; University Zurich Hospital; Torrey Pines Institute for Molecular Studies, California; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Karolinska Institutet; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Imperial College London	Martin, R (corresponding author), Univ Zurich, Univ Hosp Zurich, Neurol Clin, Neuroimmunol & MS Res Sect NIMS, CH-8091 Zurich, Switzerland.	roland.martin@usz.ch	Jelčić, Ilijas/K-5912-2019; SOSPEDRA, MIREIA/AAP-3106-2021; Planas, Raquel/B-6092-2019; Frauenknecht, Katrin/AAF-1638-2020; Nimer, Faiez Al/ABB-9465-2020	Jelčić, Ilijas/0000-0003-3090-7319; Planas, Raquel/0000-0002-2478-997X; Frauenknecht, Katrin/0000-0002-1372-3297; Boyman, Onur/0000-0001-8279-5545; Jelcic, Ivan/0000-0002-6187-7098; Reynolds, Richard/0000-0003-4622-4694; Lentsch, Verena/0000-0001-7440-4604; Al Nimer, Faiez/0000-0003-0937-5995; Sospedra, Mireia/0000-0001-8333-7423; Olsson, Tomas/0000-0002-2938-1877	European Research Council [ERC-2013ADG 340733]; Clinical Research Priority Program MS (CRPPMS) of the University of Zurich (UZH); Swiss National Science Foundation (SNF) Sinergia grant UnmetMS; SwissMSsociety; Swedish Society for Medical Research; Swedish Foundation for MS Research; Stavros Niarchos Foundation; SNF [3347CO-108792]; Swedish Medical Research Council [2012-2284, 2014-3077]; Knut and Alice Wallenberg Foundation; Swedish Brain Foundation; MAUS foundation; Multiple Sclerosis National Research Institute; NEURO Sweden; UK MS Society Tissue Bank [007/14]	European Research Council(European Research Council (ERC)European Commission); Clinical Research Priority Program MS (CRPPMS) of the University of Zurich (UZH); Swiss National Science Foundation (SNF) Sinergia grant UnmetMS(Swiss National Science Foundation (SNSF)); SwissMSsociety; Swedish Society for Medical Research; Swedish Foundation for MS Research; Stavros Niarchos Foundation; SNF; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Brain Foundation; MAUS foundation; Multiple Sclerosis National Research Institute; NEURO Sweden; UK MS Society Tissue Bank	This study was supported by European Research Council grant ERC-2013ADG 340733 to R. M., the Clinical Research Priority Program MS (CRPPMS) of the University of Zurich (UZH), Swiss National Science Foundation (SNF) Sinergia grant UnmetMS, a grant to Ivan Jelcic from the SwissMSsociety, grants to F.A.N. from the Swedish Society for Medical Research, Swedish Foundation for MS Research and NEURO Sweden, and a career development award from the Stavros Niarchos Foundation to K.F. G.R. received support from the SNF for the Swiss IBD Cohort Study (3347CO-108792); T.O. and F.P. received grants from the Swedish Medical Research Council (2012-2284 and 2014-3077); and T.O. received grants from the Knut and Alice Wallenberg Foundation, the Swedish Brain Foundation, and the MAUS foundation. R.S. and C.P. were supported by the Multiple Sclerosis National Research Institute. We thank the UK MS Society Tissue Bank (grant 007/14 to R.R.) for frozen MS tissue samples; I. Metz and W. Bruck (University Medical Center Gottingen) for histopathology of brain lesions; V. Tosevski (UZH) for help with sorting; R. Schlapbach, A. Bratus, and B. Roschitzki (Functional Genomics Center Zurich) for expert support; B. Kwok (Benaroya Research Institute) for providing BLS cells; N. Vilarrasa, D. Istanbullu, P. Tomas, C. Cruciani (NIMS, University Hospital Zurich, USZ), and F. Catto (USZ) for technical support; A. Kolios (USZ) for samples from psoriasis patients; members of the INIMS, University Medical Center Eppendorf, Hamburg for blood samples; M. Manz and A. Muller (USZ) for leukaphereses; M. Foege for regulatory support; and T. Eng and the staff of the MS Outpatient Clinic and Day Hospital (Neurology Clinic, USZ) for patient-care-related aspects. We thank S. Fillatreau (Universite Descartes, Paris) and C. Munz (UZH) for their helpful comments.	[Anonymous], 2017, NAT REV DRUG DISCOV; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Basdeo SA, 2017, J IMMUNOL, V198, P2249, DOI 10.4049/jimmunol.1600737; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cai GF, 2007, EUR J IMMUNOL, V37, P602, DOI 10.1002/eji.200636787; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; DAVIDSEN B, 1986, ACTA MED SCAND, V219, P113; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Duszczyszyn DA, 2006, CLIN EXP IMMUNOL, V143, P305, DOI 10.1111/j.1365-2249.2005.02990.x; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Geginat J, 2013, SEMIN IMMUNOL, V25, P252, DOI 10.1016/j.smim.2013.10.012; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Guo TN, 2015, NAT MED, V21, P407, DOI 10.1038/nm.3807; HAFLER DA, 1985, J NEUROIMMUNOL, V9, P339, DOI 10.1016/S0165-5728(85)80034-5; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hug A, 2003, J IMMUNOL, V171, P432, DOI 10.4049/jimmunol.171.1.432; JERSILD C, 1973, LANCET, V2, P1221; Kitas G D, 1988, Scand J Rheumatol Suppl, V76, P161; Kondo T, 2001, NAT IMMUNOL, V2, P932, DOI 10.1038/ni711; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Laplaud DA, 2004, BRAIN, V127, P981, DOI 10.1093/brain/awh119; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4176; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Lutterotti A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006168; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Mohme M, 2013, BRAIN, V136, P1783, DOI 10.1093/brain/awt108; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Olsson T, 2017, NAT REV NEUROL, V13, P25, DOI 10.1038/nrneurol.2016.187; Palanichamy A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008930; Paroni M, 2017, J ALLERGY CLIN IMMUN, V140, P797, DOI 10.1016/j.jaci.2016.11.045; PINILLA C, 1994, BIOCHEM J, V301, P847, DOI 10.1042/bj3010847; Planas R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00509; Planas R, 2015, ANN CLIN TRANSL NEUR, V2, P875, DOI 10.1002/acn3.218; Planas R, 2012, EUR J IMMUNOL, V42, P790, DOI 10.1002/eji.201142108; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SCHOPF RE, 1986, ARCH DERMATOL RES, V279, P89, DOI 10.1007/BF00417528; Singh SP, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0779-z; Sorensen PS, 2014, J NEUROL, V261, P1170, DOI 10.1007/s00415-014-7325-8; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sospedra M, 2010, J IMMUNOL METHODS, V353, P93, DOI 10.1016/j.jim.2009.12.006; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Toki S, 2001, J COMP NEUROL, V437, P398, DOI 10.1002/cne.1291; Tuller T, 2013, GENES IMMUN, V14, P67, DOI 10.1038/gene.2012.55; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Yamano T, 2015, IMMUNITY, V42, P1048, DOI 10.1016/j.immuni.2015.05.013; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yousef S, 2012, J IMMUNOL, V189, P3618, DOI 10.4049/jimmunol.1201612; Zhao YD, 2001, J IMMUNOL, V167, P2130, DOI 10.4049/jimmunol.167.4.2130; Zvyagin IV, 2014, P NATL ACAD SCI USA, V111, P5980, DOI 10.1073/pnas.1319389111	58	230	238	3	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	2018	175	1					85	+	100.e1	10.1016/j.cell.2018.08.011	http://dx.doi.org/10.1016/j.cell.2018.08.011			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GU2SI	30173916	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000445120000016
J	Mooley, KP; Deller, AT; Gottlieb, O; Nakar, E; Hallinan, G; Bourke, S; Frail, DA; Horesh, A; Corsi, A; Hotokezaka, K				Mooley, K. P.; Deller, A. T.; Gottlieb, O.; Nakar, E.; Hallinan, G.; Bourke, S.; Frail, D. A.; Horesh, A.; Corsi, A.; Hotokezaka, K.			Superluminal motion of a relativistic jet in the neutron-star merger GW170817	NATURE			English	Article							X-RAY; STRUCTURED JETS; SHORT GRBS; EMISSION; RADIO; COUNTERPARTS; BREAKING; 170817A	The binary neutron-star merger GW170817(1) was accompanied by radiation across the electromagnetic spectrum(2) and localized(2) to the galaxy NGC 4993 at a distance(3) of about 41 megaparsecs from Earth. The radio and X-ray afterglows of GW170817 exhibited delayed onset(4-7), a gradual increase' in the emission with time (proportional to t(0.8)) to a peak about 150 days after the merger event(9), followed by a relatively rapid decline(9,)(10). So far, various models have been proposed to explain the afterglow emission, including a choked-jet cocoon(4,8,11-13) and a successful-jet cocoon(4,8,11-18) (also called a structured jet). However, the observational data have remained inconclusive(10,15,19,20) as to whether GW170817 launched a successful relativistic jet. Here we report radio observations using very long-baseline interferometry. We find that the compact radio source associated with GW170817 exhibits superluminal apparent motion between 75 days and 230 days after the merger event. This measurement breaks the degeneracy between the choked- and successful-jet cocoon models and indicates that, although the early-time radio emission was powered by a wide-angle outflow(8) (a cocoon), the late-time emission was most probably dominated by an energetic and narrowly collimated jet (with an opening angle of less than five degrees) and observed from a viewing angle of about 20 degrees. The imaging of a collimated relativistic outflow emerging from GW170817 adds substantial weight to the evidence linking binary neutron-star mergers and short -gamma-my bursts.	[Mooley, K. P.; Frail, D. A.] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Mooley, K. P.; Hallinan, G.] Caltech, Pasadena, CA 91125 USA; [Deller, A. T.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic, Australia; [Deller, A. T.] ARC Ctr Excellence Gravitat Wave Discovery OzGrav, Hawthorn, Vic, Australia; [Gottlieb, O.; Nakar, E.] Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys & Astron, Tel Aviv, Israel; [Bourke, S.] Chalmers Univ Technol, Onsala Space Observ, Dept Space Earth & Environm, Onsala, Sweden; [Horesh, A.] Hebrew Univ Jerusalem, Racah Inst Phys, Jerusalem, Israel; [Corsi, A.] Texas Tech Univ, Dept Phys & Astron, Lubbock, TX 79409 USA; [Hotokezaka, K.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	National Radio Astronomy Observatory (NRAO); California Institute of Technology; Swinburne University of Technology; Tel Aviv University; Chalmers University of Technology; Hebrew University of Jerusalem; Texas Tech University System; Texas Tech University; Princeton University	Mooley, KP (corresponding author), Natl Radio Astron Observ, Socorro, NM 87801 USA.; Mooley, KP (corresponding author), Caltech, Pasadena, CA 91125 USA.; Gottlieb, O (corresponding author), Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys & Astron, Tel Aviv, Israel.	kunal@astro.caltech.edu; oregottlieb@gmail.com	Hotokezaka, Kenta/AAA-3890-2022; Horesh, Assaf/O-9873-2016	Horesh, Assaf/0000-0002-5936-1156; Deller, Adam/0000-0001-9434-3837; Gottlieb, Ore/0000-0003-3115-2456	Oxford Centre for Astrophysical Surveys; Hintze Family Charitable Foundation; ERC [1277/13]; ISF [1277/13]; Australian Research Council Future Fellowship [FT150100415]; NSF [AST-1654815]; I-Core Program of the Planning and Budgeting Committee; Israel Science Foundation; NSF CAREER [1455090]	Oxford Centre for Astrophysical Surveys; Hintze Family Charitable Foundation; ERC(European Research Council (ERC)European Commission); ISF(Israel Science Foundation); Australian Research Council Future Fellowship(Australian Research Council); NSF(National Science Foundation (NSF)); I-Core Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD))	We are grateful to the VLBA, VLA and GBT staff, especially M. Claussen, A. Mioduszewski, T. Minter, F. Ghigo, W. Brisken, K. O'Neill and M. McKinnon, for their support with the HSA observations. We thank V. Dhawan and P. Demorest for help with observational issues with the VLBI system at the VLA. K.P.M. thanks A. Mioduszewski, E. Momjian, E. Greisen, T. Pearson and S. Kulkarni for discussions. We thank M. Kasliwal for providing comments on the manuscript. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities. K.P.M. is currently a Jansky Fellow of the National Radio Astronomy Observatory. K.P.M. acknowledges support from the Oxford Centre for Astrophysical Surveys, which is funded through the Hintze Family Charitable Foundation, for some initial work presented here. E.N. acknowledges the support of an ERC starting grant (GRB/SN) and an ISF grant (1277/13). A.T.D. is the recipient of an Australian Research Council Future Fellowship (FT150100415). G.H. acknowledges the support of NSF award AST-1654815. A.H. acknowledges support by the I-Core Program of the Planning and Budgeting Committee and the Israel Science Foundation. A. C. acknowledges support from the NSF CAREER award number 1455090 titled 'CAREER: Radio and gravitational-wave emission from the largest explosions since the Big Bang'.	Abbott BP, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.161101; Abbott BP, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa91c9; Alexander KD, 2018, ASTROPHYS J LETT, V863, DOI 10.3847/2041-8213/aad637; Boutelier T, 2011, MON NOT R ASTRON SOC, V418, P1913, DOI 10.1111/j.1365-2966.2011.19609.x; Bromberg O, 2018, MON NOT R ASTRON SOC, V475, P2971, DOI 10.1093/mnras/stx3316; Condon JJ, 1997, PUBL ASTRON SOC PAC, V109, P166, DOI 10.1086/133871; Corsi A, 2018, ASTROPHYS J LETT, V861, DOI 10.3847/2041-8213/aacdfd; D'Avanzo P, 2018, ASTRON ASTROPHYS, V613, DOI 10.1051/0004-6361/201832664; Dobie D, 2018, ASTROPHYS J LETT, V858, DOI 10.3847/2041-8213/aac105; Eichler D, 2017, ASTROPHYS J LETT, V851, DOI 10.3847/2041-8213/aa9aec; Fong W, 2015, ASTROPHYS J, V815, DOI 10.1088/0004-637X/815/2/102; Gill R, 2018, MON NOT R ASTRON SOC, V478, P4128, DOI 10.1093/mnras/sty1214; Gottlieb O, 2018, MON NOT R ASTRON SOC, V479, P588, DOI 10.1093/mnras/sty1462; Gottlieb O, 2018, MON NOT R ASTRON SOC, V473, P576, DOI 10.1093/mnras/stx2357; Granot J, 2012, MON NOT R ASTRON SOC, V421, P570, DOI 10.1111/j.1365-2966.2011.20335.x; Greisen E.W., 2003, INFORM HANDLING ASTR, P109; Haggard D, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa8ede; Hallinan G, 2017, SCIENCE, V358, P1579, DOI 10.1126/science.aap9855; Hjorth J, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa9110; Hotokezaka K, 2018, PREPRINT; Kasliwal MM, 2017, SCIENCE, V358, P1559, DOI 10.1126/science.aap9455; Kathirgamaraju A, 2018, MON NOT R ASTRON SOC, V473, pL121, DOI 10.1093/mnrasl/slx175; Lamb GP, 2017, MON NOT R ASTRON SOC, V472, P4953, DOI 10.1093/mnras/stx2345; Lazzati D, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.241103; Lazzati D, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa8f3d; LIND KR, 1985, ASTROPHYS J, V295, P358, DOI 10.1086/163380; Lyman JD, 2018, NAT ASTRON, V2, P751, DOI 10.1038/s41550-018-0511-3; Margutti R, 2018, ASTROPHYS J LETT, V856, DOI 10.3847/2041-8213/aab2ad; Margutti R, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa9057; Mooley KP, 2018, NATURE, V554, P207, DOI 10.1038/nature25452; Nakar E., 2018, PREPRINT; Nakar E, 2018, MON NOT R ASTRON SOC, V478, P407, DOI 10.1093/mnras/sty952; Pozanenko AS, 2018, ASTROPHYS J LETT, V852, DOI 10.3847/2041-8213/aaa2f6; Pradel N, 2006, ASTRON ASTROPHYS, V452, P1099, DOI 10.1051/0004-6361:20053021; Resmi L, 2018, PREPRINT; Ryan G., 2018, ASTRON TELEGR, P11619; Shepherd MC, 1997, ASTR SOC P, V125, P77; Taylor G, 2004, AIP CONF PROC, V727, P324, DOI 10.1063/1.1810857; Tingay SJ, 2001, ASTRON J, V122, P1697, DOI 10.1086/323097; Troja E, 2018, MON NOT R ASTRON SOC, V478, pL18, DOI 10.1093/mnrasl/sly061; Troja E, 2017, NATURE, V551, P71, DOI 10.1038/nature24290; TZIOUMIS AK, 1989, ASTRON J, V98, P36, DOI 10.1086/115124; Wanderman D, 2015, MON NOT R ASTRON SOC, V448, P3026, DOI 10.1093/mnras/stv123; Xie XY, 2018, ASTROPHYS J, V863, DOI 10.3847/1538-4357/aacf9c	45	290	292	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2018	561	7723					355	+		10.1038/s41586-018-0486-3	http://dx.doi.org/10.1038/s41586-018-0486-3			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU1HZ	30185904	Green Accepted, Green Submitted			2022-12-28	WOS:000445011500046
J	de Jager, E; Goralnick, E; McCarty, JC; Hashmi, ZG; Jarman, MP; Haider, AH				de Jager, Elzerie; Goralnick, Eric; McCarty, Justin C.; Hashmi, Zain G.; Jarman, Molly P.; Haider, Adil H.			Lethality of Civilian Active Shooter Incidents With and Without Semiautomatic Rifles in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ASSAULT WEAPONS		[de Jager, Elzerie; McCarty, Justin C.; Hashmi, Zain G.; Jarman, Molly P.; Haider, Adil H.] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, 75 Francis St, Boston, MA 02115 USA; [Goralnick, Eric] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Haider, AH (corresponding author), Brigham & Womens Hosp, Ctr Surg & Publ Hlth, 75 Francis St, Boston, MA 02115 USA.	ahhaider@bwh.harvard.edu	McCarty, Justin/O-8893-2019	McCarty, Justin/0000-0003-0149-608X; de Jager, Elzerie/0000-0002-6261-8231; Jarman, Molly/0000-0001-7117-5869				COBLE YD, 1992, JAMA-J AM MED ASSOC, V267, P3067, DOI 10.1001/jama.1992.03480220085033; CUMMINGS W, 2018, US TODAY; Federal Bureau of Investigation, 2018, ACT SHOOT RES ADV LA; Koper CS, 2002, J QUANT CRIMINOL, V18, P239, DOI 10.1023/A:1016055919939	4	18	18	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2018	320	10					1034	1035		10.1001/jama.2018.11009	http://dx.doi.org/10.1001/jama.2018.11009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT2QE	30208444	Green Published, Bronze			2022-12-28	WOS:000444341400019
J	Cornwall, W				Cornwall, Warren			How triage became a dirty word	SCIENCE			English	Editorial Material																			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					965	965		10.1126/science.361.6406.965	http://dx.doi.org/10.1126/science.361.6406.965			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS7OT	30190388				2022-12-28	WOS:000443892700053
J	Escobar, H				Escobar, Herton			CULTURAL HERITAGE In a 'foretold tragedy,' fire consumes Brazil museum	SCIENCE			English	News Item																			0	12	12	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					960	960		10.1126/science.361.6406.960	http://dx.doi.org/10.1126/science.361.6406.960			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190385				2022-12-28	WOS:000443892700013
J	Morschhauser, F; Fowler, NH; Feugier, P; Bouabdallah, R; Tilly, H; Palomba, ML; Fruchart, C; Libby, EN; Casasnovas, RO; Flinn, IW; Haioun, C; Maisonneuve, H; Ysebaert, L; Bartlett, NL; Bouabdallah, K; Brice, P; Ribrag, V; Daguindau, N; Le Gouill, S; Pica, GM; Garcia-Sancho, AM; Lopez-Guillermo, A; Larouche, JF; Ando, K; da Silva, MG; Andre, M; Zachee, P; Sehn, LH; Tobinai, K; Cartron, G; Liu, D; Wang, J; Xerri, L; Salles, GA				Morschhauser, F.; Fowler, N. H.; Feugier, P.; Bouabdallah, R.; Tilly, H.; Palomba, M. L.; Fruchart, C.; Libby, E. N.; Casasnovas, R-O.; Flinn, I. W.; Haioun, C.; Maisonneuve, H.; Ysebaert, L.; Bartlett, N. L.; Bouabdallah, K.; Brice, P.; Ribrag, V.; Daguindau, N.; Le Gouill, S.; Pica, G. M.; Martin Garcia-Sancho, A.; Lopez-Guillermo, A.; Larouche, J-F.; Ando, K.; Gomes da Silva, M.; Andre, M.; Zachee, P.; Sehn, L. H.; Tobinai, K.; Cartron, G.; Liu, D.; Wang, J.; Xerri, L.; Salles, G. A.		RELEVANCE Trial Investigators	Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MANTLE CELL LYMPHOMA; 1ST-LINE TREATMENT; OPEN-LABEL; INDOLENT; IKAROS; IMMUNOCHEMOTHERAPY; POMALIDOMIDE; DEGRADATION; PHASE-3; AIOLOS	BACKGROUND Rituximab plus chemotherapy has been shown to be effective in patients with advanced-stage, previously untreated follicular lymphoma; nevertheless, most patients will have a relapse. Combination immunotherapy with lenalidomide and rituximab is an immunomodulatory regimen that has shown promising activity in patients with indolent B-cell non-Hodgkin's lymphoma. METHODS We conducted this multicenter, international, phase 3 superiority trial to evaluate rituximab plus lenalidomide, as compared with rituximab plus chemotherapy, in patients with previously untreated follicular lymphoma. Patients were randomly assigned to receive one of the two regimens, followed by maintenance monotherapy with rituximab. Treatment with rituximab plus lenalidomide consisted of 18 cycles of the two drugs, followed by rituximab maintenance therapy every 8 weeks for 12 cycles (six additional doses). Treatment with rituximab plus chemotherapy consisted of the investigator's choice of one of three rituximab-based regimens, followed by maintenance monotherapy with rituximab every 8 weeks for 12 cycles. The primary end points were complete response (confirmed or unconfirmed) at 120 weeks and progression-free survival. RESULTS A total of 1030 patients were randomly assigned to receive rituximab plus lenalidomide (513 patients) or rituximab plus chemotherapy (517 patients). The rate of confirmed or unconfirmed complete response at 120 weeks was similar in the two groups: 48% (95% confidence interval [CI], 44 to 53) in the rituximab-lenalidomide group and 53% (95% CI, 49 to 57) in the rituximab-chemotherapy group (P = 0.13). The interim 3-year rate of progression-free survival was 77% (95% CI, 72 to 80) and 78% (95% CI, 74 to 82), respectively. A higher percentage of patients in the rituximabchemotherapy group had grade 3 or 4 neutropenia (32% vs. 50%) and febrile neutropenia of any grade (2% vs. 7%), and a higher percentage of patients in the rituximab-lenalidomide group had grade 3 or 4 cutaneous reactions (7% vs. 1%). CONCLUSIONS Among patients with previously untreated follicular lymphoma, efficacy results were similar with rituximab plus lenalidomide and rituximab plus chemotherapy (with both regimens followed by rituximab maintenance therapy). The safety profile differed in the two groups.	[Morschhauser, F.] Univ Lille, CHU, Grp Rech Formes Injectables & Technol Associees, Lille, France; [Feugier, P.] CHU Reg Nancy, Serv Hematol, Vandoeuvre Les Nancy, France; [Bouabdallah, R.] Inst Paoli Calmettes, Marseille, France; [Xerri, L.] Aix Marseille Univ, Ctr Rech Cancerol Marseille, CNRS, Dept Pathol,Inst Paoli Calmettes,INSERM, Marseille, France; [Tilly, H.] Univ Rouen, Ctr Henri Becquerel, U1245, Rouen, France; [Tilly, H.] Univ Rouen, Dept Hematol, Rouen, France; [Fruchart, C.] Inst Hematol Basse Normandie, Caen, France; [Casasnovas, R-O.] CHU Bocage, Serv Hematol Clin, Dijon, France; [Haioun, C.] Hop Henri Mondor, Unite Hemopathies Lymphoides, Creteil, France; [Maisonneuve, H.] Ctr Hosp Dept Vendee, Serv Oncohematol, La Roche Sur Yon, France; [Ysebaert, L.] Inst Univ Canc Toulouse Oncopole, Serv Hematol, Toulouse, France; [Bouabdallah, K.] CHU Bordeaux, Serv Hematol, Bordeaux, France; [Brice, P.] Hop St Louis, Serv Oncohematol, Paris, France; [Ribrag, V.] Gustave Roussy Canc, Villejuif, France; [Daguindau, N.] Ctr Hosp Annecy Genevois Serv, Annecy, France; [Le Gouill, S.] Univ Nantes, Ctr Rech Cancerol & Immunol, CNRS, Hotel Dieu,Serv Hematol Clin,INSERM, Nantes, France; [Pica, G. M.] Ctr Hosp Metropole Savoie, Serv Hematol, Chambery, France; [Cartron, G.] Univ Montpellier, CHU Montpellier, Dept Hematol, Montpellier, France; [Salles, G. A.] Univ Lyon, Ctr Hosp Lyon Sud, Hosp Civils Lyon, Pierre Benite, France; [Fowler, N. H.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Palomba, M. L.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Libby, E. N.] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA; [Flinn, I. W.] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA; [Bartlett, N. L.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA; [Martin Garcia-Sancho, A.] Hosp Univ Salamanca, Dept Hematol, Salamanca, Spain; [Martin Garcia-Sancho, A.] Ctr Invest Biomed Red Canc, Inst Invest Biomed Salamanca, Salamanca, Spain; [Lopez-Guillermo, A.] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain; [Larouche, J-F.] CHU Quebec, Hop Enfant Jesus, Quebec City, PQ, Canada; [Sehn, L. H.] Univ British Columbia, British Columbia Canc Ctr Lymphoid Canc, Vancouver, BC, Canada; [Ando, K.] Tokai Univ Hosp, Dept Hematol & Oncol, Isehara, Kanagawa, Japan; [Gomes da Silva, M.] Inst Portugues Oncol Francisco Gentil, Dept Hematol, Lisbon, Portugal; [Andre, M.] Univ Catholique Louvain Namur, CHU, Dept Hematol, Yvoir, Belgium; [Zachee, P.] Ziekenhuis Netwerk Antwerpen Stuivenberg, Dept Hematol, Antwerp, Belgium; [Tobinai, K.] Natl Canc Ctr, Dept Hematol, Tokyo, Japan; [Liu, D.; Wang, J.] Celgene, Summit, NJ USA	Universite de Lille - ISITE; CHU Lille; Universite de Lille; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Centre Henri Becquerel; Universite de Rouen Normandie; Universite de Rouen Normandie; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHD Vendee; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Annecy Genevois; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Universite de Montpellier; CHU de Montpellier; CHU Lyon; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle; Sarah Cannon Research Institute; Tennessee Oncology; Siteman Cancer Center; Washington University (WUSTL); University of Salamanca; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Barcelona; Hospital Clinic de Barcelona; Laval University; University of British Columbia; Tokai University; Portuguese Institute of Oncology; ZNA Stuivenberg; National Cancer Center - Japan; Bristol-Myers Squibb; Celgene Corporation	Morschhauser, F (corresponding author), Univ Lille, CHU Lille, EA 7365, GRITA Grp Rech Formes Injectables & Technol Assoc, F-59000 Lille, France.	franck.morschhauser@chru-lille.fr	Salles, Gilles/Z-2336-2019; Ysebaert, Loic/H-1554-2016; AndrÃ©, Marc/AAP-2355-2020; Remy, GRESSIN/G-7303-2014; Lopez-Guillermo, Armando/Z-5684-2019; DECONINCK, ERIC/AAF-3647-2021; Martín, Alejandro/B-8611-2018; , Van Eygen Koen/AAF-7668-2020; Soubeyran, Pierre-Louis/F-4523-2012	Salles, Gilles/0000-0002-9541-8666; Ysebaert, Loic/0000-0001-8478-5623; Remy, GRESSIN/0000-0002-9188-3501; DECONINCK, ERIC/0000-0002-6006-8088; Martín, Alejandro/0000-0001-6330-1028; , Van Eygen Koen/0000-0001-8285-906X; Bartlett, Nancy/0000-0001-8470-394X; Gomes da Silva, Maria/0000-0002-6993-2450; DEAU FISCHER, Benedicte/0000-0002-7468-5466; Delmer, Alain/0000-0002-1430-2574; le gouill, steven/0000-0001-9840-2128; GYAN, Emmanuel/0000-0002-7651-9189; Soubeyran, Pierre-Louis/0000-0003-3244-7299; Novelli, Silvana/0000-0001-8750-0195; Haioun, Corinne/0000-0003-0095-5379	Celgene	Celgene(Bristol-Myers SquibbCelgene Corporation)	Funded by Celgene; RELEVANCE ClinicalTrials.gov numbers, NCT01476787 and NCT01650701, and EudraCT number,2011-002792-42.	Bjorklund CC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.66; Brice P, 1997, J CLIN ONCOL, V15, P1110, DOI 10.1200/JCO.1997.15.3.1110; Casulo C, 2015, BLOOD, V125, P40, DOI 10.1182/blood-2014-04-516815; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Chiu HL, 2017, BLOOD, V130; Crawford J, 2010, ANN ONCOL, V21, pv248, DOI 10.1093/annonc/mdq195; Dumortier A, 2003, BLOOD, V101, P2219, DOI 10.1182/blood-2002-05-1336; Flinn IW, 2014, BLOOD, V123, P2944, DOI 10.1182/blood-2013-11-531327; Fowler N., 2015, HEMATOL ONCOL, V33, P200; Fowler NH, 2014, LANCET ONCOL, V15, P1311, DOI 10.1016/S1470-2045(14)70455-3; GAIL M, 1985, BIOMETRICS, V41, P361, DOI 10.2307/2530862; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Hernandez-Ilizaliturri FJ, 2005, CLIN CANCER RES, V11, P5984, DOI 10.1158/1078-0432.CCR-05-0577; HUBBARD SM, 1982, BLOOD, V59, P258; Kimby E, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.1099.1099; Kridel R, 2012, J CLIN INVEST, V122, P3424, DOI 10.1172/JCI63186; Lagrue K, 2015, BLOOD, V126, P50, DOI 10.1182/blood-2015-01-625004; Link BK, 2013, J CLIN ONCOL, V31, P3272, DOI 10.1200/JCO.2012.48.3990; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Marcus R, 2017, NEW ENGL J MED, V377, P1331, DOI 10.1056/NEJMoa1614598; Martin P, 2017, ANN ONCOL, V28, P2806, DOI 10.1093/annonc/mdx496; Ramsay AG, 2009, BLOOD, V114, P4713, DOI 10.1182/blood-2009-04-217687; Reddy N, 2008, BRIT J HAEMATOL, V140, P36, DOI 10.1111/j.1365-2141.2007.06841.x; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; SALLES GA, 2017, BLOOD S1, V130; Salles G, 2011, LANCET, V377, P42, DOI 10.1016/S0140-6736(10)62175-7; Salles Gilles A, 2007, Hematology Am Soc Hematol Educ Program, P216; Schulz H, 2007, JNCI-J NATL CANCER I, V99, P706, DOI 10.1093/jnci/djk152; Shi Q, 2017, J CLIN ONCOL, V35, P552, DOI 10.1200/JCO.2016.70.8651; Smith TJ, 2015, J CLIN ONCOL, V33, P3199, DOI 10.1200/JCO.2015.62.3488; Zhang L, 2009, AM J HEMATOL, V84, P553, DOI 10.1002/ajh.21468	31	184	189	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2018	379	10					934	947		10.1056/NEJMoa1805104	http://dx.doi.org/10.1056/NEJMoa1805104			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5XM	30184451	Bronze			2022-12-28	WOS:000443748200008
J	Munschauer, M; Nguyen, CT; Sirokman, K; Hartigan, CR; Hogstrom, L; Engreitz, JM; Ulirsch, JC; Fulco, CP; Subramanian, V; Chen, J; Schenone, M; Guttman, M; Carr, SA; Lander, ES				Munschauer, Mathias; Nguyen, Celina T.; Sirokman, Klara; Hartigan, Christina R.; Hogstrom, Larson; Engreitz, Jesse M.; Ulirsch, Jacob C.; Fulco, Charles P.; Subramanian, Vidya; Chen, Jenny; Schenone, Monica; Guttman, Mitchell; Carr, Steven A.; Lander, Eric S.			The NORAD lncRNA assembles a topoisomerase complex critical for genome stability	NATURE			English	Article							RNA-BINDING PROTEIN; DNA-DAMAGE; REPLICATION STRESS; NONCODING RNAS; TRANSCRIPTION; WIDE; GENE; IDENTIFICATION; INSTABILITY; INTERACTS	The human genome contains thousands of long non-coding RNAs1, but specific biological functions and biochemical mechanisms have been discovered for only about a dozen(2-7). A specific long non-coding RNA-non-coding RNA activated by DNA damage (NORAD)-has recently been shown to be required for maintaining genomic stability(8), but its molecular mechanism is unknown. Here we combine RNA antisense purification and quantitative mass spectrometry to identify proteins that directly interact with NORAD in living cells. We show that NORAD interacts with proteins involved in DNA replication and repair in steady-state cells and localizes to the nucleus upon stimulation with replication stress or DNA damage. In particular, NORAD interacts with RBMX, a component of the DNA-damage response, and contains the strongest RBMX-binding site in the transcriptome. We demonstrate that NORAD controls the ability of RBMX to assemble a ribonucleoprotein complex-which we term NORAD-activated ribonucleoprotein complex 1 (NARC1)-that contains the known suppressors of genomic instability topoisomerase I (TOP1), ALYREF and the PRPF19-CDC5L complex. Cells depleted for NORAD or RBMX display an increased frequency of chromosome segregation defects, reduced replication-fork velocity and altered cell-cycle progression-which represent phenotypes that are mechanistically linked to TOP1 and PRPF19-CDC5L function. Expression of NORAD in trans can rescue defects caused by NORAD depletion, but rescue is significantly impaired when the RBMX-binding site in NORAD is deleted. Our results demonstrate that the interaction between NORAD and RBMX is important for NORAD function, and that NORAD is required for the assembly of the previously unknown topoisomerase complex NARC1, which contributes to maintaining genomic stability. In addition, we uncover a previously unknown function for long non-coding RNAs in modulating the ability of an RNA-binding protein to assemble a higher-order ribonucleoprotein complex.	[Munschauer, Mathias; Nguyen, Celina T.; Sirokman, Klara; Hartigan, Christina R.; Hogstrom, Larson; Engreitz, Jesse M.; Ulirsch, Jacob C.; Fulco, Charles P.; Subramanian, Vidya; Chen, Jenny; Schenone, Monica; Carr, Steven A.; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ulirsch, Jacob C.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Ulirsch, Jacob C.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA; [Ulirsch, Jacob C.] Harvard Univ, Program Biol & Biomed Sci, Cambridge, MA 02138 USA; [Chen, Jenny] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Guttman, Mitchell] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Lander, Eric S.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); California Institute of Technology; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Munschauer, M; Lander, ES (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Lander, ES (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lander, ES (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	mathias@broadinstitute.org; eric@broadinstitute.org	Carr, Steven A./AAH-8366-2019; Munschauer, Mathias/AAK-2789-2020	Munschauer, Mathias/0000-0001-6143-4548; Ulirsch, Jacob/0000-0002-7947-0827	Deutsche Forschungsgemeinschaft (DFG); Harvard Society of Fellows; NIH [DP5OD012190]; NIH 4DN program Nucleome Project [U01 DA040612, U01 HL130007]; New York Stem Cell Foundation; Edward Mallinckrodt Foundation; Sontag Foundation; Searle Scholars Program; Pew-Steward Scholars program; California Institute of Technology; Broad Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL130007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA040612] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012190] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Harvard Society of Fellows; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH 4DN program Nucleome Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; Edward Mallinckrodt Foundation; Sontag Foundation; Searle Scholars Program; Pew-Steward Scholars program; California Institute of Technology; Broad Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. A. McHugh for help setting up RAP MS; K. A. Knouse for help imaging mitotic cells; C. W. Garvie for help with size-exclusion chromatography; L. Ludwig for help with cell-cycle data visualization; L. Gaffney for artwork; T. Wang, B. Cleary, S. R. Grossman, M. Yassour, C. M. Vockley, B. Cimini, K. W. Karhohs, M. Doan, S. A. Myers, D. R. Mani and V. G. Sankaran for discussions. M. M. is supported by a Deutsche Forschungsgemeinschaft (DFG) Research Fellowship. J.M.E. is supported by the Harvard Society of Fellows. M. G. is supported by an NIH Director's Early Independence Award (DP5OD012190), the NIH 4DN program Nucleome Project (U01 DA040612 and U01 HL130007), the New York Stem Cell Foundation, the Edward Mallinckrodt Foundation, Sontag Foundation, Searle Scholars Program, Pew-Steward Scholars program and funds from the California Institute of Technology. M. G. is a NYSCF-Robertson Investigator. Work in the Lander Laboratory is supported by the Broad Institute.	Abbas M, 2014, J BIOL CHEM, V289, P14009, DOI 10.1074/jbc.M113.520056; Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Boeing S, 2016, CELL REP, V15, P1597, DOI 10.1016/j.celrep.2016.04.047; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Chen J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0880-9; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Garcia-Muse T, 2016, NAT REV MOL CELL BIO, V17, P553, DOI 10.1038/nrm.2016.88; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hu Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1026; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Lee S, 2016, CELL, V164, P69, DOI 10.1016/j.cell.2015.12.017; Li M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7720; Liu NA, 2017, NUCLEIC ACIDS RES, V45, P6051, DOI 10.1093/nar/gkx141; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahajan K, 2016, ONCOGENE, V35, P2279, DOI 10.1038/onc.2015.321; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; Matsunaga S, 2012, CELL REP, V1, P299, DOI 10.1016/j.celrep.2012.02.005; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Miao ZH, 2007, CANCER RES, V67, P8752, DOI 10.1158/0008-5472.CAN-06-4554; Mueller F, 2013, NAT METHODS, V10, P277, DOI 10.1038/nmeth.2406; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Tichon A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12209; Trincado JL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1417-1; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wiese S, 2007, PROTEOMICS, V7, P340, DOI 10.1002/pmic.200600422; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101; Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	201	204	4	70	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					132	+		10.1038/s41586-018-0453-z	http://dx.doi.org/10.1038/s41586-018-0453-z			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30150775	Green Published			2022-12-28	WOS:000443755200046
J	Trajanoska, K; Morris, JA; Oei, L; Zheng, HF; Evans, DM; Kiel, DP; Ohlsson, C; Richards, JB; Rivadeneira, F				Trajanoska, Katerina; Morris, John A.; Oei, Ling; Zheng, Hou-Feng; Evans, David M.; Kiel, Douglas P.; Ohlsson, Claes; Richards, J. Brent; Rivadeneira, Fernando		GEFOS GENOMOS Consortium; 23andMe Res Team	Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BONE-MINERAL DENSITY; BODY-MASS INDEX; VITAMIN-D SUPPLEMENTATION; HIGH-TRAUMA FRACTURES; SERUM-CALCIUM LEVELS; ALCOHOL DEPENDENCE; GLYCEMIC TRAITS; OSTEOPOROSIS; WOMEN; LOCI	OBJECTIVE To identify the genetic determinants of fracture risk and assess the role of 15 clinical risk factors on osteoporotic fracture risk. DESIGN Meta-analysis of genome wide association studies (GWAS) and a two-sample mendelian randomisation approach. SETTING 25 cohorts from Europe, United States, east Asia, and Australia with genome wide genotyping and fracture data. PARTICIPANTS A discovery set of 37 857 fracture cases and 227 116 controls; with replication in up to 147 200 fracture cases and 150 085 controls. Fracture cases were defined as individuals (> 18 years old) who had fractures at any skeletal site confirmed by medical, radiological, or questionnaire reports. Instrumental variable analyses were performed to estimate effects of 15 selected clinical risk factors for fracture in a twosample mendelian randomisation framework, using the largest previously published GWAS meta-analysis of each risk factor. RESULTS Of 15 fracture associated loci identified, all were also associated with bone mineral density and mapped to genes clustering in pathways known to be critical to bone biology (eg, SOST, WNT16, and ESR1) or novel pathways (FAM210A, GRB10, and ETS2). Mendelian bone mineral density on fracture risk. One standard deviation decrease in genetically determined bone mineral density of the femoral neck was associated with a 55% increase in fracture risk (odds ratio 1.55 (95% confidence interval 1.48 to 1.63; P= 1.5x10-68). Hand grip strength was inversely associated with fracture risk, but this result was not significant after multiple testing correction. The remaining clinical risk factors (including vitamin D levels) showed no evidence for an effect on fracture. CONCLUSIONS This large scale GWAS meta-analysis for fracture identified 15 genetic determinants of fracture, all of which also influenced bone mineral density. Among the clinical risk factors for fracture assessed, only bone mineral density showed a major causal effect on fracture. Genetic predisposition to lower levels of vitamin D and estimated calcium intake from dairy sources were not associated with fracture risk.	[Trajanoska, Katerina; Oei, Ling; Rivadeneira, Fernando] Univ Med Ctr, Dept Internal Med, Erasmus MC, Rotterdam, Netherlands; [Trajanoska, Katerina; Oei, Ling; Rivadeneira, Fernando] Univ Med Ctr, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands; [Morris, John A.; Richards, J. Brent] McGill Univ, Lady Davis Inst, Jewish Gen Hosp, Montreal, PQ, Canada; [Morris, John A.; Richards, J. Brent] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Zheng, Hou-Feng] Westlake Univ, DaP Lab Sch Life Sci, Hangzhou, Zhejiang, Peoples R China; [Zheng, Hou-Feng] Westlake Univ, Westlake Inst Adv Study, Hangzhou, Zhejiang, Peoples R China; [Zheng, Hou-Feng] Hangzhou Normal Univ, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China; [Zheng, Hou-Feng] Hangzhou Normal Univ, Affiliated Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Evans, David M.] Univ Bristol, Med Res Council Integrat Epidemiol Unit, Bristol, Avon, England; [Evans, David M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Kiel, Douglas P.] Harvard Med Sch, Hebrew SeniorLife, Inst Aging Res, Boston, MA USA; [Kiel, Douglas P.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Kiel, Douglas P.] Harvard Med Sch, Boston, MA USA; [Ohlsson, Claes] Sahlgrenska, Inst Med, Ctr Bone & Arthrit Res, Dept Internal Med, Gothenburg, Sweden	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Lady Davis Institute; McGill University; McGill University; Westlake University; Westlake University; Hangzhou Normal University; Hangzhou Normal University; University of Bristol; University of Queensland; Harvard University; Harvard Medical School; Hebrew SeniorLife; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Rivadeneira, F (corresponding author), Univ Med Ctr, Dept Internal Med, Erasmus MC, Rotterdam, Netherlands.; Rivadeneira, F (corresponding author), Univ Med Ctr, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands.; Richards, JB (corresponding author), McGill Univ, Lady Davis Inst, Jewish Gen Hosp, Montreal, PQ, Canada.; Richards, JB (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	brent.richards@mcgill.ca; f.rivadeneira@erasmusmc.nl	Oei, Ling/E-8163-2013; Balcells, Susana/C-5222-2017; Ohlsson, Claes/HIR-6959-2022; Reeve, Jonathan/C-7551-2012; Garcia-Giralt, Natalia/AAA-7588-2021; Evans, David M/H-6325-2013; Brown, Matthew A/E-5749-2010; Warrington, Nicole/P-4868-2014; Andersen, Marianne Skovsager/AAE-1751-2019; Oei, Edwin HG/E-8174-2013; Richards, J Brent/AAF-4225-2019; Rivadeneira, Fernando/O-5385-2015; van der Eerden, Bram CJ/I-7496-2012; Ackert-Bicknell, Cheryl/AAC-6833-2019; Ohlsson, Claes/AGP-3544-2022; Grinberg, Daniel/F-3641-2010; Szulc, Pawel/N-5238-2018; Gudnason, Vilmundur/K-6885-2015; Vandenput, Liesbeth/AAP-3655-2020; Duncan, Emma/L-1224-2013; Smith, Albert Vernon/K-5150-2015	Oei, Ling/0000-0003-3523-458X; Balcells, Susana/0000-0003-1211-1907; Ohlsson, Claes/0000-0002-9633-2805; Reeve, Jonathan/0000-0002-4364-2682; Garcia-Giralt, Natalia/0000-0001-6507-0147; Evans, David M/0000-0003-0663-4621; Brown, Matthew A/0000-0003-0538-8211; Warrington, Nicole/0000-0003-4195-775X; Andersen, Marianne Skovsager/0000-0002-4603-9504; Richards, J Brent/0000-0002-3746-9086; Rivadeneira, Fernando/0000-0001-9435-9441; van der Eerden, Bram CJ/0000-0003-4403-6497; Ackert-Bicknell, Cheryl/0000-0003-4253-4775; Ohlsson, Claes/0000-0002-9633-2805; Grinberg, Daniel/0000-0001-9859-2590; Szulc, Pawel/0000-0003-4168-6697; Gudnason, Vilmundur/0000-0001-5696-0084; brandi, maria luisa/0000-0002-8741-0592; Rejnmark, Lars/0000-0002-2152-4247; Vandenput, Liesbeth/0000-0002-1712-6131; Michaelsson, Karl/0000-0003-2815-1217; Ioannidis, John P./0000-0003-3118-6859; Duncan, Emma/0000-0002-8143-4403; Kim, Beom-Jun/0000-0001-8591-1759; van Meurs, Joyce/0000-0001-6245-2123; Van Duijn, Cornelia/0000-0002-2374-9204; Smith, Albert Vernon/0000-0003-1942-5845; Pettersson Kymmer, Ulrika/0000-0002-0557-9803; Nogues, Xavier/0000-0002-5537-1859; Olmos, Jose M./0000-0002-7765-0891; Trajanoska, Katerina/0000-0002-3792-4296; Kahonen, Mika/0000-0002-4510-7341; Tsilidis, Konstantinos/0000-0002-8452-8472; Kammerer, Candace M/0000-0002-2841-4761; Alipanahi, Babak/0000-0001-8216-7178; de Groot, Lisette/0000-0003-2778-2789; van der Velde, Nathalie/0000-0002-6477-6209; Liu, Ching-Ti/0000-0002-0703-0742; Forgetta, Vincenzo/0000-0002-6061-4720; marc, janja/0000-0001-6013-9758; Medina-Gomez, Carolina/0000-0001-7999-5538; Van Hul, Wim/0000-0002-5065-7858; Nethander, Maria/0000-0003-3688-906X; Formosa, Melissa/0000-0002-7852-2701; Chapurlat, Roland/0000-0001-8214-6385	European Commission [HEALTH-F2-2008-201865-GEFOS]; NIH [N01AG-12100]; NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); Icelandic Heart Association; Anglo-Australasian Osteoporosis Genetics Consortium (AOGC): National Health and Medical Research Council (Australia) [511132]; Australian Cancer Research Foundation (Australia); National Health and Medical Research Council (Australia); National Health and Medical Research Council (Australia) Career Development Award [569807]; Medical Research Council New Investigator Award [MRC G0800582]; Health Research Council of New Zealand.; Sanofi-Aventis; Eli Lilly; Novartis; Pfizer; Proctor & Gamble Pharmaceutical; Roche; National Health and Medical Research Council, Australia; Rebecca Cooper Foundation (Australia); Australian National Health and Medical Research Council; MBF Living Well foundation; Ernst Heine Family Foundation; Amgen; Eli Lilly International; GE-Lunar; Merck Australia; Sanofi-Aventis Australia; Servier; Medical Research Council UK; Arthritis Research UK; The Victorian Health Promotion Foundation; Geelong Region Medical Research Foundation; National Health and Medical Research Council, Australia [628582]; Action Research UK; Australian Research Council Future Fellowship [FT130101709]; Medical Research Council programme [MC_UU_12013/4]; The Netherlands Organisation for Health Research and Development (ZonMw), The Hague [6130.0031]; NZO (Dutch Dairy Association), Zoetermeer; Orthica, Almere; Netherlands Consortium Healthy Ageing (NCHA) Leiden/Rotterdam; Ministry of Economic Affairs, Agriculture and Innovation, The Hague [KB-15-004-003]; Wageningen University, Wageningen; VUmc, Amsterdam; Erasmus Medical Center, Rotterdam; National Heart Lung and Blood Institute (NHLBI) [HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, U01HL080295, R01HL087652, R01HL105756, R01HL103612, R01HL120393, R01HL130114]; National Institute of Neurological Disorders and Stroke (NINDS); National Center for Advancing Translational Sciences, CTSI [UL1TR000124]; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) [DK063491]; Medical Research Council [G9321536, G9800062]; MAFF [AN0523]; EU FP5 [QLK6-CT-2002-02629]; Food Standards Agency [N05046]; GEFOS EU FP7 Integrated Project [201865]; The UK's National Institute for Health Research (NIHR) Biomedical Research Centre Grant; Estonian Genome Center University of Tartu (EGCUT); EU H2020 [692145, 676550, 654248]; Estonian Research Council [IUT20-60]; NIASC and EIT-Health through the European Regional Development Fund [2014-2020.4.01.15-0012]; Netherlands Organisation for Scientific Research (NWO); Erasmus University Medical Centre; the Centre for Medical Systems Biology (CMSB1 and CMSB2) of the Netherlands Genomics Initiative (NGI); National Institute for Arthritis; Musculoskeletal and Skin Diseases and National Institute on Ageing [R01 AR41398, R01 AR 050066]; National Heart, Lung, and Blood Institute's Framingham Heart Study [N01-HC-25195, N02-HL-6-4278]; Swedish Research Council [K2010-54X-09894-19-3, 2006-3832, K2010-52X-20229-05-3]; Swedish Foundation for Strategic Research; ALF/LUA research grant in Gothenburg; Lundberg Foundation; Torsten and Ragnar Soderberg's Foundation; Vastra Gotaland Foundation; Goteborg Medical Society; Novo Nordisk Foundation; Intramural Research Program of the National Institute of Health (NIH); National Institute on Ageing; US National Institute of Ageing (NIA) [N01AG62101, N01AG62103, N01AG62106, 1R01AG032098]; Center for Inherited Disease Research (CIDR); National Institutes of Health [HHSN268200782096C]; Hong Kong Research Grant Council (HKU) [768610M]; Bone Health Fund of HKU Foundation; KC Wong Education Foundation; Committee on research and conference (CRCG) Grant; Osteoporosis and Endocrine Research Fund; Genomics Strategic Research Theme of the University of Hong Kong; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Ageing (NIA); National Center for Research Resources (NCRR); National Institute of Health (NIH) [U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, UL1 RR024140]; European Union's Seventh Framework Programme (FP7/2007-2013) [HEALTH-F2-2009-223004 PHASE]; Netherlands Organisation of Scientific Research (NWO) Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015]; Netherlands Genomics Initiative/Netherlands Consortium for Healthy Ageing [050-060-810]; German Bundesministerium fuer Forschung und Technology [01 AK 803 A-H, 01 IG 07015 G]; Netherlands Organisation for Health Research and Development ZonMw VIDI [016.136.367]; National Institute on Ageing (NIA) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01 AG005407, R01 AR35582, R01 AR35583, R01 AR35584, R01 AG005394, R01 AG027574, R01 AG027576, R01 AG026720]; NIHR Biomedical Research Centre; Chronic Disease Research Foundation; Wellcome Trust; Canadian Institutes of Health Research; Canadian Foundation for Innovation; Fonds de la Recherche en Sante Quebec; Lady Davis Institute; Jewish General Hospital; Ministere du Developpement economique, de l'Innovation et de l'Exportation du Quebec; University of Queensland [2014002959]; University of Western Australia-University of Queensland Bilateral Research Collaboration Award [2014001711]; National Health and Medical Research Council Early Career Fellowship [APP1104818]; National Heart, Lung, and Blood Institute [HL 043851, HL69757]; National Cancer Institute [CA 047988]; Donald W Reynolds Foundation; Fondation Leducq Amgen; National Heart, Lung, and Blood Institute; National Institutes of Health; US. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; Academy of Finland [286284, 134309, 126925, 121584, 124282, 129378, 117787, 41071]; Social Insurance Institution of Finland; Tampere University Hospital [X51001]; Turku University Hospital [X51001]; Kuopio University Hospital [X51001]; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association; EU Horizon 2020 [755320]; Red de Envejecimiento y fragilidad RETICEF; CIBERER; Instituto Carlos III. Fondos FEDER; Fondo de Investigacion Sanitaria [FIS PI13/00116]; Spanish MINECO [SAF2014-56562-R]; Catalan Government [2014SGR932]; BioPersMed [825329]; Competence Center CBmed [844609]; Austrian Federal Ministry of Transport, Innovation and Technology (BMVIT); Austrian Federal Ministry of Economics and Labour/ the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Styrian Business Promotion Agency (SFG; Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias [PI 06/34, PI09/539, PI12/615, PI15/521]; Healthway Health Promotion Foundation of Western Australia; Australasian Menopause Society; Australian National Health and Medical Research Council [254627, 303169, 572604]; Canadian Institutes for Health Research (CIHR) [MOP111103]; Fonds du Recherche Quebec Sante; Arthritis Research UK [15389]; EU Biomed 1 [BMHICT920182, CIPDCT925012, ERBC1PDCT 940229, ERBC1PDCT930105]; Wellcome Trust Collaborative Research Initiative 1995; UK's National Institute for Health Research (NIHR) Biomedical Research Centre; Canadian Institutes for health research [86748]; University of Athens, Greece; National Institute for Health Research (NIHR) Musculoskeletal BRU Oxford; National Institute for Health Research (NIHR) Nutrition BRC Southampton; The Hong Kong Jockey Club Charities Trust; VC discretionary fund of The Chinese University of Hong Kong; Research Grants Council [CUHK4101/02M.]; Korea Health Technology R D Project; Ministry of Health and Welfare, Republic of Korea [HI14C2258]; Republic of Korea [HI15C0377]; Netherlands Ministry of Health Welfare and Sports, Directorate of Long term Care; Merck-Sharp-Dohme Chibret company; European Union Strategic Educational Pathways Scholarhip scheme (STEPS); The Swedish Research Council [2006-3832, K201054X- 09894-19-3]; World Anti-Doping Agency; Danish Ministry of Culture; Institute of Clinical Research of the University of Southern Denmark; Slovenian research agency; Ragnar Soderberg Foundation [E9/11]; National Institute on Ageing/NIH [P01-AG005842, P01-AG005842-20S2, P30-AG012810, T32-AG000186-23]; Swedish Department of Higher Education; European Commission European Network for Genetic and Genomic Epidemiology (ENGAGE: 7th Framework Program [HEALTH-F4-2007-201413]; GenomEUtwin: 5th Framework program " Quality of Life and Management of the Living Resources" [QLG2-CT-2002-01254]; Swedish Foundation for Strategic Research [ICA08-0047]; Jan Wallander and Tom Hedelius Foundation; Swedish Council for Working Life and Social Research; Swedish Sports Research Council [87/06]; Swedish Society of Medicine; Kempe-Foundation [JCK-1021]; Medical Faculty of Umea University [ALFVLL: 968: 22-2005, ALFVL:-937-2006, ALFVLL: 223: 11-2007, ALFVLL: 78151-2009]; county council of Vasterbotten [SpjutspetsanslagVLL: 159: 33-2007]; Wellcome Trust [101123, 110141, 094134]; National Institute on Arthritis Musculoskeletal and Skin Diseases [R01 AR041398];  [R01AG023629];  [201007176237]; MRC [G9800062, MC_U147585819, MC_UU_12013/4, MR/M004422/1, MR/N003284/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL130114, R01HL120393, R01HL105756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR072199, R01AR041398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG027810, R01AG005407, R01AG026720, P30AG012810, T32AG000186, P01AG005842, R01AG023629] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Althingi (the Icelandic Parliament); Icelandic Heart Association; Anglo-Australasian Osteoporosis Genetics Consortium (AOGC): National Health and Medical Research Council (Australia); Australian Cancer Research Foundation (Australia); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (Australia) Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Research Council of New Zealand.(Health Research Council of New Zealand); Sanofi-Aventis(Sanofi-Aventis); Eli Lilly(Eli Lilly); Novartis(Novartis); Pfizer(Pfizer); Proctor & Gamble Pharmaceutical; Roche(Roche Holding); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca Cooper Foundation (Australia); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MBF Living Well foundation; Ernst Heine Family Foundation; Amgen(Amgen); Eli Lilly International(Eli Lilly); GE-Lunar(General Electric); Merck Australia; Sanofi-Aventis Australia(Sanofi-Aventis); Servier(Servier); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); The Victorian Health Promotion Foundation; Geelong Region Medical Research Foundation; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Action Research UK; Australian Research Council Future Fellowship(Australian Research Council); Medical Research Council programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Netherlands Organisation for Health Research and Development (ZonMw), The Hague; NZO (Dutch Dairy Association), Zoetermeer; Orthica, Almere; Netherlands Consortium Healthy Ageing (NCHA) Leiden/Rotterdam; Ministry of Economic Affairs, Agriculture and Innovation, The Hague; Wageningen University, Wageningen; VUmc, Amsterdam; Erasmus Medical Center, Rotterdam; National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Advancing Translational Sciences, CTSI; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MAFF(Ministry of Agriculture Forestry & Fisheries - Japan); EU FP5(European Commission); Food Standards Agency; GEFOS EU FP7 Integrated Project; The UK's National Institute for Health Research (NIHR) Biomedical Research Centre Grant(National Institute for Health Research (NIHR)); Estonian Genome Center University of Tartu (EGCUT); EU H2020; Estonian Research Council(Estonian Research Council); NIASC and EIT-Health through the European Regional Development Fund; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Erasmus University Medical Centre; the Centre for Medical Systems Biology (CMSB1 and CMSB2) of the Netherlands Genomics Initiative (NGI); National Institute for Arthritis(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Musculoskeletal and Skin Diseases and National Institute on Ageing; National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); ALF/LUA research grant in Gothenburg; Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg's Foundation; Vastra Gotaland Foundation; Goteborg Medical Society; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Intramural Research Program of the National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US National Institute of Ageing (NIA); Center for Inherited Disease Research (CIDR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong Research Grant Council (HKU)(University of Hong KongHong Kong Research Grants Council); Bone Health Fund of HKU Foundation; KC Wong Education Foundation; Committee on research and conference (CRCG) Grant; Osteoporosis and Endocrine Research Fund; Genomics Strategic Research Theme of the University of Hong Kong; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Ageing (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union's Seventh Framework Programme (FP7/2007-2013); Netherlands Organisation of Scientific Research (NWO) Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative/Netherlands Consortium for Healthy Ageing; German Bundesministerium fuer Forschung und Technology; Netherlands Organisation for Health Research and Development ZonMw VIDI; National Institute on Ageing (NIA) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Chronic Disease Research Foundation; Wellcome Trust(Wellcome Trust); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); Lady Davis Institute; Jewish General Hospital(General Electric); Ministere du Developpement economique, de l'Innovation et de l'Exportation du Quebec; University of Queensland(University of Queensland); University of Western Australia-University of Queensland Bilateral Research Collaboration Award; National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W Reynolds Foundation; Fondation Leducq Amgen; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US. Department of Health and Human Services; Academy of Finland(Academy of Finland); Social Insurance Institution of Finland; Tampere University Hospital; Turku University Hospital; Kuopio University Hospital; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association; EU Horizon 2020; Red de Envejecimiento y fragilidad RETICEF; CIBERER; Instituto Carlos III. Fondos FEDER; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Spanish MINECO(Spanish Government); Catalan Government; BioPersMed; Competence Center CBmed; Austrian Federal Ministry of Transport, Innovation and Technology (BMVIT); Austrian Federal Ministry of Economics and Labour/ the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Styrian Business Promotion Agency (SFG; Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Healthway Health Promotion Foundation of Western Australia; Australasian Menopause Society; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds du Recherche Quebec Sante; Arthritis Research UK(Versus Arthritis); EU Biomed 1; Wellcome Trust Collaborative Research Initiative 1995; UK's National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Canadian Institutes for health research(Canadian Institutes of Health Research (CIHR)); University of Athens, Greece; National Institute for Health Research (NIHR) Musculoskeletal BRU Oxford(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Nutrition BRC Southampton; The Hong Kong Jockey Club Charities Trust; VC discretionary fund of The Chinese University of Hong Kong; Research Grants Council(Hong Kong Research Grants Council); Korea Health Technology R D Project; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Republic of Korea; Netherlands Ministry of Health Welfare and Sports, Directorate of Long term Care; Merck-Sharp-Dohme Chibret company; European Union Strategic Educational Pathways Scholarhip scheme (STEPS); The Swedish Research Council(Swedish Research Council); World Anti-Doping Agency; Danish Ministry of Culture; Institute of Clinical Research of the University of Southern Denmark; Slovenian research agency(Slovenian Research Agency - Slovenia); Ragnar Soderberg Foundation; National Institute on Ageing/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Swedish Department of Higher Education; European Commission European Network for Genetic and Genomic Epidemiology (ENGAGE: 7th Framework Program(General Electric); GenomEUtwin: 5th Framework program " Quality of Life and Management of the Living Resources"; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Jan Wallander and Tom Hedelius Foundation; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Sports Research Council; Swedish Society of Medicine; Kempe-Foundation; Medical Faculty of Umea University; county council of Vasterbotten; Wellcome Trust(Wellcome Trust); National Institute on Arthritis Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research and the Genetic Factors for Osteoporosis (GEFOS) consortium have been funded by the European Commission (HEALTH-F2-2008-201865-GEFOS). AGES: NIH contract N01AG- 12100 and NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and Althingi (the Icelandic Parliament). Icelandic Heart Association. Anglo-Australasian Osteoporosis Genetics Consortium (AOGC): National Health and Medical Research Council (Australia) (grant reference 511132). Australian Cancer Research Foundation and Rebecca Cooper Foundation (Australia). National Health and Medical Research Council (Australia). National Health and Medical Research Council (Australia) Career Development Award (569807). Medical Research Council New Investigator Award (MRC G0800582). Health Research Council of New Zealand. Sanofi-Aventis, Eli Lilly, Novartis, Pfizer, Proctor & Gamble Pharmaceuticals and Roche. National Health and Medical Research Council, Australia. Australian National Health and Medical Research Council, MBF Living Well foundation, the Ernst Heine Family Foundation and from untied educational grants from Amgen, Eli Lilly International, GE-Lunar, Merck Australia, Novartis, Sanofi-Aventis Australia and Servier. Medical Research Council UK and Arthritis Research UK. The Victorian Health Promotion Foundation and the Geelong Region Medical Research Foundation, and the National Health and Medical Research Council, Australia (project grant 628582). Action Research UK. DME is supported by an Australian Research Council Future Fellowship (FT130101709). This work was supported by a Medical Research Council programme grant (MC_UU_12013/4).. B-Vitamins for the PRevention Of Osteoporotic Fractures (BPROOF) study: supported and funded so far by The Netherlands Organisation for Health Research and Development (ZonMw, grant 6130.0031), The Hague; unrestricted grant from NZO (Dutch Dairy Association), Zoetermeer; Orthica, Almere; Netherlands Consortium Healthy Ageing (NCHA) Leiden/Rotterdam; Ministry of Economic Affairs, Agriculture and Innovation (project KB-15-004-003), The Hague; Wageningen University, Wageningen; VUmc, Amsterdam; Erasmus Medical Center, Rotterdam. Cardiovascular Health Study (CHS): National Heart Lung and Blood Institute (NHLBI) contracts HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086; and NHLBI grants U01HL080295, R01HL087652, R01HL105756, R01HL103612, R01HL120393, and R01HL130114 with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided through R01AG023629 from the National Institute on Ageing (NIA). Genotyping supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR000124, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center. deCODE Genetics. EPIC-Norfolk: Medical Research Council G9321536 and G9800062, MAFF AN0523, EU FP5 (QLK6-CT-2002-02629), Food Standards Agency N05046, GEFOS EU FP7 Integrated Project Grant Reference: 201865, The UK's National Institute for Health Research (NIHR) Biomedical Research Centre Grant to Cambridge contributed to the costs of genotyping.; Estonian Genome Center University of Tartu (EGCUT): This study was supported by EU H2020 grants 692145, 676550, 654248, Estonian Research Council Grant IUT20-60, NIASC and EIT-Health and EU through the European Regional Development Fund (project No 2014-2020.4.01.15-0012 GENTRANSMED). Erasmus Rucphen Family Study (ERF): Netherlands Organisation for Scientific Research (NWO), Erasmus University Medical Centre, the Centre for Medical Systems Biology (CMSB1 and CMSB2) of the Netherlands Genomics Initiative (NGI). Framingham Osteoporosis Study (FOS): National Institute for Arthritis, Musculoskeletal and Skin Diseases and National Institute on Ageing (R01 AR41398; DPK and R01 AR 050066; DK National Heart, Lung, and Blood Institute's Framingham Heart Study (N01-HC-25195) and its contract with Affymetrix for genotyping services (N02-HL-6-4278). The Gothenburg Osteoporosis and Obesity Determinan Study (GOOD): Swedish Research Council (K2010-54X-09894-19-3, 2006-3832 and K2010-52X-20229-05-3), Swedish Foundation for Strategic Research, ALF/LUA research grant in Gothenburg, Lundberg Foundation, Torsten and Ragnar Soderberg's Foundation, Vastra Gotaland Foundation, Goteborg Medical Society, Novo Nordisk Foundation, and European Commission grant HEALTH-F2-2008201865-GEFOS. Health Aging and Body Composition Study (HealthABC): the Intramural Research Program of the National Institute of Health (NIH), National Institute on Ageing. US National Institute of Ageing (NIA) contracts N01AG62101, N01AG62103, and N01AG62106. NIA grant 1R01AG032098. The Center for Inherited Disease Research (CIDR). National Institutes of Health contract number HHSN268200782096C. Hong Kong Osteoporosis Study (HKOS): Hong Kong Research Grant Council (HKU 768610M); Bone Health Fund of HKU Foundation; KC Wong Education Foundation; Small Project Funding (201007176237); Matching Grant, Committee on research and conference (CRCG) Grant and Osteoporosis and Endocrine Research Fund; and the Genomics Strategic Research Theme of the University of Hong Kong. The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health funding. The following institutes provide support: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institute on Ageing (NIA), National Center for Research Resources (NCRR), and National Institute of Health (NIH) Roadmap for Medical Research under the following grant numbers: U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, and UL1 RR024140. Prospective study of pravastatin in the elderly at risk (PROSPER): European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No HEALTH-F2-2009-223004 PHASE. Rotterdam study I, Rotterdam study II, Rotterdam study III: Netherlands Organisation of Scientific Research (NWO) Investments (No 175.010.2005.011, 911-03-012); Research Institute for Diseases in the Elderly (014-93-015; RIDE2); Netherlands Genomics Initiative/Netherlands Consortium for Healthy Ageing (050-060-810); German Bundesministerium fuer Forschung und Technology under grants #01 AK 803 A-H and #01 IG 07015 G. the Netherlands Organisation for Health Research and Development ZonMw VIDI 016.136.367 (funding FR, CM-G, KT). Study of Osteoporotic Fractures (SOF): supported by National Institutes of Health funding.; The National Institute on Ageing (NIA) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) provides support under the following grant numbers: R01 AG005407, R01 AR35582, R01 AR35583, R01 AR35584, R01 AG005394, R01 AG027574, R01 AG027576, and R01 AG026720. TwinsUK1, TwinsUK2: NIHR Biomedical Research Centre (grant to Guys' and St Thomas' Hospitals and King's College London); Chronic Disease Research Foundation; Wellcome Trust; Canadian Institutes of Health Research, Canadian Foundation for Innovation, Fonds de la Recherche en Sante Quebec, Lady Davis Institute, Jewish General Hospital, and Ministere du Developpement economique, de l'Innovation et de l'Exportation du Quebec. UK Biobank: This research has been conducted using the UK Biobank Resource (application No 12703). Access to the UK Biobank study data was funded by a University of Queensland Early Career Researcher Grant (2014002959). Access to the UK Biobank study data was funded by University of Queensland Early Career Researcher Grant (2014002959) and University of Western Australia-University of Queensland Bilateral Research Collaboration Award (2014001711). NMW is supported by a National Health and Medical Research Council Early Career Fellowship (APP1104818). Women's Genome Health Study (WGHS): HL 043851 and HL69757 from the National Heart, Lung, and Blood Institute and CA 047988 from the National Cancer Institute, the Donald W Reynolds Foundation, and the Fondation Leducq Amgen. Women's Health Initiative (WHI) program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, US. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. Young Finns study (YFS): has been financially supported by the Academy of Finland: grants 286284 (TL), 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), and 41071 (Skidi); the Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Tampere, Turku and Kuopio University Hospitals (grant X51001); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; and Diabetes Research Foundation of Finnish Diabetes Association; and EU Horizon 2020 (grant 755320 for TAXINOMISIS). Barcelona cohort osteoporosis (BARCOS): Red de Envejecimiento y fragilidad RETICEF, CIBERER, Instituto Carlos III. Fondos FEDER. Fondo de Investigacion Sanitaria (FIS PI13/00116). Spanish MINECO (SAF2014-56562-R), Catalan Government (2014SGR932). Austrios-A, Austrios-B: was supported by BioPersMed (COMET K project 825329), and the Competence Center CBmed (COMET K1 centre 844609), funded by the Austrian Federal Ministry of Transport, Innovation and Technology (BMVIT) and the Austrian Federal Ministry of Economics and Labour/ the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ) and the Styrian Business Promotion Agency (SFG). Cantabria-Camargo study (Cabrio-C), Cantabria osteoporosis case-control study (Cabrio-CC): Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias Grants PI 06/34, PI09/539, PI12/615 and PI15/521 (that could be cofunded by European Union-FEDER funds).; Calcium Intake Fracture Outcome Study (CAIFOS): Healthway Health Promotion Foundation of Western Australia, Australasian Menopause Society and the Australian National Health and Medical Research Council Project Grant (254627, 303169 and 572604). Canadian Multicentre Osteoporosis Study (CaMos): was supported by a grant from the Canadian Institutes for Health Research (CIHR) (grant No MOP111103). JBR and JAM are funded by the Canadian Institutes of Health Research, Fonds du Recherche Quebec Sante, and Jewish General Hospital. Edinburgh Osteoporosis Study (EDOS): was supported by a grant from Arthritis Research UK (grant number 15389). European Prospective Osteoporosis Study (EPOS): EU Biomed 1 (BMHICT920182, CIPDCT925012, ERBC1PDCT 940229, ERBC1PDCT930105), Medical Research Council G9321536 and G9800062, Wellcome Trust Collaborative Research Initiative 1995, MAFF AN0523, EU FP5 (QLK6-CT-2002-02629), Food Standards Agency N05046, GEFOS EU FP7 Integrated Project Grant Reference: 201865. The UK's National Institute for Health Research (NIHR) Biomedical Research Centre Grant to Cambridge contributed to the costs of genotyping. Geelong Osteoporosis Study (GEOS): Canadian Institutes for health research operating grant funding reference # 86748. Genetic analysis of osteoporosis in Greece (GROS): University of Athens, Greece (Kapodistrias 2009). Hertfordshire Cohort Study (HCS): supported by Medical Research Council UK; Arthritis Research UK; National Institute for Health Research (NIHR) Musculoskeletal BRU Oxford; National Institute for Health Research (NIHR) Nutrition BRC Southampton. Hong Kong: The projects have been supported by The Hong Kong Jockey Club Charities Trust, VC discretionary fund of The Chinese University of Hong Kong, and Research Grants Council Earmarked Grant CUHK4101/02M. Korean osteoporosis study in Asan Medical Center (KorAMC): a grant of the Korea Health Technology R& D Project, the Ministry of Health and Welfare, Republic of Korea (project No HI14C2258); a grant of the Korea Health Technology R& D Project, the Ministry of Health and Welfare, Republic of Korea (project No HI15C0377). Longitudinal Aging Study Amsterdam (LASA): largely supported by a grant from the Netherlands Ministry of Health Welfare and Sports, Directorate of Long term Care. MINOS study was supported by a grant from the Merck-Sharp-Dohme Chibret company. Malta osteoporotic fracture study (MOFS): financial support was received from the European Union Strategic Educational Pathways Scholarhip scheme (STEPS). The Osteoporotic Fractures in Men (MrOS) Sweden: financial support was received from the Swedish Research Council (K201054X- 09894-19-, 2006-3832), Swedish Foundation for Strategic Research, ALF/LUA research grant in Gothenburg, Lundberg Foundation, Torsten and Ragnar Soderberg's Foundation, Vastra Gotaland Foundation, Goteborg Medical Society, Novo Nordisk foundation, and European Commission grant HEALTH-F2-2008201865- GEFOS. Odense androgen study (OAS): World Anti-Doping Agency, Danish Ministry of Culture, Institute of Clinical Research of the University of Southern Denmark. Prevalence of osteoporosis in Slovenia (Slo-preval): was created as part of projects financially supported by the Slovenian research agency: P3-298 Geni, Hormoni in osebnostne spremembe pri hormonskih motnjah; Z1-3238: Genski in okoljski dejavniki tveganja za razvoj motnje pri remodellaciji kosti; J2-3314 Genetski faktorji in hormoni pri presnovnih boleznih; and J3-2330 Genetski dejavniki pri osteoporozi.; TWINGENE: supported in part by the Ragnar Soderberg Foundation (E9/11); the National Science Foundation (EArly Concept Grants for Exploratory Research: " Workshop for the Formation of a Social Science Genetic Association Consortium," SES-1064089) as supplemented by the National Institutes of Health's (NIH) Office of Behavioural and Social Sciences Research; and the National Institute on Ageing/NIH through Grants P01-AG005842, P01-AG005842-20S2, P30-AG012810, and T32-AG000186-23 to the National Bureau of Economic Research. The Swedish Twin Registry is supported by the Swedish Department of Higher Education, European Commission European Network for Genetic and Genomic Epidemiology (ENGAGE: 7th Framework Program (FP7/2007-2013)/Grant agreement HEALTH-F4-2007-201413; and GenomEUtwin: 5th Framework program " Quality of Life and Management of the Living Resources" Grant QLG2-CT-2002-01254); NIH (DK U01-066134); Swedish Research Council (M-2005-1112 and 2009-2298); Swedish Foundation for Strategic Research (ICA08-0047); Jan Wallander and Tom Hedelius Foundation; and Swedish Council for Working Life and Social Research. The Umea Fracture and Osteoporosis Study (UFO) is supported by the Swedish Research Council (K2000672X-20155013), Swedish Sports Research Council (87/06), Swedish Society of Medicine, Kempe-Foundation (JCK-1021), and by grants from the Medical Faculty of Umea University (ALFVLL: 968: 22-2005, ALFVL:-937-2006, ALFVLL: 223: 11-2007, ALFVLL: 78151-2009) and county council of Vasterbotten (SpjutspetsanslagVLL: 159: 33-2007). GRW and JHDB were funded by the Wellcome Trust (Strategic Award grant No 101123; Joint Investigator Award No 110141; project grant No 094134). DPK was funded by a grant from the National Institute on Arthritis Musculoskeletal and Skin Diseases R01 AR041398. The funding agencies had no role in the study design, analysis, or interpretation of data; the writing of the manuscript; or in the decision to submit the article for publication.	Ahmad OS, 2017, J BONE MINER RES, V32, P1072, DOI 10.1002/jbmr.3063; Andrew T, 2005, J BONE MINER RES, V20, P67, DOI 10.1359/JBMR.041015; Bauer DC, 2013, NEW ENGL J MED, V369, P1537, DOI 10.1056/NEJMcp1210380; Bergman GJD, 2010, CURR MED RES OPIN, V26, P1193, DOI 10.1185/03007991003659814; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Compston JE, 2014, J BONE MINER RES, V29, P487, DOI 10.1002/jbmr.2051; Cooper C, 1996, MAGNITUDE IMPACT OST; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Ding M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1000; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; El-Khoury F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6234; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Frank J, 2012, ADDICT BIOL, V17, P171, DOI 10.1111/j.1369-1600.2011.00395.x; Gage SH, 2017, PSYCHOL MED, V47, P971, DOI 10.1017/S0033291716003172; Gelernter J, 2014, MOL PSYCHIATR, V19, P41, DOI 10.1038/mp.2013.145; Harvey N, 2010, NAT REV RHEUMATOL, V6, P99, DOI 10.1038/nrrheum.2009.260; Hurle MR, 2016, NAT REV DRUG DISCOV, V15, P596, DOI [10.1038/nrd.2016.164, 10.1038/nrd.2016.187]; Johansson H, 2014, J BONE MINER RES, V29, P223, DOI 10.1002/jbmr.2017; Johnson T., 2012, EFFICIENT CALCULATIO; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Kanis JA, 2011, OSTEOPOROSIS INT, V22, P2395, DOI 10.1007/s00198-011-1713-z; Khosla S, 2016, J BONE MINER RES, V31, P1485, DOI 10.1002/jbmr.2888; Koek WNH, 2010, J BONE MINER RES, V25, P1980, DOI 10.1002/jbmr.83; Larsson SC, 2018, J BONE MINER RES, V33, P840, DOI 10.1002/jbmr.3389; Larsson SC, 2017, JAMA-J AM MED ASSOC, V318, P371, DOI 10.1001/jama.2017.8981; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Leong A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001751; Li SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep33202; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Medina-Gomez C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002718; Melorose J, 2015, WORLD POP PROSP, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Michaelsson K, 2005, ARCH INTERN MED, V165, P1825, DOI 10.1001/archinte.165.16.1825; Mokry LE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001866; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Munafo MR, 2018, INT J EPIDEMIOL, V47, P226, DOI 10.1093/ije/dyx206; Nguyen ND, 2007, OSTEOPOROSIS INT, V18, P1109, DOI 10.1007/s00198-007-0362-8; Nguyen ND, 2007, J CLIN ENDOCR METAB, V92, P955, DOI 10.1210/jc.2006-1476; O'Seaghdha CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003796; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pierce BL, 2013, AM J EPIDEMIOL, V178, P1177, DOI 10.1093/aje/kwt084; Porcu E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003266; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rooney MR, 2017, JAMA-J AM MED ASSOC, V317, P2448, DOI 10.1001/jama.2017.4392; Sanders KM, 1998, J BONE MINER RES, V13, P1337, DOI 10.1359/jbmr.1998.13.8.1337; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Styrkarsdottir Unnur, 2008, N Engl J Med, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Taylor AE, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006141; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897; Willems SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16015; Zhao JG, 2017, JAMA-J AM MED ASSOC, V318, P2466, DOI 10.1001/jama.2017.19344; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878; Zheng HF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002745	75	119	124	3	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2018	362								k3225	10.1136/bmj.k3225	http://dx.doi.org/10.1136/bmj.k3225			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU9VE	30158200	Green Published, hybrid			2022-12-28	WOS:000445701700002
J	Devi, S				Devi, Sharmila			Reconstructing Iraq	LANCET			English	Editorial Material								At a time of competing priorities, Iraq provides a striking example of how humanitarian aid must continue its support to the country after fighting has subsided. Sharmila Devi reports.											0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2018	392	10147					541	542		10.1016/S0140-6736(18)31731-8	http://dx.doi.org/10.1016/S0140-6736(18)31731-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ8MN	30152378				2022-12-28	WOS:000442009500009
J	Zannad, F; Anker, SD; Byra, WM; Cleland, JGF; Fu, M; Gheorghiade, M; Lam, CSP; Mehra, MR; Neaton, JD; Nessel, CC; Spiro, TE; van Veldhuisen, DJ; Greenberg, B				Zannad, Faiez; Anker, Stefan D.; Byra, William M.; Cleland, John G. F.; Fu, Min; Gheorghiade, Mihai; Lam, Carolyn S. P.; Mehra, Mandeep R.; Neaton, James D.; Nessel, Christopher C.; Spiro, Theodore E.; van Veldhuisen, Dirk J.; Greenberg, Barry		COMMANDER HF Investigators	Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR XA INHIBITOR; RANDOMIZED-TRIAL; MORTALITY; WARFARIN; THERAPY; ASPIRIN; THROMBIN; EFFICACY	BACKGROUND Heart failure is associated with activation of thrombin-related pathways, which predicts a poor prognosis. We hypothesized that treatment with rivaroxaban, a factor Xa inhibitor, could reduce thrombin generation and improve outcomes for patients with worsening chronic heart failure and underlying coronary artery disease. METHODS In this double-blind, randomized trial, 5022 patients who had chronic heart failure, a left ventricular ejection fraction of 40% or less, coronary artery disease, and elevated plasma concentrations of natriuretic peptides and who did not have atrial fibrillation were randomly assigned to receive rivaroxaban at a dose of 2.5 mg twice daily or placebo in addition to standard care after treatment for an episode of worsening heart failure. The primary efficacy outcome was the composite of death from any cause, myocardial infarction, or stroke. The principal safety outcome was fatal bleeding or bleeding into a critical space with a potential for causing permanent disability. RESULTS Over a median follow-up period of 21.1 months, the primary end point occurred in 626 (25.0%) of 2507 patients assigned to rivaroxaban and in 658 (26.2%) of 2515 patients assigned to placebo (hazard ratio, 0.94; 95% confidence interval [CI], 0.84 to 1.05; P = 0.27). No significant difference in all-cause mortality was noted between the rivaroxaban group and the placebo group (21.8% and 22.1%, respectively; hazard ratio, 0.98; 95% CI, 0.87 to 1.10). The principal safety outcome occurred in 18 patients who took rivaroxaban and in 23 who took placebo (hazard ratio, 0.80; 95% CI, 0.43 to 1.49; P = 0.48). CONCLUSIONS Rivaroxaban at a dose of 2.5 mg twice daily was not associated with a significantly lower rate of death, myocardial infarction, or stroke than placebo among patients with worsening chronic heart failure, reduced left ventricular ejection fraction, coronary artery disease, and no atrial fibrillation.	[Zannad, Faiez] Univ Lorraine, INSERM Unite 1116, Vandoeuvre Les Nancy, France; [Zannad, Faiez] Ctr Hosp Reg, Clin Invest Ctr 1433, French Clin Res Infrastruct Network, Invest Network Initiat Cardiovasc & Renal Clin Tr, Vandoeuvre Les Nancy, France; [Zannad, Faiez] Univ Nancy, Vandoeuvre Les Nancy, France; [Anker, Stefan D.] Chariot Univ Med Berlin, Dept Cardiol, Berlin, Germany; [Anker, Stefan D.] Chariot Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, German Ctr Cardiovasc Res Partner Site Berlin, Berlin, Germany; [Byra, William M.; Nessel, Christopher C.] Janssen Res & Dev, Raritan, NJ USA; [Spiro, Theodore E.] Bayer US, Res & Dev, Pharmaceut Thrombosis & Hematol Therapeut Area, Whippany, NJ USA; [Cleland, John G. F.] Univ Glasgow, Robertson Ctr Biostat & Clin Trials, Glasgow, Lanark, Scotland; [Cleland, John G. F.] Imperial Coll London, Lung Inst, London, England; [Fu, Min] Janssen Res & Dev, Spring House, PA USA; [Gheorghiade, Mihai] Northwestern Univ, Chicago, IL 60611 USA; [Lam, Carolyn S. P.] Natl Heart Ctr Singapore, Singapore, Singapore; [Lam, Carolyn S. P.] Duke Natl Univ Singapore, Singapore, Singapore; [Lam, Carolyn S. P.; van Veldhuisen, Dirk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Mehra, Mandeep R.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Mehra, Mandeep R.] Harvard Med Sch, Boston, MA USA; [Neaton, James D.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Greenberg, Barry] Univ Calif San Diego, Dept Med, Cardiol Div, San Diego, CA 92103 USA	Universite de Lorraine; Centre Hospitalier Annecy Genevois; CHU de Nancy; Universite de Lorraine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johnson & Johnson; Janssen Pharmaceuticals; University of Glasgow; Imperial College London; Johnson & Johnson; Janssen Pharmaceuticals; Northwestern University; National Heart Centre Singapore; National University of Singapore; University of Groningen; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego	Zannad, F (corresponding author), CHU Nancy, CIC Inserm, Inst Lorrain Coeur & Vaisseaux, F-54500 Vandoeuvre Les Nancy, France.	f.zannad@chru-nancy.fr	Kaidashev, Igor/L-2606-2019; Malynovsky, Yaroslav/T-1898-2017; Mehra, Mandeep R/O-7273-2019; Shpagina, Lyubov/Y-7864-2018; Prozesky, Hans Walter/ABE-6956-2020; Cleland, John G./AAZ-4185-2020; Lam, Carolyn SP/ABD-6810-2021; Andreev, Denis А/W-2390-2017; Zannad, Faiez/K-4649-2019; Mirolyubova, Olga/C-8376-2018; Mehra, Mandeep R/G-3484-2013; Grinshtein, Yury/M-4091-2014; celik, Ahmet/AAA-6615-2021; Braile-Sternieri, Maria Christiane Valeria Braga/P-9461-2018	Kaidashev, Igor/0000-0002-4708-0859; Malynovsky, Yaroslav/0000-0002-9118-1104; Mehra, Mandeep R/0000-0001-8683-7044; Shpagina, Lyubov/0000-0003-0871-7551; Prozesky, Hans Walter/0000-0001-9715-3449; Cleland, John G./0000-0002-1471-7016; Lam, Carolyn SP/0000-0003-1903-0018; Andreev, Denis А/0000-0002-0276-7374; Mirolyubova, Olga/0000-0003-4562-8398; Mehra, Mandeep R/0000-0001-8683-7044; Grinshtein, Yury/0000-0001-8847-235X; celik, Ahmet/0000-0002-9417-7610; Verheul, Henk/0000-0001-5981-922X; GALINIER, Michel/0000-0003-1735-3390; Braile-Sternieri, Maria Christiane Valeria Braga/0000-0003-2704-2481; FREIXA-PAMIAS, ROMAN/0000-0001-5301-4236; Lubinski, Andrzej/0000-0003-2779-0041; Perez-Villa, Felix/0000-0001-9244-938X; BORDES SISCAR, PASCUAL/0000-0002-7657-1008; Kosior, Dariusz/0000-0002-7821-4442; Madej, Andrzej/0000-0002-7626-0840	Janssen Research and Development	Janssen Research and Development	Funded by Janssen Research and Development; COMMANDER HF ClinicalTrials.gov number, NCT01877915.	Al-Khadra AS, 1998, J AM COLL CARDIOL, V31, P749, DOI 10.1016/S0735-1097(98)00006-0; [Anonymous], 2012, ADV COMM BRIEF DOC A; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Branch KR., 2018, LAT BREAK TRIAL 4 RE; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Cleland JGF, 2004, AM HEART J, V148, P157, DOI 10.1016/j.ahj.2004.03.010; Cokkinos DV, 2006, EUR J HEART FAIL, V8, P428, DOI 10.1016/j.ejheart.2006.02.012; Eikelboom JW, 2017, NEW ENGL J MED, V377, P1319, DOI 10.1056/NEJMoa1709118; Gerotziafas GT, 2007, J THROMB HAEMOST, V5, P886, DOI 10.1111/j.1538-7836.2007.02429.x; Gheorghiade M, 2013, JAMA-J AM MED ASSOC, V309, P1125, DOI 10.1001/jama.2013.1954; Homma S, 2012, NEW ENGL J MED, V366, P1859, DOI 10.1056/NEJMoa1202299; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Maggioni AP, 2013, EUR J HEART FAIL, V15, P808, DOI 10.1093/eurjhf/hft050; Massie BM, 2009, CIRCULATION, V119, P1616, DOI 10.1161/CIRCULATIONAHA.108.801753; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Packer M, 2017, NEW ENGL J MED, V376, P1956, DOI 10.1056/NEJMoa1601895; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Perzborn E, 2011, NAT REV DRUG DISCOV, V10, P61, DOI 10.1038/nrd3185; Solomon SD, 2007, CIRCULATION, V116, P1482, DOI 10.1161/CIRCULATIONAHA.107.696906; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Zannad F, 2015, EUR J HEART FAIL, V17, P735, DOI 10.1002/ejhf.266; Zannad F, 2013, INT J CARDIOL, V167, P1772, DOI 10.1016/j.ijcard.2012.12.018	26	196	204	2	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2018	379	14					1332	1342		10.1056/NEJMoa1808848	http://dx.doi.org/10.1056/NEJMoa1808848			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV6QX	30146935	Green Accepted, Bronze			2022-12-28	WOS:000446240100008
J	Goler, N; Conway, A; Young-Wolff, KC				Goler, Nancy; Conway, Amy; Young-Wolff, Kelly C.			Data Are Needed on the Potential Adverse Effects of Marijuana Use in Pregnancy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRENDS		[Goler, Nancy; Conway, Amy] Kaiser Permanente Northern Calif, 1950 Franklin St, Oakland, CA 94162 USA; [Young-Wolff, Kelly C.] Kaiser Permanente Northern Calif, Div Res, 2000 Broadway, Oakland, CA 94162 USA	Kaiser Permanente; Kaiser Permanente	Young-Wolff, KC (corresponding author), Kaiser Permanente Northern Calif, Div Res, 2000 Broadway, Oakland, CA 94162 USA.	kelly.c.young-wolff@kp.org			National Institutes of Health, National Institute on Drug Abuse [DA043604]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA043604] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By K01 award DA043604 from the National Institutes of Health, National Institute on Drug Abuse.	Amer Coll Obstetricians Gynecolo, 2017, OBSTET GYNECOL, V130, pE200, DOI [10.1097/AOG.0000000000002354, 10.1097/AOG.0000000000002353]; [Anonymous], STAT MED MAR LAWS; Brown QL, 2017, JAMA-J AM MED ASSOC, V317, P207, DOI 10.1001/jama.2016.17383; Child Welfare Information Gateway, 2016, PAR DRUG US CHILD AB; Committee on the Health Effects of Marijuana National Academies of Sciences Engineering and Medicine, 2017, HLTH EFF CANN CANN C; Conner SN, 2016, OBSTET GYNECOL, V128, P713, DOI 10.1097/AOG.0000000000001649; Jarlenski M, 2016, WOMEN HEALTH ISS, V26, P452, DOI 10.1016/j.whi.2016.03.010; Ko JY, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.03.021; Mark K, 2017, J ADDICT MED, V11, P211, DOI 10.1097/ADM.0000000000000299; Young-Wolff KC, 2017, JAMA-J AM MED ASSOC, V318, P2490, DOI 10.1001/jama.2017.17225	10	15	15	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2018	169	7					492	+		10.7326/M18-1141	http://dx.doi.org/10.7326/M18-1141			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV4BN	30140934	Green Accepted			2022-12-28	WOS:000446042400011
J	Gupta, A; Mackay, J; Whitehouse, A; Godec, T; Collier, T; Pocock, S; Poulter, N; Sever, P				Gupta, Ajay; Mackay, Judith; Whitehouse, Andrew; Godec, Thomas; Collier, Tim; Pocock, Stuart; Poulter, Neil; Sever, Peter			Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial	LANCET			English	Article							SYSTOLIC HYPERTENSION; TASK-FORCE; PREVENTION; THERAPY; ARM; CHOLESTEROL; AMLODIPINE; GUIDELINES; MANAGEMENT; CORONARY	Background In patients with hypertension, the long-term cardiovascular and all-cause mortality effects of different blood pressure-lowering regimens and lipid-lowering treatment are not well documented, particularly in clinical trial settings. The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy Study reports mortality outcomes after 16 years of follow-up of the UK participants in the original ASCOT trial. Methods ASCOT was a multicentre randomised trial with a 2 x 2 factorial design. UK-based patients with hypertension were followed up for all-cause and cardiovascular mortality for a median of 15.7 years (IQR 9.7-16.4 years). At baseline, all patients enrolled into the blood pressure-lowering arm (BPLA) of ASCOT were randomly assigned to receive either amlodipine-based or atenolol-based blood pressure-lowering treatment. Of these patients, those who had total cholesterol of 6.5 mmol/L or lower and no previous lipid-lowering treatment underwent further randomisation to receive either atorvastatin or placebo as part of the lipid-lowering arm (LLA) of ASCOT. The remaining patients formed the non-LLA group. A team of two physicians independently adjudicated all causes of death. Findings Of 8580 UK-based patients in ASCOT, 3282 (38.3%) died, including 1640 (38.4%) of 4275 assigned to atenolol-based treatment and 1642 (38.1%) of 4305 assigned to amlodipine-based treatment. 1768 of the 4605 patients in the LLA died, including 903 (39.5%) of 2288 assigned placebo and 865 (37.3%) of 2317 assigned atorvastatin. Of all deaths, 1210 (36.9%) were from cardiovascular-related causes. Among patients in the BPLA, there was no overall difference in all-cause mortality between treatments (adjusted hazard ratio [HR] 0.90, 95% CI 0.81-1.01, p=0.0776]), although significantly fewer deaths from stroke (adjusted HR 0.71, 0.53-0.97, p=0.0305) occurred in the amlodipine-based treatment group than in the atenolol-based treatment group. There was no interaction between treatment allocation in the BPLA and in the LLA. However, in the 3975 patients in the non-LLA group, there were fewer cardiovascular deaths (adjusted HR 0.79, 0.67-0.93, p=0.0046) among those assigned to amlodipine-based treatment compared with atenolol-based treatment (p=0.022 for the test for interaction between the two blood pressure treatments and allocation to LLA or not). In the LLA, significantly fewer cardiovascular deaths (HR 0.85, 0.72-0.99, p=0.0395) occurred among patients assigned to statin than among those assigned placebo. Interpretation Our findings show the long-term beneficial effects on mortality of antihypertensive treatment with a calcium channel blocker-based treatment regimen and lipid-lowering with a statin: patients on amlodipine-based treatment had fewer stroke deaths and patients on atorvastatin had fewer cardiovascular deaths more than 10 years after trial closure. Overall, the ASCOT Legacy study supports the notion that interventions for blood pressure and cholesterol are associated with long-term benefits on cardiovascular outcomes.	[Gupta, Ajay] Queen Mary Univ London, William Harvey Res Inst, London, England; [Mackay, Judith; Whitehouse, Andrew; Sever, Peter] Imperial Coll London, Natl Heart & Lung Inst, London W12 0NN, England; [Godec, Thomas; Collier, Tim; Pocock, Stuart] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Poulter, Neil] Imperial Coll London, Imperial Clin Trials Unit, London, England	University of London; Queen Mary University London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Sever, P (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London W12 0NN, England.	p.sever@imperial.ac.uk	Gupta, Ajay/AAG-9859-2020; Whitehouse, Andrew J.O./AGJ-2519-2022	Gupta, Ajay/0000-0001-5807-8503; Whitehouse, Andrew J.O./0000-0001-8722-1575	Pfizer	Pfizer(Pfizer)	Pfizer.	Bakris GL, 2010, LANCET, V375, P1173, DOI 10.1016/S0140-6736(09)62100-0; Chowdhury EK, 2014, AM J HYPERTENS, V27, P199, DOI 10.1093/ajh/hpt212; Cushman WC, 2012, J CLIN HYPERTENS, V14, P20, DOI 10.1111/j.1751-7176.2011.00568.x; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; FORD CE, 1988, JAMA-J AM MED ASSOC, V259, P2113; Ford I, 2016, CIRCULATION, V133, P1073, DOI 10.1161/CIRCULATIONAHA.115.019014; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Hague WE, 2016, CIRCULATION, V133, P1851, DOI 10.1161/CIRCULATIONAHA.115.018580; Heart Protection Study Collaborative Group, 2011, Lancet, V378, P2013, DOI 10.1016/S0140-6736(11)61125-2; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kostis JB, 2005, AM J CARDIOL, V95, P29, DOI 10.1016/j.amjcard.2004.08.059; Kostis WJ, 2011, J CLIN LIPIDOL, V5, P97, DOI 10.1016/j.jacl.2011.01.006; Kostis WJ, 2010, HYPERTENSION, V56, P1060, DOI 10.1161/HYPERTENSIONAHA.110.160291; Krause T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4891; Leung AA, 2016, CAN J CARDIOL, V32, P569, DOI 10.1016/j.cjca.2016.02.066; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Margolis KL, 2013, J CLIN HYPERTENS, V15, P542, DOI 10.1111/jch.12139; McManus RJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e181; Nelson MR, 2015, J HYPERTENS, V33, P2331, DOI 10.1097/HJH.0000000000000709; Poulter NR, 2005, LANCET, V366, P907, DOI 10.1016/S0140-6736(05)67186-3; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Sever PS, 2008, EUR HEART J, V29, P499, DOI 10.1093/eurheartj/ehm583; Sever PS, 2001, J HYPERTENS, V19, P1139, DOI 10.1097/00004872-200106000-00020; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Staessen JA, 2004, J HYPERTENS, V22, P847, DOI 10.1097/00004872-200404000-00029; Stephan D, 2015, ARCH CARDIOVASC DIS, V108, P453, DOI 10.1016/j.acvd.2015.05.006; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Whelton PK, 2018, CIRCULATION, V138, pE484, DOI 10.1161/CIR.0000000000000596; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Yamal JM, 2014, J AM SOC HYPERTENS, V8, P808, DOI 10.1016/j.jash.2014.08.003	35	48	55	3	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2018	392	10153					1127	1137		10.1016/S0140-6736(18)31776-8	http://dx.doi.org/10.1016/S0140-6736(18)31776-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV3BV	30158072	Green Submitted, Green Accepted			2022-12-28	WOS:000445968800027
J	Lee-Six, H; Obro, NF; Shepherd, MS; Grossmann, S; Dawson, K; Belmonte, M; Osborne, RJ; Huntly, BJP; Martincorena, I; Anderson, E; O'Neill, L; Stratton, MR; Laurenti, E; Green, AR; Kent, DG; Campbell, PJ				Lee-Six, Henry; Obro, Nina Friesgaard; Shepherd, Mairi S.; Grossmann, Sebastian; Dawson, Kevin; Belmonte, Miriam; Osborne, Robert J.; Huntly, Brian J. P.; Martincorena, Inigo; Anderson, Elizabeth; O'Neill, Laura; Stratton, Michael R.; Laurenti, Elisa; Green, Anthony R.; Kent, David G.; Campbell, Peter J.			Population dynamics of normal human blood inferred from somatic mutations	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; CHRONIC MYELOCYTIC-LEUKEMIA; CLONAL HEMATOPOIESIS; IN-VIVO; MARROW-CELLS; PATTERNS; ORIGIN; TRACKING; COMMON; RATES	Haematopoietic stem cells drive blood production, but their population size and lifetime dynamics have not been quantified directly in humans. Here we identified 129,582 spontaneous, genome-wide somatic mutations in 140 single-cell-derived haematopoietic stem and progenitor colonies from a healthy 59-year-old man and applied population-genetics approaches to reconstruct clonal dynamics. Cell divisions from early embryogenesis were evident in the phylogenetic tree; all blood cells were derived from a common ancestor that preceded gastrulation. The size of the stem cell population grew steadily in early life, reaching a stable plateau by adolescence. We estimate the numbers of haematopoietic stem cells that are actively making white blood cells at any one time to be in the range of 50,000-200,000. We observed adult haematopoietic stem cell clones that generate multilineage outputs, including granulocytes and B lymphocytes. Harnessing naturally occurring mutations to report the clonal architecture of an organ enables the high-resolution reconstruction of somatic cell dynamics in humans.	[Lee-Six, Henry; Grossmann, Sebastian; Dawson, Kevin; Osborne, Robert J.; Martincorena, Inigo; Anderson, Elizabeth; O'Neill, Laura; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Obro, Nina Friesgaard; Shepherd, Mairi S.; Belmonte, Miriam; Huntly, Brian J. P.; Laurenti, Elisa; Green, Anthony R.; Kent, David G.] Univ Cambridge, Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England; [Obro, Nina Friesgaard; Shepherd, Mairi S.; Belmonte, Miriam; Huntly, Brian J. P.; Laurenti, Elisa; Green, Anthony R.; Kent, David G.] Univ Cambridge, Dept Haematol, Cambridge, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England.; Green, AR; Kent, DG (corresponding author), Univ Cambridge, Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England.; Green, AR; Kent, DG (corresponding author), Univ Cambridge, Dept Haematol, Cambridge, England.	arg1000@cam.ac.uk; dgk23@cam.ac.uk; pc8@sanger.ac.uk	Kent, David/AAZ-4916-2021; huntly, brian/E-6725-2014	Kent, David/0000-0001-7871-8811; Shepherd, Mairi/0000-0002-4328-9882; Laurenti, Elisa/0000-0002-9917-9092; Martincorena, Inigo/0000-0003-1122-4416; Green, Anthony/0000-0002-9795-0218; Friesgaard Obro, Nina/0000-0002-1254-7332; huntly, brian/0000-0003-0312-161X	Leukemia Lymphoma Society; WBH Foundation; Wellcome Trust; Wellcome Trust PhD studentship; Danish Lundbeck Fellowship (2016-17); BBSRC CASE Industrial PhD Studentship; Bloodwise Bennett Fellowship [15008]; European Research Council [ERC-2016-STG-715371]; European Hematology Association Non-Clinical Advanced Research Fellowship; Bloodwise; Cancer Research UK; Kay Kendall Leukaemia Fund; Leukemia and Lymphoma Society of America; Wellcome Trust Sir Henry Dale Fellowship; BBSRC; European Haematology Association NonClinical Advanced Research Fellowship; Medical Research Council; BBSRC [1800757] Funding Source: UKRI; MRC [MC_PC_16040, MR/S036113/1, MR/M008975/1, MR/M010392/1, MR/R009708/1] Funding Source: UKRI	Leukemia Lymphoma Society(Leukemia and Lymphoma Society); WBH Foundation; Wellcome Trust(Wellcome Trust); Wellcome Trust PhD studentship(Wellcome Trust); Danish Lundbeck Fellowship (2016-17); BBSRC CASE Industrial PhD Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bloodwise Bennett Fellowship; European Research Council(European Research Council (ERC)European Commission); European Hematology Association Non-Clinical Advanced Research Fellowship; Bloodwise; Cancer Research UK(Cancer Research UK); Kay Kendall Leukaemia Fund; Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); Wellcome Trust Sir Henry Dale Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Haematology Association NonClinical Advanced Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Leukemia Lymphoma Society, the WBH Foundation and the Wellcome Trust. P.J.C. is a Wellcome Trust Senior Clinical Fellow (WT088340MA). H.L.-S. is a recipient of a Wellcome Trust PhD studentship. N.F.O. is the recipient of a Danish Lundbeck Fellowship (2016-17) and M.S.S. is the recipient of a BBSRC CASE Industrial PhD Studentship. Work in the D.G.K. laboratory is supported by a Bloodwise Bennett Fellowship (15008), a European Research Council Starting Grant (ERC-2016-STG-715371) and a European Hematology Association Non-Clinical Advanced Research Fellowship. Work in the A.R.G. laboratory is supported by the Wellcome Trust, Bloodwise, Cancer Research UK, the Kay Kendall Leukaemia Fund, and the Leukemia and Lymphoma Society of America. Work in E.L. laboratory is supported by a Wellcome Trust Sir Henry Dale Fellowship, BBSRC and a European Haematology Association NonClinical Advanced Research Fellowship. The D.G.K., E.L. and A.R.G. laboratories are supported by a core support grant from the Wellcome Trust and Medical Research Council to the Cambridge Stem Cell Institute. We acknowledge further assistance from the National Institute for Health Research Cambridge Biomedical Research Centre and the Cambridge Experimental Cancer Medicine Centre. We thank R. Grenfell and M. Strzelecki in the Flow Cytometry Facility of the Cancer Research UK Cambridge Institute for technical assistance and suggestions; C. Eaves and P. Beer for discussions about the experimental design; P. Goodell for discussions about the results; J. Grinfeld and C. Gonzalez-Arias for drawing peripheral blood; and G. Collord for providing negative control samples for targeted sequencing.	Abkowitz JL, 1996, NAT MED, V2, P190, DOI 10.1038/nm0296-190; Bae T, 2018, SCIENCE, V359, P550, DOI 10.1126/science.aan8690; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Bystrykh LV, 2012, NAT METHODS, V9, P567, DOI [10.1038/NMETH.2043, 10.1038/nmeth.2043]; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; FIALKOW PJ, 1967, P NATL ACAD SCI USA, V58, P1468, DOI 10.1073/pnas.58.4.1468; FIALKOW PJ, 1977, AM J MED, V63, P125, DOI 10.1016/0002-9343(77)90124-3; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Ju YS, 2017, NATURE, V543, P714, DOI 10.1038/nature21703; Kim S, 2014, CELL STEM CELL, V14, P473, DOI 10.1016/j.stem.2013.12.012; Koelle SJ, 2017, BLOOD, V129, P1448, DOI 10.1182/blood-2016-07-728691; Lan SW, 2015, BIOINFORMATICS, V31, P3282, DOI 10.1093/bioinformatics/btv378; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Pei WK, 2017, NATURE, V548, P456, DOI 10.1038/nature23653; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Werner B, 2015, ELIFE, V4, DOI 10.7554/eLife.08687; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Young AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12484; Zink F, 2017, BLOOD, V130, P742, DOI 10.1182/blood-2017-02-769869	36	254	254	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2018	561	7724					473	+		10.1038/s41586-018-0497-0	http://dx.doi.org/10.1038/s41586-018-0497-0			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU8WA	30185910	Green Accepted, Green Submitted			2022-12-28	WOS:000445622500044
J	Grunstein, M; Allis, CD				Grunstein, Michael; Allis, C. David			Genetics, Biochemistry, and "Simple" Organisms Converge to Unlock Secrets in Histone Biology The 2018 Albert Lasker Basic Medical Research Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							YEAST GCN5P; IN-VIVO; ACTIVATION; ACETYLTRANSFERASE; ACETYLATION		[Grunstein, Michael] Univ Calif Los Angeles, 611 Young Dr E,Boyer Hall,Room 340, Los Angeles, CA 90095 USA; [Allis, C. David] Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA	University of California System; University of California Los Angeles; Rockefeller University	Grunstein, M (corresponding author), Univ Calif Los Angeles, 611 Young Dr E,Boyer Hall,Room 340, Los Angeles, CA 90095 USA.; Allis, CD (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	mg@mbi.ucla.edu; alliscd@rockefeller.edu						ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; Gorovsky M A, 1975, Methods Cell Biol, V9, P311, DOI 10.1016/S0091-679X(08)60080-1; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Pfister SX, 2017, NAT REV DRUG DISCOV, V16, P241, DOI 10.1038/nrd.2016.256; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408	9	1	1	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2018	320	12					1233	1234		10.1001/jama.2018.12437	http://dx.doi.org/10.1001/jama.2018.12437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU8GX	30208392				2022-12-28	WOS:000445577000008
J	Knouse, KA; Lopez, KE; Bachofner, M; Amon, A				Knouse, Kristin A.; Lopez, Kristina E.; Bachofner, Marc; Amon, Angelika			Chromosome Segregation Fidelity in Epithelia Requires Tissue Architecture	CELL			English	Article							MEROTELIC KINETOCHORE ORIENTATION; CELL-DIVISION; MESENCHYMAL TRANSITION; SPINDLE CHECKPOINT; EXTRA CENTROSOMES; CANCER-CELLS; DNA-DAMAGE; INSTABILITY; ANEUPLOIDY; HEPATOCYTES	Much of our understanding of chromosome segregation is based on cell culture systems. Here, we examine the importance of the tissue environment for chromosome segregation by comparing chromosome segregation fidelity across several primary cell types in native and nonnative contexts. We discover that epithelial cells have increased chromosome missegregation outside of their native tissues. Using organoid culture systems, we show that tissue architecture, specifically integrin function, is required for accurate chromosome segregation. We find that tissue architecture enhances the correction of merotelic microtubule-kinetochore attachments, and this is especially important for maintaining chromosome stability in the polyploid liver. We propose that disruption of tissue architecture could underlie the widespread chromosome instability across epithelial cancers. Moreover, our findings highlight the extent to which extracellular context can influence intrinsic cellular processes and the limitations of cell culture systems for studying cells that naturally function within a tissue.	[Knouse, Kristin A.; Lopez, Kristina E.; Amon, Angelika] MIT, Howard Hughes Med Inst, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Knouse, Kristin A.] Harvard Med Sch, Div Hlth Sci & Technol, Boston, MA 02115 USA; [Bachofner, Marc] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Zurich, Switzerland; [Knouse, Kristin A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Swiss Federal Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of Technology (MIT); Whitehead Institute	Knouse, KA; Amon, A (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Knouse, KA (corresponding author), Harvard Med Sch, Div Hlth Sci & Technol, Boston, MA 02115 USA.; Knouse, KA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	knouse@wi.mit.edu; angelika@mit.edu		Lopez, Kristina/0000-0002-5098-2431; /0000-0003-0649-7428	NIH [CA206157-22]; Kathy and Curt Marble Cancer Research Fund; Koch Institute Support grant from the National Cancer Institute [P30-CA14051]; NIGMS Training Grant [T32GM007753]; NATIONAL CANCER INSTITUTE [R01CA206157, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R35GM118066] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kathy and Curt Marble Cancer Research Fund; Koch Institute Support grant from the National Cancer Institute; NIGMS Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sarah Paracha for technical assistance, Konstantina Rowald and Rocio Sotillo for help with establishing spheroid culture, Wendy Salmon for imaging guidance, Summer Morrill and Eghosa Eke for computational assistance, Jie Wu and Duan Ma of the Barbara K. Ostrom (1978) Bioinformatics and Computing Facility for bioinformatics support, and Stefano Santaguida, Buzz Baum, and Iain Cheeseman for helpful discussions. This work was supported by NIH grant CA206157-22 to A.A., the Kathy and Curt Marble Cancer Research Fund, and the Koch Institute Support grant P30-CA14051 from the National Cancer Institute. A.A. is an investigator of the Howard Hughes Medical Institute, the Paul F. Glenn Center for Biology of Aging Research at MIT, and the Ludwig Institute for Cancer Research. K.A.K. was supported by the NIGMS Training Grant T32GM007753.	Akhtar N, 2013, NAT CELL BIOL, V15, P17, DOI 10.1038/ncb2646; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bergstralh DT, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0291; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Comaills V, 2016, CELL REP, V17, P2632, DOI 10.1016/j.celrep.2016.11.022; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Duncan AW, 2012, GASTROENTEROLOGY, V142, P25, DOI 10.1053/j.gastro.2011.10.029; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Haruki N, 2001, CANCER LETT, V162, P201, DOI 10.1016/S0304-3835(00)00675-3; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jechlinger M, 2009, GENE DEV, V23, P1677, DOI 10.1101/gad.1801809; Kamala T, 2007, J IMMUNOL METHODS, V328, P204, DOI 10.1016/j.jim.2007.08.004; Knouse KA, 2017, ANNU REV CANC BIOL, V1, P335, DOI 10.1146/annurev-cancerbio-042616-072231; Knouse KA, 2014, P NATL ACAD SCI USA, V111, P13409, DOI 10.1073/pnas.1415287111; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee JL, 2014, J CELL SCI, V127, P3217, DOI 10.1242/jcs.146142; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Muthuswamy SK, 2012, ANNU REV CELL DEV BI, V28, P599, DOI 10.1146/annurev-cellbio-092910-154244; NEUMANN CM, 1992, INT J IMMUNOPHARMACO, V14, P1295, DOI 10.1016/0192-0561(92)90066-T; Ragkousi K, 2014, J CELL BIOL, V207, P181, DOI 10.1083/jcb.201408044; Roschke A, 2008, NEOPLASIA, V10, P1222, DOI 10.1593/neo.08682; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Silkworth WT, 2012, MOL BIOL CELL, V23, P401, DOI 10.1091/mbc.E11-02-0095; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Speicher T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4862; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tighe A, 2001, EMBO REP, V2, P609, DOI 10.1093/embo-reports/kve127; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	48	71	72	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	2018	175	1					200	+		10.1016/j.cell.2018.07.042	http://dx.doi.org/10.1016/j.cell.2018.07.042			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GU2SI	30146160	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000445120000024
J	Anderson, S				Anderson, Sarah			Outsmarting our instruments	SCIENCE			English	Editorial Material									[Anderson, Sarah] Northwestern Univ, Evanston, IL 60208 USA	Northwestern University	Anderson, S (corresponding author), Northwestern Univ, Evanston, IL 60208 USA.	SciCareerEditor@aaas.org							0	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					1042	1042		10.1126/science.361.6406.1042	http://dx.doi.org/10.1126/science.361.6406.1042			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS7OT	30190409				2022-12-28	WOS:000443892700052
J	Choi, SH; Bylykbashi, E; Chatila, ZK; Lee, SW; Pulli, B; Clemenson, GD; Kim, E; Rompala, A; Oram, MK; Asselin, C; Aronson, J; Zhang, C; Miller, SJ; Lesinski, A; Chen, JW; Kim, DY; van Praag, H; Spiegelman, BM; Gage, FH; Tanzi, RE				Choi, Se Hoon; Bylykbashi, Enjana; Chatila, Zena K.; Lee, Star W.; Pulli, Benjamin; Clemenson, Gregory D.; Kim, Eunhee; Rompala, Alexander; Oram, Mary K.; Asselin, Caroline; Aronson, Jenna; Zhang, Can; Miller, Sean J.; Lesinski, Andrea; Chen, John W.; Kim, Doo Yeon; van Praag, Henriette; Spiegelman, Bruce M.; Gage, Fred H.; Tanzi, Rudolph E.			Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer's mouse model	SCIENCE			English	Article							PROGENITOR-CELL PROLIFERATION; HIPPOCAMPAL NEUROGENESIS; TRANSGENIC MICE; DENTATE GYRUS; ENVIRONMENTAL ENRICHMENT; BRAIN HEALTH; AGED MICE; DISEASE; NEURODEGENERATION; IL-6	Adult hippocampal neurogenesis (AHN) is impaired before the onset of Alzheimer's disease (AD) pathology. We found that exercise provided cognitive benefit to 5xFAD mice, a mouse model of AD, by inducing AHN and elevating levels of brain-derived neurotrophic factor (BDNF). Neither stimulation of AHN alone, nor exercise, in the absence of increased AHN, ameliorated cognition. We successfully mimicked the beneficial effects of exercise on AD mice by genetically and pharmacologically inducing AHN in combination with elevating BDNF levels. Suppressing AHN later led to worsened cognitive performance and loss of preexisting dentate neurons. Thus, pharmacological mimetics of exercise, enhancing AHN and elevating BDNF levels, may improve cognition in AD. Furthermore, applied at early stages of AD, these mimetics may protect against subsequent neuronal cell death.	[Choi, Se Hoon; Bylykbashi, Enjana; Chatila, Zena K.; Kim, Eunhee; Rompala, Alexander; Oram, Mary K.; Asselin, Caroline; Aronson, Jenna; Zhang, Can; Miller, Sean J.; Lesinski, Andrea; Kim, Doo Yeon; Tanzi, Rudolph E.] Harvard Med Sch, Massachusetts Gen Hosp, Genet & Aging Res Unit, Dept Neurol, Charlestown, MA 02129 USA; [Lee, Star W.; Clemenson, Gregory D.; Gage, Fred H.] Salk Inst Biol Studies, Lab Genet, La Jolla, CA 92037 USA; [Pulli, Benjamin; Chen, John W.] Massachusetts Gen Hosp, Inst Innovat Imaging, Dept Radiol, Boston, MA 02114 USA; [van Praag, Henriette] Florida Atlantic Univ, Dept Biomed Sci, Charles E Schmidt Coll Med, Jupiter, FL 33458 USA; [van Praag, Henriette] Florida Atlantic Univ, Brain Inst, Jupiter, FL 33458 USA; [Spiegelman, Bruce M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Chatila, Zena K.] Columbia Univ, Dept Neurosci, New York, NY 10036 USA; [Lee, Star W.] Univ Calif Riverside, Dept Evolut Ecol & Organismal Biol, Riverside, CA 92521 USA; [Clemenson, Gregory D.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Aronson, Jenna] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Miller, Sean J.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Lesinski, Andrea] Univ Rhode Isl, Cell & Mol Biol, Kingston, RI 02881 USA	Harvard University; Massachusetts General Hospital; Salk Institute; Harvard University; Massachusetts General Hospital; State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; Harvard University; Dana-Farber Cancer Institute; Columbia University; University of California System; University of California Riverside; University of California System; University of California Irvine; Massachusetts Institute of Technology (MIT); Stanford University; University of Rhode Island	Tanzi, RE (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Genet & Aging Res Unit, Dept Neurol, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	van Praag, Henriette/F-3939-2015; Tanzi, Rudolph/AAE-9622-2019	van Praag, Henriette/0000-0002-5727-434X; Tanzi, Rudolph/0000-0002-7032-1454; Asselin, Caroline/0000-0002-3598-5247; Kim, Eunhee/0000-0002-9297-2848; Bylykbashi, Enjana/0000-0003-3533-0192; Pulli, Benjamin/0000-0002-1795-9897; Chatila, Zena/0000-0002-4383-6305; Oram, Mary/0000-0003-4693-2009	Cure Alzheimer's Fund; JPB Foundation; NIA [5R01MH060009]; NIMH [5R01MH060009]; Henry and Allison McCance Center for Brain Health at MGH; NIH/NIA [1RF1AG048080-01]; NIH/NIA grant [2R01AG014713]; Mather's Foundation; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG048080, R01AG014713, R01AG055784] Funding Source: NIH RePORTER	Cure Alzheimer's Fund; JPB Foundation; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Henry and Allison McCance Center for Brain Health at MGH; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NIA grant; Mather's Foundation; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Cure Alzheimer's Fund (R.E.T. and S.H.C.); the JPB Foundation (R.E.T., B.M.S., and F.H.G.); NIA and NIMH grant 5R01MH060009 (R.E.T.); The Henry and Allison McCance Center for Brain Health at MGH (R.E.T.); NIH/NIA grant 1RF1AG048080-01 (R.E.T. and D.Y.K.); NIH/NIA grant 2R01AG014713 (D.Y.K.); and the Mather's Foundation and the Leona M. and Harry B. Helmsley Charitable Trust (F.H.G.).	Baier PC, 2009, BEHAV BRAIN RES, V200, P192, DOI 10.1016/j.bbr.2009.01.013; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Bowen KK, 2011, NEUROREPORT, V22, P126, DOI 10.1097/WNR.0b013e3283430a44; Briley D, 2016, SCI REP-UK, V6, DOI 10.1038/srep27812; Buckwalter MS, 2006, AM J PATHOL, V169, P154, DOI 10.2353/ajpath.2006.051272; Cho J, 2015, MED SCI SPORT EXER, V47, P1814, DOI 10.1249/MSS.0000000000000612; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Deuker L, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00064; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FINCH CE, 1993, J CELL BIOCHEM, V53, P314, DOI 10.1002/jcb.240530408; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gomez-Nicola D, 2014, BRAIN, V137, P2312, DOI 10.1093/brain/awu155; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Guerrieri D, 2015, ONCOTARGET, V6, P18293, DOI 10.18632/oncotarget.4715; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Hong XP, 2010, HIPPOCAMPUS, V20, P1339, DOI 10.1002/hipo.20712; Horder H, 2018, NEUROLOGY, V90, pE1298, DOI 10.1212/WNL.0000000000005290; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kandasamy M, 2014, J CELL MOL MED, V18, P1444, DOI 10.1111/jcmm.12298; Klassen HJ, 2003, CYTOKINE, V22, P101, DOI 10.1016/S1043-4666(03)00120-0; Kobilo T, 2014, LEARN MEMORY, V21, P119, DOI 10.1101/lm.033332.113; Lamb SE, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1675; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Llorens-Martin M, 2008, NEUROMOL MED, V10, P99, DOI 10.1007/s12017-008-8026-1; Lovell MA, 2006, NEUROBIOL AGING, V27, P909, DOI 10.1016/j.neurobiolaging.2005.05.004; McPherson CA, 2011, BRAIN BEHAV IMMUN, V25, P850, DOI 10.1016/j.bbi.2010.09.003; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Perry EK, 2012, NEUROBIOL DIS, V47, P155, DOI 10.1016/j.nbd.2012.03.033; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Proctor DT, 2010, J ALZHEIMERS DIS, V21, P795, DOI 10.3233/JAD-2010-100090; Radak Z, 2010, J ALZHEIMERS DIS, V20, P777, DOI 10.3233/JAD-2010-091531; Rasmussen P, 2011, ACTA PHYSIOL, V201, P475, DOI 10.1111/j.1748-1716.2010.02223.x; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Santos-Lozano A, 2016, MAYO CLIN PROC, V91, P999, DOI 10.1016/j.mayocp.2016.04.024; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu Y, 2001, NEUROCHEM INT, V38, P227, DOI 10.1016/S0197-0186(00)00084-X	55	338	353	13	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					991	+	eaan8821	10.1126/science.aan8821	http://dx.doi.org/10.1126/science.aan8821			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190379	Green Accepted			2022-12-28	WOS:000443892700038
J	Hastings, A; Abbott, KC; Cuddington, K; Francis, T; Gellner, G; Lai, YC; Morozov, A; Petrovskii, S; Scranton, K; Zeeman, ML				Hastings, Alan; Abbott, Karen C.; Cuddington, Kim; Francis, Tessa; Gellner, Gabriel; Lai, Ying-Cheng; Morozov, Andrew; Petrovskii, Sergei; Scranton, Katherine; Zeeman, Mary Lou			Transient phenomena in ecology	SCIENCE			English	Review							REGIME SHIFTS; POPULATION; DYNAMICS; TIME; MODELS; CONSERVATION; BIODIVERSITY; PERSISTENCE; TIMESCALES; ATTRACTORS	The importance of transient dynamics in ecological systems and in the models that describe them has become increasingly recognized. However, previous work has typically treated each instance of these dynamics separately. We review both empirical examples and model systems, and outline a classification of transient dynamics based on ideas and concepts from dynamical systems theory. This classification provides ways to understand the likelihood of transients for particular systems, and to guide investigations to determine the timing of sudden switches in dynamics and other characteristics of transients. Implications for both management and underlying ecological theories emerge.				amhastings@ucdavis.edu	Hastings, Alan/O-6864-2019; Morozov, Andrew/AAI-6528-2020; Francis, Tessa/B-6965-2012	Hastings, Alan/0000-0002-0717-8026; Francis, Tessa/0000-0002-3383-5392; Petrovskii, Sergei/0000-0001-6259-2695; Abbott, Karen/0000-0001-5143-0690; Lai, Ying-Cheng/0000-0002-0723-733X; Scranton, Katherine/0000-0002-7656-676X; Gellner, Gabriel/0000-0001-8170-1463	National Institute for Mathematical Biological Synthesis, a synthesis center - National Science Foundation [DBI-1300426]; University of Tennessee, Knoxville	National Institute for Mathematical Biological Synthesis, a synthesis center - National Science Foundation; University of Tennessee, Knoxville	This work resulted from a working group supported by the National Institute for Mathematical Biological Synthesis, a synthesis center sponsored by the National Science Foundation through award DBI-1300426 with additional support from the University of Tennessee, Knoxville.	Abbott KC, 2017, ECOL COMPLEX, V32, P181, DOI 10.1016/j.ecocom.2016.11.004; Baraniuk RG, 2007, IEEE SIGNAL PROC MAG, V24, P6, DOI 10.1109/MSP.2007.909718; Barbosa P., 1987, INSECT OUTBREAKS, P505; Boettiger C, 2012, J R SOC INTERFACE, V9, P2527, DOI 10.1098/rsif.2012.0125; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Bulman CR, 2007, ECOL APPL, V17, P1460, DOI 10.1890/06-1032.1; BUSS LW, 1979, AM NAT, V113, P223, DOI 10.1086/283381; Candes E, 2006, INT C MATH, P1433, DOI DOI 10.4171/022-3/69; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; CRUTCHFIELD JP, 1988, PHYS REV LETT, V60, P2715, DOI 10.1103/PhysRevLett.60.2715; Cushing J.M., 2002, CHAOS ECOLOGY EXPT N; Cushing JM, 1998, J ANIM ECOL, V67, P298, DOI 10.1046/j.1365-2656.1998.00194.x; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Daufresne T, 2005, P NATL ACAD SCI USA, V102, P9212, DOI 10.1073/pnas.0406427102; Dennis B, 2003, OIKOS, V102, P329, DOI 10.1034/j.1600-0706.2003.12387.x; Frank KT, 2011, NATURE, V477, P86, DOI 10.1038/nature10285; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fukami T, 2004, ECOLOGY, V85, P3234, DOI 10.1890/04-0340; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GINZBURG LR, 1994, J ANIM ECOL, V63, P79, DOI 10.2307/5585; GREBOGI C, 1983, PHYSICA D, V7, P181, DOI 10.1016/0167-2789(83)90126-4; Greenman JV, 2003, AM NAT, V161, P225, DOI 10.1086/345784; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; HASTINGS A, 1993, ANNU REV ECOL SYST, V24, P1, DOI 10.1146/annurev.es.24.110193.000245; HASTINGS A, 1994, SCIENCE, V263, P1133, DOI 10.1126/science.263.5150.1133; Hastings A, 2001, ECOL LETT, V4, P215, DOI 10.1046/j.1461-0248.2001.00220.x; Hastings A, 2016, P NATL ACAD SCI USA, V113, P14568, DOI 10.1073/pnas.1604974113; Hastings A, 2010, ECOLOGY, V91, P3471, DOI 10.1890/10-0776.1; Higgins K, 1997, SCIENCE, V276, P1431, DOI 10.1126/science.276.5317.1431; Hornfeldt B, 2004, OIKOS, V107, P376, DOI 10.1111/j.0030-1299.2004.13348.x; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P149, DOI 10.1016/j.tree.2012.08.022; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Jager CG, 2008, ECOLOGY, V89, P1272, DOI 10.1890/07-0347.1; Jankovic M, 2014, THEOR ECOL-NETH, V7, P335, DOI 10.1007/s12080-014-0222-z; Kapitaniak T, 1999, PHYS LETT A, V259, P445, DOI 10.1016/S0375-9601(99)00479-X; Kot M., 2001, ELEMENTS MATHMATICAL; Kuang Y., 1993, DELAY DIFFERENTIAL E; Kuehn C., 2016, MULTIPLE TIME SCALE; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; LAI YC, 1995, PHYS REV LETT, V74, P5208, DOI 10.1103/PhysRevLett.74.5208; Lai YC, 2011, APPL MATH SCI, V173, P3, DOI 10.1007/978-1-4419-6987-3; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; MacHunter J, 2006, CAN J FOREST RES, V36, P2756, DOI 10.1139/X06-159; MARRS RH, 1986, J APPL ECOL, V23, P1029, DOI 10.2307/2403953; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MCCANN K, 1994, AM NAT, V144, P873, DOI 10.1086/285714; Morozov AY, 2016, J THEOR BIOL, V396, P116, DOI 10.1016/j.jtbi.2016.02.016; NERC Centre for Population Biology Imperial College, 1999, GLOB POP DYN DAT; Nisbet RM, 1982, MODELLING FLUCTUATIN; Pastor J, 2006, OIKOS, V112, P698, DOI 10.1111/j.0030-1299.2006.14478.x; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Rinaldi S, 2000, ECOSYSTEMS, V3, P507, DOI 10.1007/s100210000045; Scheffer M, 2001, LIMNOL OCEANOGR, V46, P1780, DOI 10.4319/lo.2001.46.7.1780; Schreiber SJ, 2003, THEOR POPUL BIOL, V64, P201, DOI 10.1016/S0040-5809(03)00072-8; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Smith H, 2011, INTRO DELAY DIFFEREN; SOMMER U, 1985, LIMNOL OCEANOGR, V30, P335, DOI 10.4319/lo.1985.30.2.0335; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Van Geest GJ, 2007, ECOSYSTEMS, V10, P36, DOI 10.1007/s10021-006-9000-0; Wilson RS, 2016, CONSERV BIOL, V30, P42, DOI 10.1111/cobi.12632; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Zeeman ML, 2018, NAT RESOUR MODEL, V31, DOI 10.1111/nrm.12170	71	214	217	16	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					990	+	eaat6412	10.1126/science.aat6412	http://dx.doi.org/10.1126/science.aat6412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190378	Green Submitted			2022-12-28	WOS:000443892700037
J	Sullivan, LB				Sullivan, Lucas B.			Metabolic Frugality Marks Cancer Cells for Immune Targeting	CELL			English	Editorial Material								Altered cell metabolism is ubiquitous in cancer cells; however, it remains challenging to exploit these alterations for cancer therapy. A new study reveals that metabolic alterations to the urea cycle promote tumor growth but unexpectedly also trigger mutations that mark cancer cells for recognition by immunotherapy.	[Sullivan, Lucas B.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Sullivan, LB (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA.	lucas@fredhutch.org		Sullivan, Lucas/0000-0002-6745-8222				Chowell D, 2015, P NATL ACAD SCI USA, V112, pE1754, DOI 10.1073/pnas.1500973112; Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202; Garcia-Bermudez J, 2018, NAT CELL BIOL, V20, P775, DOI 10.1038/s41556-018-0118-z; Kim J, 2017, NATURE, V546, P168, DOI 10.1038/nature22359; Lee JS, 2018, CELL, V174, P1559, DOI 10.1016/j.cell.2018.07.019; Rabinovich S, 2015, NATURE, V527, P379, DOI 10.1038/nature15529; Schvartzman JM, 2018, J CELL BIOL, V217, P2247, DOI 10.1083/jcb.201803061; Sullivan LB, 2018, NAT CELL BIOL, V20, P782, DOI 10.1038/s41556-018-0125-0; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039	9	5	5	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1344	1346		10.1016/j.cell.2018.08.023	http://dx.doi.org/10.1016/j.cell.2018.08.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193108	Bronze			2022-12-28	WOS:000443841000006
J	Tsao, A; Sugar, J; Lu, L; Wang, C; Knierim, JJ; Moser, MB; Moser, EI				Tsao, Albert; Sugar, Jorgen; Lu, Li; Wang, Cheng; Knierim, James J.; Moser, May-Britt; Moser, Edvard I.			Integrating time from experience in the lateral entorhinal cortex	NATURE			English	Article							EPISODIC MEMORY RETRIEVAL; ACTIVITY PATTERNS; NEURAL BASIS; HIPPOCAMPUS; CELLS; REPRESENTATION; INFORMATION; SEQUENCES; SPACE; ORGANIZATION	The encoding of time and its binding to events are crucial for episodic memory, but how these processes are carried out in hippocampal-entorhinal circuits is unclear. Here we show in freely foraging rats that temporal information is robustly encoded across time scales from seconds to hours within the overall population state of the lateral entorhinal cortex. Similarly pronounced encoding of time was not present in the medial entorhinal cortex or in hippocampal areas CA3-CA1. When animals' experiences were constrained by behavioural tasks to become similar across repeated trials, the encoding of temporal flow across trials was reduced, whereas the encoding of time relative to the start of trials was improved. The findings suggest that populations of lateral entorhinal cortex neurons represent time inherently through the encoding of experience. This representation of episodic time may be integrated with spatial inputs from the medial entorhinal cortex in the hippocampus, allowing the hippocampus to store a unified representation of what, where and when.	[Tsao, Albert; Sugar, Jorgen; Lu, Li; Moser, May-Britt; Moser, Edvard I.] NTNU, Kavli Inst Syst Neurosci, Trondheim, Norway; [Tsao, Albert; Sugar, Jorgen; Lu, Li; Moser, May-Britt; Moser, Edvard I.] NTNU, Ctr Neural Computat, Trondheim, Norway; [Wang, Cheng; Knierim, James J.] Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD USA; [Tsao, Albert] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Lu, Li] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Johns Hopkins University; Stanford University; Baylor College of Medicine	Tsao, A; Moser, EI (corresponding author), NTNU, Kavli Inst Syst Neurosci, Trondheim, Norway.; Tsao, A; Moser, EI (corresponding author), NTNU, Ctr Neural Computat, Trondheim, Norway.; Tsao, A (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	tsao@ntnu.no; edvard.moser@ntnu.no	Sugar, Jørgen/AAN-3440-2020	Sugar, Jorgen/0000-0002-5771-9441; Wang, Cheng/0000-0003-2917-877X	Helen Hay Whitney Foundation; European Research Council (GRIDCODE) [338865]; Centre of Excellence scheme; National Infrastructure Scheme of the Research Council of Norway (Centre for Neural Computation) [223262]; National Infrastructure Scheme of the Research Council of Norway (NORBRAIN1) [197467]; Louis Jeantet Prize; Korber Prize; Kavli Foundation	Helen Hay Whitney Foundation; European Research Council (GRIDCODE); Centre of Excellence scheme; National Infrastructure Scheme of the Research Council of Norway (Centre for Neural Computation); National Infrastructure Scheme of the Research Council of Norway (NORBRAIN1); Louis Jeantet Prize; Korber Prize; Kavli Foundation	We thank A. M. Amundsgard, K. Haugen, K. Jenssen, E. Krakvik, and H. Waade for technical assistance and M. P. Witter for help with determining recording locations in the LEC. The work was supported by a fellowship from the Helen Hay Whitney Foundation (to A.T.), an Advanced Investigator Grant from the European Research Council (GRIDCODE', grant number 338865), the Centre of Excellence scheme and the National Infrastructure Scheme of the Research Council of Norway (Centre for Neural Computation, grant number 223262; NORBRAIN1, grant number 197467), the Louis Jeantet Prize, the Korber Prize, and the Kavli Foundation.	Aggarwal CC, 2001, LECT NOTES COMPUT SC, V1973, P420; [Anonymous], 2015, NEURON, V87, P1078; Bota M, 2015, P NATL ACAD SCI USA, V112, pE2093, DOI 10.1073/pnas.1504394112; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Buzsaki G, 2017, SCIENCE, V358, P482, DOI 10.1126/science.aan8869; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Dede AJO, 2016, P NATL ACAD SCI USA, V113, P13480, DOI 10.1073/pnas.1617025113; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Eichenbaum H, 2017, NEURON, V95, P1007, DOI 10.1016/j.neuron.2017.06.036; Eichenbaum H, 2014, NAT REV NEUROSCI, V15, P732, DOI 10.1038/nrn3827; Ekstrom AD, 2007, LEARN MEMORY, V14, P645, DOI 10.1101/lm.575107; Ezzyat Y, 2014, NEURON, V81, P1179, DOI 10.1016/j.neuron.2014.01.042; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Ferbinteanu J, 2006, HIPPOCAMPUS, V16, P691, DOI 10.1002/hipo.20204; Finnerty GT, 2015, J NEUROSCI, V35, P13912, DOI 10.1523/JNEUROSCI.2654-15.2015; Folkerts S, 2018, J NEUROSCI, V38, P4200, DOI 10.1523/JNEUROSCI.2312-17.2018; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Howard MW, 2014, J NEUROSCI, V34, P4692, DOI 10.1523/JNEUROSCI.5808-12.2014; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; Hsieh LT, 2014, NEURON, V81, P1165, DOI 10.1016/j.neuron.2014.01.015; Hyman JM, 2012, P NATL ACAD SCI USA, V109, P5086, DOI 10.1073/pnas.1114415109; Igarashi KM, 2014, NATURE, V510, P143, DOI 10.1038/nature13162; Jin DZZ, 2009, P NATL ACAD SCI USA, V106, P19156, DOI 10.1073/pnas.0909881106; Keene CS, 2016, J NEUROSCI, V36, P3660, DOI 10.1523/JNEUROSCI.4368-15.2016; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Kraus BJ, 2015, NEURON, V88, P578, DOI 10.1016/j.neuron.2015.09.031; Kropff E, 2015, NATURE, V523, P419, DOI 10.1038/nature14622; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Lu L, 2013, NAT NEUROSCI, V16, P1085, DOI 10.1038/nn.3462; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Mankin EA, 2015, NEURON, V85, P190, DOI 10.1016/j.neuron.2014.12.001; Mankin EA, 2012, P NATL ACAD SCI USA, V109, P19462, DOI 10.1073/pnas.1214107109; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; Mau W, 2018, CURR BIOL, V28, P1499, DOI 10.1016/j.cub.2018.03.051; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; McEchron MD, 2003, J NEUROSCI, V23, P1535, DOI 10.1523/JNEUROSCI.23-04-01535.2003; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Naya Y, 2011, SCIENCE, V333, P773, DOI 10.1126/science.1206773; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pilkiw M, 2017, ELIFE, V6, DOI 10.7554/eLife.28611; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Rowland DC, 2016, ANNU REV NEUROSCI, V39, P19, DOI 10.1146/annurev-neuro-070815-013824; Rubin A, 2015, ELIFE, V4, DOI 10.7554/eLife.12247; Skaggs WE, 1993, ADV NEURAL INFORM PR, V5, P1030, DOI DOI 10.1109/PROC.1977.10559; Tsao A, 2013, CURR BIOL, V23, P399, DOI 10.1016/j.cub.2013.01.036; Tulving E., 1985, ELEMENTS EPISODIC ME; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	53	180	181	13	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					57	+		10.1038/s41586-018-0459-6	http://dx.doi.org/10.1038/s41586-018-0459-6			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30158699	Green Submitted			2022-12-28	WOS:000443755200031
J	Hatsukami, DK; Luo, XH; Jensen, JA; al'Absi, M; Allen, SS; Carmella, SG; Chen, ML; Cinciripini, PM; Denlinger-Apte, R; Drobes, DJ; Koopmeiners, JS; Lane, T; Le, CT; Leischow, S; Luo, K; McClernon, FJ; Murphy, SE; Paiano, V; Robinson, JD; Severson, H; Sipe, C; Strasser, AA; Strayer, LG; Tang, MK; Vandrey, R; Hecht, SS; Benowitz, NL; Donny, EC				Hatsukami, Dorothy K.; Luo, Xianghua; Jensen, Joni A.; al'Absi, Mustafa; Allen, Sharon S.; Carmella, Steven G.; Chen, Menglan; Cinciripini, Paul M.; Denlinger-Apte, Rachel; Drobes, David J.; Koopmeiners, Joseph S.; Lane, Tonya; Le, Chap T.; Leischow, Scott; Luo, Kai; McClernon, F. Joseph; Murphy, Sharon E.; Paiano, Viviana; Robinson, Jason D.; Severson, Herbert; Sipe, Christopher; Strasser, Andrew A.; Strayer, Lori G.; Tang, Mei Kuen; Vandrey, Ryan; Hecht, Stephen S.; Benowitz, Neal L.; Donny, Eric C.			Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIGH-THROUGHPUT LIQUID; TOBACCO; DEPENDENCE; VALIDATION; METABOLITE; ACROLEIN	IMPORTANCE The optimal temporal approach for reducing nicotine to minimally or nonaddictive levels in all cigarettes sold in the United States has not been determined. OBJECTIVES To determine the effects of immediate vs gradual reduction in nicotine content to very low levels and as compared with usual nicotine level cigarettes on biomarkers of toxicant exposure. DESIGN, SETTING, AND PARTICIPANTS A double-blind, randomized, parallel-design study with 2 weeks of baseline smoking and 20 weeks of intervention was conducted at 10 US sites. A volunteer sample of daily smokers with no intention to quit within 30 days was recruited between July 2014 and September 2016, with the last follow-up completed in March 2017. INTERVENTIONS (1) Immediate reduction to 0.4mg of nicotine per gram of tobacco cigarettes; (2) gradual reduction from 15.5mg to 0.4mg of nicotine per gram of tobacco cigarettes with 5 monthly dose changes; or (3) maintenance on 15.5mg of nicotine per gram of tobacco cigarettes. MAIN OUTCOMES AND MEASURES Between-group differences in 3 co-primary biomarkers of smoke toxicant exposure: breath carbon monoxide (CO), urine 3-hydroxypropylmercapturic acid (3-HPMA, metabolite of acrolein), and urine phenanthrene tetraol (PheT, indicator of polycyclic aromatic hydrocarbons) calculated as area under the concentration-time curve over the 20 weeks of intervention. RESULTS Among 1250 randomized participants (mean age, 45 years; 549 women [44%]; 958 [77%] completed the trial), significantly lower levels of exposure were observed in the immediate vs gradual reduction group for CO (mean difference, -4.06 parts per million [ppm] [95% CI, -4.89 to -3.23]; P < .0055), 3-HPMA (ratio of geometric means, 0.83 [95% CI, 0.77 to 0.88]; P < .0055), and PheT (ratio of geometric means, 0.88 [95% CI, 0.83 to 0.93]; P < .0055). Significantly lower levels of exposure were observed in the immediate reduction vs control group for CO (mean difference, -3.38 [95% CI, -4.40 to -2.36]; P < .0055), 3-HPMA (ratio of geometric means, 0.81 [95% CI, 0.75 to 0.88]; P < .0055), and PheT (ratio of geometric means, 0.86 [95% CI, 0.81 to 0.92]; P < .0055). No significant differences were observed between the gradual reduction vs control groups for CO (mean difference, 0.68 [95% CI, -0.31 to 1.67]; P = .18), 3-HPMA (ratio of geometric means, 0.98 [95% CI, 0.91 to 1.06]; P = .64), and PheT (ratio of geometric means, 0.98 [95% CI, 0.92 to 1.04]; P = .52). CONCLUSIONS AND RELEVANCE Among smokers, immediate reduction of nicotine in cigarettes led to significantly greater decreases in biomarkers of smoke exposure across time compared with gradual reduction or a control group, with no significant differences between gradual reduction and control.	[Hatsukami, Dorothy K.; Luo, Xianghua; Jensen, Joni A.; Carmella, Steven G.; Chen, Menglan; Koopmeiners, Joseph S.; Lane, Tonya; Le, Chap T.; Luo, Kai; Murphy, Sharon E.; Paiano, Viviana; Sipe, Christopher; Strayer, Lori G.; Tang, Mei Kuen; Hecht, Stephen S.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [al'Absi, Mustafa] Univ Minnesota, Sch Med, Behav Med Labs, Duluth, MN 55812 USA; [Allen, Sharon S.] Univ Minnesota, Sch Med, Family Med & Community Hlth, Minneapolis, MN 55455 USA; [Cinciripini, Paul M.; Robinson, Jason D.] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA; [Denlinger-Apte, Rachel] Brown Univ, Dept Behav & Social Sci, Providence, RI 02912 USA; [Drobes, David J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL USA; [Leischow, Scott] Mayo Clin, Hlth Sci Res, Scottsdale, AZ USA; [McClernon, F. Joseph] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Severson, Herbert] Oregon Res Inst, Eugene, OR 97403 USA; [Strasser, Andrew A.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Vandrey, Ryan] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Donny, Eric C.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; UTMD Anderson Cancer Center; Brown University; H Lee Moffitt Cancer Center & Research Institute; Mayo Clinic; Mayo Clinic Phoenix; Duke University; Oregon Research Institute; University of Pennsylvania; Johns Hopkins University; University of California System; University of California San Francisco; Wake Forest University	Hatsukami, DK (corresponding author), Univ Minnesota, 717 Delaware St SE, Minneapolis, MN 55414 USA.	hatsu001@umn.edu	Robinson, Jason D/C-6433-2009; Luo, Kai/AAM-4845-2020; Tang, Mei Kuen/W-4533-2018	Robinson, Jason D/0000-0002-1588-9637; Luo, Kai/0000-0002-2303-5260; Tang, Mei Kuen/0000-0002-4491-8038; Strayer, Lori G/0000-0002-7859-3876; Allen, Sharon/0000-0003-2797-8001	National Institute on Drug Abuse and Food and Drug Administration grant [U54DA031659]; National Cancer Institute Cancer Center Support grant [P30CA077598]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000114]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027232, U54DA031659] Funding Source: NIH RePORTER	National Institute on Drug Abuse and Food and Drug Administration grant; National Cancer Institute Cancer Center Support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by National Institute on Drug Abuse and Food and Drug Administration grant U54DA031659. All mass spectrometry was carried out in the Analytical Biochemistry Shared Resource of the Masonic Cancer Center, supported in part by National Cancer Institute Cancer Center Support grant P30CA077598. REDCap (Research Electronic Data Capture) services were provided by grant UL1TR000114 from the National Center for Advancing Translational Sciences of the National Institutes of Health.	Allenby CE, 2016, J NEUROIMMUNE PHARM, V11, P471, DOI 10.1007/s11481-016-9656-y; [Anonymous], 2012, IARC MONOGR EVAL C E, P43; Apelberg BJ, 2018, NEW ENGL J MED, V378, P1725, DOI 10.1056/NEJMsr1714617; Benowitz NL, 2017, ADDICTION, V112, P6, DOI 10.1111/add.13534; Benowitz NL, 2012, CANCER EPIDEM BIOMAR, V21, P761, DOI 10.1158/1055-9965.EPI-11-0644; Camella SG, 2013, CHEM RES TOXICOL, V26, P1209, DOI 10.1021/tx400121n; Carmella SG, 2013, J CHROMATOGR B, V935, P36, DOI 10.1016/j.jchromb.2013.07.004; Carmella SG, 2009, CHEM RES TOXICOL, V22, P734, DOI 10.1021/tx800479s; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; Denlinger Rachel L, 2016, Tob Regul Sci, V2, P186, DOI 10.18001/TRS.2.2.9; Donny EC, 2015, NEW ENGL J MED, V373, P1340, DOI 10.1056/NEJMsa1502403; Ensel W. M., 1986, SOCIAL SUPPORT LIFE, P51, DOI [DOI 10.1016/B978-0-12-450660-2.50011-2, DOI 10.1037/1040-3590.2.1.64]; Food and Drug Administration, 2018, FR, P11818; Hatsukami DK, 2017, ADDICTION, V112, P156, DOI 10.1111/add.13603; Hatsukami DK, 2013, CANCER EPIDEM BIOMAR, V22, P1015, DOI 10.1158/1055-9965.EPI-12-1439; Hatsukami DK, 2010, ADDICTION, V105, P343, DOI 10.1111/j.1360-0443.2009.02780.x; Haussmann HJ, 2012, CHEM RES TOXICOL, V25, P794, DOI 10.1021/tx200536w; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Henning RJ, 2017, CARDIOVASC TOXICOL, V17, P227, DOI 10.1007/s12012-016-9396-5; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Kozlowski LT, 1998, TOB CONTROL, V7, P369, DOI 10.1136/tc.7.4.369; Little R.J.A., 2002, STAT ANAL MISSING DA, V2nd Edn, DOI [10.1002/9781119013563, DOI 10.1002/9781119013563]; Mercincavage M, 2016, CANCER EPIDEM BIOMAR, V25, P1125, DOI 10.1158/1055-9965.EPI-15-1088; Molenberghs G., 2007, MISSING DATA CLIN ST, DOI [10.1002/9780470510445, DOI 10.1002/9780470510445]; National Institute on Drug Abuse, NIC RES CIG DRUG SUP; National Institute on Drug Abuse Clinical Trials Network, COMM DAT EL FAG TEST; R Development Core Team, 2009, R LANG ENV STAT COMP; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI [10.1201/9781439821862, DOI 10.1201/9781439821862]; Smith SS, 2010, NICOTINE TOB RES, V12, P489, DOI 10.1093/ntr/ntq032; Solomon SR, 2009, J MOD APPL STAT METH, V8, P448, DOI 10.22237/jmasm/1257034080; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; U.S. Department of Health and Human Services, 1988, DHHS PUBLICATION; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zarth AT, 2014, J CHROMATOGR B, V953, P126, DOI 10.1016/j.jchromb.2014.02.001; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2	40	87	96	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2018	320	9					880	891		10.1001/jama.2018.11473	http://dx.doi.org/10.1001/jama.2018.11473			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS4OQ	30193275	Green Accepted, Bronze			2022-12-28	WOS:000443627300012
J	Kinzler, KD; Shutts, K				Kinzler, Katherine D.; Shutts, Kristin			Stronger together	NATURE			English	Editorial Material									[Kinzler, Katherine D.] Cornell Univ, Ithaca, NY 10021 USA; [Shutts, Kristin] Univ Wisconsin, Madison, WI 53706 USA	Cornell University; University of Wisconsin System; University of Wisconsin Madison	Kinzler, KD (corresponding author), Cornell Univ, Ithaca, NY 10021 USA.								0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					673	673		10.1038/d41586-018-06037-5	http://dx.doi.org/10.1038/d41586-018-06037-5			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS0SZ	30158610	Bronze			2022-12-28	WOS:000443218600056
J	Tanne, JH				Tanne, Janice Hopkins			Sexually transmitted diseases reach record highs in US	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Centers for Disease Control and Prevention, 2018, 2018 STD PREV C 28 A	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2018	362								k3747	10.1136/bmj.k3747	http://dx.doi.org/10.1136/bmj.k3747			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5ZI	30166283				2022-12-28	WOS:000443758100019
J	James, S				James, Stefan			How far will the FIREHAWK stent fly?	LANCET			English	Editorial Material							DRUG-ELUTING STENTS		[James, Stefan] Uppsala Univ, Cardiol, Dept Med Sci, S-75237 Uppsala, Sweden	Uppsala University	James, S (corresponding author), Uppsala Univ, Cardiol, Dept Med Sci, S-75237 Uppsala, Sweden.	stefan.james@ucr.uu.se	James, Stefan K/J-4554-2014		Boston Scientific; Abbott; Biotronik	Boston Scientific(Boston Scientific); Abbott(Abbott Laboratories); Biotronik	I have received research grants from Boston Scientific, Abbott, and Biotronik, and speaker fees from Boston Scientific, Abbott, and Biotronik. I am a member of the Data and Safety Monitoring Board of the TARGET trial by Lansky and colleagues discussed in this Comment.	Bangalore S, 2018, CIRCULATION, V138, P2216, DOI 10.1161/CIRCULATIONAHA.118.034456; Byrne RA, 2015, EUR HEART J, V36, P2608, DOI 10.1093/eurheartj/ehv203; Kandzari DE, 2017, LANCET, V390, P1843, DOI 10.1016/S0140-6736(17)32249-3; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lansky A, 2018, LANCET, V392, P1117, DOI 10.1016/S0140-6736(18)31649-0; MedMarket Diligence, 2016, CARD SURG INT PROC 2; MedMarket Diligence, 2016, CARDIOVASCULAR SURG; Sarno G, 2017, CATHETER CARDIO INTE, V90, P881, DOI 10.1002/ccd.27030; Sarno G, 2012, EUR HEART J, V33, P606, DOI 10.1093/eurheartj/ehr479; Windecker S, 2015, RUSS J CARDIOL, V2, P5	10	5	5	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2018	392	10153					1091	1092		10.1016/S0140-6736(18)31768-9	http://dx.doi.org/10.1016/S0140-6736(18)31768-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV3BV	30190205				2022-12-28	WOS:000445968800006
J	Starodubov, VI; Marczak, LB; Varavikova, E; Bikbov, B; Ermakov, SP; Gall, J; Glenn, SD; Griswold, M; Idrisov, B; Kravchenko, M; Lioznov, D; Loyola, E; Rakovac, I; Vladimirov, SK; Vlassov, V; Murray, CJL; Naghavi, M				Starodubov, Vladimir I.; Marczak, Laurie B.; Varavikova, Elena; Bikbov, Boris; Ermakov, Sergey Petrovich; Gall, Julia; Glenn, Scott D.; Griswold, Max; Idrisov, Bulat; Kravchenko, Michael; Lioznov, Dmitry; Loyola, Enrique; Rakovac, Ivo; Vladimirov, Sergey Konstantinovitch; Vlassov, Vasiliy; Murray, Christopher J. L.; Naghavi, Mohsen		GBD 2016 Russia Collaborators	The burden of disease in Russia from 1980 to 2016: a systematic analysis for the Global Burden of Disease Study 2016	LANCET			English	Article							CAUSE-SPECIFIC MORTALITY; LIFE EXPECTANCY; ALCOHOL	Background Over the past few decades, social and economic changes have had substantial effects on health and wellbeing in Russia. We aimed to use data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to evaluate trends in mortality, causes of death, years lived with disability (YLDs), years of life lost (YLLs), disability-adjusted life-years (DALYs), and associated risk factors in Russia from 1980 to 2016. Methods We estimated all-cause mortality by use of a multistage modelling process that synthesised data from vital registration systems, surveys, and censuses. A composite measure of health loss due to both fatal and non-fatal disease burden (DALYs) was calculated as the sum of YLLs and YLDs for each age, sex, year, and location. Health progress was evaluated in comparison with patterns of change in similar countries by use of the Socio-demographic Index that was developed for GBD 2016. Findings Following rapid decreases in life expectancy after the collapse of the Soviet Union, life expectancy at birth in Russia improved between 2006 and 2016. The all-cause mortality rate decreased by 16.6% (95% uncertainty interval 9.4-33.8) between 1980 and 2016. This overall decrease encompasses the cycles of sharp increases and plateaus in mortality that occurred before 2005. Child mortality decreased by 57.5% (53.5-61.1) between 2000 and 2016. However, compared with countries at similar Socio-demographic Index levels, rates of mortality and disability in Russia remain high and life expectancy is low. Russian men have a disproportionate burden of disease relative to women. In 2016, 59.2% (55.3-62.6) of mortality in men aged 15-49 years and 46.8% (44.5-49.5) of mortality in women were attributable to behavioural risk factors, including alcohol use, drug use, and smoking. Interpretation Trends in mortality in Russia from 1980 to 2016 might be related to complicated patterns of behavioural risk factors associated with economic and social change, to shifts in disease burden, and to changes in the capacity of and access to health care. Ongoing mortality and disability from causes and risks amenable to health-care interventions and behaviour modifications present opportunities to continue to improve the wellbeing of Russian citizens.	[Varavikova, Elena] Minist Hlth Russian Federat, Fed Res Inst Hlth Org & Informat, Management & Planning Res, Moscow, Russia; [Ermakov, Sergey Petrovich] Minist Hlth Russian Federat, Fed Res Inst Hlth Org & Informat, Dept Med Stat & Documentary, Moscow, Russia; [Starodubov, Vladimir I.; Vladimirov, Sergey Konstantinovitch] Minist Hlth Russian Federat, Fed Res Inst Hlth Org & Informat, Moscow, Russia; [Marczak, Laurie B.; Gall, Julia; Glenn, Scott D.; Griswold, Max; Murray, Christopher J. L.; Naghavi, Mohsen] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Bikbov, Boris] Academician VI Shumakov Fed Res Ctr Transplantol, Dept Nephrol Issues Transplanted Kidney, Moscow, Russia; [Ermakov, Sergey Petrovich] Russian Acad Sci, Inst Social & Econ Studies Populat, Moscow, Russia; [Idrisov, Bulat] Bashkir State Med Univ, Dept Infect Dis, Ufa, Russia; [Kravchenko, Michael] Res Ctr Neurol, Moscow, Russia; [Lioznov, Dmitry] Res Inst Influenza, St Petersburg, Russia; [Lioznov, Dmitry] Pavlov First State Med Univ, Dept Infect Dis, St Petersburg, Russia; [Loyola, Enrique] WHO, Noncommunicable Dis & Hlth Promot Life Course, Moscow, Russia; [Rakovac, Ivo] WHO, Prevent & Control Noncommunicable Dis, Moscow, Russia; [Vladimirov, Sergey Konstantinovitch] IM Sechenov First Moscow State Med Univ, Dept Informat & Internet Technol, Moscow, Russia; [Vlassov, Vasiliy] Natl Res Univ Higher Sch Econ, Dept Healthcare Adm & Econ, Moscow, Russia	Ministry of Health of the Russian Federation; Ministry of Health of the Russian Federation; Ministry of Health of the Russian Federation; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs; Russian Academy of Sciences; Federal Center of Theoretical & Applied Sociology - FCTAS; Institute of Social & Economic Studies of Population; Bashkir State Medical University; Research Center of Neurology; World Health Organization; World Health Organization; Sechenov First Moscow State Medical University; HSE University (National Research University Higher School of Economics)	Naghavi, M (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	nagham@uw.edu	Kravchenko, Michael A/B-2596-2012; Bikbov, Boris/I-4594-2013; Vladimirov, Sergey/N-5209-2019; Varavikova, Elena A/F-2609-2017; Idrisov, Bulat/A-8271-2018	Kravchenko, Michael A/0000-0001-5187-5518; Bikbov, Boris/0000-0002-1925-7506; Vladimirov, Sergey/0000-0003-3341-3533; Varavikova, Elena A/0000-0003-3408-3417; Marczak, Laurie/0000-0001-5979-4261; Griswold, Max/0000-0002-6387-128X; Rakovac, Ivo/0000-0002-6815-5274	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Bill & Melinda Gates Foundation.	Brainerd E, 2005, J ECON PERSPECT, V19, P107, DOI 10.1257/0895330053147921; Brooke HSG, 2016, PROBL POST-COMMUNISM, V63, P1, DOI 10.1080/10758216.2015.1039438; Cervellati M, 2015, AM ECON J-MACROECON, V7, P189, DOI 10.1257/mac.20130170; Droznin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174373; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/S0140-6736(18)31310-2, 10.1016/s0140-6736(18)31310-2, 10.1136/bmj.l94]; Leon DA, 1998, JAMA-J AM MED ASSOC, V279, P790, DOI 10.1001/jama.279.10.790; Leon DA, 2015, NAT REV CARDIOL, V12, DOI 10.1038/nrcardio.2015.167; Lunze K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-64; Miller AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148910; Razvodovsky YE, 2016, J SOCIALOMICS, V5, P4; Razvodovsky YE, 2015, J COMMUNITY MED HLTH, V5; Razvodovsky YE, 2015, J DRUG ADDICT ED ERA, V11, P177; Rehm J, 2016, SUBST ABUSE TREAT PR, V11, DOI 10.1186/s13011-016-0081-2; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Rhodes T., 2004, International Journal of Drug Policy, V15, P1, DOI 10.1016/j.drugpo.2003.09.001; Ross H, 2014, NICOTINE TOB RES, V16, pS37, DOI 10.1093/ntr/ntt024; Russian Federation Federal State Statistics Service, 2017, RUSS FIG; Shkolnikov VM, 1998, WORLD DEV, V26, P1995, DOI 10.1016/S0305-750X(98)00102-8; Starodubov V I, 2002, Probl Tuberk, P5; Stefler D, 2018, NICOTINE TOB RES, V20, P749, DOI 10.1093/ntr/ntx122; Stuckler D, 2009, LANCET, V373, P399, DOI 10.1016/S0140-6736(09)60005-2; Timonin S, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0094-0; Vallin J, 2017, HIST METHOD, V50, P191, DOI 10.1080/01615440.2017.1338977; Vishnevsky A., 2015, WE ARE ONCE AGAIN EX; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Wirtz AL, 2016, AIDS BEHAV, V20, P523, DOI 10.1007/s10461-015-1066-2; World Health Organization, 2017, WHO REP GLOB TOB EP; Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	30	30	36	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2018	392	10153					1138	1146		10.1016/S0140-6736(18)31485-5	http://dx.doi.org/10.1016/S0140-6736(18)31485-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV3BV	30173906	hybrid, Green Published			2022-12-28	WOS:000445968800028
J	Hafez, HA; Kovalev, S; Deinert, JC; Mics, Z; Green, B; Awari, N; Chen, M; Germanskiy, S; Lehnert, U; Teichert, J; Wang, Z; Tielrooij, KJ; Liu, ZY; Chen, ZP; Narita, A; Mullen, K; Bonn, M; Gensch, M; Turchinovich, D				Hafez, Hassan A.; Kovalev, Sergey; Deinert, Jan-Christoph; Mics, Zoltan; Green, Bertram; Awari, Nilesh; Chen, Min; Germanskiy, Semyon; Lehnert, Ulf; Teichert, Jochen; Wang, Zhe; Tielrooij, Klaas-Jan; Liu, Zhaoyang; Chen, Zongping; Narita, Akimitsu; Muellen, Klaus; Bonn, Mischa; Gensch, Michael; Turchinovich, Dmitry			Extremely efficient terahertz high-harmonic generation in graphene by hot Dirac fermions	NATURE			English	Article							THZ; CONDUCTIVITY; ABSORPTION; EXCITATION; DETECTORS; OPTICS; COPPER; FILMS; ZNTE	Multiple optical harmonic generation-the multiplication of photon energy as a result of nonlinear interaction between light and matter-is a key technology in modern electronics and optoelectronics, because it allows the conversion of optical or electronic signals into signals with much higher frequency, and the generation of frequency combs. Owing to the unique electronic band structure of graphene, which features massless Dirac fermions(1-3), it has been repeatedly predicted that optical harmonic generation in graphene should be particularly efficient at the technologically important terahertz frequencies(4-6). However, these predictions have yet to be confirmed experimentally under technologically relevant operation conditions. Here we report the generation of terahertz harmonics up to the seventh order in single-layer graphene at room temperature and under ambient conditions, driven by terahertz fields of only tens of kilovolts per centimetre, and with field conversion efficiencies in excess of 10(-3), 10(-4) and 10(-5) for the third, fifth and seventh terahertz harmonics, respectively. These conversion efficiencies are remarkably high, given that the electromagnetic interaction occurs in a single atomic layer. The key to such extremely efficient generation of terahertz high harmonics in graphene is the collective thermal response of its background Dirac electrons to the driving terahertz fields. The terahertz harmonics, generated via hot Dirac fermion dynamics, were observed directly in the time domain as electromagnetic field oscillations at these newly synthesized higher frequencies. The effective nonlinear optical coefficients of graphene for the third, fifth and seventh harmonics exceed the respective nonlinear coefficients of typical solids by 7-18 orders of magnitude(7-9). Our results provide a direct pathway to highly efficient terahertz frequency synthesis using the present generation of graphene electronics, which operate at much lower fundamental frequencies of only a few hundreds of gigahertz.	[Hafez, Hassan A.; Turchinovich, Dmitry] Univ Duisburg Essen, Fac Phys, Duisburg, Germany; [Hafez, Hassan A.; Mics, Zoltan; Liu, Zhaoyang; Chen, Zongping; Narita, Akimitsu; Muellen, Klaus; Bonn, Mischa; Turchinovich, Dmitry] Max Planck Inst Polymer Res, Mainz, Germany; [Hafez, Hassan A.] Helwan Univ, Dept Phys, Fac Sci, Cairo, Egypt; [Kovalev, Sergey; Deinert, Jan-Christoph; Green, Bertram; Awari, Nilesh; Chen, Min; Germanskiy, Semyon; Lehnert, Ulf; Teichert, Jochen; Wang, Zhe; Gensch, Michael] Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Awari, Nilesh] Univ Groningen, Groningen, Netherlands; [Tielrooij, Klaas-Jan] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Barcelona, Spain	University of Duisburg Essen; Max Planck Society; Egyptian Knowledge Bank (EKB); Helwan University; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of Groningen; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Turchinovich, D (corresponding author), Univ Duisburg Essen, Fac Phys, Duisburg, Germany.; Turchinovich, D (corresponding author), Max Planck Inst Polymer Res, Mainz, Germany.; Gensch, M (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany.	m.gensch@hzdr.de; dmitry.turchinovich@uni-due.de	Green, Bert/R-8129-2019; Teichert, Jochen/B-4921-2014; Deinert, Jan-Christoph/GPG-1081-2022; Kovalev, Sergey/M-7678-2019; Awari, Nilesh/AAZ-5844-2020; Narita, Akimitsu/AAD-2005-2019; Tielrooij, Klaas-Jan/R-7133-2019; Green, Bertram/O-1453-2019; Turchinovich, Dmitry/A-8872-2010; Bonn, Mischa/H-7446-2012; Chen, Zongping/G-6679-2012	Green, Bert/0000-0002-7184-5620; Kovalev, Sergey/0000-0002-2290-1016; Awari, Nilesh/0000-0002-1848-8556; Narita, Akimitsu/0000-0002-3625-522X; Tielrooij, Klaas-Jan/0000-0002-0055-6231; Turchinovich, Dmitry/0000-0003-0054-7092; Bonn, Mischa/0000-0001-6851-8453; Deinert, Jan-Christoph/0000-0001-6211-0158; Chen, Min/0000-0001-5230-360X; Wang, Zhe/0000-0001-7464-5408; Chen, Zongping/0000-0001-7760-8821; Germanskiy, Semyon/0000-0002-5649-2548	Deutsche Forschungsgemeinschaft [SFB 1242, TP B08]; European Commission (EU Career Integration Grant) [EU CIG 334324 LIGHTER]; Max Planck Society; European Cluster of Advanced Laser Light Sources (EUCALL) project from the European Union's Horizon 2020 research and innovation program [654220]; Mineco Young Investigator Grant [FIS2014-59639-JIN]; EuCARD-2 project from the European Commission [312453]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission (EU Career Integration Grant); Max Planck Society(Max Planck Society); European Cluster of Advanced Laser Light Sources (EUCALL) project from the European Union's Horizon 2020 research and innovation program; Mineco Young Investigator Grant; EuCARD-2 project from the European Commission	D. T. acknowledges financial support from the Deutsche Forschungsgemeinschaft (SFB 1242 'Non-Equilibrium Dynamics of Condensed Matter in the Time Domain', TP B08), European Commission (EU Career Integration Grant EU CIG 334324 LIGHTER) and the Max Planck Society. M.G. and B.G. acknowledge support from the European Cluster of Advanced Laser Light Sources (EUCALL) project which has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no 654220. K.J.T. acknowledges support through the Mineco Young Investigator Grant (FIS2014-59639-JIN). J.T. and U.L. acknowledge support from the EuCARD-2 project, which has received funding from the European Commission under grant agreement No 312453. We thank J. Laegsgaard, K. Krewer, E. Unger, W. Zhang, T.V.A.G. de Oliveira and M. Mittendorff for discussions. We thank the ELBE team for the operation of the TELBE facility.	Al-Naib I, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.205407; Bowlan P, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.041408; Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; Breusing M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.153410; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Das Sarma S, 2011, REV MOD PHYS, V83, P407, DOI 10.1103/RevModPhys.83.407; Dawlaty JM, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2990753; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Frenzel AJ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4795858; Gallot G, 1999, APPL PHYS LETT, V74, P3450, DOI 10.1063/1.124124; Gierz I, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.086803; Gierz I, 2013, NAT MATER, V12, P1119, DOI [10.1038/NMAT3757, 10.1038/nmat3757]; GLOVER RE, 1957, PHYS REV, V108, P243, DOI 10.1103/PhysRev.108.243; Gosciniak J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01897; Green B, 2016, SCI REP-UK, V6, DOI 10.1038/srep22256; Hafez HA, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4938081; Hafez HA, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.035422; Hao YF, 2013, SCIENCE, V342, P720, DOI 10.1126/science.1243879; Hendry E, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.097401; Hohenleutner M, 2015, NATURE, V523, P572, DOI 10.1038/nature14652; Hong SY, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021014; Hwang EH, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115449; Hwang EH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.165404; Hwang HY, 2013, J PHYS CHEM B, V117, P15819, DOI 10.1021/jp407548a; Jadidi MM, 2016, NANO LETT, V16, P2734, DOI 10.1021/acs.nanolett.6b00405; Jnawali G, 2013, NANO LETT, V13, P524, DOI 10.1021/nl303988q; Kampfrath T, 2013, NAT NANOTECHNOL, V8, P256, DOI [10.1038/nnano.2013.43, 10.1038/NNANO.2013.43]; Konig-Otto JC, 2017, NANO LETT, V17, P2184, DOI 10.1021/acs.nanolett.6b04665; Kovalev S, 2017, STRUCT DYNAM-US, V4, DOI 10.1063/1.4978042; Kumar N, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.121406; Kuznetsov SA, 2014, EUR MICROW CONF, P881, DOI 10.1109/EuMC.2014.6986576; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Lin IT, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235446; Liu XM, 2010, OPT LETT, V35, P913, DOI 10.1364/OL.35.000913; Lundstrom M, 2000, FUNDAMENTALS CARRIER; Mak KF, 2012, SOLID STATE COMMUN, V152, P1341, DOI 10.1016/j.ssc.2012.04.064; Marder M. P., 2010, CONDENS MATTER PHYS, P483; Mics Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8655; Mikhailov SA, 2009, MICROELECTRON J, V40, P712, DOI 10.1016/j.mejo.2008.11.042; Muller R, 2014, J INFRARED MILLIM TE, V35, P659, DOI 10.1007/s10762-014-0066-z; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; PARKER TJ, 1978, INFRARED PHYS, V18, P215, DOI 10.1016/0020-0891(78)90033-7; Perebeinos V, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195442; Reshef O, 2017, OPT LETT, V42, P3225, DOI 10.1364/OL.42.003225; Reyna AS, 2017, ADV OPT PHOTONICS, V9, P720, DOI 10.1364/AOP.9.000720; Saltiel SM, 2005, PROG OPTICS, V47, P1, DOI 10.1016/S0079-6638(05)47001-8; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/NPHOTON.2013.349, 10.1038/nphoton.2013.349]; Schwierz F, 2013, P IEEE, V101, P1567, DOI 10.1109/JPROC.2013.2257633; Shearer CJ, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/12/125704; Song JCW, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.155429; Steiger A, 2013, OPT EXPRESS, V21, P14466, DOI 10.1364/OE.21.014466; Suess RJ, 2016, ACS PHOTONICS, V3, P1069, DOI 10.1021/acsphotonics.6b00141; Tielrooij KJ, 2013, NAT PHYS, V9, P248, DOI [10.1038/nphys2564, 10.1038/NPHYS2564]; Tomadin A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035430; Wang HI, 2017, J PHYS CHEM C, V121, P4083, DOI 10.1021/acs.jpcc.7b00347; Wehling TO, 2014, ADV PHYS, V63, P1, DOI 10.1080/00018732.2014.927109; Winnerl S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.237401; Winnerl S, 2017, ANN PHYS-BERLIN, V529, DOI 10.1002/andp.201700022; Winzer T, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.241404; Wu Q, 1996, APPL PHYS LETT, V68, P1604, DOI 10.1063/1.115665; Wu Q, 1996, APPL PHYS LETT, V68, P2924, DOI 10.1063/1.116356; Yoshikawa N, 2017, SCIENCE, V356, P736, DOI 10.1126/science.aam8861; Zaks B, 2012, NATURE, V483, P580, DOI 10.1038/nature10864	65	244	248	24	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2018	561	7724					507	+		10.1038/s41586-018-0508-1	http://dx.doi.org/10.1038/s41586-018-0508-1			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU8WA	30202091	Green Published			2022-12-28	WOS:000445622500050
J	Bagcchi, S				Bagcchi, Sanjeet			Advice for Indian states to ban electronic nicotine delivery systems spark criticism	BMJ-BRITISH MEDICAL JOURNAL			English	News Item											No Org, Kolkata, India.							Association of Vapers India, 2018, CONS RESP CENTR ADV; Government of India, 2018, ADV EL NIC DEL SYST	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2018	362								k3838	10.1136/bmj.k3838	http://dx.doi.org/10.1136/bmj.k3838			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WS	30190346				2022-12-28	WOS:000444507200015
J	Holmes, D				Holmes, David			RETINAL REPAIR: VISIONS OF THE FUTURE	NATURE			English	Editorial Material																			0	11	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					S1	S1		10.1038/d41586-018-06110-z	http://dx.doi.org/10.1038/d41586-018-06110-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS5YU	30185969	Bronze			2022-12-28	WOS:000443755200004
J	Murphy, DC				Murphy, Declan C.			Solution must be found for 116m pound cost of outsourcing scans, says radiologists' president	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Murphy, Declan C/0000-0001-9295-7712				Rimmer A, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4683; Royal College of Radiologists, 2018, CLIN RAD UK WORKF CE	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2018	362								k3835	10.1136/bmj.k3835	http://dx.doi.org/10.1136/bmj.k3835			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WS	30190410				2022-12-28	WOS:000444507200014
J	Iacobucci, G				Iacobucci, Gareth			Sales of energy drinks to children to be banned in England under government plan	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2018, RADIO BBC        AUG; Department of Health and Social Care, 2018, END SAL EN DRINKS CH; Hashem KM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018136	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2018	362								k3741	10.1136/bmj.k3741	http://dx.doi.org/10.1136/bmj.k3741			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5ZI	30166285				2022-12-28	WOS:000443758100016
J	Chowdhury, R; Ramond, A; O'Keeffe, LM; Shahzad, S; Kunutsor, SK; Muka, T; Gregson, J; Willeit, P; Warnakula, S; Khan, H; Chowdhury, S; Gobin, R; Franco, OH; Di Angelantonio, E				Chowdhury, Rajiv; Ramond, Anna; O'Keeffe, Linda M.; Shahzad, Sara; Kunutsor, Setor K.; Muka, Taulant; Gregson, John; Willeit, Peter; Warnakula, Samantha; Khan, Hassan; Chowdhury, Susmita; Gobin, Reeta; Franco, Oscar H.; Di Angelantonio, Emanuele			Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORONARY-HEART-DISEASE; BLOOD LEAD LEVELS; POPULATION-BASED-COHORT; LEVEL ARSENIC EXPOSURE; CADMIUM-POLLUTED AREA; TRACE-ELEMENT LEVELS; MYOCARDIAL-INFARCTION; DRINKING-WATER; OXIDATIVE STRESS; SERUM COPPER	OBJECTIVE To conduct a systematic review and meta-analysis of epidemiological studies investigating the association of arsenic, lead, cadmium, mercury, and copper with cardiovascular disease. DESIGN Systematic review and meta-analysis. DATA SOURCES PubMed, Embase, and Web of Science searched up to December 2017. REVIEW METHODS Studies reporting risk estimates for total cardiovascular disease, coronary heart disease, and stroke for levels of arsenic, lead, cadmium, mercury, or copper were included. Two investigators independently extracted information on study characteristics and outcomes in accordance with PRISMA and MOOSE guidelines. Relative risks were standardised to a common scale and pooled across studies for each marker using random effects meta-analyses. RESULTS The review identified 37 unique studies comprising 348 259 non-overlapping participants, with 13 033 coronary heart disease, 4205 stroke, and 15 274 cardiovascular disease outcomes in aggregate. Comparing top versus bottom thirds of baseline levels, pooled relative risks for arsenic and lead were 1.30 (95% confidence interval 1.04 to 1.63) and 1.43 (1.16 to 1.76) for cardiovascular disease, 1.23 (1.04 to 1.45) and 1.85 (1.27 to 2.69) for coronary heart disease, and 1.15 (0.92 to 1.43) and 1.63 (1.14 to 2.34) for stroke. Relative risks for cadmium and copper were 1.33 (1.09 to 1.64) and 1.81 (1.05 to 3.11) for cardiovascular disease, 1.29 (0.98 to 1.71) and 2.22 (1.31 to 3.74) for coronary heart disease, and 1.72 (1.29 to 2.28) and 1.29 (0.77 to 2.17) for stroke. Mercury had no distinctive association with cardiovascular outcomes. There was a linear doseresponse relation for arsenic, lead, and cadmium with cardiovascular disease outcomes. CONCLUSIONS Exposure to arsenic, lead, cadmium, and copper is associated with an increased risk of cardiovascular disease and coronary heart disease. Mercury is not associated with cardiovascular risk. These findings reinforce the importance of environmental toxic metals in cardiovascular risk, beyond the roles of conventional behavioural risk factors.	[Chowdhury, Rajiv; Ramond, Anna; Shahzad, Sara; Willeit, Peter; Warnakula, Samantha; Chowdhury, Susmita; Di Angelantonio, Emanuele] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England; [O'Keeffe, Linda M.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [O'Keeffe, Linda M.] Univ Bristol Sch Med, Bristol Populat Hlth Sci Inst, Bristol, Avon, England; [Kunutsor, Setor K.] Natl Inst Hlth Res, Bristol Biomed Res Ctr, Bristol, Avon, England; [Kunutsor, Setor K.] Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England; [Kunutsor, Setor K.] Univ Bristol, Translat Hlth Sci, Bristol Med Sch, Musculoskeletal Res Unit, Bristol, Avon, England; [Muka, Taulant; Franco, Oscar H.] Inst Social & Prevent Med, Bern, Switzerland; [Gregson, John] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Willeit, Peter] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Khan, Hassan] Emory Univ, Atlanta, GA 30322 USA; [Gobin, Reeta] Univ Guyana, Georgetown, Guyana; [Di Angelantonio, Emanuele] Univ Cambridge, Natl Inst Hlth Res, Blood & Transplant Res Unit Donor Hlth & Gen, Dept Publ Hlth & Primary Care, Cambridge, England; [Di Angelantonio, Emanuele] NHS Blood & Transplant, Cambridge, England	University of Cambridge; University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; Medical University of Innsbruck; Emory University; University of Cambridge	Shahzad, S (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England.	ss2231@medschl.cam.ac.uk	Chowdhury, Rajiv/AHB-1253-2022; Kunutsor, Setor K/H-9807-2019; Franco, Óscar H/ABE-2305-2020; Khan, Hassan/D-6267-2013; Willeit, Peter/HCI-7091-2022; DiAngelantonio, Emanuele/ABE-6852-2020	Kunutsor, Setor K/0000-0002-2625-0273; Franco, Óscar H/0000-0002-4606-4929; Khan, Hassan/0000-0003-1468-8654; Willeit, Peter/0000-0002-1866-7159; Di Angelantonio, Emanuele/0000-0001-8776-6719; Ramond, Anna/0000-0002-9958-3693; O'Keeffe, Linda/0000-0002-0003-0774	MRC [MR/L003120/1, MR/N015959/1, MR/M014509/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abhyankar LN, 2012, ENVIRON HEALTH PERSP, V120, P494, DOI 10.1289/ehp.1103988; Afridi HI, 2011, BIOL TRACE ELEM RES, V141, P26, DOI 10.1007/s12011-010-8713-2; [Anonymous], 2012, LANCET, V380, P1532, DOI 10.1016/S0140-6736(12)61862-5; Aoki Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002223; ATSDR (Agency for Toxic Substances and Disease Registry), 1999, TOX PROF MERC; Barregard L, 2016, ENVIRON HEALTH PERSP, V124, P594, DOI 10.1289/ehp.1509735; Bergdahl IA, 2013, INT ARCH OCC ENV HEA, V86, P71, DOI [10.1007/s00420-012-0746-8, 10.100]; Bhatnagar A, 2006, CIRC RES, V99, P692, DOI 10.1161/01.RES.0000243586.99701.cf; Blacksmith Institute Green Cross, GREEN CROSS WORLDS W; Chen CJ, 1996, ARTERIOSCL THROM VAS, V16, P504, DOI 10.1161/01.ATV.16.4.504; Chen Y, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2431; Chene G, 1996, AM J EPIDEMIOL, V144, P610; Chowdhury R, 2015, EUR J EPIDEMIOL, V30, P577, DOI 10.1007/s10654-015-0037-2; Chowdhury R, 2014, ENVIRON RES, V132, P100, DOI 10.1016/j.envres.2014.03.008; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; D'Ippoliti D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138182; Daneshmand R, 2016, BRIT J NUTR, V115, P1851, DOI 10.1017/S0007114516000982; Downer MK, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-016-0435-8; Druwe IL, 2012, TOXICOL APPL PHARM, V261, P263, DOI 10.1016/j.taap.2012.04.005; Dubben HH, 2005, BRIT MED J, V331, P433, DOI 10.1136/bmj.38478.497164.F7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekong EB, 2006, KIDNEY INT, V70, P2074, DOI 10.1038/sj.ki.5001809; Ellinsworth DC, 2015, J PHARMACOL EXP THER, V353, P458, DOI 10.1124/jpet.115.223289; Farzan SF, 2015, TOXICOL APPL PHARM, V287, P93, DOI 10.1016/j.taap.2015.05.013; Fawell J, 2003, BRIT MED BULL, V68, P199, DOI 10.1093/bmb/ldg027; Fewtrell L., 2003, LEAD ASSESSING ENV B; Ford ES, 2000, AM J EPIDEMIOL, V151, P1182, DOI 10.1093/oxfordjournals.aje.a010168; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; GARLAND M, 1993, CANCER EPIDEM BIOMAR, V2, P493; Ghiani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099239; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Hallgren CG, 2001, BRIT J NUTR, V86, P397, DOI 10.1079/BJN2001415; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; IARC, 2012, ARSENIC METALS FIBRE, V100C; JAIN VK, 1991, BIOL TRACE ELEM RES, V31, P317, DOI 10.1007/BF02990200; James KA, 2015, ENVIRON HEALTH PERSP, V123, P128, DOI 10.1289/ehp.1307839; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Jomova K, 2011, J APPL TOXICOL, V31, P95, DOI 10.1002/jat.1649; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kang YJ, 2011, PHARMACOL THERAPEUT, V129, P321, DOI 10.1016/j.pharmthera.2010.11.004; Khalil N, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-15; KINSMAN GD, 1990, BIOCHEM SOC T, V18, P1186, DOI 10.1042/bst0181186; KOK FJ, 1988, AM J EPIDEMIOL, V128, P352, DOI 10.1093/oxfordjournals.aje.a114975; Kosnett MJ, 2010, CLIN PHARMACOL THER, V88, P412, DOI 10.1038/clpt.2010.132; KROMHOUT D, 1988, ENVIRON HEALTH PERSP, V78, P43, DOI 10.2307/3430497; Lamas GA, 2013, JAMA-J AM MED ASSOC, V309, P1241, DOI 10.1001/jama.2013.2107; Lei LJ, 2012, TOXICOL APPL PHARM, V265, P373, DOI 10.1016/j.taap.2012.09.006; Lemaire M, 2011, TOXICOL SCI, V122, P211, DOI 10.1093/toxsci/kfr097; Leone N, 2006, EPIDEMIOLOGY, V17, P308, DOI 10.1097/01.ede.0000209454.41466.b7; Li Q, 2011, CHINESE MED J-PEKING, V124, P3504, DOI 10.3760/cma.j.issn.0366-6999.2011.21.013; Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090; Liao YT, 2012, TOXICOL APPL PHARM, V262, P232, DOI 10.1016/j.taap.2012.04.028; Lustberg M, 2002, ARCH INTERN MED, V162, P2443, DOI 10.1001/archinte.162.21.2443; Marniemi J, 2005, NUTR METAB CARDIOVAS, V15, P188, DOI 10.1016/j.numecd.2005.01.001; Masters SB, 2008, KATZUNG TREVORS PHAR; McElvenny DM, 2015, OCCUP ENVIRON MED, V72, P625, DOI 10.1136/oemed-2014-102637; Menke A, 2009, ENVIRON HEALTH PERSP, V117, P190, DOI 10.1289/ehp.11236; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; Misra R, 1978, Indian Heart J, V30, P339; Mitchell E, 2011, METALLOMICS, V3, P874, DOI 10.1039/c1mt00052g; MOLLER L, 1992, AM J EPIDEMIOL, V136, P1091, DOI 10.1093/oxfordjournals.aje.a116574; Monrad M, 2017, ENVIRON RES, V154, P318, DOI 10.1016/j.envres.2017.01.028; Moon K, 2012, CURR ATHEROSCLER REP, V14, P542, DOI 10.1007/s11883-012-0280-x; Moon KA, 2017, INT J EPIDEMIOL, V46, P1924, DOI 10.1093/ije/dyx202; Moon KA, 2013, ANN INTERN MED, V159, P649, DOI 10.7326/0003-4819-159-10-201311190-00719; Mozaffarian D, 2011, NEW ENGL J MED, V364, P1116, DOI 10.1056/NEJMoa1006876; Muntner P, 2005, ARCH INTERN MED, V165, P2155, DOI 10.1001/archinte.165.18.2155; Nakagawa H, 2006, ENVIRON RES, V100, P323, DOI 10.1016/j.envres.2005.08.014; Nakano E, 2004, BBA-MOL BASIS DIS, V1688, P33, DOI 10.1016/j.bbadis.2003.10.005; Navas-Acien A, 2005, AM J EPIDEMIOL, V162, P1037, DOI 10.1093/aje/kwi330; Navas-Acien A, 2005, ENVIRON HEALTH PERSP, V113, P164, DOI 10.1289/ehp.7329; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Nawrot TS, 2008, ENVIRON HEALTH PERSP, V116, P1620, DOI 10.1289/ehp.11667; NISKANEN J, 1986, ACTA PHARMACOL TOX, V59, P340; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Pierce BL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002522; POCOCK SJ, 1988, ENVIRON HEALTH PERSP, V78, P23, DOI 10.2307/3430494; Reunanen A, 1996, EUR J CLIN NUTR, V50, P431; Ruiz-Navarro ML, 1998, SCI TOTAL ENVIRON, V216, P55, DOI 10.1016/S0048-9697(98)00136-3; SALONEN JT, 1991, AM J EPIDEMIOL, V134, P268, DOI 10.1093/oxfordjournals.aje.a116080; Sania N, 2018, TIME DELIVER REPORT; Schober SE, 2006, ENVIRON HEALTH PERSP, V114, P1538, DOI 10.1289/ehp.9123; Shiue I, 2014, BLOOD PRESSURE, V23, P363, DOI 10.3109/08037051.2014.925228; Singh R, 2015, ECOTOX ENVIRON SAFE, V112, P247, DOI 10.1016/j.ecoenv.2014.10.009; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Srivastava S, 2009, TOXICOL APPL PHARM, V241, P90, DOI 10.1016/j.taap.2009.08.004; Straif K, 2009, LANCET ONCOL, V10, P453, DOI 10.1016/S1470-2045(09)70134-2; Tellez-Plaza M, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0356-2; Tellez-Plaza M, 2013, EPIDEMIOLOGY, V24, P421, DOI 10.1097/EDE.0b013e31828b0631; Tellez-Plaza M, 2012, ENVIRON HEALTH PERSP, V120, P1017, DOI 10.1289/ehp.1104352; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; Tseng CH, 2005, J ENVIRON SCI HEAL C, V23, P55, DOI 10.1081/GNC-200051860; Tseng CH, 2008, ATHEROSCLEROSIS, V199, P12, DOI 10.1016/j.atherosclerosis.2008.02.013; Tsuji JS, 2014, TOXICOLOGY, V323, P78, DOI 10.1016/j.tox.2014.06.008; Virtanen JK, 2005, ARTERIOSCL THROM VAS, V25, P228, DOI 10.1161/01.ATV.0000150040.20950.61; Wade TJ, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0022-y; Waghe P, 2015, CHEM-BIOL INTERACT, V237, P104, DOI 10.1016/j.cbi.2015.06.014; Weisskopf MG, 2009, CIRCULATION, V120, P1056, DOI 10.1161/CIRCULATIONAHA.108.827121; Wennberg M, 2007, BRIT J NUTR, V98, P1038, DOI 10.1017/S0007114507756519; Wennberg M, 2011, AM J CLIN NUTR, V93, P27, DOI 10.3945/ajcn.2010.29408; World Health Organization, PREV NONC DIS NCDS R; World Health Organization, TOP 10 CHEM MAJ PUBL; Wu MM, 2010, TOXICOL APPL PHARM, V248, P226, DOI 10.1016/j.taap.2010.08.005; Yoshizawa K, 2002, NEW ENGL J MED, V347, P1755, DOI 10.1056/NEJMoa021437; Zhang H, 2015, TOXICOL SCI, V146, P354, DOI 10.1093/toxsci/kfv101	108	109	114	4	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2018	362								k3310	10.1136/bmj.k3310	http://dx.doi.org/10.1136/bmj.k3310			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU9VE	30158148	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000445701700003
J	Lee, JSH; Kibbe, WA; Grossman, RL				Lee, Jerry Ssu-Hsien; Kibbe, Warren Alden; Grossman, Robert Lee			Data Harmonization for a Molecularly Driven Health System	CELL			English	Editorial Material							CANCER	Data commons have emerged as the best current method for enabling data aggregation across multiple projects and multiple data sources. Good data harmonization techniques are critical to maintain quality of data within a data commons, as well as to allow future meta-analysis across different data commons. We present some of the current best practices for data harmonization.	[Lee, Jerry Ssu-Hsien] Univ Southern Calif, Keck Sch Med, Dept Med Oncol, Los Angeles, CA USA; [Lee, Jerry Ssu-Hsien] Univ Southern Calif, Viterbi Sch Engn, Dept Chem Engn & Mat Sci, Los Angeles, CA USA; [Lee, Jerry Ssu-Hsien] Univ Southern Calif, Lawrence J Ellison Inst Transformat Med, Los Angeles, CA USA; [Kibbe, Warren Alden] Duke Univ, Duke Canc Inst, Durham, NC 27708 USA; [Kibbe, Warren Alden] Duke Univ, Duke Sch Med, Durham, NC 27708 USA; [Grossman, Robert Lee] Univ Chicago, Ctr Translat Data Sci, Chicago, IL 60637 USA	University of Southern California; University of Southern California; University of Southern California; Duke University; Duke University; University of Chicago	Kibbe, WA (corresponding author), Duke Univ, Duke Canc Inst, Durham, NC 27708 USA.; Kibbe, WA (corresponding author), Duke Univ, Duke Sch Med, Durham, NC 27708 USA.	warren.kibbe@duke.edu	Lee, Jerry S.H./AAL-1072-2021; Kibbe, Warren/B-2106-2010	Lee, Jerry S.H./0000-0003-1515-0952; Kibbe, Warren/0000-0001-5622-7659	National Cancer Institute, National Institutes of Health [17X053, HHSN261200800001E]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in part with Federal funds from the National Cancer Institute, National Institutes of Health, Task Order No. 17X053 under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. We would like to thank David Agus, Patrick Gilmore, Norbert Tavares, and Sarah Elder for their inputs in preparing this paper.	Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goodman AM, 2018, JAMA ONCOL, V4, P1237, DOI 10.1001/jamaoncol.2018.1701; Grossman RL, 2017, CLIN PHARMACOL THER, V101, P589, DOI 10.1002/cpt.666; Kazandjian D, 2014, ONCOLOGIST, V19, pE5, DOI 10.1634/theoncologist.2014-0241; Leprevost FD, 2017, BIOINFORMATICS, V33, P2580, DOI 10.1093/bioinformatics/btx192; O'Connor Brian D, 2017, F1000Res, V6, P52, DOI 10.12688/f1000research.10137.1; Rodriguez H, 2018, CELL, V173, P533, DOI 10.1016/j.cell.2018.04.008; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tatlow PJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep39259	11	8	8	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2018	174	5					1045	1048		10.1016/j.cell.2018.08.012	http://dx.doi.org/10.1016/j.cell.2018.08.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GR3WU	30142341	Bronze			2022-12-28	WOS:000442529100002
J	Levine, D; McDonald, RJ; Kressel, HY				Levine, Deborah; McDonald, Robert J.; Kressel, Herbert Y.			Gadolinium Retention After Contrast-Enhanced MRI	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Levine, Deborah; Kressel, Herbert Y.] Beth Israel Deaconess Med Ctr, Dept Radiol, 330 Brookline Ave, Boston, MA 02215 USA; [McDonald, Robert J.] Mayo Clin, Dept Radiol, Div Neuroradiol, Rochester, MN USA	Harvard University; Beth Israel Deaconess Medical Center; Mayo Clinic	Levine, D (corresponding author), Beth Israel Deaconess Med Ctr, Dept Radiol, 330 Brookline Ave, Boston, MA 02215 USA.	dlevine@bidmc.harvard.edu			Bayer AG	Bayer AG(Bayer AG)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Levine reported serving as expert witness in a trial regarding the Essure device (Bayer Healthcare). Dr McDonald reported receiving an investigator-initiated grant and serving as a consultant to GE Healthcare regarding contrast agent development and safety, with all funds going to Mayo Clinic; serving as a consultant to Bracco Diagnostics regarding contrast agent safety, with all funds going to Mayo Clinic; and receiving indirect financial support from Bayer AG in the form of a scholar grant, with all funds going to RSNA. Dr Kressel reported receiving compensation for serving as director of science and communication from the International Society for Strategic Studies in Radiology; and receiving compensation from RSNA for serving as the editor of Radiology, 2008-2017.	Abraham JL, 2008, BRIT J DERMATOL, V158, P273, DOI 10.1111/j.1365-2133.2007.08335.x; Bayer Bracco Diagnostics GE Healthcare Guerbet, 2018, IMPORTANT DRUG WARNI; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; McDonald RJ, RADIOLOGY; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Murata N, 2016, INVEST RADIOL, V51, P447, DOI 10.1097/RLI.0000000000000252; US Food and Drug Administration, 2017, FDA BRIEF DOC GAD RE; US Food and Drug Administration, 2009, GAD BAS CONTR AG NEP; Welk B, 2016, JAMA-J AM MED ASSOC, V316, P96, DOI 10.1001/jama.2016.8096	9	39	39	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2018	320	18					1853	1854		10.1001/jama.2018.13362	http://dx.doi.org/10.1001/jama.2018.13362			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA1BH	30208489				2022-12-28	WOS:000449945900005
J	Kato, HE; Kim, YS; Paggi, JM; Evans, KE; Allen, WE; Richardson, C; Inoue, K; Ito, S; Ramakrishnan, C; Fenno, LE; Yamashita, K; Hilger, D; Lee, SY; Berndt, A; Shen, K; Kandori, H; Dror, RO; Kobilka, BK; Deisseroth, K				Kato, Hideaki E.; Kim, Yoon Seok; Paggi, Joseph M.; Evans, Kathryn E.; Allen, William E.; Richardson, Claire; Inoue, Keiichi; Ito, Shota; Ramakrishnan, Charu; Fenno, Lief E.; Yamashita, Keitaro; Hilger, Daniel; Lee, Soo Yeun; Berndt, Andre; Shen, Kang; Kandori, Hideki; Dror, Ron O.; Kobilka, Brian K.; Deisseroth, Karl			Structural mechanisms of selectivity and gating in anion channelrhodopsins	NATURE			English	Article							MOLECULAR-DYNAMICS; FORCE-FIELD; OPTOGENETICS; VALIDATION; AMBER	Both designed and natural anion-conducting channelrhodopsins (dACRs and nACRs, respectively) have been widely applied in optogenetics (enabling selective inhibition of target-cell activity during animal behaviour studies), but each class exhibits performance limitations, underscoring trade-offs in channel structure-function relationships. Therefore, molecular and structural insights into dACRs and nACRs will be critical not only for understanding the fundamental mechanisms of these light-gated anion channels, but also to create next-generation optogenetic tools. Here we report crystal structures of the dACR iC++, along with spectroscopic, electrophysiological and computational analyses that provide unexpected insights into pH dependence, substrate recognition, channel gating and ion selectivity of both dACRs and nACRs. These results enabled us to create an anion-conducting channelrhodopsin integrating the key features of large photocurrent and fast kinetics alongside exclusive anion selectivity.	[Kato, Hideaki E.; Hilger, Daniel; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Kato, Hideaki E.; Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Kim, Yoon Seok; Evans, Kathryn E.; Allen, William E.; Ramakrishnan, Charu; Fenno, Lief E.; Lee, Soo Yeun; Berndt, Andre; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kim, Yoon Seok; Evans, Kathryn E.; Allen, William E.; Ramakrishnan, Charu; Fenno, Lief E.; Lee, Soo Yeun; Berndt, Andre; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Kim, Yoon Seok; Evans, Kathryn E.; Allen, William E.; Ramakrishnan, Charu; Fenno, Lief E.; Lee, Soo Yeun; Berndt, Andre; Shen, Kang; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Paggi, Joseph M.; Richardson, Claire; Dror, Ron O.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Paggi, Joseph M.; Dror, Ron O.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Inoue, Keiichi; Ito, Shota; Kandori, Hideki] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Nagoya, Aichi, Japan; [Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Nagoya, Aichi, Japan; [Yamashita, Keitaro] RIKEN, SPring Ctr 8, Sayo, Hyogo, Japan	Stanford University; Japan Science & Technology Agency (JST); Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Nagoya Institute of Technology; Nagoya Institute of Technology; RIKEN	Kato, HE (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Kato, HE (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan.; Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	hekato@stanford.edu; deissero@stanford.edu	Fenno, Lief/AAF-9638-2019; Hilger, Daniel/C-7297-2019; Kato, Hideaki/AAQ-4323-2020; Fenno, Lief/AAK-2924-2020; Inoue, Keiichi/AEO-3337-2022	Hilger, Daniel/0000-0001-5179-1357; Kato, Hideaki/0000-0002-1941-5535; Inoue, Keiichi/0000-0002-6898-4347; Dror, Ron/0000-0002-6418-2793; Yamashita, Keitaro/0000-0002-5442-7582; Berndt, Andre/0000-0003-4758-5598; Kobilka, Brian/0000-0001-5958-3990; Evans, Kathryn/0000-0003-4352-005X; Richardson, Claire/0000-0002-7532-1808	JST PRESTO [JPMJPR1782, JPMJPR15P2]; Stanford Bio-X; Kwanjeong Foundation; German Academic Exchange Service; MEXT [17H03007, 25104009/15H02391]; JST CREST [JPMJCR1753]; US Department of Energy, Scientific Discovery through Advanced Computing (SciDAC) program; Mathers Charitable Foundation; NIMH [R01MH075957]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, R37MH075957] Funding Source: NIH RePORTER	JST PRESTO(Japan Science & Technology Agency (JST)); Stanford Bio-X; Kwanjeong Foundation; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); US Department of Energy, Scientific Discovery through Advanced Computing (SciDAC) program(United States Department of Energy (DOE)); Mathers Charitable Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Lee, M. Lo, K. Geiselhart and M. Lima for technical support; K.K. Kumar, N.R. Latorraca, M. Inoue and K. Katayama for comments on the manuscript; E.E. Steinberg, M.A. Wright, and R.C. Malenka for inputs on mouse experiments; K. Hirata, M. Yamamoto and other staffs at BL32XU of SPring-8, and the staff at BL23ID-B/23ID-D of APS for assistance in data collection. We acknowledge support by JST PRESTO (JPMJPR1782 for H.E.K., JPMJPR15P2 for K. I.), Stanford Bio-X and the Kwanjeong Foundation (Y.S.K.), German Academic Exchange Service (D.H.); MEXT (17H03007 for K. I. and 25104009/15H02391 for H.K.), JST CREST (JPMJCR1753, H.K.), the US Department of Energy, Scientific Discovery through Advanced Computing (SciDAC) program (R.O.D.) and Mathers Charitable Foundation (B.K.K.). The project was supported by a grant for channelrhodopsin crystal structure determination from the NIMH (R01MH075957 to K.D.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen WE, 2017, SCIENCE, V357, P1149, DOI 10.1126/science.aan6747; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Best RB, 2012, BIOPHYS J, V103, P1045, DOI 10.1016/j.bpj.2012.07.042; Case D. A., 2017, AMBER 2017; Chung S, 2017, NATURE, V545, P477, DOI 10.1038/nature22350; Deisseroth K, 2017, SCIENCE, V357, DOI 10.1126/science.aan5544; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Govorunova EG, 2017, SCI REP-UK, V7, DOI 10.1038/srep43358; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jun JJ, 2017, NATURE, V551, P232, DOI 10.1038/nature24636; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kim CK, 2017, NAT REV NEUROSCI, V18, P222, DOI 10.1038/nrn.2017.15; Kim YS, 2018, NATURE, V561, P343, DOI 10.1038/s41586-018-0511-6; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mamad O, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002365; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Selimbeyoglu A, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6733; Sineshchekov OA, 2016, P NATL ACAD SCI USA, V113, pE1993, DOI 10.1073/pnas.1525269113; Steinbrecher T, 2012, J CHEM THEORY COMPUT, V8, P4405, DOI 10.1021/ct300613v; Takemoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131094; VanGordon MR, 2017, BIOPHYS J, V112, P943, DOI 10.1016/j.bpj.2017.01.023; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wietek J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14807; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Yamashita K, 2018, ACTA CRYSTALLOGR D, V74, P441, DOI 10.1107/S2059798318004576; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F; Zhu SS, 2013, J AM CHEM SOC, V135, P9391, DOI 10.1021/ja4002986	47	45	45	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2018	561	7723					349	+		10.1038/s41586-018-0504-5	http://dx.doi.org/10.1038/s41586-018-0504-5			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU1HZ	30158697	Green Accepted			2022-12-28	WOS:000445011500045
J	Marshall, F; Reid, REB; Goldstein, S; Storozum, M; Wreschnig, A; Hu, L; Kiura, P; Shahack-Gross, R; Ambrose, SH				Marshall, Fiona; Reid, Rachel E. B.; Goldstein, Steven; Storozum, Michael; Wreschnig, Andrew; Hu, Lorraine; Kiura, Purity; Shahack-Gross, Ruth; Ambrose, Stanley H.			Ancient herders enriched and restructured African grasslands	NATURE			English	Article							ABANDONED PASTORAL SETTLEMENTS; IRON-AGE; LARGE HERBIVORES; IDENTIFICATION; NITROGEN; GRASSES; SITES; DUNG	Grasslands are one of the world's most extensive terrestrial biomes and are central to the survival of herders, their livestock and diverse communities of large wild mammals(1-3). In Africa, tropical soils are predominantly nutrient-limited(4-)(6) but productive grassy patches in wooded grassland savannah ecosystems(2)(,4) grow on fertile soils created by geologic and edaphic factors, megafauna, fire and termites(4-6). Mobile pastoralists also create soil-fertility hotspots by penning their herds at night, which concentrates excrement-and thus nutrients-from grazing of the surrounding savannahs(7-11). Historical anthropogenic hotspots produce high-quality forage, attract wildlife and increase spatial heterogeneity in African savannahs(4,)(12-15). Archaeological research suggests this effect extends back at least 1,000 years(16-19) but little is known about nutrient persistence at millennial scales. Here we use chemical, isotopic and sedimentary analyses to show high nutrient and N-15 enrichment in on-site degraded dung deposits relative to off-site soils at five Pastoral Neolithic(20) sites (radiocarbon dated to between 3,700 and 1,550 calibrated years before present (cal. BP)). This study demonstrates the longevity of nutrient hotspots and the long-term legacy of ancient herders, whose settlements enriched and diversified African savannah landscapes over three millennia.	[Marshall, Fiona; Reid, Rachel E. B.; Hu, Lorraine] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Goldstein, Steven] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany; [Storozum, Michael] Nanyang Technol Univ, Earth Observ Singapore, N2-01a-15, Singapore, Singapore; [Wreschnig, Andrew] AECOM, Charlotte, NC USA; [Kiura, Purity] Natl Museums Kenya, Directorate Museums Sites & Monuments, Nairobi, Kenya; [Shahack-Gross, Ruth] Univ Haifa, Dept Maritime Civilizat, Leon Recanati Inst Maritime Studies, Leon H Charney Sch Marine Sci, Haifa, Israel; [Ambrose, Stanley H.] Univ Illinois, Dept Anthropol, 109 Davenport Hall, Urbana, IL 61801 USA	Washington University (WUSTL); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Haifa; University of Illinois System; University of Illinois Urbana-Champaign	Marshall, F (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.; Ambrose, SH (corresponding author), Univ Illinois, Dept Anthropol, 109 Davenport Hall, Urbana, IL 61801 USA.	fmarshal@wustl.edu; ambrose@illinois.edu		Hu, Lorraine/0000-0002-8982-1870	National Museums of Kenya; Washington University in St Louis I-CARES; Liu laboratory; Kidder laboratory; NSF [ECS-0335765]; University of Illinois Environmental Isotope Paleobiogeochemistry Laboratory; Nano Research Facility at Washington University; Kenya Ministry of Science and Technology [MOST 13/001/38C234, NCST RRI/12/BS011/38]	National Museums of Kenya; Washington University in St Louis I-CARES; Liu laboratory; Kidder laboratory; NSF(National Science Foundation (NSF)); University of Illinois Environmental Isotope Paleobiogeochemistry Laboratory; Nano Research Facility at Washington University; Kenya Ministry of Science and Technology	We thank the Kenya Ministry of Science and Technology for permission to conduct research (MOST 13/001/38C234, NCST RRI/12/BS011/38) and National Museums of Kenya for research affiliation, excavation licence and support. We are grateful to J. K. Mulwa and M. Mulwa, for site access at Lukenya and to A. Kabiru, J. M. Munyiri, N. Ole Simpai, H. Ole Saitabau and J. K. Ole Tumpuya for research assistance. Funding was received from Washington University in St Louis I-CARES and support from the Liu and the Kidder laboratories, the Nano Research Facility at Washington University, NSF Grant No. ECS-0335765 and the University of Illinois Environmental Isotope Paleobiogeochemistry Laboratory.	Ambrose S.H., 2001, ENCY PREHISTORY VOLU, V1, P97, DOI [10.1007/978-1-4615-1193-9_8, DOI 10.1007/978-1-4615-1193-9_8]; AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; [Anonymous], 1977, AZANIA; Augustine DJ, 2003, ECOL APPL, V13, P1325, DOI 10.1890/02-5283; BELL RHV, 1982, ECOL STUD, V42, P193; Boles OJC, 2016, AZANIA, V51, P507, DOI 10.1080/0067270X.2016.1249587; Bronk Ramsey C., 2009, RADIOCARBON, V51, P227; Bruno M.C., 2016, ARCHAEOLOGY ANDEAN P, P55; Cech PG, 2008, ECOSYSTEMS, V11, P991, DOI 10.1007/s10021-008-9175-7; DENBOW JR, 1979, S AFR J SCI, V75, P405; Frachetti MD, 2008, PASTORALIST LANDSCAPES AND SOCIAL INTERACTION IN BRONZE AGE EURASIA, P1; Frank DA, 2004, BIOGEOCHEMISTRY, V68, P169, DOI 10.1023/B:BIOG.0000025736.19381.91; GEORGIADIS NJ, 1990, J APPL ECOL, V27, P623, DOI 10.2307/2404307; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Huffman TN, 2013, J ARCHAEOL SCI, V40, P3553, DOI 10.1016/j.jas.2013.03.026; Lamprey RH, 2004, J BIOGEOGR, V31, P997, DOI 10.1111/j.1365-2699.2004.01062.x; Lane Paul, 2011, Smithsonian Contributions to Zoology, P11; Macharia AN, 2012, J ARCHAEOL SCI, V39, P2198, DOI 10.1016/j.jas.2012.02.005; Muchiru AN, 2009, J ARID ENVIRON, V73, P322, DOI 10.1016/j.jaridenv.2008.09.018; Muchiru AN, 2008, J ARID ENVIRON, V72, P940, DOI 10.1016/j.jaridenv.2007.11.012; Nelson C.M., 1984, ORIGIN EARLY DEV FOO, P481; Porensky LM, 2015, RANGELAND ECOL MANAG, V68, P131, DOI 10.1016/j.rama.2015.01.002; Porensky LM, 2012, OECOLOGIA, V168, P749, DOI 10.1007/s00442-011-2123-9; Reid RS, 2012, SAVANNAS OF OUR BIRTH: PEOPLE, WILDLIFE, AND CHANGE IN EAST AFRICA, P1; Robertshaw P., 1990, EARLY PASTORALISTS S, P36; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; Shahack-Gross R, 2004, J ARCHAEOL SCI, V31, P1259, DOI 10.1016/j.jas.2004.02.004; Shahack-Gross R, 2003, J ARCHAEOL SCI, V30, P439, DOI 10.1006/jasc.2002.0853; Shahack-Gross R, 2008, J ARCHAEOL SCI, V35, P965, DOI 10.1016/j.jas.2007.06.019; Shahack-Gross R, 2008, J ARCHAEOL SCI, V35, P983, DOI 10.1016/j.jas.2007.07.002; Shahack-Gross R, 2011, J ARCHAEOL SCI, V38, P205, DOI 10.1016/j.jas.2010.09.019; Simons A, 2004, THESIS; Suttie J. M., 2006, P1; Turner MD, 1998, J BIOGEOGR, V25, P669, DOI 10.1046/j.1365-2699.1998.2540669.x; van der Waal C, 2011, OECOLOGIA, V165, P1095, DOI 10.1007/s00442-010-1899-3; WESTERN D, 1979, HUM ECOL, V7, P75, DOI 10.1007/BF00889353; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	38	86	88	5	82	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 20	2018	561	7723					387	+		10.1038/s41586-018-0456-9	http://dx.doi.org/10.1038/s41586-018-0456-9			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU1HZ	30158702				2022-12-28	WOS:000445011500053
J	Nitta, N; Sugimura, T; Isozaki, A; Mikami, H; Hiraki, K; Sakuma, S; Iino, T; Arai, F; Endo, T; Fujiwaki, Y; Fukuzawa, H; Hase, M; Hayakawa, T; Hiramatsu, K; Hoshino, Y; Inaba, M; Ito, T; Karakawa, H; Kasai, Y; Koizumi, K; Lee, S; Lei, C; Li, M; Maeno, T; Matsusaka, S; Murakami, D; Nakagawa, A; Oguchi, Y; Oikawa, M; Ota, T; Shiba, K; Shintaku, H; Shirasaki, Y; Suga, K; Suzuki, Y; Suzuki, N; Tanaka, Y; Tezuka, H; Toyokawa, C; Yalikun, Y; Yamada, M; Yamagishi, M; Yamano, T; Yasumoto, A; Yatomi, Y; Yazawa, M; Carlo, D; Hosokawa, Y; Uemura, S; Ozeki, Y; Goda, K				Nitta, Nao; Sugimura, Takeaki; Isozaki, Akihiro; Mikami, Hideharu; Hiraki, Kei; Sakuma, Shinya; Iino, Takanori; Arai, Fumihito; Endo, Taichiro; Fujiwaki, Yasuhiro; Fukuzawa, Hideya; Hase, Misa; Hayakawa, Takeshi; Hiramatsu, Kotaro; Hoshino, Yu; Inaba, Mary; Ito, Takuro; Karakawa, Hiroshi; Kasai, Yusuke; Koizumi, Kenichi; Lee, SangWook; Lei, Cheng; Li, Ming; Maeno, Takanori; Matsusaka, Satoshi; Murakami, Daichi; Nakagawa, Atsuhiro; Oguchi, Yusuke; Oikawa, Minoru; Ota, Tadataka; Shiba, Kiyotaka; Shintaku, Hirofumi; Shirasaki, Yoshitaka; Suga, Kanako; Suzuki, Yuta; Suzuki, Nobutake; Tanaka, Yo; Tezuka, Hiroshi; Toyokawa, Chihana; Yalikun, Yaxiaer; Yamada, Makoto; Yamagishi, Mai; Yamano, Takashi; Yasumoto, Atsushi; Yatomi, Yutaka; Yazawa, Masayuki; Di Carlo, Dino; Hosokawa, Yoichiroh; Uemura, Sotaro; Ozeki, Yasuyuki; Goda, Keisuke			Intelligent Image-Activated Cell Sorting	CELL			English	Article							CHLAMYDOMONAS-REINHARDTII; FLOW-CYTOMETRY; PROTEIN; GROWTH; MICROSCOPY; MECHANISM; REVEALS; CULTURE; SYSTEM	A fundamental challenge of biology is to understand the vast heterogeneity of cells, particularly how cellular composition, structure, and morphology are linked to cellular physiology. Unfortunately, conventional technologies are limited in uncovering these relations. We present a machine-intelligence technology based on a radically different architecture that realizes real-time image-based intelligent cell sorting at an unprecedented rate. This technology, which we refer to as intelligent image-activated cell sorting, integrates high-throughput cell microscopy, focusing, and sorting on a hybrid software-hardware data-management infrastructure, enabling real-time automated operation for data acquisition, data processing, decision-making, and actuation. We use it to demonstrate real-time sorting of microalgal and blood cells based on intracellular protein localization and cell-cell interaction from large heterogeneous populations for studying photosynthesis and atherothrombosis, respectively. The technology is highly versatile and expected to enable machine-based scientific discovery in biological, pharmaceutical, and medical sciences.	[Nitta, Nao; Sugimura, Takeaki; Isozaki, Akihiro; Mikami, Hideharu; Hiraki, Kei; Hase, Misa; Hiramatsu, Kotaro; Ito, Takuro; Karakawa, Hiroshi; Lee, SangWook; Lei, Cheng; Ota, Tadataka; Di Carlo, Dino; Goda, Keisuke] Univ Tokyo, Dept Chem, Tokyo 1130033, Japan; [Nitta, Nao; Sugimura, Takeaki; Ito, Takuro; Goda, Keisuke] Japan Sci & Technol Agcy, Saitama 3320012, Japan; [Sakuma, Shinya; Arai, Fumihito; Kasai, Yusuke] Nagoya Univ, Dept Micronano Mech Sci & Engn, Nagoya, Aichi 4648603, Japan; [Iino, Takanori; Fujiwaki, Yasuhiro; Suzuki, Yuta; Ozeki, Yasuyuki] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan; [Endo, Taichiro; Yamada, Makoto] RIKEN, Ctr Adv Intelligence Project, Tokyo 1030027, Japan; [Endo, Taichiro] ExaWizards Inc, Tokyo 1050013, Japan; [Fukuzawa, Hideya; Toyokawa, Chihana; Yamano, Takashi] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Hayakawa, Takeshi] Chuo Univ, Dept Precis Mech, Tokyo 1128551, Japan; [Hoshino, Yu] Kyushu Univ, Dept Chem Engn, Fukuoka, Fukuoka 8190395, Japan; [Inaba, Mary; Koizumi, Kenichi; Murakami, Daichi; Tezuka, Hiroshi] Univ Tokyo, Dept Creat Informat, Tokyo 1130033, Japan; [Li, Ming; Di Carlo, Dino] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Maeno, Takanori] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; [Matsusaka, Satoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo 1358550, Japan; [Nakagawa, Atsuhiro] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 9808577, Japan; [Oguchi, Yusuke; Shirasaki, Yoshitaka; Suzuki, Nobutake; Yamagishi, Mai; Uemura, Sotaro] Univ Tokyo, Dept Biol Sci, Tokyo 1130033, Japan; [Oikawa, Minoru] Kochi Univ, Nat Sci Cluster, Sci & Technol Unit, Kochi 7808520, Japan; [Shiba, Kiyotaka; Suga, Kanako] Japanese Fdn Canc Res, Canc Inst, Div Prot Engn, Tokyo 1358550, Japan; [Shintaku, Hirofumi] Kyoto Univ, Dept Micro Engn, Kyoto 6068501, Japan; [Tanaka, Yo; Yalikun, Yaxiaer] RIKEN, Ctr Biosyst Dynam Res, Osaka 5650871, Japan; [Yamada, Makoto] Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan; [Yasumoto, Atsushi; Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo 1130033, Japan; [Yazawa, Masayuki] Columbia Univ, Dept Rehabil & Regenerat Med, Pharmacol, New York, NY 10032 USA; [Di Carlo, Dino] Univ Calif Los Angeles, Dept Mech Engn, Los Angeles, CA 90095 USA; [Di Carlo, Dino] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Hosokawa, Yoichiroh] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma 6300192, Japan; [Goda, Keisuke] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA	University of Tokyo; Japan Science & Technology Agency (JST); Nagoya University; University of Tokyo; RIKEN; Kyoto University; Chuo University; Kyushu University; University of Tokyo; University of California System; University of California Los Angeles; University of Tokyo; Japanese Foundation for Cancer Research; Tohoku University; University of Tokyo; Kochi University; Japanese Foundation for Cancer Research; Kyoto University; RIKEN; Kyoto University; University of Tokyo; Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Nara Institute of Science & Technology; University of California System; University of California Los Angeles	Goda, K (corresponding author), Univ Tokyo, Dept Chem, Tokyo 1130033, Japan.; Goda, K (corresponding author), Japan Sci & Technol Agcy, Saitama 3320012, Japan.; Goda, K (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA.	goda@chem.s.u-tokyo.ac.jp	YAMANO, Takashi/B-4999-2010; Fukuzawa, Hideya/I-5906-2018; Mikami, Hideharu/AAC-6368-2019; Tanaka, Yo/ABE-5075-2020; GODA, KEISUKE/G-4997-2014; Hoshino, Yu/S-4141-2019; Hiramatsu, Kotaro/P-4567-2018; Li, Ming/K-5925-2018; Isozaki, Akihiro/W-3159-2019; Shiba, Kiyotaka/I-9588-2014; Yalikun, Yaxiaer/AAA-1728-2020; Isozaki, Akihiro/AAV-4271-2021; Hayakawa, Takeshi/M-1818-2019; Nitta, Nao/J-8231-2019	YAMANO, Takashi/0000-0001-6578-8095; Fukuzawa, Hideya/0000-0003-0963-5662; Tanaka, Yo/0000-0003-1034-5718; Hoshino, Yu/0000-0001-9628-6979; Hiramatsu, Kotaro/0000-0003-0767-019X; Li, Ming/0000-0001-7450-6205; Isozaki, Akihiro/0000-0003-0391-9832; Shiba, Kiyotaka/0000-0001-6459-0204; Hayakawa, Takeshi/0000-0002-8420-3758; Nitta, Nao/0000-0002-9093-9016; Yamagishi, Mai/0000-0002-4449-5899; Ito, Takuro/0000-0001-5043-1886; Kasai, Yusuke/0000-0003-0637-4575; Yatomi, Yutaka/0000-0003-1719-4297; Goda, Keisuke/0000-0001-6302-6038; Toyokawa, Chihana/0000-0001-5664-7565	ImPACT program of the Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan)	ImPACT program of the Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan)	This work was funded by the ImPACT program of the Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan). We thank M. Kanematsu, M. Urakawa, and A. Komiya for assistance. N.N. is an ISAC Marylou Ingram Scholar.	Abadi Martin, 2016, arXiv; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Basiji DA, 2007, CLIN LAB MED, V27, P653, DOI 10.1016/j.cll.2007.05.008; Boutros M, 2015, CELL, V163, P1314, DOI 10.1016/j.cell.2015.11.007; Bradski G., 2000, DR DOBBS J SOFTW TOO; Brasko C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02628-4; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; Caicedo JC, 2017, NAT METHODS, V14, P849, DOI [10.1038/nmeth.4397, 10.1038/NMETH.4397]; Chattopadhyay PK, 2014, NAT IMMUNOL, V15, P128, DOI 10.1038/ni.2796; Chen Y, 2013, ANALYST, V138, P7308, DOI 10.1039/c3an01266b; Cheng CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19757; Chollet F., 2015, KERAS DEEP LEARNING; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Eulenberg P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00623-3; Fabbri F, 2013, CANCER LETT, V335, P225, DOI 10.1016/j.canlet.2013.02.015; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; George TC, 2004, CYTOM PART A, V59A, P237, DOI 10.1002/cyto.a.20048; Girault M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40072; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/NMETH.1452, 10.1038/nmeth.1452]; Grys BT, 2017, J CELL BIOL, V216, P65, DOI 10.1083/jcb.201610026; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Henery S, 2008, APOPTOSIS, V13, P1054, DOI 10.1007/s10495-008-0227-4; Hennig H, 2017, METHODS, V112, P201, DOI 10.1016/j.ymeth.2016.08.018; Hung PJ, 2005, LAB CHIP, V5, P44, DOI 10.1039/b410743h; Jiang YY, 2017, LAB CHIP, V17, P2426, DOI 10.1039/c7lc00396j; Kasai F, 2004, NIES COLLECTION LIST, P257; Kobayashi H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12378-4; Lauersen KJ, 2015, APPL MICROBIOL BIOT, V99, P3491, DOI 10.1007/s00253-014-6354-7; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee D, 2018, J PARALLEL DISTR COM, V113, P167, DOI 10.1016/j.jpdc.2017.11.013; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Lodha M, 2008, EUKARYOT CELL, V7, P172, DOI 10.1128/EC.00055-07; Mackinder LCM, 2017, CELL, V171, P133, DOI 10.1016/j.cell.2017.08.044; Meng PF, 2016, ACM T RECONFIG TECHN, V9, DOI 10.1145/2840811; Mikami H, 2018, OPTICA, V5, P117, DOI 10.1364/OPTICA.5.000117; Moor AE, 2017, SCIENCE, V357, P1299, DOI 10.1126/science.aan2399; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nielsen J, 2016, CELL, V164, P1185, DOI 10.1016/j.cell.2016.02.004; Ota S, 2018, SCIENCE, V360, P1246, DOI 10.1126/science.aan0096; Pernas L, 2018, CELL METAB, V27, P886, DOI 10.1016/j.cmet.2018.02.018; Piatkevich KD, 2018, NAT CHEM BIOL, V14, P352, DOI 10.1038/s41589-018-0004-9; R Development Core Team, 2009, R LANG ENV STAT COMP; Rosenzweig ESF, 2017, CELL, V171, P148, DOI 10.1016/j.cell.2017.08.008; Sakuma S, 2017, LAB CHIP, V17, P2760, DOI 10.1039/c7lc00536a; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sun T, 2014, ANAL CHEM, V86, P977, DOI 10.1021/ac403777g; Tung JW, 2007, CLIN LAB MED, V27, P453, DOI 10.1016/j.cll.2007.05.001; von Erlach TC, 2018, NAT MATER, V17, P237, DOI 10.1038/s41563-017-0014-0; Wakisaka Y, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.124, 10.1038/nmicrobiol.2016.124]; Wang LY, 2016, P NATL ACAD SCI USA, V113, P12586, DOI 10.1073/pnas.1606519113; Wu CY, 2018, MICROSYST NANOENG, V4, DOI 10.1038/s41378-018-0020-7; Yamano T, 2014, PHOTOSYNTH RES, V121, P193, DOI 10.1007/s11120-013-9963-6; Yamano T, 2013, J BIOSCI BIOENG, V115, P691, DOI 10.1016/j.jbiosc.2012.12.020; Zenker J, 2017, SCIENCE, V357, P925, DOI 10.1126/science.aam9335	56	275	282	21	202	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	2018	175	1					266	+		10.1016/j.cell.2018.08.028	http://dx.doi.org/10.1016/j.cell.2018.08.028			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GU2SI	30166209	Bronze, Green Published			2022-12-28	WOS:000445120000029
J	Makohon-Moore, AP; Matsukuma, K; Zhang, M; Reiter, JG; Gerold, JM; Jiao, YC; Sikkema, L; Attiyeh, MA; Yachida, S; Sandone, C; Hruban, RH; Klimstra, DS; Papadopoulos, N; Nowak, MA; Kinzler, KW; Vogelstein, B; Iacobuzio-Donahue, CA				Makohon-Moore, Alvin P.; Matsukuma, Karen; Zhang, Ming; Reiter, Johannes G.; Gerold, Jeffrey M.; Jiao, Yuchen; Sikkema, Lisa; Attiyeh, Marc A.; Yachida, Shinichi; Sandone, Corinne; Hruban, Ralph H.; Klimstra, David S.; Papadopoulos, Nickolas; Nowak, Martin A.; Kinzler, Kenneth W.; Vogelstein, Bert; Iacobuzio-Donahue, Christine A.			Precancerous neoplastic cells can move through the pancreatic ductal system	NATURE			English	Article							INTRAEPITHELIAL NEOPLASIA; MUTATIONAL PROCESSES; SOMATIC MUTATIONS; GENOMIC ANALYSES; CANCER GENOME; MODEL; HETEROGENEITY; PROGRESSION; EVOLUTION; GENES	Most adult carcinomas develop from noninvasive precursor lesions, a progression that is supported by genetic analysis. However, the evolutionary and genetic relationships among co-existing lesions are unclear. Here we analysed the somatic variants of pancreatic cancers and precursor lesions sampled from distinct regions of the same pancreas. After inferring evolutionary relationships, we found that the ancestral cell had initiated and clonally expanded to form one or more lesions, and that subsequent driver gene mutations eventually led to invasive pancreatic cancer. We estimate that this multi-step progression generally spans many years. These new data reframe the step-wise progression model of pancreatic cancer by illustrating that independent, high-grade pancreatic precursor lesions observed in a single pancreas often represent a single neoplasm that has colonized the ductal system, accumulating spatial and genetic divergence over time.	[Makohon-Moore, Alvin P.; Sikkema, Lisa; Attiyeh, Marc A.; Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, David M Rubenstein Ctr Pancreat Canc Res, 1275 York Ave, New York, NY 10021 USA; [Matsukuma, Karen] Univ Calif Davis, Dept Pathol, Sacramento, CA 95817 USA; [Zhang, Ming; Hruban, Ralph H.; Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA; [Reiter, Johannes G.] Stanford Univ, Sch Med, Dept Radiol, Canary Ctr Canc Early Detect, Palo Alto, CA 94304 USA; [Reiter, Johannes G.; Gerold, Jeffrey M.; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Jiao, Yuchen; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Ludwig Ctr, Baltimore, MD USA; [Sikkema, Lisa] Vrije Univ Amsterdam, VU Univ Med Ctr, Masters Oncol Program, Amsterdam, Netherlands; [Yachida, Shinichi] Osaka Univ, Grad Sch Med, Dept Canc Genome Informat, Osaka, Japan; [Sandone, Corinne] Johns Hopkins Univ, Sch Med, Dept Art Appl Med, Baltimore, MD USA; [Hruban, Ralph H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Hruban, Ralph H.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Klimstra, David S.; Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Dept Math, Cambridge, MA 02138 USA; [Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD USA	Memorial Sloan Kettering Cancer Center; University of California System; University of California Davis; Johns Hopkins University; Stanford University; Harvard University; Johns Hopkins University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Osaka University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Harvard University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Iacobuzio-Donahue, CA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, David M Rubenstein Ctr Pancreat Canc Res, 1275 York Ave, New York, NY 10021 USA.; Iacobuzio-Donahue, CA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	iacobuzc@mskcc.org	Makohon-Moore, Alvin/ABH-1764-2020; Iacobuzio-Donahue, Christine/ABF-1295-2020; Reiter, Johannes G./Y-4083-2019	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Reiter, Johannes G./0000-0002-0170-7353; Jiao, Yuchen/0000-0001-7917-8810; Attiyeh, Marc/0000-0002-9949-1449; Makohon-Moore, Alvin/0000-0002-4781-3565	V Foundation for Cancer Research; NIH [F31 CA180682, 2T32 CA160001-06, 5T32 CA067751-13]; Erwin Schrodinger fellowship (Austrian Science Fund FWF) [J-3996]; SPORE grant [P50 CA062924]; Michael Rolfe Foundation; Lustgarten Foundation for Cancer Research; Sol Goldman Center for Pancreatic Cancer Research; Virginia and D.K. Ludwig Fund for Cancer Research; NATIONAL CANCER INSTITUTE [T32CA160001, P50CA062924, F31CA180682] Funding Source: NIH RePORTER	V Foundation for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Erwin Schrodinger fellowship (Austrian Science Fund FWF); SPORE grant; Michael Rolfe Foundation; Lustgarten Foundation for Cancer Research; Sol Goldman Center for Pancreatic Cancer Research; Virginia and D.K. Ludwig Fund for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the V Foundation for Cancer Research, NIH grants F31 CA180682, 2T32 CA160001-06 and 5T32 CA067751-13, an Erwin Schrodinger fellowship (Austrian Science Fund FWF J-3996), SPORE grant P50 CA062924, the Michael Rolfe Foundation, The Lustgarten Foundation for Cancer Research, the Sol Goldman Center for Pancreatic Cancer Research, The Virginia and D.K. Ludwig Fund for Cancer Research and D. Troper and S. Wojcicki.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; AMIKURA K, 1995, INT J PANCREATOL, V17, P139; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Basturk O, 2015, AM J SURG PATHOL, V39, P1730, DOI 10.1097/PAS.0000000000000533; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Cancer Genome Atlas Research Network, 2017, CANC CELL, V32; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Durrett R, 2015, MATH BIOSCI INST LEC, V1-1, P1, DOI 10.1007/978-3-319-16065-8_1; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Hosoda W, 2017, J PATHOL, V242, P16, DOI 10.1002/path.4884; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Klein WM, 2002, MODERN PATHOL, V15, P441, DOI 10.1038/modpathol.3880544; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Makohon-Moore A, 2016, NAT REV CANCER, V16, P553, DOI 10.1038/nrc.2016.66; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; Matsuda Y, 2017, PANCREAS, V46, P658, DOI 10.1097/MPA.0000000000000786; Mose LE, 2014, BIOINFORMATICS, V30, P2813, DOI 10.1093/bioinformatics/btu376; Murphy SJ, 2013, GASTROENTEROLOGY, V145, P1098, DOI 10.1053/j.gastro.2013.07.049; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; Pea A, 2017, ANN SURG, V266, P133, DOI 10.1097/SLA.0000000000001817; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Reiter JG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14114; Reiter JG, 2017, NAT REV GASTRO HEPAT, V14, P7, DOI 10.1038/nrgastro.2016.190; Roberts NJ, 2016, CANCER DISCOV, V6, P166, DOI 10.1158/2159-8290.CD-15-0402; Roerink SF, 2018, NATURE, V556, P457, DOI 10.1038/s41586-018-0024-3; Sanli O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.22; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Tokheim CJ, 2016, P NATL ACAD SCI USA, V113, P14330, DOI 10.1073/pnas.1616440113; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; van Heek NT, 2002, AM J PATHOL, V161, P1541, DOI 10.1016/S0002-9440(10)64432-X; Vogelstein B, 2015, NEW ENGL J MED, V373, P1895, DOI 10.1056/NEJMp1508811; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamasaki S, 2002, PANCREATOLOGY, V2, P407, DOI 10.1159/000065089	46	56	56	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2018	561	7722					201	+		10.1038/s41586-018-0481-8	http://dx.doi.org/10.1038/s41586-018-0481-8			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT3XQ	30177826	Green Accepted			2022-12-28	WOS:000444437900035
J	Goldacre, B; DeVito, NJ; Heneghan, C; Irving, F; Bacon, S; Fleminger, J; Curtis, H				Goldacre, Ben; DeVito, Nicholas J.; Heneghan, Carl; Irving, Francis; Bacon, Seb; Fleminger, Jessica; Curtis, Helen			Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICALTRIALS.GOV; PUBLICATION; DATABASE	OBJECTIVES To ascertain compliance rates with the European Commission's requirement that all trials on the EU Clinical Trials Register (EUCTR) post results to the registry within 12 months of completion (final compliance date 21 December 2016); to identify features associated with non-compliance; to rank sponsors by compliance; and to build a tool for live ongoing audit of compliance. DESIGN Retrospective cohort study. SETTING EUCTR. PARTICIPANTS 7274 of 11 531 trials listed as completed on EUCTR and where results could be established as due. MAIN OUTCOME MEASURES Publication of results on EUCTR. RESULTS Of 7274 trials where results were due, 49.5% (95% confidence interval 48.4% to 50.7%) reported results. Trials with a commercial sponsor were substantially more likely to post results than those with a noncommercial sponsor (68.1% v11.0%, adjusted odds ratio 23.2, 95% confidence interval 19.2 to 28.2); as were trials by a sponsor who conducted a large number of trials (77.9% v18.4%, adjusted odds ratio 18.4, 15.3 to 22.1). More recent trials were more likely to report results (per year odds ratio 1.05, 95% confidence interval 1.03 to 1.07). Extensive evidence was found of errors, omissions, and contradictory entries in EUCTR data that prevented ascertainment of compliance for some trials. CONCLUSIONS Compliance with the European Commission requirement for all trials to post results on to the EUCTR within 12 months of completion has been poor, with half of all trials non-compliant. EU registry data commonly contain inconsistencies that might prevent even regulators assessing compliance. Accessible and timely information on the compliance status of each individual trial and sponsor may help to improve reporting rates.	[Goldacre, Ben; DeVito, Nicholas J.; Irving, Francis; Bacon, Seb; Fleminger, Jessica; Curtis, Helen] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, EBM DataLab, Radcliffe Observ Quarter, Oxford OX2 6GG, England; [Heneghan, Carl] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England	University of Oxford; University of Oxford	Goldacre, B (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, EBM DataLab, Radcliffe Observ Quarter, Oxford OX2 6GG, England.	ben.goldacre@phc.ox.ac.uk	DeVito, Nicholas J./Q-5952-2017	DeVito, Nicholas J./0000-0001-8286-1995; Goldacre, Ben/0000-0002-5127-4728; Fleminger, Jessica/0000-0002-5744-5137	Laura and John Arnold Foundation	Laura and John Arnold Foundation	BG is funded by the Laura and John Arnold Foundation to conduct work on research integrity. No specific funding was sought for this project. The funder had no involvement in the study design or the decision to submit.	Anderson ML, 2015, NEW ENGL J MED, V372, P1031, DOI 10.1056/NEJMsa1409364; Benjamin A, 2008, BMJ-BRIT MED J, V336, P1241, DOI 10.1136/bmj.39527.628322.AD; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chen RJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i637; Dept. of Health and Human Services, 2016, FIN RUL CLIN TRIALS, V81, P64982; European Medicines Agency, 2014, POST CLIN TRIAL SUMM; European Medicines Agency, 2016, EUDRACT HOM PAG; European Medicines Agency, 2016, TRIAL RES MOD TIM PO; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Goldacre B, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1290-8; Hartung DM, 2014, ANN INTERN MED, V160, P477, DOI 10.7326/M13-0480; Miller JE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009758; Moorthy VS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001819; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Schmucker C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114023; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Stockmann C, 2014, J ALLERGY CLIN IMMUN, V134, P1443, DOI 10.1016/j.jaci.2014.09.019; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60	20	78	78	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2018	362								k3218	10.1136/bmj.k3218	http://dx.doi.org/10.1136/bmj.k3218			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JJ	30209058	Green Published, hybrid			2022-12-28	WOS:000445016500001
J	Iacobucci, G				Iacobucci, Gareth			Ian Gilmore quits as government alcohol adviser in opposition to industry deal	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Public Health England, 2018, WHY PUBL HLTH ENGL I; Smyth C, ALCOHOL ADVISER QUIT	2	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2018	362								k3882	10.1136/bmj.k3882	http://dx.doi.org/10.1136/bmj.k3882			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JF	30206063				2022-12-28	WOS:000445015700007
J	Grace, BL; Bais, R; Roth, BJ				Grace, Breanne L.; Bais, Rajeev; Roth, Benjamin J.			The Violence of Uncertainty - Undermining Immigrant and Refugee Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Grace, Breanne L.; Roth, Benjamin J.] Univ South Carolina, Coll Social Work, Columbia, SC 29208 USA; [Bais, Rajeev] Univ South Carolina, Coll Med, Columbia, SC USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Grace, BL (corresponding author), Univ South Carolina, Coll Social Work, Columbia, SC 29208 USA.			Roth, Benjamin/0000-0002-1549-4440; Grace, Breanne/0000-0003-4654-919X				[Anonymous], 2017, CIVIL RIGHTS DATA QU; [Anonymous], 2016, 10 DAYS HARASSMENT I; Derose KP, 2007, HEALTH AFFAIR, V26, P1258, DOI 10.1377/hlthaff.26.5.1258; Farmer P, 1996, DAEDALUS, V125, P261; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059	5	35	35	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2018	379	10					904	905		10.1056/NEJMp1807424	http://dx.doi.org/10.1056/NEJMp1807424			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS5XM	30184446				2022-12-28	WOS:000443748200002
J	Hoffman, EA; Rowe, TB				Hoffman, Eva A.; Rowe, Timothy B.			Jurassic stem-mammal perinates and the origin of mammalian reproduction and growth	NATURE			English	Article							SKELETON FORMATION; EVOLUTION; OSSIFICATION; REPTILIA; ONTOGENY; PATTERNS; SIZE	Transformations in morphology, physiology and behaviour along the mammalian stem lineage were accompanied by profound modifications to reproduction and growth, including the emergence of a reproductive strategy characterized by high maternal investment in a small number of offspring(1,2) and heterochronic changes in early cranial development associated with the enlargement of the brain(3). Because direct fossil evidence of these transitions is lacking, the timing and sequence of these modifications are unknown. Here we present what is, to our knowledge, the first fossil record of pre- or near-hatching young of any non-mammalian synapsid. A large clutch of well-preserved perinates of the tritylodontid Kayentatherium wellesi (Cynodontia, Mammaliamorpha) was found with a presumed maternal skeleton in Early Jurassic sediments of the Kayenta Formation. The single clutch comprises at least 38 individuals, well outside the range of litter sizes documented in extant mammals. This discovery confirms that production of high numbers of offspring represents the ancestral condition for amniotes, and also constrains the timing of a reduction in clutch size along the mammalian stem. Although tiny, the perinates have an overall skull shape that is similar to that of adults, with no allometric lengthening of the face during ontogeny. The only positive allometries are associated with the bones that support the masticatory musculature. Kayentatherium diverged just before a hypothesized pulse of brain expansion that reorganized cranial architecture at the base of Mammaliaformes(4-6). The association of a high number of offspring and largely isometric cranial growth in Kayentatherium is consistent with a scenario in which encephalization-and attendant shifts in metabolism and development(7,8)-drove later changes to mammalian reproduction.	[Hoffman, Eva A.; Rowe, Timothy B.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Rowe, Timothy B.] Univ Texas Austin, Univ Texas High Resolut Xray Comp Tomog Facil, Austin, TX 78712 USA; [Rowe, Timothy B.] Univ Texas Austin, Vertebrate Paleontol Lab, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Hoffman, EA (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.	eva.hoffman@utexas.edu			National Science Foundation [EAR 1561622, IIS-9874781]; Geology Foundation of The University of Texas; Jackson School of Geosciences	National Science Foundation(National Science Foundation (NSF)); Geology Foundation of The University of Texas; Jackson School of Geosciences	We thank A. Zaman and B. Niessemeyer of the Navajo Nation Minerals Division for issuing the permit (dated 27 March 2000) under which this specimen was collected, and K. Calsoyas and T. Anderson for promoting our collaboration with the Navajo EcoScouts Program. Funding was provided by the National Science Foundation (EAR 1561622, IIS-9874781), by the Geology Foundation of The University of Texas and by the Jackson School of Geosciences. We thank B. Andres, S. Egberts, J. Franzosa, R. Gary, E. Gordon, T. Macrini, P. Owen, C. Sagebiel and R. S. Wallace for field, laboratory and curatorial assistance; M. Colbert, J. Maisano, J. Berlin and G. Rogers for computed tomography scanning the specimens described here; and S. Regnault, J. Hutchinson, C. Bell and digimorph.org for Sphenodon computed tomography scans.	Cardini A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3458; Carter DR, 1998, ZOOL J LINN SOC-LOND, V123, P163, DOI 10.1006/zjls.1997.0108; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; CROMPTON A W, 1972, Bulletin of the British Museum (Natural History) Geology, V21, P27; CROMPTON AW, 1978, AM SCI, V66, P192; CUI GH, 1987, VERTEBRAT PALASIATIC, V25, P245; Hill J. P. V., 1933, T ZOOL SOC LONDON, V24, P443; HOPSON JA, 1973, AM NAT, V107, P446, DOI 10.1086/282846; Hu YM, 2009, ACTA PALAEONTOL POL, V54, P385, DOI 10.4202/app.2008.0053; Jasinoski SC, 2017, PEERJ, V5, DOI 10.7717/peerj.2875; Jasinoski SC, 2015, ANAT REC, V298, P1440, DOI 10.1002/ar.23116; KEMP TS, 1983, ZOOL J LINN SOC-LOND, V77, P353, DOI 10.1111/j.1096-3642.1983.tb00859.x; KERMACK DM, 1982, ZOOL J LINN SOC-LOND, V76, P1, DOI 10.1111/j.1096-3642.1982.tb01953.x; Koyabu D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4625; Kuhne W.G., 1956, LIASSIC THERAPSID OL, P149; Liu J, 2010, J MAMM EVOL, V17, P151, DOI 10.1007/s10914-010-9136-8; Luo ZX, 2015, P NATL ACAD SCI USA, V112, pE7101, DOI 10.1073/pnas.1519387112; MARTIN RD, 1981, NATURE, V293, P57, DOI 10.1038/293057a0; Mock D. W., 1998, EVOLUTION SIBLING RI; R Core Team, 2020, R LANG ENV STAT COMP; Ray Sanghamitra, 2009, Palaeoworld, V18, P53, DOI 10.1016/j.palwor.2008.09.001; Regnault S., 2017, OPEN SCI FRAMEWORK; Regnault S, 2017, J MORPHOL, V278, P62, DOI 10.1002/jmor.20619; Richardson MK, 2009, J EXP ZOOL PART B, V312B, P639, DOI 10.1002/jez.b.21250; RIEPPEL O, 1993, ZOOL J LINN SOC-LOND, V109, P301, DOI 10.1111/j.1096-3642.1993.tb02537.x; RIEPPEL O, 1993, J ZOOL, V231, P487, DOI 10.1111/j.1469-7998.1993.tb01933.x; RIEPPEL O, 1992, J ZOOL, V227, P87, DOI 10.1111/j.1469-7998.1992.tb04346.x; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Rowe T.B., 2017, EVOLUTION NERVOUS SY, P1; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Sanchez-Villagra MR, 2010, P ROY SOC B-BIOL SCI, V277, P1139, DOI 10.1098/rspb.2009.2005; Sander PM, 2012, SCIENCE, V337, P806, DOI 10.1126/science.1224301; Sues H.-D., 1985, Journal of Vertebrate Paleontology, V5, P328; SUES H-D, 1986, Bulletin of the Museum of Comparative Zoology, V151, P217; Sues Hans-Dieter, 2006, P114; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Wealthall RJ, 2006, ANAT REC PART A, V288A, P1163, DOI 10.1002/ar.a.20385; Weisbecker V, 2011, EVOLUTION, V65, P1323, DOI 10.1111/j.1558-5646.2011.01234.x; Young NM, 2014, DEVELOPMENT, V141, P1059, DOI 10.1242/dev.099994	41	27	27	0	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					104	+		10.1038/s41586-018-0441-3	http://dx.doi.org/10.1038/s41586-018-0441-3			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30158701				2022-12-28	WOS:000443755200040
J	Patil, KR; Ralser, M				Patil, Kiran R.; Ralser, Markus			Freeing Yeast from Alcohol Addiction (Just) to Make (It) Fat Instead	CELL			English	Editorial Material								Synthetically re-designing eukaryotic metabolism has proven immensely challenging, raising the question of whether evolution has metabolically hardwired eukaryotic cells. Yu et al. now report that, through orchestrating multiple genetic changes and laboratory evolution, Saccharomyces metabolism can be reprogrammed from its evolutionary objective of producing ethanol to produce large amounts of free fatty acids.	[Patil, Kiran R.] EMBL, Heidelberg, Germany; [Ralser, Markus] Francis Crick Inst, London, England; [Ralser, Markus] Charite, Dept Biochem, Berlin, Germany	European Molecular Biology Laboratory (EMBL); Francis Crick Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ralser, M (corresponding author), Francis Crick Inst, London, England.; Ralser, M (corresponding author), Charite, Dept Biochem, Berlin, Germany.	markus.ralser@crick.ac.uk	Patil, Kiran R/B-9709-2009	Patil, Kiran R/0000-0002-6166-8640; Ralser, Markus/0000-0001-9535-7413				Alam MT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16018; Gallone B, 2016, CELL, V166, P1397, DOI 10.1016/j.cell.2016.08.020; Gruning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017; Nilsson A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22264; Ponomarova O, 2017, CELL SYST, V5, P345, DOI 10.1016/j.cels.2017.09.002; Sitepu IR, 2014, BIOTECHNOL ADV, V32, P1336, DOI 10.1016/j.biotechadv.2014.08.003; Sutherland JD, 2016, ANGEW CHEM INT EDIT, V55, P104, DOI 10.1002/anie.201506585; Yu T, 2018, CELL, V174, P1549, DOI 10.1016/j.cell.2018.07.013	8	0	0	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1342	1344		10.1016/j.cell.2018.08.024	http://dx.doi.org/10.1016/j.cell.2018.08.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193107	Bronze			2022-12-28	WOS:000443841000005
J	Wang, PY; Mason, TG				Wang, Po-Yuan; Mason, Thomas G.			A Brownian quasi-crystal of pre-assembled colloidal Penrose tiles	NATURE			English	Article							HOLOGRAPHIC LITHOGRAPHY; PHOTONIC CRYSTALS; PHASON-STRAIN; PARTICLES; TRANSITIONS; FABRICATION; SYMMETRY; TILINGS; ORDER; GLASS	Penrose's pentagonal P2 quasi-crystal(1-4) is a beautiful, hierarchically organized multiscale structure in which kite-and dart-shaped tiles are arranged into local motifs, such as pentagonal stars, which are in turn arranged into various close-packed superstructural patterns that become increasingly complex at larger length scales. Although certain types of quasi-periodic structure have been observed in hard and soft matter, such structures are difficult to engineer, especially over large areas, because generating the necessary, highly specific interactions between constituent building blocks is challenging. Previously reported soft-matter quasi-crystals of dendrimers(5), triblock copolymers(6), nanoparticles(7) and polymeric micelles(8) have been limited to 12- or 18-fold symmetries. Because routes for self-assembling complex colloidal building blocks(9-11) into low-defect dynamic superstructures remain limited(12), alternative methods, such as using optical and directed assembly, are being explored(13,14). Holographic laser tweezers(15) and optical standing waves(16) have been used to hold microspheres in local quasi-crystalline arrangements, and magnetic microspheres of two different sizes have been assembled into local five-fold-symmetric quasi-crystalline arrangements in two dimensions(17). But a Penrose quasi-crystal of mobile colloidal tiles has hitherto not been fabricated over large areas. Here we report such a quasi-crystal in two dimensions, created using a highly parallelizable method of lithographic printing and subsequent release of pre-assembled kite- and dart-shaped tiles into a solution-dispersion containing a depletion agent. After release, the positions and orientations of the tiles within the quasi-crystal can fluctuate, and these tiles undergo random, Brownian motion in the monolayer owing to frequent collisions between neighbouring tiles, even after the system reaches equilibrium. Using optical microscopy, we study both the equilibrium fluctuations of the system at high tile densities and also the 'melting' of the pattern as the tile density is lowered. At high tile densities we find signatures of a five-fold pentatic liquid quasi-crystalline phase, analogous to a six-fold hexatic liquid crystal. Our fabrication approach is applicable to tiles of different sizes and shapes, and with different initial positions and orientations, enabling the creation of two-dimensional quasi-crystalline systems (and other systems that possess multiscale complexity at high tile densities) beyond those of current self-or directed-assembly methods(18-20). We anticipate that our approach for generating lithographically pre-assembled monolayers could be extended to create three-dimensional Brownian systems of fluctuating particles with custom-designed shapes through holographic lithography(21,22) or stereolithography(23).	[Wang, Po-Yuan; Mason, Thomas G.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Wang, Po-Yuan] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90024 USA; [Mason, Thomas G.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mason, TG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Mason, TG (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	mason@chem.ucla.edu			UCLA	UCLA(University of California System)	We thank C. M. Knobler for discussions and UCLA for financial support. We acknowledge the use of the Integrated Systems Nanofabrication Cleanroom at the California NanoSystems Institute at UCLA.	Bae WG, 2014, ADV MATER, V26, P675, DOI 10.1002/adma.201303412; Boles MA, 2016, CHEM REV, V116, P11220, DOI 10.1021/acs.chemrev.6b00196; BURSILL LA, 1985, NATURE, V316, P50, DOI 10.1038/316050a0; Campbell M, 2000, NATURE, V404, P53, DOI 10.1038/35003523; Caspar DLD, 1996, P NATL ACAD SCI USA, V93, P14271, DOI 10.1073/pnas.93.25.14271; Cavallaro M, 2011, P NATL ACAD SCI USA, V108, P20923, DOI 10.1073/pnas.1116344108; Chen K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.025501; Dontabhaktuni J, 2014, P NATL ACAD SCI USA, V111, P2464, DOI 10.1073/pnas.1312670111; Dotera T, 2014, NATURE, V506, P208, DOI 10.1038/nature12938; Fischer S, 2011, P NATL ACAD SCI USA, V108, P1810, DOI 10.1073/pnas.1008695108; Gardner M, 1989, PENROSE TILES TRAPDO; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Grzelczak M, 2010, ACS NANO, V4, P3591, DOI 10.1021/nn100869j; Gummelt P, 1996, GEOMETRIAE DEDICATA, V62, P1, DOI 10.1007/bf00239998; Hayashida K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195502; Hernandez CJ, 2007, J PHYS CHEM C, V111, P4477, DOI 10.1021/jp0672095; HOOVER MD, 1990, J AEROSOL SCI, V21, P569, DOI 10.1016/0021-8502(90)90132-H; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; LEVINE D, 1984, PHYS REV LETT, V53, P2477, DOI 10.1103/PhysRevLett.53.2477; Lewandowski EP, 2009, SOFT MATTER, V5, P886, DOI 10.1039/b812257a; LI FH, 1992, ULTRAMICROSCOPY, V45, P299, DOI 10.1016/0304-3991(92)90141-6; Mikhael J, 2008, NATURE, V454, P501, DOI 10.1038/nature07074; Nelson D. R, 2002, DEFECTS GEOMETRY CON; NELSON DR, 1982, PHILOS MAG A, V46, P105, DOI 10.1080/01418618208236211; Niederberger M, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201703647; Penrose R, 1979, MATH INTELL, V2, P32, DOI 10.1007/BF03024384; Penrose R., 1974, B I MATH APPL, V10, P266; Roichman Y, 2005, OPT EXPRESS, V13, P5434, DOI 10.1364/OPEX.13.005434; Saitoh K, 1997, JPN J APPL PHYS 2, V36, pL1400, DOI 10.1143/JJAP.36.L1400; SOCOLAR JES, 1986, J PHYS-PARIS, V47, P217, DOI 10.1051/jphyscol:1986323; Steinhardt PJ, 1996, NATURE, V382, P431, DOI 10.1038/382431a0; Steurer W, 2009, SPRINGER SER MATER S, V126, P1; Talapin DV, 2009, NATURE, V461, P964, DOI 10.1038/nature08439; Ullal CK, 2004, APPL PHYS LETT, V84, P5434, DOI 10.1063/1.1765734; Wang PY, 2017, PHYS CHEM CHEM PHYS, V19, P7167, DOI 10.1039/c6cp08350a; Wang PY, 2015, J AM CHEM SOC, V137, P15308, DOI 10.1021/jacs.5b10549; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Wen WJ, 2000, PHYS REV LETT, V85, P5464, DOI 10.1103/PhysRevLett.85.5464; Yang SM, 2008, J MATER CHEM, V18, P2177, DOI 10.1039/b716393b; Zeng CJ, 2016, SCIENCE, V354, P1580, DOI 10.1126/science.aak9750; Zeng XB, 2004, NATURE, V428, P157, DOI 10.1038/nature02368; Zhao K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.268301; Zhao K, 2015, P NATL ACAD SCI USA, V112, P12063, DOI 10.1073/pnas.1507897112; Zhao K, 2012, J AM CHEM SOC, V134, P18125, DOI 10.1021/ja308214m; Zhao K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1803; Zhao K, 2011, P NATL ACAD SCI USA, V108, P2684, DOI 10.1073/pnas.1014942108; Zhao K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.208302	48	17	17	8	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					94	+		10.1038/s41586-018-0464-9	http://dx.doi.org/10.1038/s41586-018-0464-9			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30158703				2022-12-28	WOS:000443755200038
J	Voelker, R				Voelker, Rebecca			New Endometriosis Drug Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2018	320	9					864	864		10.1001/jama.2018.12146	http://dx.doi.org/10.1001/jama.2018.12146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS4OQ	30193259				2022-12-28	WOS:000443627300004
J	Wise, J				Wise, Jacqui			Burnout linked to suboptimal patient care, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Panagioti M, 2018, JAMA INTERN MED, V178, P1317, DOI 10.1001/jamainternmed.2018.3713; Peckham C., MEDSCAPE LIFESTYLE R	3	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2018	362								k3771	10.1136/bmj.k3771	http://dx.doi.org/10.1136/bmj.k3771			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4VO	30181357				2022-12-28	WOS:000444503800014
J	Pimm, J				Pimm, Jonathan			Ulana Suprun: the accidental reformer	LANCET			English	Biographical-Item																		[Anonymous], PUBLICATION LIST	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2018	392	10149					727	727		10.1016/S0140-6736(18)31855-5	http://dx.doi.org/10.1016/S0140-6736(18)31855-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS0VL	30191822				2022-12-28	WOS:000443226900013
J	Dyer, O				Dyer, Owen			Vaccine safety: Russian bots and trolls stoked online debate, research finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Broniatowski DA, 2018, AM J PUBLIC HEALTH, V108, P1378, DOI 10.2105/AJPH.2018.304567; Paterlini M, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3506	2	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2018	362								k3739	10.1136/bmj.k3739	http://dx.doi.org/10.1136/bmj.k3739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS5ZI	30166280				2022-12-28	WOS:000443758100015
J	Pallansch, MA				Pallansch, Mark A.			Ending Use of Oral Poliovirus Vaccine - A Difficult Move in the Polio Endgame	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pallansch, Mark A.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Pallansch, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA 30333 USA.				Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		[Anonymous], 2013, POL ER ENDG STRAT PL; Dowdle WR, 2003, REV MED VIROL, V13, P277, DOI 10.1002/rmv.401; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284	3	9	9	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2018	379	9					801	803		10.1056/NEJMp1808903	http://dx.doi.org/10.1056/NEJMp1808903			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GR9EA	30157390	Green Accepted, Bronze			2022-12-28	WOS:000443047800001
J	Childers, CP; Maggard-Gibbons, M				Childers, Christopher P.; Maggard-Gibbons, Melinda			Estimation of the Acquisition and Operating Costs for Robotic Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Childers, Christopher P.; Maggard-Gibbons, Melinda] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Childers, CP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Ronald Reagan UCLA Med Ctr, 10833 Le Conte Ave,CHS 72-247, Los Angeles, CA 90095 USA.	cchilders@mednet.ucla.edu	Childers, Christopher P/L-6935-2017; Childers, Christopher P/HHM-4860-2022	Childers, Christopher P/0000-0002-6489-8222; Childers, Christopher P/0000-0002-6489-8222	Agency for Healthcare Research and Quality [F32HS025079]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS025079] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was funded by grant F32HS025079 from Agency for Healthcare Research and Quality (Dr Childers).	Childers CP, 2018, JAMA SURG, V153, DOI 10.1001/jamasurg.2017.6233; Jayne D, 2017, JAMA-J AM MED ASSOC, V318, P1569, DOI 10.1001/jama.2017.7219; Jeong IG, 2017, JAMA-J AM MED ASSOC, V318, P1561, DOI 10.1001/jama.2017.14586; Siu J, 2017, ANZ J SURG, V87, P28, DOI 10.1111/ans.13856; Stey AM, 2015, J AM COLL SURGEONS, V220, P207, DOI 10.1016/j.jamcollsurg.2014.10.021	5	86	87	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					835	836		10.1001/jama.2018.9219	http://dx.doi.org/10.1001/jama.2018.9219			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167686	Green Published, Bronze			2022-12-28	WOS:000442958800027
J	Slomski, A				Slomski, Anita			No Benefit for Women From Sigmoidoscopy Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					749	749		10.1001/jama.2018.12040	http://dx.doi.org/10.1001/jama.2018.12040			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167695				2022-12-28	WOS:000442958800008
J	Dzau, VJ; Johnson, PA				Dzau, Victor J.; Johnson, Paula A.			Ending Sexual Harassment in Academic Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dzau, Victor J.] Natl Acad Med, Washington, DC 20001 USA; [Johnson, Paula A.] Wellesley Coll, Wellesley, MA 02181 USA; [Johnson, Paula A.] NASEM Comm, Washington, DC USA	National Academies of Sciences, Engineering & Medicine; Wellesley College; National Academies of Sciences, Engineering & Medicine	Dzau, VJ (corresponding author), Natl Acad Med, Washington, DC 20001 USA.							Chisholm-Burns MA, 2017, AM J HEALTH-SYST PH, V74, P312, DOI 10.2146/ajhp160930; Cortina LM, 2013, J MANAGE, V39, P1579, DOI 10.1177/0149206311418835; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Konik J, 2008, SOC JUSTICE RES, V21, P313, DOI 10.1007/s11211-008-0074-z; National Academies of Sciences Engineering and Medicine, 2018, SEX HAR WOM CLIM CUL	5	59	59	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2018	379	17					1589	1591		10.1056/NEJMp1809846	http://dx.doi.org/10.1056/NEJMp1809846			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY1GI	30207831				2022-12-28	WOS:000448273500001
J	Saleem, AB; Diamanti, EM; Fournier, J; Harris, KD; Carandini, M				Saleem, Aman B.; Diamanti, E. Mika; Fournier, Julien; Harris, Kenneth D.; Carandini, Matteo			Coherent encoding of subjective spatial position in visual cortex and hippocampus	NATURE			English	Article							SINGLE UNIT-ACTIVITY; PLACE CELLS; BEHAVIOR; REPRESENTATION; PERFORMANCE; INTEGRATION; LOCOMOTION; NAVIGATION; DYNAMICS; SYSTEM	A major role of vision is to guide navigation, and navigation is strongly driven by vision(1-4). Indeed, the brain's visual and navigational systems are known to interact(5,6), and signals related to position in the environment have been suggested to appear as early as in the visual cortex(6,7). Here, to establish the nature of these signals, we recorded in the primary visual cortex (V1) and hippocampal area CA1 while mice traversed a corridor in virtual reality. The corridor contained identical visual landmarks in two positions, so that a purely visual neuron would respond similarly at those positions. Most V1 neurons, however, responded solely or more strongly to the landmarks in one position rather than the other. This modulation of visual responses by spatial location was not explained by factors such as running speed. To assess whether the modulation is related to navigational signals and to the animal's subjective estimate of position, we trained the mice to lick for a water reward upon reaching a reward zone in the corridor. Neuronal populations in both CA1 and V1 encoded the animal's position along the corridor, and the errors in their representations were correlated. Moreover, both representations reflected the animal's subjective estimate of position, inferred from the animal's licks, better than its actual position. When animals licked in a given location-whether correctly or incorrectly-neural populations in both V1 and CA1 placed the animal in the reward zone. We conclude that visual responses in V1 are controlled by navigational signals, which are coherent with those encoded in hippocampus and reflect the animal's subjective position. The presence of such navigational signals as early as a primary sensory area suggests that they permeate sensory processing in the cortex.	[Saleem, Aman B.; Diamanti, E. Mika; Fournier, Julien; Carandini, Matteo] UCL, UCL Inst Ophthalmol, London, England; [Saleem, Aman B.] UCL, Dept Expt Psychol, London, England; [Diamanti, E. Mika] UCL, Dept Comp Sci, CoMPLEX, London, England; [Harris, Kenneth D.] UCL, UCL Inst Neurol, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Saleem, AB (corresponding author), UCL, UCL Inst Ophthalmol, London, England.; Saleem, AB (corresponding author), UCL, Dept Expt Psychol, London, England.	aman.saleem@ucl.ac.uk	Carandini, Matteo/ABD-8296-2021	Carandini, Matteo/0000-0003-4880-7682; Diamanti, Efthymia (Mika)/0000-0003-1199-3362; Harris, Kenneth/0000-0002-5930-6456; Fournier, Julien/0000-0001-7167-8132; Saleem, Aman/0000-0002-7100-1954	Sir Henry Dale Fellowship - Wellcome Trust/Royal Society [200501]; EPSRC PhD award [F500351/1351]; Human Frontier Science Program; EC Horizon 2020 grants [709030]; Wellcome Trust [205093, 108726]; Simons Collaboration on the Global Brain [325512]	Sir Henry Dale Fellowship - Wellcome Trust/Royal Society; EPSRC PhD award(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Human Frontier Science Program(Human Frontier Science Program); EC Horizon 2020 grants; Wellcome Trust(Wellcome TrustEuropean Commission); Simons Collaboration on the Global Brain	We thank N. Burgess and B. Haider for helpful discussions, and C. Reddy, S. Schroeder, and M. Krumin for help with experiments. This work was funded by a Sir Henry Dale Fellowship, awarded by the Wellcome Trust/Royal Society (grant 200501) to A.B.S., EPSRC PhD award F500351/1351 to E.M.D., Human Frontier Science Program and EC Horizon 2020 grants to J.F. (grant 709030), the Wellcome Trust (grants 205093 and 108726) to M. C. and K.D.H., the Simons Collaboration on the Global Brain (grant 325512) to M. C. and K.D.H. M.C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	Aronov D, 2014, NEURON, V84, P442, DOI 10.1016/j.neuron.2014.08.042; Ayaz A, 2013, CURR BIOL, V23, P890, DOI 10.1016/j.cub.2013.04.012; Carandini M, 2015, J NEUROSCI, V35, P53, DOI 10.1523/JNEUROSCI.0594-14.2015; Chen GF, 2018, ELIFE, V7, DOI 10.7554/eLife.34789; Chen GF, 2013, P NATL ACAD SCI USA, V110, P378, DOI 10.1073/pnas.1215834110; Cushman JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080465; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Dipoppa M, 2018, NEURON, V98, P602, DOI 10.1016/j.neuron.2018.03.037; Eichenbaum H, 2014, NAT REV NEUROSCI, V15, P732, DOI 10.1038/nrn3827; Fiser A, 2016, NAT NEUROSCI, V19, P1658, DOI 10.1038/nn.4385; Geiller T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14531; Grieves RM, 2017, BEHAV PROCESS, V135, P113, DOI 10.1016/j.beproc.2016.12.012; Haggerty DC, 2015, ELIFE, V4, DOI 10.7554/eLife.08902; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hok V, 2007, J NEUROSCI, V27, P472, DOI 10.1523/JNEUROSCI.2864-06.2007; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jurjut O, 2017, J NEUROSCI, V37, P6460, DOI 10.1523/JNEUROSCI.3485-16.2017; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Lenck-Santini PP, 2002, J NEUROSCI, V22, P9035; Lenck-Santini PP, 2001, HIPPOCAMPUS, V11, P377, DOI 10.1002/hipo.1052; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Makino H, 2015, NAT NEUROSCI, V18, P1116, DOI 10.1038/nn.4061; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; MULLER RU, 1987, J NEUROSCI, V7, P1951; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; Pachitariu M., 2016, PREPRINT; Peron SP, 2015, NEURON, V86, P783, DOI 10.1016/j.neuron.2015.03.027; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Poort J, 2015, NEURON, V86, P1478, DOI 10.1016/j.neuron.2015.05.037; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; Ravassard P, 2013, SCIENCE, V340, P1342, DOI 10.1126/science.1232655; Rosenzweig ES, 2003, NAT NEUROSCI, V6, P609, DOI 10.1038/nn1053; Rossant C, 2016, NAT NEUROSCI, V19, P634, DOI 10.1038/nn.4268; Saleem AB, 2013, NAT NEUROSCI, V16, P1864, DOI 10.1038/nn.3567; Steinmetz NA, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0207-17.2017; Wang QX, 2011, J NEUROSCI, V31, P1905, DOI 10.1523/JNEUROSCI.3488-10.2011; Wekselblatt JB, 2016, J NEUROPHYSIOL, V115, P2852, DOI 10.1152/jn.01056.2015; WIENER SI, 1989, J NEUROSCI, V9, P2737; WIENER SI, 1995, EUR J NEUROSCI, V7, P2206, DOI 10.1111/j.1460-9568.1995.tb00642.x; Witter MP, 2000, HIPPOCAMPUS, V10, P398; Yang ZY, 2007, J NEUROPHYSIOL, V98, P1002, DOI 10.1152/jn.00417.2007	44	79	80	4	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2018	562	7725					124	+		10.1038/s41586-018-0516-1	http://dx.doi.org/10.1038/s41586-018-0516-1			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV6AF	30202092	Green Accepted, Green Submitted			2022-12-28	WOS:000446187900050
J	Rediger, K; Miles, DRB				Rediger, Katherine; Miles, D. R. Bailey			Clinical-Community Partnerships to Reduce Food Insecurity Among High-Need, High-Cost Medicaid Patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Rediger, Katherine; Miles, D. R. Bailey] Johns Hopkins Community Phys, 1000 East Eager St, Baltimore, MD 21202 USA; [Rediger, Katherine] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA; [Miles, D. R. Bailey] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Miles, DRB (corresponding author), Johns Hopkins Community Phys, 1000 East Eager St, Baltimore, MD 21202 USA.	dmiles9@jhmi.edu		Miles, Donald/0000-0003-3051-4099				Amarasingham R., 2018, USING COMMUNITY PART; [Anonymous], 2018, FOOD SEC STAT US HOU; Berkowitz SA, 2018, HEALTH AFFAIR, V37, P535, DOI 10.1377/hlthaff.2017.0999; Blumenthal D, 2016, NEW ENGL J MED, V375, P909, DOI 10.1056/NEJMp1608511; Freda B., 2018, PARTNERSHIPS HLTH LE; Gundersen C, 2015, HEALTH AFFAIR, V34, P1830, DOI 10.1377/hlthaff.2015.0645; Gurvey J, 2013, J PRIM CARE COMMUNIT, V4, P311, DOI 10.1177/2150131913490737; Phipps EJ, 2016, POPUL HEALTH MANAG, V19, P414, DOI 10.1089/pop.2015.0127; U.S. Government Accountability Office, 2015, MED SMALL SHAR ENR C; Waxman E., 2018, FAR SNAP BENEFITS FA	10	6	6	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2018	169	7					490	+		10.7326/M18-1104	http://dx.doi.org/10.7326/M18-1104			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV4BN	30140936				2022-12-28	WOS:000446042400010
J	Lansky, A; Wijns, W; Xu, B; Kelbaek, H; van Royen, N; Zheng, M; Morel, MA; Knaapen, P; Slagboom, T; Johnson, TW; Vlachojannis, G; Arkenbout, KE; Holmvang, L; Janssens, L; Ochala, A; Brugaletta, S; Naber, CK; Anderson, R; Rittger, H; Berti, S; Barbato, E; Toth, GG; Maillard, L; Valina, C; Buszman, P; Thiele, H; Schachinger, V; Baumbach, A				Lansky, Alexandra; Wijns, William; Xu, Bo; Kelbaek, Henning; van Royen, Niels; Zheng, Ming; Morel, Marie-Angele; Knaapen, Paul; Slagboom, Ton; Johnson, Thomas W.; Vlachojannis, Georgios; Arkenbout, Karin E.; Holmvang, Lene; Janssens, Luc; Ochala, Andrzej; Brugaletta, Salvatore; Naber, Christoph K.; Anderson, Richard; Rittger, Harald; Berti, Sergio; Barbato, Emanuele; Toth, Gabor G.; Maillard, Luc; Valina, Christian; Buszman, Pawel; Thiele, Holger; Schachinger, Volker; Baumbach, Andreas		TARGET All Comers Investigators	Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial	LANCET			English	Article							BARE-METAL STENTS; POOLED ANALYSIS; EFFICACY; SAFETY; METAANALYSIS; OUTCOMES	Background The FIREHAWK is a drug-eluting stent with a fully biodegradable sirolimus-containing polymer coating localised to recessed abluminal grooves on the stent surface. We investigated clinical outcomes with this targeted, low-dose, biodegradable polymer, sirolimus-eluting stent compared with XIENCE durable polymer, everolimus-eluting stents in an all-comers population. Methods The TARGET All Comers study was a prospective, multicentre, open-label randomised non-inferiority trial done at 21 centres in ten European countries. Patients with symptomatic or asymptomatic coronary artery disease and objective evidence of myocardial ischaemia who qualified for percutaneous coronary intervention were randomised 1: 1 to undergo implantation of a FIREHAWK or XIENCE. Randomisation was web-based, with random block allocation and stratification by centre and ST elevation myocardial infarction. Outcome assessors were masked to treatment allocation, but treating physicians and patients were not. The primary endpoint was target lesion failure at 12 months, a composite of cardiac death, target vessel myocardial infarction, or ischaemia-driven target lesion revascularisation. The control event rate for XIENCE was assumed to be 7%, the non-inferiority margin was 3.5%, and the primary analysis was in the intention-to-treat population, censoring patients who did not have either an event before 365 days or contact beyond 365 days. Late lumen loss was the primary endpoint of an angiographic substudy designed to investigate the non-inferiority of the FIREHAWK compared with the XIENCE stent. This trial is registered with ClinicalTrials.gov, number NCT02520180. Findings From Dec 17, 2015, to Oct 14, 2016, 1653 patients were randomly assigned to implantation of the FIREHAWK (n=823) or XIENCE (n=830). 65 patients in the FIREHAWK group and 66 in the XIENCE group had insufficient follow-up data and were excluded from the analyses. At 12 months, target lesion failure occurred in 46 (6.1%) of 758 patients in the FIREHAWK group and in 45 (5.9%) of 764 patients in the XIENCE group (difference 0.2%, 90% CI -1.9 to 2.2, p(non-inferiority)=0.004, 95% CI -2.2 to 2.6, p(superiority)=0.88). There were no differences in ischaemia-driven revascularisation or stent thrombosis rates at 12 months. 176 patients were included in the angiographic substudy, in which in-stent late lumen loss was 0.17 mm (SD 0.48) in the FIREHAWK group and 0.11 mm (0.52) in the XIENCE group (p=0.48), with an absolute difference of 0.05 mm (95% CI -0.09 to 0.18, p(non-inferiority)=0.024). Interpretation In a broad all-comers population of patients requiring stent implantation for myocardial ischaemia, the FIREHAWK was non-inferior to the XIENCE as assessed with the primary endpoint of target lesion failure at 12 months and in-stent late lumen loss at 13 months. The FIREHAWK is a safe and effective alternative stent to treat patients with ischaemic coronary artery disease in clinical practice.	[Lansky, Alexandra; Baumbach, Andreas] Yale Univ, Sch Med, New Haven, CT 06510 USA; [Lansky, Alexandra; Baumbach, Andreas] Barts Heart Ctr, London, England; [Lansky, Alexandra; Baumbach, Andreas] Queen Mary Univ London, London, England; [Wijns, William] Natl Univ Ireland, Lambe Inst Translat Med, Galway, Ireland; [Wijns, William] Natl Univ Ireland, Curam, Galway, Ireland; [Wijns, William] Saolta Univ, Healthcare Grp, Univ Coll Hosp Galway, Galway, Ireland; [Xu, Bo] Chinese Acad Med Sci, Fu Wai Hosp, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Kelbaek, Henning] Roskilde Univ Hosp, Dept Cardiol, Roskilde, Denmark; [van Royen, Niels; Knaapen, Paul] Vrije Univ Amsterdam Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Zheng, Ming] Shanghai MicroPort Med Grp, Shanghai, Peoples R China; [Morel, Marie-Angele] Cardialysis, Rotterdam, Netherlands; [Slagboom, Ton] Onze Lieve Vrouw Hosp, Amsterdam Dept Intervent Cardiolody, Amsterdam, Netherlands; [Johnson, Thomas W.] Univ Hosp Bristol NHS Fdn Trust, Bristol Heart Inst, Bristol, Avon, England; [Vlachojannis, Georgios] Maasstad Ziekenhuis, Dept Cardiol, Rotterdam, Netherlands; [Arkenbout, Karin E.] Tergooi Ziekenhuis, Dept Cardiol, Blaricum, Netherlands; [Holmvang, Lene] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Janssens, Luc] Imelda Ziekenhuis, Ctr Heart, Bonheiden, Belgium; [Ochala, Andrzej] Silesian Med Univ, Dept Invas Cardiol, Katowice, Poland; [Brugaletta, Salvatore] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Cardiovasc Inst, Barcelona, Spain; [Naber, Christoph K.] Elisabeth Hosp, Contilia Heart & Vasc Ctr, Essen, Germany; [Anderson, Richard] Univ Hosp Wales, Dept Cardiol, Cardiff, S Glam, Wales; [Rittger, Harald] Univ Erlangen Nurnberg, Klinikum Furth, Med Klin 1, Furth, Germany; [Berti, Sergio] Osped Cuore, Fdn CNR Reg Toscana G Monasterio, UOC Cardiol Diagnost & Interventist, Massa, Italy; [Barbato, Emanuele] Onze Lieve Vrouw Hosp, Cardiovasc Res Ctr Aalst, Aalst, Belgium; [Barbato, Emanuele] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Toth, Gabor G.] Med Univ Graz, Dept Cardiol, Graz, Austria; [Maillard, Luc] Clin Axium, Serv Cardiol, Aix En Provence, France; [Valina, Christian] Univ Herzzentrum Freiburg Bad Krozingen, Klin Kardiol & Angiol 2, Bad Krozingen, Germany; [Buszman, Pawel] Amer Heart Poland, Katowice, Poland; [Thiele, Holger] Herzzentrum Leipzig, Leipzig, Germany; [Schachinger, Volker] Klinikum Fulda, Herz Thorax Zentrum, Med Klin 1, Fulda, Germany	Yale University; University of London; Queen Mary University London; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Cardialysis; Onze Lieve Vrouwe Gasthuis Hospital; University of Bristol; Maasstad Hospital; Tergooi Blaricum; Rigshospitalet; University of Copenhagen; Imeldaziekenhuis; Medical University Silesia; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Cardiff University; University of Erlangen Nuremberg; University of Naples Federico II; Medical University of Graz; Universitats Herzzentrum Freiburg; University of Freiburg; Heart Center Leipzig GMBH; Klinikum Fulda	Lansky, A (corresponding author), Yale Univ, Sch Med, New Haven, CT 06510 USA.	alexandra.lansky@yale.edu	Thiele, Holger/ABE-6792-2020; Anderson, Richard/S-2020-2019; Buszman, Pawel/AAX-9336-2020; Brugaletta, Salvatore/AAJ-2090-2020; van Royen, Niels/Q-1097-2017; Xu, Bo/GQZ-1711-2022; Berti, Sergio/AAV-6619-2021; Ochala, Andrzej/AAH-3855-2020	Thiele, Holger/0000-0002-0169-998X; Wijns, William/0000-0002-7267-4376; Johnson, Thomas/0000-0003-4638-601X; Ochala, Andrzej/0000-0002-2484-967X; Buszman, Pawel/0000-0002-2511-4077	Shanghai Microport Medical	Shanghai Microport Medical	Shanghai Microport Medical.	BANGALORE S, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6625; Baumbach A, 2018, EUROINTERVENTION, V14, P1121, DOI 10.4244/EIJ-D-18-00226; Byrne R A, 2009, Minerva Cardioangiol, V57, P567; Byrne RA, 2015, EUR HEART J, V36, P2608, DOI 10.1093/eurheartj/ehv203; Byrne RA, 2011, J AM COLL CARDIOL, V58, P1325, DOI 10.1016/j.jacc.2011.06.027; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dangas GD, 2013, JACC-CARDIOVASC INTE, V6, P914, DOI 10.1016/j.jcin.2013.05.005; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Gao RL, RANDOMISED COMPARISO; Gao Z, 2015, CATHETER CARDIO INTE, V85, P734, DOI 10.1002/ccd.25861; Kandzari DE, 2017, LANCET, V390, P1843, DOI 10.1016/S0140-6736(17)32249-3; Kang SH, 2014, EUR HEART J, V35, P1147, DOI 10.1093/eurheartj/eht570; Kufner S, 2016, EUROINTERVENTION, V11, P1372, DOI 10.4244/EIJY14M11_02; Lupi A, 2014, EUR J PREV CARDIOL, V21, P411, DOI 10.1177/2047487312467745; Mori H, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007244; Nakazawa G, 2014, EUROINTERVENTION, V10, P717, DOI 10.4244/EIJV10I6A124; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Pilgrim T, 2014, LANCET, V384, P2111, DOI 10.1016/S0140-6736(14)61038-2; Qian J, 2012, CHINESE MED J-PEKING, V125, P970, DOI 10.3760/cma.j.issn.0366-6999.2012.06.003; Saito S, 2014, EUR HEART J, V35, P2021, DOI 10.1093/eurheartj/ehu210; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Virmani R., 2014, EUROPCR 2014; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Xu B, 2014, CHINESE MED J-PEKING, V127, P1027, DOI 10.3760/cma.j.issn.0366-6999.20133222; Xu B, 2013, CHINESE MED J-PEKING, V126, P1026, DOI 10.3760/cma.j.issn.0366-6999.20123206	30	40	43	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2018	392	10153					1117	1126		10.1016/S0140-6736(18)31649-0	http://dx.doi.org/10.1016/S0140-6736(18)31649-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV3BV	30190206				2022-12-28	WOS:000445968800026
J	Adli, E; Ahuja, A; Apsimon, O; Apsimon, R; Bachmann, AM; Barrientos, D; Batsch, F; Bauche, J; Olsen, VKB; Bernardini, M; Bohl, T; Bracco, C; Braunmuller, F; Burt, G; Buttenschon, B; Caldwell, A; Cascella, M; Chappell, J; Chevallay, E; Chung, M; Cooke, D; Damerau, H; Deacon, L; Deubner, LH; Dexter, A; Doebert, S; Farmer, J; Fedosseev, VN; Fiorito, R; Fonseca, RA; Friebel, F; Garolfi, L; Gessner, S; Gorgisyan, I; Gorn, AA; Granados, E; Grulke, O; Gschwendtner, E; Hansen, J; Helm, A; Henderson, JR; Huther, M; Ibison, M; Jensen, L; Jolly, S; Keeble, F; Kim, SY; Kraus, F; Li, Y; Liu, S; Lopes, N; Lotov, KV; Brun, LM; Martyanov, M; Mazzoni, S; Godoy, DM; Minakov, VA; Mitchell, J; Molendijk, JC; Moody, JT; Moreira, M; Muggli, P; Oz, E; Pasquino, C; Pardons, A; Asmus, FP; Pepitone, K; Perera, A; Petrenko, A; Pitman, S; Pukhov, A; Rey, S; Rieger, K; Ruhl, H; Schmidt, JS; Shalimova, IA; Sherwood, P; Silva, LO; Soby, L; Sosedkin, AP; Speroni, R; Spitsyn, RI; Tuev, PV; Turner, M; Velotti, F; Verra, L; Verzilov, VA; Vieira, J; Welsch, CP; Williamson, B; Wing, M; Woolley, B; Xia, G				Adli, E.; Ahuja, A.; Apsimon, O.; Apsimon, R.; Bachmann, A. -M.; Barrientos, D.; Batsch, F.; Bauche, J.; Olsen, V. K. Berglyd; Bernardini, M.; Bohl, T.; Bracco, C.; Braunmueller, F.; Burt, G.; Buttenschoen, B.; Caldwell, A.; Cascella, M.; Chappell, J.; Chevallay, E.; Chung, M.; Cooke, D.; Damerau, H.; Deacon, L.; Deubner, L. H.; Dexter, A.; Doebert, S.; Farmer, J.; Fedosseev, V. N.; Fiorito, R.; Fonseca, R. A.; Friebel, F.; Garolfi, L.; Gessner, S.; Gorgisyan, I.; Gorn, A. A.; Granados, E.; Grulke, O.; Gschwendtner, E.; Hansen, J.; Helm, A.; Henderson, J. R.; Huether, M.; Ibison, M.; Jensen, L.; Jolly, S.; Keeble, F.; Kim, S. -Y.; Kraus, F.; Li, Y.; Liu, S.; Lopes, N.; Lotov, K. V.; Brun, L. Maricalva; Martyanov, M.; Mazzoni, S.; Godoy, D. Medina; Minakov, V. A.; Mitchell, J.; Molendijk, J. C.; Moody, J. T.; Moreira, M.; Muggli, P.; Oez, E.; Pasquino, C.; Pardons, A.; Asmus, F. Pena; Pepitone, K.; Perera, A.; Petrenko, A.; Pitman, S.; Pukhov, A.; Rey, S.; Rieger, K.; Ruhl, H.; Schmidt, J. S.; Shalimova, I. A.; Sherwood, P.; Silva, L. O.; Soby, L.; Sosedkin, A. P.; Speroni, R.; Spitsyn, R. I.; Tuev, P. V.; Turner, M.; Velotti, F.; Verra, L.; Verzilov, V. A.; Vieira, J.; Welsch, C. P.; Williamson, B.; Wing, M.; Woolley, B.; Xia, G.			Acceleration of electrons in the plasma wakefield of a proton bunch	NATURE			English	Article							BEAM; AWAKE	High-energy particle accelerators have been crucial in providing a deeper understanding of fundamental particles and the forces that govern their interactions. To increase the energy of the particles or to reduce the size of the accelerator, new acceleration schemes need to be developed. Plasma wakefield acceleration(1-5), in which the electrons in a plasma are excited, leading to strong electric fields (so called 'wakefields'), is one such promising acceleration technique. Experiments have shown that an intense laser pulse(6-9) or electron bunch(10,11) traversing a plasma can drive electric fields of tens of gigavolts per metre and above-well beyond those achieved in conventional radio-frequency accelerators (about 0.1 gigavolt per metre). However, the low stored energy of laser pulses and electron bunches means that multiple acceleration stages are needed to reach very high particle energies(5,12). The use of proton bunches is compelling because they have the potential to drive wakefields and to accelerate electrons to high energy in a single acceleration stage(13). Long, thin proton bunches can be used because they undergo a process called self-modulation(14-16), a particle-plasma interaction that splits the bunch longitudinally into a series of high-density microbunches, which then act resonantly to create large wakefields. The Advanced Wakefield (AWAKE) experiment at CERN17-19 uses high-intensity proton bunches-in which each proton has an energy of 400 gigaelectronvolts, resulting in a total bunch energy of 19 kilojoules-to drive a wakefield in a ten-metrelong plasma. Electron bunches are then injected into this wakefield. Here we present measurements of electrons accelerated up to two gigaelectronvolts at the AWAKE experiment, in a demonstration of proton-driven plasma wakefield acceleration. Measurements were conducted under various plasma conditions and the acceleration was found to be consistent and reliable. The potential for this scheme to produce very high-energy electron bunches in a single accelerating stage(20) means that our results are an important step towards the development of future high-energy particle accelerators(21-22).	[Adli, E.; Olsen, V. K. Berglyd] Univ Oslo, Oslo, Norway; [Ahuja, A.; Bachmann, A. -M.; Barrientos, D.; Batsch, F.; Bauche, J.; Bernardini, M.; Bohl, T.; Bracco, C.; Chevallay, E.; Damerau, H.; Doebert, S.; Fedosseev, V. N.; Friebel, F.; Garolfi, L.; Gessner, S.; Gorgisyan, I.; Granados, E.; Gschwendtner, E.; Hansen, J.; Jensen, L.; Brun, L. Maricalva; Mazzoni, S.; Godoy, D. Medina; Molendijk, J. C.; Moreira, M.; Muggli, P.; Pasquino, C.; Pardons, A.; Pepitone, K.; Petrenko, A.; Rey, S.; Schmidt, J. S.; Soby, L.; Speroni, R.; Turner, M.; Velotti, F.; Verra, L.; Woolley, B.] CERN, Geneva, Switzerland; [Apsimon, O.; Li, Y.; Williamson, B.; Xia, G.] Univ Manchester, Manchester, Lancs, England; [Apsimon, O.; Apsimon, R.; Burt, G.; Dexter, A.; Fiorito, R.; Henderson, J. R.; Ibison, M.; Li, Y.; Mitchell, J.; Perera, A.; Pitman, S.; Welsch, C. P.; Williamson, B.; Xia, G.] Cockcroft Inst, Daresbury, England; [Apsimon, R.; Burt, G.; Dexter, A.; Henderson, J. R.; Mitchell, J.; Pitman, S.] Univ Lancaster, Lancaster, England; [Bachmann, A. -M.; Batsch, F.; Braunmueller, F.; Caldwell, A.; Huether, M.; Martyanov, M.; Moody, J. T.; Muggli, P.; Oez, E.; Asmus, F. Pena; Rieger, K.] Max Planck Inst Phys & Astrophys, Munich, Germany; [Bachmann, A. -M.; Batsch, F.; Asmus, F. Pena] Tech Univ Munich, Munich, Germany; [Buttenschoen, B.; Grulke, O.] Max Planck Inst Plasma Phys, Greifswald, Germany; [Cascella, M.; Chappell, J.; Cooke, D.; Deacon, L.; Jolly, S.; Keeble, F.; Sherwood, P.; Wing, M.] UCL, London, England; [Chung, M.; Kim, S. -Y.] UNIST, Ulsan, South Korea; [Deubner, L. H.; Kraus, F.] Philipps Univ Marburg, Marburg, Germany; [Farmer, J.; Pukhov, A.] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany; [Fiorito, R.; Ibison, M.; Perera, A.; Welsch, C. P.] Univ Liverpool, Liverpool, Merseyside, England; [Fonseca, R. A.] Univ Lisbon, ISCTE Inst, Lisbon, Portugal; [Gorn, A. A.; Lotov, K. V.; Minakov, V. A.; Petrenko, A.; Sosedkin, A. P.; Spitsyn, R. I.; Tuev, P. V.] RAS, Budker Inst Nucl Phys SB, Novosibirsk, Russia; [Gorn, A. A.; Lotov, K. V.; Minakov, V. A.; Shalimova, I. A.; Sosedkin, A. P.; Spitsyn, R. I.; Tuev, P. V.] Novosibirsk State Univ, Novosibirsk, Russia; [Grulke, O.] Tech Univ Denmark, Lyngby, Denmark; [Helm, A.; Lopes, N.; Moreira, M.; Silva, L. O.; Vieira, J.] Univ Lisbon, Inst Super Tecn, GoLP Inst Plasmas & Fusao Nucl, Lisbon, Portugal; [Liu, S.; Verzilov, V. A.] TRIUMF, Vancouver, BC, Canada; [Ruhl, H.] Ludwig Maximilians Univ Munchen, Munich, Germany; [Shalimova, I. A.] RAS, Inst Computat Math & Math Geophys SB, Novosibirsk, Russia; [Verra, L.] Univ Milan, Milan, Italy	University of Oslo; European Organization for Nuclear Research (CERN); University of Manchester; STFC Daresbury Laboratory; Lancaster University; Max Planck Society; Technical University of Munich; Max Planck Society; University of London; University College London; Ulsan National Institute of Science & Technology (UNIST); Philipps University Marburg; Heinrich Heine University Dusseldorf; University of Liverpool; Instituto Universitario de Lisboa; Universidade de Lisboa; Russian Academy of Sciences; Budker Institute of Nuclear Physics; Novosibirsk State University; Technical University of Denmark; Universidade de Lisboa; Instituto Superior Tecnico; University of British Columbia; University of Munich; Russian Academy of Sciences; University of Milan	Wing, M (corresponding author), UCL, London, England.	m.wing@ucl.ac.uk	Helm, Anton/G-2101-2019; Shalimova, Irina/E-4001-2014; Mazzoni, Stefano/P-7521-2019; Tuev, Petr/R-7929-2016; Farmer, John/AAP-5214-2021; Martyanov, Mikhail/AAN-7476-2020; Apsimon, Robert/AAR-1435-2020; Xia, Guoxing/N-8189-2013; Vieira, Jorge/M-4373-2013; Granados, Eduardo/U-8779-2019; Dexter, Amos Christopher/AAV-9515-2021; pukhov, alexander/C-8082-2016; Petrenko, Alexey/GXW-1911-2022; Lopes, Nelson M C/C-6540-2009; Petrenko, Alexey/R-6313-2016; Lotov, Konstantin/H-6217-2016; Kraus, Florian/G-2843-2012; Spitsyn, Roman/L-9366-2018; Petrenko, Alexey/P-2751-2019; Fonseca, Ricardo A/B-7680-2009; Fedosseev, Valentin/A-6240-2010; Moreira, Mariana/AAK-9097-2020; Gorn, Alexander/S-2738-2018; /C-3169-2009	Helm, Anton/0000-0003-4519-6345; Shalimova, Irina/0000-0002-2083-5676; Mazzoni, Stefano/0000-0001-5176-4391; Tuev, Petr/0000-0001-9156-7405; Farmer, John/0000-0002-6758-2127; Apsimon, Robert/0000-0001-6346-5989; Xia, Guoxing/0000-0002-3683-386X; Vieira, Jorge/0000-0002-5515-3624; Granados, Eduardo/0000-0002-6549-9303; Dexter, Amos Christopher/0000-0001-6660-9466; pukhov, alexander/0000-0001-5043-960X; Lopes, Nelson M C/0000-0001-8355-4727; Petrenko, Alexey/0000-0002-7772-8206; Kraus, Florian/0000-0003-4368-8418; Spitsyn, Roman/0000-0002-9297-6662; Petrenko, Alexey/0000-0002-7772-8206; Fonseca, Ricardo A/0000-0001-6342-6226; Barrientos, Diego/0000-0001-9693-2942; PEPITONE, Kevin/0000-0002-4514-293X; Fedosseev, Valentin/0000-0001-8767-1445; Burt, Graeme/0000-0001-8288-1216; Moreira, Mariana/0000-0002-7083-7952; Batsch, Fabian/0000-0002-6254-6557; Chappell, James/0000-0003-2997-0150; Gorn, Alexander/0000-0001-9297-7289; Pena Asmus, Felipe/0000-0001-6755-513X; Williamson, Barney/0000-0002-5987-3776; Turner, Marlene/0000-0002-8861-1521; Gessner, Spencer/0000-0002-9713-1116; Wing, Matthew/0000-0002-6319-4135; Berglyd Olsen, Veronica/0000-0002-3634-6367; Friebel, Florence/0000-0001-7077-2645; /0000-0003-2906-924X	Leverhulme Trust Research Project [RPG-2017-143]; STFC, UK; Russian Science Foundation [14-50-00080]; Deutsche Forschungsgemeinschaft [PU 213-6/1]; National Research Foundation of Korea [NRF-2015R1D1A1A01061074, NRF-2016R1A5A1013277]; Portuguese FCT-Foundation for Science and Technology [CERN/FIS-TEC/0032/2017, PTDC-FIS-PLA-2940-2014, UID/FIS/50010/2013, SFRH/IF/01635/2015]; NSERC; CNRC; Alexander von Humboldt Stiftung; DESY, Hamburg; Research Council of Norway; STFC [ST/P001777/1, 1690577, ST/P002056/1, ST/K002317/1, ST/P001939/1, 2021482, ST/K002244/1, ST/N001613/1, 1787274, ST/R002347/1, ST/R002304/1, ST/M004570/1, ST/N001001/1, ST/R002312/1, ST/R002339/1, 1698498, ST/N001486/1, AWAKE] Funding Source: UKRI	Leverhulme Trust Research Project(Leverhulme Trust); STFC, UK(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Russian Science Foundation(Russian Science Foundation (RSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Research Foundation of Korea(National Research Foundation of Korea); Portuguese FCT-Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CNRC; Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); DESY, Hamburg; Research Council of Norway(Research Council of Norway); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	All authors are members of the AWAKE Collaboration. This work was supported in part by: a Leverhulme Trust Research Project Grant RPG-2017-143 and by STFC (AWAKE-UK, Cockroft Institute core and UCL consolidated grants), UK; the Russian Science Foundation (project number 14-50-00080) for simulations of oblique injection performed by Budker INP group; a Deutsche Forschungsgemeinschaft project grant PU 213-6/1 'Three-dimensional quasi-static simulations of beam self-modulation for plasma wakefield acceleration'; the National Research Foundation of Korea (numbers NRF-2015R1D1A1A01061074 and NRF-2016R1A5A1013277); the Portuguese FCT-Foundation for Science and Technology, through grants CERN/FIS-TEC/0032/2017, PTDC-FIS-PLA-2940-2014, UID/FIS/50010/2013 and SFRH/IF/01635/2015; NSERC and CNRC for TRIUMF's contribution; and the Research Council of Norway. M. Wing acknowledges the support of the Alexander von Humboldt Stiftung and DESY, Hamburg. For their advice and contributions to the development of the magnetic spectrometer, we acknowledge B. Biskup, P. La Penna and M. Quattri. A. Petrenko acknowledges G. Demeter (Wigner Institute, Budapest) for calculating the rubidium ionization probability at AWAKE. F. Keeble acknowledges the operators of the CLEAR facility for their assistance during the calibration of the spectrometer. The AWAKE collaboration acknowledge the SPS team for proton delivery.	Batsch F, 2018, NUCL INSTRUM METH A, V909, P359, DOI 10.1016/j.nima.2018.02.067; Blumenfeld I, 2007, NATURE, V445, P741, DOI 10.1038/nature05538; Caldwell A, 2016, NUCL INSTRUM METH A, V829, P3, DOI 10.1016/j.nima.2015.12.050; Caldwell A, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3641973; Caldwell A, 2009, NAT PHYS, V5, P363, DOI 10.1038/NPHYS1248; CHEN PS, 1985, PHYS REV LETT, V55, P1537, DOI 10.1103/PhysRevLett.55.1537; Deacon L, 2015, P 6 INT PART ACC C J; Esarey E, 2009, REV MOD PHYS, V81, P1229, DOI 10.1103/RevModPhys.81.1229; Faure J, 2004, NATURE, V431, P541, DOI 10.1038/nature02963; Fedosseev V. N, 2016, P 7 INT PART ACC C J; Geddes CGR, 2004, NATURE, V431, P538, DOI 10.1038/nature02900; Gschwendtner E, 2016, NUCL INSTRUM METH A, V829, P76, DOI 10.1016/j.nima.2016.02.026; Joshi C, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2721965; Kumar N, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.255003; Litos M, 2014, NATURE, V515, P92, DOI 10.1038/nature13882; Lotov KV, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4933129; Mangles SPD, 2004, NATURE, V431, P535, DOI 10.1038/nature02939; MODENA A, 1995, NATURE, V377, P606, DOI 10.1038/377606a0; Muggli P, 2018, PLASMA PHYS CONTR F, V60, DOI 10.1088/1361-6587/aa941c; Muggli P, 2015, P 6 INT PART ACC C J; Nevay L, 2018, PREPRINT; Oz E, 2014, NUCL INSTRUM METH A, V740, P197, DOI 10.1016/j.nima.2013.10.093; Pepitone K, 2018, NUCL INSTRUM METH A, V909, P102, DOI 10.1016/j.nima.2018.02.044; Petrenko A, 2016, NUCL INSTRUM METH A, V829, P63, DOI 10.1016/j.nima.2016.01.063; Plyushchev G, 2018, J PHYS D APPL PHYS, V51, DOI 10.1088/1361-6463/aa9dd7; Pukhov A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.145003; Schroeder CB, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.145002; Schroeder CB, 2010, PHYS REV SPEC TOP-AC, V13, DOI 10.1103/PhysRevSTAB.13.101301; Sprangle P, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.056405; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Turner M, 2017, NUCL INSTRUM METH A, V854, P100, DOI 10.1016/j.nima.2017.02.064; Vieira J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.145005; Xia G, 2014, NUCL INSTRUM METH A, V740, P173, DOI 10.1016/j.nima.2013.11.006	35	113	114	8	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2018	561	7723					363	+		10.1038/s41586-018-0485-4	http://dx.doi.org/10.1038/s41586-018-0485-4			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU1HZ	30188496	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000445011500048
J	Naylor, CD				Naylor, C. David			On the Prospects for a (Deep) Learning Health Care System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ARTIFICIAL-INTELLIGENCE; MEDICINE		[Naylor, C. David] Univ Toronto, Dept Med, 4 Shorncliffe Ave, Toronto, ON M4V 1T1, Canada	University of Toronto	Naylor, CD (corresponding author), Univ Toronto, Dept Med, 4 Shorncliffe Ave, Toronto, ON M4V 1T1, Canada.	david.naylor@utoronto.ca						Combi C, 2017, ARTIF INTELL MED, V76, P37, DOI 10.1016/j.artmed.2017.01.003; Fogel AL, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-017-0012-2; Hinton G, 2018, JAMA-J AM MED ASSOC, V320, P1101, DOI 10.1001/jama.2018.11100; Maxmen JS, 1976, POSTPHYSICIAN ERA ME; Patel VL, 2009, ARTIF INTELL MED, V46, P5, DOI 10.1016/j.artmed.2008.07.017; Topol E., 2015, PATIENT WILL SEE YOU	6	108	110	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2018	320	11					1099	1100		10.1001/jama.2018.11103	http://dx.doi.org/10.1001/jama.2018.11103			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT9QL	30178068				2022-12-28	WOS:000444878600006
J	Oliver, D				Oliver, David			David Oliver: Government's approach to alcohol harm is incoherent	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Advisory Council on the Misuse of Drugs, 2017, ACMD WARNS MIN FALL; Alcohol Concern, ALCOHOL STAT; Alcohol Health Alliance UK, 2017, POCK MON PRIC ALC CO; [Anonymous], 2017, SPEND PUBL HLTH; Boniface Sadie, 2017, BMJ Open, V7, pe013497, DOI 10.1136/bmjopen-2016-013497; Bowman S, 2017, MINIMUM ALCOHOL PRIC; Bulman M., 2017, INDEPENDENT; Gammie J, 2018, HSJ; Griffith R, 2013, REFORMS ALCOHOL TAXE; Ham C, 2018, NHS 10 YEAR PLAN SHO; Institute of Alcohol Studies, 2017, PRICE; Institute of Alcohol Studies, 2018, THE ALC IND; King's Fund, HAS GOV DEL NEW ER P; Out-Law.com, 2018, WAL BRING FORW ALC M; Paddison C., 2017, CUTS PUBLIC HLTH WHY; Public Health England, 2018, ALC DRUG PREV TREATM; Stevens Gammie J., 2018, HSJ	17	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2018	362								k3836	10.1136/bmj.k3836	http://dx.doi.org/10.1136/bmj.k3836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JF	30206113	Bronze			2022-12-28	WOS:000445015700002
J	Wang, J; Zhou, L; Shi, H; Chern, M; Yu, H; Yi, H; He, M; Yin, JJ; Zhu, XB; Li, Y; Li, WT; Liu, JL; Wang, JC; Chen, XQ; Qing, H; Wang, YP; Liu, GF; Wang, WM; Li, P; Wu, XJ; Zhu, LH; Zhou, JM; Ronald, PC; Li, SG; Li, JY; Chen, XW				Wang, Jing; Zhou, Lian; Shi, Hui; Chern, Mawsheng; Yu, Hong; Yi, Hong; He, Min; Yin, Junjie; Zhu, Xiaobo; Li, Yan; Li, Weitao; Liu, Jiali; Wang, Jichun; Chen, Xiaoqiong; Qing, Hai; Wang, Yuping; Liu, Guifu; Wang, Wenming; Li, Ping; Wu, Xianjun; Zhu, Lihuang; Zhou, Jian-Min; Ronald, Pamela C.; Li, Shigui; Li, Jiayang; Chen, Xuewei			A single transcription factor promotes both yield and immunity in rice	SCIENCE			English	Article							DISEASE RESISTANCE; PLANT ARCHITECTURE; BLAST RESISTANCE; OSSPL14; BINDING; WRKY45	Plant immunity often penalizes growth and yield. The transcription factor Ideal Plant Architecture 1 (IPA1) reduces unproductive tillers and increases grains per panicle, which results in improved rice yield. Here we report that higher IPA1 levels enhance immunity. Mechanistically, phosphorylation of IPA1 at amino acid Ser(163) within its DNA binding domain occurs in response to infection by the fungus Magnaporthe oryzae and alters the DNA binding specificity of IPA1. Phosphorylated IPA1 binds to the promoter of the pathogen defense gene WRKY45 and activates its expression, leading to enhanced disease resistance. IPA1 returns to a nonphosphorylated state within 48 hours after infection, resuming support of the growth needed for high yield. Thus, IPA1 promotes both yield and disease resistance by sustaining a balance between growth and immunity.	[Wang, Jing; Zhou, Lian; Shi, Hui; Yi, Hong; He, Min; Yin, Junjie; Zhu, Xiaobo; Li, Yan; Li, Weitao; Liu, Jiali; Wang, Jichun; Chen, Xiaoqiong; Qing, Hai; Wang, Yuping; Wang, Wenming; Li, Ping; Wu, Xianjun; Li, Shigui; Chen, Xuewei] Sichuan Agr Univ Wenjiang, Rice Res Inst, Key Lab Major Crop Dis, State Key Lab Hybrid Rice, Chengdu 611130, Sichuan, Peoples R China; [Wang, Jing; Zhou, Lian; Shi, Hui; Yi, Hong; He, Min; Yin, Junjie; Zhu, Xiaobo; Li, Yan; Li, Weitao; Liu, Jiali; Wang, Jichun; Chen, Xiaoqiong; Qing, Hai; Wang, Yuping; Wang, Wenming; Li, Ping; Wu, Xianjun; Li, Shigui; Chen, Xuewei] Sichuan Agr Univ Wenjiang, Rice Res Inst, Collaborat Innovat Ctr Hybrid Rice Yangtze River, Chengdu 611130, Sichuan, Peoples R China; [Chern, Mawsheng; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Chern, Mawsheng; Ronald, Pamela C.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Yu, Hong; Liu, Guifu; Zhu, Lihuang; Zhou, Jian-Min; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Yu, Hong; Liu, Guifu; Zhu, Lihuang; Zhou, Jian-Min; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, Beijing 100101, Peoples R China; [Zhou, Jian-Min; Li, Jiayang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	University of California System; University of California Davis; University of California System; University of California Davis; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, J; Chen, XW (corresponding author), Sichuan Agr Univ Wenjiang, Rice Res Inst, Key Lab Major Crop Dis, State Key Lab Hybrid Rice, Chengdu 611130, Sichuan, Peoples R China.; Wang, J; Chen, XW (corresponding author), Sichuan Agr Univ Wenjiang, Rice Res Inst, Collaborat Innovat Ctr Hybrid Rice Yangtze River, Chengdu 611130, Sichuan, Peoples R China.; Li, JY (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China.; Li, JY (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, Beijing 100101, Peoples R China.; Li, JY (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	jingwang406@sicau.edu.cn; jyli@genetics.ac.cn; xwchen88@163.com	Zhou, Jian-Min/A-3140-2013; Ronald, Pamela/AAK-7664-2020; Wang, Wenming/G-3678-2012; Yu, Hong/H-2770-2012; Li, Jiayang/AAG-4377-2020	Zhou, Jian-Min/0000-0002-9943-2975; Yu, Hong/0000-0002-1748-8693; Zhu, Xiaobo/0000-0002-6041-8586; Chern, Mawsheng/0000-0001-8049-719X; Wang, J/0000-0002-7984-1392; LI, YAN/0000-0002-6443-9245	NSFC [31171622, 31571994, 31788103, 31401351, 31601290, 31701779]; NKRDPC [2016YFD0100600]; PNCETC [NECT-13-0920]; NSF [1237975]; NIH [GM59962]; NIFA [2017-67013-26590]	NSFC(National Natural Science Foundation of China (NSFC)); NKRDPC; PNCETC; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIFA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by NSFC (31171622, 31571994, 31788103, 31401351, 31601290, and 31701779), NKRDPC (2016YFD0100600), PNCETC (NECT-13-0920), the NSF (1237975), the NIH (GM59962), and NIFA (2017-67013-26590).	Birkenbihl RP, 2005, J MOL BIOL, V352, P585, DOI 10.1016/j.jmb.2005.07.013; Brown JKM, 2003, TRENDS GENET, V19, P667, DOI 10.1016/j.tig.2003.10.008; Deng YW, 2017, SCIENCE, V355, P962, DOI 10.1126/science.aai8898; Fan M, 2014, PLANT CELL, V26, P828, DOI 10.1105/tpc.113.121111; Goto S, 2015, PLANT BIOTECHNOL J, V13, P753, DOI 10.1111/pbi.12303; Inoue H, 2013, P NATL ACAD SCI USA, V110, P9577, DOI 10.1073/pnas.1222155110; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Li WT, 2017, CELL, V170, P114, DOI 10.1016/j.cell.2017.06.008; Lozano-Duran R, 2013, ELIFE, V2, DOI 10.7554/eLife.00983; Lu ZF, 2013, PLANT CELL, V25, P3743, DOI 10.1105/tpc.113.113639; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Nelson R, 2018, NAT REV GENET, V19, P21, DOI 10.1038/nrg.2017.82; Pajerowska-Mukhtar KM, 2012, CURR BIOL, V22, P103, DOI 10.1016/j.cub.2011.12.015; Shi H, 2013, PLANT CELL, V25, P1143, DOI 10.1105/tpc.112.107904; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Wang L, 2015, P NATL ACAD SCI USA, V112, P15504, DOI 10.1073/pnas.1521949112; Wang YH, 2005, PLANT MOL BIOL, V59, P75, DOI 10.1007/s11103-004-4038-x; Xu GY, 2017, NATURE, V545, P491, DOI 10.1038/nature22372; Zhou XG, 2018, P NATL ACAD SCI USA, V115, P3174, DOI 10.1073/pnas.1705927115	19	177	214	69	404	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					1026	1028		10.1126/science.aat7675	http://dx.doi.org/10.1126/science.aat7675			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190406				2022-12-28	WOS:000443892700049
J	Hirmas, DR; Gimenez, D; Nemes, A; Kerry, R; Brunsell, NA; Wilson, CJ				Hirmas, Daniel R.; Gimenez, Daniel; Nemes, Attila; Kerry, Ruth; Brunsell, Nathaniel A.; Wilson, Cassandra J.			Climate-induced changes in continental-scale soil macroporosity may intensify water cycle	NATURE			English	Article							CONSEQUENCES; TRANSPORT	Soil macroporosity affects field-scale water-cycle processes, such as infiltration, nutrient transport and runoff(1,2), that are important for the development of successful global strategies that address challenges of food security, water scarcity, human health and loss of biodiversity(3). Macropores-large pores that freely drain water under the influence of gravity-often represent less than 1 per cent of the soil volume, but can contribute more than 70 per cent of the total soil water infiltration(4), which greatly magnifies their influence on the regional and global water cycle. Although climate influences the development of macropores through soil-forming processes, the extent and rate of such development and its effect on the water cycle are currently unknown. Here we show that drier climates induce the formation of greater soil macroporosity than do more humid ones, and that such climate-induced changes occur over shorter timescales than have previously been considered-probably years to decades. Furthermore, we find that changes in the effective porosity, a proxy for macroporosity, predicted from mean annual precipitation at the end of the century would result in changes in saturated soil hydraulic conductivity ranging from - 55 to 34 per cent for five physiographic regions in the USA. Our results indicate that soil macroporosity may be altered rapidly in response to climate change and that associated continental-scale changes in soil hydraulic properties may set up unexplored feedbacks between climate and the land surface and thus intensify the water cycle.	[Hirmas, Daniel R.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA; [Gimenez, Daniel] Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ USA; [Nemes, Attila] Norwegian Inst Bioecon Res, Div Environm & Nat Resources, As, Norway; [Kerry, Ruth] Brigham Young Univ, Dept Geog, Provo, UT 84602 USA; [Brunsell, Nathaniel A.; Wilson, Cassandra J.] Univ Kansas, Dept Geog & Atmospher Sci, Lawrence, KS 66045 USA; [Wilson, Cassandra J.] KRNV News 4, Reno, NV USA	University of California System; University of California Riverside; Rutgers State University New Brunswick; Norwegian Institute of Bioeconomy Research; Brigham Young University; University of Kansas	Hirmas, DR (corresponding author), Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.	daniel.hirmas@ucr.edu	Brunsell, Nathaniel/G-2904-2012	Brunsell, Nathaniel/0000-0002-4460-8283; Nemes, Attila/0000-0003-2955-5985; Kerry, Ruth/0000-0001-9174-0167	Norwegian Institute of Bioeconomy Research (NIBIO); USDA-AFRI [2014-67003-22070]	Norwegian Institute of Bioeconomy Research (NIBIO); USDA-AFRI(United States Department of Agriculture (USDA))	D.R.H. and D.G. thank R. Miskewitz for assistance in assigning Koppen-Geiger classes to the samples in the dataset. A.N., D.G. and D.R.H. thank the Norwegian Institute of Bioeconomy Research (NIBIO) for financial support. N.A.B. acknowledges funding support through USDA-AFRI 2014-67003-22070.	Anselin L., 1998, HDB APPL EC STAT; Anselin L, 2005, EXPLORING SPATIAL DA; Beven K, 2013, WATER RESOUR RES, V49, P3071, DOI 10.1002/wrcr.20156; BRIMHALL GH, 1992, SCIENCE, V255, P695, DOI 10.1126/science.255.5045.695; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Clark MP, 2015, WATER RESOUR RES, V51, P5929, DOI 10.1002/2015WR017096; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Hassink J, 1997, PLANT SOIL, V191, P77, DOI 10.1023/A:1004213929699; Huntington TG, 2006, J HYDROL, V319, P83, DOI 10.1016/j.jhydrol.2005.07.003; Janzen HH, 2011, SOIL SCI SOC AM J, V75, P1, DOI 10.2136/sssaj2009.0216; Jarvis NJ, 2007, EUR J SOIL SCI, V58, P523, DOI 10.1111/j.1365-2389.2007.00915.x; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Korkmaz S, 2014, R J, V6, P151, DOI 10.32614/rj-2014-031; Lawrence DM, 2011, J ADV MODEL EARTH SY, V3, DOI 10.1029/2011MS000045; Mersiovsky E.P, 2017, THE SOILS OF THE US; Nemes A, 2005, SOIL SCI SOC AM J, V69, P1330, DOI 10.2136/sssaj2004.0055; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Petrie MD, 2012, ECOHYDROLOGY, V5, P337, DOI 10.1002/eco.224; Platt BF, 2016, SOIL SCI, V181, P175, DOI 10.1097/SS.0000000000000150; R Development Core Team, 2009, R LANG ENV STAT COMP; Rawls WJ, 1998, T ASAE, V41, P983, DOI 10.13031/2013.17270; Taina IA, 2013, CAN J SOIL SCI, V93, P533, DOI [10.4141/cjss2012-044, 10.4141/CJSS2012-044]; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Venables WN., 2002, MODERN APPL STAT S; WATSON KW, 1986, SOIL SCI SOC AM J, V50, P578, DOI 10.2136/sssaj1986.03615995005000030007x; Williams Jr C. N., 2006, US HIST CLIMATOLOGY	29	56	59	11	168	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					100	+		10.1038/s41586-018-0463-x	http://dx.doi.org/10.1038/s41586-018-0463-x			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30185954				2022-12-28	WOS:000443755200039
J	O'Dowd, A				O'Dowd, Adrian			Death certificates should record antimicrobial resistance as cause of deaths, says CMO	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Owen J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2863; Torjesen I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1597	2	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2018	362								k3832	10.1136/bmj.k3832	http://dx.doi.org/10.1136/bmj.k3832			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WS	30190362				2022-12-28	WOS:000444507200012
J	Shah, R; Patel, T; Freedman, JE				Shah, Ravi; Patel, Tushar; Freedman, Jane E.			Circulating Extracellular Vesicles in Human Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TUMOR-DERIVED EXOSOMES; CHRONIC HEART-FAILURE; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; CANCER EXOSOMES; ENDOTHELIAL MICROPARTICLES; MYOCARDIAL-INFARCTION; DIAGNOSTIC BIOMARKERS; NEURITE OUTGROWTH; CLINICAL IMPACT		[Shah, Ravi] Harvard Med Sch, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA USA; [Freedman, Jane E.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Patel, Tushar] Mayo Clin, Dept Transplantat, Jacksonville, FL 32224 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; Mayo Clinic	Freedman, JE (corresponding author), Univ Massachusetts, Med Ctr, AS7-1051,368 Plantat St, Worcester, MA 01605 USA.	jane.freedman@umassmed.edu						Akers JC, 2017, ONCOTARGET, V8, P68769, DOI 10.18632/oncotarget.18332; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Amabile N, 2014, EUR HEART J, V35, P2972, DOI 10.1093/eurheartj/ehu153; Arbelaiz A, 2017, HEPATOLOGY, V66, P1125, DOI 10.1002/hep.29291; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Baran J, 2010, CANCER IMMUNOL IMMUN, V59, P841, DOI 10.1007/s00262-009-0808-2; Cheng L, 2015, MOL PSYCHIATR, V20, P1188, DOI 10.1038/mp.2014.127; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Hoog VC, 2013, EUR HEART J-ACUTE CA, V2, P53, DOI 10.1177/2048872612471212; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Emanueli C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154274; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Gardiner C, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32945; Gilligan KE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061122; Goetzl EJ, 2018, FASEB J, V32, P888, DOI 10.1096/fj.201700731R; Gui YX, 2015, ONCOTARGET, V6, P37043, DOI 10.18632/oncotarget.6158; He M, 2016, JALA-J LAB AUTOM, V21, P599, DOI 10.1177/2211068216651035; Hong CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103310; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Hubal MJ, 2017, OBESITY, V25, P102, DOI 10.1002/oby.21709; Hubert A, 2015, JAIDS-J ACQ IMM DEF, V70, P219, DOI 10.1097/QAI.0000000000000756; Jansen F, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0367-8; Jeppesen DK, 2014, PROTEOMICS, V14, P699, DOI 10.1002/pmic.201300452; Jiang X, 2017, AM J PHYSIOL-HEART C, V312, pH818, DOI 10.1152/ajpheart.00673.2016; Kennel PJ, 2018, J HEART LUNG TRANSPL, V37, P409, DOI 10.1016/j.healun.2017.07.012; Kervadec A, 2016, J HEART LUNG TRANSPL, V35, P795, DOI 10.1016/j.healun.2016.01.013; Khan M, 2015, CIRC RES, V117, P52, DOI 10.1161/CIRCRESAHA.117.305990; Khan S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-176; Kim MS, 2016, NANOMED-NANOTECHNOL, V12, P655, DOI 10.1016/j.nano.2015.10.012; Ko J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31215; Lener T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.30087; Lobb RJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27031; Logozzi M, 2017, CANCER LETT, V403, P318, DOI 10.1016/j.canlet.2017.06.036; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lyu LM, 2015, J MOL CELL CARDIOL, V89, P268, DOI 10.1016/j.yjmcc.2015.10.022; Mateescu B, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1286095; Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Muralidharan-Chari V, 2016, ONCOTARGET, V7, P50365, DOI 10.18632/oncotarget.10395; Ngolab J, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0445-5; Nozaki T, 2009, J AM COLL CARDIOL, V54, P601, DOI 10.1016/j.jacc.2009.05.022; Nuzhat Z, 2017, ONCOTARGET, V8, P17279, DOI 10.18632/oncotarget.13973; Properzi F, 2015, J GEN VIROL, V96, P1969, DOI 10.1099/vir.0.000117; Qu Z, 2017, ONCOTARGET, V8, P80666, DOI 10.18632/oncotarget.20881; Raab-Traub N, 2017, NAT REV MICROBIOL, V15, P559, DOI 10.1038/nrmicro.2017.60; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Rodriguez M, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0726-4; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Sandfeld-Paulsen B, 2016, J THORAC ONCOL, V11, P1701, DOI 10.1016/j.jtho.2016.05.034; Shedden K, 2003, CANCER RES, V63, P4331; Shiromizu T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13092-x; Silva J, 2012, GENE CHROMOSOME CANC, V51, P409, DOI 10.1002/gcc.21926; Slrnalley DM, 2008, J PROTEOME RES, V7, P2088, DOI 10.1021/pr700775x; Stepanian A, 2013, OBESITY, V21, P2236, DOI 10.1002/oby.20365; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Tanaka Y, 2013, CANCER-AM CANCER SOC, V119, P1159, DOI 10.1002/cncr.27895; Tang XJ, 2015, ONCOTARGET, V6, P44179, DOI 10.18632/oncotarget.6175; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; van der Pol E, 2016, J THROMB HAEMOST, V14, P48, DOI 10.1111/jth.13190; Wang CX, 2017, MOL THER, V25, P192, DOI 10.1016/j.ymthe.2016.09.001; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Ye SB, 2014, ONCOTARGET, V5, P5439, DOI 10.18632/oncotarget.2118; Ye W, 2017, MOL IMMUNOL, V87, P114, DOI 10.1016/j.molimm.2017.03.011; Yeung CLA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11150	70	326	332	9	103	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2018	379	10					958	966		10.1056/NEJMra1704286	http://dx.doi.org/10.1056/NEJMra1704286			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5XM	30184457				2022-12-28	WOS:000443748200010
J	Han, QF; Hsieh, YT; Meng, L; Wu, JL; Sun, PY; Yao, EP; Chang, SY; Bae, SH; Kato, T; Bermudez, V; Yang, Y				Han, Qifeng; Hsieh, Yao-Tsung; Meng, Lei; Wu, Jyh-Lih; Sun, Pengyu; Yao, En-Ping; Chang, Sheng-Yung; Bae, Sang-Hoon; Kato, Takuya; Bermudez, Veronica; Yang, Yang			High-performance perovskite/Cu(In,Ga)Se-2 monolithic tandem solar cells	SCIENCE			English	Article							ITO THIN-FILM; HALIDE PEROVSKITES; EFFICIENCY; POLYCRYSTALLINE; STABILITY; SINGLE	The combination of hybrid perovskite and Cu(In,Ga)Se-2 (CIGS) has the potential for realizing high-efficiency thin-film tandem solar cells because of the complementary tunable bandgaps and excellent photovoltaic properties of these materials. In tandem solar device architectures, the interconnecting layer plays a critical role in determining the overall cell performance, requiring both an effective electrical connection and high optical transparency. We used nanoscale interface engineering of the CIGS surface and a heavily doped poly[bis(4-phenyl)(2,4,6-trimethylphenyl) amine] (PTAA) hole transport layer between the subcells that preserves open-circuit voltage and enhances both the fill factor and short-circuit current. A monolithic perovskite/CIGS tandem solar cell achieved a 22.43% efficiency, and unencapsulated devices under ambient conditions maintained 88% of their initial efficiency after 500 hours of aging under continuous 1-sun illumination.	[Han, Qifeng; Hsieh, Yao-Tsung; Meng, Lei; Sun, Pengyu; Yao, En-Ping; Chang, Sheng-Yung; Bae, Sang-Hoon; Yang, Yang] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Wu, Jyh-Lih; Kato, Takuya; Bermudez, Veronica] Solar Frontier KK, Atsugi Res Ctr, Atsugi, Kanagawa 2430206, Japan	University of California System; University of California Los Angeles	Han, QF; Yang, Y (corresponding author), Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA.	qfhan@ucla.edu; yangy@ucla.edu	yang, yang/GWB-9426-2022; Yang, Yang/A-2944-2011; yang, yang/GVT-5210-2022; yang, yang/HGT-7999-2022; Lang, Ming/HIK-0758-2022; Kato, Takuya/F-8155-2017	Kato, Takuya/0000-0002-9366-7458; Hsieh, Yao-Tsung/0000-0003-0690-3895; Han, Qifeng/0000-0002-0127-181X	National Science Foundation [ECCS-1509955]; Air Force Office of Scientific Research [FA9550-15-1-0333]	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work is financially supported by grants from the National Science Foundation (grant no. ECCS-1509955; program director: N. El-Masry), and the Air Force Office of Scientific Research (grant no. FA9550-15-1-0333; program manager: C. Lee)	Abdi-Jalebi M, 2018, NATURE, V555, P497, DOI 10.1038/nature25989; Albrecht S, 2016, ENERG ENVIRON SCI, V9, P81, DOI 10.1039/c5ee02965a; Bailie CD, 2015, MRS BULL, V40, P681, DOI 10.1557/mrs.2015.167; Beal RE, 2016, J PHYS CHEM LETT, V7, P746, DOI 10.1021/acs.jpclett.6b00002; Bi C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8747; Brown AS, 2002, PROG PHOTOVOLTAICS, V10, P299, DOI 10.1002/pip.425; Bush KA, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.9; Bush KA, 2016, ADV MATER, V28, P3937, DOI 10.1002/adma.201505279; Chirila A, 2013, NAT MATER, V12, P1107, DOI [10.1038/NMAT3789, 10.1038/nmat3789]; Chirila A, 2011, NAT MATER, V10, P857, DOI [10.1038/NMAT3122, 10.1038/nmat3122]; Choi GW, 2006, MICROELECTRON ENG, V83, P2213, DOI 10.1016/j.mee.2006.10.006; Coutts TJ, 2003, PROG PHOTOVOLTAICS, V11, P359, DOI 10.1002/pip.491; Domanski K, 2018, NAT ENERGY, V3, P61, DOI 10.1038/s41560-017-0060-5; Dou LT, 2013, ADV MATER, V25, P6642, DOI 10.1002/adma.201302563; Eperon GE, 2016, SCIENCE, V354, P861, DOI 10.1126/science.aaf9717; Fu F, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2016.190; Graetzel M, 2012, NATURE, V488, P304, DOI 10.1038/nature11476; Guchhait A, 2017, ACS ENERGY LETT, V2, P807, DOI 10.1021/acsenergylett.7b00187; HENRY CH, 1980, J APPL PHYS, V51, P4494, DOI 10.1063/1.328272; Jackson P, 2016, PHYS STATUS SOLIDI-R, V10, P583, DOI 10.1002/pssr.201600199; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Jung HS, 2015, SMALL, V11, P10, DOI 10.1002/smll.201402767; Jung S, 2010, CURR APPL PHYS, V10, P990, DOI 10.1016/j.cap.2009.11.082; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Kim J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7391; Kim JY, 2007, SCIENCE, V317, P222, DOI 10.1126/science.1141711; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Kranz L, 2015, J PHYS CHEM LETT, V6, P2676, DOI 10.1021/acs.jpclett.5b01108; Lee JW, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201501310; Lee KY, 2012, J KOREAN PHYS SOC, V60, P388, DOI 10.3938/jkps.60.388; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Li YW, 2015, J AM CHEM SOC, V137, P15540, DOI 10.1021/jacs.5b10614; Mathew S, 2014, NAT CHEM, V6, P242, DOI [10.1038/NCHEM.1861, 10.1038/nchem.1861]; McGehee MD, 2013, NATURE, V501, P323, DOI 10.1038/nature12557; McMeekin DP, 2016, SCIENCE, V351, P151, DOI 10.1126/science.aad5845; Meillaud F, 2006, SOL ENERG MAT SOL C, V90, P2952, DOI 10.1016/j.solmat.2006.06.002; Saliba M, 2018, SCIENCE, V359, P388, DOI 10.1126/science.aar5684; Shao YC, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2015.1, 10.1038/NENERGY.2015.1]; Stranks SD, 2015, ANGEW CHEM INT EDIT, V54, P3240, DOI 10.1002/anie.201410214; Todorov T, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201500799; Todorov TK, 2013, PROG PHOTOVOLTAICS, V21, P82, DOI 10.1002/pip.1253; Wang Q, 2015, NANO ENERGY, V15, P275, DOI 10.1016/j.nanoen.2015.04.029; Werner J, 2016, J PHYS CHEM LETT, V7, P161, DOI 10.1021/acs.jpclett.5b02686; Xu J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8081; Yang WS, 2015, SCIENCE, V348, P1234, DOI 10.1126/science.aaa9272; You JB, 2016, NAT NANOTECHNOL, V11, P75, DOI [10.1038/nnano.2015.230, 10.1038/NNANO.2015.230]; Zheng XP, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.102; Zuo CT, 2016, ADV SCI, V3, DOI 10.1002/advs.201500324	48	244	248	35	389	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					904	+		10.1126/science.aat5055	http://dx.doi.org/10.1126/science.aat5055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166487				2022-12-28	WOS:000443547000035
J	Imielinski, M; Ladanyi, M				Imielinski, Marcin; Ladanyi, Marc			Fusion oncogenes-genetic musical chairs	SCIENCE			English	Editorial Material							CANCER; COMPLEXITY; PROXIMITY; DELETION		[Imielinski, Marcin] Weill Cornell Med, Englander Inst Precis Med, Dept Pathol & Lab Med, Inst Computat Biomed,Meyer Canc Ctr, New York, NY 10065 USA; [Imielinski, Marcin] New York Genome Ctr, New York, NY 10013 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Imielinski, M (corresponding author), Weill Cornell Med, Englander Inst Precis Med, Dept Pathol & Lab Med, Inst Computat Biomed,Meyer Canc Ctr, New York, NY 10065 USA.; Imielinski, M (corresponding author), New York Genome Ctr, New York, NY 10013 USA.	mai9037@med.cornell.edu; ladanyim@mskcc.org	Ladanyi, Marc/AAG-8585-2019					Anderson ND, 2018, SCIENCE, V361, DOI 10.1126/science.aam8419; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Brohl AS, 2017, GENET MED, V19, P955, DOI 10.1038/gim.2016.206; Grunewald TGP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0003-x; Henssen AG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9078; Huang HY, 2005, J CLIN ONCOL, V23, P548, DOI 10.1200/JCO.2005.02.081; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Mertens F, 2015, NAT REV CANCER, V15, P371, DOI 10.1038/nrc3947; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Roberts P, 2008, GENE CHROMOSOME CANC, V47, P207, DOI 10.1002/gcc.20523; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Turajlic S, 2017, LANCET ONCOL, V18, P1009, DOI 10.1016/S1470-2045(17)30516-8; Viswanathan SR, 2018, CELL, V174, P433, DOI 10.1016/j.cell.2018.05.036	13	3	4	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					848	+		10.1126/science.aau8231	http://dx.doi.org/10.1126/science.aau8231			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS3UB	30166475				2022-12-28	WOS:000443547000017
J	Sigal, YM; Zhou, RB; Zhuang, XW				Sigal, Yaron M.; Zhou, Ruobo; Zhuang, Xiaowei			Visualizing and discovering cellular structures with super-resolution microscopy	SCIENCE			English	Review							SINGLE-MOLECULE LOCALIZATION; SUBCORTICAL CYTOSKELETON PERIODICITY; RESOLUTION FLUORESCENCE MICROSCOPY; SUBDIFFRACTION-RESOLUTION; DIFFRACTION BARRIER; MEMBRANE SKELETON; IMAGING REVEALS; STED NANOSCOPY; ACTIVE ZONE; PROTEIN	Super-resolution microscopy has overcome a long-held resolution barrier-the diffraction limit-in light microscopy and enabled visualization of previously invisible molecular details in biological systems. Since their conception, super-resolution imaging methods have continually evolved and can now be used to image cellular structures in three dimensions, multiple colors, and living systems with nanometer-scale resolution. These methods have been applied to answer questions involving the organization, interaction, stoichiometry, and dynamics of individual molecular building blocks and their integration into functional machineries in cells and tissues. In this Review, we provide an overview of super-resolution methods, their state-of-the-art capabilities, and their constantly expanding applications to biology, with a focus on the latter. We will also describe the current technical challenges and future advances anticipated in super-resolution imaging.	[Sigal, Yaron M.; Zhou, Ruobo; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Dept Phys, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu		Zhou, Ruobo/0000-0001-8628-0282	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is in part supported by the National Institutes of Health. X.Z. is a Howard Hughes Medical Institute Investigator.	Albrecht D, 2016, J CELL BIOL, V215, P37, DOI 10.1083/jcb.201603108; Aquino D, 2011, NAT METHODS, V8, P353, DOI [10.1038/NMETH.1583, 10.1038/nmeth.1583]; Ricci MA, 2015, CELL, V160, P1145, DOI 10.1016/j.cell.2015.01.054; Balzarotti F, 2017, SCIENCE, V355, P606, DOI 10.1126/science.aak9913; Berning S, 2012, SCIENCE, V335, P551, DOI 10.1126/science.1215369; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bohm U, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10504; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Chang JB, 2017, NAT METHODS, V14, P593, DOI [10.1038/NMETH.4261, 10.1038/nmeth.4261]; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Chmyrov A, 2013, NAT METHODS, V10, P737, DOI 10.1038/nmeth.2556; Cho I, 2018, J MICROSC-OXFORD, V271, P123, DOI 10.1111/jmi.12712; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; D'Este E, 2017, P NATL ACAD SCI USA, V114, pE191, DOI 10.1073/pnas.1619553114; D'Este E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22741; D'Este E, 2015, CELL REP, V10, P1246, DOI 10.1016/j.celrep.2015.02.007; Dai MJ, 2016, NAT NANOTECHNOL, V11, P798, DOI [10.1038/NNANO.2016.95, 10.1038/nnano.2016.95]; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/nmeth.1768, 10.1038/NMETH.1768]; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Eggeling C, 2015, Q REV BIOPHYS, V48, P178, DOI [10.1017/S0033583515000219, 10.1017/S0033583514000146]; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Fei JY, 2015, SCIENCE, V347, P1371, DOI 10.1126/science.1258849; French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054; Gartenmann L, 2017, CURR BIOL, V27, pR1054, DOI 10.1016/j.cub.2017.08.009; Giannone G, 2010, BIOPHYS J, V99, P1303, DOI 10.1016/j.bpj.2010.06.005; Gradinaru V, 2018, ANNU REV BIOPHYS, V47, P355, DOI 10.1146/annurev-biophys-070317-032905; Grosse L, 2016, EMBO J, V35, P402, DOI 10.15252/embj.201592789; Gustavsson AK, 2018, OPT EXPRESS, V26, P13122, DOI 10.1364/OE.26.013122; Hamel V, 2017, CURR BIOL, V27, P2486, DOI 10.1016/j.cub.2017.07.011; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Han BR, 2017, P NATL ACAD SCI USA, V114, pE6678, DOI 10.1073/pnas.1705043114; He J, 2016, P NATL ACAD SCI USA, V113, P6029, DOI 10.1073/pnas.1605707113; Heine J, 2017, P NATL ACAD SCI USA, V114, P9797, DOI 10.1073/pnas.1708304114; Heintzmann R, 2009, NAT PHOTONICS, V3, P362, DOI 10.1038/nphoton.2009.102; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang CYM, 2017, J NEUROSCI, V37, P11323, DOI 10.1523/JNEUROSCI.2113-17.2017; Huang F, 2016, CELL, V166, P1028, DOI 10.1016/j.cell.2016.06.016; Huang F, 2013, NAT METHODS, V10, P653, DOI [10.1038/NMETH.2488, 10.1038/nmeth.2488]; Jia S, 2014, NAT PHOTONICS, V8, P302, DOI [10.1038/nphoton.2014.13, 10.1038/NPHOTON.2014.13]; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klar TA, 1999, OPT LETT, V24, P954, DOI 10.1364/OL.24.000954; Krieg M, 2014, NAT CELL BIOL, V16, P224, DOI 10.1038/ncb2915; Lau L, 2012, BIOPHYS J, V102, P2926, DOI 10.1016/j.bpj.2012.05.015; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Li D, 2015, SCIENCE, V349, DOI 10.1126/science.aab3500; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; MacGillavry HD, 2013, NEURON, V78, P615, DOI 10.1016/j.neuron.2013.03.009; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Moffitt JR, 2016, ELIFE, V5, DOI 10.7554/eLife.13065; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Nixon-Abell J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf3928; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Pertsinidis A, 2010, NATURE, V466, P647, DOI 10.1038/nature09163; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Puchner EM, 2013, P NATL ACAD SCI USA, V110, P16015, DOI 10.1073/pnas.1309676110; Rego EH, 2012, P NATL ACAD SCI USA, V109, pE135, DOI 10.1073/pnas.1107547108; Renz M, 2012, P NATL ACAD SCI USA, V109, pE2989, DOI 10.1073/pnas.1211753109; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sage D, 2015, NAT METHODS, V12, P717, DOI [10.1038/NMETH.3442, 10.1038/nmeth.3442]; Sahl SJ, 2017, NAT REV MOL CELL BIO, V18, P685, DOI 10.1038/nrm.2017.71; Sahl SJ, 2010, P NATL ACAD SCI USA, V107, P6829, DOI 10.1073/pnas.0912894107; Salvador-Gallego R, 2016, EMBO J, V35, P389, DOI 10.15252/embj.201593384; Schmidt R, 2008, NAT METHODS, V5, P539, DOI 10.1038/nmeth.1214; Schneider J, 2015, NAT METHODS, V12, P827, DOI [10.1038/NMETH.3481, 10.1038/nmeth.3481]; Shah S, 2018, CELL, V174, P363, DOI 10.1016/j.cell.2018.05.035; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Shi XY, 2017, NAT CELL BIOL, V19, P1178, DOI 10.1038/ncb3599; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Sigal YM, 2015, CELL, V163, P493, DOI 10.1016/j.cell.2015.08.033; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Ta H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8977; Tang AH, 2016, NATURE, V536, P210, DOI 10.1038/nature19058; Tonnesen J, 2018, CELL, V172, P1108, DOI 10.1016/j.cell.2018.02.007; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; Vaughan JC, 2012, NAT METHODS, V9, P1181, DOI [10.1038/NMETH.2214, 10.1038/nmeth.2214]; von Diezmann A, 2017, CHEM REV, V117, P7244, DOI 10.1021/acs.chemrev.6b00629; Wang X, 2018, SCIENCE, V361, DOI 10.1126/science.aat5691; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zhang YD, 2017, P NATL ACAD SCI USA, V114, P6098, DOI 10.1073/pnas.1705823114; Zhong GS, 2014, ELIFE, V3, DOI 10.7554/eLife.04581	100	312	321	47	492	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					880	887		10.1126/science.aau1044	http://dx.doi.org/10.1126/science.aau1044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166485	Green Accepted			2022-12-28	WOS:000443547000029
J	Torjesen, I				Torjesen, Ingrid			Oncology trial authors don't fully disclose financial conflicts of interests, analysis finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Wayant C, 2018, JAMA ONCOL, V4, P1426, DOI 10.1001/jamaoncol.2018.3738	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2018	362								k3749	10.1136/bmj.k3749	http://dx.doi.org/10.1136/bmj.k3749			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5ZI	30166277				2022-12-28	WOS:000443758100020
J	Dyer, O				Dyer, Owen			Undiagnosed Chagas disease is causing sudden cardiac deaths, warns American Heart Association	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Navarro M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001962; Nunes MCP, 2018, CIRCULATION, V138, pE169, DOI 10.1161/CIR.0000000000000599	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2018	362								k3658	10.1136/bmj.k3658	http://dx.doi.org/10.1136/bmj.k3658			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5YZ	30154189				2022-12-28	WOS:000443756600007
J	Rimmer, A				Rimmer, Abi			Bawa-Garba case: GMC chief executive should resign, says consultants' union	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							MANSLAUGHTER											Dyer C, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3510; Dyer C, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k417; Dyer C, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2928; Dyer C, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5969; Kmietowicz Z, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2818	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2018	362								k3673	10.1136/bmj.k3673	http://dx.doi.org/10.1136/bmj.k3673			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5YZ	30154265				2022-12-28	WOS:000443756600010
J	Khan, MS; Hashmani, FN				Khan, Mishal S.; Hashmani, Farah N.			Political and technical barriers to improving quality of health care	LANCET			English	Editorial Material									[Khan, Mishal S.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1E 7HT, England; [Hashmani, Farah N.] Peoples Primary Healthcare Initiat, Karachi, Pakistan	University of London; London School of Hygiene & Tropical Medicine	Khan, MS (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1E 7HT, England.	mishal.khan@lshtm.ac.uk		Hashmani, Farah Naz/0000-0001-6055-4337				Chuc NTK, 1999, EUR J CLIN PHARMACOL, V55, P325, DOI 10.1007/s002280050636; Codlin AJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-331; Das J, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.2.93; Ghebreyesus TA, 2017, LANCET GLOB HEALTH, V5, pE839, DOI 10.1016/S2214-109X(17)30295-4; Hanefeld J, 2017, B WORLD HEALTH ORGAN, V95, P368, DOI [10.2471/BLT.16.179309, 10.2471/blt.16.179309]; Khan MS, 2015, HEALTH POLICY PLANN, V30, P1289, DOI 10.1093/heapol/czu137; Kruk ME, 2018, LANCET, V392, P2203, DOI [10.1016/S0140-6736(18)31668-4, 10.1016/s0140-6736(18)31668-4]; McPake B, 2016, LANCET, V388, P622, DOI 10.1016/S0140-6736(16)00344-5; Organization WH, 2018, DEL QUAL HLTH SERV G; Peters DH., 2013, IMPLEMENTATION RES H	10	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2018	392	10160					2146	2147		10.1016/S0140-6736(18)32075-0	http://dx.doi.org/10.1016/S0140-6736(18)32075-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HA5ZQ	30195399	hybrid, Green Accepted			2022-12-28	WOS:000450358900007
J	Parmet, WE; Berman, ML; Smith, JA				Parmet, Wendy E.; Berman, Micah L.; Smith, Jason A.			The Supreme Court's Crisis Pregnancy Center Case - Implications for Health Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Parmet, Wendy E.] Northeastern Univ, Sch Law, Boston, MA 02115 USA; [Berman, Micah L.] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Berman, Micah L.] Ohio State Univ, Moritz Coll Law, Columbus, OH 43210 USA; [Smith, Jason A.] Calif State Univ East Bay, Hayward, CA USA	Northeastern University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; California State University System; California State University East Bay	Parmet, WE (corresponding author), Northeastern Univ, Sch Law, Boston, MA 02115 USA.			Berman, Micah/0000-0002-0336-1317				Corbin C., 2014, WASH LEE LAW REV, V71, P1175; Haupt CB, 2016, YALE LAW J, V125, P1238	2	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2018	379	16					1489	1491		10.1056/NEJMp1809488	http://dx.doi.org/10.1056/NEJMp1809488			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX4EI	30156965				2022-12-28	WOS:000447679900001
J	Rehm, J; Ferreira-Borges, C				Rehm, Jurgen; Ferreira-Borges, Carina			Risk factor policies, morbidity, and mortality in Russia	LANCET			English	Editorial Material							ALCOHOL-CONSUMPTION; UNRECORDED ALCOHOL		[Rehm, Jurgen] Ctr Addict & Mental Hlth, WHO Collaborat Ctr, Toronto, ON M5S 2S1, Canada; [Rehm, Jurgen] Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, Toronto, ON M5S 2S1, Canada; [Rehm, Jurgen] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON M5S 2S1, Canada; [Rehm, Jurgen] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Rehm, Jurgen] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON, Canada; [Rehm, Jurgen] Univ Toronto, Fac Med, Addict Policy, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Jurgen] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany; [Rehm, Jurgen] Tech Univ Dresden, Ctr Clin Epidemiol & Longitudinal Studies CELOS, Dresden, Germany; [Ferreira-Borges, Carina] WHO European Off Prevent & Control Noncommunicabl, Moscow, Russia; [Ferreira-Borges, Carina] WHO Reg Off Europe, Moscow, Russia	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; Technische Universitat Dresden; Technische Universitat Dresden	Rehm, J (corresponding author), Ctr Addict & Mental Hlth, WHO Collaborat Ctr, Toronto, ON M5S 2S1, Canada.; Rehm, J (corresponding author), Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, Toronto, ON M5S 2S1, Canada.; Rehm, J (corresponding author), Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON M5S 2S1, Canada.; Rehm, J (corresponding author), Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada.; Rehm, J (corresponding author), Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON, Canada.; Rehm, J (corresponding author), Univ Toronto, Fac Med, Addict Policy, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Rehm, J (corresponding author), Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany.; Rehm, J (corresponding author), Tech Univ Dresden, Ctr Clin Epidemiol & Longitudinal Studies CELOS, Dresden, Germany.	jtrehm@gmail.com		Ferreira-Borges, Carina/0000-0003-2910-2572	WHO European Office for Prevention and Control of Non communicable diseases; Government of Russia	WHO European Office for Prevention and Control of Non communicable diseases; Government of Russia	We declare no competing interests. Part of the work of CF-B was financially supported by the WHO European Office for Prevention and Control of Non communicable diseases, which is in part supported by the Government of Russia.	Forouzanfar MH, 1990, GLOBAL BURDEN HYPERT; Nemtsov A., 2015, DEMOGRAFICHESKOE OBO, V2, P113; Neufeld M, 2018, INT J DRUG POLICY, V51, P1, DOI 10.1016/j.drugpo.2017.09.006; Neufeld M, 2013, ALCOHOL ALCOHOLISM, V48, P222, DOI 10.1093/alcalc/ags134; Rehm J, 2014, ADDICTION, V109, P880, DOI 10.1111/add.12498; Shield KD, 2016, TRENDS ALCOHOL CONSU; Starodubov VI, 2018, LANCET, V392, P1138, DOI 10.1016/S0140-6736(18)31485-5; WHO Regional Office Office for Europe, 2016, GLOB AD TOB SURV GAT; World Health Organization, 2017, TACKL NCDS BEST BUYS; World Health Organization, 2018, AIR POLL CHILD HLTH; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	11	4	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2018	392	10153					1094	1095		10.1016/S0140-6736(18)32043-9	http://dx.doi.org/10.1016/S0140-6736(18)32043-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV3BV	30173908	hybrid			2022-12-28	WOS:000445968800008
J	Lee, GK; Sheckter, CC				Lee, Gordon K.; Sheckter, Clifford C.			Breast Reconstruction Following Breast Cancer Treatment-2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lee, Gordon K.] Stanford Plast & Reconstruct Surg, 770 Welch Rd,Ste 400, Palo Alto, CA 94304 USA; [Sheckter, Clifford C.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Lee, GK (corresponding author), Stanford Plast & Reconstruct Surg, 770 Welch Rd,Ste 400, Palo Alto, CA 94304 USA.	glee@stanford.edu						Albornoz CR, 2013, PLAST RECONSTR SURG, V131, P15, DOI 10.1097/PRS.0b013e3182729cde; American Society of Plastic Surgeons, 2017, 2017 PLAST SURG STAT; de Boer M, 2018, JAMA ONCOL, V4, P335, DOI 10.1001/jamaoncol.2017.4510; Lee CNH, 2017, JAMA SURG, V152, P741, DOI 10.1001/jamasurg.2017.0977; Losken A, 2017, PLAST RECONSTR SURG, V139, DOI 10.1097/PRS.0000000000003226; Nelson JA, 2017, PLAST RECONSTR SURG, V140, p60S, DOI 10.1097/PRS.0000000000003943; Park SH, 2016, J BREAST CANCER, V19, P68, DOI 10.4048/jbc.2016.19.1.68; Santosa KB, 2018, JAMA SURG, V153, P891, DOI 10.1001/jamasurg.2018.1677	8	36	38	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2018	320	12					1277	1278		10.1001/jama.2018.12190	http://dx.doi.org/10.1001/jama.2018.12190			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU8GX	30178060				2022-12-28	WOS:000445577000020
J	Hinton, G				Hinton, Geoffrey			Deep Learning-A Technology With the Potential to Transform Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hinton, Geoffrey] Univ Toronto, Google Brain Team, 6 Kings Coll Rd, Toronto, ON M5S 1A1, Canada; [Hinton, Geoffrey] Univ Toronto, Dept Comp Sci, 6 Kings Coll Rd, Toronto, ON M5S 1A1, Canada	University of Toronto; University of Toronto	Hinton, G (corresponding author), Univ Toronto, Google Brain Team, 6 Kings Coll Rd, Toronto, ON M5S 1A1, Canada.; Hinton, G (corresponding author), Univ Toronto, Dept Comp Sci, 6 Kings Coll Rd, Toronto, ON M5S 1A1, Canada.	geoffrey.hinton@gmail.com						Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Naylor CD, 2018, JAMA-J AM MED ASSOC, V320, P1099, DOI 10.1001/jama.2018.11103; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0	7	269	270	4	64	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2018	320	11					1101	1102		10.1001/jama.2018.11100	http://dx.doi.org/10.1001/jama.2018.11100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT9QL	30178065				2022-12-28	WOS:000444878600007
J	Thompson, D; Zhu, LX; Mittapally, R; Sadat, S; Xing, Z; McArdle, P; Qazilbash, MM; Reddy, P; Meyhofer, E				Thompson, Dakotah; Zhu, Linxiao; Mittapally, Rohith; Sadat, Seid; Xing, Zhen; McArdle, Patrick; Qazilbash, M. Mumtaz; Reddy, Pramod; Meyhofer, Edgar			Hundred-fold enhancement in far-field radiative heat transfer over the blackbody limit	NATURE			English	Article							NANOSCALE GAPS; NEAR-FIELD	Radiative heat transfer (RHT) has a central role in entropy generation and energy transfer at length scales ranging from nanometres to light years(1). The blackbody limit(2), as established in Max Planck's theory of RHT, provides a convenient metric for quantifying rates of RHT because it represents the maximum possible rate of RHT between macroscopic objects in the far field-that is, at separations greater than Wien's wavelength(3). Recent experimental work has verified the feasibility of overcoming the blackbody limit in the near field(4-7), but heat-transfer rates exceeding the blackbody limit have not previously been demonstrated in the far field. Here we use custom-fabricated calorimetric nanostructures with embedded thermometers to show that RHT between planar membranes with sub-wavelength dimensions can exceed the blackbody limit in the far field by more than two orders of magnitude. The heat-transfer rates that we observe are in good agreement with calculations based on fluctuational electrodynamics. These findings may be directly relevant to various fields, such as energy conversion, atmospheric sciences and astrophysics, in which RHT is important.	[Thompson, Dakotah; Zhu, Linxiao; Mittapally, Rohith; Sadat, Seid; Reddy, Pramod; Meyhofer, Edgar] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Xing, Zhen; McArdle, Patrick; Qazilbash, M. Mumtaz] Coll William & Mary, Dept Phys, Williamsburg, VA 23185 USA; [Reddy, Pramod] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; William & Mary; University of Michigan System; University of Michigan	Reddy, P; Meyhofer, E (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.; Reddy, P (corresponding author), Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.	pramodr@umich.edu; meyhofer@umich.edu	Xing, Zhen/K-7411-2019	Xing, Zhen/0000-0002-6444-4204; Meyhofer, Edgar/0000-0001-5719-6030; Mittapally, Rohith/0000-0002-0784-1369	Office of Naval Research [N00014-16-1-2672]; Army Research Office [W911NF-18-1-0004]; Department of Energy Basic Energy Sciences [DE-SC0004871]; National Science Foundation [DMR-1255156]	Office of Naval Research(Office of Naval Research); Army Research Office; Department of Energy Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	P.R. and E.M. acknowledge support from the Office of Naval Research under award number N00014-16-1-2672 (device fabrication), from the Army Research Office under award number W911NF-18-1-0004 (computational modelling) and from Department of Energy Basic Energy Sciences under award number DE-SC0004871 (instrumentation for radiative measurements). M.M.Q. is grateful for support from the National Science Foundation under award number DMR-1255156 (characterization of dielectric functions). L.Z. thanks C.R. Otey for discussions. We acknowledge the Lurie Nanofabrication Facility for facilitating the fabrication of the devices and the Advanced Research Computing Technology Services at the University of Michigan for computational resources.	Au YY, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085402; Ben-Abdallah P, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.044301; Biehs SA, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.165405; Cataldo G, 2012, OPT LETT, V37, P4200, DOI 10.1364/OL.37.004200; Chandrasekhar S., 1950, Q J R METEOROLOG SOC; Draine BT, 1996, ASTROPHYS J, V470, P551, DOI 10.1086/177887; Fernandez-Hurtado V, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.045408; Golyk VA, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046603; Goody R.M., 1989, ATMOSPHERIC RAD THEO, Vsecond, DOI [10.1093/OSO/9780195051346.001.0001, DOI 10.1093/OSO/9780195051346.001.0001]; Guler U, 2014, SCIENCE, V344, P263, DOI 10.1126/science.1252722; Hochbaum AI, 2008, NATURE, V451, P163, DOI 10.1038/nature06381; KATTAWAR GW, 1970, APPL OPTICS, V9, P2685, DOI 10.1364/AO.9.002685; Kim K, 2015, NATURE, V528, P387, DOI 10.1038/nature16070; Kim P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.215502; Modest MF, 2013, RADIATIVE HEAT TRANSFER, 3RD EDITION, P1; Otey CR, 2014, J QUANT SPECTROSC RA, V132, P3, DOI 10.1016/j.jqsrt.2013.04.017; Otey CR, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.154301; Planck M., 1914, THEORY HEAT RAD; POLDER D, 1971, PHYS REV B, V4, P3303, DOI 10.1103/PhysRevB.4.3303; Raman AP, 2014, NATURE, V515, P540, DOI 10.1038/nature13883; Reid MTH, 2015, IEEE T ANTENN PROPAG, V63, P3588, DOI 10.1109/TAP.2015.2438393; REIPURTH B, 2007, PROTOSTARS PLANETS, V5; Rodriguez AW, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.220302; Rousseau E, 2009, NAT PHOTONICS, V3, P514, DOI 10.1038/NPHOTON.2009.144; Rytov S.M, 1987, PRINCIPLES STAT RADI; Sadat S, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802239; Sadat S, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3617473; Schuller JA, 2009, NAT PHOTONICS, V3, P658, DOI 10.1038/NPHOTON.2009.188; Shen S, 2009, NANO LETT, V9, P2909, DOI 10.1021/nl901208v; Song B, 2016, NAT NANOTECHNOL, V11, P509, DOI [10.1038/NNANO.2016.17, 10.1038/nnano.2016.17]; St-Gelais R, 2016, NAT NANOTECHNOL, V11, P515, DOI [10.1038/nnano.2016.20, 10.1038/NNANO.2016.20]; Wuttke C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.024301	32	62	62	4	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2018	561	7722					216	+		10.1038/s41586-018-0480-9	http://dx.doi.org/10.1038/s41586-018-0480-9			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT3XQ	30177825				2022-12-28	WOS:000444437900038
J	Danczak, GPA				Danczak, Avril G. P.			Breaking good news: an essential skill for avoiding too much medicine?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												avril.danczak@btinternet.com						BUCKMAN R, 1984, BRIT MED J, V288, P1597, DOI 10.1136/bmj.288.6430.1597; Danczak A, 2016, MAPPING UNCERTAINTY; Warraich HJ., BREAKING GOOD NEWS C	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2018	362								k3843	10.1136/bmj.k3843	http://dx.doi.org/10.1136/bmj.k3843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JF	30206143				2022-12-28	WOS:000445015700003
J	Dyer, O				Dyer, Owen			Leading US cancer researcher failed to disclose industry ties in dozens of articles	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Baselga Jose, 2013 8 CHRONOLOGICAL, DOI [10.1056/NEJMoa150230926287849, DOI 10.1056/NEJMOA150230926287849]; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Wayant C, 2018, JAMA ONCOL, DOI [10.1001/jamaoncol.2018.3738.30178024, DOI 10.1001/JAMAONCOL.2018.3738.30178024]	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2018	362								k3868	10.1136/bmj.k3868	http://dx.doi.org/10.1136/bmj.k3868			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JF	30206176				2022-12-28	WOS:000445015700005
J	Gupta, A; Cifu, AS; Khanna, S				Gupta, Arjun; Cifu, Adam S.; Khanna, Sahil			Diagnosis and Treatment of Clostridium difficile Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADULTS		[Gupta, Arjun] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Cifu, Adam S.] Univ Chicago, Dept Internal Med, Chicago, IL 60637 USA; [Khanna, Sahil] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Chicago; Mayo Clinic	Khanna, S (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.	khanna.sahil@mayo.edu			Premier Inc; Merck and Co; Facile Therapeutics; Pro Biotech LLC; Rebiotix Inc.	Premier Inc; Merck and Co(Merck & Company); Facile Therapeutics; Pro Biotech LLC; Rebiotix Inc.	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Khanna reports receipt of personal fees from Premier Inc, Merck and Co, Facile Therapeutics, and Pro Biotech LLC and a grant from Rebiotix Inc. No other disclosures were reported.	Abramowicz M, 2017, JAMA-J AM MED ASSOC, V318, P659, DOI 10.1001/jama.2017.10092; Bagdasarian N, 2015, JAMA-J AM MED ASSOC, V313, P398, DOI 10.1001/jama.2014.17103; Comely OA, 2012, CLIN INFECT DIS, V55, pS154, DOI 10.1093/cid/cis462; Gupta A, 2016, JAMA-J AM MED ASSOC, V316, P2422, DOI 10.1001/jama.2016.17173; Kao D, 2017, JAMA-J AM MED ASSOC, V318, P1985, DOI 10.1001/jama.2017.17077; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Ma GK, 2017, ANN INTERN MED, V167, P152, DOI [10.7326/M16-2733, 10.7326/m16-2733]; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/ciy149, 10.1093/cid/cix1085]	8	22	24	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2018	320	10					1031	1032		10.1001/jama.2018.12194	http://dx.doi.org/10.1001/jama.2018.12194			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT2QE	30178042				2022-12-28	WOS:000444341400018
J	Mayor, S				Mayor, Susan			NHS long term plan must tackle current challenges to set realistic targets, says NHS Providers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS Providers, 2018, 5 TESTS NHS LONG TER	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2018	362								k3853	10.1136/bmj.k3853	http://dx.doi.org/10.1136/bmj.k3853			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JC	30201739				2022-12-28	WOS:000445015400011
J	Li, Y; Kalnay, E; Motesharrei, S; Rivas, J; Kucharski, F; Kirk-Davidoff, D; Bach, E; Zeng, N				Li, Yan; Kalnay, Eugenia; Motesharrei, Safa; Rivas, Jorge; Kucharski, Fred; Kirk-Davidoff, Daniel; Bach, Eviatar; Zeng, Ning			Climate model shows large-scale wind and solar farms in the Sahara increase rain and vegetation	SCIENCE			English	Article							2 DEGREES-C; SAHEL RAINFALL; CO2 EMISSIONS; IMPACTS; VARIABILITY; TEMPERATURE; DYNAMICS; DROUGHT; RELIABILITY; ELECTRICITY	Wind and solar farms offer a major pathway to clean, renewable energies. However, these farms would significantly change land surface properties, and, if sufficiently large, the farms may lead to unintended climate consequences. In this study, we used a climate model with dynamic vegetation to show that large-scale installations of wind and solar farms covering the Sahara lead to a local temperature increase and more than a twofold precipitation increase, especially in the Sahel, through increased surface friction and reduced albedo. The resulting increase in vegetation further enhances precipitation, creating a positive albedo-precipitation-vegetation feedback that contributes similar to 80% of the precipitation increase for wind farms. This local enhancement is scale dependent and is particular to the Sahara, with small impacts in other deserts.	[Li, Yan; Kalnay, Eugenia; Motesharrei, Safa; Kirk-Davidoff, Daniel; Bach, Eviatar; Zeng, Ning] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA; [Li, Yan] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Li, Yan] Beijing Normal Univ, Fac Geog Sci, State Key Lab Earth Surface Proc & Resources Ecol, Beijing 100875, Peoples R China; [Kalnay, Eugenia; Motesharrei, Safa; Bach, Eviatar] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Motesharrei, Safa] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Kucharski, Fred] Abdus Salam Int Ctr Theoret Phys, Earth Syst Phys Sect, I-34100 Trieste, Italy; [Zeng, Ning] Chinese Acad Sci, LASG, Inst Atmospher Phys, Beijing 100029, Peoples R China	University System of Maryland; University of Maryland College Park; University of Illinois System; University of Illinois Urbana-Champaign; Beijing Normal University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Abdus Salam International Centre for Theoretical Physics (ICTP); Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS	Li, Y; Kalnay, E; Motesharrei, S (corresponding author), Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA.; Li, Y (corresponding author), Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA.; Li, Y (corresponding author), Beijing Normal Univ, Fac Geog Sci, State Key Lab Earth Surface Proc & Resources Ecol, Beijing 100875, Peoples R China.; Kalnay, E; Motesharrei, S (corresponding author), Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA.; Motesharrei, S (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	yanli.geo@gmail.com; ekalnay@umd.edu; ssm@iumd.edu	Li, Yan/C-3891-2016; Zeng, Ning/A-3130-2008; Bach, Eviatar/AAH-6201-2019	Li, Yan/0000-0002-6336-0981; Zeng, Ning/0000-0002-7489-7629; Bach, Eviatar/0000-0002-9725-0203; Mote, Safa/0000-0001-5905-3842; Kalnay, Eugenia/0000-0002-9984-9906	National Key R&D Program of China [2017YFA0604701];  [2956713]	National Key R&D Program of China; 	Y.L. acknowledges support from the National Key R&D Program of China (no. 2017YFA0604701). E.K. and S.M. acknowledge Lev Gandin funding (grant 2956713) provided by G. Brin.	Barthelmie RJ, 2014, NAT CLIM CHANGE, V4, P684, DOI [10.1038/NCLIMATE2269, 10.1038/nclimate2269]; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; CHARNEY J, 1977, J ATMOS SCI, V34, P1366, DOI 10.1175/1520-0469(1977)034<1366:ACSOTE>2.0.CO;2; CHARNEY JG, 1975, Q J ROY METEOR SOC, V101, P193, DOI 10.1002/qj.49710142802; Hernandez RR, 2014, RENEW SUST ENERG REV, V29, P766, DOI 10.1016/j.rser.2013.08.041; Hu AX, 2016, NAT CLIM CHANGE, V6, P290, DOI [10.1038/NCLIMATE2843, 10.1038/nclimate2843]; Jacobson MZ, 2015, P NATL ACAD SCI USA, V112, P15060, DOI 10.1073/pnas.1510028112; Jakob M, 2014, NAT CLIM CHANGE, V4, P961, DOI 10.1038/NCLIMATE2370; Keith DW, 2004, P NATL ACAD SCI USA, V101, P16115, DOI 10.1073/pnas.0406930101; Kucharski F, 2013, CLIM DYNAM, V40, P1453, DOI 10.1007/s00382-012-1397-x; Li Y., 2018, MODEL SIMULATION DAT, DOI [10.6084/m9.figshare.6662963, DOI 10.6084/M9.FIGSHARE.6662963]; Li Y, 2016, EARTH SYST DYNAM, V7, P167, DOI 10.5194/esd-7-167-2016; Lu X, 2009, P NATL ACAD SCI USA, V106, P10933, DOI 10.1073/pnas.0904101106; MacDonald AE, 2016, NAT CLIM CHANGE, V6, P526, DOI [10.1038/nclimate2921, 10.1038/NCLIMATE2921]; Marvel K, 2013, NAT CLIM CHANGE, V3, P118, DOI [10.1038/NCLIMATE1683, 10.1038/nclimate1683]; McGlade C, 2015, NATURE, V517, P187, DOI 10.1038/nature14016; Millar RJ, 2017, NAT GEOSCI, V10, P741, DOI 10.1038/NGEO3031; Miller LM, 2011, EARTH SYST DYNAM, V2, P1, DOI 10.5194/esd-2-1-2011; Millstein D, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034001; Motesharrei S, 2016, NATL SCI REV, V3, P470, DOI 10.1093/nsr/nww081; Roy SB, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004763; Roy SB, 2010, P NATL ACAD SCI USA, V107, P17899, DOI 10.1073/pnas.1000493107; Scaife AA, 2009, CLIM DYNAM, V33, P603, DOI 10.1007/s00382-008-0451-1; Seneviratne SI, 2016, NATURE, V529, P477, DOI 10.1038/nature16542; Shindell DT, 2016, NAT CLIM CHANGE, V6, P503, DOI [10.1038/nclimate2935, 10.1038/NCLIMATE2935]; SUD YC, 1985, BOUND-LAY METEOROL, V33, P15, DOI 10.1007/BF00137034; Taha H, 2013, SOL ENERGY, V91, P358, DOI 10.1016/j.solener.2012.09.014; Vautard R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4196; Wang C, 2010, ATMOS CHEM PHYS, V10, P2053, DOI 10.5194/acp-10-2053-2010; Wang GL, 2000, GEOPHYS RES LETT, V27, P795, DOI 10.1029/1999GL011089; Wang GL, 2000, WATER RESOUR RES, V36, P1013, DOI 10.1029/1999WR900361; Wu GC, 2017, P NATL ACAD SCI USA, V114, pE3004, DOI 10.1073/pnas.1611845114; Xue YK, 2016, CLIM DYNAM, V47, P3517, DOI 10.1007/s00382-016-3224-2; Zeng N, 1999, SCIENCE, V286, P1537, DOI 10.1126/science.286.5444.1537; Zeng N, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039699; Zhou LM, 2012, NAT CLIM CHANGE, V2, P539, DOI 10.1038/NCLIMATE1505	36	63	74	36	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					1019	1022		10.1126/science.aar5629	http://dx.doi.org/10.1126/science.aar5629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190404	Green Submitted			2022-12-28	WOS:000443892700047
J	Kumar, A; Wu, TY; Giraldo, F; Weiss, DS				Kumar, Aishwarya; Wu, Tsung-Yao; Giraldo, Felipe; Weiss, David S.			Sorting ultracold atoms in a three-dimensional optical lattice in a realization of Maxwell's demon	NATURE			English	Article							NEUTRAL ATOMS; ENTROPY	In 1872, Maxwell proposed his famous 'demon' thought experiment(1). By discerning which particles in a gas are hot and which are cold, and then performing a series of reversible actions, Maxwell's demon could rearrange the particles into a manifestly lower-entropy state. This apparent violation of the second law of thermodynamics was resolved by twentieth-century theoretical work(2): the entropy of the Universe is often increased while gathering information(3), and there is an unavoidable entropy increase associated with the demon's memory(4). The appeal of the thought experiment has led many real experiments to be framed as demon-like. However, past experiments had no intermediate information storage(5), yielded only a small change in the system entropy(6,7) or involved systems of four or fewer particles(8-10). Here we present an experiment that captures the full essence of Maxwell's thought experiment. We start with a randomly half-filled three-dimensional optical lattice with about 60 atoms. We make the atoms sufficiently vibrationally cold so that the initial disorder is the dominant entropy. After determining where the atoms are, we execute a series of reversible operations to create a fully filled sublattice, which is a manifestly low-entropy state. Our sorting process lowers the total entropy of the system by a factor of 2.44. This highly filled ultracold array could be used as the starting point for a neutral-atom quantum computer.	[Kumar, Aishwarya; Wu, Tsung-Yao; Giraldo, Felipe; Weiss, David S.] Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Weiss, DS (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.	dsweiss@phys.psu.edu	Weiss, David S/B-7886-2010; Kumar, Aishwarya/T-1294-2017	Kumar, Aishwarya/0000-0001-7787-6367	US National Science Foundation [PHY-1520976]	US National Science Foundation(National Science Foundation (NSF))	This work was supported by the US National Science Foundation through grant PHY-1520976.	ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Barredo D, 2018, NATURE, V561, P79, DOI 10.1038/s41586-018-0450-2; Barredo D, 2016, SCIENCE, V354, P1021, DOI 10.1126/science.aah3778; Bernien H, 2017, NATURE, V551, P579, DOI 10.1038/nature24622; BRILLOUIN L, 1951, J APPL PHYS, V22, P334, DOI 10.1063/1.1699951; CHU S, 1985, PHYS REV LETT, V55, P48, DOI 10.1103/PhysRevLett.55.48; Deutsch IH, 1998, PHYS REV A, V57, P1972, DOI 10.1103/PhysRevA.57.1972; Endres M, 2016, SCIENCE, V354, P1024, DOI 10.1126/science.aah3752; Gaunt AL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.200406; Hu JZ, 2017, SCIENCE, V358, P1078, DOI 10.1126/science.aan5614; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; Kaufman AM, 2015, NATURE, V527, P208, DOI 10.1038/nature16073; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13317; Labuhn H, 2016, NATURE, V534, P667, DOI 10.1038/nature18274; LANDAUER R, 1961, IBM J RES DEV, V5, P183, DOI 10.1147/rd.53.0183; Leff H., 1990, MAXWELLS DEMON ENTRO; Lester BJ, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.073003; Li X, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.103001; Maxwell J. C., 1871, THEORY HEAT; Nelson KD, 2007, NAT PHYS, V3, P556, DOI 10.1038/nphys645; Olshanii M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.090404; Price GN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093004; Robens C, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.065302; Saffman M, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/20/202001; Strasberg P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.040601; Szilard L, 1929, Z PHYS, V53, P840, DOI 10.1007/BF01341281; Vala J, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.032324; Wang Y, 2016, SCIENCE, V352, P1562, DOI 10.1126/science.aaf2581; Wang Y, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.043003; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614; Weiss DS, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.040302; Williams RA, 2008, OPT EXPRESS, V16, P16977, DOI 10.1364/OE.16.016977	34	77	77	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					83	+		10.1038/s41586-018-0458-7	http://dx.doi.org/10.1038/s41586-018-0458-7			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30185956	Green Submitted			2022-12-28	WOS:000443755200036
J	Hawkes, N				Hawkes, Nigel			Childhood leukaemia: Novartis immunotherapy drug approved after deal with NHS	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2018	362								k3799	10.1136/bmj.k3799	http://dx.doi.org/10.1136/bmj.k3799			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WB	30185629				2022-12-28	WOS:000444505300016
J	Cohen, J				Cohen, Jon			In dogs, CRISPR fixes a muscular dystrophy	SCIENCE			English	News Item																			0	5	5	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					835	835		10.1126/science.361.6405.835	http://dx.doi.org/10.1126/science.361.6405.835			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166469				2022-12-28	WOS:000443547000010
J	Iacobucci, G				Iacobucci, Gareth			NHS chief tells hospitals to send patients to private providers to cut waiting times	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Morris J., 2018, ACCESS WAITING TIMES	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2018	362								k3759	10.1136/bmj.k3759	http://dx.doi.org/10.1136/bmj.k3759			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5ZN	30171035				2022-12-28	WOS:000443758900005
J	Kaiser, J				Kaiser, Jocelyn			THE ALZHEIMER'S GAMBLE	SCIENCE			English	Editorial Material																			0	10	10	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					839	841		10.1126/science.361.6405.838	http://dx.doi.org/10.1126/science.361.6405.838			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166471				2022-12-28	WOS:000443547000012
J	Gorman, MP; Gombolay, GY; Mehan, WA; Thibert, RL				Gorman, Mark P.; Gombolay, Grace Y.; Mehan, William A., Jr.; Thibert, Ronald L.			Case 27-2018: A 3-Year-Old Boy with Seizures	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR ENCEPHALITIS; ETIOLOGIES		[Gorman, Mark P.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Gombolay, Grace Y.; Thibert, Ronald L.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Mehan, William A., Jr.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Thibert, Ronald L.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Gorman, Mark P.; Gombolay, Grace Y.; Thibert, Ronald L.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Mehan, William A., Jr.] Harvard Med Sch, Dept Radiol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gorman, MP (corresponding author), Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.; Gorman, MP (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.		Gombolay, Grace/AAR-6626-2021; Gombolay, Grace/GXH-9077-2022	Gombolay, Grace/0000-0003-4830-7792	CRICO; Ovid Therapeutics; Roche	CRICO; Ovid Therapeutics; Roche(Roche Holding)	Dr. Mehan reports receiving fees for expert testimony from CRICO; and Dr. Thibert, receiving consulting fees from Ovid Therapeutics and Roche. No other potential conflict of interest relevant to this article was reported.	Azizyan A, 2014, J RADIOL CASE REP, V8, P1, DOI 10.3941/jrcr.v8i8.1566; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Gable MS, 2009, EUR J CLIN MICROBIOL, V28, P1421, DOI 10.1007/s10096-009-0799-0; Gable MS, 2012, CLIN INFECT DIS, V54, P899, DOI 10.1093/cid/cir1038; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9; Iizuka T, 2010, J NEUROL, V257, P1686, DOI 10.1007/s00415-010-5604-6; Remy KE, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00250; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1	11	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2018	379	9					870	878		10.1056/NEJMcpc1802824	http://dx.doi.org/10.1056/NEJMcpc1802824			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR9EA	30157393				2022-12-28	WOS:000443047800012
J	Ram, J; Jinagal, J				Ram, Jagat; Jinagal, Jitender			Bitot's Spots	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ram, Jagat; Jinagal, Jitender] Post Grad Inst Med Educ & Res, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Ram, J (corresponding author), Post Grad Inst Med Educ & Res, Chandigarh, India.	drjagatram@gmail.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2018	379	9					869	869		10.1056/NEJMicm1715354	http://dx.doi.org/10.1056/NEJMicm1715354			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GR9EA	30157394				2022-12-28	WOS:000443047800010
J	Foks, KA; van den Brand, CL; Lingsma, HF; van der Naalt, J; Jacobs, B; de Jong, E; den Boogert, HF; Sir, O; Patka, P; Polinder, S; Gaakeer, MI; Schutte, CE; Jie, KE; Visee, HF; Hunink, MGM; Reijners, E; Braaksma, M; Schoonman, GG; Steyerberg, EW; Jellema, K; Dippel, DWJ				Foks, Kelly A.; van den Brand, Crispijn L.; Lingsma, Hester F.; van der Naalt, Joukje; Jacobs, Bram; de Jong, Eline; den Boogert, Hugo F.; Sir, Ozcan; Patka, Peter; Polinder, Suzanne; Gaakeer, Menno I.; Schutte, Charlotte E.; Jie, Kim E.; Visee, Huib F.; Hunink, Myriam G. M.; Reijners, Eef; Braaksma, Meriam; Schoonman, Guus G.; Steyerberg, Ewout W.; Jellema, Korne; Dippel, Diederik W. J.			External validation of computed tomography decision rules for minor head injury: prospective, multicentre cohort study in the Netherlands	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; INTRACRANIAL INJURY; METAANALYSIS; EPIDEMIOLOGY; MANAGEMENT; MORTALITY; ADULTS	OBJECTIVE To externally validate four commonly used rules in computed tomography (CT) for minor head injury. DESIGN Prospective, multicentre cohort study. SETTING Three university and six non-university hospitals in the Netherlands. PARTICIPANTS Consecutive adult patients aged 16 years and over who presented with minor head injury at the emergency department with a Glasgow coma scale score of 13-15 between March 2015 and December 2016. MAIN OUTCOME MEASURES The primary outcome was any intracranial traumatic finding on CT; the secondary outcome was a potential neurosurgical lesion on CT, which was defined as an intracranial traumatic finding on CT that could lead to a neurosurgical intervention or death. The sensitivity, specificity, and clinical usefulness (defined as net proportional benefit, a weighted sum of true positive classifications) of the four CT decision rules. The rules included the CT in head injury patients (CHIP) rule, New Orleans criteria (NOC), Canadian CT head rule CCHR), and National Institute for Health and Care Excellence (NICE) guideline for head injury. RESULTS For the primary analysis, only six centres that included patients with and without CT were selected. Of 4557 eligible patients who presented with minor head injury, 3742 (82%) received a CT scan; 384 (8%) had a intracranial traumatic finding on CT, and 74 (2%) had a potential neurosurgical lesion. The sensitivity for any intracranial traumatic finding on CT ranged from 73% (NICE) to 99% (NOC); specificity ranged from 4% (NOC) to 61% (NICE). Sensitivity for a potential neurosurgical lesion ranged between 85% (NICE) and 100% (NOC); specificity from 4% (NOC) to 59% (NICE). Clinical usefulness depended on thresholds for performing CT scanning: the NOC rule was preferable at a low threshold, the NICE rule was preferable at a higher threshold, whereas the CHIP rule was preferable for an intermediate threshold. CONCLUSIONS Application of the CHIP, NOC, CCHR, or NICE decision rules can lead to a wide variation in CT scanning among patients with minor head injury, resulting in many unnecessary CT scans and some missed intracranial traumatic findings. Until an existing decision rule has been updated, any of the four rules can be used for patients presenting minor head injuries at the emergency department. Use of the CHIP rule is recommended because it leads to a substantial reduction in CT scans while missing few potential neurosurgical lesions.	[Foks, Kelly A.; Lingsma, Hester F.; Polinder, Suzanne; Steyerberg, Ewout W.] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Foks, Kelly A.; Dippel, Diederik W. J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands; [van den Brand, Crispijn L.; de Jong, Eline] Haaglanden Med Ctr, Dept Emergency Med, The Hague, Netherlands; [van den Brand, Crispijn L.; Patka, Peter] Erasmus MC Univ Med Ctr Rotterdam, Dept Emergency Med, Rotterdam, Netherlands; [van der Naalt, Joukje; Jacobs, Bram] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [den Boogert, Hugo F.] Radboud Univ Nijmegen, Dept Neurosurg, Med Ctr, Nijmegen, Netherlands; [Sir, Ozcan] Radboud Univ Nijmegen, Dept Emergency Med, Med Ctr, Nijmegen, Netherlands; [Gaakeer, Menno I.; Schutte, Charlotte E.] Admiraal De Ruyter Hosp, Dept Emergency Med, Goes, Netherlands; [Jie, Kim E.] Jeroen Bosch Hosp, Dept Emergency Med, sHertogenbosch, Netherlands; [Visee, Huib F.] Jeroen Bosch Hosp, Dept Neurol, sHertogenbosch, Netherlands; [Hunink, Myriam G. M.] Erasmus MC Univ Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands; [Hunink, Myriam G. M.] Erasmus MC Univ Med Ctr Rotterdam, Dept Epidemiol, Rotterdam, Netherlands; [Hunink, Myriam G. M.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA; [Reijners, Eef] Elisabeth Tweesteden Hosp, Dept Emergency Med, Tilburg, Netherlands; [Braaksma, Meriam; Schoonman, Guus G.] Elisabeth Tweesteden Hosp, Dept Neurol, Tilburg, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [Jellema, Korne] Haaglanden Med Ctr, Dept Neurol, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Haaglanden Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Elisabeth-TweeSteden Ziekenhuis (ETZ); Elisabeth-TweeSteden Ziekenhuis (ETZ); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center	Foks, KA (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.; Foks, KA (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands.	k.foks@erasmusmc.nl	Boogert, Hugo F den/B-2782-2016; Dippel, Diederik/AAJ-2192-2020	Dippel, Diederik/0000-0002-9234-3515; van der Naalt, Joukje/0000-0001-9873-2418	St Jacobus Foundation	St Jacobus Foundation	This study did not receive any specific funding. CLvdB received a personal grant from the St Jacobus Foundation, which is a non-profit organisation that supports research; the funder played no role in the design, analysis, or presentation of the study.	af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Dunning J, 2004, J NEUROTRAUM, V21, P877, DOI 10.1089/0897715041526122; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hunink M, 2014, DECISION MAKING HLTH, DOI [10.1017/CBO9781139506779, DOI 10.1017/CB09781139506779]; Leard Statistics, 2018, COCHR Q TEST US SPSS; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; National Clinical Guideline C. National Clinical Guidance Centre, 2014, CG 176 HEAD INJ TRIA; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2016, J CLIN EPIDEMIOL, V69, P245, DOI 10.1016/j.jclinepi.2015.04.005; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sullivan TR, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0414-5; Van den Brand CL, 2018, EUR J EMERG MED, V25, P355, DOI 10.1097/MEJ.0000000000000457; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; Vickers AJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i6	31	34	35	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2018	362								k3527	10.1136/bmj.k3527	http://dx.doi.org/10.1136/bmj.k3527			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8SY	30143521	Green Published, hybrid			2022-12-28	WOS:000443000000002
J	Thiele, H; Akin, I; Sandri, M; de Waha-Thiele, S; Meyer-Saraei, R; Fuernau, G; Eitel, I; Nordbeck, P; Geisler, T; Landmesser, U; Skurk, C; Fach, A; Jobs, A; Lapp, H; Piek, JJ; Noc, M; Goslar, T; Felix, SB; Maier, LS; Stepinska, J; Oldroyd, K; Serpytis, P; Montalescot, G; Barthelemy, O; Huber, K; Windecker, S; Hunziker, L; Savonitto, S; Torremante, P; Vrints, C; Schneider, S; Zeymer, U; Desch, S				Thiele, H.; Akin, I.; Sandri, M.; de Waha-Thiele, S.; Meyer-Saraei, R.; Fuernau, G.; Eitel, I.; Nordbeck, P.; Geisler, T.; Landmesser, U.; Skurk, C.; Fach, A.; Jobs, A.; Lapp, H.; Piek, J. J.; Noc, M.; Goslar, T.; Felix, S. B.; Maier, L. S.; Stepinska, J.; Oldroyd, K.; Serpytis, P.; Montalescot, G.; Barthelemy, O.; Huber, K.; Windecker, S.; Hunziker, L.; Savonitto, S.; Torremante, P.; Vrints, C.; Schneider, S.; Zeymer, U.; Desch, S.		CULPRIT-SHOCK Investigators	One-Year Outcomes after PCI Strategies in Cardiogenic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; ST-SEGMENT ELEVATION; ONE-YEAR SURVIVAL; CULPRIT LESION; EARLY REVASCULARIZATION; ANGIOGRAPHIC FINDINGS; RANDOMIZED-TRIAL; OPEN-LABEL; MULTIVESSEL	BACKGROUND Among patients with acute myocardial infarction, cardiogenic shock, and multivessel coronary artery disease, the risk of a composite of death from any cause or severe renal failure leading to renal-replacement therapy at 30 days was found to be lower with percutaneous coronary intervention (PCI) of the culprit lesion only than with immediate multivessel PCI. We evaluated clinical outcomes at 1 year. METHODS We randomly assigned 706 patients to either culprit-lesion-only PCI or immediate multivessel PCI. The results for the primary end point of death or renal-replacement therapy at 30 days have been reported previously. Prespecified secondary end points at 1 year included death from any cause, recurrent myocardial infarction, repeat revascularization, rehospitalization for congestive heart failure, the composite of death or recurrent infarction, and the composite of death, recurrent infarction, or rehospitalization for heart failure. RESULTS As reported previously, at 30 days, the primary end point had occurred in 45.9% of the patients in the culprit-lesion-only PCI group and in 55.4% in the multivessel PCI group (P = 0.01). At 1 year, death had occurred in 172 of 344 patients (50.0%) in the culpritlesion-only PCI group and in 194 of 341 patients (56.9%) in the multivessel PCI group (relative risk, 0.88; 95% confidence interval [CI], 0.76 to 1.01). The rate of recurrent infarction was 1.7% with culprit-lesion-only PCI and 2.1% with multivessel PCI (relative risk, 0.85; 95% CI, 0.29 to 2.50), and the rate of a composite of death or recurrent infarction was 50.9% and 58.4%, respectively (relative risk, 0.87; 95% CI, 0.76 to 1.00). Repeat revascularization occurred more frequently with culprit-lesion-only PCI than with multivessel PCI (in 32.3% of the patients vs. 9.4%; relative risk, 3.44; 95% CI, 2.39 to 4.95), as did rehospitalization for heart failure (5.2% vs. 1.2%; relative risk, 4.46; 95% CI, 1.53 to 13.04). CONCLUSIONS Among patients with acute myocardial infarction and cardiogenic shock, the risk of death or renal-replacement therapy at 30 days was lower with culprit-lesion-only PCI than with immediate multivessel PCI, and mortality did not differ significantly between the two groups at 1 year of follow-up. (Funded by the European Union Seventh Framework Program and others; CULPRIT-SHOCK ClinicalTrials.gov number, NCT01927549.)	[Thiele, H.; Sandri, M.; Jobs, A.; Desch, S.] Univ Leipzig, Heart Ctr Leipzig, Leipzig, Germany; [Thiele, H.; Sandri, M.; Jobs, A.; Desch, S.] Leipzig Heart Inst, Leipzig, Germany; [Akin, I.] Univ Med Mannheim, Mannheim, Germany; [de Waha-Thiele, S.; Meyer-Saraei, R.; Fuernau, G.; Eitel, I.] Univ Heart Ctr Lubeck, Lubeck, Germany; [Akin, I.; de Waha-Thiele, S.; Meyer-Saraei, R.; Fuernau, G.; Eitel, I.; Landmesser, U.; Skurk, C.; Jobs, A.; Felix, S. B.; Desch, S.] German Ctr Cardiovasc Res, Berlin, Germany; [Landmesser, U.; Skurk, C.] Univ Klinikum Charite, Campus Benjamin Franklin, Berlin, Germany; [Nordbeck, P.] Univ Klinikum Wurzburg, Wurzburg, Germany; [Geisler, T.] Klinikum Eberhard Karls Univ Tubingen, Tubingen, Germany; [Fach, A.] Klinikum Links der Weser, Bremen, Germany; [Lapp, H.] Helios Klin Erfurt, Erfurt, Germany; [Felix, S. B.] Ernst Moritz Arndt Univ, Greifswald, Germany; [Maier, L. S.] Univ Herzzentrum Regensburg, Regensburg, Germany; [Schneider, S.; Zeymer, U.] Inst Herzinfarktforsch, Ludwigshafen, Germany; [Zeymer, U.] Klinikum Ludwigshafen, Ludwigshafen, Germany; [Piek, J. J.] Acad Med Ctr, Amsterdam, Netherlands; [Noc, M.; Goslar, T.] Univ Med Ctr Ljubljana, Ljubljana, Slovenia; [Stepinska, J.] Inst Cardiol, Warsaw, Poland; [Oldroyd, K.] Golden Jubilee Natl Hosp, Glasgow, Lanark, Scotland; [Serpytis, P.] Vilnius Univ, Vilnius Univ Hosp Santaros Klin, Vilnius, Lithuania; [Serpytis, P.] Vilnius Univ, Fac Med, Vilnius, Lithuania; [Montalescot, G.; Barthelemy, O.] Sorbonne Univ Paris 6, ACTION Study Grp, Ctr Hosp Univ Pitie Salpetriere, Paris, France; [Torremante, P.] Soc Act Simplifiee, Ind Collaborat, Appl Res, Technol Transfer, Paris, France; [Huber, K.] Wilhelminenpital, Dept Cardiol, Vienna, Austria; [Huber, K.] Sigmund Freud Univ, Sch Med, Vienna, Austria; [Windecker, S.; Hunziker, L.] Univ Bern, Inselspital Bern, Dept Cardiol, Bern, Switzerland; [Savonitto, S.] Manzoni Hosp, Lecce, Italy; [Vrints, C.] Univ Ziekenhuis Antwerp, Antwerp, Belgium	Heart Center Leipzig GMBH; Leipzig University; Heart Center Leipzig GMBH; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helios Kliniken; Ernst Moritz Arndt Universitat Greifswald; Institute Heart Attack Research; Ludwigshafen Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University Medical Centre Ljubljana; Institute of Cardiology - Poland; Golden Jubilee Hospital; Vilnius University; Vilnius University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Wilhelminenspital; University of Bern; University Hospital of Bern; University of Antwerp	Thiele, H (corresponding author), Univ Leipzig, Heart Ctr Leipzig, Dept Internal Med Cardiol, Strumpellstr 39, D-04289 Leipzig, Germany.	holger.thiele@medizin.uni-leipzig.de	Geisler, Tobias/AAO-4472-2020; Akin, Ibrahim/AAF-1356-2020; Fuernau, Georg/HCI-4640-2022; Thiele, Holger/ABE-6792-2020; Mamas, Mamas Andreas/A-2549-2019; Fuernau, Georg/T-8798-2017; van Geuns, Robert-Jan M/N-7976-2017; Milewski, Krzysztof/W-9701-2018; Jeger, Raban/ABG-1678-2021; Goslar, Tomaž/GXZ-9182-2022; Nordbeck, Peter/D-4771-2018; Zaruba, Marc-Michael/AAI-8571-2020; Maier, Lars/AAQ-8313-2021	Fuernau, Georg/0000-0002-3813-8772; Thiele, Holger/0000-0002-0169-998X; Mamas, Mamas Andreas/0000-0001-9241-8890; Fuernau, Georg/0000-0002-3813-8772; van Geuns, Robert-Jan M/0000-0003-2943-5932; Milewski, Krzysztof/0000-0001-7976-3323; Jeger, Raban/0000-0003-1290-5491; Nordbeck, Peter/0000-0002-2560-4068; Zaruba, Marc-Michael/0000-0003-1074-5463; Maier, Lars/0000-0001-9915-4429; Piek, Jan/0000-0001-8666-7129; CARRIE, didier/0000-0003-2479-8144; Goslar, Tomaz/0000-0001-9051-2074; Ferrari, Markus/0000-0003-3986-1943	European Union Seventh Framework Program	European Union Seventh Framework Program(European Commission)	Funded by the European Union Seventh Framework Program and others; CULPRIT-SHOCK ClinicalTrials. gov number, NCT01927549	de Waha S, 2018, EUR HEART J-ACUTE CA, V7, P28, DOI 10.1177/2048872617719640; Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1; Gershlick AH, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.117.006020; Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190; Hochman JS, 2007, JAMA-J AM MED ASSOC, V297, P1657; Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511; Ibanez B, 2018, EUR HEART J, V39, P4239, DOI 10.1093/eurheartj/ehy294; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Kolte D, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.117.005582; Lee JM, 2018, J AM COLL CARDIOL, V71, P844, DOI 10.1016/j.jacc.2017.12.028; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Neumann F-J, 2018, EUR HEART J; Patel MR, 2017, J AM COLL CARDIOL, V69, P570, DOI 10.1016/j.jacc.2016.10.034; Sanborn TA, 2003, J AM COLL CARDIOL, V42, P1373, DOI 10.1016/S0735-1097(03)01051-9; Smits PC, 2017, NEW ENGL J MED, V376, P1234, DOI 10.1056/NEJMoa1701067; Thiele H, 2017, NEW ENGL J MED, V377, P2419, DOI 10.1056/NEJMoa1710261; Thiele H, 2018, CIRCULATION, V137, P1314, DOI 10.1161/CIRCULATIONAHA.117.032907; Thiele H, 2016, AM HEART J, V172, P160, DOI 10.1016/j.ahj.2015.11.006; Thiele H, 2015, EUR HEART J, V36, P1223, DOI 10.1093/eurheartj/ehv051; Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Webb JG, 2003, J AM COLL CARDIOL, V42, P1380, DOI 10.1016/S0735-1097(03)01050-7; Wong SC, 2000, J AM COLL CARDIOL, V36, P1077, DOI 10.1016/S0735-1097(00)00873-1	26	199	211	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2018	379	18					1699	1710		10.1056/NEJMoa1808788	http://dx.doi.org/10.1056/NEJMoa1808788			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8OL	30145971	Green Accepted			2022-12-28	WOS:000448891600005
J	Ren, J; Friedmann, D; Xiong, J; Liu, CD; Ferguson, BR; Weerakkody, T; DeLoach, KE; Ran, C; Pun, A; Sun, YW; Weissbourd, B; Neve, RL; Huguenard, J; Horowitz, MA; Luo, LQ				Ren, Jing; Friedmann, Drew; Xiong, Jing; Liu, Cindy D.; Ferguson, Brielle R.; Weerakkody, Tanya; DeLoach, Katherine E.; Ran, Chen; Pun, Albert; Sun, Yanwen; Weissbourd, Brandon; Neve, Rachael L.; Huguenard, John; Horowitz, Mark A.; Luo, Liqun			Anatomically Defined and Functionally Distinct Dorsal Raphe Serotonin Sub-systems	CELL			English	Article							ASCENDING PROJECTIONS; CELL-BODIES; NEURONS; ANXIETY; ACTIVATION; GLUTAMATE; CIRCUITS; NUCLEUS; 5-HT; ORGANIZATION	The dorsal raphe (DR) constitutes a major serotonergic input to the forebrain and modulates diverse functions and brain states, including mood, anxiety, and sensory and motor functions. Most functional studies to date have treated DR serotonin neurons as a single population. Using viral-genetic methods, we found that subcortical- and cortical-projecting serotonin neurons have distinct cell-body distributions within the DR and differentially co-express a vesicular glutamate transporter. Further, amygdala- and frontal-cortex-projecting DR serotonin neurons have largely complementary whole-brain collateralization patterns, receive biased inputs from presynaptic partners, and exhibit opposite responses to aversive stimuli. Gain- and loss-of-function experiments suggest that amygdala-projecting DR serotonin neurons promote anxiety-like behavior, whereas frontal-cortex-projecting neurons promote active coping in the face of challenge. These results provide compelling evidence that the DR serotonin system contains parallel sub-systems that differ in input and output connectivity, physiological response properties, and behavioral functions.	[Ren, Jing; Friedmann, Drew; Liu, Cindy D.; DeLoach, Katherine E.; Ran, Chen; Pun, Albert; Weissbourd, Brandon; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Ren, Jing; Friedmann, Drew; Liu, Cindy D.; DeLoach, Katherine E.; Ran, Chen; Pun, Albert; Weissbourd, Brandon; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Xiong, Jing; Horowitz, Mark A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Ferguson, Brielle R.; Weerakkody, Tanya; Huguenard, John] Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Sun, Yanwen] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Neve, Rachael L.] Massachusetts Gen Hosp, Delivery Technol Core, Cambridge, MA 02139 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Harvard University; Massachusetts General Hospital	Luo, LQ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu	Xiong, Jing/AAB-3856-2021; Huguenard, John/I-5016-2012; Core, Vector/CAF-4832-2022; Huguenard, John/K-6429-2019; Ren, Jing/ABA-8444-2020	Xiong, Jing/0000-0002-9856-2022; Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Ren, Jing/0000-0002-6665-7457; Ran, Chen/0000-0002-6632-2366; Luo, Liqun/0000-0001-5467-9264	National Institutes of Health [R01 NS104698]; National Science Foundation (NeuroNex); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007280, R01NS034774, R01NS104698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NeuroNex)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Adams and M. Tessier-Lavigne for advice on iDISCO<SUP>+</SUP>; T. David-son and K. Deisseroth for advice on fiber photometry; E. Steinberg and R. Mal-enka for advice on behavior; Q. Wu for Tph2<SUP>flox/flox</SUP> mice; A. Karpova for the AAV<INF>retro</INF> vector; Stanford, Salk, and UNC Viral Core for viruses; Allen Institute for the reference atlas and T. Gilbert for the advice on its use; M. Chen for code files for data analysis; K. Beier and G. Nachtrab for sharing AAVs; S. Bell for advice on 2D registration; and R. Malenka, A. Mizrahi, A. Shuster, L. DeNardo, J. Lui, M. Wagner, and W. Allen for critiques on the manuscript. This work was supported by BRAIN initiative grants from National Institutes of Health (R01 NS104698) and National Science Foundation (NeuroNex). L.L. is an HHMI investigator.	Abrams JK, 2004, ANN NY ACAD SCI, V1018, P46, DOI 10.1196/annals.1296.005; Albert PR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00199; Allen Brain Atlas, 2017, PROJ ALL BRAIN ATL M; Allen Institute for Brain Science, 2015, ALL BRAIN ATL API; Allen WE, 2017, SCIENCE, V357, P1149, DOI 10.1126/science.aan6747; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Beier KT, 2017, NATURE, V549, P345, DOI 10.1038/nature23888; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1038/nrdp.2016.65; Calhoon GG, 2015, NAT NEUROSCI, V18, P1394, DOI 10.1038/nn.4101; Calizo LH, 2011, NEUROPHARMACOLOGY, V61, P524, DOI 10.1016/j.neuropharm.2011.04.008; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cohen JY, 2015, ELIFE, V4, DOI 10.7554/eLife.06346; Commons KG, 2015, J COMP NEUROL, V523, P1488, DOI 10.1002/cne.23748; Correia PA, 2017, ELIFE, V6, DOI 10.7554/eLife.20975; Dayan P, 2015, ELIFE, V4, DOI 10.7554/eLife.07390; Do-Monte FH, 2015, NATURE, V519, P460, DOI 10.1038/nature14030; Dorocic IP, 2014, NEURON, V83, P663, DOI 10.1016/j.neuron.2014.07.002; Fonseca MS, 2015, CURR BIOL, V25, P306, DOI 10.1016/j.cub.2014.12.002; Franklin K.B.J., 2013, PAXINOS FRANKLINS MO; Gagnon D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087709; Gomez JL, 2017, SCIENCE, V357, P503, DOI 10.1126/science.aan2475; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gras C, 2002, J NEUROSCI, V22, P5442; Grimes WN, 2011, VISUAL NEUROSCI, V28, P381, DOI 10.1017/S0952523811000290; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; ISHIMURA K, 1988, NEUROSCI LETT, V91, P265, DOI 10.1016/0304-3940(88)90691-X; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Li Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10503; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Lowry CA, 2005, STRESS, V8, P233, DOI 10.1080/10253890500492787; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Makinson CD, 2017, NEURON, V93, P1165, DOI 10.1016/j.neuron.2017.01.031; Marcinkiewcz CA, 2016, NATURE, V537, P97, DOI 10.1038/nature19318; MELTZER HY, 1994, J CLIN PSYCHIAT, V55, P47; Miyazaki KW, 2012, J NEUROSCI, V32, P10451, DOI 10.1523/JNEUROSCI.0915-12.2012; Muller CP., 2010, HDB BEHAV NEUROBIOLO; Muzerelle A, 2016, BRAIN STRUCT FUNCT, V221, P535, DOI 10.1007/s00429-014-0924-4; Neve RL, 2005, BIOTECHNIQUES, V39, P381, DOI 10.2144/05393PS01; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; Niederkofler V, 2016, CELL REP, V17, P1934, DOI 10.1016/j.celrep.2016.10.063; Ogawa SK, 2014, CELL REP, V8, P1105, DOI 10.1016/j.celrep.2014.06.042; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Okaty BW, 2015, NEURON, V88, P774, DOI 10.1016/j.neuron.2015.10.007; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Prouty EW, 2017, BRAIN RES, V1675, P28, DOI 10.1016/j.brainres.2017.08.031; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ren J, 2011, NEURON, V69, P445, DOI 10.1016/j.neuron.2010.12.038; Renier N, 2016, CELL, V165, P1789, DOI 10.1016/j.cell.2016.05.007; Schwarz LA, 2015, NATURE, V524, P88, DOI 10.1038/nature14600; Sengupta A, 2017, J NEUROSCI, V37, P1785, DOI 10.1523/JNEUROSCI.2238-16.2016; Shamonin DP, 2014, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00050; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Teissier A, 2015, CELL REP, V13, P1965, DOI 10.1016/j.celrep.2015.10.061; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Urban DJ, 2016, NEUROPSYCHOPHARMACOL, V41, P1404, DOI 10.1038/npp.2015.293; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Waselus M, 2011, J CHEM NEUROANAT, V41, P266, DOI 10.1016/j.jchemneu.2011.05.011; Weissbourd B, 2014, NEURON, V83, P645, DOI 10.1016/j.neuron.2014.06.024; Whitney MS, 2016, J NEUROSCI, V36, P9828, DOI 10.1523/JNEUROSCI.1469-16.2016; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; World Health Organization (WHO), 2017, DEPRESSION; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Xiong J, 2018, BIORXIV, DOI [10.1101/357475, DOI 10.1101/357475]	71	159	162	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 4	2018	175	2					472	+		10.1016/j.cell.2018.07.043	http://dx.doi.org/10.1016/j.cell.2018.07.043			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GV7PQ	30146164	Green Accepted, Bronze			2022-12-28	WOS:000446321300018
J	Josephson, SA; Kamel, H				Josephson, S. Andrew; Kamel, Hooman			The Acute Stroke Care Revolution Enhancing Access to Therapeutic Advances	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ENDOVASCULAR THROMBECTOMY; ISCHEMIC-STROKE; TIME; METAANALYSIS		[Josephson, S. Andrew] Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave,Box 0114, San Francisco, CA 94143 USA; [Josephson, S. Andrew] Univ Calif San Francisco, Weill Inst Neurosci, 505 Parnassus Ave,Box 0114, San Francisco, CA 94143 USA; [Kamel, Hooman] Weill Cornell Med, Feil Family Brain & Mind Res Inst, Clin & Translat Neurosci Unit, New York, NY USA; [Kamel, Hooman] Weill Cornell Med, Dept Neurol, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cornell University; Cornell University	Josephson, SA (corresponding author), Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave,Box 0114, San Francisco, CA 94143 USA.; Josephson, SA (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, 505 Parnassus Ave,Box 0114, San Francisco, CA 94143 USA.	Andrew.Josephson@ucsf.edu	Kamel, Hooman/AGG-9071-2022					Albers GW, 2018, NEW ENGL J MED, V378, P708, DOI 10.1056/NEJMoa1713973; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Jadhav AP, 2018, STROKE, V49, P1015, DOI 10.1161/STROKEAHA.117.020273; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab	8	21	22	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2018	320	12					1239	1240		10.1001/jama.2018.11122	http://dx.doi.org/10.1001/jama.2018.11122			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU8GX	30208486				2022-12-28	WOS:000445577000011
J	Capodanno, D; Angiolillo, DJ				Capodanno, Davide; Angiolillo, Dominick J.			Aspirin for primary prevention of cardiovascular disease	LANCET			English	Editorial Material									[Capodanno, Davide] AOU Policlin Vittorio Emanuele, Div Cardiol, PO Rodol, I-95123 Catania, Sicily, Italy; [Angiolillo, Dominick J.] Univ Florida, Jacksonville, FL USA	Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; State University System of Florida; University of Florida	Capodanno, D (corresponding author), AOU Policlin Vittorio Emanuele, Div Cardiol, PO Rodol, I-95123 Catania, Sicily, Italy.	dcapodanno@gmail.com	Capodanno, Davide/AAP-4949-2020		NCATS NIH HHS [UL1 TR000064] Funding Source: Medline; NIH HHS [UL1 HG007269] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Bothwell PM, 2018, LANCET, V392, P387, DOI [10.1016/s0140-6736(18)31133-4, 10.1016/S0140-6736(18)31133-4]; Capodanno D, 2016, CIRCULATION, V134, P1579, DOI 10.1161/CIRCULATIONAHA.116.023164; Capodanno D, 2011, CIRC-CARDIOVASC INTE, V4, P180, DOI 10.1161/CIRCINTERVENTIONS.110.960187; Gaziano JM, 2018, LANCET, V392, P1036, DOI 10.1016/S0140-6736(18)31924-X; Guirguis-Blake JM, 2016, ANN INTERN MED, V164, P804, DOI 10.7326/M15-2113; Patrignani P, 2016, J AM COLL CARDIOL, V68, P967, DOI 10.1016/j.jacc.2016.05.083; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Whitlock EP, 2016, ANN INTERN MED, V164, P826, DOI 10.7326/M15-2112	10	12	13	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2018	392	10152					988	990		10.1016/S0140-6736(18)31990-1	http://dx.doi.org/10.1016/S0140-6736(18)31990-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GU2KP	30158070				2022-12-28	WOS:000445098800005
J	Maurer, MS; Schwartz, JH; Gundapaneni, B; Elliott, PM; Merlini, G; Waddington-Cruz, M; Kristen, AV; Grogan, M; Witteles, R; Damy, T; Drachman, BM; Shah, SJ; Hanna, M; Judge, DP; Barsdorf, AI; Huber, P; Patterson, TA; Riley, S; Schumacher, J; Stewart, M; Sultan, MB; Rapezzi, C				Maurer, Mathew S.; Schwartz, Jeffrey H.; Gundapaneni, Balarama; Elliott, Perry M.; Merlini, Giampaolo; Waddington-Cruz, Marcia; Kristen, Arnt V.; Grogan, Martha; Witteles, Ronald; Damy, Thibaud; Drachman, Brian M.; Shah, Sanjiv J.; Hanna, Mazen; Judge, Daniel P.; Barsdorf, Alexandra I.; Huber, Peter; Patterson, Terrell A.; Riley, Steven; Schumacher, Jennifer; Stewart, Michelle; Sultan, Marla B.; Rapezzi, Claudio		ATTR-ACT Study Investigators	Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TTR-CARDIAC AMYLOIDOSIS; HEART-FAILURE; CLINICAL-TRIALS; SCINTIGRAPHY; DIAGNOSIS; DISEASE; POLYNEUROPATHY; MULTICENTER; PROGRESSION; PHENOTYPE	BACKGROUND Transthyretin amyloid cardiomyopathy is caused by the deposition of transthyretin amyloid fibrils in the myocardium. The deposition occurs when wild-type or variant transthyretin becomes unstable and misfolds. Tafamidis binds to transthyretin, preventing tetramer dissociation and amyloidogenesis. METHODS In a multicenter, international, double-blind, placebo-controlled, phase 3 trial, we randomly assigned 441 patients with transthyretin amyloid cardiomyopathy in a 2:1:2 ratio to receive 80 mg of tafamidis, 20 mg of tafamidis, or placebo for 30 months. In the primary analysis, we hierarchically assessed all-cause mortality, followed by frequency of cardiovascular-related hospitalizations according to the Finkelstein-Schoenfeld method. Key secondary end points were the change from baseline to month 30 for the 6-minute walk test and the score on the Kansas City Cardiomyopathy Questionnaire-Overall Summary (KCCQ-OS), in which higher scores indicate better health status. RESULTS In the primary analysis, all-cause mortality and rates of cardiovascular-related hospitalizations were lower among the 264 patients who received tafamidis than among the 177 patients who received placebo (P<0.001). Tafamidis was associated with lower all-cause mortality than placebo (78 of 264 (29.5%) vs. 76 of 177 (42.9%); hazard ratio, 0.70; 95% confidence interval (CI), 0.51 to 0.96) and a lower rate of cardiovascular-related hospitalizations, with a relative risk ratio of 0.68 (0.48 per year vs. 0.70 per year; 95% CI, 0.56 to 0.81). At month 30, tafamidis was also associated with a lower rate of decline in distance for the 6-minute walk test (P<0.001) and a lower rate of decline in KCCQ-OS score (P<0.001). The incidence and types of adverse events were similar in the two groups. CONCLUSIONS In patients with transthyretin amyloid cardiomyopathy, tafamidis was associated with reductions in all-cause mortality and cardiovascular-related hospitalizations and reduced the decline in functional capacity and quality of life as compared with placebo.	[Maurer, Mathew S.] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Schwartz, Jeffrey H.; Barsdorf, Alexandra I.; Huber, Peter; Schumacher, Jennifer; Sultan, Marla B.] Pfizer, New York, NY USA; [Gundapaneni, Balarama] Syneos Hlth, Raleigh, NC USA; [Elliott, Perry M.] UCL, London, England; [Elliott, Perry M.] St Bartholomews Hosp, London, England; [Merlini, Giampaolo] Ist Ricovero & Cura Carattere Sci Policlin, Amyloidosis Ctr, Pavia, Italy; [Merlini, Giampaolo] Univ Pavia, Pavia, Italy; [Rapezzi, Claudio] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Waddington-Cruz, Marcia] Univ Fed Rio de Janeiro, Amyloidosis Ctr CEPARM, Rio De Janeiro, Brazil; [Kristen, Arnt V.] Med Univ Heidelberg, Amyloidosis Ctr, Heidelberg, Germany; [Grogan, Martha] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA; [Witteles, Ronald] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Damy, Thibaud] GRC Amyloid Res Inst, French Referral Ctr Cardiac Amyloidosis, Amyloidosis Mondor Network, Creteil, France; [Damy, Thibaud] CHU Henri Mondor, AP HP, Dept Cardiol, Creteil, France; [Damy, Thibaud] INSERM, Unite 955, Clin Invest Ctr 006, Creteil, France; [Damy, Thibaud] DHU ATVB, Creteil, France; [Drachman, Brian M.] Univ Penn Hlth Syst, Penn Presbyterian Med Ctr, Philadelphia, PA USA; [Shah, Sanjiv J.] Northwestern Univ, Dept Med, Div Cardiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Hanna, Mazen] Cleveland Clin, Cleveland, OH 44106 USA; [Judge, Daniel P.] Med Univ South Carolina, Charleston, SC 29425 USA; [Patterson, Terrell A.; Riley, Steven; Stewart, Michelle] Pfizer, Groton, CT USA	Columbia University; Pfizer; University of London; University College London; University of London; Queen Mary University London; University of Pavia; University of Bologna; Universidade Federal do Rio de Janeiro; Ruprecht Karls University Heidelberg; Mayo Clinic; Stanford University; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Presbyterian Medical Center; Northwestern University; Feinberg School of Medicine; Cleveland Clinic Foundation; Medical University of South Carolina; Pfizer	Maurer, MS (corresponding author), Columbia Univ, Irving Med Ctr, 622 W 168th St,PH 12 Stem Rm 134, New York, NY 10032 USA.	msm10@cumc.columbia.edu	Elliott, Perry/AAR-3430-2020; Barriales-Villa, Roberto/AAC-6889-2020; Merlini, Giampaolo/A-3817-2008; Shah, Sanjiv J./AFQ-9480-2022; LOPEZ, ANGELA/AAF-6630-2021; cappelli, Francesco/AAJ-1725-2020; Pascual-Figal, Domingo/B-3794-2008; Gallego-Delgado, Maria/E-1593-2018; Perlini, Stefano/E-2670-2012	Elliott, Perry/0000-0003-3383-3984; Barriales-Villa, Roberto/0000-0002-6721-3487; Merlini, Giampaolo/0000-0001-7680-3254; LOPEZ, ANGELA/0000-0001-7433-2137; cappelli, Francesco/0000-0002-1622-0732; Pascual-Figal, Domingo/0000-0002-4993-9540; Samad, Zainab/0000-0003-2422-3199; Gopalan, Radha/0000-0002-3024-3762; Riley, Steve/0000-0003-2440-5830; Gallego-Delgado, Maria/0000-0003-0726-9646; Judge, Daniel/0000-0002-3407-0248; Zucker, Mark/0000-0002-2999-0146; Plante Bordeneuve, Violaine/0000-0002-7880-2316; spini, valentina/0000-0002-3332-0778; Kobashigawa, Jon/0000-0001-9308-3172; Shah, Sanjiv/0000-0002-5655-8201; Mereles, Derliz/0000-0001-9601-7103; Perlini, Stefano/0000-0002-0320-8574	Pfizer	Pfizer(Pfizer)	Supported by Pfizer. Preparatory support for the formatting and submission of the article for publication was provided by Joshua Fink, Ph.D., of Engage Scientific Solutions and funded by Pfizer; no contribution was made to editorial content.	BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Bokhari S, 2013, CIRC-CARDIOVASC IMAG, V6, P195, DOI 10.1161/CIRCIMAGING.112.000132; Castano A, 2017, EUR HEART J, V38, P2879, DOI 10.1093/eurheartj/ehx350; Castano A, 2016, JAMA CARDIOL, V1, P880, DOI 10.1001/jamacardio.2016.2839; Castano A, 2015, HEART FAIL REV, V20, P163, DOI 10.1007/s10741-014-9462-7; Coelho T, 2016, NEUROL THER, V5, P1, DOI 10.1007/s40120-016-0040-x; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Damy T, 2016, EUR HEART J, V37, P1826, DOI 10.1093/eurheartj/ehv583; Finkelstein DM, 1999, STAT MED, V18, P1341, DOI 10.1002/(SICI)1097-0258(19990615)18:11&lt;1341::AID-SIM129&gt;3.0.CO;2-7; Galat A, 2015, AMYLOID, V22, P210, DOI 10.3109/13506129.2015.1072089; Gillmore JD, 2017, EUR HEART J; Gillmore JD, 2016, CIRCULATION, V133, P2404, DOI 10.1161/CIRCULATIONAHA.116.021612; Glaudemans AWJM, 2014, AMYLOID, V21, P35, DOI 10.3109/13506129.2013.871250; Gonzalez-Lopez E, 2015, EUR HEART J, V36, P2585, DOI 10.1093/eurheartj/ehv338; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Groenning BA, 2000, J AM COLL CARDIOL, V36, P2072, DOI 10.1016/S0735-1097(00)01006-8; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Haq M, 2017, JACC-CARDIOVASC IMAG, V10, P713, DOI 10.1016/j.jcmg.2016.06.003; Keohane D, 2017, AMYLOID, V24, P30, DOI 10.1080/13506129.2017.1301419; KONSTAM MA, 1992, CIRCULATION, V86, P431, DOI 10.1161/01.CIR.86.2.431; Maurer MS, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003815; Maurer MS, 2016, J AM COLL CARDIOL, V68, P161, DOI 10.1016/j.jacc.2016.03.596; Maurer MS, 2015, CIRC-HEART FAIL, V8, P519, DOI 10.1161/CIRCHEARTFAILURE.113.000890; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Pocock SJ, 2012, EUR HEART J, V33, P176, DOI 10.1093/eurheartj/ehr352; Rapezzi C, 2010, NAT REV CARDIOL, V7, P398, DOI 10.1038/nrcardio.2010.67; Rosenblum H, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004769; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Solomon SD, 2010, CIRCULATION, V122, P985, DOI 10.1161/CIRCULATIONAHA.110.955039; Sultan MB, 2017, CLIN MED INSIGHTS-CA, V11, DOI 10.1177/1179546817730322; Wolfinger R D, 1997, J Biopharm Stat, V7, P481, DOI 10.1080/10543409708835203	33	966	989	5	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					1007	1016		10.1056/NEJMoa1805689	http://dx.doi.org/10.1056/NEJMoa1805689			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4UV	30145929	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000444501600005
J	Collins, ME; Rum, SA; Sugarman, J				Collins, Megan E.; Rum, Steven A.; Sugarman, Jeremy			Navigating the Ethical Boundaries of Grateful Patient Fundraising	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHILANTHROPY		[Collins, Megan E.; Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Deering Hall 203,1809 Ashland Ave, Baltimore, MD 21205 USA; [Collins, Megan E.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Rum, Steven A.] Johns Hopkins Med Philanthropy Inst, Baltimore, MD USA; [Sugarman, Jeremy] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Sugarman, J (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Deering Hall 203,1809 Ashland Ave, Baltimore, MD 21205 USA.	jsugarman@jhu.edu		Sugarman, Jeremy/0000-0001-7022-8332	Johns Hopkins Medicine Philanthropy Institute; Association for Healthcare Philanthropy; Merck KGaA (Bioethics Advisory Panel and Stem Cell Research Oversight Committee); IQVIA Ethics Advisory Panel	Johns Hopkins Medicine Philanthropy Institute; Association for Healthcare Philanthropy; Merck KGaA (Bioethics Advisory Panel and Stem Cell Research Oversight Committee); IQVIA Ethics Advisory Panel	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. The authors reported that Johns Hopkins Medicine Philanthropy Institute and the Association for Healthcare Philanthropy provided funds to support a Summit on the Ethics of Grateful Patient Fundraising in June 2018. Dr Sugarman reported receiving personal fees and other support from Merck KGaA (Bioethics Advisory Panel and Stem Cell Research Oversight Committee) and IQVIA Ethics Advisory Panel.	Association for Health Care Philanthropy (AHP), 2017, 2017 AHP REP GIV FY; Collins M, ETHICAL ISSUES RECOM, DOI [10.1097/ACM.0000000000002355, DOI 10.1097/ACM.0000000000002355]; Council on Ethical and Judicial Affairs, 2004, 7A04 CEJA AM MED ASS; Konrath SH, 2014, WELLBEING COMPLETE R, V6; Rum SA, 2016, J CLIN ONCOL, V34, P1423, DOI 10.1200/JCO.2015.65.3394; Tackett S, 2016, HEALTHCARE PHILANTHR, P12; Walter JK, 2015, J CLIN ONCOL, V33, P3796, DOI 10.1200/JCO.2015.62.6804; Wright SM, 2013, J GEN INTERN MED, V28, P645, DOI 10.1007/s11606-012-2246-7	8	6	6	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2018	320	10					975	976		10.1001/jama.2018.11655	http://dx.doi.org/10.1001/jama.2018.11655			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT2QE	30178043				2022-12-28	WOS:000444341400008
J	Iacobucci, G				Iacobucci, Gareth			Hancock's digital revolution	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mayor S, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3844; NHS England, GLOB DIG EX	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2018	362								k3861	10.1136/bmj.k3861	http://dx.doi.org/10.1136/bmj.k3861			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JC	30201605				2022-12-28	WOS:000445015400013
J	Ho, HH; Ong, PJL				Ho, Hee Hwa; Ong, Paul Jau Lueng			BASKET-SMALL 2: advancing DCB beyond in-stent restenosis	LANCET			English	Editorial Material							PACLITAXEL-COATED BALLOON; SMALL CORONARY VESSELS; DRUG-ELUTING STENT; MULTICENTER		[Ho, Hee Hwa; Ong, Paul Jau Lueng] Tan Tock Seng Hosp, Dept Cardiol, Singapore 308433, Singapore	Tan Tock Seng Hospital	Ho, HH (corresponding author), Tan Tock Seng Hosp, Dept Cardiol, Singapore 308433, Singapore.	hee_hwa_ho@ttsh.com.sg						Akiyama T, 1998, J AM COLL CARDIOL, V32, P1610, DOI 10.1016/S0735-1097(98)00444-6; Cortese B, 2010, HEART, V96, P1291, DOI 10.1136/hrt.2010.195057; HUBER MS, 1991, AM J CARDIOL, V68, P467, DOI 10.1016/0002-9149(91)90780-O; Jeger RV, 2018, LANCET, DOI [10.1016/10.1016/S0140-6736(18)31719-7, DOI 10.1016/10.1016/S0140-6736(18)31719-7]; Kleber FX, 2013, CLIN RES CARDIOL, V102, P785, DOI 10.1007/s00392-013-0609-7; Latib A, 2012, J AM COLL CARDIOL, V60, P2473, DOI 10.1016/j.jacc.2012.09.020; Rittger H, 2012, J AM COLL CARDIOL, V59, P1377, DOI 10.1016/j.jacc.2012.01.015; Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254; Unverdorben M, 2010, CLIN RES CARDIOL, V99, P165, DOI 10.1007/s00392-009-0101-6; Unverdorben M, 2009, CIRCULATION, V119, P2986, DOI 10.1161/CIRCULATIONAHA.108.839282; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Zeymer U, 2014, HEART, V100, P311, DOI 10.1136/heartjnl-2013-304881	12	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2018	392	10150					802	804		10.1016/S0140-6736(18)31926-3	http://dx.doi.org/10.1016/S0140-6736(18)31926-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT0KV	30170851				2022-12-28	WOS:000444130000008
J	Bayer, EA; Hobert, O				Bayer, Emily A.; Hobert, Oliver			Past experience shapes sexually dimorphic neuronal wiring through monoaminergic signalling	NATURE			English	Article							CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; SEROTONIN; BEHAVIOR; RECEPTORS; MODULATION; OCTOPAMINE; RESPONSES; SYNAPSES; CIRCUIT	Differences between female and male brains exist across the animal kingdom and extend from molecular to anatomical features. Here we show that sexually dimorphic anatomy, gene expression and function in the nervous system can be modulated by past experiences. In the nematode Caenorhabditis elegans, sexual differentiation entails the sex-specific pruning of synaptic connections between neurons that are shared by both sexes, giving rise to sexually dimorphic circuits in adult animals(1). We discovered that starvation during juvenile stages is memorized in males to suppress the emergence of sexually dimorphic synaptic connectivity. These circuit changes result in increased chemosensory responsiveness in adult males following juvenile starvation. We find that an octopamine-mediated starvation signal dampens the production of serotonin (5-HT) to convey the memory of starvation. Serotonin production is monitored by a 5-HT1A serotonin receptor homologue that acts cell-autonomously to promote the pruning of sexually dimorphic synaptic connectivity under well-fed conditions. Our studies demonstrate how life history shapes neurotransmitter production, synaptic connectivity and behavioural output in a sexually dimorphic circuit.	[Bayer, Emily A.; Hobert, Oliver] Columbia Univ, Dept Biol Sci, Howard Hughes Med Inst, New York, NY 10027 USA	Columbia University; Howard Hughes Medical Institute	Hobert, O (corresponding author), Columbia Univ, Dept Biol Sci, Howard Hughes Med Inst, New York, NY 10027 USA.	or38@columbia.edu		Bayer, Emily/0000-0002-5254-9199	NIH [R37NS039996, F31NS096863]; HHMI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS096863, R01NS039996, R37NS039996] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Q. Chen for generating transgenic strains, K. Ashrafi for providing DNA constructs, the CGC (supported by the NIH P40 OD010440) for strains and members of the Hobert laboratory, I. Greenwald, and M. Oren-Suissa for comments on the manuscript. This work was supported by the HHMI and NIH (R37NS039996, O.H., F31NS096863, E.A.B.).	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Barr MM, 2018, GENETICS, V208, P909, DOI 10.1534/genetics.117.300294; BRENNER S, 1974, GENETICS, V77, P71; Carre-Pierrat Maite, 2006, Invertebrate Neuroscience, V6, P189, DOI 10.1007/s10158-006-0033-z; Churgin MA, 2017, J NEUROSCI, V37, P7811, DOI [10.1523/JNEUROSCI.2636-16.2017, 10.1523/jneurosci.2636-16.2017]; Desbois M, 2015, GENETICS, V200, P697, DOI 10.1534/genetics.115.177006; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Goldstein JL, 2011, COLD SH Q B, V76, P121, DOI 10.1101/sqb.2011.76.010447; Gurel G, 2012, GENETICS, V192, P1359, DOI 10.1534/genetics.112.142125; Harris G, 2010, J NEUROSCI, V30, P7889, DOI 10.1523/JNEUROSCI.0497-10.2010; Harris GP, 2009, J NEUROSCI, V29, P1446, DOI 10.1523/JNEUROSCI.4585-08.2009; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Houwing DJ, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00117; Jafari G, 2011, J NEUROSCI, V31, P8948, DOI 10.1523/JNEUROSCI.1692-11.2011; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Ji Ni, 2012, WormBook, P1, DOI 10.1895/wormbook.1.153.1; Lajud N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00003; Liang B, 2006, CELL METAB, V4, P429, DOI 10.1016/j.cmet.2006.11.004; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Noble T, 2013, CELL METAB, V18, P672, DOI 10.1016/j.cmet.2013.09.007; Oren-Suissa M, 2016, NATURE, V533, P206, DOI 10.1038/nature17977; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; Sherlekar AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060597; Tao J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501372; Van den Hove D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022715; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang FF, 2014, DEVELOPMENT, V141, P422, DOI 10.1242/dev.099721; Zheng XW, 2005, DEV BIOL, V286, P618, DOI 10.1016/j.ydbio.2005.08.013	29	17	17	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					117	+		10.1038/s41586-018-0452-0	http://dx.doi.org/10.1038/s41586-018-0452-0			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30150774	Green Accepted			2022-12-28	WOS:000443755200043
J	Falcon, B; Zhang, WJ; Murzin, AG; Murshudov, G; Garringer, HJ; Vidal, R; Crowther, RA; Ghetti, B; Scheres, SHW; Goedert, M				Falcon, Benjamin; Zhang, Wenjuan; Murzin, Alexey G.; Murshudov, Garib; Garringer, Holly J.; Vidal, Ruben; Crowther, R. Anthony; Ghetti, Bernardino; Scheres, Sjors H. W.; Goedert, Michel			Structures of filaments from Pick's disease reveal a novel tau protein fold	NATURE			English	Article							MICROTUBULE-ASSOCIATED-PROTEIN; PAIRED HELICAL FILAMENTS; ALZHEIMERS; DEMENTIA; BRAINS; TAUOPATHIES; ISOFORM; FIBRILS; STRAINS; NEURONS	The ordered assembly of tau protein into abnormal filamentous inclusions underlies many human neurodegenerative diseases(1). Tau assemblies seem to spread through specific neural networks in each disease(2), with short filaments having the greatest seeding activity(3). The abundance of tau inclusions strongly correlates with disease symptoms(4). Six tau isoforms are expressed in the normal adult human brain-three isoforms with four microtubule-binding repeats each (4R tau) and three isoforms that lack the second repeat (3R tau) 1. In various diseases, tau filaments can be composed of either 3R or 4R tau, or of both. Tau filaments have distinct cellular and neuroanatomical distributions(5), with morphological and biochemical differences suggesting that they may be able to adopt disease-specific molecular conformations(6,7). Such conformers may give rise to different neuropathological phenotypes(8,9), reminiscent of prion strains(10). However, the underlying structures are not known. Using electron cryo-microscopy, we recently reported the structures of tau filaments from patients with Alzheimer's disease, which contain both 3R and 4R tau(11). Here we determine the structures of tau filaments from patients with Pick's disease, a neurodegenerative disorder characterized by frontotemporal dementia. The filaments consist of residues Lys254-Phe378 of 3R tau, which are folded differently from the tau filaments in Alzheimer's disease, establishing the existence of conformers of assembled tau. The observed tau fold in the filaments of patients with Pick's disease explains the selective incorporation of 3R tau in Pick bodies, and the differences in phosphorylation relative to the tau filaments of Alzheimer's disease. Our findings show how tau can adopt distinct folds in the human brain in different diseases, an essential step for understanding the formation and propagation of molecular conformers.	[Falcon, Benjamin; Zhang, Wenjuan; Murzin, Alexey G.; Murshudov, Garib; Crowther, R. Anthony; Scheres, Sjors H. W.; Goedert, Michel] MRC Lab Mol Biol, Cambridge, England; [Garringer, Holly J.; Vidal, Ruben; Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	MRC Laboratory Molecular Biology; Indiana University System; Indiana University Bloomington	Scheres, SHW; Goedert, M (corresponding author), MRC Lab Mol Biol, Cambridge, England.	scheres@mrc-lmb.cam.ac.uk; mg@mrc-lmb.cam.ac.uk	Scheres, Sjors H.W./AAY-2265-2021	Scheres, Sjors H.W./0000-0002-0462-6540; Ryskeldi-Falcon, Benjamin/0000-0002-8176-2618; Zhang, Wenjuan/0000-0002-3011-9956	UK Medical Research Council [MC_UP_A025_1012, MC_UP_A025_1013, MC_U105184291]; European Union (Joint Programme-Neurodegeneration Research REfrAME); European Union (Innovative Medicines Initiative 2 IMPRiND) [115881]; US National Institutes of Health [P30-AG010133]; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine; Alzheimer's Association Zenith Award; MRC [MC_UP_A025_1012, MC_U105192716] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [P30AG010133] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union (Joint Programme-Neurodegeneration Research REfrAME); European Union (Innovative Medicines Initiative 2 IMPRiND); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology and Laboratory Medicine, Indiana University School of Medicine; Alzheimer's Association Zenith Award(Alzheimer's Association); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the patients' families for donating brain tissue; M. R. Farlow for clinical evaluation; F. Epperson, R. M. Richardson and U. Kuederli for human brain collection and analysis; P. Davies, P. Seubert and M. Hasegawa for antibodies MC1, 12E8 and TauC4, respectively; S. Chen, C. Savva and G. Cannone for support with electron microscopy; T. Darling and J. Grimmett for help with computing; W. W. Seeley and M. G. Spillantini for discussions. M.G. is an Honorary Professor in the Department of Clinical Neurosciences of the University of Cambridge. This work was supported by the UK Medical Research Council (MC_UP_A025_1012 to G.M., MC_UP_A025_1013 to S.H.W.S. and MC_U105184291 to M.G.), the European Union (Joint Programme-Neurodegeneration Research REfrAME to M.G. and B.F. and the Innovative Medicines Initiative 2 IMPRiND, project number 115881, to M.G.), the US National Institutes of Health (grant P30-AG010133 to B.G.), the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (to B.G.) and an Alzheimer's Association Zenith Award (to R.V.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Braak H, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023630; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; Delacourte A, 1996, J NEUROPATH EXP NEUR, V55, P159, DOI 10.1097/00005072-199602000-00004; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Farlow JL, 2016, JAMA NEUROL, V73, P68, DOI 10.1001/jamaneurol.2015.3266; Fernandez-Leiro R, 2016, NATURE, V537, P339, DOI 10.1038/nature19948; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00070; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; Miki Y, 2014, NEUROPATHOLOGY, V34, P386, DOI 10.1111/neup.12104; Munoz DG, 2011, NEURODEGENERATION MO, P156, DOI DOI 10.1002/9781444341256.CH16; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; POLLOCK NJ, 1986, LANCET, V2, P1211; Probst A, 1996, ACTA NEUROPATHOL, V92, P588, DOI 10.1007/s004010050565; RASOOL CG, 1985, NEW ENGL J MED, V312, P700, DOI 10.1056/NEJM198503143121107; REWCASTLE NB, 1968, NEUROLOGY, V18, P1205, DOI 10.1212/WNL.18.12.1205; Saijo E, 2017, ACTA NEUROPATHOL, V133, P751, DOI 10.1007/s00401-017-1692-z; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SCHOCHET SS, 1968, ACTA NEUROPATHOL, V11, P330, DOI 10.1007/BF00686729; Seeley WW, 2006, ANN NEUROL, V60, P660, DOI 10.1002/ana.21055; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Spina S, 2008, BRAIN, V131, P72, DOI 10.1093/brain/awm280; Taniguchi-Watanabe S, 2016, ACTA NEUROPATHOL, V131, P267, DOI 10.1007/s00401-015-1503-3; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISNIEWSKI HM, 1972, ARCH NEUROL-CHICAGO, V26, P97, DOI 10.1001/archneur.1972.00490080015001; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	48	396	397	10	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					137	+		10.1038/s41586-018-0454-y	http://dx.doi.org/10.1038/s41586-018-0454-y			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30158706	Green Submitted, Green Accepted			2022-12-28	WOS:000443755200047
J	Li, JJ; Pan, CP; Zhang, S; Spin, JM; Deng, A; Leung, LLK; Dalman, RL; Tsao, PS; Snyder, M				Li, Jingjing; Pan, Cuiping; Zhang, Sai; Spin, Joshua M.; Deng, Alicia; Leung, Lawrence L. K.; Dalman, Ronald L.; Tsao, Philip S.; Snyder, Michael			Decoding the Genomics of Abdominal Aortic Aneurysm	CELL			English	Article							WIDE ASSOCIATION; DISEASE; METAANALYSIS; CHALLENGES; VARIANTS; INSIGHTS; MICE	A key aspect of genomic medicine is to make individualized clinical decisions from personal genomes. We developed a machine-learning framework to integrate personal genomes and electronic health record (EHR) data and used this framework to study abdominal aortic aneurysm (AAA), a prevalent irreversible cardiovascular disease with unclear etiology. Performing whole-genome sequencing on AAA patients and controls, we demonstrated its predictive precision solely from personal genomes. By modeling personal genomes with EHRs, this framework quantitatively assessed the effectiveness of adjusting personal lifestyles given personal genome baselines, demonstrating its utility as a personal health management tool. We showed that this new framework agnostically identified genetic components involved in AAA, which were subsequently validated in human aortic tissues and in murine models. Our study presents a new framework for disease genome analysis, which can be used for both health management and understanding the biological architecture of complex diseases.	[Li, Jingjing; Pan, Cuiping; Zhang, Sai; Snyder, Michael] Stanford Univ, Sch Med, Ctr Genom & Personalized Med, Dept Genet, Stanford, CA 94305 USA; [Li, Jingjing] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Pan, Cuiping; Spin, Joshua M.; Deng, Alicia; Leung, Lawrence L. K.; Tsao, Philip S.] VA Palo Alto Hlth Care Syst, VA Palo Alto Epidemiol Res & Informat Ctr Genom, Palo Alto, CA 94304 USA; [Spin, Joshua M.; Deng, Alicia; Leung, Lawrence L. K.; Tsao, Philip S.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Dalman, Ronald L.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Li, Jingjing; Pan, Cuiping; Zhang, Sai; Spin, Joshua M.; Deng, Alicia; Leung, Lawrence L. K.; Dalman, Ronald L.; Tsao, Philip S.; Snyder, Michael] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University	Snyder, M (corresponding author), Stanford Univ, Sch Med, Ctr Genom & Personalized Med, Dept Genet, Stanford, CA 94305 USA.; Tsao, PS (corresponding author), VA Palo Alto Hlth Care Syst, VA Palo Alto Epidemiol Res & Informat Ctr Genom, Palo Alto, CA 94304 USA.; Tsao, PS (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.; Tsao, PS; Snyder, M (corresponding author), Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.	ptsao@stanford.edu; mpsnyder@stanford.edu		Pan, Cuiping/0000-0002-8152-2489; Snyder, Michael/0000-0003-0784-7987; Spin, Joshua/0000-0002-4256-9161	NIH [CEGS 5P50HG00773504, 1P50HL083800, 1R01HL101388, 1R01-HL122939, S10OD020141]; University of California [TRDRP 26IP-0041]; Veterans Affairs Office of Research and Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); Veterans Affairs Office of Research and Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the anonymous reviewers for all the constructive comments. We acknowledge the Stanford Genetics Bioinformatics Service Center for providing computational infrastructure for this study. This work was supported by research grants from the NIH (CEGS 5P50HG00773504, 1P50HL083800, 1R01HL101388, 1R01-HL122939, and S10OD020141), the University of California (TRDRP 26IP-0041), and the Veterans Affairs Office of Research and Development.	Aggarwal S, 2011, EXP CLIN CARDIOL, V16, P11; Auer PL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0138-2; Betz HH, 2015, J PHYS ACT HEALTH, V12, P376, DOI 10.1123/jpah.2013-0124; Biros E, 2015, ONCOTARGET, V6, P12984, DOI 10.18632/oncotarget.3848; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Bown MJ, 2014, ANN ROY COLL SURG, V96, P405, DOI 10.1308/003588414X13946184901560; Bradley DT, 2016, EUR J VASC ENDOVASC, V51, P64, DOI 10.1016/j.ejvs.2015.09.006; Brangsch J, 2017, TRENDS MOL MED, V23, P150, DOI 10.1016/j.molmed.2016.12.002; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Cho H, 2016, CELL SYST, V3, P540, DOI 10.1016/j.cels.2016.10.017; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Deuse T, 2014, NATURE, V509, P641, DOI 10.1038/nature13232; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Golledge J, 2007, CIRCULATION, V116, P2275, DOI 10.1161/CIRCULATIONAHA.107.717926; Hernandez-Camacho JD, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00044; Hinterseher I, 2011, ANN VASC SURG, V25, P388, DOI 10.1016/j.avsg.2010.09.004; Hobbs SD, 2003, EUR J VASC ENDOVASC, V26, P618, DOI 10.1016/S1078-5884(03)00412-X; Jones GT, 2017, CIRC RES, V120, P341, DOI 10.1161/CIRCRESAHA.116.308765; Kanazawa S, 2005, J CARDIOVASC SURG, V46, P273; Kuivaniemi H, 2008, CIRCULATION, V117, P242, DOI 10.1161/CIRCULATIONAHA.107.690982; Lelieveld SH, 2015, HUM MUTAT, V36, P815, DOI 10.1002/humu.22813; Li JJ, 2015, CELL SYST, V1, P361, DOI 10.1016/j.cels.2015.11.002; Li JJ, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145487; Maegdefessel L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6214; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maxim LD, 2014, INHAL TOXICOL, V26, P811, DOI 10.3109/08958378.2014.955932; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; MENASHI S, 1987, J VASC SURG, V6, P578, DOI 10.1067/mva.1987.avs0060578; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Moxon JV, 2010, CURR PROB CARDIOLOGY, V35, P512, DOI 10.1016/j.cpcardiol.2010.08.004; Myers J, 2014, J AGING PHYS ACTIV, V22, P87, DOI 10.1123/japa.2012-0133; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Pan CP, 2017, BIOINFORMATICS, V33, P3709, DOI 10.1093/bioinformatics/btx468; Pearce WH, 2008, CIRCULATION, V118, P2860, DOI 10.1161/CIRCULATIONAHA.108.191176; Pincemail J, 2012, REDOX REP, V17, P139, DOI 10.1179/1351000212Y.0000000012; Snyder M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.32; Spin JM, 2011, PHYSIOL GENOMICS, V43, P993, DOI 10.1152/physiolgenomics.00044.2011; Stackelberg O, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004725; Stefely JA, 2017, TRENDS BIOCHEM SCI, V42, P824, DOI 10.1016/j.tibs.2017.06.008; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Tedesco MM, 2009, ARTERIOSCL THROM VAS, V29, P1452, DOI 10.1161/ATVBAHA.109.187757; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Torsney E, 2012, ARTERIOSCL THROM VAS, V32, P2678, DOI 10.1161/ATVBAHA.112.00009; Wahlgren CM, 2010, J VASC SURG, V51, P3, DOI 10.1016/j.jvs.2009.08.036; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	49	40	41	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1361	+		10.1016/j.cell.2018.07.021	http://dx.doi.org/10.1016/j.cell.2018.07.021			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193110	Bronze			2022-12-28	WOS:000443841000008
J	Ghaffari, S; Pourafkari, L				Ghaffari, Samad; Pourafkari, Leili			Koilonychia in Iron-Deficiency Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ghaffari, Samad; Pourafkari, Leili] Tabriz Univ Med Sci, Tabriz, Iran	Tabriz University of Medical Science	Pourafkari, L (corresponding author), Tabriz Univ Med Sci, Tabriz, Iran.	leili.p@gmail.com		Ghaffari, Samad/0000-0001-6806-9387					0	3	3	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2018	379	9					E13	E13		10.1056/NEJMicm1802104	http://dx.doi.org/10.1056/NEJMicm1802104			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GR9EA	30157401				2022-12-28	WOS:000443047800011
J	Mahlangu, J; Oldenburg, J; Paz-Priel, I; Negrier, C; Niggli, M; Mancuso, ME; Schmitt, C; Jimenez-Yuste, V; Kempton, C; Dhalluin, C; Callaghan, MU; Bujan, W; Shima, M; Adamkewicz, JI; Asikanius, E; Levy, GG; Kruse-Jarres, R				Mahlangu, J.; Oldenburg, J.; Paz-Priel, I.; Negrier, C.; Niggli, M.; Mancuso, M. E.; Schmitt, C.; Jimenez-Yuste, V.; Kempton, C.; Dhalluin, C.; Callaghan, M. U.; Bujan, W.; Shima, M.; Adamkewicz, J. I.; Asikanius, E.; Levy, G. G.; Kruse-Jarres, R.			Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BISPECIFIC ANTIBODY; THERAPY; BURDEN	BACKGROUND Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. In a phase 3, multicenter trial, we investigated its use as prophylaxis in persons who have hemophilia A without factor VIII inhibitors. METHODS We randomly assigned, in a 2: 2: 1 ratio, participants 12 years of age or older who had been receiving episodic treatment with factor VIII to receive a subcutaneous maintenance dose of emicizumab of 1.5 mg per kilogram of body weight per week (group A) or 3.0 mg per kilogram every 2 weeks (group B) or no prophylaxis (group C). The primary end point was the difference in rates of treated bleeding (group A vs. group C and group B vs. group C). Participants who had been receiving factor VIII prophylaxis received emicizumab at a maintenance dose of 1.5 mg per kilogram per week (group D); intraindividual comparisons were performed in those who had participated in a noninterventional study. RESULTS A total of 152 participants were enrolled. The annualized bleeding rate was 1.5 events (95% confidence interval [CI], 0.9 to 2.5) in group A and 1.3 events (95% CI, 0.8 to 2.3) in group B, as compared with 38.2 events (95% CI, 22.9 to 63.8) in group C; thus, the rate was 96% lower in group A and 97% lower in group B (P<0.001 for both comparisons). A total of 56% of the participants in group A and 60% of those in group B had no treated bleeding events, as compared with those in group C, who all had treated bleeding events. In the intraindividual comparison involving 48 participants, emicizumab prophylaxis resulted in an annualized bleeding rate that was 68% lower than the rate with previous factor VIII prophylaxis (P<0.001). The most frequent adverse event was low-grade injection-site reaction. There were no thrombotic or thrombotic microangiopathy events, development of antidrug antibodies, or new development of factor VIII inhibitors. CONCLUSIONS Emicizumab prophylaxis administered subcutaneously once weekly or every 2 weeks led to a significantly lower bleeding rate than no prophylaxis among persons with hemophilia A without inhibitors; more than half the participants who received prophylaxis had no treated bleeding events. In an intraindividual comparison, emicizumab therapy led to a significantly lower bleeding rate than previous factor VIII prophylaxis.	[Mahlangu, J.] Univ Witwatersrand, Fac Hlth Sci, Haemophilia Comprehens Care Ctr, Johannesburg, South Africa; [Mahlangu, J.] Natl Hlth Lab Serv, 7 York Rd, ZA-2194 Johannesburg, South Africa; [Oldenburg, J.] Univ Klinikum Bonn, Bonn, Germany; [Paz-Priel, I.; Adamkewicz, J. I.; Levy, G. G.] Genentech Inc, San Francisco, CA 94080 USA; [Negrier, C.] Louis Pradel Univ Hosp, Lyon, France; [Niggli, M.; Schmitt, C.; Dhalluin, C.; Asikanius, E.] F Hoffmann La Roche, Basel, Switzerland; [Mancuso, M. E.] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Jimenez-Yuste, V.] Univ Autonoma Madrid, Hosp Univ La Paz, Hematol Dept, Madrid, Spain; [Kempton, C.] Emory Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Callaghan, M. U.] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Bujan, W.] Inst Costarricense Invest Cient, San Jose, Costa Rica; [Shima, M.] Nara Med Univ, Dept Pediat, Kashihara, Nara, Japan; [Kruse-Jarres, R.] Bloodworks Northwest, Washington Ctr Bleeding Disorders, Seattle, WA USA	University of Witwatersrand; National Health Laboratory Service; University of Bonn; Roche Holding; Genentech; CHU Lyon; Roche Holding; IRCCS Ca Granda Ospedale Maggiore Policlinico; Autonomous University of Madrid; Hospital Universitario La Paz; Emory University; Children's Hospital of Michigan; Nara Medical University	Mahlangu, J (corresponding author), Univ Witwatersrand, Fac Hlth Sci, 7 York Rd, ZA-2194 Johannesburg, South Africa.; Mahlangu, J (corresponding author), Natl Hlth Lab Serv, 7 York Rd, ZA-2194 Johannesburg, South Africa.	johnny.mahlangu@nhls.ac.za	Kempton, Christine/ABG-4398-2020; Jimenez-Yuste, Victor/C-3762-2013; Callaghan, Michael/AAH-2059-2019; Oldenburg, Johannes/ABB-7817-2020; Mancuso, Maria Elisa/L-1552-2019; Mancuso, Maria Elisa/AAT-4785-2020; Mahlangu, Johnny Ndoni/H-7558-2019	Kempton, Christine/0000-0002-2391-2016; Jimenez-Yuste, Victor/0000-0003-3937-3499; Mancuso, Maria Elisa/0000-0002-7113-4028; Mahlangu, Johnny Ndoni/0000-0001-5781-7669; Oldenburg, Johannes/0000-0002-1585-4100; Chamouard, Valerie/0000-0002-4443-1609; Negrier, Claude/0000-0003-3569-0366	F. Hoffmann-La Roche; Chugai Pharmaceutical; Bayer; Baxalta; CSL Behring; Alnylam Pharmaceuticals; Shire; Biotest Pharmaceuticals; Novo Nordisk; Octapharma; Grifols; Pfizer; Sobi; LFB; Bayer Healthcare; Sobi-Biogen; Baxalta-Shire; Genentech; Bioverativ; Hema Biologics; BioMarin; Sanofi	F. Hoffmann-La Roche(Hoffmann-La Roche); Chugai Pharmaceutical; Bayer(Bayer AG); Baxalta; CSL Behring; Alnylam Pharmaceuticals; Shire; Biotest Pharmaceuticals; Novo Nordisk(Novo Nordisk); Octapharma; Grifols; Pfizer(Pfizer); Sobi; LFB; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Sobi-Biogen; Baxalta-Shire; Genentech(Roche HoldingGenentech); Bioverativ; Hema Biologics; BioMarin; Sanofi	Supported by F. Hoffmann-La Roche and Chugai Pharmaceutical.; Dr. Mahlangu reports receiving grant support from Bayer, Baxalta, and CSL Behring, grant support and lecture fees from Alnylam Pharmaceuticals and F. Hoffmann-La Roche, and grant support and fees for serving on an advisory board from Shire; Dr. Oldenburg, receiving grant support, fees for serving on an advisory board, fees for participating in symposia, and travel support from Bayer, Biotest Pharmaceuticals, CSL Behring, Novo Nordisk, Octapharma, and Shire, and fees for serving on an advisory board, fees for participating in symposia, and travel support from Chugai Pharmaceutical, Grifols, Pfizer, F. Hoffmann-La Roche, and Sobi; Drs. Paz-Priel and Adamkewicz, being employed by Genentech; Dr. Negrier, receiving grant support, honoraria, and fees for serving on an advisory board from Alnylam Pharmaceuticals, Bayer, CSL Behring, LFB, Novo Nordisk, Octapharma, Pfizer, Shire, and Sobi; Drs. Niggli and Schmitt, being employed by F. Hoffmann-La Roche; Dr. Mancuso, receiving lecture fees and fees for serving on an advisory board from Bayer Healthcare, CSL Behring, Novo Nordisk, F. Hoffmann-La Roche, and Sobi-Biogen, lecture fees from Pfizer, Octapharma, and Biotest Pharmaceuticals, and fees for serving on an advisory board from Baxalta-Shire; Dr. Jimenez-Yuste, receiving grant support, lecture fees, and consulting fees from Pfizer, Novo Nordisk, Shire, Grifols, Sobi, CSL Behring, and Bayer and lecture fees and consulting fees from F. Hoffmann-La Roche; Dr. Kempton, receiving fees for serving on an advisory board from Genentech and Bayer Healthcare, grant support and consulting fees from Novo Nordisk, and honoraria from Grifols; Dr. Dhalluin, being employed by F. Hoffmann-La Roche; Dr. Callaghan, receiving grant support, fees for serving on an advisory board, and fees for serving on a speakers bureau from Shire and Bayer, fees for serving on an advisory board from Octapharma, Grifols, Bioverativ, and Hema Biologics, grant support and fees for serving on an advisory board from Pfizer, serving as site investigator for a sub-phase 1 clinical trial for Novo Nordisk, Global Blood Therapeutics, Sancilio Pharmaceuticals Company, and Amgen, and owning stock in Alnylam Pharmaceuticals; Dr. Shima, receiving grant support, honoraria, and consulting fees from Bayer, Chugai Pharmaceutical, and Novo Nordisk, honoraria and consulting fees from Bioverativ, grant support and honoraria from CSL Behring, Baxalta, and Pfizer, consulting fees from BioMarin and Sanofi, and fees for serving on an advisory board and consulting fees from F. Hoffmann-La Roche; Ms. Asikanius, being employed by and owning stock in F. Hoffmann-La Roche; Dr. Levy, being employed by Genentech and owning stock and being a shareholder in F. Hoffmann-La Roche; and Dr. Kruse-Jarres, receiving fees for serving on an advisory board, consulting fees and travel support from Baxalta-Shire, fees for serving on an advisory board from Grifols, grant support and fees for serving on an advisory board from Pfizer, grant support, fees for serving on an advisory board, and travel support from CSL Behring, fees for serving on an advisory board and travel support from Octapharma, and fees for serving on an advisory board, fees for internal education, and travel support from Novo Nordisk. No other potential conflict of interest relevant to this article was reported.	Adamkewicz JI, 2017, RES PRACT THROMB SS1, V1, P724; Adamkewicz JI, 2017, HAEMOPHILIA, V23, P26; [Anonymous], 1997, INT DIG HLTH LEGIS, V48, P231; [Anonymous], 2017, HEML EM PRESCR INF; [Anonymous], 2018, HEML EM SUMM PROD CH; Eton DT, 2013, PATIENT-RELAT OUTCOM, V4, P7, DOI 10.2147/PROM.S44694; Franchini M, 2013, BLOOD REV, V27, P179, DOI 10.1016/j.blre.2013.06.002; George LA, 2017, NEW ENGL J MED, V377, P2215, DOI 10.1056/NEJMoa1708538; Khawaji M, 2012, EUR J HAEMATOL, V88, P329, DOI 10.1111/j.1600-0609.2012.01750.x; Kingdon HS, 2002, BIOTECHNOL APPL BIOC, V35, P141, DOI 10.1042/BA20010082; Kitazawa T, 2017, THROMB HAEMOSTASIS, V117, P1348, DOI 10.1160/TH17-01-0030; Kitazawa T, 2012, NAT MED, V18, P1570, DOI 10.1038/nm.2942; Kruse- Jarres R, 2018, 11 ANN C EUR ASS HAE; Ljung R, 2015, BRIT J HAEMATOL, V169, P777, DOI 10.1111/bjh.13365; Mair FS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6680; Mancuso ME, 2017, ANN M AM SOC HEM ATL; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307; Miesbach W, 2018, BLOOD, V131, P1022, DOI 10.1182/blood-2017-09-804419; Miller CH, 2013, J THROMB HAEMOST, V11, P1300, DOI 10.1111/jth.12259; Nogami K, 2018, J THROMB HAEMOST, V16, P1078, DOI 10.1111/jth.14022; Oldenburg J, 2017, NEW ENGL J MED, V377, P809, DOI 10.1056/NEJMoa1703068; Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI [10.1056/NEJMoa1616569, 10.1056/NEJMoa1708483]; Peyvandi F, 2013, J THROMB HAEMOST, V11, P84, DOI 10.1111/jth.12270; Pipe S, 2018, 2018 WORLD C WORLD F; Sampei Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057479; Shima M, 2016, NEW ENGL J MED, V374, P2044, DOI 10.1056/NEJMoa1511769; von Mackensen S, 2005, HAEMATOLOGICA S2, V20, P115; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wyrwich KW, 2015, HAEMOPHILIA, V21, P578, DOI 10.1111/hae.12642; Yoneyama K, 2017, CLIN PHARMACOKINET; Young G, 2017, ANN M AM SOC HEM ATL	31	334	340	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2018	379	9					811	822		10.1056/NEJMoa1803550	http://dx.doi.org/10.1056/NEJMoa1803550			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR9EA	30157389	Bronze			2022-12-28	WOS:000443047800005
J	Murphy, D				Murphy, Declan			Women in England will be allowed to take second early medical abortion pill at home	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Murphy, Declan C/0000-0001-9295-7712				[Anonymous], 2018, GOV CONF PLANS APPR; Craig C, 2018, CLAUDIAS OPEN LETT I; Ngo TD, 2011, B WORLD HEALTH ORGAN, V89, P360, DOI 10.2471/BLT.10.084046	3	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2018	362								k3675	10.1136/bmj.k3675	http://dx.doi.org/10.1136/bmj.k3675			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5YZ	30154075				2022-12-28	WOS:000443756600011
J	Tan, JY; Wisdom, V; Collingridge, D				Tan, Jiaying; Wisdom, Vania; Collingridge, David			Advancing haematological research and clinical practice: a call for papers for ASH 2018	LANCET			English	Editorial Material									[Tan, Jiaying] 50 Hampshire St, Cambridge, MA USA; [Wisdom, Vania; Collingridge, David] 125 London Wall, London EC2Y 5AS, England		Wisdom, V (corresponding author), 125 London Wall, London EC2Y 5AS, England.	vcwisdom@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2018	392	10147					540	540		10.1016/S0140-6736(18)31881-6	http://dx.doi.org/10.1016/S0140-6736(18)31881-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ8MN	30152377				2022-12-28	WOS:000442009500008
J	Iversen, K; Ihlemann, N; Gill, SU; Madsen, T; Elming, H; Jensen, KT; Bruun, NE; Hofsten, DE; Fursted, K; Christensen, JJ; Schultz, M; Klein, CF; Fosboll, EL; Rosenvinge, F; Schonheyder, HC; Kober, L; Torp-Pedersen, C; Helweg-Larsen, J; Tonder, N; Moser, C; Bundgaard, H				Iversen, Kasper; Ihlemann, Nikolaj; Gill, Sabine U.; Madsen, Trine; Elming, Hanne; Jensen, Kaare T.; Bruun, Niels E.; Hofsten, Dan E.; Fursted, Kurt; Christensen, Jens J.; Schultz, Martin; Klein, Christine F.; Fosboll, Emil L.; Rosenvinge, Flemming; Schonheyder, Henrik C.; Kober, Lars; Torp-Pedersen, Christian; Helweg-Larsen, Jannik; Tonder, Niels; Moser, Claus; Bundgaard, Henning			Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-HOSPITAL MORTALITY; INFECTIVE ENDOCARDITIS; ANTIMICROBIAL THERAPY; RISK-FACTORS; DRUG-USERS; FUNCTIONAL DECLINE; MANAGEMENT; DIAGNOSIS; CRITERIA	BACKGROUND Patients with infective endocarditis on the left side of the heart are typically treated with intravenous antibiotic agents for up to 6 weeks. Whether a shift from intravenous to oral antibiotics once the patient is in stable condition would result in efficacy and safety similar to those with continued intravenous treatment is unknown. METHODS In a randomized, noninferiority, multicenter trial, we assigned 400 adults in stable condition who had endocarditis on the left side of the heart caused by streptococcus, Enterococcus faecalis, Staphylococcus aureus, or coagulase-negative staphylococci and who were being treated with intravenous antibiotics to continue intravenous treatment (199 patients) or to switch to oral antibiotic treatment (201 patients). In all patients, antibiotic treatment was administered intravenously for at least 10 days. If feasible, patients in the orally treated group were discharged to outpatient treatment. The primary outcome was a composite of all-cause mortality, unplanned cardiac surgery, embolic events, or relapse of bacteremia with the primary pathogen, from the time of randomization until 6 months after antibiotic treatment was completed. RESULTS After randomization, antibiotic treatment was completed after a median of 19 days (interquartile range, 14 to 25) in the intravenously treated group and 17 days (interquartile range, 14 to 25) in the orally treated group (P=0.48). The primary composite outcome occurred in 24 patients (12.1%) in the intravenously treated group and in 18 (9.0%) in the orally treated group (between-group difference, 3.1 percentage points; 95% confidence interval, -3.4 to 9.6; P=0.40), which met noninferiority criteria. CONCLUSIONS In patients with endocarditis on the left side of the heart who were in stable condition, changing to oral antibiotic treatment was noninferior to continued intravenous anti-biotic treatment.	[Iversen, Kasper; Schultz, Martin; Klein, Christine F.] Herlev Gentofte Univ Hosp, Dept Cardiol, Herlev, Denmark; [Ihlemann, Nikolaj; Hofsten, Dan E.; Fosboll, Emil L.; Kober, Lars; Bundgaard, Henning] Copenhagen Univ Hosp, Rigshosp, Heart Ctr, Dept Cardiol, Copenhagen, Denmark; [Helweg-Larsen, Jannik] Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Moser, Claus] Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark; [Tonder, Niels] Hillerod Hosp, Dept Cardiol, Hillerod, Denmark; [Christensen, Jens J.] Univ Copenhagen, Slagelse Hosp, Dept Clin Microbiol, Copenhagen, Denmark; [Christensen, Jens J.] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark; [Gill, Sabine U.] Odense Univ Hosp, Dept Cardiol, Odense, Denmark; [Rosenvinge, Flemming] Odense Univ Hosp, Dept Clin Microbiol, Odense, Denmark; [Madsen, Trine] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Epidemiol & Biostat, Aalborg, Denmark; [Schonheyder, Henrik C.] Aalborg Univ, Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Elming, Hanne] Zealand Univ Hosp, Dept Cardiol, Roskilde, Denmark; [Jensen, Kaare T.] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark; [Bruun, Niels E.] Univ Hosp Copenhagen, Dept Cardiol, Gentofte, Denmark; [Fursted, Kurt] Statens Serum Inst, Dept Bacteria Parasites & Fungi, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aarhus University; University of Copenhagen; Statens Serum Institut	Bundgaard, H (corresponding author), Copenhagen Univ Hosp, Rigshosp, Heart Ctr, Dept Cardiol B 2141, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	henning.bundgaard@regionh.dk	Christensen, Jens Jørgen/L-4078-2019; Iversen, Kasper/GSD-6427-2022; Moser, Claus Ernst/N-5951-2017; Moser, Claus Ernst/GPK-5546-2022; Bundgaard, Henning/AAA-4381-2020	Moser, Claus Ernst/0000-0002-7664-8570; Moser, Claus Ernst/0000-0002-7664-8570; Bundgaard, Henning/0000-0002-0563-7049; Falk Klein, Christine/0000-0001-9401-6502; Kober, Lars/0000-0002-6635-1466; Iversen, Kasper/0000-0003-0504-8487; Fosbol, Emil/0000-0002-2048-4167; Helweg-Larsen, Jannik/0000-0001-7192-0144	Danish Heart Foundation; Capital Regions Research Council; Hartmann's Foundation; Svend Aage Andersens Foundation; Novo Nordisk Foundation (Borregaard Clinical Scientist Fellowship in translational research) [NNF17OC0025074]	Danish Heart Foundation; Capital Regions Research Council; Hartmann's Foundation; Svend Aage Andersens Foundation; Novo Nordisk Foundation (Borregaard Clinical Scientist Fellowship in translational research)	Supported by unrestricted grants from the Danish Heart Foundation, the Capital Regions Research Council, the Hartmann's Foundation, Svend Aage Andersens Foundation, and the Novo Nordisk Foundation (Borregaard Clinical Scientist Fellowship in translational research; grant no. NNF17OC0025074).	Al-Omari A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-140; Andrews MM, 2001, CLIN INFECT DIS, V33, P203, DOI 10.1086/321814; [Anonymous], PRODLIM PRODUCT LIMI; Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Berg SK, 2010, EUR J CARDIOVASC NUR, V9, P126, DOI 10.1016/j.ejcnurse.2009.11.007; BLOOMFIELD AL, 1950, CIRCULATION, V2, P801, DOI 10.1161/01.CIR.2.6.801; De Saint-Hubert M, 2009, ACTA CLIN BELG, V64, P187, DOI 10.1179/acb.2009.034; Delahaye F, 2007, SCAND J INFECT DIS, V39, P849, DOI 10.1080/00365540701393088; Dickerman SA, 2007, AM HEART J, V154, P1086, DOI 10.1016/j.ahj.2007.07.023; DWORKIN RJ, 1989, LANCET, V2, P1071; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Heldman AW, 1996, AM J MED, V101, P68, DOI 10.1016/S0002-9343(96)00070-8; Isaia G, 2009, AGING CLIN EXP RES, V21, P453, DOI 10.1007/BF03327448; Iversen K, 2013, AM HEART J, V165, P116, DOI 10.1016/j.ahj.2012.11.006; Kehlet H, 2008, LANCET, V371, P791, DOI 10.1016/S0140-6736(08)60357-8; Khoo CK, 2007, ANN SURG, V245, P867, DOI 10.1097/01.sla.0000259219.08209.36; Lacroix A, 2014, MED MALADIES INFECT, V44, P327, DOI 10.1016/j.medmal.2014.05.001; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Martin-Davila P, 2005, AM HEART J, V150, P1099, DOI 10.1016/j.ahj.2005.02.009; Mistiaen WP, 2018, SCAND CARDIOVASC J, V52, P58, DOI 10.1080/14017431.2018.1433318; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Mzabi A, 2016, CLIN MICROBIOL INFEC, V22, P607, DOI 10.1016/j.cmi.2016.04.003; R Development Core Team, 2017, R LANG ENV STAT COMP; Sy RW, 2010, EUR HEART J, V31, P1890, DOI 10.1093/eurheartj/ehq110; THOMAS D J, 1949, Med J Aust, V1, P377; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wind J, 2006, BRIT J SURG, V93, P800, DOI 10.1002/bjs.5384; [No title captured]	28	286	291	3	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2019	380	5					415	424		10.1056/NEJMoa1808312	http://dx.doi.org/10.1056/NEJMoa1808312			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HJ4HS	30152252	Bronze, Green Published			2022-12-28	WOS:000457135700005
J	Fonn, S; Ayiro, LP; Cotton, P; Habib, A; Mbithi, PMF; Mtenje, A; Nawangwe, B; Ogunbodede, EO; Olayinka, I; Golooba-Mutebi, F; Ezeh, A				Fonn, Sharon; Ayiro, Laban Peter; Cotton, Philip; Habib, Adam; Mbithi, Peter Mulwa Felix; Mtenje, Alfred; Nawangwe, Barnabas; Ogunbodede, Eyitope O.; Olayinka, Idowu; Golooba-Mutebi, Frederick; Ezeh, Alex			Repositioning Africa in global knowledge production	LANCET			English	Editorial Material									[Fonn, Sharon] Univ Witwatersrand, Consortium Adv Res Training Africa, Johannesburg, South Africa; [Fonn, Sharon] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Ayiro, Laban Peter] Moi Univ, Eldoret, Kenya; [Cotton, Philip] Univ Rwanda, Kigali, Rwanda; [Habib, Adam] Univ Witwatersrand, Johannesburg, South Africa; [Mbithi, Peter Mulwa Felix] Univ Nairobi, Nairobi, Kenya; [Mtenje, Alfred] Univ Malawi, Zomba, Malawi; [Nawangwe, Barnabas] Makerere Univ, Kampala, Uganda; [Ogunbodede, Eyitope O.] Obafemi Awolowo Univ, Ife, Nigeria; [Olayinka, Idowu] Univ Ibadan, Ibadan, Nigeria; [Ezeh, Alex] African Populat & Hlth Res Ctr, Consortium Adv Res Training Africa, Nairobi, Kenya; [Ezeh, Alex] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; Moi University; University of Rwanda; University of Witwatersrand; University of Nairobi; University of Malawi; Makerere University; Obafemi Awolowo University; University of Ibadan; African Population & Health Research Centre; University of Witwatersrand	Ezeh, A (corresponding author), African Populat & Hlth Res Ctr, APHRC Campus, Nairobi 00100, Kenya.	acezeh@gmail.com	Golooba-Mutebi, Frederick/AAA-1661-2019; Golooba-Mutebi, Frederick/AAO-4368-2020	Fonn, Sharon/0000-0001-6115-8707; Ogunbodede, Eyitope/0000-0002-8808-9833	Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]; DELTAS Africa Initiative [107768/Z/15/Z]; DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK) [107768/Z/15/Z]; UK government	Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government	This Viewpoint was developed at a meeting of the Vice Chancellors and Heads of Partner institutions of the Consortium for Advanced Research Training in Africa (CARTA) at the University of Nairobi on July 10-11, 2017. CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No: 54100029), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) (Grant No: 107768/Z/15/Z) and the UK government. The list of attendees at the meeting is included in the appendix. The views expressed are those of the authors and not necessarily those of the funders of CARTA or attendees of the meeting at the University of Nairobi.	Adams J., 2010, GLOBAL RES REPORT AF; Aina T. A., 1994, QUALITY RELEVANCE AF; Bloom D., 2005, HIGHER ED EC DEV AFR; Callaghy T, 1993, RESPONSES AFRICAS EC; Christoplos I, 2015, EVALUATION CONSORTIU; Hinchliffe K, 1987, HIGHER ED SUB SAHARA; Juma C, REINVENTING AFRICAS; Kamola Isaac, AFRICAN U GLOBAL U; Mamdani, 2007, SCHOLARS MARKET PLAC; Mamdani M, 2011, 3 MISR MAK U; Mamdani M, 2012, 9 MISR MEK U SOC RES; Mellamby K, 1958, BIRTH NIGERIAS U; Mkude D, 2003, HIGHER ED TANZANIA C, P1; Onyancha OB, 2011, SCIENTOMETRICS, V87, P315, DOI 10.1007/s11192-010-0330-5; RAVENHILL J, 1986, AFRICA EC CRISIS; Salmi J, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7865-6; The Africa-America Institute, 2015, STAT ED AFR REP; Tijssen RJW, 2007, SCIENTOMETRICS, V71, P303, DOI 10.1007/s11192-007-1658-3; Trust Africa, POST 2015 DAK AFR HI; VANDERHOEVEN R, 1994, STRUCTURAL ADJUSTMEN; Woldegiorgis E.T., 2013, HIGHER ED STUDIES, V3, P35; World Bank, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7738-3; World Bank, 2014, DEC DEV SUB SAH AFR; Yesufu T., 1973, CREATING AFRICAN U	24	20	20	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2018	392	10153					1163	1166		10.1016/S0140-6736(18)31068-7	http://dx.doi.org/10.1016/S0140-6736(18)31068-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV3BV	30173909				2022-12-28	WOS:000445968800031
J	Dyer, O				Dyer, Owen			Microwave weapon caused syndrome in diplomats in Cuba, US medical team believes	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							GOVERNMENT PERSONNEL											Bartholomew RE, 2018, JAMA-J AM MED ASSOC, V320, P602, DOI 10.1001/jama.2018.8702; Swanson RL, 2018, JAMA-J AM MED ASSOC, V319, P1125, DOI 10.1001/jama.2018.1742	2	2	2	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2018	362								k3848	10.1136/bmj.k3848	http://dx.doi.org/10.1136/bmj.k3848			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JC	30201627				2022-12-28	WOS:000445015400010
J	Chen, QS; Wu, J; Ou, XY; Huang, BL; Almutlaq, J; Zhumekenov, AA; Guan, XW; Han, SY; Liang, LL; Yi, ZG; Li, J; Xie, XJ; Wang, Y; Li, Y; Fan, DY; Teh, DBL; All, AH; Mohammed, OF; Bakr, OM; Wu, T; Bettinelli, M; Yang, HH; Huang, W; Liu, XG				Chen, Qiushui; Wu, Jing; Ou, Xiangyu; Huang, Bolong; Almutlaq, Jawaher; Zhumekenov, Ayan A.; Guan, Xinwei; Han, Sanyang; Liang, Liangliang; Yi, Zhigao; Li, Juan; Xie, Xiaoji; Wang, Yu; Li, Ying; Fan, Dianyuan; Teh, Daniel B. L.; All, Angelo H.; Mohammed, Omar F.; Bakr, Osman M.; Wu, Tom; Bettinelli, Marco; Yang, Huanghao; Huang, Wei; Liu, Xiaogang			All-inorganic perovskite nanocrystal scintillators	NATURE			English	Article							X-RAY-DETECTORS; SINGLE-CRYSTALS; LARGE-AREA	The rising demand for radiation detection materials in many applications has led to extensive research on scintillators(1-3). The ability of a scintillator to absorb high-energy (kiloelectronvolt-scale) X-ray photons and convert the absorbed energy into low-energy visible photons is critical for applications in radiation exposure monitoring, security inspection, X-ray astronomy and medical radiography(4,5). However, conventional scintillators are generally synthesized by crystallization at a high temperature and their radioluminescence is difficult to tune across the visible spectrum. Here we describe experimental investigations of a series of all-inorganic perovskite nanocrystals comprising caesium and lead atoms and their response to X-ray irradiation. These nanocrystal scintillators exhibit strong X-ray absorption and intense radioluminescence at visible wavelengths. Unlike bulk inorganic scintillators, these perovskite nanomaterials are solution-processable at a relatively low temperature and can generate X-ray-induced emissions that are easily tunable across the visible spectrum by tailoring the anionic component of colloidal precursors during their synthesis. These features allow the fabrication of flexible and highly sensitive X-ray detectors with a detection limit of 13 nanograys per second, which is about 400 times lower than typical medical imaging doses. We show that these colour-tunable perovskite nanocrystal scintillators can provide a convenient visualization tool for X-ray radiography, as the associated image can be directly recorded by standard digital cameras. We also demonstrate their direct integration with commercial flat-panel imagers and their utility in examining electronic circuit boards under low-dose X-ray illumination.	[Chen, Qiushui; Han, Sanyang; Liang, Liangliang; Yi, Zhigao; Liu, Xiaogang] Natl Univ Singapore, Dept Chem, Singapore, Singapore; [Wu, Jing] China Univ Geosci, Sch Sci, Beijing, Peoples R China; [Ou, Xiangyu; Li, Juan; Yang, Huanghao] Fuzhou Univ, MOE Key Lab Analyt Sci Food Safety & Biol, Fuzhou, Fujian, Peoples R China; [Ou, Xiangyu; Li, Juan; Yang, Huanghao] Fuzhou Univ, State Key Lab Photocatalysis Energy & Environm, Fuzhou, Fujian, Peoples R China; [Huang, Bolong] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Almutlaq, Jawaher; Zhumekenov, Ayan A.; Guan, Xinwei; Mohammed, Omar F.; Bakr, Osman M.] King Abdullah Univ Sci & Technol, Div Phys Sci & Engn, Thuwal, Saudi Arabia; [Xie, Xiaoji; Huang, Wei] Nanjing Tech Univ, Inst Adv Mat, Nanjing, Jiangsu, Peoples R China; [Wang, Yu; Li, Ying; Fan, Dianyuan; Liu, Xiaogang] Shenzhen Univ, SZU NUS Collaborat Innovat Ctr Optoelect Sci & Te, Shenzhen, Peoples R China; [Teh, Daniel B. L.; All, Angelo H.] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore, Singapore; [All, Angelo H.] Johns Hopkins Sch Med, Dept Biomed Engn, Baltimore, MD USA; [Wu, Tom] Univ New South Wales, Sch Mat Sci & Engn, Sydney, NSW, Australia; [Bettinelli, Marco] Univ Verona, DB, Luminescent Mat Lab, Verona, Italy; [Huang, Wei] Nanjing Univ Posts & Telecommun, Key Lab Organ Elect & Informat Displays, Nanjing, Jiangsu, Peoples R China; [Huang, Wei] Nanjing Univ Posts & Telecommun, Inst Adv Mat, Nanjing, Jiangsu, Peoples R China; [Huang, Wei] Northwestern Polytech Univ, Shaanxi Inst Flexible Elect, Xian, Shaanxi, Peoples R China; [Liu, Xiaogang] NUS Suzhou Res Inst, Ctr Funct Mat, Suzhou, Jiangsu, Peoples R China	National University of Singapore; China University of Geosciences; Fuzhou University; Fuzhou University; Hong Kong Polytechnic University; King Abdullah University of Science & Technology; Nanjing Tech University; Shenzhen University; National University of Singapore; Johns Hopkins University; Johns Hopkins Medicine; University of New South Wales Sydney; University of Verona; Nanjing University of Posts & Telecommunications; Nanjing University of Posts & Telecommunications; Northwestern Polytechnical University	Liu, XG (corresponding author), Natl Univ Singapore, Dept Chem, Singapore, Singapore.; Yang, HH (corresponding author), Fuzhou Univ, MOE Key Lab Analyt Sci Food Safety & Biol, Fuzhou, Fujian, Peoples R China.; Yang, HH (corresponding author), Fuzhou Univ, State Key Lab Photocatalysis Energy & Environm, Fuzhou, Fujian, Peoples R China.; Huang, W (corresponding author), Nanjing Tech Univ, Inst Adv Mat, Nanjing, Jiangsu, Peoples R China.; Liu, XG (corresponding author), Shenzhen Univ, SZU NUS Collaborat Innovat Ctr Optoelect Sci & Te, Shenzhen, Peoples R China.; Huang, W (corresponding author), Nanjing Univ Posts & Telecommun, Key Lab Organ Elect & Informat Displays, Nanjing, Jiangsu, Peoples R China.; Huang, W (corresponding author), Nanjing Univ Posts & Telecommun, Inst Adv Mat, Nanjing, Jiangsu, Peoples R China.; Huang, W (corresponding author), Northwestern Polytech Univ, Shaanxi Inst Flexible Elect, Xian, Shaanxi, Peoples R China.; Liu, XG (corresponding author), NUS Suzhou Res Inst, Ctr Funct Mat, Suzhou, Jiangsu, Peoples R China.	hhyang@fzu.edu.cn; iamwhuang@nwpu.edu.cn; chmlx@nus.edu.sg	Bakr, Osman M./R-4963-2019; LIU, XIAOGANG/A-8038-2011; Yang, Huang-Hao/L-9905-2019; Huang, Bolong/AAG-5165-2019; Xie, Xiaoji/L-2567-2014; Li, Ying/AAC-1331-2021; Mohammed, Omar F./Q-5092-2016; Yi, Zhigao/I-6116-2015; Huang, Wei/A-4461-2009; Wu, Tom/A-1158-2012; Wang, Yu/N-4119-2018; Bettinelli, Marco/A-2616-2008; Loong, Daniel Teh Boon/AAF-6660-2019	Bakr, Osman M./0000-0002-3428-1002; LIU, XIAOGANG/0000-0003-2517-5790; Huang, Bolong/0000-0002-2526-2002; Xie, Xiaoji/0000-0002-4830-1246; Mohammed, Omar F./0000-0001-8500-1130; Yi, Zhigao/0000-0003-0853-2055; Huang, Wei/0000-0001-7004-6408; Wu, Tom/0000-0003-0845-4827; Wang, Yu/0000-0001-5971-6597; Bettinelli, Marco/0000-0002-1271-4241; Loong, Daniel Teh Boon/0000-0002-4560-8568; Zhumekenov, Ayan/0000-0002-3216-5315; Liang, Liangliang/0000-0003-4958-3801; Guan, Xinwei/0000-0002-0100-480X; Almutlaq, Jawaher/0000-0003-4558-6773	King Abdullah University of Science and Technology; Singapore Ministry of Education [R143000627112, R143000642112]; Agency for Science, Technology and Research (A*STAR) (Singapore) [122-PSE-0014, 1231AFG028]; National Research Foundation, Prime Minister's Office, Singapore under its Competitive Research Program (CRP award) [NRF-CRP15-2015-03]; National Basic Research Program of China (973 Program) [2015CB932200]; National Natural Science Foundation of China [21635002, 21471109, 21210001, 21405143]; Natural Science Foundation of Jiangsu Province [BE2015699]	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Singapore Ministry of Education(Ministry of Education, Singapore); Agency for Science, Technology and Research (A*STAR) (Singapore)(Agency for Science Technology & Research (A*STAR)); National Research Foundation, Prime Minister's Office, Singapore under its Competitive Research Program (CRP award)(National Research Foundation, Singapore); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work is supported by the King Abdullah University of Science and Technology; the Singapore Ministry of Education (grants R143000627112 and R143000642112); the Agency for Science, Technology and Research (A*STAR) under contracts 122-PSE-0014 and 1231AFG028 (Singapore); the National Research Foundation, Prime Minister's Office, Singapore under its Competitive Research Program (CRP award number NRF-CRP15-2015-03); the National Basic Research Program of China (973 Program, grant number 2015CB932200); the National Natural Science Foundation of China (21635002, 21471109, 21210001 and 21405143); and the Natural Science Foundation of Jiangsu Province (BE2015699). We thank H. Jiang, B. Deng, Z. Fang, Z. Zhou, Y. Zhang, X. Ling, M. Sun and A. Malko for technical assistance.	BACCARO S, 1995, NUCL INSTRUM METH A, V361, P209, DOI 10.1016/0168-9002(95)00016-X; Becker MA, 2018, NATURE, V553, P189, DOI 10.1038/nature25147; Berger M.J., 2013, XCOM PHOTON CROSS SE; Birowosuto MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep37254; Buechele P, 2015, NAT PHOTONICS, V9, P843, DOI [10.1038/NPHOTON.2015.216, 10.1038/nphoton.2015.216]; Dong QF, 2015, SCIENCE, V347, P967, DOI 10.1126/science.aaa5760; DURIE BGM, 1975, SCIENCE, V190, P1093, DOI 10.1126/science.1188385; Hossu M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3674313; Hu FR, 2015, ACS NANO, V9, P12410, DOI 10.1021/acsnano.5b05769; Huang SQ, 2016, J AM CHEM SOC, V138, P5749, DOI 10.1021/jacs.5b13101; Im JH, 2014, NAT NANOTECHNOL, V9, P927, DOI [10.1038/nnano.2014.181, 10.1038/NNANO.2014.181]; Kim YC, 2017, NATURE, V550, P87, DOI 10.1038/nature24032; Kovalenko MV, 2017, SCIENCE, V358, P745, DOI 10.1126/science.aam7093; Li X, 2016, SCIENCE, V353, P58, DOI 10.1126/science.aaf8060; Miyata A, 2015, NAT PHYS, V11, P582, DOI 10.1038/NPHYS3357; Moretti F, 2014, J PHYS CHEM C, V118, P9670, DOI 10.1021/jp501717z; Nagarkar VV, 1998, IEEE T NUCL SCI, V45, P492, DOI 10.1109/23.682433; Nikl M, 2006, MEAS SCI TECHNOL, V17, pR37, DOI 10.1088/0957-0233/17/4/R01; Nikl M, 2015, ADV OPT MATER, V3, P463, DOI 10.1002/adom.201400571; Pan WC, 2017, NAT PHOTONICS, V11, P726, DOI 10.1038/s41566-017-0012-4; Protesescu L, 2015, NANO LETT, V15, P3692, DOI 10.1021/nl5048779; Rodnyi P.A., 1997, PHYS PROCESSES INORG; Rontgen W C, 1896, Science, V3, P227, DOI 10.1126/science.3.59.227; Rowlands JA, 2017, NATURE, V550, P47, DOI 10.1038/550047a; Saidaminov MI, 2017, ADV OPT MATER, V5, DOI 10.1002/adom.201600704; Saidaminov MI, 2016, ACS ENERGY LETT, V1, P840, DOI 10.1021/acsenergylett.6b00396; Shi D, 2015, SCIENCE, V347, P519, DOI 10.1126/science.aaa2725; Shrestha S, 2017, NAT PHOTONICS, V11, P436, DOI 10.1038/NPHOTON.2017.94; Son DY, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2016.81, 10.1038/NENERGY.2016.81]; Swarnkar A, 2016, SCIENCE, V354, P92, DOI 10.1126/science.aag2700; Tan HR, 2017, SCIENCE, V355, P722, DOI 10.1126/science.aai9081; Weber MJ, 2002, J LUMIN, V100, P35, DOI 10.1016/S0022-2313(02)00423-4; Wei HT, 2017, NAT MATER, V16, P826, DOI [10.1038/NMAT4927, 10.1038/nmat4927]; Wei HT, 2016, NAT PHOTONICS, V10, P333, DOI [10.1038/nphoton.2016.41, 10.1038/NPHOTON.2016.41]; Wei W, 2017, NAT PHOTONICS, V11, P315, DOI [10.1038/NPHOTON.2017.43, 10.1038/nphoton.2017.43]; Yaffe MJ, 1997, PHYS MED BIOL, V42, P1, DOI 10.1088/0031-9155/42/1/001; Yakunin S, 2015, NAT PHOTONICS, V9, P444, DOI [10.1038/nphoton.2015.82, 10.1038/NPHOTON.2015.82]	37	806	817	177	1729	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					88	93		10.1038/s41586-018-0451-1	http://dx.doi.org/10.1038/s41586-018-0451-1			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30150772				2022-12-28	WOS:000443755200037
J	Eelen, G; Dubois, C; Cantelmo, AR; Goveia, J; Bruning, U; DeRan, M; Jarugumilli, G; van Rijssel, J; Saladino, G; Comitani, F; Zecchin, A; Rocha, S; Chen, RY; Huang, HL; Vandekeere, S; Kalucka, J; Lange, C; Morales-Rodriguez, F; Cruys, B; Treps, L; Ramer, L; Vinckier, S; Brepoels, K; Wyns, S; Souffreau, J; Schoonjans, L; Lamers, WH; Wu, Y; Haustraete, J; Hofkens, J; Liekens, S; Cubbon, R; Ghesquiere, B; Dewerchin, M; Gervasio, FL; Li, XR; van Buul, JD; Wu, X; Carmeliet, P				Eelen, Guy; Dubois, Charlotte; Cantelmo, Anna Rita; Goveia, Jermaine; Bruning, Ulrike; DeRan, Michael; Jarugumilli, Gopala; van Rijssel, Jos; Saladino, Giorgio; Comitani, Federico; Zecchin, Annalisa; Rocha, Susana; Chen, Rongyuan; Huang, Hongling; Vandekeere, Saar; Kalucka, Joanna; Lange, Christian; Morales-Rodriguez, Francisco; Cruys, Bert; Treps, Lucas; Ramer, Leanne; Vinckier, Stefan; Brepoels, Katleen; Wyns, Sabine; Souffreau, Joris; Schoonjans, Luc; Lamers, Wouter H.; Wu, Yi; Haustraete, Jurgen; Hofkens, Johan; Liekens, Sandra; Cubbon, Richard; Ghesquiere, Bart; Dewerchin, Mieke; Gervasio, Francesco L.; Li, Xuri; van Buul, Jaap D.; Wu, Xu; Carmeliet, Peter			Role of glutamine synthetase in angiogenesis beyond glutamine synthesis	NATURE			English	Article							RHO GTPASE; PROTEIN PALMITOYLATION; ENDOTHELIAL-CELLS; GLYCOLYSIS; VASCULATURE; DEFICIENCY; MIGRATION; JUNCTIONS; PATHWAY; MODEL	Glutamine synthetase, encoded by the gene GLUL, is an enzyme that converts glutamate and ammonia to glutamine. It is expressed by endothelial cells, but surprisingly shows negligible glutamine-synthesizing activity in these cells at physiological glutamine levels. Here we show in mice that genetic deletion of Glul in endothelial cells impairs vessel sprouting during vascular development, whereas pharmacological blockade of glutamine synthetase suppresses angiogenesis in ocular and inflammatory skin disease while only minimally affecting healthy adult quiescent endothelial cells. This relies on the inhibition of endothelial cell migration but not proliferation. Mechanistically we show that in human umbilical vein endothelial cells GLUL knockdown reduces membrane localization and activation of the GTPase RHOJ while activating other Rho GTPases and Rho kinase, thereby inducing actin stress fibres and impeding endothelial cell motility. Inhibition of Rho kinase rescues the defect in endothelial cell migration that is induced by GLUL knockdown. Notably, glutamine synthetase palmitoylates itself and interacts with RHOJ to sustain RHOJ palmitoylation, membrane localization and activation. These findings reveal that, in addition to the known formation of glutamine, the enzyme glutamine synthetase shows unknown activity in endothelial cell migration during pathological angiogenesis through RHOJ palmitoylation.	[Eelen, Guy; Dubois, Charlotte; Cantelmo, Anna Rita; Goveia, Jermaine; Bruning, Ulrike; Zecchin, Annalisa; Huang, Hongling; Vandekeere, Saar; Kalucka, Joanna; Lange, Christian; Morales-Rodriguez, Francisco; Cruys, Bert; Treps, Lucas; Ramer, Leanne; Vinckier, Stefan; Brepoels, Katleen; Wyns, Sabine; Souffreau, Joris; Schoonjans, Luc; Cubbon, Richard; Dewerchin, Mieke; Carmeliet, Peter] Univ Leuven, Ctr Canc Biol, Leuven, Belgium; [Eelen, Guy; Chen, Rongyuan; Li, Xuri; Carmeliet, Peter] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Eelen, Guy; Dubois, Charlotte; Cantelmo, Anna Rita; Goveia, Jermaine; Bruning, Ulrike; Zecchin, Annalisa; Huang, Hongling; Vandekeere, Saar; Kalucka, Joanna; Lange, Christian; Morales-Rodriguez, Francisco; Cruys, Bert; Treps, Lucas; Ramer, Leanne; Vinckier, Stefan; Brepoels, Katleen; Wyns, Sabine; Souffreau, Joris; Schoonjans, Luc; Cubbon, Richard; Dewerchin, Mieke; Carmeliet, Peter] VIB, Ctr Canc Biol, Leuven, Belgium; [DeRan, Michael; Jarugumilli, Gopala; Wu, Xu] Harvard Med Sch, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; [van Rijssel, Jos; van Buul, Jaap D.] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands; [Saladino, Giorgio; Comitani, Federico; Gervasio, Francesco L.] UCL, Dept Chem, London, England; [Rocha, Susana; Hofkens, Johan] Univ Leuven, Mol Imaging & Photon, Leuven, Belgium; [Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Gastrointestinal Res, Amsterdam, Netherlands; [Wu, Yi] Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modelling, Farmington, CT USA; [Haustraete, Jurgen] VIB, Inflammat Res Ctr, Ghent, Belgium; [Haustraete, Jurgen] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Liekens, Sandra] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Ghesquiere, Bart] VIB, Ctr Canc Biol, Metabol Core Facil, Leuven, Belgium; [Gervasio, Francesco L.] UCL, Inst Struct Mol Biol, London, England; [Cantelmo, Anna Rita] Univ Lille, INSERM U1003, Physiol Cellulaire, Lille, France; [Bruning, Ulrike] Max Delbruck Ctr Mol Med, Berlin, Germany; [Huang, Hongling] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Lange, Christian] Tech Univ Dresden, DFG Res Ctr Regenerat Therapies, Dresden, Germany; [Ramer, Leanne] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Cubbon, Richard] Univ Leeds, Div Cardiovasc & Diabet Res, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England	KU Leuven; Sun Yat Sen University; Flanders Institute for Biotechnology (VIB); Harvard University; Massachusetts General Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; KU Leuven; University of Amsterdam; Academic Medical Center Amsterdam; University of Connecticut; Flanders Institute for Biotechnology (VIB); Ghent University; KU Leuven; Flanders Institute for Biotechnology (VIB); University of London; Birkbeck University London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Helmholtz Association; Max Delbruck Center for Molecular Medicine; St Jude Children's Research Hospital; Technische Universitat Dresden; Simon Fraser University; University of Leeds	Eelen, G; Carmeliet, P (corresponding author), Univ Leuven, Ctr Canc Biol, Leuven, Belgium.; Eelen, G; Li, XR; Carmeliet, P (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.; Eelen, G; Carmeliet, P (corresponding author), VIB, Ctr Canc Biol, Leuven, Belgium.	guy.eelen@kuleuven.vib.be; lixr6@mail.sysu.edu.cn; peter.carmeliet@kuleuven.vib.be	van Buul, Jaap D/AAJ-4371-2021; Rocha, Susana/AAH-8343-2020; Hofkens, Johan/AAP-9255-2020; Hofkens, Johan/AAL-4204-2020; Lamers, Wouter H./D-2965-2012; Rocha, Susana/O-7622-2016; Cantelmo, Anna Rita/G-6766-2018; Comitani, Federico/AAE-7435-2022; Gervasio, Francesco/AAD-1036-2022; Carmeliet, Peter/AAQ-5140-2020; Ghesquiere, Bart/HGU-8736-2022; Treps, Lucas/AAF-2499-2020; Hofkens, Johan/D-4284-2017	van Buul, Jaap D/0000-0003-0054-7949; Rocha, Susana/0000-0003-1258-9396; Rocha, Susana/0000-0003-1258-9396; Cantelmo, Anna Rita/0000-0002-2748-264X; Comitani, Federico/0000-0003-3226-1179; Gervasio, Francesco/0000-0003-4831-5039; Carmeliet, Peter/0000-0001-7961-1821; Ghesquiere, Bart/0000-0003-1547-1705; Treps, Lucas/0000-0003-0735-9000; Hofkens, Johan/0000-0002-9101-0567; Kalucka, Joanna/0000-0003-4887-7672; DUBOIS, Charlotte/0000-0001-6231-3748; DeRan, Michael/0000-0003-4760-3928; van Rijssel, Jos/0000-0001-8077-1371	FWO; LERN/FDRS; IWT; Marie Curie-IEF Fellowship; EMBO Long-Term Fellowship; LSBR fellowship; British Heart Foundation Intermediate Clinical Fellowship; American Cancer Society RSG; NIH/NCI; NIH/NIDDK; EPSRC; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center at Sun Yat-Sen University; National Natural Science Foundation of China [81330021, 81670855]; Federal Government Belgium; Flemish Government, a Concerted Research Activities Belgium grant; Foundation against Cancer; ERC Advanced Research Grant; EPSRC [EP/P011306/1, EP/L000253/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117061] Funding Source: NIH RePORTER	FWO(FWO); LERN/FDRS; IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Marie Curie-IEF Fellowship(European Commission); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); LSBR fellowship; British Heart Foundation Intermediate Clinical Fellowship; American Cancer Society RSG(American Cancer Society); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center at Sun Yat-Sen University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Federal Government Belgium; Flemish Government, a Concerted Research Activities Belgium grant; Foundation against Cancer; ERC Advanced Research Grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge R. Levine for supplying purified bacterial GS; L. Van Den Bosch and W. Scheveneels for providing primary mouse astrocytes; S. Trenson, I. Crevecoeur, S. Noppen, L. Van Berckelaer and R. Van Berwaer for technical assistance; S.-M. Fendt, D. Verdegem and C. Ulens for discussions and suggestions; W. Vermaelen, A. Acosta Sanchez, A. Brajic, A. Sobrino and M. Cockx for experimental assistance; L.-C. Conradi and A. Pircher for supplying materials; and E. Wauters, A. Wolthuis and J. Jaekers for providing tissues for EC isolations. HecBioSim and PRACE are acknowledged for allocation of computer time. J.G., A. R. C., C. D., C. L., J.K., F.M.-R., S. R. and S.Va. are supported by the FWO; A.Z. by LE & B.C. by IWT; U.B. by a Marie Curie-IEF Fellowship; H.H. by an EMBO Long-Term Fellowship; J.D.v.B. by a LSBR fellowship; R.Cu. by a British Heart Foundation Intermediate Clinical Fellowship; and X.W. by the American Cancer Society RSG, NIH/NCI and NIH/NIDDK. F.C., G.S. and F.L.G. are supported by the EPSRC; X.L. by the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center at Sun Yat-Sen University, and the National Natural Science Foundation of China (81330021 and 81670855). P.C. is supported by a Federal Government Belgium grant, long-term structural Methusalem funding by the Flemish Government, a Concerted Research Activities Belgium grant, grants from the FWO, Foundation against Cancer and ERC Advanced Research Grant. G.E. and M. Dew. received a Foundation against Cancer grant and G.E. received a FWO 'Krediet aan navorsers'.	ABCOUWER SF, 1995, SURGERY, V118, P325, DOI 10.1016/S0039-6060(05)80341-1; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ackermann KL, 2016, J BIOL CHEM, V291, P23604, DOI 10.1074/jbc.M116.750026; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Blanc Mathieu, 2015, F1000Res, V4, P261, DOI 10.12688/f1000research.6464.1; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Dadsetan S, 2013, J CEREBR BLOOD F MET, V33, P1235, DOI 10.1038/jcbfm.2013.73; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; de Toledo M, 2003, MOL BIOL CELL, V14, P4846, DOI 10.1091/mbc.E03-04-0254; Dedecker P, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126008; Fiers W. C, 1998, Belgian patent, Patent No. [WO 98/48025, 9848025]; Fraccaroli A, 2015, CIRC RES, V117, P29, DOI 10.1161/CIRCRESAHA.117.305818; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Haberle J, 2005, NEW ENGL J MED, V353, P1926, DOI 10.1056/NEJMoa050456; Hamel LD, 2014, ANAL BIOCHEM, V460, P1, DOI 10.1016/j.ab.2014.05.013; He Y, 2007, DEV DYNAM, V236, P1865, DOI 10.1002/dvdy.21185; He YJ, 2010, GLIA, V58, P741, DOI 10.1002/glia.20960; Heasman Sarah J, 2010, Small GTPases, V1, P174, DOI 10.4161/sgtp.1.3.14724; Heemskerk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10493; Ho CY, 2013, NATURE, V497, P507, DOI 10.1038/nature12105; Huang H, 2017, EMBO J, V36, P2334, DOI 10.15252/embj.201695518; Kaur S, 2011, ARTERIOSCL THROM VAS, V31, P657, DOI 10.1161/ATVBAHA.110.216341; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Kim C, 2014, CANCER CELL, V25, P102, DOI 10.1016/j.ccr.2013.12.010; Kummel D, 2006, P NATL ACAD SCI USA, V103, P12701, DOI 10.1073/pnas.0603513103; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Leszczynska K, 2011, BIOCHEM SOC T, V39, P1606, DOI 10.1042/BST20110702; LEVINE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2120, DOI 10.1073/pnas.78.4.2120; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Mertens N. M. A. C, 2004, Belgian patent, Patent No. [WO 04/074488, 04074488]; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Persson F, 2013, NAT METHODS, V10, P265, DOI [10.1038/NMETH.2367, 10.1038/nmeth.2367]; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Schoors S, 2014, CELL CYCLE, V13, P16, DOI 10.4161/cc.27519; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Timmerman I, 2015, J CELL SCI, V128, P3041, DOI 10.1242/jcs.168674; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; Van Den Bosch L, 2000, J NEUROL SCI, V180, P29, DOI 10.1016/S0022-510X(00)00414-7; Wan JM, 2013, CHEM BIOL, V20, P1421, DOI 10.1016/j.chembiol.2013.09.018; Wei XC, 2014, ARTERIOSCL THROM VAS, V34, P346, DOI 10.1161/ATVBAHA.113.302848; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Zheng BH, 2015, ACS CHEM BIOL, V10, P115, DOI 10.1021/cb500758s	48	79	83	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					63	+		10.1038/s41586-018-0466-7	http://dx.doi.org/10.1038/s41586-018-0466-7			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30158707	Green Submitted, Green Accepted			2022-12-28	WOS:000443755200032
J	Suzuki, K; Yuzaki, M				Suzuki, Kunimichi; Yuzaki, Michisuke			La Dolce Vita of Neurexin: Synaptic Partnerships through Glycosaminoglycans	CELL			English	Editorial Material								Various neurexin transcripts are thought to serve as presynaptic "hub'' molecules by binding to their specific synaptic partners. In this issue, Zhang et al. demonstrate that neurexins are heparan sulfate (HS) proteoglycans and that the HS modification is important for synaptic function in vitro and in vivo. These findings open up the possibility of many more binding partners for the neurexins.	[Suzuki, Kunimichi; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan	Keio University	Yuzaki, M (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan.	myuzaki@keio.jp	Suzuki, Kunimichi/ABB-4501-2020; Yuzaki, Michisuke/K-5328-2013	Suzuki, Kunimichi/0000-0001-7699-2163; Yuzaki, Michisuke/0000-0002-5750-3544				Condomitti G, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00014; de Wit J, 2013, NEURON, V79, P696, DOI 10.1016/j.neuron.2013.06.049; Schreiner D, 2014, NEURON, V84, P386, DOI 10.1016/j.neuron.2014.09.011; Sudhof TC, 2017, CELL, V171, P745, DOI 10.1016/j.cell.2017.10.024; Tanabe Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00333-w; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yuzaki M, 2018, ANNU REV PHYSIOL, V80, P243, DOI 10.1146/annurev-physiol-021317-121322; Zhang P, 2018, CELL, V174, P1450, DOI 10.1016/j.cell.2018.07.002	9	0	0	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1337	1338		10.1016/j.cell.2018.08.052	http://dx.doi.org/10.1016/j.cell.2018.08.052			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193105	Bronze			2022-12-28	WOS:000443841000003
J	Xu, DC; Jin, TJ; Zhu, H; Chen, HB; Ofengeim, D; Zou, CY; Mifflin, L; Pan, LF; Amin, P; Li, WJ; Shan, B; Naito, MG; Meng, HY; Li, Y; Pan, HL; Aron, L; Adiconis, X; Levin, JZ; Yankner, BA; Yuan, JY				Xu, Daichao; Jin, Taijie; Zhu, Hong; Chen, Hongbo; Ofengeim, Dimitry; Zou, Chengyu; Mifflin, Lauren; Pan, Lifeng; Amin, Palak; Li, Wanjin; Shan, Bing; Naito, Masanori Gomi; Meng, Huyan; Li, Ying; Pan, Heling; Aron, Liviu; Adiconis, Xian; Levin, Joshua Z.; Yankner, Bruce A.; Yuan, Junying			TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging	CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TANK-BINDING KINASE-1; CUTTING EDGE; RIP1 KINASE; ACTIVATION; NECROPTOSIS; CELL; PHOSPHORYLATION; NECROSIS; TAK1	Aging is a major risk factor for both genetic and sporadic neurodegenerative disorders. However, it is unclear how aging interacts with genetic predispositions to promote neurodegeneration. Here, we investigate how partial loss of function of TBK1, a major genetic cause for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) comorbidity, leads to age-dependent neurodegeneration. We show that TBK1 is an endogenous inhibitor of RIPK1 and the embryonic lethality of Tbk1(-/-) mice is dependent on RIPK1 kinase activity. In aging human brains, another endogenous RIPK1 inhibitor, TAK1, exhibits a marked decrease in expression. We show that in Tbk1(+/-) mice, the reduced myeloid TAK1 expression promotes all the key hallmarks of ALS/FTD, including neuroinflammation, TDP-43 aggregation, axonal degeneration, neuronal loss, and behavior deficits, which are blocked upon inhibition of RIPK1. Thus, aging facilitates RIPK1 activation by reducing TAK1 expression, which cooperates with genetic risk factors to promote the onset of ALS/FTD.	[Xu, Daichao; Zhu, Hong; Chen, Hongbo; Ofengeim, Dimitry; Zou, Chengyu; Mifflin, Lauren; Amin, Palak; Li, Wanjin; Naito, Masanori Gomi; Yuan, Junying] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Jin, Taijie; Shan, Bing; Meng, Huyan; Li, Ying; Pan, Heling; Yuan, Junying] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, 26 Qiuyue Rd, Shanghai 201210, Peoples R China; [Jin, Taijie; Meng, Huyan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Pan, Lifeng] Chinese Acad Sci, Shanghai Inst Organ Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China; [Aron, Liviu; Yankner, Bruce A.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Adiconis, Xian; Levin, Joshua Z.; Yuan, Junying] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Yuan, JY (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.; Yuan, JY (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, 26 Qiuyue Rd, Shanghai 201210, Peoples R China.; Yuan, JY (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	jyuan@hms.harvard.edu	Aron, LIviu/E-5192-2013; Chen, Hongbo/P-5263-2019	Chen, Hongbo/0000-0002-9084-7277; Jin, Taijie/0000-0003-4238-7293; Zhu, Hong/0000-0002-2575-4031; Levin, Joshua/0000-0002-0170-3598; Mifflin, Lauren/0000-0003-1607-5851; Li, Ying/0000-0002-3506-1255; Amin, Palak/0000-0001-5617-8703; Xu, Daichao/0000-0002-3286-4968; Li, Wanjin/0000-0003-4177-8006; Shan, Bing/0000-0003-4178-3526	NIA [RF1AG055521, 1RO1AG047231, R21AG059073, RO1AG046174]; NINDS [1RO1NS082257]; National Key RAMP;D Program of China [2016YFA0501900]; China National Natural Science Foundation [31530041]; Chinese Academy of Sciences [XDPB10]; NIMH [RO1MH113279]; National Natural Science Foundation of China [31701207]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH113279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046174, R01AG047231, RF1AG055521] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Key RAMP;D Program of China; China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Shizuo Akira of Osaka University, Japan, for Tbk1<SUP>+/-</SUP> mice and Tak1<SUP>fl/fl</SUP> mice, Michelle Kelliher of University of Massachusetts and Manolis Pasparakis of University of Cologne, Germany, for Ripk1<SUP>D138N</SUP> mice, and Vishva Dixit of Genentech for Ripk3<SUP>-/-</SUP> mice. We thank Drs. Maria Ericsson of the HMS Electron Microscopy Facility for assistance with electron microscopy, Jennifer Waters at the HMS Nikon microscope facility for help with microscopy, and Barbara Caldarone of the Neuro Behavior Laboratory, HIM, for assisting mouse behavior analysis. This work was supported by grants from the NIA (RF1AG055521, 1RO1AG047231, and R21AG059073), the NINDS (1RO1NS082257), the National Key R&D Program of China (2016YFA0501900), the China National Natural Science Foundation (31530041), the Chinese Academy of Sciences (XDPB10 to J.Y.), the NIA RO1AG046174, NIMH RO1MH113279 (to B.A.Y.), and a grant from the National Natural Science Foundation of China (31701207 to H.C.).	Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Caccamo A, 2017, NAT NEUROSCI, V20, P1236, DOI 10.1038/nn.4608; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Conde JR, 2006, J NEUROPATH EXP NEUR, V65, P199, DOI 10.1097/01.jnen.0000202887.22082.63; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dondelinger Y, 2013, CELL DEATH DIFFER, V20, P1381, DOI 10.1038/cdd.2013.94; Dziedzic SA, 2018, NAT CELL BIOL, V20, P58, DOI 10.1038/s41556-017-0003-1; Freischmidt A, 2017, JAMA NEUROL, V74, P110, DOI 10.1001/jamaneurol.2016.3712; Geng JF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00406-w; Ghasemi M., 2017, COLD SPRING HARB PER, V8; Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Jaco I, 2017, MOL CELL, V66, P698, DOI 10.1016/j.molcel.2017.05.003; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kuai J, 2004, J BIOL CHEM, V279, P53266, DOI 10.1074/jbc.M411037200; Lall D, 2017, J CLIN INVEST, V127, P3250, DOI 10.1172/JCI90607; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; McCartney RR, 2016, BBA-PROTEINS PROTEOM, V1864, P1518, DOI 10.1016/j.bbapap.2016.08.007; Meng HY, 2018, P NATL ACAD SCI USA, V115, pE2001, DOI 10.1073/pnas.1722013115; Menon MB, 2017, NAT CELL BIOL, V19, P1248, DOI 10.1038/ncb3614; Mihaly SR, 2014, CELL DEATH DIFFER, V21, P1667, DOI 10.1038/cdd.2014.123; Morioka S, 2014, J CELL BIOL, V204, P607, DOI 10.1083/jcb.201305070; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Niccoli T, 2017, HUM MOL GENET, V26, pR105, DOI 10.1093/hmg/ddx247; Ofengeim D, 2017, P NATL ACAD SCI USA, V114, pE8788, DOI 10.1073/pnas.1714175114; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Onyike CU, 2013, INT REV PSYCHIATR, V25, P130, DOI 10.3109/09540261.2013.776523; PERRY VH, 1993, GLIA, V7, P60, DOI 10.1002/glia.440070111; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Xie T, 2013, STRUCTURE, V21, P493, DOI 10.1016/j.str.2013.01.016; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zimmermann KC, 2001, J ALLERGY CLIN IMMUN, V108, pS99, DOI 10.1067/mai.2001.117819	50	195	201	9	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1477	+		10.1016/j.cell.2018.07.041	http://dx.doi.org/10.1016/j.cell.2018.07.041			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30146158	Green Accepted, Bronze			2022-12-28	WOS:000443841000016
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: "Why did they put her on a geriatric ward?"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2016, BMJ-BRIT MED J, V353, pi2886, DOI [10.1136/bmj.i288627220842, DOI 10.1136/BMJ.I2886]; Asplund K, 1997, STROKE, V28, P2139, DOI 10.1161/01.STR.28.11.2139; BritainThinks, 2015, FRAILT LANG PERC REP; Campbell D, 2018, GUARDIAN; Centre for Policy on Ageing, 2009, AG AG DISCR SEC HLTH; Cooke M, 2012, QUALITY CARE OLDER P; Davidson S, 2013, AGE UK ENG LIFE EVID; Ellis G, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub3; Fleming J, 2016, DEATH OLDEST OLD ATT, DOI [10.1371/journal.pone.0150686, DOI 10.1371/JOURNAL.PONE.0150686]; Hawley S, 2016, AGE AGEING, V45, P236, DOI 10.1093/ageing/afv204; Oliver D, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5195; Oliver David, 2016, Future Hosp J, V3, P49, DOI 10.7861/futurehosp.3-1-49; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Tadd W., 2011, DIGNITY PRACTICE EXP	14	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2018	362								k3701	10.1136/bmj.k3701	http://dx.doi.org/10.1136/bmj.k3701			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4VO	30181132	Bronze			2022-12-28	WOS:000444503800005
J	Yazdany, J; Dudley, RA; Lin, GA; Chen, R; Tseng, CW				Yazdany, Jinoos; Dudley, R. Adams; Lin, Grace A.; Chen, Randi; Tseng, Chien-Wen			Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Yazdany, Jinoos] Univ Calif San Francisco, Div Rheumatol, 1001 Potrero Ave,Bldg 30, San Francisco, CA 94110 USA; [Dudley, R. Adams; Lin, Grace A.] Univ Calif San Francisco, Ctr Healthcare Value, San Francisco, CA 94143 USA; [Chen, Randi] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Tseng, Chien-Wen] Univ Hawaii, Dept Family Practice & Community Hlth, Honolulu, HI 96822 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pacific Health Research & Education Institute; University of Hawaii System	Yazdany, J (corresponding author), Univ Calif San Francisco, Div Rheumatol, 1001 Potrero Ave,Bldg 30, San Francisco, CA 94110 USA.	jinoos.yazdany@ucsf.edu			Agency for Healthcare Research and Quality [R03HS016772]; Robert L. Kroc Endowed Chair in Rheumatic and Connective Tissue Diseases [NIH/NIAMS P30 AR070155]; Hawaii Medical Services Association Endowed Chair in Health Services and Quality Research at the University of Hawaii; Russell/Engleman Medical Research Center for Arthritis at the University of California, San Francisco; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS016772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR070155] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Robert L. Kroc Endowed Chair in Rheumatic and Connective Tissue Diseases; Hawaii Medical Services Association Endowed Chair in Health Services and Quality Research at the University of Hawaii; Russell/Engleman Medical Research Center for Arthritis at the University of California, San Francisco; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by grant R03HS016772 from the Agency for Healthcare Research and Quality (Dr Tseng), grant NIH/NIAMS P30 AR070155 from the Robert L. Kroc Endowed Chair in Rheumatic and Connective Tissue Diseases (Dr Yazdany), the Hawaii Medical Services Association Endowed Chair in Health Services and Quality Research at the University of Hawaii (Dr Tseng), and the Russell/Engleman Medical Research Center for Arthritis at the University of California, San Francisco (Dr Yazdany).	Centers for Medicare & Medicaid Services, 2015 MED DRUG SPEND; Cubanski J., SUMMARY RECENT PROPO; Hakim A, 2017, JAMA-J AM MED ASSOC, V317, P2163, DOI 10.1001/jama.2017.5202; Kaiser Family Foundation, MED D; Mulcahy AW., BIOSIMILAR COST SAVI; Yazdany J, 2015, ARTHRITIS RHEUMATOL, V67, P1474, DOI 10.1002/art.39079	6	22	22	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2018	320	9					931	933		10.1001/jama.2018.7316	http://dx.doi.org/10.1001/jama.2018.7316			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS4OQ	30193264	Green Published, Bronze			2022-12-28	WOS:000443627300019
J	Goebel, THW; Brodsky, EE				Goebel, Thomas H. W.; Brodsky, Emily E.			The spatial footprint of injection wells in a global compilation of induced earthquake sequences	SCIENCE			English	Article							INDUCED SEISMICITY; FLUID-INJECTION; STIMULATION; RESERVOIR; DISPOSAL; SWARM	Fluid injection can cause extensive earthquake activity, sometimes at unexpectedly large distances. Appropriately mitigating associated seismic hazards requires a better understanding of the zone of influence of injection. We analyze spatial seismicity decay in a global dataset of 18 induced cases with clear association between isolated wells and earthquakes. We distinguish two populations. The first is characterized by near-well seismicity density plateaus and abrupt decay, dominated by square-root space-time migration and pressure diffusion. Injection at these sites occurs within the crystalline basement. The second population exhibits larger spatial footprints and magnitudes, as well as a power law-like, steady spatial decay over more than 10 kilometers, potentially caused by poroelastic effects. Far-reaching spatial effects during injection may increase event magnitudes and seismic hazard beyond expectations based on purely pressure-driven seismicity.	[Goebel, Thomas H. W.; Brodsky, Emily E.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Goebel, THW (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	tgoebel@ucsc.edu		Goebel, Thomas H.W./0000-0003-1552-0861; Brodsky, Emily/0000-0002-6855-6860	U.S. Department of Energy [DE-SC0015539]	U.S. Department of Energy(United States Department of Energy (DOE))	We gratefully acknowledge funding from the U.S. Department of Energy, grant DE-SC0015539.	Albaric J, 2014, GEOTHERMICS, V52, P120, DOI 10.1016/j.geothermics.2013.10.013; Baisch S, 2002, B SEISMOL SOC AM, V92, P2369, DOI 10.1785/0120010236; Baisch S, 2006, B SEISMOL SOC AM, V96, P2242, DOI 10.1785/0120050255; Bao XW, 2016, SCIENCE, V354, P1406, DOI 10.1126/science.aag2583; Block LV, 2014, SEISMOL RES LETT, V85, P609, DOI 10.1785/0220130188; Brown MRM, 2017, J GEOPHYS RES-SOL EA, V122, P6569, DOI 10.1002/2017JB014456; Detournay E, 1993, ANAL DESIGN METHODS, P113, DOI DOI 10.1016/B978-0-08-040615-2.50011-3; Diehl T, 2017, J GEOPHYS RES-SOL EA, V122, P7272, DOI 10.1002/2017JB014473; Duboeuf L, 2017, J GEOPHYS RES-SOL EA, V122, P8285, DOI 10.1002/2017JB014535; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; Evans KF, 2012, GEOTHERMICS, V41, P30, DOI 10.1016/j.geothermics.2011.08.002; Felzer KR, 2006, NATURE, V441, P735, DOI 10.1038/nature04799; Goebel THW, 2017, EARTH PLANET SC LETT, V472, P50, DOI 10.1016/j.epsl.2017.05.011; Goebel THW, 2016, GEOPHYS RES LETT, V43, P1092, DOI 10.1002/2015GL066948; Guglielmi Y, 2015, SCIENCE, V348, P1224, DOI 10.1126/science.aab0476; Horton S, 2012, SEISMOL RES LETT, V83, P250, DOI 10.1785/gssrl.83.2.250; Houston H, 2011, NAT GEOSCI, V4, P404, DOI [10.1038/ngeo1157, 10.1038/NGEO1157]; HSIEH PA, 1981, J GEOPHYS RES, V86, P903, DOI 10.1029/JB086iB02p00903; Keranen KM, 2014, SCIENCE, V345, P448, DOI 10.1126/science.1255802; Kim KH, 2018, SCIENCE, V360, P1007, DOI 10.1126/science.aat6081; Kraft T, 2014, GEOTHERMICS, V52, P59, DOI 10.1016/j.geothermics.2014.05.014; Ma XD, 2017, J GEOPHYS RES-SOL EA, V122, P2478, DOI 10.1002/2016JB013668; Martinez-Garzon P, 2014, J GEOPHYS RES-SOL EA, V119, P8378, DOI 10.1002/2014JB011385; McGarr A, 2014, J GEOPHYS RES-SOL EA, V119, P1008, DOI 10.1002/2013JB010597; Mukuhira Y, 2017, GEOPHYS RES LETT, V44, P3109, DOI 10.1002/2017GL072809; Ogwari PO, 2018, J GEOPHYS RES-SOL EA, V123, P553, DOI 10.1002/2017JB015003; RALEIGH CB, 1976, SCIENCE, V191, P1230, DOI 10.1126/science.191.4233.1230; Segall P, 2015, J GEOPHYS RES-SOL EA, V120, P5082, DOI 10.1002/2015JB012060; Skoumal RJ, 2014, EARTH PLANET SC LETT, V405, P274, DOI 10.1016/j.epsl.2014.08.033; Sumy DF, 2014, J GEOPHYS RES-SOL EA, V119, P1904, DOI 10.1002/2013JB010612; van der Elst NJ, 2016, J GEOPHYS RES-SOL EA, V121, P4575, DOI 10.1002/2016JB012818; Wang H.F., 2000, PRI SER GEO; Yeck WL, 2017, GEOPHYS RES LETT, V44, P711, DOI 10.1002/2016GL071685; Zaliapin I, 2013, J GEOPHYS RES-SOL EA, V118, P2847, DOI 10.1002/jgrb.50179	34	101	104	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					899	903		10.1126/science.aat5449	http://dx.doi.org/10.1126/science.aat5449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166486				2022-12-28	WOS:000443547000034
J	Gouveia, SF				Gouveia, Sidney F.			The detour that became a shortcut	SCIENCE			English	Editorial Material									[Gouveia, Sidney F.] Univ Fed Sergipe, Sao Cristovao, Brazil	Universidade Federal de Sergipe	Gouveia, SF (corresponding author), Univ Fed Sergipe, Sao Cristovao, Brazil.	SciCareerEditor@aaas.org	Gouveia, Sidney F/G-6438-2013	Gouveia, Sidney F/0000-0003-4941-7440					0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					942	942		10.1126/science.361.6405.942	http://dx.doi.org/10.1126/science.361.6405.942			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS3UB	30166493				2022-12-28	WOS:000443547000041
J	Kolch, W; Kiel, C				Kolch, Walter; Kiel, Christina			From oncogenic mutation to dynamic code	SCIENCE			English	Editorial Material							BRAF		[Kolch, Walter; Kiel, Christina] Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Kolch, Walter; Kiel, Christina] Univ Coll Dublin, Sch Med, Dublin 4, Ireland; [Kolch, Walter] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Kiel, Christina] Univ Coll Dublin, Charles Inst, Dublin 4, Ireland	University College Dublin; University College Dublin; University College Dublin; University College Dublin	Kolch, W (corresponding author), Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland.; Kolch, W (corresponding author), Univ Coll Dublin, Sch Med, Dublin 4, Ireland.; Kolch, W (corresponding author), Univ Coll Dublin, Conway Inst, Dublin 4, Ireland.	walter.kolch@ucd.ie	Kolch, Walter/ABF-2102-2021; Admin, SBI/HGB-2738-2022	Kiel, Christina/0000-0001-8454-6008				Bugaj LJ, 2018, SCIENCE, V361, DOI 10.1126/science.aao3048; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Holderfield M, 2013, CANCER CELL, V23, P594, DOI 10.1016/j.ccr.2013.03.033; Kholodenko BN, 2015, CELL REP, V12, P1939, DOI 10.1016/j.celrep.2015.08.014; Lu SY, 2016, CHEM REV, V116, P6607, DOI 10.1021/acs.chemrev.5b00542; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Selimkhanov J, 2014, SCIENCE, V346, P1370, DOI 10.1126/science.1254933; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Unal EB, 2017, FEBS LETT, V591, P2607, DOI 10.1002/1873-3468.12740; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001	15	5	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					844	+		10.1126/science.aau8059	http://dx.doi.org/10.1126/science.aau8059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS3UB	30166473				2022-12-28	WOS:000443547000014
J	Beroza, GC				Beroza, Gregory C.			Aftershock forecasts turn to AI	NATURE			English	Editorial Material								Understanding how earthquakes interact is key to reliable earthquake forecasting. A machine-learning study reveals how the stress change induced by earthquakes at geological faults affects these interactions.	[Beroza, Gregory C.] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA	Stanford University	Beroza, GC (corresponding author), Stanford Univ, Dept Geophys, Stanford, CA 94305 USA.	beroza@stanford.edu						Cattania C, 2018, SEISMOL RES LETT, V89, P1238, DOI 10.1785/0220180033; DeVries PMR, 2018, NATURE, V560, P632, DOI 10.1038/s41586-018-0438-y; HILL DP, 1993, SCIENCE, V260, P1617, DOI 10.1126/science.260.5114.1617; KING GCP, 1994, B SEISMOL SOC AM, V84, P935; Mai PM, 2016, SEISMOL RES LETT, V87, P690, DOI 10.1785/0220150231; Marzocchi W, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701239; Meng XF, 2014, GEOPHYS J INT, V197, P1750, DOI 10.1093/gji/ggu085; REASENBERG PA, 1989, SCIENCE, V243, P1173, DOI 10.1126/science.243.4895.1173; Segou M, 2016, SEISMOL RES LETT, V87, P816, DOI 10.1785/0220150195; Smith DE, 2010, PURE APPL GEOPHYS, V167, P1067, DOI 10.1007/s00024-010-0093-1; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; TCHALENKO JS, 1970, GEOL SOC AM BULL, V81, P1625, DOI 10.1130/0016-7606(1970)81[1625:SBSZOD]2.0.CO;2; Toda S, 2012, NAT GEOSCI, V5, P410, DOI [10.1038/ngeo1465, 10.1038/NGEO1465]	13	2	2	6	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					556	+		10.1038/d41586-018-06030-y	http://dx.doi.org/10.1038/d41586-018-06030-y			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS0SZ	30158611	Bronze			2022-12-28	WOS:000443218600030
J	Kuehn, B				Kuehn, Bridget			Chronic Fatigue Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					750	750		10.1001/jama.2018.11469	http://dx.doi.org/10.1001/jama.2018.11469			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167707				2022-12-28	WOS:000442958800012
J	Wang, HE; Schmicker, RH; Daya, MR; Stephens, SW; Idris, AH; Carlson, JN; Colella, MR; Herren, H; Hansen, M; Richmond, NJ; Puyana, JCJ; Aufderheide, T; Gray, RE; Gray, PC; Verkest, M; Owens, PC; Brienza, AM; Sternig, KJ; May, SJ; Sopko, GR; Weisfeldt, ML; Nichol, G				Wang, Henry E.; Schmicker, Robert H.; Daya, Mohamud R.; Stephens, Shannon W.; Idris, Ahamed H.; Carlson, Jestin N.; Colella, M. Riccardo; Herren, Heather; Hansen, Matthew; Richmond, Neal J.; Puyana, Juan Carlos J.; Aufderheide, Tomp.; Gray, Randal E.; Gray, Pamela C.; Verkest, Mike; Owens, Pamela C.; Brienza, Ashley M.; Sternig, Kenneth J.; May, Susanne J.; Sopko, George R.; Weisfeldt, Myron L.; Nichol, Graham			Effect of a Strategy of Initial Laryngeal Tube Insertion vs Endotracheal Intubation on 72-Hour Survival in Adults With Out-of-Hospital Cardiac Arrest A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine (SAEM)	MAY 15-18, 2018	Indianapolis, IN	Soc Acad Emergency Med			AMERICAN-HEART-ASSOCIATION; ADVANCED AIRWAY MANAGEMENT; EMERGENCY CARDIOVASCULAR CARE; CARDIOPULMONARY-RESUSCITATION; SUPRAGLOTTIC AIRWAY; SUCCESS RATES; PART; EXPERIENCE; DEVICE; IMPLEMENTATION	IMPORTANCE Emergency medical services(EMS) commonly perform endotracheal intubation(ETI) or insertion of supraglottic airways, such as the laryngeal tube (LT), on patients with out-of-hospital cardiac arrest (OHCA). The optimal method for OHCA advanced airway management is unknown. OBJECTIVE To compare the effectiveness of a strategy of initial LT insertion vs initial ETI in adults with OHCA. DESIGN, SETTING, AND PARTICIPANTS Multicenter pragmatic cluster-crossover clinical trial involving EMS agencies from the Resuscitation Outcomes Consortium. The trial included 3004 adults with OHCA and anticipated need for advanced airway management who were enrolled from December 1, 2015, to November 4, 2017. The final date of follow-up was November 10, 2017. INTERVENTIONS Twenty-seven EMS agencies were randomized in 13 clusters to initial airway management strategy with LT (n = 1505 patients) or ETI (n = 1499 patients), with crossover to the alternate strategy at 3- to 5-month intervals. MAIN OUTCOMES AND MEASURES The primary outcome was 72-hour survival. Secondary outcomes included return of spontaneous circulation, survival to hospital discharge, favorable neurological status at hospital discharge (Modified Rankin Scale score <= 3), and key adverse events. RESULTS Among 3004 enrolled patients (median [interquartile range] age, 64 [53-76] years, 1829 [60.9%] men), 3000 were included in the primary analysis. Rates of initial airway success were 90.3% with LT and 51.6% with ETI. Seventy-two hour survival was 18.3% in the LT group vs 15.4% in the ETI group (adjusted difference, 2.9%[95% CI, 0.2%-5.6%]; P=.04). Secondary outcomes in the LT group vs ETI group were return of spontaneous circulation (27.9% vs 24.3%; adjusted difference, 3.6%[95% CI, 0.3%-6.8%]; P=.03); hospital survival (10.8% vs 8.1%; adjusted difference, 2.7%[95% CI, 0.6%-4.8%]; P=.01); and favorable neurological status at discharge (7.1% vs 5.0%; adjusted difference, 2.1%[95% CI, 0.3%-3.8%]; P=.02). There were no significant differences in oropharyngeal or hypopharyngeal injury (0.2% vs 0.3%), airway swelling (1.1% vs 1.0%), or pneumonia or pneumonitis (26.1% vs 22.3%). CONCLUSIONS AND RELEVANCE Among adults with OHCA, a strategy of initial LT insertion was associated with significantly greater 72-hour survival compared with a strategy of initial ETI. These findings suggest that LT insertion may be considered as an initial airway management strategy in patients with OHCA, but limitations of the pragmatic design, practice setting, and ETI performance characteristics suggest that further research is warranted.	[Wang, Henry E.] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, 6431 Fannin St,JJL 434, Houston, TX 77030 USA; [Wang, Henry E.; Stephens, Shannon W.; Gray, Randal E.; Gray, Pamela C.] Univ Alabama Birmingham, Dept Emergency Med, Birmingham, AL USA; [Schmicker, Robert H.; Herren, Heather; May, Susanne J.] Univ Washington, Dept Biostat, Clin Trials Ctr, Seattle, WA 98195 USA; [Daya, Mohamud R.; Hansen, Matthew] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; [Idris, Ahamed H.; Owens, Pamela C.] Univ Texas Southwestern Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA; [Carlson, Jestin N.] St Vincent Hosp, Allegheny Hlth Network, Dept Emergency Med, Erie, PA USA; [Carlson, Jestin N.; Puyana, Juan Carlos J.; Brienza, Ashley M.] Univ Pittsburgh, Pittsburgh, PA USA; [Colella, M. Riccardo; Aufderheide, Tomp.] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Richmond, Neal J.] MedStar Mobile Healthcare, Ft Worth, TX USA; [Richmond, Neal J.] John Peter Smith Hlth Network, Dept Emergency Med, Ft Worth, TX USA; [Verkest, Mike] Clackamas Fire Dist 1, Milwaukie, OR USA; [Sternig, Kenneth J.] Milwaukee Cty Off Emergency Management, Milwaukee, WI USA; [Sopko, George R.] NHLBI, Bldg 10, Bethesda, MD 20892 USA; [Weisfeldt, Myron L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Nichol, Graham] Univ Washington, Harborview Ctr Prehosp Emergency Care, Dept Emergency Med, Seattle, WA 98195 USA; [Nichol, Graham] Univ Washington, Harborview Ctr Prehosp Emergency Care, Dept Med, Seattle, WA 98195 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; Oregon Health & Science University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle	Wang, HE (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, 6431 Fannin St,JJL 434, Houston, TX 77030 USA.	henry.e.wang@uth.tmc.edu	Daya, Mohamud R/A-9322-2012; Nichol, Graham/Z-4996-2019	Brienza, Ashley/0000-0003-2371-6338	NHLBI [UH2/UH3-HL125163, 5U01 HL077863, HL077866, HL077871, HL077873, HL077881, HL077887]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077887, U01HL077871, U01HL077881, U01HL077866, U01HL077873, U01HL077863, UH3HL125163] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by award UH2/UH3-HL125163 from the NHLBI. The Resuscitation Outcomes Consortium institutions participating in the trial were supported by a series of cooperative agreements from the NHLBI, including 5U01 HL077863 (University of Washington Data Coordinating Center), HL077866 (Medical College of Wisconsin), HL077871 (University of Pittsburgh), HL077873 (Oregon Health and Science University), HL077881 (University of Alabama at Birmingham), and HL077887 (University of Texas Southwestern Medical Center/Dallas). Ambu Inc provided laryngeal tube airways to replace equipment used by emergency medical services (EMS) agencies during the trial.	Andersen LW, 2018, RESUSCITATION, V125, P79, DOI 10.1016/j.resuscitation.2018.02.006; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2011, NEW ENGL J MED, V365, P798, DOI 10.1056/NEJMoa1010821; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Benger JR, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002467; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Benoit JL, 2015, RESUSCITATION, V93, P124, DOI 10.1016/j.resuscitation.2015.06.005; Benoit JL, 2015, RESUSCITATION, V93, P20, DOI 10.1016/j.resuscitation.2015.05.007; Cady CE, 2005, AM J EMERG MED, V23, P868, DOI 10.1016/j.ajem.2005.07.013; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Department of Health and Human Services, 2013, LOW COST PRAGM PAT C; Frascone RJ, 2011, RESUSCITATION, V82, P1529, DOI 10.1016/j.resuscitation.2011.07.009; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Hanif MA, 2010, ACAD EMERG MED, V17, P926, DOI 10.1111/j.1553-2712.2010.00829.x; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; Jabre P, 2018, JAMA-J AM MED ASSOC, V319, P779, DOI 10.1001/jama.2018.0156; Kajino K, 2011, CRIT CARE, V15, DOI 10.1186/cc10483; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Kittelson JM, 1999, BIOMETRICS, V55, P874, DOI 10.1111/j.0006-341X.1999.00874.x; Kurz MC, 2016, RESUSCITATION, V98, P35, DOI 10.1016/j.resuscitation.2015.10.011; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; McMullan J, 2014, RESUSCITATION, V85, P617, DOI 10.1016/j.resuscitation.2014.02.007; Nichol G, 2015, NEW ENGL J MED, V373, P2203, DOI 10.1056/NEJMoa1509139; Ochs M, 2000, Prehosp Emerg Care, V4, P333, DOI 10.1080/10903120090941065; PAMPALLONA S, 1994, J STAT PLAN INFER, V42, P19, DOI 10.1016/0378-3758(94)90187-2; Park MJ, 2017, ACAD EMERG MED, V24, P1464, DOI 10.1111/acem.13309; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Ritter SC, 2011, PREHOSP EMERG CARE, V15, P401, DOI 10.3109/10903127.2011.561400; Stiell IG, 2011, NEW ENGL J MED, V365, P787, DOI 10.1056/NEJMoa1010076; Taylor J, 2016, RESUSCITATION, V109, P25, DOI 10.1016/j.resuscitation.2016.09.016; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2003, RESUSCITATION, V58, P49, DOI 10.1016/S0300-9572(03)00058-3; Wang HE, 2016, RESUSCITATION, V101, P57, DOI 10.1016/j.resuscitation.2016.01.012; Wang HE, 2012, RESUSCITATION, V83, P1061, DOI 10.1016/j.resuscitation.2012.05.018; Wang HE, 2009, ANN EMERG MED, V54, P645, DOI 10.1016/j.annemergmed.2009.05.024	37	179	183	3	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					769	778		10.1001/jama.2018.7044	http://dx.doi.org/10.1001/jama.2018.7044			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	GR8HM	30167699	Bronze, Green Published			2022-12-28	WOS:000442958800022
J	Bowman, L; Mafham, M; Wallendszus, K; Stevens, W; Buck, G; Barton, J; Murphy, K; Aung, T; Haynes, R; Cox, J; Murawska, A; Young, A; Lay, M; Chen, F; Sammons, E; Waters, E; Adler, A; Bodansky, J; Farmer, A; McPherson, R; Neil, A; Simpson, D; Peto, R; Baigent, C; Collins, R; Parish, S; Armitage, J				Bowman, Louise; Mafham, Marion; Wallendszus, Karl; Stevens, Will; Buck, Georgina; Barton, Jill; Murphy, Kevin; Aung, Theingi; Haynes, Richard; Cox, Jolyon; Murawska, Aleksandra; Young, Allen; Lay, Michael; Chen, Fang; Sammons, Emily; Waters, Emma; Adler, Amanda; Bodansky, Jonathan; Farmer, Andrew; McPherson, Roger; Neil, Andrew; Simpson, David; Peto, Richard; Baigent, Colin; Collins, Rory; Parish, Sarah; Armitage, Jane		ASCEND Study Collaborative Grp	Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-DOSE ASPIRIN; CARDIOVASCULAR EVENTS; COLORECTAL-CANCER; RANDOMIZED-TRIAL; PEOPLE; RISK; METAANALYSIS; MORTALITY; DISEASE; DESIGN	BACKGROUND Diabetes mellitus is associated with an increased risk of cardiovascular events. Aspirin use reduces the risk of occlusive vascular events but increases the risk of bleeding; the balance of benefits and hazards for the prevention of first cardiovascular events in patients with diabetes is unclear. METHODS We randomly assigned adults who had diabetes but no evident cardiovascular disease to receive aspirin at a dose of 100 mg daily or matching placebo. The primary efficacy outcome was the first serious vascular event (i.e., myocardial infarction, stroke or transient ischemic attack, or death from any vascular cause, excluding any confirmed intracranial hemorrhage). The primary safety outcome was the first major bleeding event (i.e., intracranial hemorrhage, sight-threatening bleeding event in the eye, gastrointestinal bleeding, or other serious bleeding). Secondary outcomes included gastrointestinal tract cancer. RESULTS A total of 15,480 participants underwent randomization. During a mean follow-up of 7.4 years, serious vascular events occurred in a significantly lower percentage of participants in the aspirin group than in the placebo group (658 participants [8.5%] vs. 743 [9.6%]; rate ratio, 0.88; 95% confidence interval [CI], 0.79 to 0.97; P=0.01). In contrast, major bleeding events occurred in 314 participants (4.1%) in the aspirin group, as compared with 245 (3.2%) in the placebo group (rate ratio, 1.29; 95% CI, 1.09 to 1.52; P=0.003), with most of the excess being gastrointestinal bleeding and other extracranial bleeding. There was no significant difference between the aspirin group and the placebo group in the incidence of gastrointestinal tract cancer (157 participants [2.0%] and 158 [2.0%], respectively) or all cancers (897 [11.6%] and 887 [11.5%]); long-term follow-up for these outcomes is planned. CONCLUSIONS Aspirin use prevented serious vascular events in persons who had diabetes and no evident cardiovascular disease at trial entry, but it also caused major bleeding events. The absolute benefits were largely counterbalanced by the bleeding hazard. (Funded by the British Heart Foundation and others; ASCEND Current Controlled Trials number, ISRCTN60635500; ClinicalTrials.gov number, NCT00135226.)	[Bowman, Louise; Mafham, Marion; Wallendszus, Karl; Stevens, Will; Buck, Georgina; Barton, Jill; Murphy, Kevin; Haynes, Richard; Cox, Jolyon; Murawska, Aleksandra; Young, Allen; Lay, Michael; Chen, Fang; Sammons, Emily; Waters, Emma; Simpson, David; Peto, Richard; Baigent, Colin; Collins, Rory; Parish, Sarah; Armitage, Jane] Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Bowman, Louise; Mafham, Marion; Wallendszus, Karl; Stevens, Will; Buck, Georgina; Barton, Jill; Murphy, Kevin; Haynes, Richard; Cox, Jolyon; Murawska, Aleksandra; Young, Allen; Lay, Michael; Chen, Fang; Sammons, Emily; Waters, Emma; Simpson, David; Peto, Richard; Baigent, Colin; Collins, Rory; Parish, Sarah; Armitage, Jane] Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England; [Farmer, Andrew] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Neil, Andrew] Univ Oxford, Wolfson Coll, Oxford, England; [Aung, Theingi] Royal Berkshire NHS Fdn Trust, Reading, Berks, England; [Adler, Amanda] Addenbrookes Hosp, Cambridge, England; [Bodansky, Jonathan] Leeds Gen Infirm, Leeds, W Yorkshire, England; [McPherson, Roger] Univ Hosp Wales, Cardiff, S Glam, Wales	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Royal Berkshire Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Leeds General Infirmary; University of Leeds; Cardiff University	Armitage, J (corresponding author), Nuffield Dept Populat Hlth, MRC, Populat Hlth Res Unit, Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.; Armitage, J (corresponding author), Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	jane.armitage@ndph.ox.ac.uk	Collins, Rory/ABA-8487-2020; Twomey, Patrick J/AAN-7614-2021; Car, Josip/H-6755-2015	Twomey, Patrick J/0000-0001-7284-4673; Farmer, Andrew/0000-0002-6170-4402; Craig, Martin/0000-0003-4956-4512; Haynes, Richard/0000-0002-1179-0023; Offer, Alison/0000-0002-3367-3207; Wallendszus, Karl/0000-0003-0971-3026; Chen, Fang/0000-0003-0374-8519; Car, Josip/0000-0001-8969-371X	British Heart Foundation; MRC [MC_U137686853, MC_UU_12026/5, MC_U137686861, 1935732] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the British Heart Foundation and others; ASCEND Current Controlled Trials number, ISRCTN60635500; ClinicalTrials.gov number, NCT00135226.	Ajjan R, 2008, DIABETOLOGIA, V51, P385, DOI 10.1007/s00125-007-0898-3; Aung T, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1354-9; Belch J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2582; Bosch J, 2017, CAN J CARDIOL, V33, P1027, DOI 10.1016/j.cjca.2017.06.001; Bothwell PM, 2018, LANCET, V392, P387, DOI [10.1016/s0140-6736(18)31133-4, 10.1016/S0140-6736(18)31133-4]; Bowman L, 2018, NEW ENGL J MED, V379, P1540, DOI 10.1056/NEJMoa1804989; Bowman L, 2018, AM HEART J, V198, P135, DOI 10.1016/j.ahj.2017.12.006; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Eikelboom JW, 2017, NEW ENGL J MED, V377, P1319, DOI 10.1056/NEJMoa1709118; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Ikeda Y, 2014, JAMA-J AM MED ASSOC, V312, P2510, DOI 10.1001/jama.2014.15690; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Scally B, 2018, LANCET GASTROENTEROL, V3, P231, DOI 10.1016/S2468-1253(18)30037-2; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; van Rooij FG, 2016, CEREBROVASC DIS, V42, P1, DOI 10.1159/000444282; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	24	567	592	1	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2018	379	16					1529	1539		10.1056/NEJMoa1804988	http://dx.doi.org/10.1056/NEJMoa1804988			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX4EI	30146931	Bronze, Green Published			2022-12-28	WOS:000447679900008
J	Bowman, L; Mafham, M; Wallendszus, K; Stevens, W; Buck, G; Barton, J; Murphy, K; Aung, T; Haynes, R; Cox, J; Murawska, A; Young, A; Lay, M; Chen, F; Sammons, E; Waters, E; Adler, A; Bodansky, J; Farmer, A; McPherson, R; Neil, A; Simpson, D; Peto, R; Baigent, C; Collins, R; Parish, S; Armitage, J				Bowman, Louise; Mafham, Marion; Wallendszus, Karl; Stevens, Will; Buck, Georgina; Barton, Jill; Murphy, Kevin; Aung, Theingi; Haynes, Richard; Cox, Jolyon; Murawska, Aleksandra; Young, Allen; Lay, Michael; Chen, Fang; Sammons, Emily; Waters, Emma; Adler, Amanda; Bodansky, Jonathan; Farmer, Andrew; McPherson, Roger; Neil, Andrew; Simpson, David; Peto, Richard; Baigent, Colin; Collins, Rory; Parish, Sarah; Armitage, Jane		ASCEND Study Collaborative Grp	Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; FISH CONSUMPTION; EICOSAPENTAENOIC ACID; SECONDARY-PREVENTION; DOUBLE-BLIND; OUTCOMES; TRIAL; RISK; OIL; OMEGA-3-FATTY-ACIDS	BACKGROUND Increased intake of n-3 fatty acids has been associated with a reduced risk of cardiovascular disease in observational studies, but this finding has not been confirmed in randomized trials. It remains unclear whether n-3 (also called omega-3) fatty acid supplementation has cardiovascular benefit in patients with diabetes mellitus. METHODS We randomly assigned 15,480 patients with diabetes but without evidence of atherosclerotic cardiovascular disease to receive 1-g capsules containing either n-3 fatty acids (fatty acid group) or matching placebo (olive oil) daily. The primary outcome was a first serious vascular event (i.e., nonfatal myocardial infarction or stroke, transient ischemic attack, or vascular death, excluding confirmed intracranial hemorrhage). The secondary outcome was a first serious vascular event or any arterial revascularization. RESULTS During a mean follow-up of 7.4 years (adherence rate, 76%), a serious vascular event occurred in 689 patients (8.9%) in the fatty acid group and in 712 (9.2%) in the placebo group (rate ratio, 0.97; 95% confidence interval [CI], 0.87 to 1.08; P=0.55). The composite outcome of a serious vascular event or revascularization occurred in 882 patients (11.4%) and 887 patients (11.5%), respectively (rate ratio, 1.00; 95% CI, 0.91 to 1.09). Death from any cause occurred in 752 patients (9.7%) in the fatty acid group and in 788 (10.2%) in the placebo group (rate ratio, 0.95; 95% CI, 0.86 to 1.05). There were no significant between-group differences in the rates of nonfatal serious adverse events. CONCLUSIONS Among patients with diabetes without evidence of cardiovascular disease, there was no significant difference in the risk of serious vascular events between those who were assigned to receive n-3 fatty acid supplementation and those who were assigned to receive placebo. (Funded by the British Heart Foundation and others; Current Controlled Trials number, ISRCTN60635500; ClinicalTrials.gov number, NCT00135226.)	[Bowman, Louise; Mafham, Marion; Wallendszus, Karl; Stevens, Will; Buck, Georgina; Barton, Jill; Murphy, Kevin; Haynes, Richard; Cox, Jolyon; Murawska, Aleksandra; Young, Allen; Lay, Michael; Chen, Fang; Sammons, Emily; Waters, Emma; Simpson, David; Peto, Richard; Baigent, Colin; Collins, Rory; Parish, Sarah; Armitage, Jane] Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Bowman, Louise; Mafham, Marion; Wallendszus, Karl; Stevens, Will; Buck, Georgina; Barton, Jill; Murphy, Kevin; Haynes, Richard; Cox, Jolyon; Murawska, Aleksandra; Young, Allen; Lay, Michael; Chen, Fang; Sammons, Emily; Waters, Emma; Simpson, David; Peto, Richard; Baigent, Colin; Collins, Rory; Parish, Sarah; Armitage, Jane] Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England; [Farmer, Andrew] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Neil, Andrew] Univ Oxford, Wolfson Coll, Oxford, England; [Aung, Theingi] Royal Berkshire NHS Fdn Trust, Reading, Berks, England; [Adler, Amanda] Addenbrookes Hosp, Cambridge, England; [Bodansky, Jonathan] Leeds Gen Infirm, Leeds, W Yorkshire, England; [McPherson, Roger] Univ Hosp Wales, Cardiff, S Glam, Wales	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Royal Berkshire Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Leeds General Infirmary; University of Leeds; Cardiff University	Bowman, L (corresponding author), Nuffield Dept Populat Hlth, MRC, Populat Hlth Res Unit, Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.; Bowman, L (corresponding author), Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.	louise.bowman@ndph.ox.ac.uk	Collins, Rory/ABA-8487-2020; Twomey, Patrick J/AAN-7614-2021; Car, Josip/H-6755-2015	Twomey, Patrick J/0000-0001-7284-4673; Haynes, Richard/0000-0002-1179-0023; Car, Josip/0000-0001-8969-371X; Offer, Alison/0000-0002-3367-3207; Chen, Fang/0000-0003-0374-8519; Craig, Martin/0000-0003-4956-4512; Farmer, Andrew/0000-0002-6170-4402; Wallendszus, Karl/0000-0003-0971-3026	British Heart Foundation; MRC [MC_U137686853, MC_U137686849, MC_UU_12026/6, 1935732, MC_U137686861, MC_UU_12026/5] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the British Heart Foundation and others; Current Controlled Trials number, ISRCTN60635500; ClinicalTrials.gov number, NCT00135226.	Abdelhamid AS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003177.pub3; Aung T, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1354-9; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Bowman L, 2018, NEW ENGL J MED, V379, P1529, DOI 10.1056/NEJMoa1804988; Bowman L, 2018, AM HEART J, V198, P135, DOI 10.1016/j.ahj.2017.12.006; BURR ML, 1989, LANCET, V2, P757; Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hartweg J, 2009, CURR OPIN LIPIDOL, V20, P30, DOI 10.1097/MOL.0b013e328321b3be; Kotwal S, 2012, CIRC-CARDIOVASC QUAL, V5, P808, DOI 10.1161/CIRCOUTCOMES.112.966168; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Pradhan AD, 2016, J STEROID BIOCHEM, V155, P252, DOI 10.1016/j.jsbmb.2015.04.006; Rimm EB, 2018, CIRCULATION, V138, pE35, DOI [10.1161/CIR.0000000000000574, 10.1161/cir.0000000000000574]; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Roncaglioni MC, 2013, NEW ENGL J MED, V368, P1800, DOI 10.1056/NEJMoa1205409; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; SHEKELLE RB, 1985, NEW ENGL J MED, V313, P820; Siscovick DS, 2017, CIRCULATION, V135, pe867, DOI 10.1161/CIR.0000000000000482; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Aung T, 2018, JAMA CARDIOL, V3, P225, DOI 10.1001/jamacardio.2017.5205; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	28	354	379	4	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2018	379	16					1540	1550		10.1056/NEJMoa1804989	http://dx.doi.org/10.1056/NEJMoa1804989			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX4EI	30146932	Green Published, Bronze			2022-12-28	WOS:000447679900009
J	Tsikou, D; Yan, Z; Holt, DB; Abel, NB; Reid, DE; Madsen, LH; Bhasin, H; Sexauer, M; Stougaard, J; Markmann, K				Tsikou, Daniela; Yan, Zhe; Holt, Dennis B.; Abel, Nikolaj B.; Reid, Dugald E.; Madsen, Lene H.; Bhasin, Hemal; Sexauer, Moritz; Stougaard, Jens; Markmann, Katharina			Systemic control of legume susceptibility to rhizobial infection by a mobile microRNA	SCIENCE			English	Article							LOTUS-JAPONICUS; GENE-EXPRESSION; NODULATION; KINASE; LOVE; TOO	Nitrogen-fixing root nodules on legumes result from two developmental processes, bacterial infection and nodule organogenesis. To balance symbiosis and plant growth, legume hosts restrict nodule numbers through an inducible autoregulatory process. Here, we present a mechanism where repression of a negative regulator ensures symbiotic susceptibility of uninfected roots of the host Lotus japonicus. We show that microRNA miR2111 undergoes shoot-to-root translocation to control rhizobial infection through posttranscriptional regulation of the symbiosis suppressor TOO MUCH LOVE in roots. miR2111 maintains a susceptible default status in uninfected hosts and functions as an activator of symbiosis downstream of LOTUS HISTIDINE KINASE1-mediated cytokinin perception in roots and HYPERNODULATION ABERRANT ROOT FORMATION1, a shoot factor in autoregulation. The miR2111-TML node ensures activation of feedback regulation to balance infection and nodulation events.	[Tsikou, Daniela; Yan, Zhe; Holt, Dennis B.; Abel, Nikolaj B.; Reid, Dugald E.; Madsen, Lene H.; Stougaard, Jens; Markmann, Katharina] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Bhasin, Hemal; Sexauer, Moritz; Markmann, Katharina] Tubingen Univ, Zentrum Mol Biol Pflanzen, Tubingen, Germany; [Tsikou, Daniela] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Yan, Zhe] Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China; [Holt, Dennis B.] DNA Diagnost, Risskov, Denmark; [Abel, Nikolaj B.] Univ Freiburg, Dept Plant Cell Biol, Freiburg, Germany	Aarhus University; Eberhard Karls University of Tubingen; University of Thessaly; Southwest University of Science & Technology - China; University of Freiburg	Markmann, K (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.; Markmann, K (corresponding author), Tubingen Univ, Zentrum Mol Biol Pflanzen, Tubingen, Germany.	katharina.markmann@zmbp.uni-tuebingen.de	Tsikou, Daniela/AAT-3646-2021	Tsikou, Daniela/0000-0001-6295-4860; Sexauer, Moritz/0000-0003-1475-5167; Reid, Dugald/0000-0001-9291-9775; bhasin, hemal/0000-0002-8559-464X; Yan, Zhe/0000-0003-0369-6245; Abel, Nikolaj/0000-0002-8968-7501; Stougaard, Jens/0000-0002-9312-2685	Danish National Research Foundation [DNRF79]; ERC [268523]; German Research Foundation [CRC1101, C07]; Ministry of Science, Research and Art of Baden-Wuerttemberg [Az:7533-30-20/1]	Danish National Research Foundation(Danmarks Grundforskningsfond); ERC(European Research Council (ERC)European Commission); German Research Foundation(German Research Foundation (DFG)); Ministry of Science, Research and Art of Baden-Wuerttemberg	This work was funded by the Danish National Research Foundation (grant DNRF79); ERC (advanced grant 268523); German Research Foundation (grant CRC1101, project C07); and Ministry of Science, Research and Art of Baden-Wuerttemberg (Az:7533-30-20/1).	De Luis A, 2012, PLANT PHYSIOL, V160, P2137, DOI 10.1104/pp.112.204883; Holt D. B., 2014, THESIS; Holt DB, 2015, NEW PHYTOL, V208, P241, DOI 10.1111/nph.13445; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Magori S, 2009, MOL PLANT MICROBE IN, V22, P259, DOI 10.1094/MPMI-22-3-0259; Malolepszy A, 2016, PLANT J, V88, P306, DOI 10.1111/tpj.13243; Mortier V, 2012, PLANT J, V70, P367, DOI 10.1111/j.1365-313X.2011.04881.x; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; Nishida H, 2016, J PLANT RES, V129, P909, DOI 10.1007/s10265-016-0842-z; Okamoto S, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2014.1000138; Okamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3191; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Reid D, 2017, PLANT PHYSIOL, V175, P361, DOI 10.1104/pp.17.00832; Sasaki T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5983; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Searle IR, 2003, SCIENCE, V299, P109, DOI 10.1126/science.1077937; Soyano T, 2015, PLANT CELL PHYSIOL, V56, P368, DOI 10.1093/pcp/pcu168; Takahara M, 2013, PLANT CELL PHYSIOL, V54, P433, DOI 10.1093/pcp/pct022; Verdier J, 2013, PLANT J, V74, P351, DOI 10.1111/tpj.12119	19	141	147	20	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2018	362	6411			SI		233	235		10.1126/science.aat6907	http://dx.doi.org/10.1126/science.aat6907			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW9RX	30166437	Green Submitted			2022-12-28	WOS:000447337200057
J	Bohula, EA; Wiviott, SD; McGuire, DK; Inzucchi, SE; Kuder, J; Im, KA; Fanola, CL; Qamar, A; Brown, C; Budaj, A; Garcia-Castillo, A; Gupta, M; Leiter, LA; Weissman, NJ; White, HD; Patel, T; Francis, B; Miao, W; Perdomo, C; Dhadda, S; Bonaca, MP; Ruff, CT; Keech, AC; Smith, SR; Sabatine, MS; Scirica, BM				Bohula, E. A.; Wiviott, S. D.; McGuire, D. K.; Inzucchi, S. E.; Kuder, J.; Im, K. A.; Fanola, C. L.; Qamar, A.; Brown, C.; Budaj, A.; Garcia-Castillo, A.; Gupta, M.; Leiter, L. A.; Weissman, N. J.; White, H. D.; Patel, T.; Francis, B.; Miao, W.; Perdomo, C.; Dhadda, S.; Bonaca, M. P.; Ruff, C. T.; Keech, A. C.; Smith, S. R.; Sabatine, M. S.; Scirica, B. M.		CAMELLIA-TIMI61 Steering Comm & In	Cardiovascular Safety of Lorcaserin in Overweigh or Obese Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEIGHT-LOSS; BARIATRIC SURGERY; AMERICAN-COLLEGE; ASSOCIATION; ADULTS; TRIAL; MULTICENTER; MORTALITY; OUTCOMES; EVENTS	BACKGROUND Lorcaserin, a selective serotonin 2C receptor agonist that modulates appetite, has proven efficacy for weight management in overweight or obese patients. The cardiovascular safety and efficacy of lorcaserin are undefined. METHODS We randomly assigned 12,000 overweight or obese patients with atherosclerotic cardiovascular disease or multiple cardiovascular risk factors to receive either lorcaserin (10 mg twice daily) or placebo. The primary safety outcome of major cardiovascular events (a composite of cardiovascular death, myocardial infarction, or stroke) was assessed at an interim analysis to exclude a noninferiority boundary of 1.4. If noninferiority was met, the primary cardiovascular efficacy outcome (a composite of major cardiovascular events, heart failure, hospitalization for unstable angina, or coronary revascularization (extended major cardiovascular events)) was assessed for superiority at the end of the trial. RESULTS At 1 year, weight loss of at least 5% had occurred in 1986 of 5135 patients (38.7%) in the lorcaserin group and in 883 of 5083 (17.4%) in the placebo group (odds ratio, 3.01; 95% confidence interval [CI], 2.74 to 3.30; P<0.001). Patients in the lorcaserin group had slightly better values with respect to cardiac risk factors (including blood pressure, heart rate, glycemic control, and lipids) than those in the placebo group. During a median follow-up of 3.3 years, the rate of the primary safety outcome was 2.0% per year in the lorcaserin group and 2.1% per year in the placebo group (hazard ratio, 0.99; 95% CI, 0.85 to 1.14; P<0.001 for noninferiority); the rate of extended major cardiovascular events was 4.1% per year and 4.2% per year, respectively (hazard ratio, 0.97; 95% CI, 0.87 to 1.07; P=0.55). Adverse events of special interest were uncommon, and the rates were generally similar in the two groups, except for a higher number of patients with serious hypoglycemia in the lorcaserin group (13 vs. 4, P=0.04). CONCLUSIONS In a high-risk population of overweight or obese patients, lorcaserin facilitated sustained weight loss without a higher rate of major cardiovascular events than that with placebo.	[Bohula, E. A.; Wiviott, S. D.; Kuder, J.; Im, K. A.; Qamar, A.; Bonaca, M. P.; Ruff, C. T.; Sabatine, M. S.; Scirica, B. M.] Brigham & Womens Hosp, Div Cardiovasc, Thrombolysis Myocardial Infarct TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA; [McGuire, D. K.] Univ Texas Southwestern Med Ctr Dallas, Cardiovasc Div, Dallas, TX 75390 USA; [Inzucchi, S. E.] Yale Sch Med, Sect Endocrinol, New Haven, CT USA; [Fanola, C. L.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Brown, C.] Partners Clin Res Ctr, Nassau, Bahamas; [Budaj, A.] Grochowski Hosp, Postgrad Med Sch, Dept Cardiol, Warsaw, Poland; [Garcia-Castillo, A.] Cardiolink Clin Trials, Monterrey, Mexico; [Gupta, M.] McMaster Univ, Brampton, ON, Canada; [Leiter, L. A.] Univ Toronto, St Michaels Hosp, Div Endocrinol & Metab, Toronto, ON, Canada; [Weissman, N. J.] MedStar Hlth Res Inst, Hyattsville, MD USA; [White, H. D.] Auckland City Hosp, Cardiol Dept, Auckland, New Zealand; [Patel, T.; Francis, B.; Miao, W.; Perdomo, C.; Dhadda, S.] Eisai, Woodcliff Lake, NJ USA; [Keech, A. C.] Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW, Australia; [Smith, S. R.] Florida Hosp, Translat Res Inst Metab & Diabet, Winter Pk, FL USA; [Smith, S. R.] Sanford Burnham Inst, Winter Pk, FL USA	Harvard University; Brigham & Women's Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; University of Minnesota System; University of Minnesota Twin Cities; Centre of Postgraduate Medical Education - Poland; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; MedStar Health Research Institute; Auckland City Hospital; Eisai Co Ltd; University of Sydney; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Winter Park; Sanford Burnham Prebys Medical Discovery Institute	Bohula, EA (corresponding author), Brigham & Womens Hosp, Cardiovasc Div, TIMI Study Grp, 60 Fenwood Rd,Suite 7022, Boston, MA 02115 USA.	ebohula11@bwh.harvard.edu	Leiter, Lawrence/AAG-4059-2020; Bonaca, Marc/AAJ-2397-2021; McGuire, Darren K./AAL-4172-2021; Bohula, Erin/AAW-7276-2020; Wiviott, Stephen/HIK-2534-2022; Inzucchi, Silvio/ABF-4121-2021; Smith, Steven/HDM-9496-2022; Sabatine, Marc/AAJ-6751-2020	Bonaca, Marc/0000-0002-9860-3584; Sabatine, Marc/0000-0002-0691-3359; Lanas, Fernando/0000-0003-3595-9759; Budaj, Andrzej/0000-0002-6395-2098; Smith, Steven/0000-0002-5098-8147	Eisai; Merck; Amgen; AstraZeneca; Sanofi Aventis; Arena; Bristol-Myers Squibb; Daiichi Sankyo; Eli Lilly; Janssen; Aegerion; Allergan; Angelmed; Boehringer Ingelheim; Boston Clinical Research Institute; Icon Clinical; Lexicon; St. Jude Medical; Xoma; Sanofi US; Novo Nordisk; Astra-Zeneca; Merck Sharp; Dohme; Metavant; Esperion; Bristol-Myers Squibb/Pfizer; Novartis; GlaxoSmithKline; Bayer; Sanofi; Omthera Pharmaceuticals; DalCor Pharmaceuticals; Sirtex; Acetelion; CVS Caremark; Dyrnamix; Alnylam; Ionis; MyoKardia; Biogen Idec; Covance; Dr. Reddy's Laboratories; Elsevier PracticeUpdate Cardiology; Servier; MD Conference Express; Medscape; Academic CME; Paradigm	Eisai(Eisai Co Ltd); Merck(Merck & Company); Amgen(Amgen); AstraZeneca(AstraZeneca); Sanofi Aventis(Sanofi-Aventis); Arena(Australian Renewable Energy Agency (ARENA)); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Aegerion; Allergan(AbbVieAllergan); Angelmed; Boehringer Ingelheim(Boehringer Ingelheim); Boston Clinical Research Institute; Icon Clinical; Lexicon; St. Jude Medical(St. Jude Medical); Xoma; Sanofi US; Novo Nordisk(Novo Nordisk); Astra-Zeneca(AstraZeneca); Merck Sharp; Dohme; Metavant; Esperion; Bristol-Myers Squibb/Pfizer(Bristol-Myers SquibbPfizer); Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Bayer(Bayer AG); Sanofi; Omthera Pharmaceuticals; DalCor Pharmaceuticals; Sirtex; Acetelion; CVS Caremark; Dyrnamix; Alnylam; Ionis; MyoKardia; Biogen Idec(Biogen); Covance; Dr. Reddy's Laboratories; Elsevier PracticeUpdate Cardiology; Servier(Servier); MD Conference Express; Medscape; Academic CME; Paradigm	Supported by Eisai.; Dr. Bohula reports receiving lecture fees from Servier, grant support and advisory board fees from Merck, consulting fees from Lexicon and MD Conference Express, fees for continuing medical education from Medscape, Academic CME, and Paradigm, advisory board fees from Novartis, and grant support from Amgen and AstraZeneca; Dr. Wiviott, receiving grant support from Amgen and Sanofi Aventis, grant support and consulting fees from Arena, Bristol-Myers Squibb, Daiichi Sankyo, Eisai, Eli Lilly, Janssen, Merck, and AstraZeneca, and consulting fees from Aegerion, Allergan, Angelmed, Boehringer Ingelheim, Boston Clinical Research Institute, Icon Clinical, Lexicon, St. Jude Medical, and Xoma; Dr. McGuire, receiving fees for serving on a clinical trial executive committee and consulting fees from Boehringer Ingelheim, Sanofi US, Novo Nordisk, and Astra-Zeneca, fees for serving on a clinical trial data monitoring committee from Janssen Research and Development and GlaxoSmithKline, fees for serving on a clinical trial executive committee and advisory board fees from Merck Sharp and Dohme, consulting fees from Eli Lilly and Metavant, fees for serving as clinical trials chair from Lexicon, fees for serving on a clinical trial executive committee from Eisai, fees for serving on a clinical trial steering committee from Esperion, and fees for serving on a clinical trial scientific advisory committee from Pfizer; Dr. Inzucchi, receiving advisory fees from Merck, Janssen, Alere, and vTv Therapeutics, fees for serving on a clinical trial steering committee and medical writing support from Boehringer Ingelheim, fees for serving on a clinical trial executive committee from AstraZeneca, fees for serving on a clinical trial steering committee from Novo Nordisk, Sanofi/Lexicon, and Daiichi Sankyo, and fees for serving as data monitoring committee member and chair from Intarcia Therapeutics; Dr. Fanola, receiving advisory board fees and travel support from Janssen; Dr. Budaj, receiving an investigator's fee, consulting fees, and lecture fees from AstraZeneca, Sanofi Aventis, Bristol-Myers Squibb/Pfizer, Novartis, and GlaxoSmithKline and consulting fees and lecture fees from Bayer; Dr. Leiter, receiving grant support, advisory fees, and lecture fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, Novo Nordisk, and Sanofi, advisory fees and lecture fees from Servier, and grant support from GlaxoSmithKline; Dr. White, receiving grant support and fees for serving as an executive committee member and national coordinator of the ACCELERATE study from Eli Lilly, grant support and fees for serving as a steering committee member and national leader of the STRENGTH trial from Omthera Pharmaceuticals, grant support and fees for serving on a steering committee from Pfizer New Zealand, grant support and fees for serving as a steering committee member and national leader of the dal-GenE Study from DalCor Pharmaceuticals, advisory board fees from Sirtex and Acetelion, grant support and fees for serving as a steering committee member and national country lead for the AEGIS-II study, grant support and fees for serving on a steering committee from Luitpold Pharmaceuticals, grant support and fees for serving as an executive committee member and national coordinator of ODYSSEY from Sanofi Aventis, and advisory board fees, lecture fees, and travel support from AstraZeneca; Drs. Patel, Francis, and Miao, being employed by Eisai; Dr.; Bonaca, receiving grant support, paid to Brigham and Women's Hospital, and consulting fees from Amgen, AstraZeneca, and Merck, consulting fees from Aralez, Bayer, Janssen, and Sanofi, and grant support, paid to Brigham and Women's Hospital, from MedImmune and Pfizer; Dr. Ruff, receiving grant support and consulting fees from Boehringer Ingelheim and Daiichi Sankyo and consulting fees from Bayer, Janssen, and Portola; Dr. Keech, receiving grant support, honoraria, and advisory fees from Abbott, honoraria and advisory fees from Amgen, lecture fees from AstraZeneca, Pfizer, and Bayer, grant support and honoraria from Mylan, and grant support from Sanofi and Novartis; Dr. Smith, being previously employed by Eisai; Dr. Sabatine, receiving grant support, paid to Brigham and Women's Hospital, and consulting fees from Amgen, AstraZeneca, Intarcia Therapeutics, Janssen Research and Development, the Medicines Company, MedImmune, Merck, and Novartis, grant support, paid to Brigham and Women's Hospital, from Daiichi Sankyo, Eisai, GlaxoSmithKline, Pfizer, Poxel, Takeda, Abbott Laboratories, Critical Diagnostics, Genzyme, Gilead, and Roche Diagnostics, and consulting fees from Bristol-Myers Squibb, CVS Caremark, Dyrnamix, Esperion, Alnylam, Ionis, and MyoKardia; Dr. Scirica, receiving grant support, paid to Brigham and Women's Hospital, and consulting fees from AstraZeneca and Merck, grant support, paid to Brigham and Women's Hospital, from Novartis, consulting fees from Biogen Idec, Boehringer Ingelheim, Covance, Dr. Reddy's Laboratories, Eisai, Elsevier PracticeUpdate Cardiology, GlaxoSmithKline, Novo Nordisk, Sanofi, and St. Jude Medical, and equity from Health at Scale. No other potential conflict of interest relevant to this article was reported.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Bohula EA, 2018, AM HEART J, V202, P39, DOI 10.1016/j.ahj.2018.03.012; Brashier DBS, 2014, J PHARMACOL PHARMACO, V5, P175, DOI 10.4103/0976-500X.130158; Bray GA, 2018, ENDOCR REV, V39, P79, DOI 10.1210/er.2017-00253; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Fidler MC, 2011, J CLIN ENDOCR METAB, V96, P3067, DOI 10.1210/jc.2011-1256; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Food and Drug Administration (FDA), 2007, GUID IND DEV PROD WE; Garvey WT, 2014, ENDOCR PRACT, V20, P977, DOI 10.4158/EP14280.PS; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; Hiatt WR, 2012, CIRCULATION, V125, P1171, DOI 10.1161/CIRCULATIONAHA.111.023499; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Jordan J, 2014, J HYPERTENS, V32, P1178, DOI 10.1097/HJH.0000000000000145; LeBlanc ES, 2011, ANN INTERN MED, V155, P434, DOI 10.7326/0003-4819-155-7-201110040-00006; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Meltzer HY, 2013, J CLIN INVEST, V123, P4986, DOI 10.1172/JCI70678; Nissen SE, 2016, JAMA-J AM MED ASSOC, V315, P990, DOI 10.1001/jama.2016.1558; O'Neil PM, 2012, OBESITY, V20, P1426, DOI 10.1038/oby.2012.66; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Sundstrom J, 2017, CIRCULATION, V135, P1577, DOI 10.1161/CIRCULATIONAHA.116.025629; Thomsen WJ, 2008, J PHARMACOL EXP THER, V325, P577, DOI 10.1124/jpet.107.133348; Topol EJ, 2010, LANCET, V376, P517, DOI 10.1016/S0140-6736(10)60935-X; Vorsanger MH, 2016, J AM COLL CARDIOL, V68, P849, DOI 10.1016/j.jacc.2016.06.007; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; World Health Organization, 2016, OB OV FACT SHEET; Zhou X, 2016, OBES SURG, V26, P2590, DOI 10.1007/s11695-016-2144-x	29	138	141	2	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2018	379	12					1107	1117		10.1056/NEJMoa1808721	http://dx.doi.org/10.1056/NEJMoa1808721			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1KV	30145941	Bronze			2022-12-28	WOS:000445020900005
J	Iyasere, CA; Takvorian, RW; Simeone, FJ; Siegele, BJ				Iyasere, Christiana A.; Takvorian, Ronald W.; Simeone, F. Joseph; Siegele, Bradford J.			Case 28-2018: A 39-Year-Old Man with Epistaxis, Pain and Erythema of the Forearm, and Pancytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HAIRY-CELL LEUKEMIA; TERM-FOLLOW-UP; NEW-ONSET PANCYTOPENIA; CLADRIBINE; DIAGNOSIS; BRAF; PENTOSTATIN; DISEASE		[Iyasere, Christiana A.; Takvorian, Ronald W.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Simeone, F. Joseph] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Siegele, Bradford J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Iyasere, Christiana A.; Takvorian, Ronald W.] Harvard Med Sch, Dept Med, Boston, MA USA; [Simeone, F. Joseph] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Siegele, Bradford J.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Iyasere, CA (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Arcaini L, 2012, BLOOD, V119, P188, DOI 10.1182/blood-2011-08-368209; Bakken JS, 1996, JAMA-J AM MED ASSOC, V275, P199, DOI 10.1001/jama.275.3.199; Bethel KJ, 2003, BEST PRACT RES CL HA, V16, P15, DOI 10.1016/S1521-6926(02)00087-7; Dearden CE, 1999, BRIT J HAEMATOL, V106, P515, DOI 10.1046/j.1365-2141.1999.01546.x; Devitt KA, 2014, LEUKEMIA LYMPHOMA, V55, P1099, DOI 10.3109/10428194.2013.821703; Else M, 2009, BRIT J HAEMATOL, V145, P733, DOI 10.1111/j.1365-2141.2009.07668.x; Falini B, 2016, BLOOD, V128, P1918, DOI 10.1182/blood-2016-07-418434; Freedman AS, 2018, CLIN PRESENTATION DI; Getta BM, 2015, BEST PRACT RES CL HA, V28, P269, DOI 10.1016/j.beha.2015.10.015; Grever MR, 2017, BLOOD, V129, P553, DOI 10.1182/blood-2016-01-689422; Kreitman RJ, 2018, CLIN ADV HEMATOL ONC, V16, P205; Lauria F, 2009, LEUKEMIA LYMPHOMA, V50, P18, DOI 10.3109/10428190903142273; Mhawech-Fauceglia P, 2006, ARCH PATHOL LAB MED, V130, P374; Pettirossi V, 2015, BLOOD, V125, P1207, DOI 10.1182/blood-2014-10-603100; Salles Gilles A, 2007, Hematology Am Soc Hematol Educ Program, P216; Santos FPS, 2012, CANCER J, V18, P396, DOI 10.1097/PPO.0b013e31826cda2d; Schrier SL, 2018, APLASTIC ANEMIA PATH; Shao HP, 2013, LEUKEMIA RES, V37, P401, DOI 10.1016/j.leukres.2012.11.021; Swerdlow SH, 2016, WHO CLASSIFICATION T; Tallman MS, 2018, CLIN FEATURES DIAGNO; Tiacci E, 2015, NEW ENGL J MED, V373, P1733, DOI 10.1056/NEJMoa1506583; Weinzierl EP, 2013, AM J CLIN PATHOL, V139, P9, DOI 10.1309/AJCP50AEEYGREWUZ	22	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					1072	1081		10.1056/NEJMcpc1807498	http://dx.doi.org/10.1056/NEJMcpc1807498			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4UV	30207921				2022-12-28	WOS:000444501600013
J	Sohn, E				Sohn, Emily			That sinking feeling	NATURE			English	Editorial Material							AGE-SPECIFIC DEMOGRAPHY; POPULATION; PLANTAGO											GRELSSON G, 1991, FRESHWATER BIOL, V26, P199, DOI 10.1111/j.1365-2427.1991.tb01729.x; Merritt DM, 2010, ECOL MONOGR, V80, P609, DOI 10.1890/09-1533.1; Roach DA, 2004, AM NAT, V164, P60, DOI 10.1086/421301; Roach DA, 2003, ECOLOGY, V84, P749, DOI 10.1890/0012-9658(2003)084[0749:ASDIPV]2.0.CO;2; Williams R., 2018, OCEANOGRAPHY	5	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2018	561	7722					275	277		10.1038/d41586-018-06618-4	http://dx.doi.org/10.1038/d41586-018-06618-4			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT3XQ	30206401	Bronze			2022-12-28	WOS:000444437900051
J	Reiling, J				Reiling, Jennifer			Biological Problems of Death (Reprinted from JAMA, vol 21, pg 424-425, 1893)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1893, JAMA, V21, P424	1	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2018	320	10					1041	1041		10.1001/jama.2017.12567	http://dx.doi.org/10.1001/jama.2017.12567			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT2QE	30208443				2022-12-28	WOS:000444341400030
J	Ball, IM; Sibbald, R; Truog, RD				Ball, Ian M.; Sibbald, Robert; Truog, Robert D.			Voluntary Euthanasia - Implications for Organ Donation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ball, Ian M.] Western Univ, Dept Med, London, ON, Canada; [Ball, Ian M.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Sibbald, Robert] London Hlth Sci Ctr, Eth Program, London, ON, Canada; [Truog, Robert D.] Harvard Med Sch, Ctr Bioeth, Boston, MA USA	Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; Harvard University; Harvard Medical School	Ball, IM (corresponding author), Western Univ, Dept Med, London, ON, Canada.; Ball, IM (corresponding author), Western Univ, Dept Epidemiol & Biostat, London, ON, Canada.		Ball, Ian/GRR-4073-2022	Ball, Ian/0000-0002-8503-2153				Bollen J, 2016, AM J TRANSPLANT, V16, P1967, DOI 10.1111/ajt.13746; Bollen J, 2016, J MED ETHICS, V42, P486, DOI 10.1136/medethics-2015-102898; Hawryluck LA, 2000, J PALLIATIVE CARE, V16, pS24, DOI 10.1177/082585970001601S06; Robertson JA, 1999, HASTINGS CENT REP, V29, P6, DOI 10.2307/3527865	4	14	14	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2018	379	10					909	911		10.1056/NEJMp1804276	http://dx.doi.org/10.1056/NEJMp1804276			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS5XM	30184447				2022-12-28	WOS:000443748200005
J	Ho, CM; Beck, JR; Lai, M; Cui, YX; Goldberg, DE; Egea, PF; Zhou, ZH				Ho, Chi-Min; Beck, Josh R.; Lai, Mason; Cui, Yanxiang; Goldberg, Daniel E.; Egea, Pascal F.; Zhou, Z. Hong			Malaria parasite translocon structure and mechanism of effector export	NATURE			English	Article							PROTEIN EXPORT; PTEX COMPONENT; PLASMODIUM; HOST; REVEALS; DISAGGREGASE; VIRULENCE; ERYTHROCYTE; TOXOPLASMA; PREDICTION	The putative Plasmodium translocon of exported proteins (PTEX) is essential for transport of malarial effector proteins across a parasite-encasing vacuolar membrane into host erythrocytes, but the mechanism of this process remains unknown. Here we show that PTEX is a bona fide translocon by determining structures of the PTEX core complex at near-atomic resolution using cryo-electron microscopy. We isolated the endogenous PTEX core complex containing EXP2, PTEX150 and HSP101 from Plasmodium falciparum in the 'engaged' and 'resetting' states of endogenous cargo translocation using epitope tags inserted using the CRISPR-Cas9 system. In the structures, EXP2 and PTEX150 interdigitate to form a static, funnel-shaped pseudo-seven-fold-symmetric protein-conducting channel spanning the vacuolar membrane. The spiral-shaped AAA+ HSP101 hexamer is tethered above this funnel, and undergoes pronounced compaction that allows three of six tyrosine-bearing pore loops lining the HSP101 channel to dissociate from the cargo, resetting the translocon for the next threading cycle. Our work reveals the mechanism of P. falciparum effector export, and will inform structure-based design of drugs targeting this unique translocon.	[Ho, Chi-Min; Egea, Pascal F.; Zhou, Z. Hong] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Ho, Chi-Min; Lai, Mason; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Ho, Chi-Min; Egea, Pascal F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Beck, Josh R.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Beck, Josh R.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Beck, Josh R.] Iowa State Univ, Dept Biomed Sci, Ames, IA USA; [Cui, Yanxiang; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Washington University (WUSTL); Washington University (WUSTL); Iowa State University; University of California System; University of California Los Angeles	Egea, PF; Zhou, ZH (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.; Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Egea, PF (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.; Zhou, ZH (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.	pegea@mednet.ucla.edu; hong.zhou@UCLA.edu	Egea, Pascal Francois/AAI-2759-2020; Zhou, Z Hong/HDN-0747-2022; egea, pascal/V-7662-2019; cui, yanxiang/M-7767-2019	egea, pascal/0000-0003-4432-8625; cui, yanxiang/0000-0002-8909-6576; Ho, Chi-Min/0000-0003-2132-7320	National Institutes of Health [R21AI125983, R01GM071940/AI094386/DE025567, K99/R00 HL133453]; Ruth L. Kirschstein National Research Service Award [AI007323]; UCLA; NIH [S10RR23057, S10OD018111, U24GM116792]; NSF [DBI-1338135, DMR-1548924]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL133453, K99HL133453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI125983, T32AI007323, R01AI094386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940, U24GM116792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by grants from National Institutes of Health (R21AI125983 to P.F.E., R01GM071940/AI094386/DE025567 to Z.H.Z. and K99/R00 HL133453 to J.R.B.). P.F.E. is the Alexander and Renee Kolin Endowed Chair in Molecular Biology and Biophysics. C.-M.H. acknowledges funding from the Ruth L. Kirschstein National Research Service Award (AI007323). We thank the UCLA Proteome Research Center for assistance in mass spectrometry and acknowledge the use of instruments in the Electron Imaging Center for Nanomachines supported by UCLA and grants from NIH (S10RR23057, S10OD018111 and U24GM116792) and NSF (DBI-1338135 and DMR-1548924). We thank A. W. P. Fitzpatrick for input on cryo-EM aspects of the project and J. Su for helping with Fig. 1a.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; AhYoung AP, 2015, PROTEIN SCI, V24, P1508, DOI 10.1002/pro.2739; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Batinovic S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16044; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chisholm SA, 2018, FEBS J, V285, P2037, DOI 10.1111/febs.14463; Cowman AF, 2016, CELL, V167, P610, DOI 10.1016/j.cell.2016.07.055; de Koning-Ward TF, 2016, NAT REV MICROBIOL, V14, P494, DOI 10.1038/nrmicro.2016.79; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Deville C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701726; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Elsworth B, 2016, CELL MICROBIOL, V18, P1551, DOI 10.1111/cmi.12596; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Garten M, 2018, NAT MICROBIOL, V3, P1090, DOI 10.1038/s41564-018-0222-7; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; Gehde N, 2009, MOL MICROBIOL, V71, P613, DOI 10.1111/j.1365-2958.2008.06552.x; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Gold DA, 2015, CELL HOST MICROBE, V17, P642, DOI 10.1016/j.chom.2015.04.003; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; JOHNSON D, 1994, PARASITOLOGY, V109, P1, DOI 10.1017/S0031182000077696; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; Lingelbach K, 1998, J CELL SCI, V111, P1467; Lipinska N, 2013, J BIOL CHEM, V288, P2857, DOI 10.1074/jbc.M112.387589; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Przyborski JM, 2016, MOL MICROBIOL, V101, P1, DOI 10.1111/mmi.13380; Puchades C, 2017, SCIENCE, V358, P609, DOI 10.1126/science.aao0464; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Spillman NJ, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12719; Spillman NJ, 2015, ANNU REV BIOCHEM, V84, P813, DOI 10.1146/annurev-biochem-060614-034157; Wiederstein M, 2014, STRUCTURE, V22, P1063, DOI 10.1016/j.str.2014.05.005; World Health Organization, 2017, DEPRESSION; Yokom AL, 2016, NAT STRUCT MOL BIOL, V23, P830, DOI 10.1038/nsmb.3277; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	58	98	100	4	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					70	+		10.1038/s41586-018-0469-4	http://dx.doi.org/10.1038/s41586-018-0469-4			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30150771	Green Accepted, Green Submitted			2022-12-28	WOS:000443755200033
J	Suez, J; Zmora, N; Zilberman-Schapira, G; Mor, U; Dori-Bachash, M; Bashiardes, S; Zur, M; Regev-Lehavi, D; Brik, RB; Federici, S; Horn, M; Cohen, Y; Moor, AE; Zeevi, D; Korem, T; Kotler, E; Harmelin, A; Itzkovitz, S; Maharshak, N; Shibolet, O; Pevsner-Fischer, M; Shapiro, H; Sharon, I; Halpern, Z; Segal, E; Elinav, E				Suez, Jotham; Zmora, Niv; Zilberman-Schapira, Gili; Mor, Uria; Dori-Bachash, Mally; Bashiardes, Stavros; Zur, Maya; Regev-Lehavi, Dana; Brik, Rotem Ben-Zeev; Federici, Sara; Horn, Max; Cohen, Yotam; Moor, Andreas E.; Zeevi, David; Korem, Tal; Kotler, Eran; Harmelin, Alon; Itzkovitz, Shalev; Maharshak, Nitsan; Shibolet, Oren; Pevsner-Fischer, Meirav; Shapiro, Hagit; Sharon, Itai; Halpern, Zamir; Segal, Eran; Elinav, Eran			Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT	CELL			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; LACTOBACILLUS-PLANTARUM 299V; COLONIZATION RESISTANCE; REPEATED EXPOSURE; DOUBLE-BLIND; PREVENTION; QUANTIFICATION; BACTERIOCINS; DIVERSITY; CHILDREN	Probiotics are widely prescribed for prevention of antibiotics-associated dysbiosis and related adverse effects. However, probiotic impact on post-antibiotic reconstitution of the gut mucosal host-microbiome niche remains elusive. We invasively examined the effects of multi-strain probiotics or autologous fecal microbiome transplantation (aFMT) on post-antibiotic reconstitution of the murine and human mucosal microbiome niche. Contrary to homeostasis, antibiotic perturbation enhanced probiotics colonization in the human mucosa but only mildly improved colonization in mice. Compared to spontaneous post-antibiotic recovery, probiotics induced a markedly delayed and persistently incomplete indigenous stool/mucosal microbiome reconstitution and host transcriptome recovery toward homeostatic configuration, while aFMT induced a rapid and near-complete recovery within days of administration. In vitro, Lactobacillus-secreted soluble factors contributed to probiotics-induced microbiome inhibition. Collectively, potential post-antibiotic probiotic benefits may be offset by a compromised gut mucosal recovery, highlighting a need of developing aFMT or personalized probiotic approaches achieving mucosal protection without compromising microbiome recolonization in the antibiotics-perturbed host.	[Suez, Jotham; Zmora, Niv; Zilberman-Schapira, Gili; Mor, Uria; Dori-Bachash, Mally; Bashiardes, Stavros; Zur, Maya; Regev-Lehavi, Dana; Brik, Rotem Ben-Zeev; Federici, Sara; Horn, Max; Cohen, Yotam; Pevsner-Fischer, Meirav; Shapiro, Hagit; Elinav, Eran] Weizmann Inst Sci, Immunol Dept, IL-7610001 Rehovot, Israel; [Zmora, Niv] Tel Aviv Sourasky Med Ctr, Internal Med Dept, IL-6423906 Tel Aviv, Israel; [Moor, Andreas E.; Zeevi, David; Korem, Tal; Kotler, Eran; Itzkovitz, Shalev; Segal, Eran] Weizmann Inst Sci, Department Mol Cell Biol, IL-7610001 Rehovot, Israel; [Zeevi, David; Korem, Tal; Kotler, Eran; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-7610001 Rehovot, Israel; [Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, IL-7610001 Rehovot, Israel; [Maharshak, Nitsan; Shibolet, Oren; Halpern, Zamir] Tel Aviv Sourasky Med Ctr, Dept Gastroenterol & Liver Dis, IL-6423906 Tel Aviv, Israel; [Maharshak, Nitsan; Shibolet, Oren; Halpern, Zamir] Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, IL-6423906 Tel Aviv, Israel; [Maharshak, Nitsan; Shibolet, Oren; Halpern, Zamir] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Sharon, Itai] Migal Galilee Res Inst, IL-11016 Kiryat Shmona, Israel; [Sharon, Itai] Tel Hai Coll, IL-1220800 Upper Galilee, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Hai Academy College	Elinav, E (corresponding author), Weizmann Inst Sci, Immunol Dept, IL-7610001 Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Department Mol Cell Biol, IL-7610001 Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-7610001 Rehovot, Israel.; Halpern, Z (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Gastroenterol & Liver Dis, IL-6423906 Tel Aviv, Israel.; Halpern, Z (corresponding author), Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, IL-6423906 Tel Aviv, Israel.; Halpern, Z (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel.	zamir@tlvmc.gov.il; eran.segal@weizmann.ac.il; eran.elinav@weizmann.ac.il	Elinav, Eran/ABE-8881-2020; Suez, Jotham/AAZ-5433-2020; Federici, Sara/ABD-4056-2021; Horn, Max/AAB-5655-2020; Segal, Eran/AAF-4855-2019; Korem, Tal/D-4155-2018; Sharon, Itai/M-4472-2019; Shapiro, Hagit/F-8648-2015	Elinav, Eran/0000-0002-5775-2110; Suez, Jotham/0000-0003-3836-972X; Horn, Max/0000-0002-8269-9948; Korem, Tal/0000-0002-0609-0858; Sharon, Itai/0000-0003-0705-2316; Zeevi, David/0000-0002-6492-6078; Moor, Andreas/0000-0001-8715-8449; Mor, Uria/0000-0002-2918-6406; Federici, Sara/0000-0002-3663-5142	Gilead Sciences International Research Scholars Program in Liver Disease; Strauss Institute research fellowship; Crown Human Genome Center; Else Kroener Fresenius Foundation; European Research Council; Israel Science Foundation; Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; French National Center for Scientific Research (CNRS); V.R. Schwartz Research Fellow Chair - European Research Council; Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development; Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation; European Foundation for the Study of Diabetes	Gilead Sciences International Research Scholars Program in Liver Disease; Strauss Institute research fellowship; Crown Human Genome Center; Else Kroener Fresenius Foundation; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); V.R. Schwartz Research Fellow Chair - European Research Council; Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation(Helmholtz Association); European Foundation for the Study of Diabetes	We thank the members of the Elinav and Segal laboratories for discussions and apologize to authors whose work was not included due to space constraints. We thank Refael Kohen from the Weizmann Institute of Science bioinformatics unit, Nadin Jbara from the Elinav lab, and Pierre Bost from the Amit lab for their help with DNA/RNA sequencing analysis. We thank Carmit Bar-Natan for dedicated animal husbandry. N.Z. is supported by the Gilead Sciences International Research Scholars Program in Liver Disease. J.S. is the recipient of the Strauss Institute research fellowship. E.S. is supported by the Crown Human Genome Center, the Else Kroener Fresenius Foundation, Donald L. Schwarz (Sherman Oaks, CA), Jack N. Halpern (New York, NY), Leesa Steinberg (Canada), and grants funded by the European Research Council and the Israel Science Foundation. E.E. is supported by Y. and R. Ungar, the Abisch Frenkel Foundation for the Promotion of Life Sciences, the Gurwin Family Fund for Scientific Research, the Leona M. and Harry B. Helmsley Charitable Trust, the Crown Endowment Fund for Immunological Research, the estate of J. Gitlitz, the estate of L. Hershkovich, the Benoziyo Endowment Fund for the Advancement of Science, the Adelis Foundation, J.L. and V. Schwartz, A. and G. Markovitz, A. and C. Adelson, the French National Center for Scientific Research (CNRS), D.L. Schwarz, the V.R. Schwartz Research Fellow Chair, L. Steinberg, J.N. Halpern, A. Edelheit, grants funded by the European Research Council, a Marie Curie Integration grant, the German-Israeli Foundation for Scientific Research and Development, the Israel Science Foundation, the Minerva Foundation, the Rising Tide Foundation, the Helmholtz Foundation, and the European Foundation for the Study of Diabetes. E.E. is a senior fellow of the Canadian Institute of Advanced Research (CIFAR) and an international scholar of the Bill and Melinda Gates Foundation and Howard Hughes Medical Institute (HHMI).	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Allen SJ, 2013, LANCET, V382, P1249, DOI 10.1016/S0140-6736(13)61218-0; Arvonen M, 2015, J RHEUMATOL, V42, P521, DOI 10.3899/jrheum.140348; Bafeta A, 2018, ANN INTERN MED, V169, P240, DOI 10.7326/M18-0343; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caballero S, 2017, CELL HOST MICROBE, V21, P592, DOI 10.1016/j.chom.2017.04.002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ekmekciu I, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00167; Ferrer M, 2014, GUT MICROBES, V5, P64, DOI 10.4161/gmic.27128; FRANKER CK, 1977, ANTIMICROB AGENTS CH, V12, P410, DOI 10.1128/AAC.12.3.410; Franz CMAP, 2007, FEMS MICROBIOL REV, V31, P293, DOI 10.1111/j.1574-6976.2007.00064.x; Furet JP, 2004, INT J FOOD MICROBIOL, V97, P197, DOI 10.1016/j.ijfoodmicro.2004.04.020; Goossens DAM, 2006, ALIMENT PHARM THER, V23, P255, DOI 10.1111/j.1365-2036.2006.02749.x; Grazul H, 2016, GUT MICROBES, V7, P101, DOI 10.1080/19490976.2016.1138197; Haarman M, 2005, APPL ENVIRON MICROB, V71, P2318, DOI 10.1128/AEM.71.5.2318-2324.2005; Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507; Herbel SR, 2013, J APPL MICROBIOL, V115, P1402, DOI 10.1111/jam.12341; Hoskin-Parr L, 2013, PEDIAT ALLERG IMM-UK, V24, P762, DOI 10.1111/pai.12153; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klarin B, 2005, CRIT CARE, V9, pR285, DOI 10.1186/cc3522; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Kootte RS, 2017, CELL METAB, V26, P611, DOI 10.1016/j.cmet.2017.09.008; Kronman MP, 2012, PEDIATRICS, V130, pE794, DOI 10.1542/peds.2011-3886; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lankelma JM, 2017, GUT, V66, P1623, DOI 10.1136/gutjnl-2016-312132; Lichtman JS, 2016, CELL REP, V14, P1049, DOI 10.1016/j.celrep.2016.01.009; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maldonado-Gomez MX, 2016, CELL HOST MICROBE, V20, P515, DOI 10.1016/j.chom.2016.09.001; Manor O, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0231-4; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McFarland LV, 1998, DIGEST DIS, V16, P292, DOI 10.1159/000016879; McFarland LV, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005047; Olek A, 2017, J PEDIATR-US, V186, P82, DOI 10.1016/j.jpeds.2017.03.047; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Ruggirello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114280; Schwendimann L, 2015, J MICROBIOL METH, V115, P94, DOI 10.1016/j.mimet.2015.05.022; Shao XQ, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00170; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Smith M, 2014, NAT BIOTECHNOL, V32, P867, DOI 10.1038/nbt.3006; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Terveer EM, 2017, CLIN MICROBIOL INFEC, V23, P924, DOI 10.1016/j.cmi.2017.05.015; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Vangay P, 2015, CELL HOST MICROBE, V17, P553, DOI 10.1016/j.chom.2015.04.006; Virta L, 2012, AM J EPIDEMIOL, V175, P775, DOI 10.1093/aje/kwr400; Wistrom J, 2001, J ANTIMICROB CHEMOTH, V47, P43, DOI 10.1093/jac/47.1.43; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zmora N, 2018, CELL, V174, P1388, DOI 10.1016/j.cell.2018.08.041	61	477	501	39	345	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1406	+		10.1016/j.cell.2018.08.047	http://dx.doi.org/10.1016/j.cell.2018.08.047			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193113	Bronze			2022-12-28	WOS:000443841000011
J	Torjesen, I				Torjesen, Ingrid			One in seven operations cancelled on day of surgery, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Wong DJN, 2018, BRIT J ANAESTH, V121, P730, DOI 10.1016/j.bja.2018.07.002	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2018	362								k3767	10.1136/bmj.k3767	http://dx.doi.org/10.1136/bmj.k3767			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WS	30190367				2022-12-28	WOS:000444507200004
J	Schmidt, M; Sorensen, HT; Pedersen, L				Schmidt, Morten; Sorensen, Henrik Toft; Pedersen, Lars			Diclofenac use and cardiovascular risks: series of nationwide cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED-TRIAL; PROSTACYCLIN; INHIBITORS; OSTEOARTHRITIS; METAANALYSES; CELECOXIB; ASPIRIN	OBJECTIVE To examine the cardiovascular risks of diclofenac initiation compared with initiation of other traditional non-steroidal anti-inflammatory drugs, initiation of paracetamol, and no initiation. DESIGN Series of 252 nationwide cohort studies, each mimicking the strict design criteria of a clinical trial (emulated trial design). SETTING Danish, nationwide, population based health registries (1996-2016). PARTICIPANTS Individuals eligible for inclusion were all adults without malignancy; schizophrenia; dementia; or cardiovascular, kidney, liver, or ulcer diseases (that is, with low baseline risk). The study included 1 370 832 diclofenac initiators, 3 878 454 ibuprofen initiators, 291 490 naproxen initiators, 764 781 healthcare seeking paracetamol initiators matched by propensity score, and 1 303 209 healthcare seeking non-initiators also matched by propensity score. MAIN OUTCOME MEASURE Cox proportional hazards regression was used to compute the intention to treat hazard ratio (as a measure of the incidence rate ratio) of major adverse cardiovascular events within 30 days of initiation. RESULT The adverse event rate among diclofenac initiators increased by 50% compared with non-initiators (incidence rate ratio 1.5, 95% confidence interval 1.4 to 1.7), 20% compared with paracetamol or ibuprofen initiators (both 1.2, 1.1 to 1.3), and 30% compared with naproxen initiators (1.3, 1.1 to 1.5). The event rate for diclofenac initiators increased for each component of the combined endpoint (1.2 (1.1 to 1.4) for atrial fibrillation/flutter, 1.6 (1.3 to 2.0) for ischaemic stroke, 1.7 (1.4 to 2.0) for heart failure, 1.9 (1.6 to 2.2) for myocardial infarction, and 1.7 (1.4 to 2.1) for cardiac death) as well as for low doses of diclofenac, compared with non-initiators. Although the relative risk of major adverse cardiovascular events was highest in individuals with low or moderate baseline risk (that is, diabetes mellitus), the absolute risk was highest in individuals with high baseline risk (that is, previous myocardial infarction or heart failure).Diclofenac initiation also increased the risk of upper gastrointestinal bleeding at 30 days, by approximately 4.5-fold compared with no initiation, 2.5-fold compared with initiation of ibuprofen or paracetamol, and to a similar extent as naproxen initiation. CONCLUSION Diclofenac poses a cardiovascular health risk compared with non-use, paracetamol use, and use of other traditional non-steroidal anti-inflammatory drugs.	[Schmidt, Morten; Sorensen, Henrik Toft; Pedersen, Lars] Aarhus Univ Hosp, Dept Clin Epidemiol, Olof Palmes 43-45, DK-8200 Aarhus, Denmark; [Schmidt, Morten] Reg Hosp West Jutland, Dept Cardiol, Herning, Denmark; [Sorensen, Henrik Toft] Stanford Univ, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA	Aarhus University; Stanford University	Schmidt, M (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Olof Palmes 43-45, DK-8200 Aarhus, Denmark.; Schmidt, M (corresponding author), Reg Hosp West Jutland, Dept Cardiol, Herning, Denmark.	morten.schmidt@clin.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Schmidt, Morten/0000-0002-4935-4059	Department of Clinical Epidemiology's Research Foundation at Aarhus University; Program for Clinical Research Infrastructure (PROCRIN); Danish Research Council [11-108354, 11-115818]	Department of Clinical Epidemiology's Research Foundation at Aarhus University; Program for Clinical Research Infrastructure (PROCRIN); Danish Research Council(Det Frie Forskningsrad (DFF))	The study was supported by the Department of Clinical Epidemiology's Research Foundation at Aarhus University and the Program for Clinical Research Infrastructure (PROCRIN) established by the Lundbeck Foundation, Novo Nordisk Foundation, and Danish Research Council (grants 11-108354 and 11-115818). The funding sources had no role in the design, conduct, analysis, or reporting of the study.	Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Aw TJ, 2005, ARCH INTERN MED, V165, P490, DOI 10.1001/archinte.165.5.IOI50013; Bally M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1909; Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Capone ML, 2007, PROSTAG OTH LIPID M, V82, P85, DOI 10.1016/j.prostaglandins.2006.05.019; COKER SJ, 1981, NATURE, V291, P323, DOI 10.1038/291323a0; COKER SJ, 1981, BRIT J PHARMACOL, V74, P155, DOI 10.1111/j.1476-5381.1981.tb09968.x; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Danaei G, 2013, STAT METHODS MED RES, V22, P70, DOI 10.1177/0962280211403603; Danish Medicines Agency, COUNT MED REIMB MED; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; European Medicines Agency E, 2006, PUBLIC CHMP ASS REP; European Medicines Agency (European Network of Centres for Pharmacoepidemiology and Pharmacovigilance), 2017, EMEAHA311344 EUR MED; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; MacDonald TM, 2017, EUR HEART J, V38, P1843, DOI 10.1093/eurheartj/ehw387; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; MIYAZAKI T, 1990, CIRC RES, V66, P163, DOI 10.1161/01.RES.66.1.163; MIYAZAKI T, 1990, CIRCULATION, V82, P1008, DOI 10.1161/01.CIR.82.3.1008; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Pottegard A, 2017, INT J EPIDEMIOL, V46, P798, DOI 10.1093/ije/dyw213; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Schmidt M, 2016, EUR HEART J, V37, P1015, DOI 10.1093/eurheartj/ehv505; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Schmidt M, 2014, CLIN EPIDEMIOL, V6, P155, DOI 10.2147/CLEP.S59156; Schmidt M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3450; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Scott PA, 2008, EUR J HEART FAIL, V10, P1102, DOI 10.1016/j.ejheart.2008.07.013; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Sundboll J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012832; Timmers L, 2007, CIRCULATION, V115, P326, DOI 10.1161/CIRCULATIONAHA.106.647230; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Wang DR, 2009, P NATL ACAD SCI USA, V106, P7548, DOI 10.1073/pnas.0805806106; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	43	69	70	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2018	362								k3426	10.1136/bmj.k3426	http://dx.doi.org/10.1136/bmj.k3426			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4VO	30181258	Green Published, hybrid			2022-12-28	WOS:000444503800003
J	Deutsch, CA; Tewksbury, JJ; Tigchelaar, M; Battisti, DS; Merrill, SC; Huey, RB; Naylor, RL				Deutsch, Curtis A.; Tewksbury, Joshua J.; Tigchelaar, Michelle; Battisti, David S.; Merrill, Scott C.; Huey, Raymond B.; Naylor, Rosamond L.			Increase in crop losses to insect pests in a warming climate	SCIENCE			English	Article							TEMPERATURE; IMPACTS	Insect pests substantially reduce yields of three staple grains-rice, maize, and wheat-but models assessing the agricultural impacts of global warming rarely consider crop losses to insects. We use established relationships between temperature and the population growth and metabolic rates of insects to estimate how and where climate warming will augment losses of rice, maize, and wheat to insects. Global yield losses of these grains are projected to increase by 10 to 25% per degree of global mean surface warming. Crop losses will be most acute in areas where warming increases both population growth and metabolic rates of insects. These conditions are centered primarily in temperate regions, where most grain is produced.	[Deutsch, Curtis A.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Deutsch, Curtis A.; Huey, Raymond B.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Tewksbury, Joshua J.] Univ Colorado, Future Earth, Boulder, CO 80303 USA; [Tewksbury, Joshua J.] Univ Colorado, Dept Environm Studies, Boulder, CO 80303 USA; [Tewksbury, Joshua J.] Colorado State Univ, Sch Global Environm Studies, Ft Collins, CO 80523 USA; [Tigchelaar, Michelle; Battisti, David S.] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Merrill, Scott C.] Univ Vermont, Dept Plant & Soil Sci, Burlington, VT 05405 USA; [Naylor, Rosamond L.] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Naylor, Rosamond L.] Stanford Univ, Ctr Food Secur & Environm, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Colorado State University; University of Washington; University of Washington Seattle; University of Vermont; Stanford University; Stanford University	Deutsch, CA (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.; Deutsch, CA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	cdeutsch@uw.edu	Huey, Raymond/F-1597-2010; Battisti, David S/A-3340-2013	Battisti, David S/0000-0003-4871-1293; Tigchelaar, Michelle/0000-0001-7964-229X; Merrill, Scott/0000-0001-5574-9703	Gordon and Betty Moore Foundation (GBMF) [3775]; National Science Foundation [OCE-1419323, OCE-1458967, OCE-1542240]	Gordon and Betty Moore Foundation (GBMF)(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF))	This work was made possible by grants to C.A.D. from the Gordon and Betty Moore Foundation (GBMF#3775) and the National Science Foundation (OCE-1419323, OCE-1458967, and OCE-1542240).	Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Deryng D, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003765; Deutsch C., 2018, DRYAD, DOI [10.5061/dryad.b7q3g2q, DOI 10.5061/DRYAD.B7Q3G2Q]; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Irlich UM, 2009, AM NAT, V174, P819, DOI 10.1086/647904; Lesk C, 2017, NAT CLIM CHANGE, V7, P713, DOI [10.1038/NCLIMATE3375, 10.1038/nclimate3375]; Liu JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057750; Liu ZJ, 2013, GLOBAL CHANGE BIOL, V19, P3481, DOI 10.1111/gcb.12324; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Petersen C, 2000, PHYSIOL ENTOMOL, V25, P35, DOI 10.1046/j.1365-3032.2000.00163.x; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Potter KA, 2013, GLOBAL CHANGE BIOL, V19, P2932, DOI [10.1111/, 10.1111/gcb.12257]; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Williams CM, 2015, BIOL REV, V90, P214, DOI 10.1111/brv.12105; Zhao C, 2017, P NATL ACAD SCI USA, V114, P9326, DOI 10.1073/pnas.1701762114; Zvereva EL, 2006, GLOBAL CHANGE BIOL, V12, P27, DOI 10.1111/j.1365-2486.2005.01086.x	20	410	425	54	348	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					916	919		10.1126/science.aat3466	http://dx.doi.org/10.1126/science.aat3466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166490				2022-12-28	WOS:000443547000038
J	Webber, L; Chalkidou, K; Morrow, S; Ferguson, B; McPherson, K				Webber, Laura; Chalkidou, Kalipso; Morrow, Susie; Ferguson, Brian; McPherson, Klim			What are the best societal investments for improving people's health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBLIC-HEALTH; UK; INTERVENTIONS; INEQUALITIES; BENEFITS; ALCOHOL; SMOKING; DISEASE; COSTS		[Webber, Laura] UK Hlth Forum, London, England; [Chalkidou, Kalipso] Imperial Coll London, Ctr Global Dev, London, England; [Morrow, Susie] Wandsworth Living St Grp, London, England; [Ferguson, Brian] Publ Hlth England, London, England; [McPherson, Klim] Univ Oxford, New Coll, Oxford, England	Center for Global Development - Europe; Imperial College London; Public Health England; University of Oxford	Webber, L (corresponding author), UK Hlth Forum, London, England.	laura.webber@ukhealthforum.org.uk			MRC [MR/R015600/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams J, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1001990, 10.1371/journal.pmed.1002045]; Bellis M, 2017, MODELLING IMPACT MIN; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Claxton K, 2015, HEALTH ECON, V24, P1, DOI 10.1002/hec.3130; Cutler D. M., 2004, PANEL RACE NATL RES; Darzi A, BETTER HLTH CARE ALL; Donkin A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000603; Ferguson B., 2018, PUBLIC HLTH MATTERS; Folsom AR, 2009, CIRC-HEART FAIL, V2, P11, DOI 10.1161/CIRCHEARTFAILURE.108.794933; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Government HM, 2018, UKS IND STRAT; Government HM, 2012, GOV ALC STRAT; Hunt D, 2018, TOB CONTROL, V27, P129, DOI 10.1136/tobaccocontrol-2016-053507; Institute for Alcohol Studies, GOV U TURN MIN UN PR; Institute for Fiscal Studies, 2011, ALC PRIC TAX POL; Katikireddi SV, 2017, J PUBLIC HEALTH-UK, V39, P241, DOI 10.1093/pubmed/fdw031; Katikireddi SV, 2016, EVID POLICY, V12, P521, DOI 10.1332/174426415X14430986392944; Katikireddi SV, 2013, J EPIDEMIOL COMMUN H, V67, P715, DOI 10.1136/jech-2012-202064; Knuchel-Takano A, 2017, TOB CONTROL, DOI [10.1136/tobaccocontrol-2017-05386029212863, DOI 10.1136/TOBACCOCONTROL-2017-05386029212863]; Landon J., 2018, BREXIT TIME GET SERI; Lelliott P, 2008, ROYAL COLL PSYCHIAT; Mackenbach JP, 2011, J EPIDEMIOL COMMUN H, V65, P412, DOI 10.1136/jech.2010.112680; Masters R, 2017, J EPIDEMIOL COMMUN H, V71, P827, DOI 10.1136/jech-2016-208141; McCrone P, 2008, PAYING THE PRICE; Merkur S, 2013, POLICY SUMMARY; Miller H, 2017, TAX REVENUES DOES MO; National Institute for Health and Care Excellence, TYP GUID; National Institute for Health and Care Excellence, 2018, PHYS ACT ENV; Neumann PJ, 2009, SYNTH PROJ RES SYNTH, V18, P48508; Ofsted, 2012, DEV EC IND LEARN GOV; Owen L, 2012, J PUBLIC HEALTH-UK, V34, P37, DOI 10.1093/pubmed/fdr075; Pimpin L, 2018, HEPAHEALTH PROJECT R; Pimpin L, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002602; Pordes Bowers A, 2012, EQUAL START IMPROVIN; Public Health England Institute of Health Equity, 2014, LOC ACT HLTH IN EV P; Rinaldi M, 2007, J VOCAT REHABIL, V27, P21; Roberts A., 2015, NHS FUNDING PROJECTI; Rutter H, 2017, LANCET, V390, P2602, DOI 10.1016/S0140-6736(17)31267-9; Sassi F, 2018, LANCET, V391, P2059, DOI [10.1016/S0140-6736(18)30531-2, 10.1016/s0140-6736(18)30531-2]; Savedoff W., 2018, NEW TASK FORCE LED M; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; SD Commission, 2011, FAIRN CAR DEP SOC; Smith PC, 2017, VALUE HEALTH, V20, P60, DOI 10.1016/j.jval.2016.01.004; Statista, 2017, RET PRIC PREM PACK 2; Stuckler D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3311; Tran LD, 2017, SSM-POPUL HLTH, V3, P185, DOI 10.1016/j.ssmph.2017.01.004; UK Health Forum, 2016, CANC RES UK TIPP SCA; UK Health Forum Cancer Research UK, 2016, SHORT SWEET WHY GOV; Webber L, 2014, EUR J EPIDEMIOL, V29, P867, DOI 10.1007/s10654-014-9978-0; Williams DR, 2008, J PUBLIC HEALTH MAN, pS8, DOI 10.1097/01.PHH.0000338382.36695.42; World Health Organization, 1986, OTT CHART GES; World Health Organization Europe, CAS INV PUBL HLTH	52	7	7	3	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2018	362								k3377	10.1136/bmj.k3377	http://dx.doi.org/10.1136/bmj.k3377			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5ZI	30166316				2022-12-28	WOS:000443758100003
J	O'Connell, R; Brannen, J; Knight, A				O'Connell, Rebecca; Brannen, Julia; Knight, Abigail			Child food poverty requires radical long term solutions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADOLESCENTS; BREAKFAST; HUNGER; UK		[O'Connell, Rebecca; Brannen, Julia; Knight, Abigail] UCL, Inst Educ, Thomas Coram Res Unit, London, England	University of London; University College London; UCL Institute of Education	Brannen, J (corresponding author), UCL, Inst Educ, Thomas Coram Res Unit, London, England.	j.brannen@ucl.ac.uk		O'Connell, Rebecca/0000-0003-1515-2659	European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant [337977]	European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant(European Research Council (ERC))	Rebecca O'Connell is coauthor, with Julia Brannen, of Food, Families, and Work (2016) and principal investigator of the study of Families and Food in Hard Times. This research project was funded by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement 337977.	Burns C., 2017, VIOLENCE AUSTERITY, P149, DOI [10.2307/j.ctt1pv8988, DOI 10.2307/J.CTT1PV8988, 10.2307/j.ctt1pv8988.19, DOI 10.2307/J.CTT1PV8988.19]; Davis A., 2018, MINIMUM INCOME STAND; Department for Education, 2018, FREE HOL ACT MEALS D; Fram MS, 2016, MEASUREMENT FOOD INS; Gordon D, 2013, IMPOVERISHMENT UK PO; Hoyland A, 2009, NUTR RES REV, V22, P220, DOI 10.1017/S0954422409990175; Kirkpatrick SI, 2008, J NUTR, V138, P604, DOI 10.1093/jn/138.3.604; Kirkpatrick SI, 2010, ARCH PEDIAT ADOL MED, V164, P754, DOI 10.1001/archpediatrics.2010.117; Lambie-Mumford H, 2018, CHILD SOC, V32, P244, DOI 10.1111/chso.12272; Lang T, 2018, FEEDING BRIT FOOD SE; Lansley S., 2015, BREADLINE BRITAIN RI; O'Connell RE, 2018, SOCIAL POLICY SOC; Osborne H., 2018, GUARDIAN; Ridge T, 2011, CHILD SOC, V25, P73, DOI 10.1111/j.1099-0860.2010.00345.x; Royal College of Paediatrics and Child Health Child Poverty Action Group, 2017, POV CHILD HLTH VIEWS; Thomas Coram Research Unit UCL Institute of Education University College London, FAM FOOD HARD TIM; Townsend P., 1979, POVERTY UK SURVEY HO	17	2	2	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2018	362								k3608	10.1136/bmj.k3608	http://dx.doi.org/10.1136/bmj.k3608			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5YZ	30154224	Green Published			2022-12-28	WOS:000443756600004
J	Eickhoff, MJ; Bassler, BL				Eickhoff, Michaela J.; Bassler, Bonnie L.			SnapShot: Bacterial Quorum Sensing	CELL			English	Editorial Material									[Eickhoff, Michaela J.; Bassler, Bonnie L.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Bassler, Bonnie L.] Howard Hughes Med Inst, Chevy Chase, MD USA	Princeton University; Howard Hughes Medical Institute	Eickhoff, MJ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Bassler, Bonnie/0000-0002-0043-746X; Eickhoff, Michaela/0000-0003-2376-9237				Erez Z, 2017, NATURE, V541, P488, DOI 10.1038/nature21049; Ismail AS, 2016, CELL HOST MICROBE, V19, P470, DOI 10.1016/j.chom.2016.02.020; Lo Svenningsen S, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.RWR-0017-2018; Lyon GJ, 2000, P NATL ACAD SCI USA, V97, P13330, DOI 10.1073/pnas.97.24.13330; Mukherjee S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006504; Papenfort K, 2017, NAT CHEM BIOL, V13, P551, DOI [10.1038/NCHEMBIO.2336, 10.1038/nchembio.2336]; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Thompson JA, 2015, CELL REP, V10, P1861, DOI 10.1016/j.celrep.2015.02.049	8	53	55	12	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2018	174	5					1328	+		10.1016/j.cell.2018.08.003	http://dx.doi.org/10.1016/j.cell.2018.08.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GR3WU	30142348	Bronze			2022-12-28	WOS:000442529100026
J	Nalin, DR; Cash, RA				Nalin, David R.; Cash, Richard A.			50 years of oral rehydration therapy: the solution is still simple	LANCET			English	Editorial Material							NASOGASTRIC MAINTENANCE THERAPY; CHOLERA; ELECTROLYTE; DISEASE		[Nalin, David R.] Albany Med Coll, Ctr Immunol & Microbial Dis, W Chester, PA USA; [Cash, Richard A.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02446 USA	Albany Medical College; Harvard University; Harvard T.H. Chan School of Public Health	Cash, RA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02446 USA.	racash@hsph.harvard.edu						[Anonymous], 1978, LANCET, V2, P300; CASH RA, 1970, LANCET, V2, P549; CASH RA, 1970, AM J TROP MED HYG, V19, P653, DOI 10.4269/ajtmh.1970.19.653; Chowdhury A.M.R., 1996, SIMPLE SOLUTION TEAC; Lamontagne F, 2018, LANCET, V391, P700, DOI 10.1016/S0140-6736(17)31795-6; Luquero FJ, 2016, EMERG INFECT DIS, V22, P410, DOI 10.3201/eid2203.141970; MAHALANABIS D, 1973, JOHNS HOPKINS MED J, V132, P197; Mata LJ, 1978, CHILDREN SANTA MARIA; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; NALIN DR, 1971, J PEDIATR-US, V78, P355, DOI 10.1016/S0022-3476(71)80028-8; NALIN DR, 1970, T ROY SOC TROP MED H, V64, P769, DOI 10.1016/0035-9203(70)90020-9; NALIN DR, 1968, LANCET, V2, P370; Patino AM, 2018, NEW ENGL J MED, V378, P1475, DOI 10.1056/NEJMp1801772; PIERCE NF, 1969, ANN INTERN MED, V70, P1173, DOI 10.7326/0003-4819-70-6-1173; Pinker S., 2018, ENLIGHTENMENT NOW CA; RUXIN JN, 1994, MED HIST, V38, P363, DOI 10.1017/S0025727300036905; SNYDER JD, 1982, B WORLD HEALTH ORGAN, V60, P605; United Nations Children Fund, 2008, UNICEF DAT MON SIT C; 2017, LANCET, V390, P626	19	21	22	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2018	392	10147					536	538		10.1016/S0140-6736(18)31488-0	http://dx.doi.org/10.1016/S0140-6736(18)31488-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ8MN	30152375				2022-12-28	WOS:000442009500006
J	Goetghebeur, M; Castro-Jaramillo, H; Baltussen, R; Daniels, N				Goetghebeur, Mireille; Castro-Jaramillo, Hector; Baltussen, Rob; Daniels, Norman			The art of priority setting	LANCET			English	Editorial Material									[Goetghebeur, Mireille] Univ Montreal, Sch Publ Hlth, Dept Hlth Management Evaluat & Policy, Montreal, PQ, Canada; [Castro-Jaramillo, Hector] Minist Hlth & Social Protect, Bogota, Colombia; [Baltussen, Rob] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, Nijmegen, Netherlands; [Daniels, Norman] Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Universite de Montreal; Radboud University Nijmegen; Harvard University; Harvard T.H. Chan School of Public Health	Goetghebeur, M (corresponding author), Univ Montreal, Sch Publ Hlth, Dept Hlth Management Evaluat & Policy, Montreal, PQ, Canada.	mm.goetghebeur@umontreal.ca	Baltussen, R.M.P.M./L-4181-2015					Baltussen R, 2017, VALUE HEALTH, V20, P256, DOI 10.1016/j.jval.2016.11.019; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Daniels N, 2016, INT J HEALTH POLICY, V5, P1, DOI 10.15171/ijhpm.2015.187; Daniels N, 2010, LANCET, V375, P114, DOI 10.1016/S0140-6736(10)60037-2; Goetghebeur MM, 2017, MULTICRITERIA DECISI; Jaramillo HEC, 2016, INT J TECHNOL ASSESS, V32, P307, DOI 10.1017/S0266462316000350; Radaelli G, 2014, INT J TECHNOL ASSESS, V30, P105, DOI 10.1017/S0266462313000639	7	19	19	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2368	2369		10.1016/S0140-6736(17)31573-8	http://dx.doi.org/10.1016/S0140-6736(17)31573-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX6ED	30199663				2022-12-28	WOS:000403334400016
J	Guo, L; Winzer, T; Yang, XF; Li, Y; Ning, ZM; He, ZS; Teodor, R; Lu, Y; Bowser, TA; Graham, IA; Ye, K				Guo, Li; Winzer, Thilo; Yang, Xiaofei; Li, Yi; Ning, Zemin; He, Zhesi; Teodor, Roxana; Lu, Ying; Bowser, Tim A.; Graham, Ian A.; Ye, Kai			The opium poppy genome and morphinan production	SCIENCE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROVIDES INSIGHTS; IDENTIFICATION; ANNOTATION; TRANSCRIPTOME; BIOSYNTHESIS; EVOLUTION; TOOLKIT; FUSION; TIME	Morphinan-based painkillers are derived from opium poppy. We report a draft of the opium poppy genome, with 2.72Gb assembled into 11 chromosomes with contig N50 and scaffold N50 of 1.77Mb and 204Mb, respectively. Synteny analysis suggests a whole genome duplication at approximately 7.8 million years ago (MYA) and ancient segmental or whole genome duplication(s) that occurred before the Papaveraceae-Ranunculaceae divergence 110 MYA. Syntenic blocks representative of phthalideisoquinoline and morphinan components of a benzylisoquinoline alkaloid cluster of 15 genes provides insight into how it evolved. Paralog analysis identified P450 and oxidoreductase genes that combined to form the STORR gene fusion essential for morphinan biosynthesis in opium poppy. Thus gene duplication, rearrangement and fusion events have led to evolution of specialized metabolic products in opium poppy.	[Guo, Li; Yang, Xiaofei; Ye, Kai] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, MOE Key Lab Intelligent Networks & Networks Secur, Xian 710049, Peoples R China; [Guo, Li; Ye, Kai] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian 710061, Peoples R China; [Guo, Li; Ye, Kai] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Peoples R China; [Winzer, Thilo; Li, Yi; He, Zhesi; Teodor, Roxana; Graham, Ian A.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5YW, N Yorkshire, England; [Yang, Xiaofei] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Dept Comp Sci, Xian 710049, Peoples R China; [Ning, Zemin] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Lu, Ying] Shanghai Ocean Univ, Shanghai 201306, Peoples R China; [Bowser, Tim A.] Sun Pharmaceut Ind Australia Pty Ltd, Princes Highway, Port Fairy, Vic 3284, Australia; [Ye, Kai] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; University of York - UK; Xi'an Jiaotong University; Wellcome Trust Sanger Institute; Shanghai Ocean University; Fudan University	Ye, K (corresponding author), Xi An Jiao Tong Univ, Sch Elect & Informat Engn, MOE Key Lab Intelligent Networks & Networks Secur, Xian 710049, Peoples R China.; Ye, K (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian 710061, Peoples R China.; Ye, K (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Peoples R China.; Graham, IA (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5YW, N Yorkshire, England.; Ye, K (corresponding author), Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China.	ian.graham@york.ac.uk; kaiye@xjtu.edu.cn	Guo, Li/AAD-4771-2019; Ning, Zemin/D-2411-2013; Ye, Kai/GSD-9856-2022; TEODOR, Roxana Iuliana/R-6929-2018	Guo, Li/0000-0001-6100-3481; Ye, Kai/0000-0002-2851-6741; Ning, Zemin/0000-0003-4359-776X; Li, Yi/0000-0002-4526-7185; TEODOR, Roxana Iuliana/0000-0003-2652-1894; Graham, Ian Alexander/0000-0003-4007-1770; Yang, Xiaofei/0000-0002-5118-7755; Bowser, Tim/0000-0002-2126-8538	BBSRC [BB/K018809/1] Funding Source: UKRI; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Avni R, 2017, SCIENCE, V357, P93, DOI 10.1126/science.aan0032; Badouin H, 2017, NATURE, V546, P148, DOI 10.1038/nature22380; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bastian M, 2009, INT AAAI C WEBL SOC; Beaudoin GAW, 2013, BIOCHEM BIOPH RES CO, V431, P597, DOI 10.1016/j.bbrc.2012.12.129; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonfield JK, 2010, BIOINFORMATICS, V26, P1699, DOI 10.1093/bioinformatics/btq268; Campbell Michael S, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0411s48; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen X, 2018, NAT CHEM BIOL, V14, P738, DOI 10.1038/s41589-018-0059-7; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Farrow SC, 2015, NAT CHEM BIOL, V11, P728, DOI [10.1038/NCHEMBIO.1879, 10.1038/nchembio.1879]; Frazee AC., 2014, BIORXIV; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; GATES M, 1956, J AM CHEM SOC, V78, P1380, DOI 10.1021/ja01588a033; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hirsch CN, 2016, PLANT CELL, V28, P2700, DOI 10.1105/tpc.16.00353; Hulse-Kemp AM, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-017-0011-0; Jacomet S, 2009, VEG HIST ARCHAEOBOT, V18, P47, DOI 10.1007/s00334-007-0138-2; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiao YN, 2014, PLANT CELL, V26, P2792, DOI 10.1105/tpc.114.127597; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kautsar SA, 2017, NUCLEIC ACIDS RES, V45, pW55, DOI 10.1093/nar/gkx305; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Knaul FM, 2018, LANCET, V391, P1391, DOI 10.1016/S0140-6736(17)32513-8; Koepfli KP, 2015, ANNU REV ANIM BIOSCI, V3, P57, DOI 10.1146/annurev-animal-090414-014900; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7914; Luo MC, 2017, NATURE, V551, P498, DOI 10.1038/nature24486; Magnavaca R., 1987, DEV PLANT SOIL SCI, V27, P255; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Mostovoy Y, 2016, NAT METHODS, V13, P587, DOI [10.1038/NMETH.3865, 10.1038/nmeth.3865]; Murat F, 2017, NAT GENET, V49, P490, DOI 10.1038/ng.3813; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Nakagawa A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10390; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Osbourn A, 2010, PLANT PHYSIOL, V154, P531, DOI 10.1104/pp.110.161315; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Raymond M. J., 2004, THESIS; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scrucca L, 2016, R J, V8, P289; Seo JS, 2016, NATURE, V538, P243, DOI 10.1038/nature20098; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tang HB, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0573-1; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Van De Peer Y, 2017, NAT REV GENET, V18, P411, DOI 10.1038/nrg.2017.26; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Weisenfeld NI, 2017, GENOME RES, V27, P757, DOI 10.1101/gr.214874.116; Winzer T, 2015, SCIENCE, V349, P309, DOI 10.1126/science.aab1852; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757; Xiao CL, 2017, NAT METHODS, V14, P1072, DOI [10.1038/NMETH.4432, 10.1038/nmeth.4432]; Zhao GY, 2017, NAT PLANTS, V3, P946, DOI 10.1038/s41477-017-0067-8	75	119	133	21	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					343	+		10.1126/science.aat4096	http://dx.doi.org/10.1126/science.aat4096			75	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG0KF	30166436	Green Accepted			2022-12-28	WOS:000454632300001
J	Xiang, Z; Kasahara, Y; Asaba, T; Lawson, B; Tinsman, C; Chen, L; Sugimoto, K; Kawaguchi, S; Sato, Y; Li, G; Yao, S; Chen, YL; Iga, F; Singleton, J; Matsuda, Y; Li, L				Xiang, Z.; Kasahara, Y.; Asaba, T.; Lawson, B.; Tinsman, C.; Chen, Lu; Sugimoto, K.; Kawaguchi, S.; Sato, Y.; Li, G.; Yao, S.; Chen, Y. L.; Iga, F.; Singleton, John; Matsuda, Y.; Li, Lu			Quantum oscillations of electrical resistivity in an insulator	SCIENCE			English	Article							METALLIC STATE; GAP; SURFACE; YBB12	In metals, orbital motions of conduction electrons on the Fermi surface are quantized in magnetic fields, which is manifested by quantum oscillations in electrical resistivity. This Landau quantization is generally absent in insulators. Here, we report a notable exception in an insulator-ytterbium dodecaboride (YbB12). The resistivity of YbB12, which is of a much larger magnitude than the resistivity in metals, exhibits distinct quantum oscillations. These unconventional oscillations arise from the insulating bulk, even though the temperature dependence of the oscillation amplitude follows the conventional Fermi liquid theory of metals with a large effective mass. Quantum oscillations in the magnetic torque are also observed, albeit with a lighter effective mass.	[Xiang, Z.; Asaba, T.; Lawson, B.; Tinsman, C.; Chen, Lu; Li, G.; Li, Lu] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Kasahara, Y.; Sato, Y.; Matsuda, Y.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Lawson, B.] Univ Chretienne Bilingue Congo, Fac Appl Sci, Beni, North Kivu, DEM REP CONGO; [Sugimoto, K.; Kawaguchi, S.] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Yao, S.] Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210093, Jiangsu, Peoples R China; [Chen, Y. L.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Iga, F.] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Singleton, John] Los Alamos Natl Lab, Natl High Magnet Field Lab, Los Alamos, NM 87545 USA	University of Michigan System; University of Michigan; Kyoto University; Japan Synchrotron Radiation Research Institute; Nanjing University; University of Oxford; Ibaraki University; United States Department of Energy (DOE); Los Alamos National Laboratory	Li, L (corresponding author), Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA.; Matsuda, Y (corresponding author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.	matsuda@scphys.kyoto-u.ac.jp; luli@umich.edu	Sugimoto, Kunihisa/R-2799-2019; Chen, Yulin/C-1918-2012; Li, Lu/AAF-9416-2019; Li, Gang/E-3033-2015; Matsuda, Yuji/ABH-7166-2020; Kasahara, Yuichi/N-8436-2013	Li, Lu/0000-0002-8054-7406; Li, Gang/0000-0002-1137-7642; Matsuda, Yuji/0000-0001-9947-9418; Xiang, Ziji/0000-0001-7132-6591; Sugimoto, Kunihisa/0000-0002-0103-8153; Tinsman, Colin/0000-0002-1439-7999; Sato, Yuki/0000-0002-9209-2437; Chen, Lu/0000-0002-0407-9209; Asaba, Tomoya/0000-0003-4631-9589	National Science Foundation [DMR-1707620, DMR-1644779, DMR-1157490]; Office of Naval Research through the Young Investigator Prize [N00014-15-1-2382]; Japan Society for the Promotion of Science (JSPS) [25220710, 15H02106, 15H03688, 16K05460, 16K13837, 18H01180, 18H05227, 15H05852]; National Science Foundation Major Research Instrumentation [DMR-1428226]; U.S. Department of Energy (DOE) [DE-SC0008110]; DOE; state of Florida; DOE BES Program "Science in 100 T"; QuantEmX grant from the Institute for Complex Adaptive Matter; Gordon and Betty Moore Foundation [GBMF5305]; Nakajima Foundation; National Science Foundation Graduate Research Fellowship [F031543]; National Science Foundation East Asia and Pacific Summer Institute Fellowship [1614138]	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research through the Young Investigator Prize(Office of Naval Research); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); state of Florida; DOE BES Program "Science in 100 T"(United States Department of Energy (DOE)); QuantEmX grant from the Institute for Complex Adaptive Matter; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Nakajima Foundation; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation East Asia and Pacific Summer Institute Fellowship	This work is mainly supported by the National Science Foundation under award DMR-1707620 (high field magnetization and resistivity measurements), by the Office of Naval Research through the Young Investigator Prize under award N00014-15-1-2382 (sample structure and low field electrical transport characterizations), by Grants-in-Aid for Scientific Research (KAKENHI) (25220710, 15H02106, 15H03688, 16K05460, 16K13837 18H01180, and 18H05227) and on Innovative Areas Topological Material Science (15H05852) from the Japan Society for the Promotion of Science (JSPS). The synchrotron radiation x-ray powder diffraction measurements were carried out at BL02B2/SPring-8 in Japan (proposal 2017A1856). Some results are obtained with equipment supported by the National Science Foundation Major Research Instrumentation award under DMR-1428226 (the equipment of the thermodynamic and electrical transport characterizations). The development of the torque magnetometry technique in intense magnetic fields was supported by the U.S. Department of Energy (DOE) under award DE-SC0008110. A portion of this work was performed at the National High Magnetic Field Laboratory, which is supported by National Science Foundation Cooperative Agreement DMR-1644779 and DMR-1157490, the DOE, and the state of Florida. J.S. acknowledges support from the DOE BES Program "Science in 100 T." The experiment in NHMFL is funded in part by a QuantEmX grant from the Institute for Complex Adaptive Matter and the Gordon and Betty Moore Foundation through grant GBMF5305 to Z.X., T.A., L.C., C.T., and L.L.T.A. thanks the Nakajima Foundation for support. B.L. acknowledges support by the National Science Foundation Graduate Research Fellowship under grant No. F031543 and the National Science Foundation East Asia and Pacific Summer Institute Fellowship award 1614138.	Baskaran G., 2015, ARXIV150703477CONDMA; Beach KSD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.026401; BOEBINGER GS, 1995, PHYSICA B, V211, P227, DOI 10.1016/0921-4526(94)00992-5; Chowdhury D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04163-2; COOLEY C, 1995, PHYS REV LETT, V74, P1629, DOI 10.1103/PhysRevLett.74.1629; Cooley JC, 1999, J SUPERCOND, V12, P171, DOI 10.1023/A:1007771030747; COOLEY JC, 1995, PHYS REV B, V52, P7322, DOI 10.1103/PhysRevB.52.7322; Erten O, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.057603; GURVITCH M, 1981, PHYS REV B, V24, P7404, DOI 10.1103/PhysRevB.24.7404; Hagiwara K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12690; Iga F, 1998, J MAGN MAGN MATER, V177, P337, DOI 10.1016/S0304-8853(97)00493-9; KASAYA M, 1983, J MAGN MAGN MATER, V31-4, P437, DOI 10.1016/0304-8853(83)90312-8; KASAYA M, 1985, J MAGN MAGN MATER, V47-8, P429, DOI 10.1016/0304-8853(85)90458-5; KASUYA T, 1994, EUROPHYS LETT, V26, P277, DOI 10.1209/0295-5075/26/4/007; Knolle J, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.096604; Knolle J, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.146401; Li G, 2014, SCIENCE, V346, P1208, DOI 10.1126/science.1250366; Luo YK, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.075130; Mignot JM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.247204; Okawa M, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.161108; Pal HK, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.125140; Riseborough PS, 2000, ADV PHYS, V49, P257, DOI 10.1080/000187300243345; Shoenberg D., 2009, MAGNETIC OSCILLATION; Sodemann I, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.045152; SUGIYAMA K, 1988, J PHYS SOC JPN, V57, P3946, DOI 10.1143/JPSJ.57.3946; TAKABATAKE T, 1992, PHYS REV B, V45, P5740, DOI 10.1103/PhysRevB.45.5740; Tan BS, 2015, SCIENCE, V349, P287, DOI 10.1126/science.aaa7974; Terashima TT, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.257206; Terashima TT, 2017, J PHYS SOC JPN, V86, DOI 10.7566/JPSJ.86.054710; Tsunetsugu H, 1997, REV MOD PHYS, V69, P809, DOI 10.1103/RevModPhys.69.809; Utsumi Y, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.155130; Weng HM, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.016403; Wolgast S, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.115110; Yamaguchi J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125121; Zhang L, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.046404	35	53	54	6	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2018	362	6410			SI		65	68		10.1126/science.aap9607	http://dx.doi.org/10.1126/science.aap9607			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0IN	30166438	Green Submitted			2022-12-28	WOS:000446547100042
J	Chou, KS; Blumoff, JZ; Wang, CS; Reinhold, PC; Axline, CJ; Gao, YY; Frunzio, L; Devoret, MH; Jiang, L; Schoelkopf, RJ				Chou, Kevin S.; Blumoff, Jacob Z.; Wang, Christopher S.; Reinhold, Philip C.; Axline, Christopher J.; Gao, Yvonne Y.; Frunzio, L.; Devoret, M. H.; Jiang, Liang; Schoelkopf, R. J.			Deterministic teleportation of a quantum gate between two logical qubits	NATURE			English	Article							STATE; ENTANGLEMENT; CHANNELS; CAVITIES; NETWORK; MATTER; ATOMS	A quantum computer has the potential to efficiently solve problems that are intractable for classical computers. However, constructing a large-scale quantum processor is challenging because of the errors and noise that are inherent in real-world quantum systems. One approach to addressing this challenge is to utilize modularity-a strategy used frequently in nature and engineering to build complex systems robustly. Such an approach manages complexity and uncertainty by assembling small, specialized components into a larger architecture. These considerations have motivated the development of a quantum modular architecture, in which separate quantum systems are connected into a quantum network via communication channels(1,2). In this architecture, an essential tool for universal quantum computation is the teleportation of an entangling quantum gate(3-5), but such teleportation has hitherto not been realized as a deterministic operation. Here we experimentally demonstrate the teleportation of a controlled-NOT (CNOT) gate, which we make deterministic by using real-time adaptive control. In addition, we take a crucial step towards implementing robust, error-correctable modules by enacting the gate between two logical qubits, encoding quantum information redundantly in the states of superconducting cavities(6). By using such an error-correctable encoding, our teleported gate achieves a process fidelity of 79 per cent. Teleported gates have implications for fault-tolerant quantum computation(3), and when realized within a network can have broad applications in quantum communication, metrology and simulations(1,2,7). Our results illustrate a compelling approach for implementing multi-qubit operations on logical qubits and, if integrated with quantum error-correction protocols, indicate a promising path towards fault-tolerant quantum computation using a modular architecture.	[Chou, Kevin S.; Blumoff, Jacob Z.; Wang, Christopher S.; Reinhold, Philip C.; Axline, Christopher J.; Gao, Yvonne Y.; Frunzio, L.; Devoret, M. H.; Jiang, Liang; Schoelkopf, R. J.] Yale Univ, Dept Appl Phys & Phys, New Haven, CT 06520 USA; [Chou, Kevin S.; Blumoff, Jacob Z.; Wang, Christopher S.; Reinhold, Philip C.; Axline, Christopher J.; Gao, Yvonne Y.; Frunzio, L.; Devoret, M. H.; Jiang, Liang; Schoelkopf, R. J.] Yale Univ, Yale Quantum Inst, New Haven, CT 06520 USA; [Blumoff, Jacob Z.] HRL Labs, Malibu, CA USA	Yale University; Yale University; HRL Laboratories	Chou, KS; Schoelkopf, RJ (corresponding author), Yale Univ, Dept Appl Phys & Phys, New Haven, CT 06520 USA.; Chou, KS; Schoelkopf, RJ (corresponding author), Yale Univ, Yale Quantum Inst, New Haven, CT 06520 USA.	kevin.chou@yale.edu; robert.schoelkopf@yale.edu	Frunzio, Luigi/O-1573-2019; Jiang, Liang/A-9847-2008; Gao, Yvonne/AAY-5024-2021; Schoelkopf, Robert J/J-8178-2012; Jiang, Liang/GVU-8654-2022	Frunzio, Luigi/0000-0002-0272-5481; Jiang, Liang/0000-0002-0000-9342; Gao, Yvonne/0000-0002-6360-9679; Jiang, Liang/0000-0002-0000-9342; Axline, Christopher/0000-0002-1708-3688	Yale SEAS cleanroom; YINQE; NSF MRSEC [DMR-1119826]; Army Research Office [W911NF-14-1-0011, W911NF-16-10349]; Air Force Office of Scientific Research [FA9550-14-1-0052, FA9550-15-1-0015]; NSF Graduate Research Fellowship [DGE-1122492]; A*STAR NSS Fellowship; Alfred P. Sloan Foundation [BR2013-049]; Packard Foundation [2013-39273]	Yale SEAS cleanroom; YINQE; NSF MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Army Research Office; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); A*STAR NSS Fellowship(Agency for Science Technology & Research (A*STAR)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Packard Foundation(The David & Lucile Packard Foundation)	We thank B. J. Lester, Z. K. Minev, A. Narla, U. Vool and I. L. Chuang for discussions on the manuscript, and A. Narla, K. Sliwa and N. Frattini for assistance on the parametric amplifier. Facilities use was supported by the Yale SEAS cleanroom, YINQE and NSF MRSEC DMR-1119826. This research was supported by the Army Research Office under grant numbers W911NF-14-1-0011 and W911NF-16-10349 and by the Air Force Office of Scientific Research under grant numbers FA9550-14-1-0052 and FA9550-15-1-0015. C.J.A. acknowledges support from a NSF Graduate Research Fellowship under grant number DGE-1122492. Y.Y.G. was supported by an A*STAR NSS Fellowship. L.J. acknowledges additional support from the Alfred P. Sloan Foundation under grant number BR2013-049 and from the Packard Foundation under grant number 2013-39273.	Axline C, 2016, APPL PHYS LETT, V109, DOI 10.1063/1.4959241; Barrett SD, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.060310; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Blumoff JZ, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031041; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Gao WB, 2010, P NATL ACAD SCI USA, V107, P20869, DOI 10.1073/pnas.1005720107; Gilchrist A, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.062310; Gottesman D., 1998, PREPRINT; Hann CT, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.022305; Heeres RW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00045-1; Huang YF, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.240501; Hucul D, 2015, NAT PHYS, V11, P37, DOI [10.1038/nphys3150, 10.1038/NPHYS3150]; Jiang L, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.062323; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Monroe C, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.022317; Narla A, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031036; Nickerson NH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2773; Ofek N, 2016, NATURE, V536, P441, DOI 10.1038/nature18949; Olmschenk S, 2009, SCIENCE, V323, P486, DOI 10.1126/science.1167209; Paik H, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.250502; Panigrahi P.K, 2017, EXPT DEMONSTRATION N; Reagor M, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.014506; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Roch N, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.170501; Rosenblum S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03059-5; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; Vlastakis B, 2013, SCIENCE, V342, P607, DOI 10.1126/science.1243289; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245	40	104	105	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2018	561	7723					368	+		10.1038/s41586-018-0470-y	http://dx.doi.org/10.1038/s41586-018-0470-y			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU1HZ	30185908	Green Submitted			2022-12-28	WOS:000445011500049
J	Dechartres, A; Atal, I; Riveros, C; Meerpohl, J; Ravaud, P				Dechartres, Agnes; Atal, Ignacio; Riveros, Carolina; Meerpohl, Joerg; Ravaud, Philippe			Association Between Publication Characteristics and Treatment Effect Estimates A Meta-epidemiologic Study	ANNALS OF INTERNAL MEDICINE			English	Article							GREY LITERATURE; TRIALS; INTERVENTION; REVIEWS; METAANALYSES; LANGUAGE; BIAS	Background: Evidence about the effect on meta-analysis results of including unpublished trials or those published in languages other than English is unclear or discordant. Purpose: To compare treatment effects between published and unpublished randomized controlled trials (RCTs) and between trials published in English and other languages using a meta-epidemiologic approach. Data Sources: Cochrane reviews published between March 2011 and January 2017 and trial references cited in the reviews. Study Selection: RCTs included in meta-analyses of 3 or more trials with a binary efficacy outcome. Data Extraction: Trial characteristics were extracted by original review authors. A single reviewer assessed publication status and language, with quality assurance by another investigator. Data Synthesis: Among 5659 RCTs included in 698 meta-analyses, 5303 (93.7%) were published in journal articles and 356 (6.3%) were unpublished. Of journal articles, 92.6% (4910 of 5303) were published in English and 7.4% (393 of 5303) in another language. Treatment effects were larger in published than unpublished trials (combined ratio of odds ratios [ROR] for 174 meta-analyses, 0.90 [95% CI, 0.82 to 0.98]; l(2) = 19.3%; tau(2) = 0.0492). Treatment effects were also larger for trials published in a language other than English than in English (combined ROR for 147 meta-analyses, 0.86 [CI, 0.78 to 0.95]; l(2) = 0%; tau(2) = 0.0000). Limitation: Reliance on the primary reference cited by review authors as the record of interest. Conclusion: In meta-analyses, treatment effects were larger in published than unpublished trials and, for published trials, in those published in a language other than English than in English.	[Dechartres, Agnes] Univ Paris 05, Hop Hotel Dieu, Assistance Publ Hop Paris, Sorbonne Paris Cite,INSERM,U1153,Cochrane France, Paris, France; [Dechartres, Agnes] Sorbonne Univ, Hop Univ Pitie Salpetriere Charles Foix, Assistance Publ Hop Paris, Inst Pierre Louis Sante Publ, Paris, France; [Atal, Ignacio; Riveros, Carolina] INSERM, U1153, Paris, France; [Atal, Ignacio; Meerpohl, Joerg; Ravaud, Philippe] Cochrane France, Hotel Dieu, 1 Pl Parvis Notre Dame, F-75004 Paris, France; [Meerpohl, Joerg; Ravaud, Philippe] Cochrane France, Paris, France; [Riveros, Carolina; Meerpohl, Joerg] Hop Hotel Dieu, Assistance Publ Hop Paris, Paris, France; [Meerpohl, Joerg] Univ Freiburg, Inst Evidence Med, Cochrane Germany Fdn, Med Ctr, Breisacher Str 153, D-79110 Freiburg, Germany; [Ravaud, Philippe] Univ Paris 05, Hop Hotel Dieu, Assistance Publ Hop Paris, Sorbonne Paris Cite,INSERM,U1153, Paris, France; [Ravaud, Philippe] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Dechartres, Agnes] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Dept Biostat Sante Publ & Informat Med, 47-83 Blvd Hop, F-75013 Paris, France; [Riveros, Carolina; Ravaud, Philippe] Hop Hotel Dieu, Ctr Epidemiol Clin, 1 Pl Parvis Notre Dame, F-75004 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Freiburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Columbia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Dechartres, A (corresponding author), Hop Univ Pitie Salpetriere Charles Foix, Dept Biostat Sante Publ & Informat Med, 47-83 Blvd Hop, F-75013 Paris, France.	agnes.dechartres@aphp.fr	Meerpohl, Joerg J/J-4224-2013; ravaud, philippe/C-1694-2009	Meerpohl, Joerg J/0000-0002-1333-5403; Atal, Ignacio/0000-0002-7323-6511	Cochrane France	Cochrane France	The researchers did not receive any external funding. This work was internally funded by Cochrane France.	Balshem H, 2008, METHODS GUIDE EFFECT; Bassler D, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010024; COOK DJ, 1993, JAMA-J AM MED ASSOC, V269, P2749, DOI 10.1001/jama.269.21.2749; Dechartres A, 2016, J CLIN EPIDEMIOL, V77, P24, DOI 10.1016/j.jclinepi.2016.04.005; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Djulbegovic B, 2017, LANCET, V390, P415, DOI 10.1016/S0140-6736(16)31592-6; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Egger M, 2003, Health Technol Assess, V7, P1; Galandi Daniel, 2006, BMC Med Res Methodol, V6, P30, DOI 10.1186/1471-2288-6-30; Hartling L, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0347-z; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hopewell S, 2005, CLIN TRIALS, V2, P265, DOI 10.1191/1740774505cn091oa; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Mahood Q, 2014, RES SYNTH METHODS, V5, P221, DOI 10.1002/jrsm.1106; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; Meerpohl JJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006666; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Page MJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002028; Pham B, 2005, J CLIN EPIDEMIOL, V58, P769, DOI 10.1016/j.jclinepi.2004.08.021; Sampson M, 2003, J CLIN EPIDEMIOL, V56, P943, DOI 10.1016/S0895-4356(03)00110-0; Savovic J, 2018, AM J EPIDEMIOL, V187, P1113, DOI 10.1093/aje/kwx344; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Scherer RW, 2015, J CLIN EPIDEMIOL, V68, P803, DOI 10.1016/j.jclinepi.2015.01.027; Schmucker CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176210; Schroll JB, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2231; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Sox HC, 2010, MED CARE, V48, pS7, DOI 10.1097/MLR.0b013e3181da3709; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van Driel ML, 2009, J CLIN EPIDEMIOL, V62, P838, DOI 10.1016/j.jclinepi.2008.09.010	35	18	18	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2018	169	6					385	+		10.7326/M18-1517	http://dx.doi.org/10.7326/M18-1517			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT7CZ	30140933				2022-12-28	WOS:000444679800015
J	Bagley, N; Sachs, RE				Bagley, Nicholas; Sachs, Rachel E.			Limiting State Flexibility in Drug Pricing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bagley, Nicholas] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA; [Sachs, Rachel E.] Washington Univ, Law Sch, St Louis, MO USA	University of Michigan System; University of Michigan; Washington University (WUSTL)	Bagley, N (corresponding author), Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA.							Centers for Medicare and Medicaid Services, 2018, MED DRUG REB PROGR N; Hill T., 2018, COMMUNICATION   0627; Park E., 2018, COMMENTS HHS BLUEPRI; Pear R, 2018, NY TIMES; Sudders M., COMMUNICATION   0908	5	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					1002	1004		10.1056/NEJMp1809358	http://dx.doi.org/10.1056/NEJMp1809358			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT4UV	30207910	Green Published			2022-12-28	WOS:000444501600003
J	Healton, C				Healton, Cheryl			The Tobacco Master Settlement Agreement - Strategic Lessons for Addressing Public Health Problems	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Healton, Cheryl] NYU, Coll Global Publ Hlth, New York, NY 10003 USA	New York University	Healton, C (corresponding author), NYU, Coll Global Publ Hlth, New York, NY 10003 USA.							Abate RS, 2010, WASH LAW REV, V85, P197; Kearns CE, 2016, JAMA INTERN MED, V176, P1680, DOI 10.1001/jamainternmed.2016.5394; Schroeder SA, 2004, NEW ENGL J MED, V350, P293, DOI 10.1056/NEJMsr031421; Schwartz J., 2016, NY TIMES, pB3	4	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					997	1000		10.1056/NEJMp1802633	http://dx.doi.org/10.1056/NEJMp1802633			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT4UV	30207911	Bronze			2022-12-28	WOS:000444501600001
J	Shiber, A; Doring, K; Friedrich, U; Klann, K; Merker, D; Zedan, M; Tippmann, F; Kramer, G; Bukau, B				Shiber, Ayala; Doering, Kristina; Friedrich, Ulrike; Klann, Kevin; Merker, Dorina; Zedan, Mostafa; Tippmann, Frank; Kramer, Gunter; Bukau, Bernd			Cotranslational assembly of protein complexes in eukaryotes revealed by ribosome profiling	NATURE			English	Article							NASCENT POLYPEPTIDE-CHAINS; FATTY-ACID SYNTHASE; SYNTHETASE COMPLEX; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; QUALITY-CONTROL; YEAST; SUBUNIT; ALPHA; TRANSLATION	The folding of newly synthesized proteins to the native state is a major challenge within the crowded cellular environment, as nonproductive interactions can lead to misfolding, aggregation and degradation(1). Cells cope with this challenge by coupling synthesis with polypeptide folding and by using molecular chaperones to safeguard folding cotranslationally(2). However, although most of the cellular proteome forms oligomeric assemblies(3), little is known about the final step of folding: the assembly of polypeptides into complexes. In prokaryotes, a proof-of-concept study showed that the assembly of heterodimeric luciferase is an organized cotranslational process that is facilitated by spatially confined translation of the subunits encoded on a polycistronic mRNA(4). In eukaryotes, however, fundamental differences-such as the rarity of polycistronic mRNAs and different chaperone constellations-raise the question of whether assembly is also coordinated with translation. Here we provide a systematic and mechanistic analysis of the assembly of protein complexes in eukaryotes using ribosome profiling. We determined the in vivo interactions of the nascent subunits from twelve hetero-oligomeric protein complexes of Saccharomyces cerevisiae at near-residue resolution. We find nine complexes assemble cotranslationally; the three complexes that do not show cotranslational interactions are regulated by dedicated assembly chaperones(5-7). Cotranslational assembly often occurs uni-directionally, with one fully synthesized subunit engaging its nascent partner subunit, thereby counteracting its propensity for aggregation. The onset of cotranslational subunit association coincides directly with the full exposure of the nascent interaction domain at the ribosomal tunnel exit. The action of the ribosome-associated Hsp70 chaperone Ssb(8) is coordinated with assembly. Ssb transiently engages partially synthesized interaction domains and then dissociates before the onset of partner subunit association, presumably to prevent premature assembly interactions. Our study shows that cotranslational subunit association is a prevalent mechanism for the assembly of hetero-oligomers in yeast and indicates that translation, folding and the assembly of protein complexes are integrated processes in eukaryotes.	[Shiber, Ayala; Doering, Kristina; Friedrich, Ulrike; Klann, Kevin; Merker, Dorina; Zedan, Mostafa; Tippmann, Frank; Kramer, Gunter; Bukau, Bernd] Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, Heidelberg, Germany; [Shiber, Ayala; Doering, Kristina; Friedrich, Ulrike; Klann, Kevin; Merker, Dorina; Zedan, Mostafa; Tippmann, Frank; Kramer, Gunter; Bukau, Bernd] German Canc Res Ctr, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Shiber, A; Kramer, G; Bukau, B (corresponding author), Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, Heidelberg, Germany.; Shiber, A; Kramer, G; Bukau, B (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	a.shiber@zmbh.uni-heidelberg.de; g.kramer@zmbh.uni-heidelberg.de; bukau@zmbh.uni-heidelberg.de		Shiber, Ayala/0000-0002-3167-1494; Kramer, Gunter/0000-0001-7552-8393; Friedrich, Ulrike Anne/0000-0001-7295-4549; Bukau, Bernd/0000-0003-0521-7199; Klann, Kevin/0000-0003-2276-8128	ERC [743118]; Alexander von Humboldt fellowship;  [SFB1036]	ERC(European Research Council (ERC)European Commission); Alexander von Humboldt fellowship(Alexander von Humboldt Foundation); 	We thank members of the Bukau laboratory for discussions, D. H. Wolf for FAS antisera and the DKFZ Core facility for sequencing. This work was supported by ERC Advanced grant (743118), SFB1036 and an Alexander von Humboldt fellowship to A.S.	Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; Benschop JJ, 2010, MOL CELL, V38, P916, DOI 10.1016/j.molcel.2010.06.002; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Cazals F, 2006, PROTEIN SCI, V15, P2082, DOI 10.1110/ps.062245906; Cherkasov V, 2015, FEBS LETT, V589, P3654, DOI 10.1016/j.febslet.2015.10.010; Doring K, 2017, CELL, V170, P298, DOI 10.1016/j.cell.2017.06.038; Duncan CDS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002398; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Esmaielbeiki R, 2016, BRIEF BIOINFORM, V17, P117, DOI 10.1093/bib/bbv027; Frechin M, 2014, MOL CELL, V56, P763, DOI 10.1016/j.molcel.2014.10.015; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gipson P, 2010, P NATL ACAD SCI USA, V107, P9164, DOI 10.1073/pnas.0913547107; Gloge F, 2014, CURR OPIN STRUC BIOL, V24, P24, DOI 10.1016/j.sbi.2013.11.004; Gumiero A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13563; Halbach A, 2009, EMBO J, V28, P2959, DOI 10.1038/emboj.2009.240; HANNIG EM, 1993, MOL CELL BIOL, V13, P506, DOI 10.1128/MCB.13.1.506; HANSEN WJ, 1994, J BIOL CHEM, V269, P26610; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; Herbert AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114749; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Karanasios E, 2007, J MOL BIOL, V374, P1077, DOI 10.1016/j.jmb.2007.10.010; Koehler C, 2013, NUCLEIC ACIDS RES, V41, P667, DOI 10.1093/nar/gks1072; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Meurisse J, 2014, NUCLEIC ACIDS RES, V42, P13174, DOI 10.1093/nar/gku1095; Pfund C, 2001, MOL BIOL CELL, V12, P3773, DOI 10.1091/mbc.12.12.3773; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Sakahira H, 2002, J BIOL CHEM, V277, P3364, DOI 10.1074/jbc.M110071200; Scazzari M, 2015, J BIOL CHEM, V290, P4677, DOI 10.1074/jbc.M114.596064; SCHULLER HJ, 1992, EUR J BIOCHEM, V203, P607, DOI 10.1111/j.1432-1033.1992.tb16590.x; Shieh YW, 2015, SCIENCE, V350, P678, DOI 10.1126/science.aac8171; Simader H, 2006, NUCLEIC ACIDS RES, V34, P3968, DOI 10.1093/nar/gkl560; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001	38	148	149	7	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2018	561	7722					268	+		10.1038/s41586-018-0462-y	http://dx.doi.org/10.1038/s41586-018-0462-y			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT3XQ	30158700	Green Accepted			2022-12-28	WOS:000444437900049
J	Dyar, KA; Lutter, D; Artati, A; Ceglia, NJ; Liu, Y; Armenta, D; Jastroch, M; Schneider, S; de Mateo, S; Cervantes, M; Abbondante, S; Tognini, P; Orozco-Solis, R; Kinouchi, K; Wang, C; Swerdloff, R; Nadeef, S; Masri, S; Magistretti, P; Orlando, V; Borrelli, E; Uhlenhaut, NH; Baldi, P; Adamski, J; Tschop, MH; Eckel-Mahan, K; Sassone-Corsi, P				Dyar, Kenneth A.; Lutter, Dominik; Artati, Anna; Ceglia, Nicholas J.; Liu, Yu; Armenta, Danny; Jastroch, Martin; Schneider, Sandra; de Mateo, Sara; Cervantes, Marlene; Abbondante, Serena; Tognini, Paola; Orozco-Solis, Ricardo; Kinouchi, Kenichiro; Wang, Christina; Swerdloff, Ronald; Nadeef, Seba; Masri, Selma; Magistretti, Pierre; Orlando, Valerio; Borrelli, Emiliana; Uhlenhaut, N. Henriette; Baldi, Pierre; Adamski, Jerzy; Tschoep, Matthias H.; Eckel-Mahan, Kristin; Sassone-Corsi, Paolo			Atlas of Circadian Metabolism Reveals System-wide Coordination and Communication between Clocks	CELL			English	Article							BROWN ADIPOSE-TISSUE; AMINO-ACID-METABOLISM; MITOCHONDRIAL PROTON; INSULIN SENSITIVITY; PURINE NUCLEOTIDES; SIGNALING PATHWAYS; GLUCOSE-UPTAKE; MUSCLE; PROTEIN; METABOLOMICS	Metabolic diseases are often characterized by circadian misalignment in different tissues, yet how altered coordination and communication among tissue clocks relate to specific pathogenic mechanisms remains largely unknown. Applying an integrated systems biology approach, we performed 24-hr metabolomics profiling of eight mouse tissues simultaneously. We present a temporal and spatial atlas of circadian metabolism in the context of systemic energy balance and under chronic nutrient stress (high-fat diet [HFD]). Comparative analysis reveals how the repertoires of tissue metabolism are linked and gated to specific temporal windows and how this highly specialized communication and coherence among tissue clocks is rewired by nutrient challenge. Overall, we illustrate how dynamic metabolic relationships can be reconstructed across time and space and how integration of circadian metabolomics data from multiple tissues can improve our understanding of health and disease.	[Dyar, Kenneth A.; Lutter, Dominik; Jastroch, Martin; Uhlenhaut, N. Henriette; Tschoep, Matthias H.] Helmholtz Zentrum Munchen, HDC, IDO, D-85764 Neuherberg, Germany; [Dyar, Kenneth A.; Lutter, Dominik; Jastroch, Martin; Uhlenhaut, N. Henriette; Adamski, Jerzy; Tschoep, Matthias H.] German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany; [Artati, Anna; Adamski, Jerzy] Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, D-85764 Neuherberg, Germany; [Ceglia, Nicholas J.; Liu, Yu; Armenta, Danny; Baldi, Pierre] Univ Calif Irvine, Sch Informat & Comp Sci, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Schneider, Sandra] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [de Mateo, Sara; Cervantes, Marlene; Abbondante, Serena; Tognini, Paola; Orozco-Solis, Ricardo; Kinouchi, Kenichiro; Masri, Selma; Borrelli, Emiliana; Eckel-Mahan, Kristin; Sassone-Corsi, Paolo] Univ Calif Irvine, INSERM, U1233, Ctr Epigenet & Metab,Dept Biol Chem, Irvine, CA 92697 USA; [Wang, Christina; Swerdloff, Ronald] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Wang, Christina; Swerdloff, Ronald] Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Nadeef, Seba; Magistretti, Pierre; Orlando, Valerio] King Abdullah Univ Sci & Technol, KAUST Environm Epigenet Program, BESE Div, Thuwal, Saudi Arabia; [Adamski, Jerzy] Tech Univ Munich, Chair Expt Genet, D-85350 Freising Weihenstephan, Germany; [Tschoep, Matthias H.] Tech Univ Munich, Div Metab Dis, D-80333 Munich, Germany; [Eckel-Mahan, Kristin] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California Irvine; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; King Abdullah University of Science & Technology; Technical University of Munich; Technical University of Munich; University of Texas System; University of Texas Health Science Center Houston	Tschop, MH (corresponding author), Helmholtz Zentrum Munchen, HDC, IDO, D-85764 Neuherberg, Germany.; Adamski, J; Tschop, MH (corresponding author), German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany.; Adamski, J (corresponding author), Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, D-85764 Neuherberg, Germany.; Eckel-Mahan, K; Sassone-Corsi, P (corresponding author), Univ Calif Irvine, INSERM, U1233, Ctr Epigenet & Metab,Dept Biol Chem, Irvine, CA 92697 USA.; Adamski, J (corresponding author), Tech Univ Munich, Chair Expt Genet, D-85350 Freising Weihenstephan, Germany.; Tschop, MH (corresponding author), Tech Univ Munich, Div Metab Dis, D-80333 Munich, Germany.; Eckel-Mahan, K (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA.	adamski@helmholtz-muenchen.de; matthias.tschoep@helmholtz-muenchen.de; kristin.l.mahan@uth.tmc.edu; psc@uci.edu	Jastroch, Martin/I-7494-2017; Lutter, Dominik RL/B-7790-2013; Uhlenhaut, Henriette/AAP-5400-2020; Liu, Yu/C-3867-2016; Dyar, Kenneth/K-4735-2014; Dyar, Kenneth/N-8399-2019; Uhlenhaut, Henriette/AFR-1141-2022; Borrelli, Emiliana/M-8994-2018; Kinouchi, Kenichiro/AAW-8471-2021	Lutter, Dominik RL/0000-0002-8800-0683; Liu, Yu/0000-0003-3698-4892; Dyar, Kenneth/0000-0002-9010-8757; Kinouchi, Kenichiro/0000-0003-4743-2583; Eckel-Mahan, Kristin/0000-0001-8201-1675; Cervantes, Marlene/0000-0003-4619-6144; Adamski, Jerzy/0000-0001-9259-0199; Masri, Selma/0000-0002-8619-8331; Uhlenhaut, Henriette/0000-0002-4220-4779	NIH [GM123558, DK114037]; DARPA grant [D17AP00002]; DFG Emmy Noether [NHU 275/1-1]; Alexander von Humboldt Foundation; INSERM (Institut National de la Sante et de la Recherche Medicale, France); KAUST (King Abdullah University of Science and Technology), National Institutes of Health; Novo Nordisk Foundation Challenge Grant [NNF140C0011493]; German Federal Ministry of Education and Research (BMBF) to the German Center Diabetes Research (DZD e.V.) grant; NATIONAL CANCER INSTITUTE [K22CA212045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK114652, R01DK114037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM117942, R01GM123558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA036408] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA grant(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DFG Emmy Noether(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); INSERM (Institut National de la Sante et de la Recherche Medicale, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); KAUST (King Abdullah University of Science and Technology), National Institutes of Health; Novo Nordisk Foundation Challenge Grant; German Federal Ministry of Education and Research (BMBF) to the German Center Diabetes Research (DZD e.V.) grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grant GM123558 and DARPA grant D17AP00002 (P.B.); DFG Emmy Noether NHU 275/1-1 (N.H.U.); the Alexander von Humboldt Foundation (M.H.T.); NIH DK114037 (K.E.M.); by INSERM (Institut National de la Sante et de la Recherche Medicale, France), KAUST (King Abdullah University of Science and Technology), National Institutes of Health, and Novo Nordisk Foundation Challenge Grant NNF140C0011493 (P.S.-C.); and by the German Federal Ministry of Education and Research (BMBF) to the German Center Diabetes Research (DZD e.V.) grant to J.A.	Abbondante S, 2016, J BIOL CHEM, V291, P2812, DOI 10.1074/jbc.M115.681130; Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; ADIBI SA, 1968, J APPL PHYSIOL, V25, P52, DOI 10.1152/jappl.1968.25.1.52; Agostinelli F, 2016, BIOINFORMATICS, V32, P8, DOI 10.1093/bioinformatics/btw243; Aguilar-Arnal L, 2016, P NATL ACAD SCI USA; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Aviram R, 2016, MOL CELL, V62, P636, DOI 10.1016/j.molcel.2016.04.002; Batch BC, 2013, METABOLISM, V62, P961, DOI 10.1016/j.metabol.2013.01.007; Bender D, 2011, AMINO ACID METABIS; Brown SA, 2016, TRENDS ENDOCRIN MET, V27, P415, DOI 10.1016/j.tem.2016.03.015; Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Davies SK, 2014, P NATL ACAD SCI USA, V111, P10761, DOI 10.1073/pnas.1402663111; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Dudzinska W, 2004, DIABETES METAB, V30, P557, DOI 10.1016/S1262-3636(07)70155-6; Dunford EC, 2016, METABOLITES, V6, DOI 10.3390/metabo6040044; Dyar KA, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00369; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; ELIA M, 1981, BRIT MED J, V282, P351, DOI 10.1136/bmj.282.6261.351; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Fustin JM, 2012, CELL REP, V1, P341, DOI 10.1016/j.celrep.2012.03.001; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; German JB, 2005, METABOLOMICS, V1, P3, DOI 10.1007/s11306-005-1102-8; Giskeodegard GF, 2015, SCI REP-UK, V5, DOI 10.1038/srep14843; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Goodacre R, 2007, J NUTR, V137, p259S, DOI 10.1093/jn/137.1.259S; Gooley JJ, 2014, J GENET GENOMICS, V41, P231, DOI 10.1016/j.jgg.2014.04.001; GUGGENHEIM KY, 1991, J NUTR, V121, P1701, DOI 10.1093/jn/121.11.1701; Hatting M, 2018, ANN NY ACAD SCI, V1411, P21, DOI 10.1111/nyas.13435; Herrero MC, 1997, INT J OBESITY, V21, P698, DOI 10.1038/sj.ijo.0800464; Hirschberg Verena, 2011, Front Endocrinol (Lausanne), V2, P63, DOI 10.3389/fendo.2011.00063; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Isherwood CM, 2017, FASEB J, V31, P5557, DOI 10.1096/fj.201700323R; Jastroch M, 2012, BBA-BIOENERGETICS, V1817, P1660, DOI 10.1016/j.bbabio.2012.05.014; Jastroch M, 2012, METHODS MOL BIOL, V810, P153, DOI 10.1007/978-1-61779-382-0_10; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Jouffe C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24631; Kim K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086223; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Krishnaiah SY, 2017, CELL METAB, V25, P961, DOI 10.1016/j.cmet.2017.03.019; Lee P, 2016, CELL METAB, V23, P602, DOI 10.1016/j.cmet.2016.02.007; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; LU X, 2017, SCI REP UK, V7; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Mauvoisin D, 2017, CELL REP, V20, P1729, DOI 10.1016/j.celrep.2017.07.065; McKee EE, 1999, BIOCHEM BIOPH RES CO, V257, P466, DOI 10.1006/bbrc.1999.0489; Mori S, 2005, J BIOL CHEM, V280, P24104, DOI 10.1074/jbc.M502518200; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; Noguchi R, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.19; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Oakes ND, 1997, DIABETES, V46, P2022, DOI 10.2337/diabetes.46.12.2022; ODESSEY R, 1979, BIOCHEM J, V178, P475, DOI 10.1042/bj1780475; Park S, 2015, MOL CELLS, V38, P587, DOI 10.14348/molcells.2015.0126; Patel VR, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2111; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; POZEFSKY T, 1969, J CLIN INVEST, V48, P2273, DOI 10.1172/JCI106193; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rey G, 2016, CELL METAB, V24, P462, DOI 10.1016/j.cmet.2016.07.024; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Roenneberg T, 2016, CURR BIOL, V26, pR432, DOI 10.1016/j.cub.2016.04.011; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Roseno SL, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0037-y; Scheer FAJL, 2010, P NATL ACAD SCI USA, V107, P20541, DOI 10.1073/pnas.1006749107; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; SERRA F, 1994, BIOCHEM MOL BIOL INT, V32, P1173; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Shimizu N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7693; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Sinues PML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114422; Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189; SNELL K, 1979, INT J BIOCHEM, V10, P423, DOI 10.1016/0020-711X(79)90066-1; Song SM, 2001, AM J PHYSIOL-ENDOC M, V281, pE275, DOI 10.1152/ajpendo.2001.281.2.E275; Sugimoto M, 2012, NUCLEIC ACIDS RES, V40, pD809, DOI 10.1093/nar/gkr1170; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; van der Veen DR, 2012, OBESITY, V20, P1527, DOI 10.1038/oby.2012.78; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10; Zhao X, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2794591; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056072; Zwighaft Z, 2015, CELL METAB, V22, P874, DOI 10.1016/j.cmet.2015.09.011	95	155	157	4	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1571	+		10.1016/j.cell.2018.08.042	http://dx.doi.org/10.1016/j.cell.2018.08.042			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193114	Green Accepted, Bronze			2022-12-28	WOS:000443841000023
J	Owen, J				Owen, Jonathan			NEWS ANALYSIS Children are still being forced to travel far for mental healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS England, IMPL 5 YEAR FORW VIE	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2018	362								k3769	10.1136/bmj.k3769	http://dx.doi.org/10.1136/bmj.k3769			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT4VO	30181238				2022-12-28	WOS:000444503800013
J	Masnadi, MS; El-Houjeiri, HM; Schunack, D; Li, YP; Englander, JG; Badahdah, A; Monfort, JC; Anderson, JE; Wallington, TJ; Bergerson, JA; Gordon, D; Koomey, J; Przesmitzki, S; Azevedo, IL; Bi, XT; Duffy, JE; Heath, GA; Keoleian, GA; McGlade, C; Meehan, DN; Yeh, S; You, FQ; Wang, M; Brandt, AR				Masnadi, Mohammad S.; El-Houjeiri, Hassan M.; Schunack, Dominik; Li, Yunpo; Englander, Jacob G.; Badahdah, Alhassan; Monfort, Jean-Christophe; Anderson, James E.; Wallington, Timothy J.; Bergerson, Joule A.; Gordon, Deborah; Koomey, Jonathan; Przesmitzki, Steven; Azevedo, Ines L.; Bi, Xiaotao T.; Duffy, James E.; Heath, Garvin A.; Keoleian, Gregory A.; McGlade, Christophe; Meehan, D. Nathan; Yeh, Sonia; You, Fengqi; Wang, Michael; Brandt, Adam R.			Global carbon intensity of crude oil production	SCIENCE			English	Editorial Material							EMISSIONS					masnadi@stanford.edu; abrandt@stanford.edu	You, Fengqi/B-5040-2011; Anderson, James E/C-9935-2010; Yeh, Sonia/Q-3632-2017; Anderson, James/R-3906-2019; Koomey, Jonathan/AAR-6685-2021	You, Fengqi/0000-0001-9609-4299; Anderson, James E/0000-0003-0878-5271; Yeh, Sonia/0000-0002-4852-1177; Koomey, Jonathan/0000-0002-2983-344X; Monfort, Jean-Christophe/0000-0002-6096-8860; Heath, Garvin/0000-0001-6010-4475	Natural Sciences and Engineering Research Council of Canada (NSERC); Aramco Services Company (MI, USA); Ford Motor Company; Carnegie Endowment; Carnegie Endowment for International Peace; Carnegie's endowment; Hewlett Foundation; ClimateWorks Foundation; Alfred P. Sloan Foundation; Directorate For Engineering [1643244] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Aramco Services Company (MI, USA); Ford Motor Company; Carnegie Endowment; Carnegie Endowment for International Peace; Carnegie's endowment; Hewlett Foundation; ClimateWorks Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The Natural Sciences and Engineering Research Council of Canada (NSERC) provided financial support to M.S.M. Aramco Services Company (MI, USA) and Ford Motor Company provided funding for D.S. and A.R.B. A.R.B. also received funding from the Carnegie Endowment for prior research and data collection. D.G. and J.K. were funded through the Carnegie Endowment for International Peace, with primary funding from Carnegie's endowment and additional funding from the Hewlett Foundation, ClimateWorks Foundation, and Alfred P. Sloan Foundation. The authors are grateful to G. Cooney from National Energy Technology Laboratory (PA, USA) for constructive comments.	Baron R., 2015, DIVESTMENT STRANDED; Brandt AR, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaae76; C-NLOPB, 2017, NEWF LABR OFFSH AR G; California Environmental Protection Agency/ Air Resources Board, LOW CARB FUEL STAND; El-Houjeiri H.M., 2017, OIL PRODUCTION GREEN; El-Houjeiri HM, 2013, ENVIRON SCI TECHNOL, V47, P5998, DOI 10.1021/es304570m; Environment and Climate Change Canada, 2017, CLEAN FUEL STAND; Gilblom Kelly, 2018, BLOOMBERG; Gould T., 2017, ENV CASE NATURAL GAS; IHS CERA, 2012, OIL SANDS GREENH GAS; Le Quere C, 2016, EARTH SYST SCI DATA, V8, P605, DOI 10.5194/essd-8-605-2016; Masnadi MS, 2018, NAT ENERGY, V3, P220, DOI 10.1038/s41560-018-0090-7; Masnadi MS, 2017, NAT CLIM CHANGE, V7, P551, DOI [10.1038/NCLIMATE3347, 10.1038/nclimate3347]; Wang JF, 2017, ENERGY, V118, P884, DOI 10.1016/j.energy.2016.10.107	14	106	106	7	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					851	853		10.1126/science.aar6859	http://dx.doi.org/10.1126/science.aar6859			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS3UB	30166477	Green Submitted			2022-12-28	WOS:000443547000019
J	Rumball-Smith, J; Gurvey, J; Friedberg, MW				Rumball-Smith, Juliet; Gurvey, Jill; Friedberg, Mark W.			Personalized Hospital Ratings - Transparency for the Internet Age	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rumball-Smith, Juliet] Northland Dist Hlth Board, Whangarei, New Zealand; [Rumball-Smith, Juliet; Gurvey, Jill] RAND Corp, Santa Monica, CA 90406 USA; [Friedberg, Mark W.] RAND Corp, Boston, MA USA; [Friedberg, Mark W.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Friedberg, Mark W.] Harvard Med Sch, Boston, MA USA	RAND Corporation; RAND Corporation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Rumball-Smith, J (corresponding author), Northland Dist Hlth Board, Whangarei, New Zealand.; Rumball-Smith, J (corresponding author), RAND Corp, Santa Monica, CA 90406 USA.		Friedberg, Mark William/Y-2607-2019	Friedberg, Mark William/0000-0002-7907-8358				Friedberg M. W., 2011, METHODOLOGICAL CONSI; Hibbard J., 2010, BEST PRACTICES PUBLI; Hibbard J H, 2001, Jt Comm J Qual Improv, V27, P591; Rajaram R, 2015, JAMA-J AM MED ASSOC, V313, P897, DOI 10.1001/jama.2015.52; Yale New Haven Health Services Corporation/ Center for Outcomes Research & Evaluation, 2016, OV HOSP QUAL STAR RA	5	3	3	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2018	379	9					806	807		10.1056/NEJMp1805000	http://dx.doi.org/10.1056/NEJMp1805000			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GR9EA	30157399				2022-12-28	WOS:000443047800003
J	Gomes, T; Khuu, W; Martins, D; Tadrous, M; Mamdani, MM; Paterson, JM; Juurlink, DN				Gomes, Tara; Khuu, Wayne; Martins, Diana; Tadrous, Mina; Mamdani, Muhammad M.; Paterson, J. Michael; Juurlink, David N.			Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OVERDOSE-RELATED DEATHS; FENTANYL OVERDOSES; BRITISH-COLUMBIA; HEROIN; MORTALITY; PAIN; ANALGESICS; GUIDELINE; EPIDEMIC; PATTERNS	OBJECTIVE To describe the contributions of prescribed and non-prescribed opioids to opioid related deaths. DESIGN Population based cohort study. SETTING Ontario, Canada, from 1 January 2013 to 31 December 2016. PARTICIPANTS All Ontarians who died of an opioid related cause. EXPOSURE Active opioid prescriptions, defined as those with a duration overlapping the date of death, and recent opioid prescriptions, defined as those dispensed in the 30 and 180 days preceding death. Postmortem toxicology results from the Drug and Drug/Alcohol Related Death database were used to characterise deaths on the basis of presence of prescribed and non-prescribed (that is, diverted or illicit) opioids, overall and stratified by year and age. RESULTS 2833 opioid related deaths occurred. An active opioid prescription on the date of death was relatively common but declined slightly throughout the study period (38.2% (241/631) in 2013 and 32.5% (278/855) in 2016; P for trend=0.03). Older people and women were relatively more likely to have an active opioid prescription at time of death. In 2016, 46% (169/364) of people aged 45-64 had an active opioid prescription compared with only 12% (8/69) among those aged 24 or younger (P for trend<0.001). Similarly, 46% (124/272) of women had an active opioid prescription at time of death compared with 26.4% (154/583) of men (P<0.001). Among people with active opioid prescriptions at time of death, 37.8% (375/993) also had evidence of a non-prescribed opioid on postmortem toxicology. By 2016, the non-prescribed opioid most commonly identified after death was fentanyl (41%; 47 of 115 cases). Among people without an active opioid prescription at time of death, fentanyl was detected in 20% (78/390) of deaths in 2013, increasing to 47.5% (274/577) by 2016 (P<0.001). CONCLUSIONS Prescribed, diverted, and illicit opioids all play an important role in opioid related deaths. Although more than half of all opioid related deaths still involved prescription drugs (either dispensed or diverted) in 2016, the increased rate of deaths involving fentanyl between 2015 and 2016 is concerning and suggests the need for a multifactorial approach to this problem that considers both the prescribed and illicit opioid environments.	[Gomes, Tara; Martins, Diana; Tadrous, Mina] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Khuu, Wayne; Paterson, J. Michael] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Mamdani, Muhammad M.] St Michaels Hosp, Li Ka Shing Ctr Healthcare Analyt Res & Training, Toronto, ON, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Gomes, T (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.	GomesT@smh.ca	; Tadrous, Mina/E-9136-2018	Gomes, Tara/0000-0002-1468-1965; Tadrous, Mina/0000-0003-1911-6129	Ontario Ministry of Health and Long-Term Care (MOHLTC) [06673]; Canadian Institutes for Health Research [153070]; Institute for Clinical Evaluative Sciences (ICES); Ontario MOHLTC	Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario MOHLTC(Ministry of Health and Long-Term Care, Ontario)	This study was supported by a grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC; grant # 06673) and the Canadian Institutes for Health Research (grant # 153070). It was also supported by the Institute for Clinical Evaluative Sciences (ICES), a non-profit research institute sponsored by the Ontario MOHLTC. The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.	Alberta Health, 2017, OP SUBST MIS ALB REP; Baldwin N, 2018, DRUG ALCOHOL DEPEN, V185, P322, DOI 10.1016/j.drugalcdep.2017.12.032; Barry CL, 2018, PSYCHIAT SERV, V69, P100, DOI 10.1176/appi.ps.201700235; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; British Columbia Coroners Service, 2018, FENT DET ILL DRUG OV; Busse JW, 2017, CAN MED ASSOC J, V189, pE659, DOI 10.1503/cmaj.170363; Cheng T, 2017, CAN J PUBLIC HEALTH, V108, pE325, DOI [10.17269/CJPH.108.6075, 10.17269/cjph.108.6075]; Ciccarone D, 2017, INT J DRUG POLICY, V46, P107, DOI 10.1016/j.drugpo.2017.06.010; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Fairbairn N, 2017, INT J DRUG POLICY, V46, P172, DOI 10.1016/j.drugpo.2017.06.005; Fischer B, 2018, PREV MED, V107, P109, DOI 10.1016/j.ypmed.2017.11.001; Gladstone EJ, 2015, MED CARE, V53, P954, DOI 10.1097/MLR.0000000000000431; Gomes T, 2017, ONTARIO DRUG POLICY, DOI [10.31027/ODPRN.2017.04, DOI 10.31027/ODPRN.2017.04]; Gomes T, 2018, J ADDICT MED, V12, P418, DOI 10.1097/ADM.0000000000000412; Gomes Tara, 2017, CMAJ Open, V5, pE800, DOI 10.9778/cmajo.20170104; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Government of Canada, 2017, ACT OP 2016 2017; Juurlink DN, 2012, J MED TOXICOL, V8, P393, DOI 10.1007/s13181-012-0269-4; O'Donnell JK, 2017, MMWR-MORBID MORTAL W, V66, P1197, DOI 10.15585/mmwr.mm6643e1; Ontario College of Pharmacists, 2016, PATCH FOR PATCH FENT; Ontario Ministry of Health and Long-Term Care, 2015, ONT NARC STRAT CHANG; Park TW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2698; Public Health Ontario, 2018, OP REL MORB MORT ONT; RUBIN R, 2017, JAMA-J AM MED ASSOC, V318, P2174, DOI DOI 10.1001/JAMA.2017.18602; Slavova S, 2017, INT J DRUG POLICY, V46, P120, DOI 10.1016/j.drugpo.2017.05.051; Special Advisory Committee on the Epidemic of Opioid Overdoses, 2017, NAT REP APP OP REL D; U. S. Centers for Disease Control and Prevention, 2017, OP OV	28	89	89	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2018	362								k3207	10.1136/bmj.k3207	http://dx.doi.org/10.1136/bmj.k3207			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU9VE	30158106	Green Published, hybrid			2022-12-28	WOS:000445701700001
J	Pulikkan, JA; Hegde, M; Ahmad, HM; Belaghzal, H; Illendula, A; Yu, J; O'Hagan, K; Ou, JH; Muller-Tidow, C; Wolfe, SA; Zhu, LJ; Dekker, J; Bushweller, JH; Castilla, LH				Pulikkan, John Anto; Hegde, Mahesh; Ahmad, Hafiz Mohd; Belaghzal, Houda; Illendula, Anuradha; Yu, Jun; O'Hagan, Kelsey; Ou, Jianhong; Muller-Tidow, Carsten; Wolfe, Scot A.; Zhu, Lihua Julie; Dekker, Job; Bushweller, John Hackett; Castilla, Lucio Hernan			CBF beta-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia (vol 174, pg 172, 2018)	CELL			English	Correction												lucio.castilla@umassmed.edu	Hegde, MahesH/ABE-2057-2020; Ahmad, Mohd Hafiz/S-3938-2019	Hegde, MahesH/0000-0002-7853-6281; Bushweller, John/0000-0002-5386-1758				Pulikkan JA, 2018, CELL, V174, P172, DOI 10.1016/j.cell.2018.05.048	1	11	11	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2018	174	5					1325	1325		10.1016/j.cell.2018.08.014	http://dx.doi.org/10.1016/j.cell.2018.08.014			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GR3WU	30142347	Bronze			2022-12-28	WOS:000442529100024
J	Pan, XJ; Li, ZQ; Zhou, Q; Shen, HZ; Wu, K; Huang, XS; Chen, JF; Zhang, JR; Zhu, XC; Lei, JL; Xiong, W; Gong, HP; Xiao, BL; Yan, N				Pan, Xiaojing; Li, Zhangqiang; Zhou, Qiang; Shen, Huaizong; Wu, Kun; Huang, Xiaoshuang; Chen, Jiaofeng; Zhang, Juanrong; Zhu, Xuechen; Lei, Jianlin; Xiong, Wei; Gong, Haipeng; Xiao, Bailong; Yan, Nieng			Structure of the human voltage-gated sodium channel Na(v)1.4 in complex with beta 1	SCIENCE			English	Article							MOLECULAR DETERMINANTS; FUNCTIONAL EXPRESSION; CRYSTAL-STRUCTURE; CHARGE MOVEMENT; INACTIVATION; SENSOR; NA+; IV; MECHANISMS; MYOTONIA		[Pan, Xiaojing; Li, Zhangqiang; Zhou, Qiang; Shen, Huaizong; Huang, Xiaoshuang; Yan, Nieng] Tsinghua Univ, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Pan, Xiaojing; Li, Zhangqiang; Zhou, Qiang; Shen, Huaizong; Huang, Xiaoshuang; Zhang, Juanrong; Gong, Haipeng; Yan, Nieng] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Pan, Xiaojing; Li, Zhangqiang; Wu, Kun; Chen, Jiaofeng; Zhang, Juanrong; Xiong, Wei; Xiao, Bailong; Yan, Nieng] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Pan, Xiaojing; Zhou, Qiang; Shen, Huaizong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Li, Zhangqiang; Wu, Kun; Huang, Xiaoshuang; Chen, Jiaofeng; Zhang, Juanrong; Zhu, Xuechen; Lei, Jianlin; Xiong, Wei; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Wu, Kun; Xiao, Bailong] Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China; [Lei, Jianlin] Tsinghua Univ, Technol Ctr Prot Sci, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China; [Yan, Nieng] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Princeton University	Yan, N (corresponding author), Tsinghua Univ, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.; Yan, N (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.; Yan, N (corresponding author), Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China.; Yan, N (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Yan, N (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	nyan@princeton.edu	Xiong, Wei/AAY-5944-2020; Bourinet, Emmanuel/S-4396-2017	Xiong, Wei/0000-0002-2784-7696; Bourinet, Emmanuel/0000-0001-8021-0419; Shen, Huaizong/0000-0002-1216-5393; Wu, Kun/0000-0002-3075-8272; Pan, Xiaojing/0000-0003-1882-5361	National Key Basic Research (973) Program [2015CB910101]; National Key RAMP;D Program from Ministry of Science and Technology of China [2016YFA0500402, 2016YFA0501100]; National Natural Science Foundation of China [31621092, 31630017, 81861138009]; China Postdoctoral Science Foundation [BX201600089]; Princeton University	National Key Basic Research (973) Program(National Basic Research Program of China); National Key RAMP;D Program from Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Princeton University(Princeton University)	This work was funded by the National Key Basic Research (973) Program (2015CB910101 to N.Y.) and the National Key R&D Program (2016YFA0500402 to N.Y. and 2016YFA0501100 to J.L.) from Ministry of Science and Technology of China, the National Natural Science Foundation of China (projects 31621092, 31630017, and 81861138009 to N.Y.), and China Postdoctoral Science Foundation (BX201600089 to X.P.). We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for providing the cryo-EM facility support. We thank the computational facility support on the cluster of Bio-Computing Platform (Tsinghua University Branch of China National Center for Protein Sciences Beijing) and the "Explorer 100" cluster system of Tsinghua National Laboratory for Information Science and Technology. N.Y. is supported by the Shirley M. Tilghman endowed professorship from Princeton University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahern CA, 2016, J GEN PHYSIOL, V147, P1, DOI 10.1085/jgp.201511492; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Bagal SK, 2015, CHANNELS, V9, P360, DOI 10.1080/19336950.2015.1079674; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bouhours M, 2005, J PHYSIOL-LONDON, V565, P415, DOI 10.1113/jphysiol.2004.081018; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Catterall WA, 2014, ANNU REV PHARMACOL, V54, P317, DOI 10.1146/annurev-pharmtox-011112-140232; CHAHINE M, 1994, PFLUG ARCH EUR J PHY, V427, P136, DOI 10.1007/BF00585952; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; DeLano WL, 2002, THE PYMOL MOLECULAR; Dong Xiao-Wei, 2004, Curr Protoc Pharmacol, VChapter 11, DOI 10.1002/0471141755.ph1108s23; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Goldschen-Ohm MP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2356; Gosselin-Badaroudine P, 2012, P NATL ACAD SCI USA, V109, P19250, DOI 10.1073/pnas.1217990109; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hayward LJ, 1996, J GEN PHYSIOL, V107, P559, DOI 10.1085/jgp.107.5.559; He Y, 2014, PROTEIN CELL, V5, P658, DOI 10.1007/s13238-014-0086-4; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; HILLE B, 1972, J GEN PHYSIOL, V59, P637, DOI 10.1085/jgp.59.6.637; Hille B., 2001, ION CHANNELS EXCITAB, P814; HODGKIN AL, 1945, J PHYSIOL-LONDON, V104, P176, DOI 10.1113/jphysiol.1945.sp004114; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang WY, 2017, PROTEIN CELL, V8, P401, DOI 10.1007/s13238-017-0372-z; Israel MR, 2017, ADV PHARMACOL, V79, P67, DOI 10.1016/bs.apha.2017.01.004; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kass Robert S, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS21, DOI 10.1111/j.1540-8167.2006.00381.x; Kass RS, 2004, J GEN PHYSIOL, V124, P7, DOI 10.1085/jgp.200409123; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kubota T, 2017, P NATL ACAD SCI USA, V114, pE1857, DOI 10.1073/pnas.1700453114; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lei JL, 2005, J STRUCT BIOL, V150, P69, DOI 10.1016/j.jsb.2005.01.002; LERCHE H, 1993, J PHYSIOL-LONDON, V470, P13, DOI 10.1113/jphysiol.1993.sp019843; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; Miller C, 2006, SCIENCE, V312, P534, DOI 10.1126/science.1127186; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Muroi Y, 2010, NAT STRUCT MOL BIOL, V17, P230, DOI 10.1038/nsmb.1749; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; O'Malley HA, 2015, ANNU REV PHYSIOL, V77, P481, DOI 10.1146/annurev-physiol-021014-071846; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rubinstein M, 2018, MOL PSYCHIATR, V23, P231, DOI 10.1038/mp.2016.222; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schoser BGH, 2007, MUSCLE NERVE, V35, P599, DOI 10.1002/mus.20733; Shen HZ, 2018, SCIENCE, V362, DOI 10.1126/science.aau2596; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith MR, 1997, BIOPHYS J, V73, P1885, DOI 10.1016/S0006-3495(97)78219-5; Sokolov S, 2010, J GEN PHYSIOL, V136, P225, DOI 10.1085/jgp.201010414; Tang LH, 1996, J GEN PHYSIOL, V108, P89, DOI 10.1085/jgp.108.2.89; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Webb J, 2009, PFLUG ARCH EUR J PHY, V457, P1253, DOI 10.1007/s00424-008-0600-8; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yan Z, 2017, CELL, V170, P470, DOI 10.1016/j.cell.2017.06.039; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhang JR, 2018, PROTEIN CELL, V9, P580, DOI 10.1007/s13238-018-0522-y; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	88	204	209	9	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412							eaau2486	10.1126/science.aau2486	http://dx.doi.org/10.1126/science.aau2486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30190309				2022-12-28	WOS:000447680100037
J	Amoasii, L; Hildyard, JCW; Li, H; Sanchez-Ortiz, E; Mireault, A; Caballero, D; Harron, R; Stathopoulou, TR; Massey, C; Shelton, JM; Bassel-Duby, R; Piercy, RJ; Olson, EN				Amoasii, Leonela; Hildyard, John C. W.; Li, Hui; Sanchez-Ortiz, Efrain; Mireault, Alex; Caballero, Daniel; Harron, Rachel; Stathopoulou, Thaleia-Rengina; Massey, Claire; Shelton, John M.; Bassel-Duby, Rhonda; Piercy, Richard J.; Olson, Eric N.			Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy	SCIENCE			English	Article							MOUSE MODEL; MUSCLE; ETEPLIRSEN; THERAPY	Mutations in the gene encoding dystrophin, a protein that maintains muscle integrity and function, cause Duchenne muscular dystrophy (DMD). The deltaE50-MD dog model of DMD harbors a mutation corresponding to a mutational "hotspot" in the human DMD gene. We used adeno-associated viruses to deliver CRISPR gene editing components to four dogs and examined dystrophin protein expression 6 weeks after intramuscular delivery (n = 2) or 8 weeks after systemic delivery (n = 2). After systemic delivery in skeletal muscle, dystrophin was restored to levels ranging from 3 to 90% of normal, depending on muscle type. In cardiac muscle, dystrophin levels in the dog receiving the highest dose reached 92% of normal. The treated dogs also showed improved muscle histology. These large-animal data support the concept that, with further development, gene editing approaches may prove clinically useful for the treatment of DMD.	[Amoasii, Leonela; Li, Hui; Sanchez-Ortiz, Efrain; Mireault, Alex; Caballero, Daniel; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Hamon Ctr Regenerat Sci & Med, Sen Paul D Wellstone Muscular Dystrophy Cooperat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Amoasii, Leonela] Exon Therapeut, 75 Kneeland St, Boston, MA 02111 USA; [Hildyard, John C. W.; Harron, Rachel; Massey, Claire; Piercy, Richard J.] Royal Vet Coll, Dept Clin Sci & Serv, Comparat Neuromuscular Dis Lab, London NW1 0TU, England; [Stathopoulou, Thaleia-Rengina] Royal Vet Coll, Sect Anaesthesia & Analgesia, London NW1 0TU, England; [Shelton, John M.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Hamon Ctr Regenerat Sci & Med, Sen Paul D Wellstone Muscular Dystrophy Cooperat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Hildyard, John/AAB-2260-2021; LI, HUI/G-1227-2011; Caballero, Daniel/GXV-3082-2022	Hildyard, John/0000-0003-2283-2118; LI, HUI/0000-0002-4114-8349; Massey, Claire/0000-0003-0823-6547; Harron, Rachel/0000-0001-9418-0708; Amoasii, Leonela/0000-0001-7960-2749; Caballero, Daniel/0000-0001-9232-8991	NIH [HL130253, AR-067294]; Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant [U54 HD 087351]; Robert A. Welch Foundation [1-0025]; Cure Duchenne; Exonics Therapeutics; Wellcome Trust [101550/Z/13/Z]; Muscular Dystrophy UK [RA3/3077]; Joining Jack; Duchenne Ireland; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067294] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant(Ohio State University); Robert A. Welch Foundation(The Welch Foundation); Cure Duchenne; Exonics Therapeutics; Wellcome Trust(Wellcome TrustEuropean Commission); Muscular Dystrophy UK; Joining Jack; Duchenne Ireland; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the NIH (HL130253 and AR-067294), a Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant (U54 HD 087351), the Robert A. Welch Foundation (grant 1-0025 to E.N.O.), Cure Duchenne, and Exonics Therapeutics. The RVC dog colony program was established and/or is supported by grants from the Wellcome Trust (101550/Z/13/Z), Muscular Dystrophy UK (RA3/3077), Joining Jack, and Duchenne Ireland.	Aartsma-Rus A, 2017, NUCLEIC ACID THER, V27, P1, DOI 10.1089/nat.2016.0657; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Amoasii L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8081; BEGGS AH, 1991, AM J HUM GENET, V49, P54; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Dowling JJ, 2016, NAT REV NEUROL, V12, P675, DOI 10.1038/nrneurol.2016.180; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Godfrey C, 2015, HUM MOL GENET, V24, P4225, DOI 10.1093/hmg/ddv155; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Hildyard J, 2018, NEUROMUSCULAR DISORD, V28, pS18, DOI 10.1016/S0960-8966(18)30342-0; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Li YY, 2016, J INT MED RES, V44, P99, DOI 10.1177/0300060515613223; Long CZ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9004; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Mendell JR, 2016, ANN NEUROL, V79, P257, DOI 10.1002/ana.24555; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; O'Brien KF, 2001, MOL GENET METAB, V74, P75, DOI 10.1006/mgme.2001.3220; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Shimizu-Motohashi Y, 2016, AM J TRANSL RES, V8, P2471; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Stein CA, 2016, MOL THER, V24, P1884, DOI 10.1038/mt.2016.188; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Tremblay JP, 2016, MOL THER, V24, P1888, DOI 10.1038/mt.2016.191; van Putten M, 2014, J MOL CELL CARDIOL, V69, P17, DOI 10.1016/j.yjmcc.2014.01.009; Walmsley GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008647; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Yue YP, 2015, HUM MOL GENET, V24, P5880, DOI 10.1093/hmg/ddv310; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	35	292	307	12	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2018	362	6410			SI		86	90		10.1126/science.aau1549	http://dx.doi.org/10.1126/science.aau1549			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW0IN	30166439	Green Accepted			2022-12-28	WOS:000446547100048
J	Lieberman, J				Lieberman, Judy			Unveiling the RNA World	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INITIATION		[Lieberman, Judy] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Lieberman, Judy] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Lieberman, J (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.		Lieberman, Judy/A-2717-2015					LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; Lieberman J, 2018, NAT STRUCT MOL BIOL, V25, P357, DOI [10.1038/S41594-018-0054-4, 10.1038/s41594-018-0054-4]; STEITZ JA, 1975, P NATL ACAD SCI USA, V72, P4734, DOI 10.1073/pnas.72.12.4734; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0	5	4	4	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2018	379	13					1278	1280		10.1056/NEJMcibr1808725	http://dx.doi.org/10.1056/NEJMcibr1808725			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV1KS	30200806				2022-12-28	WOS:000445835100017
J	Ikebuchi, Y; Aoki, S; Honma, M; Hayashi, M; Sugamori, Y; Khan, M; Kariya, Y; Kato, G; Tabata, Y; Penninger, JM; Udagawa, N; Aoki, K; Suzuki, H				Ikebuchi, Yuki; Aoki, Shigeki; Honma, Masashi; Hayashi, Madoka; Sugamori, Yasutaka; Khan, Masud; Kariya, Yoshiaki; Kato, Genki; Tabata, Yasuhiko; Penninger, Josef M.; Udagawa, Nobuyuki; Aoki, Kazuhiro; Suzuki, Hiroshi			Coupling of bone resorption and formation by RANKL reverse signalling	NATURE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; OSTEOCLASTOGENESIS; GROWTH; MICE; PROLIFERATION; SUPPRESSION; EXPRESSION; VESICLES	Receptor activator of nuclear factor-kappa B (RANK) ligand (RANKL) binds RANK on the surface of osteoclast precursors to trigger osteoclastogenesis. Recent studies have indicated that osteocytic RANKL has an important role in osteoclastogenesis during bone remodelling; however, the role of osteoblastic RANKL remains unclear. Here we show that vesicular RANK, which is secreted from the maturing osteoclasts, binds osteoblastic RANKL and promotes bone formation by triggering RANKL reverse signalling, which activates Runt-related transcription factor 2 (Runx2). The proline-rich motif in the RANKL cytoplasmic tail is required for reverse signalling, and a RANKL(Pro29Ala) point mutation reduces activation of the reverse signalling pathway. The coupling of bone resorption and formation is disrupted in RANKL(Pro29Ala) mutant mice, indicating that osteoblastic RANKL functions as a coupling signal acceptor that recognizes vesicular RANK. RANKL reverse signalling is therefore a potential pharmacological target for avoiding the reduced bone formation associated with inhibition of osteoclastogenesis.	[Ikebuchi, Yuki; Aoki, Shigeki; Honma, Masashi; Hayashi, Madoka; Kariya, Yoshiaki; Suzuki, Hiroshi] Univ Tokyo, Univ Tokyo Hosp, Dept Pharm, Fac Med, Tokyo, Japan; [Sugamori, Yasutaka; Khan, Masud; Aoki, Kazuhiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Basic Oral Hlth Engn, Tokyo, Japan; [Kato, Genki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Biomatrix Pharmacol, Tokyo, Japan; [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Regenerat Sci & Engn, Lab Biomat, Kyoto, Japan; [Penninger, Josef M.] Austrian Acad Sci, Vienna Bioctr, Inst Mol Biotechnol, Vienna, Austria; [Udagawa, Nobuyuki] Matsumoto Dent Univ, Dept Biochem, Shiojiri, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kyoto University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Matsumoto Dental University	Honma, M (corresponding author), Univ Tokyo, Univ Tokyo Hosp, Dept Pharm, Fac Med, Tokyo, Japan.	mhonma-tky@umin.ac.jp	AOKI, Kazuhiro/GRO-6475-2022; Penninger, Josef M/I-6860-2013; Aoki, Shigeki/ABB-2942-2020	AOKI, Kazuhiro/0000-0001-6643-6315; Penninger, Josef M/0000-0002-8194-3777; 	JSPS KAKENHI [JP16H05445, JP24390349, JP26713045, JP24890048, JP25670632]; MEXT KAKENHI [JP22136015]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Toritani, M. Maeda, and M. A. Al Mamun for their technical assistance. This work was supported in part by JSPS KAKENHI grant numbers JP16H05445, JP24390349, JP26713045, JP24890048, JP25670632; and by MEXT KAKENHI grant number JP22136015.	Alles N, 2010, ENDOCRINOLOGY, V151, P4626, DOI 10.1210/en.2010-0399; Andersen TL, 2013, AM J PATHOL, V183, P235, DOI 10.1016/j.ajpath.2013.03.006; Boyce Brendan F, 2007, Curr Osteoporos Rep, V5, P98; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Fei QM, 2010, ACTA BIOCH BIOPH SIN, V42, P801, DOI 10.1093/abbs/gmq086; Florencio-Silva R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/421746; George J, 2006, BIOTECHNOL BIOENG, V95, P404, DOI 10.1002/bit.20939; Huynh N, 2016, J DENT RES, V95, P673, DOI 10.1177/0022034516633189; Kadono Y, 2005, EMBO REP, V6, P171, DOI 10.1038/sj.embor.7400345; Kariya Y, 2009, J BONE MINER RES, V24, P1741, DOI [10.1359/JBMR.090409, 10.1359/jbmr.090409]; Kisiswa L, 2013, NAT NEUROSCI, V16, P865, DOI 10.1038/nn.3430; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Martin TJ, 2015, REV ENDOCR METAB DIS, V16, P131, DOI 10.1007/s11154-014-9308-6; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Sakai A, 1998, BONE, V23, P443, DOI 10.1016/S8756-3282(98)00121-5; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Sato N, 2004, J EXP MED, V200, P601, DOI 10.1084/jem.20040689; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Singha UK, 2008, J CELL BIOCHEM, V103, P434, DOI 10.1002/jcb.21411; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sugamori Y, 2016, BIOESSAYS, V38, P717, DOI 10.1002/bies.201600104; Takeshita S, 2013, J CLIN INVEST, V123, P3914, DOI 10.1172/JCI69493; Tomimori Y, 2009, J BONE MINER RES, V24, P1194, DOI [10.1359/JBMR.090217, 10.1359/jbmr.090217]; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Van Deun J, 2017, NAT METHODS, V14, P228, DOI 10.1038/nmeth.4185; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Watzl C., 2006, CURR PROTOC PROTEIN, V19; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448	34	249	266	15	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2018	561	7722					195	+		10.1038/s41586-018-0482-7	http://dx.doi.org/10.1038/s41586-018-0482-7			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT3XQ	30185903				2022-12-28	WOS:000444437900034
J	White, AA; Stevenson, DD				White, Andrew A.; Stevenson, Donald D.			Aspirin-Exacerbated Respiratory Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ENDOSCOPIC SINUS SURGERY; SENSITIVE RHINOSINUSITIS-ASTHMA; LEUKOTRIENE C-4 SYNTHASE; LONG-TERM TREATMENT; LOW-DOSE ASPIRIN; DESENSITIZATION-TREATMENT; NASAL POLYPS; INFLAMMATORY CELLS; INTOLERANT ASTHMA; CROSS-SENSITIVITY		[White, Andrew A.; Stevenson, Donald D.] Scripps Clin, Div Allergy Asthma & Immunol, 3811 Valley Ctr Dr, San Diego, CA 92130 USA	Scripps Research Institute	Stevenson, DD (corresponding author), Scripps Clin, Div Allergy Asthma & Immunol, 3811 Valley Ctr Dr, San Diego, CA 92130 USA.	dstevensonmd@gmail.com			AstraZeneca	AstraZeneca(AstraZeneca)	Dr. White reports receiving fees for serving on a speakers' bureau from AstraZeneca. No other potential conflict of interest relevant to this article was reported.	Adappa ND, 2018, INT FORUM ALLERGY RH, V8, P49, DOI 10.1002/alr.22036; Adelman J, 2016, OTOLARYNG HEAD NECK, V155, P220, DOI 10.1177/0194599816640723; Alonso-Llamazares A, 2002, ALLERGY, V57, P632, DOI 10.1034/j.1398-9995.2002.t01-1-13447.x; ARM JP, 1989, AM REV RESPIR DIS, V140, P148, DOI 10.1164/ajrccm/140.1.148; Bankova LG, 2016, P NATL ACAD SCI USA, V113, P6242, DOI 10.1073/pnas.1605957113; Bavbek S, 2007, INT ARCH ALLERGY IMM, V142, P64, DOI 10.1159/000096000; Berges-Gimeno MP, 2003, J ALLERGY CLIN IMMUN, V111, P180, DOI 10.1067/mai.2003.7; Berges-Gimeno MP, 2002, ANN ALLERG ASTHMA IM, V89, P474, DOI 10.1016/S1081-1206(10)62084-4; BIANCO S, 1977, IRCS (International Research Communications System) Medical Science Library Compendium, V5, P129; Bochenek G, 2014, J ALLERGY CLIN IMMUN, V133, P98, DOI 10.1016/j.jaci.2013.07.004; Buchheit KM, 2016, J ALLERGY CLIN IMMUN, V137, P1566, DOI 10.1016/j.jaci.2015.10.020; Cahill KN, 2017, J ALLERGY CLIN IMMUN, V139, P819, DOI 10.1016/j.jaci.2016.05.048; Cahill KN, 2016, AM J RESP CELL MOL, V54, P34, DOI 10.1165/rcmb.2014-0486OC; Cahill KN, 2015, J ALLERGY CLIN IMMUN, V135, P245, DOI 10.1016/j.jaci.2014.07.031; Campobasso CP, 2008, AM J FOREN MED PATH, V29, P358, DOI 10.1097/PAF.0b013e318185a00a; Cardet JC, 2014, J ALLER CL IMM-PRACT, V2, P208, DOI 10.1016/j.jaip.2013.12.003; Chen JR, 2015, J ALLER CL IMM-PRACT, V3, P926, DOI 10.1016/j.jaip.2015.06.013; Cho KS, 2014, OTOLARYNG HEAD NECK, V151, P575, DOI 10.1177/0194599814545750; CHRISTIE PE, 1991, AM REV RESPIR DIS, V143, P1025, DOI 10.1164/ajrccm/143.5_Pt_1.1025; Cowburn AS, 1998, J CLIN INVEST, V101, P834, DOI 10.1172/JCI620; Dahlen B, 1998, AM J RESP CRIT CARE, V157, P1187, DOI 10.1164/ajrccm.157.4.9707089; Dahlin A, 2016, IMMUNOL ALLERGY CLIN, V36, P765, DOI 10.1016/j.iac.2016.06.010; DELANEY JC, 1976, CLIN ALLERGY, V6, P177, DOI 10.1111/j.1365-2222.1976.tb01896.x; Divekar R, 2016, J ALLER CL IMM-PRACT, V4, P665, DOI 10.1016/j.jaip.2016.03.004; Divekar R, 2015, J ALLER CL IMM-PRACT, V3, P934, DOI 10.1016/j.jaip.2015.06.018; Dursun AB, 2008, ANN ALLERG ASTHMA IM, V100, P420, DOI 10.1016/S1081-1206(10)60465-6; Esmaeilzadeh H, 2015, CLIN IMMUNOL, V160, P349, DOI 10.1016/j.clim.2015.05.012; Fan YP, 2012, AM J RHINOL ALLERGY, V26, pE20, DOI 10.2500/ajra.2012.26.3738; Fruth K, 2013, ALLERGY, V68, P659, DOI 10.1111/all.12131; Gauvreau GM, 2001, AM J RESP CRIT CARE, V164, P1495, DOI 10.1164/ajrccm.164.8.2102033; Kanaoka Y, 2013, J BIOL CHEM, V288, P10967, DOI 10.1074/jbc.C113.453704; Katial RK, 2010, J ALLERGY CLIN IMMUN, V126, P738, DOI 10.1016/j.jaci.2010.06.036; Kim JE, 2007, ENT-EAR NOSE THROAT, V86, P396, DOI 10.1177/014556130708600715; KOWALSKI ML, 1986, EUR J RESPIR DIS, V69, P219; Laidlaw TM, 2016, NEW ENGL J MED, V374, P484, DOI 10.1056/NEJMcibr1514013; Laidlaw TM, 2012, BLOOD, V119, P3790, DOI 10.1182/blood-2011-10-384826; LAITINEN LA, 1993, LANCET, V341, P989, DOI 10.1016/0140-6736(93)91073-U; Lee JY, 2007, J ALLERGY CLIN IMMUN, V119, P157, DOI 10.1016/j.jaci.2006.09.011; Lee RU, 2010, ANN ALLERG ASTHMA IM, V105, P130, DOI 10.1016/j.anai.2010.05.020; LEE TH, 1984, P NATL ACAD SCI-BIOL, V81, P4922, DOI 10.1073/pnas.81.15.4922; Lee-Sarwar K, 2015, J ALLER CL IMM-PRACT, V3, P449, DOI 10.1016/j.jaip.2015.01.007; Levy JM, 2016, INT FORUM ALLERGY RH, V6, P1273, DOI 10.1002/alr.21826; Liu T, 2015, J IMMUNOL, V195, P3537, DOI 10.4049/jimmunol.1500905; LUMRY WR, 1983, J ALLERGY CLIN IMMUN, V71, P580, DOI 10.1016/0091-6749(83)90440-2; Machado-Carvalho L, 2016, J ALLERGY CLIN IMMUN, V137, P99, DOI 10.1016/j.jaci.2015.09.028; Macy E, 2007, ANN ALLERG ASTHMA IM, V98, P172, DOI 10.1016/S1081-1206(10)60692-8; Mann CC, 1991, ASPIRIN WARS, P22; Mascia K, 2005, ANN ALLERG ASTHMA IM, V94, P652, DOI 10.1016/S1081-1206(10)61323-3; Mascia K, 2005, J ALLERGY CLIN IMMUN, V116, P970, DOI 10.1016/j.jaci.2005.08.035; Morales DR, 2015, ALLERGY, V70, P828, DOI 10.1111/all.12629; Morales DR, 2014, J ALLERGY CLIN IMMUN, V134, P40, DOI 10.1016/j.jaci.2013.10.057; Morrissey DK, 2016, INT FORUM ALLERGY RH, V6, P820, DOI 10.1002/alr.21739; NASSER SMS, 1995, AM J RESP CRIT CARE, V151, P1326, DOI 10.1164/ajrccm.151.5.7735581; Nizankowska E, 2000, EUR RESPIR J, V15, P863, DOI 10.1034/j.1399-3003.2000.15e09.x; Rajan JP, 2015, J ALLERGY CLIN IMMUN, V135, P676, DOI 10.1016/j.jaci.2014.08.020; Rozsasi A, 2008, ALLERGY, V63, P1228, DOI 10.1111/j.1398-9995.2008.01658.x; Rudmikl L, 2016, RHINOLOGY, V54, P117, DOI 10.4193/Rhino16.023; SAMTER M, 1968, ANN INTERN MED, V68, P975, DOI 10.7326/0003-4819-68-5-975; SAMTER M, 1967, J ALLERGY, V40, P281, DOI 10.1016/0021-8707(67)90076-7; Sanak M, 2000, AM J RESP CELL MOL, V23, P290, DOI 10.1165/ajrcmb.23.3.4051; Sestini P, 1996, AM J RESP CRIT CARE, V153, P572, DOI 10.1164/ajrccm.153.2.8564100; SETTIPANE RA, 1989, J ALLERGY CLIN IMMUN, V84, P26, DOI 10.1016/0091-6749(89)90174-7; Shaker M, 2008, J ALLERGY CLIN IMMUN, V121, P81, DOI 10.1016/j.jaci.2007.06.047; Sousa AR, 2002, NEW ENGL J MED, V347, P1493, DOI 10.1056/NEJMoa013508; Steinke JW, 2013, J ALLERGY CLIN IMMUN, V132, P856, DOI 10.1016/j.jaci.2013.05.008; Steinke JW, 2009, J ALLERGY CLIN IMMUN, V124, P724, DOI 10.1016/j.jaci.2009.07.031; STEVENSON DD, 1980, J ALLERGY CLIN IMMUN, V66, P82, DOI 10.1016/0091-6749(80)90143-8; STEVENSON DD, 1990, J ALLERGY CLIN IMMUN, V86, P749, DOI 10.1016/S0091-6749(05)80179-4; STEVENSON DD, 1984, J ALLERGY CLIN IMMUN, V73, P500, DOI 10.1016/0091-6749(84)90361-0; Stevenson DD, 1996, J ALLERGY CLIN IMMUN, V98, P751, DOI 10.1016/S0091-6749(96)70123-9; Stevenson DD, 2006, J ALLERGY CLIN IMMUN, V118, P801, DOI 10.1016/j.jaci.2006.06.019; SWEET JM, 1990, J ALLERGY CLIN IMMUN, V85, P59, DOI 10.1016/0091-6749(90)90222-P; Swierczynska-Krepa M, 2014, J ALLERGY CLIN IMMUN, V134, P883, DOI 10.1016/j.jaci.2014.02.041; SZCZEKLIK A, 1975, BRIT MED J, V1, P67, DOI 10.1136/bmj.1.5949.67; SZCZEKLIK A, 1988, CLIN ALLERGY, V18, P15, DOI 10.1111/j.1365-2222.1988.tb02838.x; SZCZEKLIK A, 1990, EUR RESPIR J, V3, P535; Szczeklik A, 2000, EUR RESPIR J, V16, P432, DOI 10.1034/j.1399-3003.2000.016003432.x; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; VANSELOW NA, 1967, ANN INTERN MED, V66, P568, DOI 10.7326/0003-4819-66-3-568; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Waldram J, 2018, J ALLERGY CLIN IMMUN, V141, P250, DOI 10.1016/j.jaci.2017.05.006; WEBER RW, 1979, J ALLERGY CLIN IMMUN, V64, P32, DOI 10.1016/0091-6749(79)90080-0; White A, 2006, ANN ALLERG ASTHMA IM, V97, P688, DOI 10.1016/S1081-1206(10)61101-5; White A, 2006, ANN ALLERG ASTHMA IM, V97, P190, DOI 10.1016/S1081-1206(10)60012-9; Widal F., 1922, PRESSE MED, V30, P189; ZEISS CR, 1976, J ALLERGY CLIN IMMUN, V57, P440, DOI 10.1016/0091-6749(76)90059-2	86	124	125	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					1060	1070		10.1056/NEJMra1712125	http://dx.doi.org/10.1056/NEJMra1712125			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4UV	30207919				2022-12-28	WOS:000444501600010
J	Anderson, TS; Wray, CM; Jing, BC; Fung, K; Ngo, S; Xu, E; Shi, Y; Steinman, MA				Anderson, Timothy S.; Wray, Charlie M.; Jing, Bocheng; Fung, Kathy; Ngo, Sarah; Xu, Edison; Shi, Ying; Steinman, Michael A.			Intensification of older adults' outpatient blood pressure treatment at hospital discharge: national retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PATIENTS AFTER-DISCHARGE; ADVERSE EVENTS; ELDERLY-PATIENTS; MEDICATION RECONCILIATION; CHRONIC DISEASE; HYPERTENSION; PREVALENCE; MANAGEMENT; ADHERENCE; RISK	OBJECTIVES To assess how often older adults admitted to hospital for common non-cardiac conditions were discharged with intensified antihypertensive treatment, and to identify markers of appropriateness for these intensifications. DESIGN Retrospective cohort study. SETTING US Veterans Administration Health System. PARTICIPANTS Patients aged 65 years or over with hypertension admitted to hospital with non-cardiac conditions between 2011 and 2013. MAIN OUTCOME MEASURES Intensification of antihypertensive treatment, defined as receiving a new or higher dose antihypertensive agent at discharge compared with drugs used before admission. Hierarchical logistic regression analyses were used to control for characteristics of patients and hospitals. RESULTS Among 14915 older adults (median age 76, interquartile range 69-84), 9636 (65%) had well controlled outpatient blood pressure before hospital admission. Overall, 2074 (14%) patients were discharged with intensified antihypertensive treatment, more than half of whom (1082) had well controlled blood pressure before admission. After adjustment for potential confounders, elevated inpatient blood pressure was strongly associated with being discharged on intensified antihypertensive regimens. Among patients with previously well controlled outpatient blood pressure, 8% (95% confidence interval 7% to 9%) of patients without elevated inpatient blood pressure, 24% (21% to 26%) of patients with moderately elevated inpatient blood pressure, and 40% (34% to 46%) of patients with severely elevated inpatient blood pressure were discharged with intensified antihypertensive regimens. No differences were seen in rates of intensification among patients least likely to benefit from tight blood pressure control (limited life expectancy, dementia, or metastatic malignancy), nor in those most likely to benefit (history of myocardial infarction, cerebrovascular disease, or renal disease). CONCLUSIONS One in seven older adults admitted to hospital for common non-cardiac conditions were discharged with intensified antihypertensive treatment. More than half of intensifications occurred in patients with previously well controlled outpatient blood pressure. More attention is needed to reduce potentially harmful overtreatment of blood pressure as older adults transition from hospital to home.	[Anderson, Timothy S.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94123 USA; [Wray, Charlie M.] Univ Calif San Francisco, Div Hosp Med, San Francisco, CA 94143 USA; [Jing, Bocheng; Fung, Kathy; Ngo, Sarah; Xu, Edison; Shi, Ying] San Francisco VA Med Ctr, San Francisco, CA USA; [Steinman, Michael A.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Anderson, TS (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94123 USA.	timothy.anderson@ucsf.edu			National Institute of Aging [K24AG049057, P30AG044281]; national research service award training grant [NRSA T32HP19025-14-00]; NATIONAL INSTITUTE ON AGING [K24AG049057, P30AG044281] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); national research service award training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	MAS was supported by grants from the National Institute of Aging (K24AG049057 and P30AG044281). TSA was supported by a national research service award training grant (NRSA T32HP19025-14-00) to the University of California, San Francisco. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation or approval of the manuscript; or the decision to submit the manuscript for publication. The views expressed herein are those of the authors and do not necessarily represent the views of the US Department of Veterans Affairs or the University of California, San Francisco.	Axon RN, 2011, J HOSP MED, V6, P417, DOI 10.1002/jhm.804; Blecker S, 2017, J HOSP MED, V12, P162, DOI 10.12788/jhm.2699; Cappelleri C, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007692; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; Coleman EA, 2005, ARCH INTERN MED, V165, P1842, DOI 10.1001/archinte.165.16.1842; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Franklin SS, 2016, J AM COLL CARDIOL, V68, P2033, DOI 10.1016/j.jacc.2016.08.035; Goedken Amber M, 2016, BMC Res Notes, V9, P272, DOI 10.1186/s13104-016-2076-5; Gray SL, 1999, ANN PHARMACOTHER, V33, P1147, DOI 10.1345/aph.19036; Harris CM, 2013, J PATIENT SAF, V9, P150, DOI 10.1097/PTS.0b013e318286f87d; Healthcare Cost and Utilization Project, 2017, CLIN CLASS SOFTW CCS; Kansagara D, 2011, ANN INTERN MED, V154, P268, DOI 10.7326/0003-4819-154-4-201102150-00008; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; Kwan JL, 2013, ANN INTERN MED, V158, P397, DOI 10.7326/0003-4819-158-5-201303051-00006; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Mansur N, 2008, ANN PHARMACOTHER, V42, P783, DOI 10.1345/aph.1L070; Steinman MA, 2013, JAMA INTERN MED, V173, P1857, DOI 10.1001/jamainternmed.2013.9511; Sussman JB, 2015, JAMA INTERN MED, V175, P1942, DOI 10.1001/jamainternmed.2015.5110; Szeto HC, 2002, AM J MANAG CARE, V8, P37; Thomas EJ, 2000, BRIT MED J, V320, P741, DOI 10.1136/bmj.320.7237.741; Unroe KT, 2010, AM J GERIATR PHARMAC, V8, P115, DOI 10.1016/j.amjopharm.2010.04.002; Weder AB, 2011, HYPERTENSION, V57, P18, DOI 10.1161/HYPERTENSIONAHA.110.164194; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006	26	12	12	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2018	362								k3503	10.1136/bmj.k3503	http://dx.doi.org/10.1136/bmj.k3503			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JJ	30209052	Green Published, hybrid			2022-12-28	WOS:000445016500003
J	Iacobucci, G				Iacobucci, Gareth			UK women living shorter lives than most European counterparts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Office for National Statistics, 2018, CHANG TRENDS MORT IN; Public Health England, HLTH PROF ENGL 2018	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2018	362								k3871	10.1136/bmj.k3871	http://dx.doi.org/10.1136/bmj.k3871			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JF	30206179				2022-12-28	WOS:000445015700006
J	Angiolillo, DJ				Angiolillo, Dominick J.			Vascular access and antithrombotic therapy in patients with acute coronary syndrome	LANCET			English	Editorial Material							BIVALIRUDIN; HEPARIN; TRIAL; PCI		[Angiolillo, Dominick J.] Univ Florida, Coll Med Jacksonville, Jacksonville, FL 32209 USA	State University System of Florida; University of Florida	Angiolillo, DJ (corresponding author), Univ Florida, Coll Med Jacksonville, Jacksonville, FL 32209 USA.	dominick.angiolillo@jax.ufl.edu			Amgen; Aralez; AstraZeneca; Bayer; Biosensors; Bristol-Myers Squibb; Chiesi; Daiichi-Sankyo; Eli Lilly; Janssen; Merck; PLx Pharma; Pfizer; Sanofi; Medicines Company; CeloNova; St Jude Medical; CSL Behring; Eisai; Eli-Lilly; Gilead; Matsutani Chemical Industry Co; Novartis; Osprey Medical; Renal Guard Solutions; Scott R MacKenzie Foundation; National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science [UL1 TR000064, NIH/NHGRI U01 HG007269]	Amgen(Amgen); Aralez; AstraZeneca(AstraZeneca); Bayer(Bayer AG); Biosensors; Bristol-Myers Squibb(Bristol-Myers Squibb); Chiesi(Chiesi Pharmaceuticals Inc); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); PLx Pharma; Pfizer(Pfizer); Sanofi; Medicines Company; CeloNova; St Jude Medical(St. Jude Medical); CSL Behring; Eisai(Eisai Co Ltd); Eli-Lilly(Eli Lilly); Gilead(Gilead Sciences); Matsutani Chemical Industry Co; Novartis(Novartis); Osprey Medical; Renal Guard Solutions; Scott R MacKenzie Foundation; National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science	DJA reports receiving consulting fees or honoraria from Amgen, Aralez, AstraZeneca, Bayer, Biosensors, Bristol-Myers Squibb, Chiesi, Daiichi-Sankyo, Eli Lilly, Janssen, Merck, PLx Pharma, Pfizer, Sanofi, and The Medicines Company; payments for participation in review activities from CeloNova and St Jude Medical; and institutional payments for grants from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli-Lilly, Gilead, Janssen, Matsutani Chemical Industry Co, Merck, Novartis, Osprey Medical, and Renal Guard Solutions. In addition, DJA is a recipient of funding from the Scott R MacKenzie Foundation and the National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science Award to the University of Florida (grant numbers UL1 TR000064 and NIH/NHGRI U01 HG007269) outside the submitted work.	Ando G, 2016, JACC-CARDIOVASC INTE, V9, P660, DOI 10.1016/j.jcin.2015.12.008; Angiolillo DJ, 2018, J AM COLL CARDIOL, V71, P1243, DOI 10.1016/j.jacc.2018.01.040; Angiolillo DJ, 2017, CIRCULATION, V136, P1955, DOI 10.1161/CIRCULATIONAHA.117.031164; Berger PB, 2015, NEW ENGL J MED, V373, P1069, DOI 10.1056/NEJMe1509637; Capodanno D, 2018, NAT REV CARDIOL, V15, P480, DOI 10.1038/s41569-018-0049-1; Franchi F, 2017, NAT REV CARDIOL, V14, P361, DOI 10.1038/nrcardio.2017.18; Franchi F, 2015, NAT REV CARDIOL, V12, P30, DOI 10.1038/nrcardio.2014.156; Moon JY, 2018, PROG CARDIOVASC DIS, V60, P478, DOI 10.1016/j.pcad.2017.12.004; Navarese EP, 2015, JACC-CARDIOVASC INTE, V8, P201, DOI 10.1016/j.jcin.2014.10.003; Valgimigli M, 2015, NEW ENGL J MED, V373, P997, DOI 10.1056/NEJMoa1507854; Valgimigli M, 2018, LANCET, V392, P835, DOI 10.1016/S0140-6736(18)31714-8; Valgimigli M, 2015, LANCET, V385, P2465, DOI 10.1016/S0140-6736(15)60292-6	12	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2018	392	10150					801	802		10.1016/S0140-6736(18)31921-4	http://dx.doi.org/10.1016/S0140-6736(18)31921-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT0KV	30153987				2022-12-28	WOS:000444130000007
J	Heinz, S; Texari, L; Hayes, MGB; Urbanowski, M; Chang, MW; Givarkes, N; Rialdi, A; White, KM; Albrecht, RA; Pache, L; Marazzi, I; Garcia-Sastre, A; Shaw, ML; Benner, C				Heinz, Sven; Texari, Lorane; Hayes, Michael G. B.; Urbanowski, Matthew; Chang, Max W.; Givarkes, Ninvita; Rialdi, Alexander; White, Kris M.; Albrecht, Randy A.; Pache, Lars; Marazzi, Ivan; Garcia-Sastre, Adolfo; Shaw, Megan L.; Benner, Christopher			Transcription Elongation Can Affect Genome 3D Structure	CELL			English	Article							RNA-POLYMERASE-II; INFLUENZA-A VIRUS; MAMMALIAN GENOMES; PHASE-SEPARATION; GENE-EXPRESSION; NS1 PROTEIN; COHESIN; DOMAINS; PRINCIPLES; BINDING	How transcription affects genome 3D organization is not well understood. We found that during influenza A (IAV) infection, rampant transcription rapidly reorganizes host cell chromatin interactions. These changes occur at the ends of highly transcribed genes, where global inhibition of transcription termination by IAV NS1 protein causes readthrough transcription for hundreds of kilobases. In these readthrough regions, elongating RNA polymerase II disrupts chromatin interactions by inducing cohesin displacement from CTCF sites, leading to locus decompaction. Readthrough transcription into heterochromatin regions switches them from the inert (B) to the permissive (A) chromatin compartment and enables transcription factor binding. Data from non-viral transcription stimuli show that transcription similarly affects cohesin-mediated chromatin contacts within gene bodies. Conversely, inhibition of transcription elongation allows cohesin to accumulate at previously transcribed intragenic CTCF sites and to mediate chromatin looping and compaction. Our data indicate that transcription elongation by RNA polymerase II remodels genome 3D architecture.	[Heinz, Sven; Texari, Lorane; Hayes, Michael G. B.; Chang, Max W.; Givarkes, Ninvita; Benner, Christopher] Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Urbanowski, Matthew; Rialdi, Alexander; White, Kris M.; Albrecht, Randy A.; Marazzi, Ivan; Garcia-Sastre, Adolfo; Shaw, Megan L.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Albrecht, Randy A.; Marazzi, Ivan] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Pache, Lars] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA	University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Sanford Burnham Prebys Medical Discovery Institute; Icahn School of Medicine at Mount Sinai	Heinz, S; Benner, C (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sheinz@ucsd.edu; cbenner@ucsd.edu	Texari, Lorane/AAP-1238-2021	Benner, Christopher/0000-0002-4618-0719; Heinz, Sven/0000-0002-4665-1007; Chang, Max/0000-0002-4526-489X; Shaw, Megan/0000-0002-1267-0891	NIH-NIAID award [U19 AI106754]; Pilot Project Grant; SNSF Advanced Postdoc Mobility fellowship [P300PA_164714]; Salk Institute's NGS Core Facility; NIH-NCI CCSG [P30 014195]; Chapman Foundation; Helmsley Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106754] Funding Source: NIH RePORTER	NIH-NIAID award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pilot Project Grant; SNSF Advanced Postdoc Mobility fellowship; Salk Institute's NGS Core Facility; NIH-NCI CCSG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chapman Foundation; Helmsley Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Georg and Meinrad Busslinger for early access to results, discussion, and the suggestion to analyze cohesin, Julia Minderjahn and Michael Rehli for advice on mRNA electroporation, Sascha Duttke for Start-seq advice, and Bing Ren, Christopher Glass, and Kees Murre for comments on the manuscript. This study was funded by NIH-NIAID award U19 AI106754 (Fluomics) to A.G.-S., C.B., M.L.S., I.M., and R.A.A. and a Pilot Project Grant sub-award to S.H. L.T. was supported by SNSF Advanced Postdoc Mobility fellowship P300PA_164714. This work was supported by the Salk Institute's NGS Core Facility with funding from NIH-NCI CCSG: P30 014195, the Chapman Foundation, and the Helmsley Charitable Trust. Additional RNA-seq library prep and sequencing were conducted at UCSD's IGM Genomics Center.	Amaral PP, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1405-5; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bercovich-Kinori A, 2016, ELIFE, V5, DOI 10.7554/eLife.18311; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Busslinger GA, 2017, NATURE, V544, P503, DOI 10.1038/nature22063; Castelo-Branco G, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r98; Cremer T, 2000, CRIT REV EUKAR GENE, V10, P179; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eaton JD, 2018, GENE DEV, V32, P127, DOI 10.1101/gad.308528.117; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Gassler J, 2017, EMBO J, V36, P3600, DOI 10.15252/embj.201798083; Gu B, 2018, SCIENCE, V359, P1050, DOI 10.1126/science.aao3136; Haarhuis JHI, 2017, CELL, V169, P693, DOI 10.1016/j.cell.2017.04.013; Haarhuis JHI, 2013, CURR BIOL, V23, P2071, DOI 10.1016/j.cub.2013.09.003; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Hansen AS, 2017, ELIFE, V6, DOI 10.7554/eLife.25776; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Isoda T, 2017, CELL, V171, P103, DOI 10.1016/j.cell.2017.09.001; Jubb AW, 2017, CELL REP, V21, P3022, DOI 10.1016/j.celrep.2017.11.053; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Keil C, 2016, TREEVIEW 3 0 ALPHA 3; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Krug RM, 2015, CURR OPIN VIROL, V12, P1, DOI 10.1016/j.coviro.2015.01.007; Kubo N., 2017, BIORXIV, DOI [10.1101/118737, DOI 10.1101/118737]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MARK GE, 1979, J VIROL, V29, P744, DOI 10.1128/JVI.29.2.744-752.1979; Nag A, 2007, NAT STRUCT MOL BIOL, V14, P662, DOI 10.1038/nsmb1253; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowley MJ, 2017, MOL CELL, V67, P837, DOI 10.1016/j.molcel.2017.07.022; Rutkowski AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8126; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Shah N, 2018, MOL CELL, V69, P48, DOI 10.1016/j.molcel.2017.12.009; Shimizu K, 1999, VIROLOGY, V254, P213, DOI 10.1006/viro.1998.9555; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terrier O, 2014, VIROLOGY, V456, P39, DOI 10.1016/j.virol.2014.03.013; Wutz G, 2017, EMBO J, V36, P3573, DOI 10.15252/embj.201798004; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zuin J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004153	61	168	170	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1522	+		10.1016/j.cell.2018.07.047	http://dx.doi.org/10.1016/j.cell.2018.07.047			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30146161	Green Accepted, Bronze			2022-12-28	WOS:000443841000019
J	Knott, GJ; Doudna, JA				Knott, Gavin J.; Doudna, Jennifer A.			CRISPR-Cas guides the future of genetic engineering	SCIENCE			English	Review							NUCLEIC-ACID DETECTION; DNA-REPAIR; GENOMIC DNA; RNA; CLEAVAGE; SYSTEM; CELLS; DELIVERY; BASE; RIBONUCLEOPROTEIN	The diversity, modularity, and efficacy of CRISPR-Cas systems are driving a biotechnological revolution. RNA-guided Cas enzymes have been adopted as tools to manipulate the genomes of cultured cells, animals, and plants, accelerating the pace of fundamental research and enabling clinical and agricultural breakthroughs. We describe the basic mechanisms that set the CRISPR-Cas toolkit apart from other programmable gene-editing technologies, highlighting the diverse and naturally evolved systems now functionalized as biotechnologies. We discuss the rapidly evolving landscape of CRISPR-Cas applications, from gene editing to transcriptional regulation, imaging, and diagnostics. Continuing functional dissection and an expanding landscape of applications position CRISPR-Cas tools at the cutting edge of nucleic acid manipulation that is rewriting biology.	[Knott, Gavin J.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	doudna@berkeley.edu		Knott, Gavin J./0000-0002-9007-6273	HHMI; NIH; NSF [1244557]; Allen Distinguished Investigator Program through The Paul G. Allen Frontiers Group; William M. Keck foundation; Defense Advanced Research Projects Agency (DARPA) [HR0011-17-2-0043]; American Australian Association	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Allen Distinguished Investigator Program through The Paul G. Allen Frontiers Group; William M. Keck foundation(W.M. Keck Foundation); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); American Australian Association	J.A.D. receives support for her research from the HHMI, the NIH, the NSF (grant 1244557), the Allen Distinguished Investigator Program through The Paul G. Allen Frontiers Group, the William M. Keck foundation, and the Defense Advanced Research Projects Agency (DARPA) (award HR0011-17-2-0043). The views, opinions, and/or findings expressed are those of the author and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. government. G.J.K. receives support from the American Australian Association.	Abudayyeh OO, 2017, NATURE, V550, P280, DOI 10.1038/nature24049; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Aman R, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1381-1; Bak RO, 2018, NAT PROTOC, V13, P358, DOI 10.1038/nprot.2017.143; Bak RO, 2017, ELIFE, V6, DOI 10.7554/eLife.27873.001; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Batra R, 2017, CELL, V170, P899, DOI 10.1016/j.cell.2017.07.010; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Canny MD, 2018, NAT BIOTECHNOL, V36, P95, DOI 10.1038/nbt.4021; Charlesworth C. T., 2018, 243345 BIORXIV; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180; Dugar G, 2018, MOL CELL, V69, P893, DOI 10.1016/j.molcel.2018.01.032; East-Seletsky A, 2017, MOL CELL, V66, P373, DOI 10.1016/j.molcel.2017.04.008; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Fellmann C, 2017, NAT REV DRUG DISCOV, V16, P89, DOI 10.1038/nrd.2016.238; Gaj T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aar3952; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Glass Z, 2018, TRENDS BIOTECHNOL, V36, P173, DOI 10.1016/j.tibtech.2017.11.006; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Hess GT, 2017, MOL CELL, V68, P26, DOI 10.1016/j.molcel.2017.09.029; Howe FS, 2017, ELIFE, V6, DOI 10.7554/eLife.29878; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kampmann M, 2018, ACS CHEM BIOL, V13, P406, DOI 10.1021/acschembio.7b00657; Kan YN, 2017, GENOME RES, V27, P1099, DOI 10.1101/gr.214775.116; Kim E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14500; Kim HK, 2018, NAT BIOTECHNOL, V36, P239, DOI 10.1038/nbt.4061; Kim S, 2018, GENOME RES, V28, P367, DOI 10.1101/gr.231936.117; Knight SC, 2018, ANGEW CHEM INT EDIT, V57, P4329, DOI 10.1002/anie.201709201; Komor AC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4774; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2018, CELL, V173, P665, DOI 10.1016/j.cell.2018.02.033; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Lee K, 2017, NAT BIOMED ENG, V1, P889, DOI 10.1038/s41551-017-0137-2; Liao HK, 2017, CELL, V171, P1495, DOI 10.1016/j.cell.2017.10.025; Liu XS, 2018, CELL, V172, P979, DOI 10.1016/j.cell.2018.01.012; Long CZ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9004; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; Maass PG, 2018, NAT STRUCT MOL BIOL, V25, P176, DOI 10.1038/s41594-017-0015-3; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Murugan K, 2017, MOL CELL, V68, P15, DOI 10.1016/j.molcel.2017.09.007; Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Niu D, 2017, SCIENCE, V357, P1303, DOI 10.1126/science.aan4187; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Pawelczak KS, 2018, ACS CHEM BIOL, V13, P389, DOI 10.1021/acschembio.7b00777; Pulecio J, 2017, CELL STEM CELL, V21, P431, DOI 10.1016/j.stem.2017.09.006; Qin PW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14725; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Richter F, 2017, CURR OPIN BIOTECH, V48, P119, DOI 10.1016/j.copbio.2017.03.025; Rousseau BA, 2018, MOL CELL, V69, P906, DOI 10.1016/j.molcel.2018.01.025; Rupp LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00462-8; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Staahl BT, 2017, NAT BIOTECHNOL, V35, P431, DOI 10.1038/nbt.3806; Strutt SC, 2018, ELIFE, V7, DOI 10.7554/eLife.32724; Urnov FD, 2018, CRISPR J, V1, P34, DOI 10.1089/crispr.2018.29007.fyu; Waltz E, 2018, NAT BIOTECHNOL, V36, P6, DOI 10.1038/nbt0118-6b; Yan WX, 2018, MOL CELL, V70, P327, DOI 10.1016/j.molcel.2018.02.028; Yin H, 2018, NAT CHEM BIOL, V14, P311, DOI [10.1038/NCHEMBIO.2559, 10.1038/nchembio.2559]; Yin KQ, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.107; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602814; Zheng Y, 2018, NAT NEUROSCI, V21, P447, DOI 10.1038/s41593-018-0077-5; Zuo EW, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1354-4	75	637	671	119	811	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					866	869		10.1126/science.aat5011	http://dx.doi.org/10.1126/science.aat5011			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166482	Green Accepted			2022-12-28	WOS:000443547000026
J	Qing, YJ; Ionescu, SA; Pulcu, GS; Bayley, H				Qing, Yujia; Ionescu, Sandra A.; Pulcu, Gokce Su; Bayley, Hagan			Directional control of a processive molecular hopper	SCIENCE			English	Article							KINESIN; PORE; DNA; MECHANISM; NANOPORE	Intrigued by the potential of nanoscale machines, scientists have long attempted to control molecular motion. We monitored the individual 0.7-nanometer steps of a single molecular hopper as it moved in an electric field along a track in a nanopore controlled by a chemical ratchet. The hopper demonstrated characteristics desired in a moving molecule: defined start and end points, processivity, no chemical fuel requirement, directional motion, and external control. The hopper was readily functionalized to carry cargos. For example, a DNA molecule could be ratcheted along the track in either direction, a prerequisite for nanopore sequencing.	[Qing, Yujia; Ionescu, Sandra A.; Pulcu, Gokce Su; Bayley, Hagan] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	University of Oxford	Bayley, H (corresponding author), Univ Oxford, Dept Chem, Oxford OX1 3TA, England.	hagan.bayley@chem.ox.ac.uk		Qing, Yujia/0000-0002-2110-4269; Pulcu, Gokce Su/0000-0002-1128-3443; Bayley, Hagan/0000-0003-2499-6116	European Research Council Advanced Grant; China Scholarship Council-University of Oxford Scholarship; Amelia Jackson Studentship, Exeter College, Oxford	European Research Council Advanced Grant(European Research Council (ERC)); China Scholarship Council-University of Oxford Scholarship; Amelia Jackson Studentship, Exeter College, Oxford	Supported by a European Research Council Advanced Grant; a China Scholarship Council-University of Oxford Scholarship (Y.Q.); and an Amelia Jackson Studentship, Exeter College, Oxford (S.A.I.).	Bach RD, 2008, J ORG CHEM, V73, P12, DOI 10.1021/jo702051f; Bayley H, 2015, CLIN CHEM, V61, P25, DOI 10.1373/clinchem.2014.223016; Bosco A, 2014, NUCLEIC ACIDS RES, V42, P2064, DOI 10.1093/nar/gkt1089; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Cross RA, 2014, NAT REV MOL CELL BIO, V15, P257, DOI 10.1038/nrm3768; Erbas-Cakmak S, 2015, CHEM REV, V115, P10081, DOI 10.1021/acs.chemrev.5b00146; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gyarfas B, 2009, ACS NANO, V3, P1457, DOI 10.1021/nn900303g; Howorka S, 2002, BIOPHYS J, V83, P3202, DOI 10.1016/S0006-3495(02)75322-8; Hunter CA, 2009, ANGEW CHEM INT EDIT, V48, P7488, DOI 10.1002/anie.200902490; Iacovache I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12062; Jiang JS, 2015, NATURE, V521, P545, DOI 10.1038/nature14247; Pulcu GS, 2015, NAT NANOTECHNOL, V10, P76, DOI [10.1038/NNANO.2014.264, 10.1038/nnano.2014.264]; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Venkatraman J, 2002, J AM CHEM SOC, V124, P4987, DOI 10.1021/ja0174276; Walter WJ, 2012, P NATL ACAD SCI USA, V109, P5289, DOI 10.1073/pnas.1116315109; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231	19	39	43	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					908	911		10.1126/science.aat3872	http://dx.doi.org/10.1126/science.aat3872			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166488	Green Submitted			2022-12-28	WOS:000443547000036
J	Riback, JA; Bowman, MA; Zmyslowski, A; Knoverek, CR; Jumper, J; Kaye, EB; Freed, KF; Clark, PL; Sosnick, T				Riback, Joshua A.; Bowman, Micayla A.; Zmyslowski, Adam; Knoverek, Catherine R.; Jumper, John; Kaye, Emily B.; Freed, Karl F.; Clark, Patricia L.; Sosnick, TobinR.			Response to Comment on "Innovative scattering analysis shows that hydrophobic disordered proteins are expanded in water"	SCIENCE			English	Editorial Material							MOLECULE FRET SPECTROSCOPY; CHAIN COLLAPSE; SIMULATIONS; DIMENSIONS; DENATURANT; STATE; SAXS; STEP	Best et al. claim that we provide no convincing basis to assert that a discrepancy remains between FRETand SAXS results on the dimensions of disordered proteins under physiological conditions. We maintain that a clear discrepancy is apparent in our and other recent publications, including results shown in the Best et al. comment. A plausible origin is fluorophore interactions in FRET experiments.	[Riback, Joshua A.] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA; [Bowman, Micayla A.; Knoverek, Catherine R.; Kaye, Emily B.; Clark, Patricia L.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Zmyslowski, Adam; Jumper, John; Sosnick, TobinR.] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Jumper, John; Freed, Karl F.] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA; [Jumper, John; Freed, Karl F.] Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Sosnick, TobinR.] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Notre Dame; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Clark, PL (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.; Sosnick, T (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.; Sosnick, T (corresponding author), Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA.	pclark1@nd.edu; trsosnic@uchicago.edu	Freed, Karl F/J-7764-2018	Freed, Karl F/0000-0001-6240-2599; Riback, Joshua/0000-0002-1516-4484; Clark, Patricia/0000-0001-5462-8248; Sosnick, Tobin/0000-0002-2871-7244; Zmyslowski, Adam/0000-0001-7778-1659; Knoverek, Catherine/0000-0003-2660-9466	NIH [GM055694, GM097573, GM103622, 1S10OD018090-01, T32 EB009412, T32 GM007183, T32 GM008720]; NSF [GRF DGE-1144082, MCB 1516959]; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183, T32GM008720, R01GM055694, R01GM097573, P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH grants GM055694 (T.R.S., K.F.F.), GM097573 (P.L.C.), GM103622 and 1S10OD018090-01 (T.C. Irving), T32 EB009412 (T.R.S.), T32 GM007183 (B. Glick), and T32 GM008720 (J. Picirrilli) and by NSF grants GRF DGE-1144082 (J.A.R.) and MCB 1516959 (C.R. Matthews). Use of the Advanced Photon Source was supported by the U.S. Department of Energy under contract DE-AC02-06CH11357.	Best RB, 2018, SCIENCE, V361, DOI 10.1126/science.aar7101; Borgia A, 2016, J AM CHEM SOC, V138, P11714, DOI 10.1021/jacs.6b05917; Contreras-Martos S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04611-x; Fuertes G, 2017, P NATL ACAD SCI USA, V114, pE6342, DOI 10.1073/pnas.1704692114; Gates ZP, 2017, P NATL ACAD SCI USA, V114, P2241, DOI 10.1073/pnas.1609579114; Hofmann H, 2012, P NATL ACAD SCI USA, V109, P16155, DOI 10.1073/pnas.1207719109; Jacob J, 2004, J MOL BIOL, V338, P369, DOI 10.1016/j.jmb.2004.02.065; Kathuria SV, 2014, J MOL BIOL, V426, P1980, DOI 10.1016/j.jmb.2014.02.020; Kolonko M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162950; Maity H, 2016, J AM CHEM SOC, V138, P2609, DOI 10.1021/jacs.5b11300; Martin EW, 2016, J AM CHEM SOC, V138, P15323, DOI 10.1021/jacs.6b10272; Merchant KA, 2007, P NATL ACAD SCI USA, V104, P1528, DOI 10.1073/pnas.0607097104; Plaxco KW, 1999, NAT STRUCT BIOL, V6, P554; Renner M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14448-z; Riback JA, 2017, SCIENCE, V358, P238, DOI 10.1126/science.aan5774; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Skinner JJ, 2014, P NATL ACAD SCI USA, V111, P15975, DOI 10.1073/pnas.1404213111; Song JH, 2017, BIOPHYS J, V113, P1012, DOI 10.1016/j.bpj.2017.07.023; Song JH, 2015, J PHYS CHEM B, V119, P15191, DOI 10.1021/acs.jpcb.5b09133; Watkins HM, 2015, P NATL ACAD SCI USA, V112, P6631, DOI 10.1073/pnas.1418673112; Yoo TY, 2012, J MOL BIOL, V418, P226, DOI 10.1016/j.jmb.2012.01.016; Zheng WW, 2016, J AM CHEM SOC, V138, P11702, DOI 10.1021/jacs.6b05443	23	22	22	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405							eaar7949	10.1126/science.aar7949	http://dx.doi.org/10.1126/science.aar7949			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS3UB	30166460				2022-12-28	WOS:000443547000002
J	Colangeli, R; Jedrey, H; Kim, S; Connell, R; Ma, S; Venkata, UDC; Chakravorty, S; Gupta, A; Sizemore, EE; Diem, L; Sherman, DR; Okwera, A; Dietze, R; Boom, WH; Johnson, JL; Mac Kenzie, WR; Alland, D				Colangeli, R.; Jedrey, H.; Kim, S.; Connell, R.; Ma, S.; Venkata, U. D. Chippada; Chakravorty, S.; Gupta, A.; Sizemore, E. E.; Diem, L.; Sherman, D. R.; Okwera, A.; Dietze, R.; Boom, W. H.; Johnson, J. L.; Mac Kenzie, W. R.; Alland, D.		DMID 01-009 Tuberculosis	Bacterial Factors That Predict Relapse after Tuberculosis Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; DRUG; RISK; SUSCEPTIBILITY; VALIDATION; CHILDHOOD; EFFICACY; RIFAMPIN	BACKGROUND Approximately 5% of patients with drug-susceptible tuberculosis have a relapse after 6 months of first-line therapy, as do approximately 20% of patients after 4 months of short-course therapy. We postulated that by analyzing pretreatment isolates of Mycobacterium tuberculosis obtained from patients who subsequently had a relapse or were cured, we could determine any correlations between the minimum inhibitory concentration (MIC) of a drug below the standard resistance breakpoint and the relapse risk after treatment. METHODS Using data from the Tuberculosis Trials Consortium Study 22 (development cohort), we assessed relapse and cure isolates to determine the MIC values of isoniazid and rifampin that were below the standard resistance breakpoint (0.1 mu g per milliliter for isoniazid and 1.0 mu g per milliliter for rifampin). We combined this analysis with clinical, radiologic, and laboratory data to generate predictive relapse models, which we validated by analyzing data from the DMID 01-009 study (validation cohort). RESULTS In the development cohort, the mean (+/- SD) MIC of isoniazid below the breakpoint was 0.0334 +/- 0.0085 mu g per milliliter in the relapse group and 0.0286 +/- 0.0092 mu g per milliliter in the cure group, which represented a higher value in the relapse group by a factor of 1.17 (P = 0.02). The corresponding MIC values of rifampin were 0.0695 +/- 0.0276 and 0.0453 +/- 0.0223 mu g per milliliter, respectively, which represented a higher value in the relapse group by a factor of 1.53 (P<0.001). Higher MIC values remained associated with relapse in a multivariable analysis that included other significant between-group differences. In an analysis of receiver-operating-characteristic curves of relapse based on these MIC values, the area under the curve (AUC) was 0.779. In the development cohort, the AUC in a multivariable model that included MIC values was 0.875. In the validation cohort, the MIC values either alone or combined with other patient characteristics were also predictive of relapse, with AUC values of 0.964 and 0.929, respectively. The use of a model score for the MIC values of isoniazid and rifampin to achieve 75.0% sensitivity in cross-validation analysis predicted relapse with a specificity of 76.5% in the development cohort and a sensitivity of 70.0% and a specificity of 100% in the validation cohort. CONCLUSIONS In pretreatment isolates of M. tuberculosis with decrements of MIC values of isoniazid or rifampin below standard resistance breakpoints, higher MIC values were associated with a greater risk of relapse than lower MIC values.	[Colangeli, R.; Jedrey, H.; Venkata, U. D. Chippada; Chakravorty, S.; Gupta, A.; Alland, D.] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Kim, S.; Connell, R.] Rutgers Sch Publ Hlth, Dept Biostat, Newark, NJ USA; [Ma, S.; Sherman, D. R.] Ctr Infect Dis Res, Seattle, WA USA; [Sizemore, E. E.; Diem, L.; Mac Kenzie, W. R.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Okwera, A.] Uganda Case Western Reserve Univ Res Collaborat, Kampala, Uganda; [Dietze, R.] Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, Vitoria, Brazil; [Boom, W. H.; Johnson, J. L.] Case Western Reserve Univ, Sch Med, Dept Med, TB Res Unit, Cleveland, OH 44106 USA; [Boom, W. H.; Johnson, J. L.] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); Centers for Disease Control & Prevention - USA; Case Western Reserve University; Universidade Federal do Espirito Santo; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Alland, D (corresponding author), Rutgers New Jersey Med Sch, Ctr Emerging Pathogens, MSB A920C, Newark, NJ 07103 USA.	allandda@njms.rutgers.edu		ROBERTO, COLANGELI/0000-0003-3263-7404; Ma, Shuyi/0000-0003-0783-1328; Dietze, Reynaldo/0000-0002-6995-8001	National Institute of Allergy and Infectious Diseases [U01AI065663, U19AI11276, NO1-AI95383, HHSN266200700022C/NO1-AI-70022]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111276, U01AI065663, T32AI007509, R01AI126788, N01AI095383] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the National Institute of Allergy and Infectious Diseases (U01AI065663, U19AI11276, NO1-AI95383, and HHSN266200700022C/NO1-AI-70022).	Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; [Anonymous], 1983, Stat Bull Metrop Life Found, V64, P3; Babalik A, 2011, CAN RESPIR J, V18, P225, DOI 10.1155/2011/307150; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; de Steenwinkel JEM, 2012, ANTIMICROB AGENTS CH, V56, P4937, DOI 10.1128/AAC.00124-12; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P2157, DOI 10.1128/JCM.00691-14; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Lee J, 2014, ANTIMICROB AGENTS CH, V58, P11, DOI 10.1128/AAC.01209-13; Marks SM, 2016, INT J TUBERC LUNG D, V20, P435, DOI 10.5588/ijtld.15.0575; Mehta JB, 2001, CHEST, V120, P1520, DOI 10.1378/chest.120.5.1520; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Seifert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119628; Senousy BE, 2010, NAT REV GASTRO HEPAT, V7, P543, DOI 10.1038/nrgastro.2010.134; Springer B, 2009, J CLIN MICROBIOL, V47, P1773, DOI 10.1128/JCM.02501-08; Srivastava S, 2016, EBIOMEDICINE, V6, P126, DOI 10.1016/j.ebiom.2016.02.040; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; Totapally BR, 1998, CHEST, V113, P1207, DOI 10.1378/chest.113.5.1207; Ukwaja KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073134	27	73	76	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2018	379	9					823	833		10.1056/NEJMoa1715849	http://dx.doi.org/10.1056/NEJMoa1715849			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR9EA	30157391	Bronze, Green Accepted			2022-12-28	WOS:000443047800006
J	Schramm, C				Schramm, Christoph			Bile Acids, the Microbiome, Immunity, and Liver Tumors	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Martin Zeitz Ctr Rare Dis, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schramm, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany.; Schramm, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Martin Zeitz Ctr Rare Dis, Hamburg, Germany.							Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Shetty S, 2018, NAT REV GASTROENTERO; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	5	24	24	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2018	379	9					888	890		10.1056/NEJMcibr1807106	http://dx.doi.org/10.1056/NEJMcibr1807106			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GR9EA	30157405				2022-12-28	WOS:000443047800016
J	Slomski, A				Slomski, Anita			Drug Improves Glucose Levels and Drives Weight Loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					749	749		10.1001/jama.2018.12046	http://dx.doi.org/10.1001/jama.2018.12046			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167698				2022-12-28	WOS:000442958800011
J	Slomski, A				Slomski, Anita			Melatonin Improves Sleep in Patients With Circadian Disruption	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					749	749		10.1001/jama.2018.10903	http://dx.doi.org/10.1001/jama.2018.10903			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167694				2022-12-28	WOS:000442958800007
J	Petrosky, E; Harpaz, R; Fowler, KA; Bohm, MK; Helmick, CG; Yuan, KM; Betz, CJ				Petrosky, Emiko; Harpaz, Rafael; Fowler, Katherine A.; Bohm, Michele K.; Helmick, Charles G.; Yuan, Keming; Betz, Carter J.			Chronic Pain Among Suicide Decedents, 2003 to 2014: Findings From the National Violent Death Reporting System	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; NONCANCER PAIN; RISK; DEPRESSION; BEHAVIORS; FIBROMYALGIA; PREVALENCE; THOUGHTS; IDEATION; DISEASE	Background: More than 25 million adults in the United States have chronic pain. Chronic pain has been associated with suicidality, but previous studies primarily examined nonfatal suicidal behaviors rather than suicide deaths associated with chronic pain or the characteristics of such deaths. Objective: To estimate the prevalence of chronic pain among suicide decedents in a large multistate sample and to characterize suicide decedents with and without chronic pain. Design: Retrospective analysis of National Violent Death Reporting System (NVDRS) data. The NVDRS links death certificate, coroner or medical examiner, and law enforcement data collected by investigators, who often interview informants who knew the decedent to gather information on precipitating circumstances surrounding the suicide. Information is abstracted by using standard coding guidance developed by the Centers for Disease Control and Prevention. Setting: 18 states participating in the NVDRS. Participants: Suicide decedents with and without chronic pain who died during 1 January 2003 to 31 December 2014. Measurements: Demographic characteristics, mechanism of death, toxicology results, precipitating circumstances (mental health, substance use, interpersonal problems, life stressors), and suicide planning and intent. Results: Of 123 181 suicide decedents included in the study, 10 789 (8.8%) had evidence of chronic pain, and the percentage increased from 7.4% in 2003 to 10.2% in 2014. More than half (53.6%) of suicide decedents with chronic pain died of firearm-related injuries and 16.2% by opioid overdose. Limitation: The results probably underrepresent the true percentage of suicide decedents who had chronic pain, given the nature of the data and how they were captured. Conclusion: Chronic pain may be an important contributor to suicide. Access to quality, comprehensive pain care and adherence to clinical guidelines may help improve pain management and patient safety. Primary Funding Source: None.	[Petrosky, Emiko; Harpaz, Rafael; Fowler, Katherine A.; Bohm, Michele K.; Helmick, Charles G.; Yuan, Keming; Betz, Carter J.] Ctr Dis Control & Prevent, Atlanta, GA 30341 USA; [Petrosky, Emiko; Yuan, Keming] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Violence Prevent, 4770 Buford Highway Northeast,MS F-63, Atlanta, GA 30341 USA; [Harpaz, Rafael] 1600 Clifton Rd Northeast,MS A-34, Atlanta, GA 30329 USA; [Fowler, Katherine A.; Betz, Carter J.] Ctr Dis Control & Prevent, 4770 Buford Highway Northeast,MS F-64, Atlanta, GA 30341 USA; [Bohm, Michele K.] Ctr Dis Control & Prevent, 4770 Buford Highway Northeast,MS F-62, Atlanta, GA 30341 USA; [Helmick, Charles G.] Ctr Dis Control & Prevent, 4770 Buford Highway Northeast,MS F-78, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Petrosky, E (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Violence Prevent, 4770 Buford Highway Northeast,MS F-63, Atlanta, GA 30341 USA.	xfq7@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		American Chronic Pain Association, 2018, COND A TO Z; [Anonymous], 2011, REL PAIN AM BLUEPR T; Arnow BA, 2006, PSYCHOSOM MED, V68, P262, DOI 10.1097/01.psy.0000204851.15499.fc; Blair JM, 2016, INJURY PREV, V22, P6, DOI 10.1136/injuryprev-2015-041819; Calandre EP, 2011, RHEUMATOLOGY, V50, P1889, DOI 10.1093/rheumatology/ker203; Calati R, 2015, J PSYCHIATR RES, V71, P16, DOI 10.1016/j.jpsychires.2015.09.004; Centers for Disease Control and Prevention, 2015, WEB BAS INJ STAT QUE; Cheatle MD, 2011, PAIN MED, V12, pS43, DOI 10.1111/j.1526-4637.2011.01131.x; Curtin Sally C, 2016, NCHS Data Brief, P1; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Dworkin RH, 2016, J PAIN, V17, pT1, DOI 10.1016/j.jpain.2016.02.010; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Fishbain DA, 2014, PAIN MED, V15, P1835, DOI 10.1111/pme.12463; Fowler KA, 2015, AM J PUBLIC HEALTH, V105, P311, DOI 10.2105/AJPH.2014.301945; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Grol-Prokopczyk H, 2017, PAIN, V158, P313, DOI 10.1097/j.pain.0000000000000762; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Hassett AL, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0436-1; Ilgen MA, 2013, JAMA PSYCHIAT, V70, P692, DOI 10.1001/jamapsychiatry.2013.908; Juurlink DN, 2004, ARCH INTERN MED, V164, P1179, DOI 10.1001/archinte.164.11.1179; Kazan D, 2016, J AFFECT DISORDERS, V190, P585, DOI 10.1016/j.jad.2015.11.003; Nahin RL, 2015, J PAIN, V16, P769, DOI 10.1016/j.jpain.2015.05.002; National Pain Strategy Task Force, 2016, NAT PAIN STRAT COMPR; Novic A, 2016, CLIN J PAIN, V32, P351, DOI 10.1097/AJP.0000000000000256; Okifuji A, 2011, J APPL BIOBEHAV RES, V16, P57, DOI 10.1111/j.1751-9861.2011.00065.x; Patten SB, 2008, GEN HOSP PSYCHIAT, V30, P407, DOI 10.1016/j.genhosppsych.2008.05.001; Racine M, 2018, PROG NEURO-PSYCHOPH, V87, P269, DOI 10.1016/j.pnpbp.2017.08.020; Racine M, 2017, PAIN MED, V18, P283, DOI 10.1093/pm/pnw115; Raphael KG, 2006, PAIN, V124, P117, DOI 10.1016/j.pain.2006.04.004; Shim EJ, 2017, INT J BEHAV MED, V24, P501, DOI 10.1007/s12529-017-9648-1; Smith MT, 2004, CLIN J PAIN, V20, P111, DOI 10.1097/00002508-200403000-00008; Stone DM., 2017, NATL CTR INJURY PREV; Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859; The Management of Posttraumatic Stress Disorder Work Group, 2017, VA DOD CLIN PRACT GU; Wolfe F, 2011, ARTHRIT CARE RES, V63, P94, DOI 10.1002/acr.20301; World Health Organization, 2004, INT STAT CLASS DIS R	36	56	57	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2018	169	7					448	+		10.7326/M18-0830	http://dx.doi.org/10.7326/M18-0830			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV4BN	30208405	Green Accepted			2022-12-28	WOS:000446042400004
J	McWilliams, JM; Hatfield, LA; Landon, BE; Hamed, P; Chernew, ME				McWilliams, J. Michael; Hatfield, Laura A.; Landon, Bruce E.; Hamed, Pasha; Chernew, Michael E.			Medicare Spending after 3 Years of the Medicare Shared Savings Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACCOUNTABLE CARE ORGANIZATIONS; PHYSICIAN PRACTICES; ASSOCIATION; INTEGRATION	BACKGROUND Health care providers who participate as an accountable care organization (ACO) in the voluntary Medicare Shared Savings Program (MSSP) have incentives to lower spending for Medicare patients while achieving high performance on a set of quality measures. Little is known about the extent to which early savings achieved by ACOs in the program have grown and been replicated by ACOs that entered the program in later years. ACOs that are physician groups have stronger incentives to lower spending than hospital-integrated ACOs. METHODS Using fee-for-service Medicare claims from 2009 through 2015, we performed difference-in-differences analyses to compare changes in Medicare spending for patients in ACOs before and after entry into the MSSP with concurrent changes in spending for local patients served by providers not participating in the MSSP (control group). We estimated differential changes (i.e., the between-group difference in the change from the pre-entry period) separately for hospital-integrated ACOs and physician-group ACOs that entered the MSSP in 2012, 2013, or 2014. RESULTS MSSP participation was associated with differential spending reductions in physician-group ACOs. These reductions grew with longer participation in the program and were significantly greater than the reductions in hospital-integrated ACOs. By 2015, the mean differential change in per-patient Medicare spending was -$474 (-4.9% of the pre-entry mean, P<0.001) for physician-group ACOs that entered in 2012, -$342 (-3.5% of the pre-entry mean, P<0.001) for those that entered in 2013, and -$156 (-1.6% of the pre-entry mean, P=0.009) for those that entered in 2014. The corresponding differential changes for hospital-integrated ACOs were -$169 (P=0.005), -$18 (P=0.78), and $88 (P=0.14), which were significantly lower than for physician-group ACOs (P<0.001). Spending reductions in physician-group ACOs constituted a net savings to Medicare of $256.4 million in 2015, whereas spending reductions in hospital-integrated ACOs were offset by bonus payments. CONCLUSIONS After 3 years of the MSSP, participation in shared-savings contracts by physician groups was associated with savings for Medicare that grew over the study period, whereas hospital-integrated ACOs did not produce savings (on average) during the same period.	[McWilliams, J. Michael; Hatfield, Laura A.; Landon, Bruce E.; Hamed, Pasha; Chernew, Michael E.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [McWilliams, J. Michael] Harvard Med Sch, Boston, MA USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	McWilliams, JM (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mcwilliams@hcp.med.harvard.edu	Hatfield, Laura A./I-6835-2019	Hatfield, Laura A./0000-0003-0366-3929	National Institute on Aging of the National Institutes of Health [P01-AG032952]; NATIONAL INSTITUTE ON AGING [P01AG032952] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a grant (P01-AG032952) from the National Institute on Aging of the National Institutes of Health.	AHRQ, 2016, PREV QUAL IND TECHN; [Anonymous], MED SHAR SAV PROGR A; [Anonymous], 2015 SHAR SAV PROGR; [Anonymous], 2016, FIN MED SHAR SAV PRO; Barnett ML, 2018, AM J MANAG CARE, V24, pE141; Burns LR, 2013, ADV HEALTH CARE MANA, V15, P39, DOI 10.1108/S1474-8231(2013)0000015009; Casalino LP, 2014, HEALTH AFFAIR, V33, P1680, DOI 10.1377/hlthaff.2014.0434; Centers for Medicare and Medicaid Services, 2018, MED SHAR SAV PROGR F; Centers for Medicare & Medicaid Services, 2014, SHAR SAV LOSS ASS ME; Chernew ME, 2017, SAVINGS REPORTED CMS, DOI [10.1377/hblog20170619.060649/full/, DOI 10.1377/HBLOG20170619.060649/FULL/]; Colla CH, 2016, JAMA INTERN MED, V176, P1167, DOI 10.1001/jamainternmed.2016.2827; D'Aunno T, 2018, HEALTH SERV RES, V53, P120, DOI 10.1111/1475-6773.12642; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Kerrissey MJ, 2017, HEALTH AFFAIR, V36, P885, DOI 10.1377/hlthaff.2016.0909; McWilliams JM, 2017, HEALTH AFFAIR, V36, P2085, DOI 10.1377/hlthaff.2017.0814; McWilliams JM, 2017, JAMA INTERN MED, V177, P518, DOI 10.1001/jamainternmed.2016.9115; McWilliams JM, 2016, ANN INTERN MED, V165, P873, DOI 10.7326/M16-1846; McWilliams JM, 2016, JAMA-J AM MED ASSOC, V316, P1711, DOI 10.1001/jama.2016.12049; McWilliams JM, 2016, NEW ENGL J MED, V374, P2357, DOI 10.1056/NEJMsa1600142; McWilliams JM, 2015, NEW ENGL J MED, V372, P1927, DOI 10.1056/NEJMsa1414929; McWilliams JM, 2014, JAMA INTERN MED, V174, P938, DOI 10.1001/jamainternmed.2014.1073; McWilliams JM, 2013, JAMA INTERN MED, V173, P1447, DOI 10.1001/jamainternmed.2013.6886; Neprash HT, 2017, HEALTH AFFAIR, V36, P346, DOI 10.1377/hlthaff.2016.0840; Nyweide DJ, 2015, JAMA-J AM MED ASSOC, V313, P2152, DOI 10.1001/jama.2015.4930; Roberts ET, 2017, HEALTH AFFAIR, V36, P855, DOI 10.1377/hlthaff.2016.1266; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Yun HF, 2010, HEALTH SERV OUTCOME, V10, P100, DOI 10.1007/s10742-010-0060-4	27	120	120	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2018	379	12					1139	1149		10.1056/NEJMsa1803388	http://dx.doi.org/10.1056/NEJMsa1803388			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GU1KV	30183495	Green Accepted, Bronze			2022-12-28	WOS:000445020900008
J	Mongera, A; Rowghanian, P; Gustafson, HJ; Shelton, E; Kealhofer, DA; Carn, EK; Serwane, F; Lucio, AA; Giammona, J; Campas, O				Mongera, Alessandro; Rowghanian, Payam; Gustafson, Hannah J.; Shelton, Elijah; Kealhofer, David A.; Carn, Emmet K.; Serwane, Friedhelm; Lucio, Adam A.; Giammona, James; Campas, Otger			A fluid-to-solid jamming transition underlies vertebrate body axis elongation	NATURE			English	Article							LIVING EMBRYONIC-TISSUES; SOMITE MORPHOGENESIS; SEGMENTATION CLOCK; CELL-MIGRATION; MECHANICS; DYNAMICS; EPITHELIUM; CADHERIN; FORCES; FLOW	Just as in clay moulding or glass blowing, physically sculpting biological structures requires the constituent material to locally flow like a fluid while maintaining overall mechanical integrity like a solid. Disordered soft materials, such as foams, emulsions and colloidal suspensions, switch from fluid-like to solid-like behaviours at a jamming transition(1-4). Similarly, cell collectives have been shown to display glassy dynamics in 2D and 3D(5,6) and jamming in cultured epithelial monolayers(7,)(8), behaviours recently predicted theoretically(9-11) and proposed to influence asthma pathobiology(8) and tumour progression(12). However, little is known about whether these seemingly universal behaviours occur in vivo(13) and, specifically, whether they play any functional part during embryonic morphogenesis. Here, by combining direct in vivo measurements of tissue mechanics with analysis of cellular dynamics, we show that during vertebrate body axis elongation, posterior tissues undergo a jamming transition from a fluid-like behaviour at the extending end, the mesodermal progenitor zone, to a solid-like behaviour in the presomitic mesoderm. We uncover an anteroposterior, N-cadherindependent gradient in yield stress that provides increasing mechanical integrity to the presomitic mesoderm, consistent with the tissue transiting from a wetter to a dryer foam-like architecture. Our results show that cell-scale stresses fluctuate rapidly (within about 1 min), enabling cell rearrangements and effectively 'melting' the tissue at the growing end. Persistent (more than 0.5 h) stresses at supracellular scales, rather than cell-scale stresses, guide morphogenetic flows in fluid-like tissue regions. Unidirectional axis extension is sustained by the reported rigidification of the presomitic mesoderm, which mechanically supports posterior, fluid-like tissues during remodelling before their maturation. The spatiotemporal control of fluid-like and solid-like tissue states may represent a generic physical mechanism of embryonic morphogenesis.	[Mongera, Alessandro; Rowghanian, Payam; Gustafson, Hannah J.; Shelton, Elijah; Carn, Emmet K.; Serwane, Friedhelm; Lucio, Adam A.; Campas, Otger] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA; [Mongera, Alessandro; Rowghanian, Payam; Gustafson, Hannah J.; Shelton, Elijah; Serwane, Friedhelm; Lucio, Adam A.; Giammona, James; Campas, Otger] Univ Calif Santa Barbara, Calif NanoSyst Inst, Santa Barbara, CA 93106 USA; [Gustafson, Hannah J.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Kealhofer, David A.; Giammona, James] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Campas, Otger] Univ Calif Santa Barbara, Dept Mol Cell & Dev Biol, Santa Barbara, CA 93106 USA; [Campas, Otger] Univ Calif Santa Barbara, Ctr Bioengn, Santa Barbara, CA 93106 USA; [Mongera, Alessandro] European Mol Biol Lab, Heidelberg, Germany; [Serwane, Friedhelm] Max Planck Inst Med Res, Heidelberg, Germany	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; European Molecular Biology Laboratory (EMBL); Max Planck Society	Campas, O (corresponding author), Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA.; Campas, O (corresponding author), Univ Calif Santa Barbara, Calif NanoSyst Inst, Santa Barbara, CA 93106 USA.; Campas, O (corresponding author), Univ Calif Santa Barbara, Dept Mol Cell & Dev Biol, Santa Barbara, CA 93106 USA.; Campas, O (corresponding author), Univ Calif Santa Barbara, Ctr Bioengn, Santa Barbara, CA 93106 USA.	campas@ucsb.edu	Serwane, Friedhelm/AAY-6057-2020; Bagher, Saeed/U-1068-2019; Serwane, Friedhelm/A-6720-2018	Shelton, Elijah/0000-0001-9311-1567; Giammona, James/0000-0003-2381-7630; Serwane, Friedhelm/0000-0001-6943-8244; Kealhofer, David/0000-0002-6022-9515; Mongera, Alessandro/0000-0001-9344-9808	UCSB Animal Research Center; EMBO [EMBO ALTF 509-2013]; Errett Fisher Foundation; Otis Williams Fund; National Science Foundation [CMMI-1562910]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [R21HD084285, R01HD095797]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD095797, R21HD084285] Funding Source: NIH RePORTER	UCSB Animal Research Center; EMBO(European Molecular Biology Organization (EMBO)); Errett Fisher Foundation; Otis Williams Fund; National Science Foundation(National Science Foundation (NSF)); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank E. Sletten for sharing custom-made fluorinated dyes. We also thank all laboratory members and the UCSB Animal Research Center for support. P.R. thanks B. Aigouy for assistance with Tissue Analyzer. A.M. thanks EMBO (EMBO ALTF 509-2013), Errett Fisher Foundation and Otis Williams Fund for financial support. This work was partially supported by the National Science Foundation (CMMI-1562910) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (R21HD084285; R01HD095797).	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Angelini TE, 2011, P NATL ACAD SCI USA, V108, P4714, DOI 10.1073/pnas.1010059108; Atia L, 2018, NAT PHYS, V14, P613, DOI 10.1038/s41567-018-0089-9; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Benazeraf B, 2013, ANNU REV CELL DEV BI, V29, P1, DOI 10.1146/annurev-cellbio-101011-155703; Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Bi DP, 2015, NAT PHYS, V11, P1074, DOI [10.1038/NPHYS3471, 10.1038/nphys3471]; Bi DP, 2014, SOFT MATTER, V10, P1885, DOI 10.1039/c3sm52893f; Bonn D, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.035005; Campas O, 2016, SEMIN CELL DEV BIOL, V55, P119, DOI 10.1016/j.semcdb.2016.03.011; Campas O, 2014, NAT METHODS, V11, P183, DOI [10.1038/NMETH.2761, 10.1038/nmeth.2761]; Chal J, 2017, DEVELOPMENT, V144, P664, DOI 10.1242/dev.143974; Cohen-Addad S, 2013, ANNU REV FLUID MECH, V45, P241, DOI 10.1146/annurev-fluid-011212-140634; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Holtze C, 2008, LAB CHIP, V8, P1632, DOI 10.1039/b806706f; Kimelman D, 2016, CURR TOP DEV BIOL, V116, P517, DOI 10.1016/bs.ctdb.2015.12.008; Lawton AK, 2013, DEVELOPMENT, V140, P573, DOI 10.1242/dev.090381; Lele Z, 2002, DEVELOPMENT, V129, P3281; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Marmottant P, 2009, P NATL ACAD SCI USA, V106, P17271, DOI 10.1073/pnas.0902085106; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Miller CJ, 2013, NAT REV GENET, V14, P733, DOI 10.1038/nrg3513; Mosaliganti KR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002780; Nusslein-Volhard C, 2002, ZEBRAFISH; Oswald L, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa8e83; Park JA, 2015, NAT MATER, V14, P1040, DOI [10.1038/NMAT4357, 10.1038/nmat4357]; RALLISON JM, 1984, ANNU REV FLUID MECH, V16, P45, DOI 10.1146/annurev.fl.16.010184.000401; Rowghanian P, 2016, J FLUID MECH, V802, P245, DOI 10.1017/jfm.2016.447; Sadati M, 2013, DIFFERENTIATION, V86, P121, DOI 10.1016/j.diff.2013.02.005; Schotz EM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0726; Serwane F, 2017, NAT METHODS, V14, P181, DOI [10.1038/NMETH.4101, 10.1038/nmeth.4101]; Shelton E, 2018, J MICROSC-OXFORD, V269, P259, DOI 10.1111/jmi.12624; Sletten EM, 2014, J AM CHEM SOC, V136, P13574, DOI 10.1021/ja507848f; Thompson D.W, 1917, GROWTH FORM; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; Zhang LX, 2008, DEVELOPMENT, V135, P2065, DOI 10.1242/dev.022673	37	262	263	11	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2018	561	7723					401	+		10.1038/s41586-018-0479-2	http://dx.doi.org/10.1038/s41586-018-0479-2			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU1HZ	30185907	Green Accepted			2022-12-28	WOS:000445011500056
J	Samaha, H; Pignata, A; Fousek, K; Ren, J; Lam, FW; Stossi, F; Dubrulle, J; Salsman, VS; Krishnan, S; Hong, SH; Baker, ML; Shree, A; Gad, AZ; Shum, T; Fukumura, D; Byrd, TT; Mukherjee, M; Marrelli, SP; Orange, JS; Joseph, SK; Sorensen, PH; Taylor, MD; Hegde, M; Mamonkin, M; Jain, RK; El-Naggar, S; Ahmed, N				Samaha, Heba; Pignata, Antonella; Fousek, Kristen; Ren, Jun; Lam, Fong W.; Stossi, Fabio; Dubrulle, Julien; Salsman, Vita S.; Krishnan, Shanmugarajan; Hong, Sung-Ha; Baker, Matthew L.; Shree, Ankita; Gad, Ahmed Z.; Shum, Thomas; Fukumura, Dai; Byrd, Tiara T.; Mukherjee, Malini; Marrelli, Sean P.; Orange, Jordan S.; Joseph, Sujith K.; Sorensen, Poul H.; Taylor, Michael D.; Hegde, Meenakshi; Mamonkin, Maksim; Jain, Rakesh K.; El-Naggar, Shahenda; Ahmed, Nabil			A homing system targets therapeutic T cells to brain cancer (Publication with Expression of Concern. See vol. 567, pg. 132, 2019)	NATURE			English	Article; Publication with Expression of Concern							ADHESION MOLECULE; LEUKOCYTE; GLIOBLASTOMA; CD6; TRANSMIGRATION; MIGRATION; TALIN; IMMUNOTHERAPY; MECHANISMS; EXPRESSION	Successful T cell immunotherapy for brain cancer requires that the T cells can access tumour tissues, but this has been difficult to achieve. Here we show that, in contrast to inflammatory brain diseases such as multiple sclerosis, where endothelial cells upregulate ICAM1 and VCAM1 to guide the extravasation of pro-inflammatory cells, cancer endothelium downregulates these molecules to evade immune recognition. By contrast, we found that cancer endothelium upregulates activated leukocyte cell adhesion molecule (ALCAM , which allowed us to overcome this immune-evasion mechanism by creating an ALCAM-restricted homing system (HS). We re-engineered the natural ligand of ALCAM, CD6, in a manner that triggers initial anchorage of T cells to ALCAM and conditionally mediates a secondary wave of adhesion by sensitizing T cells to low-level ICAM1 on the cancer endothelium, thereby creating the adhesion forces necessary to capture T cells from the bloodstream. Cytotoxic HS T cells robustly infiltrated brain cancers after intravenous injection and exhibited potent antitumour activity. We have therefore developed a molecule that targets the delivery of T cells to brain cancer.	[Samaha, Heba; Gad, Ahmed Z.; El-Naggar, Shahenda] Childrens Canc Hosp Egypt, Cairo 57357, Egypt; [Samaha, Heba; Pignata, Antonella; Fousek, Kristen; Salsman, Vita S.; Shree, Ankita; Gad, Ahmed Z.; Shum, Thomas; Byrd, Tiara T.; Joseph, Sujith K.; Hegde, Meenakshi; Mamonkin, Maksim; Ahmed, Nabil] Houston Methodist Hosp, Texas Childrens Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Samaha, Heba; Pignata, Antonella; Fousek, Kristen; Lam, Fong W.; Stossi, Fabio; Dubrulle, Julien; Salsman, Vita S.; Baker, Matthew L.; Shree, Ankita; Gad, Ahmed Z.; Shum, Thomas; Byrd, Tiara T.; Mukherjee, Malini; Orange, Jordan S.; Joseph, Sujith K.; Hegde, Meenakshi; Mamonkin, Maksim; Ahmed, Nabil] Baylor Coll Med, Houston, TX 77030 USA; [Samaha, Heba; Pignata, Antonella; Fousek, Kristen; Salsman, Vita S.; Shree, Ankita; Gad, Ahmed Z.; Byrd, Tiara T.; Mukherjee, Malini; Joseph, Sujith K.; Hegde, Meenakshi; Mamonkin, Maksim; Ahmed, Nabil] Texas Childrens Hosp, Houston, TX 77030 USA; [Fousek, Kristen; Gad, Ahmed Z.; Shum, Thomas; Byrd, Tiara T.; Mamonkin, Maksim; Ahmed, Nabil] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Ren, Jun; Krishnan, Shanmugarajan; Fukumura, Dai; Jain, Rakesh K.] Harvard Med Sch, Massachusetts Gen Hosp, Edwin L Steele Labs Tumor Biol, Boston, MA USA; [Lam, Fong W.; Orange, Jordan S.; Ahmed, Nabil] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lam, Fong W.] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX USA; [Stossi, Fabio; Dubrulle, Julien] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Integrated Microscopy Core, Adv Technol Cores, Houston, TX USA; [Hong, Sung-Ha; Marrelli, Sean P.] McGovern Med Sch UT Hlth, Dept Neurol, Houston, TX USA; [Baker, Matthew L.] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Mukherjee, Malini; Orange, Jordan S.] Texas Childrens Hosp, Baylor Coll Med, Ctr Human Immunobiol, Houston, TX 77030 USA; [Sorensen, Poul H.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Taylor, Michael D.] Univ Toronto, Developmental & Stem Cell Biol Program, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg,Dept Surg, Toronto, ON, Canada; [Taylor, Michael D.] Univ Toronto, Developmental & Stem Cell Biol Program, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg,Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Taylor, Michael D.] Univ Toronto, Developmental & Stem Cell Biol Program, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg,Dept Med Biophys, Toronto, ON, Canada; [Hegde, Meenakshi; Ahmed, Nabil] Houston Methodist Hosp, Houston, TX USA; [Hegde, Meenakshi; Ahmed, Nabil] Texas Childrens Hosp, Baylor Coll Med, Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA; [Mamonkin, Maksim; Ahmed, Nabil] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Children's Cancer Hospital 57357; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of British Columbia; University of Toronto; University of Toronto; University of Toronto; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine	Ahmed, N (corresponding author), Houston Methodist Hosp, Texas Childrens Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.; Ahmed, N (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.; Ahmed, N (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.; Ahmed, N (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Ahmed, N (corresponding author), Houston Methodist Hosp, Houston, TX USA.; Ahmed, N (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA.; Ahmed, N (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	nahmed@bcm.edu	Jain, Rakesh K/I-1384-2017; Joseph, Sujith/C-2835-2012	Jain, Rakesh K/0000-0001-7571-3548; orange, jordan/0000-0001-7117-7725; Joseph, Sujith/0000-0003-4596-1270; Gad, Ahmed/0000-0002-6149-3414; Fousek, Kristen/0000-0002-2307-5000; El-Naggar, Shahenda/0000-0001-6465-9881; Taylor, Michael/0000-0001-7009-3466; Mamonkin, Maksim/0000-0001-7178-8163	SU2C-St. Baldrick's Pediatric Dream Team Translational Research Grant [SU2C-AACR-DT1113]; Alex's Lemonade Stand; NIH [T32HL092332, R01AI067946, T32GM08812, DK56338, CA125123, 1S10OD020151-01]; CPRIT [RP150578]; Dan L. Duncan CCC;  [P01-CA080124];  [R35-CA197743];  [K08-GM123261];  [P50-CA165962]; NATIONAL CANCER INSTITUTE [P30CA125123, R35CA197743, P01CA080124, P50CA165962] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL092332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM123261] Funding Source: NIH RePORTER	SU2C-St. Baldrick's Pediatric Dream Team Translational Research Grant; Alex's Lemonade Stand; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Dan L. Duncan CCC; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. K. Brenner and C. Gillespie for scientific advice and linguistic editing, respectively, and S. Roberge and M. Duquette for technical assistance. The D3 antibody was a gift from M. Brown. This work was funded by an SU2C-St. Baldrick's Pediatric Dream Team Translational Research Grant (SU2C-AACR-DT1113; NA/PS/MDT). SU2C is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. Also funded by Alex's Lemonade Stand, NIH-T32HL092332 (K.F./T.B.; H. Heslop), R01AI067946 (J.S.O.), T32GM08812 (K.F./T.B.; M. Estes), DK56338, CA125123, and 1S10OD020151-01, CPRIT (RP150578), the Dan L. Duncan CCC and P01-CA080124 (R.K.J./D.F.); R35-CA197743, K08-GM123261 (F.L.) and P50-CA165962 (R.K.J.). This content does not necessarily represent the official views of the funding agencies, the Department of Veterans Affairs or the U.S. Government.	Ager A, 2016, BIOCHEM SOC T, V44, P377, DOI 10.1042/BST20150254; Ahmed N, 2017, JAMA ONCOL, V3, P1094, DOI 10.1001/jamaoncol.2017.0184; Ahmed N, 2010, CLIN CANCER RES, V16, P474, DOI 10.1158/1078-0432.CCR-09-1322; Arima Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/898165; Auerbach SD, 2007, PROG INFLAMM RES SER, P99; Baumann Kim, 2012, Nat Rev Mol Cell Biol, V13, P138, DOI 10.1038/nrm3297; Bonini C, 2015, EUR J IMMUNOL, V45, P2457, DOI 10.1002/eji.201545552; Brown MH, 2016, CURR DRUG TARGETS, V17, P619, DOI 10.2174/1389450116666150825120536; Bughani U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180088; Bullard DC, 2007, J IMMUNOL, V178, P851, DOI 10.4049/jimmunol.178.2.851; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Carrithers MD, 2000, BRAIN, V123, P1092, DOI 10.1093/brain/123.6.1092; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chappell PE, 2015, STRUCTURE, V23, P1426, DOI 10.1016/j.str.2015.05.019; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; D'Aloia MM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0278-6; Davenport MP, 2000, IMMUNOL TODAY, V21, P315, DOI 10.1016/S0167-5699(00)01644-3; Dorovini-Zis K., 2015, BLOOD BRAIN BARRIER, VOne; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Fukurnura D, 2018, NAT REV CLIN ONCOL, V15, P325, DOI 10.1038/nrclinonc.2018.29; Green CE, 2006, BLOOD, V107, P2101, DOI 10.1182/blood-2005-06-2303; Gu MX, 2012, J PROTEOME RES, V11, P2365, DOI 10.1021/pr300098f; Hansen AG, 2014, CANCER RES, V74, P1404, DOI 10.1158/0008-5472.CAN-13-1296; Hegde M, 2016, J CLIN INVEST, V126, P3036, DOI 10.1172/JCI83416; Kijima N, 2012, NEURO-ONCOLOGY, V14, P1254, DOI 10.1093/neuonc/nor202; Krummel MF, 2016, NAT REV IMMUNOL, V16, P193, DOI 10.1038/nri.2015.16; Laschinger M, 2002, EUR J IMMUNOL, V32, P3598, DOI 10.1002/1521-4141(200212)32:12<3598::AID-IMMU3598>3.0.CO;2-6; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Lee BPL, 2008, NAT IMMUNOL, V9, P117, DOI 10.1038/ni0208-117; Li Y, 2017, P NATL ACAD SCI USA, V114, P2687, DOI 10.1073/pnas.1615253114; Liu Y, 2004, J IMMUNOL, V172, P7, DOI 10.4049/jimmunol.172.1.7; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nelissen JMDT, 2000, MOL BIOL CELL, V11, P2057, DOI 10.1091/mbc.11.6.2057; Orta-Mascaro M, 2016, J EXP MED, V213, P1387, DOI 10.1084/jem.20151785; Paris D, 2010, J NEUROSCI, V30, P11251, DOI 10.1523/JNEUROSCI.2586-10.2010; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Poria RB, 2006, CANCER BIOTHER RADIO, V21, P418, DOI 10.1089/cbr.2006.21.418; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sackstein R, 2017, LAB INVEST, V97, P669, DOI 10.1038/labinvest.2017.25; Steiner O, 2010, J IMMUNOL, V185, P4846, DOI 10.4049/jimmunol.0903732; Sudha T, 2017, HORM CANCER-US, V8, P157, DOI 10.1007/s12672-017-0293-6	46	29	30	3	106	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 20	2018	561	7723					331	+		10.1038/s41586-018-0499-y	http://dx.doi.org/10.1038/s41586-018-0499-y			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU1HZ	30185905	Green Accepted			2022-12-28	WOS:000445011500042
J	Conti, L; Gatt, S				Conti, Luca; Gatt, Simon			Squamous-Cell Carcinoma of the Lung	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Conti, Luca; Gatt, Simon] Mater Dei Hosp, Msida, Malta		Conti, L (corresponding author), Mater Dei Hosp, Msida, Malta.	luca.conti@gov.mt							0	9	9	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					E17	E17		10.1056/NEJMicm1802514	http://dx.doi.org/10.1056/NEJMicm1802514			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT4UV	30207918				2022-12-28	WOS:000444501600012
J	Murphy, DC				Murphy, Declan C.			Leading hospital suspends complex heart surgery to maintain patient safety	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Murphy, Declan C/0000-0001-9295-7712				Bewick M, 2018, INDEPENDENT REV CARD; Dyer C, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3697	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2018	362								k3896	10.1136/bmj.k3896	http://dx.doi.org/10.1136/bmj.k3896			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JJ	30209063				2022-12-28	WOS:000445016500014
J	Murphy, DC				Murphy, Declan C.			Doctors who turn down flu vaccine could be redeployed	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Murphy, Declan C/0000-0001-9295-7712				IACOBUCCI G, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J4766; NHS Improvement, 2018, NHS REV WINT 2017; Pereira M, 2017, CLIN MED, V17, P484, DOI 10.7861/clinmedicine.17-6-484; Public Health England, 2018, INFL VACC EFF SEAS E	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2018	362								k3872	10.1136/bmj.k3872	http://dx.doi.org/10.1136/bmj.k3872			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JJ	30206056				2022-12-28	WOS:000445016500011
J	Valgimigli, M; Frigoli, E; Leonardi, S; Vranckx, P; Rothenbuhler, M; Tebaldi, M; Varbella, F; Calabro, P; Garducci, S; Rubartelli, P; Briguori, C; Ando, G; Ferrario, M; Limbruno, U; Garbo, R; Sganzerla, P; Russo, F; Nazzaro, M; Lupi, A; Cortese, B; Ausiello, A; Ierna, S; Esposito, G; Ferrante, G; Santarelli, A; Sardella, G; de Cesare, N; Tosi, P; van 't Hof, A; Omerovic, E; Brugaletta, S; Windecker, S; Heg, D; Juni, P				Valgimigli, Marco; Frigoli, Enrico; Leonardi, Sergio; Vranckx, Pascal; Rothenbuhler, Martina; Tebaldi, Matteo; Varbella, Ferdinando; Calabro, Paolo; Garducci, Stefano; Rubartelli, Paolo; Briguori, Carlo; Ando, Giuseppe; Ferrario, Maurizio; Limbruno, Ugo; Garbo, Roberto; Sganzerla, Paolo; Russo, Filippo; Nazzaro, Marco; Lupi, Alessandro; Cortese, Bernardo; Ausiello, Arturo; Ierna, Salvatore; Esposito, Giovanni; Ferrante, Giuseppe; Santarelli, Andrea; Sardella, Gennaro; de Cesare, Nicoletta; Tosi, Paolo; van 't Hof, Arnoud; Omerovic, Elmir; Brugaletta, Salvatore; Windecker, Stephan; Heg, Dik; Juni, Peter		MATRIX Investigators	Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY-DISEASE; 2017 ESC; METAANALYSIS; ANGIOGRAPHY; MONOTHERAPY; SITE	Background The Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess the comparative safety and effectiveness of radial versus femoral access and of bivalirudin versus unfractionated heparin with optional glycoprotein IIb/IIIa inhibitors in patients with the whole spectrum of acute coronary syndrome undergoing invasive management. Here we describe the prespecified final 1-year outcomes of the entire programme. Methods MATRIX was a programme of three nested, randomised, multicentre, open-label, superiority trials in patients with acute coronary syndrome in 78 hospitals in Italy, the Netherlands, Spain, and Sweden. Patients with ST-elevation myocardial infarction were simultaneously randomly assigned (1:1) before coronary angiography to radial or femoral access and to bivalirudin, with or without post-percutaneous coronary intervention infusion or unfractionated heparin (one-step inclusion). Patients with non-ST-elevation acute coronary syndrome were randomly assigned (1:1) before coronary angiography to radial or femoral access and, only if deemed eligible to percutaneous coronary intervention after angiography (two-step inclusion), entered the antithrombin type and treatment duration programmes. Randomisation sequences were computer generated, blocked, and stratified by intended new or current use of P2Y12 inhibitor (clopidogrel vs ticagrelor or prasugrel), and acute coronary syndrome type (ST-elevation myocardial infarction, troponin-positive, or troponin-negative non-ST-elevation acute coronary syndrome). Bivalirudin was given as a bolus of 0.75 mg/kg, followed immediately by an infusion of 1.75 mg/kg per h until completion of percutaneous coronary intervention. Heparin was given at 70-100 units per kg in patients not receiving glycoprotein IIb/IIIa inhibitors, and at 50-70 units per kg in patients receiving glycoprotein IIb/IIIa inhibitors. Clinical follow-up was done at 30 days and 1 year. Co-primary outcomes for MATRIX access and MATRIX antithrombin type were major adverse cardiovascular events, defined as the composite of all-cause mortality, myocardial infarction, or stroke up to 30 days; and net adverse clinical events, defined as the composite of non-coronary artery bypass graft-related major bleeding, or major adverse cardiovascular events up to 30 days. The primary outcome for MATRIX treatment duration was the composite of urgent target vessel revascularisation, definite stent thrombosis, or net adverse clinical events up to 30 days. Analyses were done according to the intention-to-treat principle. Findings Between Oct 11,2011, and Nov 7,2014, we randomly assigned 8404 patients to receive radial (4197 patients) or femoral (4207 patients) access. Of these 8404 patients, 7213 were included in the MATRIX antithrombin type study and were randomly assigned to bivalirudin (3610 patients) or heparin (3603 patients). Patients assigned to bivalirudin were included in the MATRIX treatment duration study, and were randomly assigned to post-procedure infusion (1799 patients) or no post-procedure infusion (1811 patients). At 1 year, major adverse cardiovascular events did not differ between patients assigned to radial access compared with those assigned to femoral access (14.2% vs 15.7%; rate ratio 0.89, 95% CI 0.80-1.00; p=0.0526), but net adverse clinical events were fewer with radial than with femoral access (15.2% vs 17.2%; 0.87,0.78-0.97; p=0.0128). Compared with heparin, bivalirudin was not associated with fewer major adverse cardiovascular (15.8% vs 16.8%; 0.94,0.83-1.05; 13=0.28) or net adverse clinical events (17.0% vs 18.4%; 0.91,0.81-1.02; p=0.10). The composite of urgent target vessel revascularisation, stent thrombosis, or net adverse clinical events did not differ with or without post-procedure bivalirudin infusion (17.4% vs 17.4%; 0.99,0.84-1.16; p=0.90). Interpretation In patients with acute coronary syndrome, radial access was associated with lower rates of net adverse clinical events compared with femoral access, but not major adverse cardiovascular events at 1 year. Bivalirudin with or without post-procedure infusion was not associated with lower rates of major adverse cardiovascular events or net adverse clinical events. Radial access should become the default approach in acute coronary syndrome patients undergoing invasive management.	[Valgimigli, Marco; Windecker, Stephan] Univ Bern, Bern Univ Hosp, Inselspital, Bern, Switzerland; [Frigoli, Enrico; Rothenbuhler, Martina; Heg, Dik] Univ Bern, Clin Trials Unit, Bern, Switzerland; [Leonardi, Sergio; Ferrario, Maurizio] Fdn IRCCS Policlin San Matteo, Dipartimento Cardiotoracovasc, UOC Cardiol, Pavia, Italy; [Vranckx, Pascal] Jessa Ziekenhuis, Hartcentrum Hasselt, Dept Cardiol & Crit Care Med, Hasselt, Belgium; [Tebaldi, Matteo] Univ Hosp Ferrara, Ferrara, Italy; [Varbella, Ferdinando] ASL Torino 3, Osped Riuniti Rivoli, Cardiol Unit, Turin, Italy; [Calabro, Paolo] St Anna & San Sebastiano Hosp, Div Clin Cardiol, Caserta, Italy; [Calabro, Paolo] Univ Campania Luigi Vanvitelli, Dept Translat Med Sci, Naples, Italy; [Garducci, Stefano] AO Osped Civile Vimercate, Vimercate, Italy; [Rubartelli, Paolo] ASL3 Osped Villa Scassi, Dept Cardiol, Genoa, Italy; [Briguori, Carlo] Clin Mediterranea, Naples, Italy; [Ando, Giuseppe] Univ Messina, Azienda Osped Univ Policlin Gaetano Martino, Messina, Italy; [Limbruno, Ugo] ASL 9 Grosseto, UO Cardiol, Grosseto, Italy; [Garbo, Roberto] San Giovanni Bosco Hosp, Turin, Italy; [Sganzerla, Paolo] AO Osped Treviglio Caravaggio, Treviglio, Italy; [Russo, Filippo] Azienda Osped St Anna, Como, Italy; [Nazzaro, Marco] San Camillo Forlanini, Rome, Italy; [Lupi, Alessandro] ASL VCO, Div Cardiol, Verbania, Italy; [Cortese, Bernardo] Osped FatebeneFratelli, Milan, Italy; [Ausiello, Arturo] Casa Cura Villa Verde, Taranto, Italy; [Ierna, Salvatore] Osped Sirai, Carbonia, Italy; [Esposito, Giovanni] Federico II Univ Naples, Dept Adv Biomed Sci, Div Cardiol, Naples, Italy; [Ferrante, Giuseppe] IRCCS Humanitas, Milan, Italy; [Santarelli, Andrea] Infermi Hosp, Cardiovasc Dept, Rimini, Italy; [Sardella, Gennaro] Sapienza Univ Rome, Policlin Umberto 1, Rome, Italy; [de Cesare, Nicoletta] Policlin San Marco, Zingonia, Italy; [Tosi, Paolo] Mater Salutis Hosp, Legnago, Italy; [van 't Hof, Arnoud] Maastricht Univ, Med Ctr MUMC, Dept Cardiol, Maastricht, Netherlands; [Omerovic, Elmir] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Brugaletta, Salvatore] Univ Barcelona, Thorax Inst, Hosp Clin, Dept Cardiol, Barcelona, Spain; [Juni, Peter] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, AHRC,Dept Med, Toronto, ON, Canada; [Juni, Peter] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Bern; University Hospital of Bern; University of Bern; IRCCS Fondazione San Matteo; University of Ferrara; Arcispedale Sant'Anna; Universita della Campania Vanvitelli; Mediterranean Clinic; University of Messina; Ospedale di Treviglio-Caravaggio; Ospedale Sant'Anna di Como; Azienda Ospedaliera San Camillo-Forlanini; University of Naples Federico II; Hospital of Rimini; Sapienza University Rome; University Hospital Sapienza Rome; ULSS 9 Scaligera; Ospedale Mater Salutis di Legnago; Maastricht University; Maastricht University Medical Centre (MUMC); Sahlgrenska University Hospital; University of Barcelona; Hospital Clinic de Barcelona; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Valgimigli, M (corresponding author), Bern Univ Hosp, Swiss Cardiovasc Ctr Bern, CH-3010 Bern, Switzerland.	marco.valgimigli@insel.ch	BOCCUZZI, GIACOMO/C-2265-2019; Rigattieri, Stefano/AAL-9063-2020; Cortese, Bernardo/M-4374-2016; Ferrante, Giuseppe/AAN-7122-2020; Romagnoli, Enrico/M-7725-2017; Leonardi, Sergio/AAK-1490-2020; Lupi, Alessandro/AAH-8299-2020; Valgimigli, Marco/AAE-9103-2019; Andò, Giuseppe/E-6368-2015; Calabro, Paolo/AAC-2704-2022; De+Servi, Stefano/AAT-2631-2021; VARBELLA, FERDINANDO/AAA-9428-2019; Juni, Peter/Q-8700-2016; limbruno, ugo/GPG-3729-2022; GUIDUCCI, VINCENZO/AAL-5995-2021; Santarelli, Andrea/AAW-9703-2021; Limbruno, Ugo/ACC-3935-2022; Brugaletta, Salvatore/AAJ-2090-2020; ESPOSITO, Giovanni/F-2880-2010	BOCCUZZI, GIACOMO/0000-0003-4220-758X; Rigattieri, Stefano/0000-0001-5116-2737; Cortese, Bernardo/0000-0002-5808-7810; Ferrante, Giuseppe/0000-0001-9175-1464; Romagnoli, Enrico/0000-0003-1611-7708; Leonardi, Sergio/0000-0002-4800-6132; Lupi, Alessandro/0000-0003-3644-0449; Valgimigli, Marco/0000-0002-4353-7110; Andò, Giuseppe/0000-0001-5552-6382; VARBELLA, FERDINANDO/0000-0002-8213-359X; Juni, Peter/0000-0002-5985-0670; limbruno, ugo/0000-0002-1538-2967; GUIDUCCI, VINCENZO/0000-0002-0833-2785; Zingarelli, Antonio/0000-0002-8240-2622; ESPOSITO, Giovanni/0000-0003-0565-7127; Campo, Gianluca/0000-0002-5150-188X; Rothenbuhler, Martina/0000-0001-8009-4104; Casu, Gavino/0000-0001-9923-9473; Mangiacapra, Fabio/0000-0002-3505-0716; Heg, Dik/0000-0002-8766-7945; van 't Hof, Arnoud/0000-0002-2344-7564; Sabate Tenas, Manel/0000-0002-2316-3705; Saia, Francesco/0000-0001-9969-2649; Santarelli, Andrea/0000-0001-7575-6118	Italian Society of Invasive Cardiology; Medicines Company; Terumo; Canada Research Chairs Programme	Italian Society of Invasive Cardiology; Medicines Company; Terumo; Canada Research Chairs Programme(Canada Research Chairs)	Italian Society of Invasive Cardiology, The Medicines Company, Terumo, amd Canada Research Chairs Programme.	Amin AP, 2017, JACC-CARDIOVASC INTE, V10, P342, DOI 10.1016/j.jcin.2016.11.049; Angiolillo DJ, 2018, J AM COLL CARDIOL, V71, P1243, DOI 10.1016/j.jacc.2018.01.040; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Erlinge D, 2017, NEW ENGL J MED, V377, P1132, DOI 10.1056/NEJMoa1706443; Ferrante G, 2016, JACC-CARDIOVASC INTE, V9, P1419, DOI 10.1016/j.jcin.2016.04.014; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Jolly SS, 2014, J AM COLL CARDIOL, V63, P954, DOI 10.1016/j.jacc.2013.10.052; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Navarese EP, 2015, JACC-CARDIOVASC INTE, V8, P201, DOI 10.1016/j.jcin.2014.10.003; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Shahzad A, 2014, LANCET, V384, P1849, DOI 10.1016/S0140-6736(14)60924-7; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096; Stone GW, 2011, LANCET, V377, P2193, DOI 10.1016/S0140-6736(11)60764-2; Valgimigli M, 2015, NEW ENGL J MED, V373, P997, DOI 10.1056/NEJMoa1507854; Valgimigli M, 2015, LANCET, V385, P2465, DOI 10.1016/S0140-6736(15)60292-6; Valgimigli M, 2014, AM HEART J, V168, P838, DOI 10.1016/j.ahj.2014.08.013	16	151	152	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2018	392	10150					835	848		10.1016/S0140-6736(18)31714-8	http://dx.doi.org/10.1016/S0140-6736(18)31714-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT0KV	30153988				2022-12-28	WOS:000444130000029
J	Cornwall, W				Cornwall, Warren			SHOULD IT BE SAVED?	SCIENCE			English	Editorial Material									[Cornwall, Warren] Canadas Lake Revelstoke Valley, Vancouver, BC, Canada		Cornwall, W (corresponding author), Canadas Lake Revelstoke Valley, Vancouver, BC, Canada.								0	8	8	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					962	965		10.1126/science.361.6406.962	http://dx.doi.org/10.1126/science.361.6406.962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS7OT	30190387				2022-12-28	WOS:000443892700015
J	Minchin, M; Roland, M; Richardson, J; Rowark, S; Guthrie, B				Minchin, Mark; Roland, Martin; Richardson, Judith; Rowark, Shaun; Guthrie, Bruce			Quality of Care in the United Kingdom after Removal of Financial Incentives	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAY-FOR-PERFORMANCE; HEALTH-CARE	BACKGROUND The benefits of pay-for-performance schemes in improving the quality of care remain uncertain. There is little information on the effect of removing incentives from existing pay-for-performance schemes. METHODS We conducted interrupted time-series analyses of electronic medical record (EMR) data from 2010 to 2017 for 12 quality-of-care indicators in the United Kingdom's Quality and Outcomes Framework for which financial incentives were removed in 2014 and 6 indicators for which incentives were maintained. We estimated the effects of removing incentives on changes in performance on quality-of-care measures. RESULTS Complete longitudinal data were available for 2819 English primary care practices with more than 20 million registered patients. There were immediate reductions in documented quality of care for all 12 indicators in the first year after the removal of financial incentives. Reductions were greatest for indicators related to health advice, with a reduction of 62.3 percentage points (95% confidence interval [CI], -65.6 to -59.0) in EMR documentation of lifestyle counseling for patients with hypertension. Changes were smaller for indicators involving clinical actions that automatically update the EMR, such as laboratory testing, with a reduction of 10.7 percentage points (95% CI, -13.6 to -7.8) in control of cholesterol in patients with coronary heart disease and 12.1 percentage points (95% CI, -13.6 to -10.6) for thyroid-function testing in patients with hypothyroidism. There was little change in performance on the 6 quality measures for which incentives were maintained. CONCLUSIONS Removal of financial incentives was associated with an immediate decline in performance on quality measures. In part, the decline probably reflected changes in EMR documentation, but declines on measures involving laboratory testing suggest that incentive removal also changed the care delivered.	[Minchin, Mark; Richardson, Judith; Rowark, Shaun] Natl Inst Hlth & Care Excellence NICE, Manchester, Lancs, England; [Roland, Martin] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Guthrie, Bruce] Univ Dundee, Populat Hlth & Genom Div, Mackenzie Bldg,Kirsty Semple Way, Dundee DD2 4BF, Scotland	National Institute for Health & Care Excellence; University of Cambridge; University of Dundee	Guthrie, B (corresponding author), Univ Dundee, Populat Hlth & Genom Div, Mackenzie Bldg,Kirsty Semple Way, Dundee DD2 4BF, Scotland.	b.guthrie@dundee.ac.uk	Guthrie, Bruce/HHM-9696-2022	Guthrie, Bruce/0000-0003-4191-4880; Roland, Martin/0000-0002-8533-3060; Minchin, Mark/0000-0002-2778-6627				[Anonymous], 2017, INT TIM SER ITS AN; Arrowsmith ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092205; Benzer JK, 2014, J GEN INTERN MED, V29, P127, DOI 10.1007/s11606-013-2572-4; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Cashin C, 2014, PAYING PERFORMANCE H; Department for Communities and Local Government, 2015, ENGL IND DEPR 2015; Dewhurst A, 2017, PATIENT EDUC COUNS, V100, P897, DOI 10.1016/j.pec.2016.12.017; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Dreischulte T, 2016, NEW ENGL J MED, V374, P1053, DOI 10.1056/NEJMsa1508955; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Eijkenaar F, 2012, MED CARE RES REV, V69, P251, DOI 10.1177/1077558711432891; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Guthrie B, 2005, WHAT CHANGES INCENTI; Guthrie B, 2016, WHAT DID WE LEARN 12; Hocking JS, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0489-0; KONTOPANTELIS E, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G330; Kristensen SR, 2014, NEW ENGL J MED, V371, P540, DOI 10.1056/NEJMoa1400962; Lester H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1898; Mendelson A, 2017, ANN INTERN MED, V166, P341, DOI 10.7326/M16-1881; Petersen LA, 2013, JAMA-J AM MED ASSOC, V310, P1042, DOI 10.1001/jama.2013.276303; Reeves D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1717; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Roland M, 2016, BMJ-BRIT MED J, V352, pi942, DOI [10.1136/bmj.i942.26887896, DOI 10.1136/BMJ.I942.26887896]; Roland M, 2015, HEALTH SERV RES, V50, P2090, DOI 10.1111/1475-6773.12419; Scott A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD008451.PUB2	27	56	57	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2018	379	10					948	957		10.1056/NEJMsa1801495	http://dx.doi.org/10.1056/NEJMsa1801495			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5XM	30184445	Green Published, Bronze			2022-12-28	WOS:000443748200009
J	Vinding, RK; Stokholm, J; Sevelsted, A; Sejersen, T; Chawes, BL; Bonnelykke, K; Thorsen, J; Howe, LD; Krakauer, M; Bisgaard, H				Vinding, Rebecca Kofod; Stokholm, Jakob; Sevelsted, Astrid; Sejersen, Tobias; Chawes, Bo L.; Bonnelykke, Klaus; Thorsen, Jonathan; Howe, Laura D.; Krakauer, Martin; Bisgaard, Hans			Effect of fish oil supplementation in pregnancy on bone, lean, and fat mass at six years: randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DHA SUPPLEMENTATION; AND/OR LACTATION; MATERNAL FISH; ACID INTAKE; FOLLOW-UP; BIRTH; GROWTH; INFANT; HEALTH; ADIPOSITY	OBJECTIVE To examine the effect of supplementation with n-3 long chain polyunsaturated fatty acids (n-3 LCPUFA) in pregnancy on anthropometry and body composition in offspring. DESIGN Double blinded, randomised controlled trial. SETTING Copenhagen Prospective Studies on Asthma in Childhood(2010) cohort. PARTICIPANTS 736 pregnant women and their offspring. INTERVENTION n-3 LCPUFA (fish oil) or control (olive oil) daily from pregnancy week 24 until one week after birth. MAIN OUTCOME MEASURES Height/length, weight, head, and waist measurements and body composition from dual energy x ray absorptiometry (all pre-specified secondary endpoints of the n-3 LCPUFA trial; the primary outcome for the trial was persistent wheeze/asthma). RESULTS The mean body mass index (BMI) z score was increased between age 0 and 6 years in the fish oil supplementation group compared with the control group (0.14 (95% confidence interval 0.04 to 0.23); P=0.006). At 6 years, supplementation was associated with a higher BMI z score (0.19 (0.06 to 0.32); P=0.004), a higher weight/height (3.48 (0.38 to 6.57) g/cm; P=0.03), and a larger waist circumference (0.6 (0.0 to 1.2) cm; P=0.04) but not a higher proportion of obese children, using International Obesity Task Force grades. The dual energy x ray absorptiometry scan at age 6 years showed a higher total mass (395.4 (86.6 to 704.3) g; P=0.01) in the supplementation versus the control group, explained by a higher lean mass (280.7 (98.9 to 462.4) g; P=0.002), a higher bone mineral content (10.3 (2.3 to 18.1) g; P=0.01), and a non-significantly higher fat mass (116.3 (-92.9 to 325.5) g; P=0.28), but no differences were seen in total body fat or lean mass percentage. CONCLUSION Fish oil supplementation from the 24th week of pregnancy led to a higher BMI in the offspring from 0 to 6 years of age but not an increased risk of obesity at age 6. The body composition at age 6 years in children given fish oil supplementation was characterised by a proportional increase in lean, bone, and fat mass suggesting a general growth stimulating effect of n-3 LCPUFA.	[Vinding, Rebecca Kofod; Stokholm, Jakob; Sevelsted, Astrid; Sejersen, Tobias; Chawes, Bo L.; Bonnelykke, Klaus; Thorsen, Jonathan; Bisgaard, Hans] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood, COPSAC, Copenhagen, Denmark; [Vinding, Rebecca Kofod; Sejersen, Tobias] Naestved Hosp, Dept Pediat, Naestved, Denmark; [Howe, Laura D.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Krakauer, Martin] Univ Copenhagen Hosp, Herlev & Gentofte Hosp, Dept Clin Physiol & Nucl Med, Copenhagen, Denmark	University of Copenhagen; Naestved Hospital; University of Bristol; University of Copenhagen	Bisgaard, H (corresponding author), Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood, COPSAC, Copenhagen, Denmark.	bisgaard@copsac.com	Krakauer, Martin/M-4657-2019; Thorsen, Jonathan/AAQ-9269-2021; Bisgaard, Hans/N-4761-2016	Krakauer, Martin/0000-0002-2191-1861; Thorsen, Jonathan/0000-0003-0200-0461; Bonnelykke, Klaus/0000-0003-2003-1018; Howe, Laura/0000-0003-3357-2796; Bisgaard, Hans/0000-0003-4131-7592; Stokholm, Jakob/0000-0003-4989-9769	Lundbeck Foundation [R16-A1694]; Ministry of Health [903516]; Danish Council for Strategic Research [0603-00280B]; Capital Region Research Foundation; UK Medical Research Council career development award [MR/M020894/1]; UK Medical Research Council; University of Bristol [MC_UU_12013/5]; MRC [MR/M020894/1] Funding Source: UKRI	Lundbeck Foundation(Lundbeckfonden); Ministry of Health; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Capital Region Research Foundation; UK Medical Research Council career development award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All funding received by COPSAC is listed on www.copsac.com. The Lundbeck Foundation (grant no R16-A1694), the Ministry of Health (grant no 903516), the Danish Council for Strategic Research (grant no 0603-00280B), and the Capital Region Research Foundation have provided core support to the COPSAC research centre. LDH is funded by a UK Medical Research Council career development award (MR/M020894/1) and works in a unit funded by the UK Medical Research Council and the University of Bristol (MC_UU_12013/5). The funding agencies did not have any role in the design and conduct of the trial; the collection, management, and interpretation of the data; or the preparation, review, or approval of the manuscript. No pharmaceutical company was involved in the trial.	Ailhaud G, 2006, PROG LIPID RES, V45, P203, DOI 10.1016/j.plipres.2006.01.003; Bergmann RL, 2012, J PERINAT MED, V40, P677, DOI 10.1515/jpm-2012-0080; Bisgaard H, 2013, CLIN EXP ALLERGY, V43, P1384, DOI 10.1111/cea.12213; Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BONJOUR JP, 1994, OSTEOPOROSIS INT, V4, P7; Carlson SE, 2013, AM J CLIN NUTR, V97, P808, DOI 10.3945/ajcn.112.050021; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Delgado-Noguera MF, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007901.pub3; Gordon CM, 2014, J CLIN DENSITOM, V17, P219, DOI 10.1016/j.jocd.2014.01.007; Helland IB, 2008, PEDIATRICS, V122, pE472, DOI 10.1542/peds.2007-2762; Imhoff-Kunsch B, 2012, PAEDIATR PERINAT EP, V26, P91, DOI 10.1111/j.1365-3016.2012.01292.x; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Lauritzen L, 2005, PEDIATR RES, V58, P235, DOI 10.1203/01.PDR.0000169978.92437.58; Lauritzen L, 2016, BRIT J NUTR, V116, P2082, DOI 10.1017/S0007114516004293; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Much D, 2013, PEDIATR RES, V74, P230, DOI 10.1038/pr.2013.82; Muhlhausler BS, 2011, PROSTAG LEUKOTR ESS, V85, P83, DOI 10.1016/j.plefa.2011.04.027; Muhlhausler BS, 2016, AM J CLIN NUTR, V103, P1489, DOI 10.3945/ajcn.115.126714; OLSEN SF, 1992, LANCET, V339, P1003, DOI 10.1016/0140-6736(92)90533-9; OLSEN SF, 1993, J EPIDEMIOL COMMUN H, V47, P436, DOI 10.1136/jech.47.6.436; Ong KK, 2006, HORM RES, V65, P65, DOI 10.1159/000091508; Rytter D, 2011, AM J CLIN NUTR, V94, P701, DOI 10.3945/ajcn.111.014969; Steer Colin D, 2012, Hum Mol Genet, V21, P1504, DOI 10.1093/hmg/ddr588; Stratakis N, 2014, EUR J CLIN NUTR, V68, P1277, DOI 10.1038/ejcn.2014.158; Tinggaard J, 2014, ACTA PAEDIATR, V103, P214, DOI 10.1111/apa.12468; Voortman T, 2015, PROG LIPID RES, V59, P67, DOI 10.1016/j.plipres.2015.05.001; WHO, 2009, WHO CHILD GROWTH STA	31	21	22	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2018	362								k3312	10.1136/bmj.k3312	http://dx.doi.org/10.1136/bmj.k3312			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4VO	30181143	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000444503800002
J	Mao, S; Vinson, V				Mao, Steve; Vinson, Valda			POWER COUPLE: SCIENCE AND TECHNOLOGY	SCIENCE			English	Editorial Material													Vinson, Valda/GVR-8232-2022						0	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					864	865		10.1126/science.361.6405.864	http://dx.doi.org/10.1126/science.361.6405.864			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS3UB	30166481				2022-12-28	WOS:000443547000025
J	Naiman, S; Cohen, HY				Naiman, Shoshana; Cohen, Haim Y.			Embryonic role for a longevity protein	NATURE			English	Editorial Material							SIRT6		[Naiman, Shoshana; Cohen, Haim Y.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel	Bar Ilan University	Cohen, HY (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	haim.cohen@biu.ac.il	Kornweitz, Haya/L-6469-2018	Kornweitz, Haya/0000-0002-3562-0141; Cohen, Haim Y./0000-0002-6613-8710				Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8; Ferrer CM, 2018, GENE DEV, V32, P373, DOI 10.1101/gad.307330.117; Hirvonen K, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0401-z; Kaluski S, 2017, CELL REP, V18, P3052, DOI 10.1016/j.celrep.2017.03.008; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Peshti V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176371; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Tennen RI, 2011, TRENDS BIOCHEM SCI, V36, P39, DOI 10.1016/j.tibs.2010.07.009; Zuo EW, 2017, CELL RES, V27, P933, DOI 10.1038/cr.2017.81	12	5	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2018	560	7720					558	+		10.1038/d41586-018-05970-9	http://dx.doi.org/10.1038/d41586-018-05970-9			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS0SZ	30143756	Bronze			2022-12-28	WOS:000443218600032
J	Kuehn, B				Kuehn, Bridget			Discussions About Cognitive Decline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					750	750		10.1001/jama.2018.11889	http://dx.doi.org/10.1001/jama.2018.11889			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8HM	30167708				2022-12-28	WOS:000442958800013
J	Marino, ND; Zhang, JY; Borges, AL; Sousa, AA; Leon, LM; Rauch, BJ; Walton, RT; Berry, JD; Joung, JK; Kleinstiver, BP; Bondy-Denomy, J				Marino, Nicole D.; Zhang, Jenny Y.; Borges, Adair L.; Sousa, Alexander A.; Leon, Lina M.; Rauch, Benjamin J.; Walton, Russell T.; Berry, Joel D.; Joung, J. Keith; Kleinstiver, Benjamin P.; Bondy-Denomy, Joseph			Discovery of widespread type I and type V CRISPR-Cas inhibitors	SCIENCE			English	Article							INFECTIOUS BOVINE KERATOCONJUNCTIVITIS; CPF1; MECHANISMS; PROTEINS; SYSTEM; RNA	Bacterial CRISPR-Cas systems protect their host from bacteriophages and other mobile genetic elements. Mobile elements, in turn, encode various anti-CRISPR (Acr) proteins to inhibit the immune function of CRISPR-Cas. To date, Acr proteins have been discovered for type I (subtypes I-D, I-E, and I-F) and type II (II-A and II-C) but not other CRISPR systems. Here, we report the discovery of 12 acr genes, including inhibitors of type V-A and I-C CRISPR systems. AcrVA1 inhibits a broad spectrum of Cas12a (Cpf1) orthologs-including MbCas12a, Mb3Cas12a, AsCas12a, and LbCas12a-when assayed in human cells. The acr genes reported here provide useful biotechnological tools and mark the discovery of acr loci in many bacteria and phages.	[Marino, Nicole D.; Zhang, Jenny Y.; Borges, Adair L.; Leon, Lina M.; Rauch, Benjamin J.; Berry, Joel D.; Bondy-Denomy, Joseph] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Sousa, Alexander A.; Walton, Russell T.; Joung, J. Keith; Kleinstiver, Benjamin P.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Sousa, Alexander A.; Walton, Russell T.; Joung, J. Keith; Kleinstiver, Benjamin P.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Sousa, Alexander A.; Walton, Russell T.; Joung, J. Keith; Kleinstiver, Benjamin P.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Joung, J. Keith; Kleinstiver, Benjamin P.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Bondy-Denomy, Joseph] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA; [Rauch, Benjamin J.] Zymergen, Emeryville, CA 94608 USA; [Berry, Joel D.] Caribou Biosci, Berkeley, CA 94710 USA	University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Bondy-Denomy, J (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Bondy-Denomy, J (corresponding author), Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA.	joseph.bondy-denomy@ucsf.edu	Kleinstiver, Benjamin/K-4498-2014	Kleinstiver, Benjamin/0000-0002-5469-0655; Marino, Nicole/0000-0002-7305-8225; Walton, Russell/0000-0002-0546-474X; Borges, Adair/0000-0002-1477-7908; Zhang, Yujie/0000-0003-1352-8018	University of California; San Francisco Program for Breakthrough in Biomedical Research; Sandler Foundation; National Institutes of Health (NIH) Office of the Director Early Independence Award [DP5-OD021344]; DARPA Safe Genes grant [HR0011-17-2-0043]; Desmond and Ann Heathwood MGH Research Scholar Award; NIH [K99 CA218870, R35 GM118158]; NATIONAL CANCER INSTITUTE [K99CA218870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118158, R01GM127489] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD021344] Funding Source: NIH RePORTER	University of California(University of California System); San Francisco Program for Breakthrough in Biomedical Research; Sandler Foundation; National Institutes of Health (NIH) Office of the Director Early Independence Award; DARPA Safe Genes grant; Desmond and Ann Heathwood MGH Research Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work in the Bondy-Denomy laboratory was supported by the University of California, San Francisco Program for Breakthrough in Biomedical Research, funded in part by the Sandler Foundation, and a National Institutes of Health (NIH) Office of the Director Early Independence Award (DP5-OD021344). Acr discovery efforts were specifically supported by DARPA Safe Genes grant HR0011-17-2-0043. Work in the Joung laboratory was supported by the Desmond and Ann Heathwood MGH Research Scholar Award (to J.K.J.) and the NIH awards K99 CA218870 (B.P.K.) and R35 GM118158 (J.K.J.).	Angelos JA, 2007, INT J SYST EVOL MICR, V57, P789, DOI 10.1099/ijs.0.64333-0; Ariff A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2104-1; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Borges AL, 2017, ANNU REV VIROL, V4, P37, DOI 10.1146/annurev-virology-101416-041616; Dickey AM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0316-2; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Pawluk A, 2018, NAT REV MICROBIOL, V16, P12, DOI 10.1038/nrmicro.2017.120; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; van Belkum A, 2015, MBIO, V6, DOI 10.1128/mBio.01796-15; Watters KE, 2018, SCIENCE, V362, P236, DOI 10.1126/science.aau5138; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	18	129	140	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2018	362	6411			SI		240	242		10.1126/science.aau5174	http://dx.doi.org/10.1126/science.aau5174			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW9RX	30190308	Green Accepted			2022-12-28	WOS:000447337200058
J	Papp, K; Gordon, K; Thaci, D; Morita, A; Gooderham, M; Foley, P; Girgis, IG; Kundu, S; Banerjee, S				Papp, Kim; Gordon, Kenneth; Thaci, Diamant; Morita, Akimichi; Gooderham, Melinda; Foley, Peter; Girgis, Ihab G.; Kundu, Sudeep; Banerjee, Subhashis			Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EFFICACY; SAFETY; THERAPY; PLACEBO; TYK2	BACKGROUND Tyrosine kinase 2 (TYK2) signaling pathways, which mediate cytokine signaling, are implicated in the pathophysiology of psoriasis. Selective inhibitors of TYK2 may be effective in treating psoriasis. METHODS We conducted a phase 2, double-blind trial of a TYK2 inhibitor, BMS-986165, in adults with moderate-to-severe psoriasis, excluding patients with a previous lack of response to agents targeting cytokine signaling through the same tyrosine kinase pathway. Patients were randomly assigned to receive the drug orally at a dose of 3 mg every other day, 3 mg daily, 3 mg twice daily, 6 mg twice daily, or 12 mg daily or to receive placebo. The primary end point was a 75% or greater reduction from baseline in the Psoriasis Area and Severity Index (PASI) score at week 12 (higher scores indicate greater severity of psoriasis). RESULTS A total of 267 patients received at least one dose in an intervention group of the trial. At week 12, the percentage of patients with a 75% or greater reduction in the PASI score was 7% (3 of 45 patients) with placebo, 9% (4 of 44 patients) with 3 mg of BMS-986165 every other day (P = 0.49 vs. placebo), 39% (17 of 44 patients) with 3 mg daily (P<0.001 vs. placebo), 69% (31 of 45 patients) with 3 mg twice daily (P<0.001 vs. placebo), 67% (30 of 45 patients) with 6 mg twice daily (P<0.001 vs. placebo), and 75% (33 of 44 patients) with 12 mg daily (P<0.001 vs. placebo). There were three serious adverse events in patients receiving the active drug, as well as one case of malignant melanoma 96 days after the start of treatment. CONCLUSIONS Selective inhibition of TYK2 with the oral agent BMS-986165 at doses of 3 mg daily and higher resulted in greater clearing of psoriasis than did placebo over a period of 12 weeks. Larger and longer-duration trials of this drug are required to determine its safety and durability of effect in patients with psoriasis.	[Papp, Kim] Clin Res & Prob Med Res, Waterloo, ON, Canada; [Gooderham, Melinda] SKiN Ctr Dermatol & Prob Med Res, Peterborough, ON, Canada; [Gooderham, Melinda] Queens Univ, Kingston, ON, Canada; [Gordon, Kenneth] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Thaci, Diamant] Univ Lubeck, Lubeck, Germany; [Morita, Akimichi] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Foley, Peter] Univ Melbourne, St Vincents Hosp Melbourne, Skin & Canc Fdn, Melbourne, Vic, Australia; [Foley, Peter] Prob Med Res, Melbourne, Vic, Australia; [Girgis, Ihab G.; Kundu, Sudeep; Banerjee, Subhashis] Bristol Myers Squibb, Princeton, NJ USA	Queens University - Canada; Medical College of Wisconsin; University of Lubeck; Nagoya City University; SKIN & CANCER FOUNDATION AUSTRALIA; St Vincent's Hospital Melbourne; University of Melbourne; Bristol-Myers Squibb	Papp, K (corresponding author), Clin Res & Prob Med Res, Waterloo, ON, Canada.; Papp, K (corresponding author), Prob Med Res, 139 Union St East, Waterloo, ON N2J 1C4, Canada.	kapapp@probitymedical.com	Thaci, Diamant/AAE-7310-2022	Thaci, Diamant/0000-0001-8513-550X	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Funded by Bristol-Myers Squibb; ClinicalTrials.gov number, NCT02931838.	AbbVie, 2017, HUM PRESCR INF; Catlett I, 2017, ANN RHEUM DIS, V76, P859, DOI 10.1136/annrheumdis-2017-eular.3809; Celgene, 2017, OT PRESCR INF; Dendrou CA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1974; Dogra S, 2013, J EUR ACAD DERMATOL, V27, pe305, DOI 10.1111/j.1468-3083.2012.04644.x; Drugs. com, 2016, RHEUM PRESCR INF; Dubertret L, 2006, BRIT J DERMATOL, V155, P729, DOI 10.1111/j.1365-2133.2006.07405.x; Eli Lilly, 2018, OL PRESCR INF; Eli Lilly, 2018, TALTZ PRESCR INF; Feldman SR, 2005, ANN RHEUM DIS, V64, P65, DOI 10.1136/ard.2004.031237; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; GILLOOLY K, 2016, ARTHRITIS RHEUMA S10, V68; Harden JL, 2015, J AUTOIMMUN, V64, P66, DOI 10.1016/j.jaut.2015.07.008; Helmick CG, 2014, AM J PREV MED, V47, P37, DOI 10.1016/j.amepre.2014.02.012; Ho VC, 1999, BRIT J DERMATOL, V141, P283; Jani M, 2014, ANN RHEUM DIS, V73, P1750, DOI 10.1136/annrheumdis-2014-205440; Janssen, 2017, REM PRESCR INF; Janssen, 2017, STEL PRESCR INF; Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001; Mahil SK, 2016, SEMIN IMMUNOPATHOL, V38, P11, DOI 10.1007/s00281-015-0539-8; Majoros A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00029; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Novartis, 2018, COS PRESCR INF; Novartis, 2009, NEOR PRESCR INF; Papp KA, 2012, BRIT J DERMATOL, V167, P668, DOI 10.1111/j.1365-2133.2012.11168.x; Pfizer, 2017, XELJ PRESCR INF; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; Sbidian E, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011535.pub2; Shaw MH, 2003, P NATL ACAD SCI USA, V100, P11594, DOI 10.1073/pnas.1930781100; Singh S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181039; Thomas CL, 2007, BRIT J DERMATOL, V157, P1080, DOI 10.1111/j.1365-2133.2007.08183.x; Tokarski JS, 2015, J BIOL CHEM, V290, P11061, DOI 10.1074/jbc.M114.619502; Tucci M, 2008, CLIN EXP IMMUNOL, V154, P247, DOI 10.1111/j.1365-2249.2008.03758.x; Valeant Pharmaceuticals North America, 2017, SIL PRESCR INF; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737	36	184	195	3	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2018	379	14					1313	1321		10.1056/NEJMoa1806382	http://dx.doi.org/10.1056/NEJMoa1806382			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV6QX	30205746	Bronze			2022-12-28	WOS:000446240100006
J	Ooms, G; Ottersen, T; Jahn, A; Agyepong, IA				Ooms, Gorik; Ottersen, Trygve; Jahn, Albrecht; Agyepong, Irene Akua			Addressing the fragmentation of global health: the Lancet Commission on synergies between universal health coverage, health security, and health promotion	LANCET			English	Editorial Material									[Ooms, Gorik] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England; [Ottersen, Trygve] Norwegian Inst Publ Hlth, Div Hlth Serv, Oslo, Norway; [Ottersen, Trygve] Univ Oslo, Dept Community Med & Global Hlth, Oslo, Norway; [Ottersen, Trygve] Univ Oslo, Ctr Global Hlth, Oslo, Norway; [Jahn, Albrecht] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany; [Agyepong, Irene Akua] Dodowa Hlth Res Ctr, Ghana Hlth Serv, Div Res & Dev, Dodowa, Ghana; [Agyepong, Irene Akua] Ghana Coll Phys & Surg, Publ Hlth Fac, Accra, Ghana	University of London; London School of Hygiene & Tropical Medicine; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo; Ruprecht Karls University Heidelberg; Ghana Health Service	Ooms, G (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England.	gorik.ooms@lshtm.ac.uk	Ooms, Gorik/A-2537-2015	Ooms, Gorik/0000-0002-9804-0128	German Federal Ministry for Economic Cooperation and Development; Norwegian Agency for Development Cooperation; Swiss Agency for Development and Cooperation; Wellcome Trust	German Federal Ministry for Economic Cooperation and Development; Norwegian Agency for Development Cooperation; Swiss Agency for Development and Cooperation; Wellcome Trust(Wellcome TrustEuropean Commission)	The Lancet Commission on synergies between universal health coverage, health security, and health promotion is supported by the German Federal Ministry for Economic Cooperation and Development (implemented by the Gesellschaft fur Internationale Zusammenarbeit), the Norwegian Agency for Development Cooperation, the Swiss Agency for Development and Cooperation, and the Wellcome Trust. The funders were not involved in writing this Comment.	Macfarlane SB, 2008, J PUBLIC HEALTH POL, V29, P383, DOI 10.1057/jphp.2008.25; Mills A, 2005, B WORLD HEALTH ORGAN, V83, P315; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; World Health Organization, 2018, 13 GEN PROGR WORK 20	4	17	17	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2018	392	10153					1098	1099		10.1016/S0140-6736(18)32072-5	http://dx.doi.org/10.1016/S0140-6736(18)32072-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV3BV	30201272	Green Submitted			2022-12-28	WOS:000445968800010
J	Fernandez, DC; Fogerson, PM; Ospri, LL; Thomsen, MB; Layne, RM; Severin, D; Zhan, J; Singer, JH; Kirkwood, A; Zhao, HQ; Berson, DM; Hattar, S				Fernandez, Diego Carlos; Fogerson, P. Michelle; Ospri, Lorenzo Lazzerini; Thomsen, Michael B.; Layne, Robert M.; Severin, Daniel; Zhan, Jesse; Singer, Joshua H.; Kirkwood, Alfredo; Zhao, Haiqing; Berson, David M.; Hattar, Samer			Light Affects Mood and Learning through Distinct Retina-Brain Pathways	CELL			English	Article							GANGLION-CELLS; MELANOPSIN; PROJECTIONS; EXPRESSION; NEURONS; MICE; TRANSCRIPTION; ARCHITECTURE; DEPRESSION; RHYTHM	Light exerts a range of powerful biological effects beyond image vision, including mood and learning regulation. While the source of photic information affecting mood and cognitive functions is well established, viz. intrinsically photosensitive retinal ganglion cells (ipRGCs), the central mediators are unknown. Here, we reveal that the direct effects of light on learning and mood utilize distinct ipRGC output streams. ipRGCs that project to the suprachiasmatic nucleus (SCN) mediate the effects of light on learning, independently of the SCN's pacemaker function. Mood regulation by light, on the other hand, requires an SCN-independent pathway linking ipRGCs to a previously unrecognized thalamic region, termed perihabenular nucleus (PHb). The PHb is integrated in a distinctive circuitry with mood-regulating centers and is both necessary and sufficient for driving the effects of light on affective behavior. Together, these results provide new in-sights into the neural basis required for light to influence mood and learning.	[Fernandez, Diego Carlos; Thomsen, Michael B.; Zhan, Jesse; Zhao, Haiqing; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Fogerson, P. Michelle; Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Ospri, Lorenzo Lazzerini; Severin, Daniel; Kirkwood, Alfredo] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; [Layne, Robert M.; Singer, Joshua H.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Fernandez, Diego Carlos; Thomsen, Michael B.; Hattar, Samer] NIMH, SLCR, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Brown University; Johns Hopkins University; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Fernandez, DC; Hattar, S (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.; Fernandez, DC; Hattar, S (corresponding author), NIMH, SLCR, NIH, Bethesda, MD 20892 USA.	diego.fernandez@nih.gov; samer.hattar@nih.gov	Hattar, Samer/W-6927-2019; Core, Vector/CAF-4832-2022	Lazzerini Ospri, Lorenzo/0000-0001-9744-5820; Fernandez, Diego Carlos/0000-0002-4363-1318	Johns Hopkins Biology Mouse Tri-Lab; NIH [GM076430, EY027202, EY012793, EY017137]; PEW Charitable Trusts; NSF [I2011104359]; National Institute of Mental Health; NATIONAL EYE INSTITUTE [R01EY012793, R01EY017137, R01EY027202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231, R01GM076430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002964] Funding Source: NIH RePORTER	Johns Hopkins Biology Mouse Tri-Lab; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PEW Charitable Trusts; NSF(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank the Johns Hopkins Biology Mouse Tri-Lab-especially Dr. Rejji Kuruvilla-for support and discussion; the Department of Biology at the University of Maryland and Dianne and Kimberly Boghossian for assistance maintaining and genotyping mice; Dr. Antonello Bonci, Dr. Yeka Aponte, and their lab members for help addressing reviewers' concerns; and Elaine Nguyen for help with tracer injections. We would like to thank Mio Akasako for her key assistance with the retrolabeling experiments. This work was supported by the NIH (GM076430, EY027202, EY012793, and EY017137), the generous contributions of the Alcon Research Institute (to D.M.B.), PEW Charitable Trusts (to D.C.F.), the NSF (I2011104359 to P.M.F.), and the intramural research at the National Institute of Mental Health.	Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bedrosian TA, 2011, PSYCHONEUROENDOCRINO, V36, P1062, DOI 10.1016/j.psyneuen.2011.01.004; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chawla S, 2002, EUR J PHARMACOL, V447, P131, DOI 10.1016/S0014-2999(02)01837-X; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Choi SH, 2013, KOREAN J PHYSIOL PHA, V17, P321, DOI 10.4196/kjpp.2013.17.4.321; Coogan AN, 2003, J NEUROSCI, V23, P3085; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernandez DC, 2016, P NATL ACAD SCI USA, V113, P6047, DOI 10.1073/pnas.1523629113; Fernandez F, 2014, SCIENCE, V346, P854, DOI 10.1126/science.1259652; Francis TC, 2017, BIOL PSYCHIAT, V81, P645, DOI 10.1016/j.biopsych.2016.09.007; Frodl T, 2009, WORLD J BIOL PSYCHIA, V10, P202, DOI 10.1080/15622970701624603; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hammar A, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.026.2009; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hillhouse TM, 2015, EXP CLIN PSYCHOPHARM, V23, P1, DOI 10.1037/a0038550; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YH, 2004, NEUROSCI LETT, V363, P280, DOI 10.1016/j.neulet.2004.04.011; Izumo M, 2014, ELIFE, V3, DOI 10.7554/eLife.04617; Jaeger J, 2006, PSYCHIAT RES, V145, P39, DOI 10.1016/j.psychres.2005.11.011; Kako K, 1998, NEUROSCI RES, V31, P257, DOI 10.1016/S0168-0102(98)00054-6; Kerestes R, 2014, NEUROIMAGE-CLIN, V4, P209, DOI 10.1016/j.nicl.2013.11.009; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Kim Y, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00003; Kurlansik SL, 2012, AM FAM PHYSICIAN, V86, P1037; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; LeGates TA, 2012, NATURE, V491, P594, DOI 10.1038/nature11673; Melrose Sherri, 2015, Depress Res Treat, V2015, P178564, DOI 10.1155/2015/178564; Meng C, 2014, BRAIN, V137, P598, DOI 10.1093/brain/awt290; Morin LP, 2014, J COMP NEUROL, V522, P3733, DOI 10.1002/cne.23635; Morin LP, 2013, EXP NEUROL, V243, P4, DOI 10.1016/j.expneurol.2012.06.026; Nagalski A, 2016, BRAIN STRUCT FUNCT, V221, P2493, DOI 10.1007/s00429-015-1052-5; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Ospri LL, 2017, ANNU REV NEUROSCI, V40, P539, DOI 10.1146/annurev-neuro-072116-031324; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Roh SC, 2016, J AFFECT DISORDERS, V204, P124, DOI 10.1016/j.jad.2016.06.033; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Schwarz LA, 2015, NATURE, V524, P88, DOI 10.1038/nature14600; Scott, 1997, Int J Occup Environ Health, V3, pS2; Shen XY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05507-6; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Shrestha P, 2015, ELIFE, V4, DOI 10.7554/eLife.08752; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Venzala E, 2012, PSYCHOPHARMACOLOGY, V224, P313, DOI 10.1007/s00213-012-2754-5; Vertes RP, 2015, NEUROSCI BIOBEHAV R, V54, P89, DOI 10.1016/j.neubiorev.2015.01.014; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wagner F, 2017, PHARMACOL BIOCHEM BE, V162, P38, DOI 10.1016/j.pbb.2017.07.008; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wilsbacher LD, 2002, P NATL ACAD SCI USA, V99, P489, DOI 10.1073/pnas.012248599; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027	63	186	192	8	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	2018	175	1					71	+	84.e1	10.1016/j.cell.2018.08.004	http://dx.doi.org/10.1016/j.cell.2018.08.004			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	GU2SI	30173913	Bronze, Green Accepted			2022-12-28	WOS:000445120000015
J	Oikonomou, EK; Marwan, M; Desai, MY; Mancio, J; Alashi, A; Centeno, EH; Thomas, S; Herdman, L; Kotanidis, CP; Thomas, KE; Griffin, BP; Flamm, SD; Antonopoulos, AS; Shirodaria, C; Sabharwal, N; Deanfield, J; Neubauer, S; Hopewell, JC; Channon, KM; Achenbach, S; Antoniades, C				Oikonomou, Evangelos K.; Marwan, Mohamed; Desai, Milind Y.; Mancio, Jennifer; Alashi, Alaa; Centeno, Erika Hutt; Thomas, Sheena; Herdman, Laura; Kotanidis, Christos P.; Thomas, Katharine E.; Griffin, Brian P.; Flamm, Scott D.; Antonopoulos, Alexios S.; Shirodaria, Cheerag; Sabharwal, Nikant; Deanfield, John; Neubauer, Stefan; Hopewell, Jemma C.; Channon, Keith M.; Achenbach, Stephan; Antoniades, Charalambos			Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome	LANCET			English	Article							AMERICAN-COLLEGE; ARTERY-DISEASE; ADIPOSE-TISSUE; ANGIOGRAPHY; PLAQUE; ATHEROSCLEROSIS; RADIOLOGY	Background Coronary artery inflammation inhibits adipogenesis in adjacent perivascular fat. A novel imaging biomarker the perivascular fat attenuation index (FAI) captures coronary inflammation by mapping spatial changes of perivascular fat attenuation on coronary computed tomography angiography (CTA). However, the ability of the perivascular FAI to predict clinical outcomes is unknown. Methods In the Cardiovascular RISk Prediction using Computed Tomography (CRISP-CT) study, we did a post-hoc analysis of outcome data gathered prospectively from two independent cohorts of consecutive patients undergoing coronary CTA in Erlangen, Germany (derivation cohort) and Cleveland, OH, USA (validation cohort). Perivascular fat attenuation mapping was done around the three major coronary arteries the proximal right coronary artery, the left anterior descending artery, and the left circumflex artery. We assessed the prognostic value of perivascular fat attenuation mapping for all-cause and cardiac mortality in Cox regression models, adjusted for age, sex, cardiovascular risk factors, tube voltage, modified Duke coronary artery disease index, and number of coronary CTA-derived high risk plaque features. Findings Between 2005 and 2009, 1872 participants in the derivation cohort underwent coronary CTA (median age 62 years [range 17-89]). Between 2008 and 2016, 2040 patients in the validation cohort had coronary CTA (median age 53 years [range 19-87]). Median follow-up was 72 months (range 51-109) in the derivation cohort and 54 months (range 4-105) in the validation cohort. In both cohorts, high perivascular FAI values around the proximal right coronary artery and left anterior descending artery (but not around the left circumflex artery) were predictive of all-cause and cardiac mortality and correlated strongly with each other. Therefore, the perivascular FAI measured around the right coronary artery was used as a representative biomarker of global coronary inflammation (for prediction of cardiac mortality, hazard ratio [HR] 2.15, 95% CI 1.33-3.48; p=0.0017 in the derivation cohort, and 2.06, 1.50-2.83; p<0.0001 in the validation cohort). The optimum cutoff for the perivascular FAI, above which there is a steep increase in cardiac mortality, was ascertained as -70.1 Hounsfield units (HU) or higher in the derivation cohort (HR 9.04, 95% CI 3.35-24. 40; p<0.0001 for cardiac mortality; 2.55, 1. 65-3.92; p<0.0001 for all-cause mortality). This cutoff was confirmed in the validation cohort (HR 5.62, 95% CI 2. 90-10. 88; p<0.0001 for cardiac mortality; 3.69, 2. 26-6. 02; p<0.0001 for all-cause mortality). Perivascular FAI improved risk discrimination in both cohorts, leading to significant reclassification for all-cause and cardiac mortality. Interpretation The perivascular FAI enhances cardiac risk prediction and restratification over and above current state-of-the-art assessment in coronary CTA by providing a quantitative measure of coronary inflammation. High perivascular FAI values (cutoff >= 70.1 HU) are an indicator of increased cardiac mortality and, therefore, could guide early targeted primary prevention and intensive secondary prevention in patients. Funding British Heart Foundation, and the National Institute of Health Research Oxford Biomedical Research Centre. Copyright (C) 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Oikonomou, Evangelos K.; Mancio, Jennifer; Thomas, Sheena; Herdman, Laura; Kotanidis, Christos P.; Thomas, Katharine E.; Antonopoulos, Alexios S.; Neubauer, Stefan; Channon, Keith M.; Antoniades, Charalambos] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Marwan, Mohamed; Achenbach, Stephan] Friedrich Alexander Univ Erlangen Nurnberg, Dept Cardiol, Erlangen, Germany; [Desai, Milind Y.; Alashi, Alaa; Centeno, Erika Hutt; Griffin, Brian P.; Flamm, Scott D.] Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44106 USA; [Shirodaria, Cheerag; Sabharwal, Nikant] Oxford Univ Hosp NHS Fdn Trust, Cardiol Dept, Oxford, England; [Deanfield, John] UCL, Inst Cardiovasc Sci, London, England; [Neubauer, Stefan; Channon, Keith M.; Antoniades, Charalambos] British Heart Fdn, Oxford Ctr Res Excellence, Oxford, England; [Neubauer, Stefan; Channon, Keith M.; Antoniades, Charalambos] Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford, England; [Hopewell, Jemma C.] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Shirodaria, Cheerag] Caristo Diagnost, Oxford, England	University of Oxford; University of Erlangen Nuremberg; Cleveland Clinic Foundation; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; University of Oxford; University of Oxford	Antoniades, C (corresponding author), Univ Oxford, John Radcliffe Hosp, Div Cardiovasc Med, Oxford OX3 9DU, England.	antoniad@well.ox.ac.uk	Mancio, Jennifer/AAB-6786-2021; Christos P. Kotanidis, MSc/AAK-1788-2020; Flamm, Scott/K-9034-2019; Antonopoulos, Alexios S./I-3504-2019; Evangelos K. Oikonomou, DPhil/N-1847-2019; Silva, Jennifer/HGD-1346-2022	Mancio, Jennifer/0000-0003-0814-6672; Antonopoulos, Alexios S./0000-0001-9137-0143; Evangelos K. Oikonomou, DPhil/0000-0003-4362-0720; channon, keith/0000-0002-1043-4342; Alashi, Alaa/0000-0002-6377-2564; Antoniades, Charalambos/0000-0002-6983-5423; Antonopoulos, Alexios/0000-0002-5151-0444; Neubauer, Stefan/0000-0001-9017-5645; Hutt, Erika/0000-0002-8271-6648; Deanfield, John/0000-0001-8806-6052; Kotanidis, Christos/0000-0002-1494-8340; Hopewell, Jemma/0000-0002-3870-8018	British Heart Foundation [FS/16/15/32047, TG/16/3/32687, CH/16/1/32013, FS/14/55/30806]; National Institute for Health Research Oxford Biomedical Research Centre; State Scholarships Foundation of Greece (Leonidas Nikolaidis scholarship); Haslam family endowed chair in Cardiovascular Medicine; Khouri family; Oxford British Heart Foundation Centre of Research Excellence; EPSRC [2119518] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); State Scholarships Foundation of Greece (Leonidas Nikolaidis scholarship); Haslam family endowed chair in Cardiovascular Medicine; Khouri family; Oxford British Heart Foundation Centre of Research Excellence; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study was funded by the British Heart Foundation (FS/16/15/32047 and TG/16/3/32687 to CA; CH/16/1/32013 to KMC; FS/14/55/30806 to JCH) and the National Institute for Health Research Oxford Biomedical Research Centre. EKO acknowledges support from the State Scholarships Foundation of Greece (Leonidas Nikolaidis scholarship). MYD is a recipient of the Haslam family endowed chair in Cardiovascular Medicine and acknowledges the Khouri family for their support of research in early detection of coronary artery disease. CA, SN, and KMC acknowledge support from the Oxford British Heart Foundation Centre of Research Excellence.	Alexopoulos N, 2013, J AM COLL CARDIOL, V61, P1956, DOI 10.1016/j.jacc.2012.12.051; Antonopoulos AS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2658; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Camici PG, 2012, EUR HEART J, V33, P1309, DOI 10.1093/eurheartj/ehs067; Cury RC, 2016, J CARDIOVASC COMPUT, V10, P269, DOI 10.1016/j.jcct.2016.04.005; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Dreisbach JG, 2018, HEART, V104, P921, DOI 10.1136/heartjnl-2017-311846; Fishbein MC, 1996, CIRCULATION, V94, P2662, DOI 10.1161/01.CIR.94.10.2662; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; Fleg JL, 2012, JACC-CARDIOVASC IMAG, V5, P941, DOI 10.1016/j.jcmg.2012.07.007; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab; Hedgire S, 2018, RADIOLOGY, V287, P808, DOI 10.1148/radiol.2017171568; Hong MK, 2005, J AM COLL CARDIOL, V46, P261, DOI 10.1016/j.jacc.2005.03.067; Joshi NV, 2014, LANCET, V383, P705, DOI 10.1016/S0140-6736(13)61754-7; Knaapen P, 2010, NETH HEART J, V18, P90, DOI 10.1007/BF03091744; Mahabadi AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183514; Marwan M, 2017, J COMPUT ASSIST TOMO, V41, P762, DOI 10.1097/RCT.0000000000000589; Matter CM, 2009, EUR HEART J, V30, P2566, DOI 10.1093/eurheartj/ehp419; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Mulvihill NT, 2002, HEART, V87, P201, DOI 10.1136/heart.87.3.201; Newby D, 2015, LANCET, V385, P2383, DOI 10.1016/S0140-6736(15)60291-4; NICE, 2016, CHEST PAIN REC ONS A; Otero HJ, 2009, RADIOL CLIN N AM, V47, P79, DOI 10.1016/j.rcl.2008.11.001; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Puchner SB, 2014, J AM COLL CARDIOL, V64, P684, DOI 10.1016/j.jacc.2014.05.039; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Sun Z, 2012, BRIT J RADIOL, V85, P495, DOI 10.1259/bjr/15296170; Tarkin JM, 2016, CIRC RES, V118, P750, DOI 10.1161/CIRCRESAHA.115.306247; Taylor AJ, 2010, J CARDIOVASC COMPUT, V4, P407, DOI 10.1016/j.jcct.2010.11.001; Weintraub WS, 2000, EUR HEART J, V21, P958, DOI 10.1053/euhj.2000.2109	35	307	328	12	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 15	2018	392	10151					929	939		10.1016/S0140-6736(18)31114-0	http://dx.doi.org/10.1016/S0140-6736(18)31114-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4LN	30170852	Green Published, hybrid			2022-12-28	WOS:000444475700025
J	Extance, A				Extance, Andy			AI TAMES THE SCIENTIFIC LITERATURE	NATURE			English	Editorial Material																			0	24	24	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2018	561	7722					273	274		10.1038/d41586-018-06617-5	http://dx.doi.org/10.1038/d41586-018-06617-5			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GT3XQ	30202054	Bronze			2022-12-28	WOS:000444437900050
J	Xu, Y; Shi, JH				Xu, Yan; Shi, Juhong			Disseminated Actinomycosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Xu, Yan; Shi, Juhong] Beijing Union Med Coll Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Shi, JH (corresponding author), Beijing Union Med Coll Hosp, Beijing, Peoples R China.	juhong_shi@hotmail.com		, Yan/0000-0002-2832-2664					0	2	2	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2018	379	11					1071	1071		10.1056/NEJMicm1802090	http://dx.doi.org/10.1056/NEJMicm1802090			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT4UV	30207906				2022-12-28	WOS:000444501600011
J	Dyer, C				Dyer, Clare			Doctors' personal reflections should not include case details, says new guidance	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Academy of Medical Royal Colleges, 2018, C POSTGR MED DEANS; DYER C, 2018, BMJ-BRIT MED J, V360, DOI DOI 10.1136/BMJ.K57229437673	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2018	362								k3890	10.1136/bmj.k3890	http://dx.doi.org/10.1136/bmj.k3890			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JJ	30209056				2022-12-28	WOS:000445016500012
J	Wen, SW; White, RR; Rybak, N; Gaudet, LM; Robson, S; Hague, W; Simms-Stewart, D; Carroli, G; Smith, G; Fraser, WD; Wells, G; Davidge, ST; Kingdom, J; Coyle, D; Fergusson, D; Corsi, DJ; Champagne, J; Sabri, E; Ramsay, T; Mol, BJ; Oudijk, MA; Walker, MC				Wen, Shi Wu; White, Ruth Rennicks; Rybak, Natalie; Gaudet, Laura M.; Robson, Stephen; Hague, William; Simms-Stewart, Donnette; Carroli, Guillermo; Smith, Graeme; Fraser, William D.; Wells, George; Davidge, Sandra T.; Kingdom, John; Coyle, Doug; Fergusson, Dean; Corsi, Daniel J.; Champagne, Josee; Sabri, Elham; Ramsay, Tim; Mol, Ben Willem J.; Oudijk, Martijn A.; Walker, Mark C.			Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): double blind, phase III, randomised controlled, international, multicentre trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEURAL-TUBE DEFECTS; HYPERTENSIVE DISORDERS; MULTIVITAMIN SUPPLEMENTATION; PREVENTION; WOMEN; RISK; DIAGNOSIS; COHORT	OBJECTIVE To determine the efficacy of high dose folic acid supplementation for prevention of pre-eclampsia in women with at least one risk factor: pre-existing hypertension, prepregnancy diabetes (type 1 or 2), twin pregnancy, pre-eclampsia in a previous pregnancy, or body mass index >= 35. DESIGN Randomised, phase III, double blinded international, multicentre clinical trial. SETTING 70 obstetrical centres in five countries (Argentina, Australia, Canada, Jamaica, and UK). PARTICIPANTS 2464 pregnant women with at least one high risk factor for pre-eclampsia were randomised between 2011 and 2015 (1144 to the folic acid group and 1157 to the placebo group); 2301 were included in the intention to treat analyses. INTERVENTION Eligible women were randomised to receive either daily high dose folic acid (four 1.0 mg oral tablets) or placebo from eight weeks of gestation to the end of week 16 of gestation until delivery. Clinicians, participants, adjudicators, and study staff were masked to study treatment allocation. MAIN OUTCOME MEASURE The primary outcome was pre-eclampsia, defined as hypertension presenting after 20 weeks' gestation with major proteinuria or HELLP syndrome (haemolysis, elevated liver enzymes, low platelets). RESULTS Pre-eclampsia occurred in 169/1144 (14.8%) women in the folic acid group and 156/1157 (13.5%) in the placebo group (relative risk 1.10, 95% confidence interval 0.90 to 1.34; P=0.37). There was no evidence of differences between the groups for any other adverse maternal or neonatal outcomes. CONCLUSION Supplementation with 4.0 mg/day folic acid beyond the first trimester does not prevent pre-eclampsia in women at high risk for this condition.	[Wen, Shi Wu; White, Ruth Rennicks; Rybak, Natalie; Gaudet, Laura M.; Corsi, Daniel J.; Walker, Mark C.] Ottawa Hosp, Res Inst, OMNI Res Grp, Clin Epidemiol Program, Ottawa, ON, Canada; [Wen, Shi Wu; Gaudet, Laura M.; Wells, George; Coyle, Doug] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Wen, Shi Wu; Gaudet, Laura M.] Univ Ottawa, Dept Obstet Gynecol & Newborn Care, Ottawa, ON, Canada; [Robson, Stephen] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Hague, William; Mol, Ben Willem J.] Univ Adelaide, Robinson Res Inst, Obstet Med, Adelaide, SA, Australia; [Hague, William] Womens & Childrens Hosp, Adelaide, SA, Australia; [Simms-Stewart, Donnette] Univ West Indies, Dept Obstet & Gynaecol, Fac Med Sci, Kingston, Jamaica; [Carroli, Guillermo] CREP, Rosario, Santa Fe, Argentina; [Smith, Graeme] Queens Univ, Dept Obstet & Gynecol, Kingston Gen Hosp, Queens Perinatal Res Unit, Kingston, ON, Canada; [Fraser, William D.] CHU Sherbrooke, Ctr Rech, Mother & Child Axis, Sherbrooke, PQ, Canada; [Fraser, William D.] Univ Sherbrooke, Ctr Rech, Sherbrooke, PQ, Canada; [Fraser, William D.] Univ Sherbrooke, Ctr Rech CHUS, Fac Med & Hlth Sci, Dept Obstet & Gynecol, Sherbrooke, PQ, Canada; [Wells, George] Univ Ottawa, Inst Heart, Cardiovasc Res Methods Ctr, Ottawa, ON, Canada; [Wells, George] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Wells, George; Fergusson, Dean; Champagne, Josee; Sabri, Elham; Ramsay, Tim] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Kingdom, John] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Maternal Fetal Med Div, Toronto, ON, Canada; [Fergusson, Dean; Ramsay, Tim] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Dept Med, Ottawa, ON, Canada; [Mol, Ben Willem J.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia; [Oudijk, Martijn A.] Univ Med Ctr Utrecht, Dept Obstet, Utrecht, Netherlands; [Oudijk, Martijn A.; Walker, Mark C.] Acad Med Ctr, Dept Obstet, Amsterdam, Netherlands	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Newcastle University - UK; Robinson Research Institute; University of Adelaide; Womens & Childrens Hospital Australia; University West Indies Mona Jamaica; Queens University - Canada; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Alberta; University of Alberta; University of Alberta; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Ottawa; Monash University; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Walker, MC (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada.	mwalker@ohri.ca	Smith, Graeme Neil/ABB-6863-2021; Oudijk, Martijn A/C-1520-2019; Corsi, Daniel J/S-4689-2018; Lawrence, Annemarie/I-4180-2013; Sabri, Elham/GXG-8198-2022; Kingdom, John/AAF-2145-2020	Smith, Graeme Neil/0000-0002-3128-4523; Oudijk, Martijn A/0000-0001-8672-4365; Corsi, Daniel J/0000-0001-7063-3354; Lawrence, Annemarie/0000-0002-8736-4741; Fergusson, Dean/0000-0002-3389-2485; Davidge, Sandra/0000-0002-5559-4905; Ramsay, Tim/0000-0001-8478-8170	Ottawa Hospital Research Institute; Canadian Institutes of Health Research [198801, 98030]; FACT	Ottawa Hospital Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); FACT	This study was sponsored by the Ottawa Hospital Research Institute, and funded by the Canadian Institutes of Health Research (grants 198801 and 98030). FACT was conceived, designed, and coordinated independently of the funding source. The funder did not act as sponsor for the trial and had no role in analysis, interpretation of the data, writing of the report, or decision to submit for publication.	Catov JM, 2009, AM J EPIDEMIOL, V169, P1304, DOI 10.1093/aje/kwp052; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Czeizel AE, 2015, EUR J OBSTET GYN R B, V193, P34, DOI 10.1016/j.ejogrb.2015.06.024; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x; Gomes S, 2016, PUBLIC HEALTH NUTR, V19, P176, DOI 10.1017/S1368980015000555; Hashemi M, 2016, J RES MED SCI, V21, DOI 10.4103/1735-1995.193505; Hua XL, 2016, HYPERTENS PREGNANCY, V35, P447, DOI 10.1080/10641955.2016.1183673; Institute of Obstetricians & Gynecologists Royal College of Physicians of Ireland, 2016, CLIN PRACT GUID NUTR; Lassi ZS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006896.pub2; Li ZW, 2013, HYPERTENSION, V61, P873, DOI 10.1161/HYPERTENSIONAHA.111.00230; Liu AZ, 2009, HYPERTENS PREGNANCY, V28, P76, DOI 10.1080/10641950802366252; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Merchant AT, 2005, J NUTR, V135, P1776, DOI 10.1093/jn/135.7.1776; Papadopoulou E, 2013, EUR J NUTR, V52, P327, DOI 10.1007/s00394-012-0339-z; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Saccone G, 2016, J MATERN-FETAL NEO M, V29, P916, DOI 10.3109/14767058.2015.1023189; Sayyah-Melli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154400; Shahraki Azar Danesh, 2016, Adv Biomed Res, V5, P192, DOI 10.4103/2277-9175.190944; TOLAROVA M, 1995, TERATOLOGY, V51, P71, DOI 10.1002/tera.1420510205; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Uzan J, 2011, VASC HEALTH RISK MAN, V7, P467, DOI 10.2147/VHRM.S20181; Vanderlelie J, 2016, MATERN CHILD NUTR, V12, P339, DOI 10.1111/mcn.12133; WALD N, 1991, LANCET, V338, P131; Walker MC, 2011, J OBSTET GYNAECOL CA, V33, P1124, DOI 10.1016/S1701-2163(16)35080-0; Wen SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149818; Wen SW, 2008, CAN MED ASSOC J, V179, P1263, DOI 10.1503/cmaj.080859; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067; Wen SW, 2014, ENCY HUMAN BIOL; Whitfield MF, 1997, ARCH DIS CHILD-FETAL, V77, pF85, DOI 10.1136/fn.77.2.F85; Wilson RD, 2015, J OBSTET GYNAECOL CA, V37, P534, DOI 10.1016/S1701-2163(15)30230-9; Zhang J, 2003, HYPERTENS PREGNANCY, V22, P203, DOI 10.1081/PRG-120021066	32	44	47	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2018	362								k3478	10.1136/bmj.k3478	http://dx.doi.org/10.1136/bmj.k3478			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JJ	30209050	Green Published, hybrid			2022-12-28	WOS:000445016500002
J	O'Gara, B; Talmor, D				O'Gara, Brian; Talmor, Daniel			Perioperative lung protective ventilation	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RESPIRATORY-DISTRESS-SYNDROME; POSTOPERATIVE PULMONARY COMPLICATIONS; END-EXPIRATORY-PRESSURE; VOLUME-CONTROLLED VENTILATION; LOW-TIDAL-VOLUME; RANDOMIZED CLINICAL-TRIAL; MORBIDLY OBESE-PATIENTS; ELECTRICAL-IMPEDANCE TOMOGRAPHY; LAPAROSCOPIC BARIATRIC SURGERY; ALVEOLAR RECRUITMENT STRATEGY	Perioperative lung injury is a major source of postoperative morbidity, excess healthcare use, and avoidable mortality. Many potential inciting factors can lead to this condition, including intraoperative ventilator induced lung injury. Questions exist as to whether protective ventilation strategies used in the intensive care unit for patients with acute respiratory distress syndrome are equally beneficial for surgical patients, most of whom do not present with any pre-existing lung pathology. Studied both individually and in combination as a package of intraoperative lung protective ventilation, the use of low tidal volumes, moderate positive end expiratory pressure, and recruitment maneuvers have been shown to improve oxygenation and pulmonary physiology and to reduce postoperative pulmonary complications in at risk patient groups. Further work is needed to define the potential contributions of alternative ventilator strategies, limiting excessive intraoperative oxygen supplementation, use of non-invasive techniques in the postoperative period, and personalized mechanical ventilation. Although the weight of evidence strongly suggests a role for lung protective ventilation in moderate risk patient groups, definitive evidence of its benefit for the general surgical population does not exist. However, given the shift in understanding of what is needed for adequate oxygenation and ventilation under anesthesia, the largely historical arguments against the use of intraoperative lung protective ventilation may soon be outdated, on the basis of its expanding track record of safety and efficacy in multiple settings.	[O'Gara, Brian; Talmor, Daniel] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	O'Gara, B (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA.	bpogara@bidmc.harvard.edu						Agostini P, 2010, THORAX, V65, P815, DOI 10.1136/thx.2009.123083; Almarakbi WA, 2009, BRIT J ANAESTH, V102, P862, DOI 10.1093/bja/aep084; Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; AVERY ME, 1959, AMA J DIS CHILD, V97, P517, DOI 10.1001/archpedi.1959.02070010519001; Bagchi A, 2017, ANAESTHESIA, V72, P1334, DOI 10.1111/anae.14039; BENDIXEN HH, 1963, NEW ENGL J MED, V269, P991, DOI 10.1056/NEJM196311072691901; BENDIXEN HH, 1964, J APPL PHYSIOL, V19, P195, DOI 10.1152/jappl.1964.19.2.195; Benoit Z, 2002, ANESTH ANALG, V95, P1777, DOI 10.1213/01.ANE.0000019201.72651.6C; Benumof JL, 1999, ANESTHESIOLOGY, V91, P603, DOI 10.1097/00000542-199909000-00006; Blank RS, 2016, ANESTHESIOLOGY, V124, P1286, DOI 10.1097/ALN.0000000000001100; Blum JM, 2011, ANESTHESIOLOGY, V115, P75, DOI 10.1097/ALN.0b013e31821a8d63; Blum JM, 2010, ANESTH ANALG, V110, P1616, DOI 10.1213/ANE.0b013e3181da82e1; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; BRISMAR B, 1985, ANESTHESIOLOGY, V62, P422, DOI 10.1097/00000542-198504000-00009; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bugedo G, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1779-x; Cadi P, 2008, BRIT J ANAESTH, V100, P709, DOI 10.1093/bja/aen067; Cai HW, 2007, J CLIN ANESTH, V19, P125, DOI 10.1016/j.jclinane.2006.08.008; Cakmakkaya OS, 2009, J CLIN ANESTH, V21, P422, DOI 10.1016/j.jclinane.2009.08.001; Canet J, 2010, ANESTHESIOLOGY, V113, P1338, DOI 10.1097/ALN.0b013e3181fc6e0a; Carpagnano GE, 2004, THORAX, V59, P1016, DOI 10.1136/thx.2003.020768; Chalhoub V, 2007, EUR J ANAESTH, V24, P283, DOI 10.1017/S0265021506001529; Chaney MA, 2000, J CARDIOTHOR VASC AN, V14, P514, DOI 10.1053/jcan.2000.9487; Chiao SS, 2018, ANESTH ANALG, V126, P1219, DOI 10.1213/ANE.0000000000002575; Choi ES, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183311; D'antini D, 2018, MINERVA ANESTESIOL, V84, P159, DOI 10.23736/S0375-9393.17.12042-0; Davidovich N, 2013, AM J RESP CELL MOL, V49, P156, DOI 10.1165/rcmb.2012-0252OC; de Jong MAC, 2016, ANN SURG, V264, P362, DOI 10.1097/SLA.0000000000001499; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; Edmark L, 2003, ANESTHESIOLOGY, V98, P28, DOI 10.1097/00000542-200301000-00008; EGBERT LD, 1963, ANESTHESIOLOGY, V24, P57, DOI 10.1097/00000542-196301000-00009; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Fernandez-Bustamante A, 2017, JAMA SURG, V152, P157, DOI 10.1001/jamasurg.2016.4065; Fernandez-Bustamante A, 2014, ANESTHESIOLOGY, V121, P469, DOI 10.1097/ALN.0000000000000301; Fernandez-Perez ER, 2006, ANESTHESIOLOGY, V105, P14, DOI 10.1097/00000542-200607000-00007; Ferrando C, 2018, LANCET RESP MED, V6, P193, DOI [10.1016/S2213-26000(18)30024-9, DOI 10.1016/S52213-26000(18)30024-9]; Ferrando C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177399; Ferrando C, 2014, ANESTH ANALG, V118, P657, DOI 10.1213/ANE.0000000000000105; Ferrer M, 2009, LANCET, V374, P1082, DOI 10.1016/S0140-6736(09)61038-2; FROESE AB, 1974, ANESTHESIOLOGY, V41, P242, DOI 10.1097/00000542-197409000-00006; Futier E, 2016, INTENS CARE MED, V42, P1888, DOI 10.1007/s00134-016-4594-y; Futier E, 2014, ANESTHESIOLOGY, V121, P400, DOI 10.1097/ALN.0000000000000335; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Futier E, 2010, ANESTHESIOLOGY, V113, P1310, DOI 10.1097/ALN.0b013e3181fc640a; Gray A, 2008, NEW ENGL J MED, V359, P142, DOI 10.1056/NEJMoa0707992; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; Gross JB, 2014, ANESTHESIOLOGY, V120, P268, DOI 10.1097/ALN.0000000000000053; Guldner A, 2015, ANESTHESIOLOGY, V123, P692, DOI 10.1097/ALN.0000000000000754; Gupta SD, 2012, INDIAN J ANAESTH, V56, P276, DOI 10.4103/0019-5049.98777; Helviz Y, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1990-4; Hemmes SNT, 2017, EUR J ANAESTH, V34, P492, DOI 10.1097/EJA.0000000000000646; Hemmes SNT, 2014, LANCET, V384, P495, DOI 10.1016/S0140-6736(14)60416-5; Hemmes SNT, 2013, CURR OPIN ANESTHESIO, V26, P126, DOI 10.1097/ACO.0b013e32835e1242; Hernandez G, 2016, JAMA-J AM MED ASSOC, V316, P1565, DOI 10.1001/jama.2016.14194; Hess DR, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.014; HICKLING KG, 1994, CRIT CARE MED, V22, P1568, DOI 10.1097/00003246-199422100-00011; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Jabaudon M, 2015, RESPIROLOGY, V20, P1131, DOI 10.1111/resp.12583; Jabaudon M, 2015, AM J RESP CRIT CARE, V192, P191, DOI 10.1164/rccm.201501-0020OC; Jaber S, 2012, ANAESTHESIA, V67, P999, DOI 10.1111/j.1365-2044.2012.07218.x; Jaber S, 2016, JAMA-J AM MED ASSOC, V315, P1345, DOI 10.1001/jama.2016.2706; Jammer I, 2015, EUR J ANAESTH, V32, P88, DOI 10.1097/EJA.0000000000000118; JOYCE CJ, 1993, J APPL PHYSIOL, V74, P1107, DOI 10.1152/jappl.1993.74.3.1107; Karsten J, 2011, ACTA ANAESTH SCAND, V55, P878, DOI 10.1111/j.1399-6576.2011.02467.x; Kim JY, 2010, SURG ENDOSC, V24, P1099, DOI 10.1007/s00464-009-0734-6; Kim KN, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0238-6; Kogan A, 2014, J CARDIAC SURG, V29, P41, DOI 10.1111/jocs.12264; KRAYER S, 1989, ANESTHESIOLOGY, V70, P891, DOI 10.1097/00000542-198906000-00002; Kurz A, 2018, BRIT J ANAESTH, V120, P117, DOI 10.1016/j.bja.2017.11.003; Ladha K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3646; Levin MA, 2014, BRIT J ANAESTH, V113, P97, DOI 10.1093/bja/aeu054; LINDBERG P, 1992, ACTA ANAESTH SCAND, V36, P546, DOI 10.1111/j.1399-6576.1992.tb03516.x; Lumb AB, 2010, BRIT J ANAESTH, V104, P643, DOI 10.1093/bja/aeq080; LUNDQUIST H, 1995, ACTA RADIOL, V36, P626, DOI 10.3109/02841859509176761; MEAD J, 1970, J APPL PHYSIOL, V28, P596, DOI 10.1152/jappl.1970.28.5.596; Meininger D, 2005, ACTA ANAESTH SCAND, V49, P778, DOI 10.1111/j.1399-6576.2005.00713.x; Meyhoff CS, 2009, JAMA-J AM MED ASSOC, V302, P1543, DOI 10.1001/jama.2009.1452; Michelet P, 2006, ANESTHESIOLOGY, V105, P911, DOI 10.1097/00000542-200611000-00011; Milot J, 2001, CHEST, V119, P884, DOI 10.1378/chest.119.3.884; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; Nestler C, 2017, BRIT J ANAESTH, V119, P1194, DOI 10.1093/bja/aex192; Neto AS, 2016, LANCET RESP MED, V4, P272, DOI 10.1016/S2213-2600(16)00057-6; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Neumann P, 1999, ACTA ANAESTH SCAND, V43, P295, DOI 10.1034/j.1399-6576.1999.430309.x; NICHOLAS TE, 1983, RESP PHYSIOL, V52, P69, DOI 10.1016/0034-5687(83)90137-8; Noordzij PG, 2010, ANESTHESIOLOGY, V112, P1105, DOI 10.1097/ALN.0b013e3181d5f95c; O'Gara B, 2016, INTENS CARE MED, V42, P1487, DOI 10.1007/s00134-016-4429-x; Pang CK, 2003, ANAESTH INTENS CARE, V31, P176, DOI 10.1177/0310057X0303100206; Park HP, 2009, ANAESTH INTENS CARE, V37, P593, DOI 10.1177/0310057X0903700419; Park SJ, 2016, SURG ENDOSC, V30, P4598, DOI 10.1007/s00464-016-4797-x; Prella M, 2002, CHEST, V122, P1382, DOI 10.1378/chest.122.4.1382; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reinius H, 2009, ANESTHESIOLOGY, V111, P979, DOI 10.1097/ALN.0b013e3181b87edb; Rochwerg B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02426-2016; Rothen HU, 1996, ACTA ANAESTH SCAND, V40, P524, DOI 10.1111/j.1399-6576.1996.tb04483.x; ROTHEN HU, 1995, ACTA ANAESTH SCAND, V39, P118, DOI 10.1111/j.1399-6576.1995.tb05602.x; Rusca M, 2003, ANESTH ANALG, V97, P1835, DOI 10.1213/01.ANE.0000087042.02266.F6; Sato H, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0209-y; Scherer M, 2009, CARDIOVASC ENG, V9, P1, DOI 10.1007/s10558-009-9063-6; Sen O, 2017, REV BRAS ANESTESIOL, V67, P28, DOI [10.1016/j.bjane.2015.08.015, 10.1016/j.bjan.2016.10.005]; Neto AS, 2015, ANESTHESIOLOGY, V123, P66, DOI 10.1097/ALN.0000000000000706; Severgnini P, 2013, ANESTHESIOLOGY, V118, P1307, DOI 10.1097/ALN.0b013e31829102de; Shander A, 2011, CRIT CARE MED, V39, P2163, DOI 10.1097/CCM.0b013e31821f0522; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Squadrone V, 2005, JAMA-J AM MED ASSOC, V293, P589, DOI 10.1001/jama.293.5.589; Staehr-Rye AK, 2017, BRIT J ANAESTH, V119, P140, DOI 10.1093/bja/aex128; Stephan F, 2015, JAMA-J AM MED ASSOC, V313, P2331, DOI 10.1001/jama.2015.5213; STOCK MC, 1985, CHEST, V87, P151, DOI 10.1378/chest.87.2.151; Sundar S, 2011, ANESTHESIOLOGY, V114, P1102, DOI 10.1097/ALN.0b013e318215e254; SUTER PM, 1978, CHEST, V73, P158, DOI 10.1378/chest.73.2.158; Talab HF, 2009, ANESTH ANALG, V109, P1511, DOI 10.1213/ANE.0b013e3181ba7945; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]; TOKICS L, 1987, ANESTHESIOLOGY, V66, P157, DOI 10.1097/00000542-198702000-00009; Tsuchida S, 2006, AM J RESP CRIT CARE, V174, P279, DOI 10.1164/rccm.200506-1006OC; Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001; Unzueta C, 2012, BRIT J ANAESTH, V108, P517, DOI 10.1093/bja/aer415; Verbeek GL, 2017, ANAESTHESIA, V72, P993, DOI 10.1111/anae.13964; Wadhwa A, 2014, ANESTH ANALG, V119, P357, DOI 10.1213/ANE.0000000000000318; Weingarten TN, 2010, BRIT J ANAESTH, V104, P16, DOI 10.1093/bja/aep319; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Whalen FX, 2006, ANESTH ANALG, V102, P298, DOI 10.1213/01.ane.0000183655.57275.7a; Wilson WC, 2005, MILLERS ANESTHESIA, P1894; WOLLMER P, 1990, ACTA ANAESTH SCAND, V34, P572, DOI 10.1111/j.1399-6576.1990.tb03147.x; World Health Organization, 2016, GLOB GUID PREV SURG; Yang DJ, 2016, ANN SURG, V263, P881, DOI 10.1097/SLA.0000000000001443; Zupancich E, 2005, J THORAC CARDIOV SUR, V130, P378, DOI 10.1016/j.jtcvs.2004.11.061	129	37	37	5	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2018	362								k3030	10.1136/bmj.k3030	http://dx.doi.org/10.1136/bmj.k3030			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JC	30201797	Green Published			2022-12-28	WOS:000445015400001
J	Greene, GH; Dong, XN				Greene, George H.; Dong, Xinnian			To grow and to defend	SCIENCE			English	Editorial Material							RESISTANCE; YIELD; IPA1		[Greene, George H.; Dong, Xinnian] Duke Univ, Howard Hughes Med Inst, Dept Biol, Durham, NC 27708 USA	Duke University; Howard Hughes Medical Institute	Dong, XN (corresponding author), Duke Univ, Howard Hughes Med Inst, Dept Biol, Durham, NC 27708 USA.	xdong@duke.edu			NIGMS NIH HHS [R35 GM118036] Funding Source: Medline; NIH HHS [S10 OD018164] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118036] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashkani S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00886; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Deng YW, 2017, SCIENCE, V355, P962, DOI 10.1126/science.aai8898; Fitzgerald HA, 2004, MOL PLANT MICROBE IN, V17, P140, DOI 10.1094/MPMI.2004.17.2.140; Fukuoka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07773; Ke YG, 2017, PLANT J, V90, P738, DOI 10.1111/tpj.13438; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Vijayan J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00371; Wang BB, 2017, MOL PLANT, V10, P779, DOI 10.1016/j.molp.2017.04.011; Wang J, 2018, SCIENCE, V361, P1026, DOI 10.1126/science.aat7675; Xu GY, 2017, NATURE, V545, P491, DOI 10.1038/nature22372; Zeng D., 2017, NATURE, V3, P4; Zhang L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14789; Zhou XG, 2018, P NATL ACAD SCI USA, V115, P3174, DOI 10.1073/pnas.1705927115	15	5	5	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					976	977		10.1126/science.aau9065	http://dx.doi.org/10.1126/science.aau9065			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS7OT	30190392				2022-12-28	WOS:000443892700028
J	Jesmer, BR; Merkle, JA; Goheen, JR; Aikens, EO; Beck, JL; Courtemanch, AB; Hurley, MA; MeWhicter, DE; Miyasaki, HM; Monteith, KL; Kauffman, MJ				Jesmer, Brett R.; Merkle, Jerod A.; Goheen, Jacob R.; Aikens, Ellen O.; Beck, Jeffrey L.; Courtemanch, Alyson B.; Hurley, Mark A.; MeWhicter, Douglas E.; Miyasaki, Hollie M.; Monteith, Kevin L.; Kauffman, Matthew J.			Is ungulate migration culturally transmitted? Evidence of social learning from translocated animals	SCIENCE			English	Article							HERBIVORE; GROWTH	Ungulate migrations are assumed to stem from learning and cultural transmission of information regarding seasonal distribution of forage, but this hypothesis has not been tested empirically. We compared the migratory propensities of bighorn sheep and moose translocated into novel habitats with those of historical populations that had persisted for hundreds of years. Whereas individuals from historical populations were largely migratory, translocated individuals initially were not. After multiple decades, however, translocated populations gained knowledge about surfing green waves of forage (tracking plant phenology) and increased their propensity to migrate. Our findings indicate that learning and cultural transmission are the primary mechanisms by which ungulate migrations evolve. Loss of migration will therefore expunge generations of knowledge about the locations of high-quality forage and likely suppress population abundance.	[Jesmer, Brett R.; Goheen, Jacob R.; Aikens, Ellen O.] Univ Wyoming, Dept Zool & Physiol, Program Ecol, Laramie, WY 82071 USA; [Jesmer, Brett R.; Merkle, Jerod A.; Aikens, Ellen O.; Monteith, Kevin L.] Univ Wyoming, Dept Zool & Physiol, Wyoming Cooperat Fish & Wildlife Res Unit, Laramie, WY 82071 USA; [Beck, Jeffrey L.] Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA; [Courtemanch, Alyson B.; MeWhicter, Douglas E.] Wyoming Game & Fish Dept, Jackson, WY 83001 USA; [Hurley, Mark A.; Miyasaki, Hollie M.] Idaho Dept Fish & Game, Boise, ID 83712 USA; [Monteith, Kevin L.] Univ Wyoming, Haub Sch Environm & Nat Resources, Laramie, WY 82072 USA; [Kauffman, Matthew J.] Univ Wyoming, US Geol Survey, Wyoming Cooperat Fish & Wildlife Res Unit, Dept Zool & Physiol, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming; University of Wyoming; University of Wyoming; United States Department of the Interior; United States Geological Survey; University of Wyoming	Jesmer, BR (corresponding author), Univ Wyoming, Dept Zool & Physiol, Program Ecol, Laramie, WY 82071 USA.; Jesmer, BR (corresponding author), Univ Wyoming, Dept Zool & Physiol, Wyoming Cooperat Fish & Wildlife Res Unit, Laramie, WY 82071 USA.	bjesmer@uwyo.edu	Merkle, Jerod A/ABB-5431-2021; Aikens, Ellen/AAT-4481-2020	Merkle, Jerod A/0000-0003-0100-1833; Aikens, Ellen/0000-0003-0827-3006; Beck, Jeffrey/0000-0003-0236-7343	Wyoming Governor's Big Game License Coalition; Wyoming Game and Fish Department; Idaho Department of Fish and Game; Wyoming NASA Space Grant Consortium; American Society of Mammalogists; Safari Club International Foundation; Idaho Safari Club; Idaho Transportation Department; Bureau of Land Management; U.S. Forest Service; Pittman-Robertson Wildlife Restoration funds; Wild Sheep Foundation; Wyoming Wild Sheep Foundation; Teton Conservation District; Grand Teton National Park Foundation; Wyoming Wildlife-Livestock Disease Research Partnership; Alces Society	Wyoming Governor's Big Game License Coalition; Wyoming Game and Fish Department; Idaho Department of Fish and Game; Wyoming NASA Space Grant Consortium; American Society of Mammalogists; Safari Club International Foundation; Idaho Safari Club; Idaho Transportation Department; Bureau of Land Management; U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Pittman-Robertson Wildlife Restoration funds; Wild Sheep Foundation; Wyoming Wild Sheep Foundation; Teton Conservation District; Grand Teton National Park Foundation; Wyoming Wildlife-Livestock Disease Research Partnership; Alces Society	This research was financially supported by the Wyoming Governor's Big Game License Coalition (A.B.C., B.R.J., D.E.M., J.L.B., J.R.G., K.L.M., M.J.K.), the Wyoming Game and Fish Department (D.E.M.), the Idaho Department of Fish and Game (M.A.H., H.M.M.), the Wyoming NASA Space Grant Consortium (B.R.J., J.R.G., M.J.K.), the American Society of Mammalogists (B.R.J.), the Safari Club International Foundation (M.J.K.), the Idaho Safari Club (M.A.H., H.M.M.), the Idaho Transportation Department (M.A.H., H.M.M.), the Bureau of Land Management (M.A.H., H.M.M.), the U.S. Forest Service (M.A.H., H.M.M., A.B.C., J.R.G., M.J.K.), Pittman-Robertson Wildlife Restoration funds (M.A.H., H.M.M.), the Wild Sheep Foundation (H.M.M., M.A.H.), the Wyoming Wild Sheep Foundation (A.B.C., D.E.M., J.L.B., K.L.M., M.J.K.), the Teton Conservation District (A.B.C., M.J.K.), the Grand Teton National Park Foundation (A.B.C., M.J.K.), the Wyoming Wildlife-Livestock Disease Research Partnership (K.L.M.), and the Alces Society (B.R.J.).	Aikens EO, 2017, ECOL LETT, V20, P741, DOI 10.1111/ele.12772; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Bolger DT, 2008, ECOL LETT, V11, P63; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; Bracis C, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0449; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; FRYXELL JM, 1988, AM NAT, V131, P781, DOI 10.1086/284822; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hnilicka P. A., 2003, NO WILD SHEEP GOAT C, V13, P69; Jesmer B. R., 2018, DRYAD, DOI [10.5061/dryad.8165qv5, DOI 10.5061/DRYAD.8165QV5]; Keith SA, 2017, ECOGRAPHY, V40, DOI 10.1111/ecog.02481; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Merkle JA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0456; Merkle JA, 2015, ECOL LETT, V18, P799, DOI 10.1111/ele.12457; Mueller T, 2013, SCIENCE, V341, P999, DOI 10.1126/science.1237139; Nelson ME, 1998, CAN J ZOOL, V76, P426, DOI 10.1139/cjz-76-3-426; Oates B. A., 2016, THESIS; Peters W, 2017, ECOL MONOGR, V87, P297, DOI 10.1002/ecm.1250; Rolandsen CM, 2017, OIKOS, V126, P547, DOI 10.1111/oik.02996; Sasaki T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15049; Sawyer H, 2013, J APPL ECOL, V50, P68, DOI 10.1111/1365-2664.12013; Sawyer H, 2011, J ANIM ECOL, V80, P1078, DOI 10.1111/j.1365-2656.2011.01845.x; Shettleworth S. J., 2010, COGNITION EVOLUTION, P417; SWEANOR PY, 1989, J APPL ECOL, V26, P25, DOI 10.2307/2403648; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; van der Graaf SAJ, 2006, ARDEA, V94, P567; Whitehead H, 2010, LEARN BEHAV, V38, P329, DOI 10.3758/LB.38.3.329; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023	30	152	155	12	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					1023	1025		10.1126/science.aat0985	http://dx.doi.org/10.1126/science.aat0985			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190405				2022-12-28	WOS:000443892700048
J	Chen, B; Li, Y; Yu, B; Zhang, ZC; Brommer, B; Williams, PR; Liu, YY; Hegarty, SV; Zhou, SL; Zhu, JJ; Guo, H; Lu, Y; Zhang, YM; Gu, XS; He, ZG				Chen, Bo; Li, Yi; Yu, Bin; Zhang, Zicong; Brommer, Benedikt; Williams, Philip Raymond; Liu, Yuanyuan; Hegarty, Shane Vincent; Zhou, Songlin; Zhu, Junjie; Guo, Hong; Lu, Yi; Zhang, Yiming; Gu, Xiaosong; He, Zhigang			Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations (vol 174, pg 521, 2018)	CELL			English	Correction												nervegu@ntu.edu.cn; zhigang.he@childrens.harvard.edu	Zhang, Zicong/V-7853-2019; liu, yuanyuan/GWZ-5838-2022; Zhang, Yiming/HGB-7344-2022	Zhang, Zicong/0000-0002-6453-5528; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096294] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY012196] Funding Source: Medline; NICHD NIH HHS [U54 HD090255] Funding Source: Medline; NINDS NIH HHS [R01 NS096294] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chen B, 2018, CELL, V174, P521, DOI 10.1016/j.cell.2018.06.005	1	28	28	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 6	2018	174	6					1599	1599		10.1016/j.cell.2018.08.050	http://dx.doi.org/10.1016/j.cell.2018.08.050			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GS6WP	30193115	Green Accepted, Bronze			2022-12-28	WOS:000443841000025
J	Newby, DE; Adamson, PD; Berry, C; Boon, NA; Dweck, MR; Flather, M; Forbes, J; Hunter, A; Lewis, S; MacLean, S; Mills, NL; Norrie, J; Roditi, G; Shah, ASV; Timmis, AD; van Beek, EJR; Williams, MC				Newby, David E.; Adamson, Philip D.; Berry, Colin; Boon, Nicholas A.; Dweck, Marc R.; Flather, Marcus; Forbes, John; Hunter, Amanda; Lewis, Stephanie; MacLean, Scott; Mills, Nicholas L.; Norrie, John; Roditi, Giles; Shah, Anoop S. V.; Timmis, Adam D.; van Beek, Edwin J. R.; Williams, Michelle C.		SCOT-HEART Investigators	Coronary CT Angiography and 5-Year Risk of Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; UNSTABLE ANGINA; CHEST-PAIN; METAANALYSIS; GUIDELINES; MANAGEMENT; INTERVENTIONS; PROGNOSIS; SCORE; CARE	BACKGROUND Although coronary computed tomographic angiography (CTA) improves diagnostic certainty in the assessment of patients with stable chest pain, its effect on 5-year clinical outcomes is unknown. METHODS In an open-label, multicenter, parallel-group trial, we randomly assigned 4146 patients with stable chest pain who had been referred to a cardiology clinic for evaluation to standard care plus CTA (2073 patients) or to standard care alone (2073 patients). Investigations, treatments, and clinical outcomes were assessed over 3 to 7 years of follow-up. The primary end point was death from coronary heart disease or nonfatal myocardial infarction at 5 years. RESULTS The median duration of follow-up was 4.8 years, which yielded 20,254 patient-years of follow-up. The 5-year rate of the primary end point was lower in the CTA group than in the standard-care group (2.3% [48 patients] vs. 3.9% [81 patients]; hazard ratio, 0.59; 95% confidence interval [CI], 0.41 to 0.84; P = 0.004). Although the rates of invasive coronary angiography and coronary revascularization were higher in the CTA group than in the standard-care group in the first few months of follow-up, overall rates were similar at 5 years: invasive coronary angiography was performed in 491 patients in the CTA group and in 502 patients in the standard- care group (hazard ratio, 1.00; 95% CI, 0.88 to 1.13), and coronary revascularization was performed in 279 patients in the CTA group and in 267 in the standard-care group (hazard ratio, 1.07; 95% CI, 0.91 to 1.27). However, more preventive therapies were initiated in patients in the CTA group (odds ratio, 1.40; 95% CI, 1.19 to 1.65), as were more antianginal therapies (odds ratio, 1.27; 95% CI, 1.05 to 1.54). There were no significant between-group differences in the rates of cardiovascular or noncardiovascular deaths or deaths from any cause. CONCLUSIONS In this trial, the use of CTA in addition to standard care in patients with stable chest pain resulted in a significantly lower rate of death from coronary heart disease or nonfatal myocardial infarction at 5 years than standard care alone, without resulting in a significantly higher rate of coronary angiography or coronary revascularization.	[Newby, David E.; Adamson, Philip D.; Boon, Nicholas A.; Dweck, Marc R.; Hunter, Amanda; Lewis, Stephanie; Mills, Nicholas L.; Norrie, John; Shah, Anoop S. V.; van Beek, Edwin J. R.; Williams, Michelle C.] Univ Edinburgh, Rm SU314,Chancellors Bldg, Edinburgh EH16 4SA, Midlothian, Scotland; [Berry, Colin; Roditi, Giles] Univ Glasgow, Glasgow, Lanark, Scotland; [Flather, Marcus] Univ East Anglia, Norwich, Norfolk, England; [MacLean, Scott] NHS Fife, Kirkcaldy, Scotland; [Timmis, Adam D.] Queen Mary Univ, London, England; [Forbes, John] Univ Limerick, Limerick, Ireland	University of Edinburgh; University of Glasgow; University of East Anglia; University of Dundee; University of London; Queen Mary University London; University of Limerick	Newby, DE (corresponding author), Univ Edinburgh, Rm SU314,Chancellors Bldg, Edinburgh EH16 4SA, Midlothian, Scotland.	d.e.newby@ed.ac.uk	Newby, David Ernest/AAB-1364-2019; Dweck, Marc/AAY-1509-2021; Spratt, James/AAH-3589-2020; Adamson, Philip/AAC-3699-2019; Williams, Michelle C/K-7555-2012	Spratt, James/0000-0001-8719-4538; Adamson, Philip/0000-0002-6177-956X; Williams, Michelle C/0000-0003-3556-2428; dweck, marc/0000-0001-9847-5917; Shah, Anoop/0000-0002-2825-3419; Fairbairn, Tim/0000-0003-1491-6231; Mills, Nicholas/0000-0003-0533-7991	Scottish Government Chief Scientist Office; MRC [G0701127, MR/N003403/1] Funding Source: UKRI	Scottish Government Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Scottish Government Chief Scientist Office and others; SCOT-HEART ClinicalTrials.gov number, NCT01149590.	Adamson PD, 2018, HEART, V104, P4, DOI [10.1136/heartjnl-2017-311706, 10.1136/heartjnl-2016-311037, 10.1136/heartjnl-2017-311508]; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; Cheng Victor Y, 2011, Circulation, V124, P2423, DOI 10.1161/CIRCULATIONAHA.111.039255; Daly CA, 2006, BMJ-BRIT MED J, V332, P262, DOI 10.1136/bmj.38695.605440.AE; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Fanning JP, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004815.pub4; Ferencik M, 2018, JAMA CARDIOL, V3, P144, DOI 10.1001/jamacardio.2017.4973; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017; Fleischmann KE, 1998, JAMA-J AM MED ASSOC, V280, P913, DOI 10.1001/jama.280.10.913; Ford I, 1995, J CLIN EPIDEMIOL, V48, P1441; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; GANDHI MM, 1995, BRIT HEART J, V73, P193; Gongora CA, 2018, HEART, V104, P215, DOI 10.1136/heartjnl-2017-311647; Greenwood JP, 2016, JAMA-J AM MED ASSOC, V316, P1051, DOI 10.1001/jama.2016.12680; MANSON JE, 1992, NEW ENGL J MED, V326, P1406, DOI 10.1056/NEJM199205213262107; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Mowatt G, 2008, HEALTH TECHNOL ASSES, V12, P1; National Institute for Health and Care Excellence, 2016, CLIN GUID 95, V95; National Institute for Health and Clinical Excellence, 2010, CLIN GUID 95, V95; Newby D, 2015, LANCET, V385, P2383, DOI 10.1016/S0140-6736(15)60291-4; Newby DE, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-184; PETROV ME, 2017, CIRCULATION, V135; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Shah ASV, 2015, LANCET, V386, P2481, DOI 10.1016/S0140-6736(15)00391-8; Williams MC, 2016, J AM COLL CARDIOL, V67, P1759, DOI 10.1016/j.jacc.2016.02.026; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	34	593	616	2	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2018	379	10					924	933		10.1056/NEJMoa1805971	http://dx.doi.org/10.1056/NEJMoa1805971			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5XM	30145934	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000443748200007
J	Murphy, D				Murphy, Declan			GP at Hand opposes NHS England's plan to cut funding for digital providers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Murphy, Declan C/0000-0001-9295-7712				Iacobucci G, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3017; NHS England, 2018, DIG 1 PRIM CAR ITS I	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2018	362								k3795	10.1136/bmj.k3795	http://dx.doi.org/10.1136/bmj.k3795			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WB	30185586				2022-12-28	WOS:000444505300014
J	Samarasekera, E; Mahammed, S; Carlisle, S; Charnley, R				Samarasekera, Eleanor; Mahammed, Shama; Carlisle, Sophie; Charnley, Richard		Guideline Comm	Pancreatitis: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY-OF-LIFE		[Samarasekera, Eleanor; Mahammed, Shama; Carlisle, Sophie] Royal Coll Physicians, Natl Guideline Ctr, London NW1 4LE, England; [Charnley, Richard] Freeman Rd Hosp, Dept Hepatopancreatobiliary Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Royal College of Physicians; Newcastle Freeman Hospital; Newcastle University - UK	Charnley, R (corresponding author), Freeman Rd Hosp, Dept Hepatopancreatobiliary Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	Richard.Charnley@nuth.nhs.uk			NICE	NICE	This work was undertaken by the National Guideline Centre, which received funding from NICE to develop this guideline. The views expressed in this publication are those of the authors and not necessarily those of NICE.	Baldini A, 2012, PRIM CARE COMPANION, V14; Hochman D, 2006, CAN J SURG, V49, P101; Knott L., 2016, CHRONIC PANCREATITIS; Knott L., 2016, ACUTE PANCREATITIS; Machicado JD, 2017, AM J GASTROENTEROL, V112, P633, DOI 10.1038/ajg.2017.42; National Confidential Enquiry into Patient Outcome and Death (NCEPOD), 2016, TREAT CAUS REV QUAL; National Institute for Health and Care Excellence, 2017, TYP 2 DIAB AD MAN; National Institute for Health and Care Excellence, 2008, CONT SUBC INS INF TR; National Institute for Health and Care Excellence, 2016, TYP 1 DIAB AD DIAGN; National Institute for Health and Care Excellence, 2016, DIAB TYP 1 TYP 2 CHI; National Institute for Health and Care Excellence, 2018, STOP SMOK INT SERV; National Institute for Health and Care Excellence, 2018, PANCR; National Institute for Health and Care Excellence, 2017, ALC US DIS DIAGN MAN; National Institute for Health and Care Excellence, 2018, DEPR AD REC MAN; Woodmansey C, 2017, DIABETES CARE, V40, P1486, DOI 10.2337/dc17-0542; Zhu Z, 2018, LISTENING VOICES MAT	16	10	13	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2018	362								k3443	10.1136/bmj.k3443	http://dx.doi.org/10.1136/bmj.k3443			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4WB	30185473				2022-12-28	WOS:000444505300004
J	Maskell, G				Maskell, Giles			PERSONAL VIEW Think before you scan	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												gilesmaskell@nhs.net							0	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2018	362								k3754	10.1136/bmj.k3754	http://dx.doi.org/10.1136/bmj.k3754			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT4VO	30181115				2022-12-28	WOS:000444503800009
J	Gill, J; Prasad, V				Gill, Jennifer; Prasad, Vinay			Improving observational studies in the era of big data	LANCET			English	Editorial Material							ASSOCIATIONS		[Gill, Jennifer; Prasad, Vinay] Oregon Hlth & Sci Univ, Div Hematol Oncol, Portland, OR 97239 USA; [Gill, Jennifer; Prasad, Vinay] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA; [Prasad, Vinay] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; [Prasad, Vinay] Oregon Hlth & Sci Univ, Ctr Hlth Care Eth, Portland, OR 97239 USA; [Gill, Jennifer; Prasad, Vinay] Oregon Hlth & Sci Univ, Div Gen Med, Dept Med, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Prasad, V (corresponding author), Oregon Hlth & Sci Univ, Div Hematol Oncol, Portland, OR 97239 USA.; Prasad, V (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA.; Prasad, V (corresponding author), Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA.; Prasad, V (corresponding author), Oregon Hlth & Sci Univ, Ctr Hlth Care Eth, Portland, OR 97239 USA.; Prasad, V (corresponding author), Oregon Hlth & Sci Univ, Div Gen Med, Dept Med, Portland, OR 97239 USA.	prasad@ohsu.edu		Prasad, Vinayak/0000-0002-6110-8221; Gill, Jennifer/0000-0002-5591-6855				El-Galaly TC, 2015, J CLIN ONCOL, V33, P3993, DOI 10.1200/JCO.2015.62.0229; Giobbie-Hurder A, 2013, J CLIN ONCOL, V31, P2963, DOI 10.1200/JCO.2013.49.5283; Hernan MA, 2008, EPIDEMIOLOGY, V19, P766, DOI 10.1097/EDE.0b013e3181875e61; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Patel CJ, 2015, J CLIN EPIDEMIOL, V68, P1046, DOI 10.1016/j.jclinepi.2015.05.029; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Senn S, 2013, STAT MED, V32, P1439, DOI 10.1002/sim.5713	7	20	20	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2018	392	10149					716	717		10.1016/S0140-6736(18)31619-2	http://dx.doi.org/10.1016/S0140-6736(18)31619-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS0VL	30191816				2022-12-28	WOS:000443226900006
J	Horton, R				Horton, Richard			Offline: Frantz Fanon and the origins of global health	LANCET			English	Editorial Material												richard.horton@lancet.com							0	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2018	392	10149					720	720		10.1016/S0140-6736(18)32041-5	http://dx.doi.org/10.1016/S0140-6736(18)32041-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS0VL	30191818	Bronze			2022-12-28	WOS:000443226900008
J	Riegler, M				Riegler, Markus			Insect threats to food security	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; RESPONSES		[Riegler, Markus] Western Sydney Univ, Hawkesbury Inst Environm, Locked Bag 1797, Penrith, NSW 2751, Australia	Western Sydney University	Riegler, M (corresponding author), Western Sydney Univ, Hawkesbury Inst Environm, Locked Bag 1797, Penrith, NSW 2751, Australia.	m.riegler@westernsydney.edu.au		Riegler, Markus/0000-0001-7363-431X	Australian Research Council	Australian Research Council(Australian Research Council)	I thank the Australian Research Council for funding via the Industrial Transformation Training Centre scheme.	Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/nclimate1990, 10.1038/NCLIMATE1990]; DeLucia EH, 2012, PLANT PHYSIOL, V160, P1677, DOI 10.1104/pp.112.204750; Deutsch CA, 2018, SCIENCE, V361, P916, DOI 10.1126/science.aat3466; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; Harris RMB, 2018, NAT CLIM CHANGE, V8, P579, DOI 10.1038/s41558-018-0187-9; Lichtenberg EM, 2017, GLOBAL CHANGE BIOL, V23, P4946, DOI 10.1111/gcb.13714; Loxdale HD, 2016, ENTOMOL EXP APPL, V159, P121, DOI 10.1111/eea.12421; Roberts RJ, 2018, J INNOV KNOWL, V3, P61, DOI 10.1016/j.jik.2017.12.006; Rosenheim JA, 2017, ANNU REV ENTOMOL, V62, P399, DOI 10.1146/annurev-ento-031616-035444; Sgro CM, 2016, ANNU REV ENTOMOL, V61, P433, DOI 10.1146/annurev-ento-010715-023859; Terblanche JS, 2015, CABI CLIM CHANGE SER, V7, P92, DOI 10.1079/9781780643786.0092; UNICEF & WHO, 2017, STAT FOOD SEC NUTR W	12	13	13	4	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					846	846		10.1126/science.aau7311	http://dx.doi.org/10.1126/science.aau7311			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS3UB	30166474				2022-12-28	WOS:000443547000015
J	Wu, X; Zhao, LL; Jin, JY; Pan, S; Li, W; Jin, XY; Wang, GJ; Zhou, MF; Frenking, G				Wu, Xuan; Zhao, Lili; Jin, Jiaye; Pan, Sudip; Li, Wei; Jin, Xiaoyang; Wang, Guanjun; Zhou, Mingfei; Frenking, Gernot			Observation of alkaline earth complexes M(CO)(8) (M = Ca, Sr, or Ba) that mimic transition metals	SCIENCE			English	Article							18-ELECTRON RULE; VALENCE; BOND	The alkaline earth metals calcium (Ca), strontium (Sr), and barium (Ba) typically engage in chemical bonding as classical main-group elements through their ns and np valence orbitals, where n is the principal quantum number. Here we report the isolation and spectroscopic characterization of eight-coordinate carbonyl complexes M(CO)(8) (where M = Ca, Sr, or Ba) in a low-temperature neon matrix. Analysis of the electronic structure of these cubic Oh-symmetric complexes reveals that the metal-carbon monoxide (CO) bonds arise mainly from [M(d(pi))] -> (CO)(8) pi backdonation, which explains the strong observed red shift of the C-O stretching frequencies. The corresponding radical cation complexes were also prepared in gas phase and characterized by mass-selected infrared photodissociation spectroscopy, confirming adherence to the 18-electron rule more conventionally associated with transition metal chemistry.	[Wu, Xuan; Jin, Jiaye; Li, Wei; Jin, Xiaoyang; Wang, Guanjun; Zhou, Mingfei] Fudan Univ, Dept Chem, Collaborat Innovat Ctr Chem Energy Mat, Shanghai Key Lab Mol Catalysts & Innovat Mat, Shanghai 200433, Peoples R China; [Zhao, Lili; Pan, Sudip; Frenking, Gernot] Nanjing Tech Univ, Inst Adv Synth, Sch Chem & Mol Engn, Jiangsu Natl Synerget Innovat Ctr Adv Mat, Nanjing 211816, Jiangsu, Peoples R China; [Frenking, Gernot] Philipps Univ Marburg, Fachbereich Chem, Hans Meerwein Str, D-35043 Marburg, Germany	Fudan University; Nanjing Tech University; Philipps University Marburg	Zhou, MF (corresponding author), Fudan Univ, Dept Chem, Collaborat Innovat Ctr Chem Energy Mat, Shanghai Key Lab Mol Catalysts & Innovat Mat, Shanghai 200433, Peoples R China.; Frenking, G (corresponding author), Nanjing Tech Univ, Inst Adv Synth, Sch Chem & Mol Engn, Jiangsu Natl Synerget Innovat Ctr Adv Mat, Nanjing 211816, Jiangsu, Peoples R China.; Frenking, G (corresponding author), Philipps Univ Marburg, Fachbereich Chem, Hans Meerwein Str, D-35043 Marburg, Germany.	mfzhou@fudan.edu.cn; frenking@chemie.uni-marburg.de	Pan, Sudip/I-8264-2014; Wu, Xuan/GZL-8532-2022	Pan, Sudip/0000-0002-0414-8366; Jin, Jiaye/0000-0001-8738-2985; pan, sudip/0000-0003-3172-926X; Wu, Xuan/0000-0003-1086-7890	National Natural Science Foundation of China [21688102, 21433005, 21703099]; Nanjing Tech University; SICAM Fellowship from Jiangsu National Synergetic Innovation Center for Advanced Materials [39837132, 39837123]; Natural Science Foundation of Jiangsu Province for Youth [BK20170964]; High Performance Computing Center of Nanjing Tech University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Tech University; SICAM Fellowship from Jiangsu National Synergetic Innovation Center for Advanced Materials; Natural Science Foundation of Jiangsu Province for Youth(Natural Science Foundation of Jiangsu Province); High Performance Computing Center of Nanjing Tech University	The authors gratefully acknowledge financial support from the National Natural Science Foundation of China (grant nos. 21688102, 21433005, and 21703099), Nanjing Tech University and SICAM Fellowship from Jiangsu National Synergetic Innovation Center for Advanced Materials (L.Z. and G.F., grant nos. 39837132 and 39837123), and the Natural Science Foundation of Jiangsu Province for Youth (grant no. BK20170964). S.P. thanks Nanjing Tech University for a postdoctoral fellowship and the High Performance Computing Center of Nanjing Tech University for supporting the computational resources.	Albright TA, 2013, ORBITAL INTERACTIONS IN CHEMISTRY, 2ND EDITION, P1, DOI 10.1002/9781118558409; BURDETT JK, 1978, INORG CHEM, V17, P2553, DOI 10.1021/ic50187a041; Diefenbach A, 2000, J AM CHEM SOC, V122, P6449, DOI 10.1021/ja000663g; Gagliardi L, 2003, THEOR CHEM ACC, V110, P205, DOI 10.1007/s00214-003-0485-8; Huber K.P., 1979, MOL SPECTRA MOL STRU; Jin JY, 2018, ANGEW CHEM INT EDIT, V57, P6236, DOI 10.1002/anie.201802590; Kaupp M, 2001, ANGEW CHEM INT EDIT, V40, P3534, DOI 10.1002/1521-3773(20011001)40:19<3534::AID-ANIE3534>3.0.CO;2-#; Langmuir I, 1921, SCIENCE, V54, P59, DOI 10.1126/science.54.1386.59; Langmuir I, 1919, J AM CHEM SOC, V41, P868, DOI 10.1021/ja02227a002; Maitland B, 2017, ANGEW CHEM INT EDIT, V56, P11880, DOI 10.1002/anie.201706786; Mitoraj MP, 2009, J CHEM THEORY COMPUT, V5, P962, DOI 10.1021/ct800503d; Pyykko P, 2006, J ORGANOMET CHEM, V691, P4336, DOI 10.1016/j.jorganchem.2006.01.064; Ricks AM, 2011, J MOL SPECTROSC, V266, P63, DOI 10.1016/j.jms.2011.03.006; Wang GJ, 2018, CHINESE J CHEM PHYS, V31, P1, DOI 10.1063/1674-0068/31/cjcp1710192; Wiberg N, 2001, HOLLEMAN WIBERG INOR, V1st; Wilson ASS, 2017, SCIENCE, V358, P1168, DOI 10.1126/science.aao5923; Wu X, 2018, ANGEW CHEM INT EDIT, V57, P3974, DOI 10.1002/anie.201713002; Zhao LL, 2018, WIRES COMPUT MOL SCI, V8, DOI 10.1002/wcms.1345	18	141	144	25	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					912	+		10.1126/science.aau0839	http://dx.doi.org/10.1126/science.aau0839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166489				2022-12-28	WOS:000443547000037
J	Pawluk, A				Pawluk, April			CRISPR: No Sign of Slowing Down	CELL			English	Editorial Material																		Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Halperin SO, 2018, NATURE, V560, P248, DOI 10.1038/s41586-018-0384-8; Luo JC, 2018, NATURE, V560, P392, DOI 10.1038/s41586-018-0374-x; Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836; Shao YY, 2018, NATURE, V560, P331, DOI 10.1038/s41586-018-0382-x	6	2	2	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2018	174	5					1039	1041		10.1016/j.cell.2018.08.010	http://dx.doi.org/10.1016/j.cell.2018.08.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GR3WU	30142340	Bronze			2022-12-28	WOS:000442529100001
J	Francis, NA; Cannings-John, R; Waldron, CA; Thomas-Jones, E; Winfield, T; Shepherd, V; Harris, D; Hood, K; Fitzsimmons, D; Roberts, A; Powell, C; Gal, M; Butler, CC				Francis, Nick A.; Cannings-John, Rebecca; Waldron, Cherry-Ann; Thomas-Jones, Emma; Winfield, Tom; Shepherd, Victoria; Harris, Debbie; Hood, Kerenza; Fitzsimmons, Deborah; Roberts, Amanda; Powell, Colin; Gal, Micaela; Butler, Christopher C.			Oral steroids for resolution of otitis media with effusion in children (OSTRICH): a double-blinded, placebo-controlled randomised trial	LANCET			English	Article								Background Children with persistent hearing loss due to otitis media with effusion are commonly managed by surgical intervention. A safe, cheap, and effective medical treatment would enhance treatment options. Underpowered, poor-quality trials have found short-term benefit from oral steroids. We aimed to investigate whether a short course of oral steroids would achieve acceptable hearing in children with persistent otitis media with effusion and hearing loss. Methods In this individually randomised, parallel, double-blinded, placebo-controlled trial we recruited children aged 2-8 years with symptoms attributable to otitis media with effusion for at least 3 months and with confirmed bilateral hearing loss. Participants were recruited from 20 ear, nose, and throat (ENT), paediatric audiology, and audiovestibular medicine outpatient departments in England and Wales. Participants were randomly allocated (1: 1) to sequentially numbered identical prednisolone (oral steroid) or placebo packs by use of computer-generated random permuted block sizes stratified by site and child's age. The primary outcome was audiometry-confirmed acceptable hearing at 5 weeks. All analyses were by intention to treat. This trial is registered with the ISRCTN Registry, number ISRCTN49798431. Findings Between March 20, 2014, and April 5, 2016, 1018 children were screened, of whom 389 were randomised. 200 were assigned to receive oral steroids and 189 to receive placebo. Hearing at 5 weeks was assessed in 183 children in the oral steroid group and in 180 in the placebo group. Acceptable hearing was observed in 73 (40%) children in the oral steroid group and in 59 (33%) in the placebo group (absolute difference 7% [95% CI -3 to 17], number needed to treat 14; adjusted odds ratio 1.36 [95% CI 0.88-2.11]; p=0.16). There was no evidence of any significant differences in adverse events or quality-of-life measures between the groups. Interpretation Otitis media with effusion in children with documented hearing loss and attributable symptoms for at least 3 months has a high rate of spontaneous resolution. A short course of oral prednisolone is not an effective treatment for most children aged 2-8 years with persistent otitis media with effusion, but is well tolerated. One in 14 children might achieve improved hearing but not quality of life. Discussions about watchful waiting and other interventions will be supported by this evidence. Copyright (c) 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.	[Francis, Nick A.; Gal, Micaela] Cardiff Univ, Sch Med, Div Populat Med, Heath Pk, Cardiff CF14 4YS, S Glam, Wales; [Cannings-John, Rebecca; Waldron, Cherry-Ann; Thomas-Jones, Emma; Shepherd, Victoria; Harris, Debbie; Hood, Kerenza] Cardiff Univ, Coll Biomed & Life Sci, Ctr Trials Res, Cardiff, S Glam, Wales; [Winfield, Tom; Fitzsimmons, Deborah] Swansea Univ, Coll Human Hlth Sci, Swansea Ctr Hlth Econ, Singleton Pk, Swansea, W Glam, Wales; [Roberts, Amanda] St Davids Children Ctr, Child Hlth Directorate, Cardiff & Vale Univ Hlth Board, Cowbridge Rd East, Cardiff, S Glam, Wales; [Powell, Colin] Childrens Hosp Wales, Dept Gen Paediat, Heath Pk, Cardiff, S Glam, Wales; [Butler, Christopher C.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	Cardiff University; Cardiff University; Swansea University; University of Oxford	Francis, NA (corresponding author), Cardiff Univ, Sch Med, Div Populat Med, Heath Pk, Cardiff CF14 4YS, S Glam, Wales.	francisna@cardiff.ac.uk	Francis, Nick/B-7413-2009; Hood, Kerenza/C-2528-2008	Francis, Nick/0000-0001-8939-7312; Waldron, Cherry-Ann/0000-0001-8465-2492; Thomas-Jones, Emma/0000-0001-7716-2786; Butler, Christopher/0000-0002-0102-3453; Gal, Micaela/0000-0002-1326-190X; Hood, Kerenza/0000-0002-5268-8631; Shepherd, Victoria/0000-0002-7687-0817	National Institute for Health Research (NIHR) Health Technology Assessment programme	National Institute for Health Research (NIHR) Health Technology Assessment programme(National Institute for Health Research (NIHR))	National Institute for Health Research (NIHR) Health Technology Assessment programme.	Bellmunt AM, 2016, OTOLARYNG HEAD NECK, V155, P139, DOI 10.1177/0194599816637845; Bennett KE, 2001, ARCH DIS CHILD, V85, P91, DOI 10.1136/adc.85.2.91; Cai T, 2017, INT J AUDIOL, V56, P65, DOI 10.1080/14992027.2016.1250960; Dengerink JE, 1984, LANG SPEECH HEAR SER, V15, P205, DOI DOI 10.1044/0161-1461.1503.205; Feeny D, PHARMACOECONOMICS; Griffin G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003423.pub3; Hussein A, 2017, J LARYNGOL OTOL, V131, P907, DOI 10.1017/S0022215117001700; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; MACKNIN ML, 1985, PEDIATRICS, V75, P329; McKinsey & Co, ACH WORLD CLASS PROD; NHSP Clinical Group, 2008, VIS REINF AUD TEST I; NICE, 2008, NICE CLIN GUID; Rosenfeld RM, 2016, OTOLARYNG HEAD NECK, V154, pS1, DOI 10.1177/0194599815623467; Rosenfeld RM, 2003, LARYNGOSCOPE, V113, P1645, DOI 10.1097/00005537-200310000-00004; Simpson SA, 2011, COCHRANE DB SYST REV, V5; Timmerman AA, 2008, EUR ARCH OTO-RHINO-L, V265, P1047, DOI 10.1007/s00405-008-0591-2; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Venekamp RP, 2016, COCHRANE DB SYST REV, V2016; Waldron CA, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1236-1; Wallace IF, 2014, PEDIATRICS, V133, P296, DOI 10.1542/peds.2013-3228; White IR, 2011, STAT MED, V30, P3192, DOI 10.1002/sim.4360; White IR, 2005, STAT METHODS MED RES, V14, P327, DOI 10.1191/0962280205sm406oa; Williamson I, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13370; Williamson I, 2015, CAN MED ASSOC J, V187, P961, DOI 10.1503/cmaj.141608; Williamson Ian, 2011, BMJ Clin Evid, V2011	25	17	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2018	392	10147					557	568		10.1016/S0140-6736(18)31490-9	http://dx.doi.org/10.1016/S0140-6736(18)31490-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ8MN	30152390	Green Published, hybrid			2022-12-28	WOS:000442009500021
J	Gostin, LO; Hodge, JG				Gostin, Lawrence O.; Hodge, James G., Jr.			Substantial Shifts in Supreme Court Health Law Jurisprudence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Hodge, James G., Jr.] Arizona State Univ, Sandra Day OConnor Coll Law, Ctr Publ Hlth Law & Policy, Phoenix, AZ USA	Georgetown University; Arizona State University; Arizona State University-Downtown Phoenix	Gostin, LO (corresponding author), Georgetown Univ, Law Ctr, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Kavanaugh BM, 2016, HARVARD LAW REV, V129, P2118; Schmidt H, 2018, JAMA-J AM MED ASSOC, V319, P2265, DOI 10.1001/jama.2018.3384; Weiss DC, 2018, TRUMPS NOMINEE SUPRE	3	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2018	320	14					1431	1432		10.1001/jama.2018.12331	http://dx.doi.org/10.1001/jama.2018.12331			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW3IX	30193377	Green Published			2022-12-28	WOS:000446792500008
J	Mirbolouk, M; Charkhchi, P; Kianoush, S; Uddin, SMI; Orimoloye, OA; Jaber, R; Bhatnagar, A; Benjamin, EJ; Hall, ME; DeFilippis, AP; Maziak, W; Nasir, K; Blaha, MJ				Mirbolouk, Mohammadhassan; Charkhchi, Paniz; Kianoush, Sina; Uddin, S. M. Iftekhar; Orimoloye, Olusola A.; Jaber, Rana; Bhatnagar, Aruni; Benjamin, Emelia J.; Hall, Michael E.; DeFilippis, Andrew P.; Maziak, Wasim; Nasir, Khurram; Blaha, Michael J.			Prevalence and Distribution of E-Cigarette Use Among US Adults: Behavioral Risk Factor Surveillance System, 2016	ANNALS OF INTERNAL MEDICINE			English	Article							NICOTINE DELIVERY-SYSTEMS; ELECTRONIC CIGARETTES; UNITED-STATES; TOBACCO	Background: Contemporary data on the prevalence of e-cigarette use in the United States are limited. Objective: To report the prevalence and distribution of current e-cigarette use among U.S. adults in 2016. Design: Cross-sectional. Setting: Behavioral Risk Factor Surveillance System, 2016. Participants: Adults aged 18 years and older. Measurements: Prevalence of current e-cigarette use by sociodemographic groups, comorbid medical conditions, and states of residence. Results: Of participants with information on e-cigarette use (n = 466 842), 15 240 were current e-cigarette users, representing a prevalence of 4.5%, which corresponds to 10.8 million adult e-cigarette users in the United States. Of the e-cigarette users, 15% were never-cigarette smokers. The prevalence of current e-cigarette use was highest among persons aged 18 to 24 years (9.2% [95% CI, 8.6% to 9.8%]), translating to approximately 2.8 million users in this age range. More than half the current e-cigarette users (51.2%) were younger than 35 years. In addition, the age-standardized prevalence of e-cigarette use was high among men; lesbian, gay, bisexual, and transgender (LGBT) persons; current combustible cigarette smokers; and those with chronic health conditions. The prevalence of e-cigarette use varied widely among states, with estimates ranging from 3.1% (CI, 2.3% to 4.1%) in South Dakota to 7.0% (CI, 6.0% to 8.2%) in Oklahoma. Limitation: Data were self-reported, and no biochemical confirmation of tobacco use was available. Conclusion: E-cigarette use is common, especially in younger adults, LGBT persons, current cigarette smokers, and persons with comorbid conditions. The prevalence of use differs across states. These contemporary estimates may inform researchers, health care policymakers, and tobacco regulators about demographic and geographic distributions of e-cigarette use. Primary Funding Source: American Heart Association Tobacco Regulation and Addiction Center, which is funded by the U.S. Food and Drug Administration and National Heart, Lung, and Blood Institute.	[Mirbolouk, Mohammadhassan; Uddin, S. M. Iftekhar; Orimoloye, Olusola A.; Jaber, Rana; Bhatnagar, Aruni; Benjamin, Emelia J.; Hall, Michael E.; DeFilippis, Andrew P.; Blaha, Michael J.] Amer Heart Assoc Tobacco Regulat & Addict Ctr, Dallas, TX USA; [Mirbolouk, Mohammadhassan; Charkhchi, Paniz; Kianoush, Sina; Uddin, S. M. Iftekhar; Orimoloye, Olusola A.; Nasir, Khurram; Blaha, Michael J.] Johns Hopkins Univ, Baltimore, MD USA; [Charkhchi, Paniz] Univ Michigan, Ann Arbor, MI 48109 USA; [Kianoush, Sina; Nasir, Khurram] Yale Univ, Sch Med, New Haven, CT USA; [Jaber, Rana; Maziak, Wasim; Nasir, Khurram] Florida Int Univ, Miami, FL 33199 USA; [Bhatnagar, Aruni; DeFilippis, Andrew P.] Univ Louisville, Louisville, KY 40292 USA; [Benjamin, Emelia J.] Boston Univ, Boston, MA 02215 USA; [Hall, Michael E.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Maziak, Wasim] Syrian Ctr Tobacco Studies, Aleppo, Syria; [Nasir, Khurram] Yale Univ, Sch Med, Sect Cardiovasc Med, Populat Hlth & Hlth Syst Res,CORE, New Haven, CT USA	Johns Hopkins University; University of Michigan System; University of Michigan; Yale University; State University System of Florida; Florida International University; University of Louisville; Boston University; University of Mississippi; University of Mississippi Medical Center; Yale University	Mirbolouk, M (corresponding author), 600 North Wolfe St,Blalock 524D1, Baltimore, MD 21287 USA.	hassan.mirbolouk@jhmi.edu; mblaha1@jhmi.edu	Benjamin, Emelia/E-7103-2011; Mirbolouk, Mohammadhassan/J-5209-2019; Orimoloye, Olusola/L-1016-2019; Jaber, Rana/J-9106-2015	Benjamin, Emelia/0000-0003-4076-2336; Mirbolouk, Mohammadhassan/0000-0001-9612-3352; Orimoloye, Olusola/0000-0001-6858-1057; Jaber, Rana/0000-0001-9366-0320	American Heart Association Tobacco Regulation and Addiction Center; U.S. Food and Drug Administration; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL120163] Funding Source: NIH RePORTER	American Heart Association Tobacco Regulation and Addiction Center; U.S. Food and Drug Administration; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	American Heart Association Tobacco Regulation and Addiction Center, which is funded by the U.S. Food and Drug Administration and National Heart, Lung, and Blood Institute.	Apelberg BJ, 2018, NEW ENGL J MED, V378, P1725, DOI 10.1056/NEJMsr1714617; Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107; Centers for Disease Control and Prevention, 2017, LLCP 2016 COD REP BE; Centers for Disease Control and Prevention, 2017, BEH RISK FACT SURV S; Centers for Medicare & Medicaid Services, 2018, FED POV LIN; Cobb NK, 2011, NEW ENGL J MED, V365, P193, DOI 10.1056/NEJMp1105249; Coleman BN, 2017, TOB CONTROL, V26, pe117, DOI 10.1136/tobaccocontrol-2016-053462; Crowley RA, 2015, ANN INTERN MED, V162, P583, DOI 10.7326/M14-2481; Delnevo CD, 2016, NICOTINE TOB RES, V18, P715, DOI 10.1093/ntr/ntv237; Glasser AM, 2017, AM J PREV MED, V52, pE33, DOI 10.1016/j.amepre.2016.10.036; Jaber RM, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.117.008178, 10.1161/jaha.117.008178]; Kalkhoran S, 2016, LANCET RESP MED, V4, P116, DOI 10.1016/S2213-2600(15)00521-4; Kasza KA, 2017, NEW ENGL J MED, V376, P342, DOI 10.1056/NEJMsa1607538; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Murthy VH, 2017, JAMA PEDIATR, V171, P209, DOI 10.1001/jamapediatrics.2016.4662; Rigotti NA, 2018, ANN INTERN MED, V168, P666, DOI 10.7326/M18-0251; Rigotti NA, 2018, ANN INTERN MED, V168, P613, DOI 10.7326/M17-2048; Schoenborn Charlotte A, 2015, NCHS Data Brief, P1; Shahab L, 2017, ANN INTERN MED, V166, P390, DOI 10.7326/M16-1107; U. S. Census Bureau, 2017, QUICK FACTS US; U. S. Department of Health and Human Services, E CIG US YOUTH YOUNG; United States Government Department of Health and Human Services, 2016, FED REGISTER, V81, P28973; Wackowski OA, 2016, ANN INTERN MED, V165, P665, DOI 10.7326/M16-1345; Zhu SH, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3262	24	213	216	1	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2018	169	7					429	+		10.7326/M17-3440	http://dx.doi.org/10.7326/M17-3440			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV4BN	30167658				2022-12-28	WOS:000446042400002
J	Tricco, AC; Lillie, E; Zarin, W; O'Brien, KK; Colquhoun, H; Levac, D; Moher, D; Peters, MDJ; Horsley, T; Weeks, L; Hempel, S; Akl, EA; Chang, C; McGowan, J; Stewart, L; Hartling, L; Aldcroft, A; Wilson, MG; Garritty, C; Lewin, S; Godfrey, CM; Macdonald, MT; Langlois, EV; Soares-Weiser, K; Moriarty, J; Clifford, T; Tuncalp, O; Straus, SE				Tricco, Andrea C.; Lillie, Erin; Zarin, Wasifa; O'Brien, Kelly K.; Colquhoun, Heather; Levac, Danielle; Moher, David; Peters, Micah D. J.; Horsley, Tanya; Weeks, Laura; Hempel, Susanne; Akl, Elie A.; Chang, Christine; McGowan, Jessie; Stewart, Lesley; Hartling, Lisa; Aldcroft, Adrian; Wilson, Michael G.; Garritty, Chantelle; Lewin, Simon; Godfrey, Christina M.; Macdonald, Marilyn T.; Langlois, Etienne V.; Soares-Weiser, Karla; Moriarty, Jo; Clifford, Tammy; Tuncalp, Oezge; Straus, Sharon E.			PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation	ANNALS OF INTERNAL MEDICINE			English	Article							SYSTEMATIC REVIEWS; METAANALYSES	Scoping reviews, a type of knowledge synthesis, follow a systematic approach to map evidence on a topic and identify main concepts, theories, sources, and knowledge gaps. Although more scoping reviews are being done, their methodological and reporting quality need improvement. This document presents the PRISMA-ScR (Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews) checklist and explanation. The checklist was developed by a 24-member expert panel and 2 research leads following published guidance from the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network. The final checklist contains 20 essential reporting items and 2 optional items. The authors provide a rationale and an example of good reporting for each item. The intent of the PRISMA-ScR is to help readers (including researchers, publishers, commissioners, policymakers, health care providers, guideline developers, and patients or consumers) develop a greater understanding of relevant terminology, core concepts, and key items to report for scoping reviews.	[Tricco, Andrea C.; Lillie, Erin; Zarin, Wasifa; Straus, Sharon E.] St Michaels Hosp, Toronto, ON, Canada; [Tricco, Andrea C.; O'Brien, Kelly K.; Colquhoun, Heather; Straus, Sharon E.] Univ Toronto, Toronto, ON, Canada; [Levac, Danielle] Northeastern Univ, Boston, MA 02115 USA; [Moher, David; Garritty, Chantelle] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Peters, Micah D. J.] Univ South Australia, Adelaide, SA, Australia; [Peters, Micah D. J.] Univ Adelaide, Adelaide, SA, Australia; [Horsley, Tanya] Royal Coll Phys & Surg Canada, Ottawa, ON, Canada; [Weeks, Laura; Clifford, Tammy] Canadian Agcy Drugs & Technol Hlth, Ottawa, ON, Canada; [Hempel, Susanne] RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA; [Akl, Elie A.] Amer Univ Beirut, Beirut, Lebanon; [Chang, Christine] Agcy Healthcare Res & Quality, 5600 Fishers Lane, Rockville, MD 20857 USA; [McGowan, Jessie] Univ Ottawa, Ottawa, ON, Canada; [Stewart, Lesley] Univ York, York, N Yorkshire, England; [Hartling, Lisa] Univ Alberta, Edmonton, AB, Canada; [Aldcroft, Adrian] BMJ Open, London, England; [Wilson, Michael G.] McMaster Univ, Hamilton, ON, Canada; [Lewin, Simon] Norwegian Inst Publ Hlth, POB 4404, N-0403 Oslo, Norway; [Lewin, Simon] South African Med Res Council, Cape Town, South Africa; [Godfrey, Christina M.] Queens Univ, Kingston, ON, Canada; [Macdonald, Marilyn T.] Dalhousie Univ, Halifax, NS, Canada; [Langlois, Etienne V.; Tuncalp, Oezge] World Hlth Org, Geneva, Switzerland; [Soares-Weiser, Karla] Cochrane, London, England; [Moriarty, Jo] Kings Coll London, London, England; [Tricco, Andrea C.; Lillie, Erin; Zarin, Wasifa; Straus, Sharon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, 209 Victoria St,East Bldg, Toronto, ON M5B 1T8, Canada; [O'Brien, Kelly K.] Univ Toronto, Dept Phys Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Colquhoun, Heather] Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Levac, Danielle] Northeastern Univ, Bouve Coll Hlth Sci, Dept Phys Therapy Movement & Rehabil Sci, 360 Huntington Ave, Boston, MA 02115 USA; [Moher, David; Garritty, Chantelle] Ottawa Hosp, Ctr Journalol, Res Inst, 501 Smyth Rd,POB 201B, Ottawa, ON K1H 8L6, Canada; [Peters, Micah D. J.] Univ South Australia, Div Hlth Sci, Sansom Inst Hlth Res, Rosemary Bryant AO Res Ctr, Adelaide, SA 5000, Australia; [Horsley, Tanya] Royal Coll Phys & Surg, 774 Echo Dr, Ottawa, ON K1S 5N8, Canada; [Weeks, Laura; Clifford, Tammy] CADTH, 865 Carling Ave,Suite 600, Ottawa, ON K1S 5S8, Canada; [Akl, Elie A.] Amer Univ Beirut, Fac Med, Dept Internal Med, Gefinor Ctr, Block B,4th Floor, Beirut, Lebanon; [McGowan, Jessie] Univ Ottawa, Dept Med, Roger Guindon Hall,451 Smyth Rd, Ottawa, ON K1H 8M5, Canada; [Stewart, Lesley] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Hartling, Lisa] Univ Alberta, Fac Med & Dent, Dept Pediat, 11405-87 Ave, Edmonton, AB T6G 1C9, Canada; [Aldcroft, Adrian] BMJ Open Editorial Off, BMA House,Tavistock Sq, London WC1H 9JR, England; [Wilson, Michael G.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, 1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Godfrey, Christina M.] Queens Univ, Sch Nursing, Queens Collaborat Hlth Care Quality, JBI Ctr Excellence, 992 Univ Ave,Barrie St, Kingston, ON K7L 3N6, Canada; [Macdonald, Marilyn T.] Dalhousie Univ, Sch Nursing, POB 15000,5869 Univ Ave, Halifax, NS B3H 4R2, Canada; [Langlois, Etienne V.] World Hlth Org, Alliance Hlth Policy & Syst Res, Ave Appia 20, CH-1211 Geneva, Switzerland; [Soares-Weiser, Karla] Cochrane, Cochrane Editorial Unit, St Albans House,57-59 Haymarket, London SW1Y 4QX, England; [Moriarty, Jo] Kings Coll London, Social Care Workforce Res Unit, London WC2R 2LS, England; [Tuncalp, Oezge] World Hlth Org, Dept Reprod Hlth & Res, Ave Appia 20, CH-1211 Geneva, Switzerland	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Northeastern University; University of Ottawa; Ottawa Hospital Research Institute; University of South Australia; University of Adelaide; RAND Corporation; American University of Beirut; University of Ottawa; University of York - UK; University of Alberta; McMaster University; Norwegian Institute of Public Health (NIPH); South African Medical Research Council; Queens University - Canada; Dalhousie University; World Health Organization; University of London; King's College London; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Northeastern University; University of Ottawa; Ottawa Hospital Research Institute; University of South Australia; American University of Beirut; University of Ottawa; University of York - UK; University of Alberta; McMaster University; Queens University - Canada; Dalhousie University; World Health Organization; University of London; King's College London; World Health Organization	Tricco, AC (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, 209 Victoria St,East Bldg, Toronto, ON M5B 1W8, Canada.	triccoa@smh.ca	O'Brien, Kelly/AFM-2205-2022; Lewin, Simon/HCH-1959-2022; Macdonald, Marilyn/X-3848-2019; Horsley, Tanya/AAH-8348-2020; Tricco, Andrea/B-9920-2011; , Micah/C-1951-2018; Akl, Elie/K-5269-2019; Garritty, Chantelle/ABG-7790-2020; Tunçalp, Ӧzge/Y-2724-2018; Garritty, Chantelle Marie/AAC-4136-2022; Levac, Danielle/O-9008-2015	Horsley, Tanya/0000-0002-1256-9582; Tricco, Andrea/0000-0002-4114-8971; , Micah/0000-0002-1108-3783; Tunçalp, Ӧzge/0000-0002-5370-682X; Stewart, Lesley/0000-0003-0287-4724; Levac, Danielle/0000-0001-7356-9335; Hempel, Susanne/0000-0003-1597-5110; Aldcroft, Adrian/0000-0003-0106-720X; Macdonald, Marilyn/0000-0002-0204-6278; Gomez-Reino, Juan/0000-0001-5229-6294	Canadian Institutes of Health Research [KRS 144046]; Tier 2 Canada Research Chair in Knowledge Synthesis; Canadian Institutes of Health Research New Investigator Award; Tier 1 Canada Research Chair in Knowledge Translation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Tier 2 Canada Research Chair in Knowledge Synthesis; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair in Knowledge Translation	By Knowledge Synthesis grant KRS 144046 from the Canadian Institutes of Health Research. Dr. Tricco is funded by a Tier 2 Canada Research Chair in Knowledge Synthesis. Dr. O'Brien was supported by a Canadian Institutes of Health Research New Investigator Award. Dr. Straus is funded by a Tier 1 Canada Research Chair in Knowledge Translation.	Altman DG, 2014, GUIDELINES REPORTING, P32, DOI [10.1002/9781118715598.ch4, DOI 10.1002/9781118715598.CH4]; [Anonymous], 2016, NON TRADITIONAL REF; Arksey, 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Beller EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001419; *BIOMED CENTR, 2018, NON TRADITIONAL REF; Booth A, 2006, LIBR HI TECH, V24, P355, DOI 10.1108/07378830610692127; CADTH, 2018, GREY MATT PRACT TOOL; Canadian Institutes of Health Research, 2010, GUID KNOWL SYNTH KNO; Cardoso R, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0569-5; Colquhoun HL, 2014, J CLIN EPIDEMIOL, V67, P1291, DOI 10.1016/j.jclinepi.2014.03.013; Constand MK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-271; Duffett M, 2013, CRIT CARE, V17, DOI 10.1186/cc13083; EQUATOR Network, 2017, PREF REP IT SYST REV; Galloway T, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18698; Hall AJ, 2017, PHYSIOTHERAPY, V103, P361, DOI 10.1016/j.physio.2017.01.001; HAYNES RB, 1990, ANN INTERN MED, V113, P69, DOI 10.7326/0003-4819-113-1-69; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hosking J, 2012, ENVIRON HEALTH PERSP, V120, P1076, DOI 10.1289/ehp.1104093; Hutchinson J, 2015, INT J ENV RES PUB HE, V12, P4833, DOI 10.3390/ijerph120504833; Joanna Briggs Institute, 2015, J BRIGGS I REV MAN 2; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Lenzen SA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188822; Leung M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194565; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Lourida I, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0528-y; Macaskill P, 2010, COCHRANE HDB SYSTEMA; McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021; McInnes MDF, 2015, RADIOLOGY, V277, P13, DOI 10.1148/radiol.2015142779; Miake-Lye IM, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0204-x; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; O'Brien KK, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1579-z; Peters M.D.J., 2017, J BRIGGS I REV MANUA, DOI DOI 10.46658/JBIMES-20-01; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Piskur B, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-177; PRISMA, 2015, EXT DEV PREF REP IT; Richardson W S, 1995, ACP J Club, V123, pA12; San A, 2017, DEMENT GERIATR COGN, V44, P182, DOI 10.1159/000479679; Sav A, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0411-8; Schmucker C, 2013, BUNDESGESUNDHEITSBLA, V56, P1390, DOI 10.1007/s00103-013-1818-y; Strand M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2176-5; The Royal Institute of International Affairs, 2018, CHATH HOUS RUL; Tricco AC, 2018, J CLIN EPIDEMIOL, V96, P133, DOI 10.1016/j.jclinepi.2017.10.014; Tricco AC, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0717-x; Tricco AC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013474; Tricco AC, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0116-4; Tricco AC, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0465-6; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; World Health Organization, 2018, ALL HLTH POL SYST RE; Zarin W, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0764-6	50	6843	6987	59	305	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2018	169	7					467	+		10.7326/M18-0850	http://dx.doi.org/10.7326/M18-0850			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV4BN	30178033	Green Accepted			2022-12-28	WOS:000446042400006
J	Lu, MC				Lu, Michael C.			Reducing Maternal Mortality in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORBIDITY		[Lu, Michael C.] George Washington Univ, Sch Publ Hlth, Milken Inst, 950 New Hampshire Ave NW,Ste 219, Washington, DC 20052 USA	George Washington University	Lu, MC (corresponding author), George Washington Univ, Sch Publ Hlth, Milken Inst, 950 New Hampshire Ave NW,Ste 219, Washington, DC 20052 USA.	mclu@gwu.edu						Caughey AB, 2017, JAMA-J AM MED ASSOC, V318, P1765, DOI 10.1001/jama.2017.16189; Centers for Disease Control and Prevention, PREGNANCY MORTALITY; Council on Patient Safety in Women's Health Care, ALLIANCE FOR INNOVAT; Lisonkova S, 2017, JAMA-J AM MED ASSOC, V318, P1777, DOI 10.1001/jama.2017.16191; Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969; MacDorman MF, 2016, OBSTET GYNECOL, V128, P447, DOI 10.1097/AOG.0000000000001556; Main EK, 2018, CLIN OBSTET GYNECOL, V61, P319, DOI 10.1097/GRF.0000000000000361; Main EK, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.017; Review to Action, REPORT FROM NINE MAT	9	35	35	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2018	320	12					1237	1238		10.1001/jama.2018.11652	http://dx.doi.org/10.1001/jama.2018.11652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU8GX	30208484				2022-12-28	WOS:000445577000010
J	Genao, I; Gelman, J				Genao, Inginia; Gelman, Jacob			The MCAT's Restrictive Effect on the Minority Physician Pipeline: A Legal Perspective	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Genao, Inginia] Yale Univ, Sch Med, New Haven, CT USA; [Gelman, Jacob] Yale Law Sch, New Haven, CT USA	Yale University; Yale University	Genao, I (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208025, New Haven, CT 06520 USA.	Inginia.genao@yale.edu						Association of American Medical Colleges, 2016, TABL A 18 MCAT SCOR; Association of American Medical Colleges, 2017, UND MED DEF; Barr Donald, 2010, QUESTIONING PREMEDIC; Camara WJ, 1999, GROUP DIFFERENCES ST; Muller D, 2010, ACAD MED, V85, P1378, DOI 10.1097/ACM.0b013e3181dbf22a; Rodriguez JE, 2015, J IMMIGR MINOR HEALT, V17, P981, DOI 10.1007/s10903-014-0054-3; Sturman N, 2013, MED EDUC, V47, P542, DOI 10.1111/medu.12211; Witzburg RA, 2013, NEW ENGL J MED, V368, P1565, DOI 10.1056/NEJMp1300411	8	5	5	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2018	169	6					403	+		10.7326/M18-0545	http://dx.doi.org/10.7326/M18-0545			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT7CZ	30167628				2022-12-28	WOS:000444679800019
J	Wood, E; Albarqouni, L; Tkachuk, S; Green, CJ; Ahamad, K; Nolan, S; McLean, M; Klimas, J				Wood, Evan; Albarqouni, Loai; Tkachuk, Stacey; Green, Carolyn J.; Ahamad, Keith; Nolan, Seonaid; McLean, Mark; Klimas, Jan			Will This Hospitalized Patient Develop Severe Alcohol Withdrawal Syndrome? The Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DELIRIUM-TREMENS; GENERAL-POPULATION; RATING-SCALE; PREDICTORS; MANAGEMENT; RELIABILITY; COMPLICATIONS; METAANALYSIS; DEPENDENCE; SEIZURES	IMPORTANCE Although severe alcohol withdrawal syndrome (SAWS) is associated with substantial morbidity and mortality, most at-risk patients will not develop this syndrome. Predicting its occurrence is important because the mortality rate is high when untreated. OBJECTIVE To assess the accuracy and predictive value of symptoms and signs for identifying hospitalized patients at risk of SAWS, defined as delirium tremens, withdrawal seizure, or clinically diagnosed severe withdrawal. DATA SOURCES MEDLINE and EMBASE (1946-January 2018) were searched for articles investigating symptoms and signs predictive of SAWS in adults. Reference lists of retrieved articles were also searched. STUDY SELECTION Original studies that were included compared symptoms, signs, and risk assessment tools among patients who developed SAWS and patients who did not. DATA EXTRACTION AND SYNTHESIS Data were extracted and used to calculate likelihood ratios (LRs), sensitivity, and specificity. A meta-analysis was performed to calculate summary LR. RESULTS Of 530 identified studies, 14 high-quality studies that included 71 295 patients and 1355 relevant cases of SAWS (1051 cases), seizure (53 cases), or delirium tremens (251 cases) were analyzed. A history of delirium tremens (LR, 2.9 [95% CI 1.7-5.2]) and baseline systolic blood pressure 140 mm Hg or higher (LR, 1.7 [95% CI, 1.3-2.3) were associated with an increased likelihood of SAWS. No single symptom or sign was associated with exclusion of SAWS. Six high-quality studies evaluated combinations of clinical findings and were useful for identifying patients in acute care facilities at high risk of developing SAWS. Of these combinations, the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) was most useful, with an LR of 174 (95% CI, 43-696; specificity, 0.93) when patients had 4 or more individual findings and an LR of 0.07 (95% CI, 0.02-0.26; sensitivity, 0.99) when there were 3 or fewer findings. CONCLUSIONS AND RELEVANCE Assessment tools that use a combination of symptoms and signs are useful for identifying patients at risk of developing severe alcohol withdrawal syndrome. Most studies of these tools were not fully validated, limiting their generalizability.	[Wood, Evan; Ahamad, Keith; Nolan, Seonaid; McLean, Mark; Klimas, Jan] British Columbia Ctr Substance Use, Vancouver, BC, Canada; [Wood, Evan; Tkachuk, Stacey; Green, Carolyn J.; Ahamad, Keith; Nolan, Seonaid; McLean, Mark; Klimas, Jan] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Albarqouni, Loai] Bond Univ, Robina, Qld, Australia	University of British Columbia; Bond University	Wood, E (corresponding author), Univ British Columbia, BC Ctr Subst Use, 400-1045 Howe St, Vancouver, BC V6Z 2A9, Canada.	bccsu-ew@bccsu.ubc.ca	Klimas, Jan/E-7191-2010; Albarqouni, Loai/I-1295-2019	Klimas, Jan/0000-0002-5179-0052; Albarqouni, Loai/0000-0002-4114-9106	Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine; ELEVATE grant from the Irish Research Council International Career Development Fellowship [PD/2014]; Marie Curie Actions; European Commission [7 01698]; Canadian Institutes of Health Research Embedded Clinician Scientist Award; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA037756] Funding Source: NIH RePORTER	Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine(Canada Research Chairs); ELEVATE grant from the Irish Research Council International Career Development Fellowship; Marie Curie Actions(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Canadian Institutes of Health Research Embedded Clinician Scientist Award(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported in part by funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine (Dr Wood); the ELEVATE grant PD/2014 from the Irish Research Council International Career Development Fellowship, cofunded by Marie Curie Actions; and grant 7 01698 from the European Commission (Dr Klimas). Dr Ahamad is supported by a Canadian Institutes of Health Research Embedded Clinician Scientist Award.	Amato L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005063.pub3; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2015, Prescrire Int, V24, P300; [Anonymous], 2005, COMPREHENSIVE METAAN; Babor T., 2001, BRIEF INTERVENTION H; Berggren U, 2009, ALCOHOL ALCOHOLISM, V44, P382, DOI 10.1093/alcalc/agp012; Brathen G, 2000, J NEUROL NEUROSUR PS, V68, P342, DOI 10.1136/jnnp.68.3.342; Caetano R, 1998, ALCOHOL HEALTH RES W, V22, P73; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cummings P, 2011, ARCH PEDIAT ADOL MED, V165, P592, DOI 10.1001/archpediatrics.2011.97; Denis CM, 2015, DRUG ALCOHOL DEPEN, V153, P229, DOI 10.1016/j.drugalcdep.2015.05.019; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doering-Silveira J, 2014, INT J ENV RES PUB HE, V11, P5783, DOI 10.3390/ijerph110605783; Dolman JM, 2005, ALCOHOL ALCOHOLISM, V40, P515, DOI 10.1093/alcalc/agh189; Erwin WE, 1998, SOUTHERN MED J, V91, P425, DOI 10.1097/00007611-199805000-00003; Eyer F, 2011, ALCOHOL ALCOHOLISM, V46, P427, DOI 10.1093/alcalc/agr053; Fiellin David A, 2002, Subst Abus, V23, P83, DOI 10.1023/A:1015350005418; Goodson CM, 2014, ALCOHOL CLIN EXP RES, V38, P2664, DOI 10.1111/acer.12529; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Haynes RB, 2005, BMJ-BRIT MED J, V330, P1179, DOI 10.1136/bmj.38446.498542.8F; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Hillbom M, 2003, CNS DRUGS, V17, P1013, DOI 10.2165/00023210-200317140-00002; Kapur JH, 2010, INT J ENV RES PUB HE, V7, P1174, DOI 10.3390/ijerph7031174; Kim DW, 2015, AM J EMERG MED, V33, P701, DOI 10.1016/j.ajem.2015.02.030; KITCHENS JM, 1994, JAMA-J AM MED ASSOC, V272, P1782, DOI 10.1001/jama.272.22.1782; Knight E, 2017, CAN FAM PHYSICIAN, V63, P691; Kraemer Kevin L, 2003, Subst Abus, V24, P197, DOI 10.1023/A:1026099426602; Lee JH, 2005, J GASTROEN HEPATOL, V20, P1833, DOI 10.1111/j.1440-1746.2005.03932.x; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Littleton J, 1998, ALCOHOL HEALTH RES W, V22, P13; Maldonado JR, 2017, CRIT CARE CLIN, V33, P559, DOI 10.1016/j.ccc.2017.03.012; Maldonado JR, 2015, ALCOHOL ALCOHOLISM, V50, P509, DOI 10.1093/alcalc/agv043; Management of Substance Abuse Unit, 2016, GLOB STAT REP ALC HL; MayoSmith MF, 1997, JAMA-J AM MED ASSOC, V278, P144, DOI 10.1001/jama.278.2.144; McKeon A, 2008, J NEUROL NEUROSUR PS, V79, P854, DOI 10.1136/jnnp.2007.128322; Medina J., DSM 5 ALCOHOL WITHDR; Mirijello A, 2015, DRUGS, V75, P353, DOI 10.1007/s40265-015-0358-1; Monte R, 2009, EUR J INTERN MED, V20, P690, DOI 10.1016/j.ejim.2009.07.008; National Institute on Alcohol Abuse and Alcoholism, 2016, NIH PUBL, V15-3770; Peacock A, 2018, ADDICTION, DOI [10.1111/add14234, DOI 10.1111/ADD14234]; Pecoraro A, 2014, J GEN INTERN MED, V29, P34, DOI 10.1007/s11606-013-2551-9; Pierucci-Lagha A, 2007, DRUG ALCOHOL DEPEN, V91, P85, DOI 10.1016/j.drugalcdep.2007.04.014; Rehm J, 2016, ALCOHOL ALCOHOLISM, V51, P422, DOI 10.1093/alcalc/agv127; Salottolo K, 2017, CRIT CARE MED, V45, P867, DOI 10.1097/CCM.0000000000002371; Schmidt KJ, 2016, ANN PHARMACOTHER, V50, P389, DOI 10.1177/1060028016629161; Schuckit MA, 2014, NEW ENGL J MED, V371, P2109, DOI 10.1056/NEJMra1407298; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Simel DL, 2013, J CLIN EPIDEMIOL, V66, P458, DOI 10.1016/j.jclinepi.2012.07.014; Simel DL, 2009, J CLIN EPIDEMIOL, V62, P1292, DOI 10.1016/j.jclinepi.2009.02.007; Simel DL, 2008, RATIONAL CLIN EXAMIN, P9; Stephane M, 2018, PSYCHIAT RES, V262, P129, DOI 10.1016/j.psychres.2018.02.021; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Trevisan LA, 1998, ALCOHOL HEALTH RES W, V22, P61; TSUANG JW, 1994, ADDICTION, V89, P73, DOI 10.1111/j.1360-0443.1994.tb00851.x; Wartenberg AA, 2014, ASAM PRINCIPLES ADDI, P635; Wetterling T, 1997, ALCOHOL ALCOHOLISM, V32, P753; Wetterling T, 2006, ALCOHOL ALCOHOLISM, V41, P611, DOI 10.1093/alcalc/agl068; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; Williams D, 2001, ALCOHOL ALCOHOLISM, V36, P104, DOI 10.1093/alcalc/36.2.104	60	38	38	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2018	320	8					825	833		10.1001/jama.2018.10574	http://dx.doi.org/10.1001/jama.2018.10574			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GR8HM	30167704	Green Accepted, Green Submitted			2022-12-28	WOS:000442958800026
J	Fulde, M; Sommer, F; Chassaing, B; van Vorst, K; Dupont, A; Hensel, M; Basic, M; Klopfleisch, R; Rosenstiel, P; Bleich, A; Backhed, F; Gewirtz, AT; Hornef, MW				Fulde, Marcus; Sommer, Felix; Chassaing, Benoit; van Vorst, Kira; Dupont, Aline; Hensel, Michael; Basic, Marijana; Klopfleisch, Robert; Rosenstiel, Philip; Bleich, Andre; Backhed, Fredrik; Gewirtz, Andrew T.; Hornef, Mathias W.			Neonatal selection by Toll-like receptor 5 influences long-term gut microbiota composition (vol 560, pg 489, 2018)	NATURE			English	Correction													Rosenstiel, Philip/A-5137-2009; Backhed, Fredrik/ABE-6613-2020	Rosenstiel, Philip/0000-0002-9692-8828; Backhed, Fredrik/0000-0002-4871-8818; Hornef, Mathias/0000-0001-6096-9110				Fulde M, 2018, NATURE, V560, P489, DOI 10.1038/s41586-018-0395-5	1	2	2	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2018	563	7731					E25	E25		10.1038/s41586-018-0507-2	http://dx.doi.org/10.1038/s41586-018-0507-2			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA2EY	30158704	Bronze			2022-12-28	WOS:000450048400013
J	Zhao, QC; Zhou, H; Chi, SP; Wang, YF; Wang, JH; Geng, J; Wu, K; Liu, WH; Zhang, TX; Dong, MQ; Wang, JW; Li, XM; Xiao, BL				Zhao, Qiancheng; Zhou, Heng; Chi, Shaopeng; Wang, Yanfeng; Wang, Jianhua; Geng, Jie; Wu, Kun; Liu, Wenhao; Zhang, Tingxin; Dong, Meng-Qiu; Wang, Jiawei; Li, Xueming; Xiao, Bailong			Structure and mechanogating mechanism of the Piezo1 channel (vol 554, pg 487, 2018)	NATURE			English	Correction													Zhang, Tingxin/GWC-9888-2022					Zhao QC, 2018, NATURE, V554, P487, DOI 10.1038/nature25743	1	4	5	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					E19	E19		10.1038/s41586-018-0513-4	http://dx.doi.org/10.1038/s41586-018-0513-4			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA1AK	30202093	Bronze			2022-12-28	WOS:000449943600002
J	Watters, KE; Fellmann, C; Bai, HB; Ren, SM; Doudna, JA				Watters, Kyle E.; Fellmann, Christof; Bai, Hua B.; Ren, Shawn M.; Doudna, Jennifer A.			Systematic discovery of natural CRISPR-Cas12a inhibitors	SCIENCE			English	Article							CRISPR-CAS; ANTI-CRISPR; RNA; ACRIIA4	Cas12a (Cpf1) is a CRISPR-associated nuclease with broad utility for synthetic genome engineering, agricultural genomics, and biomedical applications. Although bacteria harboring CRISPR-Cas9 or CRISPR-Cas3 adaptive immune systems sometimes acquire mobile genetic elements encoding anti-CRISPR proteins that inhibit Cas9, Cas3, or the DNA-binding Cascade complex, no such inhibitors have been found for CRISPR-Cas12a. Here we use a comprehensive bioinformatic and experimental screening approach to identify three different inhibitors that block or diminish CRISPR-Cas12a-mediated genome editing in human cells. We also find a widespread connection between CRISPR self-targeting and inhibitor prevalence in prokaryotic genomes, suggesting a straightforward path to the discovery of many more anti-CRISPRs from the microbial world.	[Watters, Kyle E.; Fellmann, Christof; Bai, Hua B.; Ren, Shawn M.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Fellmann, Christof; Doudna, Jennifer A.] Gladstone Inst, San Francisco, CA 94158 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Li Ka Shing Biomed & Hlth Sci Ctr, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Stanford University; Li Ka Shing Center; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Li Ka Shing Biomed & Hlth Sci Ctr, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	doudna@berkeley.edu		Bai, Hua/0000-0001-5749-5559; Fellmann, Christof/0000-0002-9545-5723	Defense Advanced Research Projects Agency (DARPA) [HR0011-17-2-0043]; Allen Distinguished Investigator Program through the Paul G. Allen Frontiers Group; National Science Foundation [MCB-1244557]; U.S. National Institutes of Health K99/R00 Pathway to Independence Award from the National Institute of General Medical Sciences [K99GM118909, R00GM118909]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM118909, K99GM118909] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Allen Distinguished Investigator Program through the Paul G. Allen Frontiers Group; National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health K99/R00 Pathway to Independence Award from the National Institute of General Medical Sciences; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was developed with funding from the Defense Advanced Research Projects Agency (DARPA) award HR0011-17-2-0043. The views, opinions, and/or findings expressed are those of the author and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. government. Approved for public release; distribution is unlimited. This research was also supported by the Allen Distinguished Investigator Program, through the Paul G. Allen Frontiers Group, and the National Science Foundation (MCB-1244557 to J.A.D.). C.F. is supported by a U.S. National Institutes of Health K99/R00 Pathway to Independence Award (K99GM118909 and R00GM118909) from the National Institute of General Medical Sciences. J.A.D. is an investigator of the Howard Hughes Medical Institute (HHMI), and this study was supported in part by HHMI; J.A.D is also a Paul Allen Distinguished Investigator.	Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Basgall EM, 2018, MICROBIOL-SGM, V164, P464, DOI 10.1099/mic.0.000635; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2018, ACS CHEM BIOL, V13, P417, DOI 10.1021/acschembio.7b00831; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Dickey AM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0316-2; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; Fellmann C, 2017, NAT REV DRUG DISCOV, V16, P89, DOI 10.1038/nrd.2016.238; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; He F, 2018, NAT MICROBIOL, V3, P461, DOI 10.1038/s41564-018-0120-z; Heussler GE, 2016, J BACTERIOL, V198, P1481, DOI 10.1128/JB.00086-16; Hudson CM, 2015, NUCLEIC ACIDS RES, V43, pD48, DOI 10.1093/nar/gku1072; Hynes AP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05092-w; Hynes AP, 2017, NAT MICROBIOL, V2, P1374, DOI 10.1038/s41564-017-0004-7; Jackson SA, 2017, SCIENCE, V356, DOI 10.1126/science.aal5056; Marino ND, 2018, SCIENCE, V362, P240, DOI 10.1126/science.aau5174; Marshall R, 2018, MOL CELL, V69, P146, DOI 10.1016/j.molcel.2017.12.007; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Shin J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701620; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sun ZZ, 2013, JOVE-J VIS EXP, DOI 10.3791/50762; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yang H, 2017, MOL CELL, V67, P117, DOI 10.1016/j.molcel.2017.05.024; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	30	101	103	7	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2018	362	6411			SI		236	239		10.1126/science.aau5138	http://dx.doi.org/10.1126/science.aau5138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW9RX	30190307	Green Accepted			2022-12-28	WOS:000447337200018
J	Minzel, W; Venkatachalam, A; Fink, A; Hung, E; Brachya, G; Burstain, I; Shaham, M; Rivlin, A; Omer, I; Zinger, A; Elias, S; Winter, E; Erdman, PE; Sullivan, RW; Fung, L; Mercurio, F; Li, DS; Vacca, J; Kaushansky, N; Shlush, L; Oren, M; Levine, R; Pikarsky, E; Snir-Alkalay, I; Ben-Neriah, Y				Minzel, Waleed; Venkatachalam, Avanthika; Fink, Avner; Hung, Eric; Brachya, Guy; Burstain, Ido; Shaham, Maya; Rivlin, Amitai; Omer, Itay; Zinger, Adar; Elias, Shlomo; Winter, Eitan; Erdman, Paul E.; Sullivan, Robert W.; Fung, Leah; Mercurio, Frank; Li, Dansu; Vacca, Joseph; Kaushansky, Nathali; Shlush, Liran; Oren, Moshe; Levine, Ross; Pikarsky, Eli; Snir-Alkalay, Irit; Ben-Neriah, Yinon			Small Molecules Co-targeting CKI alpha and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; BETA-CATENIN; DEL(5Q) MDS; STEM-CELLS; P53; CANCER; THERAPY; INHIBITION; DEGRADATION; RECRUITMENT	CKI alpha wablation induces p53 activation, and CKI alpha degradation underlies the therapeutic effect of lenalidomide in a pre-leukemia syndrome. Here we describe the development of CKI alpha inhibitors, which co-target the transcriptional kinases CDK7 and CDK9, thereby augmenting CKI alpha-induced p53 activation and its anti-leukemic activity. Oncogene-driving super-enhancers (SEs) are highly sensitive to CDK7/9 inhibition. We identified multiple newly gained SEs in primary mouse acute myeloid leukemia (AML) cells and demonstrate that the inhibitors abolish many SEs and preferentially suppress the transcription elongation of SE-driven on-cogenes. We show that blocking CKI alpha together with CDK7 and/or CDK9 synergistically stabilize p53, deprive leukemia cells of survival and proliferation-maintaining SE-driven oncogenes, and induce apoptosis. Leukemia progenitors are selectively eliminated by the inhibitors, explaining their therapeutic efficacy with preserved hematopoiesis and leukemia cure potential; they eradicate leukemia in MLL-AF9 and Tet2(-/-); Flt3(ITD) AML mouse models and in several patient-derived AML xenograft models, supporting their potential efficacy in curing human leukemia.	[Minzel, Waleed; Venkatachalam, Avanthika; Fink, Avner; Hung, Eric; Brachya, Guy; Burstain, Ido; Shaham, Maya; Rivlin, Amitai; Omer, Itay; Zinger, Adar; Elias, Shlomo; Pikarsky, Eli; Snir-Alkalay, Irit; Ben-Neriah, Yinon] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, Jerusalem, Israel; [Elias, Shlomo] Hebrew Univ Jerusalem, Hadassah Med Sch, Hadassah Med Ctr, Dept Hematol, Jerusalem, Israel; [Winter, Eitan] Hebrew Univ Jerusalem, Hadassah Med Sch, I CORE Computat Ctr, Bioinformat Unit, Jerusalem, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Hadassah Med Ctr, Dept Pathol, Jerusalem, Israel; [Erdman, Paul E.; Sullivan, Robert W.; Fung, Leah; Mercurio, Frank] BioTheryX Inc, San Diego, CA USA; [Li, Dansu; Vacca, Joseph] WuXi AppTec, Shanghai, Peoples R China; [Kaushansky, Nathali; Shlush, Liran] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Oren, Moshe] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Levine, Ross] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Weizmann Institute of Science; Weizmann Institute of Science; Memorial Sloan Kettering Cancer Center	Ben-Neriah, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, Jerusalem, Israel.	yinonb@ekmd.huji.ac.il	levine, ross/AAE-7658-2019; pikarsky, eli/GXV-7099-2022; Ben-Neriah, Yinon/L-6285-2019; Elias, Shlomo/ABF-9933-2021	Hung, Eric/0000-0002-7943-5589; Oren, Moshe/0000-0003-4311-7172; pikarsky, eli/0000-0003-4186-7105	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation (ISF)-Centers of Excellence; European Research Council [294390 PICHO, 281738 LIVERMICROENV]; Israel Cancer Research Fund Professorship; Memorial Sloan Kettering Cancer Center Support Grant [NIH P30 CA008748]; NATIONAL CANCER INSTITUTE [U10CA180827, R01CA216421, R01CA169784, R01CA173636, R01CA151949, P30CA008748, R33CA196411, R35CA197594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK104331] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation (ISF)-Centers of Excellence; European Research Council(European Research Council (ERC)European Commission); Israel Cancer Research Fund Professorship; Memorial Sloan Kettering Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Amotz Frenkel for assistance with leukemia animal studies, Drs. Kevan Shokat (Cellular and Molecular Pharmacology, UCSF) and Kyle Chen (BioTheryX) for fruitful project discussions, Dr. Mark Minden (Ontario Cancer Institute- Princess Margaret Hospital, Toronto, Canada) for providing AML PDXs, Jeremy Hunt (DiscoverX, Fremont, California, USA) for the compound-kinome interaction analysis and data interpretation, and the Technion Genome Center, Technion-Israel Institute of Technology for sequencing. We are grateful to the Dr. Berta Strulovici, Dr. Noga Kozer and Dr. Haim Barr (The Nancy and Stephen Grand, Israel National Center for Personalized Medicine, The Weizmann Institute, Rehovot, Israel) for running the kinase library screens and CreluxWuXi AppTec crystallography team (Martinsried, Germany) for assisting in solving the structures of inhibitor-bound CKIa, CKId and CDK9. We also thank Liming Xue at WuXi AppTec for the synthesis of compounds in Figure 1. This work was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) (to Y.B.-N., M.O., and E.P.), Israel Science Foundation (ISF)-Centers of Excellence (to Y. B.-N., M.O., and E.P.), the European Research Council within the FP-7 (294390 PICHO to Y.B.-N. and 281738 LIVERMICROENV to E.P.), Israel Cancer Research Fund Professorship (to Y.B.-N.), and Memorial Sloan Kettering Cancer Center Support Grant (NIH P30 CA008748 to RL.).	Abraham SA, 2016, NATURE, V534, P341, DOI 10.1038/nature18288; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Boddu P, 2017, BLOOD ADV, V1, P1312, DOI 10.1182/bloodadvances.2017008227; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Chang CH, 2017, P NATL ACAD SCI USA, V114, pE8035, DOI 10.1073/pnas.1702763114; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Coombs CC, 2016, NAT REV CLIN ONCOL, V13, P305, DOI 10.1038/nrclinonc.2015.210; Damalas A, 1999, EMBO J, V18, P3054, DOI 10.1093/emboj/18.11.3054; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dombret H, 2016, BLOOD, V127, P53, DOI 10.1182/blood-2015-08-604520; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Ferguson FM, 2018, NAT REV DRUG DISCOV, V17, P353, DOI 10.1038/nrd.2018.21; Henriques T, 2018, GENE DEV, V32, P26, DOI 10.1101/gad.309351.117; Jaras M, 2014, J EXP MED, V211, P605, DOI 10.1084/jem.20131033; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knippschild U, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00096; Kojima K, 2016, EXP HEMATOL, V44, P791, DOI 10.1016/j.exphem.2016.05.014; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lu HS, 2018, NATURE, V558, P318, DOI 10.1038/s41586-018-0174-3; Nakagawa H, 2016, P NATL ACAD SCI USA, V113, P6248, DOI 10.1073/pnas.1604765113; Ntziachristos P, 2016, NAT IMMUNOL, V17, P1016, DOI 10.1038/ni.3517; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Park SM, 2015, J CLIN INVEST, V125, P1286, DOI 10.1172/JCI78440; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005; Salami J, 2017, SCIENCE, V355, P1163, DOI 10.1126/science.aam7340; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Shafer D, 2016, BLOOD REV, V30, P275, DOI 10.1016/j.blre.2016.02.001; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Stark R., 2011, R PACKAGE VERSION, V100, P1; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Widmer N, 2014, EUR J CANCER, V50, P2020, DOI 10.1016/j.ejca.2014.04.015; Wilson CS, 2015, AM J CLIN PATHOL, V144, P219, DOI 10.1309/AJCPO58YWIBUBESX; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004; Zaborowska J, 2016, NAT STRUCT MOL BIOL, V23, P771, DOI 10.1038/nsmb.3285; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	48	75	77	5	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	2018	175	1					171	+		10.1016/j.cell.2018.07.045	http://dx.doi.org/10.1016/j.cell.2018.07.045			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GU2SI	30146162	Green Accepted, Bronze			2022-12-28	WOS:000445120000022
J	Spyropoulos, AC; Ageno, W; Albers, GW; Elliott, CG; Halperin, JL; Hiatt, WR; Maynard, GA; Steg, PG; Weitz, JI; Suh, E; Spiro, TE; Barnathan, ES; Raskob, GE; Jure, H; Alvarisqueta, A; Cartasegna, L; Hominal, M; Cursack, G; Alzogaray, M; Maillo, M; Parody, M; Caccavo, A; Dran, RD; Muntaner, JA; Casas, M; Schmidberg, J; Sarjanovich, R; Gabito, A; Garrido, M; Amuchastegui, M; Fernandez, A; Loureyro, J; Giumelli, C; Heazlewood, V; Karrasch, J; Colquhoun, D; White, H; Sabet, A; Bowler, S; Carroll, P; Khalafallah, A; Baker, R; Hedger, S; Simpson, FG; Jackson, D; Chong, B; Eichinger-Hasenauer, S; Siostrzonek, P; Gary, T; Hoppe, U; Dosta, N; Krivenchuk, V; Prystrom, A; Gorokhovsky, S; Yanushko, V; Skrahin, A; Kulik, A; Maslianski, B; Yakubtsevich, R; Timkin, I; Moguchaya, O; Tanaskovic, N; Miljkovic, S; Stojkovic, S; Kovacevic-Preradovic, T; Jovic, D; Basagic, E; Radjen, M; Mutapcic, M; Rizvanovic-Vojic, E; Galic, K; Terzic, I; Pojskic, B; Stevanovic, D; Cehajic, M; Trbojevic, S; Rech, R; Annichino-Bizzacchi, J; Stelmach, R; Blanco, D; Castro, I; Backes, LM; Saraiva, JF; Ramacciotti, E; de Barros e Silva, PGM; Reis, G; Vieira, EM; Leaes, P; Zimmermann, S; Van Bellen, B; Precoma, D; Silvestrini, TL; Hernandes, ME; Kyoleyan, M; Kalinova, T; Tiholov, R; Petrov, I; Mihov, A; Chompalova, B; Velikov, C; Pencheva, G; Atanasov, P; Raev, D; Kinova, E; Peltegov, V; Marchev, S; Mincheva, V; Siulemezova, S; Ayryanova, ID; Grigorov, M; Naydenova, I; Koteva, N; Dimov, B; Runev, N; Getov, D; Metev, H; Donchev, K; Taseva, M; Hadzhieva, A; Benov, H; Stoyanov, M; Tisheva-Gospodinova, S; Mihaylova, N; Abadzhiev, S; Atzev, B; Georgiev, R; Mollov, M; Stoikov, A; Mazhdrakov, G; Karastanev, K; Dube, F; Roth, S; Mansour, S; Carrier, M; Wu, C; Dolan, S; Pesant, Y; Pietrangelo, M; Dresser, G; Kahn, S; Kruisselbrink, R; Bonfanti, AC; Botero, R; Ossa, AQ; Poveda, CM; Cedano, J; Isaza, LG; Torres, CV; Mesa, JG; Alonso, RV; Espinosa, D; Rodriguez, JM; Sanchez, G; Mendoza, JLA; Florez, CCG; Millan, FC; Pesek, K; Horvat, D; Fuckar, K; Tudoric, N; Ruzic, A; Ostricki, B; Knezevic, A; Breitenfeld, T; Laganovic, M; Samodol, A; Sikic, J; Starcevic, B; Babic, Z; Samarzija, M; Milas, K; Votocek, S; Kvapil, M; Spinar, J; Kolman, P; Bindas, P; Simon, V; Adamek, T; Svobodova, J; Gergely, L; Lastuvka, J; Macel, I; Navratil, K; Gregor, P; Lacnak, B; Janousek, J; Kellnerova, I; Hulinsky, V; Matusek, Z; Prucek, L; Dunaj, M; Pirchala, M; Vencour, D; Pavolko, M; Gorican, K; Fiksa, J; Tuxen, C; Meyer, C; Ulrik, CS; Marandi, T; Uuetoa, T; Shaburishvili, T; Otarishvili, N; Khintibidze, I; Emukhvari, N; Kipiani, Z; Gochitashvili, D; Mamatsashvili, M; Megreladze, I; Paposhvili, K; Agladze, R; Eradze, Z; Chelidze, K; Lominadze, S; Chukhrukidze, A; Chumburidze, V; Metreveli, S; Danelia, V; Orjonikidze, S; Kobulia, B; Nikolaishvili, G; Gvenetadze, R; Melia, A; Tsinamdzgvrishvili, B; Sekhniashvili, M; Sikharulidze, I; Meuser, M; Licka, M; Beyer-Westendorf, J; Rauch-Kroehnert, U; Graf, K; Brachmann, J; Akin, I; Toumbis, M; Vassilikos, V; Konstantinides, S; Steiropoulos, P; Gogos, C; Andrikopoulos, G; Parthenakis, F; Karydi, P; Tsivgoulis, G; Mertzanos, G; Olympios, C; Karapanayiotides, T; Paraskevopoulou, E; Kifnidis, K; Hahalis, G; Skoutelis, A; Vadikolias, K; Nyirati, G; Nagy, L; Matoltsy, A; Komoly, S; Lippai, J; Kiss, K; Kalman, T; Pozsegovits, K; Csaba, K; Bereczki, D; Zolyomi, S; Boda, Z; Szakal, I; Pall, D; Futo, L; Forster, T; Lovasz, O; Papp, A; Kiraly, Z; Pozsonyi, Z; Hajko, E; Kristof, P; Lakatos, F; Zsolt, P; Kirschner, R; Lupkovics, G; Timar, G; Pinter, I; Kristof, T; Kis, E; Kovacs, A; Jakab, G; Palinkas, A; Muller, G; Turi, T; Horvath, C; Kondakor, I; Csanyi, A; Frankfurter, Z; Gurzo, M; Gafter-Gvili, A; Kuchuk, M; Azzam, Z; Elis, A; Halabi, M; Hussein, O; Blum, A; Tsoran-Rosenthal, I; Lishner, M; Hochberg-Klein, S; Caraco, Y; Atar, S; Elias, N; Gavish, D; Butnaru, A; Cosmi, F; Garbelotto, R; Pierfranceschi, MG; Simioni, L; Gronda, E; Pesci, A; D'Angelo, A; Fedele, F; Ghirarduzzi, A; Piovaccari, G; Lembo, G; Ria, L; Monaco, GL; Brunelli, C; Tosetto, A; Capucci, A; Zanatta, N; Pistolesi, M; Mazzi, V; Testa, S; Scherillo, M; Di Biase, M; Antonicelli, R; Lodigiani, C; Nassiacos, D; Krievins, D; Viksne, I; Lapkovska, Z; Rancane, G; Sime, I; Pontaga, N; Eglite, R; Puzule, S; Smolova, R; Butkiene, Z; Bagdonas, A; Raugaliene, R; Norkiene, S; Norviliene, R; Petrauskiene, B; Basijokiene, V; Stonkus, S; Griskeviciene, V; Miskiniene, A; Norvaisiene, R; Skripkauskiene, I; Jovkovska-Kaeva, B; Kochovska-Kamchevska, N; Antovski, A; Nechevska, L; Celeska, V; Ilievska-Poposka, B; Kostojchinoska, M; Donchovska, S; Kedev, S; Kuzmanovski, I; Bushletikj, O; Stojchev, S; Bakrachevski, N; Kuzmanovska, B; Angusheva, T; Esperon, GL; Lopez, HV; Pech, CM; Hernandez, MC; Carrillo, LV; Gans, S; Smulders, S; Swart, H; Middeldorp, S; Boersma, W; Goosens, M; Hovens, M; Semplonius, G; Sohne, M; Osores, JL; Perez, MDS; Rodriguez, A; Oliva, CR; Cotrina, R; Argandona, PB; Yanez, LT; Ayala, CC; Mirek-Bryniarska, E; Goch, A; Skucha, W; Skorski, M; Miekus, P; Szyszka, A; Piotrowski, G; Gniot, J; Czerski, T; Debich, P; Zaluska, R; Bebenek, W; Wozakowska-Kaplon, B; Sciborski, R; Ilkowski, J; Wojnowski, P; Uscinska, E; Gaciong, Z; Bonek, R; Sobkowicz, B; Berkowski, P; Bejgier, K; Polonski, L; Kosior, D; Lata, S; Kolodziej, P; Gessek, J; Kachel, T; Talalaj, M; Musial, J; Lewczuk, J; Krysiak, W; Kucharski, L; Wysokinski, A; Minc, P; Martinez, J; Gregorio, T; Almeida, F; Monteiro, P; Stanciulescu, G; Mercea, CD; Iosipescu, LC; Militaru, C; Ciobotaru, V; Crisu, D; Burca, M; Tudoran, M; Savu, A; Negrean, V; Cojocaru, C; Minescu, B; Popa, V; Blajan, D; Nastase-Melicovici, D; Fruntelata, A; Barbulescu, S; Lukinyh, L; Akhunova, S; Vishneva, E; Semenova, I; Nikolaev, K; Shaydyuk, O; Nilk, R; Shalnev, V; Apartsin, K; Goloshchekin, BM; Shpagina, L; Khlevchuk, T; Arkhipov, M; Malygin, A; Shvarts, Y; Khaisheva, L; Popov, D; Kobalava, Z; Lipchenko, A; Shapovalova, Y; Zrazhevsky, K; Greshnova, I; Maslova, N; Karabenenko, A; Shogenov, Z; Budankova, E; Barbarash, O; Uspenskiy, Y; Kosmacheva, E; Berns, S; Kostenko, V; Zateyshchikov, D; Vishnevsky, A; Boldueva, S; Podzolkov, V; Sergeeva, E; Grinshtein, Y; Khrustalev, O; Bugrova, O; Repin, A; Andreev, D; Petrovic, P; Matic, TB; Apostolovic, S; Lazic, Z; Stankovic, D; Stankovic, A; Mitov, V; Sofronic, D; Kopitovic, I; Zdravkovic, V; Joksimovic, Z; Lazovic, N; Petrovic-Stanojevic, N; Ilic, A; Vujadinovic, O; Pencic-Popovic, B; Andjelkovic, N; Sekularac, N; Hinic, S; Radjen, G; Zivkovic, A; Putnikovic, B; Vuckovic, B; Ivanov, I; Babic, R; Van Zyl, L; Hobson, B; Basson, M; Engelbrecht, J; Mitha, I; Siebert, H; Jacobson, B; Breedt, J; Prozesky, H; Ntsekhe, M; Bayat, J; Ellis, G; Tarr, G; Adler, D; Van Dyk, C; Ismail, SM; Spargo, CE; Abdool-Gaffar, M; Saaiman, J; Venter, K; Aroca, MLL; Portales, FF; Navas, JP; Botaro, AR; Siminiani, ASC; Reyes, RL; Company, JBI; Selfa, MP; Garrido, JV; Sobrino-Martinez, J; Delgado, GM; Llinas, ES; Coronado, JB; Bonet, LA; Gutierrez, MV; Lora, FS; Martinez, RS; Calderon, E; Blanch, JV; De la Hera Galarza, JM; Ruiz, AB; Garcia-Fuster, MJ; Vera, TR; Walter, LAS; Parra, JAT; Fernandez, JD; Ojeda, FB; Pellicer-Ciscar, C; Palomares, LJ; Granado, JQ; Bautista, AT; Bustillo, SR; Ros, JO; Tolosa-Vilella, C; Ortuno, FM; Sanchez, FG; Martin, RB; Cubero, JS; Martinez, VCM; Montejano, MG; Meseguer, ML; Comert, SS; Koksal, N; Tertemiz, K; Ernam, D; Dursun, AB; Yildiz, O; Rudenko, L; Abrahamovych, O; Goloborodko, A; Holovchenko, N; Kulyk, A; Yagensky, A; Batushkin, V; Zolotaikina, V; Kozyolkin, O; Faynyk, A; Maslovskyy, V; Petrovskyy, R; Koshlia, V; Chopey, I; Burmak, I; Malynovsky, Y; Voronkov, L; Karpenko, O; Dziublyk, O; Godlevska, O; Borovyk, V; Bezrodna, L; Serik, S; Ovsyannikova, N; Vynnychenko, L; Kopytsya, M; Rudkovskiy, V; Grishyna, O; Vyshnyvetskyy, I; Prystupa, L; Tseluyko, V; Perepeliuk, M; Koval, O; Sychov, O; Church, A; Goudie, A; Elliott, M; Ferguson, C; Welker, J; Kao, CK; Bhagwat, R; Serota, H; Rosenberg, D; Bozorgchami, H; Nambiar, R; Hazelrigg, M; Spilseth, S; Bhagwath, G; Syed, F; Morrow, L; Updegrove, J; Bercz, P; Kambo, V; Henderson, D; Wright, P; Dang, N; Nadar, V; Jaffrani, N; El-Shahawy, M; Grossman, CH; Pearle, J; Weinstein, D; Galanis, TP; Gazmuri, R; Kastelic, R; Martinez, R; Laman, D; Macchiavelli, A; Kmetzo, J; Thurm, C; Kayembe, T; Chandrashekhar, Y; Bassetti, D; Jaoude, P; Williams, H; Dewhurst, R; Naqvi, S; Burr, J; Rodriguez-Cintron, W; Jeanfreau, R; Kosinski, E; Ndukwu, IM; Sotolongo, C; Daboul, N; Wilmer, C; Simon, P; Tak, T; Rees, C; Gupta, N; Lerner, R; Tapson, V; Graffagnino, C; Reed, RM; Alford, CM; Mody, F; Wellmon, B; Hamroff, G; Rajan, R; Kaatz, S				Spyropoulos, Alex C.; Ageno, Walter; Albers, Gregory W.; Elliott, C. Gregory; Halperin, Jonathan L.; Hiatt, William R.; Maynard, Gregory A.; Steg, P. Gabriel; Weitz, Jeffrey I.; Suh, Eunyoung; Spiro, Theodore E.; Barnathan, Elliot S.; Raskob, Gary E.; Jure, Horacio; Alvarisqueta, Andres; Cartasegna, Luis; Hominal, Miguel; Cursack, Guillermo; Alzogaray, Maria; Maillo, Martin; Parody, Maria; Caccavo, Alberto; Dran, R. Dario; Muntaner, Juan Antonio; Casas, Marcelo; Schmidberg, Jorge; Sarjanovich, Rodolfo; Gabito, Andrea; Garrido, Marcelo; Amuchastegui, Marcos; Fernandez, Alberto; Loureyro, Juan; Giumelli, Carla; Heazlewood, Vernon; Karrasch, Jeff; Colquhoun, David; White, Hayden; Sabet, Arman; Bowler, Simon; Carroll, Patrick; Khalafallah, Alhossain; Baker, Ross; Hedger, Stephen; Simpson, Frederick Graham; Jackson, David; Chong Beng; Eichinger-Hasenauer, Sabine; Siostrzonek, Peter; Gary, Thomas; Hoppe, Uta; Dosta, Nikolay; Krivenchuk, Vitaly; Prystrom, Andrei; Gorokhovsky, Sergey; Yanushko, Viachaslav; Skrahin, Aliaksandr; Kulik, Anatoly; Maslianski, Boris; Yakubtsevich, Ruslan; Timkin, Ivan; Moguchaya, Olga; Tanaskovic, Natasa; Miljkovic, Sinisa; Stojkovic, Sanja; Kovacevic-Preradovic, Tamara; Jovic, Darko; Basagic, Edin; Radjen, Mirjana; Mutapcic, Meliha; Rizvanovic-Vojic, Etida; Galic, Kristina; Terzic, Ibrahim; Pojskic, Belma; Stevanovic, Dragan; Cehajic, Mili; Trbojevic, Stevan; Rech, Rafael; Annichino-Bizzacchi, Joyce; Stelmach, Rafael; Blanco, Daniela; Castro, Iran; Backes, Luciano Marcelo; Saraiva, Jose Francisco; Ramacciotti, Eduardo; de Barros e Silva, Pedro Gabriel Melo; Reis, Gilmar; Vieira, Moreira Eduardo; Leaes, Paulo; Zimmermann, Sergio; Van Bellen, Bonno; Precoma, Dalton; Silvestrini, Luiz Tiago; Hernandes, Mauro Esteves; Kyoleyan, Michael; Kalinova, Tanya; Tiholov, Rumen; Petrov, Iliyan; Mihov, Atanas; Chompalova, Boryana; Velikov, Chavdar; Pencheva, Galina; Atanasov, Peter; Raev, Dimitar; Kinova, Elena; Peltegov, Valentin; Marchev, Sotir; Mincheva, Valentina; Siulemezova, Silvia; Ayryanova, Ivaneta Dimitrova; Grigorov, Mladen; Naydenova, Iveta; Koteva, Nadya; Dimov, Bojidar; Runev, Nikolay; Getov, Dimitar; Metev, Hristo; Donchev, Krasimir; Taseva, Margarita; Hadzhieva, Antoaneta; Benov, Haralambi; Stoyanov, Miroslav; Tisheva-Gospodinova, Snezhanka; Mihaylova, Nadya; Abadzhiev, Stefan; Atzev, Borislav; Georgiev, Rosen; Mollov, Mihail; Stoikov, Anastas; Mazhdrakov, Georgi; Karastanev, Krassimir; Dube, Francois; Roth, Sherryn; Mansour, Samer; Carrier, Marc; Wu, Cynthia; Dolan, Sean; Pesant, Yves; Pietrangelo, Maria; Dresser, George; Kahn, Susan; Kruisselbrink, Rebecca; Cadena Bonfanti, Andres; Botero, Rodrigo; Quintero Ossa, Alvaro; Poveda, Claudia Marcela; Cedano, Jorge; Gomez Isaza, Luis; Villaquiran Torres, Claudio; Gomez Mesa, Juan; Vargas Alonso, Ruben; Espinosa, David; Maria Rodriguez, Jose; Sanchez, Gregorio; Accini Mendoza, Jose Luis; Gomez Florez, Carmen Cecilia; Cuervo Millan, Francisco; Pesek, Ksenija; Horvat, Davor; Fuckar, Krunoslav; Tudoric, Neven; Ruzic, Alen; Ostricki, Branko; Knezevic, Aleksandar; Breitenfeld, Tomislav; Laganovic, Mario; Samodol, Ante; Sikic, Jozica; Starcevic, Boris; Babic, Zdravko; Samarzija, Miroslav; Milas, Kresimir; Votocek, Stepan; Kvapil, Milan; Spinar, Jindrich; Kolman, Petr; Bindas, Pavol; Simon, Vladimir; Adamek, Tomas; Svobodova, Jaromira; Gergely, Ladislav; Lastuvka, Jiri; Macel, Igor; Navratil, Karel; Gregor, Pavel; Lacnak, Borek; Janousek, Jiri; Kellnerova, Ivana; Hulinsky, Vaclav; Matusek, Zdenek; Prucek, Lukas; Dunaj, Milan; Pirchala, Marian; Vencour, David; Pavolko, Martin; Gorican, Karel; Fiksa, Jan; Tuxen, Christian; Meyer, Christian; Ulrik, Suppli; Marandi, Toomas; Uuetoa, Tiina; Shaburishvili, Tamaz; Otarishvili, Nino; Khintibidze, Irakli; Emukhvari, Nodar; Kipiani, Zviad; Gochitashvili, David; Mamatsashvili, Merab; Megreladze, Irakli; Paposhvili, Kakhi; Agladze, Rusudan; Eradze, Zviad; Chelidze, Kakhaber; Lominadze, Sulkhan; Chukhrukidze, Archil; Chumburidze, Vakhtang; Metreveli, Shorena; Danelia, Vakhtang; Orjonikidze, Sergo; Kobulia, Bondo; Nikolaishvili, Giorgi; Gvenetadze, Rusudan; Melia, Anzor; Tsinamdzgvrishvili, Bezhan; Sekhniashvili, Marika; Sikharulidze, Ioseb; Meuser, Mario; Licka, Manuela; Beyer-Westendorf, Jan; Rauch-Kroehnert, Ursula; Graf, Kristof; Brachmann, Johannes; Akin, Ibrahim; Toumbis, Michalis; Vassilikos, Vassilios; Konstantinides, Stavros; Steiropoulos, Paschalis; Gogos, Charalambos; Andrikopoulos, Giorgos; Parthenakis, Fragkiskos; Karydi, Panagiota; Tsivgoulis, Georgios; Mertzanos, Georgios; Olympios, Christopher; Karapanayiotides, Theodoros; Paraskevopoulou, Efrosyni; Kifnidis, Konstantinos; Hahalis, George; Skoutelis, Athanasios; Vadikolias, Konstantinos; Nyirati, Gabor; Nagy, Laszlo; Matoltsy, Andras; Komoly, Samuel; Lippai, Jozsef; Kiss, Krisztian; Kalman, Toth; Pozsegovits, Krisztian; Csaba, Kiraly; Bereczki, Daniel; Zolyomi, Szilard; Boda, Zoltan; Szakal, Imre; Pall, Denes; Futo, Laszlo; Forster, Tamas; Lovasz, Orsolya; Papp, Aniko; Kiraly, Zsolt; Pozsonyi, Zoltan; Erik, Hajko; Kristof, Piroska; Lakatos, Ferenc; Zsolt, Ples; Kirschner, Robert; Lupkovics, Geza; Timar, Gyula; Pinter, Istvan; Kristof, Tunde; Kis, Erno; Kovacs, Aranka; Jakab, Gabor; Palinkas, Attila; Mueller, Gabor; Turi, Tibor; Horvath, Csaba; Kondakor, Istvan; Csanyi, Attila; Frankfurter, Zsuzsanna; Gurzo, Mihaly; Gafter-Gvili, Anat; Kuchuk, Michael; Azzam, Zaher; Elis, Avishay; Halabi, Majdi; Hussein, Osamah; Blum, Arnon; Tsoran-Rosenthal, Inna; Lishner, Michael; Hochberg-Klein, Sarit; Caraco, Yoseph; Atar, Shaul; Elias, Nizar; Gavish, Dov; Butnaru, Adi; Cosmi, Franco; Garbelotto, Raffaella; Pierfranceschi, Giorgi; Simioni, Livio; Gronda, Edoardo; Pesci, Alberto; D'Angelo, Armando; Fedele, Francesco; Ghirarduzzi, Angelo; Piovaccari, Giancarlo; Lembo, Giuseppe; Ria, Luigi; Monaco, Giuseppe; Brunelli, Claudio; Tosetto, Alberto; Capucci, Alessandro; Zanatta, Nello; Pistolesi, Massimo; Mazzi, Valeria; Testa, Sophie; Scherillo, Marino; Di Biase, Matteo; Antonicelli, Roberto; Lodigiani, Corrado; Nassiacos, Daniele; Krievins, Dainis; Viksne, Inese; Lapkovska, Zinaida; Rancane, Gita; Sime, Iveta; Pontaga, Natalija; Eglite, Ruta; Puzule, Sarmite; Smolova, Rita; Butkiene, Zita; Bagdonas, Alfredas; Raugaliene, Rasa; Norkiene, Sigute; Norviliene, Rita; Petrauskiene, Birute; Basijokiene, Vida; Stonkus, Sigitas; Griskeviciene, Violeta; Miskiniene, Ausra; Norvaisiene, Rima; Skripkauskiene, Irena; Jovkovska-Kaeva, Biserka; Kochovska-Kamchevska, Nade; Antovski, Antonio; Nechevska, Liljana; Celeska, Violeta; Ilievska-Poposka, Biljana; Kostojchinoska, Mira; Donchovska, Snezhana; Kedev, Sashko; Kuzmanovski, Igor; Bushletikj, Oliver; Stojchev, Sasho; Bakrachevski, Nikola; Kuzmanovska, Biljana; Angusheva, Tanja; Llamas Esperon, Guillermo; Valdez Lopez, Hector; Medina Pech, Carlos; Cortes Hernandez, Miguel; Virgen Carrillo, Luis; Gans, Stephanus; Smulders, Sietske; Swart, Henk; Middeldorp, Saskia; Boersma, Willem; Goosens, Martijn; Hovens, Marcel; Semplonius, Geesje; Sohne, M.; Osores, Lema; Salas Perez, Marcia; Rodriguez, Aldo; Rios Oliva, Carlos; Cotrina, Rosa; Berrospi Argandona, Percy; Toce Yanez, Luis; Chavez Ayala, Carlos; Mirek-Bryniarska, Ewa; Goch, Aleksander; Skucha, Wojciech; Skorski, Marcin; Miekus, Pawel; Szyszka, Andrzej; Piotrowski, Grzegorz; Gniot, Jacek; Czerski, Tomasz; Debich, Piotr; Zaluska, Roman; Bebenek, Waldemar; Wozakowska-Kaplon, Beata; Sciborski, Ryszard; Ilkowski, Jan; Wojnowski, Piotr; Uscinska, Ewa; Gaciong, Zbigniew; Bonek, Robert; Sobkowicz, Bozena; Berkowski, Piotr; Bejgier, Katarzyna; Polonski, Lech; Kosior, Dariusz; Lata, Stanislaw; Kolodziej, Piotr; Gessek, Jacek; Kachel, Tomasz; Talalaj, Marek; Musial, Jacek; Lewczuk, Jerzy; Krysiak, Waldemar; Kucharski, Lech; Wysokinski, Andrzej; Minc, Piotr; Martinez, Jorge; Gregorio, Tiago; Almeida, Filipa; Monteiro, Pedro; Stanciulescu, Gabriela; Mercea, Corina; Iosipescu, Laura; Militaru, Constantin; Ciobotaru, Valentina; Crisu, Daniela; Burca, Mitel; Tudoran, Mariana; Savu, Angelica; Negrean, Vasile; Cojocaru, Cristian; Minescu, Bogdan; Popa, Virgil; Blajan, Daniel; Nastase-Melicovici, Dorel; Fruntelata, Ana; Barbulescu, Sanziana; Lukinyh, Liya; Akhunova, Svetlana; Vishneva, Elena; Semenova, Irina; Nikolaev, Konstantin; Shaydyuk, Oxana; Nilk, Rostislav; Shalnev, Vladimir; Apartsin, Konstantin; Goloshchekin, Boris; Shpagina, Liubov; Khlevchuk, Tatiana; Arkhipov, Mikhail; Malygin, Alexander; Shvarts, Yury; Khaisheva, Larisa; Popov, Dmitry; Kobalava, Zhanna; Lipchenko, Alexander; Shapovalova, Yulia; Zrazhevsky, Konstantin; Greshnova, Irina; Maslova, Natalia; Karabenenko, Alexander; Shogenov, Zaur; Budankova, Ekaterina; Barbarash, Olga; Uspenskiy, Yury; Kosmacheva, Elena; Berns, Svetlana; Kostenko, Victor; Zateyshchikov, Dmitry; Vishnevsky, Alexandr; Boldueva, Svetlana; Podzolkov, Valeriy; Sergeeva, Elena; Grinshtein, Yury; Khrustalev, Oleg; Bugrova, Olga; Repin, Alexey; Andreev, Denis; Petrovic, Predrag; Matic, Tatjana; Apostolovic, Svetlana; Lazic, Zorica; Stankovic, Dusica; Stankovic, Aleksandar; Mitov, Vladimir; Sofronic, Dejan; Kopitovic, Ivan; Zdravkovic, Vladimir; Joksimovic, Zoran; Lazovic, Nada; Petrovic-Stanojevic, Natasa; Ilic, Aleksandra; Vujadinovic, Olivera; Pencic-Popovic, Biljana; Andjelkovic, Nebojsa; Sekularac, Nikola; Hinic, Sasa; Radjen, Goran; Zivkovic, Aleksandar; Putnikovic, Biljana; Vuckovic, Biljana; Ivanov, Igor; Babic, Rade; Van Zyl, Louis; Hobson, Biano; Basson, Matthys; Engelbrecht, Johannes; Mitha, Ismail; Siebert, Heidi; Jacobson, Barry; Breedt, Johannes; Prozesky, Hans; Ntsekhe, Mpiko; Bayat, Junaid; Ellis, Graham; Tarr, Gareth; Adler, David; Van Dyk, Christo; Ismail, S.; Spargo, Catherine; Abdool-Gaffar, Mohamed; Saaiman, Jan; Venter, Karl; Lorente Aroca, Maria; Fernandez Portales, Francisco; Pedrajas Navas, Jose; Rodriguez Botaro, Antonio; Cruz Siminiani, Antonio; Lopez Reyes, Raquel; Bisbe i Company, Josep; Piedecausa Selfa, Mar; Velasco Garrido, Jose; Sobrino-Martinez, Javier; Munoz Delgado, Gregorio; Sala Llinas, Ernest; Blanco Coronado, Jose; Almenar Bonet, Luis; Vida Gutierrez, Manuel; Sanchez Lora, Fernando; Sanchez Martinez, Rosario; Calderon, Enrique; Villalta Blanch, Jaume; De la Hera Galarza, Jesus; Bustamante Ruiz, Ana; Jose Garcia-Fuster, Maria; Ripoll Vera, Tomas; Alvarez-Sala Walter, Luis; Todoli Parra, Jose; Diaz Fernandez, Jose; Bosa Ojeda, Francisco; Pellicer-Ciscar, Concepcion; Jara Palomares, Luis; Quiles Granado, Juan; Trigo Bautista, Alberto; Ruiz Bustillo, Sonia; Ordi Ros, Josep; Tolosa-Vilella, Carles; Marin Ortuno, Francisco; Garcia Sanchez, Florentino; Barba Martin, Raquel; Segovia Cubero, Javier; Cuervas-Mons Martinez, Valentin; Galan Montejano, Miguel; Lopez Meseguer, Manuel; Sener Comert, Sevda; Koksal, Nurhan; Tertemiz, Kemal; Ernam, Dilek; Dursun, Adile; Yildiz, Oznur; Rudenko, Leonid; Abrahamovych, Orest; Goloborodko, Alla; Holovchenko, Nataliia; Kulyk, Anna; Yagensky, Andriy; Batushkin, Valerii; Zolotaikina, Viktoriia; Kozyolkin, Oleksandr; Faynyk, Andriy; Maslovskyy, Valentyn; Petrovskyy, Roman; Koshlia, Volodymyr; Chopey, Ivan; Burmak, Iurii; Malynovsky, Yaroslav; Voronkov, Leonid; Karpenko, Olexandr; Dziublyk, Oleksandr; Godlevska, Olga; Borovyk, Valentyna; Bezrodna, Larysa; Serik, Sergii; Ovsyannikova, Nataliya; Vynnychenko, Lyudmyla; Kopytsya, Mykola; Rudkovskiy, Volodymyr; Grishyna, Olena; Vyshnyvetskyy, Ivan; Prystupa, Lyudmyla; Tseluyko, Vira; Perepeliuk, Mykola; Koval, Olena; Sychov, Oleg; Church, Alistair; Goudie, Andrew; Elliott, Mark; Ferguson, Craig; Welker, James; Kao, Cheng-Kai; Bhagwat, Ravi; Serota, Harvey; Rosenberg, David; Bozorgchami, Hormozd; Nambiar, Rajesh; Hazelrigg, Monica; Spilseth, Sara; Bhagwath, Gayathri; Syed, Faizullah; Morrow, Lee; Updegrove, John; Bercz, Peter; Kambo, Varinder; Henderson, David; Wright, Patrick; Dang, Nguyen; Nadar, Venkatesh; Jaffrani, Naseem; El-Shahawy, Mohamed; Grossman, Colby; Pearle, James; Weinstein, Debra; Galanis, Taki; Gazmuri, Raul; Kastelic, Richard; Martinez, Rafael; Laman, David; Macchiavelli, Anthony; Kmetzo, James; Thurm, Craig; Kayembe, Tshiswaka; Chandrashekhar, Yellapragada; Bassetti, Dennis; Jaoude, Philippe; Williams, Hayes; Dewhurst, Robert; Naqvi, Syed; Burr, John; Rodriguez-Cintron, William; Jeanfreau, Robert; Kosinski, Edward; Ndukwu, Ikeadi; Sotolongo, Carlos; Daboul, Nizar; Wilmer, Charles; Simon, Peter; Tak, Tahir; Rees, Christopher; Gupta, Nishant; Lerner, Robert; Tapson, Victor; Graffagnino, Carmelo; Reed, Robert; Alford, Chad; Mody, Freny; Wellmon, Baxter; Hamroff, Glenn; Rajan, Raj; Kaatz, Scott		MARINER Investigators	Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENOUS THROMBOEMBOLISM; HIGH-RISK; VTE; PREVENTION; HEPARIN; TRIAL	BACKGROUND Patients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy. METHODS In this randomized, double-blind trial, medically ill patients who were at increased risk for venous thromboembolism on the basis of a modified International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) score of 4 or higher (scores range from 0 to 10, with higher scores indicating a higher risk of venous thromboembolism) or a score of 2 or 3 plus a plasma n-dimer level of more than twice the upper limit of the normal range (defined according to local laboratory criteria) were assigned at hospital discharge to either once-daily rivaroxaban at a dose of 10 mg (with the dose adjusted for renal insufficiency) or placebo for 45 days. The primary efficacy outcome was a composite of symptomatic venous thromboembolism or death due to venous thromboembolism. The principal safety outcome was major bleeding. RESULTS Of the 12,024 patients who underwent randomization, 12,019 were included in the intention-to-treat analysis. The primary efficacy outcome occurred in 50 of 6007 patients (0.83%) who were given rivaroxaban and in 66 of 6012 patients (1.10%) who were given placebo (hazard ratio, 0.76; 95% confidence interval [CI], 0.52 to 1.09; P=0.14). The prespecified secondary outcome of symptomatic nonfatal venous thromboembolism occurred in 0.18% of patients in the rivaroxaban group and 0.42% of patients in the placebo group (hazard ratio, 0.44; 95% CI, 0.22 to 0.89). Major bleeding occurred in 17 of 5982 patients (0.28%) in the rivaroxaban group and in 9 of 5980 patients (0.15%) in the placebo group (hazard ratio, 1.88; 95% CI, 0.84 to 4.23). CONCLUSIONS Rivaroxaban, given to medical patients for 45 days after hospital discharge, was not associated with a significantly lower risk of symptomatic venous thromboembolism and death due to venous thromboembolism than placebo. The incidence of major bleeding was low.	[Spyropoulos, Alex C.] Hofstra Northwell, Donald & Barbara Zucker Sch Med, Feinstein Inst Med Res, New York, NY USA; [Spyropoulos, Alex C.] Northwell Hlth, Lenox Hill Hosp, Anticoagulat & Clin Thrombosis Serv, Dept Med, New York, NY USA; [Halperin, Jonathan L.] Mt Sinai Med Ctr, Cardiovasc Inst, New York, NY 10029 USA; [Ageno, Walter] Univ Insubria, Dept Med & Surg, Varese, Italy; [Albers, Gregory W.] Stanford Univ, Med Ctr, Stanford Stroke Ctr, Stanford, CA 94305 USA; [Maynard, Gregory A.] Univ Calif Davis, Sacramento, CA 95817 USA; [Elliott, C. Gregory] Univ Utah, Dept Med, Intermt Med Ctr, Salt Lake City, UT 84112 USA; [Elliott, C. Gregory] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Hiatt, William R.] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO USA; [Hiatt, William R.] CPC Clin Res, Aurora, CO USA; [Steg, P. Gabriel] Univ Paris Diderot, Dept Hosp Univ FIRE Fibrose Inflammat Remodelage, AP HP, Paris, France; [Steg, P. Gabriel] INSERM, Unite 1148, Paris, France; [Steg, P. Gabriel] Imperial Coll, Royal Brompton Hosp, London, England; [Weitz, Jeffrey I.] McMaster Univ, Hamilton, ON, Canada; [Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Suh, Eunyoung; Barnathan, Elliot S.] Janssen Res & Dev, Raritan, NJ USA; [Spiro, Theodore E.] Bayer US, Thrombosis & Hematol Therapeut Area, Clin Dev, Pharmaceut, Whippany, NJ USA; [Raskob, Gary E.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA; [Jure, Horacio] Hosp San Roque, Clin Chutro SA, Cordoba, Argentina; [Alvarisqueta, Andres] Ctr Invest Med Mar Plata SRL, Mar Del Plata, Buenos Aires, Argentina; [Cartasegna, Luis] Hosp Italiano La Plata, La Plata, Buenos Aires, Argentina; [Hominal, Miguel] Sanat Med Diagnost, Inst Cardiovasc Rosario, Ctr Invest Clin Litoral SRL, Santa Fe, Argentina; [Cursack, Guillermo] Sanat Esperanza, Esperanza, Santa Fe, Argentina; [Alzogaray, Maria] Hosp Italiano La Plata, Inst Med Platense, La Plata, Buenos Aires, Argentina; [Maillo, Martin] Inst Buen Aire, Santa Fe, Argentina; [Parody, Maria] Hosp San Roque, Ctr Med Colon, Cordoba, Argentina; [Caccavo, Alberto] Clin Coronel Suarez SA, Coronel Suarez, Argentina; [Dran, R. Dario] Sanat Mariano Pelliza ROPHE SA, Munro, Argentina; [Muntaner, Juan Antonio] Ctr Modelo Cardil, San Miguel De Tucuman, Argentina; [Casas, Marcelo] Clin Adventista Belgrano, Ctr Med Respire, Buenos Aires, DF, Argentina; [Schmidberg, Jorge] Inst Med Aguero, Moron, Argentina; [Sarjanovich, Rodolfo] HOSP CORDOBA, Cordoba, Argentina; [Gabito, Andrea] Sanat Mujer, Cibic, Cent Invest Clin Argentina, Alvear Ctr Med, Rosario, Santa Fe, Argentina; [Garrido, Marcelo] Clin Privada Prov SA Merlo, Merlo, Argentina; [Amuchastegui, Marcos] Hosp Privado Ctr Med Cordoba, Cordoba, Argentina; [Fernandez, Alberto] Sanat Modelo Quilmes, Quilmes, Argentina; [Loureyro, Juan] Inst Caici, Rosario, Santa Fe, Argentina; [Giumelli, Carla] Inst Cardiol JF Cabral, Corrientes, Argentina; [Heazlewood, Vernon] Caboolture Private Hosp, Morayfield, Australia; [Karrasch, Jeff] Holy Spirit Northside, Chermside, Australia; [Colquhoun, David] Core Res Pty Ltd, Milton, Australia; [White, Hayden] Logan Hosp, Meadowbank, Australia; [Sabet, Arman] Gold Coast Univ Hosp, Southport, Qld, Australia; [Bowler, Simon] Mater Hlth Serv, South Brisbane, Australia; [Carroll, Patrick] Redcliffe Hosp, Monash Hlth Corp Off, Redcliffe, Australia; [Khalafallah, Alhossain] Launceston Gen Hosp, Launceston, Tas, Australia; [Baker, Ross] Royal Perth Hosp, Perth Blood Inst, Nedlands, WA, Australia; [Baker, Ross] Royal Perth Hosp, Perth Blood Inst, Perth, WA, Australia; [Hedger, Stephen] Flinders Med Ctr, Bedford Pk, SA, Australia; [Simpson, Frederick Graham] Cairns Base Hosp, Cairns, Australia; [Jackson, David] Lismore Base Hosp, Lismore, NSW, Australia; [Chong Beng] St George Hosp, Kogarah, NSW, Australia; [Chong Beng] St George Hosp, Sydney, NSW, Australia; [Eichinger-Hasenauer, Sabine] Med Univ Vienna, Univ Klin Innere Med 1, AKH Wien, Vienna, Austria; [Siostrzonek, Peter] Krankenhaus Barmherzigen Schwestern, Ordensklinikum Linz, Linz, Austria; [Gary, Thomas] LKH Univ Klinikum Graz, Graz, Austria; [Hoppe, Uta] Univ Klin Salzburg, Salzburg, Austria; [Dosta, Nikolay] Minsk Reg Clin Hosp, Minsk, BELARUS; [Krivenchuk, Vitaly] Republican Res Ctr Radiat Med & Human E, Republican Res Ctr, Gomel, BELARUS; [Prystrom, Andrei] City Clin Hosp 1, Minsk, BELARUS; [Gorokhovsky, Sergey] Gomel Reg Clin Cardiol Dispensary, Gomel, BELARUS; [Yanushko, Viachaslav] Republican Sci Clin Ctr Cardiol, Minsk, BELARUS; [Skrahin, Aliaksandr] Republic Res & Pract Ctr Pulmonol & TB, Minsk, BELARUS; [Kulik, Anatoly] Mogilev Reg Hosp, Mogilev, BELARUS; [Maslianski, Boris] Gomel Reg Hosp, Gomel Reg Clin Hosp, Gomel, BELARUS; [Yakubtsevich, Ruslan] Grodno Reg Clin Hosp, Grodno, BELARUS; [Timkin, Ivan] Vitebsk Reg Clin Hosp, Vitebsk, BELARUS; [Moguchaya, Olga] Brest Reg Hosp, Brest, BELARUS; [Tanaskovic, Natasa; Miljkovic, Sinisa; Stojkovic, Sanja; Kovacevic-Preradovic, Tamara; Jovic, Darko; Trbojevic, Stevan] Univ Clin Ctr Republ Srpska, Banja Luka, Bosnia & Herceg; [Basagic, Edin; Rizvanovic-Vojic, Etida] Cantonal Hosp Dr Irfan Ljubijankic, Bihac, Bosnia & Herceg; [Radjen, Mirjana] Univ Hosp Foca, Foca, Bosnia & Herceg; [Mutapcic, Meliha; Pojskic, Belma] Cantonal Hosp Zenica, Zenica, Bosnia & Herceg; [Galic, Kristina; Cehajic, Mili] Univ Clin Hosp Mostar, Mostar, Bosnia & Herceg; [Terzic, Ibrahim] BH Heart Ctr Tuzla, Tuzla, Bosnia & Herceg; [Stevanovic, Dragan] Gen Hosp Prim Dr Abdulah Nakas, Sarajevo, Bosnia & Herceg; [Rech, Rafael] Hosp Univ Mae De Deus Canoas, Canoas, Brazil; [Annichino-Bizzacchi, Joyce] Univ Estadual Campinas, Hemoctr, Campinas, SP, Brazil; [Stelmach, Rafael] Univ Sao Paulo, Hosp Clin, Fac Med, Heart Inst InCor, Sao Paulo, Brazil; [Blanco, Daniela] Pontificia Univ Cat, Hosp Sao Lucas PUCRS, Uniao Brasileira Educ &, Porto Alegre, RS, Brazil; [Castro, Iran] Fundacao Univ Cardiol, Inst Cardiol, Porto Alegre, RS, Brazil; [Backes, Luciano Marcelo] Hosp Sao Vicente Paulo, Bioserv SMO, Passo Fundo, RS, Brazil; [Saraiva, Jose Francisco] Univ Fed Pernambuco, Hosp & Maternidade Celso Pierro PUC Campinas, Campinas, SP, Brazil; [Ramacciotti, Eduardo] Hosp & Maternidade Dr Christovao da Gama, Santo Andre, Brazil; [de Barros e Silva, Pedro Gabriel Melo] Hosp TotalCor, Sao Paulo, Brazil; [Reis, Gilmar] Fundacao Hosp Sao Francisco Assis, Santa Casa Belo Horizonte, CARDRES Cardiol Assistencial & Pesquisa, CARDRES Cardiol Assistencial, Belo Horizonte, MG, Brazil; [Vieira, Moreira Eduardo] Hosp Coracao Brazil, Brasilia, DF, Brazil; [Leaes, Paulo] Hosp Sao Francisco, Santa Casa Porto Alegre, Porto Alegre, RS, Brazil; [Zimmermann, Sergio] Clin Procardio Ltda, Blumenau, Brazil; [Van Bellen, Bonno] Univ Sao Paulo, Fac Med, Hosp Clin, Hosp Beneficencia Portuguesa, Sao Paulo, Brazil; [Precoma, Dalton] Hosp Angelina Caron, Campina Grande Do Sul, Brazil; [Silvestrini, Luiz Tiago] IPEMI, Itajai, SC, Brazil; [Hernandes, Mauro Esteves] Santa Casa Votuporanga, Unidade Pesquisa Clin, Votuporanga, Brazil; [Kyoleyan, Michael] MHAT Sveta Sofia, Sofia, Bulgaria; [Kalinova, Tanya] Univ Specialized Hosp Act Treatment Card, Sofia, Bulgaria; [Tiholov, Rumen] NBAL SV IVAN RILSKI KOZLODUY, MHAT Sveti Ivan Rilski, Kozlodui, Bulgaria; [Petrov, Iliyan] MHAT Sv Nikolay Chudotvorets EOOD, Lom, Bulgaria; [Mihov, Atanas] MHAT St Ekaterina, Dimitrovgrad, Bulgaria; [Chompalova, Boryana] MHAT Plovdiv, MBAL Plovdiv, Plovdiv, Bulgaria; [Velikov, Chavdar] MHAT Sv Vrach, Sandanski, Bulgaria; [Pencheva, Galina] Fouth MHAT Sofia, Sofia, Bulgaria; [Atanasov, Peter] UMHATEM N I Pirogov, Sofia, Bulgaria; [Raev, Dimitar] Synexus Bulgaria DCC Ascendent, Synexus, MHAT Sveta Anna Sofia AD, Sofia, Bulgaria; [Kinova, Elena] UMBAL Tsaritsa Yoanna ISUL, Sofia, Bulgaria; [Peltegov, Valentin] MHAT Razlog, Razlog, Bulgaria; [Marchev, Sotir] SHAT Cardiol Pleven, Pleven, Bulgaria; [Mincheva, Valentina] NMTH Tsar Boris III, Diagnost Consultat Ctr Borola OOD, Sofia, Bulgaria; [Siulemezova, Silvia] MHAT Ivan Seliminski AD, Sliven, Bulgaria; [Ayryanova, Ivaneta Dimitrova] Univ Multiprofile Hosp Act Treatment Deva Maria, Burgas, Bulgaria; [Grigorov, Mladen] 2th MHAT Sofia, Sofia, Bulgaria; [Naydenova, Iveta] MHAT Sveta Petka AD, Vidin, Bulgaria; [Koteva, Nadya] SHAT Pneumophthisiatr Dis Sofia Dist, Sofia, Bulgaria; [Dimov, Bojidar] Fifth Multiprofile Hosp Act Treatment Sofia, V MH, V MBAL, UMHAT Hosp Sofia 5,MHAT Sofia EAD 5, Sofia, Bulgaria; [Runev, Nikolay] Umhat Alexandrovska, Sofia, Bulgaria; [Getov, Dimitar] Reg Hosp Pulm Dis Rousse 1, SHAT Pneumophthisiatry Dis Dr Dimitar Gramatikov, SHATPPD Ruse, MHAT Dr Tota Venkova AD Gabrovo, Ruse, Bulgaria; [Metev, Hristo] Specialized Hosp Act Treatment Pneumophtisiat, Ruse, Bulgaria; [Donchev, Krasimir] SMO Bulgaria LTD, MHAT Dr Tota Venkova AD Gabrovo, MHAT Dr Tota Venkova AD, Gabrovo, Bulgaria; [Taseva, Margarita; Benov, Haralambi] MDHAT Dr Stefan Cherkezov, Veliko Tarnovo, Bulgaria; [Hadzhieva, Antoaneta] MHAT Puls, Blagoevgrad, Bulgaria; [Stoyanov, Miroslav] SMO Bulgaria Ltd, MHAT Dr Tota Venkova AD, Gabrovo, Bulgaria; [Tisheva-Gospodinova, Snezhanka] Univ Multiprofile Hosp Act Treatment Dr Geo, Pleven, Bulgaria; [Mihaylova, Nadya] SMO Bulgaria, MHAT Stamen Iliev AD, Montana, Bulgaria; [Abadzhiev, Stefan] MHAT Prof Dr Paraskev Stoyanov, Lovech, Bulgaria; [Atzev, Borislav] MHAT Puls, Sofija, Bulgaria; [Georgiev, Rosen] 5th MHAT Sofia, Sofia, Bulgaria; [Mollov, Mihail] I St Multiprofile Hosp Act Treatment, Sofia, Bulgaria; [Stoikov, Anastas] MHAT VITA, Sofia, Bulgaria; [Mazhdrakov, Georgi] SHATC Sv Georgi, MLADOST St Ame 1, Pernik, Bulgaria; [Karastanev, Krassimir] Mhat Sveti Georgi, Plovdiv, Bulgaria; [Dube, Francois] Inst Univ Pneumol & Cardiol Quebec, Quebec City, PQ, Canada; [Roth, Sherryn] Scarborough Gen Hosp, Scarborough, ON, Canada; [Mansour, Samer] Hotel Dieu Montreal, Chum Hotel Dieu Hosp, Ctr Rech Ctr Hosp Univ, Montreal, PQ, Canada; [Carrier, Marc] Ottawa Hosp, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Wu, Cynthia] Univ Alberta Hosp, Edmonton, AB, Canada; [Dolan, Sean] St Johns Hosp, St John, NB, Canada; [Pesant, Yves] St Jerome Med Res Inc, Polyclin St Jerome, St Jerome, PQ, Canada; [Pietrangelo, Maria] Charles LeMoyne Hosp, Greenfield Pk, PQ, Canada; [Dresser, George] Pediat Asthma Clin, London, ON, Canada; [Kahn, Susan] Sir Mortimer B Davis Jewish Hosp, Jewish Gen Hosp, Montreal, PQ, Canada; [Kruisselbrink, Rebecca] McMaster Univ, St Josephs Healthcare Hamilton Cha, Hamilton, ON, Canada; [Cadena Bonfanti, Andres] Clin Costa, Barranquilla, Colombia; [Botero, Rodrigo] IPS Rodrigo Botero SAS, Clin Medellin, Medellin, Colombia; [Quintero Ossa, Alvaro] Clin Cardio VID, Ctr Cardiovasc Colombiano Clin Santa Maria, Medellin, Colombia; [Poveda, Claudia Marcela] Clin Shaio, Bogota, Colombia; [Cedano, Jorge] Ctr Med Imbanaco, INST INVEST, Cali, Colombia; [Gomez Isaza, Luis] Hosp San Vicente de Paul, Medellin, Colombia; [Villaquiran Torres, Claudio] Hosp Univ San Ignacio, Bogota, Colombia; [Gomez Mesa, Juan] Fdn Valle Lili, Clin Valle Lili, Unidad Invest Clin, Cali, Colombia; [Vargas Alonso, Ruben] Fdn Cardiovasc Colombia, Bucaramanga, Colombia; [Espinosa, David] Hosp Univ Clin San Rafael, Bogota, Colombia; [Maria Rodriguez, Jose] Hosp Gen Medellin Luz Castro de Gutierrez ESE, Medellin, Colombia; [Sanchez, Gregorio] Univ Quindio, Hosp Univ San Juan de Dios, Fdn Cardiomet Cequin, Armenia, Colombia; [Accini Mendoza, Jose Luis] Fdn Hosp Univ Norte, IPS Ctr Cient Asistencial Jose Luis Accini SAS, Barranquilla, Colombia; [Gomez Florez, Carmen Cecilia] Fdn Cardio Infantil, Invest Dept, Bogota, Colombia; [Cuervo Millan, Francisco] Clin Univ la Sabana, Jazmin Pinzon, Chia, Colombia; [Pesek, Ksenija] OB Zabok, Zabok, Croatia; [Horvat, Davor] Gen Hosp Karlovac, Karlovac, Croatia; [Fuckar, Krunoslav] Specijalna Bolnica Med Rehabil Krapinske To, Krapinske Toplice, Croatia; [Tudoric, Neven] Univ Hosp Dubrava, Zagreb, Croatia; [Ruzic, Alen] Klin Bolnicki, Ctr Rijeka, Rijeka, Croatia; [Ostricki, Branko] Zupanijska Bolnica Cakovec, Cakovec, Croatia; [Knezevic, Aleksandar] Opca Bolnica Zadar, Zadar, Croatia; [Breitenfeld, Tomislav] Klin Bolnicki, Ctr Sestre Milosrdnice, Zagreb, Croatia; [Laganovic, Mario] KBC Zagreb, Zagreb, Croatia; [Samodol, Ante] Opca Bolnica Sibenik, Shibenik, Croatia; [Sikic, Jozica] Klin Bolnica Sv Duh, Zagreb, Croatia; [Starcevic, Boris] Klin Bolnica Dubrava, Zagreb, Croatia; [Babic, Zdravko] CH Sestre Milosrdnice, Zagreb, Croatia; [Samarzija, Miroslav] Univ Hosp Ctr Zagreb, Zagreb, Croatia; [Milas, Kresimir] Opca Bolnica Pula, Pula, Croatia; [Votocek, Stepan] Nemocnice Slany, Slany, Czech Republic; [Kvapil, Milan] ResTrial Sro, Fak Nemocnice Motole, Prague 5, Czech Republic; [Spinar, Jindrich] Univ Hosp, Fak Nemocnice Brno, Vseobecna Fak Nemocnice Praze, Brno, Czech Republic; [Kolman, Petr] Nemocnice Kyjov Po, Plicni Ambulance Petr Kolman, Kyjov, Czech Republic; [Bindas, Pavol] Slezska Nemocnice Opave Po, Opava, Czech Republic; [Simon, Vladimir] Nemocnice Pardubickeho Kraje As, Orlickoustecka nemocnice, Usti Nad Orlici, Czech Republic; [Adamek, Tomas] Thomayerova Nemocnice, Prague 4, Czech Republic; [Svobodova, Jaromira] Nemocnice Cesky Krumlov As, Cesky Krumlov, Czech Republic; [Gergely, Ladislav] Nemocnice Pisek As, Pisek, Czech Republic; [Lastuvka, Jiri] Krajska Zdravotni As, Masarykova Nemocnice Usti N Labem, Usti Nad Labem, Czech Republic; [Macel, Igor] Nemocnice Nove Mesto Morave Po, Nefrol Ambulance, Nove Mesto Morav, Czech Republic; [Navratil, Karel] Vojenska Nemocnice Olomouc, Olomouc, Czech Republic; [Gregor, Pavel] Fak Nemocnice Kralovske Vinohrady, Prague 10, Czech Republic; [Lacnak, Borek] Vsetinska Nemocnice As, Sdruzene Zdravotnicke Zarizeni Krnov Op, Vsetin, Czech Republic; [Janousek, Jiri] Oblastni Nemocnice Trutnov As, Trutnov, Czech Republic; [Kellnerova, Ivana] Nemocnice Pardubickeho Kraje As, Pardubicka Nemocnice, Svitavska Nemocnice As, Svitavy, Czech Republic; [Hulinsky, Vaclav] Nemocnice Nymburk Sro, Nymburk, Czech Republic; [Matusek, Zdenek] Nemocnice Trinec Po, Trinec, Czech Republic; [Prucek, Lukas] Nemocnice Sternberk Oz, Hosp Sternberk, Stredomoravska Nemocnicni As, Sternberk, Czech Republic; [Dunaj, Milan] Litomyslska Nemocnice As, Litomysl, Czech Republic; [Pirchala, Marian] NsP Karvina RAJ, Karvina, Czech Republic; [Vencour, David] Mestska Nemocnice Mestec Kralove, Mestec Kralove, Czech Republic; [Pavolko, Martin] Nemocnice Pardubickeho Kraje As, Pardubicka Nemocnice, Pardubice, Czech Republic; [Gorican, Karel; Fiksa, Jan] Vseobecna Fak Nemocnice Praze, Prague 2, Czech Republic; [Tuxen, Christian] Bispebjerg Hosp, Copenhagen, Denmark; [Tuxen, Christian] Frederiksberg Univ Hosp, Copenhagen, Denmark; [Meyer, Christian] Roskilde Sygehus, Roskilde, Denmark; [Ulrik, Suppli] Hvidovre Univ Hosp, Hvidovre, Denmark; [Marandi, Toomas] North Estonia Med Ctr, Tallinn, Estonia; [Uuetoa, Tiina] East Tallinn Cent Hosp, Tallinn, Estonia; [Shaburishvili, Tamaz] Tbilisi Heart & Vasc Clin Ltd, Tbilisi, Georgia; [Otarishvili, Nino] LTD Clin Rustavi, Rustavi, Georgia; [Khintibidze, Irakli; Emukhvari, Nodar; Chelidze, Kakhaber] Aleksandre Aladashvili Clin LLC, Tbilisi, Georgia; [Khintibidze, Irakli] Israel Georgian Med Res Clin Helsicore, Tbilisi, Georgia; [Kipiani, Zviad] LTD NEW Hosp, Tbilisi, Georgia; New Hosp, Tbilisi, Georgia; [Gochitashvili, David] LTD MediClubGeorgia, Tbilisi, Georgia; [Gochitashvili, David] LTD MediClubGeorgia, Tbilisi, Georgia; [Mamatsashvili, Merab] LTD ADAPT, Tbilisi, Georgia; [Mamatsashvili, Merab] LTD Adapti Angiogardiol Clin, Tbilisi, Georgia; [Megreladze, Irakli] LTD Tbilisi Sea Hosp, Tbilisi, Georgia; [Paposhvili, Kakhi] Ltd Georgia Archangel St Michael Multiprofile Cli, Tbilisi, Georgia; [Agladze, Rusudan] LTD Ctr Vasc & Heart Desease, Tbilisi, Georgia; [Eradze, Zviad] LTD DIACOR, Tbilisi, Georgia; [Chelidze, Kakhaber] TSMU First Univ Clin, Tbilisi, Georgia; [Lominadze, Sulkhan] Cardiac Surg Clin Ghia GULI LTD, Tbilisi, Georgia; [Chukhrukidze, Archil] LTD Tbilisi Heart Ctr, Tbilisi, Georgia; [Chumburidze, Vakhtang] LTD Emergency Cardiol Ctr Acc G Chapidze, Tbilisi, Georgia; [Metreveli, Shorena] LTD Marnecore, Marneuli, Georgia; [Danelia, Vakhtang] LTD Med Rehabil Reg Clin Ctr Invalids & Elderly O, Marneuli, Georgia; [Orjonikidze, Sergo] Univ Clin, High Technol Med Ctr, Tbilisi, Georgia; [Kobulia, Bondo] Inst Clin Cardiol Ltd, Tbilisi, Georgia; [Nikolaishvili, Giorgi; Sikharulidze, Ioseb] LTD Hlth Ctr Medina, Batumi, Georgia; [Nikolaishvili, Giorgi] Unimed Adjara Ltd, Batumi Referral Hosp, Batumi, Georgia; [Gvenetadze, Rusudan] LTD Aversi Clin, Tbilisi, Georgia; [Melia, Anzor] LTD Cardiol Clin Guli, Tbilisi, Georgia; [Tsinamdzgvrishvili, Bezhan] Georgian Soc Hypertens Ltd, Tsinamdzgvrishvili Cardiol Ctr, German Georgian Cli, Tbilisi, Georgia; [Sekhniashvili, Marika] LTD Unimed Kakheti Kakheti Referral Hosp, Tbilisi, Georgia; [Sikharulidze, Ioseb] LTD Brothers, Batumi, Georgia; [Meuser, Mario] St Elisabeth Krankenhaus Julich, Julich, Germany; [Licka, Manuela] Univ Hosp Heidelberg, Clin Cardiol Angiol & Pneumonol, Dept Internal Med, Heidelberg, Germany; [Beyer-Westendorf, Jan] Dresden Univ, Clin Med Clin 3, Dresden, Germany; [Beyer-Westendorf, Jan] GWT TUD Dresden, Dresden, Germany; [Rauch-Kroehnert, Ursula; Graf, Kristof] Charite Univ Med Berlin, Campus Benjamin Franklin, Berlin, Germany; [Brachmann, Johannes] Med Klin 2, Kardiol Angiol & Pneumo, Coburg, Germany; [Akin, Ibrahim] Klinikum Mannheim GmbH Univ Klinikum Med, Mannheim, Germany; [Toumbis, Michalis] Gen Hosp Chest Dis Athens Sotiri, Athens, Greece; [Toumbis, Michalis] Natl & Kapodistrian Univ SOTIRA Chest Dis H, Athens, Greece; [Vassilikos, Vassilios] Gen Hosp Thessaloniki Ippokrateio, Thessaloniki, Greece; [Konstantinides, Stavros] Univ Gen Hosp Alexanrdoupolis, Alexanrdoupolis, Greece; [Steiropoulos, Paschalis] Univ Gen Hosp Evros, Alexandroupolis, Greece; [Steiropoulos, Paschalis] Univ Hosp Ioannina, Alexandroupolis, Greece; [Gogos, Charalambos] Hellen Soc Infect Dis, Patras, Greece; [Gogos, Charalambos] Patras Univ RION PATRAS, Patras, Greece; [Gogos, Charalambos] Univ Hosp Patras, Patras, Greece; [Nikolaishvili, Giorgi; Andrikopoulos, Giorgos] Errikos Dynan Hosp, Athens, Greece; [Parthenakis, Fragkiskos] Univ Gen Hosp Crete, Iraklion, Crete, Greece; [Karydi, Panagiota] Iaso Gen Hosp, Athens, Greece; [Tsivgoulis, Georgios] Attikon Gen Hosp Athens, Athens, Greece; [Mertzanos, Georgios] Gen Hosp Attica KAT, Kifissia Athens, Greece; [Olympios, Christopher] Gen Hosp Elefsina Thriassio, Magoula, Greece; [Karapanayiotides, Theodoros] Aristotle Univ Thessaloniki, Ahepa Hosp, Thessaloniki, Greece; [Paraskevopoulou, Efrosyni] Constantopoulio Gen Hosp Nea Ionia Agia Olga, Nea Ionia, Greece; [Paraskevopoulou, Efrosyni] Gen Hosp Athens Evangelismos, Nea Ionia, Greece; [Paraskevopoulou, Efrosyni] Univ Gen Hosp Crete, Nea Ionia, Greece; [Kifnidis, Konstantinos] Gen Hosp Voulas Asklipieion, Voula, Greece; [Hahalis, George] Univ Gen Hosp Patras, Rion, Greece; [Skoutelis, Athanasios] Gen Hosp Athens Evangelismos, Athens, Greece; [Vadikolias, Konstantinos] Democritus Univ Thrace, Alexandroupolis, Greece; [Nyirati, Gabor; Jakab, Gabor] Bajai Szent Rokus Korhaz, Baja, Hungary; [Nagy, Laszlo; Kovacs, Aranka] Csongrad Megyei Dr Bugyi Istvan Korhaz, Szentes, Hungary; [Nagy, Laszlo] Dr Bugyi Istvan Hosp Szentes, Szentes, Hungary; [Matoltsy, Andras] Kanizsai Dorottya Korhaz, Nagykanizsa, Hungary; [Komoly, Samuel] Pecsi Tudomanyegyet Klin Kp, Pecs, Hungary; [Komoly, Samuel] Pecsi Tudomanyegyet Klin Kozpont, Pecs, Hungary; [Lippai, Jozsef] Del Pesti Korhaz, Budapest, Hungary; [Lippai, Jozsef] Jahn Ferenc Del Pesti Korhaz, Budapest, Hungary; [Lippai, Jozsef] Jahn Ferenc Del Pesti Korhaz & Rendelointezet, Budapest, Hungary; [Lippai, Jozsef] Szent Erzsebet Korhaz, Budapest, Hungary; [Kiss, Krisztian] Meditoll Kft, Godollo, Hungary; [Kiss, Krisztian] Pest Megyei Flor Ferenc Korhaz, Godollo, Hungary; [Kalman, Toth] PTE KK Lsz, Belgyogyaszati Klin, Pecs, Hungary; [Pozsegovits, Krisztian] Dr Kenessey Albert Korhaz Rendelointeze, Balassagyarmat, Hungary; [Csaba, Kiraly; Horvath, Csaba] Bacs Kiskun Megyei Korhaz, Kecskemet, Hungary; [Bereczki, Daniel; Pozsonyi, Zoltan] Semmelweis Egyet, Budapest, Hungary; [Zolyomi, Szilard] Kalocsai Szent Kereszt Korhaz, Kalocsa, Hungary; [Boda, Zoltan; Pall, Denes] Debreceni Egyet, Debrecen, Hungary; [Boda, Zoltan] Debreceni Egyet, Klin Kozpont, Belgyogyaszati Intezet, Debrecen, Hungary; [Szakal, Imre] Selye Janos Korhaz & Rendelointezet, Komarom, Hungary; [Szakal, Imre] Selye Janos Hosp, Komarom, Hungary; [Pall, Denes] Coordinat Ctr Drug Dev, Debrecen, Hungary; [Pall, Denes] Debreceni Egyet, Klin Kozpont, Debrecen, Hungary; [Pall, Denes] Univ Debrecen, Debrecen, Hungary; [Futo, Laszlo; Mueller, Gabor] Markhot Ferenc Oktatokorhaz & Rendelointeze, Eger, Hungary; [Forster, Tamas] Clin Res Coordinat Ctr, Szeged, Hungary; [Forster, Tamas] Szegedi Tudomanyegyet, Szeged, Hungary; [Forster, Tamas] Szegedi Tudomanyegyet, Szent Gyorgyi Albert Orvos & Gy, Szeged, Hungary; [Lovasz, Orsolya] Fovarosi Onkormanyzat Uzsoki Utcai Korhaz Honved, Budapest, Hungary; [Papp, Aniko] Grof Tisza Istvan Korhaz, Berettyoujfalu, Hungary; [Kiraly, Zsolt] Veszprem Megyei Onkormanyzat Tudogyogyintezete, Farkasgyepu, Hungary; [Erik, Hajko] Toldy Ferenc Korhaz Rendelointezet, Cegled, Hungary; [Kristof, Piroska] Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz R, Neurol Osztaly, Szolnok, Hungary; [Lakatos, Ferenc] Oroshazi Korhaz, Oroshaza, Hungary; [Zsolt, Ples] Dent Med Co Bt, Satoraljaujhely, Hungary; [Kirschner, Robert] Pest Megyei Flor Ferenc Korhaz, Kistarcsa, Hungary; [Lupkovics, Geza] Zala Megyei Korhaz, Zalaegerszeg, Hungary; [Lupkovics, Geza] Zala Megyei Szent Rafael Korhaz, Zalaegerszeg, Hungary; [Timar, Gyula] Bajai Szent Rokus Korhaz, Neurol Osztaly, Baja, Hungary; [Pinter, Istvan] COROMED Kft, Siofok, Hungary; [Pinter, Istvan] COROMED SMO Kft, Siofok, Hungary; [Pinter, Istvan] Pecsi Tudomanyegyet Klin Kozpont, Siofok, Hungary; [Pinter, Istvan] Siofoki Korhaz & Rendelointezet, Siofok, Hungary; [Kristof, Tunde] BAZ Megyei Korhaz & Egyet Oktato Korhaz, Miskolc, Hungary; [Kristof, Tunde] Borsod Abauj Zemplen Megyei Korhaz & Egyet Oktato, Miskolc, Hungary; [Kristof, Tunde] Endomedix Kft, Miskolc, Hungary; [Kis, Erno; Kovacs, Aranka] MRC, Eth Comm Clin Pharm, Szekszard, Hungary; [Kis, Erno] Pulmocard Egeszsegugyi Bt, Szekszard, Hungary; [Kis, Erno] Tolna Megyei Onkormanyzat Balassa Janos Korhaz, Intezmenyi E, Szekszard, Hungary; [Kis, Erno] Tolna Megyei Onkormanyzat Balassa Janos Korhaz, Szekszard, Hungary; [Kovacs, Aranka] Dr Bugyi Istvan Korhaz Intezeti Kutatasetikai Biz, Szentes, Hungary; [Mueller, Gabor] Uzsoki Utcai Korhaz, Budapest, Hungary; [Palinkas, Attila] Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodme, Hodmezovasarhely, Hungary; [Turi, Tibor] Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Szekesfehervar, Hungary; [Horvath, Csaba] Varosi Korhaz Keszthely, Keszthely, Hungary; [Kondakor, Istvan] Tolna Megyei Balassa Janos Korhaz, Szekszard, Hungary; [Csanyi, Attila] Petz Aladar Megyei Oktato Korhaz, Gyor, Hungary; [Frankfurter, Zsuzsanna] D Kenessey A Hosp, Balassagyarmat, Hungary; [Frankfurter, Zsuzsanna] Dr Kenessey Albert Korhaz Rendelointezet, Balassagyarmat, Hungary; [Gurzo, Mihaly] Bacs Kiskun Megyei Onkormanyzat Korhaza Kutatas E, Kecskemet, Hungary; [Gurzo, Mihaly] Bacs Kiskun Megyei Korhaz, Kecskemet, Hungary; [Gurzo, Mihaly] MRC, Eth Comm Clin Pharm, Kecskemet, Hungary; [Gafter-Gvili, Anat] Beilinson Med Ctr, Petah Tiqwa, Israel; [Kuchuk, Michael] Hillel Yaffe Med Ctr, Hadera, Israel; [Azzam, Zaher] Rambam Hlth Care Campus, Haifa, Israel; [Elis, Avishay] Rabin Med Ctr, Petah Tiqwa, Israel; [Halabi, Majdi; Hussein, Osamah] Ziv Med Ctr, Safed, Israel; [Blum, Arnon] Baruch Padeh Poria Hosp, Lower Galilee, Israel; [Tsoran-Rosenthal, Inna] Rambam Med Ctr, Haifa, Israel; [Lishner, Michael] Meir Med Ctr, Kefar Sava, Israel; [Hochberg-Klein, Sarit] Hadassah Med Org, Modiin, Israel; [Hochberg-Klein, Sarit] Hadassah Hebrew Univ Hosp, Modiin, Israel; [Hochberg-Klein, Sarit] Hadassah Mt Scopus, Modiin, Israel; [Caraco, Yoseph] Hadassah Univ Hosp, Hadassah Clin Res Ce, Jerusalem, Israel; [Atar, Shaul] Galilee Med Ctr, Nahariyya, Israel; [Atar, Shaul] Western Galilee Hosp, Nahariyya, Israel; [Elias, Nizar] Bnai Zion Med Ctr, Haifa, Israel; [Gavish, Dov] E Wolfson Med Ctr, Holon, Israel; [Butnaru, Adi] Shaare Zedek Med Ctr, Jerusalem, Israel; [Cosmi, Franco] Santa Margherita Hosp, Cortona, Italy; Osped Circolo Varese, Varese, Italy; Fdn Macchi, Varese, Italy; [Garbelotto, Raffaella] Azienda ULSS7, Presidio Osped Vittorio Veneto, Vittorio Veneto, TV, Italy; [Pierfranceschi, Giorgi] AUSL Piacenza Osped Unico Val DArda, Fiorenzuola Darda, Piacenza, Italy; [Simioni, Livio] ULSS 2 Feltre, Feltre, Italy; [Gronda, Edoardo] IRCCS Multimed, Sesto San Giovanni, Italy; [Pesci, Alberto] AO San Gerardo di Monza, Monza, Italy; [D'Angelo, Armando] Osped San Raffaele, Milan, Italy; [D'Angelo, Armando] Osped San Raffaele, IRCCS, Milan, Italy; [Fedele, Francesco] Azienda Policlin Umberto I, Rome, Italy; [Fedele, Francesco] Univ Roma La Sapienza, Umberto Policlin Roma 1, Rome, Italy; [Ghirarduzzi, Angelo] Emilia Romagna Azienda Osped, Serv Sanit Reg, Reggio Emilia, Italy; [Piovaccari, Giancarlo] Azienda Unita Sanit Locale Romagna, Rimini, Italy; [Piovaccari, Giancarlo] Osped Infermi, Rimini, Italy; [Lembo, Giuseppe] IRCCS Neuromed Ist Neurol Mediterraneo, Pozzilli, IS, Italy; [Ria, Luigi] ASL LECCE, PO S CUORE DI GESU, Gallipoli, Italy; [Monaco, Giuseppe] Complesso Osped San Giovanni Addolorata, Rome, Italy; [Brunelli, Claudio] AOU S Martino, IRCCS, IST Ist Nazl Ric Can, Genoa, Italy; [Brunelli, Claudio] Univ Genoa, Clin Pneumol & Tisiol, Genoa, Italy; [Brunelli, Claudio] IRCCS AOU San Martino IST, Genoa, Italy; [Tosetto, Alberto] Osped San Bortolo, ULSS 6 Vicenza, Vicenza, Italy; [Capucci, Alessandro] AOU Osped Riuniti Umberto I GM Lancisi G Sales, Torrette Di Ancona, AN, Italy; [Zanatta, Nello] Azienda USSL7, PO Conegliano, Conegliano, Italy; [Pistolesi, Massimo] AOU Careggi, Florence, Italy; [Mazzi, Valeria] Azienda USL Nord Ovest Toscana, Livorno, Italy; [Testa, Sophie] AO Cremona, Ist Ospitalieri Cremona, Cremona, Italy; [Scherillo, Marino] Azienda Osped G Rummo, Benevento, Italy; [Di Biase, Matteo] AOU Osped Riuniti Foggia, Foggia, Italy; [Antonicelli, Roberto] INRCA IRCCS, Ancona, Italy; [Lodigiani, Corrado] IRCCS Ist Clin Humanitas, Rozzano, Italy; [Lodigiani, Corrado] Tedeschi Michele, Rozzano, Italy; [Nassiacos, Daniele] Osped Saronno, Saronno, Italy; [Krievins, Dainis] P Stradina Clin Univ Hosp, Riga, Latvia; [Viksne, Inese] Jekabpils Hosp, Jekabpils, Latvia; [Lapkovska, Zinaida] Kraslava Hosp, Kraslava, Latvia; [Rancane, Gita] Northern Kurzeme Reg Hosp, Ventspils, Latvia; [Sime, Iveta] Liepaja Reg Hosp, Liepaja, Latvia; [Pontaga, Natalija; Eglite, Ruta] Daugavpils Reg Hosp, Daugavpils, Latvia; [Puzule, Sarmite] Union Balvu & Gulbenes Hosp, Balvi & Gulbene Hosp union, Balvi, Latvia; [Smolova, Rita] SIA Jelgavas pilsetas slimnica, Jelgava, Latvia; [Butkiene, Zita] Vilnius Univ, Hosp Santariskiu Klinikos, Vilnius, Lithuania; [Bagdonas, Alfredas] Kaunas Clin Hosp, Kaunas, Lithuania; [Raugaliene, Rasa] Kaunas City Clin Hosp, Kaunas, Lithuania; [Norkiene, Sigute] Klaipeda Seamens Hosp, Klaipeda, Lithuania; [Norviliene, Rita] Klaipeda Dist Hosp, Respublikine, Klaipedos Iigonine, Klaipeda, Lithuania; [Petrauskiene, Birute] Vilnius Univ, Hosp Santariskiu Klinikos, Vilnius, Lithuania; [Basijokiene, Vida] SiaulSiauliai Republican Hosp, Reumatologijos klinika, Shiauliai, Lithuania; [Stonkus, Sigitas] Klaipeda Univ Hosp, MB A. Navicko konsultacine poliklinika, A. Navicko konsultacine poliklinika, Klaipeda, Lithuania; [Griskeviciene, Violeta] PI Utenos Iigonine, Utena, Lithuania; [Miskiniene, Ausra] Vilnius Univ, Antakalnio Hosp, Vilnius, Lithuania; [Norvaisiene, Rima] Respublikine Klaipedos Iigonine, Klaipeda, Lithuania; [Skripkauskiene, Irena] Respublikine Panevezio Iigonine, Panevezys, Lithuania; [Jovkovska-Kaeva, Biserka] PHI Univ Clin, Skopje, North Macedonia; [Kochovska-Kamchevska, Nade] PHI Gen City Hosp 8mi Septemvri, Skopje, North Macedonia; [Antovski, Antonio; Nechevska, Liljana] City Hosp 8 September, Skopje, North Macedonia; [Celeska, Violeta] Gen Hosp Ohrid, PHI Univ Clin, Ohrid, North Macedonia; [Ilievska-Poposka, Biljana] Inst Iung Dis & TB, PHI Inst Lung Diseaes TB, Skopje, North Macedonia; [Kostojchinoska, Mira] PHI Gen Hosp Struga, Struga, North Macedonia; [Donchovska, Snezhana] Clin Hosp Stip, Stip, North Macedonia; [Kedev, Sashko] Univ Clin Cardiol, Skopje, North Macedonia; [Kuzmanovski, Igor] Univ Clin Neurol, Skopje, North Macedonia; [Bushletikj, Oliver] Clin Hosp SISTINA Acibadem, Skopje, North Macedonia; [Stojchev, Sasho] Gen City Hosp 8 September, Skopje, North Macedonia; [Bakrachevski, Nikola] Inst Cardiovascular Dis Ohrid, Ohrid, North Macedonia; [Kuzmanovska, Biljana] KARIL Clin anestez, Reanimat & intes care, Skopje, North Macedonia; [Angusheva, Tanja] Special Hosp Surg Dis Filip Vtori, Skopje, North Macedonia; [Llamas Esperon, Guillermo] Hosp Cardiolog Aguascalientes, Aguascalientes, Mexico; [Valdez Lopez, Hector] CRI Ctr Regiomontano Investigac SC, Monterrey, Mexico; [Medina Pech, Carlos] Comite Etica Investigac Med Care & Res, Merida, Mexico; [Cortes Hernandez, Miguel] Consultorio Privado, Dr Miguel Cortes Hernandez, Cuernavaca, Morelos, Mexico; [Virgen Carrillo, Luis] Virgen Cardiovascular Res SC, Guadalajara, Mexico; [Gans, Stephanus] Ziekenhuis St Jansdal, Harderwijk, Netherlands; [Smulders, Sietske] Jeroen Bosch Ziekenhuis, sHertogenbosch, Netherlands; [Swart, Henk] Antonius Hosp Sneek, Antonius Hosp, D & A Res Genet, Sneek, Netherlands; [Middeldorp, Saskia] Acad Medisch Centrum Univ, Amsterdam, Netherlands; [Boersma, Willem] Noordwest Ziekenhuisgroep, Alkmaar, Netherlands; [Goosens, Martijn] Gelre Ziekenhuis Zutphen, Zutphen, Netherlands; [Hovens, Marcel] Rijnstate Arnhem, Rijnstate Ziekenhuis, Arnhem, Netherlands; [Semplonius, Geesje] Gelre Ziekenhuizen, Zutphen, Netherlands; [Sohne, M.] St Antonius Ziekenhuis St Antonius Hosp, Nieuwegein, Netherlands; [Osores, Lema] Cardiometabol Hosp Nacl Arzobispo Loayza, Ctr Investigac enfermedades, Lima, Peru; [Salas Perez, Marcia] Hosp Dos de Mayo, Lima, Peru; [Rodriguez, Aldo] EsSalud Hosp Nacl Alberto Sabogal Sologuren, Hosp IV Alberto Sabogal Sologuren EsSalud, Hosp Nacl Alberto Sabogal Sologuren ESSALUD, Callao, Peru; [Rios Oliva, Carlos] Hosp Nacl Arzobispo Loayza, Lima, Peru; [Cotrina, Rosa] Hosp Nacl Guillermo, Hosp Nacl Guillermo Almenara, Hosp Nacl Guillermo Almenara Irigoyen Orthoped, Lima, Peru; [Berrospi Argandona, Percy] Clin El Golf, Lima, Peru; [Toce Yanez, Luis] Clin Internac, Lima, Peru; [Medina Pech, Carlos; Chavez Ayala, Carlos] Hosp Nacl Daniel Alcides Carrion, Callao, Peru; [Mirek-Bryniarska, Ewa] Gabinet Lekarski dr Ewa Mirek, Szpital Specjalistyczny J Dietla Krakowie, Krakow, Poland; [Goch, Aleksander] 10 Wojskowy Szpital Klin Poliklin, Bydgoszcz, Poland; [Skucha, Wojciech] SPZOZ Proszowicach, Proszowice, Poland; [Skorski, Marcin] SP ZOZ Lecznej, SP ZOZ Leczna, Leczna, Poland; [Miekus, Pawel] NZOZ Sopockie Centrum Badan, Kardiologicznych Pro Cordis, Szpital Sw Wincentego Paulo Sp zoo, Sopot, Poland; [Szyszka, Andrzej] Uniwersytet Medyczny Karola Marcinkowskiego Pozna, NZOZ Ctr Medyczne HCP Lecznictwo Stacjonarne, Poznan, Poland; [Piotrowski, Grzegorz] Wojewodzki Szpital Specjalistyczny M Kopernika Lo, Lodz, Poland; [Gniot, Jacek] SPZOZ Szpital Specjalistyczny Pulawach, Pulawy, Poland; [Czerski, Tomasz] SPZOZ Szpital Powiatowy Wegrowie, Wegrow, Poland; [Debich, Piotr] Pabianickie Ctr Medyczne Sp zoo, Pabianice, Poland; [Zaluska, Roman] Mazowiecki Szpital Specjalistyczny dr J Psarskieg, SZPZOZ dr J Psarskiego, Szpital Specjalistyczny, Ostroleka, Poland; [Bebenek, Waldemar] Wojewodzki Szpital Zespolony L Rydygiera Toruniu, Osrodek Badan Klin CLINSANTE SC, Ewa Galczak Nowak Malgorzata Trzaska, Torun, Poland; [Wozakowska-Kaplon, Beata] Swietokrzyskie Ctr Kardiol, Kielce, Poland; [Sciborski, Ryszard] Zespol Opieki Zdrowotnej Szpital Olawie, Olawa, Poland; [Ilkowski, Jan] NZOZ NEURO KARD Ilkowski Partnerzy Sp Partnerska, SP ZOZ dr Kazimierza Hologi, Poznan, Poland; [Wojnowski, Piotr] Szpital Wojewodzki Bielsku Bialej, Bielsko Biala, Poland; [Uscinska, Ewa] Samodzielny Publ Zespol Zakladow Opieki Zdro, Ostrow Mazowiecka, Poland; [Gaciong, Zbigniew] Centralny Szpital Klin, NZOZ AURUM, Samodzielny Publiczny, Warsaw, Poland; [Bonek, Robert] 10 Wojskowy Szpital Klin Poliklin, SP ZOZ, Regionalny Szpital Specjalistyczny Dr Wl Biegansk, Bydgoszcz, SP, Poland; [Sobkowicz, Bozena] Uniwersytecki Szpital Klin Bialymstoku, Bialystok, Poland; [Berkowski, Piotr] Zespol Opieki Zdrowotnej Klodzku, Klodzko, Poland; [Bejgier, Katarzyna] Osrodek Badan Klini CLINSANTE SC Ewa Galczak Nowa, Bydgoszcz, Poland; [Polonski, Lech] 1 Klin Kardiol Slaskiej Akad Med, Silesian Ctr Heart Dis, Sosnowieckie Ctr Kardiol, Zabrze, Poland; [Kosior, Dariusz] Centralny Szpital Klin MSWiA Warszawie, Warsaw, Poland; [Lata, Stanislaw] Szpital Wojewodzki Sw Lukasza SP ZOZ, Tarnow, Poland; [Kolodziej, Piotr] Samodzielny Publ Zaklad Opieki, Zdrowotnej Siedlcach, Siedlce, Poland; [Gessek, Jacek] Prywatny Gabinet Lekarski Jacek Gessek, Specjalistyczny Szpital Miejski, Torun, Poland; [Kachel, Tomasz] Centrum Pulmonologii Torakochirurgii Bystrej, NZOZ ODDECH Sp Zoo, Specjalistyczny Gabinet Lekarski Tomasz Kachel, Bystra, Poland; [Talalaj, Marek] SP Szpital Klin prof dr Orlowskiego CMKP, Warsaw, SP, Poland; [Musial, Jacek] Szpital Uniwersytecki Krakowie, Krakow, Poland; [Lewczuk, Jerzy] Wojewodzki Szpital Specjalist, Osrodek Badawczo Rozwojowy, Wroclaw, Poland; [Krysiak, Waldemar] 109 Szpital Wojskowy Przychodnia SP ZOZ, Neocard, Szczecin, Poland; [Kucharski, Lech] Szpital Specjalistyczny S Zeromskiego, SPZOZ Krakowie, Krakow, Poland; [Wysokinski, Andrzej] Samodzielny Publ Szpital Klin 4 Lublinie, Lublin, Poland; [Minc, Piotr] Wojewodzki Szpital Specjalistyczny M Kopernika Lo, Szpital Miejski dr. K. Jonschera Lodzi 3, Przychodnia Lekarska MED POL Sc M Cieslak K Ciesl, Lodz, Poland; [Martinez, Jorge] H Pero Covilha Ctr Hospitalar Cova daBeira, Covilha, Portugal; [Gregorio, Tiago] CH Vila Nova Gaia Espinho, Vila Nova De Gaia, Portugal; [Almeida, Filipa] H Guimaraes N Senhora Oliveira Ctr Hospitalar Alt, Guimaraes, Portugal; [Monteiro, Pedro] Hospitais Univ Coimbra, Coimbra, Portugal; [Stanciulescu, Gabriela] Spitalul Judetean Urgenta Pitesti, Pitesti, Romania; [Mercea, Corina] Spitalul Judetean Urgenta Dr Constantin Opris Bai, Cabinet Med Cardiol Dr Mercea Corina, Baia Mare, Romania; [Iosipescu, Laura] Spitalul Judetean Urgenta Bacau, Bacau, Romania; [Militaru, Constantin] Emergency Hosp Craiova, Spitalul Clin Judetean Urgenta Craiova, Spitalul Clin Municipal Cluj Napoca, CARDIOMED</suborg2> <city id=0>Craiova</city> <c, ry id=0>Romania</country> <mainorg id=0>Emergency, Craiova, Romania; [Ciobotaru, Valentina] Medicalis, Timisoara, Romania; [Crisu, Daniela] Consultmed, Iasi, Romania; [Burca, Mitel] Spitalul Judetean Urgenta Sf Pantelimon, Focsani, Romania; [Tudoran, Mariana] Spitalul Clin Judetean Urgenta Timisoara, Timisoara, Romania; [Savu, Angelica] Angisan Grp, Bucharest, Romania; [Negrean, Vasile] Bendis Clin, Spitalul Clin CF Cluj Napoca, Cluj Napoca, Romania; [Cojocaru, Cristian] Netconsult, Ctr Oncol Euroclin, Iasi, Romania; [Minescu, Bogdan] Spitalul Judetean Urgenta Braila, Braila, Romania; [Popa, Virgil] Spitalul Clin Judetean Urgenta Oradea, Oradea, Romania; [Blajan, Daniel] Spitalul Judetean Urgenta Pitesti, Pitesti, Romania; [Nastase-Melicovici, Dorel] Inst Urg pt Boli Cardiovasculare si Transplant Tg, Spital clin judetean urgenta mure, Mediab, Rai Medicals, Targu Mures, Romania; [Fruntelata, Ana] Ctr Med Policlin Monza, Bucharest, Romania; [Barbulescu, Sanziana] Ambulator NEOMED, Ctr Med Diagnost si Tratament, Brasov, Romania; [Lukinyh, Liya] MUZ Vsevolzhsk Cent Reg Hosp, Vsevolzhsk, Russia; [Akhunova, Svetlana] Interreg Clinicodiagnost Ctr, Kazan, Russia; [Vishneva, Elena] City Hosp 14, Ekaterinburg, Russia; [Semenova, Irina] First City Clin Hosp, Arkhangelsk, Russia; [Nikolaev, Konstantin] State Budgetary Healthcare Inst Novosibirsk Regio, Sci Res Inst Therapy & prevent, City Clin Hosp 19, Novosibirsk, Russia; [Shaydyuk, Oxana] City Clin Hosp 15, Moscow, Russia; [Nilk, Rostislav] City Hosp 38, St Petersburg, Russia; [Shalnev, Vladimir] North Western State Med Univ, City Alexanrovskaya Hosp, Saint-Petersburg, Russia; [Apartsin, Konstantin] Hosp Irkutsk Sci Ctr Siberian, Fed State Healthcare Inst, Branch Russian Acad Sci, Irkutsk, Russia; [Goloshchekin, Boris] St Petersburg City Hosp 15, St Petersburg, Russia; [Shpagina, Liubov] MUZ City Clin Hosp 2, Novosibirsk, Russia; [Khlevchuk, Tatiana] GBUZ City Clin Hosp, City Clin Hosp 20, Moscow 20, Russia; [Arkhipov, Mikhail] Med Acad, Cent City Hosp 3, GOU VPO Ural State, Ekaterinburg, Russia; [Malygin, Alexander] Yaroslavl Clin Hosp 8, Yaroslavl, Russia; [Shvarts, Yury] Clin Hosp 3, Saratov, Russia; [Khaisheva, Larisa] Rostov state Med Univ, Rostov Na Donu, Russia; [Popov, Dmitry] Reg Clin Hosp 3, Chelyabinsk, Russia; [Kobalava, Zhanna] FGAOU VO Peoples Friendship Univ Russia, City clin Hosp 64, Moscow, Russia; [Lipchenko, Alexander] LLC Med Union New Hosp, Med Assoc New Hosp, Off Dr Alexander, Ekaterinburg, Russia; [Shapovalova, Yulia] NUZ Rd Clin Hosp st Cheliabinsk, Chelyabinsk, Russia; [Zrazhevsky, Konstantin] City Hosp 38, St Petersburg, Russia; [Greshnova, Irina] Ulyanovsk Reg Clin Hosp, SHI Cent Clin Med & Sanit Unit, Ulyanovsk, Russia; [Maslova, Natalia] State Med Univ, GOU VPO Smolensk State Med Acad Roszdrav, Smolensk, Russia; [Karabenenko, Alexander] GBUZ City Clin Hosp 12, Healthcare Dept, Moscow, Russia; [Shogenov, Zaur] City Clin Hosp 81, Moscow, Russia; [Budankova, Ekaterina] Tomsk Reg Clin Hosp, Tomsk, Russia; [Barbarash, Olga] GBOU VPO Kemerovo State Med Acad, Kemerovo Med Acad Reg Clin Hosp, FSBI Res Inst Complex Issues Cardiovascula, Inst Complex Issues Cardiovascular Dis, Kemerovo, Russia; [Uspenskiy, Yury] North Western State Med Univ, City Hosp St venerable Martyr Elizabeth, Skin venerol dispensary 10, St Petersburg, Russia; [Kosmacheva, Elena] Krasnodar Krai Clin Hosp 1, Ochapovsky Hosp, Krasnodar, Russia; [Berns, Svetlana] FSBI Res Inst Complex Issues, Dept Healthcare Moscow, Fed State Budgetary Inst Res Inst C, Inst Complex Issues Cardiovascular Dis, Moscow, Russia; [Kostenko, Victor] LCC Med Res Inst, Res Inst Emergency Care, State Budgatory Healthcare Inst City Polyclin 109, St Petersburg, Russia; [Zateyshchikov, Dmitry] City Clin Hosp 51, City Clin Hosp 17, Moscow, Russia; [Vishnevsky, Alexandr] Spb SBHI City Pokrovskaya Hosp, St Petersburg, Russia; [Boldueva, Svetlana] North Western State Med Univ, MEDEM Int Clin LLC, St Petersburg, Russia; [Podzolkov, Valeriy] M Sechenov First Moscow State Med Univ, Moscow, Russia; [Sergeeva, Elena] First Pavlov State Med Univ, St Petersburg, Russia; [Grinshtein, Yury] Krasnoyarsk State Med Univ, Krasnoyarsk, Russia; [Khrustalev, Oleg] Yaroslavl Reg Clin Hosp, Yaroslavl, Russia; [Bugrova, Olga] Orenburg State Med Univ, GBOU VPO Orenburg State Med Univ, GBUZ Orenburg Clin Reg Hosp, Orenburg, Russia; [Repin, Alexey] RAMS Inst Res Inst Cardiol Siberia, Tomsk, Russia; [Andreev, Denis] Univ Clin Hosp 1, Moscow, Russia; [Petrovic, Predrag] Gen Hosp Smederevo, Smederevo, Serbia; [Matic, Tatjana; Zdravkovic, Vladimir; Andjelkovic, Nebojsa] Clin Ctr Kragujevac, Kragujevac, Serbia; [Apostolovic, Svetlana] Clin Ctr Nis, Clin Cardiol, Clin Cardiovasc Deseases, Nish, Serbia; [Lazic, Zorica] Clin Ctr Kragujevac, Clin Pulmol, Kragujevac, Serbia; [Stankovic, Dusica] Gen Hosp Vranje, Iazar bogavac, Vranje, Serbia; [Stankovic, Aleksandar] Gen Hosp Leskovac, Leskovac, Serbia; [Mitov, Vladimir] Hlth Ctr Zajecar, Zajecar, Serbia; [Sofronic, Dejan] Gen Hosp Valjevo, Valjevo, Serbia; [Kopitovic, Ivan] Inst Pulm Dis Vojvodina, Sremska Kamenica, Serbia; [Joksimovic, Zoran] Gen Hosp Cuprija, Cuprija, Serbia; [Lazovic, Nada] Gen Hosp Cacak, Cacak, Serbia; [Petrovic-Stanojevic, Natasa] Zvezdara Univ Clin Ctr, Municipal Inst Lung Dis & TB, Internal Clin, Belgrade, Serbia; [Ilic, Aleksandra] Clin Ctr Serbia, Clin Pulmol, Belgrade, Serbia; [Vujadinovic, Olivera] Gen Hosp Sabac, Sabac, Serbia; [Pencic-Popovic, Biljana] Univ Clin Hosp Ctr Dr Dragisa Misovic Dedinje, Belgrade, Serbia; [Sekularac, Nikola] Zvezdara Univ Med Ctr, Belgrade, Serbia; [Hinic, Sasa] Clin Hosp Ctr Bezanijska Kosa, Belgrade, Serbia; [Radjen, Goran] Medigrp Bulevar Milutina Milankov 3, Belgrade, Serbia; [Zivkovic, Aleksandar] Hlth Ctr Subotica, Subotica, Serbia; [Putnikovic, Biljana] Clin Hosp Ctr Zemun, Belgrade, Serbia; [Vuckovic, Biljana] CCV, Clin Thrombosis Ad Hemostasis, Novi Sad, Serbia; [Ivanov, Igor] Inst Cardiovasc Dis Vojvodina, Sremska Kamenica, Serbia; [Babic, Rade] Inst Cardiovasc Dis Dedinje, Dedinje, Serbia; [Van Zyl, Louis] Clin Projects Res, Worcester, South Africa; [Hobson, Biano] Vergelegen Mediclin, Cape Town, South Africa; [Basson, Matthys] Karl Bremer Hosp, Tiervlei Trial Ctr, Bellville, South Africa; [Engelbrecht, Johannes] Dr JM Engelbrecht Trial Site, Vergelegen Medicity, Vergelegen Mediclin, Somerset West, South Africa; [Mitha, Ismail] WWCT Lakeview Hosp, Worthwhile Clin Trials, Benoni, South Africa; [Siebert, Heidi] Life Groenkloof Hosp, Pretoria, South Africa; [Jacobson, Barry] Charlotte Maxeke Johannesburg Hosp, Charlotte Maxeke Johannesburg Acad, Charlotte Maxeke Johannesburg Acad Hosp, Johannesburg, South Africa; [Breedt, Johannes] Jacaranda Hosp, Emmed Res, Pretoria, South Africa; [Prozesky, Hans] Univ Stellenbosch, TREAD Res CC, Tygerberg Hosp, Tygerberg, South Africa; [Ntsekhe, Mpiko] Groote Schuur Hosp, Cape Town, South Africa; [Bayat, Junaid] Practice Dr Junaid Bayat, Durban, South Africa; [Ellis, Graham] Synexus Ltd, Synexus Helderberg Clin Res Ctr, Somerset West, South Africa; [Tarr, Gareth] Winelands Med Res Ctr, Stellenbosch, South Africa; [Adler, David] Kopano Clin Trials, Johannesburg, South Africa; [Van Dyk, Christo] Boland Eth Res Grp, Worcester, South Africa; [Ismail, S.] Gatesville Med Ctr, Room 310, Gatesville Cape Town, South Africa; [Spargo, Catherine] Arthrit Clin Res Trials, Cape Town, South Africa; [Abdool-Gaffar, Mohamed] Kingsway Med Ctr, Durban, South Africa; [Saaiman, Jan] SA Endovasc Multidisciplinary Cardiovasc Practic, Dr JA Saaiman, Kuils River, South Africa; [Venter, Karl] Iatros Int, Bloemfontein, South Africa; [Lorente Aroca, Maria] HU Ribera, Alzira, Spain; [Fernandez Portales, Francisco] H San Pedro Alcantara, Caceres, Spain; [Pedrajas Navas, Jose] Hosp Clin San Carlos, Madrid, Spain; [Rodriguez Botaro, Antonio] H Inf Luisa, Seville, Spain; [Cruz Siminiani, Antonio] HU Santa Lucia, Serv Neumol, Cartagena, Spain; [Lopez Reyes, Raquel] HUP La Fe, Valencia, Spain; [Bisbe i Company, Josep] Hosp Olot & Comarcal Garrotxa, Olot, Spain; [Piedecausa Selfa, Mar] HGU Elche, Elche, Spain; [Velasco Garrido, Jose] HU Virgen de la Victoria, Malaga, Spain; [Sobrino-Martinez, Javier] Fdn Hosp Esperit St, Santa Coloma de Gramenet, Spain; [Munoz Delgado, Gregorio] H Tajo, Aranjuez, Spain; [Sala Llinas, Ernest] Hosp Son Espases, HU Son Espases, Palma de Mallorca, Spain; [Blanco Coronado, Jose] HV Mar, Almeria, Spain; [Almenar Bonet, Luis; Todoli Parra, Jose] HUP La Fe, Valencia, Spain; [Vida Gutierrez, Manuel] HV Mar, CH Torrecardenas, Almeria, Spain; [Sanchez Lora, Fernando] HU Virgen de la Victoria, Malaga, Spain; [Sanchez Martinez, Rosario] HGU Alicante, Alicante, Spain; [Calderon, Enrique] Hosp Univ Virgen del Rocio, Seville, Spain; [Calderon, Enrique] CIBERESP, Seville, Spain; [Villalta Blanch, Jaume] Hosp Clin Barcelona, Fdn Clin, HUP Hierro Majadahonda, Barcelona, Spain; [De la Hera Galarza, Jesus] HUC Asturias, Oviedo, Spain; [Bustamante Ruiz, Ana] Hosp Marques De Valdecilla, CEIC Reg Cantabria, H Sierrallana, Torrelavega, Spain; [Jose Garcia-Fuster, Maria] Hosp Clin Univ Valencia, Valencia, Spain; [Ripoll Vera, Tomas] H Son Llatzer, Palma de Mallorca, Spain; [Alvarez-Sala Walter, Luis; Diaz Fernandez, Jose] HGUG Maranon, Madrid, Spain; [Bosa Ojeda, Francisco] Fdn Rafael Clavijo, HU Canarias, San Cristobal la Laguna, Spain; [Pellicer-Ciscar, Concepcion] H Francesc Borja, Valencia, Spain; [Jara Palomares, Luis] HUV Rocio, Seville, Spain; [Quiles Granado, Juan] HU San Juan Alicante, San Juan, Spain; [Trigo Bautista, Alberto] CAAH Ntra SradeSonsoles, Avila, Spain; [Ruiz Bustillo, Sonia] Hosp del Mar, Barcelona, Spain; [Ordi Ros, Josep] Hosp Univ Vall dHebron, Barcelona, Spain; [Tolosa-Vilella, Carles] Univ Hosp, Parc Tauli, Barcelona, Spain; [Marin Ortuno, Francisco] Hosp Univ Virgen de la Arrixaca, Fdn FORMAC INVEST SANIT ENLA, El Palmar, Spain; [Garcia Sanchez, Florentino] HU Ppe Asturias, Madrid, Spain; [Barba Martin, Raquel] Hosp Rey Juan Carlos, Mostoles, Spain; [Segovia Cubero, Javier; Cuervas-Mons Martinez, Valentin] Hosp Univ Puerta Hierro Majadahonda, Majadahonda Madrid, Spain; [Galan Montejano, Miguel] HC Don Benito, Fundesalud, Don Benito, Spain; [Lopez Meseguer, Manuel] Hosp Univ Vall dHebron, Barcelona, Spain; [Sener Comert, Sevda] Kartal Lutfi Kirdar Educ & Res Hosp, Istanbul, Turkey; [Koksal, Nurhan] Ondokuz Mayis Univ, Med Fac, Samsun, Turkey; [Tertemiz, Kemal] Dokuz Eylul Univ, Med Fac, Izmir, Turkey; [Ernam, Dilek] Sureyyapasa Ctr Chest Dis, Istanbul, Turkey; [Dursun, Adile] Recep Tayyip Erdogan Univ, Med Fac, Rize, Turkey; [Yildiz, Oznur] Ankara Univ, ZEYNEP PINAR ONEN, Sch Med Pulm Dis, Ankara, Turkey; [Rudenko, Leonid] Kiev Municipal Emergency Hosp, Kiev, Ukraine; [Abrahamovych, Orest] Danylo Halytsky Lviv Natl Med Univ, Lvov, Ukraine; [Goloborodko, Alla] Odessa Reg Clin Hosp, Odessa, Ukraine; [Holovchenko, Nataliia] KZ Khersonska Miska Klin Iikarnia Imeni Afanasiia, Kherson, Ukraine; [Kulyk, Anna] Cherkaska Oblasna Iikarnia, Oblasna Iikarnia, M Cherkasy, Ukraine; [Yagensky, Andriy] Lutsk City Hosp, Lutsk, Ukraine; [Batushkin, Valerii] Kyiv City Clin Hosp 5, Kiev, Ukraine; [Zolotaikina, Viktoriia] Kharkivska Miska Klin Likarnia 27, Kharkov, Ukraine; [Kozyolkin, Oleksandr] MI City Clin Hosp 6, Zaporizhzhia, Ukraine; [Faynyk, Andriy] Lviv Reg Cardiol Ctr, Lvov, Ukraine; [Maslovskyy, Valentyn] Vinnitsa Reg Clin Hosp Vet, Vinnitsa, Ukraine; [Petrovskyy, Roman] Ivano Frankivskyy Oblasnyy Klin Kardiol, Ivano Frankivsk, Ukraine; [Koshlia, Volodymyr] SI Zaporizhzhya Med Acad Postgrad Educ, Zaporizhzhya Med Acad Postraduate Educ, Miska Klin Iikarnia 9, Zaporizhzhia, Ukraine; [Chopey, Ivan] Viddilkova Iikarnia Stantsii Uzhgorod, M Uzhgorod, Ukraine; [Burmak, Iurii] 4 City Clin Hosp, Ukranian Med Stomatol Acad, Poltava, Ukraine; [Malynovsky, Yaroslav] Reg Med Ctr CardioVasc Dis, Zaporizhzhya, Ukraine; [Voronkov, Leonid] Natl Sci Ctr MD Strazhesko Inst Car, Inst Cardiol AMS, Kiev, Ukraine; [Karpenko, Olexandr] City Clin Hosp 1, Kiev, Ukraine; [Dziublyk, Oleksandr] Nasl Inst Ftyziatrii Pulmonol Yanovskoho, Kiev, Ukraine; [Godlevska, Olga] City Clin Emergency Hosp, Khark Mis Klin Lik Shvydk Ta Nevidkladnoi Meddopo, Kharkiv City Clin Emergency Hosp, Komunalna Ustanova Okhorony Zdorovia Kharkivska M, Kharkov, Ukraine; [Borovyk, Valentyna] Chernihivska Miska Iikarnia 2, Chernihiv, Ukraine; [Bezrodna, Larysa] SI NSC Inst Cardiol, Kiev, Ukraine; [Serik, Sergii] LT Malaya Therapy Inst NAMS of Ukraine, Kharkov, Ukraine; [Ovsyannikova, Nataliya] DLPZ Tsentralna Klin Iikarnia Ukrzaliznytsi, Kharkov, Ukraine; [Vynnychenko, Lyudmyla] Sumy Reg Clin Oncol Ctr, Komunalna Ustanova Sumska Miska Klin Iikarnia 1, Sumska Miska Klin Iikarnia 1, Sumy, Ukraine; [Kopytsya, Mykola] Inst Therapy, Kharkov, Ukraine; [Rudkovskiy, Volodymyr] Kyivska Miska Klin Iikarnia 8, Kiev, Ukraine; [Grishyna, Olena] Mechnikov Inst, Miska Bagatoprofilna Iikarnia 18, Kharkov, Ukraine; [Vyshnyvetskyy, Ivan] Zhytomyr Cent City Hosp 1, Zhytomyr, Ukraine; [Prystupa, Lyudmyla] Komunalnyi Zaklad Sumskoi Oblasnoi Rady Sumska Ob, Sumska Oblasna Klin Iikarnia, Sumy, Ukraine; [Tseluyko, Vira] Kharkiv Med Acad Postgrad Educ, KZOZ Kharkivska Miska Klin Iikarnia 8, Kzoz Kh Mkl 8, Kharkov, Ukraine; [Perepeliuk, Mykola] Odesa Natl Med Univ, Odessa, Ukraine; [Koval, Olena] Kl Obied Shv Med Dop, Dnepropetrovsk, Ukraine; [Sychov, Oleg] Nasl Naukovyi Tsentr Inst Kardiol M Strazh, Kiev, Ukraine; [Church, Alistair] Queen Elizabeth Univ Hosp Glasgow, NHS Greater Gla, nSGUH, Glasgow, Lanark, Scotland; [Goudie, Andrew] Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Elliott, Mark] St James Univ Hosp, Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Ferguson, Craig] Univ Manchester, GM LCRN Great Manchester Local Clin Res Network, Manchester Royal Infirm, Manchester, Lancs, England; [Welker, James] Anne Arundel Med Ctr, Anne Arundel Hlth Syst, Annapolis, MD USA; [Kao, Cheng-Kai] Univ Chicago, Chicago, IL 60637 USA; [Bhagwat, Ravi] Cardiol Associates Northwest Indiana PC, Cardiovasc Res Northwest Indiana, Munster, Germany; [Serota, Harvey] PC SLHV Christian Hosp, St Louis Heart & Vasc, Practice Dr Harvey Serota, St Louis Heart & Vasc Res Dept, St Louis, MO USA; [Rosenberg, David] North Shore Univ Hosp, Long Isl Jewish Med Ctr, Montefiore Med Ctr, Manhasset, NY USA; [Bozorgchami, Hormozd] Oregon Hlth & Sci Univ Hosp, Portland, OR USA; [Nambiar, Rajesh] Amarillo Heart Grp, Amarillo, TX USA; [Hazelrigg, Monica] McGuire VA Med Ctr, Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Spilseth, Sara] Reg Hosp, HealthPartners Res & Educ, Bloomington, IN USA; [Bhagwath, Gayathri] Angeles Clin & Res Inst Los Angeles, Dallas, TX USA; [Syed, Faizullah] Shoals Primary Care LLC, SYED Res Res Consultants LLC Www Syedreserach Com, Res Consultants, Sheffield, S Yorkshire, England; [Morrow, Lee] Creighton Univ, Med Ctr, Alegent Creighton Clin Pulm, Omaha, NE USA; [Updegrove, John] Corsicana Med Res, Corsicana, TX USA; [Bercz, Peter] Pensacola Lung Grp PA, Pensacola, FL USA; [Kambo, Varinder] Lenox Hill Hosp, New York, NY 10021 USA; [Henderson, David] Cardiol Associates Res Co, Daytona Beach, FL USA; [Wright, Patrick] Moses Cone Hlth Syst, Piedmontresp Res Fdn, Greensboro, NC USA; [Dang, Nguyen] Cardiol Consultants Orange Cty Med Grp Inc, Anaheim, CA USA; [Nadar, Venkatesh] Capital Area Res LLC, Heritage Med Grp HMG Heritage Cardiol Associate, Camp Hill, PA USA; [Jaffrani, Naseem] Cambridge Med Trials, Alexandria Cardiol Clin, DM Clin Res, Alexandria, VA USA; [El-Shahawy, Mohamed] Acad Med Res Inst, Los Angeles, CA USA; [Grossman, Colby] Palmetto Clin Res, Summerville, SC USA; [Pearle, James] Calif Res Med Grp Inc, ClinEdge, Fullerton, CA USA; [Weinstein, Debra] Atlantic Clin Res LLC, Atlantic Clin Res Collaborat, ACRC Cardiol Atlantic Clin Res, ClinEdge Orthoped Res Inst,Vis Clin Res Zasa Clin, Boynton Beach, FL USA; [Galanis, Taki] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA; [Gazmuri, Raul] Captain James Lovell Fed Hlth Care Ctr, North Chicago VA Med Ctr, N Chicago, IL USA; [Kastelic, Richard] Richard M Kastel MD & Associates, Johnstown, PA USA; [Martinez, Rafael] Pulm & Sleep Tampa Bay, Brandon, FL USA; [Laman, David] Consolidated Clin Trials Inc, Piedmont Healthcare Piedmont Heart Inst, Pittsburgh Pulm Associates, Monroeville, PA USA; [Macchiavelli, Anthony] AtlantiCare, Atlantic City, NJ USA; [Kmetzo, James] Doylestown Hosp, Cent Bucks Cardiol VIAA, Doylestown, PA USA; [Thurm, Craig] Jamaica Hosp Med Ctr, Jamaica, NY USA; [Kayembe, Tshiswaka] Midwest Hlth Profess, Ctr Adv Med & Res, St Petersburg, FL USA; [Chandrashekhar, Yellapragada] Univ Minnesota, Minneapolis VA Med Ctr, Minneapolis, MN USA; [Bassetti, Dennis] Marquez Clin Site Partners LLC, Clin Trials Florida LLC, Bassetti Med Res Inc, Sebring, FL USA; [Jaoude, Philippe] Vet Affairs Western New York Healthcare Syst Buff, Buffalo, NY USA; [Williams, Hayes] Cent Res Associates Inc, Achieve Clin Res, Elite Res Network, Birmingham, AL USA; [Dewhurst, Robert] Bay Area Cardiol Associates PA, Brandon, FL USA; [Naqvi, Syed] Univ Missouri Hlth Car, Clin Res Ctr, Columbia, MO USA; [Burr, John] Illinois Heart & Lung Res Ctr, Normal, IL USA; [Rodriguez-Cintron, William] SODEINC Inc, VA Caribbean Healthcare Syst, San Juan, PR USA; [Jeanfreau, Robert] Medpharm LLC, Benchmark Res, Metaire, LA USA; [Kosinski, Edward] Connecticut Clin Res LLC, Bridgeport, CT USA; [Ndukwu, Ikeadi] St Anthony Mem Hosp, LaPorte Cty Inst Clin Res, Effingham, IL USA; [Sotolongo, Carlos] Jacksonville Heart Ctr, Baptist Med Ctr, Baptist Heart Specialists Baptist Beaches Off, Jacksonville, FL USA; [Daboul, Nizar; Wilmer, Charles] St Lukes Hosp, Adv Med Res, Maumee, OH USA; [Simon, Peter] Vet Affairs Pittsburgh Healthcare Syst, Highland Dri, Pittsburgh, PA USA; [Tak, Tahir] Mayo Clin Hlth Syst, La Crosse, WI USA; [Rees, Christopher] Pennsylvania Hosp, Philadelphia, PA USA; [Gupta, Nishant] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA; [Lerner, Robert] Westchester Med Ctr Valhalla, Valhalla, NY USA; [Tapson, Victor] Cedars Sinai Med Ctr, Beverly Hills, CA USA; [Graffagnino, Carmelo] Duke Univ, Med Ctr, Durham, NC USA; [Reed, Robert] Univ Maryland, Baltimore, MD USA; [Alford, Chad] Mobile Heart Specialists PC, Mobile, AL USA; [Mody, Freny] Greater Angeles Healthcare Syst, Brentwood Med Res Inst, Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Wellmon, Baxter] Biomed Res Ass, Shippensburg, PA USA; [Hamroff, Glenn] Hudson Valley Cardiol Grp Cortlandt Med Bldg, Montefiore Med Ctr, NYU Hudson Valley Cardiol, Hudson, NY USA; [Rajan, Raj] Nova Clin Res LLC, Theia Res LLC, Bradenton, FL USA; [Kaatz, Scott] Henry Ford Hosp, Detroit, MI USA	Northwell Health; Northwell Health; Icahn School of Medicine at Mount Sinai; University of Insubria; Stanford University; University of California System; University of California Davis; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Colorado System; University of Colorado Anschutz Medical Campus; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Royal Brompton Hospital; McMaster University; McMaster University; Johnson & Johnson; Janssen Pharmaceuticals; University of Oklahoma System; University of Oklahoma Health Sciences Center; Hospital Privado - Universitario de Cordoba; Gold Coast University Hospital; Mater Health Services; Royal Perth Hospital; Royal Perth Hospital; Flinders Medical Centre; St George Hospital; St George Hospital; Medical University of Vienna; University Hospital Vienna; Konventhospital Der Barmherzigen Bruder; Republican Scientific & Practical Center Cardiology; University of Mostar; Universidade Estadual de Campinas; Universidade de Sao Paulo; Pontificia Universidade Catolica Do Rio Grande Do Sul; Fundacao Universitaria de Cardiologia; Universidade Federal de Pernambuco; Universidade de Sao Paulo; Medical University Sofia; Scarborough Hospital; Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute; University of Alberta; University of Sherbrooke; McGill University; McMaster University; Hospital Universitario San Ignacio; Fundacion Valle del Lili; Universidad del Quindio; Fundacion Cardioinfantil - Instituto de Cardiologia; Universidad de La Sabana; University of Rijeka; University of Zagreb; University of Zagreb; General University Hospital Prague; University Hospital Brno; Thomayer Hospital; University Hospital Vinohrady; General University Hospital Prague; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Klinikum Coburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Patras; Henry Dunant Hospital; University of Crete; University Hospital Attikon; Aristotle University of Thessaloniki; Ahepa University Hospital; Democritus University of Thrace; University of Pecs; University of Pecs; University of Pecs; Semmelweis University; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; Szeged University; Szeged University; Rabin Medical Center; Rambam Health Care Campus; Rabin Medical Center; Ziv Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Western Galilee Hospital; Western Galilee Hospital; Bnai Zion Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Ospedale Circolo & Fondazione Macchi; ULSS 2 Marca TV; Ospedale Vittorio Veneto; ULSS 1 Dolomiti; Ospedale di Feltre; IRCCS Multimedica; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; University Hospital Sapienza Rome; Hospital of Rimini; IRCCS Neuromed; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS INRCA; IRCCS Humanitas Research Hospital; Pauls Stradins Clinical University Hospital; Vilnius University; Klaipeda Republican Hospital; Vilnius University; Klaipeda University; Klaipeda University Hospital; Vilnius University; Jeroen Bosch Ziekenhuis; Medical Center Of Alkmaar; Rijnstate Hospital; Gelre Hospitals; Seguro Social de Salud del Peru; Silesian Center for Heart Diseases; Jagiellonian University; Collegium Medicum Jagiellonian University; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Rostov State Medical University; North-Western State Medical University named after I.I. Mechnikov; North-Western State Medical University named after I.I. Mechnikov; Sechenov First Moscow State Medical University; Pavlov First Saint Petersburg State Medical University; Krasnoyarsk State Medical University; Clinical Centre of Serbia; University of Witwatersrand; Stellenbosch University; Tygerberg Hospital; University of Cape Town; Hospital Clinico San Carlos; Hospital Universitari Son Espases; Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Clinic Universitari de Valencia; Hospital Universitari Son Llatzer; Universidad de la Laguna; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitari Vall d'Hebron; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Puerta de Hierro-Majadahonda; Hospital Universitari Vall d'Hebron; Istanbul Kartal Dr Lutfi Kirdar Training & Research Hospital; Ondokuz Mayis University; Dokuz Eylul University; Recep Tayyip Erdogan University; Ankara University; Danylo Halytsky Lviv National Medical University; Poltava State Medical University; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; Ministry of Education & Science of Ukraine; Sumy State University; National Academy of Medical Sciences of Ukraine; L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine; National Academy of Medical Sciences of Ukraine; I.Mechnikov Institute of Microbiology & Immunology of the National Academy of Medical Sciences of Ukraine; Kharkiv Medical Academy of Postgraduate Education; Odessa National Medical University; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; Queen Elizabeth University Hospital (QEUH); University of Dundee; Saint James's University Hospital; University of Leeds; University of Manchester; University of Chicago; Montefiore Medical Center; Northwell Health; North Shore University Hospital; Oregon Health & Science University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Creighton University; Northwell Health; Jefferson University; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Westchester Medical Center; Cedars Sinai Medical Center; Duke University; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Montefiore Medical Center; Henry Ford Health System; Henry Ford Hospital	Spyropoulos, AC (corresponding author), Northwell Hlth, Lenox Hill Hosp, 130 E 77th St, New York, NY 10075 USA.	aspyropoul@northwell.edu	nikolaishvili, Giorgi/AAX-7868-2020; Akin, Ibrahim/AAF-1356-2020; Bowler, Simon/AAE-1630-2019; Maslovskyi, Valentyn/GQO-9125-2022; Köksal, Nurhan/AAG-5849-2021; Prozesky, Hans Walter/ABE-6956-2020; Yıldız, Öznur/AAM-7271-2020; Musiał, Jacek/U-5930-2018; Pozsonyi, Zoltán/AAD-3278-2020; Zateyshchikov, Dmitry/AGN-8590-2022; Shvarts, Yury Григорьевич/AAB-4929-2022; Weitz, Jeffrey/AAD-1929-2019; STEG, Philippe Gabriel/Z-1567-2019; Vyshnyvetskyy, Ivan/AAP-5012-2020; Maslovskyi, Valentyn/V-3896-2019; Pojskic, Belma/AAO-9702-2021; barba martin, raquel/GRE-9368-2022; Tosetto, Alberto/AAM-3200-2020; Kosmacheva, Elena/AAY-4841-2020; Bustillo, Sonia Ruiz/AAC-1329-2020; VADIKOLIAS, KONSTANTINOS/AAK-3620-2021; Ruzic, Alen/N-2117-2018; Malynovsky, Yaroslav/T-1898-2017; Apartsin, Konstantin/ABC-5678-2020; Lodigiani, Corrado/AAW-1964-2020; Faynyk, Andriy/G-5152-2019; Zateyshchikov, Dmitry A/D-6575-2012; Marchev, Sotir/AAH-6529-2020; vardas, panos/ABF-7144-2020; Reis, Gilmar/I-4500-2013; Koziolkin, Oleksandr/AAA-5382-2019; Tosetto, Alberto/AAB-9320-2022; Precoma, Dalton B/D-5674-2013; Halperin, Jonathan/AAJ-4721-2020; Abrahamovych, Orest/M-9818-2019; Nikolaev, Konstantin/P-4750-2017; Konstantinides, Stavros/AAL-3174-2021; Laganović, Mario/CAG-4680-2022; Shpagina, Lyubov/Y-7864-2018; Andreev, Denis А/W-2390-2017; Antonicelli, Roberto/AAB-3233-2021; Bereczki, Daniel/AAL-9886-2020; Sikic, Jozica/GXG-0013-2022; Forster, Tamas/AAV-9037-2020; Koval, Olena/AAF-7121-2020; Ripoll-Vera, Tomas/AAT-3535-2021; Baker, Ross/AAG-5798-2021; Segovia-Cubero, Javier/AAB-7345-2021; Apartsin, Konstantin/ACA-8088-2022; Tsivgoulis, Georgios/AAD-5360-2020; Brachmann, Johannes/AAD-1499-2021; Beyer-Westendorf, Jan/K-7569-2019; Karapanayiotides, Theodoros/ABE-4423-2020; ntsekhe, mpiko/AAI-8001-2021; Koksal, Nurhan/AAA-3249-2022; Quiles, Juan/B-9663-2009; Jara-Palomares, Luis/A-4090-2017; Chong, Beng/AAE-2617-2019; Chong, Beng/AAM-9010-2021; Middeldorp, Saskia/ABI-8197-2020; Tudoran, Mariana M/C-8126-2015; Grinshtein, Yury/M-4091-2014; Apartsin, Konstantin A/B-9179-2017; Boldueva, Svetlana/AAH-3862-2019; Zimmermann, Sérgio/AIE-5122-2022; Babic, Rade/AAO-1507-2020; dursun, adile berna/GXM-6812-2022; Cojocaru, Cristian/ADP-1201-2022; Lopez Meseguer, Manuel/D-6177-2018; Cuervas-Mons, Valentin/C-8504-2017; Serik, Serhii/T-3897-2018; Repin, Alexey/J-6150-2017; Barbarash, Olga/A-4834-2017	Maslovskyi, Valentyn/0000-0001-5184-1799; Prozesky, Hans Walter/0000-0001-9715-3449; Yıldız, Öznur/0000-0002-5379-6829; Musiał, Jacek/0000-0002-8994-0036; Zateyshchikov, Dmitry/0000-0001-7065-2045; Shvarts, Yury Григорьевич/0000-0002-5205-7311; Weitz, Jeffrey/0000-0002-1092-7550; Vyshnyvetskyy, Ivan/0000-0001-7228-3052; Maslovskyi, Valentyn/0000-0001-5184-1799; Pojskic, Belma/0000-0002-5374-990X; barba martin, raquel/0000-0002-1408-1441; Tosetto, Alberto/0000-0002-0119-5204; Bustillo, Sonia Ruiz/0000-0002-6074-914X; VADIKOLIAS, KONSTANTINOS/0000-0003-0484-369X; Ruzic, Alen/0000-0001-5031-2975; Malynovsky, Yaroslav/0000-0002-9118-1104; Apartsin, Konstantin/0000-0003-0577-9001; Lodigiani, Corrado/0000-0002-9152-9385; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Marchev, Sotir/0000-0001-9250-510X; Reis, Gilmar/0000-0002-4847-1034; Koziolkin, Oleksandr/0000-0001-9878-5798; Halperin, Jonathan/0000-0002-8318-5471; Abrahamovych, Orest/0000-0001-6862-6809; Nikolaev, Konstantin/0000-0003-4601-6203; Konstantinides, Stavros/0000-0001-6359-7279; Laganović, Mario/0000-0002-0240-4178; Shpagina, Lyubov/0000-0003-0871-7551; Andreev, Denis А/0000-0002-0276-7374; Antonicelli, Roberto/0000-0002-5921-1828; Baker, Ross/0000-0002-2728-6788; Apartsin, Konstantin/0000-0003-0577-9001; Tsivgoulis, Georgios/0000-0002-0640-3797; Beyer-Westendorf, Jan/0000-0002-6983-9993; ntsekhe, mpiko/0000-0002-0851-7675; Quiles, Juan/0000-0002-3458-6260; Jara-Palomares, Luis/0000-0002-4125-3376; Middeldorp, Saskia/0000-0002-1006-6420; Tudoran, Mariana M/0000-0001-8989-5899; Grinshtein, Yury/0000-0001-8847-235X; Apartsin, Konstantin A/0000-0003-0577-9001; Boldueva, Svetlana/0000-0002-1898-084X; Babic, Rade/0000-0002-1674-9732; Cojocaru, Cristian/0000-0001-9933-8965; Kosmacheva, Elena/0000-0001-8600-0199; Gomez-Mesa, Juan Esteban/0000-0002-6635-6224; Khalafallah, Alhossain/0000-0002-2399-3311; Gallus, Alexander/0000-0001-7347-9989; Sala-Llinas, Ernest/0000-0002-6499-1638; Lopez Meseguer, Manuel/0000-0003-2650-9238; Giorgi-Pierfranceschi, Matteo/0000-0002-7988-9652; Apostolovic, Svetlana/0000-0001-9015-297X; Sanchez Martinez, Rosario/0000-0003-0408-3029; Albers, Gregory/0000-0003-0263-4632; Khorana, Alok/0000-0002-9509-0998; Kosior, Dariusz/0000-0002-7821-4442; Csanyi, Attila/0000-0002-2368-3751; Gazmuri, Raul J./0000-0002-3848-7227; Torbicki, Adam/0000-0003-3475-8832; Cuervas-Mons, Valentin/0000-0003-3086-9463; Serik, Serhii/0000-0001-6257-3566; Gregorio, Tiago/0000-0002-0131-9430; RIPOLL-VERA, TOMAS/0000-0001-9222-325X; Ramacciotti, Eduardo/0000-0002-5735-1333; Zolotaikina, Viktoriia/0000-0002-5265-4861; Karapanayiotides, Theodoros/0000-0002-2357-7967; Repin, Alexey/0000-0001-7123-0645; Barbarash, Olga/0000-0002-4642-3610; Godlevska, Olga/0000-0001-7473-9711; Kopitovic, Ivan/0000-0003-4733-0093	Janssen Research and Development; Daiichi Sankyo; Portola; Boehringer Ingelheim; Janssen; Bayer; BMS Pfizer; Aspen; Sanofi; University of Cincinnati and Spectrum Health; Pfizer; ATLAS Group (Colorado Prevention Center); Johnson Johnson; Ortho-McNeil-Janssen; Bayer/Janssen; Merck; Amgen	Janssen Research and Development; Daiichi Sankyo(Daiichi Sankyo Company Limited); Portola; Boehringer Ingelheim(Boehringer Ingelheim); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bayer(Bayer AG); BMS Pfizer(Pfizer); Aspen; Sanofi; University of Cincinnati and Spectrum Health; Pfizer(Pfizer); ATLAS Group (Colorado Prevention Center); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Ortho-McNeil-Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bayer/Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech IncBayer AG); Merck(Merck & Company); Amgen(Amgen)	Supported by Janssen Research and Development.r Dr. Spyropoulos reports receiving advisory board fees from Daiichi Sankyo and Portola, grant support, consulting fees, and advisory board fees from Boehringer Ingelheim and Janssen, consulting fees and advisory board fees from Bayer, and a stipend from ATLAS Group (Colorado Prevention Center); Dr. Ageno, receiving grant support and advisory board fees from Bayer and BMS Pfizer and advisory board fees from Portola, Daiichi Sankyo, Aspen, Boehringer Ingelheim, and Sanofi; Dr. Albers, receiving consulting fees from Bayer; Dr. Elliott, receiving fees for serving on a steering committee from Bayer and lecture fees from the University of Cincinnati and Spectrum Health; Dr. Halperin, receiving consulting fees from Boehringer Ingelheim, Daiichi Sankyo, Pfizer, ATLAS Group (Colorado Prevention Center), Johnson & Johnson, and Ortho-McNeil-Janssen; Dr. Hiatt, receiving grant support from Janssen and Bayer; Dr. Steg, receiving grant support and fees for serving on a steering committee from Bayer/Janssen, grant support and lecture fees from Merck, grant support, consulting fees, lecture fees, and fees for serving as cochair of the ODYSSEY outcomes trial and the SCORED trial from Sanofi, grant support and fees for serving as chair of the CLARIFY registry from Servier, consulting fees and fees for serving on the executive steering committee for the REDUCE IT trial from Amarin, consulting fees and lecture fees from Amgen, consulting fees, lecture fees, and fees for critical event committee work from Bristol-Myers Squibb, fees for serving on the executive steering committee of the REDUAL PCI trial from Boehringer Ingelheim, fees for critical event committee work from Pfizer, consulting fees and fees for serving on the executive steering committee for the PARADISE MI trial from Novartis, consulting fees from Regeneron and Lilly, and consulting fees and fees for serving as cochair of the THEMIS trial from AstraZeneca; Dr. Weitz, receiving consulting fees and honoraria from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Ionis, Janssen, Merck, Novartis, Pfizer and Portola; Dr. Suh and Dr. Barnathan, being employed by Janssen Research and Development and owning stock in Johnson & Johnson; Dr. Spiro, being employed by and owning shares in Bayer U.S.; and Dr. Raskob, receiving consulting fees from Bayer, BMS, Boehringer Ingelheim, Eli Lilly, Portola, and Novartis and consulting fees and honoraria from Daiichi Sankyo and Pfizer. No other potential conflict of interest relevant to this article was reported.	Cohen AT, 2016, NEW ENGL J MED, V375, P534, DOI 10.1056/NEJMoa1601747; Cohen AT, 2013, NEW ENGL J MED, V368, P513, DOI 10.1056/NEJMoa1111096; Cohen AT, 2005, THROMB HAEMOSTASIS, V94, P750, DOI 10.1160/TH05-06-0385; Gardlund B, 1996, LANCET, V347, P1357; Gibson C Michael, 2017, TH Open, V1, pe56, DOI 10.1055/s-0037-1603929; Goldhaber SZ, 2011, NEW ENGL J MED, V365, P2167, DOI 10.1056/NEJMoa1110899; Hull RD, 2013, CLIN APPL THROMB-HEM, V19, P357, DOI 10.1177/1076029613481105; Hull RD, 2010, ANN INTERN MED, V153, P8, DOI 10.7326/0003-4819-153-1-201007060-00004; Kahn Susan R, 2012, Chest, V141, pe195S, DOI 10.1378/chest.11-2296; Kakkar AK, 2011, NEW ENGL J MED, V365, P2463, DOI 10.1056/NEJMoa1111288; Lutz J, 2014, NEPHROL DIAL TRANSPL, V29, P29, DOI 10.1093/ndt/gft209; Mahan CE, 2014, THROMB HAEMOSTASIS, V112, P692, DOI 10.1160/TH14-03-0239; Mahan CE, 2013, THROMB RES, V132, P520, DOI 10.1016/j.thromres.2013.08.013; Raskob GE, 2016, THROMB HAEMOSTASIS, V115, P1240, DOI 10.1160/TH15-09-0756; Rosenberg D, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001152; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Spyropoulos AC, 2011, CHEST, V140, P706, DOI 10.1378/chest.10-1944; Wattanakit K, 2008, J AM SOC NEPHROL, V19, P135, DOI 10.1681/ASN.2007030308	18	141	147	4	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2018	379	12					1118	1127		10.1056/NEJMoa1805090	http://dx.doi.org/10.1056/NEJMoa1805090			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1KV	30145946	Green Published			2022-12-28	WOS:000445020900006
J	Menon, BK; Al-Ajlan, FS; Najm, M; Puig, J; Castellanos, M; Dowlatshahi, D; Calleja, A; Sohn, SI; Ahn, SH; Poppe, A; Mikulik, R; Asdaghi, N; Field, TS; Jin, A; Asil, T; Boulanger, JM; Smith, EE; Coutts, SB; Barber, PA; Bal, S; Subramanian, S; Mishra, S; Trivedi, A; Dey, S; Eesa, M; Sajobi, T; Goyal, M; Hill, MD; Demchuk, AM				Menon, Bijoy K.; Al-Ajlan, Fahad S.; Najm, Mohamed; Puig, Josep; Castellanos, Mar; Dowlatshahi, Dar; Calleja, Ana; Sohn, Sung-Il; Ahn, Seong H.; Poppe, Alex; Mikulik, Robert; Asdaghi, Negar; Field, Thalia S.; Jin, Albert; Asil, Talip; Boulanger, Jean-Martin; Smith, Eric E.; Coutts, Shelagh B.; Barber, Phil A.; Bal, Simerpreet; Subramanian, Suresh; Mishra, Sachin; Trivedi, Anurag; Dey, Sadanand; Eesa, Muneer; Sajobi, Tolulope; Goyal, Mayank; Hill, Michael D.; Demchuk, Andrew M.		INTERRSeCT Study Investigators	Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; HEMORRHAGIC TRANSFORMATION; ENDOVASCULAR THROMBECTOMY; CT ANGIOGRAPHY; THROMBOLYSIS; REPERFUSION; ALTEPLASE; TIME; TENECTEPLASE; PREDICTORS	IMPORTANCE Recanalization of intracranial thrombus is associated with improved clinical outcome in patients with acute ischemic stroke. The association of intravenous alteplase treatment and thrombus characteristics with recanalization over time is important for stroke triage and future trial design. OBJECTIVE To examine recanalization over time across a range of intracranial thrombus occlusion sites and clinical and imaging characteristics in patients with ischemic stroke treated with intravenous alteplase or not treated with alteplase. DESIGN, SETTING, AND PARTICIPANTS Multicenter prospective cohort study of 575 patients from 12 centers (in Canada, Spain, South Korea, the Czech Republic, and Turkey) with acute ischemic stroke and intracranial arterial occlusion demonstrated on computed tomographic angiography (CTA). EXPOSURES Demographics, clinical characteristics, time from alteplase to recanalization, and intracranial thrombus characteristics (location and permeability) defined on CTA. MAIN OUTCOMES AND MEASURES Recanalization on repeat CTA or on first angiographic acquisition of affected intracranial circulation obtained within 6 hours of baseline CTA, defined using the revised arterial occlusion scale (rAOL) (scores from 0 [primary occlusive lesion remains the same] to 3 [complete revascularization of primary occlusion]). RESULTS Among 575 patients (median age, 72 years [IQR, 63-80]; 51.5% men; median time from patient last known well to baseline CTA of 114 minutes [IQR, 74-180]), 275 patients (47.8%) received intravenous alteplase only, 195 (33.9%) received intravenous alteplase plus endovascular thrombectomy, 48 (8.3%) received endovascular thrombectomy alone, and 57 (9.9%) received conservative treatment. Median time from baseline CTA to recanalization assessment was 158 minutes (IQR, 79-268); median time from intravenous alteplase start to recanalization assessment was 132.5 minutes (IQR, 62-238). Successful recanalization occurred at an unadjusted rate of 27.3%(157/575) overall, including in 30.4%(143/470) of patients who received intravenous alteplase and 13.3%(14/105) who did not (difference, 17.1%[95% CI, 10.2%-25.8%]). Among patients receiving alteplase, the following factors were associated with recanalization: time from treatment start to recanalization assessment (OR, 1.28 for every 30-minute increase in time [95% CI, 1.18-1.38]), more distal thrombus location, eg, distal M1 middle cerebral artery (39/84 [46.4%]) vs internal carotid artery (10/92 [10.9%]) (OR, 5.61 [95% CI, 2.38-13.26]), and higher residual flow (thrombus permeability) grade, eg, hairline streak (30/45 [66.7%]) vs none (91/377 [24.1%]) (OR, 7.03 [95% CI, 3.32-14.87]). CONCLUSIONS AND RELEVANCE In patients with acute ischemic stroke, more distal thrombus location, greater thrombus permeability, and longer time to recanalization assessment were associated with recanalization of arterial occlusion after administration of intravenous alteplase; among patients who did not receive alteplase, rates of arterial recanalization were low. These findings may help inform treatment and triage decisions in patients with acute ischemic stroke.	[Menon, Bijoy K.; Najm, Mohamed; Smith, Eric E.; Coutts, Shelagh B.; Barber, Phil A.; Bal, Simerpreet; Subramanian, Suresh; Dey, Sadanand; Eesa, Muneer; Sajobi, Tolulope; Goyal, Mayank; Hill, Michael D.; Demchuk, Andrew M.] Univ Calgary, Calgary, AB, Canada; [Al-Ajlan, Fahad S.] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia; [Puig, Josep; Castellanos, Mar] Dr Josep Trueta Univ Hosp, IDI IDIBGI, Girona, Spain; [Dowlatshahi, Dar] Univ Ottawa, Ottawa, ON, Canada; [Calleja, Ana] Univ Valladolid, Valladolid, Spain; [Sohn, Sung-Il; Ahn, Seong H.] Keimyung Univ, Daegu, South Korea; [Ahn, Seong H.] Gwangju Inst Sci & Technol, Gwangju, South Korea; [Poppe, Alex] Univ Montreal, Montreal, PQ, Canada; [Mikulik, Robert] Masaryk Univ, St Anns Univ Hosp, Int Clin Res Ctr, Dept Neurol, Brno, Czech Republic; [Asdaghi, Negar] Univ Miami, Miami, FL USA; [Field, Thalia S.] Univ British Columbia, Vancouver, BC, Canada; [Jin, Albert] Queens Univ Kingston, Kingston, ON, Canada; [Asil, Talip] Bezmialem Vakif Univ Noroloji, Istanbul, Turkey; [Mishra, Sachin] Gold Coast Univ Hosp, Gold Coast, Australia; [Trivedi, Anurag] Univ Manitoba, Winnipeg, MB, Canada	University of Calgary; King Faisal Specialist Hospital & Research Center; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University of Ottawa; Universidad de Valladolid; Keimyung University; Gwangju Institute of Science & Technology (GIST); Universite de Montreal; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); University of Miami; University of British Columbia; Queens University - Canada	Demchuk, AM (corresponding author), Univ Calgary, Cumming Sch Med, Seaman Family MR Res Ctr,Hotchkiss Brain Inst, Dept Clin Neurosci,Calgary Stroke Program, 140329 St NW, Calgary, AB T2N 2T9, Canada.; Demchuk, AM (corresponding author), Univ Calgary, Cumming Sch Med, Seaman Family MR Res Ctr,Hotchkiss Brain Inst, Calgary Stroke Program,Dept Radiol, 140329 St NW, Calgary, AB T2N 2T9, Canada.	ademchuk@ucalgary.ca	MENON, BIJOY K/B-7718-2014; Mikulik, Robert/M-1757-2016; Field, Thalia S./GRR-7961-2022; Goyal, Mayank/AAE-7323-2019; Demchuk, Andrew M/E-1103-2012; Field, Thalia/P-4103-2019; Smith, Eric E/C-5443-2012; Hill, Michael D/C-9073-2012	Field, Thalia S./0000-0002-1176-0633; Demchuk, Andrew M/0000-0002-4930-7789; Field, Thalia/0000-0002-1176-0633; Smith, Eric E/0000-0003-3956-1668; Hill, Michael D/0000-0002-6269-1543; Sohn, Sung Il/0000-0002-6900-1242; Mikulik, Robert/0000-0002-7458-5166; Dowlatshahi, Dar/0000-0003-1379-3612	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This prospective cohort study was funded by an operating grant from the Canadian Institutes of Health Research.	Adeoye O, 2015, STROKE, V46, P2529, DOI 10.1161/STROKEAHA.115.010260; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Alexandrov AV, 2001, CIRCULATION, V103, P2897, DOI 10.1161/01.CIR.103.24.2897; Barreto AD, 2012, STROKE, V43, P770, DOI 10.1161/STROKEAHA.111.625574; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Boulouis G, 2017, STROKE, V48, P2297, DOI 10.1161/STROKEAHA.117.017607; Campbell BCV, 2018, NEW ENGL J MED, V378, P1573, DOI 10.1056/NEJMoa1716405; DELZOPPO GJ, 1992, ANN NEUROL, V32, P78, DOI 10.1002/ana.410320113; Demchuk AM, 2014, RADIOLOGY, V273, P202, DOI 10.1148/radiol.14132649; Fuentes B, 2015, STROKE, V46, P2156, DOI 10.1161/STROKEAHA.115.009282; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, J NEUROINTERV SURG, V8, P1273, DOI 10.1136/neurintsurg-2015-012191; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Huang XY, 2015, STROKE, V46, P3543, DOI 10.1161/STROKEAHA.115.011290; Khatri P, 2005, STROKE, V36, P2400, DOI 10.1161/01.STR.0000185698.45720.58; Kim YD, 2015, STROKE, V46, P1877, DOI 10.1161/STROKEAHA.114.008247; Labiche LA, 2003, J NEUROIMAGING, V13, P28, DOI 10.1177/1051228402239714; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Menon BK, 2015, RADIOLOGY, V275, P510, DOI 10.1148/radiol.15142256; Millan M, 2017, STROKE, V48, P983, DOI 10.1161/STROKEAHA.116.015455; Mishra SM, 2014, AM J NEURORADIOL, V35, P2265, DOI 10.3174/ajnr.A4048; Molina CA, 2001, STROKE, V32, P1079, DOI 10.1161/01.STR.32.5.1079; Puetz V, 2008, INT J STROKE, V3, P230, DOI 10.1111/j.1747-4949.2008.00221.x; Ribo M, 2006, STROKE, V37, P1000, DOI 10.1161/01.STR.0000206443.96112.d9; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Saver JL, 2013, JAMA-J AM MED ASSOC, V310, P1856, DOI 10.1001/jama.2013.278898; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Seners P, 2016, STROKE, V47, P2409, DOI 10.1161/STROKEAHA.116.014181; Zangerle A, 2007, NEUROLOGY, V68, P39, DOI 10.1212/01.wnl.0000250341.38014.d2	30	129	133	2	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2018	320	10					1017	1026		10.1001/jama.2018.12498	http://dx.doi.org/10.1001/jama.2018.12498			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT2QE	30208455	Green Published, Bronze			2022-12-28	WOS:000444341400015
J	Shen, X; Zhao, B				Shen, Xian; Zhao, Bin			Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OPEN-LABEL; PREDICTIVE BIOMARKERS; CELL CARCINOMA; NIVOLUMAB; DOCETAXEL; MULTICENTER; PEMBROLIZUMAB; ATEZOLIZUMAB; BLOCKADE; MELANOMA	OBJECTIVE To evaluate the relative efficacy of programmed cell death 1 (PD-1) or programmed cell death ligand 1 (PD-L1) inhibitors versus conventional drugs in patients with cancer that were PD-L1 positive and PD-L1 negative. DESIGN Meta-analysis of randomised controlled trials. DATA SOURCES PubMed, Embase, Cochrane database, and conference abstracts presented at the American Society of Clinical Oncology and European Society of Medical Oncology up to March 2018. REVIEW METHODS Studies of PD-1 or PD-L1 inhibitors (avelumab, atezolizumab, durvalumab, nivolumab, and pembrolizumab) that had available hazard ratios for death based on PD-L1 positivity or negativity were included. The threshold for PD-L1 positivity or negativity was that PD-L1 stained cell accounted for 1% of tumour cells, or tumour and immune cells, assayed by immunohistochemistry staining methods. RESULTS 4174 patients with advanced or metastatic cancers from eight randomised controlled trials were included in this study. Compared with conventional agents, PD-1 or PD-L1 inhibitors were associated with significantly prolonged overall survival in both patients that were PD-L1 positive (n=2254, hazard ratio 0.66, 95% confidence interval 0.59 to 0.74) and PD-L1 negative (1920, 0.80, 0.71 to 0.90). However, the efficacies of PD-1 or PD-L1 blockade treatment in patients that were PD-L1 positive and PD-L1 negative were significantly different (P=0.02 for interaction). Additionally, in both patients that were PD-L1 positive and PD-L1 negative, the long term clinical benefits from PD-1 or PD-L1 blockade were observed consistently across interventional agent, cancer histotype, method of randomisation stratification, type of immunohistochemical scoring system, drug target, type of control group, and median follow-up time. CONCLUSIONS PD-1 or PD-L1 blockade therapy is a preferable treatment option over conventional therapy for both patients that are PD-L1 positive and PD-L1 negative. This finding suggests that PD-L1 expression status alone is insufficient in determining which patients should be offered PD-1 or PD-L1 blockade therapy.	[Zhao, Bin] Wenzhou Med Univ, Affiliated Hosp 2, Ctr Precis Med, 109 Xueyuan West Rd, Wenzhou 325027, Peoples R China; Wenzhou Med Univ, Yuying Childrens Hosp, 109 Xueyuan West Rd, Wenzhou 325027, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zhao, B (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Ctr Precis Med, 109 Xueyuan West Rd, Wenzhou 325027, Peoples R China.	doctorbinzhao@126.com						Anagnostou V, 2017, CANCER DISCOV, V7, P264, DOI 10.1158/2159-8290.CD-16-0828; Baxi S, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k793; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Blank CU, 2016, SCIENCE, V352, P658, DOI 10.1126/science.aaf2834; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brzezianska E, 2006, MUTAT RES-FUND MOL M, V599, P26, DOI 10.1016/j.mrfmmm.2005.12.013; Buttner R, 2017, J CLIN ONCOL, V35, P3867, DOI 10.1200/JCO.2017.74.7642; Dolled-Filhart M, 2016, ARCH PATHOL LAB MED, V140, P1243, DOI 10.5858/arpa.2015-0542-OA; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gibney GT, 2016, LANCET ONCOL, V17, pE542, DOI 10.1016/S1470-2045(16)30406-5; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hirsch FR, 2017, J THORAC ONCOL, V12, P208, DOI 10.1016/j.jtho.2016.11.2228; Joseph RW, 2017, UROL ONCOL-SEMIN ORI, V35, P142, DOI 10.1016/j.urolonc.2017.01.017; Khagi Y, 2017, CANCER METAST REV, V36, P179, DOI 10.1007/s10555-016-9652-y; Lee CK, 2017, J THORAC ONCOL, V12, P403, DOI 10.1016/j.jtho.2016.10.007; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Matsushita H, 2016, CANCER IMMUNOL RES, V4, P463, DOI 10.1158/2326-6066.CIR-15-0225; Melosky B, 2018, CANCER TREAT REV, V65, P65, DOI 10.1016/j.ctrv.2018.02.005; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schachter J, 2017, LANCET, V390, P1853, DOI 10.1016/S0140-6736(17)31601-X; Schuette W, 2005, J CLIN ONCOL, V23, P8389, DOI 10.1200/JCO.2005.02.3739; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Socinski MA, 2018, J THORAC ONCOL, V13, P165, DOI 10.1016/j.jtho.2017.11.111; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Takada K, 2018, CLIN LUNG CANCER, V19, P120, DOI 10.1016/j.cllc.2017.10.014; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wang JS, 2017, J MANAG CARE SPEC PH, V23, P158, DOI 10.18553/jmcp.2017.23.2.184; Xu-Monette ZY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01597; Youngnak P, 2003, BIOCHEM BIOPH RES CO, V307, P672, DOI 10.1016/S0006-291X(03)01257-9; Yousefi H, 2017, EXPERT REV CLIN IMMU, V13, P1001, DOI 10.1080/1744666X.2017.1366315	39	236	246	8	52	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2018	362								k3529	10.1136/bmj.k3529	http://dx.doi.org/10.1136/bmj.k3529			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU1JC	30201790	hybrid, Green Published			2022-12-28	WOS:000445015400002
J	Jeger, RV; Farah, A; Ohlow, MA; Mangner, N; Mobius-Winkler, S; Leibundgut, G; Weilenmann, D; Wohrle, J; Richter, S; Schreiber, M; Mahfoud, F; Linke, A; Stephan, FP; Mueller, C; Rickenbacher, P; Coslovsky, M; Gilgen, N; Osswald, S; Kaiser, C; Scheller, B				Jeger, Raban V.; Farah, Ahmed; Ohlow, Marc-Alexander; Mangner, Norman; Moebius-Winkler, Sven; Leibundgut, Gregor; Weilenmann, Daniel; Woehrle, Jochen; Richter, Stefan; Schreiber, Matthias; Mahfoud, Felix; Linke, Axel; Stephan, Frank-Peter; Mueller, Christian; Rickenbacher, Peter; Coslovsky, Michael; Gilgen, Nicole; Osswald, Stefan; Kaiser, Christoph; Scheller, Bruno		BASKET-SMALL 2 Investigators	Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial	LANCET			English	Article							ELUTING STENT; SMALL VESSELS; ANGIOPLASTY; MULTICENTER; RESTENOSIS; IMPLANTATION; CATHETER; LESIONS; SAFETY	Background Drug-coated balloons (DCB) are a novel therapeutic strategy for small native coronary artery disease. However, their safety and efficacy is poorly defined in comparison with drug-eluting stents (DES). Methods BASKET-SMALL 2 was a multicentre, open-label, randomised non-inferiority trial. 758 patients with denovo lesions (<3 mm in diameter) in coronary vessels and an indication for percutaneous coronary intervention were randomly allocated (1:1) to receive angioplasty with DCB versus implantation of a second-generation DES after successful predilatation via an interactive internet-based response system. Dual antiplatelet therapy was given according to current guidelines. The primary objective was to show non-inferiority of DCB versus DES regarding major adverse cardiac events (MACE; ie, cardiac death, non-fatal myocardial infarction, and target-vessel revascularisation) after 12 months. The non-inferiority margin was an absolute difference of 4% in MACE. Findings Between April 10, 2012, and February 1, 2017, 382 patients were randomly assigned to the DCB group and 376 to DES group. Non-inferiority of DCB versus DES was shown because the 95% CI of the absolute difference in MACE in the per-protocol population was below the predefined margin (-3.83 to 3.93%, p=0.0217). After 12 months, the proportions of MACE were similar in both groups of the full-analysis population (MACE was 7.5% for the DCB group vs 7.3% for the DES group; hazard ratio [HR] 0.97 [95% CI 0.58-1.64], p=0.9180). There were five (1.3%) cardiac-related deaths in the DES group and 12 (3.1%) in the DCB group (full analysis population). Probable or definite stent thrombosis (three [0.8%] in the DCB group vs four [1.1%] in the DES group; HR 0.73 [0.16-3.26]) and major bleeding (four [1.1%] in the DCB group vs nine [2.4%] in the DES group; HR 0.45 [0.14-1.46]) were the most common adverse events. Interpretation In small native coronary artery disease, DCB was non-inferior to DES regarding MACE up to 12 months, with similar event rates for both treatment groups.	[Jeger, Raban V.; Stephan, Frank-Peter; Mueller, Christian; Rickenbacher, Peter; Coslovsky, Michael; Gilgen, Nicole; Osswald, Stefan; Kaiser, Christoph] Univ Basel, Univ Hosp Basel, CH-4031 Basel, Switzerland; [Farah, Ahmed] Klinikum Westfalen, Knappschaftskrankhenhaus, Dortmund, Germany; [Ohlow, Marc-Alexander; Richter, Stefan; Schreiber, Matthias] Cent Clin, Bad Berka, Germany; [Mangner, Norman; Linke, Axel] Tech Univ Dresden, Herzzentrum Dresden, Dresden, Germany; [Mangner, Norman; Linke, Axel] Univ Hosp, Heart Ctr Leipzig, Leipzig, Germany; [Moebius-Winkler, Sven] Univ Hosp Jena, Jena, Germany; [Leibundgut, Gregor] Cantonal Hosp Baselland, Liestal, Switzerland; [Weilenmann, Daniel] Cantonal Hosp St Gallen, St Gallen, Switzerland; [Woehrle, Jochen] Univ Hosp Ulm, Ulm, Germany; [Mahfoud, Felix; Scheller, Bruno] Univ Hosp Saarland, Homburg, Germany	University of Basel; Technische Universitat Dresden; Heart Center Leipzig GMBH; Leipzig University; Friedrich Schiller University of Jena; Kantonsspital Baselland; Kantonsspital St. Gallen; Ulm University; Universitatsklinikum des Saarlandes	Jeger, RV (corresponding author), Univ Basel, Univ Hosp Basel, CH-4031 Basel, Switzerland.	raban.jeger@usb.ch	Mahfoud, Felix/D-7707-2011; Scheller, Bruno/S-5761-2016; Mangner, Norman/AAN-4673-2020; Kühne, Michael/AAB-5202-2022; Kaiser, Christoph/AAA-9284-2022; Osswald, Stefan/A-6904-2018; Müller, Christian/AAB-4783-2022; Jeger, Raban/ABG-1678-2021	Mangner, Norman/0000-0003-0793-7923; Kühne, Michael/0000-0002-2937-3711; Osswald, Stefan/0000-0002-9240-6731; Müller, Christian/0000-0002-1120-6405; Jeger, Raban/0000-0003-1290-5491; von Lewinski, Dirk/0000-0001-9996-6128; Ohlow, Marc-Alexander/0000-0001-9674-2129; Schmidt, Albrecht/0000-0003-4783-4603	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung; Basel Cardiovascular Research Foundation; B Braun Medical AG	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Basel Cardiovascular Research Foundation; B Braun Medical AG	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung, Basel Cardiovascular Research Foundation, and B Braun Medical AG.	Alfonso F, 2017, EUROINTERVENTION, V13, P680, DOI 10.4244/EIJ-D-17-00494; Byrne RA, 2013, LANCET, V381, P461, DOI 10.1016/S0140-6736(12)61964-3; Cannon LA, 2012, CATHETER CARDIO INTE, V80, P546, DOI 10.1002/ccd.23397; Cannon LA, 2011, EUROINTERVENTION, V6, P920, DOI 10.4244/EIJV6I8A161; Cortese B, 2011, EUROINTERVENTION, V7, pK53, DOI 10.4244/EIJV7SKA9; Cortese B, 2010, HEART, V96, P1291, DOI 10.1136/hrt.2010.195057; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; DORROS G, 1983, CIRCULATION, V67, P723, DOI 10.1161/01.CIR.67.4.723; Friede T, 2007, BIOMETRICAL J, V49, P903, DOI 10.1002/bimj.200610373; Gilgen N, 2018, CLIN CARDIOL, V41, P569, DOI 10.1002/clc.22942; HUBER MS, 1991, AM J CARDIOL, V68, P467, DOI 10.1016/0002-9149(91)90780-O; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Jeger R, 2016, POSTEP KARDIOL INTER, V12, P314, DOI 10.5114/aic.2016.63630; Kawasaki Y, 2010, AM J BIOSTATISTICS, V1, P23; Kleber FX, 2013, CLIN RES CARDIOL, V102, P785, DOI 10.1007/s00392-013-0609-7; Latib A, 2015, JACC-CARDIOVASC INTE, V8, P1132, DOI 10.1016/j.jcin.2015.04.008; Latib A, 2012, J AM COLL CARDIOL, V60, P2473, DOI 10.1016/j.jacc.2012.09.020; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mok KH, 2017, HERZ, V42, P684, DOI 10.1007/s00059-016-4502-9; Moreno R, 2004, J AM COLL CARDIOL, V43, P1964, DOI 10.1016/j.jacc.2004.01.039; R Development Core Team, 2009, R LANG ENV STAT COMP; Rittger H, 2012, J AM COLL CARDIOL, V59, P1377, DOI 10.1016/j.jacc.2012.01.015; Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254; Schunkert H, 1999, J AM COLL CARDIOL, V34, P40, DOI 10.1016/S0735-1097(99)00181-3; Siontis GCM, 2016, JACC-CARDIOVASC INTE, V9, P1324, DOI 10.1016/j.jcin.2016.03.025; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Unverdorben M, 2010, CLIN RES CARDIOL, V99, P165, DOI 10.1007/s00392-009-0101-6; Unverdorben M, 2009, CIRCULATION, V119, P2986, DOI 10.1161/CIRCULATIONAHA.108.839282; Vaquerizo B, 2015, J INTERV CARDIOL, V28, P430, DOI 10.1111/joic.12227; Venetsanos D, 2018, CATHETER CARDIO INTE, V92, pE317, DOI 10.1002/ccd.27548; Waksman R, 2013, EUROINTERVENTION, V9, P613, DOI 10.4244/EIJV9I5A98; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	32	178	182	0	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2018	392	10150					849	856		10.1016/S0140-6736(18)31719-7	http://dx.doi.org/10.1016/S0140-6736(18)31719-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT0KV	30170854	Green Accepted			2022-12-28	WOS:000444130000030
J	Johansson, KO; Head-Gordon, MP; Schrader, PE; Wilson, KR; Michelsen, HA				Johansson, K. O.; Head-Gordon, M. P.; Schrader, P. E.; Wilson, K. R.; Michelsen, H. A.			Resonance-stabilized hydrocarbon-radical chain reactions may explain soot inception and growth	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; EMISSION; PARTICLES; OXIDATION; EVOLUTION	Mystery surrounds the transition from gas-phase hydrocarbon precursors to terrestrial soot and interstellar dust, which are carbonaceous particles formed under similar conditions. Although polycyclic aromatic hydrocarbons (PAHs) are known precursors to high-temperature carbonaceous-particle formation, the molecular pathways that initiate particle formation are unknown. We present experimental and theoretical evidence for rapid molecular clustering-reaction pathways involving radicals with extended conjugation. These radicals react with other hydrocarbon species to form covalently bound complexes that promote further growth and clustering by regenerating resonance-stabilized radicals through low-barrier hydrogen-abstraction and hydrogen-ejection reactions. Such radical-chain reaction pathways may lead to covalently bound clusters of PAHs and other hydrocarbons that would otherwise be too small to condense at high temperatures, thus providing the key mechanistic steps for rapid particle formation and surface growth by hydrocarbon chemisorption.	[Johansson, K. O.; Schrader, P. E.; Michelsen, H. A.] Sandia Natl Labs, Combust Res Facil, Livermore, CA 94550 USA; [Head-Gordon, M. P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Head-Gordon, M. P.; Wilson, K. R.] Lawrence Berkeley Natl Lab, Chem Sci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Johansson, KO; Michelsen, HA (corresponding author), Sandia Natl Labs, Combust Res Facil, Livermore, CA 94550 USA.	okjohans@gmaIl.com; hamiche@sandia.gov	Head-Gordon, Martin/AAR-4028-2020	Michelsen, Hope/0000-0001-5802-6615	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES), Chemical Sciences, Geosciences, and Biosciences Division, Gas Phase Chemical Physics Program; Gas Phase Chemical Physics Program [DE-AC02-05CH11231]; DOE BES [DE-AC02-05CH11231]; DOE's National Nuclear Security Administration [DE-NA0003525]	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES), Chemical Sciences, Geosciences, and Biosciences Division, Gas Phase Chemical Physics Program; Gas Phase Chemical Physics Program; DOE BES(United States Department of Energy (DOE)); DOE's National Nuclear Security Administration(National Nuclear Security Administration)	This work was funded by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES), Chemical Sciences, Geosciences, and Biosciences Division, Gas Phase Chemical Physics Program. M.P.H.-G. and K.R.W. are supported by this program under Contract no. DE-AC02-05CH11231. The ALS at LBNL is supported by the Director, DOE BES, under Contract no. DE-AC02-05CH11231. SNL is a multimission laboratory, managed and operated by National Technology and Engineering Solutions of Sandia, LLC, a wholly owned subsidiary of Honeywell International, Inc., for the DOE's National Nuclear Security Administration under Contract DE-NA0003525. The views expressed in this article do not necessarily represent those of the DOE or U.S. Government.	ALLAMANDOLA LJ, 1985, ASTROPHYS J, V290, pL25, DOI 10.1086/184435; Bianchi F, 2016, SCIENCE, V352, P1109, DOI 10.1126/science.aad5456; Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171; Dobbins RA, 1998, COMBUST FLAME, V115, P285, DOI 10.1016/S0010-2180(98)00010-8; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; FinlaysonPitts BJ, 1997, SCIENCE, V276, P1045, DOI 10.1126/science.276.5315.1045; Frenklach M, 2002, PHYS CHEM CHEM PHYS, V4, P2028, DOI 10.1039/b110045a; Gunay B, 2018, MON NOT R ASTRON SOC, V479, P4336, DOI 10.1093/mnras/sty1582; Homann KH, 1998, ANGEW CHEM INT EDIT, V37, P2435, DOI 10.1002/(SICI)1521-3773(19981002)37:18<2434::AID-ANIE2434>3.0.CO;2-L; Ishiguro T, 1997, COMBUST FLAME, V108, P231, DOI 10.1016/S0010-2180(96)00206-4; Johansson KO, 2017, AEROSOL SCI TECH, V51, P1333, DOI 10.1080/02786826.2017.1355047; Johansson KO, 2016, P NATL ACAD SCI USA, V113, P8374, DOI 10.1073/pnas.1604772113; Knyazev VD, 2002, J PHYS CHEM A, V106, P5613, DOI 10.1021/jp0144909; LEGER A, 1984, ASTRON ASTROPHYS, V137, pL5; Michelsen HA, 2017, P COMBUST INST, V36, P717, DOI 10.1016/j.proci.2016.08.027; Musculus MPB, 2013, PROG ENERG COMBUST, V39, P246, DOI 10.1016/j.pecs.2012.09.001; Oktem B, 2005, COMBUST FLAME, V142, P364, DOI 10.1016/j.combustflame.2005.03.016; Skeen SA, 2013, J AEROSOL SCI, V58, P86, DOI 10.1016/j.jaerosci.2012.12.008; Tielens AGGM, 2008, ANNU REV ASTRON ASTR, V46, P289, DOI 10.1146/annurev.astro.46.060407.145211; TIELENS AGGM, 1990, NASA CONF P, V3061, P59; Toth P, 2015, COMBUST FLAME, V162, P2422, DOI 10.1016/j.combustflame.2015.02.009; Wang H, 2011, P COMBUST INST, V33, P41, DOI 10.1016/j.proci.2010.09.009	22	300	306	28	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2018	361	6406					997	+		10.1126/science.aat3417	http://dx.doi.org/10.1126/science.aat3417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS7OT	30190399				2022-12-28	WOS:000443892700041
J	Barredo, D; Lienhard, V; De Leseleuc, S; Lahaye, T; Browaeys, A				Barredo, Daniel; Lienhard, Vincent; De Leseleuc, Sylvain; Lahaye, Thierry; Browaeys, Antoine			Synthetic three-dimensional atomic structures assembled atom by atom	NATURE			English	Article							QUANTUM SIMULATIONS; SINGLE ATOMS; INFORMATION	A great challenge in current quantum science and technology research is to realize artificial systems of a large number of individually controlled quantum bits for applications in quantum computing and quantum simulation. Many experimental platforms are being explored, including solid-state systems, such as superconducting circuits(1) or quantum dots(2), and atomic, molecular and optical systems, such as photons, trapped ions or neutral atoms(3-7). The latter offer inherently identical qubits that are well decoupled from the environment and could provide synthetic structures scalable to hundreds of qubits or more(8). Quantum-gas microscopes(9) allow the realization of two-dimensional regular lattices of hundreds of atoms, and large, fully loaded arrays of about 50 microtraps (or 'optical tweezers') with individual control are already available in one(10) and two(11) dimensions. Ultimately, however, accessing the third dimension while keeping single-atom control will be required, both for scaling to large numbers and for extending the range of models amenable to quantum simulation. Here we report the assembly of defect-free, arbitrarily shaped three-dimensional arrays, containing up to 72 single atoms. We use holographic methods and fast, programmable moving tweezers to arrange-atom by atom and plane by plane-initially disordered arrays into target structures of almost any geometry. These results present the prospect of quantum simulation with tens of qubits arbitrarily arranged in space and show that realizing systems of hundreds of individually controlled qubits is within reach using current technology.	[Barredo, Daniel; Lienhard, Vincent; De Leseleuc, Sylvain; Lahaye, Thierry; Browaeys, Antoine] Univ Paris Saclay, CNRS, Lab Charles Fabry, Inst Opt,Grad Sch, Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Barredo, D (corresponding author), Univ Paris Saclay, CNRS, Lab Charles Fabry, Inst Opt,Grad Sch, Palaiseau, France.	daniel.barredo@gmail.com	Lahaye, Thierry/E-1551-2017; Barredo, Daniel/D-3561-2015; Browaeys, Antoine/E-1547-2017	Lahaye, Thierry/0000-0002-2260-9859; Barredo, Daniel/0000-0001-5307-1927; Browaeys, Antoine/0000-0001-9941-8869; de Leseleuc, Sylvain/0000-0002-4761-5753	EU (H2020 FET-PROACT Project RySQ); 'PALM' Labex (project QUANTICA); 'PALM' Labex (project XYLOS); Region Ile-de-France	EU (H2020 FET-PROACT Project RySQ); 'PALM' Labex (project QUANTICA); 'PALM' Labex (project XYLOS); Region Ile-de-France(Region Ile-de-France)	We thank A. Lauchli for discussions. This work benefited from financial support by the EU (H2020 FET-PROACT Project RySQ), by the 'PALM' Labex (projects QUANTICA and XYLOS) and by the Region Ile-de-France in the framework of DIM Nano-K.	Barredo D, 2016, SCIENCE, V354, P1021, DOI 10.1126/science.aah3778; Barredo D, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.113002; Beugeling W, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.235112; Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; Browaeys A, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/15/152001; Buluta I, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/10/104401; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; de Leseleuc S, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.053202; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Di Leonardo R, 2007, OPT EXPRESS, V15, P1913, DOI 10.1364/OE.15.001913; Endres M, 2016, SCIENCE, V354, P1024, DOI 10.1126/science.aah3752; Gross C, 2017, SCIENCE, V357, P995, DOI 10.1126/science.aal3837; Grunzweig T, 2010, NAT PHYS, V6, P951, DOI 10.1038/NPHYS1778; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13317; Kok P, 2007, REV MOD PHYS, V79, P135, DOI 10.1103/RevModPhys.79.135; Kuhr S, 2016, NATL SCI REV, V3, P170, DOI 10.1093/nsr/nww023; Lacki M, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.013604; Lee W, 2016, OPT EXPRESS, V24, P9816, DOI 10.1364/OE.24.009816; Lester BJ, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.073003; Meschede D, 2006, ADV ATOM MOL OPT PHY, V53, P75, DOI 10.1016/S1049-250X(06)53003-4; Nelson KD, 2007, NAT PHYS, V3, P556, DOI 10.1038/nphys645; Ningyuan J, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021031; Nogrette F, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021034; Ruegg A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.155127; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Sturm MR, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.063625; Veldhorst M, 2015, NATURE, V526, P410, DOI 10.1038/nature15263; Vitanov NV, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.015006; WALLIS JW, 1989, IEEE T MED IMAGING, V8, P297, DOI 10.1109/42.41482; Wang Y, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.043003; Weber S, 2018, QUANTUM SCI TECHNOL, V3, DOI 10.1088/2058-9565/aaca47; Weiss D, 2017, PHYS TODAY, V70, P45, DOI 10.1063/PT.3.3626	33	247	246	10	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2018	561	7721					79	82		10.1038/s41586-018-0450-2	http://dx.doi.org/10.1038/s41586-018-0450-2			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS5YU	30185955	Green Submitted			2022-12-28	WOS:000443755200035
J	Homayoun, H				Homayoun, Houman			Parkinson Disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							QUALITY STANDARDS SUBCOMMITTEE; DEEP-BRAIN-STIMULATION; MOTOR FLUCTUATIONS; PRACTICE PARAMETER; AMERICAN-ACADEMY; LEVODOPA; NEUROSTIMULATION; PATHOGENESIS; MANAGEMENT; DISORDERS		[Homayoun, Houman] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Homayoun, H (corresponding author), Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA.				American College of Physicians	American College of Physicians	American College of Physicians.	Aarsland D, 2017, NAT REV NEUROL, V13, P217, DOI 10.1038/nrneurol.2017.27; Ahlskog JE, 2011, NEUROLOGY, V77, P288, DOI 10.1212/WNL.0b013e318225ab66; AlDakheel A, 2014, NEUROTHERAPEUTICS, V11, P6, DOI 10.1007/s13311-013-0218-1; Auffret M, 2018, CLIN DRUG INVEST, V38, P287, DOI 10.1007/s40261-018-0619-3; Ba F, 2015, PARKINSONISM RELAT D, V21, P87, DOI 10.1016/j.parkreldis.2014.11.007; Bloem BR, 2015, MOVEMENT DISORD, V30, P1504, DOI 10.1002/mds.26363; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brundin P, 2016, CURR OPIN NEUROL, V29, P459, DOI 10.1097/WCO.0000000000000349; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Cummings J, 2014, LANCET, V383, P533, DOI 10.1016/S0140-6736(13)62106-6; Deuschl G, 2013, LANCET NEUROL, V12, P1025, DOI 10.1016/S1474-4422(13)70151-0; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; Dirkx MF, 2018, NEUROLOGY, V90, pE1095, DOI 10.1212/WNL.0000000000005215; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Eggers C, 2018, J NEUROL, V265, P764, DOI 10.1007/s00415-018-8761-7; Fasano A, 2017, CURR OPIN NEUROL, V30, P435, DOI 10.1097/WCO.0000000000000465; Fernandez HH, 2015, MOVEMENT DISORD, V30, P500, DOI 10.1002/mds.26123; Fox SH, 2011, MOV DISORD S3, V26, P52; Fox SH, 2018, MOV DISORD; Gallagher DA, 2012, NEUROBIOL DIS, V46, P581, DOI 10.1016/j.nbd.2011.12.041; Goldman Jennifer G, 2016, Continuum (Minneap Minn), V22, P1086, DOI 10.1212/CON.0000000000000353; Hauser RA, 2014, MOVEMENT DISORD, V29, P1028, DOI 10.1002/mds.25877; Hauser RA, 2013, LANCET NEUROL, V12, P346, DOI 10.1016/S1474-4422(13)70025-5; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; Homayoun H, 2012, FUTUR NEUROL, V7, P127, DOI 10.2217/FNL.12.4; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Korczyn AD, 2015, NAT REV NEUROL, V11, P319, DOI 10.1038/nrneurol.2015.61; Loddo G, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00042; Lopez-Sendon J, 2013, EXPERT OPIN DRUG SAF, V12, P487, DOI 10.1517/14740338.2013.787065; Marek K, 2014, NEUROLOGY, V82, P1791, DOI 10.1212/WNL.0000000000000424; Mason AR, 2014, NEUROLOGY, V83, P1470, DOI 10.1212/WNL.0000000000000894; Miyasaki Janis M, 2016, Continuum (Minneap Minn), V22, P1104, DOI 10.1212/CON.0000000000000347; Murata M, 2015, MOVEMENT DISORD, V30, P1343, DOI 10.1002/mds.26286; National Institute for Health and Care Excellence, 2017, NICE GUID NG71; Okun MS, 2013, NEW ENGL J MED, V368, P483, DOI 10.1056/NEJMc1214078; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1111/ene.14108, 10.1038/nrdp.2017.13]; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Postuma RB, 2015, NEUROLOGY, V84, P1104, DOI 10.1212/WNL.0000000000001364; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Reichmann H, 2016, CURR OPIN NEUROL, V29, P467, DOI 10.1097/WCO.0000000000000348; Robottom BJ, 2011, ARCH NEUROL-CHICAGO, V68, P567, DOI 10.1001/archneurol.2011.84; Sakakibara R, 2016, NEUROUROL URODYNAM, V35, P551, DOI 10.1002/nau.22764; Savica R, 2013, JAMA NEUROL, V70, P859, DOI 10.1001/jamaneurol.2013.114; Schapira AHV, 2017, NAT REV NEUROSCI, V18, P509, DOI 10.1038/nrn.2017.91; Schapira AHV, 2017, JAMA NEUROL, V74, P216, DOI 10.1001/jamaneurol.2016.4467; Schenk DB, 2017, MOVEMENT DISORD, V32, P211, DOI 10.1002/mds.26878; Schrag A, 2002, J NEUROL NEUROSUR PS, V73, P529, DOI 10.1136/jnnp.73.5.529; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Seppi K, 2011, MOV DISORD S3, V26, P542; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Stamelou M, 2015, NEUROL CLIN, V33, P39, DOI 10.1016/j.ncl.2014.09.012; Stowe RL, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006564.pub2; Suchowersky O, 2006, NEUROLOGY, V66, P968, DOI 10.1212/01.wnl.0000215437.80053.d0; van der Marck MA, 2013, MOVEMENT DISORD, V28, P605, DOI 10.1002/mds.25194; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Willis AW, 2011, NEUROLOGY, V77, P851, DOI 10.1212/WNL.0b013e31822c9123; Zesiewicz TA, 2010, NEUROLOGY, V74, P924, DOI 10.1212/WNL.0b013e3181d55f24	57	51	53	2	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2018	169	5					ITC33	ITC47		10.7326/AITC201809040	http://dx.doi.org/10.7326/AITC201809040			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS2MV	30178019				2022-12-28	WOS:000443385100005
J	Tan, LZ; Xing, D; Chang, CH; Li, H; Xie, S				Tan, Longzhi; Xing, Dong; Chang, Chi-Han; Li, Heng; Xie, Sunney			Three-dimensional genome structures of single diploid human cells	SCIENCE			English	Article							INACTIVE X-CHROMOSOME; HI-C; CHROMATIN ACCESSIBILITY; NUCLEAR ARCHITECTURE; REVEALS PRINCIPLES; ORGANIZATION; REORGANIZATION; LYMPHOCYTES; RESOLUTION; DOMAINS	Three-dimensional genome structures play a key role in gene regulation and cell functions. Characterization of genome structures necessitates single-cell measurements. This has been achieved for haploid cells but has remained a challenge for diploid cells. We developed a single-cell chromatin conformation capture method, termed Dip-C, that combines a transposon-based whole-genome amplification method to detect many chromatin contacts, called META (multiplex end-tagging amplification), and an algorithm to impute the two chromosome haplotypes linked by each contact. We reconstructed the genome structures of single diploid human cells from a lymphoblastoid cell line and from primary blood cells with high spatial resolution, locating specific single-nucleotide and copy number variations in the nucleus. The two alleles of imprinted loci and the two X chromosomes were structurally different. Cells of different types displayed statistically distinct genome structures. Such structural cell typing is crucial for understanding cell functions.	[Tan, Longzhi; Xing, Dong; Chang, Chi-Han; Xie, Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Tan, Longzhi] Harvard Med Sch, Syst Biol PhD Program, Boston, MA 02115 USA; [Li, Heng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Xie, Sunney] Peking Univ, Innovat Ctr Genom, Beijing 100871, Peoples R China; [Xie, Sunney] Peking Univ, Biodynam & Opt Imaging Ctr, Beijing 100871, Peoples R China	Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Peking University; Peking University	Xie, S (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Xie, S (corresponding author), Peking Univ, Innovat Ctr Genom, Beijing 100871, Peoples R China.; Xie, S (corresponding author), Peking Univ, Biodynam & Opt Imaging Ctr, Beijing 100871, Peoples R China.	sunneyxie@pku.edu.cn	Li, Heng/D-9344-2011	Li, Heng/0000-0003-4874-2874; Tan, Longzhi/0000-0002-5618-1299; Chang, Chi-Han/0000-0002-7436-2931	Beijing Advanced Innovation Center for Genomics at Peking University; Harvard Brain Initiative (HBI) Collaborative Seed Grant; National Science Foundation of China [21390412, 21327808]; HHMI International Student Research Fellowship; NHGRI [R01 HG010040]; NIH Director's Pioneer Award [DP1 CA186693]; NATIONAL CANCER INSTITUTE [DP1CA186693] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG010040] Funding Source: NIH RePORTER	Beijing Advanced Innovation Center for Genomics at Peking University; Harvard Brain Initiative (HBI) Collaborative Seed Grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); HHMI International Student Research Fellowship; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by the Beijing Advanced Innovation Center for Genomics at Peking University, an NIH Director's Pioneer Award (DP1 CA186693), a Harvard Brain Initiative (HBI) Collaborative Seed Grant, and two grants from the National Science Foundation of China (21390412 and 21327808) (X.S.X.); an HHMI International Student Research Fellowship (L.T.); and NHGRI grant R01 HG010040 (H.L.).	Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Branco MR, 2008, CHROMOSOME RES, V16, P413, DOI 10.1007/s10577-008-1230-x; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Carstens S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005292; Chen CY, 2017, SCIENCE, V356, P189, DOI 10.1126/science.aak9787; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Coriell Institute for Medical Research, 2017, 12878 COR I MED RES; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; CULLEN KE, 1993, SCIENCE, V261, P203, DOI 10.1126/science.8327891; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Darrow EM, 2016, P NATL ACAD SCI USA, V113, pE4504, DOI 10.1073/pnas.1609643113; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Giorgetti L, 2016, NATURE, V535, P575, DOI 10.1038/nature18589; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jeong MH, 2017, BIORXIV, DOI [10.1101/212928, DOI 10.1101/212928]; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Li X., 2017, PATENT APPL; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Maharana S, 2016, NUCLEIC ACIDS RES, V44, P5148, DOI 10.1093/nar/gkw131; Nagano T, 2017, NATURE, V547, P61, DOI 10.1038/nature23001; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Quinodoz SA, 2018, CELL, V174, P744, DOI 10.1016/j.cell.2018.05.024; Ramani V, 2017, NAT METHODS, V14, P263, DOI [10.1038/NMETH.4155, 10.1038/nmeth.4155]; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Robinson JT, 2018, CELL SYST, V6, P256, DOI 10.1016/j.cels.2018.01.001; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Waddington C H, 1957, STRATEGY GENES DISCU; Weierich C, 2003, CHROMOSOME RES, V11, P485, DOI 10.1023/A:1025016828544; Weinreb C, 2016, BIOINFORMATICS, V32, P1601, DOI 10.1093/bioinformatics/btv485; Xie WJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02923-6; Zhou YX, 2017, CELL RES, V27, P298, DOI 10.1038/cr.2017.9	40	188	194	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2018	361	6405					924	928		10.1126/science.aat5641	http://dx.doi.org/10.1126/science.aat5641			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS3UB	30166492	Green Accepted			2022-12-28	WOS:000443547000040
J	Torjesen, I				Torjesen, Ingrid			Longer waiting times in Northern Ireland than in rest of UK deemed "unacceptable"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health, HOSP WAIT TIM STAT	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2018	362								k3753	10.1136/bmj.k3753	http://dx.doi.org/10.1136/bmj.k3753			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GS5ZN	30171038				2022-12-28	WOS:000443758900001
J	Blake, IM; Pons-Salort, M; Molodecky, NA; Diop, OM; Chenoweth, P; Bandyopadhyay, AS; Zaffran, M; Sutter, RW; Grassly, NC				Blake, Isobel M.; Pons-Salort, Margarita; Molodecky, Natalie A.; Diop, Ousmane M.; Chenoweth, Paul; Bandyopadhyay, Ananda S.; Zaffran, Michel; Sutter, Roland W.; Grassly, Nicholas C.			Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERADICATION; POLIOMYELITIS; SURVEILLANCE; CESSATION; WORLDWIDE	BACKGROUND Mass campaigns with oral poliovirus vaccine (OPV) have brought the world close to the eradication of wild poliovirus. However, to complete eradication, OPV must itself be withdrawn to prevent outbreaks of vaccine-derived poliovirus (VDPV). Synchronized global withdrawal of OPV began with serotype 2 OPV (OPV2) in April 2016, which presented the first test of the feasibility of eradicating all polioviruses. METHODS We analyzed global surveillance data on the detection of serotype 2 Sabin vaccine (Sabin-2) poliovirus and serotype 2 vaccine-derived poliovirus (VDPV2, defined as vaccine strains that are at least 0.6% divergent from Sabin-2 poliovirus in the viral protein 1 genomic region) in stool samples from 495,035 children with acute flaccid paralysis in 118 countries and in 8528 sewage samples from four countries at high risk for transmission; the samples were collected from January 1, 2013, through July 11, 2018. We used Bayesian spatiotemporal smoothing and logistic regression to identify and map risk factors for persistent detection of Sabin-2 poliovirus and VDPV2. RESULTS The prevalence of Sabin-2 poliovirus in stool samples declined from 3.9% (95% confidence interval [CI], 3.5 to 4.3) at the time of OPV2 withdrawal to 0.2% (95% CI, 0.1 to 2.7) at 2 months after withdrawal, and the detection rate in sewage samples declined from 71.0% (95% CI, 61.0 to 80.0) to 13.0% (95% CI, 8.0 to 20.0) during the same period. However, 12 months after OPV2 withdrawal, Sabin-2 poliovirus continued to be detected in stool samples (< 0.1%; 95% CI, < 0.1 to 0.1) and sewage samples (8.0%; 95% CI, 5.0 to 13.0) because of the use of OPV2 in response to VDPV2 outbreaks. Nine outbreaks were reported after OPV2 withdrawal and were associated with low coverage of routine immunization (odds ratio, 1.64 [95% CI, 1.14 to 2.54] per 10% absolute decrease) and low levels of population immunity (odds ratio, 2.60 [95% CI, 1.35 to 5.59] per 10% absolute decrease) within affected countries. CONCLUSIONS High population immunity has facilitated the decline in the prevalence of Sabin-2 poliovirus after OPV2 withdrawal and restricted the circulation of VDPV2 to areas known to be at high risk for transmission. The prevention of VDPV2 outbreaks in these known areas before the accumulation of substantial cohorts of children susceptible to type 2 poliovirus remains a high priority.	[Blake, Isobel M.; Pons-Salort, Margarita; Molodecky, Natalie A.; Grassly, Nicholas C.] Imperial Coll London, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England; [Diop, Ousmane M.; Chenoweth, Paul; Zaffran, Michel; Sutter, Roland W.] WHO, Polio Eradicat Dept, Geneva, Switzerland; [Bandyopadhyay, Ananda S.] Bill & Melinda Gates Fdn, Seattle, WA USA	Imperial College London; World Health Organization; Bill & Melinda Gates Foundation	Blake, IM (corresponding author), Imperial Coll London, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	isobel.blake@imperial.ac.uk	Grassly, Nicholas C/C-6381-2008	Grassly, Nicholas C/0000-0001-6067-4507; Pons-Salort, Margarita/0000-0001-5597-9285; Blake, Isobel/0000-0002-3977-1318; Bandyopadhyay, Ananda/0000-0002-8395-2001	Bill and Melinda Gates Foundation [OPP1099374, OPP1171890]; World Health Organization [201926920]; MRC [MR/R015600/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); World Health Organization(World Health Organization); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the Bill and Melinda Gates Foundation (OPP1099374 and OPP1171890) and the World Health Organization (201926920).	Adams A, 2015, SCIENCE, V350, P609, DOI 10.1126/science.aad7294; Alexander LN, 2004, JAMA-J AM MED ASSOC, V292, P1696, DOI 10.1001/jama.292.14.1696; Alleman MM, 2018, MMWR-MORBID MORTAL W, V67, P300, DOI 10.15585/mmwr.mm6710a4; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P1; [Anonymous], 2004, S1 SUPPL WHO POL LAB; [Anonymous], 2016, 11 M SAGE POL WORK G; Arita I, 2006, SCIENCE, V312, P852, DOI 10.1126/science.1124959; Asghar H, 2014, J INFECT DIS, V210, pS294, DOI 10.1093/infdis/jiu384; Blake IM, 2016, EMERG INFECT DIS, V22, P449, DOI 10.3201/eid2203.151394; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P222; Diop OM, 2017, MMWR-MORBID MORTAL W, V66, pS38, DOI 10.15585/mmwr.mm6620a4; Etsano A, 2016, MMWR-MORBID MORTAL W, V65, P770, DOI 10.15585/mmwr.mm6530a4; Famulare M, 2016, J VIROL, V90, P317, DOI 10.1128/JVI.01532-15; Global Polio Eradication Initiative, 2015, GUID ENV SURV DET PO; Global Polio Eradication Initiative, 2015, POL ENV SURV EXP PLA; Grassly NC, 2012, J INFECT DIS, V205, P1554, DOI 10.1093/infdis/jis241; Hampton LM, 2016, MMWR-MORBID MORTAL W, V65, P934, DOI 10.15585/mmwr.mm6535a3; Huang QS, 2005, LANCET, V366, P394, DOI 10.1016/S0140-6736(05)66386-6; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kroiss SJ, 2017, VACCINE, V35, P5674, DOI 10.1016/j.vaccine.2017.08.048; Levitt A, 2014, MMWR-MORBID MORTAL W, V63, P356; McCarthy KA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0937-y; Polio Global Eradication Initiative, 2016, CLASS REP VACC DER P; Polio Global Eradication Initiative, CIRC VACC DER POL; Polio Global Eradication Initiative, 2017, RESP POL EV OUT BR 2; Pons-Salort M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002140; Pons-Salort M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005728; R Core Team, R LANG ENV STAT COMP; Rue H., 2014, INLA FUNCTIONS WHICH; Spatial Data Repository, MOD SURF; Stern A, 2017, CELL, V169, P35, DOI 10.1016/j.cell.2017.03.013; Sutter RW, 2014, J INFECT DIS, V210, pS434, DOI 10.1093/infdis/jiu222; Thompson KM, 2014, J INFECT DIS, V210, pS475, DOI 10.1093/infdis/jit845; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; World Health Organization, 2004, POL LAB MAN, V4th	35	34	36	2	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2018	379	9					834	845		10.1056/NEJMoa1716677	http://dx.doi.org/10.1056/NEJMoa1716677			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR9EA	30157398	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000443047800007
J	Murphy, D				Murphy, Declan			Stateless: the Rohingya refugees one year on	BMJ-BRITISH MEDICAL JOURNAL			English	News Item														Murphy, Declan C/0000-0001-9295-7712				Human Rights Council, 2018, REP IND INT FACT FIN	1	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2018	362								k3641	10.1136/bmj.k3641	http://dx.doi.org/10.1136/bmj.k3641			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU9VE	30158107				2022-12-28	WOS:000445701700008
J	Olin, A; Henckel, E; Chen, Y; Lakshmikanth, T; Pou, C; Mikes, J; Gustafsson, A; Bernhardsson, AK; Zhang, C; Bohlin, K; Brodin, P				Olin, Axel; Henckel, Ewa; Chen, Yang; Lakshmikanth, Tadepally; Pou, Christian; Mikes, Jaromir; Gustafsson, Anna; Bernhardsson, Anna Karin; Zhang, Cheng; Bohlin, Kajsa; Brodin, Petter			Stereotypic Immune System Development in Newborn Children	CELL			English	Article							YELLOW-FEVER VACCINE; MASS CYTOMETRY; T-CELLS; BACTERIAL-INFECTIONS; SUPPRESSOR-CELLS; INNATE; COLONIZATION; POPULATIONS; PARAMETERS; MICROBIOTA	Epidemiological data suggest that early life exposures are key determinants of immune-mediated disease later in life. Young children are also particularly susceptible to infections, warranting more analyses of immune system development early in life. Such analyses mostly have been performed in mouse models or human cord blood samples, but these cannot account for the complex environmental exposures influencing human newborns after birth. Here, we performed longitudinal analyses in 100 newborn children, sampled up to 4 times during their first 3 months of life. From 100 mu L of blood, we analyze the development of 58 immune cell populations by mass cytometry and 267 plasma proteins by immunoassays, uncovering drastic changes not predictable from cord blood measurements but following a stereotypic pattern. Preterm and term children differ at birth but converge onto a shared trajectory, seemingly driven by microbial interactions and hampered by early gut bacterial dysbiosis.	[Olin, Axel; Chen, Yang; Lakshmikanth, Tadepally; Pou, Christian; Mikes, Jaromir; Bernhardsson, Anna Karin; Brodin, Petter] Karolinska Inst, Dept Womens & Childrens Hlth, Sci Life Lab, S-17121 Solna, Sweden; [Henckel, Ewa; Gustafsson, Anna; Bohlin, Kajsa] Karolinska Inst, Dept Clin Sci Intervent & Technol, S-14152 Solna, Sweden; [Henckel, Ewa; Gustafsson, Anna; Bernhardsson, Anna Karin; Bohlin, Kajsa; Brodin, Petter] Karolinska Univ Hosp, Dept Neonatol, S-17176 Solna, Sweden; [Zhang, Cheng] KTH, Royal Inst Technol, Sch Biotechnol, Sci Life Lab, S-17121 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology	Brodin, P (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Sci Life Lab, S-17121 Solna, Sweden.; Brodin, P (corresponding author), Karolinska Univ Hosp, Dept Neonatol, S-17176 Solna, Sweden.	petter.brodin@ki.se	Brodin, Petter/C-3317-2011; Mikes, Jaromir/X-3588-2019; Zhang, Cheng/L-7906-2016; Henckel, Ewa/AAD-3185-2019; Tadepally, Lakshmikanth/P-5154-2019; Olin, Axel/AAX-7229-2021	Brodin, Petter/0000-0002-8103-0046; Mikes, Jaromir/0000-0002-9941-7855; Zhang, Cheng/0000-0002-3721-8586; Henckel, Ewa/0000-0003-0775-1563; Tadepally, Lakshmikanth/0000-0001-7256-5770; Olin, Axel/0000-0002-1161-4476	ERC [StG-677559]; Swedish Research Council,; Karolinska Institutet; Swedish Society for Medical Research	ERC(European Research Council (ERC)European Commission); Swedish Research Council,(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Swedish Society for Medical Research	We thank all families for their participation and nurses, midwives, and physicians for help with sample collection. We thank Jochen Schwenk and Ragna ussler at the SciLifeLab Plasma profiling platform and Lars Engstrand and Luisa Hugerth at the Clinical Genomics Facility for help with 16S rRNA profiling. P.B. is grateful to Professor Mark Davis of Stanford University for his valuable mentorship. This study was supported by an ERC Starting Grant (StG-677559), the Swedish Research Council, Karolinska Institutet, and the Swedish Society for Medical Research.	Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Annenyogbe N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0340; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Bhutta ZA, 2013, NEW ENGL J MED, V369, P2226, DOI 10.1056/NEJMra1111853; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Brinkworth JF, 2014, CURR OPIN IMMUNOL, V31, P66, DOI 10.1016/j.coi.2014.09.008; Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Davis MM, 2018, ANNU REV IMMUNOL, V36, P843, DOI 10.1146/annurev-immunol-042617-053206; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gibbons D, 2014, NAT MED, V20, P1206, DOI 10.1038/nm.3670; Gibbons DL, 2009, EUR J IMMUNOL, V39, P1794, DOI 10.1002/eji.200939222; Kaczorowski KJ, 2017, P NATL ACAD SCI USA, V114, pE6097, DOI 10.1073/pnas.1705065114; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kollmann TR, 2017, IMMUNITY, V46, P350, DOI 10.1016/j.immuni.2017.03.009; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Laforest-Lapointe I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00788; Lakshmikanth T, 2017, CELL REP, V20, P2238, DOI 10.1016/j.celrep.2017.08.021; Leiber A, 2017, EUR J IMMUNOL, V47, P1009, DOI 10.1002/eji.201646621; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lum PY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01236; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Oertli M, 2012, GUT MICROBES, V3, P566, DOI 10.4161/gmic.21750; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Patin E, 2018, NAT IMMUNOL, V19, P302, DOI 10.1038/s41590-018-0049-7; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Quach H, 2017, J EXP MED, V214, P877, DOI 10.1084/jem.20161942; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rieber N, 2013, CLIN EXP IMMUNOL, V174, P45, DOI 10.1111/cei.12143; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Sharma AA, 2012, CLIN IMMUNOL, V145, P61, DOI 10.1016/j.clim.2012.08.006; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Shen-Orr SS, 2016, CELL SYST, V3, P374, DOI 10.1016/j.cels.2016.09.009; Singh G, 2007, TOPOLOGICAL METHODS; Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Templ M, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P341; Tsang JS, 2015, TRENDS IMMUNOL, V36, P479, DOI 10.1016/j.it.2015.06.005; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; van der Maaten L., 2013, ARXIV ARXIV 1301 334; Vatanen T, 2016, CELL, V165, P1551, DOI 10.1016/j.cell.2016.05.056; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Weber LM, 2016, CYTOM PART A, V89A, P1084, DOI 10.1002/cyto.a.23030; Wehrens R, 2007, J STAT SOFTW, V21, P1; Wong EB, 2017, IMMUNOLOGY, V150, P45, DOI 10.1111/imm.12673; Zhang XM, 2017, NAT REV IMMUNOL, V17, P495, DOI 10.1038/nri.2017.54; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	57	283	289	6	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 23	2018	174	5					1277	+		10.1016/j.cell.2018.06.045	http://dx.doi.org/10.1016/j.cell.2018.06.045			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GR3WU	30142345	Green Published, hybrid			2022-12-28	WOS:000442529100021
J	Griswold, MG; Fullman, N; Hawley, C; Arian, N; Zimsen, SRM; Tymeson, HD; Venkateswaran, V; Tapp, AD; Forouzanfar, MH; Salama, JS; Abate, KH; Abate, D; Abay, SM; Abbafati, C; Abdulkader, RS; Abebe, Z; Aboyans, V; Abrar, MM; Acharya, P; Adetokunboh, OO; Adhikari, TB; Adsuar, JC; Afarideh, M; Agardh, EE; Agarwal, G; Aghayan, SA; Agrawal, S; Ahmed, MB; Akibu, M; Akinyemiju, T; Akseer, N; Al Asfoor, DH; Al-Aly, Z; Alahdab, F; Alam, K; Albujeer, A; Alene, KA; Ali, R; Ali, SD; Alijanzadeh, M; Aljunid, SM; Alkerwi, A; Allebeck, P; Alvis-Guzman, N; Amare, AT; Aminde, LN; Ammar, W; Amoako, YA; Amul, GGH; Andrei, CL; Angus, C; Ansha, MG; Antonio, CAT; Aremu, O; Arnlov, J; Artaman, A; Aryal, KK; Assadi, R; Ausloos, M; Avila-Burgos, L; Avokpaho, EFGA; Awasthi, A; Ayele, HT; Ayer, R; Ayuk, TB; Azzopardi, PS; Badali, H; Badawi, A; Banach, M; Barker-Collo, SL; Barrero, LH; Basaleem, H; Baye, E; Bazargan-Hejazi, S; Bedi, N; Bejot, Y; Belachew, AB; Belay, SA; Bennett, DA; Bensenor, IM; Bernabe, E; Bernstein, RS; Beyene, AS; Beyranvand, T; Bhaumik, S; Bhutta, ZA; Biadgo, B; Bijani, A; Bililign, N; Birlik, SM; Birungi, C; Bizuneh, H; Bjerregaard, P; Bjorge, T; Borges, G; Bosetti, C; Boufous, S; Bragazzi, NL; Brenner, H; Butt, ZA; Cahuana-Hurtado, L; Calabria, B; Campos-Nonato, IR; Rincon, JCC; Carreras, G; Carrero, JJ; Carvalho, F; Castaneda-Orjuela, CA; Rivas, JC; Catala-Lopez, F; Chang, JC; Charlson, FJ; Chattopadhyay, A; Chaturvedi, P; Chowdhury, R; Christopher, DJ; Chung, SC; Ciobanu, LG; Claro, RM; Conti, S; Cousin, E; Criqui, MH; Dachew, BA; Dargan, PI; Daryani, A; Das Neves, J; Davletov, K; De Castro, F; De Courten, B; De Neve, JW; Degenhardt, L; Demoz, GT; Des Jarlais, DC; Dey, S; Dhaliwal, RS; Dharmaratne, SD; Dhimal, M; Doku, DT; Doyle, KE; Dubey, M; Dubljanin, E; Duncan, BB; Ebrahimi, H; Edessa, D; Zaki, ME; Ermakov, SP; Erskine, HE; Esteghamati, A; Faramarzi, M; Farioli, A; Faro, A; Farvid, MS; Farzadfar, F; Feigin, VL; Felisbino-Mendes, MS; Fernandes, E; Ferrari, AJ; Ferri, CP; Fijabi, DO; Filip, I; Finger, JD; Fischer, F; Flaxman, AD; Franklin, RC; Futran, ND; Gallus, S; Ganji, M; Gankpe, FG; Gebregergs, GB; Gebrehiwot, TT; Geleijnse, JM; Ghadimi, R; Ghandour, LA; Ghimire, M; Gill, PS; Ginawi, IA; Giref, AZZ; Gona, PN; Gopalani, SV; Gotay, CC; Goulart, AC; Greaves, F; Grosso, G; Guo, YM; Gupta, R; Gupta, R; Gupta, V; Gutierrez, RA; Gvs, M; Hafezi-Nejad, N; Hagos, TB; Hailu, GB; Hamadeh, RR; Hamidi, S; Hankey, GJ; Harb, HL; Harikrishnan, S; Haro, JM; Hassen, HY; Havmoeller, R; Hay, SI; Heibati, B; Henok, A; Heredia-Pi, I; Hernandez-Llanes, NF; Herteliu, C; Hibstu, DTT; Hoogar, P; Horita, N; Hosgood, HD; Hosseini, M; Hostiuc, M; Hu, GQ; Huang, H; Husseini, A; Idrisov, B; Ileanu, BV; Ilesanmi, OS; Irvani, SSN; Islam, SMS; Jackson, MD; Jakovljevic, M; Jayatilleke, AU; Jha, RP; Jonas, JB; Jozwiak, JJ; Kabir, Z; Kadel, R; Kahsay, A; Kapil, U; Kasaeian, A; Kassa, TDD; Katikireddi, SV; Kawakami, N; Kebede, S; Kefale, AT; Keiyoro, PN; Kengne, AP; Khader, Y; Khafaie, MA; Khalil, IA; Khan, MN; Khang, YH; Khater, MM; Khubchandani, J; Kim, CI; Kim, D; Kim, YJ; Kimokoti, RW; Kisa, A; Kivimaki, M; Kochhar, S; Kosen, S; Koul, PA; Koyanagi, A; Krishan, K; Defo, BK; Bicer, BK; Kulkarni, VS; Kumar, P; Lafranconi, A; Balaji, AL; Lalloo, R; Lallukka, T; Lam, H; Lami, FH; Lan, Q; Lang, JJ; Lansky, S; Larsson, AO; Latifi, A; Leasher, JL; Lee, PH; Leigh, J; Leinsalu, M; Leung, J; Levi, M; Li, YC; Lim, LL; Linn, S; Liu, SW; Lobato-Cordero, A; Lotufo, PA; Macarayan, ERK; Machado, IE; Madotto, F; Abd El Razek, HM; Abd El Razek, MM; Majdan, M; Majdzadeh, R; Majeed, A; Malekzadeh, R; Malta, DC; Mapoma, CC; Martinez-Raga, J; Maulik, PK; Mazidi, M; Mckee, M; Mehta, V; Meier, T; Mekonen, T; Meles, KG; Melese, A; Memiah, PTN; Mendoza, W; Mengistu, DT; Mensah, GA; Meretoja, TJ; Mezgebe, HB; Miazgowski, T; Miller, TR; Mini, GK; Mirica, A; Mirrakhimov, EM; Moazen, B; Mohammad, KA; Mohammadifard, N; Mohammed, S; Monasta, L; Moraga, P; Morawska, L; Jalu, MT; Mousavi, SM; Mukhopadhyay, S; Musa, KI; Naheed, A; Naik, G; Najafi, F; Nangia, V; Nansseu, JR; Nayak, MSDP; Nejjari, C; Neupane, S; Neupane, SP; Ngunjiri, JW; Nguyen, CT; Nguyen, LH; Nguyen, TH; Ningrum, DNA; Nirayo, YL; Noubiap, JJ; Ofori-Asenso, R; Ogbo, FA; Oh, IH; Oladimeji, O; Olagunju, AT; Olivares, PR; Olusanya, BO; Olusanya, JO; Oommen, AM; Oren, E; Orpana, HM; Ortega-Altamirano, DDV; Ortiz, JR; Ota, E; Owolabi, MO; Oyekale, AS; Mahesh, PA; Pana, A; Park, EK; Parry, CDH; Parsian, H; Patle, A; Patton, GC; Paudel, D; Petzold, M; Phillips, MR; Pillay, JD; Postma, MJ; Pourmalek, F; Prabhakaran, D; Qorbani, M; Radfar, A; Rafay, A; Rafiei, A; Rahim, F; Rahimi-Movaghar, A; Rahman, M; Rahman, MA; Rai, RK; Rajsic, S; Raju, SB; Ram, U; Rana, SM; Ranabhat, CL; Rawaf, DL; Rawaf, S; Reiner, RC; Reis, C; Renzaho, AMN; Rezai, MS; Roever, L; Ronfani, L; Room, R; Roshandel, G; Rostami, A; Roth, GA; Roy, A; Sabde, YD; Saddik, B; Safiri, S; Sahebkar, A; Saleem, Z; Salomon, JA; Salvi, SS; Sanabria, J; Sanchez-Nino, MD; Santomauro, DF; Santos, IS; Milicevic, MMMS; Sarker, AR; Sarmiento-Suarez, R; Sarrafzadegan, N; Sartorius, B; Satpathy, M; Sawhney, M; Saxena, S; Saylan, M; Schaub, MP; Schmidt, MI; Schneider, IJC; Schottker, B; Schutte, AE; Schwendicke, F; Sepanlou, SG; Shaikh, MAA; Sharif, M; She, J; Sheikh, A; Shen, JB; Shiferaw, MS; Shigematsu, M; Shiri, R; Shishani, K; Shiue, I; Shukla, SR; Sigfusdottir, ID; Silva, DAS; Da Silva, NT; Silveira, DGA; Sinha, DNN; Sitas, F; Soares, AM; Soofi, M; Sorensen, RJD; Soriano, JB; Sreeramareddy, CT; Steckling, N; Stein, DJ; Sufiyan, MB; Sur, PJ; Sykes, BL; Tabares-Seisdedos, R; Tabuchi, T; Tavakkoli, M; Tehrani-Banihashemi, A; Tekle, MG; Thapa, S; Thomas, N; Topor-Madry, R; Topouzis, F; Tran, BX; Troeger, CE; Truelsen, TC; Tsilimparis, N; Tyrovolas, S; Ukwaja, KN; Ullah, I; Uthman, OA; Valdez, PR; Van Boven, JFM; Vasankari, TJ; Venketasubramanian, N; Violante, FS; Vladimirov, SK; Vlassov, V; Vollset, SE; Vos, T; Wagnew, FWS; Waheed, Y; Wang, YP; Weiderpass, E; Weldegebreal, F; Weldegwergs, KG; Werdecker, A; Westerman, R; Whiteford, HA; Widecka, J; Wijeratne, T; Wyper, GMA; Xu, GL; Yamada, T; Yano, Y; Ye, PP; Yimer, EM; Yip, P; Yirsaw, BD; Yisma, E; Yonemoto, N; Yoon, SJ; Yotebieng, M; Younis, MZ; Zachariah, G; Zaidi, Z; Zamani, M; Zhang, XY; Zodpey, S; Mokdad, AH; Naghavi, M; Murray, CJL; Gakidou, E				Griswold, Max G.; Fullman, Nancy; Hawley, Caitlin; Arian, Nicholas; Zimsen, Stephanie R. M.; Tymeson, Hayley D.; Venkateswaran, Vidhya; Tapp, Austin Douglas; Forouzanfar, Mohammad H.; Salama, Joseph S.; Abate, Kalkidan Hassen; Abate, Degu; Abay, Solomon M.; Abbafati, Cristiana; Abdulkader, Rizwan Suliankatchi; Abebe, Zegeye; Aboyans, Victor; Abrar, Mohammed Mehdi; Acharya, Pawan; Adetokunboh, Olatunji O.; Adhikari, Tara Ballav; Adsuar, Jose C.; Afarideh, Mohsen; Agardh, Emilie Elisabet; Agarwal, Gina; Aghayan, Sargis Aghasi; Agrawal, Sutapa; Ahmed, Muktar Beshir; Akibu, Mohammed; Akinyemiju, Tomi; Akseer, Nadia; Al Asfoor, Deena H.; Al-Aly, Ziyad; Alahdab, Fares; Alam, Khurshid; Albujeer, Ammar; Alene, Kefyalew Addis; Ali, Raghib; Ali, Syed Danish; Alijanzadeh, Mehran; Aljunid, Syed Mohamed; Alkerwi, Ala'a; Allebeck, Peter; Alvis-Guzman, Nelson; Amare, Azmeraw T.; Aminde, Leopold N.; Ammar, Walid; Amoako, Yaw Ampem; Amul, Gianna Gayle Herrera; Andrei, Catalina Liliana; Angus, Colin; Ansha, Mustafa Geleto; Antonio, Carl Abelardo T.; Aremu, Olatunde; Arnlov, Johan; Artaman, Al; Aryal, Krishna K.; Assadi, Reza; Ausloos, Marcel; Avila-Burgos, Leticia; Avokpaho, Euripide F. G. A.; Awasthi, Ashish; Ayele, Henok Tadesse; Ayer, Rakesh; Ayuk, Tambe B.; Azzopardi, Peter S.; Badali, Hamid; Badawi, Alaa; Banach, Maciej; Barker-Collo, Suzanne Lyn; Barrero, Lope H.; Basaleem, Huda; Baye, Estifanos; Bazargan-Hejazi, Shahrzad; Bedi, Neeraj; Bejot, Yannick; Belachew, Abate Bekele; Belay, Saba Abraham; Bennett, Derrick A.; Bensenor, Isabela M.; Bernabe, Eduardo; Bernstein, Robert S.; Beyene, Addisu Shunu; Beyranvand, Tina; Bhaumik, Soumyadeeep; Bhutta, Zulfiqar A.; Biadgo, Belete; Bijani, Ali; Bililign, Nigus; Birlik, Sait Mentes; Birungi, Charles; Bizuneh, Hailemichael; Bjerregaard, Peter; Bjorge, Tone; Borges, Guilherme; Bosetti, Cristina; Boufous, Soufiane; Bragazzi, Nicola Luigi; Brenner, Hermann; Butt, Zahid A.; Cahuana-Hurtado, Lucero; Calabria, Bianca; Campos-Nonato, Ismael R.; Campuzano Rincon, Julio Cesar; Carreras, Giulia; Carrero, Juan J.; Carvalho, Felix; Castaneda-Orjuela, Carlos A.; Castillo Rivas, Jacqueline; Catala-Lopez, Ferran; Chang, Jung-Chen; Charlson, Fiona J.; Chattopadhyay, Aparajita; Chaturvedi, Pankaj; Chowdhury, Rajiv; Christopher, Devasahayam J.; Chung, Sheng-Chia; Ciobanu, Liliana G.; Claro, Rafael M.; Conti, Sara; Cousin, Ewerton; Criqui, Michael H.; Dachew, Berihun Assefa; Dargan, Paul, I; Daryani, Ahmad; Das Neves, Jose; Davletov, Kairat; De Castro, Filipa; De Courten, Barbora; De Neve, Jan-Walter; Degenhardt, Louisa; Demoz, Gebre Teklemariam; Des Jarlais, Don C.; Dey, Subhojit; Dhaliwal, Rupinder Singh; Dharmaratne, Samath Dhamminda; Dhimal, Meghnath; Doku, David Teye; Doyle, Kerrie E.; Dubey, Manisha; Dubljanin, Eleonora; Duncan, Bruce B.; Ebrahimi, Hedyeh; Edessa, Dumessa; Zaki, Maysaa El Sayed; Ermakov, Sergei Petrovich; Erskine, Holly E.; Esteghamati, Alireza; Faramarzi, Mahbobeh; Farioli, Andrea; Faro, Andre; Farvid, Maryam S.; Farzadfar, Farshad; Feigin, Valery L.; Felisbino-Mendes, Mariana Santos; Fernandes, Eduarda; Ferrari, Alize J.; Ferri, Cleusa P.; Fijabi, Daniel Obadare; Filip, Irina; Finger, Jonas David; Fischer, Florian; Flaxman, Abraham D.; Franklin, Richard Charles; Futran, Neal D.; Gallus, Silvano; Ganji, Morsaleh; Gankpe, Fortune Gbetoho; Gebregergs, Gebremedhin Berhe; Gebrehiwot, Tsegaye Tewelde; Geleijnse, Johanna M.; Ghadimi, Reza; Ghandour, Lilian A.; Ghimire, Mamata; Gill, Paramjit Singh; Ginawi, Ibrahim Abdelmageed; Giref, Ababi Zergaw Z.; Gona, Philimon N.; Gopalani, Sameer Vali; Gotay, Carolyn C.; Goulart, Alessandra C.; Greaves, Felix; Grosso, Giuseppe; Guo, Yuming; Gupta, Rahul; Gupta, Rajeev; Gupta, Vipin; Alma Gutierrez, Reyna; Gvs, Murthy; Hafezi-Nejad, Nima; Hagos, Tekleberhan Beyene; Hailu, Gessessew Bugssa; Hamadeh, Randah R.; Hamidi, Samer; Hankey, Graeme J.; Harb, Hilda L.; Harikrishnan, Sivadasanpillai; Maria Haro, Josep; Hassen, Hamid Yimam; Havmoeller, Rasmus; Hay, Simon, I; Heibati, Behzad; Henok, Andualem; Heredia-Pi, Ileana; Francisco Hernandez-Llanes, Norberto; Herteliu, Claudiu; Hibstu, Desalegn Ts Tsegaw; Hoogar, Praveen; Horita, Nobuyuki; Hosgood, H. Dean; Hosseini, Mostafa; Hostiuc, Mihaela; Hu, Guoqing; Huang, Hsiang; Husseini, Abdullatif; Idrisov, Bulat; Ileanu, Bogdan Vasile; Ilesanmi, Olayinka Stephen; Irvani, Seyed Sina Naghibi; Islam, Sheikh Mohammed Shariful; Jackson, Maria D.; Jakovljevic, Mihajlo; Jayatilleke, Achala Upendra; Jha, Ravi Prakash; Jonas, Jost B.; Jozwiak, Jacek Jerzy; Kabir, Zubair; Kadel, Rajendra; Kahsay, Amaha; Kapil, Umesh; Kasaeian, Amir; Kassa, Tesfaye D. Dessale; Katikireddi, Srinivasa Vittal; Kawakami, Norito; Kebede, Seifu; Kefale, Adane Teshome; Keiyoro, Peter Njenga; Kengne, Andre Pascal; Khader, Yousef; Khafaie, Morteza Abdullatif; Khalil, Ibrahim A.; Khan, Md Nuruzzaman; Khang, Young-Ho; Khater, Mona M.; Khubchandani, Jagdish; Kim, Cho-Il; Kim, Daniel; Kim, Yun Jin; Kimokoti, Ruth W.; Kisa, Adnan; Kivimaki, Mika; Kochhar, Sonali; Kosen, Soewarta; Koul, Parvaiz A.; Koyanagi, Ai; Krishan, Kewal; Defo, Barthelemy Kuate; Bicer, Burcu Kucuk; Kulkarni, Veena S.; Kumar, Pushpendra; Lafranconi, Alessandra; Balaji, Arjun Lakshmana; Lalloo, Ratilal; Lallukka, Tea; Lam, Hilton; Lami, Faris Hasan; Lan, Qing; Lang, Justin J.; Lansky, Sonia; Larsson, Anders O.; Latifi, Arman; Leasher, Janet L.; Lee, Paul H.; Leigh, James; Leinsalu, Mall; Leung, Janni; Levi, Miriam; Li, Yichong; Lim, Lee-Ling; Linn, Shai; Liu, Shiwei; Lobato-Cordero, Andrea; Lotufo, Paulo A.; King Macarayan, Erlyn Rachelle; Machado, Isis Eloah; Madotto, Fabiana; Abd El Razek, Hassan Magdy; Abd El Razek, Muhammed Magdy; Majdan, Marek; Majdzadeh, Reza; Majeed, Azeem; Malekzadeh, Reza; Malta, Deborah Carvalho; Mapoma, Chabila Christopher; Martinez-Raga, Jose; Maulik, Pallab K.; Mazidi, Mohsen; Mckee, Martin; Mehta, Varshil; Meier, Toni; Mekonen, Tesfa; Meles, Kidanu Gebremariam; Melese, Addisu; Memiah, Peter T. N.; Mendoza, Walter; Mengistu, Desalegn Tadese; Mensah, George A.; Meretoja, Tuomo J.; Mezgebe, Haftay Berhane; Miazgowski, Tomasz; Miller, Ted R.; Mini, G. K.; Mirica, Andreea; Mirrakhimov, Erkin M.; Moazen, Babak; Mohammad, Karzan Abdulmuhsin; Mohammadifard, Noushin; Mohammed, Shafiu; Monasta, Lorenzo; Moraga, Paula; Morawska, Lidia; Jalu, Moti Tolera; Mousavi, Seyyed Meysam; Mukhopadhyay, Satinath; Musa, Kamarul Imran; Naheed, Aliya; Naik, Gurudatta; Najafi, Farid; Nangia, Vinay; Nansseu, Jobert Richie; Nayak, Mudavath Siva Durga Prasad; Nejjari, Chakib; Neupane, Subas; Neupane, Sudan Prasad; Ngunjiri, Josephine W.; Cuong Tat Nguyen; Long Hoang Nguyen; Trang Huyen Nguyen; Ningrum, Dina Nur Anggraini; Nirayo, Yirga Legesse; Noubiap, Jean Jacques; Ofori-Asenso, Richard; Ogbo, Felix Akpojene; Oh, In-Hwan; Oladimeji, Olanrewaju; Olagunju, Andrew T.; Olivares, Pedro R.; Olusanya, Bolajoko Olubukunola; Olusanya, Jacob Olusegun; Oommen, Anu Mary; Oren, Eyal; Orpana, Heather M.; Ortega-Altamirano, Doris D., V; Ortiz, Justin R.; Ota, Erika; Owolabi, Mayowa Ojo; Oyekale, Abayomi Samuel; Mahesh, P. A.; Pana, Adrian; Park, Eun-Kee; Parry, Charles D. H.; Parsian, Hadi; Patle, Ajay; Patton, George C.; Paudel, Deepak; Petzold, Max; Phillips, Michael R.; Pillay, Julian David; Postma, Maarten J.; Pourmalek, Farshad; Prabhakaran, Dorairaj; Qorbani, Mostafa; Radfar, Amir; Rafay, Anwar; Rafiei, Alireza; Rahim, Fakher; Rahimi-Movaghar, Afarin; Rahman, Mahfuzar; Rahman, Muhammad Aziz; Rai, Rajesh Kumar; Rajsic, Sasa; Raju, Sree Bhushan; Ram, Usha; Rana, Saleem M.; Ranabhat, Chhabi Lal; Rawaf, David Laith; Rawaf, Salman; Reiner, Robert C.; Reis, Cesar; Renzaho, Andre M. N.; Rezai, Mohammad Sadegh; Roever, Leonardo; Ronfani, Luca; Room, Robin; Roshandel, Gholamreza; Rostami, Ali; Roth, Gregory A.; Roy, Ambuj; Sabde, Yogesh Damodar; Saddik, Basema; Safiri, Saeid; Sahebkar, Amirhossein; Saleem, Zikria; Salomon, Joshua A.; Salvi, Sundeep Santosh; Sanabria, Juan; Dolores Sanchez-Nino, Maria; Santomauro, Damian Francesco; Santos, Itamar S.; Milicevic, Milena M. M. Santric; Sarker, Abdur Razzaque; Sarmiento-Suarez, Rodrigo; Sarrafzadegan, Nizal; Sartorius, Benn; Satpathy, Maheswar; Sawhney, Monika; Saxena, Sonia; Saylan, Mete; Schaub, Michael P.; Schmidt, Maria Ines; Schneider, Ione J. C.; Schoettker, Ben; Schutte, Aletta Elisabeth; Schwendicke, Falk; Sepanlou, Sadaf G.; Shaikh, Masood A. Ali; Sharif, Mehdi; She, Jun; Sheikh, Aziz; Shen, Jiabin; Shiferaw, Mekonnen Sisay; Shigematsu, Mika; Shiri, Rahman; Shishani, Kawkab; Shiue, Ivy; Shukla, Sharvari Rahul; Sigfusdottir, Inga Dora; Santos Silva, Diego Augusto; Da Silva, Natacha Torres; Alves Silveira, Dayane Gabriele; Sinha, Dhirendra Narain Narain; Sitas, Freddy; Soares Filho, Adauto Martins; Soofi, Moslem; Sorensen, Reed J. D.; Soriano, Joan B.; Sreeramareddy, Chandrashekhar T.; Steckling, Nadine; Stein, Dan J.; Sufiyan, Mu'awiyyah Babale; Sur, Patrick J.; Sykes, Bryan L.; Tabares-Seisdedos, Rafael; Tabuchi, Takahiro; Tavakkoli, Mohammad; Tehrani-Banihashemi, Arash; Tekle, Merhawi Gebremedhin; Thapa, Subash; Thomas, Nihal; Topor-Madry, Roman; Topouzis, Fotis; Tran, Bach Xuan; Troeger, Christopher E.; Truelsen, Thomas Clement; Tsilimparis, Nikolaos; Tyrovolas, Stefanos; Ukwaja, Kingsley Nnanna; Ullah, Irfan; Uthman, Olalekan A.; Valdez, Pascual R.; Van Boven, Job F. M.; Vasankari, Tommi Juhani; Venketasubramanian, Narayanaswamy; Violante, Francesco S.; Vladimirov, Sergey Konstantinovitch; Vlassov, Vasily; Vollset, Stein Emil; Vos, Theo; Wagnew, Fasil Wagnew Shiferaw; Waheed, Yasir; Wang, Yuan-Pang; Weiderpass, Elisabete; Weldegebreal, Fitsum; Weldegwergs, Kidu Gidey; Werdecker, Andrea; Westerman, Ronny; Whiteford, Harvey A.; Widecka, Justyna; Wijeratne, Tissa; Wyper, Grant M. A.; Xu, Gelin; Yamada, Tomohide; Yano, Yuichiro; Ye, Pengpeng; Yimer, Ebrahim M.; Yip, Paul; Yirsaw, Biruck Desalegn; Yisma, Engida; Yonemoto, Naohiro; Yoon, Seok-Jun; Yotebieng, Marcel; Younis, Mustafa Z.; Zachariah, Geevar; Zaidi, Zoubida; Zamani, Mohammad; Zhang, Xueying; Zodpey, Sanjay; Mokdad, Ali H.; Naghavi, Mohsen; Murray, Christopher J. L.; Gakidou, Emmanuela		GBD 2016 Alcohol Collaborators	Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016	LANCET			English	Article							ALL-CAUSE MORTALITY; REDUCED MORTALITY; RISK-FACTORS; DRINKING; CONSUMPTION; METAANALYSIS; DEPENDENCE	Background Alcohol use is a leading risk factor for death and disability, but its overall association with health remains complex given the possible protective effects of moderate alcohol consumption on some conditions. With our comprehensive approach to health accounting within the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we generated improved estimates of alcohol use and alcohol-attributable deaths and disability-adjusted life-years (DALYs) for 195 locations from 1990 to 2016, for both sexes and for 5-year age groups between the ages of 15 years and 95 years and older. Methods Using 694 data sources of individual and population-level alcohol consumption, along with 592 prospective and retrospective studies on the risk of alcohol use, we produced estimates of the prevalence of current drinking, abstention, the distribution of alcohol consumption among current drinkers in standard drinks daily (defined as 10 g of pure ethyl alcohol), and alcohol-attributable deaths and DALYs. We made several methodological improvements compared with previous estimates: first, we adjusted alcohol sales estimates to take into account tourist and unrecorded consumption; second, we did a new meta-analysis of relative risks for 23 health outcomes associated with alcohol use; and third, we developed a new method to quantify the level of alcohol consumption that minimises the overall risk to individual health. Findings Globally, alcohol use was the seventh leading risk factor for both deaths and DALYs in 2016, accounting for 2.2% (95% uncertainty interval [UI] 1.5-3.0) of age-standardised female deaths and 6.8% (5.8-8.0) of age-standardised male deaths. Among the population aged 15-49 years, alcohol use was the leading risk factor globally in 2016, with 3.8% (95% UI 3.2-4-3) of female deaths and 12.2% (10.8-13-6) of male deaths attributable to alcohol use. For the population aged 15-49 years, female attributable DALYs were 2.3% (95% UI 2.0-2.6) and male attributable DALYs were 8.9% (7.8-9.9). The three leading causes of attributable deaths in this age group were tuberculosis (1.4% [95% UI 1. 0-1. 7] of total deaths), road injuries (1.2% [0.7-1.9]), and self-harm (1.1% [0.6-1.5]). For populations aged 50 years and older, cancers accounted for a large proportion of total alcohol-attributable deaths in 2016, constituting 27.1% (95% UI 21.2-33.3) of total alcohol-attributable female deaths and 18.9% (15.3-22.6) of male deaths. The level of alcohol consumption that minimised harm across health outcomes was zero (95% UI 0.0-0.8) standard drinks per week. Interpretation Alcohol use is a leading risk factor for global disease burden and causes substantial health loss. We found that the risk of all-cause mortality, and of cancers specifically, rises with increasing levels of consumption, and the level of consumption that minimises health loss is zero. These results suggest that alcohol control policies might need to be revised worldwide, refocusing on efforts to lower overall population-level consumption.	[Griswold, Max G.; Fullman, Nancy; Hawley, Caitlin; Arian, Nicholas; Zimsen, Stephanie R. M.; Tymeson, Hayley D.; Tapp, Austin Douglas; Salama, Joseph S.; Degenhardt, Louisa; Dharmaratne, Samath Dhamminda; Feigin, Valery L.; Flaxman, Abraham D.; Hay, Simon, I; Jakovljevic, Mihajlo; Khalil, Ibrahim A.; Reiner, Robert C.; Roth, Gregory A.; Sur, Patrick J.; Troeger, Christopher E.; Vollset, Stein Emil; Vos, Theo; Whiteford, Harvey A.; Mokdad, Ali H.; Naghavi, Mohsen; Murray, Christopher J. L.; Gakidou, Emmanuela] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Charlson, Fiona J.; Kochhar, Sonali; Ortiz, Justin R.; Sorensen, Reed J. D.] Univ Washington, Dept Global Hlth, Seattle, WA 98121 USA; [Futran, Neal D.] Univ Washington, Sch Med, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98121 USA; [Oren, Eyal] Univ Washington, Seattle, WA 98121 USA; [Venkateswaran, Vidhya] Harvard Univ, Dept Epidemiol, Boston, MA USA; [Farvid, Maryam S.] Harvard Univ, Dept Nutr, Boston, MA USA; [King Macarayan, Erlyn Rachelle] Harvard Univ, Ariadne Labs, Boston, MA USA; [Sheikh, Aziz] Harvard Univ, BWH Div Gen Internal Med & Primary Care, Boston, MA USA; [Forouzanfar, Mohammad H.] Seattle Genet, Seattle, WA USA; [Abate, Kalkidan Hassen] Jimma Univ, Dept Populat & Family Hlth, Jimma, Ethiopia; [Ahmed, Muktar Beshir; Gebrehiwot, Tsegaye Tewelde] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia; [Beyene, Addisu Shunu; Tekle, Merhawi Gebremedhin] Haramaya Univ, Sch Publ Hlth, Harar, Ethiopia; [Edessa, Dumessa; Shiferaw, Mekonnen Sisay] Haramaya Univ, Sch Pharm, Harar, Ethiopia; [Weldegebreal, Fitsum] Haramaya Univ, Dept Med Lab Sci, Harar, Ethiopia; [Abate, Degu; Jalu, Moti Tolera] Haramaya Univ, Harar, Ethiopia; [Abay, Solomon M.] Addis Ababa Univ, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia; [Giref, Ababi Zergaw Z.] Addis Ababa Univ, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia; [Yisma, Engida] Addis Ababa Univ, Sch Alaide Hlth Sci, Addis Ababa, Ethiopia; [Abrar, Mohammed Mehdi; Demoz, Gebre Teklemariam] Addis Ababa Univ, Addis Ababa, Ethiopia; [Abbafati, Cristiana] Univ Roma La Sapienza, Dept Law Philosophy & Econ Studies, Rome, Italy; [Abdulkader, Rizwan Suliankatchi] Minist Hlth, Dept Publ Hlth, Riyadh, Saudi Arabia; [Al Asfoor, Deena H.] Minist Hlth, Off Undersecretary Hlth Affairs, Riyadh, Saudi Arabia; [Abebe, Zegeye] Univ Gondar, Human Nutr, Gondar, Ethiopia; [Alene, Kefyalew Addis; Dachew, Berihun Assefa] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia; [Biadgo, Belete] Univ Gondar, Dept Clin Chem, Gondar, Ethiopia; [Aboyans, Victor] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France; [Aboyans, Victor] Univ Limoges, Inst Epidemiol, Limoges, France; [Acharya, Pawan] Nepal Dev Soc, Chitwan, Nepal; [Adetokunboh, Olatunji O.] Stellenbosch Univ, Dept Global Hlth, Cape Town, South Africa; [Parry, Charles D. H.] Stellenbosch Univ, Dept Psychiat, Cape Town, South Africa; [Adetokunboh, Olatunji O.] South African Med Res Council, Cochrane South Africa, Cape Town, South Africa; [Schutte, Aletta Elisabeth] South African Med Res Council, Unit Hypertens & Cardiovasc Dis, Cape Town, South Africa; [Stein, Dan J.] South African Med Res Council, Cape Town, South Africa; [Adhikari, Tara Ballav] Ctr Social Sci & Publ Hlth Res Nepal, Nepal Hlth Res Environm, Kathmandu, Nepal; [Adhikari, Tara Ballav] Univ Southern Denmark, Unit Hlth Promot Res, Odense, Denmark; [Bjerregaard, Peter] Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark; [Thapa, Subash] Univ Southern Denmark, Dept Publ Hlth, Odense, Denmark; [Adsuar, Jose C.] Univ Extremadura, Fac Sport Sci, Badajoz, Spain; [Afarideh, Mohsen; Ebrahimi, Hedyeh; Esteghamati, Alireza; Ganji, Morsaleh] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran; [Ebrahimi, Hedyeh; Malekzadeh, Reza; Roshandel, Gholamreza; Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Farzadfar, Farshad] Univ Tehran Med Sci, Noncommun Dis Res Ctr, Tehran, Iran; [Hafezi-Nejad, Nima] Univ Tehran Med Sci, Sch Med, Tehran, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Malignancies Res Ctr, Tehran, Iran; [Kasaeian, Amir] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Majdzadeh, Reza] Univ Tehran Med Sci, KURC, Tehran, Iran; [Mousavi, Seyyed Meysam] Univ Tehran Med Sci, Dept Hlth Management & Econ, Sch Publ Hlth, Tehran, Iran; [Rahimi-Movaghar, Afarin] Univ Tehran Med Sci, INCAS, Tehran, Iran; [Majdzadeh, Reza] Univ Tehran Med Sci, Community Based Participatory Res Ctr CBP, Tehran, Iran; [Hosseini, Mostafa; Rahim, Fakher] Univ Tehran Med Sci, Tehran, Iran; [Agardh, Emilie Elisabet; Allebeck, Peter] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Arnlov, Johan] Karolinska Inst, Dept Neurobiol, Stockholm, Sweden; [Carrero, Juan J.; Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Agarwal, Gina] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Aghayan, Sargis Aghasi] Yerevan State Univ, Chair Zool, Yerevan, Armenia; [Aghayan, Sargis Aghasi] Sci Ctr Zool & Hydroecol, Res Grp Mol Parasitol, Yerevan, Armenia; [Zodpey, Sanjay] PHFI, Indian Inst Publ Hlth, Gurugram, India; [Agrawal, Sutapa; Awasthi, Ashish; Prabhakaran, Dorairaj] PHFI, Gurugram, India; [Agrawal, Sutapa] Vital Strategies, Gurugram, India; [Akibu, Mohammed] Dept Midwifery, Lexington, KY USA; [Ansha, Mustafa Geleto] Dept Publ Hlth, Lexington, KY USA; Debre Berhan Univ, Debre Berhan, Ethiopia; [Akinyemiju, Tomi] Univ Kentucky, Dept Epidemiol, Lexington, KY 40506 USA; [Badawi, Alaa] Univ Toronto, Hosp Sick Children, Fac Med, Nutr Sci, Toronto, ON, Canada; [Akseer, Nadia; Bhutta, Zulfiqar A.] Univ Toronto, Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada; [Ali, Raghib; Bennett, Derrick A.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Al-Aly, Ziyad] Washington Univ, Dept Internal Med, St Louis, MO USA; [Al-Aly, Ziyad] Dept Vet Affairs, VA St Louis Hlth Care Syst, Clin Epidemiol Ctr, St Louis, MO USA; [Alahdab, Fares] Mayo Clin Fdn Med Educ & Res, Evidence Based Pract Ctr, Rochester, MN USA; [Alahdab, Fares] Syrian Amer Med Soc, Res Comm Educ Comm & Avicenna Journal Med Editor, Washington, DC USA; [Alam, Khurshid] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia; [Hankey, Graeme J.] Univ Western Australia, Med Sch, Perth, WA, Australia; [Albujeer, Ammar] Naba Al Hayat Fdn Med Sci & Hlth Care, Najaf, Iraq; [Alene, Kefyalew Addis] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia; [Calabria, Bianca] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Ali, Raghib] New York Univ Abu Dhabi, Publ Hlth Res Ctr, Abu Dhabi, U Arab Emirates; [Ali, Syed Danish] Univ London, Islamabad, Pakistan; [Alijanzadeh, Mehran] Qazvin Univ Med Sci, Social Determinants Hlth Res Ctr, Qazvin, Iran; [Aljunid, Syed Mohamed] Kuwait Univ, Dept Hlth Policy & Management, Kuwait, Kuwait; [Aljunid, Syed Mohamed] Natl Univ Malaysia, Int Ctr Casemix & Clin Coding, Bandar Tun Razak, Malaysia; [Alkerwi, Ala'a] Luxembourg Inst Hlth, Dept Populat Hlth, Strassen, Luxembourg; [Allebeck, Peter] Swedish Res Council Hlth Working Life & Welfare, Stockholm, Sweden; [Alvis-Guzman, Nelson] Univ Cartagena, Res Grp Hlth Econ, Cartagena, Colombia; [Alvis-Guzman, Nelson] Univ Coast, Res Grp Hosp Management & Hlth Pol, Barranquilla, Colombia; [Amare, Azmeraw T.] Univ South Australia, Sansom Inst, Adelaide, SA, Australia; [Azzopardi, Peter S.] South Australian Hlth & Med Res Inst, Wardliparingga Aboriginal Res Unit, Adelaide, SA, Australia; [Mekonen, Tesfa] Bahir Dar Univ, Psychiat, Bahir Dar, Ethiopia; [Amare, Azmeraw T.] Bahir Dar Univ, Bahir Dar, Ethiopia; [Aminde, Leopold N.; Charlson, Fiona J.; Dachew, Berihun Assefa; Erskine, Holly E.; Ferrari, Alize J.; Santomauro, Damian Francesco] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Lalloo, Ratilal] Univ Queensland, Sch Dent, Brisbane, Qld, Australia; [Leung, Janni; Whiteford, Harvey A.] Univ Queensland, Brisbane, Qld, Australia; [Alves Silveira, Dayane Gabriele] Fed Minist Hlth, Dept Hlth Ind Complex & Innovat Hlth, Brasilia, DF, Brazil; [Soares Filho, Adauto Martins] Fed Minist Hlth, Dept Dis & Noncommun Dis & Hlth Promot, Brasilia, DF, Brazil; [Ammar, Walid] Fed Minist Hlth, Beirut, Lebanon; [Ammar, Walid] Amer Univ Beirut, Fac Hlth Sci, Beirut, Lebanon; [Ghandour, Lilian A.] Amer Univ Beirut, Dept Epidemiol & Populat Hlth, Beirut, Lebanon; [Amoako, Yaw Ampem] Komfo Anokye Teaching Hosp, Dept Internal Med, Kumasi, Ghana; [Amul, Gianna Gayle Herrera] Natl Univ Singapore, Lee Kuan Yew Sch Publ Pol, Singapore, Singapore; [Venketasubramanian, Narayanaswamy] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Hostiuc, Mihaela] Carol Davila Univ Med & Pharm, Dept Legal Med & Bioeth, Bucharest, Romania; [Andrei, Catalina Liliana] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Angus, Colin] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Antonio, Carl Abelardo T.] Univ Philippines Manila, Dept Hlth Policy & Adm, Manila, Philippines; [King Macarayan, Erlyn Rachelle] Univ Philippines Manila, Dev & Commun Studies, Manila, Philippines; [Aremu, Olatunde] Birmingham City Univ, Sch Hlth Sci, Birmingham, W Midlands, England; [Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden; [Artaman, Al] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Aryal, Krishna K.] ABT Associates Nepal, Monitoring Evaluat & Operat Res Project, DFID Nepal Hlth Sect Programme 3, Lalitpur, Nepal; [Assadi, Reza] Mashhad Univ Med Sci, Educ Dev Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Ci, Dept Med Biotechnol, Mashhad, Iran; [Ausloos, Marcel] Univ Leicester, Sch Business, Leicester, Leics, England; [Avila-Burgos, Leticia; Cahuana-Hurtado, Lucero; Heredia-Pi, Ileana; Ortega-Altamirano, Doris D., V] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Campos-Nonato, Ismael R.; Campuzano Rincon, Julio Cesar; De Castro, Filipa] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Avokpaho, Euripide F. G. A.] Benin Clin Res Inst IRCB, Project Deworm3, Calavi, Benin; [Avokpaho, Euripide F. G. A.] Lab Studies & Res Act Hlth LERAS, Control Infect Dis Project, Porto Novo, Benin; [Gankpe, Fortune Gbetoho] Lab Studies & Res Act Hlth LERAS, Noncommun Dis Dept, Porto Novo, Benin; [Awasthi, Ashish] Indian Inst Publ Hlth, Gandhinagar, India; [Ayele, Henok Tadesse] McGill Univ, Dept Epidemiol & Occupational Hlth, Montreal, PQ, Canada; [Ayele, Henok Tadesse] Dilla Univ, Dept Publ Hlth, Dilla, Ethiopia; [Ayer, Rakesh] Univ Tokyo, Dept Community & Global Hlth, Tokyo, Japan; [Kawakami, Norito] Univ Tokyo, Dept Mental Hlth, Tokyo, Japan; [Yamada, Tomohide] Univ Tokyo, Dept Diabet & Metab Dis, Tokyo, Japan; [Ayuk, Tambe B.] Inst Med Res & Plant Med Studies, Ctr Food & Nutr Res, Yaounde, Cameroon; [Ayuk, Tambe B.] Univ South Africa, Dept Hlth Studies, Pretoria, South Africa; [Azzopardi, Peter S.] Burnet Inst, Discipline Int Dev, Maternal & Child Hlth Program, Global Adolescent Hlth Grp, Melbourne, Vic, Australia; [Badali, Hamid] Mazandaran Univ Med Sci, Dept Med Mycol, Invas Fungi Res Ctr, Sari, Iran; [Daryani, Ahmad] Mazandaran Univ Med Sci, Toxoplasmosis Res Ctr, Sari, Iran; [Rafiei, Alireza] Mazandaran Univ Med Sci, Mol & Cell Biol Res Ctr, Sari, Iran; [Rezai, Mohammad Sadegh] Mazandaran Univ Med Sci, Dept Pediat, Sari, Iran; [Rafiei, Alireza] Mazandaran Univ Med Sci, Dept Immunol, Sari, Iran; [Badawi, Alaa] Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, Canada; [Lang, Justin J.] Publ Hlth Agcy Canada, Hlth Promot & Chron Dis Prevent Branch, Toronto, ON, Canada; [Orpana, Heather M.] Publ Hlth Agcy Canada, Appl Res Div, Toronto, ON, Canada; [Banach, Maciej] Med Univ Lodz, Dept Hypertens, Lodz, Poland; [Banach, Maciej] PMMHRI, Lodz, Poland; [Barker-Collo, Suzanne Lyn] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Barrero, Lope H.] Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia; [Basaleem, Huda] Univ Aden, Aden, Yemen; [Baye, Estifanos] Wollo Univ, Dept Publ Hlth, Dessie, Ethiopia; [Bazargan-Hejazi, Shahrzad] Charles R Drew Univ Med & Sci, Dept Psychiat, 1621 E 120th St, Los Angeles, CA 90059 USA; [Bazargan-Hejazi, Shahrzad] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Bedi, Neeraj] Gandhi Med Coll Bhopal, Dept Community Med, Bhopal, India; [Bedi, Neeraj] Jazan Univ, Jizan, Saudi Arabia; [Bejot, Yannick] Univ Hosp Dijon, Dept Neurol, Dijon, France; [Bejot, Yannick] Univ Burgundy, Fac Hlth Sci, Dijon Stroke Registry, Dijon, France; [Belachew, Abate Bekele; Gebregergs, Gebremedhin Berhe] Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia; [Hagos, Tekleberhan Beyene] Mekelle Univ, Coll Hlth Sci, Inst Biomed Sci, Dept Anat & Embryol, Mekelle, Ethiopia; [Hailu, Gessessew Bugssa; Mengistu, Desalegn Tadese] Mekelle Univ, Sch Med, Biomed Sci Div, Mekelle, Ethiopia; [Kahsay, Amaha] Mekelle Univ, Nutr & Dietet, Mekelle, Ethiopia; [Kassa, Tesfaye D. Dessale; Nirayo, Yirga Legesse; Weldegwergs, Kidu Gidey] Mekelle Univ, Clin Pharm Unit, Mekelle, Ethiopia; [Yimer, Ebrahim M.] Mekelle Univ, Sch Pharm, Mekelle, Ethiopia; [Meles, Kidanu Gebremariam] Mekelle Univ, Mekelle, Ethiopia; [Belay, Saba Abraham] Dr Tewelde Legesse Hlth Sci Coll, Mekelle, Ethiopia; [Bensenor, Isabela M.; Lotufo, Paulo A.; Santos, Itamar S.] Univ Sao Paulo, Dept Internal Med, Sao Paulo, Brazil; [Goulart, Alessandra C.] Univ Sao Paulo, Ctr Clin & Epidemiol Res, Sao Paulo, Brazil; [Wang, Yuan-Pang] Univ Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; [Bernabe, Eduardo] Kings Coll London, Dent Inst, London, England; [Dargan, Paul, I] Kings Coll London, Fac Life Sci & Med, London, England; [Bernstein, Robert S.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Bernstein, Robert S.] Univ S Florida, Dept Global Hlth, Tampa, FL USA; [Beyene, Addisu Shunu; Khan, Md Nuruzzaman] Univ Newcastle, Sch Publ Hlth & Med, Newcastle, NSW, Australia; [Heibati, Behzad] Iran Univ Med Sci, Air Pollut Res Ctr, Tehran, Iran; [Tehrani-Banihashemi, Arash] Iran Univ Med Sci, Community Med Dept, Tehran, Iran; [Tehrani-Banihashemi, Arash] Iran Univ Med Sci, Prevent Med & Publ Hlth Res Ctr, Tehran, Iran; [Beyranvand, Tina] Iran Univ Med Sci, Tehran, Iran; [Maulik, Pallab K.] George Inst Global Hlth, Res, New Delhi, India; [Bhaumik, Soumyadeeep] George Inst Global Hlth, New Delhi, India; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bijani, Ali] Babol Univ Med Sci, Social Determinants Hlth Res Ctr, Babol Sar, Iran; [Bijani, Ali; Ghadimi, Reza; Rostami, Ali] Babol Univ Med Sci, Hlth Res Inst, Babol Sar, Iran; [Parsian, Hadi] Babol Univ Med Sci, Dept Clin Biochem, Babol Sar, Iran; [Rostami, Ali] Babol Univ Med Sci, Infect Dis & Trop Med Res Ctr, Babol Sar, Iran; [Zamani, Mohammad] Babol Univ Med Sci, Student Res Comm, Babol Sar, Iran; [Faramarzi, Mahbobeh] Babol Univ Med Sci, Babol Sar, Iran; [Bililign, Nigus] Woldia Univ, Woldia, Ethiopia; [Farioli, Andrea; Violante, Francesco S.] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Birlik, Sait Mentes] Univ Bologna, Bologna, Italy; [Birlik, Sait Mentes] GBS CIDP Fdn Int, Conshohocken, PA USA; [Birungi, Charles] UCL, UCL Ctr Global Hlth Econ, London, England; [Chung, Sheng-Chia] UCL, Dept Hlth Informat, London, England; [Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Birungi, Charles] United Nations Programme HIV AIDS UNAIDS, Fast Track Implementat Dept, Gaborone, Botswana; [Bizuneh, Hailemichael] St Pauls Hosp, Publ Hlth, Millennium Med Coll, Addis Ababa, Ethiopia; [Bjorge, Tone] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Bjorge, Tone] Canc Registry Norway, Oslo, Norway; [Borges, Guilherme; Alma Gutierrez, Reyna] Natl Inst Psychiat Ramon de la Fuente Muniz, Dept Epidemiol & Psychosocial Res, Mexico City, DF, Mexico; [Bosetti, Cristina] IRCCS, Dept Oncol, Mario Negri Inst Pharmacol Res, Milan, Italy; [Gallus, Silvano] IRCCS, Dept Environm Hlth Sci, Mario Negri Inst Pharmacol Res, Milan, Italy; [Boufous, Soufiane] Univ New South Wales, Transport & Rd Safety TARS Res, Sydney, NSW, Australia; [Calabria, Bianca; Degenhardt, Louisa] Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Maulik, Pallab K.] Univ New South Wales, Sch Med, Sydney, NSW, Australia; [Sitas, Freddy] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Bragazzi, Nicola Luigi] Univ Genoa, Genoa, Italy; [Brenner, Hermann; Schoettker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Butt, Zahid A.; Pourmalek, Farshad; Sarrafzadegan, Nizal] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Gotay, Carolyn C.] Univ British Columbia, Vancouver, BC, Canada; [Butt, Zahid A.] Al Shifa Trust Eye Hosp, Al Shifa Sch Publ Hlth, Rawalpindi, Pakistan; [Campuzano Rincon, Julio Cesar] Univ Valley Cuernavaca, Sch Med, Cuernavaca, Morelos, Mexico; [Carreras, Giulia] Inst Canc Res Prevent & Clin Network ISPRO, Florence, Italy; [Carvalho, Felix] Univ Porto, Appl Mol Biosci Unit, Porto, Portugal; [Das Neves, Jose] Univ Porto, Inst Biomed Engn INEB, Porto, Portugal; [Fernandes, Eduarda] Univ Porto, Dept Chem, Porto, Portugal; [Das Neves, Jose] Univ Porto, Inst Res & Innovat Hlth I3s, Porto, Portugal; [Castaneda-Orjuela, Carlos A.] Natl Inst Hlth, Colombian Natl Hlth Observ, Bogota, Colombia; [Castaneda-Orjuela, Carlos A.] Univ Nacl Colombia, Epidemiol & Publ Hlth Evaluat Grp, Bogota, Colombia; [Castillo Rivas, Jacqueline] Costa Rican Dept Social Secur, San Jose, Costa Rica; [Castillo Rivas, Jacqueline] Univ Costa Rica, Sch Dent, San Pedro, Costa Rica; [Catala-Lopez, Ferran] Inst Hlth Carlos III, Natl Sch Publ Hlth, Dept Hlth Planning & Econ, Madrid, Spain; [Chang, Jung-Chen] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chattopadhyay, Aparajita] Int Inst Populat Sci, Dept Dev Studies, Bombay, Maharashtra, India; [Ram, Usha] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Bombay, Maharashtra, India; [Kumar, Pushpendra; Patle, Ajay] Int Inst Populat Sci, Bombay, Maharashtra, India; [Chaturvedi, Pankaj] Tata Mem Hosp, Bombay, Maharashtra, India; [Chowdhury, Rajiv] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Christopher, Devasahayam J.] Christian Med Coll & Hosp CMC, Dept Pulm Med, Vellore, Tamil Nadu, India; [Oommen, Anu Mary] Christian Med Coll & Hosp CMC, Dept Community Hlth, Vellore, Tamil Nadu, India; [Thomas, Nihal] Christian Med Coll & Hosp CMC, Dept Endocrinol, Vellore, Tamil Nadu, India; [Chung, Sheng-Chia] Hlth Data Res UK, London, England; [Ciobanu, Liliana G.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Olagunju, Andrew T.] Univ Adelaide, Adelaide, SA, Australia; [Claro, Rafael M.] Univ Fed Minas Gerais, Dept Nutr, Belo Horizonte, MG, Brazil; [Felisbino-Mendes, Mariana Santos; Malta, Deborah Carvalho] Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Belo Horizonte, MG, Brazil; [Machado, Isis Eloah] Univ Fed Minas Gerais, Sch Nursing, Belo Horizonte, MG, Brazil; [Conti, Sara; Lafranconi, Alessandra; Madotto, Fabiana] Univ Milano Bicocca, Dept Med & Surg, Monza, Italy; [Cousin, Ewerton; Duncan, Bruce B.; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Postgrad Program Epidemiol, Porto Alegre, RS, Brazil; [Criqui, Michael H.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Dargan, Paul, I] Guys & St Thomas NHS Fdn Trust, Clin Toxicol Serv, London, England; [Davletov, Kairat] Kazakh Natl Med Univ, Alma Ata, Kazakhstan; [De Courten, Barbora] Monash Univ, Monash Ctr Hlth Res & Implementat, Melbourne, Vic, Australia; [Guo, Yuming] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Ofori-Asenso, Richard] Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic, Australia; [Ofori-Asenso, Richard] Monash Hlth, Melbourne, Vic, Australia; [De Neve, Jan-Walter; Moazen, Babak; Mohammed, Shafiu] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Demoz, Gebre Teklemariam] Aksum Univ, Dept Clin Pharm, Aksum, Ethiopia; [Des Jarlais, Don C.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Dey, Subhojit] Disha Fdn, Gurgaon, India; [Dhaliwal, Rupinder Singh] Indian Council Med Res, New Delhi, India; [Dharmaratne, Samath Dhamminda] Univ Peradeniya, Dept Community Med, Peradeniya, Sri Lanka; [Dhimal, Meghnath] Nepal Hlth Res Council, Hlth Res Sect, Kathmandu, Nepal; [Doku, David Teye] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana; [Doku, David Teye; Neupane, Subas] Univ Tampere, Sch Hlth Sci, Tampere, Finland; [Doyle, Kerrie E.] RMIT Univ, Sch Hlth & Biomed Sci, Royal Melbourne Inst Technol, Bundoora, Vic, Australia; [Dubey, Manisha] United Nations World Food Programme, New Delhi, India; [Dubljanin, Eleonora] Univ Belgrade, Fac Med, Belgrade, Serbia; [Zaki, Maysaa El Sayed] Mansoura Univ, Dept Clin Pathol, Mansoura, Egypt; [Ermakov, Sergei Petrovich] Russian Acad Sci, Lab Socioecon Issues Human Dev & Qual Life, Moscow, Russia; [Ermakov, Sergei Petrovich] Minist Hlth FRIHOI, Dept Med Stat & Documentary, Fed Res Inst Hlth Org & Informat, Moscow, Russia; [Vladimirov, Sergey Konstantinovitch] Minist Hlth FRIHOI, Fed Res Inst Hlth Org & Informat, Moscow, Russia; [Santomauro, Damian Francesco] Queensland Ctr Mental Hlth Res, Policy & Epidemiol Grp, Brisbane, Qld, Australia; [Erskine, Holly E.; Ferrari, Alize J.] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Faro, Andre] Univ Fed Sergipe, Dept Psychol, Sao Cristovao, Brazil; [Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Ferri, Cleusa P.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Fijabi, Daniel Obadare] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA; [Fijabi, Daniel Obadare] Univ Memphis, Sch Publ Hlth, Memphis, TN 38152 USA; [Filip, Irina] Kaiser Permanente, Fontana, CA USA; [Filip, Irina] AT Still Univ, Dept Hlth Sci, Mesa, AZ USA; [Radfar, Amir] AT Still Univ, Mesa, AZ USA; [Finger, Jonas David] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany; [Fischer, Florian] Bielefeld Univ, Dept Publ Hlth Med, Bielefeld, Germany; [Franklin, Richard Charles] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Gankpe, Fortune Gbetoho] Sidi Mohamed Ben Abdellah Univ, Neurosurg Dept, Fes, Morocco; [Geleijnse, Johanna M.] Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands; [Ghimire, Mamata] Univ Tsukuba, Dept Hlth Care Policy & Management, Tsukuba, Ibaraki, Japan; [Gill, Paramjit Singh] Univ Warwick, Unit Acad Primary Care, Coventry, W Midlands, England; [Uthman, Olalekan A.] Univ Warwick, Div Hlth Sci, Coventry, W Midlands, England; [Ginawi, Ibrahim Abdelmageed] Univ Hail, Dept Family & Community Med, Hail, Saudi Arabia; [Gona, Philimon N.] Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; [Gopalani, Sameer Vali] Univ Oklahoma, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Gopalani, Sameer Vali] Govt Federated States Micronesia, Dept Hlth & Social Affairs, Palikir, Micronesia; [Greaves, Felix; Majeed, Azeem; Rawaf, Salman] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Rawaf, David Laith] Imperial Coll London, WHO Collaborating Ctr Publ Hlth Educ & Training, London, England; [Saxena, Sonia] Imperial Coll London, Sch Publ Hlth, London, England; [Greaves, Felix] Publ Hlth England, Hlth Improvement Directorate, London, England; [Rawaf, Salman] Publ Hlth England, London, England; [Grosso, Giuseppe] Univ Hosp Polyclin Vittorio Emanuele, Integrated Tumor Registry, Catania, Italy; [Gupta, Rahul; Gupta, Rajeev] West Virginia Bur Publ Hlth, Commissioner Publ Hlth, Charleston, WV USA; [Gupta, Rahul; Gupta, Rajeev] West Virginia Univ, Dept Hlth Policy Management & Leadership, Morgantown, WV USA; [Gupta, Rahul; Gupta, Rajeev] Rajasthan Univ Hlth Sci, Jaipur, Rajasthan, India; [Gupta, Rahul; Gupta, Rajeev] Eternal Heart Care Ctr & Res Inst, Dept Prevent Cardiol, Jaipur, Rajasthan, India; [Gupta, Vipin] Univ Delhi, Dept Anthropol, Delhi, India; [Gvs, Murthy] Publ Hlth Fdn India, Indian Inst Publ Hlth, Hyderabad, India; [Hafezi-Nejad, Nima] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Hamadeh, Randah R.] Arabian Gulf Univ, Dept Family & Community Med, Manama, Bahrain; [Hamidi, Samer] Hamdan Bin Mohammed Smart Univ, Sch Hlth & Environm Studies, Dubai, U Arab Emirates; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Neurol Dept, Perth, WA, Australia; [Harb, Hilda L.] Minist Publ Hlth, Dept Vital & Hlth Stat, Beirut, Lebanon; [Nansseu, Jobert Richie] Minist Publ Hlth, Dept Dis Epidem & Pandem Control, Lebanon, NH USA; [Harikrishnan, Sivadasanpillai] Sree Chitra Tirunal Inst Med Sci & Technol, Cardiol Dept, Trivandrum, Kerala, India; [Mini, G. K.] Sree Chitra Tirunal Inst Med Sci & Technol, Trivandrum, Kerala, India; [Maria Haro, Josep; Koyanagi, Ai; Tyrovolas, Stefanos] Parc Sanit St Joan de Deu CIBERSAM, Res & Dev Unit, St Boi De Llobregat, Spain; [Maria Haro, Josep] Univ Barcelona, Dept Med, Barcelona, Spain; [Tyrovolas, Stefanos] Univ Barcelona, Barcelona, Spain; [Hassen, Hamid Yimam] Mizan Tepi Univ, Publ Hlth Dept, Mizan Teferi, Ethiopia; [Kefale, Adane Teshome] Mizan Tepi Univ, Pharm Dept, Mizan Teferi, Ethiopia; [Henok, Andualem] Mizan Tepi Univ, Mizan Teferi, Ethiopia; [Hassen, Hamid Yimam] Univ Hosp Antwerp, Unit Epidemiol & Social Med, Antwerp, Belgium; [Havmoeller, Rasmus] Karolinska Univ Hosp, Stockholm, Sweden; [Francisco Hernandez-Llanes, Norberto] Natl Commission Against Addict, Secretary Hlth, Subdirectorate Regulat Guidelines & Tech Procedur, Mexico City, DF, Mexico; [Herteliu, Claudiu; Mirica, Andreea; Pana, Adrian] Bucharest Univ Econ Studies, Dept Stat & Econometr, Bucharest, Romania; [Ileanu, Bogdan Vasile] Bucharest Univ Econ Studies, Bucharest, Romania; [Hibstu, Desalegn Ts Tsegaw] Hawassa Univ, Dept Reprod Hlth, Hawassa, Ethiopia; [Hoogar, Praveen] Manipal Univ, Transdisciplinary Ctr Qualitat Methods, Manipal, Karnataka, India; [Horita, Nobuyuki] Yokohama City Univ, Dept Pulmonol, Yokohama, Kanagawa, Japan; [Horita, Nobuyuki] NHGRI, NIH, Bethesda, MD 20892 USA; [Hosgood, H. Dean] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Hostiuc, Mihaela] Emergency Hosp Bucharest, Dept Internal Med, Bucharest, Romania; [Hu, Guoqing] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Huang, Hsiang] Cambridge Hlth Alliance, Dept Psychiat, Cambridge, MA USA; [Husseini, Abdullatif] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Palestine; [Husseini, Abdullatif] Qatar Univ, Doha, Qatar; [Idrisov, Bulat] Bashkir State Med Univ, Infect Dis Dept, Ufa, Russia; [Ilesanmi, Olayinka Stephen] Univ Liberia, Dept Publ Hlth & Community Med, Monrovia, Liberia; [Irvani, Seyed Sina Naghibi] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Tehran, Iran; [Islam, Sheikh Mohammed Shariful] Deakin Univ, Inst Phys Act & Nutr, Waurn Ponds, Vic, Australia; [Rahman, Mahfuzar; Rahman, Muhammad Aziz] Deakin Univ, Natl Ctr Farmer Hlth, Sch Med, Waurn Ponds, Vic, Australia; [Jackson, Maria D.] Univ West Indies, Dept Community Hlth & Psychiat, Jamaica, NY USA; [Jakovljevic, Mihajlo] Univ Kragujevac, Fac Med Sci, Kragujevac, Serbia; [Jayatilleke, Achala Upendra] Univ Colombo, Fac Grad Studies, Colombo, Sri Lanka; [Jayatilleke, Achala Upendra] Univ Colombo, Postgrad Inst Med, Colombo, Sri Lanka; [Jha, Ravi Prakash] Banaras Hindu Univ, Inst Med Sci, Dept Community Med, Varanasi, Uttar Pradesh, India; [Jonas, Jost B.] Capital Med Univ, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jozwiak, Jacek Jerzy] Czestochowa Tech Univ, Inst Hlth & Nutr Sci, Czestochowa, Poland; [Jozwiak, Jacek Jerzy] Univ Opole, Fac Med & Hlth Sci, Opole, Poland; [Kabir, Zubair] Univ Coll Cork, Sch Publ Hlth, Cork, Ireland; [Kadel, Rajendra] London Sch Econ & Polit Sci, Dept Hlth Policy, Personal Social Serv Res Unit, London, England; [Kapil, Umesh; Zaidi, Zoubida] ACS Med Coll & Hosp, New Delhi, India; [Katikireddi, Srinivasa Vittal] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Kebede, Seifu] Salale Univ, Midwifery Program, Fiche, Ethiopia; [Keiyoro, Peter Njenga] Univ Nairobi, Odel Campus, Nairobi, Kenya; [Irvani, Seyed Sina Naghibi; Kengne, Andre Pascal] Med Res Council South Africa, Noncommun Dis Res Unit, Cape Town, South Africa; [Parry, Charles D. H.] Med Res Council South Africa, Alcohol Tobacco & Other Drug Use Res Unit, Cape Town, South Africa; [Kengne, Andre Pascal; Noubiap, Jean Jacques] Univ Cape Town, Dept Med, Cape Town, South Africa; [Mensah, George A.] Univ Cape Town, Groote Schuur Hosp, Cape Town, South Africa; [Stein, Dan J.] Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Khader, Yousef] Jordan Univ Sci & Technol, Dept Publ Hlth & Community Med, Alramtha, Jordan; [Khafaie, Morteza Abdullatif] Ahvaz Jundishapur Univ Med Sci, Dept Publ Hlth, Ahvaz, Iran; [Rahim, Fakher] Ahvaz Jundishapur Univ Med Sci, Thalassemia & Hemoglobinopathy Res Ctr, Hlth Res Inst, Ahvaz, Iran; [Khan, Md Nuruzzaman] Jatiya Kabi Kazi Nazrul Islam Univ, Dept Populat Sci, Mymensingh, Bangladesh; [Khang, Young-Ho] Seoul Natl Univ, Inst Hlth Policy & Management, SNU Med Res Ctr, Seoul, South Korea; [Khang, Young-Ho] Seoul Natl Univ, Dept Hlth Policy & Management, Seoul, South Korea; [Khater, Mona M.] Cairo Univ, Dept Med Parasitol, Cairo, Egypt; [Khubchandani, Jagdish] Ball State Univ, Dept Nutr & Hlth Sci, Muncie, IN 47306 USA; [Kim, Cho-Il] Korea Hlth Ind Dev Inst, Cheongju, South Korea; [Kim, Daniel] Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA; [Kim, Yun Jin] Xiamen Univ Malaysia, Sch Med, Sepang, Malaysia; [Kimokoti, Ruth W.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA; [Kisa, Adnan] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway; [Neupane, Sudan Prasad] Univ Oslo, Norwegian Ctr Addict Res SERAF, Oslo, Norway; [Kisa, Adnan] Tulane Univ, Dept Global Community Hlth & Behav Sci, New Orleans, LA 70118 USA; [Kivimaki, Mika; Lallukka, Tea] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Meretoja, Tuomo J.] Univ Helsinki, Helsinki, Finland; [Kochhar, Sonali] Erasmus Univ, Dept Publ Hlth, Med Ctr Rotterdam, Rotterdam, Netherlands; [Kochhar, Sonali] Erasmus MC, Rotterdam, Netherlands; [Patle, Ajay] Int Inst Hlth Management Res, New Delhi, India; [Koul, Parvaiz A.] Sher Ashmir Inst Med Sci, Dept Internal & Pulm Med, Srinagar, Jammu & Kashmir, India; [Krishan, Kewal] Panjab Univ, Dept Anthropol, Chandigarh, India; [Defo, Barthelemy Kuate] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Defo, Barthelemy Kuate] Univ Montreal, Dept Demog, Montreal, PQ, Canada; [Bicer, Burcu Kucuk] Yuksek Ihtisas Univ, Fac Med, Dept Publ Hlth, Ankara, Turkey; [Bicer, Burcu Kucuk] Hacettepe Univ, Fac Med, Dept Publ Hlth, Ankara, Turkey; [Kulkarni, Veena S.] Arkansas State Univ, State Univ, AR 72467 USA; [Patton, George C.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Wijeratne, Tissa] Univ Melbourne, Australian Inst Muscular Skeletal Sci, Dept Med & Neurol, Melbourne, Vic, Australia; [Nayak, Mudavath Siva Durga Prasad] Rajiv Gandhi Univ Hlth Sci, Dept Community Med, Bangalore, Karnataka, India; [Balaji, Arjun Lakshmana] Rajiv Gandhi Univ Hlth Sci, Bangalore, Karnataka, India; [Lallukka, Tea] Finnish Inst Occupat Hlth, Populat & Work Abil Program, Helsinki, Finland; [Shiri, Rahman] Finnish Inst Occupat Hlth, Helsinki, Finland; [Lam, Hilton] Natl Inst Hlth, Inst Hlth Policy & Dev Studies, Manila, Philippines; [Lami, Faris Hasan] Acad Med Sci, Dept Community & Family Med, Baghdad, Iraq; [Lan, Qing] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Lansky, Sonia] Municipal Hlth Dept Belo Horizonte, Belo Horizonte City Hall, Belo Horizonte, MG, Brazil; [Larsson, Anders O.] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Larsson, Anders O.] Akad Sjukhuset, Dept Clin Chem & Pharmacol, Uppsala, Sweden; [Safiri, Saeid] Maragheh Univ Med Sci, Managerial Epidemiol Res Ctr, Sch Nursing & Midwifery, Dept Publ Hlth, Maragheh, Iran; [Latifi, Arman] Maragheh Univ Med Sci, Sch Publ Hlth, Dept Publ Hlth, Maragheh, Iran; [Leasher, Janet L.] Nova Southeastern Univ, Coll Optometry, Ft Lauderdale, FL 33314 USA; [Lee, Paul H.] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Leigh, James] Univ Sydney, Asbestos Dis Res Inst, Sydney, NSW, Australia; [Sitas, Freddy] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Leinsalu, Mall] Sodertorn Univ, Scohost, Huddinge, Sweden; [Leinsalu, Mall] Natl Inst Hlth Dev, Dept Epidemiol & Biostat, Tallinn, Estonia; [Levi, Miriam] Tuscany Ctr, CERIMP, Local Hlth Unit, Florence, Italy; [Levi, Miriam] Univ Florence, Dept Hlth Sci, Florence, Italy; [Li, Yichong] Shenzen Inst Cardiovasc Dis, Dept Clin & Epidemiol Res, Shenzhen, Peoples R China; [Lim, Lee-Ling] Univ Malaya, Dept Med, Kuala Lumpur, Malaysia; [Lim, Lee-Ling] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Linn, Shai] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Liu, Shiwei] Ctr Chron Dis Control, Beijing, Peoples R China; [Lobato-Cordero, Andrea] Natl Inst Energy Efficiency & Renewable Energies, Quito, Ecuador; [Abd El Razek, Hassan Magdy] Damietta Univ, Dumyat, Egypt; [Abd El Razek, Muhammed Magdy] Aswan Fac Med, Opthamol Dept, Aswan, Egypt; [Majdan, Marek] Trnava Univ, Dept Publ Hlth, Trnava, Slovakia; [Malekzadeh, Reza; Sepanlou, Sadaf G.] Shiraz Univ Med Sci, Noncommun Dis Res Ctr, Shiraz, Iran; [Mapoma, Chabila Christopher] Univ Zambia, Dept Populat Studies, Lusaka, Zambia; [Martinez-Raga, Jose] Doctor Peset Univ Hosp, Psychiat Dept, Valencia, Spain; [Martinez-Raga, Jose; Tabares-Seisdedos, Rafael] Univ Valencia, Dept Med, Valencia, Spain; [Mazidi, Mohsen] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Mckee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Prabhakaran, Dorairaj] London Sch Hyg & Trop Med, Dept Noncommun Dis Epidemiol, London, England; [Mehta, Varshil] Sevenhills Hosp, Dept Internal Med, Bombay, Maharashtra, India; [Meier, Toni] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Germany; [Shiue, Ivy] Martin Luther Univ Halle Wittenberg, Inst Epidemiol Biostat & Informat, Halle, Germany; [Meier, Toni] Competence Cluster Nutr & Cardiovasc Hlth NUTRICA, Innovat Off Nutricard, Halle, Germany; [Melese, Addisu] Debre Tabor Univ, Coll Hlth Sci, Debre Tabor, Ethiopia; [Memiah, Peter T. N.] Univ West Florida, Dept Publ Hlth, Pensacola, FL USA; [Mendoza, Walter] United Nations Populat Fund UNFPA, Peru Country Off UNFPA, Lima, Peru; [Mensah, George A.] NHLBI, Ctr Translat Res & Implementat Sci, Bldg 10, Bethesda, MD 20892 USA; [Meretoja, Tuomo J.] Helsinki Univ Hosp, Comprehens Canc Ctr, Breast Surg Unit, Helsinki, Finland; [Mezgebe, Haftay Berhane] Ethiopian Acad Med Sci, Mekelle, Ethiopia; [Miazgowski, Tomasz] Pomeranian Med Univ, Dept Hypertens & Internal Med, Szczecin, Poland; [Widecka, Justyna] Pomeranian Med Univ, Zdroje Hosp, Szczecin, Poland; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Miller, Ted R.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Mini, G. K.] Amrita Inst Med Sci, Dept Publ Hlth, Kochi, Kerala, India; [Mirica, Andreea] Natl Inst Stat Romania, Presidents Off, Bucharest, Romania; [Mirrakhimov, Erkin M.] Kyrgyz State Med Acad, Bishkek, Kyrgyzstan; [Mirrakhimov, Erkin M.] Natl Ctr Cardiol & Internal Dis, Dept Atherosclerosis & Coronary Heart Dis, Bishkek, Kyrgyzstan; [Moazen, Babak] Frankfurt Univ Appl Sci, Inst Addict Res ISFF, Dept Hlth & Social Work, Frankfurt, Germany; [Mohammad, Karzan Abdulmuhsin] Salahaddin Univ, Dept Biol, Erbil, Iraq; [Mohammadifard, Noushin] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Nutr & Cohort Studies Dept, Esfahan, Iran; [Sarrafzadegan, Nizal] Isfahan Univ Med Sci, Cardiovasc Res Inst, Esfahan, Iran; [Mohammed, Shafiu] Ahmadu Bello Univ, Hlth Syst & Policy Res Unit, Zaria, Nigeria; [Sufiyan, Mu'awiyyah Babale] Ahmadu Bello Univ, Dept Community Med, Zaria, Nigeria; [Monasta, Lorenzo; Ronfani, Luca] IRCCS Burlo Garofolo, Clin Epidemiol & Publ Hlth Res Unit, Inst Maternal & Child Hlth, Trieste, Italy; [Moraga, Paula] Univ Lancaster, Lancaster, England; [Morawska, Lidia] Queensland Univ Technol, Sci & Engn Fac, Int Lab Air Qual & Hlth, Brisbane, Qld, Australia; [Jalu, Moti Tolera] St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia; [Mukhopadhyay, Satinath] Inst Postgrad Med Educ & Res, Dept Endocrinol & Metab, Kolkata, India; [Musa, Kamarul Imran] Univ Sains Malaysia, Sch Med Sci, Kubang Kerian, Malaysia; [Naheed, Aliya] Int Ctr Diarrhoeal Dis Res, Initiat Non Commun Dis, Dhaka, Bangladesh; [Naik, Gurudatta] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Najafi, Farid] Kermanshah Univ Med Sci, Epidemiol Dept, Kermanshah, Iran; [Soofi, Moslem] Kermanshah Univ Med Sci, Res Ctr Environm Determinants Hlth, Kermanshah, Iran; [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India; [Nansseu, Jobert Richie] Univ Yaounde, Fac Med & Biomed Sci, Dept Publ Heath, Yaounde, Cameroon; [Nejjari, Chakib] Univ Sidi Mohammed Ben Abdellah, Dept Epidemiol & Publ Hlth, Fes, Morocco; [Nejjari, Chakib] Mohammed Vi Univ Hlth Sci, Int Sch Publ Hlth, Casablanca, Morocco; [Neupane, Sudan Prasad] Innlandet Hosp Trust, Norwegian Natl Advisory Unit Concurrent Subst Abu, Brumunddal, Norway; [Ngunjiri, Josephine W.] Univ Embu, Dept Biol Sci, Embu, Kenya; [Cuong Tat Nguyen; Long Hoang Nguyen; Trang Huyen Nguyen] Duy Tan Univ, Inst Global Hlth Innovat, Hanoi, Vietnam; [Ningrum, Dina Nur Anggraini] Semarang State Univ, Publ Hlth Dept, Kota Semarang, Indonesia; [Ningrum, Dina Nur Anggraini] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Ofori-Asenso, Richard] Hlth Policy Consult, Res Unit, Accra, Ghana; [Renzaho, Andre M. N.] Western Sydney Univ, Sch Social Sci, Penrith, NSW, Australia; [Renzaho, Andre M. N.] Western Sydney Univ, Psychol Dept, Penrith, NSW, Australia; [Ogbo, Felix Akpojene] Western Sydney Univ, Penrith, NSW, Australia; [Oh, In-Hwan] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Oladimeji, Olanrewaju] HSRC, HIV AIDS STIs & TB HAST Programme, Durban, South Africa; [Oladimeji, Olanrewaju] Univ Namibia, Fac Hlth Sci, Sch Publ Hlth, Osakhati, Namibia; [Olagunju, Andrew T.] Univ Lagos, Dept Psychiat, Lagos, Nigeria; [Olivares, Pedro R.] Autonomous Univ Chile, Providencia, Chile; [Olusanya, Jacob Olusegun] Ctr Hlth Start Initiat, Ikoyi, Nigeria; [Oren, Eyal] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Orpana, Heather M.] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Ortiz, Justin R.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Ota, Erika] St Lukes Int Univ, Global Hlth Nursing, Chuo Ku, Tokyo, Japan; [Owolabi, Mayowa Ojo] Univ Ibadan, Coll Med, Ibadan, Nigeria; [Oyekale, Abayomi Samuel] North West Univ, Agr Econ Grp, Mafikeng, South Africa; [Schutte, Aletta Elisabeth] North West Univ, HART, Mafikeng, South Africa; [Mahesh, P. A.] Jagadguru Sri Shivarathreeswara Univ, Dept TB & Resp Med, Mysore, Karnataka, India; [Pana, Adrian] Ctr Hlth Outcomes & Evaluat, Bucharest, Romania; [Park, Eun-Kee] Kosin Univ, Dept Med Humanities & Social Med, Busan, South Korea; [Patton, George C.] Murdoch Childrens Res Inst, Populat Hlth Grp, Melbourne, Vic, Australia; [Paudel, Deepak] Save Children, Hlth Nutr & HIV AIDS Program, Kathmandu, Nepal; [Paudel, Deepak] Ludwigs Maximillians Univ, Ctr Int Hlth, Munich, Germany; [Petzold, Max] Univ Gothenburg, Inst Med, Gothenburg, Sweden; [Petzold, Max] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Shanghai, Peoples R China; [Pillay, Julian David] Durban Univ Technol, Basic Med Sci Dept, Durban, South Africa; [Postma, Maarten J.] Univ Groningen, Dept Econ & Business, Groningen, Netherlands; [Postma, Maarten J.; Van Boven, Job F. M.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Qorbani, Mostafa] Alborz Univ Med Sci, Noncommun Dis Res Ctr, Karaj, Iran; [Radfar, Amir] Medichem, St Joan Despi, Spain; [Rafay, Anwar; Rana, Saleem M.] Contech Sch Publ Hlth, Lahore, Pakistan; [Rahman, Mahfuzar; Rahman, Muhammad Aziz] BRAC, Res & Evaluat Div, Dhaka, Bangladesh; [Rahman, Mahfuzar; Rahman, Muhammad Aziz] La Trobe Univ, Austin Clin Sch Nursing, Heidelberg, Vic, Australia; [Room, Robin] La Trobe Univ, Ctr Alcohol Policy Res, Heidelberg, Vic, Australia; [Wijeratne, Tissa] La Trobe Univ, Dept Psychol & Counselling, Heidelberg, Vic, Australia; [Rai, Rajesh Kumar] Soc Hlth & Demog Surveillance, Suri, India; [Rai, Rajesh Kumar] Univ Gottingen, Dept Econ, Gottingen, Germany; [Rajsic, Sasa] Med Univ Innsbruck, Innsbruck, Austria; [Raju, Sree Bhushan] Nizams Inst Med Sci, Dept Nephrol, Hyderabad, India; [Rana, Saleem M.] Univ Hlth Sci, Publ Hlth Dept, Lahore, Pakistan; [Ranabhat, Chhabi Lal] Yonsei Univ, Inst Poverty Alleviat & Int Dev, Kathmandu, Nepal; [Rawaf, David Laith] Univ Coll London Hosp, London, England; [Reis, Cesar] Loma Linda Univ, Med Ctr, Dept Prevent Med & Occupat Med, Loma Linda, CA USA; [Roever, Leonardo] Univ Uberlandia, Dept Clin Res, Uberlandia, MG, Brazil; [Room, Robin] Stockholm Univ, Ctr Social Res Alcohol & Drugs, Dept Publ Hlth Sci, Stockholm, Sweden; [Roshandel, Gholamreza] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran; [Roy, Ambuj] AIIMS, Dept Cardiol, New Delhi, India; [Sabde, Yogesh Damodar] Indian Council Med Res, Natl Inst Res Environm Hlth, Bhopal, India; [Saddik, Basema] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates; [Saleem, Zikria] Punjab Univ, Coll Pharm, Chandigarh, India; [Salomon, Joshua A.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Salomon, Joshua A.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Salvi, Sundeep Santosh] Chest Res Fdn, Clin Res Div, Pune, Maharashtra, India; [Sanabria, Juan] Marshall Univ, Dept Surg, Huntington, WV USA; [Sanabria, Juan] Case Western Reserve Univ, Dept Nutr & Prevent Med, Cleveland, OH 44106 USA; [Dolores Sanchez-Nino, Maria] Nephrol Grp, LIS Fdn Jimenez Diaz, Madrid, Spain; [Milicevic, Milena M. M. Santric] Univ Belgrade, Fac Med, Ctr Sch Publ Hlth & Hlth Management, Inst Social Med, Belgrade, Serbia; [Sarker, Abdur Razzaque] Int Ctr Diarrhoeal Dis Res, Hlth Econ & Financing Res Grp, Dhaka, Bangladesh; [Sarmiento-Suarez, Rodrigo] Univ Appl & Environm Sci, Fac Med, Dept Hlth & Soc, Bogota, Colombia; [Sartorius, Benn] Univ Kwazulu Natal, Dept Publ Hlth Med, Howard Coll Campus, Durban, South Africa; [Satpathy, Maheswar] Utkal Univ, UGC Ctr Adv Study Psychol, Bhubaneswar, India; [Satpathy, Maheswar] Udyam Global Assoc Sustainable Dev, Bhubaneswar, India; [Sawhney, Monika] Univ North Carolina Charlotte, Dept Publ Hlth Sci, Charlotte, NC USA; [Saylan, Mete] Bayer, Market Access, Istanbul, Turkey; [Schaub, Michael P.] Univ Zurich, Swiss Res Inst Publ Hlth & Addict, Zurich, Switzerland; [Schneider, Ione J. C.; Santos Silva, Diego Augusto] Univ Fed Santa Catarina, Hlth Sci Dept, Florianopolis, SC, Brazil; [Schwendicke, Falk] Char Univ Med Ctr Berlin, Dept Operat & Prevent Dent, Berlin, Germany; [Sharif, Mehdi] Islamic Azad Univ, Dept Lab Sci, Sari, Iran; [Sharif, Mehdi] Islamic Azad Univ, Dept Basic Sci, Sari, Iran; [She, Jun] Fudan Univ, Dept Pulm Med, Shanghai, Peoples R China; [Sheikh, Aziz] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Shen, Jiabin] Nationwide Children sHosp, Res Inst, Columbus, OH USA; [Shigematsu, Mika] Natl Inst Infect Dis, Tokyo, Japan; [Shishani, Kawkab] Washington State Univ, Pullman, WA 99164 USA; [Shukla, Sharvari Rahul] Symbiosis Int Univ, Symbiosis Inst Hlth Sci, Pune, Maharashtra, India; [Sigfusdottir, Inga Dora] Reykjavik Univ, Dept Psychol, Reykjavik, Iceland; [Sigfusdottir, Inga Dora] Columbia Univ, Dept Hlth & Behav Studies, New York, NY USA; [Da Silva, Natacha Torres] Portuguese Inst Sport & Youth, Lisbon, Portugal; [Alves Silveira, Dayane Gabriele] Brasilia Univ, Brasilia, DF, Brazil; [Sinha, Dhirendra Narain Narain] Sch Prevent Oncol, Patna, Bihar, India; [Sinha, Dhirendra Narain Narain] Healis Sekhsaria Inst Publ Hlth, Dept Epidemiol, Bombay, Maharashtra, India; [Soriano, Joan B.] Univ Hosp Princess IISP, Pneumol Serv, Res Inst, Madrid, Spain; [Soriano, Joan B.] Autonomous Univ Madrid, Pneumol Serv, Madrid, Spain; [Sreeramareddy, Chandrashekhar T.] Int Med Univ, Div Community Med, Kuala Lumpur, Malaysia; [Steckling, Nadine] Univ Hosp Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Steckling, Nadine] Univ Hlth Sci Med Informat & Technol, Dept Publ Hlth, Hlth Serv Res & Hlth Technol Assessment, Hall In Tirol, Austria; [Sykes, Bryan L.] Univ Calif Irvine, Dept Criminol Law & Soc, Irvine, CA USA; [Tabares-Seisdedos, Rafael] Carlos III Hlth Inst, CIBERSAM, Madrid, Spain; [Tabuchi, Takahiro] Osaka Int Canc Inst, Canc Control Ctr, Osaka, Japan; [Tavakkoli, Mohammad] New York Med Coll, Dept Psychiat & Behav Sci, Valhalla, NY 10595 USA; [Topor-Madry, Roman] Jagiellonian Univ Med Coll, Inst Publ Hlth, Krakow, Poland; [Topouzis, Fotis] Aristotle Univ Thessaloniki, Med Sch, Dept Ophthalmol, Thessaloniki, Greece; [Tran, Bach Xuan] Hanoi Univ, Dept Hlth Econ, Hanoi, Vietnam; [Truelsen, Thomas Clement] Univ Copenhagen, Dept Neurol, Copenhagen, Denmark; [Tsilimparis, Nikolaos] Univ Heart Ctr Hamburg, Dept Vasc Med, Hamburg, Germany; [Ukwaja, Kingsley Nnanna] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Nigeria; [Ullah, Irfan] Gomal Univ, Gomal Ctr Biochem & Biotechnol, Dera Ismail Khan, Pakistan; [Ullah, Irfan] Mufti Mehmood Mem Teaching Hosp, Programmat Management Drug Resistant TB Unit, TB Culture Lab, Dera Ismail Khan, Pakistan; [Valdez, Pascual R.] Argentine Soc Med, Buenos Aires, DF, Argentina; [Valdez, Pascual R.] Hosp Velez Sarsfield, Intens Care Unit, Buenos Aires, DF, Argentina; [Vasankari, Tommi Juhani] UKK Inst, Tampere, Finland; [Venketasubramanian, Narayanaswamy] Raffles Hosp, Raffles Neurosci Ctr, Singapore, Singapore; [Vladimirov, Sergey Konstantinovitch] Sechenov First Moscow State Med Univ, Dept Informat & Internet Technol, Moscow, Russia; [Vlassov, Vasily] Natl Res Univ Higher Sch Econ, Dept Hlth Care Adm & Econ, Moscow, Russia; [Vollset, Stein Emil] Norwegian Inst Publ Hlth, Ctr Dis Burden, Bergen, Norway; [Wagnew, Fasil Wagnew Shiferaw] Debre Markos Univ, Dept Nursing, Debremarkos, Ethiopia; [Waheed, Yasir] Fdn Univ, Fdn Univ Med Coll, Rawalpindi, Pakistan; [Werdecker, Andrea] Fed Inst Populat Res, Demog Change & Ageing Res Area, Wiesbaden, Germany; [Westerman, Ronny] Fed Inst Populat Res, Competence Ctr Mortal Follow Up, German Natl Cohort, Wiesbaden, Germany; [Wyper, Grant M. A.] NHS Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [Wyper, Grant M. A.] Univ Strathclyde, Glasgow, Lanark, Scotland; [Xu, Gelin] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Yano, Yuichiro] Univ Mississippi, Med Ctr, Dept Prevent Med, Jackson, MS 39216 USA; [Ye, Pengpeng] Chinese Ctr Dis Control & Prevent, Div Injury Prevent & Mental Hlth Provement, Beijing, Peoples R China; [Yip, Paul] Univ Hong Kong, Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Yirsaw, Biruck Desalegn] Univ South Australia, Adelaide, SA, Australia; [Yonemoto, Naohiro] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan; [Yoon, Seok-Jun] Korea Univ, Dept Prevent Med, Seoul, South Korea; [Yotebieng, Marcel] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Yotebieng, Marcel] Univ Kinshasa, Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Younis, Mustafa Z.] Jackson State Univ, Dept Hlth Pol & Management, Jackson, MS USA; [Younis, Mustafa Z.] Tsinghua Univ, Beijing, Peoples R China; [Zachariah, Geevar] Mother Hosp, Dept Cardiol, Trichur, India; [Zhang, Xueying] Univ Texas Houston, Houston, TX USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard University; Harvard University; Harvard University; Seattle Genetics; Jimma University; Jimma University; Haramaya University; Haramaya University; Haramaya University; Haramaya University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Sapienza University Rome; Ministry of Health - Saudi Arabia; Ministry of Health - Saudi Arabia; University of Gondar; University of Gondar; University of Gondar; CHU Limoges; Universite de Limoges; Stellenbosch University; Stellenbosch University; South African Medical Research Council; South African Medical Research Council; South African Medical Research Council; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Universidad de Extremadura; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; McMaster University; Yerevan State University; National Academy of Sciences of Armenia; Public Health Foundation of India; Public Health Foundation of India; University of Kentucky; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oxford; Washington University (WUSTL); Mayo Clinic; University of Western Australia; University of Western Australia; Australian National University; Australian National University; Qazvin University of Medical Sciences (QUMS); Kuwait University; Luxembourg Institute of Health; Swedish Research Council; Universidad de Cartagena; Universidad de la Costa; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); Bahir Dar University; Bahir Dar University; University of Queensland; University of Queensland; University of Queensland; American University of Beirut; American University of Beirut; Kwame Nkrumah University Science & Technology; National University of Singapore; National University of Singapore; Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy; University of Sheffield; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; Birmingham City University; Dalarna University; University of Manitoba; Mashhad University Medical Science; University of Leicester; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; McGill University; Dilla University; University of Tokyo; University of Tokyo; University of Tokyo; University of South Africa; Burnet Institute; Mazandaran University Medical Sciences; Mazandaran University Medical Sciences; Mazandaran University Medical Sciences; Mazandaran University Medical Sciences; Mazandaran University Medical Sciences; Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada; Medical University Lodz; University of Auckland; Pontificia Universidad Javeriana; Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; Jazan University; CHU Dijon Bourgogne; Universite de Bourgogne; Mekelle University; Mekelle University; Mekelle University; Mekelle University; Mekelle University; Mekelle University; Mekelle University; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of London; King's College London; University of London; King's College London; Emory University; State University System of Florida; University of South Florida; University of Newcastle; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Aga Khan University; Babol University of Medical Sciences; Babol University of Medical Sciences; Babol University of Medical Sciences; Babol University of Medical Sciences; Babol University of Medical Sciences; Babol University of Medical Sciences; University of Bologna; University of Bologna; University of London; University College London; University of London; University College London; University of London; University College London; University of Bergen; University of Oslo; University of Oslo; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Genoa; Helmholtz Association; German Cancer Research Center (DKFZ); University of British Columbia; University of British Columbia; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidad Nacional de Colombia; Universidad Costa Rica; National Taiwan University; International Institute for Population Sciences; International Institute for Population Sciences; International Institute for Population Sciences; Tata Memorial Centre (TMC); Tata Memorial Hospital; University of Cambridge; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; University of Adelaide; University of Adelaide; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of Milano-Bicocca; Universidade Federal do Rio Grande do Sul; University of California System; University of California San Diego; Guy's & St Thomas' NHS Foundation Trust; Asfendiyarov Kazakh National Medical University; Monash University; Monash University; Monash University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Icahn School of Medicine at Mount Sinai; Indian Council of Medical Research (ICMR); University of Peradeniya; University of Cape Coast; Tampere University; Royal Melbourne Institute of Technology (RMIT); University of Belgrade; Egyptian Knowledge Bank (EKB); Mansoura University; Russian Academy of Sciences; Queensland Centre for Mental Health Research; Queensland Centre for Mental Health Research; Universidade Federal de Sergipe; Auckland University of Technology; Universidade Federal de Sao Paulo (UNIFESP); Brandeis University; University of Memphis; Kaiser Permanente; A.T. Still University of Health Sciences; A.T. Still University of Health Sciences; Robert Koch Institute; University of Bielefeld; James Cook University; Sidi Mohamed Ben Abdellah University of Fez; Wageningen University & Research; University of Tsukuba; University of Warwick; University of Warwick; University Ha'il; University of Massachusetts System; University of Massachusetts Boston; University of Oklahoma System; University of Oklahoma Health Sciences Center; Imperial College London; Imperial College London; Imperial College London; Public Health England; Public Health England; Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; West Virginia University; Eternal Heart Care Centre & Research Institute; University of Delhi; Public Health Foundation of India; Johns Hopkins University; Arabian Gulf University; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; University of Barcelona; University of Antwerp; Karolinska Institutet; Karolinska University Hospital; Bucharest University of Economic Studies; Bucharest University of Economic Studies; Hawassa University; Manipal Academy of Higher Education (MAHE); Yokohama City University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Yeshiva University; Albert Einstein College of Medicine; Central South University; Harvard University; Cambridge Health Alliance; Birzeit University; Qatar University; Bashkir State Medical University; Shahid Beheshti University Medical Sciences; Deakin University; Deakin University; University of Kragujevac; University of Colombo; University of Colombo; Banaras Hindu University (BHU); Capital Medical University; Technical University Czestochowa; University of Opole; University College Cork; University of London; London School Economics & Political Science; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Nairobi; University of Cape Town; University of Cape Town; University of Cape Town; Jordan University of Science & Technology; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Seoul National University (SNU); Seoul National University (SNU); Egyptian Knowledge Bank (EKB); Cairo University; Ball State University; Northeastern University; Xiamen University Malaysia Campus; Simmons University; University of Oslo; University of Oslo; Tulane University; University of Helsinki; University of Helsinki; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Sher-i-Kashmir Institute of Medical Sciences; Panjab University; Universite de Montreal; Universite de Montreal; Yuksek Ihtisas University; Hacettepe University; Arkansas State University; University of Melbourne; University of Melbourne; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uppsala University; Uppsala University; Uppsala University Hospital; Nova Southeastern University; Hong Kong Polytechnic University; University of Sydney; University of Sydney; Sodertorn University; National Institute for Health Development - Estonia; University of Florence; Universiti Malaya; Chinese University of Hong Kong; University of Haifa; Egyptian Knowledge Bank (EKB); Damietta University; University of Trnava; Shiraz University of Medical Science; University of Zambia; University of Valencia; Chalmers University of Technology; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; State University System of Florida; University of West Florida; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Helsinki; Helsinki University Central Hospital; Pomeranian Medical University; Pomeranian Medical University; Pacific Institute for Research & Evaluation (PIRE); Curtin University; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; Kyrgyz State Medical Academy; Ministry of Health - Kyrgyzstan; Salahaddin University; Isfahan University Medical Science; Isfahan University Medical Science; Ahmadu Bello University; Ahmadu Bello University; IRCCS Burlo Garofolo; Lancaster University; Queensland University of Technology (QUT); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Universiti Sains Malaysia; International Centre for Diarrhoeal Disease Research (ICDDR); University of Alabama System; University of Alabama Birmingham; Kermanshah University of Medical Sciences; Kermanshah University of Medical Sciences; Suraj Eye Institute; University of Yaounde I; Sidi Mohamed Ben Abdellah University of Fez; Mohammed VI University of Health Sciences (UM6SS); Innlandet Hospital Trust; Duy Tan University; Universitas Negeri Semarang; Taipei Medical University; Western Sydney University; Western Sydney University; Western Sydney University; Kyung Hee University; Human Sciences Research Council-South Africa; University of Namibia; University of Lagos; Universidad Autonoma de Chile; California State University System; San Diego State University; University of Ottawa; University System of Maryland; University of Maryland Baltimore; St. Luke's International Hospital; University of Ibadan; North West University - South Africa; North West University - South Africa; JSS Academy of Higher Education & Research; Murdoch Children's Research Institute; Save the Children; University of Gothenburg; University of Witwatersrand; Shanghai Jiao Tong University; Durban University of Technology; University of Groningen; University of Groningen; Bangladesh Rural Advancement Committee BRAC; La Trobe University; La Trobe University; La Trobe University; University of Gottingen; Medical University of Innsbruck; Nizam's Institute of Medical Sciences; University of Health Science - Pakistan; University College London Hospitals NHS Foundation Trust; University of London; University College London; Loma Linda University; Stockholm University; Golestan University of Medical Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Environmental Health (NIREH); University of Sharjah; Panjab University; Stanford University; Stanford University; Marshall University; Case Western Reserve University; University of Belgrade; International Centre for Diarrhoeal Disease Research (ICDDR); University of Kwazulu Natal; Utkal University; University of North Carolina; University of North Carolina Charlotte; Bayer Turkey; University of Zurich; Universidade Federal de Santa Catarina (UFSC); Islamic Azad University; Islamic Azad University; Fudan University; University of Edinburgh; National Institute of Infectious Diseases (NIID); Washington State University; Symbiosis International University; Symbiosis Institute of Health Sciences (SIHS); Reykjavik University; Columbia University; Universidade de Brasilia; Autonomous University of Madrid; International Medical University Malaysia; University of Munich; University of California System; University of California Irvine; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; New York Medical College; Jagiellonian University; Collegium Medicum Jagiellonian University; Aristotle University of Thessaloniki; University of Hanoi; University of Copenhagen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Gomal University; UKK Institute; Raffles Hospital; Sechenov First Moscow State Medical University; HSE University (National Research University Higher School of Economics); Norwegian Institute of Public Health (NIPH); NHS National Services Scotland; University of Strathclyde; Nanjing University; University of Mississippi; University of Mississippi Medical Center; Chinese Center for Disease Control & Prevention; University of Hong Kong; University of South Australia; Kyoto University; Korea University; University System of Ohio; Ohio State University; Universite de Kinshasa; Jackson State University; Tsinghua University; University of Texas System; University of Texas Health Science Center Houston	Gakidou, E (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	gakidou@uw.edu	Pourmalek, Farshad/A-8188-2010; Filho, Adauto Martins Soares/M-2176-2016; Dadi, Hailemichael Bizuneh/D-4088-2019; Gallus, Silvano/AAB-4127-2019; Al-Aly, Ziyad/S-4439-2016; Duncan, Bruce B/L-4140-2016; Ahmed, Muktar/AAY-6783-2020; Aghayan, Sargis/L-7219-2015; Brenner, Hermann/B-4627-2017; Kim, Cho-il/B-5961-2011; Leonardo, Roever MHS, PhD, Post-Doctorate, MBA (Data Science)/F-5315-2012; Abate, Kalkidan Hassen/ABA-9014-2020; S, Harikrishnan/AAT-8083-2021; rahim, fakher/AAC-3905-2019; Ghadimi, Reza/ABA-1892-2021; Kengne, Andre Pascal/ABB-3696-2020; Schneider, Ione J.C./J-8762-2013; Mehta, Varshil/L-7416-2015; Milicevic, Milena/AAV-3679-2021; abbafati, cristiana/AAD-7511-2022; Bedi, Neeraj/AGR-0606-2022; Ebrahimi, Hedyeh/AAR-2899-2021; Institute, Symbiosis Statistical/AAA-3483-2019; Yirsaw, Biruck Desalegn/D-8828-2013; Olivares, Pedro R/C-6287-2008; Carvalho, Félix/D-4914-2013; T., Olagunju Andrew/B-4746-2017; Shiri, Rahman/ABB-1780-2021; Adhikari, Tara Ballav/J-7071-2019; Rajsic, Sasa/AAS-6572-2021; Schmidt, Maria Inês/AGP-6441-2022; Conti, Sara/J-4891-2019; Krishan, Kewal/I-3285-2014; Amul, Gianna Gayle/ABA-9327-2020; Zaki, Maysaa El Sayed/C-1522-2013; Badali, Hamid/J-8036-2016; Patton, George C/B-5246-2013; wangwangwang, yuanyaun/HHN-6432-2022; Renzaho, Andre M.N./AAH-7679-2021; Raju, Sree Bhushan/ABD-1880-2020; Levi, Miriam/AAR-8512-2020; Madotto, Fabiana/AAA-9802-2019; Lami, Faris/AAW-7666-2021; Claro, Rafael/F-8996-2012; Rahman, Muhammad Aziz/B-3380-2009; kumar, Pushpendra/GRR-1736-2022; Kochhar, Sonali/H-4036-2012; Saxena, Sonia K/G-4821-2013; Islam, Mohammed Shariful/B-1219-2011; Tyrovolas, Stefanos/M-2758-2014; Ausloos, Marcel/AAC-8812-2020; Ansha, Mustafa/ADS-0968-2022; Edessa, Dumessa/K-3885-2019; Ram, Usha/AAS-4140-2020; Truelsen, Thomas/AAY-1549-2020; Kim, Yun Jin/AAE-8281-2019; Mekonen, Tesfa/AAI-6334-2020; Roshandel, Gholamreza/AAJ-9562-2021; Cousin, Ewerton/Y-4849-2019; Afarideh, Mohsen/H-8945-2019; Ileanu, Bogdan/HDM-5675-2022; Oladimeji, Olanrewaju/AAE-9633-2019; Bennett, Derrick/AAH-1220-2022; Feigin, Valery/AAF-2313-2019; Banach, Maciej/A-1271-2009; Joukar, Farahnaz/GMW-7238-2022; McKee, Marc D/E-2187-2011; Yirsaw, Biruck D/E-1705-2012; Mokdad, Ali H./AAD-1232-2022; Hamadeh, Randah R./AAE-9720-2020; Koul, Parvaiz/B-1666-2017; f, m/AAM-2063-2021; Alahdab, Fares/N-6680-2013; Khubchandani, Jagdish/D-1831-2014; Abebe, Zegeye/AAJ-6459-2020; Latifi, Arman/V-2359-2017; Ningrum, Dina Nur Anggraini/ABA-1698-2020; Stein, Dan/A-1752-2008; Ärnlöv, Johan/AAF-2746-2019; Lim, Lee-Ling/D-7697-2015; Hay, Simon Iain/F-8967-2015; Saxena, Sonia/ABD-7737-2021; Koyanagi, Ai/D-3833-2018; Sufiyan, Muawiyyah Babale/GWN-2609-2022; Idrisov, Bulat/A-8271-2018; Hernández-Llanes, Norberto F/AAR-7268-2021; Mansour-Ghanaei, Fariborz/ABC-0170-2022; Monasta, Lorenzo/B-1388-2012; Bragazzi, Nicola Luigi/G-1672-2011; Alvis-Guzman, Nelson/D-4913-2013; Hoogar, Praveen/C-4050-2017; assadi, reza/AAT-6629-2020; Topor-Madry, Roman/ABF-5449-2020; Aljunid, Syed/J-6009-2014; Gupta, Vipin/D-1704-2014; Kefale, Adane Teshome/AAP-6928-2020; FRACP, Tissa Wijeratne MD PhD/I-2086-2019; Silva, Diego Augusto Santos/AAB-9249-2020; Zamani, Mohammad/A-7733-2016; Grosso, Giuseppe/K-6730-2016; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Bennett, Derrick/AFL-9254-2022; Shanmugam, Raju/N-8120-2013; Schmidt, Maria Inês/AGT-5691-2022; Phillips, Michael Robert/AAE-7585-2021; AMINDE, Leopold/K-5684-2019; Davletov, Kairat/S-1792-2016; Rostami, Ali/R-3347-2017; Mousavi, Seyyed Meysam/P-7797-2015; Badawi, Alaa/ABC-1300-2021; Alene, Dr Kefyalew Addis/V-8240-2018; Room, Robin/ABF-7460-2021; Chowdhury, Rajiv/AHB-1253-2022; Aremu, Olatunde/AAD-1995-2019; Irvani, Seyed Sina Naghibi/O-2413-2018; Leung, Janni/H-1003-2012; Antonio, Carl Abelardo/AAP-4280-2020; Jóźwiak, Jacek/AAN-6351-2020; Ayele, Henok Tadesse/AAA-5856-2019; Oh, In Hwan/AAI-9070-2020; Schöttker, Ben/F-8183-2014; Neupane, Sudan Prasad/C-8056-2011; Ribeiro, Ana Cristina/HHN-7466-2022; Khan, Nuruzzaman/K-8677-2019; Dachew, Berihun Assefa/I-3111-2019; Kivimaki, Mika/B-3607-2012; Hankey, Graeme J/H-4968-2014; Neupane, Subas/X-7446-2019; Angus, Colin/AAT-2786-2020; Saylan, Mete/AAP-1195-2020; Yimer, Nigus Bililign/AGD-8934-2022; Wang, Yuan-Pang/A-4863-2008; Ortega-Altamirano, Doris V./ABA-8549-2020; Ghadimi, Reza/J-5307-2016; assadi, reza/AAI-1124-2021; Melese, Addisu/S-3175-2017; Wang, Yuan/HHC-1520-2022; naik, Gurudatta/O-7284-2015; Yisma, Engida/ABA-4170-2020; van Boven, Job FM/K-7942-2019; Grosso, Giuseppe/ABA-1587-2020; Santos, Itamar S/K-7055-2012; Bernabe, Eduardo/R-3441-2017; Ferrari, Alize J/G-1746-2011; Jha, Ravi Prakash/ABC-6588-2020; Room, Robin/ABH-8505-2020; Waheed, Yasir/AAC-3896-2019; Mirica, Andreea/AAN-8016-2020; Tsilimparis, Nikolaos/AGT-1850-2022; Basaleem, Huda/AAX-9878-2020; Mohammed, Shafiu/P-2016-2014; Avila-Burgos, Leticia/AAR-1815-2021; SOUNDRARAJAN, JOYSON/I-1779-2019; Naohiro, Yonemoto/Y-3761-2019; Mini, GK/GMX-3520-2022; Faro, Andre/J-1696-2014; Weldegebreal, Fitsum/AAU-4318-2021; Shukla, Sharvari/AAK-3469-2020; Shen, Jiabin/C-3655-2008; Dubljanin, Eleonora/AAW-6278-2020; Aboyans, Victor/AAN-8308-2020; Herteliu, Claudiu/K-4643-2014; Weiderpass, Elisabete/AAP-2747-2021; Martinez-Raga, Jose/AAS-1785-2020; Saleem, Zikria/AAB-5786-2022; wei, yuki/AAF-9999-2021; Khader, Yousef/AAE-9620-2019; Ullah, Irfan/L-5150-2017; Bjerregaard, Peter/ABD-8894-2020; Oren, Eyal/AAD-5561-2019; Meier, Toni/AAB-1704-2021; Felisbino-Mendes, Mariana Santos/F-9910-2014; Geleijnse, Johanna Marianna M/B-5749-2012; Ilesanmi, Olayinka/AAF-8628-2021; Zaki, Maysaa El Sayed/H-3049-2019; Waheed, Yasir/F-6390-2015; A, Naheed/AHB-2941-2022; Ginawi, Ibrahim Abdelmageed Mohamed/H-3260-2012; Radfar, Amir/I-8057-2019; Schaub, Michael P./ABF-9468-2021; Brenner, Hermann/ABE-6383-2020; A, Naheed/AHB-2940-2022; Rezai, Mohammad Sadegh/F-6274-2017; Dhimal, Meghnath/AAD-7261-2021; Santos, Itamar/M-2208-2019; Safiri, Saeid/A-1678-2017; Herteliu, Claudiu/K-3367-2019; Sahebkar, Amirhossein/B-5124-2018; Silva, Diego/GRF-5446-2022; Qorbani, Mostafa/M-8171-2017; Amare, Dr Azmeraw/B-9487-2018; Machado, Isis/I-5740-2013; Mirrakhimov, Erkin/E-6900-2017; Jakovljevic, Mihajlo/B-3002-2014; Soriano, Joan B/O-1215-2017; Soofi, Moslem/E-7665-2019; Ukwaja, Kingsley N./A-7794-2013; Bhutta, Zulfiqar/L-7822-2015; Sanchez-Nino, Maria Dolores/B-7350-2019; moosazadeh, mahmood/F-3730-2017; Tran, Khanh Bao/V-4371-2018; Lozano, Rafael/T-5352-2018; Morawska, Lidia/B-4140-2011; Kasaeian, Amir/C-8290-2017; Bijani, Ali/B-1718-2017; Li, Yichong/A-3559-2019; Castaneda-Orjuela, Carlos/N-2601-2017; das Neves, Jose/J-8369-2013; Larson, Heidi J./N-1018-2017; Schutte, Aletta/E-5126-2018; Santomauro, Damian/W-7528-2018; Salomon, Joshua/D-3898-2009; Lunevicius, Raimundas/B-2528-2018; Sarvi, Shahabeddin/F-6023-2017; Leinsalu, Mall/I-3768-2018; Rajsic, Sasa/ADY-3755-2022; McGrath, John/G-5493-2010; Rezaeian, Shahab/G-7482-2011; Moradi, Ghobad/R-1267-2016; Rahimi-Movaghar, Afarin/E-9505-2011; Lorkowski, Stefan/B-9689-2008; Sepanlou, Sadaf/H-9343-2016; Plana-Ripoll, Oleguer/E-1448-2015; Musa, Kamarul Imran/N-3198-2015; Carvalho Malta, Deborah/H-7880-2012; Khafaie, Morteza Abdullatif/J-5659-2016; Awasthi, Ashish/P-3966-2018; Franklin, Richard/H-1731-2012; Saylan, Mete/B-5648-2008; Farioli, Andrea/K-9256-2016; Samy, Abdallah/I-1415-2014; Yotebieng, Marcel/L-2083-2013; Yimer, Ebrahim M./N-4597-2018; Guo, Yuming/I-8353-2018; Catala-Lopez, Ferran/N-6018-2018; Satpathy, Maheswar/J-3135-2017; Kucuk Bicer, Burcu/G-4922-2017; Homaie Rad, Enayatollah/G-5567-2015; Olusanya, Bolajoko/F-4504-2012; De Neve, Jan-Walter/D-7547-2017; S A, Rizwan/F-5289-2014; Rahimi-Movaghar, Vafa/T-7816-2017; Patten, Scott/B-4434-2011; Uthman, Olalekan/P-7916-2014; Demoz, Gebre Teklemariam/K-6986-2019; Mehrotra, Ravi/E-3285-2010; Miazgowski, Tomasz/H-9448-2014; Yaseri, Mehdi/I-1645-2018; Kadel, Rajendra/K-7365-2016; Fernandes, Eduarda/D-4943-2013; Greaves, Felix/A-1324-2012; Hassen, Hamid/A-1105-2019; Charlson, Fiona/F-5290-2011; Kuate Defo, Barthelemy/I-4818-2017; Lalloo, Ratilal/O-5624-2014; Sachdev, Perminder/H-3968-2015; El-Khatib, Ziad/B-5161-2017; Jayatilleke, Achala Upendra/H-1714-2017; Safari, Hosein/Q-6698-2017	Pourmalek, Farshad/0000-0002-2134-0771; Filho, Adauto Martins Soares/0000-0002-0917-7473; Dadi, Hailemichael Bizuneh/0000-0003-0586-7562; Gallus, Silvano/0000-0002-8967-0400; Al-Aly, Ziyad/0000-0002-2600-0434; Duncan, Bruce B/0000-0002-7491-2630; Ahmed, Muktar/0000-0002-9524-7027; Aghayan, Sargis/0000-0001-8516-2778; Brenner, Hermann/0000-0002-6129-1572; Leonardo, Roever MHS, PhD, Post-Doctorate, MBA (Data Science)/0000-0002-7517-5548; Abate, Kalkidan Hassen/0000-0001-9752-5417; rahim, fakher/0000-0002-2857-4562; Schneider, Ione J.C./0000-0001-6339-7832; Mehta, Varshil/0000-0001-5804-9948; Bedi, Neeraj/0000-0003-4709-8423; Olivares, Pedro R/0000-0001-7371-343X; Carvalho, Félix/0000-0003-3858-3494; T., Olagunju Andrew/0000-0003-1736-9886; Shiri, Rahman/0000-0002-9312-3100; Adhikari, Tara Ballav/0000-0002-7654-5483; Schmidt, Maria Inês/0000-0002-3837-0731; Conti, Sara/0000-0002-5774-3740; Krishan, Kewal/0000-0001-5321-0958; Amul, Gianna Gayle/0000-0002-4197-9601; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Badali, Hamid/0000-0002-6010-8414; Patton, George C/0000-0001-5039-8326; Raju, Sree Bhushan/0000-0001-9409-3874; Levi, Miriam/0000-0002-0086-3952; Madotto, Fabiana/0000-0002-8829-9160; Lami, Faris/0000-0002-3673-3818; Rahman, Muhammad Aziz/0000-0003-1665-7966; Kochhar, Sonali/0000-0002-1150-5691; Saxena, Sonia K/0000-0003-3787-2083; Islam, Mohammed Shariful/0000-0001-7926-9368; Ausloos, Marcel/0000-0001-9973-0019; Edessa, Dumessa/0000-0001-6558-5829; Ram, Usha/0000-0001-6722-7347; Kim, Yun Jin/0000-0001-8853-6587; Mekonen, Tesfa/0000-0002-3188-0173; Roshandel, Gholamreza/0000-0002-5494-0722; Afarideh, Mohsen/0000-0002-3578-5640; Oladimeji, Olanrewaju/0000-0002-5356-901X; Bennett, Derrick/0000-0002-9170-8447; Banach, Maciej/0000-0001-6690-6874; Joukar, Farahnaz/0000-0003-0102-0575; McKee, Marc D/0000-0001-8349-965X; Mokdad, Ali H./0000-0002-4994-3339; Hamadeh, Randah R./0000-0002-4205-1354; Koul, Parvaiz/0000-0002-1700-9285; Alahdab, Fares/0000-0001-5481-696X; Khubchandani, Jagdish/0000-0002-9058-4278; Abebe, Zegeye/0000-0001-6922-0376; Latifi, Arman/0000-0002-6823-0561; Ningrum, Dina Nur Anggraini/0000-0002-8557-2862; Stein, Dan/0000-0001-7218-7810; Ärnlöv, Johan/0000-0002-6933-4637; Lim, Lee-Ling/0000-0002-6214-6924; Hay, Simon Iain/0000-0002-0611-7272; Saxena, Sonia/0000-0003-3787-2083; Koyanagi, Ai/0000-0002-9565-5004; Sufiyan, Muawiyyah Babale/0000-0003-3630-6995; Mansour-Ghanaei, Fariborz/0000-0001-6747-0232; Monasta, Lorenzo/0000-0001-7774-548X; Bragazzi, Nicola Luigi/0000-0001-8409-868X; Alvis-Guzman, Nelson/0000-0001-9458-864X; Hoogar, Praveen/0000-0003-2170-5643; Aljunid, Syed/0000-0002-0380-1335; Gupta, Vipin/0000-0002-0607-5543; Kefale, Adane Teshome/0000-0001-7254-4435; FRACP, Tissa Wijeratne MD PhD/0000-0002-1701-7111; Silva, Diego Augusto Santos/0000-0002-0489-7906; Zamani, Mohammad/0000-0003-1916-3873; Grosso, Giuseppe/0000-0003-3930-5285; Bennett, Derrick/0000-0002-9170-8447; Shanmugam, Raju/0000-0002-8613-9518; Phillips, Michael Robert/0000-0002-5973-2439; AMINDE, Leopold/0000-0003-2787-7518; Rostami, Ali/0000-0002-1358-1321; Mousavi, Seyyed Meysam/0000-0002-6795-7224; Alene, Dr Kefyalew Addis/0000-0002-1904-4682; Room, Robin/0000-0002-5618-385X; Aremu, Olatunde/0000-0002-5832-2403; Irvani, Seyed Sina Naghibi/0000-0002-4566-7402; Leung, Janni/0000-0001-5816-2959; Antonio, Carl Abelardo/0000-0001-7476-0553; Jóźwiak, Jacek/0000-0002-2645-7274; Ayele, Henok Tadesse/0000-0002-6117-0578; Oh, In Hwan/0000-0002-5450-9887; Schöttker, Ben/0000-0002-1217-4521; Ribeiro, Ana Cristina/0000-0002-0493-8376; Dachew, Berihun Assefa/0000-0002-4041-6129; Kivimaki, Mika/0000-0002-4699-5627; Hankey, Graeme J/0000-0002-6044-7328; Neupane, Subas/0000-0002-5868-0980; Angus, Colin/0000-0003-0529-4135; Wang, Yuan-Pang/0000-0001-7076-8312; Ghadimi, Reza/0000-0002-4296-2836; Melese, Addisu/0000-0002-2362-5500; naik, Gurudatta/0000-0001-7265-6605; Yisma, Engida/0000-0003-0703-1515; van Boven, Job FM/0000-0003-2368-2262; Grosso, Giuseppe/0000-0003-3930-5285; Santos, Itamar S/0000-0003-3212-8466; Bernabe, Eduardo/0000-0002-1858-3713; Ferrari, Alize J/0000-0002-7863-9117; Jha, Ravi Prakash/0000-0001-5230-1436; Waheed, Yasir/0000-0002-5789-4215; Tsilimparis, Nikolaos/0000-0002-6313-7595; Basaleem, Huda/0000-0002-7353-5140; Mohammed, Shafiu/0000-0001-5715-966X; Mini, GK/0000-0003-2775-629X; Faro, Andre/0000-0002-7348-6297; Weldegebreal, Fitsum/0000-0002-7867-1483; Shukla, Sharvari/0000-0002-7029-5532; Herteliu, Claudiu/0000-0001-8860-9547; Weiderpass, Elisabete/0000-0003-2237-0128; Martinez-Raga, Jose/0000-0002-2856-6562; Saleem, Zikria/0000-0003-3202-6347; Khader, Yousef/0000-0002-7830-6857; Bjerregaard, Peter/0000-0001-7153-8447; Meier, Toni/0000-0001-6056-0665; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Ilesanmi, Olayinka/0000-0003-0827-6442; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Waheed, Yasir/0000-0002-5789-4215; A, Naheed/0000-0002-6016-5603; Ginawi, Ibrahim Abdelmageed Mohamed/0000-0001-8628-1840; Radfar, Amir/0000-0001-6177-3048; Schaub, Michael P./0000-0002-8375-4005; Brenner, Hermann/0000-0002-6129-1572; A, Naheed/0000-0002-6016-5603; Rezai, Mohammad Sadegh/0000-0003-4585-9954; Dhimal, Meghnath/0000-0001-7176-7821; Santos, Itamar/0000-0003-3212-8466; Safiri, Saeid/0000-0001-7986-9072; Herteliu, Claudiu/0000-0001-8860-9547; Amare, Dr Azmeraw/0000-0002-7940-0335; azzopardi, peter/0000-0002-9280-6997; Machado, Isis/0000-0002-4678-2074; Khan, Md Nuruzzaman/0000-0002-4550-4363; Kim, Young-Eun/0000-0003-0694-6844; bosetti, cristina/0000-0003-2090-4608; Kahsay, Amaha/0000-0002-6242-8040; Mirrakhimov, Erkin/0000-0003-2982-6108; Kengne, Andre Pascal/0000-0002-5183-131X; Jakovljevic, Mihajlo/0000-0002-9160-6846; Finger, Jonas David/0000-0003-3697-6649; Soriano, Joan B/0000-0001-9740-2994; Owolabi, Mayowa/0000-0003-1146-3070; Magdy Abd El Razek, Hassan/0000-0002-8857-0408; Ebrahimi, Hedyeh/0000-0003-3647-7356; Shibuya, Kenji/0000-0003-2528-7530; Soofi, Moslem/0000-0003-4922-8412; Ukwaja, Kingsley N./0000-0002-1974-8735; Bhutta, Zulfiqar/0000-0003-0637-599X; Rafiei, AliReza/0000-0002-1766-6605; Faramarzi, Mahbobeh/0000-0002-3568-7039; Sheikh, Aziz/0000-0001-7022-3056; afshari, mahdi/0000-0002-3159-8741; Sanchez-Nino, Maria Dolores/0000-0001-7110-6409; Agarwal, Gina/0000-0002-5691-4675; moosazadeh, mahmood/0000-0002-5452-514X; Olagunju, Tinuke/0000-0003-4019-8755; , bennsartorius/0000-0001-6761-2325; Carreras, Giulia/0000-0002-1427-637X; Belachew, Abate/0000-0003-2583-9913; Abay, Solomon Mequanente/0000-0002-7844-3771; Tran, Khanh Bao/0000-0002-8730-3340; Neupane, Sudan Prasad/0000-0002-7389-4178; Lozano, Rafael/0000-0002-7356-8823; Morawska, Lidia/0000-0002-0594-9683; Barrero, Lope/0000-0003-1503-0264; BOGDAN-VASILE, ILEANU/0000-0002-9229-3431; Feigin, Valery L./0000-0002-6372-1740; Kasaeian, Amir/0000-0003-2018-9368; Kimokoti, Ruth/0000-0002-4980-3256; Temsah, Mohamad-Hani/0000-0002-4389-9322; Bijani, Ali/0000-0003-2233-8726; Li, Yichong/0000-0003-3842-475X; Castaneda-Orjuela, Carlos/0000-0002-8735-6223; Meretoja, Tuomo/0000-0002-2691-0710; Saddik, Basema/0000-0002-4682-5927; Davletov, Kairat/0000-0001-8534-1899; das Neves, Jose/0000-0002-2317-2759; Larson, Heidi J./0000-0002-8477-7583; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Griswold, Max/0000-0002-6387-128X; Kadel, Rajendra/0000-0002-2547-6342; Schutte, Aletta/0000-0001-9217-4937; Filip, Irina/0000-0002-2466-2346; Santomauro, Damian/0000-0002-6630-5435; Salomon, Joshua/0000-0003-3929-5515; Lunevicius, Raimundas/0000-0003-3295-0142; Usman, Muhammad/0000-0001-9747-8892; Moazen, Babak/0000-0002-2552-0438; Sarvi, Shahabeddin/0000-0002-3412-1033; Dargan, Paul/0000-0002-3433-9622; Leinsalu, Mall/0000-0003-4453-4760; Sitas, Freddy/0000-0001-9679-1481; Rajsic, Sasa/0000-0001-6193-3662; Chung, Sheng-Chia/0000-0001-6025-9207; Bhaumik, Soumyadeep/0000-0001-9579-4453; Rai, Rajesh Kumar/0000-0002-5249-9937; /0000-0001-5266-0201; McGrath, John/0000-0002-4792-6068; Rezaeian, Shahab/0000-0002-5094-5315; Moradi, Ghobad/0000-0003-2612-6528; Silva, Joao Pedro/0000-0002-5656-0897; Thomas, Nihal/0000-0002-4614-9519; Rahimi-Movaghar, Afarin/0000-0002-5761-1668; Lorkowski, Stefan/0000-0002-9649-840X; Mukhopadhyay, Satinath/0000-0001-8033-5748; Prabhakaran, Dorairaj/0000-0002-3172-834X; RENZAHO, ANDRE/0000-0002-6844-0833; Jackson, Maria/0000-0002-7031-7244; Sepanlou, Sadaf/0000-0002-3669-5129; Gebremedhin Tekle, Merhawi/0000-0003-4770-6361; Hendrie, Delia/0000-0001-5022-5281; Moreno Velasquez, Ilais/0000-0001-6058-8983; Lang, Justin/0000-0002-1768-319X; Ciobanu, Liliana/0000-0002-4768-5452; Al-Raddadi, Rajaa/0000-0002-8921-9628; Plana-Ripoll, Oleguer/0000-0002-6470-7465; Ortiz, Justin/0000-0002-3138-5965; shishani, kawkab/0000-0002-7792-6456; Tabb Dina, Karen/0000-0002-4722-9502; Anber, Nahla/0000-0001-5684-9298; Musa, Kamarul Imran/0000-0002-3708-0628; Claro, Rafael/0000-0001-9690-575X; Carvalho Malta, Deborah/0000-0002-8214-5734; Ullah, Irfan/0000-0001-6992-6723; Oren, Eyal/0000-0001-7817-3516; Zimsen, Stephanie Robin Marie/0000-0001-7660-4642; Moradinazar, Mahdi/0000-0001-7033-6755; Kassa, Getachew Mullu/0000-0002-8095-7376; Knudsen, Ann Kristin/0000-0002-1218-798X; Borges, Guilherme/0000-0002-3269-0507; Khafaie, Morteza Abdullatif/0000-0002-1651-3017; Awasthi, Ashish/0000-0002-9308-9782; Franklin, Richard/0000-0003-1864-4552; Saylan, Mete/0000-0002-8917-1775; Miller, Ted/0000-0002-0958-2639; Pourshams, Akram/0000-0002-7950-3983; Farioli, Andrea/0000-0003-2001-2140; siabani, soraya/0000-0003-2856-0205; Lobato Cordero, Andrea/0000-0003-0376-2687; Heibati, Behzad/0000-0002-1640-8428; Samy, Abdallah/0000-0003-3978-1134; Oommen, Anu Mary/0000-0003-2932-7827; Yotebieng, Marcel/0000-0003-2110-2631; Yimer, Ebrahim M./0000-0003-3140-4967; Shiue, Ivy/0000-0003-1788-3009; Guo, Yuming/0000-0002-1766-6592; Catala-Lopez, Ferran/0000-0002-3833-9312; Marczak, Laurie/0000-0001-5979-4261; Satpathy, Maheswar/0000-0003-3521-4781; Sabde, Yogesh/0000-0003-1787-2553; Kucuk Bicer, Burcu/0000-0002-5615-264X; Topouzis, Fotis/0000-0002-8966-537X; Lallukka, Tea/0000-0003-3841-3129; Heredia-Pi, Ileana Beatriz/0000-0002-9998-9239; Homaie Rad, Enayatollah/0000-0002-9064-0380; Olusanya, Bolajoko/0000-0002-3826-0583; De Neve, Jan-Walter/0000-0003-0090-8249; Hosseini, Masomeh/0000-0002-6329-948X; S A, Rizwan/0000-0002-3140-2614; Rahimi-Movaghar, Vafa/0000-0001-7347-8767; Carmelo Adsuar, Jose/0000-0001-7203-3168; Sarmiento Suarez, Rodrigo/0000-0002-7301-277X; Patten, Scott/0000-0001-9871-4041; Overland, Simon/0000-0001-6967-9355; Katikireddi, Srinivasa/0000-0001-6593-9092; Fekadu, Wubalem/0000-0001-7418-4955; Birlik, Sait Mentes/0000-0002-9889-8837; Yisma, Engida/0000-0002-7289-9946; Uthman, Olalekan/0000-0002-8567-3081; Farvid, Maryam/0000-0003-1783-4186; Demoz, Gebre Teklemariam/0000-0002-2534-821X; Alam, Khurshid/0000-0002-7402-7519; Postma, Maarten/0000-0002-6306-3653; Chaturvedi, Pankaj/0000-0002-3520-1342; Husseini, Abdullatif/0000-0001-8767-5956; Mirica, Andreea/0000-0002-3794-1387; Mehrotra, Ravi/0000-0001-9453-1408; Shen, Jiabin/0000-0001-6625-5215; Ye, Pengpeng/0000-0002-2924-1436; GEBRE, ABADI KAHSU/0000-0002-1975-0085; Phillips, Michael/0000-0002-0252-9085; Sunguya, Bruno/0000-0003-3625-0725; Miazgowski, Tomasz/0000-0002-4819-9376; Kumar, Manasi/0000-0002-9773-8014; Farzadfar, Farshad/0000-0001-8288-4046; Hostiuc, Sorin/0000-0003-4130-9402; Kemp, Grant/0000-0002-8614-0498; Yaseri, Mehdi/0000-0002-4066-873X; Kadel, Rajendra/0000-0002-5250-6850; Dandona, Rakhi/0000-0003-0926-788X; Fernandes, Eduarda/0000-0001-6424-0976; Boufous, Soufiane/0000-0002-5686-1729; Dubljanin, Eleonora/0000-0002-6484-3192; Haj-Mirzaian, Arvin/0000-0001-8977-6865; Bjorge, Tone/0000-0002-9096-5257; Tabuchi, Takahiro/0000-0002-1050-3125; Greaves, Felix/0000-0001-9393-3122; Kim, Daniel/0000-0001-8907-6420; Hassen, Hamid/0000-0001-6485-4193; Charlson, Fiona/0000-0003-2876-5040; Vladimirov, Sergey/0000-0003-3341-3533; Bililign, Nigus/0000-0001-5610-8369; Cahuana-Hurtado, Lucero/0000-0002-9438-1443; Kieling, Christian/0000-0001-7691-4149; Kuate Defo, Barthelemy/0000-0002-6589-0564; Lalloo, Ratilal/0000-0001-5822-1269; ZAIDI, ZOUBIDA/0000-0003-3378-4799; Maulik, Pallab Kumar/0000-0001-6835-6175; Bejot, Yannick/0000-0001-7848-7072; Noubiap, Jean Jacques/0000-0002-7722-9757; , Tariq/0000-0002-9672-6628; Sachdev, Perminder/0000-0002-9595-3220; Hamidi, Samer/0000-0002-6766-3728; Kiadaliri, Ali/0000-0002-4254-9099; Hernandez-Llanes, Norberto Francisco/0000-0001-5918-3137; Borschmann, Rohan/0000-0002-0365-7775; El-Khatib, Ziad/0000-0003-0756-7280; Esteghamati, Alireza/0000-0001-5114-3982; Olusanya, Jacob/0000-0002-1566-9554; Tabares-Seisdedos, Rafael/0000-0002-1089-2204; Kisa, Adnan/0000-0001-7825-3436; CHANG, JUNG-CHEN/0000-0001-8651-2602; S, Harikrishnan/0000-0002-7509-0712; Tolera, Moti/0000-0002-4739-1390; Jayatilleke, Achala Upendra/0000-0002-0855-7925; Yoon, Seok-Jun/0000-0003-3297-0071; Safari, Hosein/0000-0003-3477-6344; Kabir, Zubair/0000-0003-1529-004X; Baye, Estifanos/0000-0002-2937-356X; Rawaf, Salman/0000-0001-7191-2355	Bill & Melinda Gates Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG047845] Funding Source: NIH RePORTER; MRC [MR/K010174/1] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Bill & Melinda Gates Foundation.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Al-Kubaisy W, 2012, PROCD SOC BEHV, V38, P59, DOI 10.1016/j.sbspro.2012.03.324; Britton A, 2017, ADDICTION, V112, P218, DOI 10.1111/add.13585; Chikritzhs T, 2015, ADDICTION, V110, P726, DOI 10.1111/add.12828; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; Fekjaer HO, 2013, ADDICTION, V108, P2051, DOI 10.1111/add.12104; Fillmore KM, 2006, ADDICT RES THEORY, V14, P101, DOI 10.1080/16066350500497983; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Gmel G, 2003, EUR J EPIDEMIOL, V18, P631, DOI 10.1023/A:1024805021504; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Holman CDJ, 1996, MED J AUSTRALIA, V164, P141, DOI 10.5694/j.1326-5377.1996.tb122011.x; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Holst C, 2017, ADDICTION, V112, P1358, DOI 10.1111/add.13799; Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011; Institute for Health Metrics and Evaluation, GLOB BURD DIS STUD 2; Karriker-Jaffe KJ, 2018, J STUD ALCOHOL DRUGS, V79, P239, DOI 10.15288/jsad.2018.79.239; Knott CS, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h384, 10.1136/BMJ.h384]; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Naimi TS, 2017, ADDICTION, V112, P207, DOI 10.1111/add.13451; Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011; Nelson DE, 2010, ADDICTION, V105, P1589, DOI 10.1111/j.1360-0443.2010.03007.x; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222; Rehm J, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-3; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Schwarzinger M, 2018, LANCET PUBLIC HEALTH, V3, pE124, DOI 10.1016/S2468-2667(18)30022-7; Stevens GA, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002056, 10.1371/journal.pmed.1002116]; Stockwell T, 2016, J STUD ALCOHOL DRUGS, V77, P185, DOI 10.15288/jsad.2016.77.185; Topiwala A, 2018, EVID-BASED MENT HEAL, V21, P12, DOI 10.1136/eb-2017-102820; WHO, 2017, BEST BUYS OTH REC IN	33	1292	1338	58	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2018	392	10152					1015	1035		10.1016/S0140-6736(18)31310-2	http://dx.doi.org/10.1016/S0140-6736(18)31310-2			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU2KP	31339847	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000445098800025
